PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Giguere, PM; Gall, BJ; Ezekwe, EAD; Laroche, G; Buckley, BK; Kebaier, C; Wilson, JE; Ting, JP; Siderovski, DP; Duncan, JA				Giguere, Patrick M.; Gall, Bryan J.; Ezekwe, Ejiofor A. D., Jr.; Laroche, Genevieve; Buckley, Brian K.; Kebaier, Chahnaz; Wilson, Justin E.; Ting, Jenny P.; Siderovski, David P.; Duncan, Joseph A.			G Protein Signaling Modulator-3 Inhibits the Inflammasome Activity of NLRP3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSES; NALP3 INFLAMMASOME; ACTIVATES CASPASE-1; DISEASE RESISTANCE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MONOCYTIC CELLS; SGT1; INTERLEUKIN-1-BETA; SECRETION	Inflammasomes are multi-protein complexes that regulate maturation of the interleukin 1 beta-related cytokines IL-1 beta and IL-18 through activation of the cysteine proteinase caspase-1. NOD-like receptor family, pyrin domain containing 3 (NLRP3) protein is a key component of inflammasomes that assemble in response to a wide variety of endogenous and pathogen-derived danger signals. Activation of the NLRP3-inflammasome and subsequent secretion of IL-1 beta is highly regulated by at least three processes: transcriptional activation of both NLRP3 and pro-IL-1 beta genes, non-transcriptional priming of NLRP3, and final activation of NLRP3. NLRP3 is predominantly expressed in cells of the hematopoietic lineage. Using a yeast two-hybrid screen, we identified the hematopoietic-restricted protein, G protein signaling modulator-3 (GPSM3), as a NLRP3-interacting protein and a negative regulator of IL-1 beta production triggered by NLRP3-dependent inflammasome activators. In monocytes, GPSM3 associates with the C-terminal leucine-rich repeat domain of NLRP3. Bone marrow-derived macrophages lacking GPSM3 expression exhibit an increase in NLRP3-dependent IL-1 beta, but not TNF-alpha, secretion. Furthermore, GPSM3-null mice have enhanced serum and peritoneal IL-1 beta production following Alum-induced peritonitis. Our findings suggest that GPSM3 acts as a direct negative regulator of NLRP3 function.	[Giguere, Patrick M.; Ezekwe, Ejiofor A. D., Jr.; Laroche, Genevieve; Buckley, Brian K.; Duncan, Joseph A.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Wilson, Justin E.; Ting, Jenny P.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Ting, Jenny P.; Duncan, Joseph A.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Kebaier, Chahnaz] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC 27599 USA; [Gall, Bryan J.; Siderovski, David P.] W Virginia Univ, Sch Med, Dept Physiol & Pharmacol, Morgantown, WV 26506 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; West Virginia University	Siderovski, DP (corresponding author), W Virginia Univ, Sch Med, Dept Physiol & Pharmacol, 3051A Hlth Sci North,POB 9229, Morgantown, WV 26506 USA.	dpsiderovski@hsc.wvu.edu; jaduncan@med.unc.edu	Siderovski, David Peter/AAA-9603-2019; , PEP-MX Core/AGV-4051-2022	Siderovski, David Peter/0000-0002-0688-8210; Gall, Bryan/0000-0002-2284-8892	National Institutes of Health via WVCTSI Pilot Grants Program [R01 AI088255, U19 AI109965, U54 GM104942]; Burroughs Wellcome Fund Career Award for Medical Scientists; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109965, R01AI088255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	National Institutes of Health via WVCTSI Pilot Grants Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 AI088255 (to J. A. D.), U19 AI109965 (to J. A. D. and J. P. T.), and U54 GM104942 (to D. P. S.) via the WVCTSI Pilot Grants Program and by a Burroughs Wellcome Fund Career Award for Medical Scientists (to J. A. D.).	Allam R, 2011, J IMMUNOL, V186, P2714, DOI 10.4049/jimmunol.1002657; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; AYALA JM, 1994, J IMMUNOL, V153, P2592; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Cao XQ, 2004, J BIOL CHEM, V279, P27567, DOI 10.1074/jbc.M312786200; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dostert C, 2008, M S-MED SCI, V24, P916, DOI 10.1051/medsci/20082411916; Dowds TA, 2003, BIOCHEM BIOPH RES CO, V302, P575, DOI 10.1016/S0006-291X(03)00221-3; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Ge F, 2010, J PROTEOME RES, V9, P5848, DOI 10.1021/pr100616g; Giguere PM, 2013, MOL IMMUNOL, V54, P193, DOI 10.1016/j.molimm.2012.12.001; Giguere PM, 2012, J BIOL CHEM, V287, P31270, DOI 10.1074/jbc.M112.394379; Giguere PM, 2012, J BIOL CHEM, V287, P4863, DOI 10.1074/jbc.M111.311712; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hong M, 2012, IMMUNITY, V36, P337, DOI 10.1016/j.immuni.2011.12.018; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hoser R, 2013, NEW PHYTOL, V200, P158, DOI 10.1111/nph.12347; Hu Y, 2008, J IMMUNOL, V180, P8057, DOI 10.4049/jimmunol.180.12.8057; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Ippagunta SK, 2010, J BIOL CHEM, V285, P12454, DOI 10.1074/jbc.M109.093252; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kadota Y, 2010, TRENDS BIOCHEM SCI, V35, P199, DOI 10.1016/j.tibs.2009.12.005; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Levin TC, 2008, CELL MICROBIOL, V10, P2434, DOI 10.1111/j.1462-5822.2008.01220.x; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Castejon G, 2013, J BIOL CHEM, V288, P2721, DOI 10.1074/jbc.M112.422238; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Nakashima A, 2008, PLANT CELL, V20, P2265, DOI 10.1105/tpc.107.054395; Noel LD, 2007, PLANT CELL, V19, P4061, DOI 10.1105/tpc.107.051896; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Splechowicz M, 2007, BIOCHEM BIOPH RES CO, V357, P1148, DOI 10.1016/j.bbrc.2007.04.073; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Yamazaki H, 2012, RHEUMATOL INT, V32, P1625, DOI 10.1007/s00296-011-1825-y	53	22	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33245	33257		10.1074/jbc.M114.578393	http://dx.doi.org/10.1074/jbc.M114.578393			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25271165	Green Published, hybrid			2022-12-28	WOS:000345636600017
J	Berggren, G; Duraffourg, N; Sahlin, M; Sjoberg, BM				Berggren, Gustav; Duraffourg, Nicolas; Sahlin, Margareta; Sjoberg, Britt-Marie			Semiquinone-induced Maturation of Bacillus anthracis Ribonucleotide Reductase by a Superoxide Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; Free Radicals; Manganese; Ribonucleotide Reductase; Superoxide Ion; NrdF; NrdI; Cyclic Voltammetry; Maturase; Semiquinone	TYROSYL RADICAL COFACTOR; SQUARE-WAVE VOLTAMMETRY; ESCHERICHIA-COLI; CORYNEBACTERIUM-AMMONIAGENES; ELECTRON-TRANSFER; IRON CENTER; FLAVODOXIN; PROTEIN; NRDI; ELECTROCHEMISTRY	Background: Activation of ribonucleotide reductase Ib depends on the flavodoxin-like maturase NrdI. Results: The redox properties of Bacillus anthracis NrdI allow isolation of the semiquinone state, NrdI(sq), which can catalyze formation of the manganese-tyrosyl radical cofactor. Conclusion: The maturation capacity of NrdI(sq) provides evidence that Mn-NrdF is activated via a superoxide radical. Significance: Novel antibiotics may be designed to selectively target the maturation mechanism. Ribonucleotide reductases (RNRs) catalyze the conversion of ribonucleotides to deoxyribonucleotides, and represent the only de novo pathway to provide DNA building blocks. Three different classes of RNR are known, denoted I-III. Class I RNRs are heteromeric proteins built up by and subunits and are further divided into different subclasses, partly based on the metal content of the -subunit. In subclass Ib RNR the -subunit is denoted NrdF, and harbors a manganese-tyrosyl radical cofactor. The generation of this cofactor is dependent on a flavodoxin-like maturase denoted NrdI, responsible for the formation of an active oxygen species suggested to be either a superoxide or a hydroperoxide. Herein we report on the magnetic properties of the manganese-tyrosyl radical cofactor of Bacillus anthracis NrdF and the redox properties of B. anthracis NrdI. The tyrosyl radical in NrdF is stabilized through its interaction with a ferromagnetically coupled manganese dimer. Moreover, we show through a combination of redox titration and protein electrochemistry that in contrast to hitherto characterized NrdIs, the B. anthracis NrdI is stable in its semiquinone form (NrdI(sq)) with a difference in electrochemical potential of approximate to 110 mV between the hydroquinone and semiquinone state. The under anaerobic conditions stable NrdI(sq) is fully capable of generating the oxidized, tyrosyl radical-containing form of Mn-NrdF when exposed to oxygen. This latter observation strongly supports that a superoxide radical is involved in the maturation mechanism, and contradicts the participation of a peroxide species. Additionally, EPR spectra on whole cells revealed that a significant fraction of NrdI resides in its semiquinone form in vivo, underscoring that NrdI(sq) is catalytically relevant.	[Berggren, Gustav; Sahlin, Margareta; Sjoberg, Britt-Marie] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Duraffourg, Nicolas] CEA Grenoble, Lab Chim & Biol Met, UMR 5249, F-38057 Grenoble, France	Stockholm University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Sjoberg, BM (corresponding author), Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	britt-marie.sjoberg@dbb.su.se	Berggren, Gustav/H-8659-2013	Berggren, Gustav/0000-0002-6717-6612; Sjoberg, Britt-Marie/0000-0001-5953-3360	Swedish Research Council; Swedish Cancer Foundation; Carl Trygger Foundation; Magn. Bergvall Foundation; Wenner-Gren Foundations	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Carl Trygger Foundation; Magn. Bergvall Foundation; Wenner-Gren Foundations	This study was supported by grants from the Swedish Research Council, the Swedish Cancer Foundation, Carl Trygger Foundation, Magn. Bergvall Foundation, and the Wenner-Gren Foundations.	ARMSTRONG FA, 1984, J AM CHEM SOC, V106, P921, DOI 10.1021/ja00316a015; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Cotruvo JA, 2008, P NATL ACAD SCI USA, V105, P14383, DOI 10.1073/pnas.0807348105; Cotruvo JA, 2013, J AM CHEM SOC, V135, P4027, DOI 10.1021/ja312457t; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Cotruvo JA, 2011, BIOCHEMISTRY-US, V50, P1672, DOI 10.1021/bi101881d; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; Crona M, 2011, J BIOL CHEM, V286, P33053, DOI 10.1074/jbc.M111.278119; Gustafsson TN, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.413427; Heering HA, 1996, J ELECTROANAL CHEM, V404, P249, DOI 10.1016/0022-0728(95)04248-2; Helfrick JC, 2009, ANAL CHEM, V81, P9041, DOI 10.1021/ac9016874; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hoover DM, 1999, J MOL BIOL, V294, P725, DOI 10.1006/jmbi.1999.3152; Huque Y, 2000, J BIOL CHEM, V275, P25365, DOI 10.1074/jbc.M002751200; Jeuken LJC, 2002, J PHYS CHEM B, V106, P2304, DOI 10.1021/jp0134291; Johansson R, 2010, FEBS J, V277, P4265, DOI 10.1111/j.1742-4658.2010.07815.x; Komorsky-Lovric S, 2014, INT J ELECTROCHEM SC, V9, P435; Makhlynets O, 2014, J BIOL CHEM, V289, P6259, DOI 10.1074/jbc.M113.533554; MAYHEW SG, 1969, J BIOL CHEM, V244, P794; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Palmer G., 1971, FLAVINS FLAVOPROTEIN, P123; PETERSSON L, 1980, J BIOL CHEM, V255, P6706; Roca I, 2008, J BACTERIOL, V190, P4849, DOI 10.1128/JB.00185-08; Rohr AK, 2010, ANGEW CHEM INT EDIT, V49, P2324, DOI 10.1002/anie.200907143; SAHLIN M, 1987, BIOCHEMISTRY-US, V26, P5541, DOI 10.1021/bi00391a049; SAHLIN M, 1986, J MAGN RESON, V67, P135, DOI 10.1016/0022-2364(86)90417-8; SCHIMPFFWEILAND G, 1981, BIOCHEM BIOPH RES CO, V102, P1276, DOI 10.1016/S0006-291X(81)80149-0; Tomter AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033436; Torrents E, 2005, P NATL ACAD SCI USA, V102, P17946, DOI 10.1073/pnas.0506410102; WILLING A, 1988, EUR J BIOCHEM, V175, P167, DOI 10.1111/j.1432-1033.1988.tb14179.x; Zhang Y, 2011, BIOCHEMISTRY-US, V50, P5615, DOI 10.1021/bi200348q	32	10	10	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31940	31949		10.1074/jbc.M114.592535	http://dx.doi.org/10.1074/jbc.M114.592535			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25262022	Green Published, hybrid			2022-12-28	WOS:000345314700024
J	Hatami, A; Albay, R; Monjazeb, S; Milton, S; Glabe, C				Hatami, Asa; Albay, Ricardo, III; Monjazeb, Sanaz; Milton, Saskia; Glabe, Charles			Monoclonal Antibodies against A beta 42 Fibrils Distinguish Multiple Aggregation State Polymorphisms in Vitro and in Alzheimer Disease Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid; Monoclonal Antibody; Peptide Conformation; Protein Aggregation; A	BETA-AMYLOID FIBRILS; A-BETA; COGNITIVE FUNCTION; PROTEIN OLIGOMERS; MICE; VACCINATION; PEPTIDE; IMMUNOTHERAPY; IMMUNIZATION; MODEL	Amyloidogenic proteins generally form intermolecularly hydrogen-bonded -sheet aggregates, including parallel, in-register -sheets (recognized by antiserum OC) or antiparallel -sheets, -solenoids, -barrels, and -cylindrins (recognized by antiserum A11). Although these groups share many common properties, some amyloid sequences have been reported to form polymorphic structural variants or strains. We investigated the humoral immune response to A42 fibrils and produced 23 OC-type monoclonal antibodies recognizing distinct epitopes differentially associated with polymorphic structural variants. These mOC antibodies define at least 18 different immunological profiles represented in aggregates of amyloid- (A). All of the antibodies strongly prefer amyloid aggregates over monomer, indicating that they recognize conformational epitopes. Most of the antibodies react with N-terminal linear segments of A, although many recognize a discontinuous epitope consisting of an N-terminal domain and a central domain. Several of the antibodies that recognize linear A segments also react with fibrils formed from unrelated amyloid sequences, indicating that reactivity with linear segments of A does not mean the antibody is sequence-specific. The antibodies display strikingly different patterns of immunoreactivity in Alzheimer disease and transgenic mouse brain and identify spatially and temporally unique amyloid deposits. Our results indicate that the immune response to A42 fibrils is diverse and reflects the structural polymorphisms in fibrillar amyloid structures. These polymorphisms may contribute to differences in toxicity and consequent effects on pathological processes. Thus, a single therapeutic monoclonal antibody may not be able to target all of the pathological aggregates necessary to make an impact on the overall disease process.	[Hatami, Asa; Albay, Ricardo, III; Monjazeb, Sanaz; Milton, Saskia; Glabe, Charles] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Glabe, Charles] King Abdulaziz Univ, Dept Biochem, Fac Sci, Jeddah 21589, Saudi Arabia; [Glabe, Charles] King Abdulaziz Univ, Expt Biochem Unit, King Fahd Med Res Ctr, Jeddah 21589, Saudi Arabia	University of California System; University of California Irvine; King Abdulaziz University; King Abdulaziz University	Glabe, C (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	cglabe@uci.edu			National Institutes of Health [AG 033069, AG00538]; Cure Alzheimer's fund; NATIONAL INSTITUTE ON AGING [P01AG000538, R01AG033069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG 033069 and AG00538. This work was also supported by a grant from the Cure Alzheimer's fund.	Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Fanning LJ, 1996, CLIN IMMUNOL IMMUNOP, V79, P1, DOI 10.1006/clin.1996.0044; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; Goni F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013391; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Head E, 2008, J NEUROSCI, V28, P3555, DOI 10.1523/JNEUROSCI.0208-08.2008; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hock C, 2002, NAT MED, V8, P1270, DOI 10.1038/nm783; KATZMAN R, 1991, FASEB J, V5, P278, DOI 10.1096/fasebj.5.3.2001787; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-57; Kheterpal I, 2006, J MOL BIOL, V361, P785, DOI 10.1016/j.jmb.2006.06.066; Khoury MK, 2010, ANAL BIOCHEM, V397, P129, DOI 10.1016/j.ab.2009.09.041; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lee M, 2005, ANN NEUROL, V58, P430, DOI 10.1002/ana.20592; Mattson MP, 2003, SCIENCE, V301, P1847, DOI 10.1126/science.301.5641.1847; McLean D, 2013, ACS CHEM NEUROSCI, V4, P613, DOI 10.1021/cn300226q; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Murphy KM, 2010, JANEWAYS IMMUNOBIOLO; Neff F, 2008, AUTOIMMUN REV, V7, P501, DOI 10.1016/j.autrev.2008.04.010; Nussbaum JM, 2013, PRION, V7, P14, DOI 10.4161/pri.22118; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rasool S, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-37; Reineke U, 2009, METHODS MOL BIOL, V524, P145, DOI 10.1007/978-1-59745-450-6_11; Schroeter S, 2008, J NEUROSCI, V28, P6787, DOI 10.1523/JNEUROSCI.2377-07.2008; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Spooner ET, 2002, VACCINE, V21, P290, DOI 10.1016/S0264-410X(02)00464-4; Stroud JC, 2012, P NATL ACAD SCI USA, V109, P7717, DOI 10.1073/pnas.1203193109; Whittemore NA, 2005, BIOCHEMISTRY-US, V44, P4434, DOI 10.1021/bi048292u; Wilcock DM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-24; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Winton MJ, 2011, J NEUROSCI, V31, P7691, DOI 10.1523/JNEUROSCI.6637-10.2011; YANG AJ, 1995, J BIOL CHEM, V270, P14786, DOI 10.1074/jbc.270.24.14786; Yoshiike Y, 2007, NEUROMOL MED, V9, P270, DOI 10.1007/s12017-007-0003-6	46	78	80	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32131	32143		10.1074/jbc.M114.594846	http://dx.doi.org/10.1074/jbc.M114.594846			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25281743	Green Published, hybrid			2022-12-28	WOS:000345314700041
J	Murchland, I; Ahlgren-Berg, A; Priest, DG; Dodd, IB; Shearwin, KE				Murchland, Iain; Ahlgren-Berg, Alexandra; Priest, David G.; Dodd, Ian B.; Shearwin, Keith E.			Promoter Activation by CII, a Potent Transcriptional Activator from Bacteriophage 186	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Transcription; Bacteriophage; Gene Transcription; Promoter; Proteolysis; RNA Polymerase; Mutational Screen; Protein Structure-Function	AMP RECEPTOR PROTEIN; ESCHERICHIA-COLI; RNA-POLYMERASE; LAMBDA-CII; SCANNING MUTAGENESIS; STRUCTURAL BASIS; SIGMA-SUBUNIT; TARGET SITE; DNA COMPLEX; FTSH HFLB	Background: CII strongly activates transcription, binding an unusual spacing of recognition sites. Results: Genetic screens reveal insights into the CII domain structure, activation mechanism, and proteolytic degradation. Conclusion: CII contains two independent activation epitopes, contacting the sigma(70) and -subunits of RNA polymerase. CII degradation compromises self-association. Significance: A novel arrangement of factors at the promoter is proposed, which is highly sensitive to altered CII levels. The lysogeny promoting protein CII from bacteriophage 186 is a potent transcriptional activator, capable of mediating at least a 400-fold increase in transcription over basal activity. Despite being functionally similar to its counterpart in phage , it shows no homology at the level of protein sequence and does not belong to any known family of transcriptional activators. It also has the unusual property of binding DNA half-sites that are separated by 20 base pairs, center to center. Here we investigate the structural and functional properties of CII using a combination of genetics, in vitro assays, and mutational analysis. We find that 186 CII possesses two functional domains, with an independent activation epitope in each. 186 CII owes its potent activity to activation mechanisms that are dependent on both the sigma(70) and C-terminal domain (CTD) components of RNA polymerase, contacting different functional domains. We also present evidence that like CII, 186 CII is proteolytically degraded in vivo, but unlike CII, 186 CII proteolysis results in a specific, transcriptionally inactive, degradation product with altered self-association properties.	[Murchland, Iain; Ahlgren-Berg, Alexandra; Priest, David G.; Dodd, Ian B.; Shearwin, Keith E.] Univ Adelaide, Sch Mol & Biomed Sci, Dept Biochem, Adelaide, SA 5005, Australia	University of Adelaide	Shearwin, KE (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Dept Biochem, Adelaide, SA 5005, Australia.	keith.shearwin@adelaide.edu.au	Shearwin, Keith/AAS-1247-2021	Shearwin, Keith/0000-0002-7736-2742; Priest, David/0000-0003-0095-6718; Dodd, Ian/0000-0003-2969-6841	Australian Research Council [DP0665185, DP110100824]	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council Grants DP0665185 and DP110100824.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ANDERSON JE, 1987, NATURE, V326, P846, DOI 10.1038/326846a0; Anton BP, 2004, J BACTERIOL, V186, P5699, DOI 10.1128/JB.186.17.5699-5707.2004; Benoff B, 2002, SCIENCE, V297, P1562, DOI 10.1126/science.1076376; Bhende PM, 2000, J BACTERIOL, V182, P4959, DOI 10.1128/JB.182.17.4959-4969.2000; Biery MC, 2000, NUCLEIC ACIDS RES, V28, P1067, DOI 10.1093/nar/28.5.1067; Callen BP, 2004, MOL CELL, V14, P647, DOI 10.1016/j.molcel.2004.05.010; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; CAMPBELL JL, 1978, P NATL ACAD SCI USA, V75, P2276, DOI 10.1073/pnas.75.5.2276; Cao YH, 1997, J MOL BIOL, V274, P39, DOI 10.1006/jmbi.1997.1380; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Cui L, 2013, P NATL ACAD SCI USA, V110, P2922, DOI 10.1073/pnas.1221322110; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DODD IB, 1990, NUCLEIC ACIDS RES, V18, P5019, DOI 10.1093/nar/18.17.5019; Dodd IB, 2001, GENE DEV, V15, P3013, DOI 10.1101/gad.937301; GENT ME, 1987, BIOCHEM J, V242, P645, DOI 10.1042/bj2420645; Grainger DC, 2004, MOL MICROBIOL, V51, P1297, DOI 10.1111/j.1365-2958.2003.03929.x; Guota R S, 1975, Antimicrob Agents Chemother, V7, P748; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hao N, 2011, NUCLEIC ACIDS RES, V39, P3695, DOI 10.1093/nar/gkq1336; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; HERMAN C, 1993, P NATL ACAD SCI USA, V90, P10861, DOI 10.1073/pnas.90.22.10861; HO YS, 1983, NATURE, V304, P703, DOI 10.1038/304703a0; HOYT MA, 1982, CELL, V31, P565, DOI 10.1016/0092-8674(82)90312-9; INGROSSO D, 1989, BIOCHEM BIOPH RES CO, V162, P1528, DOI 10.1016/0006-291X(89)90848-6; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Jain D, 2005, MOL CELL, V19, P259, DOI 10.1016/j.molcel.2005.06.006; Jain D, 2004, MOL CELL, V13, P45, DOI 10.1016/S1097-2765(03)00483-0; Kedzierska B, 2004, NUCLEIC ACIDS RES, V32, P834, DOI 10.1093/nar/gkh230; Kobiler O, 2002, P NATL ACAD SCI USA, V99, P14964, DOI 10.1073/pnas.222172499; LAMONT I, 1993, J BACTERIOL, V175, P5286, DOI 10.1128/JB.175.16.5286-5288.1993; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; LINN T, 1990, J BACTERIOL, V172, P1077, DOI 10.1128/jb.172.2.1077-1084.1990; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Meng WM, 2001, NUCLEIC ACIDS RES, V29, P4166, DOI 10.1093/nar/29.20.4166; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; Neufing PJ, 1996, MOL MICROBIOL, V21, P751, DOI 10.1046/j.1365-2958.1996.351394.x; Neufing PJ, 2001, J BACTERIOL, V183, P2376, DOI 10.1128/JB.183.7.2376-2379.2001; PABO CO, 1982, NATURE, V298, P443, DOI 10.1038/298443a0; Palmer AC, 2009, MOL CELL, V34, P545, DOI 10.1016/j.molcel.2009.04.018; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinkett HW, 2006, MOL CELL, V21, P605, DOI 10.1016/j.molcel.2006.01.019; Ptashne M, 2004, GENETIC SWITCH PHAGE; RATTRAY A, 1984, J BACTERIOL, V159, P238, DOI 10.1128/JB.159.1.238-242.1984; Rhodius VA, 2000, J MOL BIOL, V299, P311, DOI 10.1006/jmbi.2000.3737; Shearwin KE, 2002, J BIOL CHEM, V277, P3186, DOI 10.1074/jbc.M107740200; Shearwin KE, 2000, J BIOL CHEM, V275, P29113, DOI 10.1074/jbc.M004574200; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; TANG H, 1994, GENE DEV, V8, P3058, DOI 10.1101/gad.8.24.3058; TANG H, 1995, P NATL ACAD SCI USA, V92, P4902, DOI 10.1073/pnas.92.11.4902; Trusina A, 2005, PLOS COMPUT BIOL, V1, P599, DOI 10.1371/journal.pcbi.0010074; van Dijk M, 2010, NUCLEIC ACIDS RES, V38, P5634, DOI 10.1093/nar/gkq222	54	4	4	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32094	32108		10.1074/jbc.M114.608026	http://dx.doi.org/10.1074/jbc.M114.608026			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25294872	Green Published, hybrid			2022-12-28	WOS:000345314700038
J	Hanihara-Tatsuzawa, F; Miura, H; Kobayashi, S; Isagawa, T; Okuma, A; Manabe, I; MaruYama, T				Hanihara-Tatsuzawa, Fumito; Miura, Hanae; Kobayashi, Shuhei; Isagawa, Takayuki; Okuma, Atsushi; Manabe, Ichiro; MaruYama, Takashi			Control of Toll-like Receptor-mediated T Cell-independent Type 1 Antibody Responses by the Inducible Nuclear Protein I kappa B-zeta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-SWITCH RECOMBINATION; HUMORAL IMMUNE-RESPONSE; VIVO CD40-GP39 INTERACTIONS; CYTIDINE DEAMINASE AID; STREPTOCOCCUS-PNEUMONIAE; DNA RECOMBINATION; MESSENGER-RNA; GENE-EXPRESSION; ACTIVATION; TRANSCRIPTION	Antibody responses have been classified as being either T cell-dependent or T cell-independent (TI). TI antibody responses are further classified as being either type 1 (TI-1) or type 2 (TI-2), depending on their requirement for B cell-mediated antigen receptor signaling. Although the mechanistic basis of antibody responses has been studied extensively, it remains unclear whether different antibody responses share similarities in their transcriptional regulation. Here, we show that mice deficient in I kappa B-zeta, specifically in their B cells, have impaired TI-1 antibody responses but normal T cell-dependent and TI-2 antibody responses. The absence of I kappa B-zeta in B cells also impaired proliferation triggered by Toll-like receptor (TLR) activation, plasma cell differentiation, and class switch recombination (CSR). Mechanistically, I kappa B-zeta-deficient B cells could not induce TLR-mediated induction of activation-induced cytidine deaminase (AID), a class-switch DNA recombinase. Retroviral transduction of AID in I kappa B-zeta-deficient B cells restored CSR activity. Furthermore, acetylation of histone H3 in the vicinity of the transcription start site of the gene that encodes AID was reduced in I kappa B-zeta-deficient B cells relative to I kappa B-zeta-expressing B cells. These results indicate that I kappa B-zeta regulates TLR-mediated CSR by inducing AID. Moreover, I kappa B-zeta defines differences in the transcriptional regulation of different antibody responses.	[Hanihara-Tatsuzawa, Fumito; Miura, Hanae; Kobayashi, Shuhei; Okuma, Atsushi; MaruYama, Takashi] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Cell Recognit & Response, Sendai, Miyagi 9808578, Japan; [Isagawa, Takayuki] Tokyo Med & Dent Univ, Med Res Inst, Dept Genom Pathol, Tokyo 1138510, Japan; [Manabe, Ichiro] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 38655, Japan; [MaruYama, Takashi] Gifu Univ, Sch Med, Lab Cell Signaling, Gifu 5011194, Japan	Tohoku University; Tokyo Medical & Dental University (TMDU); University of Tokyo; Gifu University	MaruYama, T (corresponding author), Gifu Univ, Sch Med, Lab Cell Signaling, Gifu 5011194, Japan.	ta-maru@umin.ac.jp	Manabe, Ichiro/E-1529-2014; Manabe, Ichiro/AAE-5105-2021; Okuma, Atsushi/V-4675-2019; MaruYama, Takashi/N-5994-2014; Okuma, Atsushi/N-7583-2018	Okuma, Atsushi/0000-0002-9086-1781; MaruYama, Takashi/0000-0003-0820-3219; Okuma, Atsushi/0000-0002-9086-1781	Ministry of Education, Culture, Sports, Science and Technology of Japan [21117004]; Ministry of Education [25118702]; Japan Society for the Promotion of Science [24790458]; Takeda Science Foundation, the Uehara Memorial Foundation [10J06513]; Novartis Foundation; Sumitomo Foundation; Joint Research Program 2024 of the Institute for Molecular and Cellular Regulation, Gunma University	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation, the Uehara Memorial Foundation; Novartis Foundation(Novartis); Sumitomo Foundation; Joint Research Program 2024 of the Institute for Molecular and Cellular Regulation, Gunma University	This work was supported by a Grant-in-aid for Scientific Research on Innovative Areas 21117004 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. M.), Grant-in-aid for Scientific Research on Innovative Areas 25118702 from the Ministry of Education (to T. M. Y.), Grant-in-aid for Young Scientists (B) 24790458 from the Japan Society for the Promotion of Science (to T. M. Y.), Grant-in-aid for JSPS Fellows 10J06513 (to F. H.-T.), grants from the Takeda Science Foundation, the Uehara Memorial Foundation, the Novartis Foundation, and the Sumitomo Foundation (to T. M. Y.), and by Joint Research Program 2024 of the Institute for Molecular and Cellular Regulation, Gunma University.	Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bekeredjian-Ding I, 2009, IMMUNOLOGY, V128, P311, DOI 10.1111/j.1365-2567.2009.03173.x; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; COUTINHO A, 1974, J EXP MED, V139, P74, DOI 10.1084/jem.139.1.74; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Dhamija S, 2010, J BIOL CHEM, V285, P29165, DOI 10.1074/jbc.M110.146365; FOY TM, 1993, J EXP MED, V178, P1567, DOI 10.1084/jem.178.5.1567; Hanihara F, 2013, INT IMMUNOL, V25, P531, DOI 10.1093/intimm/dxt017; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Khan AQ, 2005, INFECT IMMUN, V73, P298, DOI 10.1128/IAI.73.1.298-307.2005; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Lafarge S, 2011, CLIN EXP IMMUNOL, V166, P171, DOI 10.1111/j.1365-2249.2011.04465.x; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Miyake T, 2010, P NATL ACAD SCI USA, V107, P17680, DOI 10.1073/pnas.1012977107; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; MOSIER DE, 1977, J IMMUNOL, V119, P1874; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Nogai H, 2013, BLOOD, V122, P2242, DOI 10.1182/blood-2013-06-508028; Ohba T, 2012, FEBS J, V279, P211, DOI 10.1111/j.1742-4658.2011.08416.x; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Okuma A, 2013, IMMUNITY, V38, P450, DOI 10.1016/j.immuni.2012.11.016; Park SR, 2009, NAT IMMUNOL, V10, P540, DOI 10.1038/ni.1725; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Pone EJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1769; Pone EJ, 2010, CRIT REV IMMUNOL, V30, P1; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Sen G, 2005, J IMMUNOL, V175, P3084, DOI 10.4049/jimmunol.175.5.3084; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Tatemichi M, 2011, ONCOL REP, V25, P153, DOI 10.3892/or_00001055; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Tran TH, 2010, NAT IMMUNOL, V11, P148, DOI 10.1038/ni.1829; VANDENEERTWEGH AJM, 1993, J EXP MED, V178, P1555, DOI 10.1084/jem.178.5.1555; Vasilevsky S, 2008, EUR J IMMUNOL, V38, P3316, DOI 10.1002/eji.200838484; Vos Q, 2000, IMMUNOL REV, V176, P154; Watanabe S, 2007, BIOCHEM BIOPH RES CO, V356, P785, DOI 10.1016/j.bbrc.2007.03.044; Xu ZM, 2012, NAT REV IMMUNOL, V12, P517, DOI 10.1038/nri3216; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200	45	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					30925	30936		10.1074/jbc.M114.553230	http://dx.doi.org/10.1074/jbc.M114.553230			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25124037	Green Published, hybrid			2022-12-28	WOS:000344549900005
J	Koag, MC; Lai, L; Lee, S				Koag, Myong-Chul; Lai, Lara; Lee, Seongmin			Structural Basis for the Inefficient Nucleotide Incorporation Opposite Cisplatin-DNA Lesion by Human DNA Polymerase beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-MECHANISMS; CRYSTAL-STRUCTURES; EXCISION-REPAIR; GPG ADDUCTS; ETA; BYPASS; OXALIPLATIN; FIDELITY; DAMAGE; CELLS	Human DNA polymerase beta (pol beta) has been suggested to play a role in cisplatin resistance, especially in pol beta-overexpressing cancer cells. Pol beta has been shown to accurately albeit slowly bypass the cisplatin-1,2-d(GpG) (Pt-GG) intramolecular crosslink in vitro. Currently, the structural basis for the inefficient Pt-GG bypass mechanism of pol beta is unknown. To gain structural insights into the mechanism, we determined two ternary structures of pol beta incorporating dCTP opposite the templating Pt-GG lesion in the presence of the active site Mg2+ or Mn2+. The Mg2+ -bound structure shows that the bulky Pt-GG adduct is accommodated in the pol beta active site without any steric hindrance. In addition, both guanines of the Pt-GG lesion form Watson-Crick base pairing with the primer terminus dC and the incoming dCTP, providing the structural basis for the accurate bypass of the Pt-GG adduct by pol beta. The Mn2+ -bound structure shows that pol beta adopts a catalytically suboptimal semiclosed conformation during the insertion of dCTP opposite the templating Pt-GG, explaining the inefficient replication across the Pt-GG lesion by pol beta. Overall, our studies provide the first structural insights into the mechanism of the potential pol beta mediated cisplatin resistance.	[Koag, Myong-Chul; Lai, Lara; Lee, Seongmin] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Lee, S (corresponding author), Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA.	SeongminLee@austin.utexas.edu	Lee, Seongmin/AAR-2499-2021		Office of Science, Office of Basic Energy Sciences of the United States Department of Energy [DE-AC02-05CH11231]	Office of Science, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE))	Instrumentation and technical assistance for this work were provided by the Macro molecular Crystallography Facility with financial support from the College of Natural Sciences, the Office of the Executive Vice President and Provost, and the Institute for Cellular and Molecular Biology at the University of Texas at Austin, The Berkeley Center for Structural Biology is supported in part by the National Institute of General Medical Sciences. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences of the United States Department of Energy under Contract DE-AC02-05CH11231.	Alt A, 2007, SCIENCE, V318, P967, DOI 10.1126/science.1148242; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Bergoglio V, 2001, ONCOGENE, V20, P6181, DOI 10.1038/sj.onc.1204743; Boudsocq F, 2005, MOL PHARMACOL, V67, P1485, DOI 10.1124/mol.104.001776; Canitrot Y, 1999, FASEB J, V13, P1107, DOI 10.1096/fasebj.13.9.1107; Canitrot Y, 1998, P NATL ACAD SCI USA, V95, P12586, DOI 10.1073/pnas.95.21.12586; Canitrot Y, 2000, FASEB J, V14, P1765, DOI 10.1096/fj.99-1063com; Chamberlain BT, 2012, CHEMBIOCHEM, V13, P528, DOI 10.1002/cbic.201100738; Chaney SG, 2005, CRIT REV ONCOL HEMAT, V53, P3, DOI 10.1016/j.critrevonc.2004.08.008; Clausen AR, 2013, P NATL ACAD SCI USA, V110, P16802, DOI 10.1073/pnas.1309119110; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; ELDEIRY WS, 1984, P NATL ACAD SCI-BIOL, V81, P7378, DOI 10.1073/pnas.81.23.7378; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Gregory MT, 2014, P NATL ACAD SCI USA, V111, P9133, DOI 10.1073/pnas.1405739111; HOFFMANN JS, 1995, P NATL ACAD SCI USA, V92, P5356, DOI 10.1073/pnas.92.12.5356; HORTON JK, 1995, NUCLEIC ACIDS RES, V23, P3810, DOI 10.1093/nar/23.19.3810; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Koag MC, 2014, J AM CHEM SOC, V136, P5709, DOI 10.1021/ja500172d; KRAKER AJ, 1988, CANCER LETT, V38, P307, DOI 10.1016/0304-3835(88)90022-5; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Reissner T, 2010, ANGEW CHEM INT EDIT, V49, P3077, DOI 10.1002/anie.201000414; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Srivastava DK, 1999, CARCINOGENESIS, V20, P1049, DOI 10.1093/carcin/20.6.1049; TABOR S, 1989, P NATL ACAD SCI USA, V86, P4076, DOI 10.1073/pnas.86.11.4076; Ummat A, 2012, NAT STRUCT MOL BIOL, V19, P628, DOI 10.1038/nsmb.2295; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Vaisman A, 2000, J BIOL CHEM, V275, P13017, DOI 10.1074/jbc.275.17.13017; Vaisman A, 2000, BIOCHEMISTRY-US, V39, P4575, DOI 10.1021/bi000130k; Wang D, 2003, BIOCHEMISTRY-US, V42, P6747, DOI 10.1021/bi034264k; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong JHY, 2010, EMBO J, V29, P2059, DOI 10.1038/emboj.2010.101; Xie K, 2010, P NATL ACAD SCI USA, V107, P20792, DOI 10.1073/pnas.1011412107; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109	37	6	6	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31341	31348		10.1074/jbc.M114.605451	http://dx.doi.org/10.1074/jbc.M114.605451			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25237188	Green Published, hybrid			2022-12-28	WOS:000344549900038
J	Zhang, LH; Niu, YB; Zhu, L; Fang, JQ; Wang, X; Wang, L; Wang, CC				Zhang, Lihui; Niu, Yingbo; Zhu, Li; Fang, Jingqi; Wang, Xi'e; Wang, Lei; Wang, Chih-chen			Different Interaction Modes for Protein-disulfide Isomerase (PDI) as an Efficient Regulator and a Specific Substrate of Endoplasmic Reticulum Oxidoreductin-1 alpha (Ero1 alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOND FORMATION; REDOX HOMEOSTASIS; OXIDATION; ERO1; OXIDOREDUCTASES; ISOMERIZATION; INACTIVATION; MECHANISM; DOMAINS; PATHWAY	Protein-disulfide isomerase (PDI) and sulfhydryl oxidase endo-plasmic reticulum oxidoreductin- 1 alpha(Ero1 alpha) constitute the pivotal pathway for oxidative protein folding in the mammalian endoplasmic reticulum (ER). Ero1 alpha oxidizes PDI to introduce disulfides into substrates, and PDI can feedback-regulate Ero1 alpha activity. Here, we show the regulatory disulfide of Ero1 alpha responds to the redox fluctuation in ER very sensitively, relying on the availability of redox active PDI. The regulation of Ero1 alpha is rapidly facilitated by either a or a' catalytic domain of PDI, independent of the substrate binding domain. On the other hand, activated Ero1 alpha specifically binds to PDI via hydrophobic interactions and preferentially catalyzes the oxidation of domain a'. This asymmetry ensures PDI to function simultaneously as an oxidoreductase and an isomerase. In addition, several PDI family members are also characterized to be potent regulators of Ero1 alpha. The novel modes for PDI as a competent regulator and a specific substrate of Ero1 alpha govern efficient and faithful oxidative protein folding and maintain the ER redox homeostasis.	[Zhang, Lihui; Niu, Yingbo; Zhu, Li; Fang, Jingqi; Wang, Xi'e; Wang, Lei; Wang, Chih-chen] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Zhang, Lihui; Niu, Yingbo; Zhu, Li; Fang, Jingqi] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, L (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	wanglei@moon.ibp.ac.cn; chihwang@sun5.ibp.ac.cn		Wang, Lei/0000-0002-5071-5800	Chinese Ministry of Science and Technology [2011CB910303, 2012CB911002]; National Natural Science Foundation of China [31370775]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese Ministry of Science and Technology (2011CB910303 and 2012CB911002, to C. C. W.) and National Natural Science Foundation of China (31370775, to L. W.).	Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; Appenzeller-Herzog C, 2010, EMBO J, V29, P3318, DOI 10.1038/emboj.2010.203; Araki K, 2013, J CELL BIOL, V202, P861, DOI 10.1083/jcb.201303027; Araki K, 2012, ANTIOXID REDOX SIGN, V16, P790, DOI 10.1089/ars.2011.4418; Araki K, 2011, J BIOL CHEM, V286, P32705, DOI 10.1074/jbc.M111.227181; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Chambers JE, 2010, J BIOL CHEM, V285, P29200, DOI 10.1074/jbc.M110.156596; Cheng H, 2010, CELL STRESS CHAPERON, V15, P415, DOI 10.1007/s12192-009-0157-2; Chin KT, 2011, FASEB J, V25, P2583, DOI 10.1096/fj.11-184622; Chu YY, 2009, BIOCHEM BIOPH RES CO, V389, P645, DOI 10.1016/j.bbrc.2009.09.045; Eletto D, 2014, J CELL SCI, V127, P3649, DOI 10.1242/jcs.153643; Hansen HG, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405050; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Kim S, 2012, J CELL BIOL, V196, P713, DOI 10.1083/jcb.201110090; Li SJ, 2006, J BIOL CHEM, V281, P6581, DOI 10.1074/jbc.M508422200; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Otsu M, 2006, ANTIOXID REDOX SIGN, V8, P274, DOI 10.1089/ars.2006.8.274; Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Schulman S, 2010, P NATL ACAD SCI USA, V107, P15027, DOI 10.1073/pnas.1009972107; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Shepherd C, 2014, BIOCHEM J, V461, P107, DOI 10.1042/BJ20140234; Solovyov A, 2004, J BIOL CHEM, V279, P34095, DOI 10.1074/jbc.M405640200; Vitu E, 2010, J BIOL CHEM, V285, P18155, DOI 10.1074/jbc.M109.064931; Wang C, 2010, J BIOL CHEM, V285, P26788, DOI 10.1074/jbc.M110.107839; Wang L, 2014, ANTIOXID REDOX SIGN, V20, P545, DOI 10.1089/ars.2013.5236; Wang L, 2011, BIOCHEM J, V434, P113, DOI 10.1042/BJ20101357; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; Xiao RY, 2004, J BIOL CHEM, V279, P49780, DOI 10.1074/jbc.M409210200	41	39	39	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31188	31199		10.1074/jbc.M114.602961	http://dx.doi.org/10.1074/jbc.M114.602961			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25258311	Green Published, hybrid			2022-12-28	WOS:000344549900026
J	Honda, RP; Yamaguchi, K; Kuwata, K				Honda, Ryo P.; Yamaguchi, Kei-ichi; Kuwata, Kazuo			Acid-induced Molten Globule State of a Prion Protein CRUCIAL ROLE OF STRAND 1-HELIX 1-STRAND 2 SEGMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; CONVERSION; MOUSE; FIBRILLIZATION; STABILITY; EXCHANGE; HELIX-1; HAMSTER; HELICES; PH	The conversion of a cellular prion protein (PrPC) to its pathogenic isoform (PrPSc) is a critical event in the pathogenesis of prion diseases. Pathogenic conversion is usually associated with the oligomerization process; therefore, the conformational characteristics of the pre-oligomer state may provide insights into the conversion process. Previous studies indicate that PrPC is prone to oligomer formation at low pH, but the conformation of the pre-oligomer state remains unknown. In this study, we systematically analyzed the acid-induced conformational changes of PrPC and discovered a unique acid-induced molten globule state at pH 2.0 termed the "A-state." We characterized the structure of the A-state using far/near-UV CD, 1-anilino- 8-naphthalene sulfonate fluorescence, size exclusion chromatography, and NMR. Deuterium exchange experiments with NMR detection revealed its first unique structure ever reported thus far; i.e. the Strand 1-Helix 1-Strand 2 segment at the N terminus was preferentially unfolded, whereas the Helix 2-Helix 3 segment at the C terminus remained marginally stable. This conformational change could be triggered by the protonation of Asp(144), Asp(147), and Glu(196), followed by disruption of key salt bridges in PrPC. Moreover, the initial population of the A-state at low pH (pH 2.0-5.0) was well correlated with the rate of the beta-rich oligomer formation, suggesting that the A-state is the pre-oligomer state. Thus, the specific conformation of the A-state would provide crucial insights into the mechanisms of oligomerization and further pathogenic conversion as well as facilitating the design of novel medical chaperones for treating prion diseases.	[Honda, Ryo P.; Kuwata, Kazuo] Gifu Univ, Sch Med, Gifu 5011193, Japan; [Kuwata, Kazuo] Gifu Univ, Grad Sch Med, Dept Gene & Dev, Gifu 5011193, Japan; [Yamaguchi, Kei-ichi; Kuwata, Kazuo] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu 5011194, Japan	Gifu University; Gifu University; Gifu University	Kuwata, K (corresponding author), Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, 1-1 Yanagido, Gifu 5011194, Japan.	kuwata@gifu-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan (Research on Measures for Intractable Diseases (Prion Disease and Slow Virus Infections and Development of Low Molecular Weight Medical Chaperone Therapeutics for Prion Diseases)); Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Health, Labor, and Welfare of Japan (Research on Measures for Intractable Diseases (Prion Disease and Slow Virus Infections and Development of Low Molecular Weight Medical Chaperone Therapeutics for Prion Diseases)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Health, Labor, and Welfare of Japan (Research on Measures for Intractable Diseases (Prion Disease and Slow Virus Infections and Development of Low Molecular Weight Medical Chaperone Therapeutics for Prion Diseases)) and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (grants-in-aid for scientific research and the X-ray Free Electron Laser (XFEL) Program).	Abskharon RNN, 2014, J AM CHEM SOC, V136, P937, DOI 10.1021/ja407527p; Adrover M, 2010, J BIOL CHEM, V285, P21004, DOI 10.1074/jbc.M110.111815; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; Bae SH, 2009, BIOCHEMISTRY-US, V48, P8120, DOI 10.1021/bi900923b; Bjorndahl TC, 2011, BIOCHEMISTRY-US, V50, P1162, DOI 10.1021/bi101435c; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Chakroun N, 2010, FASEB J, V24, P3222, DOI 10.1096/fj.09-153924; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; COVINGTON AK, 1968, ANAL CHEM, V40, P700, DOI 10.1021/ac60260a013; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Ishikawa T, 2010, J CHEM THEORY COMPUT, V6, P538, DOI 10.1021/ct900456v; Jain S, 2008, J MOL BIOL, V382, P1228, DOI 10.1016/j.jmb.2008.07.052; Jain S, 2011, BIOCHEMISTRY-US, V50, P1153, DOI 10.1021/bi101757x; Jain S, 2010, BIOCHEMISTRY-US, V49, P7615, DOI 10.1021/bi100745j; JENG MF, 1990, BIOCHEMISTRY-US, V29, P10433, DOI 10.1021/bi00498a001; Julien O, 2011, BIOCHEMISTRY-US, V50, P7536, DOI 10.1021/bi200731e; Karp DA, 2007, BIOPHYS J, V92, P2041, DOI 10.1529/biophysj.106.090266; Katou H, 2001, J MOL BIOL, V310, P471, DOI 10.1006/jmbi.2001.4777; Kuwata K, 2004, BIOCHEMISTRY-US, V43, P4439, DOI 10.1021/bi036123o; Kuwata K, 2007, P NATL ACAD SCI USA, V104, P11921, DOI 10.1073/pnas.0702671104; Kuwata K, 2013, CURR TOP MED CHEM, V13, P2432; Masel J, 2005, J MOL BIOL, V345, P1243, DOI 10.1016/j.jmb.2004.10.088; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; MorozovaRoche LA, 1997, J MOL BIOL, V268, P903, DOI 10.1006/jmbi.1997.0996; Morrissey MP, 1999, P NATL ACAD SCI USA, V96, P11293, DOI 10.1073/pnas.96.20.11293; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pastore M, 2005, AM J PATHOL, V167, P1729, DOI 10.1016/S0002-9440(10)61254-0; Peoc'h K, 2000, HUM MUTAT, V15; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Redfield C, 2004, METHODS, V34, P121, DOI 10.1016/j.ymeth.2004.03.009; Rezaei H, 2002, J MOL BIOL, V322, P799, DOI 10.1016/S0022-2836(02)00856-2; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Singh J, 2012, J MOL BIOL, V423, P217, DOI 10.1016/j.jmb.2012.06.040; Speare JO, 2003, J BIOL CHEM, V278, P12522, DOI 10.1074/jbc.M211599200; Sreerama N, 1999, PROTEIN SCI, V8, P370; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; Ziegler J, 2003, J BIOL CHEM, V278, P50175, DOI 10.1074/jbc.M305234200	45	35	35	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30355	30363		10.1074/jbc.M114.559450	http://dx.doi.org/10.1074/jbc.M114.559450			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25217639	Green Published, hybrid			2022-12-28	WOS:000344549700018
J	Lee, S; Challa-Malladi, M; Bratton, SB; Wright, CW				Lee, Sunhee; Challa-Malladi, Madhavi; Bratton, Shawn B.; Wright, Casey W.			Nuclear Factor-kappa B-inducing Kinase (NIK) Contains an Amino-terminal Inhibitor of Apoptosis (IAP)-binding Motif (IBM) That Potentiates NIK Degradation by Cellular IAP1 (c-IAP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTAGONISTS INDUCE; SIGNALING PATHWAY; STRUCTURAL BASIS; LYMPHOMA-CELLS; SMAC/DIABLO; ACTIVATION; BINDING; PROTEIN; TRAF3; CIAP1	Activation of the noncanonical NF-kappa B pathway hinges on the stability of the NF-kappa B-inducing kinase (NIK), which is kept at low levels basally by a protein complex consisting of the E3 ubiquitin ligases cellular inhibitor of apoptosis 1 and 2 (c-IAP1/2) proteins and the tumor necrosis factor receptor-associated factors 2 and 3 (TRAF2/3). NIK is brought into close proximity to the c-IAPs through a TRAF2-TRAF3 bridge where TRAF2 recruits c-IAP1/2 and TRAF3 binds to NIK. However, it is not clear how the c-IAPs specifically recognize and ubiquitylate NIK in the complex. We have identified an IAP-binding motif (IBM) at the amino terminus of NIK. IBMs are utilized by a number of proapoptotic proteins to antagonize IAP function. Here, we utilize mutational studies to demonstrate that wild-type NIK is destabilized in the presence of c-IAP1, whereas the NIK IBM mutant is stable. NIK interacts with the second baculovirus IAP repeat (BIR2) domain of c-IAP1 via the IBM, and this interaction, in turn, provides substrate recognition for c-IAP1 mediated ubiquitylation and degradation of NIK. Furthermore, in the presence of the NIK IBM mutant, we observed an elevated processing of p100 to p52 followed by increased expression of NF-kappa B target genes. Together, these findings reveal the novel identification and function of the NIK IBM, which promotes c-IAP1-dependent ubiquitylation of NIK, resulting in optimal NIK turnover to ensure that noncanonical NF-kappa B signaling is off in the absence of an activating signal.	[Wright, Casey W.] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Ctr Mol & Cellular Toxicol, Austin, TX 78712 USA; [Lee, Sunhee; Challa-Malladi, Madhavi; Bratton, Shawn B.; Wright, Casey W.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Bratton, Shawn B.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center	Wright, CW (corresponding author), Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, BME 3-510C,107 West Dean Keeton St,Stop C0875, Austin, TX 78712 USA.	Cww@austin.utexas.edu		Wright, Casey/0000-0002-9512-1264; Bratton, Shawn/0000-0003-2895-5020	National Institutes of Health [CA129521, GM096101]; American Cancer Society [121549-RSG-11-180-01-TBE]; NATIONAL CANCER INSTITUTE [R01CA129521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants CA129521 and GM096101 (to S. B. B.) and a Research Starter Grant from the American Cancer Society 121549-RSG-11-180-01-TBE (to C. W. W.).	ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Bista P, 2010, J BIOL CHEM, V285, P12971, DOI 10.1074/jbc.M109.076091; Blankenship JW, 2009, BIOCHEM J, V417, P149, DOI 10.1042/BJ20081885; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Choi YE, 2009, J BIOL CHEM, V284, P12772, DOI 10.1074/jbc.M807550200; Csomos RA, 2009, J BIOL CHEM, V284, P20531, DOI 10.1074/jbc.M109.029983; Csomos RA, 2009, BIOCHEM J, V420, P83, DOI 10.1042/BJ20082140; de Leon-Boenig G, 2012, STRUCTURE, V20, P1704, DOI 10.1016/j.str.2012.07.013; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Giglione C, 2004, CELL MOL LIFE SCI, V61, P1455, DOI 10.1007/s00018-004-3466-8; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; He JQ, 2007, J BIOL CHEM, V282, P3688, DOI 10.1074/jbc.M610271200; Hunter AM, 2003, J BIOL CHEM, V278, P7494, DOI 10.1074/jbc.C200695200; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Lopez J, 2011, MOL CELL, V42, P569, DOI 10.1016/j.molcel.2011.04.008; Morrison MD, 2005, J BIOL CHEM, V280, P10018, DOI 10.1074/jbc.M413634200; Muro I, 2014, CELL CYCLE, V13, P1918, DOI 10.4161/cc.28895; Razani B, 2011, IMMUNOL REV, V244, P44, DOI 10.1111/j.1600-065X.2011.01059.x; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Silke J, 2001, J CELL SCI, V114, P1821; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Wilkinson JC, 2004, J BIOL CHEM, V279, P51082, DOI 10.1074/jbc.M408655200; Wright CW, 2007, J BIOL CHEM, V282, P10252, DOI 10.1074/jbc.M608817200; Wright CW, 2005, J CLIN INVEST, V115, P2673, DOI 10.1172/JCI26251; Wright CW, 2002, J BIOL CHEM, V277, P2454, DOI 10.1074/jbc.M110500200; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yeh TC, 2013, P NATL ACAD SCI USA, V110, P14284, DOI 10.1073/pnas.1306179110; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	43	18	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30680	30689		10.1074/jbc.M114.587808	http://dx.doi.org/10.1074/jbc.M114.587808			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25246529	hybrid, Green Published			2022-12-28	WOS:000344549700044
J	Li, L; Yao, YC; Fang, SH; Ma, CQ; Cen, Y; Xu, ZM; Dai, ZY; Li, C; Li, S; Zhang, T; Hong, HH; Qi, WW; Zhou, T; Li, CY; Yang, X; Gao, GQ				Li, Lei; Yao, Ya-Chao; Fang, Shu-Huan; Ma, Cai-Qi; Cen, Yi; Xu, Zu-Min; Dai, Zhi-Yu; Li, Cen; Li, Shuai; Zhang, Ting; Hong, Hong-Hai; Qi, Wei-Wei; Zhou, Ti; Li, Chao-Yang; Yang, Xia; Gao, Guo-Quan			Pigment Epithelial-derived Factor (PEDF)-triggered Lung Cancer Cell Apoptosis Relies on p53 Protein-driven Fas Ligand (Fas-L) Up-regulation and Fas Protein Cell Surface Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53-MEDIATED APOPTOSIS; SIGNALING PATHWAYS; ENDOTHELIAL-CELLS; MELANOMA-CELLS; GENE-TRANSFER; GROWTH; EXPRESSION; PEDF; ANGIOGENESIS; CD95	Pigment epithelium-derived factor (PEDF), a potent antiangiogenesis agent, has recently attracted attention for targeting tumor cells in several types of tumors. However, less is known about the apoptosis-inducing effect of PEDF on human lung cancer cells and the underlying molecular events. Here we report that PEDF has a growth-suppressive and proapoptotic effect on lung cancer xenografts. Accordingly, in vitro, PEDF apparently induced apoptosis in A549 and Calu-3 cells, predominantly via the Fas-L/Fas death signaling pathway. Interestingly, A549 and Calu-3 cells are insensitive to the Fas-L/Fas apoptosis pathway because of the low level of cell surface Fas. Our results revealed that, in addition to the enhancement of Fas-L expression, PEDF increased the sensitivity of A549 and Calu-3 cells to Fas-L-mediated apoptosis by triggering the translocation of Fas protein to the plasma membrane in a p53- and FAP-1-dependent manner. Similarly, the up-regulation of Fas-L by PEDF was also mediated by p53. Furthermore, peroxisome proliferator-activated receptor gamma was determined to be the upstream regulator of p53. Together, these findings uncover a novel mechanism of tumor cell apoptosis induced by PEDF and provide a potential therapeutic strategy for tumors that are insensitive to Fas-L/Fas-dependent apoptosis because of a low level of cell surface Fas.	[Li, Lei; Ma, Cai-Qi; Cen, Yi; Dai, Zhi-Yu; Li, Cen; Li, Shuai; Zhang, Ting; Hong, Hong-Hai; Qi, Wei-Wei; Zhou, Ti; Yang, Xia; Gao, Guo-Quan] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510080, Guangdong, Peoples R China; [Li, Chao-Yang] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Li, Lei] Guangzhou Med Univ, Dept Reprod Med Ctr, Key Lab Reprod Med Guangdong Prov, Affiliated Hosp 3, Guangzhou 510150, Guangdong, Peoples R China; [Yao, Ya-Chao] Guangdong 2 Prov Peoples Hosp, Lab Ctr, Guangzhou 510317, Guangdong, Peoples R China; [Fang, Shu-Huan] Guangzhou Univ Chinese Med, DME Ctr, Clin Pharmacol Inst, Guangzhou 510405, Guangdong, Peoples R China; [Xu, Zu-Min] Guangdong Med Coll, Affiliated Hosp, Ctr Canc, Zhanjiang 524000, Peoples R China; [Yang, Xia] Sun Yat Sen Univ, Minist Educ, China Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China; [Gao, Guo-Quan] Sun Yat Sen Univ, Dept Educ Guangdong Prov, Key Lab Funct Mol Marine Microorganisms, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University; Guangzhou University of Chinese Medicine; Guangdong Medical University; Sun Yat Sen University; Sun Yat Sen University	Li, CY (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China.	clioffice@yahoo.cn; yangxia@mail.sysu.edu.cn; gaogq@mail.sysu.edu.cn	Li, Chao/GSM-8117-2022; Dai, Zhiyu/H-3453-2019	Li, Chao/0000-0001-6110-6210; Dai, Zhiyu/0000-0002-2945-7923	National Nature Science Foundation of China [30971208, 30973449, 81070746, 81172163, 81272338, 81272515, 81200706, 81400639]; National Key Sci-Tech Special Project of China [2009ZX09103-642, 2013ZX09102-053]; Program for Doctoral Station in University Grants [20100171110049, 2011M501364, 20120171110053]; Key Project of Nature Science Foundation of Guangdong Province, China [10251008901000009]; Key Sci-tech Research Project of Guangdong Province, China [2011B031200006]; Guandong Natural Science Fund [10151008901000007, S2012010009250, S2012040006986]; Key Sci-tech Research Project of Guangzhou Municipality, China [2011Y1-00017-8, 12A52061519]; Changjiang Scholars and Innovative Research Team in University 985 project PCSIRT [0947]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Special Project of China; Program for Doctoral Station in University Grants; Key Project of Nature Science Foundation of Guangdong Province, China; Key Sci-tech Research Project of Guangdong Province, China; Guandong Natural Science Fund; Key Sci-tech Research Project of Guangzhou Municipality, China; Changjiang Scholars and Innovative Research Team in University 985 project PCSIRT	This study was supported by National Nature Science Foundation of China Grants 30971208, 30973449, 81070746, 81172163, 81272338, 81272515, 81200706, and 81400639; by National Key Sci-Tech Special Project of China Grants 2009ZX09103-642 and 2013ZX09102-053; by Program for Doctoral Station in University Grants 20100171110049, 2011M501364, and 20120171110053; by Key Project of Nature Science Foundation of Guangdong Province, China, Grant 10251008901000009; by Key Sci-tech Research Project of Guangdong Province, China, Grant 2011B031200006; by Guandong Natural Science Fund Grant 10151008901000007, S2012010009250, and S2012040006986; by Key Sci-tech Research Project of Guangzhou Municipality, China, Grants 2011Y1-00017-8 and 12A52061519; and by Changjiang Scholars and Innovative Research Team in University 985 project PCSIRT 0947.	Abe R, 2004, AM J PATHOL, V164, P1225, DOI 10.1016/S0002-9440(10)63210-5; Beltinger C, 1999, P NATL ACAD SCI USA, V96, P8699, DOI 10.1073/pnas.96.15.8699; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Bonofiglio D, 2009, BREAST CANCER RES TR, V113, P423, DOI 10.1007/s10549-008-9944-1; Broadhead ML, 2009, EXPERT OPIN THER TAR, V13, P1429, DOI 10.1517/14728220903307475; Buque A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-25; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Chen Jin-Feng, 2009, Zhonghua Yi Xue Za Zhi, V89, P485; Chen JF, 2009, INT J ONCOL, V35, P159, DOI 10.3892/ijo_00000324; Chen M, 2002, APOPTOSIS, V7, P313, DOI 10.1023/A:1016167228059; Crowe S, 2009, CELL METAB, V10, P40, DOI 10.1016/j.cmet.2009.06.001; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Ehrenschwender M, 2009, ADV EXP MED BIOL, V647, P64, DOI 10.1007/978-0-387-89520-8_5; Ek ETH, 2007, CANCER GENE THER, V14, P616, DOI 10.1038/sj.cgt.7701044; Ek ETH, 2006, MOL CANCER THER, V5, P1641, DOI 10.1158/1535-7163.MCT-06-0107; Guan M, 2004, CANCER GENE THER, V11, P325, DOI 10.1038/sj.cgt.7700675; Guan M, 2007, CANCER BIOL THER, V6, P419, DOI 10.4161/cbt.6.3.3757; Haynes AP, 2002, BRIT J HAEMATOL, V118, P488, DOI 10.1046/j.1365-2141.2002.03643.x; He SS, 2012, ONCOL REP, V27, P1142, DOI 10.3892/or.2012.1621; Ho TC, 2007, CARDIOVASC RES, V76, P213, DOI 10.1016/j.cardiores.2007.06.032; Ho TC, 2009, AM J PHYSIOL-CELL PH, V296, pC273, DOI 10.1152/ajpcell.00432.2008; Irie S, 2001, DNA SEQUENCE, V11, P519, DOI 10.3109/10425170109041336; Ivanov VN, 2003, MOL CELL BIOL, V23, P3623, DOI 10.1128/MCB.23.10.3623-3635.2003; Kawasaki M, 2000, EUR J CANCER, V36, P656, DOI 10.1016/S0959-8049(99)00332-9; Lee SH, 1999, ONCOGENE, V18, P3754, DOI 10.1038/sj.onc.1202769; Li L, 2012, INT J PHARMACEUT, V438, P1, DOI 10.1016/j.ijpharm.2012.08.043; Lin CS, 2010, CLIN VACCINE IMMUNOL, V17, P1548, DOI 10.1128/CVI.00064-10; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; Munsch D, 2000, J BIOL CHEM, V275, P3867, DOI 10.1074/jbc.275.6.3867; Muschen M, 2000, J MOL MED-JMM, V78, P312, DOI 10.1007/s001090000112; Nambu Y, 1998, J CLIN INVEST, V101, P1102, DOI 10.1172/JCI1692; OWENSCHAUB LB, 1994, CANCER RES, V54, P1580; Peter ME, 2005, BBA-REV CANCER, V1755, P25, DOI 10.1016/j.bbcan.2005.01.001; Pratesi G, 1999, BRIT J CANCER, V80, P1912, DOI 10.1038/sj.bjc.6690620; Rho JK, 2007, CANCER RES, V67, P1163, DOI 10.1158/0008-5472.CAN-06-2037; Roy J, 2010, CAN J PHYSIOL PHARM, V88, P353, DOI 10.1139/Y09-134; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Sodeman T, 2000, AM J PHYSIOL-GASTR L, V278, pG992, DOI 10.1152/ajpgi.2000.278.6.G992; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Stellmach V, 2001, P NATL ACAD SCI USA, V98, P2593, DOI 10.1073/pnas.031252398; Ungefroren H, 2001, J CELL SCI, V114, P2735; Viard-Leveugle I, 2003, J PATHOL, V201, P268, DOI 10.1002/path.1428; Villa-Morales M, 2012, EXPERT OPIN THER TAR, V16, P85, DOI 10.1517/14728222.2011.628937; Volpert OV, 2002, NAT MED, V8, P349, DOI 10.1038/nm0402-349; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; WELLER M, 1995, CANCER RES, V55, P2936; Xu G, 2007, LARYNGOSCOPE, V117, P960, DOI 10.1097/mlg.0b013e318041549c; Yamada T, 2006, FEBS LETT, V580, P4387, DOI 10.1016/j.febslet.2006.07.003; Yang HS, 2009, CANCER SCI, V100, P2419, DOI 10.1111/j.1349-7006.2009.01332.x; Zhang SX, 2006, FASEB J, V20, P323, DOI 10.1096/fj.05-4313fje; Zheng J, 2012, ALLERGY, V67, P362, DOI 10.1111/j.1398-9995.2011.02776.x	52	23	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30785	30799		10.1074/jbc.M114.590000	http://dx.doi.org/10.1074/jbc.M114.590000			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25225287	Green Published, hybrid			2022-12-28	WOS:000344549700053
J	Crowell, S; Wancket, LM; Shakibi, Y; Xu, PP; Xue, JJ; Samavati, L; Nelin, LD; Liu, YS				Crowell, Sara; Wancket, Lyn M.; Shakibi, Yasmine; Xu, Pingping; Xue, Jianjing; Samavati, Lobelia; Nelin, Leif D.; Liu, Yusen			Post-translational Regulation of Mitogen-activated Protein Kinase Phosphatase (MKP)-1 and MKP-2 in Macrophages Following Lipopolysaccharide Stimulation THE ROLE OF THE C TERMINI OF THE PHOSPHATASES IN DETERMINING THEIR STABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSES; PROINFLAMMATORY CYTOKINE BIOSYNTHESIS; DUAL-SPECIFICITY PHOSPHATASES; P38 MAP KINASE; SIGNALING PATHWAY; FEEDBACK-CONTROL; JNK; BINDING; DEGRADATION; GENES	MAPK phosphatases (MKPs) are critical modulators of the innate immune response, and yet the mechanisms regulating their accumulation remain poorly understood. In the present studies, we investigated the role of post-translational modification in the accumulation of MKP-1 and MKP-2 in macrophages following LPS stimulation. We found that upon LPS stimulation, MKP-1 and MKP-2 accumulated with different kinetics: MKP-1 level peaked at similar to 1 h, while MKP-2 levels continued to rise for at least 6 h. Accumulation of both MKP-1 and MKP-2 were attenuated by inhibition of the ERK cascade. Interestingly, p38 inhibition prior to LPS stimulation had little effect on MKP-1 and MKP-2 protein levels, but hindered their detection by an M-18 MKP-1 antibody. Studies of the epitope sequence recognized by the M-18 MKP-1 antibody revealed extensive phosphorylation of two serine residues in the C terminus of both MKP-1 and MKP-2 by the ERK pathway. Remarkably, the stability of both MKP-1 and MKP-2 was markedly decreased in macrophages in the presence of an ERK pathway inhibitor. Mutation of the two C-terminal serine residues in MKP-1 and MKP-2 to alanine decreased their half-lives, while mutating these residues to aspartate dramatically increased their half-lives. Deletion of the C terminus from MKP-1 and MKP-2 also considerably increased their stabilities. Surprisingly, enhanced stabilities of the MKP-1 and MKP-2 mutants were not associated with decreased ubiquitination. Degradation of both MKP-1 and MKP-2 was attenuated by proteasomal inhibitors. Our studies suggest that MKP-1 and MKP-2 stability is regulated by ERK-mediated phosphorylation through a degradation pathway independent of polyubiquitination.	[Crowell, Sara; Shakibi, Yasmine; Xu, Pingping; Xue, Jianjing; Nelin, Leif D.; Liu, Yusen] Nationwide Childrens Hosp, Ctr Perinatal Res, Res Inst, Columbus, OH 43205 USA; [Nelin, Leif D.; Liu, Yusen] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43205 USA; [Wancket, Lyn M.; Liu, Yusen] Ohio State Univ, Dept Vet Biosci, Coll Med, Columbus, OH 43210 USA; [Samavati, Lobelia] Wayne State Univ, Sch Med, Div Pulm Crit Care & Sleep Med, Dept Med, Detroit, MI 48201 USA; [Samavati, Lobelia] Detroit Med Ctr, Detroit, MI 48201 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Wayne State University; Detroit Medical Center	Liu, YS (corresponding author), Nationwide Childrens Hosp, Ctr Perinatal Res, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	yusen.liu@nationwidechildrens.org	Nelin, Leif/AAC-8475-2020; Liu, Yusen/E-3527-2011	Liu, Yusen/0000-0002-0994-0109	National Institutes of Health [AI 57798, AI 68956, K01 OD010985, HL113508, HL 75261]; Foundation of Nationwide Children's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113508, R01HL075261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068956, R01AI057798, R21AI057798] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD010985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation of Nationwide Children's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants AI 57798 and AI 68956 (to Y. L.), K01 OD010985 (to L. M. W.), HL113508 (to L. S.), and HL 75261 (to L. D. N.) and by the Foundation of Nationwide Children's Hospital.	Al-Mutairi MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001192; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Chen PL, 2001, J BIOL CHEM, V276, P29440, DOI 10.1074/jbc.M103463200; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Chen W, 1998, MOL CELL BIOL, V18, P5178, DOI 10.1128/MCB.18.9.5178; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Clark A, 2009, FRONT BIOSCI-LANDMRK, V14, P847, DOI 10.2741/3282; Cornell TT, 2012, AM J PHYSIOL-LUNG C, V303, pL251, DOI 10.1152/ajplung.00063.2012; Cornell TT, 2010, INFECT IMMUN, V78, P2868, DOI 10.1128/IAI.00018-10; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; HAN J, 1990, J EXP MED, V172, P391, DOI 10.1084/jem.172.1.391; Hutter D, 2000, BIOCHEM J, V352, P155, DOI 10.1042/0264-6021:3520155; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Keyse SM, 1999, FREE RADICAL RES, V31, P341, DOI 10.1080/10715769900300911; Laney Jeffrey D, 2002, Curr Protoc Protein Sci, VChapter 14, DOI 10.1002/0471140864.ps1405s29; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Liu Y., 2009, J ORGAN DYSFUNCT, V5, P66; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Rincon M, 2003, IMMUNOL REV, V192, P131, DOI 10.1034/j.1600-065X.2003.00019.x; Rincon M, 2000, FREE RADICAL BIO MED, V28, P1328, DOI 10.1016/S0891-5849(00)00219-7; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Salojin K, 2007, J LEUKOCYTE BIOL, V81, P860, DOI 10.1189/jlb.1006639; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Shepherd EG, 2004, J BIOL CHEM, V279, P54023, DOI 10.1074/jbc.M408444200; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Tsvetkov P, 2012, MOL BIOSYST, V8, P368, DOI 10.1039/c1mb05283g; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010; Zhao Q, 2006, PROTEIN EXPRES PURIF, V46, P468, DOI 10.1016/j.pep.2005.09.011; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200	40	14	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28753	28764		10.1074/jbc.M114.591925	http://dx.doi.org/10.1074/jbc.M114.591925			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25204653	Green Published, hybrid			2022-12-28	WOS:000344141000001
J	Li, BZ; Chen, P; Qu, J; Shi, L; Zhuang, WY; Fu, JX; Li, J; Zhang, XH; Sun, Y; Zhuang, WZ				Li, Bingzong; Chen, Ping; Qu, Jing; Shi, Lei; Zhuang, Wenyue; Fu, Jinxiang; Li, Jun; Zhang, Xiaohui; Sun, Yu; Zhuang, Wenzhuo			Activation of LTBP3 Gene by a Long Noncoding RNA (lncRNA) MALAT1 Transcript in Mesenchymal Stem Cells from Multiple Myeloma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER METASTASIS; LUNG-CANCER; EXPRESSION; CHROMATIN; PROTEIN; BONE; GENOME; COACTIVATOR; TGF-BETA-1; PROGRAMS	Long noncoding RNAs (lncRNAs) are emerging as important regulatory molecules in tumor suppressor and oncogenic pathways. However, the magnitude of the contribution of lncRNA expression to normal human tissues and cancers has not been investigated in a comprehensive manner. Here we explored the biology of the lncRNA MALAT1 and considered the potential significance in mesenchymal stem cells from myeloma patients. By using assays such as RNA interference, luciferase, chromatin immunoprecipitation, and RNA immunoprecipitation, we showed that in mesenchymal stem cells MALAT1 promoted the activation effect of the key transcription factor Sp1 on LTBP3 promoter by modulating recruitment of Sp1 to the LTBP3 gene that regulated the bioavailability of TGF-beta in particular. Our data suggested that lncRNA MALAT1 directly interacted with Sp1 and LTBP3 promoter to increase expression of LTBP3 gene. The specificity and efficiency of activation were ensured by the formation of a stable complex between MALAT1 and the LTBP3 promoter, direct interaction of MALAT1 with Sp1, and recruitment of Sp1 to the promoter. In this study, we showed that the mechanism of transcriptional activation of LTBP3 promoter depended on MALAT1 initiated from neighboring gene LTBP3 and involved both the direct interaction of the Sp1 and promoter-specific activation. Our knowledge of the role of MALAT1 in cellular transformation is pointing toward its potential use as a biomarker and a target for novel therapeutic approaches in multiple myeloma.	[Li, Bingzong; Chen, Ping; Fu, Jinxiang; Li, Jun; Zhang, Xiaohui; Sun, Yu] Soochow Univ, Affiliated Hosp 2, Dept Haematol, Suzhou 215006, Peoples R China; [Qu, Jing; Shi, Lei; Zhuang, Wenzhuo] Soochow Univ, Sch Biol & Basic Med Sci, Dept Cell Biol, Suzhou 215123, Peoples R China; [Zhuang, Wenyue] Beihua Univ, Med Ecsomat Coll, Dept Mol Biol, Jinlin 132013, Peoples R China	Soochow University - China; Soochow University - China; Beihua University	Zhuang, WZ (corresponding author), Soochow Univ, Sch Biol & Basic Med Sci, Dept Cell Biol, Suzhou 215123, Peoples R China.	zhuangwenzhuo@suda.edu.cn	li, bing/GWQ-9617-2022; li, bz/GVR-7133-2022		National Natural Science Foundation of China [81172256, 81102466, 81272631]; China Postdoctoral Science Foundation [2014M551650, 2014M550307]; Postdoctoral Science Foundation of Jiangsu Province, China [1302028B]; Applied Basic Research Programs of Suzhou City [SYS201132]; Jiangsu Province's Key Medical Department	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Science Foundation of Jiangsu Province, China(China Postdoctoral Science Foundation); Applied Basic Research Programs of Suzhou City; Jiangsu Province's Key Medical Department	This work was supported by grants from the National Natural Science Foundation of China (81172256, 81102466, and 81272631), China Postdoctoral Science Foundation (2014M551650 and 2014M550307), Postdoctoral Science Foundation of Jiangsu Province, China (1302028B), the Applied Basic Research Programs of Suzhou City (SYS201132), and Jiangsu Province's Key Medical Department in 2011.	Barille-Nion S, 2003, LEUKEMIA LYMPHOMA, V44, P1463, DOI 10.1080/1042819031000082966; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bumgarner SL, 2012, MOL CELL, V45, P470, DOI 10.1016/j.molcel.2011.11.029; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cassiday LA, 2002, NUCLEIC ACIDS RES, V30, P4118, DOI 10.1093/nar/gkf512; Dabovic B, 2002, J ENDOCRINOL, V175, P129, DOI 10.1677/joe.0.1750129; Dabovic B, 2002, J CELL BIOL, V156, P227, DOI 10.1083/jcb.200111080; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kantola AK, 2005, GENE, V363, P142, DOI 10.1016/j.gene.2005.07.042; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Khaitan D, 2011, CANCER RES, V71, P3852, DOI 10.1158/0008-5472.CAN-10-4460; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Li BZ, 2007, STEM CELLS DEV, V16, P921, DOI 10.1089/scd.2007.0074; Li BZ, 2010, ARCH MED RES, V41, P623, DOI 10.1016/j.arcmed.2010.11.008; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Lin R, 2011, FEBS LETT, V585, P671, DOI 10.1016/j.febslet.2011.01.030; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Matsumoto T, 2011, BONE, V48, P129, DOI 10.1016/j.bone.2010.05.036; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; O'Neill MJ, 2005, HUM MOL GENET, V14, pR113, DOI 10.1093/hmg/ddi108; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; SEYEDIN SM, 1985, P NATL ACAD SCI USA, V82, P2267, DOI 10.1073/pnas.82.8.2267; Tano K, 2010, FEBS LETT, V584, P4575, DOI 10.1016/j.febslet.2010.10.008; Xu CA, 2011, INT J ONCOL, V39, P169, DOI 10.3892/ijo.2011.1007; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200	46	84	94	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29365	29375		10.1074/jbc.M114.572693	http://dx.doi.org/10.1074/jbc.M114.572693			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25187517	hybrid, Green Published			2022-12-28	WOS:000344141000048
J	Zhou, X; Feng, Y; Zhan, ZB; Chen, JC				Zhou, Xiang; Feng, Yu; Zhan, Zhoubing; Chen, Jianchang			Hydrogen Sulfide Alleviates Diabetic Nephropathy in a Streptozotocin-induced Diabetic Rat Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENIN-ANGIOTENSIN SYSTEM; CHRONIC KIDNEY-DISEASE; NF-KAPPA-B; OXIDATIVE STRESS; MECHANISMS; PATHOGENESIS; INFLAMMATION; PROGRESSION	Accumulating evidence has demonstrated that hydrogen sulfide (H2S) plays critical roles in the pathogenesis of chronic kidney diseases. This study was designed to investigate whether H2S has protective effects against diabetic nephropathy. Diabetic rats were induced by intraperitoneal injection of streptozotocin and administrated with H2S donor NaHS for 12 weeks. Rat glomerular mesangial cells were pretreated with NaHS or MAPK inhibitors (U0126, SP600125, and SB203580) prior to high glucose exposure, and cell proliferation was determined. Our findings suggest that H2S can improve renal function and attenuate glomerular basement membrane thickening, mesangial matrix deposition, and renal interstitial fibrosis in diabetic rats. H2S was found to reduce high glucose-induced oxidative stress by activating the Nrf2 antioxidant pathway and to exert anti-inflammatory effects by inhibiting NF-kappa B signaling. In addition, H2S reduced high glucose-induced mesangial cell proliferation by blockade of MAPK signaling pathways. Moreover, H2S was also found to inhibit the renin-angiotensin system in diabetic kidney. In conclusion, our study demonstrates that H2S alleviates the development of diabetic nephropathy by attenuating oxidative stress and inflammation, reducing mesangial cell proliferation, and inhibiting renin-angiotensin system activity.	[Zhou, Xiang; Chen, Jianchang] Soochow Univ, Dept Cardiol, Affiliated Hosp 2, Suzhou 215004, Peoples R China; [Feng, Yu] Soochow Univ, Dept Endocrinol, Affiliated Hosp 2, Suzhou 215004, Peoples R China; [Zhan, Zhoubing] Soochow Univ, Dept Nephrol, Affiliated Hosp 2, Suzhou 215004, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Zhou, X (corresponding author), Soochow Univ, Dept Cardiol, Affiliated Hosp 2, 1055 Sanxiang Rd, Suzhou 215004, Peoples R China.	zhou-xiang@suda.edu.cn						Aminzadeh MA, 2012, NEPHROL DIAL TRANSPL, V27, P498, DOI 10.1093/ndt/gfr560; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Carey RM, 2003, TRENDS ENDOCRIN MET, V14, P274, DOI 10.1016/S1043-2760(03)00111-5; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Gurley SB, 2007, SEMIN NEPHROL, V27, P144, DOI 10.1016/j.semnephrol.2007.01.009; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kashihara N, 2010, CURR MED CHEM, V17, P4256, DOI 10.2174/092986710793348581; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kawano H, 2003, J AM SOC NEPHROL, V14, P584, DOI 10.1097/01.ASN.0000050415.97942.2F; Lim AKH, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/146154; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Remuzzi G, 2005, KIDNEY INT, V68, P57; Saito H, 2013, BIOCHEM PHARMACOL, V85, P865, DOI 10.1016/j.bcp.2013.01.006; Song K, 2014, KIDNEY INT, V85, P1318, DOI 10.1038/ki.2013.449; Stanton RC, 2011, CURR DIABETES REP, V11, P330, DOI 10.1007/s11892-011-0196-9; Sun YM, 2013, BIOCHEM BIOPH RES CO, V433, P359, DOI 10.1016/j.bbrc.2013.02.120; Wada J, 2013, CLIN SCI, V124, P139, DOI 10.1042/CS20120198; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x	20	115	123	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28827	28834		10.1074/jbc.M114.596593	http://dx.doi.org/10.1074/jbc.M114.596593			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25164822	Green Published, hybrid			2022-12-28	WOS:000344141000007
J	Alvarado, JJ; Tarafdar, S; Yeh, JI; Smithgall, TE				Alvarado, John Jeff; Tarafdar, Sreya; Yeh, Joanne I.; Smithgall, Thomas E.			Interaction with the Src Homology (SH3-SH2) Region of the Src-family Kinase Hck Structures the HIV-1 Nef Dimer for Kinase Activation and Effector Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CRYSTAL-STRUCTURE; TYROSINE KINASE; SH3 DOMAIN; DOWN-REGULATION; TYPE-1 NEF; C-SRC; PROTEIN; BINDING; SURFACE	HIV-1 Nef supports high titer viral replication in vivo and is essential for AIDS progression. Nef function depends on interactions with multiple host cell effectors, including Hck and other Src-family kinases. Here we describe the x-ray crystal structure of Nef in complex with the Hck SH3-SH2 regulatory region to a resolution of 1.86 angstrom. The complex crystallized as a dimer of complexes, with the conserved Nef PXXPXR motif engaging the Hck SH3 domain. Anew intercomplex contact was found between SH3 Glu-93, and Nef Arg-105. Mutagenesis of Hck SH3 Glu-93 interfered with Nef.Hck complex formation and kinase activation in cells. The Hck SH2 domains impinge on the N-terminal region of Nef to stabilize a dimer conformation that exposes Asp-123, a residue critical for Nef function. Our results suggest that in addition to serving as a kinase effector for Nef, Hck binding may reorganize the Nef dimer for functional interaction with other signaling partners.	[Alvarado, John Jeff; Tarafdar, Sreya; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Alvarado, John Jeff; Yeh, Joanne I.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15219 USA; [Tarafdar, Sreya] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yeh, JI (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, 1036 BST3,3501 5th Ave, Pittsburgh, PA 15260 USA.	jiyeh@pitt.edu; tsmithga@pitt.edu			National Institutes of Health [AI057083, AI102724]; University of Pittsburgh Center for HIV Protein Interactions (National Institutes of Health) [P50 GM082251]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057083, R01AI102724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh Center for HIV Protein Interactions (National Institutes of Health); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI057083 and AI102724. Initial phases of this work were supported by a pilot grant from the University of Pittsburgh Center for HIV Protein Interactions (National Institutes of Health P50 GM082251).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarado JJ, 2010, J BIOL CHEM, V285, P35455, DOI 10.1074/jbc.M110.145102; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Arold ST, 2001, J BIOL CHEM, V276, P17199, DOI 10.1074/jbc.M011185200; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Choi HJ, 2004, J MOL BIOL, V343, P1255, DOI 10.1016/j.jmb.2004.09.015; Collins KL, 1999, IMMUNOL REV, V168, P65, DOI 10.1111/j.1600-065X.1999.tb01283.x; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dikeakos JD, 2010, MOL BIOL CELL, V21, P3279, DOI 10.1091/mbc.E10-05-0470; ECK MJ, 1994, NATURE, V368, P764, DOI 10.1038/368764a0; Emert-Sedlak L, 2009, ACS CHEM BIOL, V4, P939, DOI 10.1021/cb900195c; Emert-Sedlak LA, 2013, CHEM BIOL, V20, P82, DOI 10.1016/j.chembiol.2012.11.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faraldo-Gomez JD, 2007, P NATL ACAD SCI USA, V104, P13643, DOI 10.1073/pnas.0704041104; Fushman D, 1999, BIOCHEMISTRY-US, V38, P10225, DOI 10.1021/bi990897g; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Geyer M, 2001, FEBS LETT, V496, P91, DOI 10.1016/S0014-5793(01)02394-8; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hanna Z, 2001, J VIROL, V75, P9378, DOI 10.1128/JVI.75.19.9378-9392.2001; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Hochrein JM, 2006, PROTEIN SCI, V15, P65, DOI 10.1110/ps.051782206; Hofmann G, 2005, BIOCHEMISTRY-US, V44, P13043, DOI 10.1021/bi050814y; Horenkamp FA, 2011, TRAFFIC, V12, P867, DOI 10.1111/j.1600-0854.2011.01205.x; Hung CH, 2007, CELL HOST MICROBE, V1, P121, DOI 10.1016/j.chom.2007.03.004; Jason-Moller L., 2006, CURR PROTOC PROTEIN, P1, DOI [10.1002/0471140864.ps1913-45, DOI 10.1002/0471140864.PS1913-45, 10.1002/0471142301.ps1914s45]; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Jolicoeur P, 2011, CURR HIV RES, V9, P524, DOI 10.2174/157016211798842062; Jung JW, 2011, PROTEINS, V79, P1609, DOI 10.1002/prot.22986; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE CH, 1995, EMBO J, V14, P5006, DOI 10.1002/j.1460-2075.1995.tb00183.x; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Liu LX, 2000, J VIROL, V74, P5310, DOI 10.1128/JVI.74.11.5310-5319.2000; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Meiselbach H, 2011, J MOL MODEL, V17, P1927, DOI 10.1007/s00894-010-0897-z; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Murphy Michael, 2006, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471142301.ps1914s45; Narute PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032561; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pene-Dumitrescu Teodora, 2012, BMC Chemical Biology, V12, P1, DOI 10.1186/1472-6769-12-1; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Ren XF, 2014, ELIFE, V3, DOI 10.7554/eLife.01754; Renkema GH, 2000, FRONT BIOSCI-LANDMRK, V5, pD268, DOI 10.2741/Renkema; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Saksela K, 2011, CURR HIV RES, V9, P531, DOI 10.2174/157016211798842107; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Trible RP, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-135; Ulmer TS, 2002, STRUCTURE, V10, P901, DOI 10.1016/S0969-2126(02)00781-5; Venzke S, 2006, J VIROL, V80, P11141, DOI 10.1128/JVI.01556-06; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yang SC, 2010, P NATL ACAD SCI USA, V107, P15757, DOI 10.1073/pnas.1004569107; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4	64	30	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28539	28553		10.1074/jbc.M114.600031	http://dx.doi.org/10.1074/jbc.M114.600031			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25122770	Green Published, hybrid			2022-12-28	WOS:000343765400044
J	Furlan, G; Minowa, T; Hanagata, N; Kataoka-Hamai, C; Kaizuka, Y				Furlan, Gabriela; Minowa, Takashi; Hanagata, Nobutaka; Kataoka-Hamai, Chiho; Kaizuka, Yoshihisa			Phosphatase CD45 Both Positively and Negatively Regulates T Cell Receptor Phosphorylation in Reconstituted Membrane Protein Clusters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACULOVIRUS EXPRESSION SYSTEM; TYROSINE-PHOSPHATASE; SIGNAL-TRANSDUCTION; KINASE LCK; ANTIGEN RECEPTOR; ALPHA-SYNUCLEIN; ZETA-CHAIN; LYMPHOCYTE; ACTIVATION; MICROCLUSTERS	T cell receptor (TCR) phosphorylation requires the kinase Lck and phosphatase CD45. CD45 activates Lck by dephosphorylating an inhibitory tyrosine of Lck to relieve autoinhibition. However, CD45 also dephosphorylates the TCR, and the spatial exclusion of CD45 from TCR clustering in the plasma membrane appears to attenuate this negative effect of CD45. To further investigate the role of CD45 in signal initiation, we reconstituted membrane TCR clusters in vitro on supported lipid bilayers. Fluorescence microscopy of single clusters showed that incorporation of CD45 enhanced phosphorylation of TCR clusters, but only when Lck co-clustered with TCR. We found that clustered Lck autophosphorylated the inhibitory tyrosine and thus could be activated by CD45, whereas diffusive Lck molecules did not. In the TCR-Lck clusters and at low CD45 density, we speculate that the effect of Lck activation may overcome dephosphorylation of TCR, resulting in a net positive regulation. The CD45 density in physiological TCR clusters is also low because of the exclusion of CD45. Thus, we propose that the spatial organization of TCR/Lck/CD45 in T cell membranes is important not only for modulating the negative role of CD45 but also for creating conditions in which CD45 has a positive role in signal initiation.	[Furlan, Gabriela; Minowa, Takashi; Hanagata, Nobutaka; Kataoka-Hamai, Chiho; Kaizuka, Yoshihisa] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050047, Japan	National Institute for Materials Science	Kaizuka, Y (corresponding author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050047, Japan.	KAIZUKA.Yoshihisa@nims.go.jp	KAIZUKA, Yoshihisa/H-2789-2011; Kataoka-Hamai, Chiho/H-2761-2011	Kataoka-Hamai, Chiho/0000-0002-4068-0405; Minowa, Takashi/0000-0003-0046-5230; Hanagata, Nobutaka/0000-0001-6079-3426	Sumitomo foundation	Sumitomo foundation	This work was supported by a grant from the Sumitomo foundation (to Y. K.).	Alexander DR, 2000, SEMIN IMMUNOL, V12, P349, DOI 10.1006/smim.2000.0218; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Berry H, 2002, BIOPHYS J, V83, P1891, DOI 10.1016/S0006-3495(02)73953-2; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Comellas G, 2012, J AM CHEM SOC, V134, P5090, DOI 10.1021/ja209019s; D'Oro U, 1999, J IMMUNOL, V162, P1879; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; FURUKAWA T, 1994, P NATL ACAD SCI USA, V91, P10928, DOI 10.1073/pnas.91.23.10928; Galush WJ, 2008, BIOPHYS J, V95, P2512, DOI 10.1529/biophysj.108.131540; Housden HR, 2003, EUR J BIOCHEM, V270, P2369, DOI 10.1046/j.1432-1033.2003.03604.x; Hui EF, 2014, NAT STRUCT MOL BIOL, V21, P133, DOI 10.1038/nsmb.2762; Ike H, 2003, CHEMPHYSCHEM, V4, P620, DOI 10.1002/cphc.200300670; Isakov N, 1996, J BIOL CHEM, V271, P15753, DOI 10.1074/jbc.271.26.15753; James JR, 2012, NATURE, V487, P64, DOI 10.1038/nature11220; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; Lipowsky R., 1995, HDB BIOL PHYS; McConnell HM, 2003, ANNU REV BIOPH BIOM, V32, P469, DOI 10.1146/annurev.biophys.32.110601.141704; McNeill L, 2007, IMMUNITY, V27, P425, DOI 10.1016/j.immuni.2007.07.015; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; OSUSKY M, 1995, J BIOL CHEM, V270, P25729, DOI 10.1074/jbc.270.43.25729; Pandey AP, 2009, BIOPHYS J, V96, P540, DOI 10.1016/j.bpj.2008.10.011; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; RAMER SE, 1991, P NATL ACAD SCI USA, V88, P6254, DOI 10.1073/pnas.88.14.6254; Rossy J, 2013, NAT IMMUNOL, V14, P82, DOI 10.1038/ni.2488; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Stirnweiss A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003607; Straus DB, 1996, J BIOL CHEM, V271, P9976, DOI 10.1074/jbc.271.17.9976; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; VEILLETTE A, 1989, MOL CELL BIOL, V9, P4441, DOI 10.1128/MCB.9.10.4441; WANG D, 1992, BIOPHYS CHEM, V43, P117, DOI 10.1016/0301-4622(92)80027-3; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Williams A.F., 1986, HDB EXPT IMMUNOLOGY; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zikherman J, 2010, IMMUNITY, V32, P342, DOI 10.1016/j.immuni.2010.03.006	41	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28514	28525		10.1074/jbc.M114.574319	http://dx.doi.org/10.1074/jbc.M114.574319			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25128530	hybrid, Green Published			2022-12-28	WOS:000343765400042
J	Haas, LT; Kostylev, MA; Strittmatter, SM				Haas, Laura T.; Kostylev, Mikhail A.; Strittmatter, Stephen M.			Therapeutic Molecules and Endogenous Ligands Regulate the Interaction between Brain Cellular Prion Protein (PrPC) and Metabotropic Glutamate Receptor 5 (mGluR5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA OLIGOMERS; LONG-TERM DEPRESSION; ALZHEIMERS-DISEASE; A-BETA; IN-VIVO; ALLOSTERIC MODULATORS; ACTIVATION MECHANISM; SYNAPTIC PLASTICITY; COUPLED RECEPTORS; IMPAIRMENT	Soluble Amyloid-beta oligomers (A beta o) can trigger Alzheimer disease (AD) pathophysiology by binding to cell surface cellular prion protein (PrPC). PrPC interacts physically with metabotropic glutamate receptor 5 (mGluR5), and this interaction controls the transmission of neurotoxic signals to intracellular substrates. Because the interruption of the signal transduction from PrPC to mGluR5 has therapeutic potential for AD, we developed assays to explore the effect of endogenous ligands, agonists/antagonists, and antibodies on the interaction between PrPC and mGluR5 in cell lines and mouse brain. We show that the PrPC segment of amino acids 91-153 mediates the interaction with mGluR5. Agonists of mGluR5 increase the mGluR5-PrPC interaction, whereas mGluR5 antagonists suppress protein association. Synthetic A beta o promotes the protein interaction in mouse brain and transfected HEK-293 cell membrane preparations. The interaction of PrPC and mGluR5 is enhanced dramatically in the brains of familial AD transgenic model mice. In brain homogenates with A beta o, the interaction of PrPC and mGluR5 is reversed by mGluR5-directed antagonists or antibodies directed against the PrPC segment of amino acids 91-153. Silent allosteric modulators of mGluR5 do not alter Glu or basal mGluR5 activity, but they disrupt the A beta o-induced interaction of mGluR5 with PrPC. The assays described here have the potential to identify and develop new compounds that inhibit the interaction of PrPC and mGluR5, which plays a pivotal role in the pathogenesis of Alzheimer disease by transmitting the signal from extracellular A beta o into the cytosol.	[Haas, Laura T.; Kostylev, Mikhail A.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Cellular Neurosci Neurodegenerat & Repair Program, Dept Neurol, New Haven, CT 06536 USA; [Haas, Laura T.] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, D-72074 Tubingen, Germany	Yale University; Eberhard Karls University of Tubingen	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Cellular Neurosci Neurodegenerat & Repair Program, 295 Congress Ave, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	; Strittmatter, Stephen/F-5739-2011	Kostylev, Mikhail/0000-0003-0435-8141; Strittmatter, Stephen/0000-0001-8188-3092	National Institutes of Health [R01AG034924]; BrightFocus Foundation; Alzheimer's Association; Falk Medical Research Trust; NATIONAL INSTITUTE ON AGING [R01AG034924] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BrightFocus Foundation(BrightFocus Foundation); Alzheimer's Association(Alzheimer's Association); Falk Medical Research Trust; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AG034924 (to S. M. S.). This work was also supported by grants from the BrightFocus Foundation, Alzheimer's Association, and Falk Medical Research Trust (to S. M. S.). S. M. S. is a cofounder of Axerion Therapeutics, seeking to develop NgR- and PrP-based therapeutics.	Agostini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074244; Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Benarroch EE, 2008, NEUROLOGY, V70, P964, DOI 10.1212/01.wnl.0000306315.03021.2a; Beraldo FH, 2011, FASEB J, V25, P265, DOI 10.1096/fj.10-161653; Berman DE, 2008, NAT NEUROSCI, V11, P547, DOI 10.1038/nn.2100; Bruno V, 2000, NEUROPHARMACOLOGY, V39, P2223, DOI 10.1016/S0028-3908(00)00079-4; Bruno V, 2001, J CEREBR BLOOD F MET, V21, P1013, DOI 10.1097/00004647-200109000-00001; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Francesconi A, 2009, J NEUROSCI, V29, P3590, DOI 10.1523/JNEUROSCI.5824-08.2009; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gandy S, 2010, ANN NEUROL, V68, P220, DOI 10.1002/ana.22052; Gasparini F, 2007, CURR NEUROPHARMACOL, V5, P187, DOI 10.2174/157015907781695900; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Gregory KJ, 2012, MOL PHARMACOL, V82, P860, DOI 10.1124/mol.112.080531; Gregory KJ, 2011, NEUROPHARMACOLOGY, V60, P66, DOI 10.1016/j.neuropharm.2010.07.007; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hu NW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4374; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leclerc Estelle, 2000, Human Antibodies, V9, P207; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lipton Stuart A., 2005, Current Alzheimer Research, V2, P155, DOI 10.2174/1567205053585846; Lu YM, 1997, J NEUROSCI, V17, P5196; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Molck C, 2014, NEUROCHEM RES, V39, P1862, DOI 10.1007/s11064-014-1248-8; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; O'Brien JA, 2003, MOL PHARMACOL, V64, P731, DOI 10.1124/mol.64.3.731; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Rammes G, 2011, NEUROPHARMACOLOGY, V60, P982, DOI 10.1016/j.neuropharm.2011.01.051; Reed MN, 2011, NEUROBIOL AGING, V32, P1784, DOI 10.1016/j.neurobiolaging.2009.11.007; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Ribeiro FM, 2010, CNS NEUROL DISORD-DR, V9, P574; Rondard P, 2011, NEUROPHARMACOLOGY, V60, P82, DOI 10.1016/j.neuropharm.2010.08.009; ROSENMUND C, 1995, J NEUROPHYSIOL, V73, P427, DOI 10.1152/jn.1995.73.1.427; Rushworth JV, 2013, J BIOL CHEM, V288, P8935, DOI 10.1074/jbc.M112.400358; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Serge A, 2002, J NEUROSCI, V22, P3910, DOI 10.1523/JNEUROSCI.22-10-03910.2002; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sheffler DJ, 2011, ADV PHARMACOL, V62, P37, DOI 10.1016/B978-0-12-385952-5.00010-5; Spinner DS, 2007, J LEUKOCYTE BIOL, V81, P1374, DOI 10.1189/jlb.1106665; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Um JW, 2013, PRION, V7, P37, DOI 10.4161/pri.22212; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Wisniewski K, 2002, CNS DRUG REV, V8, P101; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Xu J, 2009, J NEUROSCI, V29, P3676, DOI 10.1523/JNEUROSCI.5716-08.2009; Yusa S, 2012, VIRUSES-BASEL, V4, P3109, DOI 10.3390/v4113109; Zampagni M, 2010, J MOL MED, V88, P597, DOI 10.1007/s00109-010-0603-8; Zou WQ, 2011, J BIOL CHEM, V286, P15095, DOI 10.1074/jbc.M110.199356	75	57	58	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28460	28477		10.1074/jbc.M114.584342	http://dx.doi.org/10.1074/jbc.M114.584342			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25148681	Green Published, hybrid			2022-12-28	WOS:000343765400038
J	Takahashi, D; Dai, HE; Hiromasa, Y; Krishnamoorthi, R; Kanost, MR				Takahashi, Daisuke; Dai, Huaien; Hiromasa, Yasuaki; Krishnamoorthi, Ramaswamy; Kanost, Michael R.			Self-association of an Insect beta-1,3-Glucan Recognition Protein Upon Binding Laminarin Stimulates Prophenoloxidase Activation as an Innate Immune Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL CROSS-LINKING; N-TERMINAL DOMAIN; MANDUCA-SEXTA; SERINE-PROTEASE; CDNA CLONING; PYRALID MOTH; I-TASSER; DROSOPHILA; PURIFICATION; BACTERIA	Insect beta-glucan recognition protein (beta GRP), a pathogen recognition receptor for innate immune responses, detects beta-1,3glucan on fungal surfaces via its N-terminal carbohydrate-binding domain (N-beta GRP) and triggers serine protease cascades for the activation of prophenoloxidase (pro-PO) or Toll pathways. Using biophysical and biochemical methods, we characterized the interaction of the N-terminal domain from Manduca sexta beta GRP2 (N-beta GRP2) with laminarin, a soluble form of beta-1,3-glucan. We found that carbohydrate binding by N-beta GRP2 induces the formation of two types of protein-carbohydrate complexes, depending on the molar ratio of carbohydrate to protein ([C]/[P]). Precipitation, analytical ultracentrifugation, and chemical cross-linking experiments have shown that an insoluble aggregate forms when the molar ratio of carbohydrate to protein is low ([C]/[P] similar to 1). In contrast, a soluble complex, containing at least five N-beta GRP2 molecules forms at a higher molar ratio of carbohydrate/protein ([C]/[P] > 5). A hypothesis that this complex is assembled partly due to protein-protein interactions was supported by chemical cross-linking experiments combined with LC-MS/MS spectrometry analysis, which permitted identification of a specific intermolecular cross-link site between N-beta GRP molecules in the soluble complex. The pro-PO activation in naive plasma was strongly stimulated by addition of the insoluble aggregates of N-beta GRP2. The soluble complex with laminarin formed in the plasma also stimulated pro-PO activation, but at a lower level. Taken together, these results provide experimental evidence for novel mechanisms in which associations of beta GRP with microbial polysaccharide promotes assembly of beta GRP oligomers, which may form a platform needed to trigger the pro-PO pathway activation cascade.	[Takahashi, Daisuke; Dai, Huaien; Hiromasa, Yasuaki; Krishnamoorthi, Ramaswamy; Kanost, Michael R.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA	Kansas State University	Kanost, MR (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.	kanost@ksu.edu		Kanost, Michael/0000-0002-6827-0061	National Center for Research Resources [5P20 RR016464-11]; NIGMS, National Institutes of Health [8P20GM103440-11]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM041247, P20GM103440, R37GM041247, R01GM041247] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Maureen Gorman, David Quilici, and Rebekah Woolsey for helpful comments on the manuscript, and Lisa Brummett for technical assistance. The mass spectrometry experiment was performed by the Nevada Proteomics Center at the University of Nevada, which is supported by Grant 5P20 RR016464-11 from the National Center for Research Resources and Grant 8P20GM103440-11 from the NIGMS, National Institutes of Health.	An CJ, 2009, J BIOL CHEM, V284, P19716, DOI 10.1074/jbc.M109.007112; Bacic A., 2009, CHEM BIOCH BIOL 1 3B; Bennett KL, 2000, PROTEIN SCI, V9, P1503, DOI 10.1110/ps.9.8.1503; Bergenstrahle M, 2010, CARBOHYD RES, V345, P2060, DOI 10.1016/j.carres.2010.06.017; Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; Bhat S, 2010, BIOCHEMISTRY-US, V49, P5213, DOI 10.1021/bi1003734; BHATTACHARYYA L, 1990, BIOCHEMISTRY-US, V29, P7523, DOI 10.1021/bi00484a022; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Choe KM, 2005, P NATL ACAD SCI USA, V102, P1122, DOI 10.1073/pnas.0404952102; D'Ambrosio C, 2003, BIOCHEMISTRY-US, V42, P4430, DOI 10.1021/bi0206715; Dai HE, 2013, BIOCHEMISTRY-US, V52, P161, DOI 10.1021/bi301440p; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DUVIC B, 1990, J BIOL CHEM, V265, P9327; Fabrick JA, 2004, J BIOL CHEM, V279, P26605, DOI 10.1074/jbc.M403382200; Fabrick JA, 2003, INSECT BIOCHEM MOLEC, V33, P579, DOI 10.1016/S0965-1748(03)00029-8; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; GUPTA D, 1994, BIOCHEMISTRY-US, V33, P7495, DOI 10.1021/bi00190a001; Hanashima S, 2014, GLYCOCONJUGATE J, V31, P199, DOI 10.1007/s10719-013-9510-x; Hiromasa Y, 2004, J BIOL CHEM, V279, P6921, DOI 10.1074/jbc.M308172200; HRMOVA M, 1993, BIOCHEM J, V289, P453, DOI 10.1042/bj2890453; Ji CY, 2004, J BIOL CHEM, V279, P34101, DOI 10.1074/jbc.M404584200; Jiang HB, 2004, INSECT BIOCHEM MOLEC, V34, P89, DOI 10.1016/j.ibmb.2003.09.006; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanagawa M, 2011, J BIOL CHEM, V286, P29158, DOI 10.1074/jbc.M111.256701; Keller R., 2004, THESIS SWISS FEDERAL; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lim JH, 2006, J BIOL CHEM, V281, P8286, DOI 10.1074/jbc.M513030200; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; MANDAL DK, 1992, BIOCHEMISTRY-US, V31, P8465, DOI 10.1021/bi00151a012; Mishima Y, 2009, J BIOL CHEM, V284, P28687, DOI 10.1074/jbc.M109.034587; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Petrotchenko EV, 2010, MASS SPECTROM REV, V29, P862, DOI 10.1002/mas.20293; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sacchettini JC, 2001, BIOCHEMISTRY-US, V40, P3009, DOI 10.1021/bi002544j; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SODERHALL K, 1979, CAN J MICROBIOL, V25, P406, DOI 10.1139/m79-062; Takahasi K, 2009, P NATL ACAD SCI USA, V106, P11679, DOI 10.1073/pnas.0901671106; Tong YR, 2005, J BIOL CHEM, V280, P14923, DOI 10.1074/jbc.M500531200; Ueda Y, 2009, J IMMUNOL, V183, P3810, DOI 10.4049/jimmunol.0900430; Wang Y, 2011, INSECT BIOCHEM MOLEC, V41, P322, DOI 10.1016/j.ibmb.2011.01.010; Yu XQ, 2002, INSECT BIOCHEM MOLEC, V32, P1287, DOI 10.1016/S0965-1748(02)00091-7; Zhang R, 2003, J BIOL CHEM, V278, P42072, DOI 10.1074/jbc.M307475200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	48	27	29	1	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28399	28410		10.1074/jbc.M114.583971	http://dx.doi.org/10.1074/jbc.M114.583971			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25147183	Green Published, hybrid			2022-12-28	WOS:000343765400033
J	Teixeira, PC; Ducret, A; Ferber, P; Gaertner, H; Hartley, O; Pagano, S; Butterfield, M; Langen, H; Vuilleumier, N; Cutler, P				Teixeira, Priscila Camillo; Ducret, Axel; Ferber, Philippe; Gaertner, Hubert; Hartley, Oliver; Pagano, Sabrina; Butterfield, Michelle; Langen, Hanno; Vuilleumier, Nicolas; Cutler, Paul			Definition of Human Apolipoprotein A-I Epitopes Recognized by Autoantibodies Present in Patients with Cardiovascular Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; HIGH-DENSITY-LIPOPROTEIN; PERFORMANCE LIQUID-CHROMATOGRAPHY; PRIMARY ANTIPHOSPHOLIPID SYNDROME; RHEUMATOID-ARTHRITIS; A-1 AUTOANTIBODIES; OXIDIZED LDL; HUMAN-PLASMA; MYOCARDIAL-INFARCTION; REVERSIBLE BLOCKING	Autoantibodies to apolipoprotein A-I (anti-apoA-I IgG) have been shown to be both markers and mediators of cardiovascular disease, promoting atherogenesis and unstable atherosclerotic plaque. Previous studies have shown that high levels of anti-apoA-I IgGs are independently associated with major adverse cardiovascular events in patients with myocardial infarction. Autoantibody responses to apoA-I can be polyclonal and it is likely that more than one epitope may exist. To identify the specific immunoreactive peptides in apoA-I, we have developed a set of methodologies and procedures to isolate, purify, and identify novel apoA-I endogenous epitopes. First, we generated high purity apoA-I from human plasma, using thiophilic interaction chromatography followed by enzymatic digestion specifically at lysine or arginine residues. Immunoreactivity to the different peptides generated was tested by ELISA using serum obtained from patients with acute myocardial infarction and high titers of autoantibodies to native apoA-I. The immunoreactive peptides were further sequenced by mass spectrometry. Our approach successfully identified two novel immunoreactive peptides, recognized by autoantibodies from patients suffering from myocardial infarction, who contain a high titer of anti- apoA-I IgG. The discovery of these epitopes may open innovative prognostic and therapeutic opportunities potentially suitable to improve current cardiovascular risk stratification.	[Teixeira, Priscila Camillo; Ducret, Axel; Ferber, Philippe; Butterfield, Michelle; Langen, Hanno; Cutler, Paul] Roche Innovat Ctr, CH-4070 Basel, Switzerland; [Teixeira, Priscila Camillo; Pagano, Sabrina; Vuilleumier, Nicolas] 1205 Geneva Univ Hosp, Div Lab Med, Dept Genet & Lab Med, CH-1205 Geneva, Switzerland; [Gaertner, Hubert; Hartley, Oliver] Univ Geneva, Fac Med, Dept Immunopathol, CH-1205 Geneva, Switzerland	Roche Holding; University of Geneva; University of Geneva	Teixeira, PC (corresponding author), F Hoffmann La Roche, Roche Innovat Ctr Basel, Pharmaceut Sci Pharma Res & Early Dev, Grenzacherstr 124,Bldg 93,Rm 4-38, CH-4070 Basel, Switzerland.	priscila.teixeira@roche.com		, Nicolas/0000-0002-1122-438X; Camillo Teixeira, Priscila/0000-0002-9698-4563	Roche Postdoctoral Fellowship Program; Swiss National Science Foundation [31-0030_140736]	Roche Postdoctoral Fellowship Program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Roche Postdoctoral Fellowship Program and Swiss National Science Foundation Grant 31-0030_140736 (to N.V.).	Abe H, 2001, J RHEUMATOL, V28, P990; Alves JD, 2003, RHEUMATOLOGY, V42, P893, DOI 10.1093/rheumatology/keg248; Ames PRJ, 2010, LUPUS, V19, P711, DOI 10.1177/0961203309357765; Aranow C, 2000, LUPUS, V9, P166, DOI 10.1191/096120300678828208; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENDEL V, 1991, P NATL ACAD SCI USA, V88, P1536, DOI 10.1073/pnas.88.4.1536; Brouillette CG, 2001, BBA-MOL CELL BIOL L, V1531, P4, DOI 10.1016/S1388-1981(01)00081-6; BROUILLETTE CG, 1995, BBA-LIPID LIPID MET, V1256, P103, DOI 10.1016/0005-2760(95)00018-8; Brubaker G, 2006, BBA-MOL CELL BIOL L, V1761, P64, DOI 10.1016/j.bbalip.2006.01.007; BUTLER PJG, 1967, BIOCHEM J, V103, pP78; BUTLER PJG, 1969, BIOCHEM J, V112, P679, DOI 10.1042/bj1120679; Carbone F, 2013, THROMB HAEMOSTASIS, V109, P854, DOI 10.1160/TH12-10-0768; Contiero E, 1997, ELECTROPHORESIS, V18, P122, DOI 10.1002/elps.1150180123; DeMaria AN, 2002, AM J CARDIOL, V89, p33D; Deterding LJ, 2002, ELECTROPHORESIS, V23, P2296, DOI 10.1002/1522-2683(200207)23:14&lt;2296::AID-ELPS2296&gt;3.0.CO;2-I; DOHLMAN JG, 1993, BIOCHEM BIOPH RES CO, V195, P686, DOI 10.1006/bbrc.1993.2100; DUCCESCHI V, 1995, EUR HEART J, V16, P441, DOI 10.1093/oxfordjournals.eurheartj.a060934; EDELSTEIN C, 1986, METHOD ENZYMOL, V128, P339; FIDGE N, 1975, J LIPID RES, V16, P367; Foteinos G, 2005, CIRCULATION, V112, P1206, DOI 10.1161/CIRCULATIONAHA.105.547414; Frostegard J, 2008, LUPUS, V17, P364, DOI 10.1177/0961203308089988; GILL TJ, 1967, J BIOL CHEM, V242, P3308; Huang R, 2011, NAT STRUCT MOL BIOL, V18, P416, DOI 10.1038/nsmb.2028; HUGHES TA, 1988, J LIPID RES, V29, P363; Keller PF, 2012, J INTERN MED, V271, P451, DOI 10.1111/j.1365-2796.2011.02479.x; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Lyssenko NN, 2012, BBA-MOL CELL BIOL L, V1821, P456, DOI 10.1016/j.bbalip.2011.07.020; Mackay IR, 2004, AUTOIMMUN REV, V3, P487, DOI 10.1016/j.autrev.2004.07.011; Mahler M, 2010, ANN NY ACAD SCI, V1183, P267, DOI 10.1111/j.1749-6632.2009.05127.x; Montecucco F, 2011, EUR HEART J, V32, P412, DOI 10.1093/eurheartj/ehq521; Murphy TP, 2011, ATHEROSCLEROSIS, V216, P452, DOI 10.1016/j.atherosclerosis.2011.02.020; Naghavi Morteza, 2006, Crit Pathw Cardiol, V5, P187, DOI 10.1097/01.hpc.0000249784.29151.54; Nilsson J, 2004, CURR OPIN LIPIDOL, V15, P499, DOI 10.1097/00041433-200410000-00002; Nossent H, 2000, J RHEUMATOL, V27, P2282; OTT GS, 1982, J CHROMATOGR, V231, P1, DOI 10.1016/S0378-4347(00)80504-6; Pagano S, 2012, J INTERN MED, V272, P344, DOI 10.1111/j.1365-2796.2012.02530.x; Pawlak K, 2012, ATHEROSCLEROSIS, V224, P252, DOI 10.1016/j.atherosclerosis.2012.07.011; Plotz PH, 2003, NAT REV IMMUNOL, V3, P73, DOI 10.1038/nri976; PORATH J, 1985, FEBS LETT, V185, P306, DOI 10.1016/0014-5793(85)80928-5; Pruijm M, 2012, THER APHER DIAL, V16, P588, DOI 10.1111/j.1744-9987.2012.01102.x; Quercioli A, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/243158; Radwan MM, 2014, CLIN RHEUMATOL, V33, P493, DOI 10.1007/s10067-013-2399-8; Ravandi A, 2011, J LIPID RES, V52, P1829, DOI 10.1194/jlr.M015776; Rosales C, 2009, BIOCHEMISTRY-US, V48, P8070, DOI 10.1021/bi901087z; Rossier MF, 2012, ENDOCRINOLOGY, V153, P1269, DOI 10.1210/en.2011-1835; SANGER F, 1953, BIOCHEM J, V53, P366, DOI 10.1042/bj0530366; Sarzi-Puttini P, 2003, Minerva Med, V94, P63; SEGREST JP, 1992, J LIPID RES, V33, P141; Shoenfeld Y, 2007, ANN NY ACAD SCI, V1108, P227, DOI 10.1196/annals.1422.025; Sigalov AB, 2001, CHEM PHYS LIPIDS, V113, P133, DOI 10.1016/S0009-3084(01)00186-4; Sorci-Thomas MG, 2002, TRENDS CARDIOVAS MED, V12, P121, DOI 10.1016/S1050-1738(01)00163-3; SPRECHER DL, 1984, CLIN CHEM, V30, P2084; Srivastava R, 2011, ARTHRITIS RHEUM-US, V63, P201, DOI 10.1002/art.27764; Svenungsson E, 2001, CIRCULATION, V104, P1887, DOI 10.1161/hc4101.097518; TADEY T, 1995, J CHROMATOGR B, V671, P237, DOI 10.1016/0378-4347(95)00051-J; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P10351, DOI 10.1021/bi060726t; Teixeira PC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/868251; Tricerri A, 1998, BBA-LIPID LIPID MET, V1391, P67, DOI 10.1016/S0005-2760(97)00187-2; Udi N, 2008, AUTOIMMUN REV, V7, P445, DOI 10.1016/j.autrev.2008.04.001; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; Vuilleumier N, 2004, J AUTOIMMUN, V23, P353, DOI 10.1016/j.jaut.2004.08.003; Vuilleumier N, 2010, SCAND J RHEUMATOL, V39, P447, DOI 10.3109/03009741003742755; Vuilleumier N, 2013, THROMB HAEMOSTASIS, V109, P706, DOI 10.1160/TH12-10-0714; Vuilleumier N, 2010, ARTHRITIS RHEUM-US, V62, P2640, DOI 10.1002/art.27546; Vuilleumier N, 2010, EUR HEART J, V31, P815, DOI 10.1093/eurheartj/ehq055; Wick G, 1999, EXP GERONTOL, V34, P559, DOI 10.1016/S0531-5565(99)00035-2; Wick PA, 2013, J PERIODONTAL RES, V48, P350, DOI 10.1111/jre.12014; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	70	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28249	28259		10.1074/jbc.M114.589002	http://dx.doi.org/10.1074/jbc.M114.589002			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25170076	hybrid, Green Published			2022-12-28	WOS:000343765400021
J	Liu, X; Obianyo, O; Chan, CB; Huang, JJ; Xue, SH; Yang, JJ; Zeng, FX; Goodman, M; Ye, KQ				Liu, Xia; Obianyo, Obiamaka; Chan, Chi Bun; Huang, Junjian; Xue, Shenghui; Yang, Jenny J.; Zeng, Fanxing; Goodman, Mark; Ye, Keqiang			Biochemical and Biophysical Investigation of the Brain-derived Neurotrophic Factor Mimetic 7,8-Dihydroxyflavone in the Binding and Activation of the TrkB Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain-Derived Neurotrophic Factor (BDNF); Cell Signaling; Cell Surface Receptor; Endocytosis; Phosphorylation; 7; 8-Dihydroxyflavone; TrkB	NERVE GROWTH-FACTOR; MOUSE MODEL; SYNAPTIC PLASTICITY; SIGNAL-TRANSDUCTION; MEMORY DEFICITS; BDNF; AGONIST; SURVIVAL; INTERNALIZATION; IDENTIFICATION	Background: 7,8-DHF (7,8-dihydroxyflavone) is a TrkB agonist, but its receptor activation mechanism is not well understood. Results: 7,8-DHF and BDNF display differential receptor binding affinity, receptor activation kinetics, receptor phosphorylation pattern, and ligand-induced receptor degradation. Conclusion: 7,8-DHF and BDNF utilize different mechanisms to activate TrkB. Significance: This report provides mechanistic insights into how 7,8-DHF induces TrkB activation. 7,8-dihydroxyflavone (7,8-DHF), a newly identified small molecular TrkB receptor agonist, rapidly activates TrkB in both primary neurons and the rodent brain and mimics the physiological functions of the cognate ligand BDNF. Accumulating evidence supports that 7,8-DHF exerts neurotrophic effects in a TrkB-dependent manner. Nonetheless, the differences between 7,8-DHF and BDNF in activating TrkB remain incompletely understood. Here we show that 7,8-DHF and BDNF exhibit different TrkB activation kinetics in which TrkB maturation may be implicated. Employing two independent biophysical approaches, we confirm that 7,8-DHF interacts robustly with the TrkB extracellular domain, with a K-d of approximate to 10 nm. Although BDNF transiently activates TrkB, leading to receptor internalization and ubiquitination/degradation, in contrast, 7,8-DHF-triggered TrkB phosphorylation lasts for hours, and the internalized receptors are not degraded. Notably, primary neuronal maturation may be required for 7,8-DHF but not for BDNF to elicit the full spectrum of TrkB signaling cascades. Hence, 7,8-DHF interacts robustly with the TrkB receptor, and its agonistic effect may be mediated by neuronal development and maturation.	[Liu, Xia; Obianyo, Obiamaka; Chan, Chi Bun; Huang, Junjian; Ye, Keqiang] Emory Univ, Sch Med, Dept Pathol & Lab Med, Ctr Syst Imaging,Wesley Woods Hlth Ctr, Atlanta, GA 30322 USA; [Zeng, Fanxing; Goodman, Mark] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Ctr Syst Imaging,Wesley Woods Hlth Ctr, Atlanta, GA 30322 USA; [Zeng, Fanxing; Goodman, Mark] Emory Univ, Sch Med, Dept Psychiat, Ctr Syst Imaging,Wesley Woods Hlth Ctr, Atlanta, GA 30322 USA; [Zeng, Fanxing; Goodman, Mark] Emory Univ, Sch Med, Dept Hematol & Oncol, Ctr Syst Imaging,Wesley Woods Hlth Ctr, Atlanta, GA 30322 USA; [Xue, Shenghui; Yang, Jenny J.] Georgia State Univ, CDT, Dept Chem, Atlanta, GA 30303 USA; [Xue, Shenghui; Yang, Jenny J.] Georgia State Univ, CDT, Dept Biol, Atlanta, GA 30303 USA	Emory University; Emory University; Emory University; Emory University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Ye, KQ (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Ctr Syst Imaging,Wesley Woods Hlth Ctr, Atlanta, GA 30322 USA.	kye@emory.edu		, Junjian/0000-0002-9943-0865	National Institutes of Health [RO1, DC010204, NS045627]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045627, P30NS055077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1, DC010204 and NS045627 (to K. Y.).	Andero R, 2012, HIPPOCAMPUS, V22, P399, DOI 10.1002/hipo.20906; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Beattie EC, 2000, J NEUROSCI, V20, P7325; Bernard-Gauthier V, 2013, BIOORGAN MED CHEM, V21, P7816, DOI 10.1016/j.bmc.2013.10.012; Blugeot A, 2011, J NEUROSCI, V31, P12889, DOI 10.1523/JNEUROSCI.1309-11.2011; Briones TL, 2013, NEUROSCIENCE, V254, P324, DOI 10.1016/j.neuroscience.2013.09.031; Campenot RB, 2004, J NEUROBIOL, V58, P217, DOI 10.1002/neu.10322; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Choi DC, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.128; Choi DC, 2010, P NATL ACAD SCI USA, V107, P2675, DOI 10.1073/pnas.0909359107; Croll SD, 1998, EXP NEUROL, V152, P20, DOI 10.1006/exnr.1998.6836; Cunningham ME, 1997, J BIOL CHEM, V272, P10957; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Devi L, 2012, NEUROPSYCHOPHARMACOL, V37, P434, DOI 10.1038/npp.2011.191; Du J, 2003, J CELL BIOL, V163, P385, DOI 10.1083/jcb.200305134; English AW, 2013, P NATL ACAD SCI USA, V110, P16217, DOI 10.1073/pnas.1303646110; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; ESCANDON E, 1994, J NEUROSCI, V14, P2054; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Grimes ML, 1996, J NEUROSCI, V16, P7950; GUITON M, 1995, BIOCHEM SOC T, V23, pS176, DOI 10.1042/bst023176s; Gupta VK, 2013, INT J MOL SCI, V14, P10122, DOI 10.3390/ijms140510122; HANIU M, 1995, ARCH BIOCHEM BIOPHYS, V322, P256, DOI 10.1006/abbi.1995.1460; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Hung PL, 2013, STROKE, V44, P2275, DOI 10.1161/STROKEAHA.113.001552; Jadhav T, 2008, BIOCHEM BIOPH RES CO, V371, P521, DOI 10.1016/j.bbrc.2008.04.138; Jang SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011528; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Jiang ML, 2013, HUM MOL GENET, V22, P2462, DOI 10.1093/hmg/ddt098; Johnson RA, 2012, J APPL PHYSIOL, V112, P704, DOI 10.1152/japplphysiol.01361.2011; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; KNUSEL B, 1994, J NEUROSCI, V14, P1542, DOI 10.1523/JNEUROSCI.14-03-01542.1994; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; Liu X, 2012, J MED CHEM, V55, P8524, DOI 10.1021/jm301099x; Liu X, 2010, J MED CHEM, V53, P8274, DOI 10.1021/jm101206p; Makkerh JPS, 2005, EMBO REP, V6, P936, DOI 10.1038/sj.embor.7400503; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; Mantilla CB, 2012, MUSCLE NERVE, V45, P274, DOI 10.1002/mus.22295; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; OBERMEIER A, 1993, J BIOL CHEM, V268, P22963; Philippidou P, 2011, P NATL ACAD SCI USA, V108, P852, DOI 10.1073/pnas.1015981108; Tsai T, 2013, MOL CELL NEUROSCI, V56, P18, DOI 10.1016/j.mcn.2013.02.007; Ultsch MH, 1999, J MOL BIOL, V290, P149, DOI 10.1006/jmbi.1999.2816; Uluc K, 2013, CNS NEUROL DISORD-DR, V12, P360, DOI 10.2174/18715273113129990061; Wang B, 2014, J MOL HISTOL, V45, P129, DOI 10.1007/s10735-013-9539-y; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4; Wetsel WC, 2013, P NATL ACAD SCI USA, V110, P17362, DOI 10.1073/pnas.1314698110; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; WINDISCH JM, 1995, BIOCHEMISTRY-US, V34, P11256, DOI 10.1021/bi00035a035; Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6; Yu Q, 2013, J NEUROSCI, V33, P13042, DOI 10.1523/JNEUROSCI.0854-13.2013; Zeng Y, 2012, J ALZHEIMERS DIS, V31, P765, DOI 10.3233/JAD-2012-120886; Zeng Y, 2012, J NEUROCHEM, V122, P800, DOI 10.1111/j.1471-4159.2012.07830.x; Zeng Y, 2011, J NEUROSCI, V31, P17800, DOI 10.1523/JNEUROSCI.3878-11.2011; Zhang ZT, 2014, NEUROPSYCHOPHARMACOL, V39, P638, DOI 10.1038/npp.2013.243; Zhou XJ, 2011, J NEUROCHEM, V119, P1205, DOI 10.1111/j.1471-4159.2011.07528.x	59	72	74	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27571	27584		10.1074/jbc.M114.562561	http://dx.doi.org/10.1074/jbc.M114.562561			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25143381	hybrid, Green Published			2022-12-28	WOS:000342852800019
J	Trujillo, JA; Croft, NP; Dudek, NL; Channappanavar, R; Theodossis, A; Webb, AI; Dunstone, MA; Illing, PT; Butler, NS; Fett, C; Tscharke, DC; Rossjohn, J; Perlman, S; Purcell, AW				Trujillo, Jonathan A.; Croft, Nathan P.; Dudek, Nadine L.; Channappanavar, Rudragouda; Theodossis, Alex; Webb, Andrew I.; Dunstone, Michelle A.; Illing, Patricia T.; Butler, Noah S.; Fett, Craig; Tscharke, David C.; Rossjohn, Jamie; Perlman, Stanley; Purcell, Anthony W.			The Cellular Redox Environment Alters Antigen Presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antigen Presentation; Antigen Processing; Glutathionylation; Mass Spectrometry (MS); Oxidation-Reduction (Redox); Redox Regulation; T-cell; Viral Immunology	UNFOLDED PROTEIN RESPONSE; CLASS-I; T-CELLS; OXIDATIVE STRESS; GLUTATHIONE DISULFIDE; CYSTEINE RESIDUES; MOLECULAR-BASIS; A-CHAIN; VIRUS; PEPTIDE	Cysteine-containing peptides represent an important class of T cell epitopes, yet their prevalence remains underestimated. We have established and interrogated a database of around 70,000 naturally processed MHC-bound peptides and demonstrate that cysteine-containing peptides are presented on the surface of cells in an MHC allomorph-dependent manner and comprise on average 5-10% of the immunopeptidome. A significant proportion of these peptides are oxidatively modified, most commonly through covalent linkage with the antioxidant glutathione. Unlike some of the previously reported cysteine-based modifications, this represents a true physiological alteration of cysteine residues. Furthermore, our results suggest that alterations in the cellular redox state induced by viral infection are communicated to the immune system through the presentation of S-glutathionylated viral peptides, resulting in altered T cell recognition. Our data provide a structural basis for how the glutathione modification alters recognition by virus-specific T cells. Collectively, these results suggest that oxidative stress represents a mechanism for modulating the virus-specific T cell response.	[Trujillo, Jonathan A.; Channappanavar, Rudragouda; Butler, Noah S.; Fett, Craig; Perlman, Stanley] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Trujillo, Jonathan A.; Perlman, Stanley] Univ Iowa, Interdisciplinary Program Immunol, Iowa City, IA 52242 USA; [Croft, Nathan P.; Dudek, Nadine L.; Webb, Andrew I.; Illing, Patricia T.; Purcell, Anthony W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Croft, Nathan P.; Dudek, Nadine L.; Theodossis, Alex; Dunstone, Michelle A.; Rossjohn, Jamie; Purcell, Anthony W.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Tscharke, David C.; Rossjohn, Jamie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Butler, Noah S.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales	University of Iowa; University of Iowa; University of Melbourne; Monash University; Monash University; Australian National University; Cardiff University	Perlman, S (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	Stanley-perlman@uiowa.edu; anthony.purcell@monash.edu	Croft, Nathan/K-3846-2019; Illing, Patricia/AAP-6045-2021; Tscharke, David/C-9133-2009; Rossjohn, Jamie/F-9032-2013; Purcell, Anthony/AAH-1942-2019; Dunstone, Michelle/I-2895-2014	Croft, Nathan/0000-0002-2128-5127; Illing, Patricia/0000-0002-3870-0796; Tscharke, David/0000-0001-6825-9172; Rossjohn, Jamie/0000-0002-2020-7522; Purcell, Anthony/0000-0003-0532-8331; Dunstone, Michelle/0000-0002-6026-648X; Perlman, Stanley/0000-0003-4213-2354; Trujillo, Jonathan/0000-0002-0184-9773; Butler, Noah/0000-0002-1429-0796	National Institutes of Health [R01 NS036592]; Australian Research Council (ARC) [LE100100036]; Juvenile Diabetes Research Foundation [17-2012-134]; National Institutes of Health National Research Service Award [AI093129]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council (ARC)(Australian Research Council); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS036592. This work was also supported by an infrastructure grant (Grant LE100100036) from the Australian Research Council (ARC) and a project grant from the Juvenile Diabetes Research Foundation (17-2012-134).; Supported by National Institutes of Health National Research Service Award AI093129.	Abdalla MY, 2005, J MED VIROL, V76, P489, DOI 10.1002/jmv.20388; Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Anghelina D, 2006, AM J PATHOL, V169, P209, DOI 10.2353/ajpath.2006.051308; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergmann CC, 2006, NAT REV MICROBIOL, V4, P121, DOI 10.1038/nrmicro1343; Bowen DG, 2005, J EXP MED, V201, P1709, DOI 10.1084/jem.20050808; Broughton SE, 2012, IMMUNITY, V37, P611, DOI 10.1016/j.immuni.2012.07.013; BUHL R, 1989, LANCET, V2, P1294; Burnett HF, 2012, CELL STRESS CHAPERON, V17, P473, DOI 10.1007/s12192-012-0324-8; Butler NS, 2008, J IMMUNOL, V180, P3926, DOI 10.4049/jimmunol.180.6.3926; Butler NS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000186; Campos-Perez J, 2013, INT J CANCER, V133, P1400, DOI 10.1002/ijc.28156; CASTRO RF, 1995, J VIROL, V69, P8127, DOI 10.1128/JVI.69.12.8127-8131.1995; Chen WS, 1999, J EXP MED, V189, P1757, DOI 10.1084/jem.189.11.1757; Davis DA, 2003, J VIROL, V77, P3319, DOI 10.1128/JVI.77.5.3319-3325.2003; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeDiego ML, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002315; Depontieu FR, 2009, P NATL ACAD SCI USA, V106, P12073, DOI 10.1073/pnas.0903852106; Dudek NL, 2012, DIABETES, V61, P3018, DOI 10.2337/db11-1333; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gelderman KA, 2007, ANTIOXID REDOX SIGN, V9, P1541, DOI 10.1089/ars.2007.1569; Ghezzi P, 2002, MOL IMMUNOL, V38, P773, DOI 10.1016/S0161-5890(01)00114-6; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Gonzalez-Dosal R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002250; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Haque MA, 2001, J IMMUNOL, V166, P4543, DOI 10.4049/jimmunol.166.7.4543; Harada M, 2004, J IMMUNOL, V172, P2659, DOI 10.4049/jimmunol.172.4.2659; Hassan IH, 2012, J BIOL CHEM, V287, P4679, DOI 10.1074/jbc.M111.284695; Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kittlesen DJ, 1998, J IMMUNOL, V160, P2099; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lassoued S, 2008, MOL CELL BIOCHEM, V313, P179, DOI 10.1007/s11010-008-9755-z; Lawless MW, 2012, CYTOKINE, V59, P195, DOI 10.1016/j.cyto.2012.04.003; Macdonald WA, 2003, J EXP MED, V198, P679, DOI 10.1084/jem.20030066; Mannering SI, 2009, CLIN EXP IMMUNOL, V156, P226, DOI 10.1111/j.1365-2249.2009.03907.x; Mannering SI, 2005, J EXP MED, V202, P1191, DOI 10.1084/jem.20051251; Meadows L, 1997, IMMUNITY, V6, P273, DOI 10.1016/S1074-7613(00)80330-1; Merquiol E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024660; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mieyal JJ, 2012, ANTIOXID REDOX SIGN, V16, P471, DOI 10.1089/ars.2011.4454; Mohammed F, 2008, NAT IMMUNOL, V9, P1236, DOI 10.1038/ni.1660; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perlman S, 2005, NAT REV IMMUNOL, V5, P917, DOI 10.1038/nri1732; Petersen J, 2014, NAT STRUCT MOL BIOL, V21, P480, DOI 10.1038/nsmb.2817; Petersen J, 2009, J MOL MED, V87, P1045, DOI 10.1007/s00109-009-0526-4; Petersen J, 2009, P NATL ACAD SCI USA, V106, P2776, DOI 10.1073/pnas.0812901106; Pewe L, 1999, VIROLOGY, V255, P106, DOI 10.1006/viro.1998.9576; Pewe LL, 2004, J IMMUNOL, V172, P3151, DOI 10.4049/jimmunol.172.5.3151; Pierce RA, 1999, J IMMUNOL, V163, P6360; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Purcell AW, 2001, J IMMUNOL, V166, P1016, DOI 10.4049/jimmunol.166.2.1016; Qian ZK, 2012, J VIROL, V86, P6712, DOI 10.1128/JVI.00200-12; Qiao SW, 2009, CURR OPIN IMMUNOL, V21, P111, DOI 10.1016/j.coi.2009.03.004; Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085; Sakai J, 2012, IMMUNITY, V37, P1037, DOI 10.1016/j.immuni.2012.08.017; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Scull KE, 2012, MOL IMMUNOL, V51, P136, DOI 10.1016/j.molimm.2012.02.117; Shelton MD, 2008, MOL CELLS, V25, P332; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Tan CT, 2011, PROTEOMICS, V11, P2336, DOI 10.1002/pmic.201000531; Theodossis A, 2010, P NATL ACAD SCI USA, V107, P5534, DOI 10.1073/pnas.1000032107; Trujillo JA, 2014, J IMMUNOL, V192, P5245, DOI 10.4049/jimmunol.1400111; Trujillo-Alonso V, 2011, J VIROL, V85, P12594, DOI 10.1128/JVI.05620-11; van Venrooij WJ, 2011, NAT REV RHEUMATOL, V7, P391, DOI 10.1038/nrrheum.2011.76; Viswanathan K, 2005, P NATL ACAD SCI USA, V102, P5808, DOI 10.1073/pnas.0501650102; Webb AI, 2004, J BIOL CHEM, V279, P23438, DOI 10.1074/jbc.M314066200; Webb AI, 2005, J IMMUNOL, V175, P3810, DOI 10.4049/jimmunol.175.6.3810; Wu GF, 2000, J IMMUNOL, V165, P2278, DOI 10.4049/jimmunol.165.4.2278; Zarling AL, 2006, P NATL ACAD SCI USA, V103, P14889, DOI 10.1073/pnas.0604045103; Zhao JX, 2009, J IMMUNOL, V183, P5163, DOI 10.4049/jimmunol.0902164	79	34	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27979	27991		10.1074/jbc.M114.573402	http://dx.doi.org/10.1074/jbc.M114.573402			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25135637	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000342852800051
J	Menon, BRK; Fisher, K; Rigby, SEJ; Scrutton, NS; Leys, D				Menon, Binuraj R. K.; Fisher, Karl; Rigby, Stephen E. J.; Scrutton, Nigel S.; Leys, David			A Conformational Sampling Model for Radical Catalysis in Pyridoxal Phosphate- and Cobalamin-dependent Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenosylcobalamin (AdoCbl); Electron Paramagnetic Resonance (EPR); Protein Dynamic; Pyridoxal Phosphate; Radical; Conformational Sampling; Domain Dynamics; Ornithine Aminomutase	METHYLMALONYL-COA MUTASE; CARBON BOND HOMOLYSIS; ELECTRON-TRANSFERRING FLAVOPROTEIN; HYDROGEN-ATOM ABSTRACTION; HUMAN METHIONINE SYNTHASE; ORNITHINE 4,5-AMINOMUTASE; CRYSTAL-STRUCTURE; C BOND; B-12-DEPENDENT ENZYME; GLUTAMATE MUTASE	Background: Catalysis in ornithine 4,5-aminomutase (OAM) may involve large scale domain dynamics. Results: A conformational equilibrium is established following release of Lys(629) from the PLP cofactor. Conclusion: Substrate binding triggers conformational sampling of the cobalamin-binding domain to support catalysis. Significance: A model for radical catalysis involving domain conformational sampling is established for pyridoxal phosphate/cobalamin-dependent enzymes. Cobalamin-dependent enzymes enhance the rate of C-Co bond cleavage by up to approximate to 10(12)-fold to generate cob(II)alamin and a transient adenosyl radical. In the case of the pyridoxal 5-phosphate (PLP) and cobalamin-dependent enzymes lysine 5,6-aminomutase and ornithine 4,5 aminomutase (OAM), it has been proposed that a large scale domain reorientation of the cobalamin-binding domain is linked to radical catalysis. Here, OAM variants were designed to perturb the interface between the cobalamin-binding domain and the PLP-binding TIM barrel domain. Steady-state and single turnover kinetic studies of these variants, combined with pulsed electron-electron double resonance measurements of spin-labeled OAM were used to provide direct evidence for a dynamic interface between the cobalamin and PLP-binding domains. Our data suggest that following ligand binding-induced cleavage of the Lys(629)-PLP covalent bond, dynamic motion of the cobalamin-binding domain leads to conformational sampling of the available space. This supports radical catalysis through transient formation of a catalytically competent active state. Crucially, it appears that the formation of the state containing both a substrate/product radical and Co(II) does not restrict cobalamin domain motion. A similar conformational sampling mechanism has been proposed to support rapid electron transfer in a number of dynamic redox systems.	[Menon, Binuraj R. K.; Fisher, Karl; Rigby, Stephen E. J.; Scrutton, Nigel S.; Leys, David] Univ Manchester, Manchester Inst Biotechnol, Fac Life Sci, Manchester M1 7DN, Lancs, England	University of Manchester	Scrutton, NS (corresponding author), Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester M13 9PL, Lancs, England.	nigel.scrutton@manchester.ac.uk; david.leys@manchester.ac.uk	Menon, Binuraj/AAO-7752-2021; Fisher, Karl/A-5956-2013; menon, binuraj/D-6731-2015; Scrutton, Nigel/B-7352-2017	Menon, Binuraj/0000-0001-6852-8053; Fisher, Karl/0000-0003-3539-8939; Scrutton, Nigel/0000-0002-4182-3500	UK Biotechnology and Biological Research Council [BB/H000577/1]; Engineering and Physical Sciences Research Council [EP/J020192/1]; Royal Society; BBSRC [BB/E013007/1, BB/H000577/1] Funding Source: UKRI; EPSRC [EP/J020192/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H000577/1, BB/E013007/1] Funding Source: researchfish	UK Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by UK Biotechnology and Biological Research Council Grant BB/H000577/1 (to D. L., S. E. J. R., and N. S. S.).; Engineering and Physical Sciences Research Council Established Career Fellow under Grant EP/J020192/1 and a Royal Society Wolfson Merit Award holder. To whom correspondence may be addressed: Manchester Inst. of Biotechnology, Faculty of Life Sciences, University of Manchester, Manchester M13 9PL, UK. Tel.: 44-161-306-5150; Fax: 44-161-306-5199; E-mail: nigel.scrutton@manchester.ac.uk.	Brown KL, 2005, CHEM REV, V105, P2075, DOI 10.1021/cr030720z; Burgess SG, 2008, BIOCHEMISTRY-US, V47, P5168, DOI 10.1021/bi800127d; Chen ZG, 2013, CHEMBIOCHEM, V14, P1529, DOI 10.1002/cbic.201300420; Dowling DP, 2012, ANNU REV BIOPHYS, V41, P403, DOI 10.1146/annurev-biophys-050511-102225; Erales J, 2009, BIOCHEMISTRY-US, V48, P6034, DOI 10.1021/bi900569h; HAY BP, 1986, J AM CHEM SOC, V108, P4820, DOI 10.1021/ja00276a020; Huhta MS, 2001, BIOCHEM J, V355, P131, DOI 10.1042/0264-6021:3550131; Jones AR, 2013, FEBS J, V280, P2997, DOI 10.1111/febs.12223; Klug CS, 2008, METHOD CELL BIOL, V84, P617, DOI 10.1016/S0091-679X(07)84020-9; Leys D, 2003, NAT STRUCT BIOL, V10, P219, DOI 10.1038/nsb894; Maity AN, 2014, INT J MOL SCI, V15, P3064, DOI 10.3390/ijms15023064; Makins C, 2013, BIOCHEMISTRY-US, V52, P878, DOI 10.1021/bi3012719; Makins C, 2012, BIOORG CHEM, V40, P39, DOI 10.1016/j.bioorg.2011.08.003; Mancia F, 1998, STRUCTURE, V6, P711, DOI 10.1016/S0969-2126(98)00073-2; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Mancia F, 1999, BIOCHEMISTRY-US, V38, P7999, DOI 10.1021/bi9903852; Marsh ENG, 1998, BIOCHEMISTRY-US, V37, P11864, DOI 10.1021/bi980512e; MARSH ENG, 1995, BIOESSAYS, V17, P431, DOI 10.1002/bies.950170511; Matthews RG, 2008, CURR OPIN STRUC BIOL, V18, P658, DOI 10.1016/j.sbi.2008.11.005; Padmakumar R, 1997, BIOCHEMISTRY-US, V36, P3713, DOI 10.1021/bi962503g; Pang JY, 2012, J AM CHEM SOC, V134, P2367, DOI 10.1021/ja210417k; Reed GH, 2003, CURR OPIN STRUC BIOL, V13, P716, DOI 10.1016/j.sbi.2003.10.011; Robertson WD, 2011, J AM CHEM SOC, V133, P6968, DOI 10.1021/ja107052p; Roman-Melendez GD, 2014, BIOCHEMISTRY-US, V53, P169, DOI 10.1021/bi4012644; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; SCHWEIGER A, 2001, PRINCIPLES PULSE ELE, P183; STUBBE JA, 1989, ANNU REV BIOCHEM, V58, P257; Toogood HS, 2005, J BIOL CHEM, V280, P30361, DOI 10.1074/jbc.M505562200; Richard W, 2010, J MAGN RESON, V207, P164, DOI 10.1016/j.jmr.2010.08.002; Wolthers KR, 2007, BIOCHEMISTRY-US, V46, P6696, DOI 10.1021/bi700339v; Wolthers KR, 2007, FEBS J, V274, P738, DOI 10.1111/j.1742-4658.2006.05618.x; Wolthers KR, 2010, J BIOL CHEM, V285, P13942, DOI 10.1074/jbc.M109.068908; Wolthers KR, 2008, J BIOL CHEM, V283, P34615, DOI 10.1074/jbc.M807911200	33	3	3	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34161	34174		10.1074/jbc.M114.590471	http://dx.doi.org/10.1074/jbc.M114.590471			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25213862	Green Published, hybrid			2022-12-28	WOS:000346077600040
J	Gonzalez, WG; Pham, K; Miksovska, J				Gonzalez, Walter G.; Pham, Khoa; Miksovska, Jaroslava			Modulation of the Voltage-gated Potassium Channel (Kv4.3) and the Auxiliary Protein (KChIP3) Interactions by the Current Activator NS5806	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium-binding Protein; Fluorescence Resonance Energy Transfer (FRET); Isothermal Titration Calorimetry (ITC); Potassium Channel; Protein Drug Interaction; KChIP; Kv4; NCS; NS5806; Calsenilin	CALCIUM-BINDING PROTEIN; K+ CHANNELS; DNA-BINDING; TERMINAL DOMAINS; HEART-FAILURE; ION CHANNELS; INACTIVATION; DREAM; EXPRESSION; SUBUNITS	KChIP3 (potassium channel interacting protein 3) is a calcium-binding protein that binds at the N terminus of the Kv4 voltage-gated potassium channel through interactions at two contact sites and has been shown to regulate potassium current gating kinetics as well as channel trafficking in cardiac and neuronal cells. Using fluorescence spectroscopy, isothermal calorimetry, and docking simulations we show that the novel potassium current activator, NS5806, binds at a hydrophobic site on the C terminus of KChIP3 in a calcium-dependent manner, with an equilibrium dissociation constant of 2-5 m in the calcium-bound form. We further determined that the association between KChIP3 and the hydrophobic N terminus of Kv4.3 is calcium-dependent, with an equilibrium dissociation constant in the apo-state of 70 +/- 3 m and 2.7 +/- 0.1 m in the calcium-bound form. NS5806 increases the affinity between KChIP3 and the N terminus of Kv4.3 (K-d = 1.9 +/- 0.1 m) in the presence and absence of calcium. Mutation of Tyr-174 or Phe-218 on KChIP3 abolished the enhancement of Kv4.3 site 1 binding in the apo-state, highlighting the role of these residues in drug and K4.3 binding. Kinetic studies show that NS5806 decreases the rate of dissociation between KChIP3 and the N terminus of K(V)4.3. Overall, these studies support the idea that NS5806 directly interacts with KChIP3 and modulates the interactions between this calcium-binding protein and the T1 domain of the Kv4.3 channels through reorientation of helix 10 on KChIP3.	[Gonzalez, Walter G.; Pham, Khoa; Miksovska, Jaroslava] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA	State University System of Florida; Florida International University	Miksovska, J (corresponding author), Florida Int Univ, Dept Chem & Biochem, 11200 SW 8th St, Miami, FL 33199 USA.	miksovsk@fiu.edu		Gonzalez, Walter/0000-0003-1310-9323; Pham, Khoa/0000-0001-7449-1226	National Institutes of Health [R25 GM061347]; National Science Foundation [MCB 1021831]; James and Esther King eBiomedical Research Program, Florida Department of Health; Div Of Molecular and Cellular Bioscience [1021831] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); James and Esther King eBiomedical Research Program, Florida Department of Health; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R25 GM061347 (NIGMS; to W. G. G.). This work was also supported by National Science Foundation (MCB 1021831) and the James and Esther King eBiomedical Research Program, Florida Department of Health.	Adams SR, 2008, NAT PROTOC, V3, P1527, DOI 10.1038/nprot.2008.144; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; Bahring R, 2011, J PHYSIOL-LONDON, V589, P461, DOI 10.1113/jphysiol.2010.191965; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; BEECHEM JM, 1989, CHEM PHYS LIPIDS, V50, P237, DOI 10.1016/0009-3084(89)90052-2; Bourdeau ML, 2011, NEUROSCIENCE, V176, P173, DOI 10.1016/j.neuroscience.2010.11.051; Bowlby MR, 2005, BIOORGAN MED CHEM, V13, P6112, DOI 10.1016/j.bmc.2005.06.042; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Calloe K, 2010, J MOL CELL CARDIOL, V48, P191, DOI 10.1016/j.yjmcc.2009.07.017; Calloe K, 2009, CARDIOVASC RES, V81, P686, DOI 10.1093/cvr/cvn339; Callsen B, 2005, J PHYSIOL-LONDON, V568, P397, DOI 10.1113/jphysiol.2005.094359; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Chuang S, 2008, J MED CHEM, V51, P3755, DOI 10.1021/jm701192w; Cordeiro JM, 2012, J MOL CELL CARDIOL, V52, P1291, DOI 10.1016/j.yjmcc.2012.03.001; Craig TA, 2002, J BIOL CHEM, V277, P10955, DOI 10.1074/jbc.M109660200; Cui YY, 2008, NEUROCHEM RES, V33, P2078, DOI 10.1007/s11064-008-9688-7; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Foeger NC, 2010, J BIOL CHEM, V285, P33413, DOI 10.1074/jbc.M110.145185; Gebauer M, 2004, BIOPHYS J, V86, P210, DOI 10.1016/S0006-3495(04)74097-7; Gonzalez WG, 2014, BBA-PROTEINS PROTEOM, V1844, P1472, DOI 10.1016/j.bbapap.2014.05.004; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; Jerng HH, 1997, BIOPHYS J, V72, P163, DOI 10.1016/S0006-3495(97)78655-7; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kunjilwar K, 2013, J NEUROCHEM, V126, P462, DOI 10.1111/jnc.12309; Lakowicz J. R., 2010, PRINCIPLES FLUORESCE, P372; Lang F, 2007, METHOD ENZYMOL, V428, P209, DOI 10.1016/S0076-6879(07)28011-5; Li MN, 2014, ANAL BIOCHEM, V449, P99, DOI 10.1016/j.ab.2013.12.015; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Lundby A, 2010, BRIT J PHARMACOL, V160, P2028, DOI 10.1111/j.1476-5381.2010.00859.x; Lusin JD, 2008, BIOCHEMISTRY-US, V47, P2252, DOI 10.1021/bi7017267; Martens JR, 1999, TRENDS CARDIOVAS MED, V9, P253, DOI 10.1016/S1050-1738(00)00037-2; Martin MP, 2012, CHEMBIOCHEM, V13, P2128, DOI 10.1002/cbic.201200316; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Osawa M, 2001, J BIOL CHEM, V276, P41005, DOI 10.1074/jbc.M105842200; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Song WJ, 1998, J NEUROSCI, V18, P3124; Szabo I, 2010, FEBS LETT, V584, P2049, DOI 10.1016/j.febslet.2010.01.038; Wang GY, 2006, J GEN PHYSIOL, V127, P391, DOI 10.1085/jgp.200509442; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wang K., 2009, STRUCTURE FUNCTION M, P343; Witzel K, 2012, NEUROPHARMACOLOGY, V63, P1389, DOI 10.1016/j.neuropharm.2012.08.017; Yu LP, 2007, PROTEIN SCI, V16, P2502, DOI 10.1110/ps.072928007; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5; Zicha S, 2004, J PHYSIOL-LONDON, V561, P735, DOI 10.1113/jphysiol.2004.075861	53	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32201	32213		10.1074/jbc.M114.577528	http://dx.doi.org/10.1074/jbc.M114.577528			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25228688	Green Published, hybrid			2022-12-28	WOS:000345314700047
J	Neo, WH; Lim, JF; Grumont, R; Gerondakis, S; Su, IH				Neo, Wen Hao; Lim, Jun Feng; Grumont, Raelene; Gerondakis, Steve; Su, I-hsin			c-Rel Regulates Ezh2 Expression in Activated Lymphocytes and Malignant Lymphoid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Regulation; Leukemia; Lymphocyte; Lymphoma; Polycomb; Transcription Factor	POLYCOMB GROUP PROTEIN; HISTONE METHYLTRANSFERASE ACTIVITY; AGGRESSIVE BREAST-CANCER; NF-KAPPA-B; TRANSCRIPTION FACTOR; GENE-EXPRESSION; DNA-BINDING; ENHANCER; PENTOXIFYLLINE; PROLIFERATION	Background: The mechanisms by which the expression of Ezh2 is regulated in normal and malignant cells are poorly understood. Results: c-Rel recruited to the Ezh2 locus up-regulates Ezh2 expression in activated lymphocytes and malignant lymphoid cells. Conclusion: c-Rel is a critical regulator of Ezh2 expression in lymphocytes and malignant lymphoid cells. Significance: We provide a mechanistic basis for rational combinatorial therapy for Ezh2-expressing cancers. The polycomb group protein Ezh2 is a histone methyltransferase that modifies chromatin structure to alter gene expression during embryonic development, lymphocyte activation, and tumorigenesis. The mechanism by which Ezh2 expression is regulated is not well defined. In the current study, we report that c-Rel is a critical activator of Ezh2 transcription in lymphoid cells. In activated primary murine B and T cells, plus human leukemia and multiple myeloma cell lines, recruitment of c-Rel to the first intron of the Ezh2 locus promoted Ezh2 mRNA expression. This up-regulation was abolished in activated c-Rel-deficient lymphocytes and by c-Rel knockdown in Jurkat T cells. Treatment of malignant cells with the c-Rel inhibitor pentoxifylline not only reduced c-Rel nuclear translocation and Ezh2 expression, but also enhanced their sensitivity to the Ezh2-specific drug, GSK126 through increased growth inhibition and cell death. In summary, our demonstration that c-Rel regulates Ezh2 expression in lymphocytes and malignant lymphoid cells reveals a novel transcriptional network in transformed lymphoid cells expressing high levels of Ezh2 that provides a molecular justification for combinatorial drug therapy.	[Neo, Wen Hao; Lim, Jun Feng; Su, I-hsin] Nanyang Technol Univ, Sch Biol Sci, Coll Sci, Singapore 637551, Singapore; [Grumont, Raelene; Gerondakis, Steve] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Monash University	Su, IH (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Coll Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	ihsu@ntu.edu.sg	Su, I-hsin/A-2207-2011	Su, I-hsin/0000-0002-5894-9580; Neo, Wen Hao/0000-0002-6827-3027	National Medical Research Council [NMRC/IRG/1269/2010]; Singapore Ministry of Education [MOE2009-T2-1-034, MOE2013-T2-2-038]; Australian National Health and Medical Research Council [1016701, 1002580]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Singapore Ministry of Education(Ministry of Education, Singapore); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by research funding from National Medical Research Council Grant NMRC/IRG/1269/2010 (to W. H. N. and I.-H. S.), Singapore Ministry of Education Grants MOE2009-T2-1-034 (to I.-H. S.) and MOE2013-T2-2-038 (to J. F. L. and I.-H. S.), Australian National Health and Medical Research Council Program Grant 1016701 (to S. G.) and Fellowship 1002580 (to R. G.).	Albersen M, 2011, EUR UROL, V59, P286, DOI 10.1016/j.eururo.2010.10.034; Attwooll C, 2005, J BIOL CHEM, V280, P1199, DOI 10.1074/jbc.M412509200; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Bravo-Cuellar A, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-13; Bunting K, 2007, J IMMUNOL, V178, P7097, DOI 10.4049/jimmunol.178.11.7097; Caganova M, 2013, J CLIN INVEST, V123, P5009, DOI 10.1172/JCI70626; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Cheng SH, 2003, ONCOGENE, V22, P8472, DOI 10.1038/sj.onc.1206917; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Erhardt S, 2003, DEVELOPMENT, V130, P4235, DOI 10.1242/dev.00625; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Fujii S, 2011, ONCOGENE, V30, P4118, DOI 10.1038/onc.2011.118; Furger A, 2002, GENE DEV, V16, P2792, DOI 10.1101/gad.983602; Garbati MR, 2011, CANCER LETT, V302, P76, DOI 10.1016/j.canlet.2010.12.018; Gilmore TD, 2004, ONCOGENE, V23, P2275, DOI 10.1038/sj.onc.1207410; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Herz HM, 2010, GENE DEV, V24, P857, DOI 10.1101/gad.1921610; Huang DB, 2001, STRUCTURE, V9, P669, DOI 10.1016/S0969-2126(01)00635-9; Hwang C, 2008, BREAST CANCER RES TR, V107, P235, DOI 10.1007/s10549-007-9542-7; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lerma-Diaz JM, 2006, IMMUNOL LETT, V103, P149, DOI 10.1016/j.imlet.2005.10.019; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Matsukawa Y, 2006, CANCER SCI, V97, P484, DOI 10.1111/j.1349-7006.2006.00203.x; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; MOLITOR JA, 1990, P NATL ACAD SCI USA, V87, P10028, DOI 10.1073/pnas.87.24.10028; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Neri F, 2012, MOL CELL BIOL, V32, P840, DOI 10.1128/MCB.06148-11; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Rayet B, 2003, MOL CELL BIOL, V23, P1520, DOI 10.1128/MCB.23.5.1520-1533.2003; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Shan D, 2012, COCHRANE DB SYST REV, V2; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Tang XH, 2004, ONCOGENE, V23, P5759, DOI 10.1038/sj.onc.1207706; Tumes DJ, 2013, IMMUNITY, V39, P819, DOI 10.1016/j.immuni.2013.09.012; van Galen JC, 2004, EUR J IMMUNOL, V34, P1870, DOI 10.1002/eji.200424985; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Visser HPJ, 2001, BRIT J HAEMATOL, V112, P950, DOI 10.1046/j.1365-2141.2001.02641.x; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wang WH, 1997, IMMUNITY, V6, P165, DOI 10.1016/S1074-7613(00)80423-9; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; ZABEL P, 1993, IMMUNOBIOLOGY, V187, P447, DOI 10.1016/S0171-2985(11)80356-6	60	30	30	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31693	31707		10.1074/jbc.M114.574517	http://dx.doi.org/10.1074/jbc.M114.574517			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25266721	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000345314700004
J	Su, CH; McStay, GP; Tzagoloff, A				Su, Chen-Hsien; McStay, Gavin P.; Tzagoloff, Alexander			Assembly of the Rotor Component of Yeast Mitochondrial ATP Synthase Is Enhanced When Atp9p Is Supplied by Atp9p-Cox6p Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; SACCHAROMYCES-CEREVISIAE; NUCLEAR GENE; ESCHERICHIA-COLI; OXIDATIVE-PHOSPHORYLATION; ADENOSINE TRIPHOSPHATASE; MESSENGER-RNA; NATIVE PAGE; SUBUNIT; TRANSLATION	The Atp9p ring is one of several assembly modules of yeast mitochondrial ATP synthase. The ring, composed of 10 copies of Atp9p, is part of the rotor that couples proton translocation to synthesis or hydrolysis of ATP. We present evidence that before its assembly with other ATP synthase modules, most of Atp9p is present in at least three complexes with masses of 200-400 kDa that co-immunopurify with Cox6p. Pulse-labeling analysis disclosed a time-dependent reduction of radiolabeled Atp9p in the complexes and an increase of Atp9p in the ring form of wild type yeast and of mss51, pet111, and pet494 mutants lacking Cox1p, Cox2p, and Cox3p, respectively. Ring formation was not significantly different from wild type in an mss51 or atp10 mutant. The atp10 mutation blocks the interaction of the Atp9p ring with other modules of the ATP synthase. In contrast, ring formation was reduced in a cox6 mutant, consistent with a role of Cox6p in oligomerization of Atp9p. Cox6p involvement in ATP synthase assembly is also supported by studies showing that ring formation in cells adapting from fermentative to aerobic growth was less efficient in mitochondria of the cox6 mutant than the parental respiratory-competent strain or a cox4 mutant. We speculate that the constitutive and Cox6p-independent rate of Atp9p oligomerization may be sufficient to produce the level of ATP synthase needed for maintaining a membrane potential but limiting for optimal oxidative phosphorylation.	[Su, Chen-Hsien; Tzagoloff, Alexander] Columbia Univ, Dept Biol Sci, New York, NY 10128 USA; [McStay, Gavin P.] New York Inst Technol, Dept Life Sci, Old Westbury, NY 11568 USA	Columbia University; New York Institute Technology	Tzagoloff, A (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10128 USA.	spud@columbia.edu	McStay, Gavin/K-9574-2013	McStay, Gavin/0000-0003-1363-8719	National Institutes of Health [HL22174]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL022174, R37HL022174, R01HL022174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL22174.	ACKERMAN SH, 1990, J BIOL CHEM, V265, P9952; Arechaga I, 2002, FEBS LETT, V515, P189, DOI 10.1016/S0014-5793(02)02447-X; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Barros MH, 2002, FEBS LETT, V516, P119, DOI 10.1016/S0014-5793(02)02514-0; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; CHEN WL, 1969, J BIOL CHEM, V244, P2767; COSTANZO MC, 1986, MOL CELL BIOL, V6, P3694, DOI 10.1128/MCB.6.11.3694; Deckers-Hebestreit G, 2013, BIOCHEM SOC T, V41, P1288, DOI 10.1042/BST20130096; DOWHAN W, 1985, EMBO J, V4, P179, DOI 10.1002/j.1460-2075.1985.tb02334.x; Fontanesi F, 2010, MOL CELL BIOL, V30, P245, DOI 10.1128/MCB.00983-09; FORSBURG SL, 1989, ANNU REV CELL BIOL, V5, P153, DOI 10.1146/annurev.cb.05.110189.001101; Giraud MF, 2012, J STRUCT BIOL, V177, P490, DOI 10.1016/j.jsb.2011.10.015; Glerum DM, 1998, ANAL BIOCHEM, V260, P38, DOI 10.1006/abio.1998.2683; GUARENTE L, 1987, ANNU REV GENET, V21, P425, DOI 10.1146/annurev.genet.21.1.425; HADIKUSUMO RG, 1988, BIOCHIM BIOPHYS ACTA, V933, P212, DOI 10.1016/0005-2728(88)90072-2; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; Herrmann J. M., 1994, CELL BIOL LAB HDB, VI, P538; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; KOERNER TJ, 1991, METHODS ENZYMOL, V194, P477; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lichty JJ, 2005, PROTEIN EXPRES PURIF, V41, P98, DOI 10.1016/j.pep.2005.01.019; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McStay GP, 2013, J BIOL CHEM, V288, P26546, DOI 10.1074/jbc.M113.498592; McStay GP, 2013, MOL BIOL CELL, V24, P440, DOI 10.1091/mbc.E12-10-0749; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Ozaki Y, 2008, BIOCHEM BIOPH RES CO, V367, P663, DOI 10.1016/j.bbrc.2007.12.170; PENEFSKY HS, 1965, J BIOL CHEM, V240, P4694; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; PERLMAN PS, 1974, ARCH BIOCHEM BIOPHYS, V162, P248, DOI 10.1016/0003-9861(74)90125-8; POUTRE CG, 1987, GENETICS, V115, P637; Rak M, 2011, EMBO J, V30, P920, DOI 10.1038/emboj.2010.364; Rak M, 2009, P NATL ACAD SCI USA, V106, P18509, DOI 10.1073/pnas.0910351106; REPETTO B, 1989, MOL CELL BIOL, V9, P2695, DOI 10.1128/MCB.9.6.2695; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Stuart RA, 2008, J BIOENERG BIOMEMBR, V40, P411, DOI 10.1007/s10863-008-9168-4; Su CH, 2014, MOL BIOL CELL, V25, P965, DOI [10.1091/mbc.E13-0-0575, 10.1091/mbc.E13-10-0575]; Suzuki T, 2007, P NATL ACAD SCI USA, V104, P20776, DOI 10.1073/pnas.0708075105; TZAGOLOFF A, 1969, J BIOL CHEM, V244, P5027; Tzagoloff A, 2004, J BIOL CHEM, V279, P19775, DOI 10.1074/jbc.M401506200; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yumen I, 2012, PROTEIN EXPRES PURIF, V82, P396, DOI 10.1016/j.pep.2012.02.005; Zeng XM, 2008, MOL BIOL CELL, V19, P1366, DOI 10.1091/mbc.E07-08-0746	50	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31605	31616		10.1074/jbc.M114.602706	http://dx.doi.org/10.1074/jbc.M114.602706			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25253699	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000344549900060
J	Dasgupta, M; Unal, H; Willard, B; Yang, JB; Karnik, SS; Stark, GR				Dasgupta, Maupali; Unal, Hamiyet; Willard, Belinda; Yang, Jinbo; Karnik, Sadashiva S.; Stark, George R.			Critical Role for Lysine 685 in Gene Expression Mediated by Transcription Factor Unphosphorylated STAT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATES TRANSCRIPTION; SERINE PHOSPHORYLATION; ACETYLATION; METHYLATION; INHIBITION; CELLS; DNA; INDUCTION; COMPLEX; BINDING	STAT3 is a pleiotropic transcription factor that is activated by the phosphorylation of tyrosine 705 in response to many cytokines and growth factors. STAT3 without Tyr-705 phosphorylation (U-STAT3) is also a potent transcription factor, and its concentration in cells increases greatly in response to STAT3 activation because the STAT3 gene can be driven by phosphorylated STAT3 dimers. We have now searched for post-translational modifications of U-STAT3 that might have a critical role in its function. An analysis by mass spectroscopy indicated that U-STAT3 is acetylated on Lys-685, and the integrity of Lys-685 is required for the expression of most U-STAT3-dependent genes. In contrast, we found only a very minor role for Lys-685 in gene expression induced in response to tyrosine-phosphorylated STAT3. U-STAT3 plays an important role in angiotensin II-induced gene expression and in the consequent development of cardiac hypertrophy and dysfunction. Mutation of Lys-685 inhibits this function of STAT3, providing new information on the role of U-STAT3 in augmenting the development of heart failure.	[Dasgupta, Maupali; Yang, Jinbo; Stark, George R.] Cleveland Clin, Dept Mol Genet, Cleveland, OH 44195 USA; [Unal, Hamiyet; Karnik, Sadashiva S.] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Willard, Belinda] Cleveland Clin, Mass Spectrometry Lab Prot Sequencing, Lerner Res Inst, Cleveland, OH 44195 USA; [Yang, Jinbo] Lanzhou Univ, Sch Life Sci, Lanzhou 73000, Gansu, Peoples R China	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Lanzhou University	Stark, GR (corresponding author), Cleveland Clin, Dept Mol Genet, Cleveland, OH 44195 USA.	starkg@ccf.org	Karnik, Sadashiva/Y-2477-2019	Karnik, Sadashiva/0000-0003-0746-2753	National Institutes of Health [CA062220]; National Institutes of Health Shared Instrument Grant [1S10RR031537-01]; NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Shared Instrument Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA062220 (to G. R. S.) and National Institutes of Health Shared Instrument Grant 1S10RR031537-01 (to B. W.) for purchasing the Orbitrap Elite instrument.	AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bourguignon LYW, 2012, ONCOGENE, V31, P149, DOI 10.1038/onc.2011.222; Brinkman JA, 2009, J MAMMARY GLAND BIOL, V14, P67, DOI 10.1007/s10911-009-9113-0; Courapied S, 2010, J BIOL CHEM, V285, P26765, DOI 10.1074/jbc.M109.092304; Hazan-Halevy I, 2010, BLOOD, V115, P2852, DOI 10.1182/blood-2009-10-230060; Icardi L, 2012, P NATL ACAD SCI USA, V109, P12058, DOI 10.1073/pnas.1206458109; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Lee H, 2012, P NATL ACAD SCI USA, V109, P7765, DOI 10.1073/pnas.1205132109; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Liu HT, 2003, BLOOD, V102, P344, DOI 10.1182/blood-2002-11-3396; Mori T, 2006, CANCER RES, V66, P6692, DOI 10.1158/0008-5472.CAN-06-0801; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; O'Shea JJ, 2005, SCIENCE, V307, P217, DOI 10.1126/science.1108164; Pena G, 2010, EUR J IMMUNOL, V40, P2580, DOI 10.1002/eji.201040540; Perry E, 2004, ONCOGENE, V23, P8908, DOI 10.1038/sj.onc.1208149; Ray S, 2005, GASTROENTEROLOGY, V129, P1616, DOI 10.1053/j.gastro.2005.07.055; Ray S, 2014, CELL SIGNAL, V26, P1445, DOI 10.1016/j.cellsig.2014.03.007; Samraj AK, 2014, J CEREBR BLOOD F MET, V34, P759, DOI 10.1038/jcbfm.2014.15; Stark GR, 2011, CELL RES, V21, P375, DOI 10.1038/cr.2010.174; Tanaka T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001637; Waitkus MS, 2014, MOL CELL BIOL, V34, P1800, DOI 10.1128/MCB.00034-14; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yang J, 2005, CANCER RES, V65, P939; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Yue H, 2010, CARDIOVASC RES, V85, P90, DOI 10.1093/cvr/cvp285	29	41	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30763	30771		10.1074/jbc.M114.603894	http://dx.doi.org/10.1074/jbc.M114.603894			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25217633	Green Published, hybrid			2022-12-28	WOS:000344549700051
J	Wang, W; Roessler, BC; Kirk, KL				Wang, Wei; Roessler, Bryan C.; Kirk, Kevin L.			An Electrostatic Interaction at the Tetrahelix Bundle Promotes Phosphorylation-dependent Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channel Opening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; CHLORIDE CHANNEL; ALLOSTERIC MODULATION; TRANSPORTER MSBA; CL-CHANNELS; R-DOMAIN; PROTEIN; MUTATION; PORE; POTENTIATOR	The CFTR channel is an essential mediator of electrolyte transport across epithelial tissues. CFTR opening is promoted by ATP binding and dimerization of its two nucleotide binding domains (NBDs). Phosphorylation of its R domain (e. g. by PKA) is also required for channel activity. The CFTR structure is unsolved but homology models of the CFTR closed and open states have been produced based on the crystal structures of evolutionarily related ABC transporters. These models predict the formation of a tetrahelix bundle of intracellular loops (ICLs) during channel opening. Here we provide evidence that residues E267 in ICL2 and K1060 in ICL4 electrostatically interact at the interface of this predicted bundle to promote CFTR opening. Mutations or a thiol modifier that introduced like charges at these two positions substantially inhibited ATP-dependent channel opening. ATP-dependent activity was rescued by introducing a second site gain of function (GOF) mutation that was previously shown to promote ATP-dependent and ATP-independent opening (K978C). Conversely, the ATP-independent activity of the K978C GOF mutant was inhibited by charge-reversal mutations at positions 267 or 1060 either in the presence or absence of NBD2. The latter result indicates that this electrostatic interaction also promotes unliganded channel opening in the absence of ATP binding and NBD dimerization. Charge-reversal mutations at either position markedly reduced the PKA sensitivity of channel activation implying strong allosteric coupling between bundle formation and R domain phosphorylation. These findings support important roles of the tetrahelix bundle and the E267-K1060 electrostatic interaction in phosphorylation-dependent CFTR gating.	Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Wang, Wei; Roessler, Bryan C.; Kirk, Kevin L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Kirk, Kevin L.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, W (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 1720 2nd Ave S, Birmingham, AL 35294 USA.	weiwang@uab.edu; klkirk@uab.edu			National Institutes of Health [R01 DK056796]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482, R01DK056796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a National Institutes of Health Grant R01 DK056796 (to K. L. K.).	Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Billet A, 2013, J CYST FIBROS, V12, P737, DOI 10.1016/j.jcf.2013.02.002; Bozoky Z, 2013, P NATL ACAD SCI USA, V110, pE4427, DOI 10.1073/pnas.1315104110; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Csanady L, 2014, J GEN PHYSIOL, V143, P269, DOI 10.1085/jgp.201311089; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884; Davis PB, 2006, AM J RESP CRIT CARE, V173, P475, DOI 10.1164/rccm.200505-840OE; Dawson JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074347; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Doshi R, 2013, J BIOL CHEM, V288, P6801, DOI 10.1074/jbc.M112.430074; Fu J, 2001, J PHYSIOL-LONDON, V536, P459, DOI 10.1111/j.1469-7793.2001.0459c.xd; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; Hegedus T, 2008, J MOL BIOL, V378, P1052, DOI 10.1016/j.jmb.2008.03.033; Herlitze S, 2001, P NATL ACAD SCI USA, V98, P4699, DOI 10.1073/pnas.051628998; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HWANG TC, 1994, P NATL ACAD SCI USA, V91, P4698, DOI 10.1073/pnas.91.11.4698; Jih KY, 2011, J PHYSIOL-LONDON, V589, P2719, DOI 10.1113/jphysiol.2010.202861; Kirk KL, 2011, J BIOL CHEM, V286, P12813, DOI 10.1074/jbc.R111.219634; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Mathews CJ, 1998, J PHYSIOL-LONDON, V508, P365, DOI 10.1111/j.1469-7793.1998.365bq.x; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Norimatsu Y, 2012, BIOCHEMISTRY-US, V51, P2199, DOI 10.1021/bi201888a; Okeyo G, 2013, J BIOL CHEM, V288, P17122, DOI 10.1074/jbc.M112.442582; Powe AC, 2002, J PHYSIOL-LONDON, V539, P333, DOI 10.1113/jphysiol.2001.013162; Rahman KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074574; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wang W, 2005, J BIOL CHEM, V280, P23622, DOI 10.1074/jbc.M503118200; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Weng JW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.056432; Zhou J. J., 2010, J GEN PHYSIOL, V135, P229; Zhou Z, 2006, J GEN PHYSIOL, V128, P413, DOI 10.1085/jgp.200609622; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	47	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30364	30378		10.1074/jbc.M114.595710	http://dx.doi.org/10.1074/jbc.M114.595710			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25190805	Green Published, hybrid			2022-12-28	WOS:000344549700019
J	Charpentier, TH; Waldo, GL; Barrett, MO; Huang, WG; Zhang, QS; Harden, TK; Sondek, J				Charpentier, Thomas H.; Waldo, Gary L.; Barrett, Matthew O.; Huang, Weigang; Zhang, Qisheng; Harden, T. Kendall; Sondek, John			Membrane-induced Allosteric Control of Phospholipase C-beta Isozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fluorescence; G Protein; Membrane; Phospholipase C; Phospholipid	PLECKSTRIN HOMOLOGY DOMAIN; G-PROTEIN SUBUNITS; G-ALPHA-Q; GAMMA-SUBUNITS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; C-BETA(2) ACTIVITY; CATALYTIC DOMAIN; RHO GTPASES; KINASE-C; ACTIVATION	Background: Phospholipase C- (PLC-) isozymes hydrolyze phosphatidylinositol 4,5-bisphosphate to propagate signals for several physiological responses. Results: Membranes are essential for the allosteric release of autoinhibition of PLC- isozymes. Conclusion: Activators of PLC- release autoinhibition by orientating the isozymes at the membrane. Significance: The model described provides a better understanding of PLC- regulation and potential mechanisms to inhibit their activation. All peripheral membrane proteins must negotiate unique constraints intrinsic to the biological interface of lipid bilayers and the cytosol. Phospholipase C- (PLC-) isozymes hydrolyze the membrane lipid phosphatidylinositol 4,5-bisphosphate (PIP2) to propagate diverse intracellular responses that underlie the physiological action of many hormones, neurotransmitters, and growth factors. PLC- isozymes are autoinhibited, and several proteins, including G(q), G, and Rac1, directly engage distinct regions of these phospholipases to release autoinhibition. To understand this process, we used a novel, soluble analog of PIP2 that increases in fluorescence upon cleavage to monitor phospholipase activity in real time in the absence of membranes or detergents. High concentrations of G(q) or G(12) did not activate purified PLC-3 under these conditions despite their robust capacity to activate PLC-3 at membranes. In addition, mutants of PLC-3 with crippled autoinhibition dramatically accelerated the hydrolysis of PIP2 in membranes without an equivalent acceleration in the hydrolysis of the soluble analog. Our results illustrate that membranes are integral for the activation of PLC- isozymes by diverse modulators, and we propose a model describing membrane-mediated allosterism within PLC- isozymes.	[Charpentier, Thomas H.; Waldo, Gary L.; Barrett, Matthew O.; Harden, T. Kendall; Sondek, John] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Sondek, John] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Sondek, John] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Huang, Weigang; Zhang, Qisheng] Univ N Carolina, Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Sondek, J (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Dept Biochem & Biophys, 120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	sondek@med.unc.edu		Zhang, Qisheng/0000-0001-9808-5038	National Institutes of Health [R01-GM0557391, R01-GM098894]; American Cancer Society [PF-12-153-01-DMC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057391, R01GM098894] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM0557391 and R01-GM098894 (to J. S. and T. K. H.). J. S. declares competing financial interests with partial ownership of KXTbio, Inc., which licenses the production of WH-15.; Supported by American Cancer Society Grant PF-12-153-01-DMC.	Adjobo-Hermans MJW, 2013, CELL SIGNAL, V25, P255, DOI 10.1016/j.cellsig.2012.09.022; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Bonacci TM, 2005, J BIOL CHEM, V280, P10174, DOI 10.1074/jbc.M412514200; Bourdon DM, 2006, METHOD ENZYMOL, V406, P489, DOI 10.1016/S0076-6879(06)06037-X; Dowal L, 2001, BIOCHEMISTRY-US, V40, P414, DOI 10.1021/bi001923+; Gamper N, 2004, J NEUROSCI, V24, P10980, DOI 10.1523/JNEUROSCI.3869-04.2004; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Gresset A, 2010, J BIOL CHEM, V285, P35836, DOI 10.1074/jbc.M110.166512; Grobler JA, 1998, BIOCHEMISTRY-US, V37, P5020, DOI 10.1021/bi972952w; Gutman O, 2010, J BIOL CHEM, V285, P3905, DOI 10.1074/jbc.M109.085100; Harden TK, 2011, CHEM REV, V111, P6120, DOI 10.1021/cr200209p; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Huang WG, 2011, ACS CHEM BIOL, V6, P223, DOI 10.1021/cb100308n; Ilkaeva O, 2002, J BIOL CHEM, V277, P4294, DOI 10.1074/jbc.M109612200; Illenberger D, 2003, J BIOL CHEM, V278, P8645, DOI 10.1074/jbc.M211971200; Illenberger D, 2003, J BIOL CHEM, V278, P3006, DOI 10.1074/jbc.M208282200; INIGUEZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; James SR, 1997, BIOCHEMISTRY-US, V36, P848, DOI 10.1021/bi962108q; Jenco JM, 1997, BIOCHEM J, V327, P431; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kim CG, 1996, J BIOL CHEM, V271, P21187, DOI 10.1074/jbc.271.35.21187; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Kozasa T, 1996, J BIOL CHEM, V271, P12562, DOI 10.1074/jbc.271.21.12562; Kuang YN, 1996, P NATL ACAD SCI USA, V93, P2964, DOI 10.1073/pnas.93.7.2964; Lyon AM, 2014, TRENDS PHARMACOL SCI, V35, P23, DOI 10.1016/j.tips.2013.10.008; Lyon AM, 2013, MOL PHARMACOL, V84, P488, DOI 10.1124/mol.113.087403; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; Lyon AM, 2011, NAT STRUCT MOL BIOL, V18, P999, DOI 10.1038/nsmb.2095; MICHELL RH, 1975, BIOCHIM BIOPHYS ACTA, V415, P81, DOI 10.1016/0304-4157(75)90017-9; Nance MR, 2013, STRUCTURE, V21, P438, DOI 10.1016/j.str.2012.12.016; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Paulssen RH, 1996, J BIOL CHEM, V271, P26622, DOI 10.1074/jbc.271.43.26622; Philip F, 2010, CURR BIOL, V20, P1327, DOI 10.1016/j.cub.2010.06.013; Rebres RA, 2011, J BIOL CHEM, V286, P942, DOI 10.1074/jbc.M110.198200; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Runnels LW, 1999, BIOCHEMISTRY-US, V38, P1488, DOI 10.1021/bi9821519; Sankaran B, 1998, J BIOL CHEM, V273, P7148, DOI 10.1074/jbc.273.12.7148; Schnabel P, 1998, BIOCHEM J, V330, P461, DOI 10.1042/bj3300461; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Singer AU, 2002, NAT STRUCT BIOL, V9, P32, DOI 10.1038/nsb731; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wang TL, 2000, J BIOL CHEM, V275, P7466, DOI 10.1074/jbc.275.11.7466; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhang W, 2001, J BIOL CHEM, V276, P2503, DOI 10.1074/jbc.M003562200	52	24	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29545	29557		10.1074/jbc.M114.586784	http://dx.doi.org/10.1074/jbc.M114.586784			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25193662	Green Published, hybrid			2022-12-28	WOS:000344370800007
J	Jiang, S; Yan, C; Fang, QC; Shao, ML; Zhang, YL; Liu, Y; Deng, YP; Shan, B; Liu, JQ; Li, HT; Yang, L; Zhou, J; Dai, Z; Liu, Y; Jia, WP				Jiang, Shan; Yan, Cheng; Fang, Qi-chen; Shao, Meng-le; Zhang, Yong-liang; Liu, Yang; Deng, Yi-ping; Shan, Bo; Liu, Jing-qi; Li, Hua-ting; Yang, Liu; Zhou, Jian; Dai, Zhi; Liu, Yong; Jia, Wei-ping			Fibroblast Growth Factor 21 Is Regulated by the IRE1 alpha-XBP1 Branch of the Unfolded Protein Response and Counteracts Endoplasmic Reticulum Stress-induced Hepatic Steatosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ER Stress; Fibroblast Growth Factor (FGF); Hepatocyte; Liver Metabolism; Unfolded Protein Response (UPR)	FATTY LIVER-DISEASE; ER STRESS; TRANSCRIPTION FACTOR; INSULIN SENSITIVITY; PPAR-ALPHA; METABOLIC REGULATOR; ENERGY-EXPENDITURE; MESSENGER-RNA; BETA-KLOTHO; FGF21	Background: Although both are involved in metabolic homeostasis, the interconnection between ER stress and FGF21 remains incompletely understood. Results: Directly up-regulated by the IRE1-XBP1 pathway, FGF21 could alleviate ER stress-induced liver steatosis. Conclusion: FGF21 acts as a metabolic effector of the UPR program, exerting feedback effects upon lipid metabolism. Significance: These findings reveal a regulatory mechanism linking FGF21 actions to metabolic ER stress. Endoplasmic reticulum (ER) stress activates the adaptive unfolded protein response (UPR) and represents a critical mechanism that underlies metabolic dysfunctions. Fibroblast growth factor 21 (FGF21), a hormone that is predominantly secreted by the liver, exerts a broad range of effects upon the metabolism of carbohydrates and lipids. Although increased circulating levels of FGF21 have been documented in animal models and human subjects with obesity and nonalcoholic fatty liver disease, the functional interconnections between metabolic ER stress and FGF21 are incompletely understood. Here, we report that increased ER stress along with the simultaneous elevation of FGF21 expression were associated with the occurrence of nonalcoholic fatty liver disease both in diet-induced obese mice and human patients. Intraperitoneal administration of the ER stressor tunicamycin in mice resulted in hepatic steatosis, accompanied by activation of the three canonical UPR branches and increased the expression of FGF21. Furthermore, the IRE1-XBP1 pathway of the UPR could directly activate the transcriptional expression of Fgf21. Administration of recombinant FGF21 in mice alleviated tunicamycin-induced liver steatosis, in parallel with reduced eIF2-ATF4-CHOP signaling. Taken together, these results suggest that FGF21 is an integral physiological component of the cellular UPR program, which exerts beneficial feedback effects upon lipid metabolism through counteracting ER stress.	[Jiang, Shan; Fang, Qi-chen; Li, Hua-ting; Jia, Wei-ping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Diabet Inst,Shanghai Clin Ctr Diabet, Shanghai Key Lab Diabet Mellitus,Dept Endocrinol, Shanghai 200233, Peoples R China; [Jiang, Shan; Fang, Qi-chen; Li, Hua-ting; Jia, Wei-ping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Clin Ctr Metab Dis, Shanghai 200233, Peoples R China; [Yan, Cheng; Shao, Meng-le; Zhang, Yong-liang; Liu, Yang; Deng, Yi-ping; Shan, Bo; Liu, Jing-qi; Yang, Liu; Liu, Yong] Univ Chinese Acad Sci, Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Zhou, Jian; Dai, Zhi] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg, Shanghai 200032, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Fudan University	Liu, Y (corresponding author), Chinese Acad Sci, Key Lab Nutr, 294 Tai Yuan Rd, Shanghai 200031, Peoples R China.	liuy@sibs.ac.cn; wpjia@sjtu.edu.cn	Shao, Mengle/D-9951-2014; SHAN, BO/AAC-5167-2021; Shao, Mengle/AAH-8392-2019	Shao, Mengle/0000-0002-5488-9904; SHAN, BO/0000-0002-1675-5809; Shao, Mengle/0000-0002-5488-9904	Ministry of Science and Technology 973 Programs [2011CB504001, 2012CB524900, 2011CB910900]; National Natural Science Foundation of China [81170379, 30988002, 31230036, 81021002, 91213306]; Young Scientists Fund from National Natural Science Foundation [81200292]; Shanghai Rising-Star Program [13QA1402900]	Ministry of Science and Technology 973 Programs(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Scientists Fund from National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program	This work was supported by Ministry of Science and Technology 973 Programs 2011CB504001, 2012CB524900, and 2011CB910900, National Natural Science Foundation of China Grants 81170379, 30988002, 31230036, 81021002, and 91213306 (to W. J. and Y. L.), Young Scientists Fund from National Natural Science Foundation Grant 81200292, and Shanghai Rising-Star Program Grant 13QA1402900 (to H. L.).	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Chitturi S, 2007, J GASTROEN HEPATOL, V22, P778, DOI 10.1111/j.1440-1746.2007.05001.x; Christodoulides C, 2009, J CLIN ENDOCR METAB, V94, P3594, DOI 10.1210/jc.2009-0111; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Das SK, 2008, AM J PHYSIOL-ENDOC M, V295, pE393, DOI 10.1152/ajpendo.90355.2008; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Giannini C, 2013, J CLIN ENDOCR METAB, V98, P2993, DOI 10.1210/jc.2013-1250; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Li B, 2013, BIOCHEM J, V452, P139, DOI 10.1042/BJ20121671; Li HT, 2013, J HEPATOL, V58, P557, DOI 10.1016/j.jhep.2012.10.029; Li HT, 2010, J HEPATOL, V53, P934, DOI 10.1016/j.jhep.2010.05.018; Li HT, 2009, J CLIN ENDOCR METAB, V94, P2151, DOI 10.1210/jc.2008-2331; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; De Sousa-Coelho AL, 2012, BIOCHEM J, V443, P165, DOI 10.1042/BJ20111748; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Mao T, 2011, P NATL ACAD SCI USA, V108, P15852, DOI 10.1073/pnas.1107394108; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Rector RS, 2008, WORLD J GASTROENTERO, V14, P185, DOI 10.3748/wjg.14.185; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Schaap FG, 2013, BIOCHIMIE, V95, P692, DOI 10.1016/j.biochi.2012.10.019; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Shao ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4528; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Welihinda AA, 1996, J BIOL CHEM, V271, P18181, DOI 10.1074/jbc.271.30.18181; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yan HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024895; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	58	132	139	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29751	29765		10.1074/jbc.M114.565960	http://dx.doi.org/10.1074/jbc.M114.565960			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25170079	Green Published, hybrid			2022-12-28	WOS:000344370800023
J	Nemeria, NS; Ambrus, A; Patel, H; Gerfen, G; Adam-Vizi, V; Tretter, L; Zhou, JY; Wang, JJ; Jordan, F				Nemeria, Natalia S.; Ambrus, Attila; Patel, Hetalben; Gerfen, Gary; Adam-Vizi, Vera; Tretter, Laszlo; Zhou, Jieyu; Wang, Junjie; Jordan, Frank			Human 2-Oxoglutarate Dehydrogenase Complex E1 Component Forms a Thiamin-derived Radical by Aerobic Oxidation of the Enamine Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dehydrogenase; Electron Paramagnetic Resonance (EPR); Mass Spectrometry (MS); Reactive Oxygen Species (ROS); Thiamin	ALPHA-KETOGLUTARATE DEHYDROGENASE; OXYGEN SPECIES GENERATION; HUMAN DIHYDROLIPOAMIDE DEHYDROGENASE; PYRUVATE-FERREDOXIN OXIDOREDUCTASE; DISEASE-CAUSING MUTATIONS; ESCHERICHIA-COLI; LIPOAMIDE DEHYDROGENASE; LIPOIC ACID; PIG HEART; MULTIENZYME COMPLEXES	Background: The human 2-oxoglutarate dehydrogenase complex, comprising E1o, E2o, and E3 components, catalyzes conversion of 2-oxoglutarate to succinyl-CoA. Results: Human E1o generates both a thiamin-enamine-derived radical and the reactive oxygen species, superoxide, and hydrogen peroxide. Conclusion: Human E1o produces reactive oxygen species at a rate of <1% of succinyl-CoA under physiological conditions. Significance: This work presents the novel discovery that the 5-carboxyl group affects enzymatic reactivity of 2-oxoglutarate. Herein are reported unique properties of the human 2-oxoglutarate dehydrogenase multienzyme complex (OGDHc), a rate-limiting enzyme in the Krebs (citric acid) cycle. (a) Functionally competent 2-oxoglutarate dehydrogenase (E1o-h) and dihydrolipoyl succinyltransferase components have been expressed according to kinetic and spectroscopic evidence. (b) A stable free radical, consistent with the C2-(C2-hydroxy)--carboxypropylidene thiamin diphosphate (ThDP) cation radical was detected by electron spin resonance upon reaction of the E1o-h with 2-oxoglutarate (OG) by itself or when assembled from individual components into OGDHc. (c) An unusual stability of the E1o-h-bound C2-(2-hydroxy)--carboxypropylidene thiamin diphosphate (the ThDP-enamine/C2-carbanion, the first postdecarboxylation intermediate) was observed, probably stabilized by the 5-carboxyl group of OG, not reported before. (d) The reaction of OG with the E1o-h gave rise to superoxide anion and hydrogen peroxide (reactive oxygen species (ROS)). (e) The relatively stable enzyme-bound enamine is the likely substrate for oxidation by O-2, leading to the superoxide anion radical (in d) and the radical (in b). (f) The specific activity assessed for ROS formation compared with the NADH (overall complex) activity, as well as the fraction of radical intermediate occupying active centers of E1o-h are consistent with each other and indicate that radical/ROS formation is an off-pathway side reaction comprising less than 1% of the on-pathway reactivity. However, the nearly ubiquitous presence of OGDHc in human tissues, including the brain, makes these findings of considerable importance in human metabolism and perhaps disease.	[Nemeria, Natalia S.; Patel, Hetalben; Zhou, Jieyu; Wang, Junjie; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA; [Ambrus, Attila; Adam-Vizi, Vera; Tretter, Laszlo] Semmelweis Univ, Dept Med Biochem, MTA SE Lab Neurobiochem, H-1094 Budapest, Hungary; [Gerfen, Gary] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Semmelweis University; Yeshiva University; Albert Einstein College of Medicine	Jordan, F (corresponding author), Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA.	frjordan@rutgers.edu	Wang, Junjie/K-7509-2014; Tretter, Laszlo/ACI-2689-2022; Ambrus, Attila/O-4301-2017	Wang, Junjie/0000-0002-0587-2209; Ambrus, Attila/0000-0001-6014-3175; Adam-Vizi, Vera/0000-0002-8350-8701	National Institutes of Health [GM097499, GM-050380]; Hungarian Academy of Sciences MTA Grant [02001]; Hungarian Scientific Research Fund (OTKA) [85082, 81983]; Hungarian Brain Research Program [KTIA_13_NAP-A-III/6]; Bolyai fellowship; Fulbright fellowship; National Science Foundation [CHE 1213550]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097499, R01GM050380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian Academy of Sciences MTA Grant; Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Brain Research Program; Bolyai fellowship(Hungarian Academy of Sciences); Fulbright fellowship; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM097499 (to G. J. G.) and GM-050380. This work was also supported by Hungarian Academy of Sciences MTA Grant 02001 (to A.-V. V.), Hungarian Scientific Research Fund (OTKA) Grants 85082 and 81983 to A.-V. V.), Hungarian Brain Research Program Grant KTIA_13_NAP-A-III/6 (to A.-V. V.), Bolyai and Fulbright fellowships (to A. A.), and National Science Foundation Grant CHE 1213550 (to G. J. G.).	Adam-Vizi V, 2005, ANTIOXID REDOX SIGN, V7, P1140, DOI 10.1089/ars.2005.7.1140; Adam-Vizi V, 2013, NEUROCHEM INT, V62, P757, DOI 10.1016/j.neuint.2013.01.012; Adam-Vizi V, 2010, J ALZHEIMERS DIS, V20, pS413, DOI 10.3233/JAD-2010-100465; Ambrus A, 2013, ARCH BIOCHEM BIOPHYS, V538, P145, DOI 10.1016/j.abb.2013.08.015; Ambrus A, 2011, HUM MOL GENET, V20, P2984, DOI 10.1093/hmg/ddr202; Ambrus A, 2009, J NEUROCHEM, V109, P222, DOI 10.1111/j.1471-4159.2009.05942.x; Arjunan P, 2006, J BIOL CHEM, V281, P15296, DOI 10.1074/jbc.M600656200; Armstrong CT, 2014, BIOCHEM J, V459, P369, DOI 10.1042/BJ20131664; AZZI A, 1975, BIOCHEM BIOPH RES CO, V65, P597, DOI 10.1016/S0006-291X(75)80188-4; BAILLIE AC, 1988, PESTIC BIOCHEM PHYS, V30, P103, DOI 10.1016/0048-3575(88)90044-2; Balakrishnan A, 2013, J BIOL CHEM, V288, P21688, DOI 10.1074/jbc.M113.465419; Balakrishnan A, 2012, J AM CHEM SOC, V134, P18644, DOI 10.1021/ja3062375; BANDO Y, 1991, J BIOCHEM-TOKYO, V109, P450, DOI 10.1093/oxfordjournals.jbchem.a123402; BIELSKI BHJ, 1985, J PHYS CHEM REF DATA, V14, P1041, DOI 10.1063/1.555739; Biryukov AI, 1996, FEBS LETT, V382, P167, DOI 10.1016/0014-5793(96)00166-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brautigam CA, 2006, STRUCTURE, V14, P611, DOI 10.1016/j.str.2006.01.001; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; Brautigam CA, 2011, J BIOL CHEM, V286, P23476, DOI 10.1074/jbc.M110.202960; Bunik VI, 2005, BIOCHEMISTRY-US, V44, P10552, DOI 10.1021/bi0503100; Bunik VI, 2002, EUR J BIOCHEM, V269, P5004, DOI 10.1046/j.1432-1033.2002.03204.x; BURGHAUS O, 1992, MEAS SCI TECHNOL, V3, P765, DOI 10.1088/0957-0233/3/8/013; Chandrasekhar K, 2013, J BIOL CHEM, V288, P15402, DOI 10.1074/jbc.M113.466789; Ciszak EM, 2006, J BIOL CHEM, V281, P648, DOI 10.1074/jbc.M507850200; CRUTS M, 1995, NEUROSCI LETT, V199, P73, DOI 10.1016/0304-3940(95)11982-3; Dumont M, 2009, FREE RADICAL BIO MED, V47, P1019, DOI 10.1016/j.freeradbiomed.2009.07.008; Frank RAW, 2008, J AM CHEM SOC, V130, P1662, DOI 10.1021/ja076468k; Frank RAW, 2007, J MOL BIOL, V368, P639, DOI 10.1016/j.jmb.2007.01.080; FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051; Gazaryan IG, 2002, J BIOL CHEM, V277, P10064, DOI 10.1074/jbc.M108264200; Gerfen GJ, 1996, J PHYS CHEM-US, V100, P16739, DOI 10.1021/jp960709l; Gibson GE, 2010, BBA-MOL BASIS DIS, V1802, P122, DOI 10.1016/j.bbadis.2009.08.010; Gibson GE, 2000, NEUROCHEM INT, V36, P97, DOI 10.1016/S0197-0186(99)00114-X; Gibson GE, 1998, ANN NEUROL, V44, P676, DOI 10.1002/ana.410440414; GUPTA SC, 1980, J BIOL CHEM, V255, P1107; HAMADA M, 1975, J BIOCHEM-TOKYO, V77, P1047, DOI 10.1093/oxfordjournals.jbchem.a130805; HIRASHIMA M, 1967, J BIOL CHEM, V242, P902; JORDAN F, 1987, J AM CHEM SOC, V109, P4415, DOI 10.1021/ja00248a059; Khailova L S, 1977, Biokhimiia, V42, P113; KISELEVSKY YV, 1990, ACTA BIOCHIM POL, V37, P135; KLUGER R, 1979, J AM CHEM SOC, V101, P6425, DOI 10.1021/ja00515a044; KLUGER R, 1977, J AM CHEM SOC, V99, P4504, DOI 10.1021/ja00455a052; LAWLIS VB, 1981, BIOCHEMISTRY-US, V20, P2512, DOI 10.1021/bi00512a023; LIU TC, 1995, J BIOL CHEM, V270, P15545, DOI 10.1074/jbc.270.26.15545; Mansoorabadi SO, 2006, BIOCHEMISTRY-US, V45, P7122, DOI 10.1021/bi0602516; MAYO LA, 1990, METHOD ENZYMOL, V186, P567; MCCORD JM, 1968, J BIOL CHEM, V243, P5753; MCMINN CL, 1977, BIOCHEM J, V161, P569, DOI 10.1042/bj1610569; Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X; NAKANO K, 1994, EUR J BIOCHEM, V224, P179, DOI 10.1111/j.1432-1033.1994.tb20010.x; NAKANO K, 1993, BIOCHEM BIOPH RES CO, V196, P527, DOI 10.1006/bbrc.1993.2282; Nemeria N, 2004, BIOCHEMISTRY-US, V43, P6565, DOI 10.1021/bi049549r; Nemeria N, 2007, P NATL ACAD SCI USA, V104, P78, DOI 10.1073/pnas.0609973104; Nemeria NS, 2006, BIOORG CHEM, V34, P362, DOI 10.1016/j.bioorg.2006.09.001; OBRIEN TA, 1980, BIOCHIM BIOPHYS ACTA, V613, P10, DOI 10.1016/0005-2744(80)90186-2; Pan K, 1998, BIOCHEMISTRY-US, V37, P1357, DOI 10.1021/bi971835y; Patel H., 2014, THESIS RUTGERS U NEW; Patel H, 2014, BIOCHEMISTRY-US, V53, P2145, DOI 10.1021/bi4015743; Patel H, 2013, J MOL CATAL B-ENZYM, V98, P42, DOI 10.1016/j.molcatb.2013.09.010; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; Quinlan CL, 2014, J BIOL CHEM, V289, P8312, DOI 10.1074/jbc.M113.545301; Ragsdale SW, 2003, CHEM REV, V103, P2333, DOI 10.1021/cr020423e; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; ROSEN GM, 1982, ARCH BIOCHEM BIOPHYS, V215, P367, DOI 10.1016/0003-9861(82)90097-2; SCHONBRUNNHANEBECK E, 1990, BIOCHEMISTRY-US, V29, P4880, DOI 10.1021/bi00472a018; Shi QL, 2005, J BIOL CHEM, V280, P10888, DOI 10.1074/jbc.M409064200; Shim DJ, 2011, BIOCHEMISTRY-US, V50, P7705, DOI 10.1021/bi200936n; Song JY, 2010, J BIOL CHEM, V285, P4680, DOI 10.1074/jbc.M109.082842; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Starkov AA, 2013, MOL CELL NEUROSCI, V55, P13, DOI 10.1016/j.mcn.2012.07.005; STRUMILO SA, 1981, ACTA BIOL MED GER, V40, P257; Tittmann K, 2003, BIOCHEMISTRY-US, V42, P7885, DOI 10.1021/bi034465o; Tittmann K, 2005, BIOCHEMISTRY-US, V44, P13291, DOI 10.1021/bi051058z; Tittmann K, 2009, FEBS J, V276, P2454, DOI 10.1111/j.1742-4658.2009.06966.x; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Wagner T, 2014, BIOCHEM J, V457, P425, DOI 10.1042/BJ20131142; Wille G, 2006, NAT CHEM BIOL, V2, P324, DOI 10.1038/nchembio788	79	31	31	0	108	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29859	29873		10.1074/jbc.M114.591073	http://dx.doi.org/10.1074/jbc.M114.591073			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25210035	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-28	WOS:000344370800030
J	Chorba, JS; Shokat, KM				Chorba, John S.; Shokat, Kevan M.			The Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Active Site and Cleavage Sequence Differentially Regulate Protein Secretion from Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPROTEIN-RECEPTOR LDLR; ENDOPLASMIC-RETICULUM; CATALYTIC-ACTIVITY; HEPG2 CELLS; HUMAN RENIN; CHOLESTEROL; HYPERCHOLESTEROLEMIA; DEGRADATION; MUTATIONS; IDENTIFICATION	Biologic-based strategies to inhibit proprotein convertase subtilisin/kexin type 9 (PCSK9) show promise as anti-hyper-cholesterolemic and, therefore, anti-atherosclerotic therapies. Despite substantial effort, no small molecule strategy to inhibit PCSK9 has demonstrated feasibility. In this study we interrogated the chemistry of the PCSK9 active site and its adjacent residues to identify a foothold with which to drug the PCSK9 processing pathway and ultimately disrupt the interaction with the LDL receptor. Here, we develop a system in which we amplify the readout of PCSK9 proteolysis with a highly specific substrate in cells, showing that the PCSK9 catalytic domain is capable of proteolysis in trans. We use this system to show that the substrate specificity for PCSK9 proteolysis is distinct from the specificity for PCSK9 secretion, demonstrating that PCSK9 processing occurs in two separate sequential steps: that of proteolysis followed by secretion. We show that specific residues in the protease recognition sequence can differentially modulate the effects on proteolysis and secretion. Additionally, we demonstrate that the clinically described, dominant negative Q152H mutation restricts proteolysis and secretion independently. Our results suggest that the PCSK9 active site and its adjacent residues serve as an allosteric modulator of protein secretion independent of its role in proteolysis, revealing a new strategy for intracellular PCSK9 inhibition.	[Chorba, John S.] Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA; [Chorba, John S.; Shokat, Kevan M.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Shokat, Kevan M.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Chorba, JS (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, Div Cardiol, 600 16th St, San Francisco, CA 94158 USA.	john.chorba@ucsf.edu			National Institutes of Health [F32 HL116189, LRP HMOT1243]; American Heart Association [12POST11360011]; Gilead Sciences Research Scholar in Cardiovascular Sciences Award; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL116189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Gilead Sciences Research Scholar in Cardiovascular Sciences Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 HL116189 and LRP HMOT1243 (to J. S. C.). This work was also supported by American Heart Association Grant 12POST11360011 (to J. S. C.), a Gilead Sciences Research Scholar in Cardiovascular Sciences Award (to J. S. C.), and the Howard Hughes Medical Institute (to K. M. S.).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2012, J BIOL CHEM, V287, P33745, DOI 10.1074/jbc.M112.399725; Blom DJ, 2014, NEW ENGL J MED, V370, P1809, DOI 10.1056/NEJMoa1316222; Cameron J, 2009, ATHEROSCLEROSIS, V203, P161, DOI 10.1016/j.atherosclerosis.2008.10.007; Chen XW, 2013, ELIFE, V2, DOI 10.7554/eLife.00444; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Du F, 2011, J BIOL CHEM, V286, P43054, DOI 10.1074/jbc.M111.273474; Fitzgerald K, 2014, LANCET, V383, P60, DOI 10.1016/S0140-6736(13)61914-5; Fu X, 2000, J BIOL CHEM, V275, P16871, DOI 10.1074/jbc.275.22.16871; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gustafsen C, 2014, CELL METAB, V19, P310, DOI 10.1016/j.cmet.2013.12.006; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kourimate S, 2009, ATHEROSCLEROSIS, V206, P134, DOI 10.1016/j.atherosclerosis.2009.02.012; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Maibaum J, 2007, J MED CHEM, V50, P4832, DOI 10.1021/jm070316i; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayne J, 2011, CLIN CHEM, V57, P1415, DOI 10.1373/clinchem.2011.165191; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Rahuel J, 2000, CHEM BIOL, V7, P493, DOI 10.1016/S1074-5521(00)00134-4; Saavedra YGL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072113; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Strom TB, 2014, BIOCHEM J, V457, P99, DOI 10.1042/BJ20130930; Tosi I, 2007, ATHEROSCLEROSIS, V194, P102, DOI 10.1016/j.atherosclerosis.2006.10.003; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	43	23	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29030	29043		10.1074/jbc.M114.594861	http://dx.doi.org/10.1074/jbc.M114.594861			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25210046	Green Published, hybrid			2022-12-28	WOS:000344141000022
J	Helgeson, LA; Prendergast, JG; Wagner, AR; Rodnick-Smith, M; Nolen, BJ				Helgeson, Luke A.; Prendergast, Julianna G.; Wagner, Andrew R.; Rodnick-Smith, Max; Nolen, Brad J.			Interactions with Actin Monomers, Actin Filaments, and Arp2/3 Complex Define the Roles of WASP Family Proteins and Cortactin in Coordinately Regulating Branched Actin Networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; N-WASP; EXTRACELLULAR-MATRIX; CAPPING PROTEIN; WASP/SCAR PROTEINS; ACTIVATION; NUCLEATION; BINDING; POLYMERIZATION; MECHANISM	Arp2/3 complex is an important actin filament nucleator that creates branched actin filament networks required for formation of lamellipodia and endocytic actin structures. Cellular assembly of branched actin networks frequently requires multiple Arp2/3 complex activators, called nucleation promoting factors (NPFs). We recently presented a mechanism by which cortactin, a weak NPF, can displace a more potent NPF, N-WASP, from nascent branch junctions to synergistically accelerate nucleation. The distinct roles of these NPFs in branching nucleation are surprising given their similarities. We biochemically dissected these two classes of NPFs to determine how their Arp2/3 complex and actin interacting segments modulate their influences on branched actin networks. We find that the Arp2/3 complex-interacting N-terminal acidic sequence (NtA) of cortactin has structural features distinct from WASP acidic regions (A) that are required for synergy between the two NPFs. Our mutational analysis shows that differences between NtA and A do not explain the weak intrinsic NPF activity of cortactin, but instead that cortactin is a weak NPF because it cannot recruit actin monomers to Arp2/3 complex. We use TIRF microscopy to show that cortactin bundles branched actin filaments using actin filament binding repeats within a single cortactin molecule, but that N-WASP antagonizes cortactin-mediated bundling. Finally, we demonstrate that multiple WASP family proteins synergistically activate Arp2/3 complex and determine the biochemical requirements in WASP proteins for synergy. Our data indicate that synergy between WASP proteins and cortactin may play a general role in assembling diverse actin-based structures, including lamellipodia, podosomes, and endocytic actin networks.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Nolen, BJ (corresponding author), 1229 Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA.	bnolen@uoregon.edu		Nolen, Brad/0000-0002-0224-9980	National Institutes of Health [R01-GM092917, GM007759]; American Heart Association [10SDG2610189]; NICHD Summer Research Program at University of Oregon through National Institutes of Health [R25HD070817]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD070817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092917, T32GM007759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NICHD Summer Research Program at University of Oregon through National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM092917 (to B. J. N.) and Predoctoral Training Grant GM007759 (to L. A. H.). This work was also supported by American Heart Association Grant 10SDG2610189 (to B. J. N.) and the NICHD Summer Research Program at the University of Oregon through National Institutes of Health Grant R25HD070817 (to J. G. P.).	Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Basu R, 2011, CURR BIOL, V21, P905, DOI 10.1016/j.cub.2011.04.047; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Boczkowska M, 2008, STRUCTURE, V16, P695, DOI 10.1016/j.str.2008.02.013; Boczkowska M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4308; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Collins A, 2011, CURR BIOL, V21, P1167, DOI 10.1016/j.cub.2011.05.048; Cowieson NP, 2008, J BIOL CHEM, V283, P16187, DOI 10.1074/jbc.M708917200; Dang I, 2013, NATURE, V503, P281, DOI 10.1038/nature12611; DesMarais V, 2009, CELL MOTIL CYTOSKEL, V66, P303, DOI 10.1002/cm.20361; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Edelstein A., 2010, CURR PROTOC MOL BIOL, V14, P20, DOI [10.1002/0471142727.mb1420s92, DOI 10.1002/0471142727.MB1420S92]; Galletta BJ, 2008, PLOS BIOL, V6, P72, DOI 10.1371/journal.pbio.0060001; Gohl C, 2010, J BIOL CHEM, V285, P40171, DOI 10.1074/jbc.M110.139337; Goley ED, 2004, MOL CELL, V16, P269, DOI 10.1016/j.molcel.2004.09.018; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Helgeson LA, 2013, ELIFE, V2, DOI 10.7554/eLife.00884; Hetrick B, 2013, CHEM BIOL, V20, P701, DOI 10.1016/j.chembiol.2013.03.019; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Hufner K, 2001, J BIOL CHEM, V276, P35761, DOI 10.1074/jbc.M106520200; Kaksonen M, 2000, J CELL SCI, V113, P4421; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Katsube T, 2004, ARCH BIOCHEM BIOPHYS, V427, P79, DOI 10.1016/j.abb.2004.04.015; Kinley AW, 2003, CURR BIOL, V13, P384, DOI 10.1016/S0960-9822(03)00107-6; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Liu SL, 2013, J BIOL CHEM, V288, P487, DOI 10.1074/jbc.M112.406744; Liu SL, 2011, J BIOL CHEM, V286, P17039, DOI 10.1074/jbc.M111.219964; MacGrath SM, 2012, BIOCHEMISTRY-US, V51, P6644, DOI 10.1021/bi300722t; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Maritzen T, 2012, P NATL ACAD SCI USA, V109, P10382, DOI 10.1073/pnas.1206468109; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Mizutani K, 2002, CANCER RES, V62, P669; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Shvetsov A, 2009, CELL MOTIL CYTOSKEL, V66, P90, DOI 10.1002/cm.20328; Sirotkin V, 2005, J CELL BIOL, V170, P637, DOI 10.1083/jcb.200502053; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; Siton O, 2011, CURR BIOL, V21, P2092, DOI 10.1016/j.cub.2011.11.010; Skau CT, 2011, J BIOL CHEM, V286, P26964, DOI 10.1074/jbc.M111.239004; Smith BA, 2013, ELIFE, V2, DOI 10.7554/eLife.01008; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Suetsugu S, 2013, SEMIN CELL DEV BIOL, V24, P267, DOI 10.1016/j.semcdb.2013.01.006; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tehrani S, 2006, MOL BIOL CELL, V17, P2882, DOI 10.1091/mbc.E06-03-0187; Ti SC, 2011, P NATL ACAD SCI USA, V108, pE463, DOI 10.1073/pnas.1100125108; Uruno T, 2003, J BIOL CHEM, V278, P26086, DOI 10.1074/jbc.M301997200; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Wagner AR, 2013, CURR BIOL, V23, P1990, DOI 10.1016/j.cub.2013.08.029; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Xu JY, 1999, CELL MOTIL CYTOSKEL, V42, P73, DOI 10.1002/(SICI)1097-0169(1999)42:1<73::AID-CM7>3.0.CO;2-Z; Xu XP, 2012, EMBO J, V31, P236, DOI 10.1038/emboj.2011.343; Yamada H, 2013, J NEUROSCI, V33, P4514, DOI 10.1523/JNEUROSCI.2762-12.2013; Yamaguchi H, 2000, P NATL ACAD SCI USA, V97, P12631, DOI 10.1073/pnas.190351397	76	38	38	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28856	28869		10.1074/jbc.M114.587527	http://dx.doi.org/10.1074/jbc.M114.587527			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25160634	Green Published, hybrid			2022-12-28	WOS:000344141000010
J	Baureder, M; Barane, E; Hederstedt, L				Baureder, Michael; Barane, Elisabeth; Hederstedt, Lars			In Vitro Assembly of Catalase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTIC-ACID BACTERIA; ENTEROCOCCUS-FAECALIS; STREPTOCOCCUS-FAECALIS; MOLECULAR EVOLUTION; VECTOR; SYSTEM	Most aerobic organisms contain catalase, which functions to decompose hydrogen peroxide. Typical catalases are structurally complex homo-tetrameric enzymes with one heme prosthetic group buried in each subunit. It is not known how catalase in the cell is assembled from its constituents. The bacterium Enterococcus faecalis cannot synthesize heme but can acquire it from the environment to form a cytoplasmic catalase. We have in E. faecalis monitored production of the enzyme polypeptide (KatA) depending on the availability of heme and used our findings to devise a procedure for the purification of preparative amounts of in vivo-synthesized apocatalase. We show that fully active catalase can be obtained in vitro by incubating isolated apoprotein with hemin. We have characterized features of the assembly process and describe a temperature-trapped hemylated intermediate of the enzyme maturation process. Hemylation of apocatalase does not require auxiliary cell components, but rapid assembly of active enzyme seemingly is assisted in the cell. Our findings provide insight about catalase assembly and offer new experimental possibilities for detailed studies of this process.	[Baureder, Michael; Barane, Elisabeth; Hederstedt, Lars] Lund Univ, Dept Biol, Microbiol Grp, SE-22362 Lund, Sweden	Lund University	Hederstedt, L (corresponding author), Lund Univ, Dept Biol, Microbiol Grp, Solvegatan 35, SE-22362 Lund, Sweden.	lars.hederstedt@biol.lu.se		Baureder, Michael/0000-0003-0810-4341; Hederstedt, Lars/0000-0002-6650-6296	Swedish Research Council [621-2010-5672]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This research was supported by Swedish Research Council Grant 621-2010-5672.	Ascoli F, 1981, Methods Enzymol, V76, P72; Baureder M, 2013, ADV MICROB PHYSIOL, V62, P1, DOI 10.1016/B978-0-12-410515-7.00001-9; Baureder M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036725; Brugna M, 2010, FEBS J, V277, P2663, DOI [10.1111/j.1742-464X.2010.07677.x, 10.1111/j.1742-4658.2010.07677.x]; Diaz A, 2012, ARCH BIOCHEM BIOPHYS, V525, P102, DOI 10.1016/j.abb.2011.12.011; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; Frankenberg L, 2002, J BACTERIOL, V184, P6351, DOI 10.1128/JB.184.22.6351-6356.2002; Frankenberg L., 2003, THESIS LUND U LUND; Hakansson KO, 2004, ACTA CRYSTALLOGR D, V60, P1374, DOI 10.1107/S0907444904012004; HANKER JS, 1975, J CLIN MICROBIOL, V2, P463; JENSEN J, 1963, SCIENCE, V141, P45, DOI 10.1126/science.141.3575.45; Loew O, 1900, SCIENCE, V11, P701, DOI 10.1126/science.11.279.701; Nicholls P, 2001, ADV INORG CHEM, V51, P51; Nicholls P, 2012, ARCH BIOCHEM BIOPHYS, V525, P95, DOI 10.1016/j.abb.2012.01.015; PAUL KG, 1953, ACTA CHEM SCAND, V7, P1284, DOI 10.3891/acta.chem.scand.07-1284; PUGH SYR, 1983, ARCH MICROBIOL, V136, P60, DOI 10.1007/BF00415611; RUIS H, 1979, CAN J BIOCHEM CELL B, V57, P1122, DOI 10.1139/o79-144; Vatsyayan P, 2011, BIOTECHNOL LETT, V33, P347, DOI 10.1007/s10529-010-0442-2; WHITTENBURY R, 1960, NATURE, V187, P433, DOI 10.1038/187433a0; Winstedt L, 2000, J BACTERIOL, V182, P3863, DOI 10.1128/JB.182.13.3863-3866.2000; WIRTH R, 1986, J BACTERIOL, V165, P831, DOI 10.1128/jb.165.3.831-836.1986; Zamocky M, 1999, PROG BIOPHYS MOL BIO, V72, P19, DOI 10.1016/S0079-6107(98)00058-3; Zamocky M, 2012, ARCH BIOCHEM BIOPHYS, V525, P131, DOI 10.1016/j.abb.2012.01.017	23	13	13	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28411	28420		10.1074/jbc.M114.596148	http://dx.doi.org/10.1074/jbc.M114.596148			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25148685	Green Published, hybrid			2022-12-28	WOS:000343765400034
J	Eigsti, RL; Sudan, B; Wilson, ME; Graff, JW				Eigsti, Renee L.; Sudan, Bayan; Wilson, Mary E.; Graff, Joel W.			Regulation of Activation-associated MicroRNA Accumulation Rates during Monocyte-to-macrophage Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSCRIPTIONAL REGULATION; TISSUE MACROPHAGES; ACUTE-INFLAMMATION; INTERFERON-GAMMA; IMMUNE-RESPONSES; CELLS; EXPRESSION; INFECTION; POLARIZATION; HOMEOSTASIS	Circulating monocytes recruited to tissues can differentiate into macrophages and adopt unique gene expression programs in response to environmental cues. We recently described the regulated expression of several microRNAs (miRNAs) in polarized human monocyte-derived macrophages (MDMs). Basal expression of these activation-associated miRNAs was low in monocytes relative to MDMs. As development occurs in the context of specific cellular environments, we hypothesized that the rate of miRNA accumulation would be modified in the presence of microbial or cellular products during monocyte-to-macrophage differentiation. Indeed, LPS treatment augmented the accumulation of miR-146a and miR-155, whereas IL-4 treatment augmented the accumulation of miR-193b and miR-222 during development. In contrast, some stimuli repressed accumulation of specific miRNAs including interferons (IFNs) (miR-27a, miR-125a-5p, and miR-222), IL-4 (miR-125a-5p), and LPS (miR-27a). RT-PCR-based expression profiling of monocytes differentiated with distinct methods showed that activation-associated miRNAs and markers of macrophage polarization were substantially altered in MDMs differentiated in the presence of non-monocytic peripheral blood mononuclear cells due in part to NF-kappa B and STAT1 pathway activation. Expression of several of these miRNAs was regulated at a preprocessing step because the expression of the primary miRNAs, but not Dicer, correlated with mature miRNA expression. We conclude that a set of miRNAs is regulated during MDM differentiation, and the rate is uniquely modified for each miRNA by environmental factors. The low basal expression of activation-associated miRNAs in monocytes and their dynamic rates of accumulation during MDM differentiation permit monocytes to tailor miRNA profiles in peripheral tissues during differentiation to macrophages.	[Eigsti, Renee L.; Sudan, Bayan; Wilson, Mary E.; Graff, Joel W.] Univ Iowa, Carver Coll Med, Iowa City, IA 52242 USA; [Wilson, Mary E.; Graff, Joel W.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Wilson, Mary E.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Wilson, Mary E.] Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA; [Wilson, Mary E.; Graff, Joel W.] Vet Affairs Med Ctr, Iowa City, IA 52246 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Graff, JW (corresponding author), Univ Iowa, Dept Internal Med, 400 EMRB, Iowa City, IA 52242 USA.	joel-graff@uiowa.edu		Wilson, Mary/0000-0001-8680-7275	National Institutes of Health [AI080801, AI045540, AI07511, T35HL007485]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development [1IK2BX001627, 1I01BX001983, 5I01BX000536]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080801, T32AI007511, R01AI045540] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX001627, I01BX000536, I01BX001983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants AI080801, AI045540, and AI07511 (to M. E. W.) and T35HL007485 (a training grant to R. L. E.). This work was also supported by Grants 1IK2BX001627 (to J. W. G.), 1I01BX001983 (to M. E. W.), and 5I01BX000536 (to M. E. W.) from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BARTH MW, 1995, J LEUKOCYTE BIOL, V57, P361, DOI 10.1002/jlb.57.3.361; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Buck AH, 2010, RNA, V16, P307, DOI 10.1261/rna.1819210; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Coley W, 2010, J BIOL CHEM, V285, P31930, DOI 10.1074/jbc.M110.101709; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Liddiard K, 2011, EUR J IMMUNOL, V41, P2503, DOI 10.1002/eji.201141743; Liu G, 2013, ARTERIOSCL THROM VAS, V33, P170, DOI 10.1161/ATVBAHA.112.300068; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Marcinowski L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002510; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Nahid MA, 2013, J IMMUNOL, V190, P1250, DOI 10.4049/jimmunol.1103060; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shirasaki T, 2013, J VIROL, V87, P5270, DOI 10.1128/JVI.03022-12; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tserel L, 2011, J BIOL CHEM, V286, P26487, DOI 10.1074/jbc.M110.213561; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Wang Z, 2014, J IMMUNOL, V192, P2349, DOI 10.4049/jimmunol.1302982; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	36	27	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28433	28447		10.1074/jbc.M114.599316	http://dx.doi.org/10.1074/jbc.M114.599316			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25148686	Green Published, hybrid			2022-12-28	WOS:000343765400036
J	He, QY; Wen, D; Jia, QQ; Cui, CL; Wang, J; Palli, SR; Li, S				He, Qianyu; Wen, Di; Jia, Qiangqiang; Cui, Chunlai; Wang, Jian; Palli, Subba R.; Li, Sheng			Heat Shock Protein 83 (Hsp83) Facilitates Methoprene-tolerant (Met) Nuclear Import to Modulate Juvenile Hormone Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Basic Helix-loop-helix Transcription Factor (bHLH); Drosophila; Heat Shock Protein 90 (Hsp90); Hormone Receptor; Insect; bHLH Transcription Factor; Cytoplasm-Nucleus Shuttling; Insect Hormones; Molecular Chaperone	BEETLE TRIBOLIUM-CASTANEUM; BHLH-PAS FAMILY; BOMBYX FAT-BODY; DROSOPHILA-MELANOGASTER; INTRACELLULAR-LOCALIZATION; TRANSCRIPTIONAL REGULATORS; MOLECULAR CHAPERONES; BINDING-PROTEINS; KRUPPEL-HOMOLOG; GENE-EXPRESSION	Background: Methoprene-tolerant (Met) and Germ-cell expressed belonging to the bHLH-PAS family have been identified as juvenile hormone (JH) receptors in Drosophila. Results: Physical interaction with Hsp83 facilitates nuclear import of Met and JH action. Conclusion: Hsp83 modulates JH signaling through mediating the nuclear localization of Met. Significance: Our study helps in understanding the complicated molecular mechanisms of JH signaling. Juvenile hormone (JH) receptors, methoprene-tolerant (Met) and Germ-cell expressed (Gce), transduce JH signals to induce Kr-h1 expression in Drosophila. Dual luciferase assay identified a 120-bp JH response region (JHRR) in the Kr-h1 promoter. Both in vitro and in vivo experiments revealed that Met and Gce transduce JH signals to induce Kr-h1 expression through the JHRR. DNA affinity purification identified chaperone protein Hsp83 as one of the proteins bound to the JHRR in the presence of JH. Interestingly, Hsp83 physically interacts with PAS-B and basic helix-loop-helix domains of Met, and JH induces Met-Hsp83 interaction. As determined by immunohistochemistry, Met is mainly distributed in the cytoplasm of fat body cells of the larval when the JH titer is low and JH induces Met nuclear import. Hsp83 was accumulated in the cytoplasm area adjunct to the nucleus in the presence of JH and Met/Gce. Loss-of-function of Hsp83 attenuated JH binding and JH-induced nuclear import of Met, resulting in a decrease in the JHRR-driven reporter activity leading to reduction of Kr-h1 expression. These data show that Hsp83 facilitates the JH-induced nuclear import of Met that induces Kr-h1 expression through the JHRR.	[He, Qianyu; Wen, Di; Jia, Qiangqiang; Cui, Chunlai; Li, Sheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China; [He, Qianyu] Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Daqing 163319, Peoples R China; [Wang, Jian] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Palli, Subba R.] Univ Kentucky, Dept Entomol, Coll Agr, Lexington, KY 40546 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Heilongjiang Bayi Agricultural University; University System of Maryland; University of Maryland College Park; University of Kentucky	Li, S (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China.	lisheng01@sibs.ac.cn	PALLI, SUBBA REDDY/AAU-8289-2020	PALLI, SUBBA REDDY/0000-0002-0873-3247; Jia, Qiangqiang/0000-0003-2650-7566	National Science Foundation of China [31330072]; 973 program [2012CB114605]; Outstanding Youth Investigator Award [31125025]; Top Scientific Leadership in Shanghai Award [12XD1406900]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); Outstanding Youth Investigator Award; Top Scientific Leadership in Shanghai Award	This work was supported in part by the National Science Foundation of China Grant 31330072 and the 973 program Grant 2012CB114605 (to S. L.).; Supported by Outstanding Youth Investigator Award 31125025 and Top Scientific Leadership in Shanghai Award 12XD1406900.	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; Arbeitman MN, 2000, CELL, V101, P67, DOI 10.1016/S0092-8674(00)80624-8; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Baumann A, 2010, GENETICS, V185, P1327, DOI 10.1534/genetics.110.116962; Bedin M, 2004, INT J CANCER, V109, P643, DOI 10.1002/ijc.20010; Cano LQ, 2013, MOL CELL ENDOCRINOL, V369, P52, DOI 10.1016/j.mce.2013.01.023; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Freitas N, 2009, CURR GENOMICS, V10, P550, DOI 10.2174/138920209789503941; Galigniana MD, 2010, NUCLEUS-PHILA, V1, P299, DOI 10.4161/nucl.1.4.11743; Godlewski J, 2006, BIOCHEM BIOPH RES CO, V342, P1305, DOI 10.1016/j.bbrc.2006.02.097; Greb-Markiewicz B, 2011, MOL CELL ENDOCRINOL, V345, P16, DOI 10.1016/j.mce.2011.06.035; Guo EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053256; Hossain MS, 2013, INSECT BIOCHEM MOLEC, V43, P829, DOI 10.1016/j.ibmb.2013.06.007; Jackson SE, 2013, TOP CURR CHEM, V328, P155, DOI 10.1007/128_2012_356; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Jones D, 2013, GEN COMP ENDOCR, V194, P326, DOI 10.1016/j.ygcen.2013.09.021; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; Kayukawa T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01570; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Kazlauskas A, 2001, MOL CELL BIOL, V21, P2594, DOI 10.1128/MCB.21.7.2594-2607.2001; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Li YP, 2007, J BIOL CHEM, V282, P37605, DOI 10.1074/jbc.M704595200; Liu HH, 2013, INSECT BIOCHEM MOLEC, V43, P1068, DOI 10.1016/j.ibmb.2013.09.001; Liu W, 2013, BBA-GEN SUBJECTS, V1830, P5184, DOI 10.1016/j.bbagen.2013.06.037; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Niwa R, 2008, INSECT BIOCHEM MOLEC, V38, P714, DOI 10.1016/j.ibmb.2008.04.003; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Pecasse F, 2000, DEV BIOL, V221, P53, DOI 10.1006/dbio.2000.9687; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pursley S, 2000, INSECT BIOCHEM MOLEC, V30, P839, DOI 10.1016/S0965-1748(00)00056-4; RICHARD DS, 1989, J COMP PHYSIOL B, V159, P383, DOI 10.1007/BF00692410; Riddiford LM, 2010, DEVELOPMENT, V137, P1117, DOI 10.1242/dev.037218; SHEMSHEDINI L, 1990, P NATL ACAD SCI USA, V87, P2072, DOI 10.1073/pnas.87.6.2072; Shin SW, 2012, P NATL ACAD SCI USA, V109, P16576, DOI 10.1073/pnas.1214209109; SLITER TJ, 1987, INSECT BIOCHEM, V17, P161, DOI 10.1016/0020-1790(87)90156-9; Soshilov A, 2011, J BIOL CHEM, V286, P35275, DOI 10.1074/jbc.M111.246439; Tian L, 2013, AUTOPHAGY, V9, P1172, DOI 10.4161/auto.24731; Wang S, 2012, J PROTEOME RES, V11, P6187, DOI 10.1021/pr3008804; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684; Zou Z, 2013, P NATL ACAD SCI USA, V110, pE2173, DOI 10.1073/pnas.1305293110	47	56	64	1	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27874	27885		10.1074/jbc.M114.582825	http://dx.doi.org/10.1074/jbc.M114.582825			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25122763	hybrid, Green Published			2022-12-28	WOS:000342852800043
J	Wang, GQ; He, QZ; Feng, C; Liu, Y; Deng, ZQ; Qi, XX; Wu, W; Mei, PC; Chen, ZZ				Wang, Guoqiang; He, Qingzhong; Feng, Chong; Liu, Yang; Deng, Zengqin; Qi, Xiaoxuan; Wu, Wei; Mei, Pinchao; Chen, Zhongzhou			The Atomic Resolution Structure of Human AlkB Homolog 7 (ALKBH7), a Key Protein for Programmed Necrosis and Fat Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Dioxygenase; Fatty Acid Metabolism; Necrosis (Necrotic Death); Obesity; X-ray Crystallography; ALKB; ALKBH7; Protein Hydroxylase; Self-Hydroxylation	HYPOXIA-INDUCIBLE FACTOR; REPAIR ENZYME ALKB; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; TRANSFER-RNA; DNA-DAMAGE; OXIDATIVE DEMETHYLATION; SUBSTRATE RECOGNITION; CYCLOPHILIN-D; CELL-DEATH	Background: Human ALKBH7 is a mitochondrial protein required for alkylation- and oxidation-induced programmed necrosis and short chain fatty acid metabolism. Results: Atomic resolution structures of ALKBH7 in complex with two ligands were determined. Conclusion: Structural analyses and observation of self-hydroxylation demonstrate that ALKBH7 may function as a protein hydroxylase. Significance: ALKBH7 structures provide a foundation for drug design in cell death and metabolic diseases. ALKBH7 is the mitochondrial AlkB family member that is required for alkylation- and oxidation-induced programmed necrosis. In contrast to the protective role of other AlkB family members after suffering alkylation-induced DNA damage, ALKBH7 triggers the collapse of mitochondrial membrane potential and promotes cell death. Moreover, genetic ablation of mouse Alkbh7 dramatically increases body weight and fat mass. Here, we present crystal structures of human ALKBH7 in complex with Mn(II) and -ketoglutarate at 1.35 or N-oxalylglycine at 2.0 resolution. ALKBH7 possesses the conserved double-stranded -helix fold that coordinates a catalytically active iron by a conserved HX(D/E) ... X-n ... H motif. Self-hydroxylation of Leu-110 was observed, indicating that ALKBH7 has the potential to catalyze hydroxylation of its substrate. Unlike other AlkB family members whose substrates are DNA or RNA, ALKBH7 is devoid of the nucleotide recognition lid which is essential for binding nucleobases, and thus exhibits a solvent-exposed active site; two loops between -strands 6 and 7 and between 9 and 10 create a special outer wall of the minor -sheet of the double-stranded -helix and form a negatively charged groove. These distinct features suggest that ALKBH7 may act on protein substrate rather than nucleic acids. Taken together, our findings provide a structural basis for understanding the distinct function of ALKBH7 in the AlkB family and offer a foundation for drug design in treating cell death-related diseases and metabolic diseases.	[Wang, Guoqiang; Feng, Chong; Liu, Yang; Deng, Zengqin; Qi, Xiaoxuan; Wu, Wei; Chen, Zhongzhou] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [He, Qingzhong; Mei, Pinchao] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Dept Biochem & Mol Biol, Beijing 100005, Peoples R China; [He, Qingzhong; Mei, Pinchao] Peking Union Med Coll, Beijing 100005, Peoples R China	China Agricultural University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Chen, ZZ (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	chenzhongzhou@cau.edu.cn	chen, zhong/E-3900-2015; Deng, Zengqin/AAK-5194-2021	chen, zhong/0000-0003-1319-9664; Mei, Pinchao/0000-0002-1564-0372; Qi, Xiaoxuan/0000-0001-5191-3713; Liu, Yang/0000-0003-0679-2275	National Basic Research Program of China 973 Programs [2011CB965304, 2009CB825403]; National Natural Science Foundation of China [31222032, 31300135, 31370720]	National Basic Research Program of China 973 Programs(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China 973 Programs 2011CB965304 and 2009CB825403 and National Natural Science Foundation of China Grants 31222032, 31300135, and 31370720.	Aik W, 2014, NUCLEIC ACIDS RES, V42, P4741, DOI 10.1093/nar/gku085; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Bjornstad LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049045; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Dunai Z, 2011, PATHOL ONCOL RES, V17, P791, DOI 10.1007/s12253-011-9433-4; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Feng C, 2014, J BIOL CHEM, V289, P11571, DOI 10.1074/jbc.M113.546168; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Fu D, 2013, GENE DEV, V27, P1089, DOI 10.1101/gad.215533.113; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Holland PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008680; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Johannessen TCA, 2013, NEURO-ONCOLOGY, V15, P269, DOI 10.1093/neuonc/nos301; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; Li MM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2863; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Luvisetto S, 2008, NEUROSCIENCE, V155, P585, DOI 10.1016/j.neuroscience.2008.06.030; Mantri M, 2012, FEBS J, V279, P1563, DOI 10.1111/j.1742-4658.2012.08496.x; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Monsen VT, 2010, NUCLEIC ACIDS RES, V38, P6447, DOI 10.1093/nar/gkq518; Muller TA, 2010, DNA REPAIR, V9, P58, DOI 10.1016/j.dnarep.2009.10.011; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ougland R, 2012, STEM CELLS, V30, P2672, DOI 10.1002/stem.1228; Pastore C, 2012, J BIOL CHEM, V287, P2130, DOI 10.1074/jbc.M111.286187; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Solberg A, 2013, J MOL CELL BIOL, V5, P194, DOI 10.1093/jmcb/mjt012; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wang JM, 2005, ACTA CRYSTALLOGR D, V61, P67, DOI 10.1107/S0907444904026721; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	54	30	31	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27924	27936		10.1074/jbc.M114.590505	http://dx.doi.org/10.1074/jbc.M114.590505			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25122757	Green Published, hybrid			2022-12-28	WOS:000342852800047
J	Liu, LJ; Stockdreher, Y; Koch, T; Sun, ST; Fan, Z; Josten, M; Sahl, HG; Wang, Q; Luo, YM; Liu, SJ; Dahl, C; Jiang, CY				Liu, Li-Jun; Stockdreher, Yvonne; Koch, Tobias; Sun, Shu-Tao; Fan, Zheng; Josten, Michaele; Sahl, Hans-Georg; Wang, Qian; Luo, Yuan-Ming; Liu, Shuang-Jiang; Dahl, Christiane; Jiang, Cheng-Ying			Thiosulfate Transfer Mediated by DsrE/TusA Homologs from Acidothermophilic Sulfur-oxidizing Archaeon Metallosphaera cuprina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; THERMOACIDOPHILIC CRENARCHAEON; ALLOCHROMATIUM-VINOSUM; OXIDATION; PROTEINS; ACIDITHIOBACILLUS; REDUCTASE; BACTERIA; INSIGHTS	Conserved clusters of genes encoding DsrE and TusA homologs occur in many archaeal and bacterial sulfur oxidizers. TusA has a well documented function as a sulfurtransferase in tRNA modification and molybdenum cofactor biosynthesis in Escherichia coli, and DsrE is an active site subunit of the DsrEFH complex that is essential for sulfur trafficking in the phototrophic sulfur-oxidizing Allochromatium vinosum. In the acidothermophilic sulfur (S-0)-and tetrathionate (S4O62-)-oxidizing Metallosphaera cuprina Ar-4, a dsrE3A-dsrE2B-tusA arrangement is situated immediately between genes encoding dihydrolipoamide dehydrogenase and a heterodisulfide reductase-like complex. In this study, the biochemical features and sulfur transferring abilities of the DsrE2B, DsrE3A, and TusA proteins were investigated. DsrE3A and TusA proved to react with tetrathionate but not with NaSH, glutathione persulfide, polysulfide, thiosulfate, or sulfite. The products were identified as protein-Cys-S-thiosulfonates. DsrE3A was also able to cleave the thiosulfate group from TusA-Cys(18)-S-thiosulfonate. DsrE2B did not react with any of the sulfur compounds tested. DsrE3A and TusA interacted physically with each other and formed a heterocomplex. The cysteine residue (Cys(18)) of TusA is crucial for this interaction. The single cysteine mutants DsrE3A-(CS)-S-93 and DsrE3A-(CS)-S-101 retained the ability to transfer the thiosulfonate group to TusA. TusA-(CS)-S-18 neither reacted with tetrathionate nor was it loaded with thiosulfate with DsrE3A-Cys-S-thiosulfonate as the donor. The transfer of thiosulfate, mediated by a DsrE-like protein and TusA, is unprecedented not only in M. cuprina but also in other sulfur-oxidizing prokaryotes. The results of this study provide new knowledge on oxidative microbial sulfur metabolism.	[Liu, Li-Jun; Fan, Zheng; Wang, Qian; Luo, Yuan-Ming; Liu, Shuang-Jiang; Jiang, Cheng-Ying] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China; [Stockdreher, Yvonne; Koch, Tobias; Dahl, Christiane] Univ Bonn, Inst Mikrobiol & Biotechnol, D-53115 Bonn, Germany; [Sun, Shu-Tao] Chinese Acad Sci, Core Facil, Beijing 100101, Peoples R China; [Liu, Shuang-Jiang; Jiang, Cheng-Ying] Chinese Acad Sci, Environm Microbiol Res Ctr, Inst Microbiol, Beijing 100101, Peoples R China; [Liu, Li-Jun] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Josten, Michaele; Sahl, Hans-Georg] Univ Bonn, Inst Med Mikrobiol Immunol & Parasitol, Abt Pharmazeut Mikrobiol, D-53127 Bonn, Germany	Chinese Academy of Sciences; Institute of Microbiology, CAS; University of Bonn; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Bonn	Liu, SJ (corresponding author), Chinese Acad Sci, Inst Microbiol, Bei Chen Xi Lu 1, Beijing 100101, Peoples R China.	liusj@im.ac.cn; ChDahl@uni-bonn.de; jiangcy@im.ac.cn	Dahl, Christiane/H-4786-2019; Liu, Shuang-Jiang/E-5756-2013	Dahl, Christiane/0000-0001-8288-7546; 	Ministry of Science and Technology (973 Program) [2010CB630903]; Ministry of Science and Technology (863 Program) [2012AA061501]; National Nature Science Foundation of China [31070042]; open funding project of the State Key Laboratory of Bioreactor Engineering; Deutsche Forschungsgemeinschaft [Da 351/6-1]; German Academic Exchange Service; Chinese Academy of Sciences (DAAD-CAS Joint Program)	Ministry of Science and Technology (973 Program)(National Basic Research Program of China); Ministry of Science and Technology (863 Program); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); open funding project of the State Key Laboratory of Bioreactor Engineering; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Chinese Academy of Sciences (DAAD-CAS Joint Program)	This work was supported by the Ministry of Science and Technology (973 Program 2010CB630903 and 863 Program 2012AA061501) and the National Nature Science Foundation of China (Grant 31070042) and in part by an open funding project of the State Key Laboratory of Bioreactor Engineering. This work was also supported by Deutsche Forschungsgemeinschaft Grant Da 351/6-1 (to C. D.).; Recipient of a scholarship from the German Academic Exchange Service and the Chinese Academy of Sciences (DAAD-CAS Joint Program).	Auernik KS, 2008, APPL ENVIRON MICROB, V74, P682, DOI 10.1128/AEM.02019-07; Auernik KS, 2008, APPL ENVIRON MICROB, V74, P7723, DOI 10.1128/AEM.01545-08; Berg JS, 2014, APPL ENVIRON MICROB, V80, P629, DOI 10.1128/AEM.02852-13; Brito JA, 2009, BIOCHEMISTRY-US, V48, P5613, DOI 10.1021/bi9003827; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Chen ZW, 2007, APPL MICROBIOL BIOT, V74, P688, DOI 10.1007/s00253-006-0691-0; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; Dahl JU, 2013, J BIOL CHEM, V288, P5426, DOI 10.1074/jbc.M112.431569; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Denkmann K, 2012, ENVIRON MICROBIOL, V14, P2673, DOI 10.1111/j.1462-2920.2012.02820.x; Dopson M, 2012, ENVIRON MICROBIOL, V14, P2620, DOI 10.1111/j.1462-2920.2012.02749.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Friedrich CG, 2008, MICROBIAL SULFUR METABOLISM, P139, DOI 10.1007/978-3-540-72682-1_12; Ghosh W, 2009, FEMS MICROBIOL REV, V33, P999, DOI 10.1111/j.1574-6976.2009.00187.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; HUBER G, 1989, SYST APPL MICROBIOL, V12, P38; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Imhoff JF, 1998, INT J SYST BACTERIOL, V48, P1129, DOI 10.1099/00207713-48-4-1129; Kawarabayasi Y, 2001, DNA RES, V8, P123, DOI 10.1093/dnares/8.4.123; KLETZIN A, 1989, J BACTERIOL, V171, P1638, DOI 10.1128/jb.171.3.1638-1643.1989; Liu LJ, 2011, INT J SYST EVOL MICR, V61, P2395, DOI 10.1099/ijs.0.026591-0; Liu LJ, 2011, J BACTERIOL, V193, P3387, DOI 10.1128/JB.05038-11; Liu YW, 2013, MOL MICROBIOL, V88, P173, DOI 10.1111/mmi.12176; Lubbe YJ, 2006, FEMS MICROBIOL LETT, V261, P194, DOI 10.1111/j.1574-6968.2006.00343.x; Muller FH, 2004, MOL MICROBIOL, V53, P1147, DOI 10.1111/j.1365-2958.2004.04193.x; Muyzer G, 2011, STAND GENOMIC SCI, V5, P341, DOI 10.4056/sigs.2315092; Pott AS, 1998, MICROBIOL-SGM, V144, P1881, DOI 10.1099/00221287-144-7-1881; Protze J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00068; Quatrini R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-394; Reysenbach AL, 2009, J BACTERIOL, V191, P1992, DOI 10.1128/JB.01645-08; Rohwerder T, 2007, ENG LIFE SCI, V7, P301, DOI 10.1002/elsc.200720204; Rohwerder T, 2003, MICROBIOL-SGM, V149, P1699, DOI 10.1099/mic.0.26212-0; Sander J, 2006, ARCH MICROBIOL, V186, P357, DOI 10.1007/s00203-006-0156-y; SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108; Sneath PH., 1973, NUMERICAL TAXONOMY P; Stockdreher Y, 2014, J BIOL CHEM, V289, P12390, DOI 10.1074/jbc.M113.536425; Stockdreher Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040785; Sun CW, 2003, EXTREMOPHILES, V7, P131, DOI 10.1007/s00792-002-0304-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thome R, 2012, J BIOL CHEM, V287, P4671, DOI 10.1074/jbc.M111.327122; Venceslau SS, 2014, BBA-BIOENERGETICS, V1837, P1148, DOI 10.1016/j.bbabio.2014.03.007; Waksman SA, 1922, J BACTERIOL, V7, P239, DOI 10.1128/JB.7.2.239-256.1922; You XY, 2011, J GENET GENOMICS, V38, P243, DOI 10.1016/j.jgg.2011.04.006; You XY, 2011, EXTREMOPHILES, V15, P487, DOI 10.1007/s00792-011-0379-y; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	49	34	35	0	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26949	26959		10.1074/jbc.M114.591669	http://dx.doi.org/10.1074/jbc.M114.591669			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122768	Green Published, hybrid			2022-12-28	WOS:000342853900025
J	Pepenella, S; Murphy, KJ; Hayes, JJ				Pepenella, Sharon; Murphy, Kevin J.; Hayes, Jeffrey J.			A Distinct Switch in Interactions of the Histone H4 Tail Domain upon Salt-dependent Folding of Nucleosome Arrays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H4-K16 ACETYLATION; SELF-ASSOCIATION; N-TERMINI; MODEL; ORGANIZATION; PROTEIN; DNA; STABILIZATION; STABILITY; ROLES	The core histone tail domains mediate inter-nucleosomal interactions that direct folding and condensation of nucleosome arrays into higher-order chromatin structures. The histone H4 tail domain facilitates inter-array interactions by contacting both the H2A/H2B acidic patch and DNA of neighboring nucleosomes (1, 2). Likewise, H4 tail-H2A contacts stabilize array folding (3). However, whether the H4 tail domains stabilize array folding via inter-nucleosomal interactions with the DNA of neighboring nucleosomes remains unclear. We utilized defined oligonucleosome arrays containing a single specialized nucleosome with a photo-inducible cross-linker in the N terminus of the H4 tail to characterize these interactions. We observed that the H4 tail participates exclusively in intra-array interactions with DNA in unfolded arrays. These interactions are diminished during array folding, yet no inter-nucleosome, intra-array H4 tail-DNA contacts are observed in condensed chromatin. However, we document contacts between the N terminus of the H4 tail and H2A. Installation of acetylation mimics known to disrupt H4-H2A surface interactions did not increase observance of H4-DNA inter-nucleosomal interactions. These results suggest the multiple functions of the H4 tail require targeted distinct interactions within condensed chromatin.	[Pepenella, Sharon; Murphy, Kevin J.; Hayes, Jeffrey J.] Univ Rochester, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Hayes, JJ (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.	Jeffrey_Hayes@urmc.rochester.edu			National Institutes of Health [GM R01 52426, 5T32 GM068411]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052426, T32GM068411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM R01 52426 and 5T32 GM068411.	Allahverdi A, 2011, NUCLEIC ACIDS RES, V39, P1680, DOI 10.1093/nar/gkq900; ALLAN J, 1982, J CELL BIOL, V93, P285, DOI 10.1083/jcb.93.2.285; Arya G, 2009, J PHYS CHEM A, V113, P4045, DOI 10.1021/jp810375d; AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; Blacketer MJ, 2010, J BIOL CHEM, V285, P34597, DOI 10.1074/jbc.M110.140061; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; GARCIARAMIREZ M, 1992, J BIOL CHEM, V267, P19587; Gritsan NP, 1999, J PHYS CHEM A, V103, P4465, DOI 10.1021/jp990004u; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Kalashnikova AA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1022; Kan PY, 2007, MOL CELL BIOL, V27, P2084, DOI 10.1128/MCB.02181-06; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Potoyan DA, 2012, P NATL ACAD SCI USA, V109, P17857, DOI 10.1073/pnas.1201805109; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sinha D, 2010, J BIOL CHEM, V285, P16572, DOI 10.1074/jbc.M109.091298; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Tse C, 1997, BIOCHEMISTRY-US, V36, P11381, DOI 10.1021/bi970801n; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Wang XD, 2008, MOL CELL BIOL, V28, P227, DOI 10.1128/MCB.01245-07; Wolffe A, 1998, CHROMATIN - STRUCTURE AND FUNCTION, 3RD EDITION, P1, DOI 10.1016/B978-012761914-9/50003-9; Yang DR, 2011, PHYS CHEM CHEM PHYS, V13, P2911, DOI 10.1039/c0cp01487g; Zheng CY, 2005, J BIOL CHEM, V280, P33552, DOI 10.1074/jbc.M507241200; Zheng CY, 2003, J BIOL CHEM, V278, P24217, DOI 10.1074/jbc.M302817200	32	32	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27342	27351		10.1074/jbc.M114.595140	http://dx.doi.org/10.1074/jbc.M114.595140			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122771	Green Published, hybrid			2022-12-28	WOS:000342853900054
J	Sohya, S; Kamioka, T; Fujita, C; Maki, T; Ohta, Y; Kuroda, Y				Sohya, Shihori; Kamioka, Tetsuya; Fujita, Chisako; Maki, Tei; Ohta, Yoshihiro; Kuroda, Yutaka			Biochemical and Biophysical Characterization of an Unexpected Bacteriolytic Activity of VanX, a Member of the Vancomycin-resistance vanA Gene Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; EGG-WHITE; AUTOLYSIS; LYSOZYME; LYSIS; IDENTIFICATION; MICROSCOPY; MECHANISM; PROTEIN; VARIANT	VanX is a D-alanyl-D-alanine (D-Ala-D-Ala) dipeptidase encoded in the vancomycin-resistance vanA gene cluster. Here we report that strong bacteriolysis occurred when isolated VanX was expressed in Escherichia coli at temperatures lower than 30 degrees C, which was unexpected because the vanA operon confers vancomycin resistance by protecting the cell wall. Therefore, we monitored cell lysis by measuring sample turbidity with absorbance at 590 nm and VanX expression using SDS-PAGE. No cell lysis was observed when VanX was expressed, even in large quantities, in the cell inclusion bodies at 37 degrees C, suggesting that a natively folded VanX is required for lysis. In addition, VanX mutants with suppressed dipeptidase activity did not lyse E. coli cells, confirming that bacteriolysis originated from the dipeptidase activity of VanX. We also observed shape changes in E. coli cells undergoing VanX-mediated lysis with optical microscopy and classified these changes into three classes: bursting, deformation, and leaking fluid. Optical microscopic image analysis fully corroborated our interpretation of the turbidity changes in the samples. From a practical perspective, the finding that VanX expressed in isolation induces cell lysis suggests that inhibitors of VanA and VanH that act downstream from VanX could provide a new class of therapeutic chemicals against bacteria expressing the vancomycin-resistance gene cluster.	[Sohya, Shihori; Kamioka, Tetsuya; Fujita, Chisako; Ohta, Yoshihiro; Kuroda, Yutaka] Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Maki, Tei] Tokyo Univ Agr & Technol, Res Ctr Sci & Technol, Koganei, Tokyo 1848588, Japan; [Maki, Tei] JEOL Ltd, EM Business Unit, Tokyo 1968558, Japan	Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology; Jeol Ltd; JEOL Japan	Kuroda, Y (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Biotechnol & Life Sci, 2-24-16 Nakamachi, Koganei, Tokyo 1848588, Japan.	ykuroda@cc.tuat.ac.jp	Kuroda, Yutaka/G-1094-2013; Ohta, Yoshihiro/C-8741-2013	Kuroda, Yutaka/0000-0002-3221-4295; Ohta, Yoshihiro/0000-0001-7416-0507				Akiyama S, 2012, BIOCHEMISTRY-US, V51, P7974, DOI 10.1021/bi300580j; ALOBEID S, 1990, ANTIMICROB AGENTS CH, V34, P252, DOI 10.1128/AAC.34.2.252; CANFIELD RE, 1963, J BIOL CHEM, V238, P2698; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; DOI E, 1981, ANAL BIOCHEM, V118, P173, DOI 10.1016/0003-2697(81)90175-5; Heidrich C, 2001, MOL MICROBIOL, V41, P167, DOI 10.1046/j.1365-2958.2001.02499.x; Hsieh ML, 2006, ANAL BIOCHEM, V354, P104, DOI 10.1016/j.ab.2006.03.054; Islam MM, 2008, P NATL ACAD SCI USA, V105, P15334, DOI 10.1073/pnas.0802699105; Islam MM, 2009, PROTEINS, V77, P962, DOI 10.1002/prot.22522; Jang B, 2007, J MICROBIOL, V45, P593; Jovetic S, 2010, TRENDS BIOTECHNOL, V28, P596, DOI 10.1016/j.tibtech.2010.09.004; Kamioka T, 2013, ANAL BIOCHEM, V439, P212, DOI 10.1016/j.ab.2013.04.007; KELLENBERGER E, 1958, J BIOPHYS BIOCHEM CY, V4, P323, DOI 10.1083/jcb.4.3.323; LEDUC M, 1980, J BACTERIOL, V142, P52, DOI 10.1128/JB.142.1.52-59.1980; Lessard IAD, 1999, P NATL ACAD SCI USA, V96, P11028, DOI 10.1073/pnas.96.20.11028; Liu XY, 2009, P NATL ACAD SCI USA, V106, P21550, DOI 10.1073/pnas.0911953106; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Morikawa D, 2014, BIOMED OPT EXPRESS, V5, P848, DOI 10.1364/BOE.5.000848; Nakakoshi M, 2011, J ELECTRON MICROSC, V60, P401, DOI 10.1093/jmicro/dfr084; Okanojo M, 2005, J BIOSCI BIOENG, V100, P556, DOI 10.1263/jbb.100.556; Park T, 2006, P NATL ACAD SCI USA, V103, P19713, DOI 10.1073/pnas.0600943103; SCHINDLER M, 1977, BIOCHEMISTRY-US, V16, P423, DOI 10.1021/bi00622a013; Sova M, 2009, BIOORG MED CHEM LETT, V19, P1376, DOI 10.1016/j.bmcl.2009.01.034	23	2	2	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35686	35694		10.1074/jbc.M114.590265	http://dx.doi.org/10.1074/jbc.M114.590265			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25294880	hybrid, Green Published			2022-12-28	WOS:000346897900002
J	Zeymer, C; Fischer, S; Reinstein, J				Zeymer, Cathleen; Fischer, Sebastian; Reinstein, Jochen			trans-Acting Arginine Residues in the AAA plus Chaperone ClpB Allosterically Regulate the Activity through Inter- and Intradomain Communication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISAGGREGATING MACHINE; NUCLEOTIDE-BINDING DOMAINS; THERMUS-THERMOPHILUS; ATP-BINDING; MOLECULAR CHAPERONE; HSP104; THERMOTOLERANCE; HYDROLYSIS; MECHANISM; SUBUNITS	The molecular chaperone ClpB/Hsp104, a member of the AAA+ superfamily (ATPases associated with various cellular activities), rescues proteins from the aggregated state in collaboration with the DnaK/Hsp70 chaperone system. ClpB/Hsp104 forms a hexameric, ring-shaped complex that functions as a tightly regulated, ATP-powered molecular disaggregation machine. Highly conserved and essential arginine residues, often called arginine fingers, are located at the subunit interfaces of the complex, which also harbor the catalytic sites. Several AAA+ proteins, including ClpB/Hsp104, possess a pair of such trans-acting arginines in the N-terminal nucleotide binding domain (NBD1), both of which were shown to be crucial for oligomerization and ATPase activity. Here, we present a mechanistic study elucidating the role of this conserved arginine pair. First, we found that the arginines couple nucleotide binding to oligomerization of NBD1, which is essential for the activity. Next, we designed a set of covalently linked, dimeric ClpBNBD1 variants, carrying single subunits deficient in either ATP binding or hydrolysis, to study allosteric regulation and intersubunit communication. Using this well defined environment of site-specifically modified, cross-linked AAA+ domains, we found that the conserved arginine pair mediates the cooperativity of ATP binding and hydrolysis in an allosteric fashion.	[Zeymer, Cathleen; Fischer, Sebastian; Reinstein, Jochen] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany	Max Planck Society	Reinstein, J (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany.	jochen.reinstein@mpimf-heidelberg.mpg.de		Zeymer, Cathleen/0000-0001-7138-381X	Max Planck Society; German National Academic Foundation	Max Planck Society(Max Planck Society); German National Academic Foundation	This work was supported by the Max Planck Society and by a Ph.D. scholarship from the German National Academic Foundation (to C. Z.).	Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Fernandez-Higuero JA, 2011, J BIOL CHEM, V286, P25547, DOI 10.1074/jbc.M111.231365; Beinker P, 2005, J BIOL CHEM, V280, P37965, DOI 10.1074/jbc.M506672200; Biter AB, 2012, J STRUCT BIOL, V179, P172, DOI 10.1016/j.jsb.2012.05.007; Carroni M, 2014, ELIFE, V3, DOI 10.7554/eLife.02481; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; Diemand AV, 2006, J STRUCT BIOL, V156, P230, DOI 10.1016/j.jsb.2006.04.011; Le DTV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067815; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Franzmann TM, 2011, J BIOL CHEM, V286, P17992, DOI 10.1074/jbc.M110.216176; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; HAZES B, 1988, PROTEIN ENG, V2, P119, DOI 10.1093/protein/2.2.119; Hodson S, 2012, J STRUCT BIOL, V179, P161, DOI 10.1016/j.jsb.2012.05.015; Klostermeier D, 1999, J MOL BIOL, V287, P511, DOI 10.1006/jmbi.1999.2636; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; Oguchi Y, 2012, NAT STRUCT MOL BIOL, V19, P1338, DOI 10.1038/nsmb.2441; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schlee S, 2001, J MOL BIOL, V306, P889, DOI 10.1006/jmbi.2001.4455; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; Stinson BM, 2013, CELL, V153, P628, DOI 10.1016/j.cell.2013.03.029; Thrall SH, 1996, BIOCHEMISTRY-US, V35, P4609, DOI 10.1021/bi9526387; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; Wang Q, 2005, J BIOL CHEM, V280, P40515, DOI 10.1074/jbc.M509636200; Watanabe Y, 2005, J BIOL CHEM, V280, P24562, DOI 10.1074/jbc.M414623200; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Werbeck ND, 2011, BIOCHEMISTRY-US, V50, P899, DOI 10.1021/bi1018286; Werbeck ND, 2009, BIOCHEMISTRY-US, V48, P7240, DOI 10.1021/bi900880c; Yamasaki T, 2011, FEBS J, V278, P2395, DOI 10.1111/j.1742-4658.2011.08167.x; Zeymer C, 2014, ACTA CRYSTALLOGR D, V70, P582, DOI 10.1107/S1399004713030629; Zeymer C, 2013, J BIOL CHEM, V288, P7065, DOI 10.1074/jbc.M112.432583; Zolkiewski M, 2012, ARCH BIOCHEM BIOPHYS, V520, P1, DOI 10.1016/j.abb.2012.01.012	42	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.608828	http://dx.doi.org/10.1074/jbc.M114.608828			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25253689	hybrid, Green Published			2022-12-28	WOS:000345335000047
J	Al-Khalaf, HH; Aboussekhra, A				Al-Khalaf, Huda H.; Aboussekhra, Abdelilah			MicroRNA-141 and MicroRNA-146b-5p Inhibit the Prometastatic Mesenchymal Characteristics through the RNA-binding Protein AUF1 Targeting the Transcription Factor ZEB1 and the Protein Kinase AKT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; GENE-EXPRESSION; MIR-200 FAMILY; CANCER-CELLS; TRANSITION; STABILITY; INVASION; HUR; PATHWAYS; MOTILITY	miR-141 and miR-146b-5p are two important tumor suppressor microRNAs, which control several cancer-related genes and processes. In the present report, we have shown that these microRNAs bind specific sites at the 3'-untranslated region (UTR) of the mRNA-binding protein AUF1, leading to its down-regulation. This inverse correlation between the levels of these microRNAs and AUF1 has been identified in various osteosarcoma cell lines. Additionally, we present clear evidence that AUF1 promotes mesenchymal features in osteosarcoma cells and that miR-141 and miR-146b-5p suppress this prometastatic process through AUF1 repression. Indeed, both microRNAs suppressed the invasion/migration and proliferation abilities of osteosarcoma cells through inhibiting the AKT protein kinase in an AUF1-dependent manner. We have also shown that AUF1 binds to and stabilizes the mRNA of the AKT activator phosphoinositide- dependent kinase-1 (PDK1). Furthermore, miR141 and miR-146b-5p positively regulate the epithelial markers (E-cadherin and Epcam) and repress the mesenchymal markers (N-cadherin, Vimentin, Twist2, and ZEB1). These effects were mediated via the repression of the epithelial-to-mesenchymal inducer ZEB1 through targeting AUF1, which binds the 3'-UTR of the ZEB1 mRNA and reduces its turnover. These results indicate that at least some tumor suppressor functions of miR-141 and miR-146b-5p are mediated through the repression of the oncogenic potentials of AUF1. Therefore, these 3'-UTR-directed post-transcriptional gene expression regulators constitute promising new targets for diagnostic and/or therapeutic interventions.	[Al-Khalaf, Huda H.; Aboussekhra, Abdelilah] King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, Riyadh 11211, Saudi Arabia; [Al-Khalaf, Huda H.] King Abdulaziz City Sci & Technol, Joint Ctr Genom Res, Riyadh 77211, Saudi Arabia	King Faisal Specialist Hospital & Research Center	Aboussekhra, A (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, MBC 03,POB 3354, Riyadh 11211, Saudi Arabia.	aboussekhra@kfshrc.edu.sa	Alkhalaf, Huda/Z-5701-2019		Research Centre administration	Research Centre administration	We are grateful to Dr. Myriam Gorospe for kindly providing the pSILENCER-AUF1 siR1VA plasmid. We also thank the Research Centre administration for continuous help and support	Abdelmohsen K, 2012, NUCLEIC ACIDS RES, V40, P11531, DOI 10.1093/nar/gks930; Adams CJ, 2012, P NATL ACAD SCI USA, V109, P3778, DOI 10.1073/pnas.1113731109; Al-Haj L, 2012, NUCLEIC ACIDS RES, V40, P7739, DOI 10.1093/nar/gks545; Al-Khalaf HH, 2013, J BIOL CHEM, V288, P35511, DOI 10.1074/jbc.M113.512640; Al-Khalaf HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070133; Al-Khalaf HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021111; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Almhanna K, 2011, ANTICANCER RES, V31, P4387; Arcondeguy T, 2013, NUCLEIC ACIDS RES, V41, P7997, DOI 10.1093/nar/gkt539; Asirvatham AJ, 2008, MOL IMMUNOL, V45, P1995, DOI 10.1016/j.molimm.2007.10.035; Borgdorff V, 2010, ONCOGENE, V29, P2262, DOI 10.1038/onc.2009.497; Brewer G, 2003, J INTERF CYTOK RES, V23, P553, DOI 10.1089/107999003322485053; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Ciafre SA, 2013, RNA BIOL, V10, P935, DOI 10.4161/rna.24641; Geraldo MV, 2012, ONCOGENE, V31, P1910, DOI 10.1038/onc.2011.381; Gouble A, 2002, CANCER RES, V62, P1489; Gratacos FM, 2010, WIRES RNA, V1, P457, DOI 10.1002/wrna.26; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grille SJ, 2003, CANCER RES, V63, P2172; Hao J, 2014, INT J CANCER, V135, P1019, DOI 10.1002/ijc.28761; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; KAJITA Y, 1995, J BIOL CHEM, V270, P22167, DOI 10.1074/jbc.270.38.22167; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lauvrak SU, 2013, BRIT J CANCER, V109, P2228, DOI 10.1038/bjc.2013.549; Li XL, 2014, MOL CELL BIOL, V34, P533, DOI 10.1128/MCB.01043-13; Liao BS, 2007, NAT STRUCT MOL BIOL, V14, P511, DOI 10.1038/nsmb1249; Liao Y, 2010, AM J TRANSL RES, V2, P19; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Mazan-Mamczarz K, 2008, CANCER RES, V68, P7730, DOI 10.1158/0008-5472.CAN-08-2393; McConnell BB, 1999, MOL CELL BIOL, V19, P1981; Palanisamy V, 2008, J DENT RES, V87, P772, DOI 10.1177/154405910808700803; Sarkar S, 2008, J INTERF CYTOK RES, V28, P679, DOI 10.1089/jir.2008.0028; Suman S, 2014, MOL CARCINOGEN, V53, pE151, DOI 10.1002/mc.22076; Tominaga K, 2011, MOL CELL BIOL, V31, P4219, DOI 10.1128/MCB.05955-11; Trojanowicz B, 2009, ENDOCR-RELAT CANCER, V16, P857, DOI 10.1677/ERC-08-0234; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Wang WG, 2005, EMBO REP, V6, P158, DOI 10.1038/sj.embor.7400346; White EJF, 2013, BBA-GENE REGUL MECH, V1829, P680, DOI 10.1016/j.bbagrm.2012.12.002; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Zhang YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066464; Zhao G, 2013, MOL CANCER THER, V12, P2569, DOI 10.1158/1535-7163.MCT-13-0296; Zucconi BE, 2011, FRONT BIOSCI-LANDMRK, V16, P2307, DOI 10.2741/3855	48	46	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31433	31447		10.1074/jbc.M114.593004	http://dx.doi.org/10.1074/jbc.M114.593004			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25261470	Green Published, hybrid			2022-12-28	WOS:000344549900046
J	Qi, J; Huo, L; Zhu, YT; Zhu, YJ				Qi, Jin; Huo, Lei; Zhu, Yiwei Tony; Zhu, Yi-Jun			Absent, Small or Homeotic 2-like Protein (ASH2L) Enhances the Transcription of the Estrogen Receptor alpha Gene through GATA-binding Protein 3 (GATA3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; IDENTIFICATION; EXPRESSION; COMPLEX; COACTIVATOR; AMPLICON; REVEALS; FAMILY; REGULATOR; COMPASS	ASH2L is a component of MLL complexes that confer H3K4 trimethylation. The ASH2L gene is located at 8q11-12, which is often amplified in breast cancers. We found that increased ASH2L expression, which can result from gene amplification, is often correlated with increased ER alpha expression in both breast cancer cell lines and primary breast cancers. Forced expression of ASH2L induced ER alpha expression in mammary epithelial cells, whereas depletion of ASH2L suppressed ER alpha expression in breast cancer cells. To understand the mechanism by which ASH2L regulates ER alpha expression, we identified GATA3 as the binding protein of ASH2L. ASH2L was shown to potentiate the transcriptional activity of GATA3. ASH2L was recruited to the enhancer of the ER alpha gene through GATA3 to promote ER alpha transcription. This study established that ASH2L enhances ER alpha expression as a coactivator of GATA3 in breast cancers.	[Qi, Jin] Maternal & Child Hosp Shaanxi Prov, Xian, Shaanxi, Peoples R China; [Huo, Lei] Univ Texas MD Anderson Canc Ctr, Div Pathol & Lab Med, Houston, TX 77030 USA; [Zhu, Yiwei Tony; Zhu, Yi-Jun] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA	University of Texas System; UTMD Anderson Cancer Center; Northwestern University; Feinberg School of Medicine	Zhu, YJ (corresponding author), 303 East Chicago Ave, Chicago, IL 60611 USA.	y-zhu2@northwestern.edu			National Institutes of Health [CA 88898]; NATIONAL CANCER INSTITUTE [R01CA088898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA 88898 (to Y.J.Z).	ABE O, 1992, LANCET, V339, P71; Adelaide J, 1998, GENE CHROMOSOME CANC, V22, P186, DOI 10.1002/(SICI)1098-2264(199807)22:3<186::AID-GCC4>3.0.CO;2-S; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Ansari KI, 2010, FEBS J, V277, P1790, DOI 10.1111/j.1742-4658.2010.07606.x; Arnold JM, 2010, BREAST CANCER RES TR, V119, P491, DOI 10.1007/s10549-008-0269-x; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Bresnick EH, 2005, J CELL PHYSIOL, V205, P1, DOI 10.1002/jcp.20393; Brisken C, 2002, J MAMMARY GLAND BIOL, V7, P39, DOI 10.1023/A:1015718406329; Caira F, 2000, J BIOL CHEM, V275, P5308, DOI 10.1074/jbc.275.8.5308; Cao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014102; Chen Y, 2011, EMBO REP, V12, P797, DOI 10.1038/embor.2011.101; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Clarke RB, 2004, TRENDS ENDOCRIN MET, V15, P316, DOI 10.1016/j.tem.2004.07.004; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Fang SH, 2009, J SURG RES, V157, P290, DOI 10.1016/j.jss.2008.07.015; Garapaty S, 2009, J BIOL CHEM, V284, P7542, DOI 10.1074/jbc.M805872200; Garcia MJ, 2005, ONCOGENE, V24, P5235, DOI 10.1038/sj.onc.1208741; Gelsi-Boyer W, 2005, MOL CANCER RES, V3, P655, DOI 10.1158/1541-7786.MCR-05-0128; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Guo SQ, 2004, MOL CELL BIOL, V24, P8681, DOI 10.1128/MCB.24.19.8681-8690.2004; Hennighausen L, 1998, GENE DEV, V12, P449, DOI 10.1101/gad.12.4.449; Holland DG, 2011, EMBO MOL MED, V3, P167, DOI 10.1002/emmm.201100122; Hosoya T, 2010, IMMUNOL REV, V238, P110, DOI 10.1111/j.1600-065X.2010.00954.x; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Korach KS, 1996, RECENT PROG HORM RES, V51, P159; Kos M, 2001, MOL ENDOCRINOL, V15, P2057, DOI 10.1210/me.15.12.2057; Kouros-Mehr H, 2008, CURR OPIN CELL BIOL, V20, P164, DOI 10.1016/j.ceb.2008.02.003; Lacroix M, 2004, MOL CELL ENDOCRINOL, V219, P1, DOI 10.1016/j.mce.2004.02.021; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee SK, 1999, J BIOL CHEM, V274, P34283, DOI 10.1074/jbc.274.48.34283; Luscher-Firzlaff J, 2008, CANCER RES, V68, P749, DOI 10.1158/0008-5472.CAN-07-3158; Madureira PA, 2006, J BIOL CHEM, V281, P25167, DOI 10.1074/jbc.M603906200; Mahajan MA, 2000, MOL CELL BIOL, V20, P5048, DOI 10.1128/MCB.20.14.5048-5063.2000; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; McPherson LA, 1997, P NATL ACAD SCI USA, V94, P4342, DOI 10.1073/pnas.94.9.4342; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Nass SJ, 1999, HEMATOL ONCOL CLIN N, V13, P311, DOI 10.1016/S0889-8588(05)70058-7; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Park YY, 2012, EMBO MOL MED, V4, P52, DOI 10.1002/emmm.201100187; Patel A, 2011, J BIOL CHEM, V286, P3359, DOI 10.1074/jbc.M110.174524; Pinzone JJ, 2004, MOL CELL BIOL, V24, P4605, DOI 10.1128/MCB.24.11.4605-4612.2004; Porter W, 1996, MOL ENDOCRINOL, V10, P1371, DOI 10.1210/me.10.11.1371; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Ray ME, 2004, CANCER RES, V64, P40, DOI 10.1158/0008-5472.CAN-03-1022; Sarvan S, 2011, NAT STRUCT MOL BIOL, V18, P857, DOI 10.1038/nsmb.2093; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shoker BS, 1999, AM J PATHOL, V155, P1811, DOI 10.1016/S0002-9440(10)65498-3; Sircoulomb F, 2011, EMBO MOL MED, V3, P153, DOI 10.1002/emmm.201100121; Stoller JZ, 2010, EXP BIOL MED, V235, P569, DOI 10.1258/ebm.2010.009318; Tan CC, 2008, P NATL ACAD SCI USA, V105, P7472, DOI 10.1073/pnas.0711896105; Tenney K, 2005, J CELL BIOCHEM, V95, P429, DOI 10.1002/jcb.20421; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Viger RS, 2008, MOL ENDOCRINOL, V22, P781, DOI 10.1210/me.2007-0513; WEBB P, 1995, MOL ENDOCRINOL, V9, P443, DOI 10.1210/me.9.4.443; YANG J, 1980, P NATL ACAD SCI-BIOL, V77, P2088, DOI 10.1073/pnas.77.4.2088; Yang ZQ, 2006, CANCER RES, V66, P11632, DOI 10.1158/0008-5472.CAN-06-2946; Zhu YJ, 2000, J BIOL CHEM, V275, P13510, DOI 10.1074/jbc.275.18.13510	63	11	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31373	31381		10.1074/jbc.M114.579839	http://dx.doi.org/10.1074/jbc.M114.579839			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25258321	Green Published, hybrid			2022-12-28	WOS:000344549900041
J	Rodriguez, F; Lillington, J; Johnson, S; Timmel, CR; Lea, SM; Berks, BC				Rodriguez, Fernanda; Lillington, James; Johnson, Steven; Timmel, Christiane R.; Lea, Susan M.; Berks, Ben C.			Crystal Structure of the Bacillus subtilis Phosphodiesterase PhoD Reveals an Iron and Calcium-containing Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURPLE ACID-PHOSPHATASES; CHROMOFUSCUS PHOSPHOLIPASE-D; BINUCLEAR METALLOHYDROLASES; ALKALINE-PHOSPHATASES; EXPRESSION; COMPLEX; LOCALIZATION; SCATTERING; SOFTWARE; PROGRAM	The PhoD family of extra-cytoplasmic phosphodiesterases are among the most commonly occurring bacterial phosphatases. The exemplars for this family are the PhoD protein of Bacillus subtilis and the phospholipase D of Streptomyces chromofuscus. We present the crystal structure of B. subtilis PhoD. PhoD is most closely related to purple acid phosphatases (PAPs) with both types of enzyme containing a tyrosinate-ligated Fe3+ ion. However, the PhoD active site diverges from that found in PAPs and uses two Ca2+ ions instead of the single extra Fe2+, Mn2+, or Zn2+ ion present in PAPs. The PhoD crystals contain a phosphate molecule that coordinates all three active site metal ions and that is proposed to represent a product complex. A C-terminal helix lies over the active site and controls access to the catalytic center. The structure of PhoD defines a new phosphatase active site architecture based on Fe3+ and Ca2+ ions.	[Rodriguez, Fernanda; Berks, Ben C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Lillington, James; Johnson, Steven; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Lillington, James; Timmel, Christiane R.] Univ Oxford, Inorgan Chem Lab, Oxford OX1 3QR, England	University of Oxford; University of Oxford; University of Oxford	Lea, SM (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	susan.lea@path.ox.ac.uk; ben.berks@bioch.ox.ac.uk	Lea, Susan M/B-7678-2009; Johnson, Steven J/F-9182-2016; Timmel, Christiane/GLU-4087-2022	Lea, Susan M/0000-0001-9287-8053; Johnson, Steven J/0000-0002-7877-3543; Berks, Ben/0000-0001-9685-4067; Timmel, Christiane/0000-0003-1828-7700	European Molecular Biology Organization (EMBO) Fellowship; E.P. Abrahams Cephalosporin Trust Fund; Engineering and Physical Sciences Research Council; Oxford Martin School Vaccine Design Institute; Medical Research Council (MRC) Programme [G0900888]; EPSRC [EP/D048559/1, EP/L011972/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D048559/1, EP/L011972/1] Funding Source: researchfish	European Molecular Biology Organization (EMBO) Fellowship(European Molecular Biology Organization (EMBO)); E.P. Abrahams Cephalosporin Trust Fund; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Oxford Martin School Vaccine Design Institute; Medical Research Council (MRC) Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by an European Molecular Biology Organization (EMBO) Fellowship and by the E.P. Abrahams Cephalosporin Trust Fund.; Recipient of a studentship from the Engineering and Physical Sciences Research Council and also received funding from the Oxford Martin School Vaccine Design Institute (of which S. M. L. is Co-director).; Funded by Medical Research Council (MRC) Programme Grant G0900888 (to S. M. L.).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Benini S, 2001, J BIOL INORG CHEM, V6, P778, DOI 10.1007/s007750100254; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cox RS, 2007, J AM CHEM SOC, V129, P9550, DOI 10.1021/ja072647q; CROMER DT, 1983, J APPL CRYSTALLOGR, V16, P437, DOI 10.1107/S0021889883010791; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dermol U, 2011, J MOL BIOL, V412, P481, DOI 10.1016/j.jmb.2011.07.060; Eder S, 1996, MICROBIOL-SGM, V142, P2041, DOI 10.1099/13500872-142-8-2041; Ely F, 2012, J INORG BIOCHEM, V106, P19, DOI 10.1016/j.jinorgbio.2011.09.015; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feder D, 2012, CHEM BIOL DRUG DES, V80, P665, DOI 10.1111/cbdd.12001; Ferrer M, 2008, P NATL ACAD SCI USA, V105, P8878, DOI 10.1073/pnas.0800071105; GABER BP, 1979, J BIOL CHEM, V254, P8340; Guddat LW, 1999, STRUCT FOLD DES, V7, P757, DOI 10.1016/S0969-2126(99)80100-2; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jackson CJ, 2007, J MOL BIOL, V367, P1047, DOI 10.1016/j.jmb.2007.01.032; Jongbloed JDH, 2000, J BIOL CHEM, V275, P41350, DOI 10.1074/jbc.M004887200; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Lassila JK, 2011, ANNU REV BIOCHEM, V80, P669, DOI 10.1146/annurev-biochem-060409-092741; Luo HW, 2009, P NATL ACAD SCI USA, V106, P21219, DOI 10.1073/pnas.0907586106; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Matange N, 2014, J BIOL CHEM, V289, P22470, DOI 10.1074/jbc.M114.578328; Miller DJ, 2007, PROTEIN SCI, V16, P1338, DOI 10.1110/ps.072764907; Mitic N, 2006, CHEM REV, V106, P3338, DOI 10.1021/cr050318f; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/NGEO1765, 10.1038/ngeo1765]; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oganesyan VS, 2000, J CHEM PHYS, V113, P5003, DOI 10.1063/1.1289531; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schenk G, 2000, GENE, V255, P419, DOI 10.1016/S0378-1119(00)00305-X; Schenk G, 2005, P NATL ACAD SCI USA, V102, P273, DOI 10.1073/pnas.0407239102; Schenk G, 2012, ACCOUNTS CHEM RES, V45, P1593, DOI 10.1021/ar300067g; SCHLOSNAGLE DC, 1974, J BIOL CHEM, V249, P7574; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; YAMANE K, 1978, J BACTERIOL, V134, P100, DOI 10.1128/JB.134.1.100-107.1978; Yang HY, 2004, BBA-PROTEINS PROTEOM, V1703, P43, DOI 10.1016/j.bbapap.2004.09.014; Yong SC, 2014, SCIENCE, V345, P1170, DOI 10.1126/science.1254237; Zambonelli C, 2003, J BIOL CHEM, V278, P52282, DOI 10.1074/jbc.M310252200; Zambonelli C, 2003, J BIOL CHEM, V278, P13706, DOI 10.1074/jbc.M210363200	47	36	37	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					30889	30899		10.1074/jbc.M114.604892	http://dx.doi.org/10.1074/jbc.M114.604892			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25217636	hybrid, Green Published			2022-12-28	WOS:000344549900002
J	Wei, ZQ; Salmon, RM; Upton, PD; Morrell, NW; Li, W				Wei, Zhenquan; Salmon, Richard M.; Upton, Paul D.; Morrell, Nicholas W.; Li, Wei			Regulation of Bone Morphogenetic Protein 9 (BMP9) by Redox-dependent Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; MESENCHYMAL STEM-CELLS; RECEPTOR-LIKE KINASE-1; PULMONARY-HYPERTENSION; ENDOTHELIAL-CELLS; FUNCTIONAL-ANALYSIS; GENE DELIVERY; II RECEPTOR; 1 ALK1; MUTATIONS	BMP9, a member of the TGF beta superfamily, is a homodimer that forms a signaling complex with two type I and two type II receptors. Signaling through high-affinity activin receptor-like kinase 1 (ALK1) in endothelial cells, circulating BMP9 acts as a vascular quiescence factor, maintaining endothelial homeostasis. BMP9 is also the most potent BMP for inducing osteogenic signaling in mesenchymal stem cells in vitro and promoting bone formation in vivo. This activity requires ALK1, the lower affinity type I receptor ALK2, and higher concentrations of BMP9. In adults, BMP9 is constitutively expressed in hepatocytes and secreted into the circulation. Optimum concentrations of BMP9 are essential to maintain the highly specific endothelial-protective function. Factors regulating BMP9 stability and activity remain unknown. Here, we showed by chromatography and a 1.9 angstrom crystal structure that stable BMP9 dimers could form either with (D-form) or without (M-form) an intermolecular disulfide bond. Although both forms of BMP9 were capable of binding to the prodomain and ALK1, the M-form demonstrated less sustained induction of Smad1/5/8 phosphorylation. The two forms could be converted into each other by changing the redox potential, and this redox switch caused a major alteration in BMP9 stability. The M-form displayed greater susceptibility to redox-dependent cleavage by proteases present in serum. This study provides a mechanism for the regulation of circulating BMP9 concentrations and may provide new rationales for approaches to modify BMP9 levels for therapeutic purposes.	[Wei, Zhenquan; Salmon, Richard M.; Upton, Paul D.; Morrell, Nicholas W.; Li, Wei] Univ Cambridge, Dept Med, Sch Clin Med, Addenbrookes Hosp, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Morrell, NW (corresponding author), Univ Cambridge, Dept Med, Sch Clin Med, Addenbrookes Hosp, Box 157,Hills Rd, Cambridge CB2 0QQ, England.	nwm23@cam.ac.uk; wl225@cam.ac.uk	wei, wei/HHR-8613-2022	Morrell, Nicholas/0000-0001-5700-9792; Salmon, Richard/0000-0001-6327-5341	British Heart Foundation [PG/12/54/29734, CH/09/001/25945]; British Heart Foundation [RG/13/4/30107] Funding Source: researchfish; Medical Research Council [G1000847, G0800784, MR/K020919/1] Funding Source: researchfish; MRC [G1000847, MR/K020919/1, G0800784] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the British Heart Foundation Grants PG/12/54/29734 (to W. L.) and CH/09/001/25945 (to N. W. M.).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Bidart M, 2012, CELL MOL LIFE SCI, V69, P313, DOI 10.1007/s00018-011-0751-1; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Burke RM, 2013, P NATL ACAD SCI USA, V110, P19567, DOI 10.1073/pnas.1319297110; Burton VJ, 2011, BLOOD, V118, P4750, DOI 10.1182/blood-2011-05-347393; Burton VJ, 2011, BLOOD, V117, P333, DOI 10.1182/blood-2010-05-285973; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673; Dunmore BJ, 2013, HUM MOL GENET, V22, P3667, DOI 10.1093/hmg/ddt216; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Isaacs MJ, 2010, MOL ENDOCRINOL, V24, P1469, DOI 10.1210/me.2009-0496; Jerkic M, 2011, CARDIOVASC RES, V92, P375, DOI 10.1093/cvr/cvr232; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; JONES WK, 1994, GROWTH FACTORS, V11, P215, DOI 10.3109/08977199409046919; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kelley R, 2009, J CELL BIOL, V184, P597, DOI 10.1083/jcb.200808064; Knaus P, 2001, BIOL CHEM, V382, P1189, DOI 10.1515/BC.2001.149; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; LIU F, 1995, MOL CELL BIOL, V15, P3479; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Luo JY, 2010, J BIOL CHEM, V285, P29588, DOI 10.1074/jbc.M110.130518; Luther G, 2011, CURR GENE THER, V11, P229; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morrell Nicholas W, 2006, Proc Am Thorac Soc, V3, P680, DOI 10.1513/pats.200605-118SF; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Reynolds AM, 2012, EUR RESPIR J, V39, P329, DOI 10.1183/09031936.00187310; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Ricard N, 2010, BLOOD, V116, P1604, DOI 10.1182/blood-2010-03-276881; Rossi R, 2002, CLIN CHEM, V48, P742; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Seemann P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000747; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Spoelgen R, 2005, DEVELOPMENT, V132, P405, DOI 10.1242/dev.01580; Teichert-Kuliszewska K, 2006, CIRC RES, V98, P209, DOI 10.1161/01.RES.0000200180.01710.e6; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; Trembath RC, 2001, NEW ENGL J MED, V345, P325, DOI 10.1056/NEJM200108023450503; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; van Baardewijk LJ, 2013, INT ORTHOP, V37, P523, DOI 10.1007/s00264-012-1750-z; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wooderchak-Donahue WL, 2013, AM J HUM GENET, V93, P530, DOI 10.1016/j.ajhg.2013.07.004; Yao YC, 2012, BLOOD, V119, P5037, DOI 10.1182/blood-2011-10-385906; Yoshimatsu Y, 2013, P NATL ACAD SCI USA, V110, P18940, DOI 10.1073/pnas.1310479110; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505	51	30	31	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31150	31159		10.1074/jbc.M114.579771	http://dx.doi.org/10.1074/jbc.M114.579771			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25237187	Green Published, hybrid			2022-12-28	WOS:000344549900023
J	Ryall, CL; Viloria, K; Lhaf, F; Walker, AJ; King, A; Jones, P; Mackintosh, D; McNeice, R; Kocher, H; Flodstrom-Tullberg, M; Edling, C; Hill, NJ				Ryall, Claire L.; Viloria, Katrina; Lhaf, Fadel; Walker, Anthony J.; King, Aileen; Jones, Peter; Mackintosh, David; McNeice, Rosemary; Kocher, Hemant; Flodstrom-Tullberg, Malin; Edling, Charlotte; Hill, Natasha J.			Novel Role for Matricellular Proteins in the Regulation of Islet beta Cell Survival THE EFFECT OF SPARC ON SURVIVAL, PROLIFERATION, AND SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC ADENOCARCINOMA; DENDRITIC CELLS; GROWTH-FACTOR; EXTRACELLULAR-MATRIX; DIFFERENTIAL ACTIVATION; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; MESANGIAL CELLS; MESSENGER-RNA; NULL MICE	Understanding the mechanisms regulating islet growth and survival is critical for developing novel approaches to increasing or sustaining beta cell mass in both type 1 and type 2 diabetes patients. Secreted protein acidic and rich in cysteine (SPARC) is a matricellular protein that is important for the regulation of cell growth and adhesion. Increased SPARC can be detected in the serum of type 2 diabetes patients. The aim of this study was to investigate the role of SPARC in the regulation of beta cell growth and survival. We show using immunohistochemistry that SPARC is expressed by stromal cells within islets and can be detected in primary mouse islets by Western blot. SPARC is secreted at high levels by pancreatic stellate cells and is regulated by metabolic parameters in these cells, but SPARC expression was not detectable in beta cells. In islets, SPARC expression is highest in young mice, and is also elevated in the islets of non-obese diabetic (NOD) mice compared with controls. Purified SPARC inhibits growth factor-induced signaling in both INS-1 beta cells and primary mouse islets, and inhibits IGF-1-induced proliferation of INS-1 beta cells. Similarly, exogenous SPARC prevents IGF-1-induced survival of primary mouse islet cells. This study identifies the stromal-derived matricellular protein SPARC as a novel regulator of islet survival and beta cell growth.	[Hill, Natasha J.] Univ Kingston, Diabet & Cardiovasc Res Grp, Kingston Upon Thames KT1 2EE, Surrey, England; [Walker, Anthony J.] Univ Kingston, Sch Life Sci, Kingston Upon Thames KT1 2EE, Surrey, England; [McNeice, Rosemary] Univ Kingston, Sch Math, Kingston Upon Thames KT1 2EE, Surrey, England; [King, Aileen; Jones, Peter] Kings Coll London, Diabet Res Grp, Div Reprod & Endocrinol, London WC2R 2LS, England; [Kocher, Hemant] Queen Mary Univ London, Barts Canc Inst, London, England; [Edling, Charlotte] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England; [Flodstrom-Tullberg, Malin] Karolinska Inst, Ctr Infect Med, Dept Med, Stockholm, Sweden	Kingston University; Kingston University; Kingston University; University of London; King's College London; University of London; Queen Mary University London; University of London; Queen Mary University London; Karolinska Institutet	Hill, NJ (corresponding author), Univ Kingston, Sch Life Sci, Penrhyn Rd, Kingston Upon Thames KT1 2EE, Surrey, England.	n.hill@kingston.ac.uk	King, Aileen/I-5935-2013	King, Aileen/0000-0001-5759-7985; Flodstrom Tullberg, Malin/0000-0003-2685-2052; Jones, Peter/0000-0003-1201-2335; Hill, Natasha/0000-0001-7224-8185; Kocher, Hemant M/0000-0001-6771-1905	Diabetes UK; Biomedical and Pharmaceutical Sciences Research Group at Kingston University; Medical Research Council [MR/J006742/1] Funding Source: researchfish	Diabetes UK(Diabetes UK); Biomedical and Pharmaceutical Sciences Research Group at Kingston University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Diabetes UK and the Biomedical and Pharmaceutical Sciences Research Group at Kingston University.	Arnold SA, 2009, J CELL COMMUN SIGNAL, V3, P255, DOI 10.1007/s12079-009-0072-4; Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Briaud I, 2003, DIABETES, V52, P974, DOI 10.2337/diabetes.52.4.974; Chen G, 2010, BRIT J CANCER, V102, P188, DOI 10.1038/sj.bjc.6605440; Chlenski A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023880; Chlenski A, 2010, SEMIN CELL DEV BIOL, V21, P55, DOI 10.1016/j.semcdb.2009.11.018; Delostrinos CF, 2006, J CELL PHYSIOL, V206, P211, DOI 10.1002/jcp.20462; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Dickson LM, 2001, J BIOL CHEM, V276, P21110, DOI 10.1074/jbc.M101257200; Edmonds C, 2008, CANCER BIOL THER, V7, P1816; Francki A, 2004, J CELL BIOCHEM, V91, P915, DOI 10.1002/jcb.20008; Francki A, 2003, J CELL BIOCHEM, V88, P802, DOI 10.1002/jcb.10424; FRODIN M, 1995, J BIOL CHEM, V270, P7882, DOI 10.1074/jbc.270.14.7882; Froeling FEM, 2009, AM J PATHOL, V175, P636, DOI 10.2353/ajpath.2009.090131; Guweidhi A, 2005, ANN SURG, V242, P224, DOI 10.1097/01.sla.0000171866.45848.68; Harries LW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068253; Hill NJ, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-5; Hugl SR, 1998, J BIOL CHEM, V273, P17771, DOI 10.1074/jbc.273.28.17771; Hull R, 2005, DIABETOLOGIA, V48, P1350, DOI 10.1007/s00125-005-1772-9; Infante JR, 2007, J CLIN ONCOL, V25, P319, DOI 10.1200/JCO.2006.07.8824; Jandeleit-Dahm K, 2000, MICROVASC RES, V59, P61, DOI 10.1006/mvre.1999.2189; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; Kayali AG, 2007, DIABETES, V56, P703, DOI 10.2337/db06-1545; Kos K, 2009, DIABETES, V58, P1780, DOI 10.2337/db09-0211; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Lee SH, 2013, OBESITY, V21, P2296, DOI 10.1002/oby.20183; Li NF, 2009, ONCOGENE, V28, P773, DOI 10.1038/onc.2008.412; MARYNISSEN G, 1983, J DEV PHYSIOL, V5, P373; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Matveyenko AV, 2008, DIABETES OBES METAB, V10, P23, DOI 10.1111/j.1463-1326.2008.00939.x; Miller K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007739; Miyoshi K, 2010, ANTICANCER RES, V30, P867; Neuzillet C, 2013, CANCER METAST REV, V32, P585, DOI 10.1007/s10555-013-9439-3; Prenzel KL, 2006, ONCOL REP, V15, P1397; Puolakkainen PA, 2004, MOL CANCER RES, V2, P215; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Rosmalen JGM, 2000, LAB INVEST, V80, P769, DOI 10.1038/labinvest.3780080; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; SAGE H, 1989, J HISTOCHEM CYTOCHEM, V37, P819, DOI 10.1177/37.6.2723400; SAGE H, 1984, J BIOL CHEM, V259, P3993; Sato N, 2003, ONCOGENE, V22, P5021, DOI 10.1038/sj.onc.1206807; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sherry NA, 2006, DIABETES, V55, P3238, DOI 10.2337/db05-1034; Shi Q, 2004, J BIOL CHEM, V279, P52200, DOI 10.1074/jbc.M409630200; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Taneda S, 2003, J AM SOC NEPHROL, V14, P968, DOI 10.1097/01.ASN.0000054498.83125.90; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Watanabe K, 2009, J ATHEROSCLER THROMB, V16, P69, DOI 10.5551/jat.E711; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Wu DD, 2011, EUR J ENDOCRINOL, V165, P597, DOI 10.1530/EJE-11-0131; Xu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081615; Yan Q, 2005, J CELL PHYSIOL, V203, P286, DOI 10.1002/jcp.20226	56	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30614	30624		10.1074/jbc.M114.573980	http://dx.doi.org/10.1074/jbc.M114.573980			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25204658	hybrid, Green Published			2022-12-28	WOS:000344549700038
J	Ito, K; Yamazaki, S; Yamamoto, R; Tajima, Y; Yanagida, A; Kobayashi, T; Kato-Itoh, M; Kakuta, S; Iwakura, Y; Nakauchi, H; Kamiya, A				Ito, Keiichi; Yamazaki, Satoshi; Yamamoto, Ryo; Tajima, Yoko; Yanagida, Ayaka; Kobayashi, Toshihiro; Kato-Itoh, Megumi; Kakuta, Shigeru; Iwakura, Yoichiro; Nakauchi, Hiromitsu; Kamiya, Akihide			Gene Targeting Study Reveals Unexpected Expression of Brain-expressed X-linked 2 in Endocrine and Tissue Stem/Progenitor Cells in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; Gene Expression; Gene Knock-out; Hematopoietic Stem Cells; Liver; Stem Cells; Brain-expressed X-linked Gene; X-linked Gene; Endocrine Cells	HEMATOPOIETIC STEM-CELL; RNA-POLYMERASE-II; SELF-RENEWAL; NEUROTROPHIN RECEPTOR; TRANSCRIPTION FACTORS; DEFINITIVE ENDODERM; MENTAL-RETARDATION; LIVER DEVELOPMENT; PROGENITOR CELLS; MOUSE	Background: The role and precise expression pattern of individual brain-expressed X-linked genes in vivo were unknown. Results: Bex2-EGFP knock-in-knock-out mice were viable and fertile. Outside the brain, EGFP was expressed in specific cell populations. Conclusion: Bex2 plays redundant roles in vivo but is specifically expressed in endocrine and stem/progenitor cells. Significance: Bex2 is a novel marker for endocrine and stem/progenitor cells. Identification of genes specifically expressed in stem/progenitor cells is an important issue in developmental and stem cell biology. Genome-wide gene expression analyses in liver cells performed in this study have revealed a strong expression of X-linked genes that include members of the brain-expressed X-linked (Bex) gene family in stem/progenitor cells. Bex family genes are expressed abundantly in the neural cells and have been suggested to play important roles in the development of nervous tissues. However, the physiological role of its individual members and the precise expression pattern outside the nervous system remain largely unknown. Here, we focused on Bex2 and examined its role and expression pattern by generating knock-in mice; the enhanced green fluorescence protein (EGFP) was inserted into the Bex2 locus. Bex2-deficient mice were viable and fertile under laboratory growth conditions showing no obvious phenotypic abnormalities. Through an immunohistochemical analysis and flow cytometry-based approach, we observed unique EGFP reporter expression patterns in endocrine and stem/progenitor cells of the liver, pyloric stomach, and hematopoietic system. Although Bex2 seems to play redundant roles in vivo, these results suggest the significance and potential applications of Bex2 in studies of endocrine and stem/progenitor cells.	[Ito, Keiichi; Yamazaki, Satoshi; Yamamoto, Ryo; Tajima, Yoko; Yanagida, Ayaka; Kato-Itoh, Megumi; Nakauchi, Hiromitsu; Kamiya, Akihide] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Ctr Stem Cell & Regenerat Med,Minato Ku, Tokyo 1088639, Japan; [Kobayashi, Toshihiro; Kato-Itoh, Megumi; Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, NAKAUCHI Stem Cell & Organ Regenerat Project, Chiyoda Ku, Tokyo 1028666, Japan; [Kobayashi, Toshihiro] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Kakuta, Shigeru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Ctr Anim Dis Models, Noda, Chiba 2780022, Japan; [Yamamoto, Ryo; Nakauchi, Hiromitsu] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Kamiya, Akihide] Tokai Univ, Inst Innovat Sci & Technol, Lab Stem Cell Therapy, Isehara, Kanagawa 2591143, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Cambridge; University of Tokyo; Tokyo University of Science; Stanford University; Tokai University	Kamiya, A (corresponding author), Tokai Univ, Inst Innovat Sci & Technol, Lab Stem Cell Therapy, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	kamiyaa@tokai-u.jp	Iwakura, Yoichiro/E-5457-2011; Kakuta, Shigeru/L-2241-2018; Yamamoto, Ryo/Y-9464-2018; Yamamoto, Ryo/V-9312-2019	Iwakura, Yoichiro/0000-0002-9934-5775; Kakuta, Shigeru/0000-0002-5900-1425; Yamamoto, Ryo/0000-0001-5504-6004; Kobayashi, Toshihiro/0000-0001-8019-0008	Ministry of Education, Culture, Sports, and Technology, Japan	Ministry of Education, Culture, Sports, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research on innovative areas from the Ministry of Education, Culture, Sports, and Technology, Japan.	ALTABA ARI, 1993, MECH DEVELOP, V44, P91, DOI 10.1016/0925-4773(93)90060-B; Alvarez E, 2005, GENE, V357, P18, DOI 10.1016/j.gene.2005.05.012; Andrew A, 1998, J PATHOL, V186, P117, DOI 10.1002/(SICI)1096-9896(1998100)186:2<117::AID-PATH152>3.0.CO;2-J; ANDREW A, 1983, GASTROENTEROLOGY, V84, P429; ANG SL, 1993, DEVELOPMENT, V119, P1301; Barker N, 2013, DEVELOPMENT, V140, P2484, DOI 10.1242/dev.083113; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Behrens M, 2003, J NEUROCHEM, V86, P1289, DOI 10.1046/j.1471-4159.2003.01940.x; Besson V, 2011, P NATL ACAD SCI USA, V108, P11470, DOI 10.1073/pnas.1103873108; Brown AL, 1999, HUM MOL GENET, V8, P611, DOI 10.1093/hmg/8.4.611; Calmont A, 2006, DEV CELL, V11, P339, DOI 10.1016/j.devcel.2006.06.015; Ferron SR, 2011, NATURE, V475, P381, DOI 10.1038/nature10229; Fischer C, 2007, LEUKEMIA, V21, P374, DOI 10.1038/sj.leu.2404493; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Hagens O, 2006, HUM GENET, V118, P578, DOI 10.1007/s00439-005-0072-2; Hiemisch H, 1997, EMBO J, V16, P3995, DOI 10.1093/emboj/16.13.3995; Hocker M, 1998, ANN NY ACAD SCI, V859, P160, DOI 10.1111/j.1749-6632.1998.tb11120.x; Hofsli E, 2008, BRIT J CANCER, V99, P1330, DOI 10.1038/sj.bjc.6604565; Ito K, 2014, LIVER INT, V34, P1378, DOI 10.1111/liv.12387; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; Kakinuma S, 2009, J HEPATOL, V51, P127, DOI 10.1016/j.jhep.2009.02.033; Khazaei MR, 2010, J NEUROCHEM, V115, P910, DOI 10.1111/j.1471-4159.2010.06960.x; Koo JH, 2007, BIOCHEM BIOPH RES CO, V363, P405, DOI 10.1016/j.bbrc.2007.08.186; Koo JH, 2005, J COMP NEUROL, V487, P1, DOI 10.1002/cne.20486; Koo JH, 2004, J NEUROCHEM, V90, P102, DOI 10.1111/j.1471-4159.2004.02463.x; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012; Li HJ, 2011, DIABETES OBES METAB, V13, P5, DOI 10.1111/j.1463-1326.2011.01438.x; McDonald E, 2009, STEM CELLS DEV, V18, P1379, DOI 10.1089/scd.2009.0240; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Mukai J, 2002, J BIOL CHEM, V277, P13973, DOI 10.1074/jbc.M106342200; Mukai J, 2000, J BIOL CHEM, V275, P17566, DOI 10.1074/jbc.C000140200; Naderi A, 2007, CANCER RES, V67, P6725, DOI 10.1158/0008-5472.CAN-06-4394; Okada K, 2012, STEM CELLS DEV, V21, P1124, DOI 10.1089/scd.2011.0229; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Osawa M, 1996, J IMMUNOL, V156, P3207; PEARSE AGE, 1969, J HISTOCHEM CYTOCHEM, V17, P303, DOI 10.1177/17.5.303; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; SEGLEN PO, 1979, J TOXICOL ENV HEALTH, V5, P551, DOI 10.1080/15287397909529766; Sharpe RM, 2006, BEST PRACT RES CL EN, V20, P91, DOI 10.1016/j.beem.2005.09.005; Sharpe RM, 2003, PURE APPL CHEM, V75, P2023, DOI 10.1351/pac200375112023; Tanaka M, 2009, MECH DEVELOP, V126, P665, DOI 10.1016/j.mod.2009.06.939; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Venkatraman A, 2013, NATURE, V500, P345, DOI 10.1038/nature12303; Vilar M, 2006, EMBO J, V25, P1219, DOI 10.1038/sj.emboj.7601017; Yamaguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041007; Yamaoka T, 1999, INT J MOL MED, V3, P247; Yang F, 2008, GENE DEV, V22, P682, DOI 10.1101/gad.1613608; Zacharek SJ, 2011, CELL STEM CELL, V9, P272, DOI 10.1016/j.stem.2011.07.007; Zhou XP, 2012, BIOCHEM BIOPH RES CO, V427, P574, DOI 10.1016/j.bbrc.2012.09.100	50	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29892	29911		10.1074/jbc.M114.580084	http://dx.doi.org/10.1074/jbc.M114.580084			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25143383	Green Published, hybrid			2022-12-28	WOS:000344370800033
J	Soufi, N; Hall, AM; Chen, ZJ; Yoshino, J; Collier, SL; Mathews, JC; Brunt, EM; Albert, CJ; Graham, MJ; Ford, DA; Finck, BN				Soufi, Nisreen; Hall, Angela M.; Chen, Zhouji; Yoshino, Jun; Collier, Sara L.; Mathews, James C.; Brunt, Elizabeth M.; Albert, Carolyn J.; Graham, Mark J.; Ford, David A.; Finck, Brian N.			Inhibiting Monoacylglycerol Acyltransferase 1 Ameliorates Hepatic Metabolic Abnormalities but Not Inflammation and Injury in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diacylglycerol; Fatty Acid Metabolism; Inflammation; Insulin Resistance; Liver; Nonalcoholic Steatohepatitis	FATTY LIVER-DISEASE; DIET-INDUCED OBESITY; NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; TRIGLYCERIDE SYNTHESIS; MOLECULAR-MECHANISMS; MASS-SPECTROMETRY; DEFICIENT MICE; MOUSE MODEL; STEATOSIS	Background:Mogat1 inhibition improves glucose metabolism in obese mice, but its effects on liver injury are unknown. Results:Mogat1 knockdown improved hepatic metabolic abnormalities but did not reduce liver inflammation or injury. Conclusion: Hepatic injury and metabolic abnormalities are separable disease entities. Significance: Attention to liver injury markers should be made when evaluating metabolic therapies. Abnormalities in hepatic lipid metabolism and insulin action are believed to play a critical role in the etiology of nonalcoholic steatohepatitis. Monoacylglycerol acyltransferase (MGAT) enzymes convert monoacylglycerol to diacylglycerol, which is the penultimate step in one pathway for triacylglycerol synthesis. Hepatic expression of Mogat1, which encodes an MGAT enzyme, is increased in the livers of mice with hepatic steatosis, and knocking down Mogat1 improves glucose metabolism and hepatic insulin signaling, but whether increased MGAT activity plays a role in the etiology of nonalcoholic steatohepatitis is unclear. To examine this issue, mice were placed on a diet containing high levels of trans fatty acids, fructose, and cholesterol (HTF-C diet) or a low fat control diet for 4 weeks. Mice were injected with antisense oligonucleotides (ASOs) to knockdown Mogat1 or a scrambled ASO control for 12 weeks while remaining on diet. The HTF-C diet caused glucose intolerance, hepatic steatosis, and induced hepatic gene expression markers of inflammation, macrophage infiltration, and stellate cell activation. Mogat1 ASO treatment, which suppressed Mogat1 expression in liver and adipose tissue, attenuated weight gain, improved glucose tolerance, improved hepatic insulin signaling, and decreased hepatic triacylglycerol content compared with control ASO-treated mice on HTF-C chow. However, Mogat1 ASO treatment did not reduce hepatic diacylglycerol, cholesterol, or free fatty acid content; improve histologic measures of liver injury; or reduce expression of markers of stellate cell activation, liver inflammation, and injury. In conclusion, inhibition of hepatic Mogat1 in HTF-C diet-fed mice improves hepatic metabolic abnormalities without attenuating liver inflammation and injury.	[Soufi, Nisreen] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Soufi, Nisreen; Hall, Angela M.; Chen, Zhouji; Yoshino, Jun; Collier, Sara L.; Finck, Brian N.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Mathews, James C.; Brunt, Elizabeth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Albert, Carolyn J.; Ford, David A.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Graham, Mark J.] ISIS Pharmaceut Inc, Carlsbad, CA 92008 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Saint Louis University; Isis Pharmaceuticals Inc	Finck, BN (corresponding author), Washington Univ, Sch Med, 660 S Euclid Ave,Box 8031, St Louis, MO 63110 USA.	bfinck@dom.wustl.edu	; Ford, David/D-1819-2018	Yoshino, Jun/0000-0001-9833-4356; Ford, David/0000-0002-0029-1560; Hall, Angela Marie/0000-0003-0006-7910; Finck, Brian/0000-0001-5411-3674	National Institutes of Health [R01 DK078187, K01 DK087821, HL074214, HL111906]; Digestive Diseases Research Core Center [P30 DK52574]; Diabetes Research Center [P30 DK020579]; Nutrition Obesity Research Center at Washington University School of Medicine [P30 DK56341]; Washington University Institute of Clinical and Translational Sciences Grant [UL1 TR000450]; Central Society for Clinical and Translational Research Early Career Development Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000450, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074214, R21HL111906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK087821, P30DK020579, R01DK078187, P30DK056341, P30DK052574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Core Center; Diabetes Research Center; Nutrition Obesity Research Center at Washington University School of Medicine; Washington University Institute of Clinical and Translational Sciences Grant; Central Society for Clinical and Translational Research Early Career Development Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK078187 (to B. N. F.), K01 DK087821 (to A. M. H.), and HL074214 and HL111906 (to D. A. F.) and the core services of the Digestive Diseases Research Core Center (Grant P30 DK52574), Diabetes Research Center (Grant P30 DK020579), and the Nutrition Obesity Research Center (Grant P30 DK56341) at Washington University School of Medicine.; Supported by a KL2 award from Washington University Institute of Clinical and Translational Sciences Grant UL1 TR000450 and the Central Society for Clinical and Translational Research Early Career Development Award.	Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; BHAT BG, 1994, J BIOL CHEM, V269, P13172; Bowden JA, 2011, ANAL BIOCHEM, V417, P202, DOI 10.1016/j.ab.2011.06.015; Brown RJ, 2013, ANAL BIOCHEM, V433, P56, DOI 10.1016/j.ab.2012.10.007; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Cao JS, 2007, J LIPID RES, V48, P583, DOI 10.1194/jlr.M600331-JLR200; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Chen ZJ, 2010, J BIOL CHEM, V285, P25996, DOI 10.1074/jbc.M110.141598; Cheung O, 2008, SEMIN LIVER DIS, V28, P351, DOI 10.1055/s-0028-1091979; Clapper JR, 2013, AM J PHYSIOL-GASTR L, V305, pG483, DOI 10.1152/ajpgi.00079.2013; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Fan JG, 2013, J GASTROEN HEPATOL, V28, P81, DOI 10.1111/jgh.12244; Fukunishi S, 2009, J CLIN BIOCHEM NUTR, V45, P322, DOI 10.3164/jcbn.09-50; Hall AM, 2014, DIABETES, V63, P2284, DOI 10.2337/db13-1502; Hall AM, 2012, J LIPID RES, V53, P990, DOI 10.1194/jlr.P025536; Hammond LE, 2002, MOL CELL BIOL, V22, P8204, DOI 10.1128/MCB.22.23.8204-8214.2002; Hjelkrem M, 2011, ALIMENT PHARM THER, V34, P214, DOI 10.1111/j.1365-2036.2011.04695.x; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kita Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043056; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Kubota N, 2013, CLIN EXP PHARMACOL P, V40, P422, DOI 10.1111/1440-1681.12102; Lee YJ, 2012, P NATL ACAD SCI USA, V109, P13656, DOI 10.1073/pnas.1203218109; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Lin X, 2002, ARTERIOSCL THROM VAS, V22, P476, DOI 10.1161/hq0302.105271; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Nagarajan P, 2012, WORLD J GASTROENTERO, V18, P1141, DOI 10.3748/wjg.v18.i11.1141; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Sato W, 2006, HEPATOL RES, V34, P256, DOI 10.1016/j.hepres.2006.01.003; Shi YG, 2009, AM J PHYSIOL-ENDOC M, V297, pE10, DOI 10.1152/ajpendo.90949.2008; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Svegliati-Baroni G, 2006, AM J PATHOL, V169, P846, DOI 10.2353/ajpath.2006.050953; Trevaskis JL, 2012, AM J PHYSIOL-GASTR L, V302, pG762, DOI 10.1152/ajpgi.00476.2011; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; XIA T, 1993, AM J PHYSIOL, V265, pR414, DOI 10.1152/ajpregu.1993.265.2.R414; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Yang SQ, 1997, P NATL ACAD SCI USA, V94, P2557, DOI 10.1073/pnas.94.6.2557; Yang YB, 2014, LIPIDS, V49, P505, DOI 10.1007/s11745-014-3907-6; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Yue YG, 2011, LIPIDS, V46, P513, DOI 10.1007/s11745-011-3537-1; Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093	45	33	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					30177	30188		10.1074/jbc.M114.595850	http://dx.doi.org/10.1074/jbc.M114.595850			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25213859	Green Published, hybrid			2022-12-28	WOS:000344370800055
J	Vorobieva, AA; Khan, MS; Soumillion, P				Vorobieva, Anastassia A.; Khan, Mohammad Shahneawz; Soumillion, Patrice			Escherichia coli D-Malate Dehydrogenase, a Generalist Enzyme Active in the Leucine Biosynthesis Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-MALIC ENZYME; ISOCITRATE DEHYDROGENASE; HOMOISOCITRATE DEHYDROGENASE; TARTRATE DEHYDROGENASE; THERMUS-THERMOPHILUS; 3-ISOPROPYLMALATE DEHYDROGENASE; SUBSTRATE-SPECIFICITY; ALKALINE-PHOSPHATASE; CRYSTAL-STRUCTURE; EVOLUTION	The enzymes of the beta-decarboxylating dehydrogenase superfamily catalyze the oxidative decarboxylation of D-malate-based substrates with various specificities. Here, we show that, in addition to its natural function affording bacterial growth on D-malate as a carbon source, the D-malate dehydrogenase of Escherichia coli (EcDmlA) naturally expressed from its chromosomal gene is capable of complementing leucine auxotrophy in a leuB(-) strain lacking the paralogous isopropylmalate dehydrogenase enzyme. To our knowledge, this is the first example of an enzyme that contributes with a physiologically relevant level of activity to two distinct pathways of the core metabolism while expressed from its chromosomal locus. EcDmlA features relatively high catalytic activity on at least three different substrates (L(+)-tartrate, D-malate, and 3-isopropylmalate). Because of these properties both in vivo and in vitro, EcDmlA may be defined as a generalist enzyme. Phylogenetic analysis highlights an ancient origin of DmlA, indicating that the enzyme has maintained its generalist character throughout evolution. We discuss the implication of these findings for protein evolution.	[Vorobieva, Anastassia A.; Soumillion, Patrice] Catholic Univ Louvain, Inst Sci Vie, Lab Biochim Biophys & Genet Microorganismes BBGM, B-1348 Louvain, Belgium; [Khan, Mohammad Shahneawz] Univ Dhaka, Dept Fisheries, Dhaka 1000, Bangladesh	Universite Catholique Louvain; University of Dhaka	Soumillion, P (corresponding author), UCLouvain, Inst Life Sci, Croix Sud 4-5,Box L7-07-06, B-1348 Louvain, Belgium.	patrice.soumillion@uclouvain.be		Vorobieva, Anastassia/0000-0001-5554-1398; Khan, Mohammad Shahneawz/0000-0002-0141-1827; Akter, Mosammat Salma/0000-0002-2704-7701	Belgian Fonds National de la Recherche Scientifique (FNRS); Belgian "Inter-university Attraction Poles" Program [P7/44 iPROS]	Belgian Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Belgian "Inter-university Attraction Poles" Program(Belgian Federal Science Policy Office)	This work was supported by a research assistant fellowship from the Belgian Fonds National de la Recherche Scientifique (FNRS) and by Belgian "Inter-university Attraction Poles" Program Project P7/44 iPROS.	Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Chen RD, 2000, PROTEIN SCI, V9, P2344, DOI 10.1110/ps.9.12.2344; Copley SD, 2012, J BIOL CHEM, V287, P3, DOI 10.1074/jbc.R111.254714; CROUZET P, 1995, J BACTERIOL, V177, P6518, DOI 10.1128/jb.177.22.6518-6526.1995; D'Ari R, 1998, BIOESSAYS, V20, P181, DOI 10.1002/(SICI)1521-1878(199802)20:2<181::AID-BIES10>3.3.CO;2-6; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dean AM, 1996, PROTEIN SCI, V5, P341; DEAN AM, 1989, J BIOL CHEM, V264, P20482; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Fedoy AE, 2007, J MOL BIOL, V372, P130, DOI 10.1016/j.jmb.2007.06.040; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GIFFHORN F, 1983, J BACTERIOL, V155, P281, DOI 10.1128/JB.155.1.281-290.1983; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; Goncalves S, 2012, BIOCHEMISTRY-US, V51, P7098, DOI 10.1021/bi300483w; Graczer E, 2011, MOL BIOSYST, V7, P1646, DOI 10.1039/c0mb00346h; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Huang RQ, 2012, P NATL ACAD SCI USA, V109, P2966, DOI 10.1073/pnas.1019605109; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Jin JL, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-6; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; KNICHEL W, 1982, EUR J BIOCHEM, V123, P547; Lin Y, 2008, BIOCHEMISTRY-US, V47, P10809, DOI 10.1021/bi801370h; Lukas H, 2010, J BACTERIOL, V192, P2503, DOI 10.1128/JB.01665-09; Malik R, 2010, ACTA CRYSTALLOGR D, V66, P673, DOI 10.1107/S0907444910008851; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; McLoughlin SY, 2008, P NATL ACAD SCI USA, V105, P13497, DOI 10.1073/pnas.0804804105; Miller BG, 2005, BIOCHEMISTRY-US, V44, P10776, DOI 10.1021/bi0506268; Miller BG, 2004, BIOCHEMISTRY-US, V43, P6387, DOI 10.1021/bi049424m; Miyazaki J, 2005, J BACTERIOL, V187, P6779, DOI 10.1128/JB.187.19.6779-6788.2005; Miyazaki J, 2003, J BIOL CHEM, V278, P1864, DOI 10.1074/jbc.M205133200; Miyazaki K, 2005, BIOCHEM BIOPH RES CO, V336, P596, DOI 10.1016/j.bbrc.2005.08.139; Miyazaki K, 2005, BIOCHEM BIOPH RES CO, V331, P341, DOI 10.1016/j.bbrc.2005.03.169; MIYAZAKI K, 1993, FEBS LETT, V332, P35, DOI 10.1016/0014-5793(93)80477-C; Nam H, 2012, SCIENCE, V337, P1101, DOI 10.1126/science.1216861; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Ohno S., 1970, EVOLUTION GENE DUPLI; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Senisterra GA, 2006, J BIOMOL SCREEN, V11, P940, DOI 10.1177/1087057106294699; SERFOZO P, 1995, BIOCHEMISTRY-US, V34, P7517, DOI 10.1021/bi00022a027; Soo VWC, 2011, P NATL ACAD SCI USA, V108, P1484, DOI 10.1073/pnas.1012108108; STERN JR, 1966, NATURE, V212, P1611, DOI 10.1038/2121611a0; Stokke R, 2007, ARCH MICROBIOL, V187, P361, DOI 10.1007/s00203-006-0200-y; Stokke R, 2007, EXTREMOPHILES, V11, P481, DOI 10.1007/s00792-006-0060-z; Tawfik DS, 2010, NAT CHEM BIOL, V6, P692, DOI 10.1038/nchembio.441; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; TIPTON PA, 1993, BIOCHEMISTRY-US, V32, P2822, DOI 10.1021/bi00062a013; TIPTON PA, 1994, ARCH BIOCHEM BIOPHYS, V313, P15, DOI 10.1006/abbi.1994.1352; TIPTON PA, 1990, BIOCHEMISTRY-US, V29, P1749, DOI 10.1021/bi00459a013; van Loo B, 2010, P NATL ACAD SCI USA, V107, P2740, DOI 10.1073/pnas.0903951107; Voordeckers K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001446; Wallon G, 1997, J MOL BIOL, V266, P1016, DOI 10.1006/jmbi.1996.0797; WESSLER SR, 1981, J MOL BIOL, V149, P579, DOI 10.1016/0022-2836(81)90348-X; Wright BE, 1997, MICROBIOL-UK, V143, P847, DOI 10.1099/00221287-143-3-847; Yang KC, 2004, P NATL ACAD SCI USA, V101, P7919, DOI 10.1073/pnas.0400664101; Yaoi T, 1997, J BIOCHEM-TOKYO, V121, P77; Yip SHC, 2013, MOL BIOL EVOL, V30, P2001, DOI 10.1093/molbev/mst105; Zhu GP, 2005, SCIENCE, V307, P1279, DOI 10.1126/science.1106974	61	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29086	29096		10.1074/jbc.M114.595363	http://dx.doi.org/10.1074/jbc.M114.595363			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25160617	Green Published, hybrid			2022-12-28	WOS:000344141000026
J	Zhou, MH; Zheng, HY; Si, HJ; Jin, YX; Peng, JM; He, L; Zhou, YB; Munoz-Garay, C; Zawieja, DC; Kuo, L; Peng, X; Zhang, SYL				Zhou, Meng-Hua; Zheng, Hongying; Si, Hongjiang; Jin, Yixin; Peng, Jasmine M.; He, Lian; Zhou, Yubin; Munoz-Garay, Carlos; Zawieja, David C.; Kuo, Lih; Peng, Xu; Zhang, Shenyuan L.			Stromal Interaction Molecule 1 (STIM1) and Orai1 Mediate Histamine-evoked Calcium Entry and Nuclear Factor of Activated T-cells (NFAT) Signaling in Human Umbilical Vein Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRAC CHANNEL ACTIVATION; OPERATED CA2+ ENTRY; PLASMA-MEMBRANE; LEUKOCYTE EXTRAVASATION; LYMPHOCYTE-ACTIVATION; CYCLOSPORINE-A; STORE; RELEASE; RECEPTORS; INTERLEUKIN-8	Histamine is an important immunomodulator involved in allergic reactions and inflammatory responses. In endothelial cells, histamine induces Ca2+ mobilization by releasing Ca2+ from the endoplasmic reticulum and eliciting Ca2+ entry across the plasma membrane. Herein, we show that histamine-evoked Ca2+ entry in human umbilical vein endothelial cells (HUVECs) is sensitive to blockers of Ca2+ release-activated Ca2+ (CRAC) channels. RNA interference against STIM1 or Orai1, the activating subunit and the pore-forming subunit of CRAC channels, respectively, abolishes this histamine-evoked Ca2+ entry. Furthermore, overexpression of dominant-negative CRAC channel subunits inhibits while co-expression of both STIM1 and Orai1 enhances histamine-induced Ca2+ influx. Interestingly, gene silencing of STIM1 or Orai1 also interrupts the activation of calcineurin/nuclear factor of activated T-cells (NFAT) pathway and the production of interleukin 8 triggered by histamine in HUVECs. Collectively, these results suggest a central role of STIM1 and Orai1 in mediating Ca2+ mobilization linked to inflammatory signaling of endothelial cells upon histamine stimulation.	[Zhou, Meng-Hua; Zheng, Hongying; Si, Hongjiang; Jin, Yixin; Peng, Jasmine M.; Zhou, Yubin; Zawieja, David C.; Peng, Xu; Zhang, Shenyuan L.] Texas A&M Hlth Sci Ctr, Dept Med Physiol, Coll Med, Baylor Scott & White Hlth, Temple, TX 76504 USA; [Kuo, Lih] Texas A&M Hlth Sci Ctr, Dept Surg, Coll Med, Baylor Scott & White Hlth, Temple, TX 76504 USA; [He, Lian] Texas A&M Hlth Sci Ctr, Ctr Translat Canc Res, Inst Biosci & Technol, Houston, TX 77030 USA; [Munoz-Garay, Carlos] Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Mat Sci & Biophys Dept, Cuernavaca 62210, Morelos, Mexico	Baylor Health Care System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor Health Care System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Universidad Nacional Autonoma de Mexico	Kuo, L (corresponding author), Texas A&M Hlth Sci Ctr, Dept Med Physiol, Coll Med, 702 Southwest HK Dodgen Loop, Temple, TX 76504 USA.	lkuo@medicine.tamhsc.edu; xpeng@medicine.tamhsc.edu; shenyuan.zhang@medicine.tamhsc.edu	Zhou, Yubin/D-4748-2011; Si, Hongjiang/AAR-1809-2021	Zhou, Yubin/0000-0001-7962-0517; Si, Hongjiang/0000-0003-1863-2893; Kuo, Lih/0000-0002-4912-6910; Munoz-Garay, Carlos/0000-0002-7218-4027; He, Lian/0000-0002-8842-235X; Zawieja, David/0000-0002-2644-6524	National Institutes of Health [R01 HL096552, R01 GM112003]; LLS [3013-12]; AHA NCRP [13SDG17200006]; Kruse Family Centennial Chair Fund; Scott & White Memorial Hospital; TAMU-NSFC Program [M1303600]; Texas A&M-Weizmann Program; TAMU-CONACYT Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LLS; AHA NCRP(American Heart Association); Kruse Family Centennial Chair Fund; Scott & White Memorial Hospital; TAMU-NSFC Program; Texas A&M-Weizmann Program; TAMU-CONACYT Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 HL096552 (to D. C. Z.), and the LLS 3013-12 and National Institutes of Health Grant R01 GM112003 (to Y. Z.), the AHA NCRP 13SDG17200006 (to S. L. Z.), Kruse Family Centennial Chair Fund, Scott & White Memorial Hospital, and the 2013 TAMU-NSFC Program M1303600 (to L. K.), the 2012 Texas A&M-Weizmann Program (to S. L. Z. and X. P.), and the 2014 TAMU-CONACYT Program (to S. L. Z. and C. M. G.).	Abdelaziz MM, 1998, J ALLERGY CLIN IMMUN, V101, P410, DOI 10.1016/S0091-6749(98)70256-8; Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; ASAKO H, 1994, J CLIN INVEST, V93, P1508, DOI 10.1172/JCI117129; Bachert C, 1998, CLIN EXP ALLERGY, V28, P15; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boss V, 1998, MOL PHARMACOL, V54, P264, DOI 10.1124/mol.54.2.264; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; CHUNG SC, 1994, BRIT J PHARMACOL, V113, P861, DOI 10.1111/j.1476-5381.1994.tb17072.x; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Ehringer WD, 1996, J CELL PHYSIOL, V167, P562, DOI 10.1002/(SICI)1097-4652(199606)167:3<562::AID-JCP20>3.3.CO;2-K; Estrada IA, 2012, CIRC RES, V111, P1166, DOI 10.1161/CIRCRESAHA.112.275743; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; Gandhirajan RK, 2013, J CLIN INVEST, V123, P887, DOI 10.1172/JCI65647; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; HATTORI R, 1989, J BIOL CHEM, V264, P7768; Hegyesi H, 2005, SPR S BIOPH, V8, P265; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; JACOB R, 1990, J PHYSIOL-LONDON, V421, P55, DOI 10.1113/jphysiol.1990.sp017933; JEANNIN P, 1994, BLOOD, V84, P2229; Jow F, 2000, J MEMBRANE BIOL, V173, P107, DOI 10.1007/s002320001012; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; KUROSE I, 1994, J CLIN INVEST, V94, P1919, DOI 10.1172/JCI117542; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; McCarl CA, 2009, J ALLERGY CLIN IMMUN, V124, P1311, DOI 10.1016/j.jaci.2009.10.007; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mueller K, 2013, SCIENCE, V339, P155, DOI 10.1126/science.339.6116.155; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Mukaida N, 2000, INT J HEMATOL, V72, P391; Pan MG, 2013, CURR MOL MED, V13, P543; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Seifert R, 2013, TRENDS PHARMACOL SCI, V34, P33, DOI 10.1016/j.tips.2012.11.001; Skov L, 2008, J IMMUNOL, V181, P669, DOI 10.4049/jimmunol.181.1.669; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Srinivas SP, 2006, INVEST OPHTH VIS SCI, V47, P4011, DOI 10.1167/iovs.05-1127; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; Triggiani M, 2001, J IMMUNOL, V166, P4083, DOI 10.4049/jimmunol.166.6.4083; Tsai FC, 2014, NAT CELL BIOL, V16, P133, DOI 10.1038/ncb2906; Vestweber D, 2012, ANN NY ACAD SCI, V1257, P184, DOI 10.1111/j.1749-6632.2012.06558.x; Vestweber D, 2012, CURR OPIN HEMATOL, V19, P212, DOI 10.1097/MOH.0b013e3283523e78; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; Walter Miriam, 2012, Front Biosci (Schol Ed), V4, P461; Wu MH, 2005, J PHYSIOL-LONDON, V563, P95, DOI 10.1113/jphysiol.2004.076075; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; YUAN YA, 1993, AM J PHYSIOL, V264, pH1734, DOI 10.1152/ajpheart.1993.264.5.H1734; Zeilhofer HU, 2000, CURR OPIN HEMATOL, V7, P178, DOI 10.1097/00062752-200005000-00009; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2011, P NATL ACAD SCI USA, V108, P17838, DOI 10.1073/pnas.1114821108; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zheng HY, 2013, J BIOL CHEM, V288, P11263, DOI 10.1074/jbc.M113.450254; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	77	24	26	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29446	29456		10.1074/jbc.M114.578492	http://dx.doi.org/10.1074/jbc.M114.578492			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25190815	hybrid, Green Published			2022-12-28	WOS:000344141000055
J	Das, F; Ghosh-Choudhury, N; Dey, N; Bera, A; Mariappan, MM; Kasinath, BS; Choudhury, GG				Das, Falguni; Ghosh-Choudhury, Nandini; Dey, Nirmalya; Bera, Amit; Mariappan, Meenalakshmi M.; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh			High Glucose Forces a Positive Feedback Loop Connecting Akt Kinase and FoxO1 Transcription Factor to Activate mTORC1 Kinase for Mesangial Cell Hypertrophy and Matrix Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; DIABETIC-NEPHROPATHY; HIGH INSULIN; SMAD 3; MECHANISM; TARGET; GROWTH; GENES; PHOSPHORYLATION; DIFFERENTIATION	High glucose-induced Akt acts as a signaling hub for mesangial cell hypertrophy and matrix expansion, which are recognized as cardinal signatures for the development of diabetic nephropathy. How mesangial cells sustain the activated state of Akt is not clearly understood. Here we show Akt-dependent phosphorylation of the transcription factor FoxO1 by high glucose. Phosphorylation-deficient, constitutively active FoxO1 inhibited the high glucose-induced phosphorylation of Akt to suppress the phosphorylation/inactivation of PRAS40 and mTORC1 activity. In contrast, dominant negative FoxO1 increased the phosphorylation of Akt, resulting in increased mTORC1 activity similar to high glucose treatment. Notably, FoxO1 regulates high glucose-induced protein synthesis, hypertrophy, and expression of fibronectin and PAI-1. High glucose paves the way for complications of diabetic nephropathy through the production of reactive oxygen species (ROS). We considered whether the FoxO1 target antioxidant enzyme catalase contributes to sustained activation of Akt. High glucose-inactivated FoxO1 decreases the expression of catalase to increase the production of ROS. Moreover, we show that catalase blocks high glucose-stimulated Akt phosphorylation to attenuate the inactivation of FoxO1 and PRAS40, resulting in the inhibition of mTORC1 and mesangial cell hypertrophy and fibronectin and PAI-1 expression. Finally, using kidney cortices from type 1 diabetic OVE26 mice, we show that increased FoxO1 phosphorylation is associated with decreased catalase expression and increased fibronectin and PAI-1 expression. Together, our results provide the first evidence for the presence of a positive feedback loop for the sustained activation of Akt involving inactivated FoxO1 and a decrease in catalase expression, leading to increased ROS and mesangial cell hypertrophy and matrix protein expression.	[Ghosh-Choudhury, Nandini; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, Vet Affairs Res & Geriatr Res, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh] South Texas Vet Hlth Care Syst, Educ & Clin Ctr, San Antonio, TX 78229 USA; [Das, Falguni; Dey, Nirmalya; Bera, Amit; Mariappan, Meenalakshmi M.; Kasinath, Balakuntalam S.; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Choudhury, GG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu			National Institutes of Health [RO1 DK50190]; Veterans Affairs Research Service Merit Review Grant [5I01BX000926, 5I01BX000150, 5I01BX001340]; Veterans Affairs Senior Research Career Scientist Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050190] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Research Service Merit Review Grant; Veterans Affairs Senior Research Career Scientist Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK50190. This work was also supported by Veterans Affairs Research Service Merit Review Grant 5I01BX000926 (to G. G. C.).; Supported by Veterans Affairs Merit Review Grant 5I01BX000150.; Supported by Veterans Affairs Merit Review Grant 5I01BX001340.; Recipient of the Veterans Affairs Senior Research Career Scientist Award.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Arciuch VGA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007523; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Choudhury GG, 2003, CELL SIGNAL, V15, P161, DOI 10.1016/S0898-6568(02)00057-8; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Das F, 2008, J CELL PHYSIOL, V214, P513, DOI 10.1002/jcp.21236; Das F, 2013, J BIOL CHEM, V288, P7756, DOI 10.1074/jbc.M113.455782; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; Dey N, 2010, J CELL PHYSIOL, V225, P27, DOI 10.1002/jcp.22186; Eid AA, 2013, DIABETES, V62, P2935, DOI 10.2337/db12-1504; EPSTEIN PN, 1989, CELL, V58, P1067, DOI 10.1016/0092-8674(89)90505-9; Ewens KG, 2005, DIABETES, V54, P3305, DOI 10.2337/diabetes.54.11.3305; Feliers D, 2001, KIDNEY INT, V60, P495, DOI 10.1046/j.1523-1755.2001.060002495.x; Ghosh C, 2004, CELL SIGNAL, V16, P31, DOI DOI 10.1016/S0898-6568(03)00094-9; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Glorieux C, 2014, BIOCHEM PHARMACOL, V89, P217, DOI 10.1016/j.bcp.2014.02.025; Gorin Y, 2013, CLIN SCI, V125, P361, DOI 10.1042/CS20130065; Goth L, 2012, ARCH BIOCHEM BIOPHYS, V525, P195, DOI 10.1016/j.abb.2012.02.005; Hodgkinson AD, 2003, DIABETES, V52, P846, DOI 10.2337/diabetes.52.3.846; Hur J, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-49; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lehmann R, 2000, CLIN CHIM ACTA, V297, P135, DOI 10.1016/S0009-8981(00)00240-0; Ma LJ, 2009, FRONT BIOSCI-LANDMRK, V14, P2028, DOI 10.2741/3361; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Mandal CC, 2011, BIOCHEM J, V433, P393, DOI 10.1042/BJ20100357; Mariappan MM, 2008, J BIOL CHEM, V283, P30566, DOI 10.1074/jbc.M801756200; Mariappan MM, 2007, DIABETES, V56, P476, DOI 10.2337/db05-1334; Nagai K, 2005, KIDNEY INT, V68, P552, DOI 10.1111/j.1523-1755.2005.00433.x; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412; Satriano J, 2007, AMINO ACIDS, V33, P331, DOI 10.1007/s00726-007-0529-9; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Tikhanovich I, 2013, J GASTROEN HEPATOL, V28, P125, DOI 10.1111/jgh.12021; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Zhang KB, 2012, ENDOCRINOLOGY, V153, P631, DOI 10.1210/en.2011-1527; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zheng SR, 2004, DIABETES, V53, P3248, DOI 10.2337/diabetes.53.12.3248	50	33	34	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.605196	http://dx.doi.org/10.1074/jbc.M114.605196			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25288788	Green Published, hybrid			2022-12-28	WOS:000345335000027
J	Balasuriya, D; D'Sa, L; Talker, R; Dupuis, E; Maurin, F; Martin, P; Borgese, F; Soriani, O; Edwardson, JM				Balasuriya, Dilshan; D'Sa, Lauren; Talker, Ronel; Dupuis, Elodie; Maurin, Fabrice; Martin, Patrick; Borgese, Franck; Soriani, Olivier; Edwardson, J. Michael			A Direct Interaction between the Sigma-1 Receptor and the hERG Voltage-gated K+ Channel Revealed by Atomic Force Microscopy and Homogeneous Time-resolved Fluorescence (HTRF (R))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atomic Force Microscopy (AFM); Fluorescence Resonance Energy Transfer (FRET); hERG; Molecular Imaging; Protein Complex; Sigma Receptor	METHYL-D-ASPARTATE; CANCER CELL-LINES; LONG QT SYNDROME; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; BREAST-CANCER; CALCIUM-CHANNELS; CORTICAL-NEURONS; NMDA RECEPTORS; IN-VITRO	The sigma-1 receptor is an endoplasmic reticulum chaperone protein, widely expressed in central and peripheral tissues, which can translocate to the plasma membrane and modulate the function of various ion channels. The human ether-a-go-go-related gene encodes hERG, a cardiac voltage-gated K+ channel that is abnormally expressed in many human cancers and is known to interact functionally with the sigma-1 receptor. Our aim was to investigate the nature of the interaction between the sigma-1 receptor and hERG. We show that the two proteins can be co-isolated from a detergent extract of stably transfected HEK-293 cells, consistent with a direct interaction between them. Atomic force microscopy imaging of the isolated protein confirmed the direct binding of the sigma-1 receptor to hERG monomers, dimers, and tetramers. hERG dimers and tetramers became both singly and doubly decorated by sigma-1 receptors; however, hERG monomers were only singly decorated. The distribution of angles between pairs of sigma-1 receptors bound to hERG tetramers had two peaks, at approximate to 90 and approximate to 180 degrees in a ratio of approximate to 2:1, indicating that the sigma-1 receptor interacts with hERG with 4-fold symmetry. Homogeneous time-resolved fluorescence (HTRF (R)) allowed the detection of the interaction between the sigma-1 receptor and hERG within the plane of the plasma membrane. This interaction was resistant to sigma ligands, but was decreased in response to cholesterol depletion of the membrane. We suggest that the sigma-1 receptor may bind to hERG in the endoplasmic reticulum, aiding its assembly and trafficking to the plasma membrane.	[Balasuriya, Dilshan; D'Sa, Lauren; Talker, Ronel; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Dupuis, Elodie; Maurin, Fabrice] CisBio Bioassays, F-30200 Codolet, France; [Martin, Patrick; Borgese, Franck; Soriani, Olivier] Univ Nice Sophia Antipolis, UMR 7277, INSERM, IBV,CNRS,UNS,Fac Sci,U1091, F-06108 Nice 2, France	University of Cambridge; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Soriani, O (corresponding author), Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England.	olivier.soriani@unice.fr; jme1000@cam.ac.uk		BORGESE, Franck/0000-0001-7718-2111; soriani, olivier/0000-0001-9485-3992	Kidney Research UK; CNRS; University of Nice Sophia Antipolis; Association Ti'Toine Normandie; Kidney Research UK [RP17/2012] Funding Source: researchfish	Kidney Research UK(Kidney Research UK (KRUK)); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Nice Sophia Antipolis; Association Ti'Toine Normandie; Kidney Research UK(Kidney Research UK (KRUK))	This work was supported by Kidney Research UK (to J. M. E.), the CNRS, the University of Nice Sophia Antipolis, and the Association Ti'Toine Normandie (to O. S.). Elodie Dupuis and Fabrice Maurin are employees of CisBio Assays, the company that supplied the reagents used in the homogenous time-resolved fluorescence assays.	Albagli-Curiel O, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-85; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Aydar E, 2006, CANCER LETT, V242, P245, DOI 10.1016/j.canlet.2005.11.011; Balasuriya D, 2013, J NEUROSCI, V33, P18219, DOI 10.1523/JNEUROSCI.3360-13.2013; Balasuriya D, 2012, J BIOL CHEM, V287, P37021, DOI 10.1074/jbc.M112.382077; Carnally SM, 2010, BIOPHYS J, V98, P1182, DOI 10.1016/j.bpj.2009.12.4293; Crottes D, 2011, J BIOL CHEM, V286, P27947, DOI 10.1074/jbc.M111.226738; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Farrelly AM, 2003, AM J PHYSIOL-GASTR L, V284, pG883, DOI 10.1152/ajpgi.00394.2002; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Fishback JA, 2010, PHARMACOL THERAPEUT, V127, P271, DOI 10.1016/j.pharmthera.2010.04.003; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; HAYASHI T, 1995, J PHARMACOL EXP THER, V275, P207; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P726, DOI 10.1124/jpet.103.051292; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Herrera Y, 2008, J PHARMACOL EXP THER, V327, P491, DOI 10.1124/jpet.108.143974; Hiranita T, 2010, J PHARMACOL EXP THER, V332, P515, DOI 10.1124/jpet.109.159236; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Ishiguro H, 1998, NEUROSCI LETT, V257, P45, DOI 10.1016/S0304-3940(98)00797-6; Johannessen M, 2011, AM J PHYSIOL-CELL PH, V300, pC328, DOI 10.1152/ajpcell.00383.2010; Johannessen M, 2009, AM J PHYSIOL-CELL PH, V296, pC1049, DOI 10.1152/ajpcell.00431.2008; Kinoshita M, 2012, BRAIN RES, V1452, P1, DOI 10.1016/j.brainres.2012.02.070; Kourrich S, 2013, CELL, V152, P236, DOI 10.1016/j.cell.2012.12.004; Kume T, 2002, EUR J PHARMACOL, V455, P91, DOI 10.1016/S0014-2999(02)02582-7; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Lupardus PJ, 2000, J PHYSIOL-LONDON, V526, P527, DOI 10.1111/j.1469-7793.2000.00527.x; LYSKO PG, 1992, STROKE, V23, P414, DOI 10.1161/01.STR.23.3.414; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; Maurel D, 2004, ANAL BIOCHEM, V329, P253, DOI 10.1016/j.ab.2004.02.013; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Mishina M, 2008, ANN NUCL MED, V22, P151, DOI 10.1007/s12149-007-0094-z; Monnet FP, 2005, BIOL CELL, V97, P873; MONNET FP, 1990, EUR J PHARMACOL, V179, P441, DOI 10.1016/0014-2999(90)90186-A; Navarro G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061245; Navarro G, 2010, P NATL ACAD SCI USA, V107, P18676, DOI 10.1073/pnas.1008911107; Ortega-Roldan JL, 2013, J BIOL CHEM, V288, P21448, DOI 10.1074/jbc.M113.450379; Pabba M, 2014, J NEUROSCI, V34, P11325, DOI 10.1523/JNEUROSCI.0458-14.2014; Palmer CP, 2007, CANCER RES, V67, P11166, DOI 10.1158/0008-5472.CAN-07-1771; Phartiyal P, 2008, J BIOL CHEM, V283, P3702, DOI 10.1074/jbc.M708999200; Pillozzi S, 2007, BLOOD, V110, P1238, DOI 10.1182/blood-2006-02-003772; Pillozzi S, 2011, BLOOD, V117, P902, DOI 10.1182/blood-2010-01-262691; Renaudo A, 2004, J PHARMACOL EXP THER, V311, P1105, DOI 10.1124/jpet.104.072413; Renaudo A, 2007, J BIOL CHEM, V282, P2259, DOI 10.1074/jbc.M607915200; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rosati B, 2000, FASEB J, V14, P2601, DOI 10.1096/fj.00-0077com; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Seth P, 2001, BBA-MOL CELL RES, V1540, P59, DOI 10.1016/S0167-4889(01)00117-3; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spruce BA, 2004, CANCER RES, V64, P4875, DOI 10.1158/0008-5472.CAN-03-3180; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Tchedre KT, 2008, INVEST OPHTH VIS SCI, V49, P4993, DOI 10.1167/iovs.08-1867; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tsai SY, 2009, P NATL ACAD SCI USA, V106, P22468, DOI 10.1073/pnas.0909089106; Tsai Shang-Yi, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P184; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Wang B, 2004, BREAST CANCER RES TR, V87, P205, DOI 10.1007/s10549-004-6590-0; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Zhang HL, 2005, J PHARMACOL EXP THER, V313, P1387, DOI 10.1124/jpet.105.084152; Zhang HL, 2002, J NEUROPHYSIOL, V87, P2867, DOI 10.1152/jn.2002.87.6.2867; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	65	44	44	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32353	32363		10.1074/jbc.M114.603506	http://dx.doi.org/10.1074/jbc.M114.603506			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25266722	Green Published, hybrid			2022-12-28	WOS:000345314700059
J	Kamei, Y; Tamada, Y; Nakayama, Y; Fukusaki, E; Mukai, Y				Kamei, Yuka; Tamada, Yoshihiro; Nakayama, Yasumune; Fukusaki, Eiichiro; Mukai, Yukio			Changes in Transcription and Metabolism During the Early Stage of Replicative Cellular Senescence in Budding Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellular Senescence; Metabolomics; Saccharomyces cerevisiae; Transcriptomics; Tricarboxylic Acid Cycle (TCA Cycle) (Krebs Cycle); Branched-chain Amino Acids; Replicative Lifespan	GENE-EXPRESSION PROFILES; SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; STATIONARY-PHASE; CITRATE SYNTHASE; CELLS; STRAINS; IDENTIFICATION; PATHWAYS; SEQUENCE	Background: Senescence is the biological process of age-related cellular and organismal deterioration in function. Results: The transcriptome and metabolome at early stages of replicative senescence of yeast cells were measured. Conclusion: The transcriptomic and metabolomic profiles drastically changed at about half of the average replicative lifespan. Significance: This is the first integrated information on transcriptome and metabolome of aging yeast cells. Age-related damage accumulates and a variety of biological activities and functions deteriorate in senescent cells. However, little is known about when cellular aging behaviors begin and what cellular aging processes change. Previous research demonstrated age-related mRNA changes in budding yeast by the 18th to 20th generation, which is the average replicative lifespan of yeast (i.e. about half of the population is dead by this time point). Here, we performed transcriptional and metabolic profiling for yeast at early stages of senescence (4th, 7th, and 11th generation), that is, for populations in which most cells are still alive. Transcriptional profiles showed up- and down-regulation for approximate to 20% of the genes profiled after the first four generations, few further changes by the 7th generation, and an additional 12% of the genes were up- and down-regulated after 11 generations. Pathway analysis revealed that these 11th generation cells had accumulated transcripts coding for enzymes involved in sugar metabolism, the TCA cycle, and amino acid degradation and showed decreased levels of mRNAs coding for enzymes involved in amino acid biosynthetic pathways. These observations were consistent with the metabolomic profiles of aging cells: an accumulation of pyruvic acid and TCA cycle intermediates and depletion of most amino acids, especially branched-chain amino acids. Stationary phase-induced genes were highly expressed after 11 generations even though the growth medium contained adequate levels of nutrients, indicating deterioration of the nutrient sensing and/or signaling pathways by the 11th generation. These changes are presumably early indications of replicative senescence.	[Kamei, Yuka; Mukai, Yukio] Nagahama Inst Biosci & Technol, Fac Biosci, Dept Biosci, Nagahama, Shiga 5260829, Japan; [Tamada, Yoshihiro; Nakayama, Yasumune; Fukusaki, Eiichiro] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan	Osaka University	Mukai, Y (corresponding author), Nagahama Inst Biosci & Technol, Fac Biosci, Dept Biosci, 1266 Tamura Cho, Nagahama, Shiga 5260829, Japan.	y_mukai@nagahama-i-bio.ac.jp	Nakayama, Yasumune/H-2982-2019	Nakayama, Yasumune/0000-0002-6810-4354; Mukai, Yukio/0000-0003-1265-0839	 [24510279];  [2410171]; Grants-in-Aid for Scientific Research [24510279] Funding Source: KAKEN	; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-aid for Scientific Research (C) 24510279 (to Y. M.) and a Grant-in-aid for Japan Society for the Promotion of Science Fellows 2410171 (to Y. K.).	Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Brachmann CB, 1998, YEAST, V14, P115; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Coleman ST, 2001, J BIOL CHEM, V276, P244, DOI 10.1074/jbc.M007103200; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Filetici P, 1996, YEAST, V12, P1359, DOI 10.1002/(SICI)1097-0061(199610)12:13<1359::AID-YEA3>3.0.CO;2-5; Galdieri L, 2010, OMICS, V14, P629, DOI 10.1089/omi.2010.0069; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hwang ES, 2009, CELL MOL LIFE SCI, V66, P2503, DOI 10.1007/s00018-009-0034-2; Jazwinski SM, 2004, FEMS YEAST RES, V5, P119, DOI 10.1016/j.femsyr.2004.04.005; Jazwinski SM, 2001, MECH AGEING DEV, V122, P865, DOI 10.1016/S0047-6374(01)00244-5; Jia YK, 1997, MOL MICROBIOL, V24, P53, DOI 10.1046/j.1365-2958.1997.3011669.x; Kamei Y, 2011, BIOCHEM BIOPH RES CO, V407, P185, DOI 10.1016/j.bbrc.2011.02.136; KIM KS, 1986, MOL CELL BIOL, V6, P1936, DOI 10.1128/MCB.6.6.1936; Kim YM, 2013, AGING CELL, V12, P622, DOI 10.1111/acel.12087; Klinkenberg LG, 2005, EUKARYOT CELL, V4, P649, DOI 10.1128/EC.4.4.649-660.2005; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Lam YT, 2011, FREE RADICAL BIO MED, V50, P963, DOI 10.1016/j.freeradbiomed.2011.01.013; Lesur I, 2004, MOL BIOL CELL, V15, P1297, DOI 10.1091/mbc.E03-10-0742; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Luo ZL, 2009, MICROBIOL-SGM, V155, P4036, DOI 10.1099/mic.0.030726-0; Martinez MJ, 2004, MOL BIOL CELL, V15, P5295, DOI 10.1091/mbc.E03-11-0856; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; MORTIMER RK, 1986, GENETICS, V113, P35; MOTIZUKI M, 1992, MECH AGEING DEV, V64, P235, DOI 10.1016/0047-6374(92)90081-N; NIU XD, 1988, P NATL ACAD SCI USA, V85, P7546, DOI 10.1073/pnas.85.20.7546; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Padilla PA, 1998, J BACTERIOL, V180, P5718, DOI 10.1128/JB.180.21.5718-5726.1998; Park PU, 2002, METHOD ENZYMOL, V351, P468; Rachidi N, 2000, MOL MICROBIOL, V35, P1421, DOI 10.1046/j.1365-2958.2000.01807.x; RAMOS F, 1985, EUR J BIOCHEM, V149, P401, DOI 10.1111/j.1432-1033.1985.tb08939.x; Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200; WALKER ME, 1991, BIOCHEM BIOPH RES CO, V176, P1210, DOI 10.1016/0006-291X(91)90414-3; Yiu G, 2008, J GERONTOL A-BIOL, V63, P21, DOI 10.1093/gerona/63.1.21; Yoshida R, 2010, AGING CELL, V9, P616, DOI 10.1111/j.1474-9726.2010.00590.x; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200	39	27	27	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32081	32093		10.1074/jbc.M114.600528	http://dx.doi.org/10.1074/jbc.M114.600528			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25294875	Green Published, hybrid			2022-12-28	WOS:000345314700037
J	Guo, HB; Nagy, T; Pierce, M				Guo, Huabei; Nagy, Tamas; Pierce, Michael			Post-translational Glycoprotein Modifications Regulate Colon Cancer Stem Cells and Colon Adenoma Progression in Apc(min/+) Mice through Altered Wnt Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE-V; COLORECTAL-CANCER; BETA-1,6-BRANCHED OLIGOSACCHARIDES; C-MYC; EXPRESSION; GLYCOSYLATION; METASTASIS; ADHESION; TARGET; GROWTH	Deletion of GnT-V (MGAT5), which synthesizes N-glycans with beta(1,6)-branched glycans, reduced the compartment of cancer stem cells (CSC) in the her-2 mouse model of breast cancer, leading to delay of tumor onset. Because GnT-V levels are also commonly up-regulated in colon cancer, we investigated their regulation of colon CSC and adenoma development. Anchorage-independent cell growth and tumor formation induced by injection of colon tumor cells into NOD/SCID mice were positively associated with GnT-V levels, indicating regulation of proliferation and tumorigenicity. Using Apc(min/+) mice with different GnT-V backgrounds, knock-out of GnT-V had no significant effect on the number of adenoma/mouse, but adenoma size was significantly reduced and accompanied increased survival of Apc(min/+) mice with GnT-V deletion (p<0.01), suggesting an inhibition in the progression of colon adenoma caused by deletion of GnT-V. Decreased expression levels of GnT-V down-regulated the population of colon (intestine) CSC, affecting their ability for self-renewal and tumorigenicity in NOD/SCID mice. Furthermore, altered nuclear translocation of beta-catenin and expression of Wnt target genes were positively associated with expression levels of GnT-V, indicating the regulation of canonical Wnt/beta-catenin signaling. By overexpressing the Wnt receptor, FZD-7, in colon cancer cells, we found that FZD-7 receptors expressed N-linked beta(1,6) branching, indicating that FZD-7 can be modified by GnT-V. The aberrant Wnt signaling observed after modulating GnT-V levels is likely to result from altered N-linked beta(1,6) branching on FZD-7, thereby affecting Wnt signaling, the compartment of CSC, and tumor progression.	[Guo, Huabei; Pierce, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Nagy, Tamas] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Guo, HB (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, 315 Riverbend Rd, Athens, GA 30602 USA.	hbguo@uga.edu; hawkeye@uga.edu			National Institutes of Health [U01CA128454, P41-GM103490]; Georgia Research Alliance Cancer Research Award; University of Georgia Faculty Research Grant [FRG 064-417]; NATIONAL CANCER INSTITUTE [U01CA128454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance Cancer Research Award; University of Georgia Faculty Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants U01CA128454 and P41-GM103490 (to M. P.). This work was also supported by Georgia Research Alliance Cancer Research Award 2012 and University of Georgia Faculty Research Grant FRG 064-417 (to H. G.).	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Brudvik KW, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-149; Charafe-Jauffret E, 2008, PATHOBIOLOGY, V75, P75, DOI 10.1159/000123845; Chen L, 1998, ONCOGENE, V17, P2087, DOI 10.1038/sj.onc.1202124; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Ghiaur G, 2012, STEM CELLS, V30, P89, DOI 10.1002/stem.769; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Granovsky M, 2000, NAT MED, V6, P306; Guo HB, 2000, J CANCER RES CLIN, V126, P263, DOI 10.1007/s004320050341; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Guo HB, 2002, CANCER RES, V62, P6837; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Guo HB, 2010, P NATL ACAD SCI USA, V107, P21116, DOI 10.1073/pnas.1013405107; Guo HB, 2009, GLYCOBIOLOGY, V19, P547, DOI 10.1093/glycob/cwp023; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Handerson T, 2003, CANCER RES, V63, P5363; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Ihara S, 2002, J BIOL CHEM, V277, P16960, DOI 10.1074/jbc.M200673200; Jamal B, 2012, ORAL ONCOL, V48, P523, DOI 10.1016/j.oraloncology.2012.01.010; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jarde T, 2013, ONCOGENE, V32, P883, DOI 10.1038/onc.2012.103; Jiang YW, 2011, NEOPLASIA, V13, P492, DOI 10.1593/neo.11314; Johswich A, 2014, J BIOL CHEM, V289, P15927, DOI 10.1074/jbc.M114.563734; Jubb AM, 2006, ONCOGENE, V25, P3445, DOI 10.1038/sj.onc.1209382; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Kemper K, 2012, STEM CELLS, V30, P2378, DOI 10.1002/stem.1233; Kim YS, 2008, MOL CELL PROTEOMICS, V7, P1, DOI 10.1074/mcp.M700084-MCP200; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Lin L, 2011, CANCER RES, V71, P7226, DOI 10.1158/0008-5472.CAN-10-4660; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; MacDonald BT, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007880; McConnell BB, 2009, CANCER RES, V69, P4125, DOI 10.1158/0008-5472.CAN-08-4402; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Murata K, 2000, CLIN CANCER RES, V6, P1772; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pinho SS, 2009, HUM MOL GENET, V18, P2599, DOI 10.1093/hmg/ddp194; Qi J., 2014, PLOS ONE, V9; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rota LM, 2012, J MAMMARY GLAND BIOL, V17, P119, DOI 10.1007/s10911-012-9258-0; Seelentag WKF, 1998, CANCER RES, V58, P5559; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Vagin O, 2008, J BIOL CHEM, V283, P2192, DOI 10.1074/jbc.M704713200; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Walker F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022733; Weng DS, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3102; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P11312, DOI 10.1073/pnas.1203015109; Xu QS, 2011, J BIOL CHEM, V286, P4310, DOI 10.1074/jbc.M110.182576; Yeung TM, 2011, P NATL ACAD SCI USA, V108, P4382, DOI 10.1073/pnas.1014519107; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200; Zhu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032170; Ziskin JL, 2013, GUT, V62, P1012, DOI 10.1136/gutjnl-2011-301195; Zucchi I, 2007, P NATL ACAD SCI USA, V104, P10476, DOI 10.1073/pnas.0703071104	71	44	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31534	31549		10.1074/jbc.M114.602680	http://dx.doi.org/10.1074/jbc.M114.602680			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25274627	Green Published, hybrid			2022-12-28	WOS:000344549900055
J	Vadivel, K; Ponnuraj, SM; Kumar, Y; Zaiss, AK; Bunce, MW; Camire, RM; Wu, L; Evseenko, D; Herschman, HR; Bajaj, MS; Bajaj, SP				Vadivel, Kanagasabai; Ponnuraj, Sathya-Moorthy; Kumar, Yogesh; Zaiss, Anne K.; Bunce, Matthew W.; Camire, Rodney M.; Wu, Ling; Evseenko, Denis; Herschman, Harvey R.; Bajaj, Madhu S.; Bajaj, S. Paul			Platelets Contain Tissue Factor Pathway Inhibitor-2 Derived from Megakaryocytes and Inhibits Fibrinolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACENTAL PROTEIN-5 PP5; FACTOR-V; CIRCULATING LEVELS; GENE-EXPRESSION; COAGULATION INHIBITOR; PLASMINOGEN RECEPTOR; PROTEASE INHIBITORS; MESSENGER-RNA; CDNA CLONING; DOMAIN	Tissue factor pathway inhibitor-2 (TFPI-2) is a homologue of TFPI-1 and contains three Kunitz-type domains and a basic C terminus region. The N-terminal domain of TFPI-2 is the only inhibitory domain, and it inhibits plasma kallikrein, factor XIa, and plasmin. However, plasma TFPI-2 levels are negligible (<= 20 pM) in the context of influencing clotting or fibrinolysis. Here, we report that platelets contain significant amounts of TFPI-2 derived from megakaryocytes. We employed RT-PCR, Western blotting, immunohistochemistry, and confocal microscopy to determine that platelets, MEG-01 megakaryoblastic cells, and bone marrow megakaryocytes contain TFPI-2. ELISA data reveal that TFPI-2 binds factor V (FV) and partially B-domain-deleted FV (FV-1033) with K-d similar to 9 nM and binds FVa with Kd similar to 100 nM. Steady state analysis of surface plasmon resonance data reveal that TFPI-2 and TFPI-1 bind FV-1033 with Kd similar to 36-48 nM and bind FVa with K-d similar to 252-456 nM. Further, TFPI-1 (but not TFPI-1(161)) competes with TFPI-2 in binding to FV. These data indicate that the C-terminal basic region of TFPI-2 is similar to that of TFPI-1 and plays a role in binding to the FV B-domain acidic region. Using pull-down assays and Western blots, we show that TFPI-2 is associated with platelet FV/FVa. TFPI-2 (similar to 7 nM) in plasma of women at the onset of labor is also, in part, associated with FV. Importantly, TFPI-2 in platelets and in plasma of pregnant women inhibits FXIa and tissue-type plasminogen activator-induced clot fibrinolysis. In conclusion, TFPI-2 in platelets from normal or pregnant subjects and in plasma from pregnant women binds FV/Va and regulates intrinsic coagulation and fibrinolysis.	[Vadivel, Kanagasabai; Ponnuraj, Sathya-Moorthy; Kumar, Yogesh; Wu, Ling; Evseenko, Denis; Bajaj, S. Paul] Univ Calif Los Angeles, Dept Orthopaed Surg, Orthopaed Hosp, Los Angeles, CA 90095 USA; [Zaiss, Anne K.; Herschman, Harvey R.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Bajaj, Madhu S.] Univ Calif Los Angeles, Dept Med, Div Pulmonol & Crit Care, Los Angeles, CA 90095 USA; [Herschman, Harvey R.; Bajaj, S. Paul] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Bunce, Matthew W.; Camire, Rodney M.] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Div Hematol, Philadelphia, PA 19104 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Bajaj, SP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA.	pbajaj@mednet.ucla.edu	KUMAR, YOGESH/GXN-1220-2022	Vadivel, Kanagasabai/0000-0003-3777-9540	National Institutes of Health, NHLBI [RO1HL88010, R21HL89661, R01HL36365]; Department of Defense [OR12016]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089661, R01HL088010, R01HL036365, R21HL122878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR061415] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Defense(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grants RO1HL88010 (to R. M. C.), R21HL89661 (to M. S. B.), and R01HL36365 (to S. P. B.). This work was also supported by Department of Defense Grant OR12016 (to D. E.).	Andronicos NM, 2010, BLOOD, V115, P1319, DOI 10.1182/blood-2008-11-188938; Arakawa N, 2013, J PROTEOME RES, V12, P4340, DOI 10.1021/pr400282j; Bajaj MS, 2011, J BIOL CHEM, V286, P4329, DOI 10.1074/jbc.M110.191163; Biesiadecki BJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/421701; BIETH JG, 1984, BIOCHEM MED METAB B, V32, P387, DOI 10.1016/0006-2944(84)90046-2; Bos MHA, 2012, J BIOL CHEM, V287, P26342, DOI 10.1074/jbc.M112.377168; Boulaftali Y, 2010, BLOOD, V115, P97, DOI 10.1182/blood-2009-04-217240; Brenner B, 2004, THROMB RES, V114, P409, DOI 10.1016/j.thromres.2004.08.004; Brogren H, 2004, BLOOD, V104, P3943, DOI 10.1182/blood-2004-04-1439; Broos K, 2012, THROMB RES, V129, P245, DOI 10.1016/j.thromres.2011.11.002; Broze GJ, 2013, J CLIN INVEST, V123, P3710, DOI 10.1172/JCI71220; Broze GJ, 2012, FRONT BIOSCI-LANDMRK, V17, P262, DOI 10.2741/3926; BROZE GJ, 1990, BIOCHEMISTRY-US, V29, P7539, DOI 10.1021/bi00485a001; Bunce MW, 2013, J BIOL CHEM, V288, P30151, DOI 10.1074/jbc.M113.506840; BUTZOW R, 1988, CLIN CHEM, V34, P1591; Camire RM, 2009, J THROMB HAEMOST, V7, P1951, DOI 10.1111/j.1538-7836.2009.03622.x; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Chand HS, 2005, THROMB HAEMOSTASIS, V94, P1122, DOI 10.1160/TH05-07-0509; Chand HS, 2004, J BIOL CHEM, V279, P17500, DOI 10.1074/jbc.M400802200; Chand HS, 2004, BLOOD, V103, P1069, DOI 10.1182/blood-2003-06-1930; Chung D. W., 2013, HEMOSTASIS THROMBOSI, P110; Collen D, 2001, Hematology Am Soc Hematol Educ Program, P1; Crawley JTB, 2002, ARTERIOSCL THROM VAS, V22, P218, DOI 10.1161/hq0102.101842; Duckers C, 2008, BLOOD, V112, P3615, DOI 10.1182/blood-2008-06-162453; Festuccia C, 1998, CLIN EXP METASTAS, V16, P513, DOI 10.1023/A:1006590217724; Franks Douglas J., 2001, Biological Procedures Online, V3, P54, DOI 10.1251/bpo23; GIRARD TJ, 1989, THROMB RES, V55, P37, DOI 10.1016/0049-3848(89)90454-4; Hale SA, 2012, PREGNANCY HYPERTENS, V2, P152, DOI 10.1016/j.preghy.2012.01.004; Iino M, 1998, ARTERIOSCL THROM VAS, V18, P40, DOI 10.1161/01.ATV.18.1.40; Isakari Y, 2009, BIOL PHARM BULL, V32, P354, DOI 10.1248/bpb.32.354; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; Kumar Y, 2014, BIOCHEMISTRY-US, V53, P505, DOI 10.1021/bi401584b; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIOTTA LA, 1981, CANCER RES, V41, P4629; Lockwood CJ, 2006, CLIN OBSTET GYNECOL, V49, P836, DOI 10.1097/01.grf.0000211952.82206.16; London F, 1996, BIOCHEMISTRY-US, V35, P12146, DOI 10.1021/bi960097v; Mann KG, 2003, BLOOD, V101, P20, DOI 10.1182/blood-2002-01-0290; Maroney SA, 2007, BLOOD, V109, P1931, DOI 10.1182/blood-2006-07-037283; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Miles LA, 2013, SEMIN THROMB HEMOST, V39, P329, DOI 10.1055/s-0033-1334483; MIYAGI Y, 1994, J BIOCHEM-TOKYO, V116, P939, DOI 10.1093/oxfordjournals.jbchem.a124648; MONKOVIC DD, 1990, BIOCHEMISTRY-US, V29, P1118, DOI 10.1021/bi00457a004; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Morrissey JH, 2012, BLOOD, V119, P5972, DOI 10.1182/blood-2012-03-306605; Ndonwi M, 2012, J THROMB HAEMOST, V10, P1944, DOI 10.1111/j.1538-7836.2012.04834.x; NISBET AD, 1982, EUR J OBSTET GYN R B, V13, P333, DOI 10.1016/0028-2243(82)90068-5; NISBET AD, 1981, BRIT J OBSTET GYNAEC, V88, P484, DOI 10.1111/j.1471-0528.1981.tb01021.x; NOVOTNY WF, 1988, BLOOD, V72, P2020; OBIEKWE B, 1979, CLIN CHIM ACTA, V95, P509, DOI 10.1016/0009-8981(79)90203-1; Ogawa M, 2007, PLACENTA, V28, P224, DOI 10.1016/j.placenta.2006.01.023; Ortego J, 1997, EXP EYE RES, V65, P289, DOI 10.1006/exer.1997.0333; Pan JJ, 2013, INT J CARDIOL, V168, P1691, DOI 10.1016/j.ijcard.2013.03.073; Petersen LC, 1996, BIOCHEMISTRY-US, V35, P266, DOI 10.1021/bi951501d; PLOW EF, 1981, BLOOD, V58, P1069; Rao CN, 2000, BIOCHEM BIOPH RES CO, V276, P1286, DOI 10.1006/bbrc.2000.3611; Rao CN, 1996, ARCH BIOCHEM BIOPHYS, V335, P82, DOI 10.1006/abbi.1996.0484; RAO CN, 1995, ARCH BIOCHEM BIOPHYS, V317, P311, DOI 10.1006/abbi.1995.1168; Rao CN, 1998, INT J CANCER, V76, P749, DOI 10.1002/(SICI)1097-0215(19980529)76:5<749::AID-IJC21>3.0.CO;2-Y; SEPPALA M, 1979, INT J CANCER, V24, P6, DOI 10.1002/ijc.2910240103; Sierko E, 2007, SEMIN THROMB HEMOST, V33, P653, DOI 10.1055/s-2007-991532; SMITH RP, 1990, SCIENCE, V248, P1126, DOI 10.1126/science.2111585; Sperzel M, 2007, J THROMB HAEMOST, V5, P2113, DOI 10.1111/j.1538-7836.2007.02717.x; SPRECHER CA, 1994, P NATL ACAD SCI USA, V91, P3353, DOI 10.1073/pnas.91.8.3353; Storti F, 2014, INT J NUMER METH BIO, V30, P634, DOI 10.1002/cnm.2623; Sugiyama T, 2002, FEBS LETT, V517, P121, DOI 10.1016/S0014-5793(02)02588-7; Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056; Thalji N, 2013, SEMIN THROMB HEMOST, V39, P607, DOI 10.1055/s-0033-1349224; Thorelli E, 1997, EUR J BIOCHEM, V247, P12, DOI 10.1111/j.1432-1033.1997.00012.x; Udagawa K, 2002, PLACENTA, V23, P145, DOI 10.1053/plac.2001.0774; Udagawa K, 1998, PLACENTA, V19, P217, DOI 10.1016/S0143-4004(98)90011-X; VANNOSTRAND WE, 1990, SCIENCE, V248, P745, DOI 10.1126/science.2110384; Vincent LM, 2013, J CLIN INVEST, V123, P3777, DOI 10.1172/JCI69091; Walsh P. N., 2013, HEMOSTASIS THROMBOSI, P468; Wiman B., 2013, HEMOSTASIS THROMBOSI, P334; Wojtukiewicz MZ, 2003, THROMB HAEMOSTASIS, V90, P140; Wood JP, 2013, P NATL ACAD SCI USA, V110, P17838, DOI 10.1073/pnas.1310444110; Xiong Y, 2010, THROMB RES, V125, pE317, DOI 10.1016/j.thromres.2010.02.017; Xu C, 2013, FUEL CELLS, V13, P118, DOI 10.1002/fuce.201200149; ZHONG DG, 1994, P NATL ACAD SCI USA, V91, P3574, DOI 10.1073/pnas.91.9.3574; Zhu H, 2007, J BIOL CHEM, V282, P15033, DOI 10.1074/jbc.M701315200	81	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31647	31661		10.1074/jbc.M114.569665	http://dx.doi.org/10.1074/jbc.M114.569665			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25262870	Green Published, hybrid			2022-12-28	WOS:000344549900064
J	Davydova, E; Ho, AYY; Malecki, J; Moen, A; Enserink, JM; Jakobsson, ME; Loenarz, C; Falnes, PO				Davydova, Erna; Ho, Angela Y. Y.; Malecki, Jedrzej; Moen, Anders; Enserink, Jorrit M.; Jakobsson, Magnus E.; Loenarz, Christoph; Falnes, Pal O.			Identification and Characterization of a Novel Evolutionarily Conserved Lysine-specific Methyltransferase Targeting Eukaryotic Translation Elongation Factor 2 (eEF2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST RIBOSOMAL-PROTEINS; ADP-RIBOSYLATION; FACTOR 1-ALPHA; HELA-CELLS; METHYLATION; DIPHTHAMIDE; ACCURACY; TRANSLOCATION; BIOSYNTHESIS; INHIBITION	The components of the cellular protein translation machinery, such as ribosomal proteins and translation factors, are subject to numerous post-translational modifications. In particular, this group of proteins is frequently methylated. However, for the majority of these methylations, the responsible methyltransferases (MTases) remain unknown. The human FAM86A (family with sequence similarity 86) protein belongs to a recently identified family of protein MTases, and we here show that FAM86A catalyzes the trimethylation of eukaryotic elongation factor 2 (eEF2) on Lys-525. Moreover, we demonstrate that the Saccharomyces cerevisiae MTase Yjr129c, which displays sequence homology to FAM86A, is a functional FAM86A orthologue, modifying the corresponding residue (Lys-509) in yeast eEF2, both in vitro and in vivo. Finally, Yjr129c-deficient yeast cells displayed phenotypes related to eEF2 function (i.e. increased frameshifting during protein translation and hypersensitivity toward the eEF2-specific drug sordarin). In summary, the present study establishes the function of the previously uncharacterized MTases FAM86A and Yjr129c, demonstrating that these enzymes introduce a functionally important lysine methylation in eEF2. Based on the previous naming of similar enzymes, we have redubbed FAM86A and Yjr129c as eEF2-KMT and Efm3, respectively.	[Davydova, Erna; Ho, Angela Y. Y.; Malecki, Jedrzej; Moen, Anders; Jakobsson, Magnus E.; Falnes, Pal O.] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway; [Enserink, Jorrit M.] Oslo Univ Hosp, Dept Microbiol, N-0027 Oslo, Norway; [Enserink, Jorrit M.] Univ Oslo, N-0027 Oslo, Norway; [Loenarz, Christoph] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England	University of Oslo; University of Oslo; University of Oslo; University of Oxford	Falnes, PO (corresponding author), Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway.	pal.falnes@ibv.uio.no	Enserink, Jorrit/E-5383-2010; Falnes, Pål Ø./AAA-4581-2020	Enserink, Jorrit/0000-0002-2394-5387; Malecki, Jedrzej/0000-0003-0825-7962; Loenarz, Christoph/0000-0002-8843-2531; Davydova, Erna/0000-0001-7072-4539; Falnes, Pal/0000-0001-8114-6025	University of Oslo; Norwegian Cancer Society; Research Council of Norway; Leverhulme Trust	University of Oslo; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Leverhulme Trust(Leverhulme Trust)	Research in the laboratory of P.O.F. is supported by the University of Oslo and by grants from the Norwegian Cancer Society and the Research Council of Norway.; Recipient of a Leverhulme Trust Early Career Fellowship.	ALKSNE LE, 1993, P NATL ACAD SCI USA, V90, P9538, DOI 10.1073/pnas.90.20.9538; BARTEL RL, 1984, MOL PHARMACOL, V25, P418; Bernkopf M, 2014, HUM MOL GENET, V23, P4015, DOI 10.1093/hmg/ddu115; CHANG FN, 1978, BIOCHIM BIOPHYS ACTA, V518, P89, DOI 10.1016/0005-2787(78)90118-1; CHANG FN, 1976, ARCH BIOCHEM BIOPHYS, V172, P627, DOI 10.1016/0003-9861(76)90117-X; Chen TS, 2010, J BIOL CHEM, V285, P37281, DOI 10.1074/jbc.M110.157008; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; COPPARD NJ, 1983, FEBS LETT, V164, P330, DOI 10.1016/0014-5793(83)80311-1; Couttas TA, 2012, PROTEOMICS, V12, P960, DOI 10.1002/pmic.201100570; Darai-Ramqvist E, 2008, GENOME RES, V18, P370, DOI 10.1101/gr.7010208; FAUMAN EB, 1999, S ADENOSYLMETHIONINE, P1, DOI DOI 10.1142/9789812813077_0001; Figaro S, 2008, FEBS LETT, V582, P2352, DOI 10.1016/j.febslet.2008.05.045; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; FONZI WA, 1985, MOL CELL BIOL, V5, P1100, DOI 10.1128/MCB.5.5.1100; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; HIATT WR, 1982, P NATL ACAD SCI-BIOL, V79, P3433, DOI 10.1073/pnas.79.11.3433; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Jorgensen R, 2003, NAT STRUCT BIOL, V10, P379, DOI 10.1038/nsb923; Jorgensen R, 2002, ACTA CRYSTALLOGR D, V58, P712, DOI 10.1107/S0907444902003001; Justice MC, 1998, J BIOL CHEM, V273, P3148, DOI 10.1074/jbc.273.6.3148; Katz JE, 2003, MOL CELL PROTEOMICS, V2, P525, DOI 10.1074/mcp.M300037-MCP200; Kaul G, 2011, CELL BIOCHEM FUNCT, V29, P227, DOI 10.1002/cbf.1740; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; KRUISWIJK T, 1978, BIOCHEM J, V175, P221, DOI 10.1042/bj1750221; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Lipson RS, 2010, ARCH BIOCHEM BIOPHYS, V500, P137, DOI 10.1016/j.abb.2010.05.023; Liu SH, 2006, MOL CELL BIOL, V26, P3835, DOI 10.1128/MCB.26.10.3835-3841.2006; Loenarz C, 2014, P NATL ACAD SCI USA, V111, P4019, DOI 10.1073/pnas.1311750111; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Nyman T, 2002, J MOL BIOL, V317, P577, DOI 10.1006/jmbi.2002.5436; OPPENHEIMER NJ, 1981, J BIOL CHEM, V256, P8579; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Reiff RE, 2014, HUM MOL GENET, V23, P3456, DOI 10.1093/hmg/ddu054; RYAZANOV AG, 1989, FEBS LETT, V251, P187, DOI 10.1016/0014-5793(89)81452-8; Shastry M, 2001, MICROBIOL-UK, V147, P383, DOI 10.1099/00221287-147-2-383; Sprung R, 2008, J PROTEOME RES, V7, P1001, DOI [10.1021/pr0705338, 10.1021/pr8005155]; Su XY, 2013, CRIT REV BIOCHEM MOL, V48, P515, DOI 10.3109/10409238.2013.831023; Synetos D, 1996, BBA-GENE STRUCT EXPR, V1309, P156, DOI 10.1016/S0167-4781(96)00128-5; Thayer JS, 2002, APPL ORGANOMET CHEM, V16, P677, DOI 10.1002/aoc.375; Uthman S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003334; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Webb TR, 2008, J CELL SCI, V121, P3140, DOI 10.1242/jcs.035550; Williamson NA, 1997, EUR J BIOCHEM, V246, P786, DOI 10.1111/j.1432-1033.1997.00786.x; Zhang LL, 2014, BIOCHEM BIOPH RES CO, V451, P229, DOI 10.1016/j.bbrc.2014.07.110; Zhang Y, 2008, BIOCHEM J, V413, P163, DOI 10.1042/BJ20071083	53	35	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30499	30510		10.1074/jbc.M114.601658	http://dx.doi.org/10.1074/jbc.M114.601658			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231979	Green Published, hybrid			2022-12-28	WOS:000344549700029
J	Ge, HF; Zhang, J; Gong, Y; Gupte, J; Ye, J; Weiszmann, J; Samayoa, K; Coberly, S; Gardner, J; Wang, HL; Corbin, T; Chui, D; Baribault, H; Li, Y				Ge, Hongfei; Zhang, Jun; Gong, Yan; Gupte, Jamila; Ye, Jay; Weiszmann, Jennifer; Samayoa, Kim; Coberly, Suzanne; Gardner, Jonitha; Wang, Huilan; Corbin, Tim; Chui, Danny; Baribault, Helene; Li, Yang			Fibroblast Growth Factor Receptor 4 (FGFR4) Deficiency Improves Insulin Resistance and Glucose Metabolism under Diet-induced Obesity Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-KLOTHO; FGF19; ACTIVATION; EXPRESSION; FGF15/19; PATHWAY; FGF21	The role of fibroblast growth factor receptor 4 (FGFR4) in regulating bile acid synthesis has been well defined; however, its reported role on glucose and energy metabolism remains unresolved. Here, we show that FGFR4 deficiency in mice leads to improvement in glucose metabolism, insulin sensitivity, and reduction in body weight under high fat conditions. Mechanism of action studies in FGFR4-deficient mice suggest that the effects are mediated in part by increased plasma levels of adiponectin and the endocrine FGF factors FGF21 and FGF15, the latter of which increase in response to an elevated bile acid pool. Direct actions of increased bile acids on bile acid receptors, and other potential indirect mechanisms, may also contribute to the observed metabolic changes. The results described herein suggest that FGFR4 antagonists alone, or in combination with other agents, could serve as a novel treatment for diabetes.	[Ge, Hongfei; Zhang, Jun; Gong, Yan; Gupte, Jamila; Ye, Jay; Weiszmann, Jennifer; Samayoa, Kim; Coberly, Suzanne; Gardner, Jonitha; Baribault, Helene; Li, Yang] Amgen Inc, San Francisco, CA 94080 USA; [Wang, Huilan; Corbin, Tim; Chui, Danny] Amgen Inc, Thousand Oaks, CA 91320 USA	Amgen; Amgen	Li, Y (corresponding author), Amgen Inc, Dept Metab Disorders, 1120 Vet Blvd, San Francisco, CA 94080 USA.	yangl@amgen.com						Angelin B, 2012, CELL METAB, V16, P693, DOI 10.1016/j.cmet.2012.11.001; Cyphert HA, 2012, J BIOL CHEM, V287, P25123, DOI 10.1074/jbc.M112.375907; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Ge HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033603; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Huang XQ, 2007, DIABETES, V56, P2501, DOI 10.2337/db07-0648; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Jones SA, 2012, ADV EXP MED BIOL, V728, P171, DOI 10.1007/978-1-4614-0887-1_11; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Kobayashi M, 2007, DIABETES, V56, P239, DOI 10.2337/db06-0353; Kuro-o M, 2012, ADV EXP MED BIOL, V728, P25, DOI 10.1007/978-1-4614-0887-1_2; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lundasen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037787; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Potthoff MJ, 2011, CELL METAB, V13, P729, DOI 10.1016/j.cmet.2011.03.019; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Wu AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017868; Wu XL, 2013, J LIPID RES, V54, P325, DOI 10.1194/jlr.M027094; Wu XL, 2009, P NATL ACAD SCI USA, V106, P14379, DOI 10.1073/pnas.0907812106; Yu XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066923; Zhang J, 2014, DRUG DISCOV TODAY, V19, P579, DOI 10.1016/j.drudis.2013.10.021; Zhao Y, 2012, ADV EXP MED BIOL, V728, P214, DOI 10.1007/978-1-4614-0887-1_14	23	36	41	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30470	30480		10.1074/jbc.M114.592022	http://dx.doi.org/10.1074/jbc.M114.592022			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25204652	hybrid, Green Published			2022-12-28	WOS:000344549700027
J	Kaur, D; Angala, SK; Wu, SW; Khoo, KH; Chatterjee, D; Brennan, PJ; Jackson, M; McNeil, MR				Kaur, Devinder; Angala, Shiva K.; Wu, Sz-Wei; Khoo, Kay-Hooi; Chatterjee, Delphi; Brennan, Patrick J.; Jackson, Mary; McNeil, Michael R.			A Single Arabinan Chain Is Attached to the Phosphatidylinositol Mannosyl Core of the Major Immunomodulatory Mycobacterial Cell Envelope Glycoconjugate, Lipoarabinomannan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; STRUCTURAL FEATURES; TUBERCULOSIS; BIOSYNTHESIS; MANNOSYLTRANSFERASE; LIPOMANNAN; ARABINOGALACTAN; IDENTIFICATION; SUBSTITUENT; RESIDUES	Lipoarabinomannan (LAM) is composed of a phosphatidylinositol anchor followed by a mannan followed by an arabinan that may be capped with various motifs including oligosaccharides of mannose. A related polymer, lipomannan (LM), is composed of only the phosphatidylinositol and mannan core. Both the structure and the biosynthesis of LAM have been studied extensively. However, fundamental questions about the branching structure of LM and the number of arabinan chains on the mannan backbone in LAM remain. LM and LAM molecules produced by three different glycosyltransferase mutants of Mycobacterium smegmatis were used here to investigate these questions. Using an MSMEG_4241 mutant that lacks the alpha-(1,6)-mannosyltransferase used late in LM elongation, we showed that the reducing end region of the mannan that is attached to inositol has 5-7 unbranched alpha-6-linked-mannosyl residues followed by two or three alpha-6-linked mannosyl residues branched with single alpha-mannopyranose residues at O-2. After these branched mannosyl residues, the alpha-6-linked mannan chain is terminated with an alpha-mannopyranose at O-2 rather than O-6 of the penultimate residue. Analysis of the number of arabinans attached to the mannan core of LM in two other mutants (Delta embC and Delta MSMEG_4247) demonstrated exactly one arabinosyl substitution of the mannan core suggestive of the arabinosylation of a linear LM precursor with similar to 10-12 mannosyl residues followed by additional mannosylation of the core and arabinosylation of a single arabinosyl "primer." Thus, these studies suggest that only a single arabinan chain attached near the middle of the mannan core is present in mature LAM and allow for an updated working model of the biosynthetic pathway of LAM and LM.	[Kaur, Devinder; Angala, Shiva K.; Chatterjee, Delphi; Brennan, Patrick J.; Jackson, Mary; McNeil, Michael R.] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Wu, Sz-Wei; Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan	Colorado State University; Academia Sinica - Taiwan	Jackson, M (corresponding author), Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Mary.Jackson@colostate.edu; mmcneil@colostate.edu	Jackson, Mary/D-5345-2017; Khoo, Kay-Hooi/E-1989-2019; Brennan, Patrick J/G-6896-2017; McNeil, Michael/G-3325-2019	Jackson, Mary/0000-0002-9212-0258; Khoo, Kay-Hooi/0000-0003-2906-406X; 	National Research Program for Genomic Medicine Core Facilities for Proteomics and Glycomics [NSC 99-3112-B-001-025]; Taiwan National Core Facility Program for Biotechnology [NSC 100-2325-B-001-029]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064798] Funding Source: NIH RePORTER	National Research Program for Genomic Medicine Core Facilities for Proteomics and Glycomics; Taiwan National Core Facility Program for Biotechnology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The MALDI-TOF/TOF MS/MS data were acquired at the previous National Research Program for Genomic Medicine Core Facilities for Proteomics and Glycomics (NSC 99-3112-B-001-025) and current Core Facilities for Protein Structural Analysis at Academia Sinica, supported under the Taiwan National Core Facility Program for Biotechnology, NSC 100-2325-B-001-029.	Angala SK, 2014, CRIT REV BIOCHEM MOL, V49, P361, DOI 10.3109/10409238.2014.925420; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6234; CHATTERJEE D, 1991, J BIOL CHEM, V266, P9652; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; DAFFE M, 1990, J BIOL CHEM, V265, P6734; Gilleron M, 2008, MYCOBACTERIAL CELL ENVELOPE, P75; HUNTER SW, 1990, J BIOL CHEM, V265, P9272; HUNTER SW, 1986, J BIOL CHEM, V261, P2345; Joe M, 2006, J AM CHEM SOC, V128, P5059, DOI 10.1021/ja057373q; Kaur D, 2007, J BIOL CHEM, V282, P27133, DOI 10.1074/jbc.M703389200; Kaur D, 2006, P NATL ACAD SCI USA, V103, P13664, DOI 10.1073/pnas.0603049103; KHOO KH, 1995, GLYCOBIOLOGY, V5, P117, DOI 10.1093/glycob/5.1.117; MCNEIL M, 1983, CARBOHYD RES, V123, P31, DOI 10.1016/0008-6215(83)88378-5; MCNEIL MR, 1994, GLYCOBIOLOGY, V4, P165, DOI 10.1093/glycob/4.2.165; Mishra AK, 2007, MOL MICROBIOL, V65, P1503, DOI 10.1111/j.1365-2958.2007.05884.x; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Sena CBC, 2010, J BIOL CHEM, V285, P13326, DOI 10.1074/jbc.M109.077297; Shi LB, 2006, J BIOL CHEM, V281, P19512, DOI 10.1074/jbc.M513846200; Torrelles JB, 2010, TUBERCULOSIS, V90, P84, DOI 10.1016/j.tube.2010.02.003; Treumann A, 2002, J MOL BIOL, V316, P89, DOI 10.1006/jmbi.2001.5317; Turnbull WB, 2004, ANGEW CHEM INT EDIT, V43, P3918, DOI 10.1002/anie.200454119; Yu SY, 2006, GLYCOCONJUGATE J, V23, P355, DOI 10.1007/s10719-006-8492-3; Zhang N, 2003, MOL MICROBIOL, V50, P69, DOI 10.1046/j.1365-2958.2003.03681.x	24	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30249	30256		10.1074/jbc.M114.599415	http://dx.doi.org/10.1074/jbc.M114.599415			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231986	hybrid, Green Published			2022-12-28	WOS:000344549700009
J	Mori, T; Koyama, N; Segawa, T; Maeda, M; Maruyama, N; Kinoshita, N; Hou, HY; Tan, J; Town, T				Mori, Takashi; Koyama, Naoki; Segawa, Tatsuya; Maeda, Masahiro; Maruyama, Nobuhiro; Kinoshita, Noriaki; Hou, Huayan; Tan, Jun; Town, Terrence			Methylene Blue Modulates beta-Secretase, Reverses Cerebral Amyloidosis, and Improves Cognition in Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; A-BETA; MOUSE MODEL; MEMORY DEFICITS; ASPARTYL PROTEASE; TAU-AGGREGATION; BACE1; BRAIN; PRESENILIN-1	Amyloid precursor protein (APP) proteolysis is required for production of amyloid-beta (A beta) peptides that comprise beta-amyloid plaques in the brains of patients with Alzheimer disease (AD). Here, we tested whether the experimental agent methylene blue (MB), used for treatment of methemoglobinemia, might improve AD-like pathology and behavioral deficits. We orally administered MB to the aged transgenic PSAPP mouse model of cerebral amyloidosis and evaluated cognitive function and cerebral amyloid pathology. Beginning at 15 months of age, animals were gavaged with MB (3 mg/kg) or vehicle once daily for 3 months. MB treatment significantly prevented transgene-associated behavioral impairment, including hyperactivity, decreased object recognition, and defective spatial working and reference memory, but it did not alter nontransgenic mouse behavior. Moreover, brain parenchymal and cerebral vascular beta-amyloid deposits as well as levels of various A beta species, including oligomers, were mitigated in MB-treated PSAPP mice. These effects occurred with inhibition of amyloidogenic APP proteolysis. Specifically, beta-carboxyl-terminal APP fragment and beta-site APP cleaving enzyme 1 protein expression and activity were attenuated. Additionally, treatment of Chinese hamster ovary cells overexpressing human wild-type APP with MB significantly decreased A beta production and amyloidogenic APP proteolysis. These results underscore the potential for oral MB treatment against AD-related cerebral amyloidosis by modulating the amyloidogenic pathway.	[Mori, Takashi; Koyama, Naoki] Saitama Med Ctr, Dept Biomed Sci, Kawagoe, Saitama 3508550, Japan; [Mori, Takashi] Saitama Med Ctr, Dept Pathol, Kawagoe, Saitama 3508550, Japan; Univ Kawagoe, Kawagoe, Saitama 3508550, Japan; [Segawa, Tatsuya; Maeda, Masahiro; Maruyama, Nobuhiro; Kinoshita, Noriaki] Immunobiol Labs Co Ltd, Gunma 3750005, Japan; [Hou, Huayan; Tan, Jun] Univ S Florida, Morsoni Coll Med, Silver Child Dev Ctr, Rashid Lab Dev Neurobiol, Tampa, FL 33613 USA; [Tan, Jun] Univ S Florida, Morsoni Coll Med, Dept Psychiat & Behav Neurosci, Neuroimmunol Lab, Tampa, FL 33613 USA; [Town, Terrence] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA	Saitama Medical University; Saitama Medical University; Immuno-Biological Laboratories Co. Ltd.; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of Southern California	Mori, T (corresponding author), Saitama Med Ctr, Dept Biomed Sci, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	t_mori@saitama-med.ac.jp; ttown@usc.edu			National Institutes of Health from NINDS [1R01NS076794-01]; Japan Society for the Promotion of Science [22500320]; Alzheimer's Association Zenith Fellows Award [ZEN-10-174633]; American Federation of Aging Research/Ellison Medical Foundation Julie Martin Mid-Career Award in Aging Research Grant [M11472]; Zilkha Neurogenetic Institute of the Keck School of Medicine at the University of Southern California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076794] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alzheimer's Association Zenith Fellows Award(Alzheimer's Association); American Federation of Aging Research/Ellison Medical Foundation Julie Martin Mid-Career Award in Aging Research Grant; Zilkha Neurogenetic Institute of the Keck School of Medicine at the University of Southern California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01NS076794-01 from NINDS (to T. T.). This work was also supported by Grant-in-aid for Scientific Research (C) from the Japan Society for the Promotion of Science 22500320 (to T. M.), Alzheimer's Association Zenith Fellows Award ZEN-10-174633 (to T. T.), American Federation of Aging Research/Ellison Medical Foundation Julie Martin Mid-Career Award in Aging Research Grant M11472 (to T. T.), and generous start-up funds from the Zilkha Neurogenetic Institute of the Keck School of Medicine at the University of Southern California (to T. T.).	Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Alzheimer's Disease International, 2012, OV STIGM DEM WORLD A; Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; BARNES DG, 1988, REGUL TOXICOL PHARM, V8, P471, DOI 10.1016/0273-2300(88)90047-5; Bates KA, 2009, MOL PSYCHIATR, V14, P469, DOI 10.1038/mp.2008.96; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Brookmeyer R, 2000, STAT MED, V19, P1481, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1481::AID-SIM440>3.0.CO;2-U; Buchholz K, 2008, ANTIMICROB AGENTS CH, V52, P183, DOI 10.1128/AAC.00773-07; Cai J, 2012, EMBO MOL MED, V4, P980, DOI 10.1002/emmm.201101084; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Clifton Jack 2nd, 2003, Am J Ther, V10, P289; Congdon EE, 2012, AUTOPHAGY, V8, P609, DOI 10.4161/auto.19048; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Deiana S, 2009, PSYCHOPHARMACOLOGY, V202, P53, DOI 10.1007/s00213-008-1394-2; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; DISANTO AR, 1972, J PHARM SCI, V61, P1086, DOI 10.1002/jps.2600610710; Dourson ML, 1996, REGUL TOXICOL PHARM, V24, P108, DOI 10.1006/rtph.1996.0116; Ellis RJ, 1996, NEUROLOGY, V46, P1592, DOI 10.1212/WNL.46.6.1592; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Gandhi S, 2004, J MOL NEUROSCI, V24, P137, DOI 10.1385/JMN:24:1:137; Gravitz L, 2011, NATURE, V475, pS9, DOI 10.1038/475S9a; Gura T, 2008, NAT MED, V14, P894, DOI 10.1038/nm0908-894; Hahn S, 2011, J NEUROCHEM, V116, P385, DOI 10.1111/j.1471-4159.2010.07118.x; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Harvey BH, 2010, BIOCHEM PHARMACOL, V80, P1580, DOI 10.1016/j.bcp.2010.07.037; Hitt B, 2012, J BIOL CHEM, V287, P38408, DOI 10.1074/jbc.M112.415505; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V319, P733, DOI 10.1016/j.bbrc.2004.05.051; Hosokawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052389; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim KS, 2006, J NEUROSCI RES, V83, P497, DOI 10.1002/jnr.20754; King DL, 1999, BEHAV BRAIN RES, V103, P145, DOI 10.1016/S0166-4328(99)00037-6; Klamer D, 2004, BASIC CLIN PHARMACOL, V94, P65, DOI 10.1111/j.1742-7843.2004.pto940203.x; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Laghmouch A, 1997, BEHAV GENET, V27, P67, DOI 10.1023/A:1025667426222; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Mori T, 2006, J PHARMACOL EXP THER, V318, P571, DOI 10.1124/jpet.106.105171; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055774; Mori T, 2012, J BIOL CHEM, V287, P6912, DOI 10.1074/jbc.M111.294025; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; Muller T, 1998, HISTOL HISTOPATHOL, V13, P1019, DOI 10.14670/HH-13.1019; NARSAPUR SL, 1983, J AFFECT DISORDERS, V5, P155, DOI 10.1016/0165-0327(83)90008-3; NAYLOR GJ, 1986, BIOL PSYCHIAT, V21, P915, DOI 10.1016/0006-3223(86)90265-9; Necula M, 2007, BIOCHEMISTRY-US, V46, P8850, DOI 10.1021/bi700411k; Nishitomi K, 2006, J NEUROCHEM, V99, P1555, DOI 10.1111/j.1471-4159.2006.04178.x; Nordberg A, 2006, ALZ DIS ASSOC DIS, V20, pS12, DOI 10.1097/01.wad.0000213804.59187.2d; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Oz M, 2011, MED RES REV, V31, P93, DOI 10.1002/med.20177; Paban V, 2014, NEUROPHARMACOLOGY, V76, P68, DOI 10.1016/j.neuropharm.2013.06.033; Pastorino L, 2004, MOL CELL NEUROSCI, V25, P642, DOI 10.1016/j.mcn.2003.12.013; Peter C, 2000, EUR J CLIN PHARMACOL, V56, P247, DOI 10.1007/s002280000124; Riha PD, 2005, EUR J PHARMACOL, V511, P151, DOI 10.1016/j.ejphar.2005.02.001; ROZEMULLER JM, 1989, J NEUROPATH EXP NEUR, V48, P674, DOI 10.1097/00005072-198911000-00009; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schirmer RH, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.12.012; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; van Bebber F, 2010, NEUROBIOL DIS, V39, P265, DOI 10.1016/j.nbd.2010.03.023; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walter-Sack I, 2009, EUR J CLIN PHARMACOL, V65, P179, DOI 10.1007/s00228-008-0563-x; Wang H, 2010, J NEUROSCI, V30, P13808, DOI 10.1523/JNEUROSCI.1070-10.2010; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wischik C, 2009, J NUTR HEALTH AGING, V13, P367, DOI 10.1007/s12603-009-0046-5; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565; Yan RQ, 2014, LANCET NEUROL, V13, P319, DOI 10.1016/S1474-4422(13)70276-X; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107	85	34	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30303	30317		10.1074/jbc.M114.568212	http://dx.doi.org/10.1074/jbc.M114.568212			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25157105	hybrid, Green Published			2022-12-28	WOS:000344549700014
J	Ablorh, NAD; Dong, XQ; James, ZM; Xiong, Q; Zhang, JY; Thomas, DD; Karim, CB				Ablorh, Naa-Adjeley D.; Dong, Xiaoqiong; James, Zachary M.; Xiong, Qiang; Zhang, Jianyi; Thomas, David D.; Karim, Christine B.			Synthetic Phosphopeptides Enable Quantitation of the Content and Function of the Four Phosphorylation States of Phospholamban in Cardiac Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; CALCIUM-TRANSPORT REGULATION; SARCOPLASMIC-RETICULUM; HEART-FAILURE; THERAPEUTIC TARGET; ENDOMYOCARDIAL BIOPSY; PRESSURE-OVERLOAD; CA2+ HOMEOSTASIS; PHOSPHATASE 1; GENE-THERAPY	We have studied the differential effects of phospholamban(PLB) phosphorylation states on the activity of the sarcoplasmic reticulum Ca-ATPase (SERCA). It has been shown that unphosphorylated PLB (U-PLB) inhibits SERCA and that phosphorylation of PLB at Ser-16 or Thr-17 relieves this inhibition in cardiac sarcoplasmic reticulum. However, the levels of the four phosphorylation states of PLB (U-PLB, P16-PLB, P17-PLB, and doubly phosphorylated 2P-PLB) have not been measured quantitatively in cardiac tissue, and their functional effects on SERCA have not been determined directly. We have solved both problems through the chemical synthesis of all four PLB species. We first used the synthetic PLB as standards for a quantitative immunoblot assay, to determine the concentrations of all four PLB phosphorylation states in pig cardiac tissue, with and without left ventricular hypertrophy (LVH) induced by aortic banding. In both LVH and sham hearts, all phosphorylation states were significantly populated, but LVH hearts showed a significant decrease in U-PLB, with a corresponding increase in the ratio of total phosphorylated PLB to U-PLB. To determine directly the functional effects of each PLB species, we co-reconstituted each of the synthetic peptides in phospholipid membranes with SERCA and measured calcium-dependent ATPase activity. SERCA inhibition was maximally relieved by P16-PLB (the most highly populated PLB state in cardiac tissue homogenates), followed by 2P-PLB, then P17-PLB. These results show that each PLB phosphorylation state uniquely alters Ca2+ homeostasis, with important implications for cardiac health, disease, and therapy.	[Ablorh, Naa-Adjeley D.; Dong, Xiaoqiong; James, Zachary M.; Thomas, David D.; Karim, Christine B.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Xiong, Qiang; Zhang, Jianyi] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Karim, CB (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	karim002@umn.edu	Zhang, Jianyi/N-1949-2018	Zhang, Jianyi/0000-0002-3955-6554; Karim, Christine/0000-0002-7321-7695; Thomas, David D./0000-0002-8822-2040	National Institutes of Health [R37 AG26160, R21 AG42996, R01 GM27906, HL114120, T32 HL069764, T32 AR07612]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114120, T32HL069764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG042996, R37AG026160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants R37 AG26160, R21 AG42996, and R01 GM27906 (to D. D. T.), and HL114120 (to J.Z.).; Supported by National Institutes of Health Training Grant T32 HL069764.; Supported by National Institutes of Health Training Grant T32 AR07612.	Ablorh NA, 2012, ANAL BIOCHEM, V425, P68, DOI 10.1016/j.ab.2012.01.028; Akin BL, 2013, J BIOL CHEM, V288, P30181, DOI 10.1074/jbc.M113.501585; Akin BL, 2012, J BIOL CHEM, V287, P7582, DOI 10.1074/jbc.M111.334987; Alves ML, 2014, CIRC-CARDIOVASC GENE, V7, P132, DOI 10.1161/CIRCGENETICS.113.000324; Ardehali H, 2005, AM HEART J, V149, P7, DOI 10.1016/j.ahj.2004.06.007; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2010, CIRC RES, V107, P1044, DOI 10.1161/CIRCRESAHA.110.231902; Boateng S, 1997, BIOCHEM BIOPH RES CO, V239, P701, DOI 10.1006/bbrc.1997.7539; Calaghan S, 1998, BIOCHEM BIOPH RES CO, V248, P701, DOI 10.1006/bbrc.1998.9036; Calaghan S, 2008, J MOL CELL CARDIOL, V45, P88, DOI 10.1016/j.yjmcc.2008.04.004; Calaghan SC, 1998, PFLUG ARCH EUR J PHY, V436, P948, DOI 10.1007/s004240050728; Chimenti C, 2013, CIRCULATION, V128, P1531, DOI 10.1161/CIRCULATIONAHA.13.001414; COLYER J, 1991, J BIOL CHEM, V266, P17486; Colyer J, 1998, ANN NY ACAD SCI, V853, P79, DOI 10.1111/j.1749-6632.1998.tb08258.x; Cooper LT, 2007, EUR HEART J, V28, P3076, DOI 10.1093/eurheartj/ehm456; Cornea RL, 2013, J BIOMOL SCREEN, V18, P97, DOI 10.1177/1087057112456878; Dash R, 2001, J MOL CELL CARDIOL, V33, P1345, DOI 10.1006/jmcc.2001.1394; Dong XQ, 2014, BIOCHEM BIOPH RES CO, V449, P196, DOI 10.1016/j.bbrc.2014.04.166; Gong GR, 2003, AM J PHYSIOL-HEART C, V285, pH541, DOI 10.1152/ajpheart.01142.2002; Grote-Wessels S, 2008, CARDIOVASC RES, V79, P464, DOI 10.1093/cvr/cvn113; Gruber SJ, 2012, BIOCHEM BIOPH RES CO, V420, P236, DOI 10.1016/j.bbrc.2012.02.125; Guinto PJ, 2009, AM J PHYSIOL-HEART C, V297, pH614, DOI 10.1152/ajpheart.01143.2008; Hoshijima M, 2005, PHARMACOL THERAPEUT, V105, P211, DOI 10.1016/j.pharmthera.2004.10.006; Hoshijima M, 2002, NAT MED, V8, P864, DOI 10.1038/nm739; Huang BY, 1999, CIRC RES, V85, P848, DOI 10.1161/01.RES.85.9.848; Jackson WA, 1996, BIOCHEM J, V316, P201, DOI 10.1042/bj3160201; JAKAB G, 1988, BIOCHEMISTRY-US, V27, P3799, DOI 10.1021/bi00410a042; James ZM, 2012, BIOPHYS J, V103, P1370, DOI 10.1016/j.bpj.2012.08.032; Ji Y, 1999, AM J PHYSIOL-HEART C, V276, pH89, DOI 10.1152/ajpheart.1999.276.1.H89; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Karim CB, 2004, P NATL ACAD SCI USA, V101, P14437, DOI 10.1073/pnas.0402801101; Karim CB, 2001, J BIOL CHEM, V276, P38814, DOI 10.1074/jbc.M104006200; Karim CB, 2000, BIOCHEMISTRY-US, V39, P10892, DOI 10.1021/bi0003543; Karim CB, 2007, NAT PROTOC, V2, P42, DOI 10.1038/nprot.2007.2; Li JH, 2003, BIOCHEMISTRY-US, V42, P10674, DOI 10.1021/bi034708c; Li J, 2012, J MOL BIOL, V418, P379, DOI 10.1016/j.jmb.2012.02.011; Li J, 2013, BIOMED ENVIRON SCI, V26, P577, DOI 10.3967/0895-3988.2013.07.009; Lipskaia L, 2010, EXPERT OPIN BIOL TH, V10, P29, DOI 10.1517/14712590903321462; Lockamy EL, 2011, BIOCHEM BIOPH RES CO, V408, P388, DOI 10.1016/j.bbrc.2011.04.023; Lockwood NA, 2003, BIOPOLYMERS, V69, P283, DOI 10.1002/bip.10365; Loyer X, 2008, CIRCULATION, V117, P3187, DOI 10.1161/CIRCULATIONAHA.107.741702; MACDOUGALL LK, 1991, EUR J BIOCHEM, V196, P725, DOI 10.1111/j.1432-1033.1991.tb15871.x; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Mattiazzi A, 2011, HEART RHYTHM, V8, P784, DOI 10.1016/j.hrthm.2010.11.035; Mishra S, 2003, AM J PHYSIOL-HEART C, V284, pH876, DOI 10.1152/ajpheart.00266.2002; Miyamoto SD, 2014, EUR HEART J, V35, P33, DOI 10.1093/eurheartj/ehs229; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; Netticadan T, 2000, CIRC RES, V86, P596, DOI 10.1161/01.RES.86.5.596; Oh JG, 2013, J MOL CELL CARDIOL, V56, P63, DOI 10.1016/j.yjmcc.2012.12.005; Pattison JS, 2008, TRANSGENIC RES, V17, P157, DOI 10.1007/s11248-007-9139-2; Periasamy M, 2001, J MOL CELL CARDIOL, V33, P1053, DOI 10.1006/jmcc.2001.1366; RAEYMAEKERS L, 1988, BIOCHEM J, V252, P269, DOI 10.1042/bj2520269; Reddy LG, 2003, BIOCHEMISTRY-US, V42, P4585, DOI 10.1021/bi026995a; Said M, 2011, J MOL CELL CARDIOL, V51, P936, DOI 10.1016/j.yjmcc.2011.08.010; Sande JB, 2002, CARDIOVASC RES, V53, P382, DOI 10.1016/S0008-6363(01)00489-8; Schmidt AG, 2001, CARDIOVASC DRUG THER, V15, P387, DOI 10.1023/A:1013381204658; Schwinger RHG, 1999, J MOL CELL CARDIOL, V31, P479, DOI 10.1006/jmcc.1998.0897; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; Sossalla S, 2010, CIRC RES, V107, P1150, DOI 10.1161/CIRCRESAHA.110.220418; STEENAART NAE, 1992, ARCH BIOCHEM BIOPHYS, V293, P17, DOI 10.1016/0003-9861(92)90359-5; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; TADA M, 1983, J MOL CELL CARDIOL, V15, P335, DOI 10.1016/0022-2828(83)91345-7; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Traaseth NJ, 2008, BIOCHEMISTRY-US, V47, P3, DOI 10.1021/bi701668v; Wang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004133; Wang XH, 2006, AM J PHYSIOL-HEART C, V290, pH1393, DOI 10.1152/ajpheart.00871.2005; Wang Y, 2008, J BIOL CHEM, V283, P25524, DOI 10.1074/jbc.M803043200; Zhao W, 2003, CARDIOVASC RES, V57, P71, DOI 10.1016/S0008-6363(02)00609-0	69	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29397	29405		10.1074/jbc.M114.556621	http://dx.doi.org/10.1074/jbc.M114.556621			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25190804	Green Published, hybrid			2022-12-28	WOS:000344141000051
J	Speranza, F; Mahankali, M; Henkels, KM; Gomez-Cambronero, J				Speranza, Francis; Mahankali, Madhu; Henkels, Karen M.; Gomez-Cambronero, Julian			The Molecular Basis of Leukocyte Adhesion Involving Phosphatidic Acid and Phospholipase D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARP2/3 COMPLEX; CELL-MIGRATION; ACTIN POLYMERIZATION; FAMILY PROTEINS; N-WASP; BINDING; KINASE; LOCALIZATION; PHAGOCYTOSIS; ASSOCIATION	Defining how leukocytes adhere to solid surfaces, such as capillary beds, and the subsequent migration through the extracellular matrix, is a central biological issue. We show here that phospholipase D (PLD) and its enzymatic reaction product, phosphatidic acid (PA), regulate cell adhesion of immune cells (macrophages and neutrophils) to collagen and have defined the underlying molecular mechanism in a spatio-temporal manner that coincides with PLD activity timing. Arapid (t(1/2) = 4 min) and transient activation of the PLD1 isoform occurs upon adhesion, and a slower (t(1/2) = 7.5 min) but prolonged (>30 min) activation occurs for PLD2. Importantly, PA directly binds to actin-related protein 3 (Arp3) at EC50 = 22 nM, whereas control phosphatidylcholine did not bind. PA-activated Arp3 hastens actin nucleation with a kinetics of t(1/2) = 3 min at 300 nM (compared with controls of no PA, t(1/2) = 5 min). Thus, PLD and PA are intrinsic components of cell adhesion, which reinforce each other in a positive feedback loop and react from cues from their respective solid substrates. In nascent adhesion, PLD1 is key, whereas a sustained adhesion in mature or established focal points is dependent upon PLD2, PA, and Arp3. A prolonged adhesion could effectively counteract the reversible intrinsic nature of this cellular process and constitute a key player in chronic inflammation.	[Speranza, Francis; Mahankali, Madhu; Henkels, Karen M.; Gomez-Cambronero, Julian] Wright State Univ, Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	Wright State University Dayton	Gomez-Cambronero, J (corresponding author), Wright State Univ, Sch Med, Dept Biochem & Mol Biol, 3640 Colonel Glenn Hwy, Dayton, OH 45435 USA.	julian.cambronero@wright.edu		Gomez-Cambronero, Julian/0000-0002-7581-9227	National Institutes of Health [HL056653-14]; American Heart Association [13GRNT17230097]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL056653, R01HL056653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL056653-14 (to J. G.- C.). This work was also supported by American Heart Association Grant 13GRNT17230097 (to J. G.-C.).	Burianek LE, 2013, SEMIN CELL DEV BIOL, V24, P258, DOI 10.1016/j.semcdb.2012.12.005; Chae YC, 2010, MOL CELL BIOL, V30, P5086, DOI 10.1128/MCB.00443-10; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Doolittle LK, 2013, METHODS MOL BIOL, V1046, P273, DOI 10.1007/978-1-62703-538-5_16; Dowler Simon, 2002, Sci STKE, V2002, ppl6, DOI 10.1126/stke.2002.129.pl6; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; Frondorf K, 2010, J BIOL CHEM, V285, P15837, DOI 10.1074/jbc.M109.070524; HA KS, 1993, J CELL BIOL, V123, P1789, DOI 10.1083/jcb.123.6.1789; Henkels KM, 2013, ONCOGENE, V32, P5551, DOI 10.1038/onc.2013.207; Hufner K, 2002, FEBS LETT, V514, P168, DOI 10.1016/S0014-5793(02)02358-X; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; Iyer SS, 2006, J IMMUNOL, V176, P3686, DOI 10.4049/jimmunol.176.6.3686; Iyer Shankar S., 2006, V332, P281; Jeon H, 2011, CELL SIGNAL, V23, P1320, DOI 10.1016/j.cellsig.2011.03.014; Knoepp SM, 2008, MOL PHARMACOL, V74, P574, DOI 10.1124/mol.107.040105; Kooijman EE, 2009, BBA-MOL CELL BIOL L, V1791, P881, DOI 10.1016/j.bbalip.2009.04.001; KRABAK MJ, 1991, CELL REGUL, V2, P57, DOI 10.1091/mbc.2.1.57; Le Clainche C, 2001, J BIOL CHEM, V276, P46689, DOI 10.1074/jbc.C100476200; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Magdalena J, 2003, MOL BIOL CELL, V14, P670, DOI 10.1091/mbc.e02-06-0345; Mahankali M, 2011, CELL SIGNAL, V23, P1291, DOI 10.1016/j.cellsig.2011.03.010; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Neiman AM, 2000, GENETICS, V155, P1643; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; O'Luanaigh N, 2002, MOL BIOL CELL, V13, P3730, DOI 10.1091/mbc.E02-04-0213; Powner DJ, 2005, J CELL SCI, V118, P2975, DOI 10.1242/jcs.02432; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Scott SA, 2013, J BIOL CHEM, V288, P20477, DOI 10.1074/jbc.M113.451708; Shin I, 1999, MOL CELLS, V9, P292; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Yoon MS, 2011, J BIOL CHEM, V286, P29568, DOI 10.1074/jbc.M111.262816; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zhang Q, 2012, PLANT CELL, V24, P4555, DOI 10.1105/tpc.112.104182; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101; Zouwail S, 2005, BIOCHEM J, V389, P207, DOI 10.1042/BJ20050085	42	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28885	28897		10.1074/jbc.M114.597146	http://dx.doi.org/10.1074/jbc.M114.597146			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25187519	hybrid, Green Published			2022-12-28	WOS:000344141000012
J	Warner, N; Burberry, A; Pliakas, M; McDonald, C; Nunez, G				Warner, Neil; Burberry, Aaron; Pliakas, Maria; McDonald, Christine; Nunez, Gabriel			A Genome-wide Small Interfering RNA (siRNA) Screen Reveals Nuclear Factor-kappa B (NF-kappa B)-independent Regulators of NOD2-induced Interleukin-8 (IL-8) Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERMANSKY-PUDLAK-SYNDROME; CROHNS-DISEASE; PROINFLAMMATORY CYTOKINES; CARD15 MUTATIONS; BINDING-PROTEIN; NOD2; INNATE; EXPRESSION; PATHWAY; HOST	NOD2 encodes an intracellular multidomain pattern recognition receptor that is the strongest known genetic risk factor in the pathogenesis of Crohn disease (CD), a chronic relapsing inflammatory disorder of the intestinal tract. NOD2 functions as a sensor for bacterial cell wall components and activates proinflammatory and antimicrobial signaling pathways. Here, using a genome-wide small interfering RNA (siRNA) screen, we identify numerous genes that regulate secretion of the proinflammatory cytokine IL-8 in response to NOD2 activation. Moreover, many of the identified IL-8 regulators are linked by protein-protein interactions, revealing subnetworks of highly connected IL-8 regulators implicated in processes such as vesicle formation, mRNA stability, and protein ubiquitination and trafficking. A TNF alpha counterscreen to induce IL-8 secretion in an NOD2-independent manner reveals that the majority of the identified regulators affect IL-8 secretion irrespective of the initiating stimuli. Using immortalized macrophages, we validate the ubiquitin protease, USP8, and the endosomal sorting protein, VPS28, as negative regulators of NOD2-induced cytokine secretion. Interestingly, several genes that affect NOD2-induced IL-8 secretion are present in loci associated with CD risk by genome-wide association studies, supporting a role for the NOD2/IL-8 pathway, and not just NOD2, in the pathogenesis of CD. Overall, this screen provides a valuable resource in the advancement of our understanding of the genes that regulate the secretion of IL-8.	[Warner, Neil; Burberry, Aaron; Nunez, Gabriel] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Pliakas, Maria; Nunez, Gabriel] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [McDonald, Christine] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cleveland Clinic Foundation	Nunez, G (corresponding author), Univ Michigan, Dept Pathol, Sch Med, 1500 E Med Ctr Dr,Rm 4215 CC, Ann Arbor, MI 48109 USA.	gabriel.nunez@umich.edu	Warner, Neil/ABE-7329-2020; Nuñez, Gabriel/A-7160-2014	Warner, Neil/0000-0002-9207-5979; McDonald, Christine/0000-0002-6745-9487	National Institutes of Health [R01DK082437, 2R01DK61707]; Crohn's and Colitis Foundation of America; Eli and Edythe L. Broad Foundation Medical Research Program for Inflammatory Bowel Disease; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061707, R01DK082437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Eli and Edythe L. Broad Foundation Medical Research Program for Inflammatory Bowel Disease; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK082437 (to C. M.) and 2R01DK61707 (to G. N.). This work was also supported by the Crohn's and Colitis Foundation of America and the Eli and Edythe L. Broad Foundation Medical Research Program for Inflammatory Bowel Disease.	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; ADAMI C, 1993, J LEUKOCYTE BIOL, V53, P475, DOI 10.1002/jlb.53.4.475; Adler J, 2011, AM J GASTROENTEROL, V106, P699, DOI 10.1038/ajg.2011.19; Balakathiresan NS, 2009, AM J PHYSIOL-LUNG C, V296, pL1012, DOI 10.1152/ajplung.90601.2008; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Beste MT, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007988; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Cao HP, 2004, BIOCHEMISTRY-US, V43, P13724, DOI 10.1021/bi049014y; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen JD, 2010, BIOCHEM SOC T, V38, P1082, DOI 10.1042/BST0381082; Chiang CY, 2012, CELL HOST MICROBE, V11, P306, DOI 10.1016/j.chom.2012.02.002; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Cleynen I, 2013, GUT, V62, P1556, DOI 10.1136/gutjnl-2011-300777; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; Dauletbaev N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.205724; Deshmukh HS, 2009, INFECT IMMUN, V77, P1376, DOI 10.1128/IAI.00940-08; Dinarello CA, 2007, EUR J IMMUNOL, V37, pS34, DOI 10.1002/eji.200737772; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Eliopoulos AG, 1999, J BIOL CHEM, V274, P16085, DOI 10.1074/jbc.274.23.16085; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gewurz BE, 2012, P NATL ACAD SCI USA, V109, P2467, DOI 10.1073/pnas.1120542109; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hedvat CV, 2004, J BIOL CHEM, V279, P6395, DOI 10.1074/jbc.M307524200; Hisatsune J, 2008, J IMMUNOL, V180, P5017, DOI 10.4049/jimmunol.180.7.5017; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kim YG, 2011, J IMMUNOL, V187, P2849, DOI 10.4049/jimmunol.1001854; Kjellerup RB, 2008, EXP DERMATOL, V17, P498, DOI 10.1111/j.1600-0625.2007.00672.x; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lewis BA, 2003, J CELL SCI, V116, P3667, DOI 10.1242/jcs.00734; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Lipinski S, 2012, P NATL ACAD SCI USA, V109, P21426, DOI 10.1073/pnas.1209673109; Loppalainen M, 2008, INFLAMM BOWEL DIS, V14, P176, DOI 10.1002/ibd.20287; Manetsch M, 2012, CELL SIGNAL, V24, P907, DOI 10.1016/j.cellsig.2011.12.013; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Richmond AL, 2012, GASTROENTEROLOGY, V142, P1483, DOI 10.1053/j.gastro.2012.02.040; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rowlett RM, 2008, AM J PHYSIOL-GASTR L, V294, pG452, DOI 10.1152/ajpgi.00077.2007; Seidelin JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007794; Seward SL, 2013, PEDIATRICS, V132, P153, DOI 10.1542/peds.2012-4003; Sharma D, 2013, INFECT IMMUN, V81, P3035, DOI 10.1128/IAI.00653-13; Simpson JC, 2012, NAT CELL BIOL, V14, P764, DOI 10.1038/ncb2510; Smibert CA, 1999, RNA, V5, P1535, DOI 10.1017/S1355838299991392; Tanghetti Emil A, 2013, J Clin Aesthet Dermatol, V6, P27; Tao MF, 2009, CURR BIOL, V19, P1255, DOI 10.1016/j.cub.2009.06.038; Tigno-Aranjuez JT, 2012, BBA-MOL CELL RES, V1823, P2022, DOI 10.1016/j.bbamcr.2012.03.017; Till A, 2008, J CELL SCI, V121, P487, DOI 10.1242/jcs.016980; van Heel DA, 2006, INFLAMM BOWEL DIS, V12, P598, DOI 10.1097/01.ibd.0000225344.21979.89; Van Limbergen J, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.27; Warner N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003305; Watari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068351; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Wendler F, 2010, EMBO J, V29, P304, DOI 10.1038/emboj.2009.350; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; YASUMOTO K, 1992, J BIOL CHEM, V267, P22506; Yeretssian G, 2011, NATURE, V474, P96, DOI 10.1038/nature09982; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233	73	33	35	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28213	28224		10.1074/jbc.M114.574756	http://dx.doi.org/10.1074/jbc.M114.574756			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25170077	Green Published, hybrid			2022-12-28	WOS:000343765400018
J	Garcia-Pardo, J; Grana-Montes, R; Fernandez-Mendez, M; Ruyra, A; Roher, N; Aviles, FX; Lorenzo, J; Ventura, S				Garcia-Pardo, Javier; Grana-Montes, Ricardo; Fernandez-Mendez, Marc; Ruyra, Angels; Roher, Nerea; Aviles, Francesc X.; Lorenzo, Julia; Ventura, Salvador			Amyloid Formation by Human Carboxypeptidase D Transthyretin-like Domain under Physiological Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Carboxypeptidase; Protein Aggregation; Protein Misfolding; Protein Stability; Transthyretin	SENILE SYSTEMIC AMYLOIDOSIS; B-VIRUS-PARTICLES; CRYSTAL-STRUCTURE; FIBRIL FORMATION; GLOBULAR-PROTEINS; AGGREGATION; METALLOCARBOXYPEPTIDASES; INTERMEDIATE; ASSOCIATION; PROPENSITY	Background: Proteins can form amyloid aggregates from initially folded states. Results: The transthyretin-like domain of human carboxypeptidase D forms amyloid aggregates without extensive unfolding. Conclusion: The monomeric transthyretin fold has an inherent propensity to aggregate due to the presence of preformed amyloidogenic structural elements. Significance: Generic aggregation from initially folded states would have a huge impact on cell proteostasis. Protein aggregation is linked to a growing list of diseases, but it is also an intrinsic property of polypeptides, because the formation of functional globular proteins comes at the expense of an inherent aggregation propensity. Certain proteins can access aggregation-prone states from native-like conformations without the need to cross the energy barrier for unfolding. This is the case of transthyretin (TTR), a homotetrameric protein whose dissociation into its monomers initiates the aggregation cascade. Domains with structural homology to TTR exist in a number of proteins, including the M14B subfamily carboxypeptidases. We show here that the monomeric transthyretin-like domain of human carboxypeptidase D aggregates under close to physiological conditions into amyloid structures, with the population of folded but aggregation-prone states being controlled by the conformational stability of the domain. We thus confirm that the TTR fold keeps a generic residual aggregation propensity upon folding, resulting from the presence of preformed amyloidogenic -strands in the native state. These structural elements should serve for functional/structural purposes, because they have not been purged out by evolution, but at the same time they put proteins like carboxypeptidase D at risk of aggregation in biological environments and thus can potentially lead to deposition diseases.	[Garcia-Pardo, Javier; Grana-Montes, Ricardo; Fernandez-Mendez, Marc; Ruyra, Angels; Roher, Nerea; Aviles, Francesc X.; Lorenzo, Julia; Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Garcia-Pardo, Javier; Grana-Montes, Ricardo; Fernandez-Mendez, Marc; Aviles, Francesc X.; Lorenzo, Julia; Ventura, Salvador] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Roher, Nerea] Univ Autonoma Barcelona, Dept Biol Cellular Immunol & Fisiol Anim, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona	Lorenzo, J (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.	julia.lorenzo@uab.es	Garcia-Pardo, Javier/D-8911-2018; Ventura, Salvador/AAY-3170-2021; Lorenzo, Julia/E-9015-2011; Aviles, Francesc Xavier/F-3482-2019; Avilés, Francesc Xavier/A-2664-2015; Garcia-Pardo, Javier/U-3311-2019; Roher, Nerea/F-3216-2016; Garcia-Pardo, Javier/ABB-7574-2021; Ventura, Salvador/C-7021-2008	Garcia-Pardo, Javier/0000-0001-9179-6371; Ventura, Salvador/0000-0002-9652-6351; Lorenzo, Julia/0000-0001-5659-6008; Aviles, Francesc Xavier/0000-0002-1399-6789; Avilés, Francesc Xavier/0000-0002-1399-6789; Roher, Nerea/0000-0002-6659-4038; Garcia-Pardo, Javier/0000-0001-9179-6371; Ventura, Salvador/0000-0002-9652-6351; Grana-Montes, Ricardo/0000-0003-1932-1077	Spanish Ministry of Science and Innovation [BFU2010-14901, BIO2010-22321, AGL2012-33877]; Network of Excellence of the Generalitat de Catalunya; MINECO [FPI BES-2011-044872, FPU AP2009-0948]; Fundacion Ramon Areces; MINECO; ICREA	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Network of Excellence of the Generalitat de Catalunya; MINECO(Spanish Government); Fundacion Ramon Areces; MINECO(Spanish Government); ICREA(ICREA)	This work was supported in part by Spanish Ministry of Science and Innovation Grants BFU2010-14901, BIO2010-22321, and AGL2012-33877 and by the Network of Excellence of the Generalitat de Catalunya.; Recipient of Ph.D. fellowship FPI BES-2011-044872 from MINECO.; Recipient of Fellowship FPU AP2009-0948 from MINECO.; Recipient of a Ph.D. fellowship from Fundacion Ramon Areces.; Recipient of a Ramon y Cajal grant from MINECO.; Recipient of an ICREA academia award.	Aloy P, 2001, J BIOL CHEM, V276, P16177, DOI 10.1074/jbc.M011457200; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Beerten J, 2012, CURR TOP MED CHEM, V12, P2470; Bemporad F, 2008, BBA-PROTEINS PROTEOM, V1784, P1986, DOI 10.1016/j.bbapap.2008.08.021; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Castillo V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058297; Castillo V, 2011, BIOTECHNOL J, V6, P674, DOI 10.1002/biot.201000331; Castillo V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000476; Chatani E, 2012, J BIOL CHEM, V287, P22827, DOI 10.1074/jbc.M111.333310; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; CORNWELL GG, 1988, BIOCHEM BIOPH RES CO, V154, P648, DOI 10.1016/0006-291X(88)90188-X; De Baets G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002090; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; DeLano W.L, PYMOL MOL GRAPHICS S; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Dumoulin M, 2006, ACCOUNTS CHEM RES, V39, P603, DOI 10.1021/ar050070g; Eng FJ, 1998, J BIOL CHEM, V273, P8382, DOI 10.1074/jbc.273.14.8382; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fernandez D, 2010, BIOCHIMIE, V92, P1484, DOI 10.1016/j.biochi.2010.05.002; Ferrao-Gonzales AD, 2003, J MOL BIOL, V328, P963, DOI 10.1016/S0022-2836(03)00368-1; Ferreira P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082484; Foguel D, 2005, PROTEIN PEPTIDE LETT, V12, P245, DOI 10.2174/0929866053587200; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Gomis-Ruth FX, 1999, EMBO J, V18, P5817, DOI 10.1093/emboj/18.21.5817; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Hamilton JA, 2001, CELL MOL LIFE SCI, V58, P1491, DOI 10.1007/PL00000791; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Harata K, 1996, ACTA CRYSTALLOGR D, V52, P1136, DOI 10.1107/S0907444996008438; Hornberg A, 2004, BBA-PROTEINS PROTEOM, V1700, P93, DOI 10.1016/j.bbapap.2004.04.004; Hornberg A, 2000, J MOL BIOL, V302, P649, DOI 10.1006/jmbi.2000.4078; Hou X, 2007, FEBS J, V274, P1637, DOI 10.1111/j.1742-4658.2007.05712.x; Invernizzi G, 2012, INT J BIOCHEM CELL B, V44, P1541, DOI 10.1016/j.biocel.2012.05.023; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Kang YY, 2012, GENE DEV, V26, P1339, DOI 10.1101/gad.187815.112; Keil C, 2007, J MOL BIOL, V366, P504, DOI 10.1016/j.jmb.2006.11.025; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; KUROKI K, 1995, J BIOL CHEM, V270, P15022, DOI 10.1074/jbc.270.25.15022; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Levy ED, 2012, P NATL ACAD SCI USA, V109, P20461, DOI 10.1073/pnas.1209312109; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Nordlund A, 2006, P NATL ACAD SCI USA, V103, P10218, DOI 10.1073/pnas.0601696103; Olofsson A, 2004, J BIOL CHEM, V279, P5699, DOI 10.1074/jbc.M310605200; Orville AM, 1997, BIOCHEMISTRY-US, V36, P10039, DOI 10.1021/bi970468n; Pallares I, 2004, J MOL BIOL, V342, P321, DOI 10.1016/j.jmb.2004.06.089; Pechmann S, 2009, P NATL ACAD SCI USA, V106, P10159, DOI 10.1073/pnas.0812414106; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Ramirez-Alvarado M, 2003, PROTEIN SCI, V12, P567, DOI 10.1110/ps.0227403; Reverter D, 2004, J MOL BIOL, V338, P257, DOI 10.1016/j.jmb.2004.02.058; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Sabate R, 2012, BIOCHIMIE, V94, P1730, DOI 10.1016/j.biochi.2012.03.027; Sabate R, 2012, BIOMACROMOLECULES, V13, P1916, DOI 10.1021/bm3004385; Sabate R, 2012, BIOMACROMOLECULES, V13, P474, DOI 10.1021/bm201527m; SARAIVA MJM, 1983, T ASSOC AM PHYSICIAN, V96, P261; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Sidyelyeva G, 2006, J BIOL CHEM, V281, P13844, DOI 10.1074/jbc.M513499200; Soldi G, 2005, BIOPHYS J, V89, P4234, DOI 10.1529/biophysj.105.067538; Sorimachi K, 1997, STRUCTURE, V5, P647, DOI 10.1016/S0969-2126(97)00220-7; Tanco S, 2010, J MOL BIOL, V401, P465, DOI 10.1016/j.jmb.2010.06.035; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhuravlev PI, 2014, J MOL BIOL, V426, P2653, DOI 10.1016/j.jmb.2014.05.007	67	18	18	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33783	33796		10.1074/jbc.M114.594804	http://dx.doi.org/10.1074/jbc.M114.594804			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25294878	Green Published, hybrid			2022-12-28	WOS:000346077600006
J	Sinha, A; Kohrer, C; Weber, MHW; Masuda, I; Mootha, VK; Hou, YM; RajBhandary, UL				Sinha, Akesh; Koehrer, Caroline; Weber, Michael H. W.; Masuda, Isao; Mootha, Vamsi K.; Hou, Ya-Ming; RajBhandary, Uttam L.			Biochemical Characterization of Pathogenic Mutations in Human Mitochondrial Methionyl-tRNA Formyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATOR TRANSFER-RNA; FORMYLMETHIONINE TRANSFER-RNA; ACID INSERTION MODULE; COMPLEX I DEFICIENCY; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; MAMMALIAN MITOCHONDRIA; SUPPRESSOR MUTATIONS; CRYSTAL-STRUCTURE; MESSENGER-RNA	N-Formylation of initiator methionyl-tRNA (Met-tRNA(Met)) by methionyl-tRNA formyltransferase (MTF) is important for translation initiation in bacteria, mitochondria, and chloroplasts. Unlike all other translation systems, the metazoan mitochondrial system is unique in using a single methionine tRNA (tRNA(Met)) for both initiation and elongation. A portion of Met-tRNA(Met) is formylated for initiation, whereas the remainder is used for elongation. Recently, we showed that compound heterozygous mutations within the nuclear gene encoding human mitochondrial MTF (mt-MTF) significantly reduced mitochondrial translation efficiency, leading to combined oxidative phosphorylation deficiency and Leigh syndrome in two unrelated patients. Patient P1 has a stop codon mutation in one of the MTF genes and an S209L mutation in the other MTF gene. P2 has a S125L mutation in one of the MTF genes and the same S209L mutation as P1 in the other MTF gene. Here, we have investigated the effect of mutations at Ser-125 and Ser-209 on activities of human mt-MTF and of the corresponding mutations, Ala-89 or Ala-172, respectively, on activities of Escherichia coli MTF. The S125L mutant has 653-fold lower activity, whereas the S209L mutant has 36-fold lower activity. Thus, both patients depend upon residual activity of the S209L mutant to support low levels of mitochondrial protein synthesis. We discuss the implications of these and other results for whether the effect of the S209L mutation on mitochondrial translational efficiency is due to reduced activity of the mutant mt-MTF and/or reduced levels of the mutant mt-MTF.	[Sinha, Akesh; Koehrer, Caroline; Weber, Michael H. W.; RajBhandary, Uttam L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Masuda, Isao; Hou, Ya-Ming] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Mootha, Vamsi K.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Jefferson University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	RajBhandary, UL (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave,Rm 68-671, Cambridge, MA 02139 USA.	bhandary@mit.edu	Masuda, Isao/X-8797-2019	Masuda, Isao/0000-0001-9385-4424; Hou, Ya-Ming/0000-0001-6546-2597	National Institutes of Health [GM17151, 5RNIAG042169, GM097136]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097136, R37GM017151, R01GM108972, R01GM017151, F32GM017151, R56GM017151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM17151 (to U. L. R.), 5RNIAG042169 (to Y. M. H.), and GM097136 (to V. K. M.).	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; ATTARDI G, 1985, INT REV CYTOL, V93, P93, DOI 10.1016/S0074-7696(08)61373-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; CANONACO MA, 1986, FEBS LETT, V207, P198, DOI 10.1016/0014-5793(86)81488-0; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Gite S, 2000, BIOCHEMISTRY-US, V39, P2218, DOI 10.1021/bi9926072; GOLD L, 1988, ANNU REV BIOCHEM, V57, P199, DOI 10.1146/annurev.bi.57.070188.001215; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; GUILLON JM, 1992, J BACTERIOL, V174, P4294, DOI 10.1128/JB.174.13.4294-4301.1992; Haack TB, 2014, MOL GENET METAB, V111, P342, DOI 10.1016/j.ymgme.2013.12.010; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; Hanahan D., 1985, DNA CLONING PRACTICA, P109; Hou Ya-Ming, 2012, Methods Mol Biol, V941, P195, DOI 10.1007/978-1-62703-113-4_15; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003; KAHN D, 1980, EUR J BIOCHEM, V105, P489, DOI 10.1111/j.1432-1033.1980.tb04524.x; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; KOZAK M, 1983, MICROBIOL REV, V47, P1; Lalonde E, 2011, GENOME RES, V21, P545, DOI 10.1101/gr.111211.110; Li Y, 2000, BIOCHEMISTRY-US, V39, P8039, DOI 10.1021/bi000625+; Lightowlers RN, 2014, FEBS LETT, V588, P2496, DOI 10.1016/j.febslet.2014.05.054; MANDAL N, 1992, J BACTERIOL, V174, P7827, DOI 10.1128/JB.174.23.7827-7830.1992; MANGROO D, 1995, J BIOL CHEM, V270, P12203, DOI 10.1074/jbc.270.20.12203; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; MORIYA J, 1994, BIOCHEMISTRY-US, V33, P2234, DOI 10.1021/bi00174a033; Neeve VCM, 2013, MITOCHONDRION, V13, P743, DOI 10.1016/j.mito.2013.03.002; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Nilsson AI, 2006, P NATL ACAD SCI USA, V103, P6976, DOI 10.1073/pnas.0602171103; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; RAJBHANDARY UL, 1994, J BACTERIOL, V176, P547, DOI 10.1128/jb.176.3.547-552.1994; Ramesh V, 1997, P NATL ACAD SCI USA, V94, P13524, DOI 10.1073/pnas.94.25.13524; Ramesh V, 1998, BIOCHEMISTRY-US, V37, P15925, DOI 10.1021/bi981873x; Sambrook J., 2002, MOL CLONING LAB MANU; Schmitt E, 1998, EMBO J, V17, P6819, DOI 10.1093/emboj/17.23.6819; Schmitt E, 1996, EMBO J, V15, P4749, DOI 10.1002/j.1460-2075.1996.tb00852.x; SCHOFIEL.P, 1968, BIOCHIM BIOPHYS ACTA, V155, P410, DOI 10.1016/0005-2787(68)90185-8; SCHULMAN LH, 1985, BIOCHEMISTRY-US, V24, P7309, DOI 10.1021/bi00346a043; SEONG BL, 1987, P NATL ACAD SCI USA, V84, P8859, DOI 10.1073/pnas.84.24.8859; SEONG BL, 1987, P NATL ACAD SCI USA, V84, P334, DOI 10.1073/pnas.84.2.334; Spencer AC, 2004, NUCLEIC ACIDS RES, V32, P5464, DOI 10.1093/nar/gkh886; Spencer AC, 2004, BIOCHEMISTRY-US, V43, P9743, DOI 10.1021/bi049639w; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SUNDARI RM, 1976, J BIOL CHEM, V251, P3338; Takeuchi N, 2001, J BIOL CHEM, V276, P20064, DOI 10.1074/jbc.M101007200; Takeuchi N, 1998, J BIOL CHEM, V273, P15085, DOI 10.1074/jbc.273.24.15085; Thain A, 1996, TRENDS GENET, V12, P209, DOI 10.1016/S0168-9525(96)90022-0; Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010; VARSHNEY U, 1991, J BIOL CHEM, V266, P18018; VARSHNEY U, 1990, P NATL ACAD SCI USA, V87, P1586, DOI 10.1073/pnas.87.4.1586; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Woriax VL, 1996, BBA-GENE STRUCT EXPR, V1307, P66, DOI 10.1016/0167-4781(95)00240-5; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	55	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.610626	http://dx.doi.org/10.1074/jbc.M114.610626			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25288793	Green Published, hybrid			2022-12-28	WOS:000345335000029
J	Schweiger, S; Dorn, S; Fuchs, M; Kohler, A; Matthes, F; Muller, EC; Wanker, E; Schneider, R; Krauss, S				Schweiger, Susann; Dorn, Stephanie; Fuchs, Melanie; Koehler, Andrea; Matthes, Frank; Mueller, Eva-Christina; Wanker, Erich; Schneider, Rainer; Krauss, Sybille			The E3 Ubiquitin Ligase MID1 Catalyzes Ubiquitination and Cleavage of Fu	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Proteasome; Protein Phosphatase 2 (PP2A); Signal transduction; Ubiquitination; Fu; GLI3; MID1; Proteasomal Cleavage	HEDGEHOG SIGNAL-TRANSDUCTION; POLYUBIQUITIN CHAINS; QUANTITATIVE-ANALYSIS; MASS-SPECTROMETRY; PHOSPHATASE 2A; FUSED PROTEIN; GLI; KINASE; CANCER; PHOSPHORYLATION	Background: SHH signaling is an important growth-stimulating factor in diverse cancers. Results: MID1 catalyzes ubiquitination and proteasomal cleavage of Fu. Conclusion: The MID1-PP2A complex regulates the activity of the SHH effector GLI3 in cancer cell lines by regulating proteasomal cleavage of Fu. Significance: Understanding the molecular mechanisms underlying tumorigenesis is crucial for developing therapeutic approaches to treat cancers. SHH (Sonic Hedgehog)-GLI signaling plays an important role during embryogenesis and in tumorigenesis. The survival and growth of several types of cancer depend on autonomously activated SHH-GLI signaling. A protein complex containing the ubiquitin ligase MID1 and protein phosphatase 2A regulates the nuclear localization and transcriptional activity of GLI3, a transcriptional effector molecule of SHH, in cancer cell lines with autonomously activated SHH signaling. However, the exact molecular mechanisms that mediate the interaction between MID1 and GLI3 remained unknown. Here, we show that MID1 catalyzes the ubiquitination and proteasomal cleavage of the GLI3 regulator Fu. Our data suggest that Fu ubiquitination and cleavage is one of the key elements connecting the MID1-PP2A protein complex with GLI3 activity control.	[Schweiger, Susann] Johannes Gutenberg Univ Mainz, Inst Human Genet, Sch Med, D-55122 Mainz, Germany; [Dorn, Stephanie; Matthes, Frank; Krauss, Sybille] German Ctr Neurodegenerat Dis, D-53127 Bonn, Germany; [Fuchs, Melanie] Charite, Dept Dermatol, D-10117 Berlin, Germany; [Koehler, Andrea; Schneider, Rainer] Inst Biochem, A-6020 Innsbruck, Austria; [Koehler, Andrea; Schneider, Rainer] Ctr Mol Biosci Innsbruck, A-6020 Innsbruck, Austria; [Mueller, Eva-Christina; Wanker, Erich] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Johannes Gutenberg University of Mainz; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Innsbruck; University of Innsbruck; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Krauss, S (corresponding author), Univ Bonn BMZ1, German Ctr Neurodegenerat Dis, Sigmund Freud Str 25, D-53127 Bonn, Germany.	sybille.krauss@dzne.de	Krauss, Sybille/L-5328-2016	Wanker, Erich/0000-0001-8072-1630; Matthes, Frank/0000-0002-5115-8831; Krauss, Sybille/0000-0002-5653-9289				Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Carpenter D, 1998, P NATL ACAD SCI USA, V95, P13630, DOI 10.1073/pnas.95.23.13630; Chen MH, 2005, MOL CELL BIOL, V25, P7042, DOI 10.1128/MCB.25.16.7042-7053.2005; Daoud F, 2005, DEV GENES EVOL, V215, P230, DOI 10.1007/s00427-005-0469-x; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Han XF, 2011, J MOL BIOL, V407, P505, DOI 10.1016/j.jmb.2011.01.048; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jacob J, 2003, EMBO REP, V4, P761, DOI 10.1038/sj.embor.embor896; Kim YS, 2007, FEBS LETT, V581, P858, DOI 10.1016/j.febslet.2007.01.058; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kise Y, 2006, BIOCHEM BIOPH RES CO, V351, P78, DOI 10.1016/j.bbrc.2006.10.036; Krauss S, 2008, CANCER RES, V68, P4658, DOI 10.1158/0008-5472.CAN-07-6174; Krauss S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007471; Kravtsova-Ivantsiv Y, 2013, ANGEW CHEM INT EDIT, V52, P192, DOI 10.1002/anie.201205656; Li W, 2008, CELL MOL LIFE SCI, V65, P2397, DOI 10.1007/s00018-008-8090-6; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Maloveryan A, 2007, J CELL COMMUN SIGNAL, V1, P165, DOI 10.1007/s12079-007-0014-y; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Merchant M, 2005, MOL CELL BIOL, V25, P7054, DOI 10.1128/MCB.25.16.7054-7068.2005; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Murone M, 2000, NAT CELL BIOL, V2, P310, DOI 10.1038/35010610; Murone M, 1999, EXP CELL RES, V253, P25, DOI 10.1006/excr.1999.4676; Napolitano LM, 2011, BIOCHEM J, V434, P309, DOI 10.1042/BJ20101487; Nybakken K, 2002, CURR OPIN GENET DEV, V12, P503, DOI 10.1016/S0959-437X(02)00333-7; Nybakken KE, 2002, J BIOL CHEM, V277, P24638, DOI 10.1074/jbc.M110730200; Osterlund T, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-49; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041	40	18	18	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31805	31817		10.1074/jbc.M113.541219	http://dx.doi.org/10.1074/jbc.M113.541219			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25278022	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000345314700012
J	Smardon, AM; Kane, PM				Smardon, Anne M.; Kane, Patricia M.			Loss of Vacuolar H+-ATPase Activity in Organelles Signals Ubiquitination and Endocytosis of the Yeast Plasma Membrane Proton pump Pma1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arrestin; Endocytosis; pH Regulation; Plasma Membrane Proton Pumps; Ubiquitination; Vacuolar Acidification; Vacuolar ATPase; Yeast	FLUID-PHASE ENDOCYTOSIS; SACCHAROMYCES-CEREVISIAE; AMBIENT PH; CELL-SURFACE; PROTEIN; RECEPTOR; FUNGI; TRAFFICKING; TRANSPORTER; STRESS	Yeast mutants lacking the intracellular V-ATPase proton pump (vma mutants) have reduced levels of the Pma1p proton pump at the plasma membrane and increased levels in organelles including the vacuolar lumen. We examined the mechanism and physiological consequences of Pma1p mislocalization. Pma1p is ubiquitinated in vma mutants, and ubiquitination depends on the ubiquitin ligase Rsp5p and the arrestin-related adaptor protein Rim8p. vma mutant strains containing rsp5 or rim8 mutations maintain Pma1p at the plasma membrane, suggesting that ubiquitination is required for Pma1p internalization. Acute inhibition of V-ATPase activity with concanamycin A triggers Pma1p ubiquitination and internalization. In an endocytosis-deficient mutant (end4) Pma1p is ubiquitinated but retained at the plasma membrane during concanamycin A treatment. Consistent with specificity in signaling loss of V-ATPase activity to Pma1p, another plasma membrane transporter, Mup1p, is not internalized in a vma mutant, and loss of the Mup1p adaptor Art1p does not prevent Pma1p internalization in a vma mutant. Very poor growth of vma2 rsp5-1 and vma2 rim8 double mutants suggests that Pma1p internalization benefits the vma mutants. We hypothesize that loss of V-ATPase-mediated organelle acidification signals ubiquitination, internalization, and degradation of a portion of Pma1p as a means of balancing overall pH homeostasis.	[Smardon, Anne M.; Kane, Patricia M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Kane, PM (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	kanepm@upstate.edu			National Institutes of Health [R01 GM50322]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM50322 (to P. M. K.).	Alvaro CG, 2014, MOL CELL BIOL, V34, P2660, DOI 10.1128/MCB.00230-14; Ambesi A, 2000, J EXP BIOL, V203, P155; Becuwe M, 2012, J CELL BIOL, V196, P247, DOI 10.1083/jcb.201109113; BERKOWER C, 1994, MOL BIOL CELL, V5, P1185, DOI 10.1091/mbc.5.11.1185; Breker M, 2013, J CELL BIOL, V200, P839, DOI 10.1083/jcb.201301120; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CHANG A, 1991, J CELL BIOL, V115, P289, DOI 10.1083/jcb.115.2.289; Diakov TT, 2013, JOVE-J VIS EXP, DOI 10.3791/50261; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gomez-Raja J, 2012, EUKARYOT CELL, V11, P683, DOI 10.1128/EC.05211-11; Gong XH, 2001, P NATL ACAD SCI USA, V98, P9104, DOI 10.1073/pnas.161282998; Hatakeyama R, 2010, MOL CELL BIOL, V30, P5598, DOI 10.1128/MCB.00464-10; Herrador A, 2013, J BIOL CHEM, V288, P16206, DOI 10.1074/jbc.C113.452250; Herrador A, 2010, MOL CELL BIOL, V30, P897, DOI 10.1128/MCB.00132-09; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; Huang CJ, 2011, J BIOL CHEM, V286, P10058, DOI 10.1074/jbc.M110.197889; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Li SC, 2012, EUKARYOT CELL, V11, P282, DOI 10.1128/EC.05198-11; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Liu Y, 2006, J BIOL CHEM, V281, P31457, DOI 10.1074/jbc.M606643200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Maeda T, 2012, FEBS J, V279, P1407, DOI 10.1111/j.1742-4658.2012.08548.x; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Mason AB, 2014, EUKARYOT CELL, V13, P43, DOI 10.1128/EC.00201-13; Milgrom E, 2007, J BIOL CHEM, V282, P7125, DOI 10.1074/jbc.M608293200; MUNN AL, 1994, J CELL BIOL, V127, P373, DOI 10.1083/jcb.127.2.373; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636; PAINTING K, 1990, WORLD J MICROB BIOT, V6, P346, DOI 10.1007/BF01201311; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Penalva MA, 2002, MICROBIOL MOL BIOL R, V66, P426, DOI 10.1128/MMBR.66.3.426-446.2002; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Pizzirusso M, 2004, MOL BIOL CELL, V15, P2401, DOI 10.1091/mbc.E03-10-0727; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Simonin A, 2010, J BIOL CHEM, V285, P38293, DOI 10.1074/jbc.M110.115089; Smardon AM, 2014, MOL BIOL CELL, V25, P356, DOI 10.1091/mbc.E13-05-0231; Tarsio M, 2011, J BIOL CHEM, V286, P28089, DOI 10.1074/jbc.M111.251363; Teis D, 2010, EMBO J, V29, P871, DOI 10.1038/emboj.2009.408; Xu WJ, 2004, MOL BIOL CELL, V15, P5528, DOI 10.1091/mbc.E04-08-0666; Zhao YY, 2013, ELIFE, V2, DOI 10.7554/eLife.00459	51	27	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32316	32326		10.1074/jbc.M114.574442	http://dx.doi.org/10.1074/jbc.M114.574442			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25271159	Green Published, hybrid			2022-12-28	WOS:000345314700056
J	Buchinger, E; Knudsen, DH; Behrens, MA; Pedersen, JS; Aarstad, OA; Tondervik, A; Valla, S; Skjak-Braek, G; Wimmer, R; Aachmann, FL				Buchinger, Edith; Knudsen, Daniel H.; Behrens, Manja A.; Pedersen, Jan Skov; Aarstad, Olav A.; Tondervik, Anne; Valla, Svein; Skjak-Braek, Gudmund; Wimmer, Reinhard; Aachmann, Finn L.			Structural and Functional Characterization of the R-modules in Alginate C-5 Epimerases AlgE4 and AlgE6 from Azotobacter vinelandii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNURONAN C-5-EPIMERASE ALGE4; NMR STRUCTURE; I SECRETION; PROTEIN; SCATTERING; PREDICTION; PROGRAM; EPIMERIZATION; DISTRIBUTIONS; EXPRESSION	The bacterium Azotobacter vinelandii produces a family of seven secreted and calcium-dependent mannuronan C-5 epimerases (AlgE1-7). These epimerases are responsible for the epimerization of beta-D-mannuronic acid (M) to alpha-L-guluronic acid (G) in alginate polymers. The epimerases display a modular structure composed of one or two catalytic A-modules and from one to seven R-modules having an activating effect on the A-module. In this study, we have determined the NMR structure of the three individual R-modules from AlgE6 (AR1R2R3) and the overall structure of both AlgE4 (AR) and AlgE6 using small angle x-ray scattering. Furthermore, the alginate binding ability of the R-modules of AlgE4 and AlgE6 has been studied with NMR and isothermal titration calorimetry. The AlgE6 R-modules fold into an elongated parallel beta-roll with a shallow, positively charged groove across the module. Small angle x-ray scattering analyses of AlgE4 and AlgE6 show an overall elongated shape with some degree of flexibility between the modules for both enzymes. Titration of the R-modules with defined alginate oligomers shows strong interaction between AlgE4R and both oligo-M and MG, whereas no interaction was detected between these oligomers and the individual R-modules from AlgE6. A combination of all three R- modules from AlgE6 shows weak interaction with long M-oligomers. Exchanging the R-modules between AlgE4 and AlgE6 resulted in a novel epimerase called AlgE64 with increased G-block forming ability compared with AlgE6.	[Buchinger, Edith; Knudsen, Daniel H.; Wimmer, Reinhard] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, DK-9220 Aalborg, Denmark; [Buchinger, Edith; Aarstad, Olav A.; Skjak-Braek, Gudmund; Aachmann, Finn L.] Norwegian Univ Sci & Technol, Dept Biotechnol, Norwegian Biopolymer Lab NOBIPOL, N-7491 Trondheim, Norway; [Behrens, Manja A.; Pedersen, Jan Skov; Valla, Svein] Aarhus Univ, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus, Denmark; [Behrens, Manja A.; Pedersen, Jan Skov; Valla, Svein] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark; [Tondervik, Anne] Dept Bioproc Technol SINTEF Mat & Chem, N-7465 Trondheim, Norway	Aalborg University; Norwegian University of Science & Technology (NTNU); Aarhus University; Aarhus University; SINTEF	Aachmann, FL (corresponding author), Norwegian Univ Sci & Technol, Dept Biotechnol, Sem Saelands Vei 6-8, N-7491 Trondheim, Norway.	finn.l.aachmann@ntnu.no	Wimmer, Reinhard/A-7901-2012; Wimmer, Reinhard/M-2346-2019; Pedersen, Jan Skov/A-8346-2008; Aachmann, Finn/G-4136-2015	Wimmer, Reinhard/0000-0001-6942-5056; Pedersen, Jan Skov/0000-0002-7768-0206; Aachmann, Finn/0000-0003-1613-4663; Aarstad, Olav/0000-0003-3671-9060	Obel foundation; SparNord foundation	Obel foundation; SparNord foundation	The 800 MHz spectra were obtained using the Bruker Avance spectrometer of the Danish Instrument Center for NMR Spectroscopy of Biological Macromolecules. We grateful to Marianne O. Dalheim for allowing us to use some of the data on ORF-9, The NAIR laboratory at Aalborg University is supported by the Obel and SparNord foundations.	Aachmann FL, 2008, BIOMOL NMR ASSIGN, V2, P123, DOI 10.1007/s12104-008-9101-0; Aachmann FL, 2006, J BIOL CHEM, V281, P7350, DOI 10.1074/jbc.M510069200; Aachmann FL, 2005, J BIOMOL NMR, V31, P259, DOI 10.1007/s10858-004-7911-7; Aarstad O, 2013, BIOMACROMOLECULES, V14, P3409, DOI 10.1021/bm400658k; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Andreassen T, 2011, BIOMOL NMR ASSIGN, V5, P147, DOI 10.1007/s12104-010-9288-8; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bakke I, 2009, APPL ENVIRON MICROB, V75, P2002, DOI 10.1128/AEM.02315-08; Ballance S, 2005, J CHROMATOGR A, V1093, P59, DOI 10.1016/j.chroma.2005.07.051; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BAUMANN U, 1994, J MOL BIOL, V242, P244, DOI 10.1006/jmbi.1994.1576; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Buchinger E, 2011, BIOMOL NMR ASSIGN, V5, P27, DOI 10.1007/s12104-010-9259-0; Buchinger E, 2010, PROTEIN SCI, V19, P1534, DOI 10.1002/pro.432; Campa C, 2004, BIOCHEM J, V381, P155, DOI 10.1042/BJ20031265; Campa C, 2004, J CHROMATOGR A, V1026, P271, DOI 10.1016/j.chroma.2003.11.045; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dalheim M. O., 2010, THESIS; DEBYE P, 1947, J PHYS COLLOID CHEM, V51, P18, DOI 10.1021/j150451a002; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Donati I, 2005, BIOMACROMOLECULES, V6, P1031, DOI 10.1021/bm049306e; ERTESVAG H, 1995, MOL MICROBIOL, V16, P719, DOI 10.1111/j.1365-2958.1995.tb02433.x; Ertesvag H, 1999, J BACTERIOL, V181, P3033; Ertesvag H, 1999, METH BIOTEC, V10, P71; FISCHER FG, 1955, H-S Z PHYSIOL CHEM, V302, P186, DOI 10.1515/bchm2.1955.302.1-2.186; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gimmestad M, 2003, J BACTERIOL, V185, P3515, DOI 10.1128/JB.185.12.3515-3523.2003; Gimmestad M, 2006, J BACTERIOL, V188, P5551, DOI 10.1128/JB.00236-06; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HANAHAN D, 1983, METHOD ENZYMOL, V100, P333; Hartmann M, 2002, BIOPOLYMERS, V63, P77, DOI 10.1002/bip.10017.abs; HAUG A, 1967, ACTA CHEM SCAND, V21, P768, DOI 10.3891/acta.chem.scand.21-0768; Hirst E. L., 1939, J CHEM SOC, V1880, P1939; Hoidal HK, 1999, J BIOL CHEM, V274, P12316, DOI 10.1074/jbc.274.18.12316; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Keller R., 2004, THESIS; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; PEDERSEN JS, 1994, EUR BIOPHYS J BIOPHY, V22, P379, DOI 10.1007/BF00180159; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; PINDAR DF, 1975, BIOCHEM J, V152, P617, DOI 10.1042/bj1520617; Rozeboom HJ, 2008, J BIOL CHEM, V283, P23819, DOI 10.1074/jbc.M804119200; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sletmoen M, 2005, CARBOHYD RES, V340, P2782, DOI 10.1016/j.carres.2005.09.020; SMIDSROD O, 1972, ACTA CHEM SCAND, V26, P2063, DOI 10.3891/acta.chem.scand.26-2063; SMIDSROD O, 1973, CARBOHYD RES, V27, P107, DOI 10.1016/S0008-6215(00)82430-1; Svanem BIG, 2001, J BIOL CHEM, V276, P31542, DOI 10.1074/jbc.M102562200; Svanem BIG, 1999, J BACTERIOL, V181, P68, DOI 10.1128/JB.181.1.68-77.1999; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tondervik A, 2013, BIOMACROMOLECULES, V14, P2657, DOI 10.1021/bm4005194; Tondervik A, 2010, J BIOL CHEM, V285, P35284, DOI 10.1074/jbc.M110.162800; Wilkins MR, 1999, METH MOL B, V112, P531	60	19	19	2	28	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31382	31396		10.1074/jbc.M114.567008	http://dx.doi.org/10.1074/jbc.M114.567008			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25266718	hybrid, Green Published			2022-12-28	WOS:000344549900042
J	Libiad, M; Yadav, PK; Vitvitsky, V; Martinov, M; Banerjee, R				Libiad, Marouane; Yadav, Pramod Kumar; Vitvitsky, Victor; Martinov, Michael; Banerjee, Ruma			Organization of the Human Mitochondrial Hydrogen Sulfide Oxidation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOSULFATE; METABOLISM; RAT; CYSTEINE; DIOXYGENASE; TOXICITY; LIVER; H2S; OXIDOREDUCTASE; MECHANISM	Sulfide oxidation is expected to play an important role in cellular switching between low steady-state intracellular hydrogen sulfide levels and the higher concentrations where the physiological effects are elicited. Yet despite its significance, fundamental questions regarding how the sulfide oxidation pathway is wired remain unanswered, and competing proposals exist that diverge at the very first step catalyzed by sulfide quinone oxidoreductase (SQR). We demonstrate that, in addition to sulfite, glutathione functions as a persulfide acceptor for human SQR and that rhodanese preferentially synthesizes rather than utilizes thiosulfate. The kinetic behavior of these enzymes provides compelling evidence for the flow of sulfide via SQR to glutathione persulfide, which is then partitioned to thiosulfate or sulfite. Kinetic simulations at physiologically relevant metabolite concentrations provide additional support for the organizational logic of the sulfide oxidation pathway in which glutathione persulfide is the first intermediate formed.	[Libiad, Marouane; Yadav, Pramod Kumar; Vitvitsky, Victor; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA; [Martinov, Michael] Natl Res Ctr Hematol, Moscow 125167, Russia	University of Michigan System; University of Michigan; Russian Academy of Medical Sciences; National Medical Research Center for Hematology	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Yadav, Pramod K./A-6166-2010; Vitvitsky, Victor/ABA-2967-2021; Martinov, Michael V./M-5643-2014	Yadav, Pramod K./0000-0003-0026-1684; Vitvitsky, Victor/0000-0001-6251-6115; Martinov, Michael V./0000-0003-4578-9490; Libiad, Marouane/0000-0003-1717-9206	National Institutes of Health [HL58984, GM112455]; American Heart Association Postdoctoral Fellowship [14POST18760003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL58984 and GM112455 (to R.B.). This work was also supported by American Heart Association Postdoctoral Fellowship 14POST18760003 (to P.K.Y.).	BARTHOLOMEW TC, 1980, BIOCHEM PHARMACOL, V29, P2431, DOI 10.1016/0006-2952(80)90346-9; BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; BEYER RE, 1985, MECH AGEING DEV, V32, P267, DOI 10.1016/0047-6374(85)90085-5; Bouillaud F, 2011, ANTIOXID REDOX SIGN, V15, P379, DOI 10.1089/ars.2010.3678; Brito JA, 2009, BIOCHEMISTRY-US, V48, P5613, DOI 10.1021/bi9003827; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; CURTIS CG, 1972, BIOCHEM PHARMACOL, V21, P2313, DOI 10.1016/0006-2952(72)90382-6; Furne J, 2001, BIOCHEM PHARMACOL, V62, P255, DOI 10.1016/S0006-2952(01)00657-8; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; GRIFFITH OW, 1983, J BIOL CHEM, V258, P1591; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Huang J, 1998, CHEM-BIOL INTERACT, V110, P189, DOI 10.1016/S0009-2797(98)00015-5; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Jackson MR, 2012, BIOCHEMISTRY-US, V51, P6804, DOI 10.1021/bi300778t; JI AJ, 1995, CLIN CHEM, V41, P897; Kabil O, 2014, BBA-PROTEINS PROTEOM, V1844, P1355, DOI 10.1016/j.bbapap.2014.01.002; Kabil O, 2014, ANTIOXID REDOX SIGN, V20, P770, DOI 10.1089/ars.2013.5339; Kabil O, 2012, J BIOL CHEM, V287, P44561, DOI 10.1074/jbc.M112.407411; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; KAJI A, 1959, J BACTERIOL, V77, P630, DOI 10.1128/JB.77.5.630-637.1959; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Kwon DY, 2013, PLANTA MED, V79, P997, DOI 10.1055/s-0032-1328704; Melideo SL, 2014, BIOCHEMISTRY-US, V53, P4739, DOI 10.1021/bi500650h; Olson KR, 2010, ANTIOXID REDOX SIGN, V12, P1219, DOI 10.1089/ars.2009.2921; Roman HB, 2013, ANTIOXID REDOX SIGN, V19, P1321, DOI 10.1089/ars.2012.5010; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Stipanuk MH, 2004, AM J PHYSIOL-ENDOC M, V286, pE439, DOI 10.1152/ajpendo.00336.2003; Sugiyama A, 2012, J FOOD SCI, V77, pH268, DOI 10.1111/j.1750-3841.2012.02997.x; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; TOGAWA T, 1992, CHEM PHARM BULL, V40, P3000, DOI 10.1248/cpb.40.3000; UHTEG LC, 1979, ARCH BIOCHEM BIOPHYS, V195, P211, DOI 10.1016/0003-9861(79)90343-6; Vitvitsky V, 2004, AM J PHYSIOL-REG I, V287, pR39, DOI 10.1152/ajpregu.00036.2004; Vitvitsky V, 2013, MECH AGEING DEV, V134, P321, DOI 10.1016/j.mad.2013.05.004	33	152	157	2	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					30901	30910		10.1074/jbc.M114.602664	http://dx.doi.org/10.1074/jbc.M114.602664			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25225291	hybrid, Green Published			2022-12-28	WOS:000344549900003
J	Manoharan, P; Basford, JE; Pilcher-Roberts, R; Neumann, J; Hui, DY; Lingrel, JB				Manoharan, Palanikumar; Basford, Joshua E.; Pilcher-Roberts, Robyn; Neumann, Jonathan; Hui, David Y.; Lingrel, Jerry B.			Reduced Levels of microRNAs miR-124a and miR-150 Are Associated with Increased Proinflammatory Mediator Expression in Kruppel-like Factor 2 (KLF2)-deficient Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOE-DEFICIENT MICE; TRANSCRIPTION FACTOR; RHEUMATOID-ARTHRITIS; CELL MIGRATION; KEY REGULATOR; ATHEROSCLEROSIS; ACTIVATION; PROLIFERATION; SYNOVIOCYTES; INFLAMMATION	Previous studies have shown that the myeloid-specific deficiency of the transcription factor Kruppel-like factor 2 (KLF2) accelerates atherosclerosis in hypercholesterolemic Ldlr(-/-) mice due to the enhanced adhesion of myeloid cells to activated endothelial cells in the vessel wall. This study revealed elevated basal inflammation with elevated plasma levels of Ccl2, Ccl4, Ccl5, and Ccl11 in the myeloid-specific KLF2 knock-out (myeKlf2(-/-)) mice. Peritoneal macrophages isolated from myeKlf2(-/-) mice showed increased mRNA levels of several inflammatory mediators, including Ccl2, Ccl5, Ccl7, Cox-2, Cxcl1, and IL-6. In contrast, the levels of two microRNAs, miR-124a and miR-150, were lower in Klf2(-/-) macrophages compared with Klf2(+/+) macrophages. Additional studies showed a direct inverse relationship between miR-124a levels with Ccl2 expression, with anti-miR-124a increasing Ccl2 mRNA levels in Klf2(+/+) macrophages, whereas the restoration of miR-124a levels in Klf2(-/-) macrophages significantly reduced Ccl2 mRNA expression. Likewise, the inverse relationship was observed between miR-150 levels and Cxcl1 expression in Klf2(+/+) and Klf2(-/-) mice. Moreover, miR150 likely regulates the miR124a expression and thus augments expression of inflammatory mediators in myeKlf2(-/-) macrophages. This study documented that the transcription factor KLF2 modulates inflammatory chemokine production via regulation of microRNA expression levels in immune cells.	[Manoharan, Palanikumar; Pilcher-Roberts, Robyn; Neumann, Jonathan; Lingrel, Jerry B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Basford, Joshua E.; Hui, David Y.] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Lingrel, JB (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way,POB 670524, Cincinnati, OH 45267 USA.	lingrejb@ucmail.uc.edu			National Institutes of Health [HL78806, DK74932]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077, UL1TR001425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL78806 (to J. B L.) and DK74932 (to D. Y. H.).	Allen KL, 2011, BLOOD, V117, P6383, DOI 10.1182/blood-2010-10-313072; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Kawano S, 2011, ANN RHEUM DIS, V70, pI88, DOI 10.1136/ard.2010.138669; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Lai LH, 2013, J BIOL CHEM, V288, P7956, DOI 10.1074/jbc.M112.445429; Lindenblatt C, 2009, CELL CYCLE, V8, P2019, DOI 10.4161/cc.8.13.8816; Lingrel JB, 2012, CIRC RES, V110, P1294, DOI 10.1161/CIRCRESAHA.112.267310; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; MOSER B, 1990, J EXP MED, V171, P1797, DOI 10.1084/jem.171.5.1797; Nakamachi Y, 2009, ARTHRITIS RHEUM-US, V60, P1294, DOI 10.1002/art.24475; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nayak L, 2013, AM J PATHOL, V182, P1696, DOI 10.1016/j.ajpath.2013.01.029; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; O'Connell RM, 2011, BLOOD, V118, P2960, DOI 10.1182/blood-2011-03-291971; Rhodes CJ, 2013, AM J RESP CRIT CARE, V187, P294, DOI 10.1164/rccm.201205-0839OC; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Tamminen M, 1999, ARTERIOSCL THROM VAS, V19, P847, DOI 10.1161/01.ATV.19.4.847; Tano N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023114; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Wu JH, 2005, BIOCHEMISTRY-US, V44, P11098, DOI 10.1021/bi050166i; Yu JC, 2013, NEUROL SCI, V34, P1283, DOI 10.1007/s10072-012-1228-1; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	38	47	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31638	31646		10.1074/jbc.M114.579763	http://dx.doi.org/10.1074/jbc.M114.579763			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25248747	hybrid, Green Published			2022-12-28	WOS:000344549900063
J	Samejima, K; Ogawa, H; Ageichik, AV; Peterson, KL; Kaufmann, SH; Kanemaki, MT; Earnshaw, WC				Samejima, Kumiko; Ogawa, Hiromi; Ageichik, Alexander V.; Peterson, Kevin L.; Kaufmann, Scott H.; Kanemaki, Masato T.; Earnshaw, William C.			Auxin-induced Rapid Degradation of Inhibitor of Caspase-activated DNase (ICAD) Induces Apoptotic DNA Fragmentation, Caspase Activation, and Cell Death A CELL SUICIDE MODULE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE DISRUPTION REVEALS; PLASMA-MEMBRANE; LEUKEMIA-CELLS; PHOSPHATIDYLSERINE; CLEAVAGE; PROTEIN; OVEREXPRESSION; INVOLVEMENT; EXPRESSION; NUCLEASES	Caspase-activated DNase (CAD) is a major apoptotic nuclease, responsible for DNA fragmentation and chromatin condensation during apoptosis. CAD is normally activated in apoptosis as a result of caspase cleavage of its inhibitory chaperone ICAD. Other aspects of CAD regulation are poorly understood. In particular, it has been unclear whether direct CAD activation in non-apoptotic living cells can trigger cell death. Taking advantage of the auxin-inducible degron (AID) system, we have developed a suicide system with which ICAD is rapidly degraded in living cells in response to the plant hormone auxin. Our studies demonstrate that rapid ICAD depletion is sufficient to activate CAD and induce cell death in DT40 and yeast cells. In the vertebrate cells, ectopic CAD activation triggered caspase activation and subsequent hallmarks of caspase-dependent apoptotic changes, including phosphatidylserine exposure and nuclear fragmentation. These observations not only suggest that CAD activation drives apoptosis through a positive feedback loop, but also identify a unique suicide system that can be used for controlling gene-modified organisms.	[Samejima, Kumiko; Ogawa, Hiromi; Ageichik, Alexander V.; Earnshaw, William C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3BF, Midlothian, Scotland; [Peterson, Kevin L.; Kaufmann, Scott H.] Mayo Clin, Rochester, MN 55905 USA; [Kanemaki, Masato T.] Res Org Informat & Syst, Natl Inst Genet, Frontier Res Ctr, Mishima, Shizuoka 4118540, Japan; [Kanemaki, Masato T.] SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Kanemaki, Masato T.] Japan Sci & Technol Agcy JST, PREST, Kawaguchi, Saitama 3320012, Japan	University of Edinburgh; Mayo Clinic; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST)	Samejima, K (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Kings Bldg, Edinburgh EH9 3BF, Midlothian, Scotland.	kumiko.samejima@ed.ac.uk; bill.earnshaw@ed.ac.uk	Kanemaki, Masato/Q-3246-2019; Earnshaw, William/AAY-7438-2020	Kanemaki, Masato/0000-0002-7657-1649; Kaufmann, Scott/0000-0002-4900-7145; Earnshaw, William/0000-0002-7191-0621	 [077707];  [092076]; NATIONAL CANCER INSTITUTE [R01CA166741] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Itaru Samejima for comments on the manuscript. Sorting of GFP-positive cells and,flow cytometry assays for caspase activity and TUNEL positivity were performed in the How cytometry facility, Institute of Immunology and Infection Research, Edinburgh, Scotland, United Kingdom with assistance of Dr, Martin Waterfall. We thank Dr, Richard Grainger and Professor jean D. Beggs, Ph. D., for their advice on the yeast experiments. The Wellcome Trust Centre for Cell Biology is supported by Core Grants 077707 and 092076.	Adrain C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.291pe62; Ageichik AV, 2007, J BIOL CHEM, V282, P27374, DOI 10.1074/jbc.M704307200; Ben-Yehudah A, 2003, CLIN CANCER RES, V9, P1179; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; KAUFMANN SH, 1989, CANCER RES, V49, P5870; Kelle A, 2009, EMBO REP, V10, pS23, DOI 10.1038/embor.2009.119; Kimura Y, 2004, ORAL ONCOL, V40, P390, DOI 10.1016/j.oraloncology.2003.07.001; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Korfali N, 2004, J BIOL CHEM, V279, P1030, DOI 10.1074/jbc.M306277200; Launay S, 2005, ONCOGENE, V24, P5137, DOI 10.1038/sj.onc.1208524; Lee SH, 2013, CELL DEATH DIFFER, V20, P64, DOI 10.1038/cdd.2012.93; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Martin SJ, 1996, J BIOL CHEM, V271, P28753, DOI 10.1074/jbc.271.46.28753; Mathew M, 2013, APOPTOSIS, V18, P882, DOI 10.1007/s10495-013-0840-8; McIlroy D, 1999, ONCOGENE, V18, P4401, DOI 10.1038/sj.onc.1202868; McQuade JM, 2002, PHYSIOL BEHAV, V76, P315, DOI 10.1016/S0031-9384(02)00716-3; Nagata S, 2005, ANNU REV IMMUNOL, V23, P853, DOI 10.1146/annurev.immunol.23.021704.115811; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Orth JD, 2012, MOL BIOL CELL, V23, P567, DOI 10.1091/mbc.E11-09-0781; Poreba M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008680; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; Samejima K, 1998, J CELL BIOL, V143, P225, DOI 10.1083/jcb.143.1.225; Samejima K, 2008, P NATL ACAD SCI USA, V105, P2457, DOI 10.1073/pnas.0712083105; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; WILLIAMS JR, 1974, NATURE, V252, P754, DOI 10.1038/252754a0; Woo EJ, 2004, MOL CELL, V14, P531, DOI 10.1016/S1097-2765(04)00258-8; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Xiao F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm486	37	25	26	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31617	31623		10.1074/jbc.M114.583542	http://dx.doi.org/10.1074/jbc.M114.583542			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25248749	Green Published, hybrid			2022-12-28	WOS:000344549900061
J	Feld, GK; El-Etr, S; Corzett, MH; Hunter, MS; Belhocine, K; Monack, DM; Frank, M; Segelke, BW; Rasley, A				Feld, Geoffrey K.; El-Etr, Sahar; Corzett, Michele H.; Hunter, Mark S.; Belhocine, Kamila; Monack, Denise M.; Frank, Matthias; Segelke, Brent W.; Rasley, Amy			Structure and Function of REP34 Implicates Carboxypeptidase Activity in Francisella tularensis Host Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-AVIUM; VIRULENCE FACTORS; TULAREMIA; AMEBAS; METALLOCARBOXYPEPTIDASE; ELECTROSTATICS; IDENTIFICATION; INHIBITOR; SURVIVAL; COMPLEX	Francisella tularensis is the etiological agent of tularemia, or rabbit fever. Although F. tularensis is a recognized biothreat agent with broad and expanding geographical range, its mechanism of infection and environmental persistence remain poorly understood. Previously, we identified seven F. tularensis proteins that induce a rapid encystment phenotype (REP) in the free-living amoeba, Acanthamoeba castellanii. Encystment is essential to the pathogen's long term intracellular survival in the amoeba. Here, we characterize the cellular and molecular function of REP34, a REP protein with a mass of 34 kDa. A REP34 knock-out strain of F. tularensis has a reduced ability to both induce encystment in A. castellanii and invade human macrophages. We determined the crystal structure of REP34 to 2.05-angstrom resolution and demonstrate robust carboxypeptidase B-like activity for the enzyme. REP34 is a zinc-containing monomeric protein with close structural homology to the metallocarboxypeptidase family of peptidases. REP34 possesses a novel topology and substrate binding pocket that deviates from the canonical funnelin structure of carboxypeptidases, putatively resulting in a catalytic role for a conserved tyrosine and distinct S1' recognition site. Taken together, these results identify REP34 as an active carboxypeptidase, implicate the enzyme as a potential key F. tularensis effector protein, and may help elucidate a mechanistic understanding of F. tularensis infection of phagocytic cells.	[Feld, Geoffrey K.; El-Etr, Sahar; Corzett, Michele H.; Segelke, Brent W.; Rasley, Amy] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Phys & Life Sci Directorate, Livermore, CA 94550 USA; [Hunter, Mark S.; Frank, Matthias] Lawrence Livermore Natl Lab, Div Phys, Phys & Life Sci Directorate, Livermore, CA 94550 USA; [Belhocine, Kamila; Monack, Denise M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Stanford University	Rasley, A (corresponding author), Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, 7000 East Ave,L452, Livermore, CA 94550 USA.	rasley2@llnl.gov	Frank, Matthias/O-9055-2014; Pacific-Southwest, RCE/B-6155-2009	Rasley, Amy/0000-0002-4767-6628; Frank, Matthias/0000-0002-5244-0791; Feld, Geoffrey/0000-0003-0496-1995; Monack, Denise/0000-0003-3804-2209; Segelke, Brent/0000-0003-3358-5028	National Institutes of Health (NIH), NIAID [AI65359]; Lawrence Livermore National Laboratory (LLNL) Laboratory-directed Research and Development (LDRD) [06-ERD-057, 012-ERD-031]; United States Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; United States Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, NIGMS [P41GM103393]; NIH, NCI [Y1-CO-1020]; NIH, NIGMS [Y1-GM-1104, P41 GM103403]; NIH, NCRR [5P41RR015301-10]; DOE [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Lawrence Livermore National Laboratory (LLNL) Laboratory-directed Research and Development (LDRD); United States Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); United States Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NIAID, Grant AI65359 (to A. R.). This research was also supported by Lawrence Livermore National Laboratory (LLNL) Laboratory-directed Research and Development (LDRD) Project 06-ERD-057 (to A. R.) and LDRD Project 012-ERD-031 (to M. F.). Work was performed under the auspices of the United States Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. Use of the Stanford Synchrotron Radiation Laboratory (SSRL), SLAC National Accelerator Laboratory, was supported by the United States Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, NIGMS (including Grant P41GM103393). GM/CA at the Advanced Photon Source (APS) has been funded in whole or in part with Federal funds from NIH, NCI, Grant Y1-CO-1020 and NIH, NIGMS, Grant Y1-GM-1104. The Northeastern Collaborative Access Team is supported by NIH, NCRR, Grant 5P41RR015301-10 and NIH, NIGMS, Grant P41 GM103403. Use of the APS is supported by the DOE under Contract DE-AC02-06CH11357.	Abd H, 2003, APPL ENVIRON MICROB, V69, P600, DOI 10.1128/AEM.69.1.600-606.2003; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adler M, 2005, BIOCHEMISTRY-US, V44, P9339, DOI 10.1021/bi0501941; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bayes A, 2007, BIOCHEMISTRY-US, V46, P6921, DOI 10.1021/bi700480b; Berdal BP, 1996, FEMS IMMUNOL MED MIC, V13, P191, DOI 10.1111/j.1574-695X.1996.tb00235.x; Brieland J, 1996, INFECT IMMUN, V64, P2449, DOI 10.1128/IAI.64.7.2449-2456.1996; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Chen YY, 2002, J BIOL CHEM, V277, P23433, DOI 10.1074/jbc.M200811200; Cho JH, 2002, BIOORGAN MED CHEM, V10, P2015, DOI 10.1016/S0968-0896(01)00429-1; Cirillo JD, 1997, INFECT IMMUN, V65, P3759, DOI 10.1128/IAI.65.9.3759-3767.1997; Clemens DL, 2007, ANN NY ACAD SCI, V1105, P160, DOI 10.1196/annals.1409.001; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; El-Etr SH, 2009, APPL ENVIRON MICROB, V75, P7488, DOI 10.1128/AEM.01829-09; Eliasson H, 2007, SCAND J INFECT DIS, V39, P880, DOI 10.1080/00365540701402970; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feldman KA, 2001, NEW ENGL J MED, V345, P1601, DOI 10.1056/NEJMoa011374; Fischetti RF, 2009, J SYNCHROTRON RADIAT, V16, P217, DOI 10.1107/S0909049508040612; FOLK JE, 1960, J BIOL CHEM, V235, P2272; Gurcan S, 2006, JPN J INFECT DIS, V59, P391; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Maier TA, 2007, INFECT IMMUN, V75, P5376, DOI 10.1128/IAI.00238-07; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPherson A Jr, 1976, Methods Biochem Anal, V23, P249, DOI 10.1002/9780470110430.ch4; Miyake M, 2005, INFECT IMMUN, V73, P6272, DOI 10.1128/IAI.73.10.6272-6282.2005; Molmeret M, 2005, APPL ENVIRON MICROB, V71, P20, DOI 10.1128/AEM.71.1.20-28.2005; Mueller RS, 2007, J BACTERIOL, V189, P5348, DOI 10.1128/JB.01867-06; Nigrovic LE, 2008, INFECT DIS CLIN N AM, V22, P489, DOI 10.1016/j.idc.2008.03.004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Oyston PCF, 2008, J MED MICROBIOL, V57, P921, DOI 10.1099/jmm.0.2008/000653-0; Petersen JM, 2009, VET RES, V40, DOI 10.1051/vetres:2008045; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Reddy V, 2003, ACTA CRYSTALLOGR D, V59, P2200, DOI 10.1107/S0907444903020316; Reverter D, 2000, NAT STRUCT BIOL, V7, P322, DOI 10.1038/74092; Salah IB, 2009, CLIN MICROBIOL INFEC, V15, P894, DOI 10.1111/j.1469-0691.2009.03011.x; Segelke B. W., 2001, J CRYST GROWTH, V232, P553; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Steinert M, 1998, APPL ENVIRON MICROB, V64, P2256; STEPANOV VM, 1995, METHOD ENZYMOL, V248, P675; TEPLYAKOV A, 1992, EUR J BIOCHEM, V208, P281, DOI 10.1111/j.1432-1033.1992.tb17184.x; Tung CH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r31; Winiecka-Krusnell J, 2001, RES MICROBIOL, V152, P613, DOI 10.1016/S0923-2508(01)01240-2; Winiecka-Krusnell J, 2009, EXP PARASITOL, V121, P124, DOI 10.1016/j.exppara.2008.09.022; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Zaugg C, 2008, INT J MED MICROBIOL, V298, P669, DOI 10.1016/j.ijmm.2007.11.005; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	53	3	3	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30668	30679		10.1074/jbc.M114.599381	http://dx.doi.org/10.1074/jbc.M114.599381			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231992	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000344549700043
J	Jaeger, AM; Makley, LN; Gestwicki, JE; Thiele, DJ				Jaeger, Alex M.; Makley, Leah N.; Gestwicki, Jason E.; Thiele, Dennis J.			Genomic Heat Shock Element Sequences Drive Cooperative Human Heat Shock Factor 1 DNA Binding and Selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-QUALITY CONTROL; TRANSCRIPTION FACTOR-1; MOLECULAR CHAPERONES; FACTOR-I; STRESS; ACTIVATION; REPRESSION; PROMOTER; PROVIDES; DISTINCT	The heat shock transcription factor 1 (HSF1) activates expression of a variety of genes involved in cell survival, including protein chaperones, the protein degradation machinery, anti-apoptotic proteins, and transcription factors. Although HSF1 activation has been linked to amelioration of neurodegenerative disease, cancer cells exhibit a dependence on HSF1 for survival. Indeed, HSF1 drives a program of gene expression in cancer cells that is distinct from that activated in response to proteotoxic stress, and HSF1 DNA binding activity is elevated in cycling cells as compared with arrested cells. Active HSF1 homotrimerizes and binds to a DNA sequence consisting of inverted repeats of the pentameric sequence nGAAn, known as heat shock elements (HSEs). Recent comprehensive ChIP-seq experiments demonstrated that the architecture of HSEs is very diverse in the human genome, with deviations from the consensus sequence in the spacing, orientation, and extent of HSE repeats that could influence HSF1 DNA binding efficacy and the kinetics and magnitude of target gene expression. To understand the mechanisms that dictate binding specificity, HSF1 was purified as either a monomer or trimer and used to evaluate DNA-binding site preferences in vitro using fluorescence polarization and thermal denaturation profiling. These results were compared with quantitative chromatin immunoprecipitation assays in vivo. We demonstrate a role for specific orientations of extended HSE sequences in driving preferential HSF1 DNA binding to target loci in vivo. These studies provide a biochemical basis for understanding differential HSF1 target gene recognition and transcription in neurodegenerative disease and in cancer.	[Jaeger, Alex M.; Thiele, Dennis J.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Thiele, Dennis J.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA; [Makley, Leah N.; Gestwicki, Jason E.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA	Duke University; Duke University; University of California System; University of California San Francisco	Thiele, DJ (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	dennis.thiele@duke.edu			National Institutes of Health [R01-NS065890, 2 T32 GM007105, GM007767]; American Foundation for Pharmaceutical Education; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767, T32GM007105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for Pharmaceutical Education; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-NS065890.; Supported by National Institutes of Health Training Grant 2 T32 GM007105 (to Duke University Pharmacological Sciences).; Supported by National Institutes of Health Training Grant GM007767 to University of Michigan Pharmacological Sciences) and a predoctoral fellowship from the American Foundation for Pharmaceutical Education.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Anckar J, 2006, MOL CELL BIOL, V26, P955, DOI 10.1128/MCB.26.3.955-964.2006; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Clemente JC, 2012, J BIOMOL SCREEN, V17, P629, DOI 10.1177/1087057112441012; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; Farkas T, 1998, MOL CELL BIOL, V18, P906, DOI 10.1128/MCB.18.2.906; FAWCETT TW, 1994, J BIOL CHEM, V269, P32272; Glover-Cutter KM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003701; Guertin MJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002610; Guisbert E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003466; Guo YL, 2001, J BIOL CHEM, V276, P45791, DOI 10.1074/jbc.M105931200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Inouye S, 2007, J BIOL CHEM, V282, P33210, DOI 10.1074/jbc.M704471200; Jolly C, 2002, J CELL BIOL, V156, P775, DOI 10.1083/jcb.200109018; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Littlefield O, 1999, NAT STRUCT BIOL, V6, P464; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; MOSSER DD, 1990, P NATL ACAD SCI USA, V87, P3748, DOI 10.1073/pnas.87.10.3748; Neef DW, 2011, NAT REV DRUG DISCOV, V10, P930, DOI 10.1038/nrd3453; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; Riva L, 2012, J HUNTINGTONS DIS, V1, P33, DOI 10.3233/JHD-2012-120020; Sandqvist A, 2009, MOL BIOL CELL, V20, P1340, DOI 10.1091/mbc.E08-08-0864; Vihervaara A, 2013, P NATL ACAD SCI USA, V110, pE3388, DOI 10.1073/pnas.1305275110; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; ZUO JR, 1994, MOL CELL BIOL, V14, P7557, DOI 10.1128/MCB.14.11.7557	34	40	44	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30459	30469		10.1074/jbc.M114.591578	http://dx.doi.org/10.1074/jbc.M114.591578			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25204655	hybrid, Green Published			2022-12-28	WOS:000344549700026
J	Tai, LM; Koster, KP; Luo, J; Lee, SH; Wang, YT; Collins, NC; Ben Aissa, M; Thatcher, GRJ; LaDu, MJ				Tai, Leon M.; Koster, Kevin P.; Luo, Jia; Lee, Sue H.; Wang, Yue-ting; Collins, Nicole C.; Ben Aissa, Manel; Thatcher, Gregory R. J.; LaDu, Mary Jo			Amyloid-beta Pathology and APOE Genotype Modulate Retinoid X Receptor Agonist Activity in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MOUSE MODEL; MILD COGNITIVE IMPAIRMENT; APOLIPOPROTEIN-E; A-BETA; ALZHEIMERS-DISEASE; BEXAROTENE THERAPY; ABCA1; BRAIN; DEPOSITION; LIVER	Previous data demonstrate that bexarotene (Bex), retinoid X receptor (RXR) agonist, reduces soluble and insoluble amyloid-beta (A beta) in Alzheimer disease (AD)-transgenic mice either by increasing the levels of mouse apolipoprotein E (apoE) or increasing ABCA1/ABCG1-induced apoE lipoprotein association/lipidation. However, although the mechanism of action of RXR agonists remains unclear, a major concern for their use is human (h)-APOE4, the greatest AD genetic risk factor. If APOE4 imparts a toxic gain-of-function, then increasing apoE4 may increase soluble A beta, likely the proximal AD neurotoxin. If the APOE4 loss-of-function is lipidation of apoE4, then induction of ABCA1/ABCG1 may be beneficial. In novel EFAD-Tg mice (overexpressing h-A beta 42 with h-APOE), levels of soluble A beta (A beta 42 and oligomeric A beta) are highest in E4FAD hippocampus (HP) > E3FAD-HP > E4FAD cortex (CX) > E3FAD-CX, whereas levels of lipoprotein-associated/lipidated apoE have the opposite pattern (6 months). In E4FAD-HP, short-term RXR agonist treatment (Bex or LG100268; 5.75-6 months) increased ABCA1, apoE4 lipoprotein-association/lipidation, and apoE4/A beta complex, decreased soluble A beta, and increased PSD95. In addition, hydrogel delivery, which mimics low sustained release, was equally effective as gavage for Bex and LG100268. RXR agonists induced no beneficial effects in the E4FAD-HP in a prevention protocol (5-6 months) and actually increased soluble A beta levels in E3FAD-CX and E4FAD-CX with the short-term protocol, possibly the result of systemic hepatomegaly. Thus, RXR agonists address the loss-of-function associated with APOE4 and exacerbated by A beta pathology, i.e. low levels of apoE4 lipoprotein association/lipidation. Further studies are vital to address whether RXR agonists are an APOE4-specific AD therapeutic and the systemic side effects that limit translational application.	[Tai, Leon M.; Koster, Kevin P.; Collins, Nicole C.; Ben Aissa, Manel; LaDu, Mary Jo] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Luo, Jia; Lee, Sue H.; Thatcher, Gregory R. J.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA; [Wang, Yue-ting] Univ Illinois, UICtr Drug Discovery UIC, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	LaDu, MJ (corresponding author), Univ Illinois, Dept Anat & Cell Biol, 808 S Wood St,M-C 512, Chicago, IL 60612 USA.	mladu@uic.edu		Lee, Sue/0000-0002-6843-0280; LaDu, Mary Jo/0000-0003-2141-1450	National Institutes of Health from NIA [P01AG030128]; Alzheimer Drug Discovery Foundation; University of Illinois at Chicago Center for Clinical and Translational Science [UL1RR029879]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG030128] Funding Source: NIH RePORTER	National Institutes of Health from NIA; Alzheimer Drug Discovery Foundation; University of Illinois at Chicago Center for Clinical and Translational Science; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant P01AG030128 from NIA (to M. J. L.). This work was also supported by Alzheimer Drug Discovery Foundation grant (to M. J. L. and L. M. T.) and University of Illinois at Chicago Center for Clinical and Translational Science Grant UL1RR029879 (to M. J. L.). In collaboration with Skip Binder, M. J. L. developed the antibody MOAB-2 used to develop the apoE/A beta complex and oA beta ELISAs. MOAB-2 is licensed as a research tool to multiple companies. Also, for research purposes, Biosensis Pty. Ltd. has licensed the rights to ELISA kits with MOAB-2 for detection of oA beta and apoE/A beta complex.	Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Altmann A, 2014, ANN NEUROL, V75, P563, DOI 10.1002/ana.24135; Bachstetter AD, 2014, J NEUROIMMUNE PHARM, V9, P454, DOI 10.1007/s11481-014-9543-3; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; BOEHM MF, 1995, J MED CHEM, V38, P3146, DOI 10.1021/jm00016a018; Boehm-Cagan A, 2014, J NEUROSCI, V34, P7293, DOI 10.1523/JNEUROSCI.5198-13.2014; Bretsky PM, 1999, ALZ DIS ASSOC DIS, V13, P216, DOI 10.1097/00002093-199910000-00007; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; de la Monte SM, 2014, ENDOCRIN METAB CLIN, V43, P245, DOI 10.1016/j.ecl.2013.09.006; der Weij JD, 2009, ENDOCRINOLOGY, V150, P2368, DOI 10.1210/en.2008-1540; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Elliott C, 2013, DIGEST DIS SCI, V58, P2383, DOI 10.1007/s10620-013-2657-2; Erbas O, 2014, SCI WORLD J, DOI 10.1155/2014/946265; Farlow MR, 1998, NEUROLOGY, V50, P669, DOI 10.1212/WNL.50.3.669; Faul MM, 2001, J ORG CHEM, V66, P5772, DOI 10.1021/jo0103064; Fitz NF, 2013, SCIENCE, V340, DOI 10.1126/science.1235809; Fowler SW, 2014, J NEUROSCI, V34, P7871, DOI 10.1523/JNEUROSCI.0572-14.2014; Fryer JD, 2005, J NEUROSCI, V25, P2803, DOI 10.1523/JNEUROSCI.5170-04.2005; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; Hirsch-Reinshagen V, 2004, J BIOL CHEM, V279, P41197, DOI 10.1074/jbc.M407962200; Hong SY, 2011, J NEUROSCI, V31, P15861, DOI 10.1523/JNEUROSCI.3272-11.2011; Howell SR, 2001, DRUG METAB DISPOS, V29, P990; Hudry E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007000; Jacobs EG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054713; Janakiram NB, 2012, NEOPLASIA, V14, P159, DOI 10.1593/neo.111440; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Jurutka PW, 2013, J MED CHEM, V56, P8432, DOI 10.1021/jm4008517; Karran E, 2014, NEW ENGL J MED, V370, P377, DOI 10.1056/NEJMe1313943; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Kunzler J, 2014, NEUROSCI LETT, V560, P131, DOI 10.1016/j.neulet.2013.12.032; Kuo YM, 1996, J BIOL CHEM, V271, P4077; LaClair KD, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-18; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Leoni V, 2011, CLIN CHEM LAB MED, V49, P375, DOI 10.1515/CCLM.2011.088; Lewis M, 2003, QJM-INT J MED, V96, P623, DOI 10.1093/qjmed/hcg110; Li J, 2012, J BIOL CHEM, V287, P44593, DOI 10.1074/jbc.M112.420224; Lim WLF, 2014, J GENET GENOMICS, V41, P261, DOI 10.1016/j.jgg.2014.04.003; Liu S, 2002, ENDOCRINOLOGY, V143, P2880, DOI 10.1210/en.143.8.2880; Ly S, 2013, J BIOL CHEM, V288, P11628, DOI 10.1074/jbc.M112.411900; Mikulca JA, 2014, J CLIN PHARM THER, V39, P25, DOI 10.1111/jcpt.12112; Mohamed A, 2012, J NEUROSCI, V32, P6490, DOI 10.1523/JNEUROSCI.0630-12.2012; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Overk CR, 2012, NEUROBIOL DIS, V45, P479, DOI 10.1016/j.nbd.2011.08.035; Overk CR, 2011, J NEUROSCI METH, V195, P194, DOI 10.1016/j.jneumeth.2010.12.009; Payami H, 1996, AM J HUM GENET, V58, P803; Perez E, 2012, BBA-MOL CELL BIOL L, V1821, P57, DOI 10.1016/j.bbalip.2011.04.003; Price AR, 2013, SCIENCE, V340, DOI 10.1126/science.1234089; Qiu WQ, 2013, J ALZHEIMERS DIS, V37, P421, DOI 10.3233/JAD-130716; Reitz C, 2010, J ALZHEIMERS DIS, V19, P229, DOI 10.3233/JAD-2010-1255; Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369; Scarisbrick JJ, 2013, BRIT J DERMATOL, V168, P192, DOI 10.1111/bjd.12042; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Sherman SI, 2003, CLIN LYMPHOMA, V3, P249, DOI 10.3816/CLM.2003.n.006; Sonneville R, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-15; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Sultana R, 2010, J NEUROSCI RES, V88, P469, DOI 10.1002/jnr.22227; Tai LM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-2; Tai Leon M, 2011, Int J Alzheimers Dis, V2011, P810981, DOI 10.4061/2011/810981; Tai LM, 2013, J BIOL CHEM, V288, P5914, DOI 10.1074/jbc.M112.442103; Tesseur I, 2013, SCIENCE, V340, DOI 10.1126/science.1233937; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Torino F, 2013, THYROID, V23, P1345, DOI 10.1089/thy.2013.0241; Vakeva L, 2012, ACTA DERM-VENEREOL, V92, P258, DOI 10.2340/00015555-1359; Veeraraghavalu K, 2013, SCIENCE, V340, DOI 10.1126/science.1235505; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Wahrle SE, 2005, J BIOL CHEM, V280, P43236, DOI 10.1074/jbc.M508780200; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Wang Y, 2006, MOL CANCER THER, V5, P1060, DOI 10.1158/1535-7163.MCT-05-0322; Weissenborn K, 2005, AIDS, V19, pS93, DOI 10.1097/01.aids.0000192076.03443.6d; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Wu K, 2002, CANCER EPIDEM BIOMAR, V11, P467; Yaffe K, 2000, NEUROLOGY, V54, P1949, DOI 10.1212/WNL.54.10.1949; Youmans KL, 2012, J BIOL CHEM, V287, P41774, DOI 10.1074/jbc.M112.407957; Youmans KL, 2011, J NEUROSCI METH, V196, P51, DOI 10.1016/j.jneumeth.2010.12.025; Yu CJ, 2010, BBA-MOL CELL BIOL L, V1801, P819, DOI 10.1016/j.bbalip.2010.05.001; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104	87	71	71	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30538	30555		10.1074/jbc.M114.600833	http://dx.doi.org/10.1074/jbc.M114.600833			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25217640	hybrid, Green Published			2022-12-28	WOS:000344549700032
J	Tousif, S; Singh, DK; Ahmad, S; Moodley, P; Bhattacharyya, M; Van Kaer, L; Das, G				Tousif, Sultan; Singh, Dhiraj Kumar; Ahmad, Shaheer; Moodley, Prashini; Bhattacharyya, Maitree; Van Kaer, Luc; Das, Gobardhan			Isoniazid Induces Apoptosis Of Activated CD4(+) T Cells IMPLICATIONS FOR POST-THERAPY TUBERCULOSIS REACTIVATION AND REINFECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; GLOBAL TRENDS; INFECTION; SURVEILLANCE; IMMUNITY; ACCESS; INDIA	Tuberculosis (TB) remains the second highest killer from a single infectious disease worldwide. Current therapy of TB is lengthy and consists of multiple expensive antibiotics, in a strategy referred to as Directly Observed Treatment, Short Course (DOTS). Although this therapy is effective, it has serious disadvantages. These therapeutic agents are toxic and are associated with the development of a variety of drug-resistant TB strains. Furthermore, patients treated with DOTS exhibit enhanced post-treatment susceptibility to TB reactivation and reinfection, suggesting therapy-related immune impairment. Here we show that Isoniazid (INH) treatment dramatically reduces Mycobacterium tuberculosis antigen-specific immune responses, induces apoptosis in activated CD4(+) T cells, and renders treated animals vulnerable to TB reactivation and reinfection. Consequently, our findings suggest that TB treatment is associated with immune impairment.	[Ahmad, Shaheer; Das, Gobardhan] Jawaharlal Nehru Univ, SCMM, New Delhi 110067, India; [Tousif, Sultan; Moodley, Prashini; Das, Gobardhan] Univ KwaZulu Natal, Coll Hlth Sci, Sch Lab Med, ZA-4001 Durban, South Africa; [Singh, Dhiraj Kumar] ICGEB, New Delhi 110067, India; [Bhattacharyya, Maitree] Univ Calcutta, Dept Biochem, Kolkata 700019, W Bengal, India; [Van Kaer, Luc] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Jawaharlal Nehru University, New Delhi; University of Kwazulu Natal; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Calcutta; Vanderbilt University	Das, G (corresponding author), Jawaharlal Nehru Univ, Ctr Mol Med, ArunaAsaf Ali Marg, New Delhi 110067, India.	gobardhan.das07@gmail.com	Van Kaer, Luc/H-1033-2015	Van Kaer, Luc/0000-0001-5275-2309; Tousif, Sultan/0000-0001-6174-6541; Singh, Dhiraj/0000-0001-5507-1197	DBT	DBT(Department of Biotechnology (DBT) India)	We thank the DBT-supported Tuberculosis Aerosol Challenge Facility at the ICGEB (New Delhi, India). We thank the ICGEB, where the work was initiated. We thank Prof. David Sherman (Seattle Institute of Biomedical Research, Seattle, WA) for providing M. tuberculosis strain H37Rv (ATCC 27294).	Bhattacharya D, 2014, J BIOL CHEM, V289, P16508, DOI 10.1074/jbc.M114.558098; Borst P, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120066; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; Collins Kalonji R., 2002, AIDS Reviews, V4, P165; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Cox HS, 2008, BMJ-BRIT MED J, V336, P484, DOI 10.1136/bmj.39463.640787.BE; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; den Boon S, 2007, EMERG INFECT DIS, V13, P1189, DOI 10.3201/eid1308.051327; Devadas S, 2006, IMMUNITY, V25, P237, DOI 10.1016/j.immuni.2006.06.011; Dietrich J, 2009, APMIS, V117, P440, DOI 10.1111/j.1600-0463.2009.02458.x; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Falzon D, 2013, LANCET INFECT DIS, V13, P690, DOI 10.1016/S1473-3099(13)70130-0; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Fountain FF, 2005, CHEST, V128, P116, DOI 10.1378/chest.128.1.116; Gallegos AM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002052; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; HAANEN JBAG, 1991, J EXP MED, V174, P583, DOI 10.1084/jem.174.3.583; MUTIS T, 1993, EUR J IMMUNOL, V23, P2189, DOI 10.1002/eji.1830230921; Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; Pablos-Mendez A, 2002, B WORLD HEALTH ORGAN, V80, P489; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Raghuvanshi S, 2010, P NATL ACAD SCI USA, V107, P21653, DOI 10.1073/pnas.1007967107; SAHA B, 1994, EUR J IMMUNOL, V24, P2618, DOI 10.1002/eji.1830241108; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Tousif S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019864; Udwadia ZF, 2012, RESPIROLOGY, V17, P741, DOI 10.1111/j.1440-1843.2012.02192.x; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; WHO Global Tuberculosis Control Report, 2010, CENT EUR J PUBL HEAL, V18, P237; World Health Organization, 2004, WORLD REP KNOWL BETT, P16; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	33	30	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30190	30195		10.1074/jbc.C114.598946	http://dx.doi.org/10.1074/jbc.C114.598946			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25202011	Green Published, hybrid			2022-12-28	WOS:000344549700001
J	Wang, CY; Miller, TF				Wang, Connie Y.; Miller, Thomas F., III			Allosteric Response and Substrate Sensitivity in Peptide Binding of the Signal Recognition Particle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-ENERGY CALCULATIONS; FACILITATED PROTEIN TRANSLOCATION; EUKARYOTIC ENDOPLASMIC-RETICULUM; MOLECULAR-DYNAMICS SIMULATION; CRYSTAL-STRUCTURE; SRP RNA; TRANSLATING RIBOSOME; COMPUTER-SIMULATION; STRUCTURAL BASIS; GTPASE DOMAIN	We characterize the conformational dynamics and substrate selectivity of the signal recognition particle (SRP) using a thermodynamic free energy cycle approach and microsecond timescale molecular dynamics simulations. The SRP is a central component of the co-translational protein targeting machinery that binds to the N-terminal signal peptide (SP) of nascent proteins. We determined the shift in relative conformational stability of the SRP upon substrate binding to quantify allosteric coupling between SRP domains. In particular, for dipeptidyl aminopeptidase, an SP that is recognized by the SRP for co-translational targeting, it is found that substrate binding induces substantial changes in the SRP toward configurations associated with targeting of the nascent protein, and it is found that the changes are modestly enhanced by a mutation that increases the hydrophobicity of the SP. However, for alkaline phosphatase, an SP that is recognized for post-translational targeting, substrate binding induces the reverse change in the SRP conformational distribution away from targeting configurations. Microsecond timescale trajectories reveal the intrinsic flexibility of the SRP conformational landscape and provide insight into recent single molecule studies by illustrating that 10-nm lengthscale changes between FRET pairs occur via the rigid-body movement of SRP domains connected by the flexible linker region. In combination, these results provide direct evidence for the hypothesis that substrate-controlled conformational switching in the SRP provides a mechanism for discriminating between different SPs and for connecting substrate binding to downstream steps in the protein targeting pathway.	[Wang, Connie Y.; Miller, Thomas F., III] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91106 USA	California Institute of Technology	Miller, TF (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 East Calif Blvd, Pasadena, CA 91106 USA.	tfm@caltech.edu			Office of Science of the United States Department of Energy [DE-AC02-05CH11231]; Biomedical Technology Research Center for Multiscale Modeling of Biological Systems through National Institutes of Health [P41GM103712-S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103712] Funding Source: NIH RePORTER	Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); Biomedical Technology Research Center for Multiscale Modeling of Biological Systems through National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Computational resources were provided by the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the United States Department of Energy under Contract DE-AC02-05CH11231. Additionally, Anton computer time was provided by the National Resource for Biomedical Supercomputing, the Pittsburgh Supercomputing Center, and the Biomedical Technology Research Center for Multiscale Modeling of Biological Systems through National Institutes of Health Grant P41GM103712-S1. The Anton machine at NRBSC/PSC was generously made available by D. E. Shaw Research. We also thank Shu-ou Shan and David Akopian for helpful discussions.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Ariosa AR, 2013, MOL BIOL CELL, V24, P63, DOI 10.1091/mbc.E12-06-0434; Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; BASH PA, 1987, SCIENCE, V236, P564, DOI 10.1126/science.3576184; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Batson B., 2009, MILL SCAL MOL DYN SI, P1, DOI [10.1145/1654059.1654099, DOI 10.1145/1654059.1654099]; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BEUTLER TC, 1994, CHEM PHYS LETT, V222, P529, DOI 10.1016/0009-2614(94)00397-1; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Bradshaw N, 2009, SCIENCE, V323, P127, DOI 10.1126/science.1165971; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Essex JW, 1997, J PHYS CHEM B, V101, P9663, DOI 10.1021/jp971990m; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Estrozi LF, 2011, NAT STRUCT MOL BIOL, V18, P88, DOI 10.1038/nsmb.1952; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; FLETCHER R, 1963, COMPUT J, V6, P163, DOI 10.1093/comjnl/6.2.163; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Freymann DM, 1997, NATURE, V385, P361, DOI 10.1038/385361a0; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; Hainzl T, 2007, P NATL ACAD SCI USA, V104, P14911, DOI 10.1073/pnas.0702467104; Hainzl T, 2011, NAT STRUCT MOL BIOL, V18, P389, DOI 10.1038/nsmb.1994; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Hatsuzawa K, 1997, J BIOCHEM-TOKYO, V121, P270; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holtkamp W, 2012, NAT STRUCT MOL BIOL, V19, P1332, DOI 10.1038/nsmb.2421; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Jayaram B, 1998, J AM CHEM SOC, V120, P10629, DOI 10.1021/ja981307p; JORGENSEN WL, 1985, J CHEM PHYS, V83, P3050, DOI 10.1063/1.449208; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; KURZCHALIA TV, 1986, NATURE, V320, P634, DOI 10.1038/320634a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin YL, 2014, J CHEM THEORY COMPUT, V10, P2690, DOI 10.1021/ct500195p; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Noriega TR, 2014, J BIOL CHEM, V289, P19294, DOI 10.1074/jbc.M114.563239; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pohlschroder M, 1997, CELL, V91, P563, DOI 10.1016/S0092-8674(00)80443-2; Pohorille A, 2010, J PHYS CHEM B, V114, P10235, DOI 10.1021/jp102971x; PORITZ MA, 1990, SCIENCE, V250, P1111, DOI 10.1126/science.1701272; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; RAO SN, 1987, NATURE, V328, P551, DOI 10.1038/328551a0; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rosendal KR, 2003, P NATL ACAD SCI USA, V100, P14701, DOI 10.1073/pnas.2436132100; Roux B, 1996, BIOPHYS J, V71, P670, DOI 10.1016/S0006-3495(96)79267-6; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saraogi I, 2014, J CELL BIOL, V205, P693, DOI 10.1083/jcb.201311028; Satpati P, 2011, J PHYS CHEM B, V115, P6749, DOI 10.1021/jp201934p; Schaffitzel C, 2006, NATURE, V444, P503, DOI 10.1038/nature05182; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Shaw DE, 2007, CONF PROC INT SYMP C, P1, DOI 10.1145/1273440.1250664; Shen K, 2012, NATURE, V492, P271, DOI 10.1038/nature11726; Shen K, 2011, RNA, V17, P892, DOI 10.1261/rna.2610411; Siu FY, 2007, RNA, V13, P240, DOI 10.1261/rna.135407; Steinbrecher T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799191; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921; von Loeffelholz O, 2013, NAT STRUCT MOL BIOL, V20, P604, DOI 10.1038/nsmb.2546; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wild K, 2004, MOL MICROBIOL, V53, P357, DOI 10.1111/j.1365-2958.2004.04139.x; Wild K, 2010, ACTA CRYSTALLOGR D, V66, P295, DOI 10.1107/S0907444910000879; Woo HJ, 2005, P NATL ACAD SCI USA, V102, P6825, DOI 10.1073/pnas.0409005102; Zhang B, 2012, CELL REP, V2, P927, DOI 10.1016/j.celrep.2012.08.039; Zhang B, 2012, J AM CHEM SOC, V134, P13700, DOI 10.1021/ja3034526; Zhang X, 2011, P NATL ACAD SCI USA, V108, P6450, DOI 10.1073/pnas.1019051108; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106	82	2	2	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30868	30879		10.1074/jbc.M114.584912	http://dx.doi.org/10.1074/jbc.M114.584912			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25237192	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000344549700060
J	Wu, M; Lu, WY; Santos, RE; Frattini, MG; Kelly, TJ				Wu, Min; Lu, Wenyan; Santos, Ruth E.; Frattini, Mark G.; Kelly, Thomas J.			Geminin Inhibits a Late Step in the Formation of Human Pre-replicative Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; EUKARYOTIC DNA-REPLICATION; MINICHROMOSOME MAINTENANCE PROTEINS; LICENSING FACTOR CDT1; HBO1 HISTONE ACETYLASE; XENOPUS EGG EXTRACTS; HELICASE ACTIVITY; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; MCM-PROTEINS	The initial step in initiation of eukaryotic DNA replication involves the assembly of pre-replicative complexes (pre-RCs) at origins of replication during the G(1) phase of the cell cycle. In metazoans initiation is inhibited by the regulatory factor Geminin. We have purified the human pre-RC proteins, studied their interactions in vitro with each other and with origin DNA, and analyzed the effects of HsGeminin on formation of DNA-protein complexes. The formation of an initial complex containing the human origin recognition complex (HsORC), HsCdt1, HsCdc6, and origin DNA is cooperative, involving all possible binary interactions among the components. Maximal association of HsMCM2-7, a component of the replicative helicase, requires HsORC, HsCdc6, HsCdt1, and ATP, and is driven by interactions of HsCdt1 and HsCdc6 with multiple HsMCM2-7 subunits. Formation of stable complexes, resistant to high salt, requires ATP hydrolysis. In the absence of HsMCM proteins, HsGeminin inhibits the association of HsCdt1 with DNA or with HsORC-HsCdc6-DNA complexes. However, HsGeminin does not inhibit recruitment of HsMCM2-7 to DNA to form complexes containing all of the pre-RC proteins. In fact, HsGeminin itself is a component of such complexes, and interacts directly with the HsMcm3 and HsMcm5 subunits of HsMCM2-7, as well as with HsCdt1. Although HsGeminin does not prevent the initial formation of DNA-protein complexes containing the pre-RC proteins, it strongly inhibits the formation of stable preRCs that are resistant to high salt. We suggest that bound HsGeminin prevents transition of the pre-RC to a state that is competent for initiation of DNA replication.	[Wu, Min; Lu, Wenyan; Santos, Ruth E.; Kelly, Thomas J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Frattini, Mark G.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Frattini, MG (corresponding author), Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, 1130 St Nicholas Ave,Rm 216, New York, NY 10032 USA.	mwu4@jhmi.edu; mgf2122@columbia.edu; tkelly@mskcc.org			National Institutes of Health [R01 CA40414]; Mathers Foundation; NATIONAL CANCER INSTITUTE [R01CA040414, P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA40414 and The Mathers Foundation (to T. J. K.).	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bochman ML, 2007, J BIOL CHEM, V282, P33795, DOI 10.1074/jbc.M703824200; Bochman ML, 2010, NUCLEIC ACIDS RES, V38, P6078, DOI 10.1093/nar/gkq422; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; BURKHART R, 1995, EUR J BIOCHEM, V228, P431; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Duncker BP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-214; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Ferenbach A, 2005, NUCLEIC ACIDS RES, V33, P316, DOI 10.1093/nar/gki176; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Gambus A, 2011, J BIOL CHEM, V286, P11855, DOI 10.1074/jbc.M110.199521; GIACCA M, 1994, P NATL ACAD SCI USA, V91, P7119, DOI 10.1073/pnas.91.15.7119; Gillespie PJ, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-15; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Houchens CR, 2008, J BIOL CHEM, V283, P30216, DOI 10.1074/jbc.M802649200; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Ishimi Y, 1996, J BIOL CHEM, V271, P24115, DOI 10.1074/jbc.271.39.24115; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Kawasaki Y, 2006, GENES CELLS, V11, P745, DOI 10.1111/j.1365-2443.2006.00975.x; KIMURA H, 1995, NUCLEIC ACIDS RES, V23, P2097, DOI 10.1093/nar/23.12.2097; Klemm RD, 2001, P NATL ACAD SCI USA, V98, P8361, DOI 10.1073/pnas.131006898; Kulartz M, 2004, J BIOL CHEM, V279, P41686, DOI 10.1074/jbc.M405798200; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Miotto B, 2008, GENE DEV, V22, P2633, DOI 10.1101/gad.1674108; Miotto B, 2010, MOL CELL, V37, P57, DOI 10.1016/j.molcel.2009.12.012; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; MUSAHL C, 1995, EUR J BIOCHEM, V230, P1096, DOI 10.1111/j.1432-1033.1995.tb20660.x; Neuwald AF, 1999, GENOME RES, V9, P27; Ode KL, 2011, GENES CELLS, V16, P380, DOI 10.1111/j.1365-2443.2011.01501.x; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Rowles A, 1999, J CELL SCI, V112, P2011; Seki T, 2000, P NATL ACAD SCI USA, V97, P14115, DOI 10.1073/pnas.97.26.14115; Sherman DA, 1998, NUCLEIC ACIDS RES, V26, P3955, DOI 10.1093/nar/26.17.3955; Speck C, 2007, J BIOL CHEM, V282, P11705, DOI 10.1074/jbc.M700399200; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Vashee S, 2001, J BIOL CHEM, V276, P26666, DOI 10.1074/jbc.M102493200; Waga S, 2006, J BIOL CHEM, V281, P10926, DOI 10.1074/jbc.M600299200; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wong PG, 2010, CELL CYCLE, V9, P4351, DOI 10.4161/cc.9.21.13596; Yanagi K, 2005, J BIOL CHEM, V280, P19689, DOI 10.1074/jbc.C500070200; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; You ZY, 2008, J BIOL CHEM, V283, P24469, DOI 10.1074/jbc.M803212200; You ZY, 1999, MOL CELL BIOL, V19, P8003	55	7	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30810	30821		10.1074/jbc.M114.552935	http://dx.doi.org/10.1074/jbc.M114.552935			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231993	Green Published, hybrid			2022-12-28	WOS:000344549700055
J	Liu, ZH; Li, WL; Ma, XF; Ding, N; Spallotta, F; Southon, E; Tessarollo, L; Gaetano, C; Mukouyama, YS; Thiele, CJ				Liu, Zhihui; Li, Wenling; Ma, Xuefei; Ding, Nancy; Spallotta, Francesco; Southon, Eileen; Tessarollo, Lino; Gaetano, Carlo; Mukouyama, Yoh-suke; Thiele, Carol J.			Essential Role of the Zinc Finger Transcription Factor Casz1 for Mammalian Cardiac Morphogenesis and Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiac Development; Cardiovascular; Development; Heart Development; Heart Failure	CONGENITAL HEART-DISEASE; CELL-CYCLE; GENE; MUTATIONS; CARDIOMYOPATHY; CASTOR; GROWTH; DIFFERENTIATION; MYOPATHIES; EXPRESSION	Background: The CASZ1 (castor zinc finger 1) gene localizes to chromosome 1p36, and 1p36 deletion syndrome is related to congenital heart disease (CHD). Results:Casz1 knock-out mice exhibited abnormal heart development and phenocopies aspects of 1p36 deletion syndrome related CHD. Conclusion:CASZ1 is critical for mammalian heart development. Significance:CASZ1 may be a novel CHD gene, and this finding opens new avenues for human heart disease diagnosis and treatment. Chromosome 1p36 deletion syndrome is one of the most common terminal deletions observed in humans and is related to congenital heart disease (CHD). However, the 1p36 genes that contribute to heart disease have not been clearly delineated. Human CASZ1 gene localizes to 1p36 and encodes a zinc finger transcription factor. Casz1 is required for Xenopus heart ventral midline progenitor cell differentiation. Whether Casz1 plays a role during mammalian heart development is unknown. Our aim is to determine 1p36 gene CASZ1 function at regulating heart development in mammals. We generated a Casz1 knock-out mouse using Casz1-trapped embryonic stem cells. Casz1 deletion in mice resulted in abnormal heart development including hypoplasia of myocardium, ventricular septal defect, and disorganized morphology. Hypoplasia of myocardium was caused by decreased cardiomyocyte proliferation. Comparative genome-wide RNA transcriptome analysis of Casz1 depleted embryonic hearts identifies abnormal expression of genes that are critical for muscular system development and function, such as muscle contraction genes TNNI2, TNNT1, and CKM; contractile fiber gene ACTA1; and cardiac arrhythmia associated ion channel coding genes ABCC9 and CACNA1D. The transcriptional regulation of some of these genes by Casz1 was also found in cellular models. Our results showed that loss of Casz1 during mouse development led to heart defect including cardiac noncompaction and ventricular septal defect, which phenocopies 1p36 deletion syndrome related CHD. This suggests that CASZ1 is a novel 1p36 CHD gene and that the abnormal expression of cardiac morphogenesis and contraction genes induced by loss of Casz1 contributes to the heart defect.	[Liu, Zhihui; Ding, Nancy; Thiele, Carol J.] NCI, Pediat Oncol Branch, Bethesda, MD 20892 USA; [Southon, Eileen; Tessarollo, Lino] NCI, Mouse Canc Genet Program, Neural Dev Sect, Bethesda, MD 20892 USA; [Li, Wenling; Mukouyama, Yoh-suke] NHLBI, Lab Stem Cell & Neurovasc Biol, NIH, Bethesda, MD 20892 USA; [Ma, Xuefei] NHLBI, Labs Mol Cardiol, NIH, Bethesda, MD 20892 USA; [Spallotta, Francesco; Gaetano, Carlo] Goethe Univ Frankfurt, Div Cardiovasc Epigenet, Dept Cardiol, D-60596 Frankfurt, Germany	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Goethe University Frankfurt	Liu, ZH (corresponding author), 9000 Rockville Pike,Bldg 10,Rm 1W-3940,MSC 1105, Bethesda, MD 20892 USA.	liuzhihu@mail.nih.gov; thielec@mail.nih.gov	Spallotta, Francesco/AAB-6261-2019; Gaetano, Carlo/P-9997-2019	Spallotta, Francesco/0000-0002-0466-6286; Gaetano, Carlo/0000-0002-5238-1832; Mukouyama, Yoh-suke/0000-0002-9084-4922	Intramural Research Program of the National Institutes of Health; National Cancer Institute; Center for Cancer Research; LOEWE-CGT Centre of Excellence; Wolfgang Geothe University; Deutsche Forschungsgemeinschaft [SFB834]; NATIONAL CANCER INSTITUTE [ZIABC010788] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006116] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); LOEWE-CGT Centre of Excellence; Wolfgang Geothe University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, the National Cancer Institute, and the Center for Cancer Research.; Supported by the LOEWE-CGT Centre of Excellence, Wolfgang Geothe University, and by Deutsche Forschungsgemeinschaft Program SFB834, "Endothelial Signaling and Vascular Repair," Project B11 (to C.G.).	Allocati N, 2012, EXP CELL RES, V318, P1285, DOI 10.1016/j.yexcr.2012.01.023; Barone V, 2012, CURR OPIN CELL BIOL, V24, P148, DOI 10.1016/j.ceb.2011.11.006; Beffagna G, 2005, CARDIOVASC RES, V65, P366, DOI 10.1016/j.cardiores.2004.10.005; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; Bruneau BG, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008292; Cerrone M, 2012, CURR OPIN CARDIOL, V27, P242, DOI 10.1097/HCO.0b013e328352429d; Chang AN, 2005, HEART FAIL REV, V10, P225, DOI 10.1007/s10741-005-5252-6; Charpentier MS, 2013, DEV CELL, V25, P132, DOI 10.1016/j.devcel.2013.03.003; Christinel KS, 2008, DEV CELL, V14, P616, DOI 10.1016/j.devcel.2008.01.009; Clarkson E, 2004, J PATHOL, V204, P407, DOI 10.1002/path.1648; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Corda S, 2000, Heart Fail Rev, V5, P119, DOI 10.1023/A:1009806403194; CUI X, 1992, DEVELOPMENT, V116, P943; Fahed AC, 2013, CIRC RES, V112, P707, DOI 10.1161/CIRCRESAHA.112.300853; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; Gajecka M, 2007, AM J MED GENET C, V145C, P346, DOI 10.1002/ajmg.c.30154; Gerety SS, 2002, DEVELOPMENT, V129, P1397; Giudicessi JR, 2012, NAT REV CARDIOL, V9, P319, DOI 10.1038/nrcardio.2012.3; Greenberg CC, 2008, EXP CELL RES, V314, P1177, DOI 10.1016/j.yexcr.2007.12.009; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hatcher CJ, 2009, CIRC RES, V105, P620, DOI 10.1161/CIRCRESAHA.109.204123; Hein S, 2000, CARDIOVASC RES, V45, P273, DOI 10.1016/S0008-6363(99)00268-0; Henrich KO, 2012, CANCER RES, V72, P6079, DOI 10.1158/0008-5472.CAN-12-2230; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Iordanskaia T, 2011, J CELL PHYSIOL, V226, P1415, DOI 10.1002/jcp.22477; Jensen RW, 2011, JOVE-J VIS EXP, DOI 10.3791/3104; Kim SY, 2011, J NEUROL SCI, V307, P171, DOI 10.1016/j.jns.2011.04.022; Kimber E, 2006, NEUROLOGY, V67, P597, DOI 10.1212/01.wnl.0000230168.05328.f4; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Li WL, 2013, DEV CELL, V24, P359, DOI 10.1016/j.devcel.2013.01.009; Little NA, 2002, INT J BIOCHEM CELL B, V34, P6, DOI 10.1016/S1357-2725(01)00086-3; Liu Z, 2011, CELL DEATH DIFFER, V18, P1174, DOI 10.1038/cdd.2010.187; Liu ZT, 2011, EURASIP J ADV SIG PR, DOI 10.1155/2011/490289; Liu ZH, 2006, BIOCHEM BIOPH RES CO, V344, P834, DOI 10.1016/j.bbrc.2006.03.207; Lombardi R, 2011, PEDIATR CARDIOL, V32, P360, DOI 10.1007/s00246-011-9890-2; Ma XF, 2010, MOL BIOL CELL, V21, P3952, DOI 10.1091/mbc.E10-04-0293; Maitra M, 2009, DEV BIOL, V326, P368, DOI 10.1016/j.ydbio.2008.11.004; McCulley DJ, 2012, CURR TOP DEV BIOL, V100, P253, DOI 10.1016/B978-0-12-387786-4.00008-7; MELLERICK DM, 1992, NEURON, V9, P789, DOI 10.1016/0896-6273(92)90234-5; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Mosca B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2496; Nakamura S, 2010, IN VITRO CELL DEV-AN, V46, P36, DOI 10.1007/s11626-009-9239-9; Nichols CG, 2013, CIRC RES, V112, P1059, DOI 10.1161/CIRCRESAHA.112.300514; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Reid Susan W., 2009, V530, P269, DOI 10.1007/978-1-59745-471-1_14; Robaszkiewicz K, 2011, POSTEP HIG MED DOSW, V65, P347, DOI 10.5604/17322693.948191; Rossini A, 2011, CARDIOVASC RES, V89, P650, DOI 10.1093/cvr/cvq290; Solaro RJ, 2008, CARDIOVASC RES, V77, P616, DOI 10.1093/cvr/cvn004; Spallotta F, 2013, J BIOL CHEM, V288, P11004, DOI 10.1074/jbc.M112.441816; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stennard FA, 2005, DEVELOPMENT, V132, P4897, DOI 10.1242/dev.02099; Tsoutsman T, 2008, CLIN EXP PHARMACOL P, V35, P1349, DOI 10.1111/j.1440-1681.2008.05037.x; Vacalla CMH, 2002, MECH DEVELOP, V118, P265, DOI 10.1016/S0925-4773(02)00282-4; Vecellio M, 2014, DIABETES, V63, P2132, DOI 10.2337/db13-0731; Venetucci L, 2012, NAT REV CARDIOL, V9, P561, DOI 10.1038/nrcardio.2012.93; Virden RA, 2012, MOL CELL BIOL, V32, P1518, DOI 10.1128/MCB.06039-11; Wang CX, 2012, CANCER RES, V72, P315, DOI 10.1158/0008-5472.CAN-11-0961; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zhu X, 2013, GENE, V528, P352, DOI 10.1016/j.gene.2013.07.024	61	42	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29801	29816		10.1074/jbc.M114.570416	http://dx.doi.org/10.1074/jbc.M114.570416			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25190801	Green Published, hybrid			2022-12-28	WOS:000344370800026
J	Jin, HB; Chiou, TT; Serwanski, DR; Miralles, CP; Pinal, N; De Blas, AL				Jin, Hongbing; Chiou, Tzu-Ting; Serwanski, David R.; Miralles, Celia P.; Pinal, Noelia; De Blas, Angel L.			Ring Finger Protein 34 (RNF34) Interacts with and Promotes gamma-Aminobutyric Acid Type-A Receptor Degradation via Ubiquitination of the gamma 2 Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLORECTAL-CANCER CELLS; METABOTROPIC GLUTAMATE RECEPTORS; CULTURED HIPPOCAMPAL-NEURONS; GABA(A) RECEPTORS; GABAERGIC SYNAPSES; MONOCLONAL-ANTIBODIES; RAT-BRAIN; NONSYNAPTIC LOCALIZATION; INHIBITORY SYNAPSES; SURFACE EXPRESSION	We have found that the large intracellular loop of the gamma 2 GABA(A) receptor (R) subunit (gamma 2IL) interacts with RNF34 (an E3 ubiquitin ligase), as shown by yeast two-hybrid and in vitro pull-down assays. In brain extracts, RNF34 co-immunoprecipitates with assembled GABA(A)Rs. In co-transfected HEK293 cells, RNF34 reduces the expression of the gamma 2 GABA(A)R subunit by increasing the ratio of ubiquitinated/nonubiquitinated gamma 2. Mutating several lysines of the gamma 2IL into arginines makes the gamma 2 subunit resistant to RNF34-induced degradation. RNF34 also reduces the expression of the gamma 2 subunit when alpha 1 and beta 3 subunits are co-assembled with gamma 2. This effect is partially reversed by leupeptin or MG132, indicating that both the lysosomal and proteasomal degradation pathways are involved. Immunofluorescence of cultured hippocampal neurons shows that RNF34 forms clusters and that a subset of these clusters is associated with GABAergic synapses. This association is also observed in the intact rat brain by electron microscopy immunocytochemistry. RNF34 is not expressed until the 2nd postnatal week of rat brain development, being highly expressed in some interneurons. Overexpression of RNF34 in hippocampal neurons decreases the density of gamma 2 GABA(A)R clusters and the number of GABAergic contacts that these neurons receive. Knocking down endogenous RNF34 with shRNA leads to increased gamma 2 GABA(A)R cluster density and GABAergic innervation. The results indicate that RNF34 regulates postsynaptic gamma 2-GABA(A)R clustering and GABAergic synaptic innervation by interacting with and ubiquitinating the gamma 2-GABA(A)R subunit promoting GABA(A)R degradation.	[Jin, Hongbing; Chiou, Tzu-Ting; Serwanski, David R.; Miralles, Celia P.; Pinal, Noelia; De Blas, Angel L.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA	University of Connecticut	De Blas, AL (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, 75 N Eagleville Rd,U-3156, Storrs, CT 06269 USA.	angel.deblas@uconn.edu			National Institutes of Health from NINDS [R01NS038752]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038752] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS038752 from NINDS (to A. L. D.).	Araki K, 2003, J NEUROCHEM, V86, P749, DOI 10.1046/j.1471-4159.2003.01875.x; Arancibia-Carcamo IL, 2009, P NATL ACAD SCI USA, V106, P17552, DOI 10.1073/pnas.0905502106; Charych EI, 2006, J NEUROCHEM, V97, P884, DOI 10.1111/j.1471-4159.2006.03795.x; Charych EI, 2004, J BIOL CHEM, V279, P38978, DOI 10.1074/jbc.M405786200; Charych EI, 2004, J NEUROCHEM, V90, P173, DOI 10.1111/j.1471-4159.2004.02481.x; Chiou TT, 2011, J BIOL CHEM, V286, P22456, DOI 10.1074/jbc.M111.236190; Christie SB, 2006, MOL CELL NEUROSCI, V31, P1, DOI 10.1016/j.mcn.2005.08.014; Christie SB, 2003, J COMP NEUROL, V456, P361, DOI 10.1002/cne.10535; Christie SB, 2002, NEUROREPORT, V13, P2355, DOI 10.1097/00001756-200212030-00037; Christie SB, 2002, J NEUROSCI, V22, P684, DOI 10.1523/JNEUROSCI.22-03-00684.2002; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Connolly CN, 1999, MOL CELL NEUROSCI, V13, P259, DOI 10.1006/mcne.1999.0746; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; DEBLAS AL, 1983, ANAL BIOCHEM, V133, P214, DOI 10.1016/0003-2697(83)90245-2; DEBLAS AL, 1984, J NEUROSCI, V4, P265; DEBLAS AL, 1988, J NEUROSCI, V8, P602; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; FERNANDO LP, 1995, J NEUROCHEM, V64, P1305; Gallagher MJ, 2007, P NATL ACAD SCI USA, V104, P12999, DOI 10.1073/pnas.0700163104; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higgins D., 1998, CULTURING NERVE CELL, P37; Hoppe T, 2005, TRENDS BIOCHEM SCI, V30, P183, DOI 10.1016/j.tibs.2005.02.004; Ishikawa K, 1999, GENES CELLS, V4, P381, DOI 10.1046/j.1365-2443.1999.00269.x; Jurd R, 2008, J BIOL CHEM, V283, P301, DOI 10.1074/jbc.M705580200; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Kittler JT, 2000, MOL CELL NEUROSCI, V16, P440, DOI 10.1006/mcne.2000.0882; Konishi T, 2006, ONCOGENE, V25, P3160, DOI 10.1038/sj.onc.1209342; Konishi T, 2005, ANTICANCER RES, V25, P2737; Konishi T, 2005, MOL CANCER THER, V4, P743, DOI 10.1158/1535-7163.MCT-05-0020; Li RW, 2005, J COMP NEUROL, V488, P11, DOI 10.1002/cne.20566; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Li X, 2007, J NEUROCHEM, V102, P1329, DOI 10.1111/j.1471-4159.2007.04635.x; Li XJ, 2009, J BIOL CHEM, V284, P17253, DOI 10.1074/jbc.M109.008870; Li YF, 2012, J NEUROSCI, V32, P11780, DOI 10.1523/JNEUROSCI.0969-12.2012; Li YF, 2010, J COMP NEUROL, V518, P3439, DOI 10.1002/cne.22390; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lin AW, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/432057; LOVERING R, 1993, P NATL ACAD SCI USA, V90, P2112, DOI 10.1073/pnas.90.6.2112; Lussier MP, 2012, P NATL ACAD SCI USA, V109, P19426, DOI 10.1073/pnas.1217477109; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; McDonald ER, 2004, P NATL ACAD SCI USA, V101, P6170, DOI 10.1073/pnas.0307459101; Moriyoshi K, 2004, P NATL ACAD SCI USA, V101, P8614, DOI 10.1073/pnas.0403042101; Nusser Z, 1998, J NEUROSCI, V18, P1693; Pavlopoulos E, 2011, CELL, V147, P1369, DOI 10.1016/j.cell.2011.09.056; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Riquelme R, 2002, J NEUROSCI, V22, P10720; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Saliba RS, 2007, J NEUROSCI, V27, P13341, DOI 10.1523/JNEUROSCI.3277-07.2007; Sasaki S, 2006, ONCOL REP, V15, P1293; Sasaki S, 2002, ONCOGENE, V21, P5024, DOI 10.1038/sj.onc.1205627; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Serwanski DR, 2006, J COMP NEUROL, V499, P458, DOI 10.1002/cne.21115; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Todd E, 2014, NEUROBIOL DIS, V69, P215, DOI 10.1016/j.nbd.2014.05.013; Tretter V, 1997, J NEUROSCI, V17, P2728; VITORICA J, 1988, J NEUROSCI, V8, P615; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Yamada T, 2013, TRENDS NEUROSCI, V36, P218, DOI 10.1016/j.tins.2012.12.004; Yang W, 2008, CELL CYCLE, V7, P670, DOI 10.4161/cc.7.5.5701; Yang W, 2007, CANCER BIOL THER, V6, P1676, DOI 10.4161/cbt.6.11.4939; Yang WS, 2007, J BIOL CHEM, V282, P3273, DOI 10.1074/jbc.M610793200; Yu W, 2008, J NEUROCHEM, V105, P2300, DOI 10.1111/j.1471-4159.2008.05311.x; Yu WD, 2008, J NEUROCHEM, V104, P830, DOI 10.1111/j.1471-4159.2007.05014.x; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008	71	21	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29420	29436		10.1074/jbc.M114.603068	http://dx.doi.org/10.1074/jbc.M114.603068			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25193658	Green Published, hybrid			2022-12-28	WOS:000344141000053
J	Nishibuchi, G; Shibata, Y; Hayakawa, T; Hayakawa, N; Ohtani, Y; Sinmyozu, K; Tagami, H; Nakayama, J				Nishibuchi, Gohei; Shibata, Yukimasa; Hayakawa, Tomohiro; Hayakawa, Noriyo; Ohtani, Yasuko; Sinmyozu, Kaori; Tagami, Hideaki; Nakayama, Jun-ichi			Physical and Functional Interactions between the Histone H3K4 Demethylase KDM5A and the Nucleosome Remodeling and Deacetylase (NuRD) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; BREAST-CANCER; VULVAL DEVELOPMENT; H-Y; DIFFERENTIATION; BINDING; GENES; RBP2; PROTEIN; ANTIGEN	Histone H3K4 methylation has been linked to transcriptional activation. KDM5A (also known as RBP2 or JARID1A), a member of the KDM5 protein family, is an H3K4 demethylase, previously implicated in the regulation of transcription and differentiation. Here, we show that KDM5A is physically and functionally associated with two histone deacetylase complexes. Immunoaffinity purification of KDM5A confirmed a previously described association with the SIN3B-containing histone deacetylase complex and revealed an association with the nucleosome remodeling and deacetylase (NuRD) complex. Sucrose density gradient and sequential immunoprecipitation analyses further confirmed the stable association of KDM5A with these two histone deacetylase complexes. KDM5A depletion led to changes in the expression of hundreds of genes, two-thirds of which were also controlled by CHD4, the NuRD catalytic subunit. Gene ontology analysis confirmed that the genes commonly regulated by both KDM5A and CHD4 were categorized as developmentally regulated genes. ChIP analyses suggested that CHD4 modulates H3K4 methylation levels at the promoter and coding regions of target genes. We further demonstrated that the Caenorhabditis elegans homologues of KDM5 and CHD4 function in the same pathway during vulva development. These results suggest that KDM5A and the NuRD complex cooperatively function to control developmentally regulated genes.	[Nishibuchi, Gohei; Tagami, Hideaki; Nakayama, Jun-ichi] Nagoya City Univ, Grad Sch Nat Sci, Nagoya, Aichi 4678501, Japan; [Shibata, Yukimasa] Kwansei Gakuin Univ, Grad Sch Sci & Technol, Dept Biosci, Sanda, Hyogo 6691337, Japan; [Hayakawa, Tomohiro; Hayakawa, Noriyo; Ohtani, Yasuko; Nakayama, Jun-ichi] RIKEN Ctr Dev Biol, Lab Chromatin Dynam, Kobe, Hyogo 6500047, Japan; [Sinmyozu, Kaori] RIKEN Ctr Dev Biol, Prote Support Unit, Kobe, Hyogo 6500047, Japan	Nagoya City University; Kwansei Gakuin University; RIKEN; RIKEN	Nakayama, J (corresponding author), Nagoya City Univ, Grad Sch Nat Sci, Mizuho Ku, 1 Yamanohata,Mizuho Cho, Nagoya, Aichi 4678501, Japan.	jnakayam@nsc.nagoya-cu.ac.jp	Shibata, Yukimasa/H-8467-2017; Nakayama, Jun-ichi/C-6003-2011	Nakayama, Jun-ichi/0000-0002-5597-8239	National Institutes of Health; NCRR; National Bioresource Project for strains	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Bioresource Project for strains	We thank Dr. Y. Kumaki for critical experimental advice, the Caenorhabditis Genetics Center, which is funded by National Institutes of Health, NCRR, and the National Bioresource Project for strains.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Albert M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003461; Barrett A, 2002, INT J CANCER, V101, P581, DOI 10.1002/ijc.10644; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; BRENNER S, 1974, GENETICS, V77, P71; Ceol CJ, 2006, GENETICS, V173, P709, DOI 10.1534/genetics.106.056465; Chaturvedi CP, 2012, P NATL ACAD SCI USA, V109, P18845, DOI 10.1073/pnas.1213951109; Chicas A, 2012, P NATL ACAD SCI USA, V109, P8971, DOI 10.1073/pnas.1119836109; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dey BK, 2008, MOL CELL BIOL, V28, P5312, DOI 10.1128/MCB.00128-08; Di Stefano L, 2011, GENE DEV, V25, P17, DOI 10.1101/gad.1983711; DiTacchio L, 2011, SCIENCE, V333, P1881, DOI 10.1126/science.1206022; Eissenberg JC, 2007, NAT STRUCT MOL BIOL, V14, P344, DOI 10.1038/nsmb1217; Fay DS, 2007, DEV BIOL, V306, P1, DOI 10.1016/j.ydbio.2007.03.016; FERGUSON EL, 1989, GENETICS, V123, P109; Hayakawa T, 2007, GENES CELLS, V12, P811, DOI 10.1111/j.1365-2443.2007.01089.x; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; Hayakawa T, 2010, J CELL SCI, V123, P1124, DOI 10.1242/jcs.060178; Hiragami-Hamada K, 2011, MOL CELL BIOL, V31, P1186, DOI 10.1128/MCB.01012-10; Hughes-Davies L, 2003, CELL, V115, P523, DOI 10.1016/S0092-8674(03)00930-9; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Lee N, 2009, MOL CELL BIOL, V29, P1401, DOI 10.1128/MCB.01643-08; Li L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001221; Li Q, 2011, CANCER RES, V71, P6899, DOI 10.1158/0008-5472.CAN-11-1523; Lin WC, 2011, P NATL ACAD SCI USA, V108, P13379, DOI 10.1073/pnas.1110104108; Lloret-Llinares M, 2012, NUCLEIC ACIDS RES, V40, P9493, DOI 10.1093/nar/gks773; Lopez-Bigas N, 2008, MOL CELL, V31, P520, DOI 10.1016/j.molcel.2008.08.004; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; McDonel P, 2009, INT J BIOCHEM CELL B, V41, P108, DOI 10.1016/j.biocel.2008.07.022; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Nijwening JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025235; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Schmitz SU, 2011, EMBO J, V30, P4586, DOI 10.1038/emboj.2011.383; SCOTT DM, 1995, NATURE, V376, P695, DOI 10.1038/376695a0; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Solari F, 2000, CURR BIOL, V10, P223, DOI 10.1016/S0960-9822(00)00343-2; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Tu SJ, 2008, NAT STRUCT MOL BIOL, V15, P419, DOI 10.1038/nsmb.1400; von Zelewsky T, 2000, DEVELOPMENT, V127, P5277; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; WANG W, 1995, SCIENCE, V269, P1588, DOI 10.1126/science.7667640; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	54	50	50	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28956	28970		10.1074/jbc.M114.573725	http://dx.doi.org/10.1074/jbc.M114.573725			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25190814	Green Published, hybrid			2022-12-28	WOS:000344141000017
J	Velazquez-Marrero, C; Seale, GE; Treistman, SN; Martin, GE				Velazquez-Marrero, Cristina; Seale, Garrett E.; Treistman, Steven N.; Martin, Gilles E.			Large Conductance Voltage- and Ca2+-gated Potassium (BK) Channel beta 4 Subunit Influences Sensitivity and Tolerance to Alcohol by Altering Its Response to Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CA2+-ACTIVATED K+ CHANNELS; FUNCTIONAL-CHARACTERIZATION; CALCIUM; ETHANOL; PHOSPHORYLATION; EXPRESSION; HSLO; CLONING; ALPHA	Tolerance is a well described component of alcohol abuse and addiction. The large conductance voltage- and Ca2+-gated potassium channel (BK) has been very useful for studying molecular tolerance. The influence of association with the beta 4 subunit can be observed at the level of individual channels, action potentials in brain slices, and finally, drinking behavior in the mouse. Previously, we showed that 50 mM alcohol increases both alpha and alpha beta 4 BK channel open probability, but only alpha BK develops acute tolerance to this effect. Currently, we explore the possibility that the influence of the beta 4 subunit on tolerance may result from a striking effect of beta 4 on kinase modulation of the BK channel. We examine the influence of the beta 4 subunit on PKA, CaMKII, and phosphatase modulation of channel activity, and on molecular tolerance to alcohol. We record from human BK channels heterologously expressed in HEK 293 cells composed of its core subunit, alpha alone (Insertless), or co-expressed with the beta 4 BK auxiliary subunit, as well as, acutely dissociated nucleus accumbens neurons using the cell-attached patch clamp configuration. Our results indicate that BK channels are strongly modulated by activation of specific kinases (PKA and CaMKII) and phosphatases. The presence of the beta 4 subunit greatly influences this modulation, allowing a variety of outcomes for BK channel activity in response to acute alcohol.	[Velazquez-Marrero, Cristina; Seale, Garrett E.; Treistman, Steven N.] Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Worcester, MA 01604 USA; [Martin, Gilles E.] Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00901 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Puerto Rico	Treistman, SN (corresponding author), Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Worcester, MA 01604 USA.	steven.treistman@upr.edu; Gilles.Martin@Umassmed.edu		Martin, Gilles/0000-0001-6611-9678	National Center for Research Resources Grant [2G12 RR003051]; National Institute on Minority Health and Health Disparities Grant [8G12MD007600]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018038, R01AA020501] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	National Center for Research Resources Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We are grateful to the Shipston laboratory for their generosity in providing the ZERO cDNA constructs characterized by Tian and colleagues (43) for the purposes of this study. Infrastructure support was provided in part by National Center for Research Resources Grant 2G12 RR003051 and the National Institute on Minority Health and Health Disparities Grant 8G12MD007600.	Ahring PK, 1997, FEBS LETT, V415, P67, DOI 10.1016/S0014-5793(97)01096-X; Alioua A, 1998, J BIOL CHEM, V273, P32950, DOI 10.1074/jbc.273.49.32950; Alioua A, 2002, P NATL ACAD SCI USA, V99, P14560, DOI 10.1073/pnas.222348099; Amanchy Ramars, 2011, J Proteomics Bioinform, V4, P22; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; CARL A, 1991, AM J PHYSIOL, V261, pC387, DOI 10.1152/ajpcell.1991.261.2.C387; Carroll ME, 2007, PHARMACOL BIOCHEM BE, V88, P94, DOI 10.1016/j.pbb.2007.07.010; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; CICERO TJ, 1980, J PHARMACOL EXP THER, V215, P317; Cowmeadow RB, 2005, ALCOHOL CLIN EXP RES, V29, P1777, DOI 10.1097/01.alc.0000183232.56788.62; Crowley JJ, 2003, MOL PHARMACOL, V64, P365, DOI 10.1124/mol.64.2.365; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Dopico AM, 1996, MOL PHARMACOL, V49, P40; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; ERWIN VG, 1980, PHARMACOL BIOCHEM BE, V13, P297, DOI 10.1016/S0091-3057(80)80045-1; Erxleben C, 2002, J BIOL CHEM, V277, P27045, DOI 10.1074/jbc.M203087200; Feinberg-Zadek PL, 2007, ALCOHOL CLIN EXP RES, V31, P737, DOI 10.1111/j.1530-0277.2007.00371.x; Fukao M, 1999, J BIOL CHEM, V274, P10927, DOI 10.1074/jbc.274.16.10927; GORDON AG, 1993, ALCOHOL CLIN EXP RES, V17, P926, DOI 10.1111/j.1530-0277.1993.tb00867.x; Hagen BM, 2003, AM J PHYSIOL-CELL PH, V285, pC1270, DOI 10.1152/ajpcell.00153.2003; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Jin P, 2002, J BIOL CHEM, V277, P10014, DOI 10.1074/jbc.M107682200; Knott TK, 2002, MOL PHARMACOL, V62, P135, DOI 10.1124/mol.62.1.135; Koob G F, 1998, Adv Pharmacol, V42, P969; KUME H, 1989, NATURE, V341, P152, DOI 10.1038/341152a0; Ling SZ, 2000, J BIOL CHEM, V275, P30683, DOI 10.1074/jbc.M004292200; Lippiat JD, 2003, J MEMBRANE BIOL, V192, P141, DOI 10.1007/s00232-002-1070-0; Liu JX, 2006, NAT NEUROSCI, V9, P41, DOI 10.1038/nn1602; Martin G, 2004, J NEUROSCI, V24, P6563, DOI 10.1523/JNEUROSCI.0684-04.2004; Martin G, 2002, J PHARMACOL EXP THER, V302, P1135, DOI 10.1124/jpet.102.033399; Martin GE, 2008, P NATL ACAD SCI USA, V105, P17543, DOI 10.1073/pnas.0801068105; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; MEERA P, 1995, AM J PHYSIOL-CELL PH, V269, pC312, DOI 10.1152/ajpcell.1995.269.2.C312; Melendez RI, 2011, ALCOHOL CLIN EXP RES, V35, P652, DOI 10.1111/j.1530-0277.2010.01383.x; Mutschler NH, 2001, PSYCHOPHARMACOLOGY, V154, P292, DOI 10.1007/s002130000646; Nagy LE, 1996, ALCOHOL CLIN EXP RES, V20, pA106, DOI 10.1111/j.1530-0277.1996.tb01756.x; Nara M, 1998, J BIOL CHEM, V273, P14920, DOI 10.1074/jbc.273.24.14920; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Sansom SC, 2000, AM J PHYSIOL-RENAL, V279, pF283, DOI 10.1152/ajprenal.2000.279.2.F283; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Schuckit MA, 2008, AM J DRUG ALCOHOL AB, V34, P133, DOI 10.1080/00952990701877003; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Swayze RD, 2001, J BIOL CHEM, V276, P19729, DOI 10.1074/jbc.M005711200; Tian B, 2001, J BIOL CHEM, V276, P9936, DOI 10.1074/jbc.M007328200; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Tian LJ, 2003, J BIOL CHEM, V278, P8669, DOI 10.1074/jbc.M211661200; Tian LJ, 2001, J PHYSIOL-LONDON, V537, P57, DOI 10.1111/j.1469-7793.2001.0057k.x; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Treistman SN, 2009, TRENDS NEUROSCI, V32, P629, DOI 10.1016/j.tins.2009.08.001; TsengCrank J, 1996, P NATL ACAD SCI USA, V93, P9200, DOI 10.1073/pnas.93.17.9200; van Welie I, 2011, J NEUROPHYSIOL, V105, P1651, DOI 10.1152/jn.00058.2011; Wang ZJJ, 2006, LIFE SCI, V79, P1681, DOI 10.1016/j.lfs.2006.05.023; Wang ZW, 2008, MOL NEUROBIOL, V38, P153, DOI 10.1007/s12035-008-8039-7; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; WHITE RE, 1991, NATURE, V351, P570, DOI 10.1038/351570a0; WHITE RE, 1993, NATURE, V361, P263, DOI 10.1038/361263a0; Yuan C, 2008, J BIOL CHEM, V283, P5090, DOI 10.1074/jbc.M708214200; Yuan CB, 2007, J BIOL CHEM, V282, P7276, DOI 10.1074/jbc.M607593200; Yuan CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027572	60	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29261	29272		10.1074/jbc.M114.604306	http://dx.doi.org/10.1074/jbc.M114.604306			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25190810	Green Published, hybrid			2022-12-28	WOS:000344141000040
J	Vigetti, D; Deleonibus, S; Moretto, P; Bowen, T; Fischer, JW; Grandoch, M; Oberhuber, A; Love, DC; Hanover, JA; Cinquetti, R; Karousou, E; Viola, M; D'Angelo, ML; Hascall, VC; De Luca, G; Passi, A				Vigetti, Davide; Deleonibus, Sara; Moretto, Paola; Bowen, Timothy; Fischer, Jens W.; Grandoch, Maria; Oberhuber, Alexander; Love, Dona C.; Hanover, John A.; Cinquetti, Raffaella; Karousou, Eugenia; Viola, Manuela; D'Angelo, Maria Luisa; Hascall, Vincent C.; De Luca, Giancarlo; Passi, Alberto			Natural Antisense Transcript for Hyaluronan Synthase 2 (HAS2-AS1) Induces Transcription of HAS2 via Protein O-GlcNAcylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINE; LONG NONCODING RNAS; KAPPA-B ACTIVATION; INSULIN-RESISTANCE; GLCNAC; CHROMATIN; GLUCOSE; EXPRESSION; GENE; ATHEROSCLEROSIS	Changes in the microenvironment organization within vascular walls are critical events in the pathogenesis of vascular pathologies, including atherosclerosis and restenosis. Hyaluronan (HA) accumulation into artery walls supports vessel thickening and is involved in many cardiocirculatory diseases. Excessive cytosolic glucose can enter the hexosamine biosynthetic pathway, increase UDP-N-acetylglucosamine (UDP-GlcNAc) availability, and lead to modification of cytosolic proteins via O-linked attachment of the monosaccharide beta-N-GlcNAc (O-GlcNAcylation) from UDP-GlcNAc by the enzyme O-GlcNAc transferase. As many cytoplasmic and nuclear proteins can be glycosylated by O-GlcNAc, we studied whether the expression of the HA synthases that synthesize HA could be controlled by O-GlcNAcylation in human aortic smooth muscle cells. Among the three HAS isoenzymes, only HAS2 mRNA increased after O-GlcNAcylation induced by glucosamine treatments or by inhibiting O-GlcNAc transferase with PUGNAC (O-(2-acetamido- 2-deoxy-D-glucopyranosylidene) amino-N-phenylcarbamate). We found that the natural antisense transcript of HAS2 (HAS2-AS1) was absolutely necessary to induce the transcription of the HAS2 gene. Moreover, we found that O-GlcNAcylation modulated HAS2-AS1 promoter activation by recruiting the NF-kappa B subunit p65, but not the HAS2 promoter, whereas HAS2-AS1 natural antisense transcript, working in cis, regulated HAS2 transcription by altering the chromatin structure around the HAS2 proximal promoter via O-GlcNAcylation and acetylation. These results indicate that HAS2 transcription can be finely regulated not only by recruiting transcription factors to the promoter as previously described but also by modulating chromatin accessibility by epigenetic modifications.	[Vigetti, Davide; Deleonibus, Sara; Moretto, Paola; Karousou, Eugenia; Viola, Manuela; D'Angelo, Maria Luisa; De Luca, Giancarlo; Passi, Alberto] Univ Insubria, Dipartimento Sci Chirurg & Morfol, I-21100 Varese, Italy; [Bowen, Timothy] Cardiff Univ, Sch Med, Dept Nephrol, Cardiff CF14 4XN, S Glam, Wales; [Fischer, Jens W.; Grandoch, Maria] Univ Dusseldorf, Inst Pharmacol & Clin Pharmacol, Univ Hosp Dusseldorf, D-40225 Dusseldorf, Germany; [Oberhuber, Alexander] Univ Dusseldorf, Univ Hosp Dusseldorf, Dept Vasc & Endovasc Surg, Dusseldorf, Germany; [Love, Dona C.; Hanover, John A.] NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA; [Cinquetti, Raffaella] Univ Insubria, Dipertimento Biotecnol & Sci Vita, I-21100 Varese, Italy; [Hascall, Vincent C.] Cleveland Clin, Biomed Engn ND20, Cleveland, OH 44195 USA	University of Insubria; Cardiff University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Insubria; Cleveland Clinic Foundation	Passi, A (corresponding author), Univ Insubria, Dipartimento Sci Chirurg & Morfol, Via JH Dunant 5, I-21100 Varese, Italy.	alberto.passi@uninsubria.it	Oberhuber, Alexander/DBR-7823-2022; passi, alberto g/A-1752-2018; Viola, Manuela/B-7120-2011	passi, alberto g/0000-0003-3328-3089; Viola, Manuela/0000-0002-0634-6390; Oberhuber, Alexander/0000-0002-6322-7152; vigetti, davide/0000-0002-6339-8453	FAR; PRIN; Fondazione Comunitaria del Vare-sotto-ONLUS; European Union Grant IRSES INFLAMA; Ph.D. School in Biological and Medical Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060101, ZIADK060103, ZIADK060102] Funding Source: NIH RePORTER	FAR; PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondazione Comunitaria del Vare-sotto-ONLUS; European Union Grant IRSES INFLAMA; Ph.D. School in Biological and Medical Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by FAR, PRIN, Fondazione Comunitaria del Vare-sotto-ONLUS, and European Union Grant IRSES INFLAMA (to A. P.).; Recipient of a fellowship from the Ph.D. School in Biological and Medical Sciences.	Allison DF, 2012, P NATL ACAD SCI USA, V109, P16888, DOI 10.1073/pnas.1208468109; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Chao H, 2005, J BIOL CHEM, V280, P27513, DOI 10.1074/jbc.M411544200; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Du Z, 2013, NAT STRUCT MOL BIOL, V20, P908, DOI 10.1038/nsmb.2591; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jokela TA, 2011, J BIOL CHEM, V286, P33632, DOI 10.1074/jbc.M111.265637; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Magistri M, 2012, TRENDS GENET, V28, P389, DOI 10.1016/j.tig.2012.03.013; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Michael DR, 2011, J BIOL CHEM, V286, P19523, DOI 10.1074/jbc.M111.233916; Nigro J, 2006, ENDOCR REV, V27, P242, DOI 10.1210/er.2005-0007; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Raman P, 2007, J BIOL CHEM, V282, P5704, DOI 10.1074/jbc.M610965200; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2006, FASEB J, V20, P1118, DOI 10.1096/fj.05-4504com; Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656; Vigetti D, 2014, BBA-GEN SUBJECTS, V1840, P2452, DOI 10.1016/j.bbagen.2014.02.001; Vigetti D, 2014, MATRIX BIOL, V35, P8, DOI 10.1016/j.matbio.2013.10.002; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Vigetti D, 2008, THESCIENTIFICWORLDJO, V8, P1116, DOI 10.1100/tsw.2008.145; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Yang WH, 2008, P NATL ACAD SCI USA, V105, P17345, DOI 10.1073/pnas.0806198105; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yoon JH, 2013, J MOL BIOL, V425, P3723, DOI 10.1016/j.jmb.2012.11.024; Yuan W, 2012, SCIENCE, V337, P971, DOI 10.1126/science.1225237; Zhang SS, 2011, J BIOL CHEM, V286, P37483, DOI 10.1074/jbc.M111.284885	54	94	96	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28816	28826		10.1074/jbc.M114.597401	http://dx.doi.org/10.1074/jbc.M114.597401			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25183006	hybrid, Green Published			2022-12-28	WOS:000344141000006
J	Guengerich, FP				Guengerich, F. Peter			Thematic Minireview Series: Metals in Biology 2014	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review								This thematic series, the sixth in the Metals in Biology collection beginning in 2009, addresses the issue of why certain metals are used by particular enzymes, as well as the consequences of using the wrong metal. This prologue introduces the 2014 Metals in Biology thematic series. The first minireview in the series deals with general aspects of metal specificity, and the next two deal with specific cases, the enzyme ribonucleotide reductase and iron/manganese homeostasis in the bacterium Bacillus subtilis. The fourth discusses metal selection in oxidative stress, and the final minireview discusses lysosome-related organelles as mediators of metal homeostasis.	Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			National Institutes of Health [R37 CA090426]; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 CA090426 (to F. P. G.).	Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Guengerich FP, 2013, J BIOL CHEM, V288, P13164, DOI 10.1074/jbc.R113.467712; Guengerich FP, 2012, J BIOL CHEM, V287, P13508, DOI 10.1074/jbc.R112.355933; Guengerich FP, 2010, J BIOL CHEM, V285, P26727, DOI 10.1074/jbc.R110.150870; Guengerich FP, 2009, J BIOL CHEM, V284, P18557, DOI 10.1074/jbc.M109.003863; Guengerich FP, 2009, J BIOL CHEM, V284, P709, DOI 10.1074/jbc.R800060200; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300	7	8	8	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28094	28094		10.1074/jbc.R114.607093	http://dx.doi.org/10.1074/jbc.R114.607093			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25160633	Green Published, hybrid			2022-12-28	WOS:000343765400004
J	Shridas, P; Zahoor, L; Forrest, KJ; Layne, JD; Webb, NR				Shridas, Preetha; Zahoor, Lubna; Forrest, Kathy J.; Layne, Joseph D.; Webb, Nancy R.			Group X Secretory Phospholipase A(2) Regulates Insulin Secretion through a Cyclooxygenase-2-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclooxygenase (COX); Insulin Secretion; Pancreatic Islet; Prostaglandin; Type 2 Diabetes	BETA-CELL FUNCTION; RAT PANCREATIC-ISLETS; PROTEIN-KINASE-C; ARACHIDONIC-ACID; GROUP-V; EXPRESSION; GLUCOSE; INHIBITION; IDENTIFICATION; COX-2	Background: Arachidonic acid and its metabolites regulate pancreatic glucose-stimulated insulin secretion (GSIS) through multiple mechanisms. Results: Group X secretory phospholipase A(2) (GX sPLA(2)) suppresses GSIS; suppression was abolished when COX-2 activity or PGE2-EP3 receptor signaling were inhibited. Conclusion: GX sPLA(2) inhibits GSIS by augmenting PGE2 production. Significance: GX sPLA(2) may be targeted for ameliorating beta cell dysfunction in type 2 diabetes. Group X secretory phospholipase A(2) (GX sPLA(2)) potently hydrolyzes membrane phospholipids to release arachidonic acid (AA). While AA is an activator of glucose-stimulated insulin secretion (GSIS), its metabolite prostaglandin E2 (PGE2) is a known inhibitor. In this study, we determined that GX sPLA(2) is expressed in insulin-producing cells of mouse pancreatic islets and investigated its role in beta cell function. GSIS was measured in vivo in wild-type (WT) and GX sPLA(2)-deficient (GX KO) mice and ex vivo using pancreatic islets isolated from WT and GX KO mice. GSIS was also assessed in vitro using mouse MIN6 pancreatic beta cells with or without GX sPLA(2) overexpression or exogenous addition. GSIS was significantly higher in islets isolated from GX KO mice compared with islets from WT mice. Conversely, GSIS was lower in MIN6 cells overexpressing GX sPLA(2) (MIN6-GX) compared with control (MIN6-C) cells. PGE2 production was significantly higher in MIN6-GX cells compared with MIN6-C cells and this was associated with significantly reduced cellular cAMP. The effect of GX sPLA(2) on GSIS was abolished when cells were treated with NS398 (a COX-2 inhibitor) or L-798,106 (a PGE2-EP3 receptor antagonist). Consistent with enhanced beta cell function, GX KO mice showed significantly increased plasma insulin levels following glucose challenge and were protected from age-related reductions in GSIS and glucose tolerance compared with WT mice. We conclude that GX sPLA(2) plays a previously unrecognized role in negatively regulating pancreatic insulin secretion by augmenting COX-2-dependent PGE2 production.	[Shridas, Preetha; Zahoor, Lubna; Forrest, Kathy J.; Layne, Joseph D.; Webb, Nancy R.] Univ Kentucky, Med Ctr, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Shridas, Preetha; Zahoor, Lubna; Forrest, Kathy J.] Univ Kentucky, Med Ctr, Dept Internal Med, Lexington, KY 40536 USA; [Layne, Joseph D.; Webb, Nancy R.] Univ Kentucky, Med Ctr, Dept Pharmacol & Nutr Sci, Div Nutr Sci, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky	Shridas, P (corresponding author), Dept Internal Med, 537 CT Wethington Bldg,900 S Limestone St, Lexington, KY 40536 USA.	pshri2@uky.edu	Webb, Nancy/AAL-7030-2021		National Institutes of Health [R01 DK082419]; NIGMS [8 P20 GM103527-05]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082419, T32DK007778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or in part by National Institutes of Health Grant R01 DK082419 (to N. R. W.) and the NIGMS Grant 8 P20 GM103527-05 (to P. S.).	Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; BENNETT DL, 1992, J BIOL CHEM, V267, P15229; Chen M, 1996, ENDOCRINOLOGY, V137, P2901, DOI 10.1210/en.137.7.2901; COLEMAN RA, 1994, PHARMACOL REV, V46, P205; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Fryirs M, 2009, CURR OPIN LIPIDOL, V20, P159, DOI 10.1097/MOL.0b013e32832ac180; Fujita H, 2007, BIOCHEM BIOPH RES CO, V363, P37, DOI 10.1016/j.bbrc.2007.08.090; Ishida-Oku M, 2010, ISLETS, V2, P274, DOI 10.4161/isl.2.5.12728; Jemel I, 2011, J BIOL CHEM, V286, P36509, DOI 10.1074/jbc.M111.268540; Jones PM, 2004, DIABETES, V53, pS172, DOI 10.2337/diabetes.53.2007.S172; JONES PM, 1993, J ENDOCRINOL, V137, P7, DOI 10.1677/joe.0.1370007; Juhl K, 2003, AM J PHYSIOL-ENDOC M, V285, pE73, DOI 10.1152/ajpendo.00086.2003; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Keane D, 2008, BIOCHEM SOC T, V36, P955, DOI 10.1042/BST0360955; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; Kimple ME, 2013, DIABETES, V62, P1904, DOI 10.2337/db12-0769; Kruit JK, 2012, DIABETES, V61, P659, DOI 10.2337/db11-1341; Labonte ED, 2006, DIABETES, V55, P935, DOI 10.2337/diabetes.55.04.06.db05-1286; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; LANDT M, 1992, CELL CALCIUM, V13, P163, DOI 10.1016/0143-4160(92)90044-S; Li X, 2010, FASEB J, V24, P4313, DOI 10.1096/fj.10-154716; Luo PC, 2011, PROSTAG OTH LIPID M, V95, P1, DOI 10.1016/j.prostaglandins.2011.06.001; Meng ZX, 2006, DIABETOLOGIA, V49, P2959, DOI 10.1007/s00125-006-0447-5; Meng ZX, 2009, ENDOCRINOLOGY, V150, P5284, DOI 10.1210/en.2009-0671; METZ SA, 1988, DIABETES, V37, P1453, DOI 10.2337/diabetes.37.11.1453; Morioka Y, 2000, FEBS LETT, V487, P262, DOI 10.1016/S0014-5793(00)02350-4; Mounier CM, 2004, J BIOL CHEM, V279, P25024, DOI 10.1074/jbc.M313019200; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Persaud SJ, 2007, DIABETES, V56, P197, DOI 10.2337/db06-0490; Persaud SJ, 2004, DIABETES, V53, pS190, DOI 10.2337/diabetes.53.2007.S190; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P5339, DOI 10.1021/bi00071a009; Ramanadham S, 1998, BBA-LIPID LIPID MET, V1390, P301, DOI 10.1016/S0005-2760(97)00189-6; ROBERTSON RP, 1987, DIABETES, V36, P1047, DOI 10.2337/diabetes.36.9.1047; Shridas P, 2010, ARTERIOSCL THROM VAS, V30, P2014, DOI 10.1161/ATVBAHA.110.210237; Shridas P, 2010, J BIOL CHEM, V285, P20031, DOI 10.1074/jbc.M109.090423; SMEEKENS SP, 1992, P NATL ACAD SCI USA, V89, P8822, DOI 10.1073/pnas.89.18.8822; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Song K, 2005, MOL ENDOCRINOL, V19, P504, DOI 10.1210/me.2004-0169; Sorli CH, 1998, P NATL ACAD SCI USA, V95, P1788, DOI 10.1073/pnas.95.4.1788; Tran POT, 2002, DIABETES, V51, P1772, DOI 10.2337/diabetes.51.6.1772; Tran POT, 1999, J BIOL CHEM, V274, P31245, DOI 10.1074/jbc.274.44.31245; Wooton-Kee CR, 2004, ARTERIOSCL THROM VAS, V24, P762, DOI 10.1161/01.ATV.0000122363.02961.c1; Yajima H, 1999, DIABETES, V48, P1006, DOI 10.2337/diabetes.48.5.1006	49	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27410	27417		10.1074/jbc.M114.591735	http://dx.doi.org/10.1074/jbc.M114.591735			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25122761	Green Published, hybrid			2022-12-28	WOS:000342852800005
J	Stewart, MD; Cole, TR; Igumenova, TI				Stewart, Mikaela D.; Cole, Taylor R.; Igumenova, Tatyana I.			Interfacial Partitioning of a Loop Hinge Residue Contributes to Diacylglycerol Affinity of Conserved Region 1 Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diacylglycerol; Lipid Signaling; Nuclear Magnetic Resonance (NMR); Phosphatidylserine; Protein Kinase C (PKC); C1 Domain; Protein-Lipid Interaction	PROTEIN-KINASE-C; PHORBOL ESTER BINDING; CYSTEINE-RICH REGION; MEMBRANE INTERFACES; C1B DOMAIN; ACTIVATION MECHANISMS; LIPID INTERACTION; MIXED MICELLES; SIDE-CHAINS; PKC-DELTA	Background: The activity of protein kinase C isoenzymes (PKCs) is regulated by diacylglycerol (DAG). Results: Aromatic residue that tunes DAG affinity influences the recruitment of the conserved region 1 (C1) regulatory domain to a membrane mimic. Conclusion: Membrane pre-association step contributes to the affinity of C1 to diacylglycerol. Significance: This work offers insight into the origin of differential DAG affinities in PKCs. Conventional and novel isoenzymes of PKC are activated by the membrane-embedded second messenger diacylglycerol (DAG) through its interactions with the C1 regulatory domain. The affinity of C1 domains to DAG varies considerably among PKCs. To gain insight into the origin of differential DAG affinities, we conducted high-resolution NMR studies of C1B domain from PKC (C1B) and its W252Y variant. The W252Y mutation was previously shown to render C1B less responsive to DAG (Dries, D. R., Gallegos, L. L., and Newton, A. C. (2007) A single residue in the C1 domain sensitizes novel protein kinase C isoforms to cellular diacylglycerol production. J. Biol. Chem. 282, 826-830) and thereby emulate the behavior of C1B domains from conventional PKCs that have a conserved Tyr at the equivalent position. Our data revealed that W252Y mutation did not perturb the conformation of C1B in solution but significantly reduced its propensity to partition into a membrane-mimicking environment in the absence of DAG. Using detergent micelles doped with a paramagnetic lipid, we determined that both the residue identity at position 252 and complexation with diacylglycerol influence the geometry of C1B-micelle interactions. In addition, we identified the C-terminal helix 1 of C1B as an interaction site with the head groups of phosphatidylserine, a known activator of PKC. Taken together, our studies (i) reveal the identities of C1B residues involved in interactions with membrane-mimicking environment, DAG, and phosphatidylserine, as well as the affinities associated with each event and (ii) suggest that the initial ligand-independent membrane recruitment of C1B domains, which is greatly facilitated by the interfacial partitioning of Trp-252, is responsible, at least in part, for the differential DAG affinities.	[Stewart, Mikaela D.; Cole, Taylor R.; Igumenova, Tatyana I.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Igumenova, TI (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, 300 Olsen Blvd, College Stn, TX 77843 USA.	tigumenova@tamu.edu	Stewart, Mikaela/GXN-3417-2022	Stewart, Mikaela/0000-0002-0809-9469	Texas AM University; NSF CAREER Award [CHE-1151435]; Welch Foundation [A-1784]; Direct For Mathematical & Physical Scien [1151435] Funding Source: National Science Foundation	Texas AM University; NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Welch Foundation(The Welch Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the startup funds from Texas A&M University and NSF CAREER Award CHE-1151435 ( to T. I. I.).; Supported by Welch Foundation Grant A-1784 ( to T. I. I.).	Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; Balayssac S, 2009, J MAGN RESON, V196, P78, DOI 10.1016/j.jmr.2008.09.022; BELL RM, 1991, J BIOL CHEM, V266, P4661; BELL RM, 1986, CELL, V45, P631, DOI 10.1016/0092-8674(86)90774-9; Bittova L, 2001, J BIOL CHEM, V276, P4218, DOI 10.1074/jbc.M008491200; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; Choi Y, 2007, J MED CHEM, V50, P3465, DOI 10.1021/jm0702579; Dancea F, 2008, BIOPHYS J, V94, P515, DOI 10.1529/biophysj.107.115923; de Jesus AJ, 2013, BBA-BIOMEMBRANES, V1828, P864, DOI 10.1016/j.bbamem.2012.09.009; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dougherty DA, 2007, J NUTR, V137, p1504S, DOI 10.1093/jn/137.6.1504S; Dries DR, 2008, J BIOL CHEM, V283, P7885, DOI 10.1074/jbc.M709943200; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Gallegos LL, 2008, IUBMB LIFE, V60, P782, DOI 10.1002/iub.122; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Goddard D., 2008, SPARKY 3; HANNUN YA, 1985, J BIOL CHEM, V260, P39; Haynes W. M., 2014, CRC HDB CHEM PHYS, P9; HOMMEL U, 1994, NAT STRUCT BIOL, V1, P383, DOI 10.1038/nsb0694-383; Hurley JH, 1997, PROTEIN SCI, V6, P477; Irie K, 1998, J AM CHEM SOC, V120, P9159, DOI 10.1021/ja981087f; Irie K, 2002, PHARMACOL THERAPEUT, V93, P271, DOI 10.1016/S0163-7258(02)00196-1; Jackson DN, 2004, FASEB J, V18, P627, DOI 10.1096/fj.03-0979rev; Johnson JE, 2000, BIOCHEMISTRY-US, V39, P11360, DOI 10.1021/bi000902c; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P14679, DOI 10.1074/jbc.270.24.14679; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Kucerka N, 2008, BIOPHYS J, V95, P2356, DOI 10.1529/biophysj.108.132662; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAUTERWEIN J, 1979, BIOCHIM BIOPHYS ACTA, V556, P244, DOI 10.1016/0005-2736(79)90046-4; LEE MH, 1989, J BIOL CHEM, V264, P14797; LYONS BA, 1993, J MAGN RESON SER B, V101, P206, DOI 10.1006/jmrb.1993.1034; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Medkova M, 1998, BIOCHEMISTRY-US, V37, P4892, DOI 10.1021/bi972495j; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NEWTON AC, 1989, J BIOL CHEM, V264, P14909; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Pogozheva ID, 2013, BBA-BIOMEMBRANES, V1828, P2592, DOI 10.1016/j.bbamem.2013.06.023; Pu YM, 2009, J BIOL CHEM, V284, P1302, DOI 10.1074/jbc.M804796200; QUEST AFG, 1994, J BIOL CHEM, V269, P2953; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Sanchez-Bautista S, 2009, BIOPHYS J, V96, P3638, DOI 10.1016/j.bpj.2009.02.021; Saraiva L, 2004, EUR J PHARMACOL, V491, P101, DOI 10.1016/j.ejphar.2004.03.035; Schramm CA, 2012, STRUCTURE, V20, P924, DOI 10.1016/j.str.2012.03.016; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Shanmugasundararaj S, 2012, BIOPHYS J, V103, P2331, DOI 10.1016/j.bpj.2012.10.034; Shen N, 2005, BIOCHEMISTRY-US, V44, P1089, DOI 10.1021/bi0476127; Slater SJ, 1996, J BIOL CHEM, V271, P4627; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stewart MD, 2011, J MOL BIOL, V408, P949, DOI 10.1016/j.jmb.2011.03.020; Szallasi Z, 1996, J BIOL CHEM, V271, P18299, DOI 10.1074/jbc.271.31.18299; Tristram-Nagle S, 2010, J MOL BIOL, V402, P139, DOI 10.1016/j.jmb.2010.07.026; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; Wang QMJ, 2001, J BIOL CHEM, V276, P19580, DOI 10.1074/jbc.M010089200; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; Wilcox C. S., 1991, FRONTIERS SUPRAMOLEC, P123; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Xu RX, 1997, BIOCHEMISTRY-US, V36, P10709, DOI 10.1021/bi970833a; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Ziemba BP, 2014, BIOCHEMISTRY-US, V53, P1697, DOI 10.1021/bi4016082	67	12	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27653	27664		10.1074/jbc.M114.585570	http://dx.doi.org/10.1074/jbc.M114.585570			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25124034	Green Published, hybrid			2022-12-28	WOS:000342852800025
J	Wolny, M; Batchelor, M; Knight, PJ; Paci, E; Dougan, L; Peckham, M				Wolny, Marcin; Batchelor, Matthew; Knight, Peter J.; Paci, Emanuele; Dougan, Lorna; Peckham, Michelle			Stable Single alpha-Helices Are Constant Force Springs in Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atomic Force Microscopy (AFM); Circular Dichroism (CD); Cytoskeleton; Molecular Dynamics; Structural Biology; Single -Helices	COILED-COIL; CIRCULAR-DICHROISM; MYOSIN-X; MICROSCOPY; LENGTH; ACTIN; ELASTICITY; STABILITY; FILAMENT; MYOMESIN	Background: Single -helix (SAH) domains bridge two functional domains in proteins. Their force response is poorly understood. Results: Modeling and experiments show that SAH domains unfold non-cooperatively at low forces and maintain an approximately constant force as they unfold. Conclusion: SAH domains act as constant force springs. Significance: SAH domains are important mechanical elements in proteins. Single -helix (SAH) domains are rich in charged residues (Arg, Lys, and Glu) and stable in solution over a wide range of pH and salt concentrations. They are found in many different proteins where they bridge two functional domains. To test the idea that their high stability might enable these proteins to resist unfolding along their length, the properties and unfolding behavior of the predicted SAH domain from myosin-10 were characterized. The expressed and purified SAH domain was highly helical, melted non-cooperatively, and was monomeric as shown by circular dichroism and mass spectrometry as expected for a SAH domain. Single molecule force spectroscopy experiments showed that the SAH domain unfolded at very low forces (<30 pN) without a characteristic unfolding peak. Molecular dynamics simulations showed that the SAH domain unfolds progressively as the length is increased and refolds progressively as the length is reduced. This enables the SAH domain to act as a constant force spring in the mechanically dynamic environment of the cell.	[Wolny, Marcin; Batchelor, Matthew; Knight, Peter J.; Paci, Emanuele; Dougan, Lorna; Peckham, Michelle] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Peckham, M (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Miall Bldg, Leeds LS2 9JT, W Yorkshire, England.	m.peckham@leeds.ac.uk	Paci, Emanuele/B-1893-2010; Peckham, Michelle/J-4991-2015	Paci, Emanuele/0000-0002-4891-2768; Peckham, Michelle/0000-0002-3754-2028; Batchelor, Matthew/0000-0001-6338-5698; Dougan, Lorna/0000-0002-2620-5827; Wolny, Marcin/0000-0003-1030-7607	Biotechnology and Biological Sciences Research Council [BB/I007423/1]; BBSRC [BB/I007423/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/I007423/1.	Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Berg JS, 2000, J CELL SCI, V113, P3439; Berkemeier F, 2011, P NATL ACAD SCI USA, V108, P14139, DOI 10.1073/pnas.1105734108; Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; Brockwell DJ, 2002, BIOPHYS J, V83, P458, DOI 10.1016/S0006-3495(02)75182-5; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P11288, DOI 10.1073/pnas.96.20.11288; FAIRMAN R, 1989, PROTEINS, V5, P1, DOI 10.1002/prot.340050102; FLORY PJ, 1956, J AM CHEM SOC, V78, P5222, DOI 10.1021/ja01601a025; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Haberthur U, 2008, J COMPUT CHEM, V29, P701, DOI 10.1002/jcc.20832; Hoffmann T, 2013, J PHYS CHEM B, V117, P1819, DOI 10.1021/jp310442s; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Lu H, 2000, BIOPHYS J, V79, P51, DOI 10.1016/S0006-3495(00)76273-4; Lu Q, 2012, P NATL ACAD SCI USA, V109, P17388, DOI 10.1073/pnas.1208642109; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Oberhauser AF, 1999, NAT STRUCT BIOL, V6, P1025; Peckham M, 2009, SOFT MATTER, V5, P2493, DOI 10.1039/b822339d; Pinotsis N, 2008, EMBO J, V27, P253, DOI 10.1038/sj.emboj.7601944; Sarkar A, 2005, J BIOL CHEM, V280, P6261, DOI 10.1074/jbc.C400573200; Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776; Seeber M, 2007, BIOINFORMATICS, V23, P2625, DOI 10.1093/bioinformatics/btm378; Seeber M, 2011, J COMPUT CHEM, V32, P1183, DOI 10.1002/jcc.21688; Sivaramakrishnan S, 2009, BIOPHYS J, V97, P2993, DOI 10.1016/j.bpj.2009.09.009; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P13356, DOI 10.1073/pnas.0806256105; Suveges D, 2009, PROTEINS, V74, P905, DOI 10.1002/prot.22183; Takagi Y, 2014, P NATL ACAD SCI USA, V111, pE1833, DOI 10.1073/pnas.1320122111; Tomatis VM, 2013, J CELL BIOL, V200, P301, DOI 10.1083/jcb.201204092; Wolny M, 2013, J BIOL CHEM, V288, P31952, DOI 10.1074/jbc.M113.513291; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Zinober RC, 2002, PROTEIN SCI, V11, P2759, DOI 10.1110/ps.0224602; Zocher M, 2012, P NATL ACAD SCI USA, V109, pE3463, DOI 10.1073/pnas.1210373109	37	39	43	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27825	27835		10.1074/jbc.M114.585679	http://dx.doi.org/10.1074/jbc.M114.585679			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25122759	Green Published, hybrid			2022-12-28	WOS:000342852800039
J	Ying, MY; Tilghman, J; Wei, YY; Guerrero-Cazares, H; Quinones-Hinojosa, A; Ji, HK; Laterra, J				Ying, Mingyao; Tilghman, Jessica; Wei, Yingying; Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo; Ji, Hongkai; Laterra, John			Kruppel-like Factor-9 (KLF9) Inhibits Glioblastoma Stemness through Global Transcription Repression and Integrin alpha 6 Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GROWTH-FACTOR RECEPTOR; IN-VITRO; CELLS; CANCER; NETWORK; GENE; COMPLEX; IDENTIFICATION; HETEROGENEITY	It is increasingly important to understand the molecular basis for the plasticity of neoplastic cells and their capacity to transition between differentiated and stemlike phenotypes. Kruppel-like factor-9 (KLF9), a member of the large KLF transcription factor family, has emerged as a regulator of oncogenesis, cell differentiation, and neural development; however, the molecular basis for the diverse contextual functions of KLF9 remains unclear. This study focused on the functions of KLF9 in human glioblastoma stemlike cells. We established for the first time a genome-wide map of KLF9-regulated targets in human glioblastoma stemlike cells and show that KLF9 functions as a transcriptional repressor and thereby regulates multiple signaling pathways involved in oncogenesis and stem cell regulation. A detailed analysis of one such pathway, integrin signaling, showed that the capacity of KLF9 to inhibit glioblastoma cell stemness and tumorigenicity requires ITGA6 repression. These findings enhance our understanding of the transcriptional networks underlying cancer cell stemness and differentiation and identify KLF9-regulated molecular targets applicable to cancer therapeutics.	[Ying, Mingyao; Tilghman, Jessica; Laterra, John] Kennedy Krieger, Hugo W Moser Res Inst, Baltimore, MD 21205 USA; [Ying, Mingyao; Laterra, John] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Tilghman, Jessica; Quinones-Hinojosa, Alfredo; Laterra, John] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Quinones-Hinojosa, Alfredo; Laterra, John] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo] Johns Hopkins Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Ji, Hongkai] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Wei, Yingying] Chinese Univ Hong Kong, Dept Stat, Shatin, Hong Kong, Peoples R China	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Chinese University of Hong Kong	Laterra, J (corresponding author), Kennedy Krieger Res Inst, 707 North Broadway, Baltimore, MD 21205 USA.	laterra@kennedykrieger.org	Wei, Yingying/S-8001-2018	Wei, Yingying/0000-0003-3826-336X; Guerrero-Cazares, Hugo/0000-0003-1307-719X	National Institutes of Health [RO1NS076759, RO1NS073611, RO1 5R01NS070024, R01HG006841]; James S. McDonnell Foundation; Maryland Stem Cell Research Fund; American Brain Tumor Association discovery grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073611, R01NS076759, R01NS070024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; Maryland Stem Cell Research Fund; American Brain Tumor Association discovery grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1NS076759 and RO1NS073611 (to J. L.), RO1 5R01NS070024 (to A. Q. H. and H. G. C.), and R01HG006841 (to H. J.). This work was also supported by the James S. McDonnell Foundation (to J. L.), the Maryland Stem Cell Research Fund (to M. Y. and J. L.), and an American Brain Tumor Association discovery grant (to M. Y.).	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Beier D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-128; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Chen SY, 2013, DEVELOPMENT, V140, P255, DOI 10.1242/dev.083139; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Dugas JC, 2012, MOL CELL NEUROSCI, V50, P45, DOI 10.1016/j.mcn.2012.03.007; Ehtesham M, 2013, J NEURO-ONCOL, V113, P153, DOI 10.1007/s11060-013-1108-4; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Filatova A, 2013, BBA-GEN SUBJECTS, V1830, P2496, DOI 10.1016/j.bbagen.2012.10.008; Frigo DE, 2009, MOL ENDOCRINOL, V23, P1385, DOI 10.1210/me.2009-0010; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Guemar L, 2007, DEV BIOL, V310, P113, DOI 10.1016/j.ydbio.2007.07.031; Heo JS, 2007, STEM CELLS, V25, P3069, DOI 10.1634/stemcells.2007-0550; HOGERVORST F, 1993, J CELL BIOL, V121, P179, DOI 10.1083/jcb.121.1.179; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Ji HK, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl803; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kanamori M, 2007, J NEUROSURG, V106, P417, DOI 10.3171/jns.2007.106.3.417; Kang L, 2008, PATHOL INT, V58, P334, DOI 10.1111/j.1440-1827.2008.02233.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lathia JD, 2012, ANN NEUROL, V72, P766, DOI 10.1002/ana.23674; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li YQ, 2012, CANCER RES, V72, P576, DOI 10.1158/0008-5472.CAN-11-3070; Li YQ, 2011, P NATL ACAD SCI USA, V108, P9951, DOI 10.1073/pnas.1016912108; Liekens S, 2010, CURR PHARM DESIGN, V16, P3903, DOI 10.2174/138161210794455003; Liu LN, 2011, BIOCHEM BIOPH RES CO, V413, P426, DOI 10.1016/j.bbrc.2011.08.108; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Marjanovic ND, 2013, CLIN CHEM, V59, P168, DOI 10.1373/clinchem.2012.184655; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Miller RJ, 2008, J NEUROIMMUNOL, V198, P31, DOI 10.1016/j.jneuroim.2008.04.008; Mitchell DL, 2010, MOL BIOL CELL, V21, P2780, DOI 10.1091/mbc.E10-04-0290; Nancy V, 1999, J BIOL CHEM, V274, P8737, DOI 10.1074/jbc.274.13.8737; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Persano L, 2013, BIOCHEM PHARMACOL, V85, P612, DOI 10.1016/j.bcp.2012.10.001; Ping YF, 2011, J PATHOL, V224, P344, DOI 10.1002/path.2908; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Prabakaran I, 2011, J THROID RES, V2011, DOI 10.4061/2011/979840; Qian H, 2006, BLOOD, V107, P3503, DOI 10.1182/blood-2005-10-3932; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; Seo S, 2012, J BIOL CHEM, V287, P12723, DOI 10.1074/jbc.M112.351395; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Simmons CD, 2011, BIOL REPROD, V85, P378, DOI 10.1095/biolreprod.110.090654; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Staquicinia FI, 2009, P NATL ACAD SCI USA, V106, P2903, DOI 10.1073/pnas.0813286106; Sun P, 2009, STEM CELLS, V27, P1473, DOI 10.1002/stem.89; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tetreault MP, 2013, NAT REV CANCER, V13, P701, DOI 10.1038/nrc3582; Thomas Sterling, 2010, Human Genomics, V4, P353; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uchida D, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-62; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Ying MY, 2011, STEM CELLS, V29, P20, DOI 10.1002/stem.561; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001	76	51	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.588988	http://dx.doi.org/10.1074/jbc.M114.588988			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25288800	Green Published, hybrid			2022-12-28	WOS:000345335000030
J	Barta, ML; Thomas, K; Yuan, HL; Lovell, S; Battaile, KP; Schramm, VL; Hefty, PS				Barta, Michael L.; Thomas, Keisha; Yuan, Hongling; Lovell, Scott; Battaile, Kevin P.; Schramm, Vern L.; Hefty, P. Scott			Structural and Biochemical Characterization of Chlamydia trachomatis Hypothetical Protein CT263 Supports That Menaquinone Synthesis Occurs through the Futalosine Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chlamydia; Crystallography; Enzyme Kinetics; Quinone; Respiration	TRANSITION-STATE ANALOGS; ESCHERICHIA-COLI; 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE; I-TASSER; ELECTRON-TRANSPORT; ENZYME; BIOSYNTHESIS; HELICOBACTER; INHIBITOR; SEQUENCE	The obligate intracellular human pathogen Chlamydia trachomatis is the etiological agent of blinding trachoma and sexually transmitted disease. Genomic sequencing of Chlamydia indicated this medically important bacterium was not exclusively dependent on the host cell for energy. In order for the electron transport chain to function, electron shuttling between membrane-embedded complexes requires lipid-soluble quinones (e.g. menaquionone or ubiquinone). The sources or biosynthetic pathways required to obtain these electron carriers within C. trachomatis are poorly understood. The 1.58 angstrom crystal structure of C. trachomatis hypothetical protein CT263 presented here supports a role in quinone biosynthesis. Although CT263 lacks sequence-based functional annotation, the crystal structure of CT263 displays striking structural similarity to 5-methylthioadenosine nucleosidase (MTAN) enzymes. Although CT263 lacks the active site-associated dimer interface found in prototypical MTANs, co-crystal structures with product (adenine) or substrate (5-methylthioadenosine) indicate that the canonical active site residues are conserved. Enzymatic characterization of CT263 indicates that the futalosine pathway intermediate 6-amino-6-deoxyfutalosine (k(cat)/K-m = 1.8 x 10(3) m(-1) s(-1)), but not the prototypical MTAN substrates (e.g. S-adenosylhomocysteine and 5-methylthioadenosine), is hydrolyzed. Bioinformatic analyses of the chlamydial proteome also support the futalosine pathway toward the synthesis of menaquinone in Chlamydiaceae. This report provides the first experimental support for quinone synthesis in Chlamydia. Menaquinone synthesis provides another target for agents to combat C. trachomatis infection.	[Barta, Michael L.; Hefty, P. Scott] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Thomas, Keisha; Yuan, Hongling; Schramm, Vern L.] Yeshiva Univ, Dept Biochem, Albert Einstein Coll Med, Bronx, NY 10461 USA; [Lovell, Scott] Univ Kansas, Del Shankel Struct Biol Ctr, Prot Struct Lab, Lawrence, KS 66047 USA; [Battaile, Kevin P.] Hauptman Woodward Med Res Inst, Ind Macromol Crystallog Assoc, Collaborat Access Team, Argonne, IL 60439 USA	University of Kansas; Yeshiva University; Albert Einstein College of Medicine; University of Kansas; Hauptman Woodward Medical Research Institute	Hefty, PS (corresponding author), Univ Kansas, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	pshefty@ku.edu		Battaile, Kevin/0000-0003-0833-3259	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Hauptman-Woodward Medical Research Institute; National Institutes of Health from the NCRR [5P20RR017708-10]; National Institutes of Health from NIGMS [8 P20 GM103420-10]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041916, P30GM110761, R37GM041916, P20GM103420] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Hauptman-Woodward Medical Research Institute; National Institutes of Health from the NCRR; National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contact DE-AC02-06CH11357 and use of the IMCA-CAT beamline 17-ID by the companies of the Industrial Macromolecular Crystallography Association through a contract with the Hauptman-Woodward Medical Research Institute. Use of the COBRE-PSF Protein Structure Laboratory at Kansas University was supported by National Institutes of Health Grant 5P20RR017708-10 from the NCRR and Grant 8 P20 GM103420-10 from the NIGMS. We acknowledge the proteomics facility at Albert Einstein College of Medicine for conducting the mass spectroscopy analysis. We thank Brandon L. Garcia for critical reading and discussion of the manuscript. We thank Liang Tang and Haiyan Zhao for assistance with analytical size exclusion chromatography analysis.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Allart B, 1998, EUR J BIOCHEM, V256, P155, DOI 10.1046/j.1432-1327.1998.2560155.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; BENTLEY R, 1982, MICROBIOL REV, V46, P241, DOI 10.1128/MMBR.46.3.241-280.1982; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Binet R, 2011, MBIO, V2, DOI 10.1128/mBio.00051-11; Bonner CA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00017; Brooijmans R, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-28; Choi-Rhee EJ, 2005, CHEM BIOL, V12, P589, DOI 10.1016/j.chembiol.2005.04.012; Collingro A, 2011, MOL BIOL EVOL, V28, P3253, DOI 10.1093/molbev/msr161; Dairi T, 2009, J ANTIBIOT, V62, P347, DOI 10.1038/ja.2009.46; DeLano W.L, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P, 2012, SCIENCE, V336, P986, DOI 10.1126/science.1222162; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Furie B, 1999, BLOOD, V93, P1798, DOI 10.1182/blood.V93.6.1798.406k22_1798_1808; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gutierrez JA, 2009, NAT CHEM BIOL, V5, P251, DOI 10.1038/nchembio.153; Haapalainen AM, 2013, STRUCTURE, V21, P963, DOI 10.1016/j.str.2013.04.009; Hiratsuka T, 2008, SCIENCE, V321, P1670, DOI 10.1126/science.1160446; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Juul N, 2007, J BACTERIOL, V189, P6723, DOI 10.1128/JB.00279-07; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim RQ, 2014, ACTA CRYSTALLOGR D, V70, P177, DOI 10.1107/S1399004713026655; Kurosu M, 2010, MOLECULES, V15, P1531, DOI 10.3390/molecules15031531; Lee JE, 2005, J MOL BIOL, V352, P559, DOI 10.1016/j.jmb.2005.07.027; Lee JE, 2005, J BIOL CHEM, V280, P18274, DOI 10.1074/jbc.M414471200; Lee JE, 2003, J BIOL CHEM, V278, P8761, DOI 10.1074/jbc.M210836200; Lee JE, 2001, STRUCTURE, V9, P941, DOI 10.1016/S0969-2126(01)00656-6; Meganathan R, 2001, VITAM HORM, V61, P173; MILLER CH, 1968, J BIOL CHEM, V243, P92; Mishra V, 2012, BIOCHEMISTRY-US, V51, P9763, DOI 10.1021/bi301221k; Omsland A, 2014, FEMS MICROBIOL REV, V38, P779, DOI 10.1111/1574-6976.12059; Omsland A, 2012, P NATL ACAD SCI USA, V109, P19781, DOI 10.1073/pnas.1212831109; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PAJULA RL, 1979, FEBS LETT, V99, P343, DOI 10.1016/0014-5793(79)80988-6; Parveen N, 2011, MOL MICROBIOL, V79, P7, DOI 10.1111/j.1365-2958.2010.07455.x; RAGIONE ED, 1985, BIOCHEM J, V232, P335, DOI 10.1042/bj2320335; RAINA A, 1982, BIOCHEM J, V204, P697, DOI 10.1042/bj2040697; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Ronning DR, 2010, PROTEIN SCI, V19, P2498, DOI 10.1002/pro.524; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Singh V, 2005, BIOCHEMISTRY-US, V44, P11647, DOI 10.1021/bi050863a; Siu KKW, 2008, ACTA CRYSTALLOGR F, V64, P343, DOI 10.1107/S1744309108009275; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Sturm MB, 2009, ANAL CHEM, V81, P2847, DOI 10.1021/ac8026433; SUFRIN JR, 1995, ANTIMICROB AGENTS CH, V39, P2511, DOI 10.1128/AAC.39.11.2511; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Wang SZ, 2012, BIOCHEMISTRY-US, V51, P6892, DOI 10.1021/bi3009664; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Yu CM, 2006, J CHROMATOGR A, V1132, P99, DOI 10.1016/j.chroma.2006.07.017; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zeyhle P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099122; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zhi XY, 2014, GENOME BIOL EVOL, V6, P149, DOI 10.1093/gbe/evu007	69	13	13	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32214	32229		10.1074/jbc.M114.594325	http://dx.doi.org/10.1074/jbc.M114.594325			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25253688	Green Published, hybrid			2022-12-28	WOS:000345314700048
J	Auer, M; Nicolussi, A; Schutz, G; Furtmuller, PG; Obinger, C				Auer, Markus; Nicolussi, Andrea; Schuetz, Georg; Furtmueller, Paul G.; Obinger, Christian			How Covalent Heme to Protein Bonds Influence the Formation and Reactivity of Redox Intermediates of a Bacterial Peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELOPEROXIDASE COMPOUND-I; MAMMALIAN PEROXIDASES; EOSINOPHIL PEROXIDASE; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; LACTOPEROXIDASE; LINKAGE; OXIDATION; KINETICS; BINDING	The most striking feature of mammalian peroxidases, including myeloperoxidase and lactoperoxidase (LPO) is the existence of covalent bonds between the prosthetic group and the protein, which has a strong impact on their (electronic) structure and biophysical and chemical properties. Recently, a novel bacterial heme peroxidase with high structural and functional similarities to LPO was described. Being released from Escherichia coli, it contains mainly heme b, which can be autocatalytically modified and covalently bound to the protein by incubation with hydrogen peroxide. In the present study, we investigated the reactivity of these two forms in their ferric, compound I and compound II state in a multi-mixing stopped-flow study. Upon heme modification, the reactions between the ferric proteins with cyanide or H2O2 were accelerated. Moreover, apparent bimolecular rate constants of the reaction of compound I with iodide, thiocyanate, bromide, and tyrosine increased significantly and became similar to LPO. Kinetic data are discussed and compared with known structure-function relationships of the mammalian peroxidases LPO and myeloperoxidase.	[Auer, Markus; Nicolussi, Andrea; Schuetz, Georg; Furtmueller, Paul G.; Obinger, Christian] Univ Nat Resources & Life Sci, Vienna Inst BioTechnol, Div Biochem, Dept Chem, A-1190 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Furtmuller, PG (corresponding author), Univ Nat Resources & Life Sci, Vienna Inst BioTechnol, Div Biochem, Dept Chem, Muthgasse 18, A-1190 Vienna, Austria.	paul.furtmueller@boku.ac.at; christian.obinger@boku.ac.at	Obinger, Christian/AAV-3173-2021; Furtmüller, Paul G./Y-5819-2018	Furtmüller, Paul G./0000-0002-1199-2469; Obinger, Christian/0000-0002-7133-3430	Austrian Science Fund [P20664, P25270]; Doctoral Program BioToP-Biomolecular Technology of Proteins [FWF W1224]	Austrian Science Fund(Austrian Science Fund (FWF)); Doctoral Program BioToP-Biomolecular Technology of Proteins	This work was supported by Austrian Science Fund Projects P20664 and P25270 and the Doctoral Program BioToP-Biomolecular Technology of Proteins (FWF W1224).	Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Auer M, 2013, J BIOL CHEM, V288, P27181, DOI 10.1074/jbc.M113.477067; Banerjee S, 2011, BIOTECHNOL J, V6, P231, DOI 10.1002/biot.201000375; Battistuzzi G, 2011, BIOCHEMISTRY-US, V50, P7987, DOI [10.1021/bi20084321, 10.1021/bi2008432]; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V500, P21, DOI 10.1016/j.abb.2010.03.002; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V494, P72, DOI 10.1016/j.abb.2009.11.021; Blair-Johnson M, 2001, BIOCHEMISTRY-US, V40, P13990, DOI 10.1021/bi0111808; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V788, P1, DOI 10.1016/0167-4838(84)90290-5; Brogioni S, 2008, BBA-PROTEINS PROTEOM, V1784, P843, DOI 10.1016/j.bbapap.2008.02.014; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; Colas C, 2002, J BIOL CHEM, V277, P7191, DOI 10.1074/jbc.M109523200; DePillis GD, 1997, J BIOL CHEM, V272, P8857; DOLMAN D, 1968, BIOCHEMISTRY-US, V7, P3991, DOI 10.1021/bi00851a028; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furtmuller PG, 2000, FEBS LETT, V484, P139, DOI 10.1016/S0014-5793(00)02143-8; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Furtmuller PG, 2002, BIOCHEMISTRY-US, V41, P11895, DOI 10.1021/bi026326x; Furtmuller PG, 2000, BIOCHEMISTRY-US, V39, P15578, DOI 10.1021/bi0020271; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; HARRIMAN A, 1987, J PHYS CHEM-US, V91, P6102, DOI 10.1021/j100308a011; Jantschko W, 2002, ARCH BIOCHEM BIOPHYS, V398, P12, DOI 10.1006/abbi.2001.2674; Lardinois OM, 1999, J BIOL CHEM, V274, P35441, DOI 10.1074/jbc.274.50.35441; MARQUEZ LA, 1994, BIOCHEMISTRY-US, V33, P1447, DOI 10.1021/bi00172a022; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Oxvig C, 1999, J BIOL CHEM, V274, P16953, DOI 10.1074/jbc.274.24.16953; Singh AK, 2008, J MOL BIOL, V376, P1060, DOI 10.1016/j.jmb.2007.12.012; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950; Zederbauer M, 2005, BIOCHEMISTRY-US, V44, P6482, DOI 10.1021/bi0501737; Zederbauer M, 2007, NAT PROD REP, V24, P571, DOI 10.1039/b604178g; Zederbauer M, 2007, J BIOL CHEM, V282, P17041, DOI 10.1074/jbc.M610685200; Zederbauer M, 2007, BIOCHEM BIOPH RES CO, V356, P450, DOI 10.1016/j.bbrc.2007.02.157	32	13	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31480	31491		10.1074/jbc.M114.595157	http://dx.doi.org/10.1074/jbc.M114.595157			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25246525	Green Published, hybrid			2022-12-28	WOS:000344549900050
J	Kwa, MQ; Huynh, J; Aw, J; Zhang, LY; Nguyen, T; Reynolds, EC; Sweet, MJ; Hamilton, JA; Scholz, GM				Kwa, Mei Qi; Huynh, Jennifer; Aw, Jiamin; Zhang, Lianyi; Thao Nguyen; Reynolds, Eric C.; Sweet, Matthew J.; Hamilton, John A.; Scholz, Glen M.			Receptor-interacting Protein Kinase 4 and Interferon Regulatory Factor 6 Function as a Signaling Axis to Regulate Keratinocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; POPLITEAL PTERYGIUM SYNDROME; C-ASSOCIATED KINASE; HUMAN EPIDERMAL-KERATINOCYTES; AUTOSOMAL-RECESSIVE FORM; BARTSOCAS-PAPAS SYNDROME; SQUAMOUS-CELL CARCINOMA; TRANSCRIPTION FACTORS; GENE-EXPRESSION; PKC-DELTA	Receptor-interacting protein kinase 4 (RIPK4) and interferon regulatory factor 6 (IRF6) are critical regulators of keratinocyte differentiation, and their mutation causes the related developmental epidermal disorders Bartsocas-Papas syndrome and popliteal pterygium syndrome, respectively. However, the signaling pathways in which RIPK4 and IRF6 operate to regulate keratinocyte differentiation are poorly defined. Here we identify and mechanistically define a direct functional relationship between RIPK4 and IRF6. Gene promoter reporter and in vitro kinase assays, coimmunoprecipitation experiments, and confocal microscopy demonstrated that RIPK4 directly regulates IRF6 trans-activator activity and nuclear translocation. Gene knockdown and overexpression studies indicated that the RIPK4-IRF6 signaling axis controls the expression of key transcriptional regulators of keratinocyte differentiation, including Grainyhead-like 3 and OVO-like 1. Additionally, we demonstrate that the p.Ile121Asn missense mutation in RIPK4, which has been identified recently in Bartsocas-Papas syndrome, inhibits its kinase activity, thereby preventing RIPK4-mediated IRF6 activation and nuclear translocation. We show, through mutagenesis-based experiments, that Ser-413 and Ser-424 in IRF6 are important for its activation by RIPK4. RIPK4 is also important for the regulation of IRF6 expression by the protein kinase C pathway. Therefore, our findings not only provide important mechanistic insights into the regulation of keratinocyte differentiation by RIPK4 and IRF6, but they also suggest one mechanism by which mutations in RIPK4 may cause epidermal disorders (e.g. Bartsocas-Papas syndrome), namely by the impaired activation of IRF6 by RIPK4.	[Kwa, Mei Qi; Huynh, Jennifer; Aw, Jiamin; Zhang, Lianyi; Reynolds, Eric C.; Scholz, Glen M.] Univ Melbourne, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Melbourne, Vic 3010, Australia; [Kwa, Mei Qi; Huynh, Jennifer; Aw, Jiamin; Zhang, Lianyi; Reynolds, Eric C.; Scholz, Glen M.] Univ Melbourne, Bio21 Inst, Melbourne, Vic 3010, Australia; [Kwa, Mei Qi; Huynh, Jennifer; Thao Nguyen; Hamilton, John A.; Scholz, Glen M.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia; [Sweet, Matthew J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Sweet, Matthew J.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia	University of Melbourne; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; University of Queensland; University of Queensland	Scholz, GM (corresponding author), Univ Melbourne, Melbourne Dent Sch, Melbourne, Vic 3010, Australia.	glenms@unimelb.edu.au	Zhang, Lianyi/H-7491-2014; Nguyen, Thao/GWN-0419-2022; Sweet, Matthew J/F-2229-2011; Kwa, Mei/I-6802-2018	Sweet, Matthew J/0000-0002-0406-8139; Kwa, Mei/0000-0001-8890-3391; Hamilton, John A/0000-0002-9493-9224; Reynolds, Eric/0000-0002-6618-4856; Scholz, Glen/0000-0003-2722-6344	National Health and Medical Research Council Project [628769]; Oral Health CRC	National Health and Medical Research Council Project(National Health and Medical Research Council (NHMRC) of Australia); Oral Health CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by National Health and Medical Research Council Project Grant 628769 and the Oral Health CRC.	Adhikary G, 2010, J INVEST DERMATOL, V130, P2017, DOI 10.1038/jid.2010.108; Bahr C, 2000, J BIOL CHEM, V275, P36350, DOI 10.1074/jbc.M004771200; BARTSOCAS CS, 1972, J MED GENET, V9, P222, DOI 10.1136/jmg.9.2.222; Biggs LC, 2012, J INVEST DERMATOL, V132, P50, DOI 10.1038/jid.2011.272; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Botti E, 2011, P NATL ACAD SCI USA, V108, P13710, DOI 10.1073/pnas.1110931108; Bushdid PB, 1998, NATURE, V392, P615, DOI 10.1038/33435; Chen LJ, 2001, J BIOL CHEM, V276, P21737, DOI 10.1074/jbc.M008069200; Chew YC, 2013, J BIOL CHEM, V288, P17759, DOI 10.1074/jbc.M113.477133; Chew YC, 2011, J BIOL CHEM, V286, P28772, DOI 10.1074/jbc.M110.205245; de la Garza G, 2013, J INVEST DERMATOL, V133, P68, DOI 10.1038/jid.2012.269; Denning MF, 2004, INT J BIOCHEM CELL B, V36, P1141, DOI 10.1016/j.biocel.2003.12.004; Deucher A, 2002, J BIOL CHEM, V277, P17032, DOI 10.1074/jbc.M109076200; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; DLUGOSZ AA, 1994, J INVEST DERMATOL, V102, P409, DOI 10.1111/1523-1747.ep12372171; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; FUCHS E, 1988, TRENDS GENET, V4, P277, DOI 10.1016/0168-9525(88)90169-2; GORLIN RJ, 1968, PEDIATRICS, V41, P503; Gugasyan R, 2004, MOL CELL BIOL, V24, P5733, DOI 10.1128/MCB.24.13.5733-5745.2004; HENNEKAM RCM, 1994, AM J MED GENET, V53, P102, DOI 10.1002/ajmg.1320530203; Holland PM, 2002, CURR BIOL, V12, P1424, DOI 10.1016/S0960-9822(02)01075-8; Hopkin AS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002829; Huang XD, 2013, SCIENCE, V339, P1441, DOI 10.1126/science.1232253; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Kalay E, 2012, AM J HUM GENET, V90, P76, DOI 10.1016/j.ajhg.2011.11.014; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Kwa MQ, 2014, J BIOL CHEM, V289, P19758, DOI 10.1074/jbc.M114.584540; Luscher B, 2012, EUR J CELL BIOL, V91, P506, DOI 10.1016/j.ejcb.2011.07.005; Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x; MATSUI MS, 1992, J INVEST DERMATOL, V99, P565, DOI 10.1111/1523-1747.ep12667411; Matsuzawa N, 2010, AM J MED GENET A, V152A, P2262, DOI 10.1002/ajmg.a.33338; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Meylan E, 2002, EMBO REP, V3, P1201, DOI 10.1093/embo-reports/kvf236; Mitchell K, 2012, AM J HUM GENET, V90, P69, DOI 10.1016/j.ajhg.2011.11.013; Moran ST, 2003, J BIOL CHEM, V278, P21526, DOI 10.1074/jbc.M301575200; Muto A, 2002, J BIOL CHEM, V277, P31871, DOI 10.1074/jbc.M202222200; Nair M, 2006, J CELL BIOL, V173, P253, DOI 10.1083/jcb.200508196; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; Restivo G, 2011, EMBO J, V30, P4571, DOI 10.1038/emboj.2011.325; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Rountree RB, 2010, J INVEST DERMATOL, V130, P102, DOI 10.1038/jid.2009.223; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Teng A, 2007, BBA-MOL BASIS DIS, V1772, P89, DOI 10.1016/j.bbadis.2006.08.012; Thomason HA, 2010, J CLIN INVEST, V120, P1561, DOI 10.1172/JCI40266; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Watt FM, 1989, CURR OPIN CELL BIOL, V1, P1107, DOI 10.1016/S0955-0674(89)80058-4; Watt FM, 2008, NAT REV CANCER, V8, P234, DOI 10.1038/nrc2328; WATT FM, 1983, J INVEST DERMATOL, V81, pS100, DOI 10.1111/1523-1747.ep12540786; Werner S, 2001, ONCOGENE, V20, P7494, DOI 10.1038/sj.onc.1204937; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015	56	41	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31077	31087		10.1074/jbc.M114.589382	http://dx.doi.org/10.1074/jbc.M114.589382			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25246526	hybrid, Green Published			2022-12-28	WOS:000344549900017
J	Bonar, D; Hanisch, FG				Bonar, David; Hanisch, Franz-Georg			Trefoil Factor Family Domains Represent Highly Efficient Conformational Determinants for N-Linked N,N '-di-N-acetyllactosediamine (LacdiNAc) Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Biosynthesis; Glycoprotein; Glycosylation; Mass Spectrometry (MS); N-Linked glycosylation; LDN; LacdiNAc; TFF2; Trefoil Factor Family	PANCREATIC SPASMOLYTIC POLYPEPTIDE; CRYSTAL-STRUCTURE; DIFFERENTIAL EXPRESSION; ANTIBODY-RESPONSES; MOLECULAR-CLONING; GLYCAN ANTIGEN; IN-VIVO; OLIGOSACCHARIDES; GLYCOSYLATION; PROOPIOMELANOCORTIN	Background: Absent microheterogeneity of LacdiNAc N-glycan on human gastric TFF2 points to high stringency control mechanism. Results: Single intact TFF domains of TFF2 control the 4-GalNAc transfer to terminal GlcNAc residues as conformational determinants. Conclusion: The role of a hydrophobic patch is hypothesized to form the essential part of the determinant. Significance: The restricted expression of LacdiNAc on extracellular matrix proteins relates to important biological processes. The disaccharide N,N-di-N-acetyllactose diamine (LacdiNAc, GalNAc1-4GlcNAc) is found in a limited number of extracellular matrix glycoproteins and neuropeptide hormones indicating a protein-specific transfer of GalNAc by the glycosyltransferases 4GalNAc-T3/T4. Whereas previous studies have revealed evidence for peptide determinants as controlling elements in LacdiNAc biosynthesis, we report here on an entirely independent conformational control of GalNAc transfer by single TFF (Trefoil factor) domains as high stringency determinants. Human TFF2 was recombinantly expressed in HEK-293 cells as a wild type full-length probe (TFF2-Fl, containing TFF domains P1 and P2), as single P1 or P2 domain probes, as a series of Cys/Gly mutant forms with aberrant domain structures, and as a double point-mutated probe (T68Q/F59Q) lacking aromatic residues within a hydrophobic patch. The N-glycosylation probes were analyzed by mass spectrometry for their glycoprofiles. In agreement with natural gastric TFF2, the recombinant full-length and single domain probes expressed nearly exclusively fucosylated LacdiNAc on bi-antennary complex-type chains indicating that a single TFF domain was sufficient to induce transfer of this modification. Contrasting to this, the Cys/Gly mutants showed strongly reduced LacdiNAc levels and instead preponderant LacNAc expression. The probe with point mutations of two highly conserved aromatic residues in loop 3 (T68Q/F59Q) revealed that these are essential determinant components, as the probe lacked LacdiNAc expression. The structural features of the LacdiNAc-inducing determinant on human TFF2 are discussed on the basis of crystal structures of porcine TFF2, and a series of extracellular matrix-related LacdiNAc-positive glycoproteins detected as novel candidate proteins in the secretome of HEK-293 cells.	[Bonar, David; Hanisch, Franz-Georg] Univ Cologne, Inst Biochem 2, Fac Med, D-50931 Cologne, Germany; [Hanisch, Franz-Georg] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	University of Cologne; University of Cologne	Hanisch, FG (corresponding author), Univ Cologne, Inst Biochem 2, Fac Med, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	franz.hanisch@uni-koeln.de			Deutsche Forschungsgemeinschaft [HA2092/21-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant HA2092/21-1 (to F.-G. H.).	Albert TK, 2010, J PROTEOME RES, V9, P3108, DOI 10.1021/pr100020c; Benoff S, 1997, MOL HUM REPROD, V3, P599, DOI 10.1093/molehr/3.7.599; Bork P, 1996, Q REV BIOPHYS, V29, P119, DOI 10.1017/S0033583500005783; Breloy I, 2008, J BIOL CHEM, V283, P18832, DOI 10.1074/jbc.M802834200; Breloy I, 2012, J BIOL CHEM, V287, P18275, DOI 10.1074/jbc.M111.280297; CARR MD, 1994, P NATL ACAD SCI USA, V91, P2206, DOI 10.1073/pnas.91.6.2206; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Che MI, 2014, ONCOTARGET, V5, P3673, DOI 10.18632/oncotarget.1981; CHIU MH, 1994, J BIOL CHEM, V269, P16195; DE A, 1994, P NATL ACAD SCI USA, V91, P1084, DOI 10.1073/pnas.91.3.1084; DELL A, 1995, J BIOL CHEM, V270, P24116, DOI 10.1074/jbc.270.41.24116; Dell A, 2003, P NATL ACAD SCI USA, V100, P15631, DOI 10.1073/pnas.2635507100; Do KY, 1997, GLYCOBIOLOGY, V7, P183, DOI 10.1093/glycob/7.2.183; Fiete D, 2007, J BIOL CHEM, V282, P1873, DOI 10.1074/jbc.M606455200; GAJHEDE M, 1993, STRUCTURE, V1, P253, DOI 10.1016/0969-2126(93)90014-8; Gotoh M, 2004, FEBS LETT, V562, P134, DOI 10.1016/S0014-5793(04)00219-4; GREEN ED, 1985, J BIOL CHEM, V260, P5623; Hanisch FG, 2013, GLYCOBIOLOGY, V23, P2, DOI 10.1093/glycob/cws131; Hanisch FG, 2009, BIOL CHEM, V390, P619, DOI 10.1515/BC.2009.043; HOOPER LV, 1995, J BIOL CHEM, V270, P5985, DOI 10.1074/jbc.270.11.5985; Hopf M, 2001, NAT STRUCT BIOL, V8, P634, DOI 10.1038/89683; Hsu WM, 2011, AM J PATHOL, V179, P1394, DOI 10.1016/j.ajpath.2011.05.025; Kenny DT, 2012, GLYCOBIOLOGY, V22, P1077, DOI 10.1093/glycob/cws076; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Manzella SM, 1996, J BIOL CHEM, V271, P12117, DOI 10.1074/jbc.271.21.12117; Manzella SM, 1997, J BIOL CHEM, V272, P4775, DOI 10.1074/jbc.272.8.4775; Martinez-Pomares L, 1999, J BIOL CHEM, V274, P35211, DOI 10.1074/jbc.274.49.35211; Miller E, 2008, J BIOL CHEM, V283, P1985, DOI 10.1074/jbc.M708160200; Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599; Muller S, 2002, J BIOL CHEM, V277, P26103, DOI 10.1074/jbc.M202921200; Nyame AK, 2004, ARCH BIOCHEM BIOPHYS, V426, P182, DOI 10.1016/j.abb.2004.04.004; Nyame AK, 1999, GLYCOBIOLOGY, V9, P1029, DOI 10.1093/glycob/9.10.1029; Nyame AK, 2000, EXP PARASITOL, V96, P202, DOI 10.1006/expr.2000.4573; Petersen TN, 1996, ACTA CRYSTALLOGR D, V52, P730, DOI 10.1107/S0907444996001345; Sasaki N, 2011, STEM CELLS, V29, P641, DOI 10.1002/stem.615; Sato T, 2003, J BIOL CHEM, V278, P47534, DOI 10.1074/jbc.M308857200; SICILIANO RA, 1994, J BIOL CHEM, V269, P910; SKELTON TP, 1992, J BIOL CHEM, V267, P12998; van den Berg TK, 2004, J IMMUNOL, V173, P1902, DOI 10.4049/jimmunol.173.3.1902; van Die I, 2003, GLYCOBIOLOGY, V13, P471, DOI 10.1093/glycob/cwg052; van Remoortere A, 2003, EXP PARASITOL, V105, P219, DOI 10.1016/j.exppara.2003.12.005; Woodworth A, 2001, GLYCOBIOLOGY, V11, P877	42	9	9	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29677	29690		10.1074/jbc.M114.596049	http://dx.doi.org/10.1074/jbc.M114.596049			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25210040	Green Published, hybrid			2022-12-28	WOS:000344370800017
J	Ulrich, T; Oberhettinger, P; Schutz, M; Holzer, K; Ramms, AS; Linke, D; Autenrieth, IB; Rapaport, D				Ulrich, Thomas; Oberhettinger, Philipp; Schuetz, Monika; Holzer, Katharina; Ramms, Anne S.; Linke, Dirk; Autenrieth, Ingo B.; Rapaport, Doron			Evolutionary Conservation in Biogenesis of beta-Barrel Proteins Allows Mitochondria to Assemble a Functional Bacterial Trimeric Autotransporter Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Adhesion; Membrane Protein; Mitochondrial Transport; Molecular Evolution; Protein Stability; Protein Targeting; BAM Complex; Skp; YadA; Autotransporters	OUTER-MEMBRANE BIOGENESIS; YERSINIA-ENTEROCOLITICA; CHAPERONE SKP; IMPORT; COMPLEX; ADHESIN; YADA; SECRETION; MACHINERY; DOMAINS	Background: -Barrel proteins are found in the outer membrane of Gram-negative bacteria, mitochondria, and chloroplasts. Results: Mitochondria are able to assemble the bacterial trimeric autotransporter YadA in a functional form. Conclusion: The lipoproteins of the BAM machinery are not absolutely required for the biogenesis of autotransporter protein. Significance: The evolutionary link of mitochondria to bacteria allows the former to process even prokaryotic-specific proteins. Yersinia adhesin A (YadA) belongs to a class of bacterial adhesins that form trimeric structures. Their mature form contains a passenger domain and a C-terminal -domain that anchors the protein in the outer membrane (OM). Little is known about how precursors of such proteins cross the periplasm and assemble into the OM. In the present study we took advantage of the evolutionary conservation in the biogenesis of -barrel proteins between bacteria and mitochondria. We previously observed that upon expression in yeast cells, bacterial -barrel proteins including the transmembrane domain of YadA assemble into the mitochondrial OM. In the current study we found that when expressed in yeast cells both the monomeric and trimeric forms of full-length YadA were detected in mitochondria but only the trimeric species was fully integrated into the OM. The oligomeric form was exposed on the surface of the organelle in its native conformation and maintained its capacity to adhere to host cells. The co-expression of YadA with a mitochondria-targeted form of the bacterial periplasmic chaperone Skp, but not with SurA or SecB, resulted in enhanced levels of both forms of YadA. Taken together, these results indicate that the proper assembly of trimeric autotransporter can occur also in a system lacking the lipoproteins of the BAM machinery and is specifically enhanced by the chaperone Skp.	[Ulrich, Thomas; Holzer, Katharina; Ramms, Anne S.; Rapaport, Doron] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Oberhettinger, Philipp; Schuetz, Monika; Autenrieth, Ingo B.] Univ Tubingen, Interfac Inst Microbiol & Infect Med, D-72076 Tubingen, Germany; [Linke, Dirk] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Max Planck Society	Rapaport, D (corresponding author), Univ Tubingen, Interfac Inst Biochem, Hoppe Seyler Str 4, D-72076 Tubingen, Germany.	doron.rapaport@uni-tuebingen.de	Linke, Dirk/F-9147-2010	Linke, Dirk/0000-0003-3150-6752	Deutsche Forschungsgemeinschaft [SFB766/B1, SFB766/B10, SFB766/B11]; UKT fortune program [F1433253]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); UKT fortune program	This work was supported by the Deutsche Forschungsgemeinschaft (SFB766/B1, to I. A. and M. S.; SFB766/B10, to D. L.; and SFB766/B11, to D. R.) and by the UKT fortune program (F1433253, to P. O.).	Ackermann N, 2008, J BACTERIOL, V190, P5031, DOI 10.1128/JB.00161-08; Alcock FH, 2008, BIOCHEM J, V409, P377, DOI 10.1042/BJ20070877; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Chan NC, 2008, MOL BIOL CELL, V19, P126, DOI 10.1091/mbc.E07-08-0796; DAUM G, 1982, J BIOL CHEM, V257, P3028; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Grijpstra J, 2013, RES MICROBIOL, V164, P562, DOI 10.1016/j.resmic.2013.03.010; Grosskinsky U, 2007, J BACTERIOL, V189, P9011, DOI 10.1128/JB.00985-07; Habib SJ, 2005, J BIOL CHEM, V280, P6434, DOI 10.1074/jbc.M411510200; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; Ieva R, 2011, P NATL ACAD SCI USA, V108, pE383, DOI 10.1073/pnas.1103827108; Ishikawa D, 2004, J CELL BIOL, V166, P621, DOI 10.1083/jcb.200405138; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003; Koh JY, 2001, MOL CELL BIOL, V21, P7576, DOI 10.1128/MCB.21.22.7576-7586.2001; Kondo-Okamoto N, 2008, EMBO REP, V9, P63, DOI 10.1038/sj.embor.7401113; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Kozjak-Pavlovic V, 2011, J BIOL CHEM, V286, P27019, DOI 10.1074/jbc.M111.232249; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Lehr U, 2010, MOL MICROBIOL, V78, P932, DOI 10.1111/j.1365-2958.2010.07377.x; Leo JC, 2012, PHILOS T R SOC B, V367, P1088, DOI 10.1098/rstb.2011.0208; Leonhard K, 1996, EMBO J, V15, P4218, DOI 10.1002/j.1460-2075.1996.tb00796.x; Leonhard K, 1999, NATURE, V398, P348, DOI 10.1038/18704; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; Milenkovic D, 2004, J BIOL CHEM, V279, P22781, DOI 10.1074/jbc.C400120200; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Muller JEN, 2011, MOL BIOL CELL, V22, P1638, DOI 10.1091/mbc.E10-12-0943; Muller A, 2002, EMBO J, V21, P1916, DOI 10.1093/emboj/21.8.1916; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Papic D, 2011, J CELL BIOL, V194, P397, DOI 10.1083/jcb.201102041; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Paschen SA, 2005, TRENDS BIOCHEM SCI, V30, P575, DOI 10.1016/j.tibs.2005.08.009; Pavlova O, 2013, P NATL ACAD SCI USA, V110, pE938, DOI 10.1073/pnas.1219076110; Pfanner N, 2004, NAT STRUCT MOL BIOL, V11, P1044, DOI 10.1038/nsmb852; Qiu J, 2013, CELL, V154, P596, DOI 10.1016/j.cell.2013.06.033; Qu J, 2007, J MOL BIOL, V374, P91, DOI 10.1016/j.jmb.2007.09.020; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; Rapaport D, 1999, J CELL BIOL, V146, P321, DOI 10.1083/jcb.146.2.321; Sauri A, 2011, J MOL BIOL, V412, P553, DOI 10.1016/j.jmb.2011.07.035; Schlossmann J, 1996, J BIOL CHEM, V271, P17890, DOI 10.1074/jbc.271.30.17890; Schmid Y, 2004, INFECT IMMUN, V72, P6780, DOI 10.1128/IAI.72.12.6780-6789.2004; Schutz M, 2010, INFECT IMMUN, V78, P2677, DOI 10.1128/IAI.01350-09; Selkrig J, 2012, NAT STRUCT MOL BIOL, V19, P506, DOI 10.1038/nsmb.2261; Shahid SA, 2012, NAT METHODS, V9, P1212, DOI [10.1038/NMETH.2248, 10.1038/nmeth.2248]; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Tokatlidis K, 1999, J BIOL CHEM, V274, P35285, DOI 10.1074/jbc.274.50.35285; Ullers RS, 2004, P NATL ACAD SCI USA, V101, P7583, DOI 10.1073/pnas.0402398101; Ulrich T, 2012, J BIOL CHEM, V287, P27467, DOI 10.1074/jbc.M112.382093; Volokhina EB, 2011, J BACTERIOL, V193, P1612, DOI 10.1128/JB.00532-10; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Waizenegger T, 2004, EMBO REP, V5, P704, DOI 10.1038/sj.embor.7400183; Walther DM, 2010, MOL BIOL EVOL, V27, P887, DOI 10.1093/molbev/msp294; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; Walton TA, 2009, P NATL ACAD SCI USA, V106, P1772, DOI 10.1073/pnas.0809275106; Wenz LS, 2014, EMBO REP, V15, P678, DOI 10.1002/embr.201338144; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wollmann P, 2006, INT J BIOL MACROMOL, V39, P3, DOI 10.1016/j.ijbiomac.2005.11.009; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	64	26	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29457	29470		10.1074/jbc.M114.565655	http://dx.doi.org/10.1074/jbc.M114.565655			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25190806	Green Published, hybrid			2022-12-28	WOS:000344370800001
J	Holden, JK; Lim, N; Poulos, TL				Holden, Jeffrey K.; Lim, Nathan; Poulos, Thomas L.			Identification of Redox Partners and Development of a Novel Chimeric Bacterial Nitric Oxide Synthase for Structure Activity Analyses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DATA QUALITY; INHIBITION; EXPRESSION; PROTEIN; ACID; FLAVODOXIN	Production of nitric oxide (NO) by nitric oxide synthase (NOS) requires electrons to reduce the heme iron for substrate oxidation. Both FAD and FMN flavin groups mediate the transfer of NADPH derived electrons to NOS. Unlike mammalian NOS that contain both FAD and FMN binding domains within a single polypeptide chain, bacterial NOS is only composed of an oxygenase domain and must rely on separate redox partners for electron transfer and subsequent activity. Here, we report on the native redox partners for Bacillus subtilis NOS (bsNOS) and a novel chimera that promotes bsNOS activity. By identifying and characterizing native redox partners, we were also able to establish a robust enzyme assay for measuring bsNOS activity and inhibition. This assay was used to evaluate a series of established NOS inhibitors. Using the new assay for screening small molecules led to the identification of several potent inhibitors for which bsNOS-inhibitor crystal structures were determined. In addition to characterizing potent bsNOS inhibitors, substrate binding was also analyzed using isothermal titration calorimetry giving the first detailed thermodynamic analysis of substrate binding to NOS.	[Holden, Jeffrey K.; Poulos, Thomas L.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Lim, Nathan; Poulos, Thomas L.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA; [Poulos, Thomas L.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Poulos, TL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, 2206 Nat Sci 1, Irvine, CA 92697 USA.	poulos@uci.edu		Holden, Jeffrey/0000-0002-7380-6799; Lim, Nathan/0000-0002-2075-5852	National Institutes of Health [GM57353]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM57353 (to T. L. P.).	Adak S, 2002, J BIOL CHEM, V277, P16167, DOI 10.1074/jbc.M201136200; Adak S, 2002, P NATL ACAD SCI USA, V99, P107, DOI 10.1073/pnas.012470099; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bird LE, 2002, STRUCTURE, V10, P1687, DOI 10.1016/S0969-2126(02)00911-5; Boer R, 2000, MOL PHARMACOL, V58, P1026, DOI 10.1124/mol.58.5.1026; Chartier FJM, 2007, BIOCHEM J, V401, P235, DOI 10.1042/BJ20060913; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Crane BR, 2010, ANNU REV BIOCHEM, V79, P445, DOI 10.1146/annurev-biochem-062608-103436; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; Holden JK, 2013, P NATL ACAD SCI USA, V110, P18127, DOI 10.1073/pnas.1314080110; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KNOWLES RG, 1990, BIOCHEM J, V269, P207, DOI 10.1042/bj2690207; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Komori H, 2010, PROTEIN SCI, V19, P2279, DOI 10.1002/pro.508; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lawson RJ, 2004, BIOCHEMISTRY-US, V43, P12390, DOI 10.1021/bi049131t; Martasek P, 1999, METHOD ENZYMOL, V301, P70; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moore CM, 2004, J BACTERIOL, V186, P4655, DOI 10.1128/JB.186.14.4655-4664.2004; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakano MM, 2002, J BACTERIOL, V184, P1783, DOI 10.1128/JB.184.6.1783-1787.2002; NARHI LO, 1986, J BIOL CHEM, V261, P7160; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Poulos TL, 2013, ACCOUNTS CHEM RES, V46, P390, DOI 10.1021/ar300175n; PUFAHL RA, 1995, BIOCHEMISTRY-US, V34, P1930, DOI 10.1021/bi00006a014; Raman CS, 2001, BIOCHEMISTRY-US, V40, P13448, DOI 10.1021/bi010957u; Reents H, 2006, J BACTERIOL, V188, P1103, DOI 10.1128/JB.188.3.1103-1112.2006; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; Seo D, 2004, ARCH MICROBIOL, V182, P80, DOI 10.1007/s00203-004-0701-5; Seo D, 2009, BBA-PROTEINS PROTEOM, V1794, P594, DOI 10.1016/j.bbapap.2008.12.014; Sevrioukova I, 1997, ARCH BIOCHEM BIOPHYS, V340, P231, DOI 10.1006/abbi.1997.9895; Silverman RB, 2009, ACCOUNTS CHEM RES, V42, P439, DOI 10.1021/ar800201v; SIMONDSEN RP, 1982, BIOCHEMISTRY-US, V21, P6366, DOI 10.1021/bi00268a008; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; Sudhamsu J, 2009, TRENDS MICROBIOL, V17, P212, DOI 10.1016/j.tim.2009.02.003; Tejero J, 2013, IUBMB LIFE, V65, P358, DOI 10.1002/iub.1136; van Sorge NM, 2013, J BIOL CHEM, V288, P6417, DOI 10.1074/jbc.M112.448738; Wang ZQ, 2007, J BIOL CHEM, V282, P2196, DOI 10.1074/jbc.M608206200; Wang ZQ, 2004, J BIOL CHEM, V279, P19018, DOI 10.1074/jbc.M311663200; WHITE KA, 1992, BIOCHEMISTRY-US, V31, P6627, DOI 10.1021/bi00144a001; WOLFF DJ, 1994, ARCH BIOCHEM BIOPHYS, V311, P300, DOI 10.1006/abbi.1994.1241; Xue FT, 2011, J MED CHEM, V54, P2039, DOI 10.1021/jm101071n	48	10	10	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29437	29445		10.1074/jbc.M114.595165	http://dx.doi.org/10.1074/jbc.M114.595165			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25194416	hybrid, Green Published			2022-12-28	WOS:000344141000054
J	Kang, Y; Ge, Y; Cassidy, RM; Lam, V; Luo, L; Moon, KM; Lewis, R; Molday, RS; Wong, ROL; Foster, LJ; Craig, AM				Kang, Yunhee; Ge, Yuan; Cassidy, Robert M.; Lam, Vivian; Luo, Lin; Moon, Kyung-Mee; Lewis, Renate; Molday, Robert S.; Wong, Rachel O. L.; Foster, Leonard J.; Craig, Ann Marie			A Combined Transgenic Proteomic Analysis and Regulated Trafficking of Neuroligin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORY SYNAPSE DEVELOPMENT; CELL-ADHESION MOLECULE; AXON INITIAL SEGMENT; GABA(A) RECEPTOR TRAFFICKING; TANDEM AFFINITY PURIFICATION; EXTRACELLULAR-MATRIX; EXCITATORY SYNAPSES; POSTSYNAPTIC DENSITY; DEFICIENT MICE; TENASCIN-R	Synapses, the basic units of communication in the brain, require complex molecular machinery for neurotransmitter release and reception. Whereas numerous components of excitatory postsynaptic sites have been identified, relatively few proteins are known that function at inhibitory postsynaptic sites. One such component is neuroligin-2 (NL2), an inhibitory synapse-specific cell surface protein that functions in cell adhesion and synaptic organization via binding to neurexins. In this study, we used a transgenic tandem affinity purification and mass spectrometry strategy to isolate and characterize NL2-associated complexes. Complexes purified from brains of transgenic His(6)-FLAG-YFP-NL2 mice showed enrichment in the Gene Ontology terms cell-cell signaling and synaptic transmission relative to complexes purified from wild type mice as a negative control. In addition to expected components including GABA receptor subunits and gephyrin, several novel proteins were isolated in association with NL2. Based on the presence of multiple components involved in trafficking and endocytosis, we showed that NL2 undergoes dynamin-dependent endocytosis in response to soluble ligand and colocalizes with VPS35 retromer in endosomes. Inhibitory synapses in brain also present a particular challenge for imaging. Whereas excitatory synapses on spines can be imaged with a fluorescent cell fill, inhibitory synapses require a molecular tag. We find the His(6)-FLAG-YFP-NL2 to be a suitable tag, with the unamplified YFP signal localizing appropriately to inhibitory synapses in multiple brain regions including cortex, hippocampus, thalamus, and basal ganglia. Altogether, we characterize NL2-associated complexes, demonstrate regulated trafficking of NL2, and provide tools for further proteomic and imaging studies of inhibitory synapses.	[Kang, Yunhee; Ge, Yuan; Cassidy, Robert M.; Lam, Vivian; Luo, Lin; Craig, Ann Marie] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; [Kang, Yunhee; Ge, Yuan; Cassidy, Robert M.; Lam, Vivian; Luo, Lin; Craig, Ann Marie] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada; [Moon, Kyung-Mee; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Moon, Kyung-Mee; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z3, Canada; [Molday, Robert S.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Molday, Robert S.] Univ British Columbia, Ctr Macular Res, Vancouver, BC V6T 1Z3, Canada; [Lewis, Renate] Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Wong, Rachel O. L.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Washington University (WUSTL); University of Washington; University of Washington Seattle	Craig, AM (corresponding author), Univ British Columbia, Rm F149,2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	acraig@mail.ubc.ca	Craig, Ann Marie/M-2054-2014	Cassidy, Robert/0000-0002-1336-7077	Canadian Institutes of Health Research Operating Grants [69096, 77688]; National Institutes of Health Grants [EY10699, EY02422]; Bluma Tischler Postdoctoral Fellowship; Canada Research Chair Awards; NATIONAL EYE INSTITUTE [P30EY001730, R01EY002422, R01EY010699] Funding Source: NIH RePORTER	Canadian Institutes of Health Research Operating Grants(Canadian Institutes of Health Research (CIHR)); National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bluma Tischler Postdoctoral Fellowship; Canada Research Chair Awards(Canada Research Chairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by Canadian Institutes of Health Research Operating Grants 69096 (to A. M. C.) and 77688 (to L. J. F.), National Institutes of Health Grants EY10699 (to R. O. W.) and EY02422 (to R. S. M.), a Bluma Tischler Postdoctoral Fellowship (to Y. K.), and Canada Research Chair Awards (to A. M. C., R. S. M., and L. J. F.).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bayes A, 2009, NAT REV NEUROSCI, V10, P635, DOI 10.1038/nrn2701; Blundell J, 2009, GENES BRAIN BEHAV, V8, P114, DOI 10.1111/j.1601-183X.2008.00455.x; Bot N, 2011, J BIOL CHEM, V286, P2762, DOI 10.1074/jbc.M110.142521; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Choy RWY, 2014, NEURON, V82, P55, DOI 10.1016/j.neuron.2014.02.018; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Fritschy JM, 2012, CELL MOL LIFE SCI, V69, P2485, DOI 10.1007/s00018-012-0926-4; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Heller EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039572; Hines RM, 2008, J NEUROSCI, V28, P6055, DOI 10.1523/JNEUROSCI.0032-08.2008; Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kim SY, 2013, TRENDS COGN SCI, V17, P596, DOI 10.1016/j.tics.2013.10.005; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Knuesel I, 1999, EUR J NEUROSCI, V11, P4457, DOI 10.1046/j.1460-9568.1999.00887.x; Kriebel M, 2011, J BIOL CHEM, V286, P24385, DOI 10.1074/jbc.M110.212191; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Li KW, 2004, J BIOL CHEM, V279, P987, DOI 10.1074/jbc.M303116200; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McRae PA, 2012, NEUROCHEM INT, V61, P963, DOI 10.1016/j.neuint.2012.08.007; Nikonenko A, 2003, J COMP NEUROL, V456, P338, DOI 10.1002/cne.10537; O'Sullivan GA, 2009, NEUROSCI LETT, V458, P106, DOI 10.1016/j.neulet.2009.04.036; Oku S, 2013, J BIOL CHEM, V288, P19816, DOI 10.1074/jbc.M112.431676; Patrizi A, 2008, P NATL ACAD SCI USA, V105, P13151, DOI 10.1073/pnas.0802390105; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Pettem KL, 2013, J CELL BIOL, V200, P321, DOI 10.1083/jcb.201206028; Poulopoulos A, 2012, BIOCHEM J, V446, P321, DOI 10.1042/BJ20120808; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Pribiag H, 2014, P NATL ACAD SCI USA, V111, P6810, DOI 10.1073/pnas.1321774111; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saghatelyan AK, 2001, MOL CELL NEUROSCI, V17, P226, DOI 10.1006/mcne.2000.0922; Sassoe-Pognetto M, 2000, J COMP NEUROL, V420, P481, DOI 10.1002/(SICI)1096-9861(20000515)420:4<481::AID-CNE6>3.0.CO;2-5; Saura CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019430; Schapitz IU, 2010, J NEUROSCI, V30, P12733, DOI 10.1523/JNEUROSCI.0896-10.2010; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Simpson JC, 2004, J CELL SCI, V117, P6297, DOI 10.1242/jcs.01560; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Soto F, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-31; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Takahashi H, 2012, NAT NEUROSCI, V15, P389, DOI 10.1038/nn.3040; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Tretter V, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00023; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; van Weering JRT, 2014, SEMIN CELL DEV BIOL, V31, P40, DOI 10.1016/j.semcdb.2014.03.015; VANAKEN T, 1986, METHOD ENZYMOL, V125, P27; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Vithlani M, 2011, PHYSIOL REV, V91, P1009, DOI 10.1152/physrev.00015.2010; Volkel P, 2010, BIOCHEM SOC T, V38, P883, DOI 10.1042/BST0380883; Whiting PJ, 2003, DRUG DISCOV TODAY, V8, P445, DOI 10.1016/S1359-6446(03)02703-X; Wohr M, 2013, BEHAV BRAIN RES, V251, P50, DOI 10.1016/j.bbr.2012.07.024; Woo J, 2013, J CELL BIOL, V201, P929, DOI 10.1083/jcb.201209132	73	30	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29350	29364		10.1074/jbc.M114.549279	http://dx.doi.org/10.1074/jbc.M114.549279			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25190809	Green Published, hybrid			2022-12-28	WOS:000344141000047
J	Ryzhikov, M; Gupta, R; Glickman, M; Korolev, S				Ryzhikov, Mikhail; Gupta, Richa; Glickman, Michael; Korolev, Sergey			RecO Protein Initiates DNA Recombination and Strand Annealing through Two Alternative DNA Binding Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGOUS RECOMBINATION; ESCHERICHIA-COLI; BREAK REPAIR; PRESYNAPTIC FILAMENT; REPLICATION FORKS; RECFOR PROTEINS; RAD52 PROTEIN; GENETIC-RECOMBINATION; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE	Recombination mediator proteins (RMPs) are important for genome stability in all organisms. Several RMPs support two alternative reactions: initiation of homologous recombination and DNA annealing. We examined mechanisms of RMPs in both reactions with Mycobacterium smegmatis RecO (MsRecO) and demonstrated that MsRecO interacts with ssDNA by two distinct mechanisms. Zinc stimulates MsRecO binding to ssDNA during annealing, whereas the recombination function is zinc-independent and is regulated by interaction with MsRecR. Thus, different structural motifs or conformations of MsRecO are responsible for interaction with ssDNA during annealing and recombination. Neither annealing nor recombinase loading depends on MsRecO interaction with the conserved C-terminal tail of single-stranded (ss) DNA-binding protein (SSB), which is known to bind Escherichia coli RecO. However, similarly to E. coli proteins, MsRecO and MsRecOR do not dismiss SSB from ssDNA, suggesting that RMPs form a complex with SSB-ssDNA even in the absence of binding to the major protein interaction motif. We propose that alternative conformations of such complexes define the mechanism by which RMPs initiate the repair of stalled replication and support two different functions during recombinational repair of DNA breaks.	[Ryzhikov, Mikhail; Korolev, Sergey] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Gupta, Richa; Glickman, Michael] Mem Sloan Kettering Canc Ctr, Div Infect Dis, New York, NY 10065 USA; [Gupta, Richa; Glickman, Michael] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA	Saint Louis University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Korolev, S (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, 1100 S Grand Blvd, St Louis, MO 63104 USA.	korolevs@slu.edu	Korolev, Sergey/ABA-7517-2020	Korolev, Sergey/0000-0001-9313-7126; Ryzhikov, Mikhail/0000-0003-0729-1368; Glickman, Michael S/0000-0001-7918-5164	National Institutes of Health [AI064693, GM073837]; Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI064693 (to M. G.) and GM073837 (to S. K.). This work was also supported by President's Research Fund, Saint Louis University (to S. K.).	ALONSO JC, 1991, MOL GEN GENET, V228, P393, DOI 10.1007/BF00260632; Antony E, 2012, J MOL BIOL, V420, P269, DOI 10.1016/j.jmb.2012.04.021; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; ASAI T, 1994, J BACTERIOL, V176, P7113, DOI 10.1128/JB.176.22.7113-7114.1994; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; Buisson R, 2010, NAT STRUCT MOL BIOL, V17, P1247, DOI 10.1038/nsmb.1915; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Couch FJ, 2014, SCIENCE, V343, P1466, DOI 10.1126/science.1251827; Courcelle J, 2005, MUTAT RES-FUND MOL M, V577, P217, DOI 10.1016/j.mrfmmm.2005.03.019; Courcelle J, 1997, P NATL ACAD SCI USA, V94, P3714, DOI 10.1073/pnas.94.8.3714; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; COX MM, 1991, MOL MICROBIOL, V5, P1295, DOI 10.1111/j.1365-2958.1991.tb00775.x; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Ganesh N, 2003, BIOCHEMISTRY-US, V42, P7216, DOI 10.1021/bi0340548; Genois MM, 2012, NUCLEIC ACIDS RES, V40, P6570, DOI 10.1093/nar/gks306; George NP, 2012, J BIOL CHEM, V287, P22123, DOI 10.1074/jbc.M112.367573; Grimme JM, 2010, NUCLEIC ACIDS RES, V38, P2917, DOI 10.1093/nar/gkp1249; Gupta R, 2013, NUCLEIC ACIDS RES, V41, P2284, DOI 10.1093/nar/gks1298; Gupta R, 2011, MOL MICROBIOL, V79, P316, DOI 10.1111/j.1365-2958.2010.07463.x; Hanas JS, 2005, MOL B INT U, P39; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Holloman WK, 2008, FUNGAL GENET BIOL, V45, pS31, DOI 10.1016/j.fgb.2008.04.006; Inoue J, 2008, NUCLEIC ACIDS RES, V36, P94, DOI 10.1093/nar/gkm1004; Jackson D, 2002, J MOL BIOL, V321, P133, DOI 10.1016/S0022-2836(02)00541-7; JIANG H, 1993, J BIOL CHEM, V268, P7904; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Korolev S., 2011, DNA REPAIR, P1; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8461, DOI 10.1073/pnas.151260698; Lao JP, 2008, MOL CELL, V29, P517, DOI 10.1016/j.molcel.2007.12.014; Leiros I, 2005, EMBO J, V24, P906, DOI 10.1038/sj.emboj.7600582; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Lia G, 2013, MOL CELL, V49, P547, DOI 10.1016/j.molcel.2012.11.018; Liu J, 2006, J BIOL CHEM, V281, P26308, DOI 10.1074/jbc.M604349200; Liu J, 2011, CRIT REV BIOCHEM MOL, V46, P240, DOI 10.3109/10409238.2011.576007; LOVETT ST, 1983, J BACTERIOL, V153, P1471, DOI 10.1128/JB.153.3.1471-1478.1983; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; MAHDI AA, 1989, MOL GEN GENET, V216, P503, DOI 10.1007/BF00334397; Makharashvili N, 2004, STRUCTURE, V12, P1881, DOI 10.1016/j.str.2004.08.006; Manfredi C, 2010, NUCLEIC ACIDS RES, V38, P6920, DOI 10.1093/nar/gkq533; Mazloum N, 2007, BIOCHEMISTRY-US, V46, P7163, DOI 10.1021/bi700399m; Mazloum N, 2009, MOL CELL, V33, P160, DOI 10.1016/j.molcel.2008.12.023; Mcllwraith MJ, 2008, MOL CELL, V29, P510, DOI 10.1016/j.molcel.2007.11.037; Michel B, 2001, P NATL ACAD SCI USA, V98, P8181, DOI 10.1073/pnas.111008798; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Morimatsu K, 2012, J BIOL CHEM, V287, P35621, DOI 10.1074/jbc.M112.397034; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Nimonkar AV, 2009, P NATL ACAD SCI USA, V106, P3077, DOI 10.1073/pnas.0813247106; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Plate I, 2008, J BIOL CHEM, V283, P29077, DOI 10.1074/jbc.M804881200; Radzimanowski J, 2013, NUCLEIC ACIDS RES, V41, P7972, DOI 10.1093/nar/gkt572; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Robinson K, 2005, J INFECT DIS, V191, P579, DOI 10.1086/427657; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Ryzhikov Mikhail, 2012, Methods Mol Biol, V922, P123, DOI 10.1007/978-1-62703-032-8_7; Ryzhikov M, 2011, NUCLEIC ACIDS RES, V39, P6305, DOI 10.1093/nar/gkr199; Sakai A, 2009, J BIOL CHEM, V284, P3264, DOI 10.1074/jbc.M807220200; SANDLER SJ, 1994, J BACTERIOL, V176, P3661, DOI 10.1128/JB.176.12.3661-3672.1994; Satoh K, 2012, DNA REPAIR, V11, P410, DOI 10.1016/j.dnarep.2012.01.008; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Sechman EV, 2005, MOL MICROBIOL, V57, P468, DOI 10.1111/j.1365-2958.2005.04657.x; Seong C, 2008, J BIOL CHEM, V283, P12166, DOI 10.1074/jbc.M800763200; Serafini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078351; Shi I, 2009, J BIOL CHEM, V284, P33275, DOI 10.1074/jbc.M109.057752; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Southey MC, 2013, APPL CLIN GENET, V6, P43, DOI 10.2147/TACG.S34116; Stratton MR, 1996, CURR OPIN GENET DEV, V6, P93, DOI 10.1016/S0959-437X(96)90017-9; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sugiyama T, 2009, J MOL BIOL, V390, P45, DOI 10.1016/j.jmb.2009.05.009; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sweezy MA, 1997, J MOL BIOL, V266, P927, DOI 10.1006/jmbi.1996.0829; Sweezy MA, 1999, BIOCHEMISTRY-US, V38, P936, DOI 10.1021/bi9817055; Thompson LH, 1999, BIOCHIMIE, V81, P87, DOI 10.1016/S0300-9084(99)80042-X; Timmins J, 2007, EMBO J, V26, P3260, DOI 10.1038/sj.emboj.7601760; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; UMEZU K, 1994, J BIOL CHEM, V269, P30005; Venkitaraman AR, 2014, SCIENCE, V343, P1470, DOI 10.1126/science.1252230; Wang G, 2011, DNA REPAIR, V10, P373, DOI 10.1016/j.dnarep.2011.01.004; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3; Yadav T, 2012, NUCLEIC ACIDS RES, V40, P5546, DOI 10.1093/nar/gks173; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036	89	10	10	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28846	28855		10.1074/jbc.M114.585117	http://dx.doi.org/10.1074/jbc.M114.585117			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25170075	Green Published, hybrid			2022-12-28	WOS:000344141000009
J	Wang, H; Yuan, YF; Zhang, Z; Yan, H; Feng, YQ; Li, W				Wang, Hao; Yuan, Yefeng; Zhang, Zhao; Yan, Hui; Feng, Yaqin; Li, Wei			Dysbindin-1C Is Required for the Survival of Hilar Mossy Cells and the Maturation of Adult Newborn Neurons in Dentate Gyrus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEWLY GENERATED NEURONS; SCHIZOPHRENIA-RELATED PROTEIN; HERMANSKY-PUDLAK-SYNDROME; SDY MUTANT MICE; HIPPOCAMPAL NEUROGENESIS; ORGANELLES COMPLEX-1; SUSCEPTIBILITY GENE; BLOC-1; BIOGENESIS; DTNBP1	DTNBP1 (dystrobrevin-binding protein 1), which encodes dysbindin-1, is one of the leading susceptibility genes for schizophrenia. Both dysbindin-1B and -1C isoforms are decreased, but the dysbindin-1A isoform is unchanged in schizophrenic hippocampal formation, suggesting dysbindin-1 isoforms may have distinct roles in schizophrenia. We found that mouse dysbindin-1C, but not dysbindin-1A, is localized in the hilar glutamatergic mossy cells of the dentate gyrus. The maturation rate of newborn neurons in sandy (sdy) mice, in which both dysbindin-1A and -1C are deleted, is significantly delayed when compared with that in wild-type mice or with that in muted (mu) mice in which dysbindin-1A is destabilized but dysbindin-1C is unaltered. Dysbindin-1C deficiency leads to a decrease in mossy cells, which causes the delayed maturation of newborn neurons. This suggests that dysbindin-1C, rather than dysbindin-1A, regulates adult hippocampal neurogenesis in a non-cell autonomous manner.	[Wang, Hao; Yuan, Yefeng; Zhang, Zhao; Yan, Hui; Feng, Yaqin; Li, Wei] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China; [Wang, Hao; Yuan, Yefeng; Zhang, Zhao] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Yan, Hui; Feng, Yaqin] Shanxi Med Univ, Dept Histol & Embryol, Taiyuan 030001, Peoples R China; [Li, Wei] Beijing Inst Brain Disorders, Ctr Alzheimers Dis, Beijing 100053, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanxi Medical University	Li, W (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, 1 West Beichen Rd, Beijing 100101, Peoples R China.	wli@genetics.ac.cn	zhang, zhao/X-7967-2019	wang, hao/0000-0002-3267-5040; zhang, zhao/0000-0002-5086-5278	National Natural Science Foundation of China [91332116, 31230046, 30900777]; National Basic Research Program of China [2014CB942803]; Chinese Academy of Sciences [KJZD-EW-L08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by National Natural Science Foundation of China Grants 91332116, 31230046, and 30900777, by National Basic Research Program of China Grant 2014CB942803, and Chinese Academy of Sciences Grant KJZD-EW-L08.	Ayalew M, 2012, MOL PSYCHIATR, V17, P887, DOI 10.1038/mp.2012.37; Balu DT, 2011, NEUROSCI BIOBEHAV R, V35, P848, DOI 10.1016/j.neubiorev.2010.10.005; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Bhardwaj SK, 2009, BEHAV BRAIN RES, V197, P435, DOI 10.1016/j.bbr.2008.10.011; Chancey JH, 2014, J NEUROSCI, V34, P2349, DOI 10.1523/JNEUROSCI.3620-13.2014; Chen Q, 2012, EUR J NEUROSCI, V36, P2597, DOI 10.1111/j.1460-9568.2012.08180.x; Chen XW, 2008, J CELL BIOL, V181, P791, DOI 10.1083/jcb.200711021; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Fei EK, 2010, J BIOL CHEM, V285, P38630, DOI 10.1074/jbc.M110.107912; Feng YQ, 2008, SCHIZOPHR RES, V106, P218, DOI 10.1016/j.schres.2008.07.018; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gerrish A, 2009, SCHIZOPHR RES, V107, P110, DOI 10.1016/j.schres.2008.08.011; Glen WB, 2014, HIPPOCAMPUS, V24, P204, DOI 10.1002/hipo.22215; Hattori S, 2008, BIOCHEM BIOPH RES CO, V373, P298, DOI 10.1016/j.bbrc.2008.06.016; Hunsaker MR, 2009, BEHAV NEUROSCI, V123, P1315, DOI 10.1037/a0017616; Hyde TM, 2011, J NEUROSCI, V31, P11088, DOI 10.1523/JNEUROSCI.1234-11.2011; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Jeans A, 2011, NEUROPHARMACOLOGY, V61, P1345, DOI 10.1016/j.neuropharm.2011.08.007; Ji YY, 2009, P NATL ACAD SCI USA, V106, P19593, DOI 10.1073/pnas.0904289106; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2008, CURR OPIN PSYCHIATR, V21, P290, DOI 10.1097/YCO.0b013e3282fad375; Kim JY, 2012, CELL, V148, P1051, DOI 10.1016/j.cell.2011.12.037; Larimore J, 2014, J BIOL CHEM, V289, P14291, DOI 10.1074/jbc.M114.553750; Larimore J, 2011, MOL BIOL CELL, V22, P4854, DOI 10.1091/mbc.E11-07-0592; Li W, 2006, HUM MUTAT, V27, P402, DOI 10.1002/humu.20309; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Lutkenhoff E, 2012, NEUROIMAGE, V62, P120, DOI 10.1016/j.neuroimage.2012.05.008; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009325; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Morris DW, 2008, BIOL PSYCHIAT, V63, P24, DOI 10.1016/j.biopsych.2006.12.025; Mullin AP, 2011, MOL NEUROBIOL, V44, P53, DOI 10.1007/s12035-011-8183-3; Nazarian R, 2006, BIOCHEM J, V395, P587, DOI 10.1042/BJ20051965; Newell-Litwa K, 2010, J NEUROSCI, V30, P820, DOI 10.1523/JNEUROSCI.3400-09.2010; Newell-Litwa K, 2009, MOL BIOL CELL, V20, P1441, DOI 10.1091/mbc.E08-05-0456; Nihonmatsu-Kikuchi N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015886; Orozco IJ, 2014, MOL CELL NEUROSCI, V58, P76, DOI 10.1016/j.mcn.2013.12.003; Oyama S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004199; Pieper AA, 2005, P NATL ACAD SCI USA, V102, P14052, DOI 10.1073/pnas.0506713102; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Talbot K, 2009, HANDBOOK OF NEUROCHEMISTRY AND MOLECULAR NEUROBIOLOGY: SCHIZOPHRENIA, THIRD EDITION, P107, DOI 10.1007/978-0-387-30410-6_2.2; Talbot K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016886; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Verret L, 2007, J NEUROSCI, V27, P6771, DOI 10.1523/JNEUROSCI.5564-06.2007; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Wei AH, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12051; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; Zhang Q, 2002, HUM MOL GENET, V11, P697, DOI 10.1093/hmg/11.6.697; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	58	23	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29060	29072		10.1074/jbc.M114.590927	http://dx.doi.org/10.1074/jbc.M114.590927			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25157109	Green Published, hybrid			2022-12-28	WOS:000344141000024
J	Fukuda, K; Bledzka, K; Yang, J; Perera, HD; Plow, EF; Qin, J				Fukuda, Koichi; Bledzka, Kamila; Yang, Jun; Perera, H. Dhanuja; Plow, Edward F.; Qin, Jun			Molecular Basis of Kindlin-2 Binding to Integrin-linked Kinase Pseudokinase for Regulating Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX ADHESION; ILK; PROTEIN; EXPRESSION; LOCALIZATION; CYTOSKELETON; ACTIVATION; COMPLEX; ADAPTER; SYSTEM	Integrin-linked kinase (ILK) is a distinct intracellular adaptor essential for integrin-mediated cell-extracellular matrix adhesion, cell spreading, and migration. Acting as a major docking platform in focal adhesions, ILK engages many proteins to dynamically link integrins with the cytoskeleton, but the underlying mechanism remains elusive. Here, we have characterized the interaction of ILK with kindlin-2, a key regulator for integrin bidirectional signaling. We show that human kindlin-2 binds to human ILK with high affinity. Using systematic mapping approaches, we have identified a major ILK binding site involving a 20-residue fragment (residues 339-358) in kindlin-2. NMR-based analysis reveals a helical conformation of this fragment that utilizes its leucine-rich surface to recognize the ILK pseudokinase domain in a mode that is distinct from another ILK pseudokinase domain binding protein, alpha-parvin. Structure-based mutational experiments further demonstrate that the kindlin-2 binding to ILK is crucial for the kindlin-2 localization to focal adhesions and cell spreading (integrin outside-in signaling) but dispensable for the kindlin-2-mediated integrin activation (integrin inside-out signaling). These data define a specific mode of the kindlin-2/ILK interaction with mechanistic implications as to how it spatiotemporally mediates integrin signaling and cell adhesion.	[Fukuda, Koichi; Bledzka, Kamila; Yang, Jun; Perera, H. Dhanuja; Plow, Edward F.; Qin, Jun] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Plow, EF (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Mail Code NB50,9500 Euclid Ave, Cleveland, OH 44195 USA.	plowe@ccf.org; qinj@ccf.org		Qin, Jun/0000-0002-2647-9270	National Institutes of Health [R01GM62823, R01HL58758, P01HL073311]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058758, P01HL073311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM62823 and R01HL58758 (to J. Q.) and P01HL073311 (to E.F.P.).	Bledzka K, 2010, J BIOL CHEM, V285, P30370, DOI 10.1074/jbc.C110.134247; Bottcher RT, 2009, CURR OPIN CELL BIOL, V21, P670, DOI 10.1016/j.ceb.2009.05.008; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fukuda K, 2011, J BIOL CHEM, V286, P21886, DOI 10.1074/jbc.M111.240093; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Honda S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085498; Honda S, 2009, BLOOD, V113, P5304, DOI 10.1182/blood-2008-07-169136; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jones CI, 2014, J THROMB HAEMOST, V12, P1342, DOI 10.1111/jth.12620; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Lossner D, 2009, J CELL PHYSIOL, V220, P367, DOI 10.1002/jcp.21774; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Perera HD, 2011, STRUCTURE, V19, P1664, DOI 10.1016/j.str.2011.08.012; Plow EF, 2014, CURR OPIN HEMATOL, V21, P241, DOI 10.1097/MOH.0000000000000042; Plow EF, 2009, CURR OPIN HEMATOL, V16, P323, DOI 10.1097/MOH.0b013e32832ea389; Qadota H, 2012, J BIOL CHEM, V287, P28537, DOI 10.1074/jbc.M112.354852; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; Qin J, 2012, CURR OPIN CELL BIOL, V24, P607, DOI 10.1016/j.ceb.2012.06.003; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Tucker KL, 2008, BLOOD, V112, P4523, DOI 10.1182/blood-2008-03-148502; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; WOODS VL, 1984, BLOOD, V63, P368; Yates LA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.415208; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007	40	45	46	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28363	28375		10.1074/jbc.M114.596692	http://dx.doi.org/10.1074/jbc.M114.596692			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25160619	hybrid, Green Published			2022-12-28	WOS:000343765400030
J	Taberner, FJ; Lopez-Cordoba, A; Fernandez-Ballester, G; Korchev, Y; Ferrer-Montiel, A				Jose Taberner, Francisco; Lopez-Cordoba, Ainara; Fernandez-Ballester, Gregorio; Korchev, Yuri; Ferrer-Montiel, Antonio			The Region Adjacent to the C-end of the Inner Gate in Transient Receptor Potential Melastatin 8 (TRPM8) Channels Plays a Central Role in Allosteric Channel Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD SENSOR TRPM8; DOMAIN; IDENTIFICATION; DESENSITIZATION; MECHANISM; SENSATION; REVEALS; VOLTAGE; QUALITY; BOX	The ability of transient receptor potential (TRP) channels to sense and respond to environmental and endogenous cues is crucial in animal sensory physiology. The molecular mechanism of channel gating is yet elusive. The TRP box, a conserved region in the N-end of the C terminus domain, has been signaled as pivotal for allosteric activation in TRP channels. Here, we have examined the role of the linker region between the TRPM8 inner gate and the TRP box (referred to as the S6-TRP box linker) to identify structural determinants of channel gating. Stepwise substitutions of segments in the S6-TRP box linker of TRPM8 channel with the cognate TRPV1 channel sequences produced functional chimeric channels, and identified Tyr(981) as a central molecular determinant of channel function. Additionally, mutations in the 986-990 region had a profound impact on channel gating by voltage and menthol, as evidenced by the modulation of the conductance-to-voltage (G-V) relationships. Simulation of G-V curves using an allosteric model for channel activation revealed that these mutations altered the allosteric constants that couple stimuli sensing to pore opening. A molecular model of TRPM8, based on the recently reported TRPV1 structural model, showed that Tyr(981) may lie in a hydrophobic pocket at the end of the S6 transmembrane segment and is involved in inter-subunit interactions with residues from neighbor subunits. The 986-990 region holds intrasubunit interactions between the TRP domain and the S4-S5 linker. These findings substantiate a gating mechanism whereby the TRP domain acts as a coupling domain for efficient channel opening. Furthermore, they imply that protein-protein interactions of the TRP domain may be targets for channel modulation and drug intervention.	[Jose Taberner, Francisco; Lopez-Cordoba, Ainara; Fernandez-Ballester, Gregorio; Ferrer-Montiel, Antonio] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche 03202, Spain; [Korchev, Yuri] Univ London Imperial Coll Sci Technol & Med, Sch Med, London SW7 2AZ, England; [Ferrer-Montiel, Antonio] Univ Basque Country, CSIC, Unidad Biofis, Leioa 48940, Spain	Universidad Miguel Hernandez de Elche; Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika	Ferrer-Montiel, A (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Av Univ S-N, Elche 03202, Spain.	aferrer@umh.es	Ferrer-Montiel, Antonio/C-3072-2015; TABERNER, FRANCISCO J/AAA-9402-2019	Ferrer-Montiel, Antonio/0000-0002-2973-6607; TABERNER, FRANCISCO J/0000-0001-5725-6267	Ministerio de Economia y Competitividad [BFU2012-39092-C02-01, CSD2008-00005]; Generalitat Valenciana Grant [PROMETEO/2014/011]; FPU (Formacion Profesorado Universitario) fellowship form the Ministerio de Educacion; Biotechnology and Biological Sciences Research Council [C19021] Funding Source: researchfish	Ministerio de Economia y Competitividad(Spanish Government); Generalitat Valenciana Grant(Center for Forestry Research & Experimentation (CIEF)); FPU (Formacion Profesorado Universitario) fellowship form the Ministerio de Educacion(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by el Ministerio de Economia y Competitividad Grants BFU2012-39092-C02-01, CONSOLIDER-INGENIO 2010, CSD2008-00005 and la Generalitat Valenciana Grant PROMETEO/2014/011.; Recipient of a FPU (Formacion Profesorado Universitario) fellowship form the Ministerio de Educacion.	Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Daniels RL, 2009, J BIOL CHEM, V284, P1570, DOI 10.1074/jbc.M807270200; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Doerner JF, 2011, J GEN PHYSIOL, V137, P271, DOI 10.1085/jgp.200910388; Garcia-Martinez C, 2002, P NATL ACAD SCI USA, V99, P2374, DOI 10.1073/pnas.022285899; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Gregorio-Teruel L, 2014, J GEN PHYSIOL, V143, P361, DOI 10.1085/jgp.201311070; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hirschler-Laszkiewicz I, 2011, J BIOL CHEM, V286, P30636, DOI 10.1074/jbc.M111.238360; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Jun JH, 2012, INT NEUROUROL J, V16, P69, DOI 10.5213/inj.2012.16.2.69; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Parra A, 2010, NAT MED, V16, P1396, DOI 10.1038/nm.2264; Pedretti A, 2011, BIOCHEM BIOPH RES CO, V414, P14, DOI 10.1016/j.bbrc.2011.08.134; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tsavaler L, 2001, CANCER RES, V61, P3760; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; Valente P, 2011, FASEB J, V25, P1628, DOI 10.1096/fj.10-174433; Valero M, 2011, PFLUG ARCH EUR J PHY, V461, P99, DOI 10.1007/s00424-010-0895-0; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Voets T, 2012, REV PHYSIOL BIOCH P, V162, P91, DOI 10.1007/112_2011_5; Xie J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00146; Yudin Y, 2011, J PHYSIOL-LONDON, V589, P6007, DOI 10.1113/jphysiol.2011.220228	39	23	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28579	28594		10.1074/jbc.M114.577478	http://dx.doi.org/10.1074/jbc.M114.577478			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25157108	hybrid, Green Published			2022-12-28	WOS:000343765400047
J	Pavlov, TS; Levchenko, V; Staruschenko, A				Pavlov, Tengis S.; Levchenko, Vladislav; Staruschenko, Alexander			Role of Rho GDP Dissociation Inhibitor alpha in Control of Epithelial Sodium Channel (ENaC)-mediated Sodium Reabsorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; SALT-SENSITIVE HYPERTENSION; CORTICAL COLLECTING DUCT; PHOSPHOINOSITIDE 3-OH KINASE; NA+ CHANNEL; ANGIOTENSIN-II; ENAC ACTIVITY; RAC1 GTPASE; PLASMA-MEMBRANE; ION CHANNELS	The epithelial sodium channel (ENaC) is expressed in the aldosterone-sensitive distal nephron where it performs sodium reabsorption from the lumen. We have recently shown that ENaC activity contributes to the development of salt-induced hypertension as a result of deficiency of EGF level. Previous studies revealed that Rho GDP-dissociation inhibitor alpha (RhoGDI alpha) is involved in the control of salt-sensitive hypertension and renal injury via Rac1, which is one of the small GTPases activating ENaC. Here we investigated the intracellular mechanism mediating the involvement of the RhoGDI alpha/Rac1 axis in the control of ENaC and the effect of EGF on ENaC in this pathway. We demonstrated that RhoGDI alpha is highly expressed in the cortical collecting ducts of mice and rats, and its expression is down-regulated in Dahl salt-sensitive rats fed a high salt diet. Knockdown of RhoGDI alpha in cultured cortical collecting duct principal cells increased ENaC subunits expression and ENaC-mediated sodium reabsorption. Furthermore, RhoGDI alpha deficiency causes enhanced response to EGF treatment. Patch clamp analysis reveals that RhoGDI alpha significantly decreases ENaC current density and prevents its up-regulation by RhoA and Rac1. Inhibition of Rho kinase with Y27632 had no effects on ENaC response to EGF either in control or RhoGDI alpha knocked down cells. However, EGF treatment increased levels of active Rac1, which was further enhanced in RhoGDI alpha-deficient cells. We conclude that changes in the RhoGDI alpha-dependent pathway have a permissive role in the Rac1-mediated enhancement of ENaC activity observed in salt-induced hypertension.	[Pavlov, Tengis S.; Levchenko, Vladislav; Staruschenko, Alexander] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Pavlov, TS (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	tpavlov@mcw.edu; staruschenko@mcw.edu		Staruschenko, Alexander/0000-0002-5190-8356	National Institutes of Health [R01 HL108880, K99 HL116603]; National Kidney Foundation [IG1724]; Medical College of Wisconsin Research Affairs Committee; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL116603, R01HL108880, K99HL116603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation; Medical College of Wisconsin Research Affairs Committee; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL108880 (to A. S.) and K99 HL116603 (NHLBI). This work was also supported by National Kidney Foundation Grant IG1724 and a Medical College of Wisconsin Research Affairs Committee pilot grant (to T. S. P.).	Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Butterworth MB, 2012, J BIOL CHEM, V287, P32556, DOI 10.1074/jbc.M112.369520; Butterworth MB, 2012, AM J PHYSIOL-RENAL, V302, pF581, DOI 10.1152/ajprenal.00304.2011; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; CANTIELLO HF, 1991, AM J PHYSIOL, V261, pC882, DOI 10.1152/ajpcell.1991.261.5.C882; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cowley AW, 2008, HYPERTENSION, V52, P777, DOI 10.1161/HYPERTENSIONAHA.107.092858; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Cowley AW, 2013, HYPERTENSION, V62, P85, DOI 10.1161/HYPERTENSIONAHA.113.01194; COWLEY AW, 1992, PHYSIOL REV, V72, P231, DOI 10.1152/physrev.1992.72.1.231; De Miguel C, 2010, AM J PHYSIOL-REG I, V298, pR1136, DOI 10.1152/ajpregu.00298.2009; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Downs CA, 2013, J BIOL CHEM, V288, P8136, DOI 10.1074/jbc.M112.389536; Falin R, 2005, AM J PHYSIOL-CELL PH, V288, pC1003, DOI 10.1152/ajpcell.00213.2004; Falin RA, 2007, J GEN PHYSIOL, V130, P313, DOI 10.1085/jgp.200709775; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; Gaeggeler HP, 2011, KIDNEY INT, V79, P843, DOI 10.1038/ki.2010.486; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gee HY, 2013, J CLIN INVEST, V123, P3243, DOI 10.1172/JCI69134; Gonzalez-Perrett S, 2002, J BIOL CHEM, V277, P24959, DOI 10.1074/jbc.M105084200; Gonzalez-Rodriguez E, 2007, KIDNEY INT, V71, P116, DOI 10.1038/sj.ki.5002018; Grossmann C, 2004, AM J PHYSIOL-RENAL, V286, pF1226, DOI 10.1152/ajprenal.00378.2003; Gupta IR, 2013, J MED GENET, V50, P330, DOI 10.1136/jmedgenet-2012-101442; Ilatovskaya DV, 2013, AM J PHYSIOL-CELL PH, V304, pC102, DOI 10.1152/ajpcell.00231.2012; Ilatovskaya DV, 2011, FASEB J, V25, P2688, DOI 10.1096/fj.10-167262; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Karpushev AV, 2011, HYPERTENSION, V57, P996, DOI 10.1161/HYPERTENSIONAHA.110.157784; Karpushev Alexey V, 2010, BMC Res Notes, V3, P210, DOI 10.1186/1756-0500-3-210; Karpushev AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008827; Karpushev AV, 2008, BIOCHEM BIOPH RES CO, V377, P521, DOI 10.1016/j.bbrc.2008.10.014; Kawarazaki W, 2012, J AM SOC NEPHROL, V23, P997, DOI 10.1681/ASN.2011070734; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Levchenko V, 2010, J CELL PHYSIOL, V223, P252, DOI 10.1002/jcp.22033; Liu L, 2009, AM J PHYSIOL-RENAL, V296, pF1417, DOI 10.1152/ajprenal.90337.2008; Ma HP, 2011, J BIOL CHEM, V286, P32444, DOI 10.1074/jbc.M111.254102; Mamenko M, 2012, J BIOL CHEM, V287, P660, DOI 10.1074/jbc.M111.298919; Mattson DL, 2008, AM J PHYSIOL-RENAL, V295, pF837, DOI 10.1152/ajprenal.90341.2008; Mazzochi C, 2006, AM J PHYSIOL-RENAL, V291, pF1113, DOI 10.1152/ajprenal.00195.2006; MUTO S, 1991, AM J PHYSIOL, V260, pF163, DOI 10.1152/ajprenal.1991.260.2.F163; Nagase M, 2013, CURR OPIN NEPHROL HY, V22, P148, DOI 10.1097/MNH.0b013e32835d0751; Nagase M, 2013, NAT REV NEPHROL, V9, P86, DOI 10.1038/nrneph.2012.282; Nofziger C, 2005, PFLUG ARCH EUR J PHY, V451, P445, DOI 10.1007/s00424-005-1477-4; Pavlov TS, 2013, J AM SOC NEPHROL, V24, P1053, DOI 10.1681/ASN.2012080839; Pavlov TS, 2011, AM J PHYSIOL-RENAL, V301, pF672, DOI 10.1152/ajprenal.00597.2010; Pavlov TS, 2010, J AM SOC NEPHROL, V21, P833, DOI 10.1681/ASN.2009080885; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Pochynyuk O, 2007, EXP BIOL MED, V232, P1258, DOI 10.3181/0703-MR-76; Pochynyuk O, 2007, J BIOL CHEM, V282, P14576, DOI 10.1074/jbc.M701348200; Pochynyuk O, 2006, J BIOL CHEM, V281, P26520, DOI 10.1074/jbc.M603716200; Sanders PW, 1996, AM J KIDNEY DIS, V28, P775, DOI 10.1016/S0272-6386(96)90265-6; Saxena SK, 2006, BIOCHEM BIOPH RES CO, V351, P582, DOI 10.1016/j.bbrc.2006.10.087; Shen JP, 2003, AM J PHYSIOL-RENAL, V284, pF57, DOI 10.1152/ajprenal.00028.2002; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Staruschenko A, 2005, BBA-BIOMEMBRANES, V1669, P108, DOI 10.1016/j.bbamem.2005.01.005; Staruschenko A, 2004, J BIOL CHEM, V279, P49989, DOI 10.1074/jbc.M409812200; Staruschenko A, 2004, J BIOL CHEM, V279, P37771, DOI 10.1074/jbc.M402176200; Staruschenko A, 2013, AM J PHYSIOL-RENAL, V305, pF12, DOI 10.1152/ajprenal.00112.2013; Staruschenko A, 2012, COMPR PHYSIOL, V2, P1541, DOI 10.1002/cphy.c110052; Staruschenko A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00154; Staruschenko Alexander, 2006, V337, P3; STOOS BA, 1991, KIDNEY INT, V39, P1168, DOI 10.1038/ki.1991.148; Sun P, 2012, AM J PHYSIOL-RENAL, V302, pF679, DOI 10.1152/ajprenal.00368.2011; Takemura Y, 2010, AM J PHYSIOL-LUNG C, V298, pL509, DOI 10.1152/ajplung.00230.2009; Togawa A, 1999, ONCOGENE, V18, P5373, DOI 10.1038/sj.onc.1202921; VEHASKARI VM, 1989, AM J PHYSIOL, V256, pF803, DOI 10.1152/ajprenal.1989.256.5.F803; VEHASKARI VM, 1991, AM J PHYSIOL, V261, pF896, DOI 10.1152/ajprenal.1991.261.5.F896; WARDEN DH, 1993, AM J PHYSIOL, V264, pF670, DOI 10.1152/ajprenal.1993.264.4.F670	70	8	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28651	28659		10.1074/jbc.M114.558262	http://dx.doi.org/10.1074/jbc.M114.558262			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25164814	hybrid, Green Published			2022-12-28	WOS:000343765400053
J	Zemp, I; Lingner, J				Zemp, Ivo; Lingner, Joachim			The Shelterin Component TPP1 Is a Binding Partner and Substrate for the Deubiquitinating Enzyme USP7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TELOMERE LENGTH REGULATOR; END-PROTECTION; PROTEIN TPP1; COMPLEX; POT1; RECRUITMENT; P53; PROCESSIVITY; RECOGNITION; MAINTENANCE	The telomeric shelterin component TPP1 has critical functions in telomeric protein complex assembly and telomerase recruitment and regulation. Here we identify USP7 as a novel interacting protein of the oligonucleotide/oligosaccharide-binding fold of TPP1, which was previously known to recruit telomerase to telomeres. We identify amino acids in TPP1 and USP7 that are critical for their interaction and multiple lysines within TPP1 that are oligo-ubiquitinated and deubiquitinated by USP7. Mutational analysis indicated that human TPP1 does not require ubiquitination for telomere association in contrast to previous observations reported for mouse Tpp1. Ubiquitination of human TPP1 also had no detectable effects on known protein interactions of TPP1 with TIN2, POT1, the CTC1-STN1-TEN1 complex, and telomerase. However, the close proximity of USP7 and telomerase binding sites on TPP1 suggest possible cross-talks. In addition, we found that TPP1 is degraded in a proteasome-dependent manner. Prevention of TPP1 ubiquitination prolonged TPP1 half-life similar to 2-fold from 45 to 90 min, and remarkably, proteasome inhibition prompted complete stability of TPP1. This indicates that the proteasome destabilizes TPP1 through both direct and indirect pathways possibly involving TPP1-interacting proteins. Altogether, our work identifies novel regulatory circuits that contribute to TPP1 stability and function.	[Zemp, Ivo; Lingner, Joachim] Ecole Polytech Fed Lausanne, Sch Life Sci SV, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Zemp, I (corresponding author), Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, SV ISREC UPLIN, SV 1824 Batiment SV,Stn 19, CH-1015 Lausanne, Switzerland.	ivo.zemp@epfl.ch; joachim.lingner@epfl.ch		Zemp, Ivo/0000-0003-1549-9871; Lingner, Joachim/0000-0002-2853-5803	Swiss National Science Foundation; European Research Council [232812]; European Commission [316354]; Swiss Cancer League; Ecole Polytechnique Federale de Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss Cancer League; Ecole Polytechnique Federale de Lausanne	This work was supported by the Swiss National Science Foundation, a European Research Council advanced investigator grant (Grant Agreement 232812), an Initial Training Network grant (CodeAge) from the European Commission's Seventh Framework Programme (Grant Agreement 316354), the Swiss Cancer League, and Ecole Polytechnique Federale de Lausanne.	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Chen LY, 2012, NATURE, V488, P540, DOI 10.1038/nature11269; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Gietz RD, 2001, BIOTECHNIQUES, V30, P816, DOI 10.2144/01304rv02; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Grolimund L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3848; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; Jain D, 2010, ANNU REV GENET, V44, P243, DOI 10.1146/annurev-genet-102108-134841; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Rai R, 2011, NAT STRUCT MOL BIOL, V18, P1400, DOI 10.1038/nsmb.2172; Sauerwald A, 2013, NAT STRUCT MOL BIOL, V20, P454, DOI 10.1038/nsmb.2530; Sexton AN, 2012, J BIOL CHEM, V287, P34455, DOI 10.1074/jbc.M112.394767; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Soudet J, 2014, MOL CELL, V53, P954, DOI 10.1016/j.molcel.2014.02.030; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Xin HW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-232; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048; Zhang Y, 2013, P NATL ACAD SCI USA, V110, P5457, DOI 10.1073/pnas.1217733110; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012	38	19	19	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28595	28606		10.1074/jbc.M114.596056	http://dx.doi.org/10.1074/jbc.M114.596056			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25172512	Green Published, hybrid			2022-12-28	WOS:000343765400048
J	Han, WJ; Wang, WS; Zhao, M; Sugahara, K; Li, FC				Han, Wenjun; Wang, Wenshuang; Zhao, Mei; Sugahara, Kazuyuki; Li, Fuchuan			A Novel Eliminase from a Marine Bacterium That Degrades Hyaluronan and Chondroitin Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chondroitin Sulfate; Glycosaminoglycan; Hyaluronan; Hyaluronidase; Proteoglycan; Chondroitinase; Eliminase; Lyase; Marine Bacterium	DERMATAN SULFATE; HYBRID CHAINS; HEXASACCHARIDE SEQUENCES; NEURITOGENIC ACTIVITY; POLYMERIZING FACTOR; BINDING ACTIVITIES; MOLECULAR-CLONING; GROWTH-FACTORS; GENES; PROTEOGLYCANS	Background: Glycosaminoglycan (GAG) lyases have been widely isolated from terrestrial but not marine bacteria. Results: A novel GAG lyase (HCLase) was identified for the first time from a marine bacterium. Conclusion: The HCLase has very low homology to the characterized conventional GAG lyases and possesses very unique biochemical characteristics. Significance: HCLase will be useful for chondroitin sulfate/hyaluronan-related research and applications. Lyases cleave glycosaminoglycans (GAGs) in an eliminative mechanism and are important tools for the structural analysis and oligosaccharide preparation of GAGs. Various GAG lyases have been identified from terrestrial but not marine organisms even though marine animals are rich in GAGs with unique structures and functions. Herein we isolated a novel GAG lyase for the first time from the marine bacterium Vibrio sp. FC509 and then recombinantly expressed and characterized it. It showed strong lyase activity toward hyaluronan (HA) and chondroitin sulfate (CS) and was designated as HA and CS lyase (HCLase). It exhibited the highest activities to both substrates at pH 8.0 and 0.5 m NaCl at 30 degrees C. Its activity toward HA was less sensitive to pH than its CS lyase activity. As with most other marine enzymes, HCLase is a halophilic enzyme and very stable at temperatures from 0 to 40 degrees C for up to 24 h, but its activity is independent of divalent metal ions. The specific activity of HCLase against HA and CS reached a markedly high level of hundreds of thousands units/mg of protein under optimum conditions. The HCLase-resistant tetrasaccharide (4,5)HexUA1-3GalNAc(6-O-sulfate)1-4GlcUA(2-O-sulfate)1-3GalNAc(6-O-sulfate) was isolated from CS-D, the structure of which indicated that HCLase could not cleave the galactosaminidic linkage bound to 2-O-sulfated d-glucuronic acid (GlcUA) in CS chains. Site-directed mutagenesis indicated that HCLase may work via a catalytic mechanism in which Tyr-His acts as the BrOnsted base and acid. Thus, the identification of HCLase provides a useful tool for HA- and CS-related research and applications.	[Han, Wenjun; Wang, Wenshuang; Zhao, Mei; Li, Fuchuan] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China; [Han, Wenjun; Wang, Wenshuang; Zhao, Mei; Li, Fuchuan] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Sugahara, Kazuyuki] Hokkaido Univ, Grad Sch Life Sci, Fac Adv Life Sci, Proteoglycan Signaling & Therapeut Res Grp, Sapporo, Hokkaido 0010021, Japan	Shandong University; Shandong University; Hokkaido University	Li, FC (corresponding author), Shandong Univ, Natl Glycoengn Res Ctr, 27 S Shanda Rd, Jinan 250100, Peoples R China.	fuchuanli@sdu.edu.cn	Han, Wenjun/N-7214-2014		National High Technology Research and Development Program of China [2012AA021504]; Major State Basic Research Development Program of China [2012CB822102]; Shandong Province Science and Technology Development Plan Grant [2013GSF12106]; China Postdoctoral Science Foundation [2013M531588]; Specialized Research Fund for the Doctoral Program of Higher Education [20130131120079]; Japan Society for the Promotion of Science [25670018]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Major State Basic Research Development Program of China(National Basic Research Program of China); Shandong Province Science and Technology Development Plan Grant; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by National High Technology Research and Development Program of China Grant 2012AA021504, Major State Basic Research Development Program of China Grant 2012CB822102, Shandong Province Science and Technology Development Plan Grant 2013GSF12106, General Financial Grant from China Postdoctoral Science Foundation Grant 2013M531588, and Specialized Research Fund for the Doctoral Program of Higher Education Grant 20130131120079 and in part by Grant-in-aid for Challenging Exploratory Research 25670018 from the Japan Society for the Promotion of Science.	Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bergefall K, 2005, J BIOL CHEM, V280, P32193, DOI 10.1074/jbc.M503645200; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BRAMHALL S, 1969, ANAL BIOCHEM, V31, P146, DOI 10.1016/0003-2697(69)90251-6; CHENG F, 1994, GLYCOBIOLOGY, V4, P685, DOI 10.1093/glycob/4.5.685; Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847; Clement AM, 1998, J BIOL CHEM, V273, P28444, DOI 10.1074/jbc.273.43.28444; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo X., 2014, PLOS ONE, V9; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hashimoto W, 2001, APPL ENVIRON MICROB, V67, P713, DOI 10.1128/AEM.67.2.713-720.2001; HIYAMA K, 1975, J BIOL CHEM, V250, P1824; Hsiao JC, 1999, J VIROL, V73, P8750, DOI 10.1128/JVI.73.10.8750-8761.1999; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Izumikawa T, 2004, J BIOL CHEM, V279, P53755, DOI 10.1074/jbc.M409615200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Kushner D.J., 1988, HALOPHILIC BACTERIA, V1, P109; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee A, 2010, DERMATOL SURG, V36, P1071, DOI 10.1111/j.1524-4725.2010.01585.x; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Li FC, 2010, J BIOL CHEM, V285, P27673, DOI 10.1074/jbc.M110.118703; Linhardt RJ, 2006, ADV PHARMACOL, V53, P187, DOI 10.1016/S1054-3589(05)53009-6; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Mizumoto S, 2013, J BIOL CHEM, V288, P10953, DOI 10.1074/jbc.R112.437038; Mizumoto S, 2013, GLYCOBIOLOGY, V23, P155, DOI 10.1093/glycob/cws137; Nadanaka S, 1998, J BIOL CHEM, V273, P3296, DOI 10.1074/jbc.273.6.3296; Nandi S, 2006, BLOOD, V107, P786, DOI 10.1182/blood-2005-05-1822; Nandini CD, 2005, J BIOL CHEM, V280, P4058, DOI 10.1074/jbc.M412074200; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; OHYA T, 1970, BIOCHIM BIOPHYS ACTA, V198, P607, DOI 10.1016/0005-2744(70)90139-7; Pati A, 2010, NAT METHODS, V7, P455, DOI [10.1038/nmeth.1457, 10.1038/NMETH.1457]; Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; POOLE AR, 1986, BIOCHEM J, V236, P1; Ramachandra R, 2014, GLYCOBIOLOGY, V24, P195, DOI 10.1093/glycob/cwt100; Sambrook J, 2001, MOL CLONING LAB MANU; Sharma K, 2012, EXP NEUROL, V237, P370, DOI 10.1016/j.expneurol.2012.07.009; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; TAM YC, 1985, INFECT IMMUN, V47, P508, DOI 10.1128/IAI.47.2.508-513.1985; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Trowbridge JM, 2002, J BIOL CHEM, V277, P42815, DOI 10.1074/jbc.M204959200; VIEIRA RP, 1991, J BIOL CHEM, V266, P13530; Williams RK, 1997, J VIROL, V71, P1375, DOI 10.1128/JVI.71.2.1375-1380.1997; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; Yoshida K., 1993, DERMATAN SULFATE PRO, P55	65	38	43	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27886	27898		10.1074/jbc.M114.590752	http://dx.doi.org/10.1074/jbc.M114.590752			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25122756	Green Published, hybrid			2022-12-28	WOS:000342852800044
J	Resetca, D; Haftchenary, S; Gunning, PT; Wilson, DJ				Resetca, Diana; Haftchenary, Sina; Gunning, Patrick T.; Wilson, Derek J.			Changes in Signal Transducer and Activator of Transcription 3 (STAT3) Dynamics Induced by Complexation with Pharmacological Inhibitors of Src Homology 2 (SH2) Domain Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-DEUTERIUM EXCHANGE; MASS-SPECTROMETRY; SMALL MOLECULES; ABL KINASE; BINDING; MOTIONS; CANCER; PHOSPHORYLATION; RECOGNITION; PROTEINS	The activity of the transcription factor signal transducer and activator of transcription 3 (STAT3) is dysregulated in a number of hematological and solid malignancies. Development of pharmacological STAT3 Src homology 2 (SH2) domain interaction inhibitors holds great promise for cancer therapy, and a novel class of salicylic acid-based STAT3 dimerization inhibitors that includes orally bioavailable drug candidates has been recently developed. The compounds SF-1-066 and BP-1-102 are predicted to bind to the STAT3 SH2 domain. However, given the highly unstructured and dynamic nature of the SH2 domain, experimental confirmation of this prediction was elusive. We have interrogated the protein-ligand interaction of STAT3 with these small molecule inhibitors by means of time-resolved electrospray ionization hydrogen-deuterium exchange mass spectrometry. Analysis of site-specific evolution of deuterium uptake induced by the complexation of STAT3 with SF-1-066 or BP-1-102 under physiological conditions enabled the mapping of the in silico predicted inhibitor binding site to the STAT3 SH2 domain. The binding of both inhibitors to the SH2 domain resulted in significant local decreases in dynamics, consistent with solvent exclusion at the inhibitor binding site and increased rigidity of the inhibitor-complexed SH2 domain. Interestingly, inhibitor binding induced hot spots of allosteric perturbations outside of the SH2 domain, manifesting mainly as increased deuterium uptake, in regions of STAT3 important for DNA binding and nuclear localization.	[Resetca, Diana; Wilson, Derek J.] York Univ, Dept Chem, Ctr Res Mass Spectrometry, Toronto, ON M3J 1P3, Canada; [Haftchenary, Sina; Gunning, Patrick T.] Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON L5L 1C6, Canada	York University - Canada; University of Toronto; University Toronto Mississauga	Wilson, DJ (corresponding author), York Univ, Dept Chem, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	dkwilson@yorku.ca		Resetca, Diana/0000-0003-0007-7828	National Sciences and Engineering Research Council (NSERC) [257588]; Ontario Ministry of Research and Innovation; NSERC; Canadian Institutes of Health Research; Canadian Breast Cancer Research Foundation	National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Research Foundation	This work was supported in part by National Sciences and Engineering Research Council (NSERC) Discovery Grant 257588 and an Ontario Ministry of Research and Innovation early researcher award (to D. J. W.).; Supported by an NSERC postgraduate scholarship-doctoral.; Supported by the NSERC, Canadian Institutes of Health Research, and Canadian Breast Cancer Research Foundation.	Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Engen JR, 1999, BIOCHEMISTRY-US, V38, P8926, DOI 10.1021/bi982611y; Finerty PJ, 2005, BIOCHEMISTRY-US, V44, P694, DOI 10.1021/bi048641k; Fletcher S, 2011, CHEMMEDCHEM, V6, P1459, DOI 10.1002/cmdc.201100194; Fletcher S, 2009, CHEMBIOCHEM, V10, P1959, DOI 10.1002/cbic.200900172; Haan S, 1999, J BIOL CHEM, V274, P1342, DOI 10.1074/jbc.274.3.1342; Hamuro Y, 2002, J MOL BIOL, V323, P871, DOI 10.1016/S0022-2836(02)01003-3; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Iacob RE, 2009, P NATL ACAD SCI USA, V106, P1386, DOI 10.1073/pnas.0811912106; Inghirami G, 2005, CELL CYCLE, V4, P1131, DOI 10.4161/cc.4.9.1985; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; Liuni P, 2012, ANGEW CHEM INT EDIT, V51, P9666, DOI 10.1002/anie.201204903; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; Ma J, 2003, J BIOL CHEM, V278, P29252, DOI 10.1074/jbc.M304196200; Montelione GT, 2000, NAT STRUCT BIOL, V7, P982, DOI 10.1038/80768; MORAN MF, 1990, P NATL ACAD SCI USA, V87, P8622, DOI 10.1073/pnas.87.21.8622; Nkansah E, 2013, FEBS LETT, V587, P833, DOI 10.1016/j.febslet.2013.01.065; Page BDG, 2011, BIOORG MED CHEM LETT, V21, P5605, DOI 10.1016/j.bmcl.2011.06.056; Page BDG, 2011, EXPERT OPIN THER PAT, V21, P65, DOI 10.1517/13543776.2011.539205; Panjarian S, 2013, J BIOL CHEM, V288, P6116, DOI 10.1074/jbc.M112.431312; Ren ZY, 2008, BIOCHEM BIOPH RES CO, V374, P1, DOI 10.1016/j.bbrc.2008.04.049; Resetca D, 2013, FEBS J, V280, P5616, DOI 10.1111/febs.12332; Rob T, 2013, LAB CHIP, V13, P2528, DOI 10.1039/c3lc00007a; Rob T, 2012, ANAL CHEM, V84, P3771, DOI 10.1021/ac300365u; SHOELSON SE, 1993, EMBO J, V12, P795, DOI 10.1002/j.1460-2075.1993.tb05714.x; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Wilson DJ, 2003, ANAL CHEM, V75, P6408, DOI 10.1021/ac0346757; Wong L, 2005, J MOL BIOL, V351, P131, DOI 10.1016/j.jmb.2005.05.042; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109; Zhang XL, 2010, BIOCHEM PHARMACOL, V79, P1398, DOI 10.1016/j.bcp.2010.01.001	34	29	29	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.595454	http://dx.doi.org/10.1074/jbc.M114.595454			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25288792	hybrid, Green Published			2022-12-28	WOS:000345335000013
J	Patel, RS; Carter, G; Cooper, DR; Apostolatos, H; Patel, NA				Patel, Rekha S.; Carter, Gay; Cooper, Denise R.; Apostolatos, Hercules; Patel, Niketa A.			Transformer 2 beta homolog (Drosophila) (TRA2B) Regulates Protein Kinase C delta I (PKC delta I) Splice Variant Expression during 3T3L1 Preadipocyte Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipogenesis; Alternative Splicing; Cell Cycle; Obesity; Protein Kinase C (PKC); PRKCD; TRA2B	SMOOTH-MUSCLE; ADIPOCYTE DIFFERENTIATION; PROTEOLYTIC ACTIVATION; TRA2-BETA PROTEIN; RETINOIC ACID; PPAR-GAMMA; APOPTOSIS; ADIPOGENESIS; SURVIVAL; RNA	Background: PKC modulates cellular differentiation and proliferation. Results: Splice factor TRA2B regulates alternative splicing of PKCI. Conclusion: PKCI is a gate-keeper of adipocyte differentiation. Significance: Understanding the role and regulation of PKCI during adipogenesis may contribute toward developing a novel target for managing obesity and its co-morbidities. Obesity is characterized by adipocyte hyperplasia and hypertrophy. We previously showed that PKC expression is dysregulated in obesity (Carter, G., Apostolatos, A., Patel, R., Mathur, A., Cooper, D., Murr, M., and Patel, N. A. (2013) ISRN Obes. 2013, 161345). Using 3T3L1 preadipocytes, we studied adipogenesis in vitro and showed that expression of PKC splice variants, PKCI and PKCII, have different expression patterns during adipogenesis (Patel, R., Apostolatos, A., Carter, G., Ajmo, J., Gali, M., Cooper, D. R., You, M., Bisht, K. S., and Patel, N. A. (2013) J. Biol. Chem. 288, 26834-26846). Here, we evaluated the role of PKCI splice variant during adipogenesis. Our results indicate that PKCI expression level is high in preadipocytes and decreasing PKCI accelerated terminal differentiation. Our results indicate that PKCI is required for mitotic clonal expansion of preadipocytes. We next evaluated the splice factor regulating the expression of PKCI during 3T3L1 adipogenesis. Our results show TRA2B increased PKCI expression. To investigate the molecular mechanism, we cloned a heterologous splicing PKC minigene and showed that inclusion of PKC exon 9 is increased by TRA2B. Using mutagenesis and a RNA-immunoprecipitation assay, we evaluated the binding of Tra2 on PKCI exon 9 and show that its association is required for PKCI splicing. These results provide a better understanding of the role of PKCI in adipogenesis. Determination of this molecular mechanism of alternative splicing presents a novel therapeutic target in the management of obesity and its co-morbidities.	[Carter, Gay; Cooper, Denise R.; Patel, Niketa A.] Univ S Florida, James A Haley Vet Hosp, Tampa, FL 33612 USA; [Patel, Rekha S.; Cooper, Denise R.; Apostolatos, Hercules; Patel, Niketa A.] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida	Patel, NA (corresponding author), James A Haley Vet Hosp, Res Serv VAR 151, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Niketa.Patel@va.gov		Patel, Niketa A./0000-0003-4811-8596	Department of Veterans Affairs Medical Research Grant [821-MR-EN-20606]; Veterans Affairs [I01BX001424, I01BX003689] Funding Source: NIH RePORTER	Department of Veterans Affairs Medical Research Grant(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Department of Veterans Affairs Medical Research Grant 821-MR-EN-20606 (to N. A. P.).	Apostolatos A, 2012, J BIOL CHEM, V287, P9299, DOI 10.1074/jbc.M111.313080; Apostolatos H, 2010, J BIOL CHEM, V285, P25987, DOI 10.1074/jbc.M110.100735; Beil B, 1997, DNA CELL BIOL, V16, P679, DOI 10.1089/dna.1997.16.679; Bourgeois CF, 2004, PROG NUCLEIC ACID RE, V78, P37, DOI 10.1016/S0079-6603(04)78002-2; Bowles DK, 2007, AM J PHYSIOL-CELL PH, V293, pC805, DOI 10.1152/ajpcell.00127.2007; Brun RP, 1997, J ENDOCRINOL, V155, P217, DOI 10.1677/joe.0.1550217; Carter Gay, 2013, ISRN Obes, V2013, P161345, DOI 10.1155/2013/161345; Carvour M, 2008, ANN NY ACAD SCI, V1139, P197, DOI 10.1196/annals.1432.020; Dauwalder B, 1996, P NATL ACAD SCI USA, V93, P9004, DOI 10.1073/pnas.93.17.9004; Elliott DJ, 2012, BIOCHEM SOC T, V40, P784, DOI 10.1042/BST20120036; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Fikaris AJ, 2005, J BIOL CHEM, V280, P32107, DOI 10.1074/jbc.M504432200; Fu K, 2012, J BIOL CHEM, V287, P16575, DOI 10.1074/jbc.M111.325761; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; Glatz DC, 2006, J NEUROCHEM, V96, P635, DOI 10.1111/j.1471-4159.2005.03552.x; GREEN H, 1979, J CELL PHYSIOL, V101, P169, DOI 10.1002/jcp.1041010119; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Grellscheid S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002390; Grossoni VC, 2007, MOL CARCINOGEN, V46, P381, DOI 10.1002/mc.20287; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Kanthasamy AG, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-12; Lagory EL, 2010, J BIOL CHEM, V285, P1879, DOI 10.1074/jbc.M109.055392; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; Patel NA, 2006, GENE EXPRESSION, V13, P73, DOI 10.3727/000000006783991890; Patel R, 2013, J BIOL CHEM, V288, P26834, DOI 10.1074/jbc.M113.482638; Pihlajamaki J, 2011, CELL METAB, V14, P208, DOI 10.1016/j.cmet.2011.06.007; Raponi M, 2014, RNA BIOL, V11, P351, DOI 10.4161/rna.28458; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Srivastava J, 2002, BIOCHEM J, V368, P349, DOI 10.1042/BJ20020737; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; Zhou YR, 2006, INT J BIOCHEM CELL B, V38, P2151, DOI 10.1016/j.biocel.2006.06.009	32	6	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31662	31672		10.1074/jbc.M114.592337	http://dx.doi.org/10.1074/jbc.M114.592337			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25261467	Green Published, hybrid			2022-12-28	WOS:000345314700001
J	Santos, CR; Hoffmam, ZB; Martins, VPD; Zanphorlin, LM; Assis, LHD; Honorato, RV; de Oliveira, PSL; Ruller, R; Murakami, MT				Santos, Camila Ramos; Hoffmam, Zaira Bruna; de Matos Martins, Vanesa Peixoto; Zanphorlin, Leticia Maria; de Paula Assis, Leandro Henrique; Honorato, Rodrigo Vargas; Lopes de Oliveira, Paulo Sergio; Ruller, Roberto; Murakami, Mario Tyago			Molecular Mechanisms Associated with Xylan Degradation by Xanthomonas Plant Pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biotechnology; Crystal Structure; Enzyme Kinetics; Glycoside Hydrolase; Protein Engineering; GH10 Family; Xanthomonas axonopodis pv; citri; Cell Wall-degrading Enzymes; Xylan CUT System	ORYZAE PV. ORYZAE; BACILLUS-HALODURANS C-125; CRYSTAL-STRUCTURE; CELL-WALL; MACROMOLECULAR CRYSTALLOGRAPHY; FUNCTIONAL-CHARACTERIZATION; BIOLOGICAL MACROMOLECULES; GLYCOSIDE HYDROLASES; STRUCTURE REFINEMENT; BACTERIAL PATHOGENS	Xanthomonas pathogens attack a variety of economically relevant plants, and their xylan CUT system (carbohydrate utilization with TonB-dependent outer membrane transporter system) contains two major xylanase-related genes, xynA and xynB, which influence biofilm formation and virulence by molecular mechanisms that are still elusive. Herein, we demonstrated that XynA is a rare reducing end xylose-releasing exo-oligoxylanase and not an endo--1,4-xylanase as predicted. Structural analysis revealed that an insertion in the 7-7 loop induces dimerization and promotes a physical barrier at the +2 subsite conferring this unique mode of action within the GH10 family. A single mutation that impaired dimerization became XynA active against xylan, and high endolytic activity was achieved when this loop was tailored to match a canonical sequence of endo--1,4-xylanases, supporting our mechanistic model. On the other hand, the divergent XynB proved to be a classical endo--1,4-xylanase, despite the low sequence similarity to characterized GH10 xylanases. Interestingly, this enzyme contains a calcium ion bound nearby to the glycone-binding region, which is required for catalytic activity and structural stability. These results shed light on the molecular basis for xylan degradation by Xanthomonas and suggest how these enzymes synergistically assist infection and pathogenesis. Our findings indicate that XynB contributes to breach the plant cell wall barrier, providing nutrients and facilitating the translocation of effector molecules, whereas the exo-oligoxylanase XynA possibly participates in the suppression of oligosaccharide-induced immune responses.	[Santos, Camila Ramos; de Matos Martins, Vanesa Peixoto; de Paula Assis, Leandro Henrique; Honorato, Rodrigo Vargas; Lopes de Oliveira, Paulo Sergio; Murakami, Mario Tyago] Natl Ctr Res Energy & Mat, Biosci Natl Lab, BR-13083970 Campinas, SP, Brazil; [Hoffmam, Zaira Bruna; Zanphorlin, Leticia Maria; Ruller, Roberto] Natl Ctr Res Energy & Mat, Bioethanol Sci & Technol Lab, BR-13083970 Campinas, SP, Brazil		Murakami, MT (corresponding author), Natl Ctr Res Energy & Mat, Brazilian Biosci Natl Lab, Giuseppe Maximo Scolfaro 10000, BR-13083970 Campinas, SP, Brazil.	mario.murakami@lnbio.cnpem.br	Honorato, Rodrigo Vargas/AAY-9375-2020; Murakami, Mario T/F-5640-2016; Oliveira, Paulo S/K-5588-2013; Honorato, Rodrigo/H-9773-2013; Murakami, Mario T/C-2087-2012; Santos, Camila Ramos dos/F-7095-2013; Ruller, ROBERTO/D-1260-2014; Paula Assis, Leandro Henrique/Q-6823-2016	Honorato, Rodrigo Vargas/0000-0001-5267-3002; Murakami, Mario T/0000-0002-0405-8010; Honorato, Rodrigo/0000-0001-5267-3002; Santos, Camila Ramos dos/0000-0003-0652-4211; Ruller, ROBERTO/0000-0002-5087-9493; Paula Assis, Leandro Henrique/0000-0002-0610-9483; Ruller, Roberto/0000-0001-7501-5176	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [10/51890-8, 13/13309-0, 14/07135-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [476043/2011-5, 308092/2012-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	2This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grants 10/51890-8, 13/13309-0, and 14/07135-1; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grants 476043/2011-5 and 308092/2012-0; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ALBERSHEIM P, 1969, ANNU REV PHYTOPATHOL, V7, P171, DOI 10.1146/annurev.py.07.090169.001131; Vu BA, 2012, MOL PLANT MICROBE IN, V25, P1135, DOI 10.1094/MPMI-02-12-0043-R; BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI 10.1016/j.chiabu.2021.105188; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; CHEN FTA, 1995, ANAL BIOCHEM, V230, P273, DOI 10.1006/abio.1995.1474; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; Dejean G, 2013, NEW PHYTOL, V198, P899, DOI 10.1111/nph.12187; Dervilly-Pinel G, 2001, CARBOHYD RES, V330, P365, DOI 10.1016/S0008-6215(00)00300-1; Doran-Peterson J, 2009, METHODS MOL BIOL, V581, P263, DOI 10.1007/978-1-60761-214-8_17; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enkerli J, 1999, PLANT PHYSIOL, V121, P391, DOI 10.1104/pp.121.2.391; Faure D, 2002, APPL ENVIRON MICROB, V68, P1485, DOI 10.1128/AEM.68.4.1485-1490.2002; Fierens K, 2005, FEBS J, V272, P5872, DOI 10.1111/j.1742-4658.2005.04987.x; FRY SC, 1993, PLANT PHYSIOL, V103, P1, DOI 10.1104/pp.103.1.1; Fujimoto Z, 2002, J MOL BIOL, V316, P65, DOI 10.1006/jmbi.2001.5338; Furman-Matarasso N, 1999, PLANT PHYSIOL, V121, P345, DOI 10.1104/pp.121.2.345; Fushinobu S, 2005, J BIOL CHEM, V280, P17180, DOI 10.1074/jbc.M413693200; Gallardo O, 2010, J BIOL CHEM, V285, P2721, DOI 10.1074/jbc.M109.064394; GOTTWALD TR, 1992, PHYTOPATHOLOGY, V82, P930, DOI 10.1094/Phyto-82-930; GRAHAM JH, 1992, PHYTOPATHOLOGY, V82, P1319, DOI 10.1094/Phyto-82-1319; Grennan AK, 2006, PLANT PHYSIOL, V142, P809, DOI 10.1104/pp.106.900207; Guo B, 2009, APPL MICROBIOL BIOT, V84, P1107, DOI 10.1007/s00253-009-2056-y; Hammersley AP, 1997, J SYNCHROTRON RADIAT, V4, P67, DOI 10.1107/S0909049596015087; Hanania U, 1997, PLANT J, V12, P113, DOI 10.1046/j.1365-313X.1997.12010113.x; Harris GW, 1996, ACTA CRYSTALLOGR D, V52, P393, DOI 10.1107/S0907444995013540; HESPELL RB, 1995, APPL ENVIRON MICROB, V61, P3042, DOI 10.1128/AEM.61.8.3042-3050.1995; Honda Y, 2004, J BIOL CHEM, V279, P55097, DOI 10.1074/jbc.M409832200; Hu J, 2007, FEMS MICROBIOL LETT, V269, P273, DOI 10.1111/j.1574-6968.2007.00638.x; Jha G, 2005, MOL PLANT MICROBE IN, V18, P891, DOI 10.1094/MPMI-18-0891; Jha G, 2007, MOL PLANT MICROBE IN, V20, P31, DOI 10.1094/MPMI-20-0031; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; King BC, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-4; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Li JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021804; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mirande C, 2010, APPL MICROBIOL BIOT, V87, P2097, DOI 10.1007/s00253-010-2694-0; Najmudin S, 2010, J STRUCT BIOL, V172, P353, DOI 10.1016/j.jsb.2010.07.009; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALVA TK, 1993, MOL PLANT MICROBE IN, V6, P190, DOI 10.1094/MPMI-6-190; Pell G, 2004, J BIOL CHEM, V279, P9597, DOI 10.1074/jbc.M312278200; Preston GM, 2005, FEMS MICROBIOL REV, V29, P331, DOI 10.1016/j.femsre.2004.12.004; Rajeshwari R, 2005, MOL PLANT MICROBE IN, V18, P830, DOI 10.1094/MPMI-18-0830; Ray SK, 2000, MOL PLANT MICROBE IN, V13, P394, DOI 10.1094/MPMI.2000.13.4.394; RYAN CA, 1987, ANNU REV CELL BIOL, V3, P295, DOI 10.1146/annurev.cellbio.3.1.295; Santos CR, 2010, BIOCHEM BIOPH RES CO, V403, P214, DOI 10.1016/j.bbrc.2010.11.010; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shi H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-26; Shibuya N, 2001, PHYSIOL MOL PLANT P, V59, P223, DOI 10.1006/pmpp.2001.0364; Solomon V, 2007, ACTA CRYSTALLOGR D, V63, P845, DOI 10.1107/S0907444907024845; Spurway TD, 1997, J BIOL CHEM, V272, P17523, DOI 10.1074/jbc.272.28.17523; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Szczesny R, 2010, NEW PHYTOL, V187, P983, DOI 10.1111/j.1469-8137.2010.03312.x; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Veronese P, 2003, PLANT PHYSIOL, V131, P1580, DOI 10.1104/pp.102.013417; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang GZ, 2011, BIORESOURCE TECHNOL, V102, P3330, DOI 10.1016/j.biortech.2010.11.004; Yamazaki A, 2008, J GEN PLANT PATHOL, V74, P138, DOI 10.1007/s10327-008-0075-7; Yoshizawa T, 2012, J BIOL CHEM, V287, P18710, DOI 10.1074/jbc.M112.350520; Zheng HP, 2014, NAT PROTOC, V9, P156, DOI 10.1038/nprot.2013.172	69	41	44	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32186	32200		10.1074/jbc.M114.605105	http://dx.doi.org/10.1074/jbc.M114.605105			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25266726	hybrid, Green Published			2022-12-28	WOS:000345314700046
J	Wang, Y; Lauer, ME; Anand, S; Mack, JA; Maytin, EV				Wang, Yan; Lauer, Mark E.; Anand, Sanjay; Mack, Judith A.; Maytin, Edward V.			Hyaluronan Synthase 2 Protects Skin Fibroblasts against Apoptosis Induced by Environmental Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Caspase; Extracellular Matrix; Fibroblast; Hyaluronan; Skin; Stress	FASL-INDUCED APOPTOSIS; PROSTATE-CANCER CELLS; SMOOTH-MUSCLE-CELLS; DIFFERENTIAL REGULATION; ARTICULAR CHONDROCYTES; TRANSCRIPTION FACTOR; LUNG FIBROBLASTS; DOWN-REGULATION; TGF-BETA; GROWTH	A balanced turnover of dermal fibroblasts is crucial for structural integrity and normal function of the skin. During recovery from environmental injury (such as UV exposure and physical wounding), apoptosis is an important mechanism regulating fibroblast turnover. We are interested in the role that hyaluronan (HA), an extracellular matrix molecule synthesized by HA synthase enzymes (Has), plays in regulating apoptosis in fibroblasts. We previously reported that Has1 and Has3 double knock-out (Has1/3 null) mice show accelerated wound closure and increased numbers of fibroblasts in the dermis. In the present study, we report that HA levels and Has2 mRNA expression are higher in cultured Has1/3 null primary skin fibroblasts than in wild type (WT) cells. Apoptosis induced by two different environmental stressors, UV exposure and serum starvation (SS), was reduced in the Has1/3 null cells. Hyaluronidase, added to cultures to remove extracellular HA, surprisingly had no effect upon apoptotic susceptibility to UVB or SS. However, cells treated with 4-methylumbelliferone to inhibit HA synthesis were sensitized to apoptosis induced by SS or UVB. When fibroblasts were transfected with Has2-specific siRNA that lowered Has2 mRNA and HA levels by 90%, both Has1/3 null and WT cells became significantly more sensitive to apoptosis. The exogenous addition of high molecular weight HA failed to reverse this effect. We conclude that Has1/3 null skin fibroblasts (which have higher levels of Has2 gene expression) are resistant to stress-induced apoptosis.	[Wang, Yan; Lauer, Mark E.; Anand, Sanjay; Mack, Judith A.; Maytin, Edward V.] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA; [Anand, Sanjay; Mack, Judith A.; Maytin, Edward V.] Cleveland Clin, Dept Dermatol, Lerner Res Inst, Dermatol & Plast Surg Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Maytin, EV (corresponding author), Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Mailstop ND 20,9500 Euclid Ave, Cleveland, OH 44195 USA.	maytine@ccf.org			National Institutes of Health [P01 HL107147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL107147.	Alaniz L, 2006, GLYCOBIOLOGY, V16, P359, DOI 10.1093/glycob/cwj085; Alikhani ZB, 2005, J BIOL CHEM, V280, P12087, DOI 10.1074/jbc.M406313200; Anand S, 2005, J INVEST DERMATOL, V125, P323, DOI 10.1111/j.0022-202X.2005.23784.x; Averbeck M, 2007, J INVEST DERMATOL, V127, P687, DOI 10.1038/sj.jid.5700614; Bennett HL, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.50; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Buhling F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-37; Chen LQ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-52; Dai G, 2007, AM J PATHOL, V171, P1451, DOI 10.2353/ajpath.2007.070136; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Ishihara H, 2000, J INVEST DERMATOL, V115, P1065, DOI 10.1046/j.1523-1747.2000.00180.x; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Jelaska A, 2000, ARTHRITIS RHEUM-US, V43, P2230, DOI 10.1002/1529-0131(200010)43:10<2230::AID-ANR10>3.0.CO;2-8; Jun JB, 2005, J INVEST DERMATOL, V124, P298, DOI 10.1111/j.0022-202X.2004.23559.x; Kaneko T, 2000, J ASSIST REPROD GEN, V17, P162, DOI 10.1023/A:1009470206468; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; Kubo K, 2005, ARTIF ORGANS, V29, P845, DOI 10.1111/j.1525-1594.2005.00138.x; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Li ZW, 2010, J CELL BIOCHEM, V111, P811, DOI 10.1002/jcb.22731; Liu S, 2012, AM J SPORT MED, V40, P1375, DOI 10.1177/0363546512439025; Lokeshwar VB, 2010, CANCER RES, V70, P2613, DOI 10.1158/0008-5472.CAN-09-3185; Luo SK, 2001, PLAST RECONSTR SURG, V107, P87, DOI 10.1097/00006534-200101000-00014; Mack JA, 2012, J INVEST DERMATOL, V132, P198, DOI 10.1038/jid.2011.248; Manuskiatti W, 1996, INT J DERMATOL, V35, P539, DOI 10.1111/j.1365-4362.1996.tb03650.x; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Michael DR, 2011, J BIOL CHEM, V286, P19523, DOI 10.1074/jbc.M111.233916; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; Moodley YP, 2004, J PATHOL, V202, P486, DOI 10.1002/path.1531; Pannu J, 2004, CURR OPIN RHEUMATOL, V16, P739, DOI 10.1097/01.bor.0000137894.63091.1a; Peng H, 2010, INFLAMM RES, V59, P519, DOI 10.1007/s00011-010-0156-x; Porsch H, 2013, ONCOGENE, V32, P4355, DOI 10.1038/onc.2012.475; Rauhala L, 2013, J BIOL CHEM, V288, P17999, DOI 10.1074/jbc.M113.472530; Recklies AD, 2001, BIOCHEM J, V354, P17, DOI 10.1042/0264-6021:3540017; Rilla K, 2013, J BIOL CHEM, V288, P5973, DOI 10.1074/jbc.M112.443879; Rock K, 2011, J BIOL CHEM, V286, P18268, DOI 10.1074/jbc.M110.201665; Ruffell B, 2008, J IMMUNOL, V181, P7044, DOI 10.4049/jimmunol.181.10.7044; Saito T, 2013, ONCOL LETT, V5, P1068, DOI 10.3892/ol.2013.1124; Stuhlmeier KM, 2004, J BIOL CHEM, V279, P8753, DOI 10.1074/jbc.M303945200; Takagawa S, 2003, J INVEST DERMATOL, V121, P41, DOI 10.1046/j.1523-1747.2003.12308.x; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Uchakina ON, 2013, LEUKEMIA RES, V37, P1294, DOI 10.1016/j.leukres.2013.07.009; Vigetti D, 2012, J BIOL CHEM, V287, P35544, DOI 10.1074/jbc.M112.402347; Vigetti D, 2011, J BIOL CHEM, V286, P34497, DOI 10.1074/jbc.M111.266312; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Werth BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014830; Wong T, 2007, BRIT J DERMATOL, V156, P1149, DOI 10.1111/j.1365-2133.2007.07914.x; Yanagida-Suekawa T, 2013, EUR J ORAL SCI, V121, P566, DOI 10.1111/eos.12082	53	39	39	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32253	32265		10.1074/jbc.M114.578377	http://dx.doi.org/10.1074/jbc.M114.578377			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25266724	hybrid, Green Published			2022-12-28	WOS:000345314700051
J	Mansson, C; Arosio, P; Hussein, R; Kampinga, HH; Hashem, RM; Boelens, WC; Dobson, CM; Knowles, TPJ; Linse, S; Emanuelsson, C				Mansson, Cecilia; Arosio, Paolo; Hussein, Rasha; Kampinga, Harm H.; Hashem, Reem M.; Boelens, Wilbert C.; Dobson, Christopher M.; Knowles, Tuomas P. J.; Linse, Sara; Emanuelsson, Cecilia			Interaction of the Molecular Chaperone DNAJB6 with Growing Arnyloid-beta 42 (A beta 42) Aggregates Leads to Sub-stoichiometric Inhibition of Amyloid Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; PROTEIN AGGREGATION; ALZHEIMERS-DISEASE; POLYGLUTAMINE PEPTIDES; NUCLEATION MECHANISM; COMMON MECHANISM; OLIGOMERS; KINETICS; TOXICITY; BINDING	The human molecular chaperone protein DNAJB6 was recently found to inhibit the formation of amyloid fibrils from polyglutamine peptides associated with neurodegenerative disorders such as Huntington disease. We show in the present study that DNAJB6 also inhibits amyloid formation by an even more aggregation-prone peptide (the amyloid-beta peptide, A beta 42, implicated in Alzheimer disease) in a highly efficient manner. By monitoring fibril formation using Thioflavin T fluorescence and far-UV CD spectroscopy, we have found that the aggregation of A beta 42 is retarded by DNAJB6 in a concentration-dependent manner, extending to very low sub -stoichiometric molar ratios of chaperone to peptide. Quantitative kinetic analysis and immunochemistry studies suggest that the high inhibitory efficiency is due to the interactions of the chaperone with aggregated forms of A beta 42 rather than the monomeric form of the peptide. This interaction prevents the growth of such species to longer fibrils and inhibits the formation of new amyloid fibrils through both primary and secondary nucleation. A low dissociation rate of DNAJB6 from A beta 42 aggregates leads to its incorporation into growing fibrils and hence to its gradual depletion from solution with time. When DNAJB6 is eventually depleted, fibril proliferation takes place, but the inhibitory activity can be prolonged by introducing DNAJB6 at regular intervals during the aggregation reaction. These results reveal the highly efficacious mode of action of this molecular chaperone against protein aggregation, and demonstrate that the role of molecular chaperones can involve interactions with multiple aggregated species leading to the inhibition of both principal nucleation pathways through which aggregates are able to form.	[Mansson, Cecilia; Linse, Sara; Emanuelsson, Cecilia] Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, S-22100 Lund, Sweden; [Arosio, Paolo; Dobson, Christopher M.; Knowles, Tuomas P. J.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Hussein, Rasha; Kampinga, Harm H.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [Hussein, Rasha; Hashem, Reem M.] Beni Suef Univ, Fac Pharm, Dept Biochem, Bani Suwayf 62511, Egypt; [Boelens, Wilbert C.] Radboud Univ Nijmegen, Dept Biomol Chem, NL-6500 HB Nijmegen, Netherlands	Lund University; University of Cambridge; University of Groningen; Egyptian Knowledge Bank (EKB); Beni Suef University; Radboud University Nijmegen	Emanuelsson, C (corresponding author), Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, POB 124, S-22100 Lund, Sweden.	cecilia.emanuelsson@biochemistry.lu.se	Knowles, Tuomas/C-6663-2009; Boelens, Wilbert/D-8877-2012	Knowles, Tuomas/0000-0002-7879-0140; Hashem, Reem/0000-0003-3011-8109; Kampinga, Harm/0000-0002-8966-8466	LU Research School for Pharmaceutical Science; Magnus Berg walls Stiftelse; Egyptian Ministry of Higher Education; Nanometer Structure Consortium for IR system; Swedish Research Council; Linneus Centre Organizing Molecular Matter for CD spectrometer, plate readers; Alzheimer Foundation Sweden; Swiss National Science Foundation; Frances and Augustus Newman Foundation; BBSRC; European Commission; Welcome Trust; Marie Curie fellowship scheme for career development; Senter Novem [IOP-IGE07004]	LU Research School for Pharmaceutical Science; Magnus Berg walls Stiftelse; Egyptian Ministry of Higher Education(Science and Technology Development Fund (STDF)); Nanometer Structure Consortium for IR system; Swedish Research Council(Swedish Research CouncilEuropean Commission); Linneus Centre Organizing Molecular Matter for CD spectrometer, plate readers; Alzheimer Foundation Sweden; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Frances and Augustus Newman Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Welcome Trust(Wellcome Trust); Marie Curie fellowship scheme for career development; Senter Novem	This work was supported by the LU Research School for Pharmaceutical Science (to C. M.), Magnus Berg walls Stiftelse (to C. E.), the Egyptian Ministry of Higher Education (to R. H.), the Nanometer Structure Consortium for IR system (to S. L.), the Swedish Research Council (to S. L.), and its Linneus Centre Organizing Molecular Matter for CD spectrometer, plate readers (to S. L.), the Alzheimer Foundation Sweden (to S. L.), the Swiss National Science Foundation (to P. A.), the Frances and Augustus Newman Foundation (to T. P. J. K.), the BBSRC (to T. P. J. K.), the European Commission (to S. L., T. P. J. K.), the Welcome Trust (to C. M. D.), the Marie Curie fellowship scheme for career development (to P. A.), and the Senter Novem, IOP-IGE07004 (to H. H. K.).	Arosio P, 2014, TRENDS PHARMACOL SCI, V35, P127, DOI 10.1016/j.tips.2013.12.005; Assarsson A, 2014, ACS CHEM NEUROSCI, V5, P266, DOI 10.1021/cn400124r; BLENNOW A, 1995, BBA-PROTEIN STRUCT M, V1252, P69, DOI 10.1016/0167-4838(95)00111-7; Boelens WC, 2001, BBA-PROTEIN STRUCT M, V1544, P311, DOI 10.1016/S0167-4838(00)00243-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; COHEN AS, 1959, NATURE, V183, P1202, DOI 10.1038/1831202a0; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608916; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608917; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Ellis RJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0398; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Fandrich M, 2011, TRENDS BIOCHEM SCI, V36, P338, DOI 10.1016/j.tibs.2011.02.002; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; FERRONE FA, 1985, J MOL BIOL, V183, P611, DOI 10.1016/0022-2836(85)90175-5; Gillis J, 2013, J BIOL CHEM, V288, P17225, DOI 10.1074/jbc.M112.421685; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hard T, 2012, J MOL BIOL, V421, P441, DOI 10.1016/j.jmb.2011.12.062; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Hermansson E, 2014, DIS MODEL MECH, V7, P659, DOI 10.1242/dmm.014787; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; KAMPINGA HH, 1993, J CELL SCI, V104, P11; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Ladiwala ARA, 2012, J BIOL CHEM, V287, P24765, DOI 10.1074/jbc.M111.329763; Lorenzen N, 2012, BIOPHYS J, V102, P2167, DOI 10.1016/j.bpj.2012.03.047; Mannini B, 2012, P NATL ACAD SCI USA, V109, P12479, DOI 10.1073/pnas.1117799109; Mansson C, 2014, CELL STRESS CHAPERON, V19, P227, DOI 10.1007/s12192-013-0448-5; Meisl G, 2014, P NATL ACAD SCI USA, V111, P9384, DOI 10.1073/pnas.1401564111; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Narayan P, 2012, BIOCHEMISTRY-US, V51, P9270, DOI 10.1021/bi301277k; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Selkoe J. D., 2011, COLD SPRING HARBOR P, V3; Shammas SL, 2011, BIOPHYS J, V101, P1681, DOI 10.1016/j.bpj.2011.07.056; Sorensen BK, 2002, ANAL BIOCHEM, V304, P33, DOI 10.1006/abio.2001.5604; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2012, PROG MOL BIOL TRANSL, V107, P101, DOI 10.1016/B978-0-12-385883-2.00012-6; Walsh DM, 2009, FEBS J, V276, P1266, DOI 10.1111/j.1742-4658.2008.06862.x; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Willander H, 2012, J BIOL CHEM, V287, P31608, DOI 10.1074/jbc.M112.393157; Yoo BC, 2001, BIOCHEM BIOPH RES CO, V280, P249, DOI 10.1006/bbrc.2000.4109	54	111	112	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31066	31076		10.1074/jbc.M114.595124	http://dx.doi.org/10.1074/jbc.M114.595124			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25217638	Green Published, hybrid			2022-12-28	WOS:000344549900016
J	Matsuyama, M; Nomori, A; Nakakuni, K; Shimono, A; Fukushima, M				Matsuyama, Makoto; Nomori, Akane; Nakakuni, Kyonni; Shimono, Akihiko; Fukushima, Masaki			Secreted Frizzled-related Protein 1 (Sfrp1) Regulates the Progression of Renal Fibrosis in a Mouse Model of Obstructive Nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT/BETA-CATENIN; INTERSTITIAL FIBROSIS; URETERAL OBSTRUCTION; SIGNALING CONTROLS; WNT ANTAGONIST; CELL POLARITY; KIDNEY; MECHANISMS; ACTIVATION; EXPRESSION	Renal fibrosis is responsible for progressive renal diseases that cause chronic renal failure. Sfrp1 (secreted Frizzled-related protein 1) is highly expressed in kidney, although little is known about connection between the protein and renal diseases. Here, we focused on Sfrp1 to investigate its roles in renal fibrosis using a mouse model of unilateral ureteral obstruction (UUO). In wild-type mice, the expression of Sfrp1 protein was markedly increased after UUO. The kidneys from Sfrp1 knock-out mice showed significant increase in expression of myofibrobast markers, alpha-smooth muscle actin (alpha SMA). Sfrp1 deficiency also increased protein levels of the fibroblast genes, vimentin, and decreased those of the epithelial genes, E-cadherin, indicated that enhanced epithelial-to-mesenchymal transition. There was no difference in the levels of canonical Wnt signaling; rather, the levels of phosphorylated c-Jun and JNK were more increased in the Sfrp1(-/-) obstructed kidney. Moreover, the apoptotic cell population was significantly elevated in the obstructed kidneys from Sfrp1(-/-) mice following UUO but was slightly increased in those from wild-type mice. These results indicate that Sfrp1 is required for inhibition of renal damage through the non-canonical Wnt/PCP pathway.	[Matsuyama, Makoto; Nomori, Akane] Shigei Med Res Inst, Div Mol Genet, Minami Ku, Okayama 7010202, Japan; [Nakakuni, Kyonni; Fukushima, Masaki] Shigei Med Res Hosp, Minami Ku, Okayama 7010202, Japan; [Shimono, Akihiko] TransGenic Inc, Kobe, Hyogo 6500047, Japan		Matsuyama, M (corresponding author), Shigei Med Res Inst, Div Mol Genet, Minami Ku, 2117 Yamada, Okayama 7010202, Japan.	matsuyama@shigei.or.jp		Matsuyama, Makoto/0000-0003-2606-059X	Ryobi Teien Memory Foundation	Ryobi Teien Memory Foundation(Ryobi Teien Memory Foundation)	This work was supported in part by the Ryobi Teien Memory Foundation.	Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; DiRocco DP, 2013, J AM SOC NEPHROL, V24, P1399, DOI 10.1681/ASN.2012050512; Elzi DJ, 2012, MOL CELL BIOL, V32, P4388, DOI 10.1128/MCB.06023-11; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Gauger KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078320; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; He X, 2008, NAT CELL BIOL, V10, P11, DOI 10.1038/ncb0108-11; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Kawakami T, 2013, J PATHOL, V229, P221, DOI 10.1002/path.4121; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Kusaka M, 2010, ENDOCRINOLOGY, V151, P5893, DOI 10.1210/en.2010-0915; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Ma FY, 2007, J AM SOC NEPHROL, V18, P472, DOI 10.1681/ASN.2006060604; MacDonald BT, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.036; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Matsuyama Makoto, 2012, Methods Mol Biol, V839, P229, DOI 10.1007/978-1-61779-510-7_18; Matsuyama M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000427; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Mii Y, 2011, DEV GROWTH DIFFER, V53, P911, DOI 10.1111/j.1440-169X.2011.01299.x; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Ren SY, 2013, P NATL ACAD SCI USA, V110, P1440, DOI 10.1073/pnas.1211179110; Sado Y, 2006, ACTA HISTOCHEM CYTOC, V39, P89, DOI 10.1267/ahc.06001; Satoh W, 2006, DEVELOPMENT, V133, P989, DOI 10.1242/dev.02274; Satoh W, 2008, GENESIS, V46, P92, DOI 10.1002/dvg.20369; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Stambe C, 2004, J AM SOC NEPHROL, V15, P370, DOI 10.1097/01.ASN.0000109669.23650.56; Surendran K, 2005, J AM SOC NEPHROL, V16, P2373, DOI 10.1681/ASN.2004110949; Tampe D, 2014, NAT REV NEPHROL, V10, P226, DOI 10.1038/nrneph.2014.14; Trevant B, 2008, J CELL PHYSIOL, V217, P113, DOI 10.1002/jcp.21482; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Yoshino K, 2001, MECH DEVELOP, V102, P45, DOI 10.1016/S0925-4773(01)00282-9; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhang P, 2012, J BIOL CHEM, V287, P21290, DOI 10.1074/jbc.M112.357202; Zhou D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01878	44	30	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31526	31533		10.1074/jbc.M114.584565	http://dx.doi.org/10.1074/jbc.M114.584565			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25253698	hybrid, Green Published			2022-12-28	WOS:000344549900054
J	Rao, DK; Liu, HY; Ambudkar, SV; Mayer, M				Rao, Divya K.; Liu, Haiyan; Ambudkar, Suresh V.; Mayer, Michael			A Combination of Curcumin with Either Gramicidin or Ouabain Selectively Kills Cells That Express the Multidrug Resistance-linked ABCG2 Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; P-GLYCOPROTEIN; ATPASE ACTIVITY; COLLATERAL SENSITIVITY; CARDIAC-GLYCOSIDES; DRUG-RESISTANCE; TUMOR-CELLS; K+-ATPASE; APOPTOSIS; PROTEIN	This paper introduces a strategy to kill selectively multidrug-resistant cells that express the ABCG2 transporter (also called breast cancer resistance protein, or BCRP). The approach is based on specific stimulation of ATP hydrolysis by ABCG2 transporters with subtoxic doses of curcumin combined with stimulation of ATP hydrolysis by Na+, K+-ATPase with subtoxic doses of gramicidin A or ouabain. After 72 h of incubation with the drug combinations, the resulting over consumption of ATP by both pathways inhibits the efflux activity of ABCG2 transporters, leads to depletion of intracellular ATP levels below the viability threshold, and kills resistant cells selectively over cells that lack ABCG2 transporters. This strategy, which was also tested on a clinically relevant human breast adenocarcinoma cell line (MCF-7/FLV1), exploits the overexpression of ABCG2 transporters and induces caspase-dependent apoptotic cell death selectively in resistant cells. This work thus introduces a novel strategy to exploit collateral sensitivity (CS) with a combination of two clinically used compounds that individually do not exert CS. Collectively, this work expands the current knowledge on ABCG2-mediated CS and provides a potential strategy for discovery of CS drugs against drug-resistant cancer cells.	[Rao, Divya K.; Liu, Haiyan; Mayer, Michael] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Mayer, Michael] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Ambudkar, Suresh V.] NCI, Lab Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mayer, M (corresponding author), Univ Michigan, Dept Biomed Engn, 1101 Beal Ave, Ann Arbor, MI 48109 USA.	mimayer@umich.edu	Mayer, Michael/C-1299-2010; Mayer, Michael/AAS-1777-2020; Ambudkar, Suresh V/L-1317-2016	Mayer, Michael/0000-0002-6148-5756; 	National Institutes of Health [1R01GM081705]; Intramural Research Program of the NCI National Institutes of Health Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NCI National Institutes of Health Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM081705 (to M. M.) and by the Intramural Research Program of the NCI National Institutes of Health Center for Cancer Research (to S.V.A.).	ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; ANNER BM, 1994, MOL MEMBR BIOL, V11, P247, DOI 10.3109/09687689409160434; Carroll RE, 2011, CANCER PREV RES, V4, P354, DOI 10.1158/1940-6207.CAPR-10-0098; Chearwae W, 2006, MOL CANCER THER, V5, P1995, DOI 10.1158/1535-7163.MCT-06-0087; Chen JQ, 2006, BREAST CANCER RES TR, V96, P1, DOI 10.1007/s10549-005-9053-3; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Fanciulli M, 2000, CLIN CANCER RES, V6, P1590; Fearon K. C., 1987, CANCER RES, V47, P3684; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; GODFRAIND T, 1977, NATURE, V265, P165, DOI 10.1038/265165a0; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hagen P, 1939, J PHARMACOL EXP THER, V67, P50; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Hardwick LJA, 2007, BRIT J PHARMACOL, V151, P163, DOI 10.1038/sj.bjp.0707218; HAROLD FM, 1967, J BACTERIOL, V94, P53, DOI 10.1128/JB.94.1.53-60.1967; Heffeter P, 2007, BIOCHEM PHARMACOL, V73, P1873, DOI 10.1016/j.bcp.2007.03.002; HLADKY SB, 1970, NATURE, V225, P451, DOI 10.1038/225451a0; Hoffman MM, 1996, J GEN PHYSIOL, V108, P295, DOI 10.1085/jgp.108.4.295; James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x; Karwatsky J, 2003, BIOCHEMISTRY-US, V42, P12163, DOI 10.1021/bi034149+; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; Kusuhara H, 2012, BRIT J PHARMACOL, V166, P1793, DOI 10.1111/j.1476-5381.2012.01887.x; Laberge RM, 2007, BIOCHEM PHARMACOL, V73, P1727, DOI 10.1016/j.bcp.2007.02.005; Laberge RM, 2009, ARCH BIOCHEM BIOPHYS, V491, P53, DOI 10.1016/j.abb.2009.09.012; LEACH FR, 1986, METHOD ENZYMOL, V133, P51; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Leonard Gregory D, 2002, Curr Opin Investig Drugs, V3, P1652; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; LINN SC, 1995, EUR J CANCER, V31A, P1291, DOI 10.1016/0959-8049(95)00278-Q; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4; Moreno-Sanchez R, 2009, BIOFACTORS, V35, P209, DOI 10.1002/biof.31; NOBES CD, 1989, BIOCHIM BIOPHYS ACTA, V976, P241, DOI 10.1016/S0005-2728(89)80236-1; NOBLE D, 1980, CARDIOVASC RES, V14, P495, DOI 10.1093/cvr/14.9.495; Oselkin M, 2010, NEUROSCI LETT, V473, P67, DOI 10.1016/j.neulet.2009.10.021; Pluchino KM, 2012, DRUG RESIST UPDATE, V15, P98, DOI 10.1016/j.drup.2012.03.002; Robey RW, 2008, BIOCHEM PHARMACOL, V75, P1302, DOI 10.1016/j.bcp.2007.12.001; Robey RW, 2001, CLIN CANCER RES, V7, P145; ROTTENBERG H, 1989, BIOCHEMISTRY-US, V28, P4355, DOI 10.1021/bi00436a035; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SCHATZMANN HJ, 1953, HELV PHYSIOL PHARM A, V11, P346; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shim H, 1998, P NATL ACAD SCI USA, V95, P1511, DOI 10.1073/pnas.95.4.1511; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Shukla S, 2008, EXPERT OPIN DRUG MET, V4, P205, DOI 10.1517/17425255.4.2.205; Shukla S, 2006, BIOCHEMISTRY-US, V45, P8940, DOI 10.1021/bi060552f; Silva AS, 2012, CANCER RES, V72, P6362, DOI 10.1158/0008-5472.CAN-12-2235; STANKOVIC CJ, 1989, SCIENCE, V244, P813, DOI 10.1126/science.2471263; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Szakacs G, 2014, CHEM REV, V114, P5753, DOI 10.1021/cr4006236; van der Heijden J, 2004, ANN RHEUM DIS, V63, P131, DOI 10.1136/ard.2003.006494; Wallace KB, 2000, ANNU REV PHARMACOL, V40, P353, DOI 10.1146/annurev.pharmtox.40.1.353; WOODWARD GE, 1954, CANCER RES, V14, P599	58	26	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31397	31410		10.1074/jbc.M114.576819	http://dx.doi.org/10.1074/jbc.M114.576819			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25253691	Green Published, hybrid			2022-12-28	WOS:000344549900043
J	Schmidt, ML; Donninger, H; Clark, GJ				Schmidt, M. Lee; Donninger, Howard; Clark, Geoffrey J.			Ras Regulates SCF beta-TrCP Protein Activity and Specificity via Its Effector Protein NORE1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-SUPPRESSOR RASSF1A; HIPPO-YAP PATHWAY; UBIQUITIN LIGASE; DEPENDENT DEGRADATION; ORGAN SIZE; H-RAS; CATENIN; CANCER; WNT	Ras is the most frequently activated oncogene found in human cancer, but its mechanisms of action remain only partially understood. Ras activates multiple signaling pathways to promote transformation. However, Ras can also exhibit a potent ability to induce growth arrest and death. NORE1A (RASSF5) is a direct Ras effector that acts as a tumor suppressor by promoting apoptosis and cell cycle arrest. Expression of NORE1A is frequently lost in human tumors, and its mechanism of action remains unclear. Here we show that NORE1A forms a direct, Ras-regulated complex with beta-TrCP, the substrate recognition component of the SCF beta-TrCP ubiquitin ligase complex. This interaction allows Ras to stimulate the ubiquitin ligase activity of SCF beta-TrCP toward its target beta-catenin, resulting in degradation of beta-catenin by the 26 S proteasome. However, the action of Ras/NORE1A/beta-TrCP is substrate-specific because I kappa B, another substrate of SCF beta-TrCP, is not sensitive to NORE1A-promoted degradation. We identify a completely new signaling mechanism for Ras that allows for the specific regulation of SCF beta-TrCP targets. We show that the NORM levels in a cell may dictate the effects of Ras on the Wnt/beta-catenin pathway. Moreover, because NORE1A expression is frequently impaired in tumors, we provide an explanation for the observation that beta-TrCP can act as a tumor suppressor or an oncogene in different cell systems.	[Schmidt, M. Lee] Univ Louisville, Mol Targets Grp, James Graham Brown Canc Ctr, Dept Biochem & Mol Biol, Louisville, KY 40202 USA; [Donninger, Howard] Univ Louisville, Mol Targets Grp, James Graham Brown Canc Ctr, Dept Med, Louisville, KY 40202 USA; [Clark, Geoffrey J.] Univ Louisville, Mol Targets Grp, James Graham Brown Canc Ctr, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA	University of Louisville; University of Louisville; University of Louisville	Clark, GJ (corresponding author), Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, 505 S Hancock St,CTR 417, Louisville, KY 40202 USA.	gjclar01@louisville.edu	Donninger, Howard/I-9874-2019	Donninger, Howard/0000-0002-8589-1660	National Institutes of Health [R01 CA133171-01A2]; NATIONAL CANCER INSTITUTE [R01CA133171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA133171-01A2 (to G. J. C.).	Aoyama Y, 2004, ONCOGENE, V23, P3426, DOI 10.1038/sj.onc.1207486; Baeuerle PA, 1998, CELL, V95, P729, DOI 10.1016/S0092-8674(00)81694-3; Biechele T.L., 2009, COLD SPRING HARBOR P; BOS JL, 1989, CANCER RES, V49, P4682; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chen JD, 2003, CANCER CELL, V4, P405, DOI 10.1016/S1535-6108(03)00269-1; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Espada J, 1999, J CELL BIOL, V146, P967, DOI 10.1083/jcb.146.5.967; Estrabaud E, 2007, CANCER RES, V67, P1054, DOI 10.1158/0008-5472.CAN-06-2530; Fiordalisi JJ, 2001, METHOD ENZYMOL, V332, P3; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; Horst D, 2012, CANCER RES, V72, P1547, DOI 10.1158/0008-5472.CAN-11-3222; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Jang JW, 2006, MOL CELL BIOL, V26, P8109, DOI 10.1128/MCB.00404-06; Jeong WJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002242; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kim D, 2007, ONCOGENE, V26, P4571, DOI 10.1038/sj.onc.1210230; Kim SE, 2009, J CELL SCI, V122, P842, DOI 10.1242/jcs.040493; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Konsavage WM, 2013, ACTA BIOCH BIOPH SIN, V45, P71, DOI 10.1093/abbs/gms084; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Orian A, 2000, EMBO J, V19, P2580, DOI 10.1093/emboj/19.11.2580; Ortiz-Vega S, 2002, ONCOGENE, V21, P1381, DOI 10.1038/sj.onc.1205192; Pacheco-Pinedo EC, 2011, ONCOTARGET, V2, P569; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Reuter CWM, 2000, BLOOD, V96, P1655, DOI 10.1182/blood.V96.5.1655.h8001655_1655_1669; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Saifo MS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-310; Schmidt L. C. G., 2011, ATLAS GENET CYTOGENE; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Shinmura K, 2011, LUNG CANCER, V71, P19, DOI 10.1016/j.lungcan.2010.04.006; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vos MD, 2003, J BIOL CHEM, V278, P21938, DOI 10.1074/jbc.M211019200; Vos MD, 2003, J BIOL CHEM, V278, P28045, DOI 10.1074/jbc.M300554200; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Xu M. X., 2013, INT J ONCOL; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	54	17	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31102	31110		10.1074/jbc.M114.594283	http://dx.doi.org/10.1074/jbc.M114.594283			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25217643	hybrid, Green Published			2022-12-28	WOS:000344549900019
J	Brown, SD; Babbitt, PC				Brown, Shoshana D.; Babbitt, Patricia C.			New Insights about Enzyme Evolution from Large Scale Studies of Sequence and Structure Relationships	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACYLAMINO ACID RACEMASE; DIISOPROPYL FLUOROPHOSPHATASE; STRICTOSIDINE SYNTHASE; DIVERGENT EVOLUTION; PROMISCUITY; BINDING; ENOLASE; PROTEIN; SUPERFAMILIES; EXPRESSION	Understanding how enzymes have evolved offers clues about their structure-function relationships and mechanisms. Here, we describe evolution of functionally diverse enzyme superfamilies, each representing a large set of sequences that evolved from a common ancestor and that retain conserved features of their structures and active sites. Using several examples, we describe the different structural strategies nature has used to evolve new reaction and substrate specificities in each unique superfamily. The results provide insight about enzyme evolution that is not easily obtained from studies of one or only a few enzymes.	[Brown, Shoshana D.; Babbitt, Patricia C.] Univ Calif San Francisco, Sch Pharm, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Babbitt, Patricia C.] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Babbitt, Patricia C.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Babbitt, PC (corresponding author), Univ Calif San Francisco, 1700 4th St,UCSF MC2550, San Francisco, CA 94158 USA.	babbitt@cgl.ucsf.edu			National Institutes of Health [R01 GM60595]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM60595 (to P. C. B.). This is the fourth article in the Thematic Minireview series "Enzyme Evolution."	Akiva E, 2014, NUCLEIC ACIDS RES, V42, pD521, DOI 10.1093/nar/gkt1130; Allen KN, 2009, CURR OPIN STRUC BIOL, V19, P658, DOI 10.1016/j.sbi.2009.09.008; Almonacid DE, 2011, CURR OPIN CHEM BIOL, V15, P435, DOI 10.1016/j.cbpa.2011.03.008; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Armstrong RN, 2000, BIOCHEMISTRY-US, V39, P13625, DOI 10.1021/bi001814v; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Avilan Luisana, 2011, Enzyme Res, V2011, P932549, DOI 10.4061/2011/932549; Babbitt PC, 1997, J BIOL CHEM, V272, P30591, DOI 10.1074/jbc.272.49.30591; Baier F, 2014, J MOL BIOL, V426, P2442, DOI 10.1016/j.jmb.2014.04.013; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blum MM, 2006, J AM CHEM SOC, V128, P12750, DOI 10.1021/ja061887n; Blum MM, 2010, CHEM-BIOL INTERACT, V187, P373, DOI 10.1016/j.cbi.2010.02.043; Brizendine AM, 2014, BIOCHEM BIOPH RES CO, V450, P679, DOI 10.1016/j.bbrc.2014.06.034; Bruns CM, 1997, NAT STRUCT BIOL, V4, P919, DOI 10.1038/nsb1197-919; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Butterfield DA, 2009, J NEUROCHEM, V111, P915, DOI 10.1111/j.1471-4159.2009.06397.x; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Copley SD, 2012, BIOESSAYS, V34, P578, DOI 10.1002/bies.201100191; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Furnham N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002403; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; Glasner ME, 2006, J MOL BIOL, V360, P228, DOI 10.1016/j.jmb.2006.04.055; Goldman PJ, 2013, P NATL ACAD SCI USA, V110, P15949, DOI 10.1073/pnas.1312228110; Goodacre NF, 2014, MBIO, V5, DOI 10.1128/mBio.00744-13; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; He PQ, 2011, J INORG BIOCHEM, V105, P1259, DOI 10.1016/j.jinorgbio.2011.06.006; Henderson B, 2013, CURR TOP MICROBIOL, V358, P155, DOI 10.1007/82_2011_188; Hicks M. A., 2014, PROTEIN FAMILIES REL, P127; Hicks MA, 2011, PROTEINS, V79, P3082, DOI 10.1002/prot.23135; Iyer LM, 2013, NUCLEIC ACIDS RES, V41, P7635, DOI 10.1093/nar/gkt573; Katsemi V, 2005, BIOCHEMISTRY-US, V44, P9022, DOI 10.1021/bi0500675; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; KUTCHAN TM, 1989, FEBS LETT, V257, P127, DOI 10.1016/0014-5793(89)81802-2; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lukk T, 2012, P NATL ACAD SCI USA, V109, P4122, DOI 10.1073/pnas.1112081109; Mashiyama ST, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001843; Meng EC, 2011, CURR OPIN STRUC BIOL, V21, P391, DOI 10.1016/j.sbi.2011.03.007; Mursula AM, 2001, J MOL BIOL, V309, P845, DOI 10.1006/jmbi.2001.4671; Nelson KJ, 2011, PROTEINS, V79, P947, DOI 10.1002/prot.22936; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Odokonyero D, 2013, BIOCHEMISTRY-US, V52, P7512, DOI 10.1021/bi401176d; Ojha S, 2007, PLOS COMPUT BIOL, V3, P1268, DOI 10.1371/journal.pcbi.0030121; Oldfield E, 2012, ANGEW CHEM INT EDIT, V51, P1124, DOI 10.1002/anie.201103110; Omelchenko MV, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-31; Palmer DRJ, 1999, BIOCHEMISTRY-US, V38, P4252, DOI 10.1021/bi990140p; Pandya C, 2013, P NATL ACAD SCI USA, V110, pE3381, DOI 10.1073/pnas.1305519110; PIATIGORSKY J, 1988, P NATL ACAD SCI USA, V85, P3479, DOI 10.1073/pnas.85.10.3479; Sakai A, 2009, BIOCHEMISTRY-US, V48, P1445, DOI 10.1021/bi802277h; Schmidt DMZ, 2003, BIOCHEMISTRY-US, V42, P8387, DOI 10.1021/bi034769a; Schnoes AM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003063; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharkey TD, 2005, PLANT PHYSIOL, V137, P700, DOI 10.1104/pp.104.054445; Song L, 2007, NAT CHEM BIOL, V3, P486, DOI 10.1038/nchembio.2007.11; Tanaka Y, 2007, J BIOL CHEM, V282, P5770, DOI 10.1074/jbc.M607340200; TOKUYAMA S, 1995, APPL MICROBIOL BIOT, V42, P884; Uberto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074477; Vallon O, 2000, PROTEINS, V38, P95, DOI 10.1002/(SICI)1097-0134(20000101)38:1<95::AID-PROT10>3.0.CO;2-A; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Wallrapp FH, 2013, P NATL ACAD SCI USA, V110, pE1196, DOI 10.1073/pnas.1300632110	63	43	44	0	34	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30221	30228		10.1074/jbc.R114.569350	http://dx.doi.org/10.1074/jbc.R114.569350			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25210038	Green Published, hybrid			2022-12-28	WOS:000344549700006
J	Pandya, C; Farelli, JD; Dunaway-Mariano, D; Allen, KN				Pandya, Chetanya; Farelli, Jeremiah D.; Dunaway-Mariano, Debra; Allen, Karen N.			Enzyme Promiscuity: Engine of Evolutionary Innovation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BETA-PHOSPHOGLUCOMUTASE CATALYSIS; ACYLAMINO ACID RACEMASE; ESCHERICHIA-COLI; HOTDOG-FOLD; SUBSTRATE-SPECIFICITY; PHOSPHONOACETALDEHYDE HYDROLASE; DEHALOGENASE SUPERFAMILY; BIOCHEMICAL FUNCTION; ENOLASE SUPERFAMILY; HAD SUPERFAMILY	Catalytic promiscuity and substrate ambiguity are keys to evolvability, which in turn is pivotal to the successful acquisition of novel biological functions. Action on multiple substrates (substrate ambiguity) can be harnessed for performance of functions in the cell that supersede catalysis of a single metabolite. These functions include proofreading, scavenging of nutrients, removal of antimetabolites, balancing of metabolite pools, and establishing system redundancy. In this review, we present examples of enzymes that perform these cellular roles by leveraging substrate ambiguity and then present the structural features that support both specificity and ambiguity. We focus on the phosphatases of the haloalkanoate dehalogenase superfamily and the thioesterases of the hotdog fold superfamily.	[Pandya, Chetanya; Allen, Karen N.] Boston Univ, Bioinformat Grad Program, Boston, MA 02215 USA; [Farelli, Jeremiah D.; Allen, Karen N.] Boston Univ, Dept Chem, Boston, MA 02215 USA; [Dunaway-Mariano, Debra] Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA	Boston University; Boston University; University of New Mexico	Dunaway-Mariano, D (corresponding author), Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA.	dd39@unm.edu; drkallen@bu.edu	Pandya, Chetanya/N-7492-2013; Allen, Karen N./J-7045-2019	Pandya, Chetanya/0000-0003-2683-6925; Allen, Karen N./0000-0001-7296-0551	National Institutes of Health [R01 GM098760, U54 GM093342]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098760, U54GM093342] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM098760 and U54 GM093342 (to K. N. A. and D. D. M.). This is the fifth article in the Thematic Minireview series "Enzyme Evolution."	Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Asler IL, 2010, CHEMBIOCHEM, V11, P2158, DOI 10.1002/cbic.201000398; Babbitt PC, 1996, BIOCHEMISTRY-US, V35, P16489, DOI 10.1021/bi9616413; BABBITT PC, 1992, BIOCHEMISTRY-US, V31, P5594, DOI 10.1021/bi00139a024; Babtie A, 2010, CURR OPIN CHEM BIOL, V14, P200, DOI 10.1016/j.cbpa.2009.11.028; Baier F, 2014, J MOL BIOL, V426, P2442, DOI 10.1016/j.jmb.2014.04.013; Bastard K, 2014, NAT CHEM BIOL, V10, P42, DOI 10.1038/NCHEMBIO.1387; Ben-David M, 2012, J MOL BIOL, V418, P181, DOI 10.1016/j.jmb.2012.02.042; Bernat BA, 1999, BIOCHEMISTRY-US, V38, P7462, DOI 10.1021/bi990391y; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; BOHREN KM, 1992, J BIOL CHEM, V267, P20965; BRITTON KL, 1993, J MOL BIOL, V234, P938, DOI 10.1006/jmbi.1993.1647; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Cao J, 2009, BIOCHEMISTRY-US, V48, P1293, DOI 10.1021/bi801879z; Chen DQ, 2009, BIOCHEMISTRY-US, V48, P511, DOI 10.1021/bi802207t; Colletier JP, 2012, MOL BIOL EVOL, V29, P1683, DOI 10.1093/molbev/mss015; Dai JY, 2006, BIOCHEMISTRY-US, V45, P7818, DOI 10.1021/bi060136v; Dai JY, 2009, BIOCHEMISTRY-US, V48, P1984, DOI 10.1021/bi801653r; Daughtry KD, 2013, BIOCHEMISTRY-US, V52, P5372, DOI 10.1021/bi400659k; Dellus-Gur E, 2013, J MOL BIOL, V425, P2609, DOI 10.1016/j.jmb.2013.03.033; di Salvo ML, 2013, ARCH BIOCHEM BIOPHYS, V529, P55, DOI 10.1016/j.abb.2012.11.011; Dillon SC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-109; Gehring AM, 1997, BIOCHEMISTRY-US, V36, P8495, DOI 10.1021/bi970453p; Giger L, 2013, NAT CHEM BIOL, V9, P494, DOI 10.1038/nchembio.1276; Glasner ME, 2006, J MOL BIOL, V360, P228, DOI 10.1016/j.jmb.2006.04.055; Gonzalez CF, 2012, BIOCHEM J, V444, P445, DOI 10.1042/BJ20112032; Hawes JW, 1996, J BIOL CHEM, V271, P26430, DOI 10.1074/jbc.271.42.26430; Hiblot J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075272; Honaker MT, 2011, J BIOL CHEM, V286, P42770, DOI 10.1074/jbc.M111.304386; Huang FL, 2006, CHEM BIOL, V13, P475, DOI 10.1016/j.chembiol.2006.02.014; Huang H, 2011, BIOCHEMISTRY-US, V50, P8937, DOI 10.1021/bi201181q; Humble MS, 2011, EUR J ORG CHEM, V2011, P3391, DOI 10.1002/ejoc.201001664; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; LABESSE G, 1994, BIOCHEM J, V304, P95, DOI 10.1042/bj3040095; Lu ZB, 2005, BIOCHEMISTRY-US, V44, P8684, DOI 10.1021/bi050009j; Lu ZB, 2011, PROTEINS, V79, P3099, DOI 10.1002/prot.23137; McMahon MD, 2014, APPL ENVIRON MICROB, V80, P1042, DOI 10.1128/AEM.03303-13; Monecke T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090915; Morais MC, 2000, BIOCHEMISTRY-US, V39, P10385, DOI 10.1021/bi001171j; Nam H, 2012, SCIENCE, V337, P1101, DOI 10.1126/science.1216861; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; O'Brien PJ, 1998, J AM CHEM SOC, V120, P12369, DOI 10.1021/ja983390m; Palmer DRJ, 1999, BIOCHEMISTRY-US, V38, P4252, DOI 10.1021/bi990140p; Pandya C, 2014, PROTEINS, V82, P1896, DOI 10.1002/prot.24543; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Rockah-Shmuel L, 2012, NUCLEIC ACIDS RES, V40, P11627, DOI 10.1093/nar/gks944; Russell RB, 1998, J MOL BIOL, V282, P903, DOI 10.1006/jmbi.1998.2043; Song F, 2006, J BIOL CHEM, V281, P11028, DOI 10.1074/jbc.M513896200; Thoden JB, 2002, J BIOL CHEM, V277, P27468, DOI 10.1074/jbc.M203904200; Titz B, 2007, FEMS MICROBIOL LETT, V270, P49, DOI 10.1111/j.1574-6968.2007.00646.x; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Tremblay LW, 2006, BIOCHEMISTRY-US, V45, P1183, DOI 10.1021/bi051842j; van Loo B, 2010, P NATL ACAD SCI USA, V107, P2740, DOI 10.1073/pnas.0903951107; Wallden K, 2011, J MOL BIOL, V408, P684, DOI 10.1016/j.jmb.2011.02.059; Weeks AM, 2010, BIOCHEMISTRY-US, V49, P9269, DOI 10.1021/bi101102u; Willis MA, 2008, BIOCHEMISTRY-US, V47, P2797, DOI 10.1021/bi702336d; Wu R, 2014, BIOCHEMISTRY-US, V53, P4788, DOI 10.1021/bi500334v; Zhang GF, 2005, BIOCHEMISTRY-US, V44, P9404, DOI 10.1021/bi050558p; Zhang GF, 2002, BIOCHEMISTRY-US, V41, P13370, DOI 10.1021/bi026388n; Zhao H, 2012, BIOCHEMISTRY-US, V51, P6490, DOI 10.1021/bi300968n; Zhuang ZH, 2003, APPL ENVIRON MICROB, V69, P2707, DOI 10.1128/AEM.69.5.2707-2711.2003; Zhuang ZH, 2008, BIOCHEMISTRY-US, V47, P2789, DOI 10.1021/bi702334h	67	100	101	2	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30229	30236		10.1074/jbc.R114.572990	http://dx.doi.org/10.1074/jbc.R114.572990			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25210039	Green Published, hybrid			2022-12-28	WOS:000344549700007
J	Wolfenden, R				Wolfenden, Richard			Massive Thermal Acceleration of the Emergence of Primordial Chemistry, the Incidence of Spontaneous Mutation, and the Evolution of Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TRANSITION-STATE; CATALYTIC PROFICIENCIES; CYTOSINE DEAMINATION; RATE ENHANCEMENTS; HYDROLYSIS; TEMPERATURE; PROTEIN; PHOSPHODIESTER; BIOCHEMISTRY; EFFICIENCY	Kelvin considered it unlikely that sufficient time had elapsed on the earth for life to have reached its present level of complexity. In the warm surroundings in which life first appeared, however, elevated temperatures would have reduced the kinetic barriers to reaction. Recent experiments disclose the profound extent to which very slow reactions are accelerated by elevated temperatures, collapsing the time that would have been required for early events in primordial chemistry before the advent of enzymes. If a primitive enzyme, like model catalysts and most modern enzymes, accelerated a reaction by lowering its enthalpy of activation, then the rate enhancement that it produced would have increased automatically as the environment cooled, quite apart from any improvements in catalytic activity that arose from mutation and natural selection. The chemical events responsible for spontaneous mutation are also highly sensitive to temperature, furnishing an independent mechanism for accelerating evolution.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Wolfenden, R (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	water@med.unc.edu	Wolfenden, Richard/CAH-1293-2022		National Institutes of Health [GM-18325]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018325, R01GM018325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-18325 (to R. W.). This is the first article in the Thematic Minireview series "Enzyme Evolution."	Akanuma S, 2013, P NATL ACAD SCI USA, V110, P11067, DOI 10.1073/pnas.1308215110; Ball P., 2011, NATURE, DOI [10.1038/news.2010.590, DOI 10.1038/NEWS.2010.590]; Bracken K, 1997, J AM CHEM SOC, V119, P9323, DOI 10.1021/ja971448b; BRUICE TC, 1957, J AM CHEM SOC, V79, P1663, DOI 10.1021/ja01564a036; Darwin CR, 1871, COMMUNICATION; Di Giulio M, 2003, J THEOR BIOL, V221, P425, DOI 10.1006/jtbi.2003.3197; DRAKE JW, 1976, ANNU REV BIOCHEM, V45, P11, DOI 10.1146/annurev.bi.45.070176.000303; Edwards DR, 2012, J AM CHEM SOC, V134, P525, DOI 10.1021/ja208827q; FREDERICO LA, 1993, BIOCHEMISTRY-US, V32, P6523, DOI 10.1021/bi00077a005; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Harcourt A. V, 1866, PHILOS T R SOC LONDO, V156, P193, DOI [DOI 10.1098/RSTL.1866.0010, 10.1098/rstl.1866.0010]; HILVERT D, 1988, P NATL ACAD SCI USA, V85, P4953, DOI 10.1073/pnas.85.14.4953; Huber C, 2012, CHEM-EUR J, V18, P2063, DOI 10.1002/chem.201102914; JENCKS WP, 1966, J AM CHEM SOC, V88, P104, DOI 10.1021/ja00953a020; KAHNE D, 1988, J AM CHEM SOC, V110, P7529, DOI 10.1021/ja00230a041; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Lad C, 2003, P NATL ACAD SCI USA, V100, P5607, DOI 10.1073/pnas.0631607100; LEWIS C, 1991, SCIENCE, V253, P1019, DOI 10.1126/science.1887215; Maldonado AL, 2005, ORG BIOMOL CHEM, V3, P2859, DOI 10.1039/b506170a; Pedersen KJ, 1934, J PHYS CHEM-US, V38, P601, DOI 10.1021/j150356a004; PETERSHEIM M, 1983, BIOCHEMISTRY-US, V22, P256, DOI 10.1021/bi00271a004; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; Risso VA, 2013, J AM CHEM SOC, V135, P2899, DOI 10.1021/ja311630a; Schroeder GK, 2007, BIOCHEMISTRY-US, V46, P13638, DOI 10.1021/bi701480f; Schroeder GK, 2007, BIOCHEMISTRY-US, V46, P4037, DOI 10.1021/bi602600p; Sievers A, 2004, P NATL ACAD SCI USA, V101, P7897, DOI 10.1073/pnas.0402488101; Snider MG, 2004, J PHYS ORG CHEM, V17, P586, DOI 10.1002/poc.761; Snider MJ, 2000, BIOCHEMISTRY-US, V39, P9746, DOI 10.1021/bi000914y; Stockbridge RB, 2010, P NATL ACAD SCI USA, V107, P22102, DOI 10.1073/pnas.1013647107; Stockbridge RB, 2010, CHEM COMMUN, V46, P4306, DOI 10.1039/c0cc00229a; Stockbridge RB, 2009, J BIOL CHEM, V284, P22747, DOI 10.1074/jbc.M109.017806; Thomsen W., 1871, ORIGIN LIFE PRESIDEN; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; WOLFENDEN R, 1972, ACCOUNTS CHEM RES, V5, P10, DOI 10.1021/ar50049a002; Wolfenden R, 1999, J AM CHEM SOC, V121, P7419, DOI 10.1021/ja991280p; WOLFENDEN R, 1991, ACCOUNTS CHEM RES, V24, P209, DOI 10.1021/ar00007a004; Wolfenden R, 2003, BIOPHYS CHEM, V105, P559, DOI 10.1016/S0301-4622(03)00066-8; Wolfenden R, 2011, ANNU REV BIOCHEM, V80, P645, DOI 10.1146/annurev-biochem-060409-093051; Xu JA, 1999, SCIENCE, V286, P2345, DOI 10.1126/science.286.5448.2345; Zabinski RF, 2001, J AM CHEM SOC, V123, P193, DOI 10.1021/ja0026354	40	18	19	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30198	30204		10.1074/jbc.R114.567081	http://dx.doi.org/10.1074/jbc.R114.567081			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25210030	Green Published, hybrid			2022-12-28	WOS:000344549700003
J	Boras, BW; Kornev, A; Taylor, SS; McCulloch, AD				Boras, Britton W.; Kornev, Alexandr; Taylor, Susan S.; McCulloch, Andrew D.			Using Markov State Models to Develop a Mechanistic Understanding of Protein Kinase A Regulatory Subunit RI alpha Activation in Response to cAMP Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Computer Modeling; Cooperativity; Cyclic AMP (cAMP); Protein Kinase A (PKA)	HOLOENZYME; DOMAINS; LOCALIZATION; SPECIFICITY; ALLOSTERY; EPAC1	Background: Binding four cAMP molecules activates protein kinase A (PKA). Results: Mechanistic Markov models (MM) show that although one cAMP activates one catalytic subunit four are necessary for full activation. Conclusion: Conformational selection is the predominant mechanism in PKA activation, but heterodimer interactions are also required. Significance: This MM provides a mechanistic foundation for systems models of PKA signaling networks. Protein kinase A (PKA) holoenzyme consists of two catalytic (C) subunits and a regulatory (R) subunit dimer (R2C2). The kinase is activated by the binding of cAMPs to the two cyclic nucleotide binding domains (CBDs), A and B, on each R-subunit. Despite extensive study, details of the allosteric mechanisms underlying the cooperativity of holoenzyme activation remain unclear. Several Markov state models of PKA-RI were developed to test competing theories of activation for the R2C2 complex. We found that CBD-B plays an essential role in R-C interaction and promotes the release of the first C-subunit prior to the binding to CBD-A. This favors a conformational selection mechanism for release of the first C-subunit of PKA. However, the release of the second C-subunit requires all four cAMP sites to be occupied. These analyses elucidate R-C heterodimer interactions in the cooperative activation of PKA and cAMP binding and represent a new mechanistic model of R2C2 PKA-RI activation.	[Boras, Britton W.; McCulloch, Andrew D.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Kornev, Alexandr; Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [McCulloch, Andrew D.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	McCulloch, AD (corresponding author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA.	amcculloch@ucsd.edu	Kornev, Alexandr Petrovich/O-7826-2015	Kornev, Alexandr Petrovich/0000-0002-1543-3795	National Institutes of Health [R01 HL105242-01, P50 GM094503, P41 GM103426, P01 HL098053]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098053, R01HL105242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM094503, R01GM034921, P41GM103426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL105242-01, P50 GM094503, P41 GM103426, and P01 HL098053.	Abu-Abed M, 2007, PROTEINS, V69, P112, DOI 10.1002/prot.21446; Akimoto M, 2013, P NATL ACAD SCI USA, V110, P14231, DOI 10.1073/pnas.1312644110; Anderson KB, 2011, ENERG FUEL, V25, P1578, DOI 10.1021/ef1012648; Badireddy Suguna, 2011, Mol Cell Proteomics, V10, DOI 10.1074/mcp.M110.004390; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Boettcher AJ, 2011, STRUCTURE, V19, P265, DOI 10.1016/j.str.2010.12.005; Byeon IJL, 2010, J BIOL CHEM, V285, P14062, DOI 10.1074/jbc.M110.106666; Canaves JM, 2002, J MOL EVOL, V54, P17, DOI 10.1007/s00239-001-0013-1; Cheng CY, 2009, J BIOL CHEM, V284, P35916, DOI 10.1074/jbc.M109.059493; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; Grant BD, 1996, BIOCHEMISTRY-US, V35, P2022, DOI 10.1021/bi952144+; Herberg FW, 2000, J MOL BIOL, V298, P329, DOI 10.1006/jmbi.2000.3662; Herberg FW, 1996, BIOCHEMISTRY-US, V35, P2934, DOI 10.1021/bi951647c; HERBERG FW, 1994, BIOCHEMISTRY-US, V33, P7485, DOI 10.1021/bi00189a057; Ilouz R, 2012, P NATL ACAD SCI USA, V109, P12443, DOI 10.1073/pnas.1209538109; Kannan N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r264; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kopperud R, 2002, J BIOL CHEM, V277, P13443, DOI 10.1074/jbc.M109869200; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Marsden AL, 2008, COMPUT METHOD APPL M, V197, P1890, DOI 10.1016/j.cma.2007.12.009; Martin BR, 2007, CHEM BIOL, V14, P1031, DOI 10.1016/j.chembiol.2007.07.017; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Moorthy BS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002295; Moraru II, 2008, IET SYST BIOL, V2, P352, DOI 10.1049/iet-syb:20080102; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Rinaldi J, 2008, ARCH BIOCHEM BIOPHYS, V480, P95, DOI 10.1016/j.abb.2008.09.014; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Vigil D, 2004, BIOCHEMISTRY-US, V43, P5629, DOI 10.1021/bi0499157; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Zhang P, 2012, SCIENCE, V335, P712, DOI 10.1126/science.1213979	33	23	23	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					30040	30051		10.1074/jbc.M114.568907	http://dx.doi.org/10.1074/jbc.M114.568907			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25202018	Green Published, hybrid			2022-12-28	WOS:000344370800044
J	Kuang, Y; Long, MJC; Zhou, J; Shi, JF; Gao, Y; Xu, C; Hedstrom, L; Xu, B				Kuang, Yi; Long, Marcus J. C.; Zhou, Jie; Shi, Junfeng; Gao, Yuan; Xu, Chen; Hedstrom, Lizbeth; Xu, Bing			Prion-like Nanofibrils of Small Molecules (PriSM) Selectively Inhibit Cancer Cells by Impeding Cytoskeleton Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; PROTEIN; TAU; P53; ENDOCYTOSIS; DISRUPTION; INTERACTS; MECHANISM; APOPTOSIS; WATER	Emerging evidence reveals that prion-like structures play important roles to maintain the well-being of cells. Although self-assembly of small molecules also affords prion-like nanofibrils (PriSM), little is known about the functions and mechanisms of PriSM. Previous works demonstrated that PriSM formed by a dipeptide derivative selectively inhibiting the growth of glioblastoma cells over neuronal cells and effectively inhibiting xenograft tumor in animal models. Here we examine the protein targets, the internalization, and the cytotoxicity pathway of the PriSM. The results show that the PriSM selectively accumulate in cancer cells via macropinocytosis to impede the dynamics of cytoskeletal filaments via promiscuous interactions with cytoskeletal proteins, thus inducing apoptosis. Intriguingly, Tau proteins are able to alleviate the effect of the PriSM, thus protecting neuronal cells. This work illustrates PriSM as a new paradigm for developing polypharmacological agents that promiscuously interact with multiple proteins yet result in a primary phenotype, such as cancer inhibition	[Kuang, Yi; Zhou, Jie; Shi, Junfeng; Gao, Yuan; Hedstrom, Lizbeth; Xu, Bing] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; [Long, Marcus J. C.] Brandeis Univ, Grad Program Biochem & Biophys, Waltham, MA 02454 USA; [Xu, Chen] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Hedstrom, Lizbeth] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University; Brandeis University; Brandeis University	Xu, B (corresponding author), Brandeis Univ, Dept Chem, Waltham, MA 02454 USA.	bxu@brandeis.edu	Gao, Yuan/U-1539-2017; XU, Bing/A-7828-2008	Gao, Yuan/0000-0001-9714-4219; XU, Bing/0000-0002-4639-387X; Kuang, Yi/0000-0003-3643-2684; Long, marcus/0000-0002-0343-9671	National Institutes of Health [R01CA142746, P01 GM 62580]; Human Frontier Science Program (HFSP) [RGP0056/2008]; NATIONAL CANCER INSTITUTE [R01CA142746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program (HFSP)(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA142746 (to B. X.) and P01 GM 62580 (to Brandeis University) and by Human Frontier Science Program (HFSP) Grant (RGP0056/2008). J. Z. is a HHMI International Research Fellow.	Adler-Abramovich L, 2012, NAT CHEM BIOL, V8, P701, DOI [10.1038/NCHEMBIO.1002, 10.1038/nchembio.1002]; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; Brown DR, 1998, J NEUROSCI RES, V52, P260, DOI 10.1002/(SICI)1097-4547(19980501)52:3<260::AID-JNR2>3.3.CO;2-P; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Davis FJ, 2005, AM J PHYSIOL-HEART C, V288, pH1477, DOI 10.1152/ajpheart.00789.2004; Debets AJM, 2012, P NATL ACAD SCI USA, V109, P10432, DOI 10.1073/pnas.1205333109; Dos Reis S, 2002, J BIOL CHEM, V277, P5703, DOI 10.1074/jbc.M110183200; Driver Jane A, 2012, BMJ, V344, pe1442, DOI 10.1136/bmj.e1442; Duringer C, 2003, J BIOL CHEM, V278, P42131, DOI 10.1074/jbc.M306462200; Estroff LA, 2004, CHEM REV, V104, P1201, DOI 10.1021/cr0302049; FADOK VA, 1992, J IMMUNOL, V148, P2207; Gao Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2040; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Griffin J. P., 2006, TXB PHARM MED, P96; Gustafsson L, 2005, J NUTR, V135, P1299, DOI 10.1093/jn/135.5.1299; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Khan SH, 1998, CANCER RES, V58, P396; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Koss DJ, 2007, J NEUROCHEM, V102, P1009, DOI 10.1111/j.1471-4159.2007.04579.x; Kuang Y, 2014, ADV HEALTHC MATER, V3, P1217, DOI 10.1002/adhm.201300645; Kuang Y, 2013, ANGEW CHEM INT EDIT, V52, P6944, DOI 10.1002/anie.201302658; Kuang Y, 2013, RSC ADV, V3, P7704, DOI 10.1039/c3ra41523f; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Lodish H., 2004, MOL CELL BIOL, P79; MalchiodiAlbedi F, 1997, J NEUROSCI RES, V48, P425, DOI 10.1002/(SICI)1097-4547(19970601)48:5<425::AID-JNR4>3.0.CO;2-G; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Mistry P, 2004, J BIOL CHEM, V279, P1482, DOI 10.1074/jbc.M310413200; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Newby GA, 2013, TRENDS CELL BIOL, V23, P251, DOI 10.1016/j.tcb.2013.01.007; Pauwels K, 2009, CURR GENE THER, V9, P459, DOI 10.2174/156652309790031120; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Rejman J, 2005, MOL THER, V12, P468, DOI 10.1016/j.ymthe.2005.03.038; Sablina AA, 2001, ONCOGENE, V20, P899, DOI 10.1038/sj.onc.1204156; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; TISHLER RB, 1995, CANCER RES, V55, P6021; Trajkovska M., 2013, NAT CELL BIOL, V15, P729, DOI DOI 10.1038/ncb2809; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; WITMAN GB, 1976, P NATL ACAD SCI USA, V73, P4070, DOI 10.1073/pnas.73.11.4070; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119; Zhang Y, 2011, LANGMUIR, V27, P529, DOI 10.1021/la1020324; Zhou R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095759; Zorn JA, 2011, J AM CHEM SOC, V133, P19630, DOI 10.1021/ja208350u	51	41	41	1	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29208	29218		10.1074/jbc.M114.600288	http://dx.doi.org/10.1074/jbc.M114.600288			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25157102	Green Published, hybrid			2022-12-28	WOS:000344141000036
J	Blaby-Haas, CE; Merchant, SS				Blaby-Haas, Crysten E.; Merchant, Sabeeha S.			Lysosome-related Organelles as Mediators of Metal Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN STORAGE VACUOLES; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; ZINC STORAGE; IRON STORAGE; HETEROLOGOUS EXPRESSION; ENDOPLASMIC-RETICULUM; SUPEROXIDE-DISMUTASE; TRANSPORT PROTEIN; ESCHERICHIA-COLI	Metal ion assimilation is essential for all forms of life. However, organisms must properly control the availability of these nutrients within the cell to avoid inactivating proteins by mismetallation. To safeguard against an imbalance between supply and demand in eukaryotes, intracellular compartments contain metal transporters that load and unload metals. Although the vacuoles of Saccharomyces cerevisiae and Arabidopsis thaliana are well established locales for the storage of copper, zinc, iron, and manganese, related compartments are emerging as important mediators of metal homeostasis. Here we describe these compartments and review their metal transporter complement.	[Blaby-Haas, Crysten E.; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Blaby-Haas, CE (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr East, Los Angeles, CA 90095 USA.	cblaby@chem.ucla.edu		Blaby, Crysten/0000-0002-1583-1291	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FD02-04ER15529]; National Institutes of Health [GM42143]; Individual Kirschstein National Research Service Award (National Institutes of Health) [GM100753]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM042143, F32GM100753, R01GM042143] Funding Source: NIH RePORTER	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Individual Kirschstein National Research Service Award (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy (DE-FD02-04ER15529) (to David Eisenberg) and the National Institutes of Health (GM42143) (to S. M.), respectively. This is the fifth article in the Thematic Minireview series "Metals in Biology 2014."; Recipient of an Individual Kirschstein National Research Service Award (National Institutes of Health Grant GM100753).	Aguirre JD, 2013, J BIOL CHEM, V288, P8468, DOI 10.1074/jbc.M112.433540; Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; Arrivault S, 2006, PLANT J, V46, P861, DOI 10.1111/j.1365-313X.2006.02746.x; Besteiro S, 2008, J CELL SCI, V121, P561, DOI 10.1242/jcs.022574; Bhubhanil S, 2014, MICROBIOL-SGM, V160, P863, DOI 10.1099/mic.0.076802-0; Blaby-Haas C., 2013, ENCY INORGANIC BIOIN, P51; Blaby-Haas CE, 2012, BBA-MOL CELL RES, V1823, P1531, DOI 10.1016/j.bbamcr.2012.04.010; Cellier MFM, 2012, CURR TOP MEMBR, V69, P249, DOI 10.1016/B978-0-12-394390-3.00010-0; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Devirgiliis C, 2004, BIOCHEM BIOPH RES CO, V323, P58, DOI 10.1016/j.bbrc.2004.08.051; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77; Ferella M, 2008, PROTEOMICS, V8, P2735, DOI 10.1002/pmic.200700940; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Garcia-Molina A, 2011, PLANT J, V65, P848, DOI 10.1111/j.1365-313X.2010.04472.x; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Gu MZ, 2013, MOL MICROBIOL, V89, P123, DOI 10.1111/mmi.12263; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haase H, 2002, BIOCHEM BIOPH RES CO, V296, P923, DOI 10.1016/S0006-291X(02)02017-X; Haase H, 1999, BIOMETALS, V12, P247, DOI 10.1023/A:1009232311677; Hakoyama T, 2012, PLANT CELL PHYSIOL, V53, P225, DOI 10.1093/pcp/pcr167; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; HOWE G, 1992, PLANT PHYSIOL, V98, P127, DOI 10.1104/pp.98.1.127; Huang GZ, 2011, J BIOL CHEM, V286, P36619, DOI 10.1074/jbc.M111.284661; Jensen LT, 2002, J MOL BIOL, V318, P251, DOI 10.1016/S0022-2836(02)00093-1; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Jeong J, 2012, P NATL ACAD SCI USA, V109, pE3530, DOI 10.1073/pnas.1211775110; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kawachi M, 2009, PLANT CELL PHYSIOL, V50, P1156, DOI 10.1093/pcp/pcp067; Khan M, 2014, P NATL ACAD SCI USA, V111, P6786, DOI 10.1073/pnas.1405154111; KIM EJ, 1994, P NATL ACAD SCI USA, V91, P6128, DOI 10.1073/pnas.91.13.6128; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Klaumann S, 2011, NEW PHYTOL, V192, P393, DOI 10.1111/j.1469-8137.2011.03798.x; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; Kramer U, 2005, CURR OPIN BIOTECH, V16, P133, DOI 10.1016/j.copbio.2005.02.006; LABBE RF, 1987, ANN NY ACAD SCI, V514, P7, DOI 10.1111/j.1749-6632.1987.tb48755.x; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Lanquar V, 2010, PLANT PHYSIOL, V152, P1986, DOI 10.1104/pp.109.150946; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Li LT, 2001, J BIOL CHEM, V276, P5036, DOI 10.1074/jbc.M008969200; Lin W, 2010, J BIOL CHEM, V285, P39013, DOI 10.1074/jbc.M110.180620; Luk E, 2005, J BIOL CHEM, V280, P22715, DOI 10.1074/jbc.M504257200; Luk EEC, 2001, J BIOL CHEM, V276, P47556, DOI 10.1074/jbc.M108923200; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; MacDiarmid CW, 2002, J BIOL CHEM, V277, P39187, DOI 10.1074/jbc.M205052200; Macomber L, 2011, METALLOMICS, V3, P1153, DOI 10.1039/c1mt00063b; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Malasarn D, 2013, J BIOL CHEM, V288, P10672, DOI 10.1074/jbc.M113.455105; McCormick N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011078; MERCHANT S, 1991, EMBO J, V10, P1383, DOI 10.1002/j.1460-2075.1991.tb07658.x; Merchant SS, 2012, ADV MICROB PHYSIOL, V60, P91, DOI 10.1016/B978-0-12-398264-3.00002-4; Milner MJ, 2013, J EXP BOT, V64, P369, DOI 10.1093/jxb/ers315; Morrissey J, 2009, PLANT CELL, V21, P3326, DOI 10.1105/tpc.109.069401; NAR H, 1992, EUR J BIOCHEM, V205, P1123, DOI 10.1111/j.1432-1033.1992.tb16881.x; Ohrvika H, 2013, P NATL ACAD SCI USA, V110, pE4279, DOI 10.1073/pnas.1311749110; Otegui MS, 2005, PLANT J, V41, P831, DOI 10.1111/j.1365-313X.2005.02346.x; Padilla-Benavides T, 2014, J BIOL CHEM, V289, P20492, DOI 10.1074/jbc.M114.577668; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; Peiter E, 2007, P NATL ACAD SCI USA, V104, P8532, DOI 10.1073/pnas.0609507104; Pope CR, 2012, CURR TOP MEMBR, V69, P97, DOI 10.1016/B978-0-12-394390-3.00004-5; Portnoy ME, 2000, MOL CELL BIOL, V20, P7893, DOI 10.1128/MCB.20.21.7893-7902.2000; Portnoy ME, 2002, BIOCHEM J, V362, P119, DOI 10.1042/bj3620119; Portnoy ME, 2001, MOL GENET GENOMICS, V265, P873, DOI 10.1007/s004380100482; RAGUZZI F, 1988, FEBS LETT, V231, P253, DOI 10.1016/0014-5793(88)80742-7; Ramsay LM, 1997, FEMS MICROBIOL LETT, V152, P293, DOI 10.1016/S0378-1097(97)00213-9; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Rees EM, 2007, J BIOL CHEM, V282, P21629, DOI 10.1074/jbc.M703397200; Regvar M, 2011, J EXP BOT, V62, P3929, DOI 10.1093/jxb/err090; Rogers JC, 2011, PLANT CELL, V23, P4168, DOI 10.1105/tpc.111.092551; Roh HC, 2012, CELL METAB, V15, P88, DOI 10.1016/j.cmet.2011.12.003; Rubino JT, 2011, METALLOMICS, V3, P61, DOI 10.1039/c0mt00044b; Sacher A, 2001, J EXP BIOL, V204, P1053; Sankari S, 2014, J BIOL CHEM, V289, P16498, DOI 10.1074/jbc.M114.571562; Schaaf G, 2006, J BIOL CHEM, V281, P25532, DOI 10.1074/jbc.M601062200; Simm C, 2007, EUKARYOT CELL, V6, P1166, DOI 10.1128/EC.00077-07; Singh A, 2007, J BIOL CHEM, V282, P28619, DOI 10.1074/jbc.M703398200; Song WY, 2010, P NATL ACAD SCI USA, V107, P21187, DOI 10.1073/pnas.1013964107; Thomine S, 2003, PLANT J, V34, P685, DOI 10.1046/j.1365-313X.2003.01760.x; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Tripp BC, 2004, J BIOL CHEM, V279, P6683, DOI 10.1074/jbc.M311648200; Tsigelny IF, 2012, CELL BIOCHEM BIOPHYS, V63, P223, DOI 10.1007/s12013-012-9358-x; Urbanowski JL, 1999, J BIOL CHEM, V274, P38061, DOI 10.1074/jbc.274.53.38061; Urzica EI, 2012, PLANT CELL, V24, P3921, DOI 10.1105/tpc.112.102491; van de Mortel JE, 2006, PLANT PHYSIOL, V142, P1127, DOI 10.1104/pp.106.082073; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Viotti C, 2013, PLANT CELL, V25, P3434, DOI 10.1105/tpc.113.114827; Wada T, 1997, CAN J BOT, V75, P1137, DOI 10.1139/b97-125; Ward DM, 2012, BBA-MOL CELL RES, V1823, P1426, DOI 10.1016/j.bbamcr.2012.03.004; Williams RJP, 2001, COORDIN CHEM REV, V216, P583, DOI 10.1016/S0010-8545(00)00398-2; Wolfenstetter S, 2012, PLANT CELL, V24, P215, DOI 10.1105/tpc.111.090415; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Yagisawa F, 2009, PLANT J, V60, P882, DOI 10.1111/j.1365-313X.2009.04008.x; Yamada K, 2013, PLANT PHYSIOL, V161, P108, DOI 10.1104/pp.112.207654; Yang M, 2006, EMBO J, V25, P1775, DOI 10.1038/sj.emboj.7601064; Zhao FJ, 2014, TRENDS PLANT SCI, V19, P183, DOI 10.1016/j.tplants.2013.12.001	100	84	84	3	53	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28129	28136		10.1074/jbc.R114.592618	http://dx.doi.org/10.1074/jbc.R114.592618			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25160625	Green Published, hybrid			2022-12-28	WOS:000343765400009
J	Carayon, K; Mouledous, L; Combedazou, A; Mazeres, S; Haanappel, E; Salome, L; Mollereau, C				Carayon, Kevin; Mouledous, Lionel; Combedazou, Anne; Mazeres, Serge; Haanappel, Evert; Salome, Laurence; Mollereau, Catherine			Heterologous Regulation of Mu-Opioid (MOP) Receptor Mobility in the Membrane of SH-SY5Y Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; FLUORESCENCE CORRELATION SPECTROSCOPY; HUMAN NEUROBLASTOMA SH-SY5Y; CONDITIONED PLACE PREFERENCE; RAT DORSAL RAPHE; NEUROPEPTIDE-FF; FUNCTIONAL INTERACTIONS; FRAP EXPERIMENTS; PLASMA-MEMBRANE; LIVING CELLS	The dynamic organization of G protein-coupled receptors in the plasma membrane is suspected of playing a role in their function. The regulation of the diffusion mode of the mu-opioid (MOP) receptor was previously shown to be agonist-specific. Here we investigate the regulation of MOP receptor diffusion by heterologous activation of other G protein-coupled receptors and characterize the dynamic properties of the MOP receptor within the heterodimer MOP/neuropeptide FF (NPFF2) receptor. The data show that the dynamics and signaling of the MOP receptor in SH-SY5Y cells are modified by the activation of alpha(2)-adrenergic and NPFF2 receptors, but not by the activation of receptors not described to interact with the opioid receptor. By combining, for the first time, fluorescence recovery after photo-bleaching at variable radius experiments with bimolecular fluorescence complementation, we show that the MOP/NPFF2 heterodimer adopts a specific diffusion behavior that corresponds to a mix of the dynamic properties of both MOP and NPFF2 receptors. Altogether, the data suggest that heterologous regulation is accompanied by a specific organization of receptors in the membrane.	[Carayon, Kevin; Mouledous, Lionel; Combedazou, Anne; Mazeres, Serge; Haanappel, Evert; Salome, Laurence; Mollereau, Catherine] Univ Toulouse, CNRS, UMR5089, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Salome, L (corresponding author), Univ Toulouse, CNRS, UMR5089, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France.	laurence.salome@ipbs.fr; catherine.mollereau-manaute@ipbs.fr		Mollereau, Catherine/0000-0003-1543-5624; Mouledous, Lionel/0000-0002-7675-3493; Combedazou, Anne/0000-0002-0046-5057; MAZERES, Serge/0000-0002-0263-634X; SALOME, Laurence/0000-0001-9667-4154; Haanappel, Evert/0000-0003-1300-7415	PIRIbio program of the French Agence Nationale de la Recherche [ANR piribio09_445026 GPCR D-I-F]	PIRIbio program of the French Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Grant ANR piribio09_445026 GPCR D-I-F from the PIRIbio program of the French Agence Nationale de la Recherche.	Baker A, 2007, EUR BIOPHYS J BIOPHY, V36, P849, DOI 10.1007/s00249-007-0214-7; Baker AM, 2007, J BIOL CHEM, V282, P35163, DOI 10.1074/jbc.M705617200; Barnett-Norris J, 2005, LIFE SCI, V77, P1625, DOI 10.1016/j.lfs.2005.05.040; Berglund MM, 2003, J PHARMACOL EXP THER, V307, P1120, DOI 10.1124/jpet.103.055673; Brady AE, 2002, CELL SIGNAL, V14, P297, DOI 10.1016/S0898-6568(01)00239-X; Briddon SJ, 2007, TRENDS PHARMACOL SCI, V28, P637, DOI 10.1016/j.tips.2007.09.008; Briddon SJ, 2008, BBA-MOL CELL RES, V1783, P2262, DOI 10.1016/j.bbamcr.2008.07.006; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Calizo RC, 2013, ANAL BIOCHEM, V440, P40, DOI 10.1016/j.ab.2013.04.033; Carta M, 2013, EMBO J, V32, P496, DOI 10.1038/emboj.2012.334; Chabot-Dore AJ, 2015, BRIT J PHARMACOL, V172, P388, DOI 10.1111/bph.12695; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Daumas F, 2003, BIOPHYS J, V84, P356, DOI 10.1016/S0006-3495(03)74856-5; Destainville Nicolas, 2008, J Chem Biol, V1, P37, DOI 10.1007/s12154-008-0005-3; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; DUPOUY V, 1995, REGUL PEPTIDES, V59, P349, DOI 10.1016/0167-0115(95)00091-O; Dupouy V, 1997, EUR J PHARMACOL, V330, P129, DOI 10.1016/S0014-2999(97)01017-0; Evans RM, 2010, J BIOL CHEM, V285, P1032, DOI 10.1074/jbc.M109.040634; Fairbanks CA, 1999, J PHARMACOL EXP THER, V288, P1107; Fujita W, 2015, BRIT J PHARMACOL, V172, P375, DOI 10.1111/bph.12663; Golebiewska U, 2011, BIOCHEMISTRY-US, V50, P2829, DOI 10.1021/bi101701x; Harrison LM, 1998, PEPTIDES, V19, P1603, DOI 10.1016/S0196-9781(98)00126-0; Hur EM, 2002, CELL SIGNAL, V14, P397, DOI 10.1016/S0898-6568(01)00258-3; Jordan BA, 2003, MOL PHARMACOL, V64, P1317, DOI 10.1124/mol.64.6.1317; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; KAZMI SMI, 1989, BIOCHEM BIOPH RES CO, V158, P921, DOI 10.1016/0006-291X(89)92810-6; Kersante F, 2006, PEPTIDES, V27, P980, DOI 10.1016/j.peptides.2005.07.025; Kersante F, 2011, NEUROSCI LETT, V488, P305, DOI 10.1016/j.neulet.2010.11.052; Kersante F, 2010, NEUROCHEM INT, V56, P768, DOI 10.1016/j.neuint.2010.02.014; Kilpatrick LE, 2012, BBA-MOL CELL RES, V1823, P1068, DOI 10.1016/j.bbamcr.2012.03.002; Kotlinska J, 2007, PEPTIDES, V28, P2235, DOI 10.1016/j.peptides.2007.08.006; Lambert NA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115pe12; Law PY, 2005, J BIOL CHEM, V280, P11152, DOI 10.1074/jbc.M500171200; Levitt ES, 2011, MOL PHARMACOL, V79, P461, DOI 10.1124/mol.110.064816; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; LOPEZ A, 1988, BIOPHYS J, V53, P963, DOI 10.1016/S0006-3495(88)83177-1; Lopez A, 2009, CELL MOL LIFE SCI, V66, P2093, DOI 10.1007/s00018-009-0008-4; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Marchand S, 2006, PEPTIDES, V27, P964, DOI 10.1016/j.peptides.2005.07.023; Massotte D, 2015, BRIT J PHARMACOL, V172, P420, DOI 10.1111/bph.12702; Maudsley S, 2005, J PHARMACOL EXP THER, V314, P485, DOI 10.1124/jpet.105.083121; MCDONALD RL, 1995, NEUROPHARMACOLOGY, V34, P1507, DOI 10.1016/0028-3908(95)00068-H; Mollereau C, 2005, CURR TOP MED CHEM, V5, P341, DOI 10.2174/1568026053544515; Mollereau C, 2005, MOL PHARMACOL, V67, P965, DOI 10.1124/mol.104.004614; Mouledous L, 2008, BIOCHEM BIOPH RES CO, V373, P80, DOI 10.1016/j.bbrc.2008.05.174; Mouledous L, 2012, J BIOL CHEM, V287, P12736, DOI 10.1074/jbc.M111.314617; Mouledous L, 2010, BIOFACTORS, V36, P423, DOI 10.1002/biof.116; Mouledous L, 2010, SYNAPSE, V64, P672, DOI 10.1002/syn.20774; Ossipov MH, 2004, J NEUROBIOL, V61, P126, DOI 10.1002/neu.20091; Pfeiffer M, 2002, J BIOL CHEM, V277, P19762, DOI 10.1074/jbc.M110373200; Pfeiffer M, 2003, J BIOL CHEM, V278, P51630, DOI 10.1074/jbc.M307095200; Pucadyil TJ, 2004, BIOCHEMISTRY-US, V43, P15852, DOI 10.1021/bi0480887; Qiu Y, 2011, MOL PHARMACOL, V80, P210, DOI 10.1124/mol.110.070870; Rebeyrolles S, 1996, NEUROREPORT, V7, P2979, DOI 10.1097/00001756-199611250-00036; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Roumy M, 1999, BRAIN RES, V845, P208, DOI 10.1016/S0006-8993(99)01965-4; Roumy M, 1998, EUR J PHARMACOL, V345, P1, DOI 10.1016/S0014-2999(97)01604-X; Roumy M, 2003, NEUROSCI LETT, V348, P159, DOI 10.1016/S0304-3940(03)00791-2; Roumy M, 2007, J BIOL CHEM, V282, P8332, DOI 10.1074/jbc.M606946200; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Salome L, 1998, EUR BIOPHYS J BIOPHY, V27, P391, DOI 10.1007/s002490050146; Sauliere A, 2006, FEBS LETT, V580, P5227, DOI 10.1016/j.febslet.2006.08.056; Sauliere-Nzeh AN, 2010, J BIOL CHEM, V285, P14514, DOI 10.1074/jbc.M109.076695; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Specht CG, 2011, EMBO J, V30, P3842, DOI 10.1038/emboj.2011.276; Talmont F, 2009, NEUROCHEM INT, V55, P815, DOI 10.1016/j.neuint.2009.08.004; Tan M, 2009, J BIOL CHEM, V284, P6270, DOI 10.1074/jbc.M806742200; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; van Rijn RM, 2010, CURR OPIN PHARMACOL, V10, P73, DOI 10.1016/j.coph.2009.09.007; VAUGHAN PFT, 1995, GEN PHARMACOL-VASC S, V26, P1191, DOI 10.1016/0306-3623(94)00312-B; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Vilardaga JP, 2010, J CELL SCI, V123, P4215, DOI 10.1242/jcs.063354; Vukojevic V, 2008, FASEB J, V22, P3537, DOI 10.1096/fj.08-108894; Wang DX, 2005, MOL PHARMACOL, V67, P2173, DOI 10.1124/mol.104.010272; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Yang HYT, 2008, NEUROPEPTIDES, V42, P1, DOI 10.1016/j.npep.2007.06.004; Zhang YQ, 2004, BIOCHEM SOC T, V32, P856, DOI 10.1042/BST0320856; Zheng H, 2008, P NATL ACAD SCI USA, V105, P9421, DOI 10.1073/pnas.0802253105	79	16	16	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28697	28706		10.1074/jbc.M114.588558	http://dx.doi.org/10.1074/jbc.M114.588558			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25183007	Green Published, hybrid			2022-12-28	WOS:000343765400057
J	Davies, BA; Norgan, AP; Payne, JA; Schulz, ME; Nichols, MD; Tan, JA; Xu, ZH; Katzmann, DJ				Davies, Brian A.; Norgan, Andrew P.; Payne, Johanna A.; Schulz, Mary E.; Nichols, Micah D.; Tan, Jason A.; Xu, Zhaohui; Katzmann, David J.			Vps4 Stimulatory Element of the Cofactor Vta1 Contacts the ATPase Vps4 alpha 7 and alpha 9 to Stimulate ATP Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIVESICULAR BODY PATHWAY; ESCRT-III; STRUCTURAL BASIS; MEMBRANE SCISSION; ENDOSOMAL TRANSPORT; REGULATORY ROLE; MIT DOMAIN; PROTEIN; COMPLEX; RECOGNITION	The endosomal sorting complexes required for transport (ESCRTs) function in a variety of membrane remodeling processes including multivesicular body sorting, abscission during cytokinesis, budding of enveloped viruses, and repair of the plasma membrane. Vps4 ATPase activity modulates ESCRT function and is itself modulated by its cofactor Vta1 and its substrate ESCRT-III. The carboxyl-terminal Vta1/SBP-1/Lip5 (VSL) domain of Vta1 binds to the Vps4 alpha-domain to promote Vps4 oligomerization-dependent ATP hydrolysis. Additionally, the Vps4 stimulatory element (VSE) of Vta1 contributes to enhancing Vps4 oligomer ATP hydrolysis. The VSE is also required for Vta1-dependent stimulation of Vps4 by ESCRT-III subunits. However, the manner by which the Vta1 VSE contributes to Vps4 activation is unknown. Existing structural data were used to generate a model of the Vta1 VSE in complex with Vps4. This model implicated residues within the small ATPase associated with various activities (AAA) domain, specifically alpha-helices 7 and 9, as relevant contact sites. Rational generation of Vps4 mutants defective for VSE-mediated stimulation, as well as intergenic compensatory mutations, support the validity of this model. These findings have uncovered the Vps4 surface responsible for coordinating ESCRT-III-stimulated Vta1 input during ESCRT function and identified a novel mechanism of Vps4 stimulation.	[Davies, Brian A.; Norgan, Andrew P.; Payne, Johanna A.; Schulz, Mary E.; Nichols, Micah D.; Tan, Jason A.; Katzmann, David J.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Schulz, Mary E.] Lawrence Univ, Dept Biol, Appleton, WI 54911 USA; [Nichols, Micah D.] Byron High Sch, Byron, MN 55920 USA; [Xu, Zhaohui] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	Mayo Clinic; Lawrence University; University of Michigan System; University of Michigan	Katzmann, DJ (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	Katzmann.David@mayo.edu			National Institutes of Health [RO1 GM73024, 1F30DA26762, GM106693]; Mayo Graduate School; Fraternal Order of the Eagles Postdoctoral Fellowship; Lawrence University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095769, R01GM073024, F31GM106693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F30DA026762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Graduate School; Fraternal Order of the Eagles Postdoctoral Fellowship; Lawrence University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM73024 (to D. J. K.), F30 Predoctoral Fellowship 1F30DA26762 (to A. P. N.), and F31 Predoctoral Fellowship GM106693 (to J. A. T.). This work was also supported by funds from the Mayo Graduate School (to A. P. N. and J. A. T.), the Fraternal Order of the Eagles Postdoctoral Fellowship (to B. A. D.), and the Lawrence University LU-R1 Fellowship (to M. E. S.).	Adell MAY, 2014, J CELL BIOL, V205, P33, DOI 10.1083/jcb.201310114; Adell MAY, 2011, FEBS LETT, V585, P3191, DOI 10.1016/j.febslet.2011.09.001; Agromayor M, 2013, TRENDS CELL BIOL, V23, P433, DOI 10.1016/j.tcb.2013.04.006; Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Babst M, 2011, TRAFFIC, V12, P1298, DOI 10.1111/j.1600-0854.2011.01230.x; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Bajorek M, 2009, MOL BIOL CELL, V20, P1360, DOI 10.1091/mbc.E08-05-0475; Buchkovich NJ, 2013, DEV CELL, V27, P201, DOI 10.1016/j.devcel.2013.09.009; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; Davies BA, 2010, MOL BIOL CELL, V21, P3396, DOI 10.1091/mbc.E10-06-0512; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Hill CP, 2012, BBA-MOL CELL RES, V1823, P172, DOI 10.1016/j.bbamcr.2011.08.017; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Jouvenet N, 2012, CELL MOL LIFE SCI, V69, P4121, DOI 10.1007/s00018-012-1035-0; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kieffer CC, 2008, PSYCHOANAL INQ, V28, P1, DOI 10.1080/07351690701787077; Lottridge JM, 2006, P NATL ACAD SCI USA, V103, P6202, DOI 10.1073/pnas.0601712103; MacDonald C, 2012, EMBO REP, V13, P331, DOI 10.1038/embor.2012.18; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Monroe N, 2014, J MOL BIOL, V426, P510, DOI 10.1016/j.jmb.2013.09.043; Norgan AP, 2013, J BIOL CHEM, V288, P26147, DOI 10.1074/jbc.M113.494112; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shestakova A, 2013, J BIOL CHEM, V288, P26810, DOI 10.1074/jbc.M113.497032; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shields SB, 2011, TRAFFIC, V12, P1306, DOI 10.1111/j.1600-0854.2011.01242.x; Shiflett SL, 2004, J BIOL CHEM, V279, P10982, DOI 10.1074/jbc.M312669200; Shim S, 2008, MOL BIOL CELL, V19, P2661, DOI 10.1091/mbc.E07-12-1263; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Skalicky JJ, 2012, J BIOL CHEM, V287, P43910, DOI 10.1074/jbc.M112.417899; Stringer DK, 2011, J CELL BIOL, V192, P229, DOI 10.1083/jcb.201008121; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Takasu H, 2005, BIOCHEM BIOPH RES CO, V334, P460, DOI 10.1016/j.bbrc.2005.06.110; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Vajjhala PR, 2006, FEBS J, V273, P2357, DOI 10.1111/j.1742-4658.2006.05238.x; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Ward DMV, 2005, J BIOL CHEM, V280, P10548, DOI 10.1074/jbc.M413734200; Weissenhorn W, 2013, CURR OPIN VIROL, V3, P159, DOI 10.1016/j.coviro.2013.03.011; Wemmer M, 2011, J CELL BIOL, V192, P295, DOI 10.1083/jcb.201007018; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Xiao JY, 2008, DEV CELL, V14, P37, DOI 10.1016/j.devcel.2007.10.013; Xiao JY, 2007, J MOL BIOL, V374, P655, DOI 10.1016/j.jmb.2007.09.067; Xiao JY, 2009, MOL BIOL CELL, V20, P3514, DOI 10.1091/mbc.E09-05-0403; Yang D, 2010, STRUCTURE, V18, P976, DOI 10.1016/j.str.2010.04.014; Yang ZZ, 2012, J BIOL CHEM, V287, P43899, DOI 10.1074/jbc.M112.390724; Yeo SCL, 2003, J CELL SCI, V116, P3957, DOI 10.1242/jcs.00751	57	14	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28707	28718		10.1074/jbc.M114.580696	http://dx.doi.org/10.1074/jbc.M114.580696			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25164817	Green Published, hybrid			2022-12-28	WOS:000343765400058
J	Imlay, JA				Imlay, James A.			The Mismetallation of Enzymes during Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							INTRACELLULAR HYDROGEN-PEROXIDE; ENTERICA SEROVAR TYPHIMURIUM; OXYR TRANSCRIPTION FACTOR; MONONUCLEAR IRON ENZYMES; FE-S CLUSTER; ESCHERICHIA-COLI; SUPEROXIDE-DISMUTASE; 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-PHOSPHATE SYNTHASE; DNA-DAMAGE; BACILLUS-SUBTILIS	Mononuclear iron enzymes can tightly bind non-activating metals. How do cells avoid mismetallation? The model bacterium Escherichia coli may control its metal pools so that thermodynamics favor the correct metallation of each enzyme. This system is disrupted, however, by superoxide and hydrogen peroxide. These species oxidize ferrous iron and thereby displace it from many iron-dependent mononuclear enzymes. Ultimately, zinc binds in its place, confers little activity, and imposes metabolic bottlenecks. Data suggest that E. coli compensates by using thiols to extract the zinc and by importing manganese to replace the catalytic iron atom. Manganese resists oxidants and provides substantial activity.	Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Imlay, JA (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.	jimlay@illinois.edu			National Institutes of Health [GM101012, GM49640]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049640, R37GM049640, R01GM101012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM101012 and GM49640 (to J. A. I.). This is the fourth article in the Thematic Minireview series "Metals in Biology 2014."	Anbar AD, 2008, SCIENCE, V322, P1481, DOI 10.1126/science.1163100; Anjem A, 2012, J BIOL CHEM, V287, P15544, DOI 10.1074/jbc.M111.330365; Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; ARCHIBALD FS, 1981, J BACTERIOL, V145, P442, DOI 10.1128/JB.145.1.442-451.1981; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; BAASOV T, 1989, J BACTERIOL, V171, P6155, DOI 10.1128/jb.171.11.6155-6160.1989; Barnese K, 2012, P NATL ACAD SCI USA, V109, P6892, DOI 10.1073/pnas.1203051109; Becker A, 1998, NAT STRUCT BIOL, V5, P1053, DOI 10.1038/4162; Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; Breckau D, 2003, J BIOL CHEM, V278, P46625, DOI 10.1074/jbc.M308553200; Brocklehurst KR, 1999, MOL MICROBIOL, V31, P893, DOI 10.1046/j.1365-2958.1999.01229.x; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; CHANG EC, 1989, J BIOL CHEM, V264, P12172; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; COMPAN I, 1993, J BACTERIOL, V175, P1687, DOI 10.1128/JB.175.6.1687-1696.1993; Cotruvo JA, 2012, METALLOMICS, V4, P1020, DOI 10.1039/c2mt20142a; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Djaman O, 2004, J BIOL CHEM, V279, P44590, DOI 10.1074/jbc.M406487200; Dupont CL, 2006, P NATL ACAD SCI USA, V103, P17822, DOI 10.1073/pnas.0605798103; Farrugia MA, 2013, J BIOL CHEM, V288, P13178, DOI 10.1074/jbc.R112.446526; FLINT DH, 1993, J BIOL CHEM, V268, P22369; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GLASS GA, 1986, J BIOL CHEM, V261, P3247; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; Gu MZ, 2013, MOL MICROBIOL, V89, P123, DOI 10.1111/mmi.12263; HENTZE MW, 1991, NUCLEIC ACIDS RES, V19, P1739, DOI 10.1093/nar/19.8.1739; Ikeda JS, 2005, J BACTERIOL, V187, P912, DOI 10.1128/JB.187.3.912-922.2005; Ilari A, 2002, J BIOL CHEM, V277, P37619, DOI 10.1074/jbc.M206186200; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Inaoka T, 1999, J BACTERIOL, V181, P1939, DOI 10.1128/JB.181.6.1939-1943.1999; Ireton GC, 2002, J MOL BIOL, V315, P687, DOI 10.1006/jmbi.2001.5277; IRVING H, 1953, J CHEM SOC, P3192, DOI 10.1039/jr9530003192; Ishikawa K, 2007, J MOL BIOL, V366, P857, DOI 10.1016/j.jmb.2006.11.060; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Jelakovic S, 2003, J MOL BIOL, V326, P127, DOI 10.1016/S0022-2836(02)01374-8; Kehres DG, 2002, J BACTERIOL, V184, P3151, DOI 10.1128/JB.184.12.3151-3158.2002; KEYER K, 1995, J BACTERIOL, V177, P6782, DOI 10.1128/jb.177.23.6782-6790.1995; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Korshunov SS, 2002, MOL MICROBIOL, V43, P95, DOI 10.1046/j.1365-2958.2002.02719.x; KUO CF, 1987, J BIOL CHEM, V262, P4724; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; LIOCHEV SI, 1993, ARCH BIOCHEM BIOPHYS, V301, P379, DOI 10.1006/abbi.1993.1159; Liu YY, 2011, J BACTERIOL, V193, P2186, DOI 10.1128/JB.00001-11; LYNCH RE, 1978, J BIOL CHEM, V253, P4697; Ma Z, 2012, MOL MICROBIOL, V86, P1144, DOI 10.1111/mmi.12049; Ma Z, 2011, NUCLEIC ACIDS RES, V39, P9130, DOI 10.1093/nar/gkr625; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; Martin JE, 2011, MOL MICROBIOL, V80, P319, DOI 10.1111/j.1365-2958.2011.07593.x; MCCANDLISS RJ, 1978, P NATL ACAD SCI USA, V75, P4810, DOI 10.1073/pnas.75.10.4810; MEHDY MC, 1994, PLANT PHYSIOL, V105, P467, DOI 10.1104/pp.105.2.467; Mills SA, 2005, BIOCHEMISTRY-US, V44, P13553, DOI 10.1021/bi0507579; Nandal A, 2010, MOL MICROBIOL, V75, P637, DOI 10.1111/j.1365-2958.2009.06977.x; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; PUGH SYR, 1985, J BACTERIOL, V162, P196, DOI 10.1128/JB.162.1.196-202.1985; Rai P, 2001, J MOL BIOL, V312, P1089, DOI 10.1006/jmbi.2001.5010; Ramilo CA, 1997, PROTEIN EXPRES PURIF, V9, P253, DOI 10.1006/prep.1996.0690; RAY JM, 1991, J BACTERIOL, V173, P1894, DOI 10.1128/jb.173.6.1894-1901.1991; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Seib KL, 2004, J INFECT DIS, V190, P136, DOI 10.1086/421299; Shumilin IA, 1999, STRUCTURE, V7, P865, DOI 10.1016/S0969-2126(99)80109-9; Sobota JM, 2014, J BACTERIOL, V196, P1980, DOI 10.1128/JB.01573-14; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; STAUB M, 1969, BIOCHIM BIOPHYS ACTA, V178, P588, DOI 10.1016/0005-2744(69)90227-7; STEPHENS CM, 1991, J BIOL CHEM, V266, P20810; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Tseng HJ, 2002, INFECT IMMUN, V70, P1635, DOI 10.1128/IAI.70.3.1635-1639.2002; Tseng HJ, 2001, MOL MICROBIOL, V40, P1175, DOI 10.1046/j.1365-2958.2001.02460.x; Varghese S, 2007, MOL MICROBIOL, V64, P822, DOI 10.1111/j.1365-2958.2007.05701.x; Wang D, 2012, J INORG BIOCHEM, V111, P173, DOI 10.1016/j.jinorgbio.2012.02.008; Waters LS, 2011, J BACTERIOL, V193, P5887, DOI 10.1128/JB.05872-11; Whittaker MM, 2011, ARCH BIOCHEM BIOPHYS, V505, P213, DOI 10.1016/j.abb.2010.10.021; Yang JH, 2006, MOL MICROBIOL, V60, P427, DOI 10.1111/j.1365-2958.2006.05101.x; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	78	142	143	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28121	28128		10.1074/jbc.R114.588814	http://dx.doi.org/10.1074/jbc.R114.588814			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25160623	Green Published, hybrid			2022-12-28	WOS:000343765400008
J	Kosami, K; Ohki, I; Nagano, M; Furuita, K; Sugiki, T; Kawano, Y; Kawasaki, T; Fujiwara, T; Nakagawa, A; Shimamoto, K; Kojima, C				Kosami, Ken-ichi; Ohki, Izuru; Nagano, Minoru; Furuita, Kyoko; Sugiki, Toshihiko; Kawano, Yoji; Kawasaki, Tsutomu; Fujiwara, Toshimichi; Nakagawa, Atsushi; Shimamoto, Ko; Kojima, Chojiro			The Crystal Structure of the Plant Small GTPase OsRac1 Reveals Its Mode of Binding to NADPH Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE RESISTANCE; ROP GTPASE; RAC GTPASE; ARABIDOPSIS ROOTS; RAC/ROP GTPASES; RICE; ACTIVATION; P67(PHOX); RHO; IMMUNITY	Rac/Rop proteins are Rho-type small GTPases that act as molecular switches in plants. Recent studies have identified these proteins as key components in many major plant signaling pathways, such as innate immunity, pollen tube growth, and root hair formation. In rice, the Rac/Rop protein OsRac1 plays an important role in regulating the production of reactive oxygen species (ROS) by the NADPH oxidase OsRbohB during innate immunity. However, the molecular mechanism by which OsRac1 regulates OsRbohB remains unknown. Here, we report the crystal structure of OsRac1 complexed with the non-hydrolyzable GTP analog guanosine 5'-(beta,gamma-imido) triphosphate at 1.9 angstrom resolution; this represents the first active-form structure of a plant small GTPase. To elucidate the ROS production in rice cells, structural information was used to design OsRac1 mutants that displayed reduced binding to OsRbohB. Only mutations in the OsRac1 Switch I region showed attenuated interactions with OsRbohB in vitro. In particular, Tyr(39) and Asp(45) substitutions suppressed ROS production in rice cells, indicating that these residues are critical for interaction with and activation of OsRbohB. Structural comparison of active-form OsRac1 with AtRop9 in its GDP-bound inactive form showed a large conformational difference in the vicinity of these residues. Our results provide new insights into the molecular mechanism of the immune response through OsRac1 and the various cellular responses associated with plant Rac/Rop proteins.	[Kosami, Ken-ichi; Furuita, Kyoko; Sugiki, Toshihiko; Fujiwara, Toshimichi; Nakagawa, Atsushi; Kojima, Chojiro] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Ohki, Izuru; Kojima, Chojiro] Nara Inst Sci & Technol, Biophys Lab, Nara 6300192, Japan; [Ohki, Izuru; Nagano, Minoru; Kawano, Yoji; Kawasaki, Tsutomu; Shimamoto, Ko] Nara Inst Sci & Technol, Plant Mol Genet Lab, Nara 6300192, Japan; [Ohki, Izuru] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; [Kawasaki, Tsutomu] Kinki Univ, Dept Adv Biosci, Nara 6318505, Japan	Osaka University; Nara Institute of Science & Technology; Nara Institute of Science & Technology; Kyoto University; Kindai University (Kinki University)	Ohki, I (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	ohki.izuru.4a@kyoto-u.ac.jp; kojima@protein.osaka-u.ac.jp	Kosami, Ken-Ichi/U-4649-2019; Kawano, Yoji/C-7484-2011; Nakagawa, Atsushi/D-4329-2009; Ohki, Izuru/O-4816-2019; Kojima, Chojiro/AFV-4592-2022	Kawano, Yoji/0000-0003-0687-2777; Nakagawa, Atsushi/0000-0002-1700-7861; Ohki, Izuru/0000-0002-0667-5936; Furuita, Kyoko/0000-0002-9272-0026; Kojima, Chojiro/0000-0003-2723-8249	Targeted Proteins Research Program; Ministry of Agriculture, Forestry and Fisheries Genomics for Agricultural Innovation; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [26850232, 26291029] Funding Source: KAKEN	Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry and Fisheries Genomics for Agricultural Innovation(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for science research (to I. O., Y. K., C. K., and K. S.), the Targeted Proteins Research Program (to C. K. and K. S.), a Ministry of Agriculture, Forestry and Fisheries Genomics for Agricultural Innovation grant (to K. S.), Grants-in-aid for JSPS Fellows (to K. K. and M. N.), and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Akamatsu A, 2013, CELL HOST MICROBE, V13, P465, DOI 10.1016/j.chom.2013.03.007; Al-Mulla F, 1999, J PATHOL, V187, P433, DOI 10.1002/(SICI)1096-9896(199903)187:4<433::AID-PATH273>3.0.CO;2-E; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen X, 2012, CURR BIOL, V22, P1326, DOI 10.1016/j.cub.2012.05.020; Craddock C, 2012, TRENDS CELL BIOL, V22, P492, DOI 10.1016/j.tcb.2012.05.002; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DIEKMANN D, 1994, SCIENCE, V265, P531, DOI 10.1126/science.8036496; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujiwara M, 2006, PLANT PHYSIOL, V140, P734, DOI 10.1104/pp.105.068395; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Jones MA, 2007, J EXP BOT, V58, P1261, DOI 10.1093/jxb/erl279; Kawano Y, 2013, CURR OPIN PLANT BIOL, V16, P496, DOI 10.1016/j.pbi.2013.07.004; Kawano Y, 2010, RICE, V3, P112, DOI 10.1007/s12284-010-9049-4; Kawano Y, 2010, CELL HOST MICROBE, V7, P362, DOI 10.1016/j.chom.2010.04.010; Kawasaki T, 1999, P NATL ACAD SCI USA, V96, P10922, DOI 10.1073/pnas.96.19.10922; Koga H, 1999, J BIOL CHEM, V274, P25051, DOI 10.1074/jbc.274.35.25051; Kosami K, 2014, ACTA CRYSTALLOGR F, V70, P113, DOI 10.1107/S2053230X13033645; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Li ZX, 2012, J INTEGR PLANT BIOL, V54, P180, DOI 10.1111/j.1744-7909.2012.01101.x; Lin DS, 2012, CURR BIOL, V22, P1319, DOI 10.1016/j.cub.2012.05.019; Longenecker K, 2003, ACTA CRYSTALLOGR D, V59, P876, DOI 10.1107/S0907444903005390; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagawa S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001299; Nibau C, 2006, TRENDS PLANT SCI, V11, P309, DOI 10.1016/j.tplants.2006.04.003; Nibau C, 2013, J EXP BOT, V64, P3425, DOI 10.1093/jxb/ert179; Oda T, 2008, ACTA CRYSTALLOGR F, V64, P867, DOI 10.1107/S1744309108026535; Oda T, 2010, J BIOL CHEM, V285, P1435, DOI 10.1074/jbc.M109.058909; Oda Y, 2012, SCIENCE, V337, P1333, DOI 10.1126/science.1222597; Ono E, 2001, P NATL ACAD SCI USA, V98, P759, DOI 10.1073/pnas.021273498; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potocky M, 2012, J PLANT PHYSIOL, V169, P1654, DOI 10.1016/j.jplph.2012.05.014; Sormo CG, 2006, PHYTOCHEMISTRY, V67, P2332, DOI 10.1016/j.phytochem.2006.08.011; Suharsono U, 2002, P NATL ACAD SCI USA, V99, P13307, DOI 10.1073/pnas.192244099; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; Thomas C, 2009, BIOL CHEM, V390, P427, DOI 10.1515/BC.2009.049; Wong HL, 2007, PLANT CELL, V19, P4022, DOI 10.1105/tpc.107.055624; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003; XU XM, 1994, J BIOL CHEM, V269, P23569; Yamaguchi K, 2012, PLANT J, V70, P389, DOI 10.1111/j.1365-313X.2011.04874.x; Yang ZB, 2002, PLANT CELL, V14, pS375, DOI 10.1105/tpc.001065; Yang Z, 2007, CURR OPIN PLANT BIOL, V10, P490, DOI 10.1016/j.pbi.2007.07.005; Zheng ZL, 2000, PLANT MOL BIOL, V44, P1, DOI 10.1023/A:1006402628948; Zheng ZL, 2002, PLANT CELL, V14, P2787, DOI 10.1105/tpc.005611	49	24	24	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28569	28578		10.1074/jbc.M114.603282	http://dx.doi.org/10.1074/jbc.M114.603282			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25128531	Green Published, hybrid			2022-12-28	WOS:000343765400046
J	Yuan, YK; Zhang, YG; Yao, SH; Shi, HS; Huang, X; Li, YH; Wei, YQ; Lin, S				Yuan, Yike; Zhang, Yaguang; Yao, Shaohua; Shi, Huashan; Huang, Xi; Li, Yuhao; Wei, Yuquan; Lin, Shuo			The Translation Initiation Factor eIF3i Up-regulates Vascular Endothelial Growth Factor A, Accelerates Cell Proliferation, and Promotes Angiogenesis in Embryonic Development and Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR MESSENGER-RNA; GENE-EXPRESSION; GENOME-WIDE; PROTEIN; IDENTIFICATION; TRANSFORMATION; MECHANISM; P150; AKT1; PHOSPHORYLATION	Vascular endothelial growth factor A (VEGFA) is a critical proangiogenic factor that is activated by hypoxia at both the transcriptional and post-transcriptional levels. In hypoxia conditions, stabilized hypoxia-inducible factor 1 alpha (HIF1A) is the key regulator for transcriptional activation of VEGFA. However, the post-transcriptional control of VEGFA expression remains poorly understood. Here, we report that the eukaryotic translation initiation factor 3i (eIF3i) is required for VEGFA protein expression in both normal embryonic and tumorigenic angiogenesis. eIF3i is dynamically expressed in the early stages of zebrafish embryogenesis and in human hepatocellular carcinoma tissues. eIF3i homozygous mutant zebrafish embryos show severe angiogenesis defects and human hepatocellular cancer cells with depletion of eIF3i to induce less angiogenesis in tumor models. Under hypoxia, the HIF1A protein can interact with its binding sequence in the eIF3i promoter and activate eIF3i transcription. The expression of VEGFA, which should rise in hypoxia, is significantly inhibited by eIF3i siRNA treatment. Moreover, eIF3i knockdown did not cause a general translation repression but specifically reduced the translation efficiency of the VEGFA mRNAs. Taken together, our results suggest that eIF3i is induced by HIF1A under hypoxia and controls normal and tumorigenic angiogenesis through regulating VEGFA protein translation.	[Yuan, Yike; Zhang, Yaguang; Yao, Shaohua; Shi, Huashan; Huang, Xi; Wei, Yuquan; Lin, Shuo] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Shi, Huashan] Sichuan Univ, West China Hosp, West China Med Sch, Dept Head & Neck Oncol, Chengdu 610041, Sichuan, Peoples R China; [Li, Yuhao] Nankai Univ, Sch Med, Key Lab Tumor Microenvironm & Neurovasc Regulat, Tianjin 300071, Peoples R China; [Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	Sichuan University; Sichuan University; Nankai University; University of California System; University of California Los Angeles	Yao, SH (corresponding author), Sichuan Univ, West China Hosp, Ctr Canc, Lab Biotherapy,Natl Key Lab Biotherapy, Renmin Nanlu 17, Chengdu 610041, Sichuan, Peoples R China.	shaohuayao@scu.edu.cn	Zhang, Yaguang/GZM-9859-2022	Zhang, Yaguang/0000-0002-9216-1834; Shi, Hua-shan/0000-0002-9958-9892; Yao, Shaohua/0000-0002-0191-4889	National Institutes of Health [DK084349]; National Natural Science Foundation of China [81372143, 31000646, 81123003]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK084349 (to S. L.). This work was also supported by National Natural Science Foundation of China Grants 81372143, 31000646, and 81123003.	Abaza I, 2006, GENE DEV, V20, P380, DOI 10.1101/gad.371906; Arcondeguy T, 2013, NUCLEIC ACIDS RES, V41, P7997, DOI 10.1093/nar/gkt539; Asano K, 1997, J BIOL CHEM, V272, P1101, DOI 10.1074/jbc.272.2.1101; Bachmann F, 1997, CANCER RES, V57, P988; Beitner-Johnson D, 2001, CELL SIGNAL, V13, P23, DOI 10.1016/S0898-6568(00)00128-5; Carbajo-Pescador S, 2013, BRIT J CANCER, V109, P83, DOI 10.1038/bjc.2013.285; Carey Michael F, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5279; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chen GP, 1999, INT J CANCER, V84, P95, DOI 10.1002/(SICI)1097-0215(19990420)84:2<95::AID-IJC1>3.0.CO;2-N; Chen GP, 2004, INT J CANCER, V112, P393, DOI 10.1002/ijc.20443; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Chen LM, 2012, ONCOTARGET, V3, P869, DOI 10.18632/oncotarget.598; Chen N, 2009, J BIOL CHEM, V284, P10004, DOI 10.1074/jbc.M805997200; CHEN RH, 1995, NATURE, V377, P548, DOI 10.1038/377548a0; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Dachs GU, 2000, EUR J CANCER, V36, P1649, DOI 10.1016/S0959-8049(00)00159-3; de Vries S, 2013, J BIOL CHEM, V288, P5815, DOI 10.1074/jbc.M112.420711; Dellas A, 1998, CANCER, V83, P1376, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1376::AID-CNCR15>3.0.CO;2-1; Dong ZZ, 2006, CRIT REV ONCOL HEMAT, V59, P169, DOI 10.1016/j.critrevonc.2006.03.005; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gerhardt H., 2008, ORGANOGENESIS, V4, P241, DOI [DOI 10.4161/0RG.4.4.7414, DOI 10.4161/org.4.4.7414]; Gort EH, 2006, ONCOGENE, V25, P6123, DOI 10.1038/sj.onc.1209643; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Huang JS, 2004, BIOCHEM BIOPH RES CO, V315, P950, DOI 10.1016/j.bbrc.2004.01.151; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Joseph P, 2004, MOL CELL BIOCHEM, V255, P93, DOI 10.1023/B:MCBI.0000007265.38475.f7; Kubota Yoshiaki, 2012, Keio Journal of Medicine, V61, P47; Kwon CS, 2006, DEVELOPMENT, V133, P3223, DOI 10.1242/dev.02508; Liu LX, 2002, BIOCHEM BIOPH RES CO, V291, P908, DOI 10.1006/bbrc.2002.6551; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuda S, 2000, CANCER RES, V60, P13; Mentewab Ayalew B., BMC RES NOTES, V4, P93; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; Pincheira R, 2001, BRIT J CANCER, V84, P1520, DOI 10.1054/bjoc.2001.1828; Rauch J, 2004, BIOCHEM BIOPH RES CO, V323, P156, DOI 10.1016/j.bbrc.2004.08.071; Rivard A, 2000, J BIOL CHEM, V275, P29643, DOI 10.1074/jbc.M001029200; Rosenwald IB, 2004, ONCOGENE, V23, P3230, DOI 10.1038/sj.onc.1207552; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shahbazian D, 2010, MOL CELL BIOL, V30, P1478, DOI 10.1128/MCB.01218-09; Shek F. H., 2012, INT J HEPATOL, V9, P1016; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Varshney GK, 2013, GENOME RES, V23, P727, DOI 10.1101/gr.151464.112; Varshney GK, 2013, NUCLEIC ACIDS RES, V41, pD861, DOI 10.1093/nar/gks946; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang DW, 2007, P NATL ACAD SCI USA, V104, P12428, DOI 10.1073/pnas.0705502104; Wang XL, 2012, WORLD J GASTROENTERO, V18, P2540, DOI 10.3748/wjg.v18.i20.2540; Wang YW, 2013, HEPATOLOGY, V58, P239, DOI 10.1002/hep.26352; Yin JY, 2011, BIOSCIENCE REP, V31, P1, DOI 10.1042/BSR20100077; Yoo PS, 2006, WORLD J GASTROENTERO, V12, P4937, DOI 10.3748/wjg.v12.i31.4937; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200	54	19	20	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28310	28323		10.1074/jbc.M114.571356	http://dx.doi.org/10.1074/jbc.M114.571356			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25147179	Green Published, hybrid			2022-12-28	WOS:000343765400026
J	Kowalewski, B; Lubke, T; Kollmann, K; Braulke, T; Reinheckel, T; Dierks, T; Damme, M				Kowalewski, Bjoern; Luebke, Torben; Kollmann, Katrin; Braulke, Thomas; Reinheckel, Thomas; Dierks, Thomas; Damme, Markus			Molecular Characterization of Arylsulfatase G EXPRESSION, PROCESSING, GLYCOSYLATION, TRANSPORT, AND ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Processing; Heparan Sulfate; Lysosomal Glycoprotein; Lysosomal Storage Disease; Lysosome; Arylsulfatase G; Mannose 6-Phosphate; Mucopolysaccharidosis; Proteolytic Processing; Sulfatase	MANNOSE 6-PHOSPHATE RECEPTORS; CATHEPSIN-D; LYSOSOMAL SULFATASE; HUMAN-FIBROBLASTS; ACID SPHINGOMYELINASE; ENDOPLASMIC-RETICULUM; MICE DEFICIENT; HEPG2 CELLS; IN-VITRO; G ARSG	Arylsulfatase G (ARSG) is a recently identified lysosomal sulfatase that was shown to be responsible for the degradation of 3-O-sulfated N-sulfoglucosamine residues of heparan sulfate glycosaminoglycans. Deficiency of ARSG leads to a new type of mucopolysaccharidosis, as described in a mouse model. Here, we provide a detailed molecular characterization of the endogenous murine enzyme. ARSG is expressed and proteolytically processed in a tissue-specific manner. The 63-kDa single-chain precursor protein localizes to pre-lysosomal compartments and tightly associates with organelle membranes, most likely the endoplasmic reticulum. In contrast, proteolytically processed ARSG fragments of 34-, 18-, and 10-kDa were found in lysosomal fractions and lost their membrane association. The processing sites and a disulfide bridge between the 18- and 10-kDa chains could be roughly mapped. Proteases participating in the processing were identified as cathepsins B and L. Proteolytic processing is dispensable for hydrolytic sulfatase activity in vitro. Lysosomal transport of ARSG in the liver is independent of mannose 6-phosphate, sortilin, and Limp2. However, mutation of glycosylation site N-497 abrogates transport of ARSG to lysosomes in human fibrosarcoma cells, due to impaired mannose 6-phosphate modification.	[Kowalewski, Bjoern; Luebke, Torben; Dierks, Thomas; Damme, Markus] Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany; [Kollmann, Katrin; Braulke, Thomas] Univ Med Ctr Hamburg Eppendorf, Childrens Hosp, Dept Biochem, D-20246 Hamburg, Germany; [Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [Braulke, Thomas] Univ Freiburg, BIOSS Ctr Biol Signalling, D-79104 Freiburg, Germany	University of Bielefeld; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg; University of Freiburg	Dierks, T (corresponding author), Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany.	thomas.dierks@uni-bielefeld.de; mdamme@biochem.uni-kiel.de	Reinheckel, Thomas/AAL-9761-2021; Braulke, Thomas/AAV-9121-2020; Dierks, Thomas/A-3596-2012	Reinheckel, Thomas/0000-0001-9866-9105; Braulke, Thomas/0000-0002-2336-8532; Dierks, Thomas/0000-0001-6426-1339; Lubke, Torben/0000-0002-3342-0090	Deutsche Forschungsgemeinschaft [DI 575/6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant DI 575/6 (to T. D.).	Abitbol M, 2010, P NATL ACAD SCI USA, V107, P14775, DOI 10.1073/pnas.0914206107; Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Bielicki J, 1998, BIOCHEM J, V329, P145, DOI 10.1042/bj3290145; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; BRAULKE T, 1987, EUR J CELL BIOL, V43, P316; Buhling F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026247; Claussen M, 1997, ENDOCRINOLOGY, V138, P3797, DOI 10.1210/en.138.9.3797; Cohen E, 2005, FEBS LETT, V579, P2334, DOI 10.1016/j.febslet.2005.03.030; Deuschl F, 2006, FEBS LETT, V580, P5747, DOI 10.1016/j.febslet.2006.09.029; Diez-Roux G, 2005, ANNU REV GENOM HUM G, V6, P355, DOI 10.1146/annurev.genom.6.080604.162334; DIMENT S, 1988, J BIOL CHEM, V263, P6901; Dittmer F, 1998, TRANSGENIC RES, V7, P473, DOI 10.1023/A:1008823315416; Durand S, 2010, J BIOL CHEM, V285, P31233, DOI 10.1074/jbc.M110.141150; Ferrante P, 2002, EUR J HUM GENET, V10, P813, DOI 10.1038/sj.ejhg.5200887; FREEMAN C, 1987, BIOCHEM J, V246, P347, DOI 10.1042/bj2460347; FREEMAN C, 1986, BIOCHEM J, V234, P83, DOI 10.1042/bj2340083; Frese MA, 2008, J BIOL CHEM, V283, P11388, DOI 10.1074/jbc.M709917200; FROISSART R, 1995, BIOCHEM J, V309, P425, DOI 10.1042/bj3090425; FUJII T, 1992, BIOCHIM BIOPHYS ACTA, V1122, P93, DOI 10.1016/0167-4838(92)90132-W; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gamp AC, 2003, HUM MOL GENET, V12, P631, DOI 10.1093/hmg/ddg062; GIESELMANN V, 1983, J CELL BIOL, V97, P1, DOI 10.1083/jcb.97.1.1; Golabek AA, 2004, J BIOL CHEM, V279, P31058, DOI 10.1074/jbc.M400700200; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Huang RT, 2009, FEBS J, V276, P1891, DOI 10.1111/j.1742-4658.2009.06915.x; Kollmann K, 2012, BRAIN, V135, P2661, DOI 10.1093/brain/aws209; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; Kollmann K, 2009, FEBS J, V276, P1356, DOI 10.1111/j.1742-4658.2009.06877.x; Kowalewski B, 2012, P NATL ACAD SCI USA, V109, P10310, DOI 10.1073/pnas.1202071109; Lefrancois S, 2003, EMBO J, V22, P6430, DOI 10.1093/emboj/cdg629; LEMANSKY P, 1984, J BIOL CHEM, V259, P129; Ljusberg J, 2005, J BIOL CHEM, V280, P28370, DOI 10.1074/jbc.M502469200; MASUE M, 1991, J BIOCHEM-TOKYO, V110, P965, DOI 10.1093/oxfordjournals.jbchem.a123697; Matthews SP, 2010, J IMMUNOL, V184, P2423, DOI 10.4049/jimmunol.0901486; MEHL E, 1968, BIOCHIM BIOPHYS ACTA, V151, P619, DOI 10.1016/0005-2744(68)90008-9; MERION M, 1983, J CELL BIOL, V96, P644, DOI 10.1083/jcb.96.3.644; Muenzer J, 2004, J PEDIATR-US, V144, pS27, DOI 10.1016/j.jpeds.2004.01.052; Ni X, 2006, HISTOL HISTOPATHOL, V21, P899, DOI 10.14670/HH-21.899; Ni XY, 2006, TRAFFIC, V7, P889, DOI 10.1111/j.1600-0854.2006.00429.x; NISHIMURA Y, 1988, ARCH BIOCHEM BIOPHYS, V261, P64, DOI 10.1016/0003-9861(88)90104-X; NISHIMURA Y, 1995, BIOL PHARM BULL, V18, P1340; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Ong WY, 2004, NEUROSCIENCE, V128, P561, DOI 10.1016/j.neuroscience.2004.07.001; POHLMANN R, 1995, J BIOL CHEM, V270, P27311, DOI 10.1074/jbc.270.45.27311; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; RIJNBOUTT S, 1991, J BIOL CHEM, V266, P4862; RIJNBOUTT S, 1991, J BIOL CHEM, V266, P23586; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Saarela J, 1998, J BIOL CHEM, V273, P25320, DOI 10.1074/jbc.273.39.25320; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Sardiello M, 2005, HUM MOL GENET, V14, P3203, DOI 10.1093/hmg/ddi351; SCHUERMANN M, 1990, NUCLEIC ACIDS RES, V18, P4945, DOI 10.1093/nar/18.16.4945; Sleat DE, 2006, MOL CELL PROTEOMICS, V5, P686, DOI 10.1074/mcp.M500343-MCP200; STORRIE B, 1984, J CELL BIOL, V98, P108, DOI 10.1083/jcb.98.1.108; VONMOLLARD GF, 1994, EUR J CELL BIOL, V65, P319; Wahe A, 2010, J CELL SCI, V123, P2502, DOI 10.1242/jcs.067686; WATTIAUX R, 1963, ARCH INT PHYS BIOCH, V71, P140; Wiegmann EM, 2013, J BIOL CHEM, V288, P30019, DOI 10.1074/jbc.M113.499541; Zhao LY, 2007, BBA-MOL CELL BIOL L, V1771, P1397, DOI 10.1016/j.bbalip.2007.10.002; ZHU Y, 1994, J BIOL CHEM, V269, P3846	60	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27992	28005		10.1074/jbc.M114.584144	http://dx.doi.org/10.1074/jbc.M114.584144			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25135642	Green Published, hybrid			2022-12-28	WOS:000342852800052
J	Magliozzi, R; Kim, J; Low, TY; Heck, AJR; Guardavaccaro, D				Magliozzi, Roberto; Kim, Jihoon; Low, Teck Yew; Heck, Albert J. R.; Guardavaccaro, Daniele			Degradation of Tiam1 by Casein Kinase 1 and the SCF beta TrCP Ubiquitin Ligase Controls the Duration of mTOR-S6K Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 Ubiquitin Ligase; Proteasome; Proteolysis; Signal Transduction; Ubiquitin; Tiam1; betaTrCP; mTOR-S6K Signaling	I-KAPPA-B; DEPENDENT DEGRADATION; GENOTOXIC STRESS; DNA-DAMAGE; S6 KINASE; PROTEIN; COMPLEX; RAC; PHOSPHORYLATION; DESTRUCTION	Background: The guanine nucleotide exchange factor Tiam1 regulates the activity of the small GTPase Rac1, a crucial regulator of cell adhesion, proliferation, and survival. Results: The SCFTrCP ubiquitin ligase in cooperation with CK1 targets Tiam1 for proteasome-dependent degradation. Conclusion: Tiam1 degradation is required to terminate the mTOR-S6K signaling pathway. Significance: Tiam1 degradation controls the duration of mTOR-S6K signaling in response to mitogens. Tiam1 (T-cell lymphoma invasion and metastasis 1) is a guanine nucleotide exchange factor that specifically controls the activity of the small GTPase Rac, a key regulator of cell adhesion, proliferation, and survival. Here, we report that in response to mitogens, Tiam1 is degraded by the ubiquitin-proteasome system via the SCFTrCP ubiquitin ligase. Mitogenic stimulation triggers the binding of Tiam1 to the F-box protein TrCP via its degron sequence and subsequent Tiam1 ubiquitylation and proteasomal degradation. The proteolysis of Tiam1 is prevented by TrCP silencing, inhibition of CK1 and MEK, or mutation of the Tiam1 degron site. Expression of a stable Tiam1 mutant that is unable to interact with TrCP results in sustained activation of the mTOR/S6K signaling and increased apoptotic cell death. We propose that the SCFTrCP-mediated degradation of Tiam1 controls the duration of the mTOR-S6K signaling pathway in response to mitogenic stimuli.	[Magliozzi, Roberto; Kim, Jihoon; Guardavaccaro, Daniele] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Magliozzi, Roberto; Kim, Jihoon; Guardavaccaro, Daniele] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Low, Teck Yew; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Low, Teck Yew; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Low, Teck Yew; Heck, Albert J. R.] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University	Guardavaccaro, D (corresponding author), Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	d.guardavaccaro@hubrecht.eu	Low, Teck Yew/Q-5946-2019; Heck, Albert/D-7098-2011	Low, Teck Yew/0000-0001-7878-7534; Heck, Albert/0000-0002-2405-4404; Guardavaccaro, Daniele/0000-0002-4517-1765	Royal Dutch Academy of Arts and Sciences (KNAW); Dutch Cancer Society (KWF); Cancer Genomics Centre; European Union under Marie Curie Actions; Netherlands Proteomics Center	Royal Dutch Academy of Arts and Sciences (KNAW); Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Cancer Genomics Centre; European Union under Marie Curie Actions; Netherlands Proteomics Center	This work was supported by funds from the Royal Dutch Academy of Arts and Sciences (KNAW), the Dutch Cancer Society (KWF), the Cancer Genomics Centre, and the European Union under Marie Curie Actions (to D. G.) and from the Netherlands Proteomics Center (to T. Y. L. and A. J. R. H.).	Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; D'Annibale S, 2014, J BIOL CHEM, V289, P7730, DOI 10.1074/jbc.M114.549535; Dehan E, 2009, MOL CELL, V33, P109, DOI 10.1016/j.molcel.2008.12.020; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fuchs SY, 1999, ONCOGENE, V18, P2039, DOI 10.1038/sj.onc.1202760; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kruiswijk F, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002718; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Magliozzi R, 2013, DEV CELL, V27, P574, DOI 10.1016/j.devcel.2013.10.023; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Malliri A, 2004, J BIOL CHEM, V279, P30092, DOI 10.1074/jbc.M401192200; Malliri A, 2003, CURR OPIN CELL BIOL, V15, P583, DOI 10.1016/S0955-0674(03)00098-X; Mantovani F, 2003, J BIOL CHEM, V278, P42477, DOI 10.1074/jbc.M302799200; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Melixetian M, 2009, NAT CELL BIOL, V11, P1247, DOI 10.1038/ncb1969; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Raijmakers R, 2008, MOL CELL PROTEOMICS, V7, P1755, DOI 10.1074/mcp.M800093-MCP200; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Woodcock SA, 2009, MOL CELL, V33, P639, DOI 10.1016/j.molcel.2009.02.012; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2000, MOL CELL BIOL, V20, P1382, DOI 10.1128/MCB.20.4.1382-1393.2000; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Zhu GX, 2014, J BIOL CHEM, V289, P15482, DOI 10.1074/jbc.M114.553388	37	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27400	27409		10.1074/jbc.M114.575571	http://dx.doi.org/10.1074/jbc.M114.575571			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25124033	hybrid, Green Published			2022-12-28	WOS:000342852800004
J	Wang, Z; Yang, X; Guo, S; Yang, Y; Su, XC; Shen, YQ; Long, JF				Wang, Zheng; Yang, Xue; Guo, Shuang; Yang, Yin; Su, Xun-Cheng; Shen, Yuequan; Long, Jiafu			Crystal Structure of the Ubiquitin-like Domain-CUT Repeat-like Tandem of Special AT-rich Sequence Binding Protein 1 (SATB1) Reveals a Coordinating DNA-binding Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Regulation; Crystal Structure; DNA-binding Protein; Gene Regulation; Scaffold Protein; CUTL Domain; DNA Binding; SATB1; Coordination Mechanism; Global Gene Regulation	MATRIX ATTACHMENT REGION; MEDIATED DIMERIZATION; GENE-EXPRESSION; MULTIPLE GENES; TUMOR-GROWTH; CHROMATIN; TRANSCRIPTION; ARCHITECTURE; RECOGNITION; HOMEODOMAIN	Background: SATB1 is a multidomain protein that acts as a global gene organizer. Results: The newly identified CUTL domain contributes to the DNA binding ability of SATB1. Conclusion: The DNA binding ability of SATB1 requires the contribution of the CUTL domain and the other DNA-binding domains. Significance: These findings reveal a multiple-domain-coordinated mechanism whereby SATB1 recognizes DNA targets. SATB1 is essential for T-cell development and growth and metastasis of multitype tumors and acts as a global chromatin organizer and gene expression regulator. The DNA binding ability of SATB1 plays vital roles in its various biological functions. We report the crystal structure of the N-terminal module of SATB1. Interestingly, this module contains a ubiquitin-like domain (ULD) and a CUT repeat-like (CUTL) domain (ULD-CUTL tandem). Detailed biochemical experiments indicate that the N terminus of SATB1 (residues 1-248, SATB1((1-248))), including the extreme 70 N-terminal amino acids, and the ULD-CUTL tandem bind specifically to DNA targets. Our results show that the DNA binding ability of full-length SATB1 requires the contribution of the CUTL domain, as well as the CUT1-CUT2 tandem domain and the homeodomain. These findings may reveal a multiple-domain-coordinated mechanism whereby SATB1 recognizes DNA targets.	[Wang, Zheng; Yang, Xue; Guo, Shuang; Shen, Yuequan; Long, Jiafu] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Wang, Zheng; Yang, Xue; Shen, Yuequan; Long, Jiafu] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Yang, Yin; Su, Xun-Cheng] Nankai Univ, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China; [Shen, Yuequan] Synerget Innovat Ctr Chem Sci & Engn, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University	Shen, YQ (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	shenyuequan@gmail.com; jflong@nankai.edu.cn	Long, Jiafu/B-7420-2012	Long, Jiafu/0000-0002-6625-0147; , Xun-Cheng/0000-0003-3051-0047	973 Program [2014CB910201, 2012CB917201]; National Natural Science Foundation of China [31270815, 31100527]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 973 Program Grants 2014CB910201 (to J. L.) and 2012CB917201 (to Y. S.) and National Natural Science Foundation of China Grants 31270815 (to J. L.) and 31100527 (to H. Z.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahlfors H, 2010, BLOOD, V116, P1443, DOI 10.1182/blood-2009-11-252205; Alvarez JD, 2000, GENE DEV, V14, P521; BODE J, 1992, SCIENCE, V255, P195, DOI 10.1126/science.1553545; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Dickinson LA, 1997, J BIOL CHEM, V272, P11463; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Galande S, 2001, MOL CELL BIOL, V21, P5591, DOI 10.1128/MCB.21.16.5591-5604.2001; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Gong FR, 2011, NUCLEIC ACIDS RES, V39, P4640, DOI 10.1093/nar/gkr023; Gotzmann J, 2000, CELL DEATH DIFFER, V7, P425, DOI 10.1038/sj.cdd.4400668; Han B, 2013, TUMOR BIOL, V34, P2943, DOI 10.1007/s13277-013-0857-1; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Klemm JD, 1996, GENE DEV, V10, P27, DOI 10.1101/gad.10.1.27; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kumar PP, 2005, MOL CELL BIOL, V25, P1620, DOI 10.1128/MCB.25.5.1620-1633.2005; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NAKAGOMI K, 1994, MOL CELL BIOL, V14, P1852, DOI 10.1128/MCB.14.3.1852; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Purbey PK, 2008, NUCLEIC ACIDS RES, V36, P2107, DOI 10.1093/nar/gkm1151; Purbey PK, 2009, MOL CELL BIOL, V29, P1321, DOI 10.1128/MCB.00822-08; Razin SV, 2013, FEBS LETT, V587, P1840, DOI 10.1016/j.febslet.2013.04.027; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Serrano L, 2013, EXP BIOL MED, V238, P259, DOI 10.1177/1535370213480718; Sun YJ, 2006, CELL BIOL INT, V30, P244, DOI 10.1016/j.cellbi.2005.10.025; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Tan JAT, 2008, J BIOL CHEM, V283, P18124, DOI 10.1074/jbc.M800512200; Tan JAT, 2010, MOL CELL BIOL, V30, P2823, DOI 10.1128/MCB.01603-09; Tu W, 2012, LIVER INT, V32, P1064, DOI 10.1111/j.1478-3231.2012.02815.x; Wang Z, 2012, NUCLEIC ACIDS RES, V40, P4193, DOI 10.1093/nar/gkr1284; Xue Z, 2012, NUCLEIC ACIDS RES, V40, P4804, DOI 10.1093/nar/gks064; Yamasaki K, 2007, NUCLEIC ACIDS RES, V35, P5073, DOI 10.1093/nar/gkm504; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084	40	10	10	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27376	27385		10.1074/jbc.M114.562314	http://dx.doi.org/10.1074/jbc.M114.562314			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25124042	Green Published, hybrid			2022-12-28	WOS:000342852800002
J	Gallea, JI; Celej, MS				Ignacio Gallea, J.; Soledad Celej, M.			Structural Insights into Amyloid Oligomers of the Parkinson Disease-related Protein alpha-Synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENT-PROBE; FIBRIL FORMATION; AGGREGATION; DYNAMICS; NMR; PATHOGENESIS; POLYMORPHISM; TOXICITY	The presence of intraneuronal deposits mainly formed by amyloid fibrils of the presynaptic protein alpha-synuclein (AS) is a hallmark of Parkinson disease. Currently, neurotoxicity is attributed to prefibrillar oligomeric species rather than the insoluble aggregates, although their mechanisms of toxicity remain elusive. Structural details of the supramolecular organization of AS oligomers are critically needed to decipher the structure-toxicity relationship underlying their pathogenicity. In this study, we employed site-specific fluorescence to get a deeper insight into the internal architecture of AS oligomeric intermediates. We demonstrate that AS oligomers are ordered assemblies possessing a well defined pattern of intermolecular contacts. Some of these contacts involve regions that form the beta-sheet core in the fibrillar state, although their spatial arrangement may differ in the two aggregated forms. However, even though the two termini are excluded from the fibrillar core, they are engaged in a number of intermolecular interactions within the oligomer. Therefore, substantial structural remodeling of early oligomeric interactions is essential for fibril growth. The intermolecular contacts identified in AS oligomers can serve as targets for the rational design of anti-amyloid compounds directed at preventing oligomeric interactions/reorganizations.	[Ignacio Gallea, J.; Soledad Celej, M.] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba, Dept Quim Biol,CONICET, RA-5000 Cordoba, Argentina	National University of Cordoba	Celej, MS (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba, Dept Quim Biol, Ciudad Univ,X5000HUA, RA-5000 Cordoba, Argentina.	mcelej@mail.fcq.unc.edu.ar	Gallea, Jose Ignacio/AAV-6058-2020; Celej, Maria Soledad/N-5709-2019	Celej, Maria Soledad/0000-0002-7831-9244	Agencia FONCYT [PICT 1913]; CONICET [PIP-2011-2013]; SECyT-UNC;  [ISN-CAEN-2012]	Agencia FONCYT(FONCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); SECyT-UNC(Secretaria de Ciencia y Tecnologia (SECYT)); 	This work was supported in part by grants from Agencia FONCYT PICT 1913, CONICET PIP-2011-2013, SECyT-UNC, and ISN-CAEN-2012.	Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bertoncini CW, 2011, CURR PROTEIN PEPT SC, V12, P206; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Celej MS, 2009, BIOCHEMISTRY-US, V48, P7465, DOI 10.1021/bi9003843; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Esteban-Martin S, 2013, BIOPHYS J, V105, P1192, DOI 10.1016/j.bpj.2013.07.044; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Kaylor J, 2005, J MOL BIOL, V353, P357, DOI 10.1016/j.jmb.2005.08.046; Kim HY, 2009, J AM CHEM SOC, V131, P17482, DOI 10.1021/ja9077599; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lamberto GR, 2009, P NATL ACAD SCI USA, V106, P21057, DOI 10.1073/pnas.0902603106; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee JC, 2005, J AM CHEM SOC, V127, P16388, DOI 10.1021/ja0561901; Lorenzen N, 2014, J AM CHEM SOC, V136, P3859, DOI 10.1021/ja411577t; Masuda M, 2006, FEBS LETT, V580, P1775, DOI 10.1016/j.febslet.2006.02.032; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Mysling S, 2013, BIOCHEMISTRY-US, V52, P9097, DOI 10.1021/bi4009193; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; PRENDERGAST FG, 1983, J BIOL CHEM, V258, P7541; Rao JN, 2008, BIOCHEMISTRY-US, V47, P4651, DOI 10.1021/bi8002378; Celej MS, 2012, BIOCHEM J, V443, P719, DOI 10.1042/BJ20111924; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Thirunavukkuarasu S, 2008, J MOL BIOL, V378, P1064, DOI 10.1016/j.jmb.2008.03.034; Valeur B., 2001, MOL FLUORESCENCE PRI, DOI [10.1002/3527600248, DOI 10.1002/3527600248]; van Rooijen BD, 2009, J MOL BIOL, V394, P826, DOI 10.1016/j.jmb.2009.10.021; van Rooijen BD, 2009, BBA-BIOMEMBRANES, V1788, P1271, DOI 10.1016/j.bbamem.2009.03.010; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; WU CW, 1976, BIOCHEMISTRY-US, V15, P2863, DOI 10.1021/bi00658a025; Wu KP, 2010, J AM CHEM SOC, V132, P5546, DOI 10.1021/ja9105495; Yap TL, 2011, BIOCHEMISTRY-US, V50, P1963, DOI 10.1021/bi2000824; Yushchenko DA, 2010, J AM CHEM SOC, V132, P7860, DOI 10.1021/ja102838n; Zijlstra N, 2014, BIOPHYS J, V106, P440, DOI 10.1016/j.bpj.2013.12.009; Zijlstra N, 2012, ANGEW CHEM INT EDIT, V51, P8821, DOI 10.1002/anie.201200813	49	39	39	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26733	26742		10.1074/jbc.M114.566695	http://dx.doi.org/10.1074/jbc.M114.566695			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25143382	Green Published, hybrid			2022-12-28	WOS:000342853900006
J	Miyazaki, T; Kim, YS; Yoon, J; Wang, H; Suzuki, T; Morse, HC				Miyazaki, Takuya; Kim, Yong-Soo; Yoon, Jeongheon; Wang, Hongsheng; Suzuki, Teruhiko; Morse, Herbert C., III			The 3 '-5 ' DNA Exonuclease TREX1 Directly Interacts with Poly(ADP-ribose) Polymerase-1 (PARP1) during the DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL CHILBLAIN LUPUS; AICARDI-GOUTIERES-SYNDROME; MEDIATED CELL-DEATH; GENE; GRANZYME; PROTEIN; ACTIVATION; MUTATIONS; SET; ERYTHEMATOSUS	The main function of the 3'-5' DNA exonuclease TREX1 is to digest cytosolic single-stranded DNA to prevent activation of cell-intrinsic responses to immunostimulatory DNA. TREX1 translocates to the nucleus following DNA damage with its nuclear activities being less well defined. Although mutations in human TREX1 have been linked to autoimmune/inflammatory diseases, the mechanisms contributing to the pathogenesis of these diseases remain incompletely understood. Here, using mass spectrometry and co-immunoprecipitation assays and in vivo overexpression models, we show that TREX1 interacts with poly(ADP-ribose) polymerase-1 (PARP1), a nuclear enzyme involved in the DNA damage response. Two zinc finger domains at the amino terminus of PARP1 were required for the interaction with TREX1 that occurs after nuclear translocation of TREX1 in response to DNA damage. Functional studies suggested that TREX1 may contribute to stabilization of PARP1 levels in the DNA damage response and its activity. These results provide new insights into the mechanisms of single-stranded DNA repair following DNA damage and alterations induced by gene mutations.	[Miyazaki, Takuya; Kim, Yong-Soo; Yoon, Jeongheon; Wang, Hongsheng; Morse, Herbert C., III] NIAID, Virol & Cellular Immunol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Suzuki, Teruhiko] Tokyo Metropolitan Inst Med Sci, Stem Cell Project Grp, Tokyo 1568506, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Tokyo Metropolitan Institute of Medical Science	Morse, HC (corresponding author), NIAID, Virol & Cellular Immunol Sect, Immunogenet Lab, NIH, 5640 Fishers Lane, Rockville, MD 20852 USA.	hmorse@niaid.nih.gov		Morse, Herbert/0000-0002-9331-3705	National Institutes of Health Intramural Research Program of the NIAID	National Institutes of Health Intramural Research Program of the NIAID	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIAID.	Ali AAE, 2012, NAT STRUCT MOL BIOL, V19, P685, DOI 10.1038/nsmb.2335; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Brucet M, 2007, J BIOL CHEM, V282, P14547, DOI 10.1074/jbc.M700236200; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Christmann M, 2010, NUCLEIC ACIDS RES, V38, P6418, DOI 10.1093/nar/gkq455; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Ding ZY, 2006, P NATL ACAD SCI USA, V103, P15014, DOI 10.1073/pnas.0606917103; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Gamble MJ, 2007, NAT STRUCT MOL BIOL, V14, P548, DOI 10.1038/nsmb1248; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Hasan M, 2013, NAT IMMUNOL, V14, P61, DOI 10.1038/ni.2475; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Kanai M, 2007, NAT CELL BIOL, V9, P1175, DOI 10.1038/ncb1638; Kavanagh D, 2008, CELL CYCLE, V7, P1718, DOI 10.4161/cc.7.12.6162; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; Lee CH, 2006, J EXP MED, V203, P63, DOI 10.1084/jem.20051450; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Lee-Kirsch MA, 2006, AM J HUM GENET, V79, P731, DOI 10.1086/507848; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73; Pyndiah S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001556; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Wang CJ, 2009, DNA REPAIR, V8, P1179, DOI 10.1016/j.dnarep.2009.06.006; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang J, 1998, CARCINOGENESIS, V19, P1117, DOI 10.1093/carcin/19.6.1117; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Ying SM, 2009, NUCLEIC ACIDS RES, V37, P5105, DOI 10.1093/nar/gkp538; Zhu PC, 2009, BLOOD, V114, P1205, DOI 10.1182/blood-2008-12-195768	39	27	27	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.547331	http://dx.doi.org/10.1074/jbc.M114.547331			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25278026	Green Published, hybrid			2022-12-28	WOS:000345335000014
J	Xie, SW; Naslavsky, N; Caplan, S				Xie, Shuwei; Naslavsky, Naava; Caplan, Steve			Diacylglycerol Kinase alpha Regulates Tubular Recycling Endosome Biogenesis and Major Histocompatibility Complex Class I Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endocytosis; Intracellular Trafficking; Membrane Trafficking; Phosphatidic Acid; Receptor Recycling; Clathrin-independent Endocytosis; Diacylglycerol Kinase; Major Histocompatibility Complex Class I; Structured Illumination Microscopy; Tubular Recycling Endosome	PHOSPHATIDIC-ACID; ADAPTER PROTEIN; EPS15 HOMOLOGY; EHD1 INTERACT; CLATHRIN; ENDOCYTOSIS; DOMAIN; ARF6; INTERSECTIN; VESICLES	Background: Major histocompatibility complex class I (MHC I) trafficking is crucial for antigen presentation. Results: Diacylglycerol kinase (DGK) depletion interferes with tubular recycling endosome (TRE) biogenesis and delays MHC I recycling to the plasma membrane. Conclusion: DGK mediates MHC I recycling by interacting with MICAL-L1 and generating phosphatidic acid. Significance: A novel role for DGK in generating phosphatidic acid for TRE biogenesis and MHC I recycling. Major histocompatibility complex class I (MHC I) presents intracellular-derived peptides to cytotoxic T lymphocytes and its subcellular itinerary is important in regulating the immune response. While a number of diacylglycerol kinase isoforms have been implicated in clathrin-dependent internalization, MHC I lacks the typical motifs known to mediate clathrin-dependent endocytosis. Here we show that depletion of diacylglycerol kinase (DGK), a kinase devoid of a clathrin-dependent adaptor protein complex 2 binding site, caused a delay in MHC I recycling to the plasma membrane without affecting the rate of MHC I internalization. We demonstrate that DGK knock-down causes accumulation of intracellular and surface MHC I, resulting from decreased degradation. Furthermore, we provide evidence that DGK is required for the generation of phosphatidic acid required for tubular recycling endosome (TRE) biogenesis. Moreover, we show that DGK forms a complex with the TRE hub protein, MICAL-L1. Given that MICAL-L1 and the F-BAR-containing membrane-tubulating protein Syndapin2 associate selectively with phosphatidic acid, we propose a positive feedback loop in which DGK generates phosphatidic acid to drive its own recruitment to TRE via its interaction with MICAL-L1. Our data support a novel role for the involvement of DGK in TRE biogenesis and MHC I recycling.	[Naslavsky, Naava; Caplan, Steve] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Naslavsky, Naava; Caplan, Steve] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Naslavsky, N (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	nnaslavsky@unmc.edu; scaplan@unmc.edu	Xie, Shuwei/ABA-4923-2021		National Institutes of Health [R01GM087455, R01GM074876]; National Institute of General Medical Sciences of the National Institutes of Health [5P30GM106397]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397, R01GM074876, R01GM087455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM087455, R01GM074876, and an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under Grant number 5P30GM106397. Structured Illumination (SIM) images were obtained and processed at the UNMC Advanced Microscopy Core Facility.	Adams A, 2000, J BIOL CHEM, V275, P27414; Anton LC, 2014, J LEUKOCYTE BIOL, V95, P551, DOI 10.1189/jlb.1113599; Antonescu CN, 2010, MOL BIOL CELL, V21, P2944, DOI 10.1091/mbc.E10-05-0421; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Cai BS, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00022; Cai BS, 2013, J BIOL CHEM, V288, P30172, DOI 10.1074/jbc.M113.488627; Cai BS, 2012, MOL BIOL CELL, V23, P1874, DOI 10.1091/mbc.E11-10-0881; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Donaldson JG, 2009, TRAFFIC, V10, P1745, DOI 10.1111/j.1600-0854.2009.00979.x; Donaldson JG, 2009, BBA-MOL CELL BIOL L, V1791, P845, DOI 10.1016/j.bbalip.2009.05.011; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Giridharan SSP, 2013, MOL BIOL CELL, V24, P1776, DOI 10.1091/mbc.E13-01-0026; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Jovanovic OA, 2006, MOL BIOL CELL, V17, P327, DOI 10.1091/mbc.E05-06-0523; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Kawasaki T, 2008, BIOCHEM J, V409, P471, DOI 10.1042/BJ20070755; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Mettlen M, 2009, MOL BIOL CELL, V20, P3251, DOI 10.1091/mbc.E09-03-0256; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Rahajeng J, 2012, TRAFFIC, V13, P82, DOI 10.1111/j.1600-0854.2011.01294.x; Rainero E, 2012, J CELL BIOL, V196, P277, DOI 10.1083/jcb.201109112; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; Sharma M, 2009, MOL BIOL CELL, V20, P5181, DOI 10.1091/mbc.E09-06-0535; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; YLANNE J, 1995, J BIOL CHEM, V270, P9550	34	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31914	31926		10.1074/jbc.M114.594291	http://dx.doi.org/10.1074/jbc.M114.594291			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25248744	Green Published, hybrid			2022-12-28	WOS:000345314700022
J	Donninger, H; Clark, JA; Monaghan, MK; Schmidt, ML; Vos, M; Clark, GJ				Donninger, Howard; Clark, Jennifer A.; Monaghan, Megan K.; Schmidt, M. Lee; Vos, Michele; Clark, Geoffrey J.			Cell Cycle Restriction Is More Important Than Apoptosis Induction for RASSF1A Protein Tumor Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSOCIATION DOMAIN FAMILY-1; EPIGENETIC INACTIVATION; BINDING-PROTEIN; MST2 PATHWAY; K-RAS; MICROTUBULES; EFFECTOR; KINASE; METHYLATION; STABILIZES	The Ras association domain family protein 1A (RASSF1A) is arguably one of the most frequently inactivated tumor suppressors in human cancer. RASSF1A modulates apoptosis via the Hippo and Bax pathways but also modulates the cell cycle. In part, cell cycle regulation appears to be dependent upon the ability of RASSF1A to complex with microtubules and regulate their dynamics. Which property of RASSF1A, apoptosis induction or microtubule regulation, is responsible for its tumor suppressor function is not known. We have identified a short conserved motif that is essential for the binding of RASSF family proteins with microtubule-associated proteins. By making a single point mutation in the motif, we were able to generate a RASSF1A variant that retains wild-type apoptotic properties but completely loses the ability to bind microtubule-associated proteins and complex with microtubules. Comparison of this mutant to wild-type RASSF1A showed that, despite retaining its proapoptotic properties, the mutant was completely unable to induce cell cycle arrest or suppress the tumorigenic phenotype. Therefore, it appears that the cell cycle/microtubule effects of RASSF1A are key to its tumor suppressor function rather than its apoptotic effects.	[Donninger, Howard; Clark, Jennifer A.; Monaghan, Megan K.] Univ Louisville, Dept Med, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40202 USA; [Schmidt, M. Lee] Univ Louisville, Dept Biochem & Mol Biol, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40202 USA; [Clark, Geoffrey J.] Univ Louisville, Dept Pharmacol & Toxicol, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40202 USA; [Vos, Michele] NCI, Cell & Canc Biol Branch, NIH, Rockville, MD 20850 USA	University of Louisville; University of Louisville; University of Louisville; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Clark, GJ (corresponding author), Univ Louisville, Dept Pharmacol & Toxicol, James Graham Brown Canc Ctr, Mol Targets Program, 505 S Hancock St, Louisville, KY 40202 USA.	gjclar01@louisville.edu	Donninger, Howard/I-9874-2019	Donninger, Howard/0000-0002-8589-1660	National Institutes of Health [1P20 RR18733, R01 CA133171-01A2]; NATIONAL CANCER INSTITUTE [R01CA133171] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants 1P20 RR18733 and R01 CA133171-01A2 (to G.J.C.).	Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Arnette C, 2014, MOL BIOL CELL, V25, P800, DOI 10.1091/mbc.E13-07-0374; Avruch J, 2006, METHOD ENZYMOL, V407, P290, DOI 10.1016/S0076-6879(05)07025-4; Baksh S, 2005, MOL CELL, V18, P637, DOI 10.1016/j.molcel.2005.05.010; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Casar B, 2009, MOL CELL BIOL, V29, P1338, DOI 10.1128/MCB.01359-08; Chen Z, 2000, J BIOL CHEM, V275, P41251, DOI 10.1074/jbc.M006687200; Chien CL, 2005, EXP CELL RES, V308, P446, DOI 10.1016/j.yexcr.2005.05.007; Clark Jennifer, 2012, Mol Biol Int, V2012, P705948, DOI 10.1155/2012/705948; Cooper WN, 2009, ONCOGENE, V28, P2988, DOI 10.1038/onc.2009.152; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Dallol A, 2004, CANCER RES, V64, P4112, DOI 10.1158/0008-5472.CAN-04-0267; Dallol A, 2007, CANCER RES, V67, P492, DOI 10.1158/0008-5472.CAN-06-3604; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dammann R, 2005, HISTOL HISTOPATHOL, V20, P645, DOI 10.14670/HH-20.645; Demir O, 2009, MOL CELL NEUROSCI, V40, P111, DOI 10.1016/j.mcn.2008.10.004; Donninger H, 2008, BIOL CHEM, V389, P57, DOI 10.1515/BC.2008.010; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Donninger H, 2011, FRONT ONCOL, V1, DOI 10.3389/fonc.2011.00054; Donninger H, 2011, J BIOL CHEM, V286, P18483, DOI 10.1074/jbc.M110.214874; El-Kalla M, 2010, ONCOGENE, V29, P5729, DOI 10.1038/onc.2010.316; Fiordalisi JJ, 2001, METHOD ENZYMOL, V332, P3; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Liu LY, 2005, BIOCHEM BIOPH RES CO, V332, P670, DOI 10.1016/j.bbrc.2005.05.006; Liu LY, 2005, CANCER RES, V65, P1830, DOI 10.1158/0008-5472.CAN-04-3896; Malumbres M, 1998, FRONT BIOSCI-LANDMRK, V3, P887; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016; Moshnikova Anna, 2008, BMC Res Notes, V1, P13, DOI 10.1186/1756-0500-1-13; Ortiz-Vega S, 2002, ONCOGENE, V21, P1381, DOI 10.1038/sj.onc.1205192; Rong R, 2007, ONCOGENE, V26, P7700, DOI 10.1038/sj.onc.1210575; Rong R, 2004, ONCOGENE, V23, P8216, DOI 10.1038/sj.onc.1207901; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Thaler S, 2009, CANCER RES, V69, P1748, DOI 10.1158/0008-5472.CAN-08-1377; Thissen JA, 1997, J BIOL CHEM, V272, P30362, DOI 10.1074/jbc.272.48.30362; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vos MD, 2006, J BIOL CHEM, V281, P4557, DOI 10.1074/jbc.M512128200; Vos MD, 2004, CANCER RES, V64, P4244, DOI 10.1158/0008-5472.CAN-04-0339; Vos MD, 2000, J BIOL CHEM, V275, P35669, DOI 10.1074/jbc.C000463200	41	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31287	31295		10.1074/jbc.M114.609537	http://dx.doi.org/10.1074/jbc.M114.609537			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25225292	Green Published, hybrid			2022-12-28	WOS:000344549900033
J	Lambert, HP; Zenger, M; Azarias, G; Chatton, JY; Magistretti, PJ; Lengacher, S				Lambert, Helene Perreten; Zenger, Manuel; Azarias, Guillaume; Chatton, Jean-Yves; Magistretti, Pierre J.; Lengacher, Sylvain			Control of Mitochondrial pH by Uncoupling Protein 4 in Astrocytes Promotes Neuronal Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; SKELETAL-MUSCLE; SPECTROPHOTOMETRIC DETERMINATION; CORTICAL ASTROCYTES; ENERGY-METABOLISM; EXPRESSION; BRAIN; UCP4; GENE; TEMPERATURE	Brain activity is energetically costly and requires a steady and highly regulated flow of energy equivalents between neural cells. It is believed that a substantial share of cerebral glucose, the major source of energy of the brain, will preferentially be metabolized in astrocytes via aerobic glycolysis. The aim of this study was to evaluate whether uncoupling proteins (UCPs), located in the inner membrane of mitochondria, play a role in setting up the metabolic response pattern of astrocytes. UCPs are believed to mediate the transmembrane transfer of protons, resulting in the uncoupling of oxidative phosphorylation from ATP production. UCPs are therefore potentially important regulators of energy fluxes. The main UCP isoforms expressed in the brain are UCP2, UCP4, and UCP5. We examined in particular the role of UCP4 in neuron-astrocyte metabolic coupling and measured a range of functional metabolic parameters including mitochondrial electrical potential and pH, reactive oxygen species production, NAD/NADH ratio, ATP/ADP ratio, CO2 and lactate production, and oxygen consumption rate. In brief, we found that UCP4 regulates the intramitochondrial pH of astrocytes, which acidifies as a consequence of glutamate uptake, with the main consequence of reducing efficiency of mitochondrial ATP production. The diminished ATP production is effectively compensated by enhancement of glycolysis. This nonoxidative production of energy is not associated with deleterious H2O2 production. We show that astrocytes expressing more UCP4 produced more lactate, which is used as an energy source by neurons, and had the ability to enhance neuronal survival.	[Lambert, Helene Perreten; Zenger, Manuel; Magistretti, Pierre J.; Lengacher, Sylvain] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Magistretti, Pierre J.] King Abdullah Univ Sci & Technol, Thuwal 239556900, Saudi Arabia; [Azarias, Guillaume; Chatton, Jean-Yves] Univ Lausanne, Dept Fundamental Neurosci, CH-1005 Lausanne, Switzerland; [Magistretti, Pierre J.; Lengacher, Sylvain] Ctr Psychiat Neurosci, CH-7008 Prilly, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; King Abdullah University of Science & Technology; University of Lausanne	Lengacher, S (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Brain & Mind Inst, CH-1015 Lausanne, Switzerland.	Sylvain.Lengacher@epfl.ch	Lengacher, Sylvain/C-2591-2009	Lengacher, Sylvain/0000-0003-2190-9654; Chatton, Jean-Yves/0000-0002-8911-0315; Magistretti, Pierre Julius/0000-0002-6678-320X	Swiss National Science Foundation [108336, 31003A-135720]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants 108336 (to P. J. M.) and 31003A-135720 (to J. Y. C.).	Alan L, 2009, J BIOENERG BIOMEMBR, V41, P71, DOI 10.1007/s10863-009-9201-2; Allaman I, 2004, J NEUROCHEM, V88, P900, DOI 10.1046/j.1471-4159.2003.02235.x; Allaman I, 2010, J NEUROSCI, V30, P3326, DOI 10.1523/JNEUROSCI.5098-09.2010; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Azarias G, 2011, J NEUROSCI, V31, P3550, DOI 10.1523/JNEUROSCI.4378-10.2011; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bittar PG, 1996, J CEREBR BLOOD F MET, V16, P1079, DOI 10.1097/00004647-199611000-00001; Boss O, 1998, LANCET, V351, P1933, DOI 10.1016/S0140-6736(05)78617-7; Boss O, 1998, J BIOL CHEM, V273, P5, DOI 10.1074/jbc.273.1.5; BOUILLAUD F, 1988, BIOCHEM BIOPH RES CO, V157, P783, DOI 10.1016/S0006-291X(88)80318-8; Chan SL, 2006, J BIOL CHEM, V281, P37391, DOI 10.1074/jbc.M605552200; Chatton JY, 2000, EUR J NEUROSCI, V12, P3843, DOI 10.1046/j.1460-9568.2000.00269.x; de la Monte SM, 2006, J ALZHEIMERS DIS, V9, P167; Demaurex N, 2009, J PHYSIOL SCI, V59, P348; Haskew-Layton RE, 2010, P NATL ACAD SCI USA, V107, P17385, DOI 10.1073/pnas.1003996107; Horvath TL, 1999, J NEUROSCI, V19, P10417; Huang PS, 2011, NEUROSCIENCE, V196, P189, DOI 10.1016/j.neuroscience.2011.09.007; Jezek P, 2004, PHYSIOL RES, V53, pS199; Kim-Han JS, 2001, J NEUROCHEM, V79, P658, DOI 10.1046/j.1471-4159.2001.00604.x; KOZAK LP, 1988, J BIOL CHEM, V263, P12274; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lengacher S, 2004, J CEREBR BLOOD F MET, V24, P780, DOI 10.1097/01.WCB.0000122743.72175.52; Liu D, 2006, NEUROMOL MED, V8, P389, DOI 10.1385/NMM:8:3:389; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nicholls D G, 1978, Experientia Suppl, V32, P89; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Pellerin L, 2004, SCIENCE, V305, P50, DOI 10.1126/science.1100428; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pichiule P, 2003, ADV EXP MED BIOL, V540, P103; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Ricquier D, 2006, CR BIOL, V329, P578, DOI 10.1016/j.crvi.2005.10.010; ROSENBERG JC, 1966, CLIN CHEM, V12, P299; Sanchis D, 1998, J BIOL CHEM, V273, P34611, DOI 10.1074/jbc.273.51.34611; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Smorodchenko A, 2009, BBA-BIOMEMBRANES, V1788, P2309, DOI 10.1016/j.bbamem.2009.07.018; SORG O, 1992, J NEUROSCI, V12, P4923; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Szolnoki Z, 2009, NEUROMOL MED, V11, P101, DOI 10.1007/s12017-009-8071-4; Wu ZF, 2009, ANTIOXID REDOX SIGN, V11, P1805, DOI [10.1089/ars.2009.2427, 10.1089/ARS.2009.2427]; Yu XX, 2000, FASEB J, V14, P1611, DOI 10.1096/fj.14.11.1611; ZEREZ CR, 1987, ANAL BIOCHEM, V164, P367, DOI 10.1016/0003-2697(87)90506-9; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	46	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31014	31028		10.1074/jbc.M114.570879	http://dx.doi.org/10.1074/jbc.M114.570879			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25237189	hybrid, Green Published			2022-12-28	WOS:000344549900012
J	Song, LN; Bachert, C; Schjoldager, KT; Clausen, H; Linstedt, AD				Song, Lina; Bachert, Collin; Schjoldager, Katrine T.; Clausen, Henrik; Linstedt, Adam D.			Development of Isoform-specific Sensors of Polypeptide GalNAc-transferase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-GLYCOSYLATION; LECTIN DOMAINS; UDP-GALNAC; CANCER; GLYCOSYLTRANSFERASES; EXPRESSION; FAMILY; CELLS	Humans express up to 20 isoforms of GalNAc-transferase ( herein T1-T20) that localize to the Golgi apparatus and initiate O-glycosylation. Regulation of this enzyme family affects a vast array of proteins transiting the secretory pathway and diseases arise upon misregulation of specific isoforms. Surprisingly, molecular probes to monitor GalNAc-transferase activity are lacking and there exist no effective global or isoform-specific inhibitors. Here we describe the development of T2- and T3-isoform specific fluorescence sensors that traffic in the secretory pathway. Each sensor yielded little signal when glycosylated but was strongly activated in the absence of its glycosylation. Specificity of each sensor was assessed in HEK cells with either the T2 or T3 enzymes deleted. Although the sensors are based on specific substrates of the T2 and T3 enzymes, elements in or near the enzyme recognition sequence influenced their activity and required modification, which we carried out based on previous in vitro work. Significantly, the modified T2 and T3 sensors were activated only in cells lacking their corresponding isozymes. Thus, we have developed T2- and T3-specific sensors that will be valuable in both the study of GalNAc-transferase regulation and in high-throughput screening for potential therapeutic regulators of specific GalNAc-transferases.	[Song, Lina; Bachert, Collin; Linstedt, Adam D.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Schjoldager, Katrine T.; Clausen, Henrik] Univ Copenhagen, Dept Cellular Med, DK-2200 Copenhagen, Denmark; [Schjoldager, Katrine T.; Clausen, Henrik] Univ Copenhagen, Dept Mol Med, DK-2200 Copenhagen, Denmark; [Schjoldager, Katrine T.; Clausen, Henrik] Univ Copenhagen, Sch Dent, Copenhagen Ctr Glyc, DK-2200 Copenhagen, Denmark	Carnegie Mellon University; University of Copenhagen; University of Copenhagen; University of Copenhagen	Linstedt, AD (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	linstedt@cmu.edu	clausen, henrik/AAD-8016-2021	Clausen, Henrik/0000-0002-0915-5055	National Institutes of Health [GM095549, GM056779]; Novo Nordisk Foundation; Danish National Research Foundation [DNRF107]; Danish Medical Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095549, R01GM056779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM095549 and GM056779 (to A. D. L.), the Novo Nordisk Foundation and Danish National Research Foundation Grant DNRF107 (to H. C.), and the Danish Medical Research Council (to K. T. S.).	Bachert C, 2013, TRAFFIC, V14, P47, DOI 10.1111/tra.12019; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Boskovski MT, 2013, NATURE, V504, P456, DOI 10.1038/nature12723; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Brooks SA, 2007, ACTA HISTOCHEM, V109, P273, DOI 10.1016/j.acthis.2007.02.009; Chefetz I, 2009, BBA-MOL BASIS DIS, V1792, P847, DOI 10.1016/j.bbadis.2008.10.008; Contessa JN, 2010, CLIN CANCER RES, V16, P3205, DOI 10.1158/1078-0432.CCR-09-3331; Fritz TA, 2006, J BIOL CHEM, V281, P8613, DOI 10.1074/jbc.M513590200; Gao Y, 2013, ONCOL LETT, V5, P113, DOI 10.3892/ol.2012.980; Gerken TA, 2013, J BIOL CHEM, V288, P19900, DOI 10.1074/jbc.M113.477877; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; Gill DJ, 2013, P NATL ACAD SCI USA, V110, pE3152, DOI 10.1073/pnas.1305269110; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kitada S, 2013, BRIT J CANCER, V109, P472, DOI 10.1038/bjc.2013.331; Kohsaki T, 2000, J GASTROENTEROL, V35, P840, DOI 10.1007/s005350070021; Losfeld ME, 2012, FASEB J, V26, P4210, DOI 10.1096/fj.12-211656; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Schjoldager KTBG, 2011, J BIOL CHEM, V286, P40122, DOI 10.1074/jbc.M111.287912; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Tagliabracci VS, 2014, P NATL ACAD SCI USA, V111, P5520, DOI 10.1073/pnas.1402218111; van der Post S, 2013, J BIOL CHEM, V288, P14636, DOI 10.1074/jbc.M113.459479; Wandall HH, 2007, GLYCOBIOLOGY, V17, P374, DOI 10.1093/glycob/cwl082; Yoshimura Y, 2012, GLYCOBIOLOGY, V22, P429, DOI 10.1093/glycob/cwr159	34	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30556	30566		10.1074/jbc.M114.599563	http://dx.doi.org/10.1074/jbc.M114.599563			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25225288	Green Published, hybrid			2022-12-28	WOS:000344549700033
J	Papareddy, P; Kalle, M; Bhongir, RKV; Morgelin, M; Malmsten, M; Schmidtchen, A				Papareddy, Praveen; Kalle, Martina; Bhongir, Ravi K. V.; Moergelin, Matthias; Malmsten, Martin; Schmidtchen, Artur			Antimicrobial Effects of Helix D-derived Peptides of Human Antithrombin III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antithrombin (AT); Bacteria; Heparin; Membrane; Sepsis; Antimicrobial; Antithrombin iii; Peptide	HEPARIN-BINDING PEPTIDES; INFLAMMATORY RESPONSE; ENDOTHELIAL-CELLS; SEVERE SEPSIS; TISSUE FACTOR; SEPTIC SHOCK; ACTIVATION; INHIBITOR; PROTEIN; LL-37	Background: Antithrombin III (ATIII), an antiproteinase-inhibiting coagulation, was investigated for roles in host defense. Results: Extensive proteolysis of ATIII by endogenous and bacterial enzymes generated antimicrobial activity, mapped to helix D of the molecule. Conclusion: ATIII harbor cryptic host defense epitopes released during proteolysis. Significance: The results explain previously observed antimicrobial and anti-inflammatory effects of ATIII supplementation during infection. Antithrombin III (ATIII) is a key antiproteinase involved in blood coagulation. Previous investigations have shown that ATIII is degraded by Staphylococcus aureus V8 protease, leading to release of heparin binding fragments derived from its D helix. As heparin binding and antimicrobial activity of peptides frequently overlap, we here set out to explore possible antibacterial effects of intact and degraded ATIII. In contrast to intact ATIII, the results showed that extensive degradation of the molecule yielded fragments with antimicrobial activity. Correspondingly, the heparin-binding, helix d-derived, peptide FFFAKLNCRLYRKANKSSKLV (FFF21) of human ATIII, was found to be antimicrobial against particularly the Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa. Fluorescence microscopy and electron microscopy studies demonstrated that FFF21 binds to and permeabilizes bacterial membranes. Analogously, FFF21 was found to induce membrane leakage of model anionic liposomes. In vivo, FFF21 significantly reduced P. aeruginosa infection in mice. Additionally, FFF21 displayed anti-endotoxic effects in vitro. Taken together, our results suggest novel roles for ATIII-derived peptide fragments in host defense.	[Papareddy, Praveen; Kalle, Martina; Schmidtchen, Artur] Lund Univ, Biomed Ctr, Dept Clin Sci, Div Dermatol & Venereol, SE-22184 Lund, Sweden; [Papareddy, Praveen; Bhongir, Ravi K. V.; Moergelin, Matthias] Lund Univ, Biomed Ctr, Dept Clin Sci, Div Infect Med, SE-22184 Lund, Sweden; [Malmsten, Martin] Uppsala Univ, Dept Pharm, SE-75123 Uppsala, Sweden; [Schmidtchen, Artur] Nanyang Technol Univ, LKCMed, Singapore 308232, Singapore	Lund University; Lund University; Uppsala University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Papareddy, P (corresponding author), Lund Univ, Dept Clin Sci, BMC, B14,Tornavagen 10, S-22184 Lund, Sweden.	praveen.papareddy@med.lu.se	Schmidtchen, Artur/F-9507-2015; Bhongir, Ravi Kiran Varma/E-4514-2015	Bhongir, Ravi Kiran Varma/0000-0001-6648-1781; Papareddy, Praveen/0000-0002-3872-478X	Swedish Research Council [2012-1842, 2012-1883]; Knut and Alice Wallenberg Foundation; Welander-Finsen Foundation; Torsten Soderberg Foundation; Thelma-Zoegas Foundation; Crafoord Foundation; Alfred Osterlund Foundation; Kock Foundation; Swedish Government Funds for Clinical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Welander-Finsen Foundation; Torsten Soderberg Foundation; Thelma-Zoegas Foundation; Crafoord Foundation; Alfred Osterlund Foundation; Kock Foundation; Swedish Government Funds for Clinical Research	This work was supported by grants from the Swedish Research Council (Projects 2012-1842 and 2012-1883), the Knut and Alice Wallenberg Foundation, the Welander-Finsen, Torsten Soderberg, Thelma-Zoegas, Crafoord, Alfred Osterlund, and Kock Foundations, and The Swedish Government Funds for Clinical Research. Drs. Schmidtchen and Malmsten have shares in XImmune AB, a company involved in the therapeutic development of peptides for systemic use.	Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Baudo F, 1998, INTENS CARE MED, V24, P336, DOI 10.1007/s001340050576; BLAJCHMAN MA, 1994, BLOOD COAGUL FIBRIN, V5, pS5, DOI 10.1097/00001721-199401000-00002; Duensing TD, 1999, INFECT IMMUN, V67, P4463, DOI 10.1128/IAI.67.9.4463-4468.1999; Dunzendorfer S, 2001, BLOOD, V97, P1079, DOI 10.1182/blood.V97.4.1079; Fourrier F, 1998, BLOOD COAGUL FIBRIN, V9, pS39; FOURRIER F, 1995, INTENS CARE MED, V21, pS264, DOI 10.1007/BF01740765; FOURRIER F, 1992, CHEST, V101, P816, DOI 10.1378/chest.101.3.816; Ganz T, 2001, Semin Respir Infect, V16, P4; Giudici D, 1999, HAEMATOLOGICA, V84, P452; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Hoffmann JN, 2000, SHOCK, V14, P528, DOI 10.1097/00024382-200014050-00006; Hofstra JJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8040; Inthorn D, 1998, SHOCK, V10, P90, DOI 10.1097/00024382-199808000-00002; Jenssen H, 2010, METHODS MOL BIOL, V618, P329, DOI 10.1007/978-1-60761-594-1_20; Kalle M, 2013, J IMMUNOL, V190, P6303, DOI 10.4049/jimmunol.1203030; KUROSE I, 1994, THROMB HAEMOSTASIS, V71, P119; LIU CS, 1987, EUR J BIOCHEM, V167, P247, DOI 10.1111/j.1432-1033.1987.tb13330.x; Lundqvist K, 2004, THROMB HAEMOSTASIS, V92, P281, DOI 10.1160/TH03-12-0732; Malmsten M, 2006, MATRIX BIOL, V25, P294, DOI 10.1016/j.matbio.2006.04.003; Malmsten M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016400; Minnema MC, 2000, BLOOD, V95, P1117, DOI 10.1182/blood.V95.4.1117.002k12_1117_1123; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Mookherjee N, 2009, J IMMUNOL, V183, P2688, DOI 10.4049/jimmunol.0802586; Munoz EM, 2004, ARTERIOSCL THROM VAS, V24, P1549, DOI 10.1161/01.ATV.0000137189.22999.3f; Nijnik A, 2010, J IMMUNOL, V184, P2539, DOI 10.4049/jimmunol.0901813; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Nordahl EA, 2005, J BIOL CHEM, V280, P34832, DOI 10.1074/jbc.M507249200; Oehlschlager S, 2002, LUMINESCENCE, V17, P130, DOI 10.1002/bio.675; Oelschlager C, 2002, BLOOD, V99, P4015, DOI 10.1182/blood.V99.11.4015; Onoue S, 2003, LIFE SCI, V73, P2793, DOI 10.1016/S0024-3205(03)00705-7; Opal SM, 2003, SCAND J INFECT DIS, V35, P545, DOI 10.1080/00365540310015638; Ostermann H, 2002, Minerva Anestesiol, V68, P445; Papareddy P, 2010, J BIOL CHEM, V285, P28387, DOI 10.1074/jbc.M110.127019; Papareddy P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000857; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007358; PICARD V, 1995, BIOCHEMISTRY-US, V34, P8433, DOI 10.1021/bi00026a026; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; Roemisch J, 2002, BLOOD COAGUL FIBRIN, V13, P657, DOI 10.1097/00001721-200212000-00001; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Rydengard V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000116; Schmidtchen A, 2000, ACTA DERM-VENEREOL, V80, P179, DOI 10.1080/000155500750042925; Sjogren H, 2005, BIOPHYS CHEM, V116, P11, DOI 10.1016/j.bpc.2005.01.007; SMITH JW, 1987, J BIOL CHEM, V262, P11964; Souter PJ, 2001, CRIT CARE MED, V29, P134, DOI 10.1097/00003246-200101000-00027; Steinstraesser L, 2011, IMMUNOBIOLOGY, V216, P322, DOI 10.1016/j.imbio.2010.07.003; Tanaka KA, 2007, HEMATOL ONCOL CLIN N, V21, P33, DOI 10.1016/j.hoc.2006.11.008; van der Does AM, 2010, J IMMUNOL, V185, P1442, DOI 10.4049/jimmunol.1000376; Wang YQ, 1998, J BIOL CHEM, V273, P33115, DOI 10.1074/jbc.273.50.33115; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Yang LK, 2014, THROMB HAEMOSTASIS, V112, P164, DOI 10.1160/TH13-12-1029	51	16	19	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29790	29800		10.1074/jbc.M114.570465	http://dx.doi.org/10.1074/jbc.M114.570465			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25202017	Green Accepted, Green Submitted, hybrid, Green Published			2022-12-28	WOS:000344370800025
J	Chakraborty, S; Das, K; Saha, S; Mazumdar, M; Manna, A; Chakraborty, S; Mukherjee, S; Khan, P; Adhikary, A; Mohanty, S; Chattopadhyay, S; Biswas, SC; Sa, G; Das, T				Chakraborty, Samik; Das, Kaushik; Saha, Shilpi; Mazumdar, Minakshi; Manna, Argha; Chakraborty, Sreeparna; Mukherjee, Shravanti; Khan, Poulami; Adhikary, Arghya; Mohanty, Suchismita; Chattopadhyay, Samit; Biswas, Subhash C.; Sa, Gaurisankar; Das, Tanya			Nuclear Matrix Protein SMAR1 Represses c-Fos-mediated HPV18 E6 Transcription through Alteration of Chromatin Histone Deacetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CERVICAL-CANCER CELLS; APOPTOTIC PATHWAY; UTERINE CERVIX; BREAST-CANCER; GENE-PRODUCT; CROSS-TALK; P53; DNA; ADENOCARCINOMA	Matrix attachment region (MAR)-binding proteins have been implicated in the transcriptional regulation of host as well as viral genes, but their precise role in HPV-infected cervical cancer remains unclear. Here we show that HPV18 promoter contains consensus MAR element in the LCR and E6 sequences where SMAR1 binds and reinforces HPV18 E6 transcriptional silencing. In fact, curcumin-induced up-regulation of SMAR1 ensures recruitment ofSMAR1-HDAC1 repressor complex at the LCR and E6 MAR sequences, thereby decreasing histone acetylation at H3K9 and H3K18, leading to reorientation of the chromatin. As a consequence, c-Fos binding at the putative AP-1 sites on E6 promoter is inhibited. E6 depletion interrupts degradation of E6-mediated p53 and lysine acetyl transferase, Tip60. Tip60, in turn, acetylates p53, thereby restoring p53-mediated transactivation of proapoptotic genes to ensure apoptosis. This hitherto unexplained function of SMAR1 signifies the potential of this unique scaffold matrix-associated region-binding protein as a critical regulator of E6-mediated anti-apoptotic network in HPV18-infected cervical adenocarcinoma. These results also justify the candidature of curcumin for the treatment of HPV18-infected cervical carcinoma.	[Chakraborty, Samik; Das, Kaushik; Saha, Shilpi; Mazumdar, Minakshi; Manna, Argha; Chakraborty, Sreeparna; Mukherjee, Shravanti; Khan, Poulami; Adhikary, Arghya; Mohanty, Suchismita; Sa, Gaurisankar; Das, Tanya] Bose Inst, Div Mol Med, Kolkata 700054, W Bengal, India; [Chattopadhyay, Samit] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India; [Biswas, Subhash C.] SSKM Hosp, Inst Postgrad Med Educ & Res IPGMER, Dept Gynecol & Obstet, Kolkata 700020, W Bengal, India	Department of Science & Technology (India); Bose Institute; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Das, T (corresponding author), Bose Inst, Div Mol Med, P-1-12 CIT Scheme VIIM, Kolkata 700054, W Bengal, India.	tanya@jcbose.ac.in	Chakraborty, Samik/Q-1779-2018	Chakraborty, Samik/0000-0002-5232-0474	University Grants Commission (UGC); Department of Science and Technology (DST); Council of Scientific and Industrial Research (CSIR); Indian Council of Medical Research (ICMR); Department of Biotechnology (DBT) of government of India	University Grants Commission (UGC)(University Grants Commission, India); Department of Science and Technology (DST)(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Department of Biotechnology (DBT) of government of India(Department of Biotechnology (DBT) India)	This work was supported by the grants from University Grants Commission (UGC), Department of Science and Technology (DST), Council of Scientific and Industrial Research (CSIR), and Indian Council of Medical Research (ICMR) and by the Department of Biotechnology (DBT) postdoctoral fellowship program of the government of India.	Amortegui AJ, 1995, MODERN PATHOL, V8, P907; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Beaudenon S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S4; Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003; Chakraborty J, 2010, J BIOL CHEM, V285, P33104, DOI 10.1074/jbc.M110.122705; Charvet C, 2011, MOL CELL, V42, P584, DOI 10.1016/j.molcel.2011.03.033; Dar A, 2013, MOL CELL BIOL, V33, P3309, DOI 10.1128/MCB.00358-13; de Wilde J, 2008, CELL ONCOL, V30, P77; Ferguson AW, 1998, MODERN PATHOL, V11, P11; Jalota-Badhwar A, 2007, J BIOL CHEM, V282, P9902, DOI 10.1074/jbc.M608434200; Jha S, 2010, MOL CELL, V38, P700, DOI 10.1016/j.molcel.2010.05.020; Kadamb R, 2013, EUR J CELL BIOL, V92, P237, DOI 10.1016/j.ejcb.2013.09.001; Kaul R, 2003, INT J CANCER, V103, P606, DOI 10.1002/ijc.10881; Kehrmann A, 2013, CANCER GENET-NY, V206, P279, DOI 10.1016/j.cancergen.2013.06.002; Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0; Kulkarni A, 2004, BIOCHEM BIOPH RES CO, V322, P672, DOI 10.1016/j.bbrc.2004.07.170; Li JJ, 1998, ONCOGENE, V16, P2711, DOI 10.1038/sj.onc.1201798; MacLaine NJ, 2008, J BIOL CHEM, V283, P28563, DOI 10.1074/jbc.M804433200; Mahata S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-39; Maher DM, 2011, MOL CARCINOGEN, V50, P47, DOI 10.1002/mc.20695; Malonia SK, 2011, BBA-REV CANCER, V1815, P1, DOI 10.1016/j.bbcan.2010.08.003; Mohanty S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.534; Narechania A, 2005, J VIROL, V79, P15503, DOI 10.1128/JVI.79.24.15503-15510.2005; PARAZZINI F, 1990, GYNECOL ONCOL, V39, P40, DOI 10.1016/0090-8258(90)90396-3; Rampalli S, 2005, MOL CELL BIOL, V25, P8415, DOI 10.1128/MCB.25.19.8415-8429.2005; Saha B, 2012, ONCOGENE, V31, P173, DOI 10.1038/onc.2011.234; Sen GS, 2011, J BIOL CHEM, V286, P42232, DOI 10.1074/jbc.M111.262295; Shukla S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067849; Singh AK, 2013, INTERDISCIP SCI, V5, P112, DOI 10.1007/s12539-013-0159-8; Singh K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000660; Sinha S, 2012, INT J BIOCHEM CELL B, V44, P46, DOI 10.1016/j.biocel.2011.10.020; Sinitsyna NN, 2010, TOXICOL APPL PHARM, V243, P275, DOI 10.1016/j.taap.2009.12.006; Sreenath K, 2010, VIROLOGY, V400, P76, DOI 10.1016/j.virol.2010.01.017; Stunkel W, 2000, J VIROL, V74, P2489, DOI 10.1128/JVI.74.6.2489-2501.2000; Subbaramaiah K, 2007, CANCER RES, V67, P3976, DOI 10.1158/0008-5472.CAN-06-4273; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tenti P, 1998, AM J PATHOL, V152, P1057; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Wang WM, 2011, J BIOL CHEM, V286, P40974, DOI 10.1074/jbc.M111.290874; YAMAKAWA Y, 1994, GYNECOL ONCOL, V53, P190, DOI 10.1006/gyno.1994.1114; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhang XH, 2004, MOL CELL BIOL, V24, P5106, DOI 10.1128/MCB.24.12.5106-5118.2004	43	24	24	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29074	29085		10.1074/jbc.M114.564872	http://dx.doi.org/10.1074/jbc.M114.564872			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25157104	hybrid, Green Published			2022-12-28	WOS:000344141000025
J	Modica, S; Cariello, M; Morgano, A; Gross, I; Vegliante, MC; Murzilli, S; Salvatore, L; Freund, JN; Sabba, C; Moschetta, A				Modica, Salvatore; Cariello, Marica; Morgano, Annalisa; Gross, Isabelle; Vegliante, Maria Carmela; Murzilli, Stefania; Salvatore, Lorena; Freund, Jean-Noel; Sabba, Carlo; Moschetta, Antonio			Transcriptional Regulation of the Intestinal Nuclear Bile Acid Farnesoid X Receptor (FXR) by the caudal-related Homeobox 2 (CDX2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUTE TRANSPORTER-ALPHA; ACTIVATED PROTEIN-KINASE; COLON-CANCER CELLS; COLORECTAL-CANCER; MUTANT MICE; GENE CDX2; CHROMOSOMAL INSTABILITY; EXPRESSION; DIFFERENTIATION; BETA	Farnesoid X receptor (FXR, NR1H4) is a bile acid-activated transcription factor that belongs to the nuclear receptor superfamily. It is highly expressed in the enterohepatic system, where it senses bile acid levels to consequently reduce their synthesis while inducing their detoxification. Bile acids are intestinal tumor promoters and their concentrations have to be tightly regulated. Indeed, reduced expression of FXR in the intestine increases colorectal cancer susceptibility in mice, whereas its activation can promote apoptosis in genetically modified cells. Notably, despite the broad knowledge of the FXR enterohepatic transcriptional activity, the molecular mechanisms regulating FXR expression in the intestine are still unknown. Herein, by combining both gain and loss of function approaches and FXR promoter activity studies, we identified caudal-related homeobox 2 (CDX2) transcription factor as a positive regulator of FXR expression in the enterocytes. Our results provide a putative novel tool for modulating FXR expression against bile acid-related colorectal cancer progression.	[Modica, Salvatore; Sabba, Carlo; Moschetta, Antonio] Univ Bari, Dept Interdisciplinary Med, I-70124 Bari, Italy; [Modica, Salvatore; Cariello, Marica; Vegliante, Maria Carmela; Moschetta, Antonio] IRCCS Oncol Giovanni Paolo II, Natl Canc Res Ctr, I-70124 Bari, Italy; [Morgano, Annalisa; Murzilli, Stefania; Salvatore, Lorena] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Lab Lipid Metab & Canc, I-66030 Santa Maria Imbaro, Chieti, Italy; [Gross, Isabelle; Freund, Jean-Noel] INSERM, UMR S1113, F-67200 Strasbourg, France; [Gross, Isabelle; Freund, Jean-Noel] Univ Strasbourg, F-67081 Strasbourg, France	Universita degli Studi di Bari Aldo Moro; IRCCS Istituto Tumori Bari Giovanni Paolo II; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Moschetta, A (corresponding author), Univ Bari Aldo Moro, Dept Interdisciplinary Med, Clin Med Cesare Frugoni, Piazza Giulio Cesare 11, I-70124 Bari, Italy.	antonio.moschetta@uniba.it	Cariello, Marica/K-4064-2018; Vegliante, Maria Carmela/K-1732-2018; Gross, Isabelle/I-4972-2016; Vegliante, Maria Carmela/AAC-5888-2022; Moschetta, Antonio/K-6211-2016; Freund, Jean-Noel/R-4383-2016; Moschetta, Antonio/AAC-5295-2022; Gross, Isabelle/P-9859-2019	Vegliante, Maria Carmela/0000-0002-3165-1768; Gross, Isabelle/0000-0002-2783-8773; Vegliante, Maria Carmela/0000-0002-3165-1768; Freund, Jean-Noel/0000-0002-0971-3774; Gross, Isabelle/0000-0002-2783-8773; Sabba', Carlo/0000-0002-9874-8740; Moschetta, Antonio/0000-0003-2123-6074	Italian Association for Cancer Research (AIRC; Milan, Italy) [IG 14732]; Italian Ministry of University and Education (Finanziamenti per la Ricerca di Base IDEAS) [RBID08C9N7]; Italian Ministry of University and Education (Programma Operativo Nazionale) [PON01_01958]; Italian Ministry of University and Education (PRIN) [2010FHH32M_002]; Italian Ministry of Health [GR-2008-1143546, GR-2010-2314703]; Italian Ministry of Health (NR-Net Marie Curie ITN); University of Bari, Italy [ORBA 08WEZJ, 07X7Q1, 06BXVC, IDEA GRBA0802SJ]; CariSPAQ (L'Aquila, Italy)	Italian Association for Cancer Research (AIRC; Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Education (Finanziamenti per la Ricerca di Base IDEAS); Italian Ministry of University and Education (Programma Operativo Nazionale); Italian Ministry of University and Education (PRIN)(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Health (NR-Net Marie Curie ITN); University of Bari, Italy; CariSPAQ (L'Aquila, Italy)	This work was supported by Italian Association for Cancer Research (AIRC; Milan, Italy) Grant IG 14732 (to A. M.); the Italian Ministry of University and Education (Finanziamenti per la Ricerca di Base IDEAS RBID08C9N7 (to A. M., Programma Operativo Nazionale PON01_01958 (to A. M.), and PRIN 2010FHH32M_002 to (to A. M.)); Italian Ministry of Health Grants GR-2008-1143546 and GR-2010-2314703 (to A. M.); NR-Net Marie Curie ITN (to A. M.)); University of Bari, Italy, Grants ORBA 08WEZJ, 07X7Q1, 06BXVC, and IDEA GRBA0802SJ (to A. M.); and CariSPAQ (L'Aquila, Italy).	Aoki K, 2003, NAT GENET, V35, P323, DOI 10.1038/ng1265; Baba Y, 2009, CLIN CANCER RES, V15, P4665, DOI 10.1158/1078-0432.CCR-09-0401; Bai YQ, 2003, ONCOGENE, V22, P7942, DOI 10.1038/sj.onc.1206634; Beck F, 1999, P NATL ACAD SCI USA, V96, P7318, DOI 10.1073/pnas.96.13.7318; Bonhomme C, 2003, GUT, V52, P1465, DOI 10.1136/gut.52.10.1465; Brabletz T, 2004, CANCER RES, V64, P6973, DOI 10.1158/0008-5472.CAN-04-1132; CAMA A, 1995, HUM MUTAT, V5, P144, DOI 10.1002/humu.1380050208; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; da Costa LT, 1999, ONCOGENE, V18, P5010, DOI 10.1038/sj.onc.1202872; Dang DT, 2001, ONCOGENE, V20, P4884, DOI 10.1038/sj.onc.1204645; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Degirolamo C, 2011, TRENDS MOL MED, V17, P564, DOI 10.1016/j.molmed.2011.05.010; EE HC, 1995, AM J PATHOL, V147, P586; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Grober J, 1999, J BIOL CHEM, V274, P29749, DOI 10.1074/jbc.274.42.29749; Gross I, 2008, ONCOGENE, V27, P107, DOI 10.1038/sj.onc.1210601; Hinkel I, 2012, GASTROENTEROLOGY, V142, P875, DOI 10.1053/j.gastro.2011.12.037; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Houde M, 2001, J BIOL CHEM, V276, P21885, DOI 10.1074/jbc.M100236200; Huber RM, 2002, GENE, V290, P35, DOI 10.1016/S0378-1119(02)00557-7; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kazumori H, 2006, GUT, V55, P16, DOI 10.1136/gut.2005.066209; Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249; Landrier JF, 2006, AM J PHYSIOL-GASTR L, V290, pG476, DOI 10.1152/ajpgi.00430.2005; Lee H, 2006, J LIPID RES, V47, P201, DOI 10.1194/jlr.M500417-JLR200; Lorentz O, 1997, J CELL BIOL, V139, P1553, DOI 10.1083/jcb.139.6.1553; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Mallo GV, 1998, J BIOL CHEM, V273, P14030, DOI 10.1074/jbc.273.22.14030; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; Modica S, 2010, GASTROENTEROLOGY, V138, P636, DOI 10.1053/j.gastro.2009.09.060; Modica S, 2009, FRONT BIOSCI-LANDMRK, V14, P4719, DOI 10.2741/3563; Modica S, 2008, CANCER RES, V68, P9589, DOI 10.1158/0008-5472.CAN-08-1791; Otte K, 2003, MOL CELL BIOL, V23, P864, DOI 10.1128/MCB.23.3.864-872.2003; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Rings EHHM, 2001, GASTROENTEROLOGY, V121, P1437, DOI 10.1053/gast.2001.29618; Scholl C, 2007, J CLIN INVEST, V117, P1037, DOI 10.1172/JCI30182; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Stringer EJ, 2012, DEVELOPMENT, V139, P465, DOI 10.1242/dev.070722; Subtil C, 2007, CANCER LETT, V247, P197, DOI 10.1016/j.canlet.2006.04.004; Suh E, 1996, MOL CELL BIOL, V16, P619; Taupin D, 1999, GASTROENTEROLOGY, V116, P1072, DOI 10.1016/S0016-5085(99)70010-7; Thomas Maria A, 2007, Methods Mol Med, V130, P185; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Zhang YQ, 2003, J BIOL CHEM, V278, P104, DOI 10.1074/jbc.M209505200	50	10	10	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28421	28432		10.1074/jbc.M114.571513	http://dx.doi.org/10.1074/jbc.M114.571513			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25138215	Green Published, hybrid			2022-12-28	WOS:000343765400035
J	Verhamme, IM; Bock, PE				Verhamme, Ingrid M.; Bock, Paul E.			Rapid Binding of Plasminogen to Streptokinase in a Catalytic Complex Reveals a Three-step Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Fibrinolysis; Fluorescence; Kinetics; Plasmin; Streptokinase	DYSGALACTIAE SUBSP EQUISIMILIS; BLOOD-COAGULATION PROTEINASES; PEPTIDE CHLOROMETHYL KETONES; GLOBAL KINETIC EXPLORER; GROUP-A STREPTOCOCCI; ACTIVE-SITE; HIGH-AFFINITY; FLUORESCENCE PROBES; CONFORMATIONAL ACTIVATION; EQUIMOLAR COMPLEXES	Rapid kinetics demonstrate a three-step pathway of streptokinase (SK) binding to plasminogen (Pg), the zymogen of plasmin (Pm). Formation of a fluorescently silent encounter complex is followed by two conformational tightening steps reported by fluorescence quenches. Forward reactions were defined by time courses of biphasic quenching during complex formation between SK or its COOH-terminal Lys(414) deletion mutant (SKK414) and active site-labeled [Lys]Pg ([5-(acetamido)fluorescein]-d-Phe-Phe-Arg-[Lys]Pg ([5F]FFR-[Lys]Pg)) and by the SK dependences of the quench rates. Active site-blocked Pm rapidly displaced [5F]FFR-[Lys]Pg from the complex. The encounter and final SK[5F]FFR-[Lys]Pg complexes were weakened similarly by SK Lys(414) deletion and blocking of lysine-binding sites (LBSs) on Pg kringles with 6-aminohexanoic acid or benzamidine. Forward and reverse rates for both tightening steps were unaffected by 6-aminohexanoic acid, whereas benzamidine released constraints on the first conformational tightening. This indicated that binding of SK Lys(414) to Pg kringle 4 plays a role in recognition of Pg by SK. The substantially lower affinity of the final SKPg complex compared with SKPm is characterized by a approximate to 25-fold weaker encounter complex and approximate to 40-fold faster off-rates for the second conformational step. The results suggest that effective Pg encounter requires SK Lys(414) engagement and significant non-LBS interactions with the protease domain, whereas Pm binding additionally requires contributions of other lysines. This difference may be responsible for the lower affinity of the SKPg complex and the expression of a weaker pro-exosite for binding of a second Pg in the substrate mode compared with SKPm.	[Verhamme, Ingrid M.; Bock, Paul E.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University	Bock, PE (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Med Ctr North C3321A, Nashville, TN 37232 USA.	paul.bock@vanderbilt.edu			National Institutes of Health from the NHLBI [R01 HL056181]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056181] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL056181 from the NHLBI (to P. E. B.).	BAJAJ AP, 1977, J BIOL CHEM, V252, P492; Bean RR, 2005, J BIOL CHEM, V280, P7504, DOI 10.1074/jbc.M411637200; Bock PE, 1996, J BIOL CHEM, V271, P1072, DOI 10.1074/jbc.271.2.1072; BOCK PE, 1992, J BIOL CHEM, V267, P14963; BOCK PE, 1992, J BIOL CHEM, V267, P14974; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; BOK RA, 1985, BIOCHEMISTRY-US, V24, P3279, DOI 10.1021/bi00334a031; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Boxrud PD, 2000, BIOCHEMISTRY-US, V39, P13974, DOI 10.1021/bi000594i; Boxrud PD, 2004, J BIOL CHEM, V279, P36633, DOI 10.1074/jbc.M405264200; Boxrud PD, 2004, J BIOL CHEM, V279, P36642, DOI 10.1074/jbc.M405265200; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; Castellino FJ, 1997, CIBA F SYMP, V212, P46; Chang Y, 1998, BIOCHEMISTRY-US, V37, P3258, DOI 10.1021/bi972284e; CHRISTENSEN U, 1985, FEBS LETT, V182, P43, DOI 10.1016/0014-5793(85)81150-9; CHRISTENSEN U, 1992, BIOCHEM J, V285, P419, DOI 10.1042/bj2850419; CHRISTENSEN U, 1984, BIOCHEM J, V223, P413, DOI 10.1042/bj2230413; CLEMMENSEN I, 1986, EUR J BIOCHEM, V156, P327, DOI 10.1111/j.1432-1033.1986.tb09586.x; Cockell CS, 1998, BIOCHEM J, V333, P99, DOI 10.1042/bj3330099; COLLEN D, 1995, THROMB HAEMOSTASIS, V74, P167; Cook SM, 2014, BIOCHEM J, V458, P23, DOI 10.1042/BJ20131305; Cook SM, 2012, MOL MICROBIOL, V86, P1052, DOI 10.1111/mmi.12037; DAMASCHUN G, 1992, EUR BIOPHYS J BIOPHY, V20, P355; DAVIDSON DJ, 1990, BIOCHEMISTRY-US, V29, P3585, DOI 10.1021/bi00466a023; Deryugina EI, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/564259; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; HENKIN J, 1991, PROG CARDIOVASC DIS, V34, P135, DOI 10.1016/0033-0620(91)90010-J; Ho-Tin-Noe B, 2005, FEBS J, V272, P3387, DOI 10.1111/j.1742-4658.2005.04754.x; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; JACKSON KW, 1982, BIOCHEMISTRY-US, V21, P6620, DOI 10.1021/bi00269a001; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; Khil J, 2003, J INFECT DIS, V188, P497, DOI 10.1086/377100; Kroh HK, 2012, J BIOL CHEM, V287, P39149, DOI 10.1074/jbc.M112.415562; Laha M, 2011, ANAL BIOCHEM, V415, P105, DOI 10.1016/j.ab.2011.04.025; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; LERCH PG, 1980, EUR J BIOCHEM, V107, P7, DOI 10.1111/j.1432-1033.1980.tb04617.x; Lopardo HA, 2005, J CLIN MICROBIOL, V43, P802, DOI 10.1128/JCM.43.2.802-807.2005; LUCAS MA, 1983, J BIOL CHEM, V258, P4249; Malke H, 2004, INDIAN J MED RES, V119, P48; MANGEL WF, 1990, SCIENCE, V248, P69, DOI 10.1126/science.2108500; MARKUS G, 1978, J BIOL CHEM, V253, P727; MARSHALL JM, 1994, BIOCHEMISTRY-US, V33, P3599, DOI 10.1021/bi00178a017; Marti DN, 1997, BIOCHEMISTRY-US, V36, P11591, DOI 10.1021/bi971316v; MCCANCE SG, 1995, BIOCHEMISTRY-US, V34, P9581, DOI 10.1021/bi00029a035; MCCLINTOCK DK, 1971, BIOCHEM BIOPH RES CO, V43, P694, DOI 10.1016/0006-291X(71)90670-X; Nolan M, 2013, J BIOL CHEM, V288, P29482, DOI 10.1074/jbc.M113.477935; Panizzi P, 2006, J BIOL CHEM, V281, P1169, DOI 10.1074/jbc.M507955200; Panizzi P, 2006, J BIOL CHEM, V281, P26774, DOI 10.1074/jbc.C600171200; PONTING CP, 1992, BIOCHIM BIOPHYS ACTA, V1159, P155, DOI 10.1016/0167-4838(92)90020-E; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; Preziuso S, 2010, J VET SCI, V11, P67, DOI 10.4142/jvs.2010.11.1.67; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; Sanderson-Smith ML, 2006, J BIOL CHEM, V281, P25965, DOI 10.1074/jbc.M603846200; SCHICK LA, 1974, BIOCHEM BIOPH RES CO, V57, P47, DOI 10.1016/S0006-291X(74)80355-4; SJOHOLM I, 1973, EUR J BIOCHEM, V39, P471, DOI 10.1111/j.1432-1033.1973.tb03146.x; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; TAYLOR FB, 1968, BIOCHEMISTRY-US, V7, P232, DOI 10.1021/bi00841a028; THEWES T, 1990, J BIOL CHEM, V265, P3906; Tsodikov OV, 1999, BIOPHYS J, V76, P1320, DOI 10.1016/S0006-3495(99)77294-2; VALI Z, 1982, J BIOL CHEM, V257, P2104; VARADI A, 1981, BIOCHEM BIOPH RES CO, V103, P97, DOI 10.1016/0006-291X(81)91665-X; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; Verhamme IM, 2008, J BIOL CHEM, V283, P26137, DOI 10.1074/jbc.M804038200; VIOLAND BN, 1976, J BIOL CHEM, V251, P3906; VIOLAND BN, 1978, J BIOL CHEM, V253, P5395; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang SG, 2000, EUR J BIOCHEM, V267, P3994, DOI 10.1046/j.1432-1327.2000.01434.x; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; WEISEL JW, 1994, J MOL BIOL, V235, P1117, DOI 10.1006/jmbi.1994.1061; WIMAN B, 1979, BIOCHIM BIOPHYS ACTA, V579, P142, DOI 10.1016/0005-2795(79)90094-1; WOHL RC, 1980, J BIOL CHEM, V255, P2005; WOHL RC, 1978, J BIOL CHEM, V253, P1402; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	81	14	14	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					28006	28018		10.1074/jbc.M114.589077	http://dx.doi.org/10.1074/jbc.M114.589077			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25138220	Green Published, hybrid			2022-12-28	WOS:000342852800053
J	Park, SH; Kim, J; Do, KH; Park, J; Oh, CG; Choi, HJ; Song, BG; Lee, SJ; Kim, YS; Moon, Y				Park, Seong-Hwan; Kim, Juil; Do, Kee Hun; Park, Jiyeon; Oh, Chang Gyu; Choi, Hye Jin; Song, Bo Gyoung; Lee, Seung Joon; Kim, Yong Sik; Moon, Yuseok			Activating Transcription Factor 3-mediated Chemo-intervention with Cancer Chemokines in a Noncanonical Pathway under Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MESSENGER-RNA STABILITY; TNF-ALPHA; GENE-EXPRESSION; DOWN-REGULATION; PROTEIN-KINASE; RESPONSE GENE; UP-REGULATION; COLON-CANCER; CELLS	The cell-protective features of the endoplasmic reticulum (ER) stress response are chronically activated in vigorously growing malignant tumor cells, which provide cellular growth advantages over the adverse microenvironment including chemotherapy. As an intervention with ER stress responses in the intestinal cancer cells, preventive exposure to flavone apigenin potentiated superinduction of a regulatory transcription factor, activating transcription factor 3 (ATF3), which is also known to be an integral player coordinating ER stress response-related gene expression. ATF3 superinduction was due to increased turnover of ATF3 transcript via stabilization with HuR protein in the cancer cells under ER stress. Moreover, enhanced ATF3 caused inhibitory action against ER stress-induced cancer chemokines that are potent mediators determining the survival and metastatic potential of epithelial cancer cells. Although enhanced ATF3 was a negative regulator of the well known proinflammatory transcription factor NF-kappa B, blocking of NF-kappa B signaling did not affect ER stress-induced chemokine expression. Instead, immediately expressed transcription factor early growth response protein 1 (EGR-1) was positively involved in cancer chemokine induction by ER stressors. ER stress-induced EGR-1 and subsequent chemokine production were repressed by ATF3. Mechanistically, ATF3 directly interacted with and recruited HDAC1 protein, which led to epigenetic suppression of EGR-1 expression and subsequent chemokine production. Conclusively, super-induced ATF3 attenuated ER stress-induced cancer chemokine expression by epigenetically interfering with induction of EGR-1, a transcriptional modulator crucial to cancer chemokine production. Thus, these results suggest a potent therapeutic intervention of ER stress response-related cancer-favoring events by ATF3.	[Park, Seong-Hwan; Kim, Juil; Do, Kee Hun; Park, Jiyeon; Oh, Chang Gyu; Choi, Hye Jin; Song, Bo Gyoung; Lee, Seung Joon; Moon, Yuseok] Pusan Natl Univ, Sch Med, Dept Biomed Sci, Lab Mucosal Exposome & Biomodulat, Yangsan 626870, South Korea; [Park, Seong-Hwan; Moon, Yuseok] Pusan Natl Univ, Res Inst Basic Sci, Pusan 609735, South Korea; [Park, Seong-Hwan; Moon, Yuseok] Pusan Natl Univ, Med Res Inst, Pusan 609735, South Korea; [Kim, Yong Sik] Seoul Natl Univ, Dept Pharmacol, Coll Med, Seoul 110799, South Korea; [Moon, Yuseok] Immunoregulatory Therapeut Grp Brain Busan 21 Pro, Pusan 609735, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University; Seoul National University (SNU)	Moon, Y (corresponding author), Pusan Natl Univ, Sch Med, Dept Biomed Sci, Yangsan 626870, South Korea.	moon@pnu.edu	Yuseok Moon, ATS/AAE-4364-2020; KIM, Yong Sik/J-5418-2012	KIM, Yong Sik/0000-0003-3763-4544; MOON, YUSEOK/0000-0001-8686-8166	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2012R1A1A2005837]; Korean Health Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea [HI13C0259]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology; Korean Health Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by Ministry of Education, Science and Technology Grant 2012R1A1A2005837, and Grant HI13C0259 from the Korean Health Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea.	Ahmed MM, 1997, J BIOL CHEM, V272, P33056, DOI 10.1074/jbc.272.52.33056; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Bethel-Brown C, 2011, J IMMUNOL, V186, P4119, DOI 10.4049/jimmunol.1002235; Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508, DOI 10.1002/jlb.67.4.508; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; COLEMAN DL, 1992, J IMMUNOL, V149, P3045; Coope A, 2012, J BIOL CHEM, V287, P15580, DOI 10.1074/jbc.M111.315218; Cui MZ, 1996, J BIOL CHEM, V271, P2731, DOI 10.1074/jbc.271.5.2731; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Dieckgraefe BK, 1999, AM J PHYSIOL-GASTR L, V276, pG322, DOI 10.1152/ajpgi.1999.276.2.G322; Do KH, 2012, BIOCHEM PHARMACOL, V84, P513, DOI 10.1016/j.bcp.2012.05.015; Egan LJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1028, DOI 10.1152/ajpcell.00167.2003; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Goldberg JE, 2010, CURR DRUG TARGETS, V11, P1133; Hackl C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-668; Hershko DD, 2004, J CELL BIOCHEM, V91, P951, DOI 10.1002/jcb.20014; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Hollman PCH, 1999, FREE RADICAL RES, V31, pS75, DOI 10.1080/10715769900301351; Hua B, 2006, J BIOL CHEM, V281, P1620, DOI 10.1074/jbc.M508471200; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Jeong SH, 2010, EXP DERMATOL, V19, pE206, DOI 10.1111/j.1600-0625.2009.01050.x; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jiang QQ, 2000, J IMMUNOL, V165, P3541, DOI 10.4049/jimmunol.165.7.3541; Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200; Koh IU, 2010, FEBS J, V277, P2304, DOI 10.1111/j.1742-4658.2010.07646.x; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lefort EC, 2013, MOL NUTR FOOD RES, V57, P126, DOI 10.1002/mnfr.201200424; Li SG, 1997, TOXICOL APPL PHARM, V147, P331, DOI 10.1006/taap.1997.8279; Liang GS, 1996, J BIOL CHEM, V271, P1695, DOI 10.1074/jbc.271.3.1695; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu GB, 2012, J CELL MOL MED, V16, P1618, DOI 10.1111/j.1582-4934.2011.01401.x; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Martineti V, 2005, ENDOCR-RELAT CANCER, V12, P455, DOI 10.1677/erc.1.00861; Maru Yoshiro, 2011, Clin Calcium, V21, P364, DOI CliCa1103364371; Marwarha G, 2012, CELL SIGNAL, V24, P484, DOI 10.1016/j.cellsig.2011.09.029; Miean KH, 2001, J AGR FOOD CHEM, V49, P3106, DOI 10.1021/jf000892m; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Moon Y, 2007, BIOL PHARM BULL, V30, P1808, DOI 10.1248/bpb.30.1808; Niknejad N, 2014, INT J CANCER, V134, P268, DOI 10.1002/ijc.28369; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; Park SH, 2013, J IMMUNOL, V191, P5170, DOI 10.4049/jimmunol.1301145; Patel D, 2007, INT J ONCOL, V30, P233; Qin J, 2011, HEPATO-GASTROENTEROL, V58, P1951, DOI 10.5754/hge11352; Roger T, 1998, BBA-GENE STRUCT EXPR, V1398, P275, DOI 10.1016/S0167-4781(98)00075-X; Savidge TC, 2006, PEDIATR RES, V59, P89, DOI 10.1203/01.pdr.0000195101.74184.e3; Schonthal AH, 2013, BIOCHEM PHARMACOL, V85, P653, DOI 10.1016/j.bcp.2012.09.012; Schonthal Axel H, 2012, Front Biosci (Schol Ed), V4, P412; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Suganami T, 2009, CIRC RES, V105, P25, DOI 10.1161/CIRCRESAHA.109.196261; Verfaillie T, 2013, CANCER LETT, V332, P249, DOI 10.1016/j.canlet.2010.07.016; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Xu ZJ, 2001, J IMMUNOL, V167, P6975, DOI 10.4049/jimmunol.167.12.6975; Yang H, 2009, BIOCHEM PHARMACOL, V77, P1105, DOI 10.1016/j.bcp.2008.11.028; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Yuan XL, 2013, CANCER RES, V73, P3625, DOI 10.1158/0008-5472.CAN-12-3879	63	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27118	27133		10.1074/jbc.M114.568717	http://dx.doi.org/10.1074/jbc.M114.568717			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122760	Green Published, hybrid			2022-12-28	WOS:000342853900038
J	Muylaert, I; Zhao, ZY; Elias, P				Muylaert, Isabella; Zhao, Zhiyuan; Elias, Per			UL52 Primase Interactions in the Herpes Simplex Virus 1 Helicase-Primase Are Affected by Antiviral Compounds and Mutations Causing Drug Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; DNA HELICASE; UL8 PROTEIN; ACYCLOVIR; ORIGIN; POLYMERASE; MECHANISM; COMPLEX; REPLICATION; SUPERFAMILY	Herpes simplex virus 1 (HSV-1) UL5/8/52 helicase-primase complex is required for DNA unwinding at the replication fork and synthesis of primers during virus replication, and it has become a promising novel target for antiviral therapy. Using molecular cloning, we have identified three separate domains of UL52. Co-immunoprecipitation experiments in extracts from cells transiently expressing HA-tagged UL5, FLAG-UL8, and enhanced GFP-tagged UL52 domains revealed that the N-terminal domain of UL52 primase binds UL5 helicase and the middle domain interacts with the UL8 accessory protein. In addition, an interaction between the single strand DNA-binding protein ICP8 and the UL52 middle domain was observed. The complex between UL5 and UL52 was stabilized by the antiviral compound BAY 54-6322, and mutations providing resistance to the drug obliterate this effect. Our results also suggest a mechanism for accommodating conformational strain resulting from movement of UL5 and UL52 in opposite directions on the lagging strand template, and they identify molecular complexes that can be further examined by structural biology techniques to resolve the mechanism of primer synthesis during herpesvirus replication. Finally, they help to explain the mechanism of action of a novel class of antiviral compounds currently being evaluated in clinical trials.	[Muylaert, Isabella; Zhao, Zhiyuan; Elias, Per] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden	University of Gothenburg	Elias, P (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Box 440, SE-40530 Gothenburg, Sweden.	per.elias@medkem.gu.se	Zhao, Zhiyuan/Q-9330-2018	Zhao, Zhiyuan/0000-0002-6962-1791	Swedish Cancer Foundation [13 0495]	Swedish Cancer Foundation	This work was supported by Grant 13 0495 from the Swedish Cancer Foundation.	Aslani A, 2002, J BIOL CHEM, V277, P41204, DOI 10.1074/jbc.M208270200; Biswas N, 1999, J BIOL CHEM, V274, P8068, DOI 10.1074/jbc.274.12.8068; Biswas S, 2008, J ANTIMICROB CHEMOTH, V61, P1044, DOI 10.1093/jac/dkn057; CALDER JM, 1990, NUCLEIC ACIDS RES, V18, P3573, DOI 10.1093/nar/18.12.3573; Cavanaugh NA, 2009, BIOCHEMISTRY-US, V48, P10199, DOI 10.1021/bi9010144; Chen Y, 2005, J VIROL, V79, P9088, DOI 10.1128/JVI.79.14.9088-9096.2005; Chono K, 2012, BIOCHEM PHARMACOL, V84, P459, DOI 10.1016/j.bcp.2012.05.020; Constantin N, 1999, J GEN VIROL, V80, P2411, DOI 10.1099/0022-1317-80-9-2411; CRUTE JJ, 1988, NUCLEIC ACIDS RES, V16, P6585, DOI 10.1093/nar/16.14.6585; CRUTE JJ, 1989, P NATL ACAD SCI USA, V86, P2186, DOI 10.1073/pnas.86.7.2186; Danve-Szatanek C, 2004, J CLIN MICROBIOL, V42, P242, DOI 10.1128/JCM.42.1.242-249.2004; DODSON MS, 1991, P NATL ACAD SCI USA, V88, P1105, DOI 10.1073/pnas.88.4.1105; ELION GB, 1993, J MED VIROL, P2; ELION GB, 1983, J ANTIMICROB CHEMOTH, V12, P9, DOI 10.1093/jac/12.suppl_B.9; Falkenberg M, 1997, J BIOL CHEM, V272, P22766, DOI 10.1074/jbc.272.36.22766; Falkenberg M, 2000, P NATL ACAD SCI USA, V97, P3896, DOI 10.1073/pnas.97.8.3896; Hanes JW, 2007, J BIOL CHEM, V282, P25159, DOI 10.1074/jbc.M703972200; HODGMAN TC, 1988, NATURE, V333, P22, DOI 10.1038/333022b0; Iyer LM, 2005, NUCLEIC ACIDS RES, V33, P3875, DOI 10.1093/nar/gki702; Kazlauskas D, 2014, BIOINFORMATICS, V30, P2093, DOI 10.1093/bioinformatics/btu204; Kleymann G, 2002, NAT MED, V8, P392, DOI 10.1038/nm0402-392; Muylaert I, 2012, J BIOL CHEM, V287, P33142, DOI 10.1074/jbc.M112.356782; Muylaert I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.R111.233981; ODONNELL ME, 1987, J BIOL CHEM, V262, P4260; REARDON JE, 1989, J BIOL CHEM, V264, P7405; STOW ND, 1993, VIROLOGY, V196, P413, DOI 10.1006/viro.1993.1496; Stranska R, 2005, J CLIN VIROL, V32, P7, DOI 10.1016/j.jcv.2004.04.002; Wald A, 2014, NEW ENGL J MED, V370, P201, DOI 10.1056/NEJMoa1301150; Weller SK, 2013, EXPERT OPIN THER TAR, V17, P1119, DOI 10.1517/14728222.2013.827663; WU CA, 1988, J VIROL, V62, P435, DOI 10.1128/JVI.62.2.435-443.1988; ZHU L, 1992, J VIROL, V66, P469, DOI 10.1128/JVI.66.1.469-479.1992	31	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.609453	http://dx.doi.org/10.1074/jbc.M114.609453			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25278021	Green Published, hybrid			2022-12-28	WOS:000345335000017
J	Chen, L; Madura, K				Chen, Li; Madura, Kiran			Yeast Importin-alpha (Srp1) Performs Distinct Roles in the Import of Nuclear Proteins and in Targeting Proteasomes to the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Proteasome; Protein Sorting; Protein Stability; Proteolysis; Ubiquitin-dependent Protease	NUCLEOTIDE EXCISION-REPAIR; SACCHAROMYCES-CEREVISIAE; KARYOPHERIN-ALPHA; LOCALIZATION SIGNAL; PORE COMPLEX; CELL-CYCLE; IN-VIVO; UBIQUITIN/PROTEASOME PATHWAY; TRANSCRIPTIONAL REGULATOR; 26S PROTEASOME	Srp1 (importin-) can translocate proteins that contain a nuclear localization signal (NLS) into the nucleus. The loss of Srp1 is lethal, although several temperature-sensitive mutants have been described. Among these mutants, srp1-31 displays the characteristic nuclear import defect of importin- mutants, whereas srp1-49 shows a defect in protein degradation. We characterized these and additional srp1 mutants to determine whether distinct mechanisms were required for intracellular proteolysis and the import of NLS-containing proteins. We determined that srp1 mutants that failed to import NLS-containing proteins (srp1-31 and srp1-55) successfully localized proteasomes to the nucleus. In contrast, srp1 mutants that did not target proteasomes to the nucleus (srp1-49 and srp1-E402Q) were able to import NLS-containing proteins. The proteasome targeting defect of specific srp1 mutants caused stabilization of nuclear substrates and overall accumulation of multiubiquitylated proteins. Co-expression of a member of each class of srp1 mutants corrected both the proteasome localization defect and the import of NLS-containing proteins. These findings indicate that the targeting of proteasomes to the nucleus occurs by a mechanism distinct from the Srp1-mediated import of nuclear proteins.	[Chen, Li; Madura, Kiran] Rutgers State Univ, Dept Pharmacol, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Madura, K (corresponding author), Rutgers State Univ, Dept Pharmacol, Robert Wood Johnson Med Sch, 683 Hoes Lane,SPH 383, Piscataway, NJ 08854 USA.	maduraki@rwjms.rutgers.edu			National Institutes of Health (NIH), NCI [CA083875]; NIH [GM104968]; NATIONAL CANCER INSTITUTE [R01CA083875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104968] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NCI, Grant CA083875 and NIH Grant GM104968 (to K. M.). K. M. is the Founding President and CEO of CellXplore, Inc., which is characterizing the ubiquitin-proteasome system to develop diagnostic assays for human breast cancer; also an inventor on multiple patents.	Amrani N, 1996, MOL GEN GENET, V252, P552, DOI 10.1007/BF02172401; Bayliss R, 2000, TRAFFIC, V1, P448, DOI 10.1034/j.1600-0854.2000.010602.x; Blondel M, 2000, EMBO J, V19, P6085, DOI 10.1093/emboj/19.22.6085; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Chen L, 2014, GENETICS, V197, P193, DOI 10.1534/genetics.114.163824; Chen L, 2011, J BIOL CHEM, V286, P3104, DOI 10.1074/jbc.M110.135863; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; ENENKEL C, 1995, J BIOL CHEM, V270, P16499, DOI 10.1074/jbc.270.28.16499; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Garrenton LS, 2009, MOL CELL BIOL, V29, P582, DOI 10.1128/MCB.01019-08; Gilchrist D, 2002, J BIOL CHEM, V277, P18161, DOI 10.1074/jbc.M112306200; Gillette TG, 2001, GENE DEV, V15, P1528, DOI 10.1101/gad.869601; Harreman MT, 2003, J BIOL CHEM, V278, P21361, DOI 10.1074/jbc.M301114200; Harreman MT, 2003, J BIOL CHEM, V278, P5854, DOI 10.1074/jbc.M210951200; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Hood JK, 2001, J CELL SCI, V114, P589; HOUMAN F, 1994, MOL CELL BIOL, V14, P6350, DOI 10.1128/MCB.14.9.6350; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lahaye F, 2010, NUCLEIC ACIDS RES, V38, P3655, DOI 10.1093/nar/gkq098; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; Lenk U, 2000, J BIOL CHEM, V275, P39403, DOI 10.1074/jbc.M006949200; Leung SW, 2003, J BIOL CHEM, V278, P41947, DOI 10.1074/jbc.M307162200; LIANG S, 1993, EUR J CELL BIOL, V62, P270; LOEB JDJ, 1995, P NATL ACAD SCI USA, V92, P7647, DOI 10.1073/pnas.92.17.7647; Lommel L, 2002, CURR GENET, V42, P9, DOI 10.1007/s00294-002-0332-9; Miyamoto Y, 2002, EMBO J, V21, P5833, DOI 10.1093/emboj/cdf569; Moroianu J, 1996, P NATL ACAD SCI USA, V93, P6572, DOI 10.1073/pnas.93.13.6572; Niepel M, 2013, MOL BIOL CELL, V24, P3920, DOI 10.1091/mbc.E13-07-0412; Ortolan TG, 2004, NUCLEIC ACIDS RES, V32, P6490, DOI 10.1093/nar/gkh987; Pemberton LF, 1998, CURR OPIN CELL BIOL, V10, P392, DOI 10.1016/S0955-0674(98)80016-1; Pulliam KF, 2009, GENETICS, V181, P105, DOI 10.1534/genetics.108.097303; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Romero-Perez L, 2007, J BIOL CHEM, V282, P35574, DOI 10.1074/jbc.M704857200; Rubenstein EM, 2012, J CELL BIOL, V197, P761, DOI 10.1083/jcb.201203061; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; Ryan KJ, 2003, J CELL BIOL, V160, P1041, DOI 10.1083/jcb.200209116; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Scott CM, 2007, MOL BIOL CELL, V18, P3776, DOI 10.1091/mbc.E07-01-0034; Shulga N, 1996, J CELL BIOL, V135, P329, DOI 10.1083/jcb.135.2.329; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Tabb MM, 2000, MOL CELL BIOL, V20, P6062, DOI 10.1128/MCB.20.16.6062-6073.2000; Takeda K, 2005, CELL, V122, P393, DOI 10.1016/j.cell.2005.05.023; Takeda K, 2011, P NATL ACAD SCI USA, V108, P16950, DOI 10.1073/pnas.1103617108; Weberruss MH, 2013, EMBO J, V32, P2697, DOI 10.1038/emboj.2013.192; Wendler P, 2004, J BIOL CHEM, V279, P37751, DOI 10.1074/jbc.M403551200; Wu J, 2009, BIOPHYS J, V96, P3840, DOI 10.1016/j.bpj.2009.01.050; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; YANO R, 1994, P NATL ACAD SCI USA, V91, P6880, DOI 10.1073/pnas.91.15.6880; YANO R, 1992, MOL CELL BIOL, V12, P5640, DOI 10.1128/MCB.12.12.5640; Yasuhara N, 2013, DEV CELL, V26, P123, DOI 10.1016/j.devcel.2013.06.022; Young JC, 2013, BBA-MOL CELL RES, V1833, P2348, DOI 10.1016/j.bbamcr.2013.06.007	59	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32339	32352		10.1074/jbc.M114.582023	http://dx.doi.org/10.1074/jbc.M114.582023			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25274630	hybrid, Green Published			2022-12-28	WOS:000345314700058
J	Daka, JL; Achilonu, I; Dirr, HW				Daka, Jonathan L.; Achilonu, Ikechukwu; Dirr, Heini W.			The Isomerization of Delta(5)-Androstene-3,17-dione by the Human Glutathione Transferase A3-3 Proceeds via a Conjugated Heteroannular Diene Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Isotope Effect; Spectroscopy; Steroidogenesis; Thermodynamics; Androstene-3; 17-dione; Glutathione Transferase; Transition State; Intermediate	ENZYME-CATALYZED REACTIONS; MICROSCOPIC RATE CONSTANTS; STEROID ISOMERASE ACTIVITY; FREE-ENERGY PLOTS; 3-OXO-DELTA-5-STEROID ISOMERASE; CARBON ACIDS; ACTIVE-SITE; 3-OXO-DELTA(5)-STEROID ISOMERASE; DELTA-5-3-KETOSTEROID ISOMERASE; PROTON ABSTRACTION	The seemingly simple proton abstraction reactions underpin many chemical transformations, including isomerization reactions, and are thus of immense biological significance. Despite the energetic cost, enzyme-catalyzed proton abstraction reactions show remarkable rate enhancements. The pathways leading to these accelerated rates are numerous and on occasion partly enigmatic. The isomerization of the steroid (5)-androstene-3,17-dione by the glutathione transferase A3-3 in mammals was investigated to gain insight into the mechanism. Particular emphasis was placed on the nature of the transition state, the intermediate suspected of aiding this process, and the hydrogen bonds postulated to be the stabilizing forces of these transient species. The UV-visible detection of the intermediate places this species in the catalytic pathway, whereas fluorescence spectroscopy is used to obtain the binding constant of the analog intermediate, equilenin. Solvent isotope exchange reveals that proton abstraction from the substrate to form the intermediate is rate-limiting. Analysis of the data in terms of the Marcus formalism indicates that the human glutathione transferase A3-3 lowers the intrinsic kinetic barrier by 3 kcal/mol. The results lead to the conclusion that this reaction proceeds through an enforced concerted mechanism in which the barrier to product formation is kinetically insignificant.	[Daka, Jonathan L.; Achilonu, Ikechukwu; Dirr, Heini W.] Univ Witwatersrand, Sch Mol & Cell Biol, Prot Struct Funct Res Unit, ZA-2050 Johannesburg, South Africa	University of Witwatersrand	Dirr, HW (corresponding author), Univ Witwatersrand, Sch Mol & Cell Biol, Prot Struct Funct Res Unit, ZA-2050 Johannesburg, South Africa.	heinrich.dirr@wits.ac.za		Dirr, Heini/0000-0003-1455-7769	University of the Witwatersrand; South African National Research Foundation [60810, 65510, 68898]; South African Research Chairs Initiative of the Dept. of Science and Technology [64788]; National Research Foundation	University of the Witwatersrand; South African National Research Foundation(National Research Foundation - South Africa); South African Research Chairs Initiative of the Dept. of Science and Technology; National Research Foundation	This work was supported by the University of the Witwatersrand, Grants 60810, 65510, and 68898 from the South African National Research Foundation, and Grant 64788 from the South African Research Chairs Initiative of the Dept. of Science and Technology and National Research Foundation.	ALBERY WJ, 1980, ANNU REV PHYS CHEM, V31, P227, DOI 10.1146/annurev.pc.31.100180.001303; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; BENSON AM, 1977, P NATL ACAD SCI USA, V74, P158, DOI 10.1073/pnas.74.1.158; BENSON AM, 1976, BIOCHEM BIOPH RES CO, V69, P1073, DOI 10.1016/0006-291X(76)90482-4; BERNASCONI CF, 1992, ACCOUNTS CHEM RES, V25, P9, DOI 10.1021/ar00013a002; BEVINS CL, 1986, BIOCHEMISTRY-US, V25, P5159, DOI 10.1021/bi00366a026; BLADON P, 1952, J CHEM SOC, P2737, DOI 10.1039/jr9520002737; Caccuri AM, 1999, BIOCHEM J, V344, P419, DOI 10.1042/0264-6021:3440419; Calvaresi M, 2012, ACS CATAL, V2, P280, DOI 10.1021/cs200369b; CHIANG Y, 1991, SCIENCE, V253, P395, DOI 10.1126/science.253.5018.395; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; COHEN AO, 1968, J PHYS CHEM-US, V72, P4249, DOI 10.1021/j100858a052; Dalby KN, 1997, J CHEM SOC PERK T 2, P1555, DOI 10.1039/a700205j; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; DORFMAN L, 1953, CHEM REV, V53, P47, DOI 10.1021/cr60164a002; Dourado DFAR, 2014, J PHYS CHEM A, V118, P5790, DOI 10.1021/jp410810q; EAMES TCM, 1989, BIOCHEMISTRY-US, V28, P6269, DOI 10.1021/bi00441a019; GERLT JA, 1991, J AM CHEM SOC, V113, P9667, DOI 10.1021/ja00025a039; GERLT JA, 1993, BIOCHEMISTRY-US, V32, P11943, DOI 10.1021/bi00096a001; GERLT JA, 1992, J AM CHEM SOC, V114, P5928, DOI 10.1021/ja00041a004; Gu YJ, 2004, BIOCHEMISTRY-US, V43, P15673, DOI 10.1021/bi048757g; HAWKINSON DC, 1994, BIOCHEMISTRY-US, V33, P12172, DOI 10.1021/bi00206a021; HAWKINSON DC, 1991, BIOCHEMISTRY-US, V30, P10849, DOI 10.1021/bi00109a007; JENCKS WP, 1981, CHEM SOC REV, V10, P345, DOI 10.1039/cs9811000345; Johansson AS, 2001, J BIOL CHEM, V276, P33061, DOI 10.1074/jbc.M104539200; KULIOPULOS A, 1989, BIOCHEMISTRY-US, V28, P149, DOI 10.1021/bi00427a022; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Marcus RA, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2372496; MARCUS RA, 1969, J AM CHEM SOC, V91, P7224, DOI 10.1021/ja01054a003; Montgomery R., 1996, BIOCH CASE ORIENTED, P587; Pettersson PL, 2001, J BIOL CHEM, V276, P11698, DOI 10.1074/jbc.M009146200; POLLACK RM, 1989, J AM CHEM SOC, V111, P6419, DOI 10.1021/ja00198a066; SZAJEWSKI RP, 1980, J AM CHEM SOC, V102, P2011, DOI 10.1021/ja00526a042; TALALAY P, 1955, BIOCHIM BIOPHYS ACTA, V18, P300, DOI 10.1016/0006-3002(55)90079-2; Tars K, 2010, J MOL BIOL, V397, P332, DOI 10.1016/j.jmb.2010.01.023; TIAN XQ, 1993, J BIOL CHEM, V268, P14888; WANG SF, 1963, J BIOL CHEM, V238, P576; WILLIAMS A, 1994, CHEM SOC REV, V23, P93, DOI 10.1039/cs9942300093; Woodward R. B., 1941, J AM CHEM SOC, V63, P1123; Wu ZR, 1997, SCIENCE, V276, P415, DOI 10.1126/science.276.5311.415; Yao XD, 1999, J AM CHEM SOC, V121, P6220, DOI 10.1021/ja990070+; ZENG BF, 1992, BIOCHEMISTRY-US, V31, P1521, DOI 10.1021/bi00120a032; ZENG BF, 1991, J AM CHEM SOC, V113, P3838, DOI 10.1021/ja00010a028; ZHAO QJ, 1995, BIOCHEMISTRY-US, V34, P426, DOI 10.1021/bi00002a006	45	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32243	32252		10.1074/jbc.M114.601609	http://dx.doi.org/10.1074/jbc.M114.601609			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25248748	hybrid, Green Published			2022-12-28	WOS:000345314700050
J	Tiwari, A; Shivananda, S; Gopinath, KS; Kumar, A				Tiwari, Ankana; Shivananda, Swamy; Gopinath, Kodaganur S.; Kumar, Arun			RETRACTED: MicroRNA-125a Reduces Proliferation and Invasion of Oral Squamous Cell Carcinoma Cells by Targeting Estrogen-related Receptor alpha IMPLICATIONS FOR CANCER THERAPEUTICS (Retracted article. See vol. 294, pg. 5811, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication						Cancer Biology; Cell Proliferation; Head and Neck Squamous Cell Carcinoma; MicroRNA (miRNA); Post-transcriptional Regulation	ERR-ALPHA; GROWTH-FACTOR; MESENCHYMAL TRANSITION; EXPRESSION; MIR-125A; SUPPRESSOR; BIOMARKERS; REGULATOR; ERBB2	Estrogen-related receptor (ESRRA) functions as a transcription factor and regulates the expression of several genes, such as WNT11 and OPN. Up-regulation of ESRRA has been reported in several cancers. However, the mechanism underlying its up-regulation is unclear. Furthermore, the reports regarding the role and regulation of ESRRA in oral squamous cell carcinoma (OSCC) are completely lacking. Here, we show that tumor suppressor miR-125a directly binds to the 3UTR of ESRRA and represses its expression. Overexpression of miR-125a in OSCC cells drastically reduced the level of ESRRA, decreased cell proliferation, and increased apoptosis. Conversely, the delivery of an miR-125a inhibitor to these cells drastically increased the level of ESRRA, increased cell proliferation, and decreased apoptosis. miR-125a-mediated down-regulation of ESRRA impaired anchorage-independent colony formation and invasion of OSCC cells. Reduced cell proliferation and increased apoptosis of OSCC cells were dependent on the presence of the 3UTR in ESRRA. The delivery of an miR-125a mimic to OSCC cells resulted in marked regression of xenografts in nude mice, whereas the delivery of an miR-125a inhibitor to OSCC cells resulted in a significant increase of xenografts and abrogated the tumor suppressor function of miR-125a. We observed an inverse correlation between the expression levels of miR-125a and ESRRA in OSCC samples. In summary, up-regulation of ESRRA due to down-regulation of miR-125a is not only a novel mechanism for its up-regulation in OSCC, but decreasing the level of ESRRA by using a synthetic miR-125a mimic may have an important role in therapeutic intervention of OSCC and other cancers.	[Tiwari, Ankana; Kumar, Arun] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Shivananda, Swamy; Gopinath, Kodaganur S.] Bangalore Inst Oncol, Dept Surg, Bangalore 560027, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Kumar, A (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	karun@mrdg.iisc.ernet.in	Kumar, Arun/C-9149-2009	Kumar, Arun/0000-0001-8422-0219	Council of Scientific and Industrial Research (Government of India), New Delhi	Council of Scientific and Industrial Research (Government of India), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research (Government of India), New Delhi.	Ariazi EA, 2002, CANCER RES, V62, P6510; Ariazi EA, 2007, MOL CANCER RES, V5, P71, DOI 10.1158/1541-7786.MCR-06-0227; Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernatchez G, 2013, CARCINOGENESIS, V34, P2253, DOI 10.1093/carcin/bgt180; Bi Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040169; Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Bouchie A, 2013, NAT BIOTECHNOL, V31, P577, DOI 10.1038/nbt0713-577; Cavallini A, 2005, EUR J CANCER, V41, P1487, DOI 10.1016/j.ejca.2005.04.008; Chang CJ, 2011, ONCOL REP, V26, P1003, DOI 10.3892/or.2011.1360; Chaveroux C, 2013, CELL METAB, V17, P586, DOI 10.1016/j.cmet.2013.03.003; Cheung CP, 2005, J CLIN ENDOCR METAB, V90, P1830, DOI 10.1210/jc.2004-1421; Dahl KDC, 2009, NEOPLASIA, V11, P1208, DOI 10.1593/neo.09942; Deblois G, 2013, NAT REV CANCER, V13, P27, DOI 10.1038/nrc3396; Deblois G, 2010, CANCER RES, V70, P10277, DOI 10.1158/0008-5472.CAN-10-2840; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; Fisher KW, 2011, MOL CELL BIOL, V31, P2453, DOI 10.1128/MCB.05255-11; Fujimura T, 2007, INT J CANCER, V120, P2325, DOI 10.1002/ijc.22363; Gandhari MK, 2010, MOL CELL ENDOCRINOL, V315, P314, DOI 10.1016/j.mce.2009.10.001; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Guo X, 2009, RNA BIOL, V6, P575, DOI 10.4161/rna.6.5.10079; John K, 2013, INT J DENT, V2013, DOI 10.1155/2013/650218; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Laganiere J, 2004, J BIOL CHEM, V279, P18504, DOI 10.1074/jbc.M313543200; Lam SSN, 2014, MOL THER, V22, P743, DOI 10.1038/mt.2014.1; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Mori T, 2011, INT J GYNECOL CANCER, V21, P609, DOI 10.1097/IGC.0b013e3182017e9b; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nishida N, 2011, CLIN CANCER RES, V17, P2725, DOI 10.1158/1078-0432.CCR-10-2132; Ouko L, 2004, J BIOL CHEM, V279, P26707, DOI 10.1074/jbc.M402877200; Parisi S, 2012, FASEB J, V26, P3957, DOI 10.1096/fj.12-211607; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Pathare SM, 2011, ONCOL LETT, V2, P445, DOI 10.3892/ol.2011.271; Rather MI, 2013, J BIOL CHEM, V288, P608, DOI 10.1074/jbc.M112.425736; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Sharbati-Tehrani S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-34; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Sun PM, 2005, J MOL MED, V83, P457, DOI 10.1007/s00109-005-0639-3; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Tremblay Annie M, 2007, Nucl Recept Signal, V5, pe009, DOI 10.1621/nrs.05009; Ufkin ML, 2014, LEUKEMIA RES, V38, P402, DOI 10.1016/j.leukres.2013.12.021; Venkatesh T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054643; Wang GF, 2009, FEBS J, V276, P5571, DOI 10.1111/j.1742-4658.2009.07238.x; Wang J, 2010, CELL PROLIFERAT, V43, P103, DOI 10.1111/j.1365-2184.2009.00659.x; Wu F, 2009, CHEM-BIOL INTERACT, V181, P236, DOI 10.1016/j.cbi.2009.05.008; Wu XL, 2014, WORLD J GASTROENTERO, V20, P10440, DOI 10.3748/wjg.v20.i30.10440; Zhao YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039102	50	50	52	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32276	32290		10.1074/jbc.M114.584136	http://dx.doi.org/10.1074/jbc.M114.584136			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25266720	Green Published, hybrid			2022-12-28	WOS:000345314700053
J	Karkehabadi, S; Helmich, KE; Kaper, T; Hansson, H; Mikkelsen, NE; Gudmundsson, M; Piens, K; Fujdala, M; Banerjee, G; Scott-Craig, JS; Walton, JD; Phillips, GN; Sandgren, M				Karkehabadi, Saeid; Helmich, Kate E.; Kaper, Thijs; Hansson, Henrik; Mikkelsen, Nils-Egil; Gudmundsson, Mikael; Piens, Kathleen; Fujdala, Meredith; Banerjee, Goutami; Scott-Craig, John S.; Walton, Jonathan D.; Phillips, George N., Jr.; Sandgren, Mats			Biochemical Characterization and Crystal Structures of a Fungal Family 3 beta-Glucosidase, Cel3A from Hypocrea jecorina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING REGION; TRICHODERMA-REESEI; MACROMOLECULAR STRUCTURES; 3-DIMENSIONAL STRUCTURE; FUNCTIONAL EXPRESSION; STRUCTURE REFINEMENT; STRUCTURE VALIDATION; MAXIMUM-LIKELIHOOD; DIFFRACTION DATA; HYDROLASE	Cellulase mixtures from Hypocrea jecorina are commonly used for the saccharification of cellulose in biotechnical applications. The most abundant beta-glucosidase in the mesophilic fungus Hypocrea jecorina is HjCel3A, which hydrolyzes the beta-linkage between two adjacent molecules in dimers and short oligomers of glucose. It has been shown that enhanced levels of HjCel3A in H. jecorina cellulase mixtures benefit the conversion of cellulose to glucose. Biochemical characterization of HjCel3A shows that the enzyme efficiently hydrolyzes (1,4)-as well as (1,2)-, (1,3)-, and (1,6)-beta-D-linked disaccharides. For crystallization studies, HjCel3A was produced in both H. jecorina (HjCel3A) and Pichia pastoris (Pp-HjCel3A). Whereas the thermostabilities of HjCel3A and Pp-HjCel3A are the same, Pp-HjCel3A has a higher degree of N-linked glycosylation. Here, we present x-ray structures of HjCel3A with and without glucose bound in the active site. The structures have a three-domain architecture as observed previously for other glycoside hydrolase family 3 beta-glucosidases. Both production hosts resulted in HjCel3A structures that have N-linked glycosylations at Asn(208) and Asn(310). In H. jecorina-produced HjCel3A, a single N-acetylglucosamine is present at both sites, whereas in Pp-HjCel3A, the P. pastoris-produced HjCel3A enzyme, the glycan chains consist of 8 or 4 saccharides. The glycosylations are involved in intermolecular contacts in the structures derived from either host. Due to the different sizes of the glycosylations, the interactions result in different crystal forms for the two protein forms.	[Karkehabadi, Saeid; Hansson, Henrik; Mikkelsen, Nils-Egil; Gudmundsson, Mikael; Piens, Kathleen; Sandgren, Mats] Swedish Univ Agr Sci, Dept Chem & Biotechnol, SE-75007 Uppsala, Sweden; [Helmich, Kate E.; Phillips, George N., Jr.] Univ Wisconsin, Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Helmich, Kate E.; Phillips, George N., Jr.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Kaper, Thijs; Fujdala, Meredith] DuPont Ind Biosci, Palo Alto, CA 94304 USA; [Banerjee, Goutami; Scott-Craig, John S.; Walton, Jonathan D.] Michigan State Univ, Dept Energy, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Phillips, George N., Jr.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Phillips, George N., Jr.] Rice Univ, Dept Chem, Houston, TX 77251 USA	Swedish University of Agricultural Sciences; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Michigan State University; United States Department of Energy (DOE); Rice University; Rice University	Phillips, GN (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	georgep@rice.edu; mats.sandgren@slu.se		Sandgren, Mats/0000-0002-2358-4534; Hansson, Henrik/0000-0002-6003-2982; Gudmundsson, Mikael/0000-0002-8095-4423	Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences; United States Department of Energy Great Lakes Bioenergy Research Center (Department of Energy Office of Science Biological and Environmental Research (BER) [DE-FC02-07ER64494]	Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences; United States Department of Energy Great Lakes Bioenergy Research Center (Department of Energy Office of Science Biological and Environmental Research (BER)(United States Department of Energy (DOE))	This work was supported in part by the Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences through the research program "MicroDrivE." Work in the laboratories of J. D. W. and G. N. P. was supported by the United States Department of Energy Great Lakes Bioenergy Research Center (Department of Energy Office of Science Biological and Environmental Research (BER) Grant DE-FC02-07ER64494).	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Banerjee G, 2010, BIOTECHNOL BIOENG, V106, P707, DOI 10.1002/bit.22741; BARNETT CC, 1991, BIO-TECHNOL, V9, P562, DOI 10.1038/nbt0691-562; BEGUIN P, 1994, FEMS MICROBIOL REV, V13, P25, DOI 10.1016/0168-6445(94)90099-X; Bezerra RMF, 2006, APPL BIOCHEM BIOTECH, V134, P27, DOI 10.1385/ABAB:134:1:27; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CALLEBAUT I, 1994, J COMPUT AID MOL DES, V8, P175, DOI 10.1007/BF00119866; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHIRICO WJ, 1987, EUR J BIOCHEM, V165, P343, DOI 10.1111/j.1432-1033.1987.tb11447.x; CHIRICO WJ, 1987, EUR J BIOCHEM, V165, P333, DOI 10.1111/j.1432-1033.1987.tb11446.x; Collaborative Comuptational Project 4, 2002, ACTA CRYSTALLOGR D, V58, P1897; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Foreman P., 2005, International Patent, Patent No. [WO/2005/001036, 2005001036]; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Fujdala M. K., 2010, United States Patent, Patent No. [US2010/0221784A1, 20100221784]; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Gritzali M., 1979, HYDROLYSIS CELLULOSE, V181, P237, DOI DOI 10.1021/BA-1979-0181.CH012; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Hong J, 2007, APPL MICROBIOL BIOT, V73, P1331, DOI 10.1007/s00253-006-0618-9; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Hrmova M, 2005, BIOCHEMISTRY-US, V44, P16529, DOI 10.1021/bi0514818; HRMOVA M, 1995, J BIOL CHEM, V270, P14556, DOI 10.1074/jbc.270.24.14556; Hrmova M, 2004, J BIOL CHEM, V279, P4970, DOI 10.1074/jbc.M307188200; Hrmova M, 2002, PLANT CELL, V14, P1033, DOI 10.1105/tpc.010442; Hrmova M, 1998, J BIOL CHEM, V273, P11134, DOI 10.1074/jbc.273.18.11134; Jeoh T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-10; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kleywegt GJ, 1997, J MOL BIOL, V273, P371, DOI 10.1006/jmbi.1997.1309; Korotkova OG, 2009, BIOCHEMISTRY-MOSCOW+, V74, P569, DOI 10.1134/S0006297909050137; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krogh KBR, 2004, APPL BIOCHEM BIOTECH, V113, P389; Kumar R, 2009, BIOTECHNOL BIOENG, V102, P1544, DOI 10.1002/bit.22203; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liu DY, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-25; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; McAndrew RP, 2013, J BIOL CHEM, V288, P14985, DOI 10.1074/jbc.M113.458356; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Pozzo T, 2010, J MOL BIOL, V397, P724, DOI 10.1016/j.jmb.2010.01.072; Saloheimo M, 1997, EUR J BIOCHEM, V249, P584, DOI 10.1111/j.1432-1033.1997.00584.x; Salvi DA, 2010, APPL BIOCHEM BIOTECH, V161, P67, DOI 10.1007/s12010-010-8932-1; Schwarzinger S, 2002, BIOCHEMISTRY-US, V41, P12681, DOI 10.1021/bi020381o; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stubbs KA, 2007, J BIOL CHEM, V282, P21382, DOI 10.1074/jbc.M700084200; Suzuki K, 2013, BIOCHEM J, V452, P211, DOI 10.1042/BJ20130054; TEERI TT, 1987, GENE, V51, P43, DOI 10.1016/0378-1119(87)90472-0; Tengborg C, 2001, BIOTECHNOL PROGR, V17, P110, DOI 10.1021/bp000145+; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Vogel H.J., 1956, MICROB GENET B, V13, P42; WALSETH CS, 1952, TAPPI, V35, P228; Wildt S, 2005, NAT REV MICROBIOL, V3, P119, DOI 10.1038/nrmicro1087; WOOD TM, 1971, BIOCHEM J, V121, P353, DOI 10.1042/bj1210353; Yoshida E, 2010, BIOCHEM J, V431, P39, DOI 10.1042/BJ20100351; Zhang JW, 2010, BIORESOURCE TECHNOL, V101, P9815, DOI 10.1016/j.biortech.2010.07.078; Zverlov VV, 1997, MICROBIOL-SGM, V143, P3537, DOI 10.1099/00221287-143-11-3537	70	56	60	1	69	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31624	31637		10.1074/jbc.M114.587766	http://dx.doi.org/10.1074/jbc.M114.587766			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25164811	Green Published, hybrid			2022-12-28	WOS:000344549900062
J	Chen, PW; Luo, RB; Jian, XY; Randazzo, PA				Chen, Pei-Wen; Luo, Ruibai; Jian, Xiaoying; Randazzo, Paul A.			The Arf6 GTPase-activating Proteins ARAP2 and ACAP1 Define Distinct Endosomal Compartments That Regulate Integrin alpha 5 beta 1 Traffic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; RECEPTOR TRAFFICKING; ACTIN CYTOSKELETON; SORTING SIGNALS; COPI VESICLES; ADHESION; MEMBRANE; CLATHRIN; PHOSPHORYLATION; ENDOCYTOSIS	Arf6 and the Arf6 GTPase-activating protein (GAP) ACAP1 are established regulators of integrin traffic important to cell adhesion and migration. However, the function of Arf6 with ACAP1 cannot explain the range of Arf6 effects on integrin-based structures. We propose that Arf6 has different functions determined, in part, by the associated Arf GAP. We tested this idea by comparing the Arf6 GAPs ARAP2 and ACAP1. We found that ARAP2 and ACAP1 had opposing effects on apparent integrin beta 1 internalization. ARAP2 knockdown slowed, whereas ACAP1 knockdown accelerated, integrin beta 1 internalization. Integrin beta 1 association with adaptor protein containing a pleckstrin homology (PH) domain, phosphotyrosine-binding (PTB) domain, and leucine zipper motif (APPL)-positive endosomes and EEA1-positive endosomes was affected by ARAP2 knockdown and depended on ARAP2 GAP activity. ARAP2 formed a complex with APPL1 and colocalized with Arf6 and APPL in a compartment distinct from the Arf6/ACAP1 tubular recycling endosome. In addition, although ACAP1 and ARAP2 each colocalized with Arf6, they did not colocalize with each other and had opposing effects on focal adhesions (FAs). ARAP2 overexpression promoted large FAs, but ACAP1 overexpression reduced FAs. Taken together, the data support a model in which Arf6 has at least two sites of opposing action defined by distinct Arf6 GAPs.	[Chen, Pei-Wen; Luo, Ruibai; Jian, Xiaoying; Randazzo, Paul A.] NCI, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Randazzo, PA (corresponding author), NCI, Cellular & Mol Biol Lab, Bldg 37,Rm 2012, Bethesda, MD 20892 USA.	randazzp@mail.nih.gov	Chen, Pei-Wen/B-7142-2015		NCI, National Institutes of Health [BC 007365]; NATIONAL CANCER INSTITUTE [ZIABC007365] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural program of the NCI, National Institutes of Health (Project BC 007365).	Arjonen A, 2012, TRAFFIC, V13, P610, DOI 10.1111/j.1600-0854.2012.01327.x; Bai M, 2012, J BIOL CHEM, V287, P28675, DOI 10.1074/jbc.M112.378810; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Broussard JA, 2012, MOL BIOL CELL, V23, P1486, DOI 10.1091/mbc.E11-02-0124; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Campa F, 2009, J BIOL CHEM, V284, P28069, DOI 10.1074/jbc.M109.028266; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chaineau M, 2013, TRAFFIC, V14, P1109, DOI 10.1111/tra.12096; Chen PW, 2013, J BIOL CHEM, V288, P5849, DOI 10.1074/jbc.M112.415778; Chen PW, 2010, CELL ADHES MIGR, V4, P527, DOI 10.4161/cam.4.4.12399; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dai J, 2004, DEV CELL, V7, P771, DOI 10.1016/j.devcel.2004.10.002; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Dozynkiewicz MA, 2012, DEV CELL, V22, P131, DOI 10.1016/j.devcel.2011.11.008; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Goldberg J, 2000, CELL, V100, P671, DOI 10.1016/S0092-8674(00)80703-5; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Ha VL, 2008, ADV CANCER RES, V101, P1, DOI 10.1016/S0065-230X(08)00401-6; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Jackson TR, 2000, J CELL BIOL, V151, P627, DOI 10.1083/jcb.151.3.627; Jacquemet G, 2013, CURR OPIN CELL BIOL, V25, P627, DOI 10.1016/j.ceb.2013.05.008; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017; Li J, 2005, DEV CELL, V9, P663, DOI 10.1016/j.devcel.2005.09.012; Luo RB, 2007, BIOCHEM J, V402, P439, DOI 10.1042/BJ20061217; Maldonado-Baez Lymarie, 2013, Bioarchitecture, V3, P141, DOI 10.4161/bioa.26638; Maldonado-Baez L, 2013, EXP CELL RES, V319, P2759, DOI 10.1016/j.yexcr.2013.08.008; Maldonado-Baez L, 2013, J CELL BIOL, V201, P233, DOI 10.1083/jcb.201208172; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Moravec R, 2012, J BIOL CHEM, V287, P31138, DOI 10.1074/jbc.M112.383117; Morgan MR, 2013, DEV CELL, V24, P472, DOI 10.1016/j.devcel.2013.01.027; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Raaijmakers JH, 2007, CELL SIGNAL, V19, P1249, DOI 10.1016/j.cellsig.2006.12.015; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Sakurai A, 2011, J BIOL CHEM, V286, P34335, DOI 10.1074/jbc.M111.259499; Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09; Schuldt A, 2012, NAT REV MOL CELL BIO, V13, P1, DOI 10.1038/nrm3258; Shiba Y, 2013, CURR BIOL, V23, P1945, DOI 10.1016/j.cub.2013.07.087; Teckchandani A, 2009, J CELL BIOL, V186, P98, DOI 10.1083/jcb.200812160; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237	47	32	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30237	30248		10.1074/jbc.M114.596155	http://dx.doi.org/10.1074/jbc.M114.596155			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25225293	Green Published, hybrid			2022-12-28	WOS:000344549700008
J	Konigs, V; Jennings, R; Vogl, T; Horsthemke, M; Bachg, AC; Xu, Y; Grobe, K; Brakebusch, C; Schwab, A; Bahler, M; Knaus, UG; Hanley, PJ				Koenigs, Volker; Jennings, Richard; Vogl, Thomas; Horsthemke, Markus; Bachg, Anne C.; Xu, Yan; Grobe, Kay; Brakebusch, Cord; Schwab, Albrecht; Baehler, Martin; Knaus, Ulla G.; Hanley, Peter J.			Mouse Macrophages Completely Lacking Rho Subfamily GTPases (RhoA, RhoB, and RhoC) Have Severe Lamellipodial Retraction Defects, but Robust Chemotactic Navigation and Altered Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; FAMILY GTPASES; NEUTROPHIL MIGRATION; LEADING-EDGE; MYOSIN IXB; G-PROTEINS; ACTIVATION; POLARITY; ADHESION; SIGNALS	RhoA is thought to be essential for coordination of the membrane protrusions and retractions required for immune cell motility and directed migration. Whether the subfamily of Rho (Ras homolog) GTPases (RhoA, RhoB, and RhoC) is actually required for the directed migration of primary cells is difficult to predict. Macrophages isolated from myeloid-restricted RhoA/ RhoB (conditional) double knock-out (dKO) mice did not express RhoC and were essentially "pan-Rho"-deficient. Using real-time chemotaxis assays, we found that retraction of the trailing edge was dissociated from the advance of the cell body in dKO cells, which developed extremely elongated tails. Surprisingly, velocity (of the cell body) was increased, whereas chemotactic efficiency was preserved, when compared with WT macrophages. Randomly migrating RhoA/RhoB dKO macrophages exhibited multiple small protrusions and developed large "branches" due to impaired lamellipodial retraction. A mouse model of peritonitis indicated that monocyte/macrophage recruitment was, surprisingly, more rapid in RhoA/RhoB dKO mice than in WT mice. In comparison with dKO cells, the phenotypes of single RhoA-or RhoB-deficient macrophages were mild due to mutual compensation. Furthermore, genetic deletion of RhoB partially reversed the motility defect of macrophages lacking the RhoGAP (Rho GTPase-activating protein) myosin IXb (Myo9b). In conclusion, the Rho subfamily is not required for "front end" functions (motility and chemotaxis), although both RhoA and RhoB are involved in pulling up the "back end" and resorbing lamellipodial membrane protrusions. Macrophages lacking Rho proteins migrate faster in vitro, which, in the case of the peritoneum, translates to more rapid in vivo monocyte/macrophage recruitment.	[Koenigs, Volker; Horsthemke, Markus; Bachg, Anne C.; Xu, Yan; Baehler, Martin; Hanley, Peter J.] Univ Munster, Inst Mol Zellbiol, D-48149 Munster, Germany; [Jennings, Richard; Knaus, Ulla G.] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; [Vogl, Thomas] Univ Munster, Inst Immunol, D-48149 Munster, Germany; [Grobe, Kay] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Schwab, Albrecht] Univ Munster, Inst Physiol 2, D-48149 Munster, Germany; [Brakebusch, Cord] Univ Copenhagen, Biotech Res & Innovat Ctr BRIC, DK-2200 Copenhagen, Denmark	University of Munster; University College Dublin; University of Munster; University of Munster; University of Munster; University of Copenhagen	Hanley, PJ (corresponding author), Univ Munster, Inst Mol Zellbiol, D-48149 Munster, Germany.	hanley@uni-muenster.de	Grobe, Kay/F-2399-2011; Hanley, Peter J/H-4915-2017	Brakebusch, Cord/0000-0002-9342-1634	Cells in Motion (CiM) Cluster of Excellence; Deutsche Forschungsgemeinschaft (DFG) [HA 3271/3-1]; Health Research Board and Science Foundation Ireland	Cells in Motion (CiM) Cluster of Excellence; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Health Research Board and Science Foundation Ireland(Science Foundation Ireland)	This work was supported by the Cells in Motion (CiM) Cluster of Excellence, the Deutsche Forschungsgemeinschaft (DFG) Grant HA 3271/3-1 (to P. J. H.), and funding from the Health Research Board and Science Foundation Ireland (to U. G. K.).	ABERCROM.M, 1971, EXP CELL RES, V67, P359, DOI 10.1016/0014-4827(71)90420-4; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Eddy RJ, 2000, J CELL SCI, V113, P1287; Faust N, 2000, BLOOD, V96, P719; Footer MJ, 2007, P NATL ACAD SCI USA, V104, P2181, DOI 10.1073/pnas.0607052104; Gautier EL, 2013, BLOOD, V122, P2714, DOI 10.1182/blood-2013-01-478206; Goh Wah Ing, 2012, Commun Integr Biol, V5, P340, DOI 10.4161/cib.20214; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hanley PJ, 2010, P NATL ACAD SCI USA, V107, P12145, DOI 10.1073/pnas.0911986107; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Huang CH, 2013, NAT CELL BIOL, V15, P1307, DOI 10.1038/ncb2859; Jackson B, 2011, MOL BIOL CELL, V22, P593, DOI 10.1091/mbc.E09-10-0859; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kozasa T, 2011, J BIOCHEM, V150, P357, DOI 10.1093/jb/mvr105; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammers M, 2008, J BIOL CHEM, V283, P35236, DOI 10.1074/jbc.M805634200; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Melendez J, 2011, J BIOL CHEM, V286, P15132, DOI 10.1074/jbc.C111.229336; Pathak A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018423; Perez-Sala D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008117; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pestonjamasp KN, 2006, BLOOD, V108, P2814, DOI 10.1182/blood-2006-01-010363; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Reig G, 2014, DEVELOPMENT, V141, P1999, DOI 10.1242/dev.101451; Ridley AJ, 2013, J MICROSC-OXFORD, V251, P242, DOI 10.1111/jmi.12025; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Rougerie P, 2012, IMMUNOL LETT, V142, P1, DOI 10.1016/j.imlet.2011.12.003; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Thumkeo D, 2013, EUR J CELL BIOL, V92, P303, DOI 10.1016/j.ejcb.2013.09.002; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wheeler AP, 2007, EXP CELL RES, V313, P3505, DOI 10.1016/j.yexcr.2007.07.014; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Xu Y, 2014, J IMMUNOL, V192, P3559, DOI 10.4049/jimmunol.1300695; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; ZIGMOND SH, 1981, J CELL BIOL, V89, P585, DOI 10.1083/jcb.89.3.585	49	33	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30772	30784		10.1074/jbc.M114.563270	http://dx.doi.org/10.1074/jbc.M114.563270			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25213860	Green Published, hybrid			2022-12-28	WOS:000344549700052
J	Bajpai, P; Srinivasan, S; Ghosh, J; Nagy, LD; Wei, SZ; Guengerich, FP; Avadhani, NG				Bajpai, Prachi; Srinivasan, Satish; Ghosh, Jyotirmoy; Nagy, Leslie D.; Wei, Shouzou; Guengerich, F. Peter; Avadhani, Narayan G.			Targeting of Splice Variants of Human Cytochrome P450 2C8 (CYP2C8) to Mitochondria and Their Role in Arachidonic Acid Metabolism and Respiratory Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Arachidonic Acid (AA) (ARA); Cytochrome P450; Mitochondrial Respiratory Chain Complex; Mitochondrial Transport; Oxidative Stress; Splice Variant	ENDOPLASMIC-RETICULUM; MICROSOMAL CYTOCHROME-P450; EPOXYEICOSATRIENOIC ACIDS; MEDIATED PHOSPHORYLATION; LIVER-MICROSOMES; EXPRESSION; ACTIVATION; BINDING; PROTEIN; INHIBITORS	Background: Human CYP2C8 is involved in the metabolism of >20% of drugs on the market. Results: Both full-length (WT) CYP2C8 and splice variant 3 are bimodally targeted to mitochondria. Conclusion: Mitochondrial CYP2C8 metabolizes paclitaxel and arachidonic acid (-hydroxylation). Significance: Mitochondrial CYP2C8 is likely to play role in ischemic injury and oxidative stress. In this study, we found that the full-length CYP2C8 (WT CYP2C8) and N-terminal truncated splice variant 3 (approximate to 44-kDa mass) are localized in mitochondria in addition to the endoplasmic reticulum. Analysis of human livers showed that the mitochondrial levels of these two forms varied markedly. Molecular modeling based on the x-ray crystal structure coordinates of CYP2D6 and CYP2C8 showed that despite lacking the N-terminal 102 residues variant 3 possessed nearly complete substrate binding and heme binding pockets. Stable expression of cDNAs in HepG2 cells showed that the WT protein is mostly targeted to the endoplasmic reticulum and at low levels to mitochondria, whereas variant 3 is primarily targeted to mitochondria and at low levels to the endoplasmic reticulum. Enzyme reconstitution experiments showed that both microsomal and mitochondrial WT CYP2C8 efficiently catalyzed paclitaxel 6-hydroxylation. However, mitochondrial variant 3 was unable to catalyze this reaction possibly because of its inability to stabilize the large 854-Da substrate. Conversely, mitochondrial variant 3 catalyzed the metabolism of arachidonic acid into 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acids and 20-hydroxyeicosatetraenoic acid when reconstituted with adrenodoxin and adrenodoxin reductase. HepG2 cells stably expressing variant 3 generated higher levels of reactive oxygen species and showed a higher level of mitochondrial respiratory dysfunction. This study suggests that mitochondrially targeted variant 3 CYP2C8 may contribute to oxidative stress in various tissues.	[Bajpai, Prachi; Srinivasan, Satish; Ghosh, Jyotirmoy; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Bajpai, Prachi; Srinivasan, Satish; Ghosh, Jyotirmoy; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Nagy, Leslie D.; Wei, Shouzou; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Nagy, Leslie D.; Wei, Shouzou; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	University of Pennsylvania; University of Pennsylvania; Vanderbilt University; Vanderbilt University	Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	Narayan@vet.upenn.edu			National Institutes of Health [R01 GM34883, R37 CA090426, P01 DK038226]; Harriet Ellison Woodward Endowment; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harriet Ellison Woodward Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM34883 (to N. G. A.) and R37 CA090426 and P01 DK038226 (to F. P. G.). This work was also supported by the Harriet Ellison Woodward Endowment (to N. G. A.).	Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Anandatheerthavarada HK, 1997, ARCH BIOCHEM BIOPHYS, V339, P136, DOI 10.1006/abbi.1996.9855; Avadhani NG, 2011, FEBS J, V278, P4218, DOI 10.1111/j.1742-4658.2011.08356.x; Bahadur N, 2002, BIOCHEM PHARMACOL, V64, P1579, DOI 10.1016/S0006-2952(02)01354-0; Bansal S, 2014, J BIOL CHEM, V289, P9936, DOI 10.1074/jbc.M113.525659; Bansal S, 2013, J BIOL CHEM, V288, P12627, DOI 10.1074/jbc.M113.452367; Bhagwat SV, 1999, J BIOL CHEM, V274, P24014, DOI 10.1074/jbc.274.34.24014; BHAT NK, 1985, BIOCHEMISTRY-US, V24, P8107, DOI 10.1021/bi00348a041; Boopathi E, 2000, J BIOL CHEM, V275, P34415, DOI 10.1074/jbc.M004431200; Chen P, 2005, AM J PATHOL, V166, P615, DOI 10.1016/S0002-9440(10)62282-1; CLARK BJ, 1991, J BIOL CHEM, V266, P5898; Daily EB, 2009, PHARMACOGENOMICS, V10, P1489, DOI 10.2217/PGS.09.82; Dasari VR, 2006, J BIOL CHEM, V281, P30834, DOI 10.1074/jbc.M510725200; DeLozier TC, 2007, DRUG METAB DISPOS, V35, P682, DOI 10.1124/dmd.106.012823; Edin ML, 2011, FASEB J, V25, P3436, DOI 10.1096/fj.11-188300; Enayetallah AE, 2004, J HISTOCHEM CYTOCHEM, V52, P447, DOI 10.1177/002215540405200403; GASSER SM, 1982, J BIOL CHEM, V257, P3034; Granville DJ, 2004, P NATL ACAD SCI USA, V101, P1321, DOI 10.1073/pnas.0308185100; Guengerich FP, 1982, PRINCIPLES METHODS T, P609; Ishizuka T, 2008, J PHARMACOL EXP THER, V324, P103, DOI 10.1124/jpet.107.130336; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim DH, 2013, J LIPID RES, V54, P786, DOI 10.1194/jlr.M033894; Klein K, 2007, DRUG METAB DISPOS, V35, P1247, DOI 10.1124/dmd.107.015149; Klose TS, 1999, J BIOCHEM MOL TOXIC, V13, P289, DOI 10.1002/(SICI)1099-0461(1999)13:6<289::AID-JBT1>3.0.CO;2-N; Knupfer H, 2004, BREAST, V13, P28, DOI 10.1016/j.breast.2003.07.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lin FM, 1995, AM J PHYSIOL-RENAL, V269, pF806, DOI 10.1152/ajprenal.1995.269.6.F806; Lundblad MS, 2005, BIOCHEM BIOPH RES CO, V327, P1052, DOI 10.1016/j.bbrc.2004.12.116; Muthalif MM, 1998, P NATL ACAD SCI USA, V95, P12701, DOI 10.1073/pnas.95.21.12701; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Neve EPA, 2008, ANAL BIOANAL CHEM, V392, P1075, DOI 10.1007/s00216-008-2200-z; NIRANJAN BG, 1984, J BIOL CHEM, V259, P2495; Nishimura M, 2003, YAKUGAKU ZASSHI, V123, P369; OMURA T, 1964, J BIOL CHEM, V239, P2370; Omura T, 2006, CHEM-BIOL INTERACT, V163, P86, DOI 10.1016/j.cbi.2006.06.008; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; RAHMAN A, 1994, CANCER RES, V54, P5543; Rendic S, 1997, DRUG METAB REV, V29, P413, DOI 10.3109/03602539709037591; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Ryan MT, 1999, J BIOL CHEM, V274, P20619, DOI 10.1074/jbc.274.29.20619; Sangar MC, 2009, FEBS J, V276, P3440, DOI 10.1111/j.1742-4658.2009.07067.x; Schoch GA, 2004, J BIOL CHEM, V279, P9497, DOI 10.1074/jbc.M312516200; Schoch GA, 2008, J BIOL CHEM, V283, P17227, DOI 10.1074/jbc.M802180200; Singh H, 2007, HYPERTENSION, V50, P123, DOI 10.1161/HYPERTENSIONAHA.107.089599; Tang ZM, 2009, ANAL CHEM, V81, P3071, DOI 10.1021/ac900021a; Thum T, 2000, LANCET, V355, P979, DOI 10.1016/S0140-6736(00)99016-0; Totah RA, 2005, CLIN PHARMACOL THER, V77, P341, DOI 10.1016/j.clpt.2004.12.267; VandenBrink BM, 2011, DRUG METAB DISPOS, V39, P1546, DOI 10.1124/dmd.111.039065; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Wu S, 1997, J BIOL CHEM, V272, P12551, DOI 10.1074/jbc.272.19.12551; Xu XZ, 2011, ADV DRUG DELIVER REV, V63, P597, DOI 10.1016/j.addr.2011.03.006; Yasar U, 2003, PHARMACOGENETICS, V13, P715, DOI [10.1097/00008571-200312000-00002, 10.1097/01.fpc.0000054141.14659.28]; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200	58	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29614	29630		10.1074/jbc.M114.583062	http://dx.doi.org/10.1074/jbc.M114.583062			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25160618	Green Published, hybrid			2022-12-28	WOS:000344370800012
J	Chao, KL; Gorlatova, NV; Eisenstein, E; Herzberg, O				Chao, Kinlin L.; Gorlatova, Natalia V.; Eisenstein, Edward; Herzberg, Osnat			Structural Basis for the Binding Specificity of Human Recepteur d'Origine Nantais (RON) Receptor Tyrosine Kinase to Macrophage-stimulating Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Analytical Ultracentrifugation; Protein-Protein Interaction; Receptor Tyrosine Kinase; Signal Transduction; X-ray Crystallography; RON Receptor Tyrosine Kinase; Macrophage-stimulating Protein	HEPATOCYTE GROWTH-FACTOR; TUMORIGENIC ACTIVITIES; FACTOR/SCATTER FACTOR; CANCER-CELLS; BETA-CHAIN; CRYSTAL-STRUCTURE; GENE-PRODUCT; SEMA DOMAIN; C-MET; EXPRESSION	Background: RON and MET receptors bind their ligands MSP and HGF selectively and activate different signaling pathways. Results: Crystallographic and analytical ultracentrifugation studies provide important information about RON-MSP interaction. Conclusion: RON-MSP and MET-HGF exhibit 2:2 complex stoichiometry, but differences within the respective interfaces explain the strict ligand-receptor specificity. Significance: Signaling pathways must be exquisitely regulated with no cross-reactivity between related systems. Recepteur d'origine nantais (RON) receptor tyrosine kinase and its ligand, serum macrophage-stimulating protein (MSP), play important roles in inflammation, cell growth, migration, and epithelial to mesenchymal transition during tumor development. The binding of mature MSP (disulfide-linked - and -chains) to RON ectodomain modulates receptor dimerization, followed by autophosphorylation of tyrosines in the cytoplasmic receptor kinase domains. Receptor recognition is mediated by binding of MSP -chain (MSP) to the RON Sema. Here we report the structure of RON Sema-PSI-IPT1 (SPI1) domains in complex with MSP at 3.0 resolution. The MSP serine protease-like -barrel uses the degenerate serine protease active site to recognize blades 2, 3, and 4 of the -propeller fold of RON Sema. Despite the sequence homology between RON and MET receptor tyrosine kinase and between MSP and hepatocyte growth factor, it is well established that there is no cross-reactivity between the two receptor-ligand systems. Comparison of the structure of RON SPI1 in complex with MSP and that of MET receptor tyrosine kinase Sema-PSI in complex with hepatocyte growth factor -chain reveals the receptor-ligand selectivity determinants. Analytical ultracentrifugation studies of the SPI1-MSP interaction confirm the formation of a 1:1 complex. SPI1 and MSP also associate primarily as a 1:1 complex with a binding affinity similar to that of SPI1-MSP. In addition, the SPI1-MSP ultracentrifuge studies reveal a low abundance 2:2 complex with approximate to 10-fold lower binding affinity compared with the 1:1 species. These results support the hypothesis that the -chain of MSP mediates RON dimerization.	[Chao, Kinlin L.; Gorlatova, Natalia V.; Eisenstein, Edward; Herzberg, Osnat] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Eisenstein, Edward] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA; [Herzberg, Osnat] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Herzberg, O (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	osnat@umd.edu		Herzberg, Osnat/0000-0003-2823-7627	National Institutes of Health [R21-DA027024, RO1-GM087922]; United States Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102810, R01GM087922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R21-DA027024 (to J. M. and O. H.) and RO1-GM087922 (to O. H. and J. M.). The Advanced Photon Source is supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under Contract W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angeloni D, 2004, J BIOL CHEM, V279, P3726, DOI 10.1074/jbc.M309342200; Angeloni D, 2000, GENE CHROMOSOME CANC, V29, P147, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1015>3.3.CO;2-E; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Balbo Andrea, 2007, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1808s79; Bardella C, 2004, CANCER RES, V64, P5154, DOI 10.1158/0008-5472.CAN-04-0600; Basilico C, 2008, J BIOL CHEM, V283, P21267, DOI 10.1074/jbc.M800727200; Bhattacharyya R, 2003, J PROTEOME RES, V2, P255, DOI 10.1021/pr025584d; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Caldwell CC, 2008, CRIT CARE MED, V36, P1585, DOI 10.1097/CCM.0b013e318170a8c2; Camp ER, 2005, ANN SURG ONCOL, V12, P273, DOI 10.1245/ASO.2005.08.013; Carafoli F, 2005, FEBS J, V272, P5799, DOI 10.1111/j.1742-4658.2005.04968.x; Center RJ, 2001, P NATL ACAD SCI USA, V98, P14877, DOI 10.1073/pnas.261573898; Chao KLL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041912; Collesi C, 1996, MOL CELL BIOL, V16, P5518; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Danilkovitch A, 1999, J BIOL CHEM, V274, P29937, DOI 10.1074/jbc.274.42.29937; Danilkovitch-Miagkova A, 2001, APOPTOSIS, V6, P183, DOI 10.1023/A:1011384609811; DONATE LE, 1994, PROTEIN SCI, V3, P2378, DOI 10.1002/pro.5560031222; Dussault I, 2009, ANTI-CANCER AGENT ME, V9, P221, DOI 10.2174/187152009787313792; Eckerich C, 2009, J NEUROCHEM, V109, P969, DOI 10.1111/j.1471-4159.2009.06027.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Follenzi A, 2000, ONCOGENE, V19, P3041, DOI 10.1038/sj.onc.1203620; GAUDINO G, 1994, EMBO J, V13, P3524, DOI 10.1002/j.1460-2075.1994.tb06659.x; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Gorlatova N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027269; Goyette P, 2008, MUCOSAL IMMUNOL, V1, P131, DOI 10.1038/mi.2007.15; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holmes O, 2007, J MOL BIOL, V367, P395, DOI 10.1016/j.jmb.2006.12.061; Iwama A, 1996, EMBO J, V15, P5866, DOI 10.1002/j.1460-2075.1996.tb00973.x; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kornblatt JA, 2005, BIOCHEMISTRY-US, V44, P13122, DOI 10.1021/bi050895y; Kozlov G, 2004, BIOCHEM BIOPH RES CO, V321, P234, DOI 10.1016/j.bbrc.2004.06.132; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lu Y, 2007, CANCER LETT, V257, P157, DOI 10.1016/j.canlet.2007.08.007; Ma Q, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-307; Ma Q, 2010, INT J ONCOL, V36, P1551, DOI 10.3892/ijo_00000642; Manzanares D, 2007, AM J RESP CELL MOL, V37, P160, DOI 10.1165/rcmb.2006-0413OC; Matsumoto K, 1998, J BIOL CHEM, V273, P22913, DOI 10.1074/jbc.273.36.22913; Matzke A, 2005, CANCER RES, V65, P6105, DOI 10.1158/0008-5472.CAN-05-0207; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; Niemann HH, 2011, EUR J CELL BIOL, V90, P972, DOI 10.1016/j.ejcb.2010.11.014; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Padhye SS, 2011, MOL PHARMACEUT, V8, P2310, DOI 10.1021/mp200193u; Ross J, 2012, GASTROENTEROLOGY, V142, P897, DOI 10.1053/j.gastro.2011.12.006; Saha RP, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-11; SKEEL A, 1991, J EXP MED, V173, P1227, DOI 10.1084/jem.173.5.1227; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Thobe MN, 2010, ONCOGENE, V29, P214, DOI 10.1038/onc.2009.331; Thomas RM, 2007, CANCER RES, V67, P6075, DOI 10.1158/0008-5472.CAN-06-4128; Tolbert WD, 2010, P NATL ACAD SCI USA, V107, P13264, DOI 10.1073/pnas.1005183107; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Waltz SE, 1997, J BIOL CHEM, V272, P30526, DOI 10.1074/jbc.272.48.30526; Wang J, 2009, J BIOL CHEM, V284, P10912, DOI 10.1074/jbc.M809551200; WANG MH, 1995, P NATL ACAD SCI USA, V92, P3933, DOI 10.1073/pnas.92.9.3933; Wang MH, 2002, SCAND J IMMUNOL, V56, P545, DOI 10.1046/j.1365-3083.2002.01177.x; WANG MH, 1994, SCIENCE, V266, P117, DOI 10.1126/science.7939629; Wang MH, 1997, J BIOL CHEM, V272, P16999, DOI 10.1074/jbc.272.27.16999; Wang MH, 2007, CANCER BIOL THER, V6, P1121, DOI 10.4161/cbt.6.7.4337; Wilson CB, 2008, J IMMUNOL, V181, P2303, DOI 10.4049/jimmunol.181.4.2303; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yao HP, 2013, NAT REV CANCER, V13, P466, DOI 10.1038/nrc3545; Yu PT, 2012, INT J CANCER, V131, P1744, DOI 10.1002/ijc.27447; Zhao HY, 2012, J GEN PHYSIOL, V139, P371, DOI 10.1085/jgp.201210770; Zhou DH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-353	72	13	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29948	29960		10.1074/jbc.M114.594341	http://dx.doi.org/10.1074/jbc.M114.594341			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25193665	Green Published, hybrid			2022-12-28	WOS:000344370800037
J	Kossmann, S; Hu, HH; Steven, S; Schonfelder, T; Fraccarollo, D; Mikhed, Y; Brahler, M; Knorr, M; Brandt, M; Karbach, SH; Becker, C; Oelze, M; Bauersachs, J; Widder, J; Munzel, T; Daiber, A; Wenzel, P				Kossmann, Sabine; Hu, Hanhan; Steven, Sebastian; Schoenfelder, Tanja; Fraccarollo, Daniela; Mikhed, Yuliya; Braehler, Melanie; Knorr, Maike; Brandt, Moritz; Karbach, Susanne H.; Becker, Christian; Oelze, Matthias; Bauersachs, Johann; Widder, Julian; Muenzel, Thomas; Daiber, Andreas; Wenzel, Philip			Inflammatory Monocytes Determine Endothelial Nitric-oxide Synthase Uncoupling and Nitro-oxidative Stress Induced by Angiotensin II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiotensin II; Endothelial Dysfunction; Inflammation; Monocyte; Nitric-oxide Synthase; Tetrahydrobiopterin (BH4)	GTP-CYCLOHYDROLASE-I; VASCULAR SUPEROXIDE-PRODUCTION; CELL-LINEAGE-ABLATION; INTERFERON-GAMMA; HUMAN ATHEROSCLEROSIS; DIABETES-MELLITUS; NAD(P)H OXIDASE; GENE-EXPRESSION; TETRAHYDROBIOPTERIN; DYSFUNCTION	Background: Inflammatory monocytes are drivers of vascular injury and disease. Results: Depletion of lysozyme M-positive monocytes prevents eNOS uncoupling and iNOS-derived nitro-oxidative stress. Conclusion: Monocytes determine eNOS and iNOS function by directly modulating tetrahydrobiopterin bioavailability. Significance: Understanding the impact of inflammation on endothelial function in detail is essential to identify tailored therapeutic strategies. Endothelial nitric-oxide synthase (eNOS) uncoupling and increased inducible NOS (iNOS) activity amplify vascular oxidative stress. The role of inflammatory myelomonocytic cells as mediators of these processes and their impact on tetrahydrobiopterin availability and function have not yet been defined. Angiotensin II (ATII, 1 mg/kg/day for 7 days) increased Ly6C(high) and CD11b(+)/iNOS(high) leukocytes and up-regulated levels of eNOS glutathionylation in aortas of C57BL/6 mice. Vascular iNOS-dependent NO formation was increased, whereas eNOS-dependent NO formation was decreased in aortas of ATII-infused mice as assessed by electron paramagnetic resonance (EPR) spectroscopy. Diphtheria toxin-mediated ablation of lysozyme M-positive (LysM(+)) monocytes in ATII-infused LysM(iDTR) transgenic mice prevented eNOS glutathionylation and eNOS-derived N-nitro-l-arginine methyl ester-sensitive superoxide formation in the endothelial layer. ATII increased vascular guanosine triphosphate cyclohydrolase I expression and biopterin synthesis in parallel, which was reduced in monocyte-depleted LysM(iDTR) mice. Vascular tetrahydrobiopterin was increased by ATII infusion but was even higher in monocyte-depleted ATII-infused mice, which was paralleled by a strong up-regulation of dihydrofolate reductase expression. EPR spectroscopy revealed that both vascular iNOS- and eNOS-dependent NO formation were normalized in ATII-infused mice following monocyte depletion. Additionally, deletion as well as pharmacologic inhibition of iNOS prevented ATII-induced endothelial dysfunction. In summary, ATII induces an inflammatory cell-dependent increase of iNOS, guanosine triphosphate cyclohydrolase I, tetrahydrobiopterin, NO formation, and nitro-oxidative stress as well as eNOS uncoupling in the vessel wall, which can be prevented by ablation of LysM(+) monocytes.	[Kossmann, Sabine; Steven, Sebastian; Mikhed, Yuliya; Knorr, Maike; Karbach, Susanne H.; Oelze, Matthias; Muenzel, Thomas; Daiber, Andreas; Wenzel, Philip] Univ Med Ctr Mainz, Med Clin 2, D-55131 Mainz, Germany; [Kossmann, Sabine; Hu, Hanhan; Steven, Sebastian; Schoenfelder, Tanja; Braehler, Melanie; Knorr, Maike; Brandt, Moritz; Becker, Christian; Wenzel, Philip] Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis, D-55131 Mainz, Germany; [Braehler, Melanie; Becker, Christian] Univ Med Ctr Mainz, Dept Dermatol, D-55131 Mainz, Germany; [Fraccarollo, Daniela; Bauersachs, Johann; Widder, Julian] Hannover Med Sch, Clin Cardiol & Angiol, D-30625 Hannover, Germany; [Brandt, Moritz] Stanford Sch Med, Stanford, CA 94305 USA	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Hannover Medical School; Stanford University	Wenzel, P (corresponding author), Univ Med Ctr Mainz, Dept Med 2, Langenbeckstr 1, D-55131 Mainz, Germany.	wenzelp@uni-mainz.de	Karbach, Susanne/GPC-8804-2022; Becker, Christian/AAD-4549-2020; Munzel, Thomas/A-2912-2014; Karbach, Susanne/X-8136-2019; Brandt, Moritz/ABB-5621-2021; Wenzel, Philip/HIA-0033-2022; Wenzel, Philip/Z-1503-2019; Steven, Sebastian/Z-1583-2019; Becker, Christian/GLS-0862-2022	Becker, Christian/0000-0002-1716-7208; Munzel, Thomas/0000-0001-5503-4150; Wenzel, Philip/0000-0002-5397-2781; Wenzel, Philip/0000-0002-5397-2781; Becker, Christian/0000-0002-1716-7208; Wild, Sabine/0000-0002-1403-0978; Steven, Sebastian/0000-0002-5332-9294	German Research Foundation DFG [WE 4361/3-1]; Stiftung Mainzer Herz; Federal Ministry of Education and Research [BMBF 01EO1003]	German Research Foundation DFG(German Research Foundation (DFG)); Stiftung Mainzer Herz; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported in part by the German Research Foundation DFG Grant WE 4361/3-1 (to P. W.). This work contains results that are part of the doctoral thesis of Hanhan Hu.; Supported by grants from the Stiftung Mainzer Herz.; Supported by Federal Ministry of Education and Research Grant BMBF 01EO1003. To whom correspondence should be addressed: Dept. of Medicine 2 and CTH Junior Group "Vascular Biology," University Medical Center Mainz, Langenbeckstr. 1, 55131 Mainz, Germany. Tel.: 49-6131-177695; Fax: 49-6131-175532; E-mail: wenzelp@uni-mainz.de.	Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P445, DOI 10.1161/01.ATV.0000115637.48689.77; Alp NJ, 2003, J CLIN INVEST, V112, P725, DOI 10.1172/JCI200317786; Antoniades C, 2007, CIRCULATION, V116, P2851, DOI 10.1161/CIRCULATIONAHA.107.704155; Antoniades C, 2011, CIRCULATION, V124, P335, DOI 10.1161/CIRCULATIONAHA.110.985150; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Cortez-Retamozo V, 2013, IMMUNITY, V38, P296, DOI 10.1016/j.immuni.2012.10.015; Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Gao L, 2012, HYPERTENSION, V59, P158, DOI 10.1161/HYPERTENSIONAHA.111.181644; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Guzik TJ, 2002, CIRCULATION, V105, P1656, DOI 10.1161/01.CIR.0000012748.58444.08; Heitzer T, 2000, CIRC RES, V86, pE36, DOI 10.1161/01.RES.86.2.e36; Hink U, 2001, CIRC RES, V88, pE14; Ihlemann N, 2003, AM J PHYSIOL-HEART C, V285, pH875, DOI 10.1152/ajpheart.00008.2003; Kase H, 2005, J HYPERTENS, V23, P1375, DOI 10.1097/01.hjh.0000173520.13976.7d; Kessler P, 1997, ARTERIOSCL THROM VAS, V17, P1746, DOI 10.1161/01.ATV.17.9.1746; Kleschyov AL, 2002, METHOD ENZYMOL, V359, P42; Kossmann S, 2013, ARTERIOSCL THROM VAS, V33, P1313, DOI 10.1161/ATVBAHA.113.301437; Kroller-Schon S, 2014, ANTIOXID REDOX SIGN, V20, P247, DOI 10.1089/ars.2012.4953; Kuzkaya N, 2003, J BIOL CHEM, V278, P22546, DOI 10.1074/jbc.M302227200; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Landmesser U, 2007, ARTERIOSCL THROM VAS, V27, P943, DOI 10.1161/01.ATV.0000258415.32883.bf; Lee DY, 2013, J BIOL CHEM, V288, P28668, DOI 10.1074/jbc.M113.470971; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Puhakka A, 2002, MUTAT RES-GEN TOX EN, V514, P7, DOI 10.1016/S1383-5718(01)00322-9; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Schiffrin EL, 2014, CLIN SCI, V126, P267, DOI 10.1042/CS20130407; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tan CK, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000269; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; WERNER ER, 1990, J BIOL CHEM, V265, P3189; XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779	39	81	83	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27540	27550		10.1074/jbc.M114.604231	http://dx.doi.org/10.1074/jbc.M114.604231			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25143378	Green Published, hybrid			2022-12-28	WOS:000342852800016
J	Fogg, PCM; O'Neill, JS; Dobrzycki, T; Calvert, S; Lord, EC; McIntosh, RLL; Elliott, CJH; Sweeney, ST; Hastings, MH; Chawla, S				Fogg, Paul C. M.; O'Neill, John S.; Dobrzycki, Tomasz; Calvert, Shaun; Lord, Emma C.; McIntosh, Rebecca L. L.; Elliott, Christopher J. H.; Sweeney, Sean T.; Hastings, Michael H.; Chawla, Sangeeta			Class IIa Histone Deacetylases Are Conserved Regulators of Circadian Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Circadian Rhythm; Clock Gene; Drosophila; Histone Deacetylase (HDAC); Nuclear Translocation	CLOCK GENE-EXPRESSION; TRANSCRIPTION FACTORS; SIRT1 DEACETYLASE; PHOSPHORYLATION; REPRESSION; RHYTHMS; BMAL1; TRANSACTIVATION; SUMOYLATION; FIBROBLASTS	Background: Class IIa HDACs are signal-dependent transcriptional corepressors that regulate cell differentiation programs and liver gluconeogenesis. Results: HDAC5 influences BMAL1 acetylation and interfering with normal expression levels of class IIa HDACs disrupts circadian rhythms. Conclusion: Class IIa HDACs regulate the robustness of cellular clocks and behavioral activity rhythms. Significance: Class IIa HDACs provide a conserved link between circadian clocks and metabolic signaling pathways. Class IIa histone deacetylases (HDACs) regulate the activity of many transcription factors to influence liver gluconeogenesis and the development of specialized cells, including muscle, neurons, and lymphocytes. Here, we describe a conserved role for class IIa HDACs in sustaining robust circadian behavioral rhythms in Drosophila and cellular rhythms in mammalian cells. In mouse fibroblasts, overexpression of HDAC5 severely disrupts transcriptional rhythms of core clock genes. HDAC5 overexpression decreases BMAL1 acetylation on Lys-537 and pharmacological inhibition of class IIa HDACs increases BMAL1 acetylation. Furthermore, we observe cyclical nucleocytoplasmic shuttling of HDAC5 in mouse fibroblasts that is characteristically circadian. Mutation of the Drosophila homolog HDAC4 impairs locomotor activity rhythms of flies and decreases period mRNA levels. RNAi-mediated knockdown of HDAC4 in Drosophila clock cells also dampens circadian function. Given that the localization of class IIa HDACs is signal-regulated and influenced by Ca2+ and cAMP signals, our findings offer a mechanism by which extracellular stimuli that generate these signals can feed into the molecular clock machinery.	[Fogg, Paul C. M.; Dobrzycki, Tomasz; Calvert, Shaun; Lord, Emma C.; McIntosh, Rebecca L. L.; Elliott, Christopher J. H.; Sweeney, Sean T.; Chawla, Sangeeta] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [O'Neill, John S.; Hastings, Michael H.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	University of York - UK; MRC Laboratory Molecular Biology	Chawla, S (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	sangeeta.chawla@york.ac.uk		Dobrzycki, Tomasz/0000-0002-7708-3188; Fogg, Paul/0000-0001-5324-4293; Sweeney, Sean/0000-0003-2673-9578; O'Neill, John Stuart/0000-0003-2204-6096; Elliott, Chris/0000-0002-5805-3645; Hastings, Michael Harvey/0000-0001-8576-6651; Lord, Emma/0000-0001-9216-7382	Medical Research Council UK; Biotechnology and Biological Sciences Research Council UK [8/JF/20603]; Department of Biology, University of York; Medical Research Council [MC_UP_1201/4]; Wellcome Trust [093734/Z/10/Z]; MRC [MC_U105170643, MC_UP_1201/4] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [JF20603] Funding Source: researchfish; Medical Research Council [MC_U105170643] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department of Biology, University of York; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Medical Research Council UK, Biotechnology and Biological Sciences Research Council UK Grant 8/JF/20603 (to S. C.), and pump-priming funds from the Department of Biology, University of York.; Supported by the Medical Research Council (MC_UP_1201/4) and the Wellcome Trust (093734/Z/10/Z).	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Blanchard FJ, 2010, J NEUROSCI, V30, P5855, DOI 10.1523/JNEUROSCI.2688-09.2010; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Dardente H, 2007, BIOCHEM J, V402, P525, DOI 10.1042/BJ20060827; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Ha CH, 2010, P NATL ACAD SCI USA, V107, P15467, DOI 10.1073/pnas.1000462107; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nebbioso A, 2020, EMBO REP, V21, DOI [10.1038/embor.2009.88, 10.15252/embr.202051028]; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; O'Neill JS, 2008, J BIOL RHYTHM, V23, P483, DOI 10.1177/0748730408326682; Parra M, 2010, CURR OPIN PHARMACOL, V10, P454, DOI 10.1016/j.coph.2010.04.004; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Schmid B, 2011, J BIOL RHYTHM, V26, P464, DOI 10.1177/0748730411414264; Soriano FX, 2013, J NEUROCHEM, V124, P26, DOI 10.1111/jnc.12058; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Takahata S, 2000, GENES CELLS, V5, P739, DOI 10.1046/j.1365-2443.2000.00363.x; Tamaru T, 2003, GENES CELLS, V8, P973, DOI 10.1046/j.1365-2443.2003.00686.x; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005; Zheng XZ, 2008, GENETICS, V178, P1147, DOI 10.1534/genetics.107.088658	32	29	29	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34341	34348		10.1074/jbc.M114.606392	http://dx.doi.org/10.1074/jbc.M114.606392			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25271152	Green Published, hybrid			2022-12-28	WOS:000346077600054
J	Feng, Y; Hadjikyriacou, A; Clarke, SG				Feng, You; Hadjikyriacou, Andrea; Clarke, Steven G.			Substrate Specificity of Human Protein Arginine Methyltransferase 7 (PRMT7) THE IMPORTANCE OF ACIDIC RESIDUES IN THE DOUBLE E LOOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 TAT; N-METHYLTRANSFERASE; GENE-EXPRESSION; BREAST-CANCER; HISTONE H4; METHYLATION; REGIONS; CELLS; IDENTIFICATION; TRANSCRIPTION	Protein arginine methyltransferase 7 (PRMT7) methylates arginine residues on various protein substrates and is involved in DNA transcription, RNA splicing, DNA repair, cell differentiation, and metastasis. The substrate sequences it recognizes in vivo and the enzymatic mechanism behind it, however, remain to be explored. Here we characterize methylation catalyzed by a bacterially expressed GST-tagged human PRMT7 fusion protein with a broad range of peptide and protein substrates. After confirming its type III activity generating only omega-N-G-monomethylarginine and its distinct substrate specificity for RXR motifs surrounded by basic residues, we performed site-directed mutagenesis studies on this enzyme, revealing that two acidic residues within the double E loop, Asp-147 and Glu-149, modulate the substrate preference. Furthermore, altering a single acidic residue, Glu-478, on the C-terminal domain to glutamine nearly abolished the activity of the enzyme. Additionally, we demonstrate that PRMT7 has unusual temperature dependence and salt tolerance. These results provide a biochemical foundation to understanding the broad biological functions of PRMT7 in health and disease.	[Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu		Feng, You/0000-0002-4710-7396	National Institutes of Health [GM026020, GM007185]; Ruth L. Kirschstein National Research Service Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020, T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM026020 (to S. G. C.) and GM007185, a Ruth L. Kirschstein National Research Service Award (to A. H.).	Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Baldwin R Mitchell, 2014, World J Biol Chem, V5, P115, DOI 10.4331/wjbc.v5.i2.115; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bleibel WK, 2009, HUM GENET, V125, P173, DOI 10.1007/s00439-008-0607-4; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Buhr N, 2008, ELECTROPHORESIS, V29, P2381, DOI 10.1002/elps.200700738; Cura V, 2014, ACTA CRYSTALLOGR D, V70, P2401, DOI 10.1107/S1399004714014278; Dhar SS, 2012, GENE DEV, V26, P2749, DOI 10.1101/gad.203356.112; EBRALIDSE KK, 1988, NATURE, V331, P365, DOI 10.1038/331365a0; Feng Y, 2013, J BIOL CHEM, V288, P37010, DOI 10.1074/jbc.M113.525345; Feng Y, 2011, BIOCHEMISTRY-US, V50, P7033, DOI 10.1021/bi200456u; Feng Y, 2011, J BIOL CHEM, V286, P20323, DOI 10.1074/jbc.M110.207258; Fisk JC, 2009, J BIOL CHEM, V284, P11590, DOI 10.1074/jbc.M807279200; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; Gros L, 2003, CANCER RES, V63, P164; Gros L, 2006, BBA-GEN SUBJECTS, V1760, P1646, DOI 10.1016/j.bbagen.2006.08.026; Hasegawa M, 2014, FEBS LETT, V588, P1942, DOI 10.1016/j.febslet.2014.03.053; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Kim C, 2010, BBA-GEN SUBJECTS, V1800, P977, DOI 10.1016/j.bbagen.2010.06.004; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Lu H, 2012, EPIGENETICS-US, V7, P914, DOI 10.4161/epi.21113; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Parra MA, 2006, MOL CELL BIOL, V26, P3842, DOI 10.1128/MCB.26.10.3842-3852.2006; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Thomassen M, 2009, BREAST CANCER RES TR, V113, P239, DOI 10.1007/s10549-008-9927-2; Truant R, 1999, MOL CELL BIOL, V19, P1210; Verbiest V, 2008, FEBS LETT, V582, P1483, DOI 10.1016/j.febslet.2008.03.031; Wang CY, 2014, STRUCTURE, V22, P756, DOI 10.1016/j.str.2014.03.003; Wyrick JJ, 2009, BBA-GENE REGUL MECH, V1789, P37, DOI 10.1016/j.bbagrm.2008.07.001; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yao RS, 2014, CANCER RES, V74, P5656, DOI 10.1158/0008-5472.CAN-14-0800; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	41	40	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.609271	http://dx.doi.org/10.1074/jbc.M114.609271			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25294873	hybrid, Green Published			2022-12-28	WOS:000345335000019
J	Liang, YX; Eng, WS; Colquhoun, DR; Dinglasan, RR; Graham, DR; Mahal, LK				Liang, Yaxuan; Eng, William S.; Colquhoun, David R.; Dinglasan, Rhoel R.; Graham, David R.; Mahal, Lara K.			Complex N-Linked Glycans Serve as a Determinant for Exosome/Microvesicle Cargo Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRASPANIN-ENRICHED MICRODOMAINS; EPITHELIAL-CELLS; B-LYMPHOCYTES; EXOSOMAL PROTEINS; RECEPTOR ERGIC-53; VESICLES EXOSOMES; CD81 PARTNER; MAJOR CD9; TRAFFICKING; MICROVESICLES	Exosomes, also known as microvesicles (EMVs), are nano-sized membranous particles secreted from nearly all mammalian cell types. These nanoparticles play critical roles in many physiological processes including cell-cell signaling, immune activation, and suppression and are associated with disease states such as tumor progression. The biological functions of EMVs are highly dependent on their protein composition, which can dictate pathogenicity. Although some mechanisms have been proposed for the regulation of EMV protein trafficking, little attention has been paid to N-linked glycosylation as a potential sorting signal. Previous work from our laboratory found a conserved glycan signature for EMVs, which differed from that of the parent cell membranes, suggesting a potential role for glycosylation in EMV biogenesis. In this study, we further explore the role of glycosylation in EMV protein trafficking. We identify EMV glycoproteins and demonstrate alteration of their recruitment as a function of their glycosylation status upon pharmacological manipulation. Furthermore, we show that genetic manipulation of the glycosylation levels of a specific EMV glycoprotein, EWI-2, directly impacts its recruitment as a function of N-linked glycan sites. Taken together, our data provide strong evidence that N-linked glycosylation directs glycoprotein sorting into EMVs.	[Liang, Yaxuan; Eng, William S.; Mahal, Lara K.] NYU, Inst Biomed Chem, Dept Chem, New York, NY 10003 USA; [Colquhoun, David R.; Graham, David R.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Dinglasan, Rhoel R.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feistone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	New York University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Mahal, LK (corresponding author), NYU, Inst Biomed Chem, 100 Washington Sq East,Rm 1001, New York, NY 10003 USA.	lkmahal@nyu.edu	L, Yaxuan/M-3785-2016; Mahal, Lara/GRY-7287-2022	L, Yaxuan/0000-0003-2729-5171; Dinglasan, Rhoel/0000-0001-5433-8179; Dinglasan, Rhoel/0000-0001-6563-1506; Mahal, Lara/0000-0003-4791-8524	National Institutes of Health [7 DP2 OD004711-02]; Mitzutani Foundation for Glycoscience [130107]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mitzutani Foundation for Glycoscience; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant 7 DP2 OD004711-02). This work was also supported by Mitzutani Foundation for Glycoscience Grant 130107.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Barres C, 2010, BLOOD, V115, P696, DOI 10.1182/blood-2009-07-231449; Batista BS, 2011, J PROTEOME RES, V10, P4624, DOI 10.1021/pr200434y; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BRADBURY LE, 1992, J IMMUNOL, V149, P2841; Cao XW, 2012, CELL RES, V22, P793, DOI 10.1038/cr.2012.64; Charrin S, 2003, BIOCHEM J, V373, P409, DOI 10.1042/BJ20030343; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; Chen Y, 2013, GLYCOBIOLOGY, V23, P904, DOI 10.1093/glycob/cwt027; Clark KL, 2001, J IMMUNOL, V167, P5115, DOI 10.4049/jimmunol.167.9.5115; CROWLEY JF, 1984, ARCH BIOCHEM BIOPHYS, V231, P524, DOI 10.1016/0003-9861(84)90417-X; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; ELBEIN AD, 1991, FASEB J, V5, P3055, DOI 10.1096/fasebj.5.15.1743438; Escrevente C, 2008, BBA-GEN SUBJECTS, V1780, P905, DOI 10.1016/j.bbagen.2008.03.004; Escrevente C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078631; FUHRMANN U, 1984, NATURE, V307, P755, DOI 10.1038/307755a0; GREEN ED, 1987, ANAL BIOCHEM, V167, P62, DOI 10.1016/0003-2697(87)90134-5; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Horvath G, 1998, J BIOL CHEM, V273, P30537, DOI 10.1074/jbc.273.46.30537; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Klaus JP, 2013, CELL HOST MICROBE, V14, P522, DOI 10.1016/j.chom.2013.10.010; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Krishnamoorthy L, 2009, NAT CHEM BIOL, V5, P244, DOI 10.1038/nchembio.151; Lee HK, 2013, ONCOTARGET, V4, P346, DOI 10.18632/oncotarget.868; Ludwig AK, 2012, INT J BIOCHEM CELL B, V44, P11, DOI 10.1016/j.biocel.2011.10.005; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; MATSUMOTO AK, 1993, J EXP MED, V178, P1407, DOI 10.1084/jem.178.4.1407; Mattila PE, 2012, TRAFFIC, V13, P433, DOI 10.1111/j.1600-0854.2011.01315.x; Mishra R, 2010, P NATL ACAD SCI USA, V107, P17633, DOI 10.1073/pnas.1012424107; Montpellier C, 2011, J BIOL CHEM, V286, P13954, DOI 10.1074/jbc.M111.220103; Morelle W, 2009, BIOL CHEM, V390, P529, DOI 10.1515/BC.2009.075; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Neve EPA, 2005, J MOL BIOL, V354, P556, DOI 10.1016/j.jmb.2005.09.077; Nydegger S, 2006, J CELL BIOL, V173, P795, DOI 10.1083/jcb.200508165; Parish LA, 2011, J PROTEOME RES, V10, P5150, DOI 10.1021/pr2006268; Perez-Hernandez D, 2013, J BIOL CHEM, V288, P11649, DOI 10.1074/jbc.M112.445304; Rakus JF, 2011, ANNU REV ANAL CHEM, V4, P367, DOI 10.1146/annurev-anchem-061010-113951; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Shen BY, 2011, J BIOL CHEM, V286, P14383, DOI 10.1074/jbc.M110.208660; Shoham T, 2003, J IMMUNOL, V171, P4062, DOI 10.4049/jimmunol.171.8.4062; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Stipp CS, 2003, J CELL BIOL, V163, P1167, DOI 10.1083/jcb.200309113; Stipp CS, 2001, J BIOL CHEM, V276, P40545, DOI 10.1074/jbc.M107338200; Stipp CS, 2001, J BIOL CHEM, V276, P4853, DOI 10.1074/jbc.M009859200; Sun QL, 2009, ARCH BIOCHEM BIOPHYS, V484, P24, DOI 10.1016/j.abb.2009.01.009; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Varki A, 2009, ESSENTIALS GLYCOBIOL, P1; Yamamoto H, 2013, J CELL SCI, V126, P2931, DOI 10.1242/jcs.126052	60	96	99	2	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.606269	http://dx.doi.org/10.1074/jbc.M114.606269			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25261472	Green Published, hybrid			2022-12-28	WOS:000345335000012
J	Kimura, Y; Chihara, K; Oh, CH; Takeuchi, K; Yamauchi, S; Yoshiki, H; Fujieda, S; Sada, K				Kimura, Yukihiro; Chihara, Kazuyasu; Oh, Chisato Honj; Takeuchi, Kenji; Yamauchi, Shota; Yoshiki, Hatsumi; Fujieda, Shigeharu; Sada, Kiyonao			Dectin-1-mediated Signaling Leads to Characteristic Gene Expressions and Cytokine Secretion via Spleen Tyrosine Kinase (Syk) in Rat Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCAN RECEPTOR; KAPPA-B-ZETA; AFFINITY IGE RECEPTOR; ADAPTER PROTEIN 3BP2; TNF-ALPHA; LECTIN RECEPTORS; DENDRITIC CELLS; PERITONEAL INFLAMMATION; RHEUMATOID-ARTHRITIS; DECTIN-1 STIMULATION	Dectin-1 recognizes beta-glucan and plays important roles for the antifungal immunity through the activation of spleen tyrosine kinase (Syk) in dendritic cells or macrophages. Recently, expression of Dectin-1 was also identified in human and mouse mast cells, although its physiological roles were largely unknown. In this report, rat mast cell line RBL-2H3 was analyzed to investigate the molecular mechanism of Dectin-1-mediated activation and responses of mast cells. Treatment of cells with Dectin-1-specific agonist curdlan induced tyrosine phosphorylation of cellular proteins and the interaction of Dectin-1 with the Src homology 2 domain of Syk. These responses depended on tyrosine phosphorylation of the hemi-immunoreceptor tyrosine-based activation motif in the cytoplasmic tail of Dectin-1, whereas they were independent of the gamma-subunit of high-affinity IgE receptor. DNAmicroarray and real-time PCR analyses showed that Dectin-1-mediated signaling stimulated gene expression of transcription factor Nfkbiz and inflammatory cytokines, such as monocyte chemoattractant protein-1, IL-3, IL-4, IL-13, and tumor necrosis factor (TNF)-alpha. The response was abrogated by pretreatment with Syk inhibitor R406. These results suggest that Syk is critical for Dectin-1-mediated activation of mast cells, although the signaling differs from that triggered by Fc epsilon RI activation. In addition, these gene expressions induced by curdlan stimulation were specifically observed in mast cells, suggesting that Dectin-1-mediated signaling of mast cells offers new insight into the antifungal immunity.	[Kimura, Yukihiro; Fujieda, Shigeharu] Univ Fukui, Fac Med Sci, Dept Sensory & Locomotor Med, Div Otorhinolaryngol Head & Neck Surg, Fukui 9101193, Japan; [Kimura, Yukihiro; Chihara, Kazuyasu; Oh, Chisato Honj; Takeuchi, Kenji; Yamauchi, Shota; Yoshiki, Hatsumi; Sada, Kiyonao] Univ Fukui, Fac Med Sci, Dept Pathol Sci, Div Genome Sci & Microbiol, Fukui 9101193, Japan; [Oh, Chisato Honj] Univ Fukui, Fac Med Sci, Dept Internal Med 3, Fukui 9101193, Japan; [Chihara, Kazuyasu; Takeuchi, Kenji; Yamauchi, Shota; Sada, Kiyonao] Univ Fukui, Org Life Sci Adv Programs, Fukui 9101193, Japan	University of Fukui; University of Fukui; University of Fukui; University of Fukui	Sada, K (corresponding author), Univ Fukui, Fac Med Sci, Dept Pathol Sci, Div Genome Sci & Microbiol, 23-3 Matsuoka Shimoaizuki, Fukui 9101193, Japan.	ksada@u-fukui.ac.jp	Sada, Kiyonao/H-7373-2015; Kimura, Yukihiro/AAI-6300-2020	Sada, Kiyonao/0000-0001-6124-3100; 	Japan Society for the Promotion of Science; University of Fukui	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of Fukui	This work was supported in part by research funding from grants-in-aid from the Japan Society for the Promotion of Science and research funding from the University of Fukui (to S. F. and K. S.).	Ajuebor MN, 1998, J LEUKOCYTE BIOL, V63, P108, DOI 10.1002/jlb.63.1.108; Allendoerfer R, 1998, J IMMUNOL, V160, P6072; Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; BENHAMOU M, 1993, J BIOL CHEM, V268, P23318; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Chihara K, 2014, EXP CELL RES, V322, P99, DOI 10.1016/j.yexcr.2013.12.026; Cortez-Espinosa N, 2012, METABOLISM, V61, P1538, DOI 10.1016/j.metabol.2012.03.020; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Eberle ME, 2012, J IMMUNOL, V188, P5644, DOI 10.4049/jimmunol.1103068; Elcombe SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060086; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Heinsbroek SEM, 2006, J IMMUNOL, V176, P5513, DOI 10.4049/jimmunol.176.9.5513; Hildebrand DG, 2013, J IMMUNOL, V190, P4812, DOI 10.4049/jimmunol.1300089; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Kataoka K, 2002, J BIOL CHEM, V277, P36825, DOI 10.1074/jbc.M206756200; Kato Y, 2008, MICROBIOL IMMUNOL, V52, P418, DOI 10.1111/j.1348-0421.2008.00055.x; Kawakami K, 1996, CLIN EXP IMMUNOL, V106, P468, DOI 10.1046/j.1365-2249.1996.d01-870.x; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; KIHARA H, 1994, J BIOL CHEM, V269, P22427; Kolaczkowska E, 2001, J LEUKOCYTE BIOL, V69, P33; LeibundGut-Landmann S, 2008, BLOOD, V112, P4971, DOI 10.1182/blood-2008-05-158469; Lilly LM, 2012, J IMMUNOL, V189, P3653, DOI 10.4049/jimmunol.1201797; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; McIntosh M, 2005, APPL MICROBIOL BIOT, V68, P163, DOI 10.1007/s00253-005-1959-5; Mehrad B, 1999, J IMMUNOL, V162, P1633; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Netea MG, 1999, J IMMUNOL, V163, P1498; Ogi K, 2011, GENES CELLS, V16, P951, DOI 10.1111/j.1365-2443.2011.01539.x; Olsson S, 2007, MOL IMMUNOL, V44, P1509, DOI 10.1016/j.molimm.2006.09.004; Olynych TJ, 2006, J ALLERGY CLIN IMMUN, V118, P837, DOI 10.1016/j.jaci.2006.06.008; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Plantinga TS, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2933; Rand TG, 2013, ARCH TOXICOL, V87, P1841, DOI 10.1007/s00204-013-1042-4; Rand TG, 2010, ARCH TOXICOL, V84, P205, DOI 10.1007/s00204-009-0481-4; RAO TS, 1994, J PHARMACOL EXP THER, V269, P917; Ribbing C, 2011, ALLERGY, V66, P110, DOI 10.1111/j.1398-9995.2010.02437.x; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Sada K, 2002, BLOOD, V100, P2138, DOI 10.1182/blood-2001-12-0340; Sada K, 2001, BLOOD, V97, P1352, DOI 10.1182/blood.V97.5.1352; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; Salazar-Aldrete C, 2013, J CLIN IMMUNOL, V33, P368, DOI 10.1007/s10875-012-9821-x; Shukla U, 2009, J BIOL CHEM, V284, P33719, DOI 10.1074/jbc.M109.049999; Slack EC, 2007, EUR J IMMUNOL, V37, P1600, DOI 10.1002/eji.200636830; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Takahashi M, 2009, J IMMUNOL, V183, P3463, DOI 10.4049/jimmunol.0802812; Takeshita K, 2003, J PHARMACOL EXP THER, V307, P1072, DOI 10.1124/jpet.103.057489; Tassi I, 2009, EUR J IMMUNOL, V39, P1369, DOI 10.1002/eji.200839313; Taylor PR, 2004, J IMMUNOL, V172, P1157, DOI 10.4049/jimmunol.172.2.1157; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Thornton BP, 1996, J IMMUNOL, V156, P1235; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Vautier S, 2012, CYTOKINE, V58, P89, DOI 10.1016/j.cyto.2011.08.031; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Willment JA, 2001, J BIOL CHEM, V276, P43818, DOI 10.1074/jbc.M107715200; Willment JA, 2003, J IMMUNOL, V171, P4569, DOI 10.4049/jimmunol.171.9.4569; Xie ZH, 2000, J IMMUNOL, V164, P1521, DOI 10.4049/jimmunol.164.3.1521; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yang Z, 2009, IMMUNOBIOLOGY, V214, P321, DOI 10.1016/j.imbio.2008.09.002; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758	71	30	33	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31565	31575		10.1074/jbc.M114.581322	http://dx.doi.org/10.1074/jbc.M114.581322			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25246527	Green Published, hybrid			2022-12-28	WOS:000344549900057
J	Li, QX; Yan, CY; Xu, HS; Wang, Z; Long, JF; Li, WQ; Wu, JP; Yin, P; Yan, N				Li, Quanxiu; Yan, Chuangye; Xu, Huisha; Wang, Zheng; Long, Jiafu; Li, Wenqi; Wu, Jianping; Yin, Ping; Yan, Nieng			Examination of the Dimerization States of the Single-stranded RNA Recognition Protein Pentatricopeptide Repeat 10 (PPR10)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULAR RECOGNITION; RESTORES FERTILITY; STRUCTURAL BASIS; SIGNAL PEPTIDES; BINDING; IDENTIFICATION; STABILIZES; PREDICTION; MECHANISM; INSIGHTS	Pentatricopeptide repeat (PPR) proteins, particularly abundant in plastids and mitochrondria of angiosperms, include a large number of sequence-specific RNA binding proteins that are involved in diverse aspects of organelle RNA metabolisms. PPR proteins contain multiple tandom repeats, and each repeat can specifically recognize a RNA base through residues 2, 5, and 35 in a modular fashion. The crystal structure of PPR10 from maize chloroplast exhibits dimeric existence both in the absence and presence of the 18-nucleotide psaJ RNA element. However, previous biochemical analysis suggested a monomeric shift of PPR10 upon RNA binding. In this report, we show that the amino-terminal segments of PPR10 determine the dimerization state of PPR10. A single amino acid alteration of cysteine to serine within repeat 10 of PPR10 further drives dimerization of PPR10. The biochemical elucidation of the determinants for PPR10 dimerization may provide an important foundation to understand the working mechanisms of PPR proteins underlying their diverse physiological functions.	[Li, Quanxiu; Li, Wenqi; Yan, Nieng] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Li, Quanxiu; Yan, Chuangye; Li, Wenqi; Wu, Jianping; Yan, Nieng] Tsinghua Univ, Sch Life Sci, Ctr Struct Biol, Beijing 100084, Peoples R China; [Li, Quanxiu; Yan, Chuangye; Li, Wenqi; Wu, Jianping; Yan, Nieng] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Yan, Chuangye; Wu, Jianping] Tsinghua Univ, Minist Educ, Key Lab Prot Sci, Beijing 100084, Peoples R China; [Xu, Huisha; Wang, Zheng; Long, Jiafu] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Xu, Huisha; Wang, Zheng; Long, Jiafu] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Yin, Ping] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Yin, Ping] Huazhong Agr Univ, Natl Ctr Plant Gene Res, Wuhan 430070, Peoples R China; [Yin, Ping] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Nankai University; Nankai University; Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Yin, P (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Peoples R China.	yinping@mail.hzau.edu.cn; nyan@tsinghua.edu.cn	Long, Jiafu/B-7420-2012; Yan, Chuangye/AAJ-5832-2021	Long, Jiafu/0000-0002-6625-0147; Yan, Chuangye/0000-0001-9338-8048	Ministry of Science and Technology Grant [2011CB910501]; National Natural Science Foundation of China [91017011, 31070644, 31200567]; Fundamental Research Funds for the Central Universities [2662014PY026]; Howard Hughes Medical Institute	Ministry of Science and Technology Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by Ministry of Science and Technology Grant 2011CB910501 (to N. Y.) and Projects 91017011 (to N. Y.), 31070644 (to N. Y.), and 31200567 (to P. Y.) of the National Natural Science Foundation of China and Project 2662014PY026 (to P. Y.) of the Fundamental Research Funds for the Central Universities.; Supported in part by an international early career scientist grant from the Howard Hughes Medical Institute. To whom correspondence may be addressed: School of Life Sciences and School of Medicine, Tsinghua University, Beijing 100084, China. E-mail: nyan@tsinghua.edu.cn.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban T, 2013, J BIOL CHEM, V288, P31540, DOI 10.1074/jbc.M113.496828; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Beick S, 2008, MOL CELL BIOL, V28, P5337, DOI 10.1128/MCB.00563-08; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cushing DA, 2005, PLANTA, V221, P424, DOI 10.1007/s00425-004-1452-x; DeLano W.L, PYMOL MOL GRAPHICS S; Desloire S, 2003, EMBO REP, V4, P588, DOI 10.1038/sj.embor.embor848; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2541; Filipovska A, 2012, MOL BIOSYST, V8, P699, DOI 10.1039/c2mb05392f; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Hu J, 2012, PLANT CELL, V24, P109, DOI 10.1105/tpc.111.093211; Kang CB, 2013, SCI REP-UK, V3, DOI 10.1038/srep02985; Ke JY, 2013, NAT STRUCT MOL BIOL, V20, P1377, DOI 10.1038/nsmb.2710; Khrouchtchova A, 2012, RNA, V18, P1197, DOI 10.1261/rna.032623.112; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; Meierhoff K, 2003, PLANT CELL, V15, P1480, DOI 10.1105/tpc.010397; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Nakamura T, 2003, EUR J BIOCHEM, V270, P4070, DOI 10.1046/j.1432-1033.2003.03796.x; Nakamura T, 2012, PLANT CELL PHYSIOL, V53, P1171, DOI 10.1093/pcp/pcs069; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HC, 2011, MOL CELLS, V32, P143, DOI 10.1007/s10059-011-2297-3; Pfalz J, 2009, EMBO J, V28, P2042, DOI 10.1038/emboj.2009.121; Prikryl J, 2011, P NATL ACAD SCI USA, V108, P415, DOI 10.1073/pnas.1012076108; Saha D, 2007, PLANT PHYSIOL BIOCH, V45, P521, DOI 10.1016/j.plaphy.2007.03.026; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Thebault P, 2012, BIOCHEM J, V448, P321, DOI 10.1042/BJ20121448; Wang ZH, 2006, PLANT CELL, V18, P676, DOI 10.1105/tpc.105.038240; Williams-Carrier R, 2008, RNA, V14, P1930, DOI 10.1261/rna.1077708; Yagi Y, 2014, PLANT J, V78, P772, DOI 10.1111/tpj.12377; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651	43	15	17	1	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31503	31512		10.1074/jbc.M114.575472	http://dx.doi.org/10.1074/jbc.M114.575472			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25231995	Green Published, hybrid			2022-12-28	WOS:000344549900052
J	Tian, J; Tep, C; Benedick, A; Saidi, N; Ryu, JC; Kim, ML; Sadasivan, S; Oberdick, J; Smeyne, R; Zhu, MX; Yoon, SO				Tian, JinBin; Tep, Chhavy; Benedick, Alex; Saidi, Nabila; Ryu, Jae Cheon; Kim, Mi Lyang; Sadasivan, Shankar; Oberdick, John; Smeyne, Richard; Zhu, Michael X.; Yoon, Sung Ok			p75 Regulates Purkinje Cell Firing by Modulating SK Channel Activity through Rac1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIC FACTOR; NMDA RECEPTOR; RHO-GTPASES; CEREBELLAR; EXPRESSION; BDNF; CONDUCTANCE; ACTIVATION; PROTEIN; GROWTH	p75 is expressed among Purkinje cells in the adult cerebellum, but its function has remained obscure. Here we report that p75 is involved in maintaining the frequency and regularity of spontaneous firing of Purkinje cells. The overall spontaneous firing activity of Purkinje cells was increased in p75(-/-) mice during the phasic firing period due to a longer firing period and accompanying reduction in silence period than in the wild type. We attribute these effects to a reduction in small conductance Ca2+-activated potassium (SK) channel activity in Purkinje cells from p75(-/-) mice compared with the wild type littermates. The mechanism by which p75 regulates SK channel activity appears to involve its ability to activate Rac1. In organotypic cultures of cerebellar slices, brain-derived neurotrophic factor increased RacGTP levels by activating p75 but not TrkB. These results correlate with a reduction in RacGTP levels in synaptosome fractions from the p75(-/-) cerebellum, but not in that from the cortex of the same animals, compared with wild type littermates. More importantly, we demonstrate that Rac1 modulates SK channel activity and firing patterns of Purkinje cells. Along with the finding that spine density was reduced in p75(-/-) cerebellum, these data suggest that p75 plays a role in maintaining normalcy of Purkinje cell firing in the cerebellum in part by activating Rac1 in synaptic compartments and modulating SK channels.	[Tep, Chhavy; Benedick, Alex; Saidi, Nabila; Ryu, Jae Cheon; Kim, Mi Lyang; Yoon, Sung Ok] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Tep, Chhavy; Oberdick, John] Ohio State Univ, Biochem Program, Columbus, OH 43210 USA; [Tian, JinBin; Zhu, Michael X.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Sadasivan, Shankar; Smeyne, Richard] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Tian, JinBin; Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; St Jude Children's Research Hospital; University of Texas System; University of Texas Health Science Center Houston	Zhu, MX (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	michael.x.zhu@uth.tmc.edu; sung.yoon@osumc.edu	Yoon, Sung Ok/C-5992-2012; tian, jinbin/L-6006-2019; Tian, JinBin/B-7001-2019	Tian, JinBin/0000-0002-5516-7778; Benedick, Alex/0000-0001-5044-8151; Smeyne, Richard/0000-0002-8459-5472	National Institutes of Health [NS039472, GM092759, P30NS045758]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039472, P30NS045758] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS039472 (to S.O.Y.), GM092759 (to M.X.Z.), and P30NS045758 (to the Ohio State Neuroscience Center Core).	del Rio JA, 2010, NAT PROTOC, V5, P217, DOI 10.1038/nprot.2009.202; Beech D. J., 2007, V179, P109; Bentley CA, 2000, J NEUROSCI, V20, P7706; Blum R, 2002, NATURE, V419, P687, DOI 10.1038/nature01085; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; Boyer SB, 2009, J CELL PHYSIOL, V218, P385, DOI 10.1002/jcp.21610; Buttery P, 2006, P NATL ACAD SCI USA, V103, P1924, DOI 10.1073/pnas.0510655103; Carter AR, 2002, J NEUROSCI, V22, P1316, DOI 10.1523/JNEUROSCI.22-04-01316.2002; Carter AR, 2003, MOL CELL NEUROSCI, V22, P1, DOI 10.1016/S1044-7431(02)00015-5; CASTLE NA, 1989, TRENDS NEUROSCI, V12, P59, DOI 10.1016/0166-2236(89)90137-9; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chapleau C. A., 2012, NEURAL PLAST, V2012; Chen LY, 2010, J NEUROSCI, V30, P10977, DOI 10.1523/JNEUROSCI.1077-10.2010; Cingolani LA, 2002, J NEUROSCI, V22, P4456, DOI 10.1523/JNEUROSCI.22-11-04456.2002; CONSTANTI A, 1987, J PHYSIOL-LONDON, V387, P173, DOI 10.1113/jphysiol.1987.sp016569; Coulson EJ, 2008, J NEUROSCI, V28, P315, DOI 10.1523/JNEUROSCI.2699-07.2008; De Curtis I, 2008, DEV NEUROSCI-BASEL, V30, P47, DOI 10.1159/000109851; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; Faber ESL, 2002, J NEUROSCI, V22, P1618, DOI 10.1523/JNEUROSCI.22-05-01618.2002; Harrington AW, 2002, J NEUROSCI, V22, P156, DOI 10.1523/JNEUROSCI.22-01-00156.2002; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; He XP, 2010, J NEUROSCI, V30, P6188, DOI 10.1523/JNEUROSCI.5821-09.2010; Hosy E, 2011, J PHYSIOL-LONDON, V589, P3433, DOI 10.1113/jphysiol.2011.205823; Ito M, 1984, CEREBELLUM NEURAL CO; Karpushev AV, 2011, HYPERTENSION, V57, P996, DOI 10.1161/HYPERTENSIONAHA.110.157784; Karpushev AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008827; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Kinoshita H, 2008, HYPERTENSION, V52, P507, DOI 10.1161/HYPERTENSIONAHA.108.118216; Lang SB, 2007, J NEUROSCI, V27, P1097, DOI 10.1523/JNEUROSCI.3590-06.2007; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Liebau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018148; Lippman JJ, 2008, GLIA, V56, P1463, DOI 10.1002/glia.20712; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Meyer DK, 2000, J NEUROSCI, V20, P6743, DOI 10.1523/JNEUROSCI.20-18-06743.2000; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Oh D, 2010, J NEUROSCI, V30, P14134, DOI 10.1523/JNEUROSCI.1711-10.2010; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Raman IM, 1999, J NEUROSCI, V19, P1663; Richard V, 2008, INT J DEV NEUROSCI, V26, P723, DOI 10.1016/j.ijdevneu.2008.07.010; ROCAMORA N, 1993, MOL BRAIN RES, V17, P1, DOI 10.1016/0169-328X(93)90065-W; SAH P, 1992, J NEUROPHYSIOL, V68, P2237, DOI 10.1152/jn.1992.68.6.2237; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Storey NM, 2002, CURR BIOL, V12, P27, DOI 10.1016/S0960-9822(01)00625-X; Swensen AM, 2003, J NEUROSCI, V23, P9650; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tep C, 2012, J BIOL CHEM, V287, P1600, DOI 10.1074/jbc.M111.312736; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tolias KF, 2007, P NATL ACAD SCI USA, V104, P7265, DOI 10.1073/pnas.0702044104; van der Wijst J, 2009, MAGNESIUM RES, V22, P127; Ven TJV, 2005, J NEUROSCI, V25, P9488, DOI 10.1523/JNEIROSCI.2450-05.2005; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; WilkBlaszczak MA, 1997, J NEUROSCI, V17, P4094; Womack M, 2002, J NEUROSCI, V22, P10603; Womack MD, 2009, NEUROSCIENCE, V162, P989, DOI 10.1016/j.neuroscience.2009.05.016; Womack MD, 2004, J NEUROSCI, V24, P3511, DOI 10.1523/JNEUROSCI.0290-04.2004; Womack MD, 2003, J NEUROSCI, V23, P2600; Xie Z, 2008, J NEUROSCI, V28, P6079, DOI 10.1523/JNEUROSCI.1170-08.2008; Xu ZQ, 2011, EUR J NEUROSCI, V33, P1376, DOI 10.1111/j.1460-9568.2011.07635.x; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030	70	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31458	31472		10.1074/jbc.M114.589937	http://dx.doi.org/10.1074/jbc.M114.589937			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25253694	Green Published, hybrid			2022-12-28	WOS:000344549900048
J	Tripathi, K; Mani, C; Barnett, R; Nalluri, S; Bachaboina, L; Rocconi, RP; Athar, M; Owen, LB; Palle, K				Tripathi, Kaushlendra; Mani, Chinnadurai; Barnett, Reagan; Nalluri, Sriram; Bachaboina, Lavanya; Rocconi, Rodney P.; Athar, Mohammed; Owen, Laurie B.; Palle, Komaraiah			Gli1 Protein Regulates the S-phase Checkpoint in Tumor Cells via Bid Protein, and Its Inhibition Sensitizes to DNA Topoisomerase 1 Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE-INDUCED SENESCENCE; TRANSCRIPTION FACTORS; HEDGEHOG PATHWAY; REPLICATION FORKS; HUMAN HOMOLOG; STEM-CELL; CANCER; DAMAGE; SURVIVAL; GROWTH	Aberrant expression of hedgehog molecules, particularly Gli1, iscommonin cancers of many tissues and is responsible for their aggressive behavior and chemoresistance. Here we demonstrate a novel and tumor-specific role for aberrant Gli1 in the regulation of the S-phase checkpoint that suppresses replication stress and resistance to chemotherapy. Inhibition of Gli1 in tumor cells induced replication stress-mediated DNA damage response, attenuated their clonogenic potential, abrogated camptothecin (CPT)-induced Chk1 phosphorylation, and potentiated its cytotoxicity. However, in normal fibroblasts, Gli1 siRNAs showed no significant changes in CPT-induced Chk1 phosphorylation. Further analysis of ataxia telangiectasia and Rad3-related protein (ATR)/Chk1 signaling cascade genes in tumor cells revealed an unexpected mechanism whereby Gli1 regulates ATR-mediated Chk1 phosphorylation by transcriptional regulation of the BH3-only protein Bid. Consistent with its role in DNA damage response, Bid down-regulation in tumor cells abolished CPT-induced Chk1 phosphorylation and sensitized them to CPT. Correspondingly, Gli1 inhibition affected the expression of Bid and the association of replication protein A (RPA) with the ATR-interacting protein (ATRIP)-ATR complex, and this compromised the S-phase checkpoint. Conversely, complementation of Bid in Gli1-deficient cells restored CPT-induced Chk1 phosphorylation. An in silico analysis of the Bid promoter identified a putative Gli1 binding site, and further studies using luciferase reporter assays confirmed Gli1-dependent promoter activity. Collectively, our studies established a novel connection between aberrant Gli1 and Bid in the survival of tumor cells and their response to chemotherapy, at least in part, by regulating the S-phase checkpoint. Importantly, our data suggest a novel drug combination of Gli1 and Top1 inhibitors as an effective therapeutic strategy in treating tumors that expresses Gli1.	[Tripathi, Kaushlendra; Mani, Chinnadurai; Barnett, Reagan; Nalluri, Sriram; Bachaboina, Lavanya; Rocconi, Rodney P.; Owen, Laurie B.; Palle, Komaraiah] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36604 USA; [Athar, Mohammed] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA	University of South Alabama; University of Alabama System; University of Alabama Birmingham	Palle, K (corresponding author), Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, 1660 Springhill Ave, Mobile, AL 36604 USA.	kpalle@health.southalabama.edu	tripathi, kaushlendra/O-3022-2013	tripathi, kaushlendra/0000-0002-3578-2917; Barnett, Reagan/0000-0002-6612-2241	National Institutes of Health [R01GM098956, RO1 CA138998]; Abraham Mitchell Cancer Research scholar endowment grant; NATIONAL CANCER INSTITUTE [R01CA138998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abraham Mitchell Cancer Research scholar endowment grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM098956 (to K. P.) and RO1 CA138998 (to M. A.). This work was also supported by an Abraham Mitchell Cancer Research scholar endowment grant (to K. P.).	Agyeman A, 2012, ONCOTARGET, V3, P854; Athar M, 2014, CANCER RES, V74, P4967, DOI 10.1158/0008-5472.CAN-14-1666; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Burrows AE, 2008, GENE DEV, V22, P1416, DOI 10.1101/gad.1685108; Chen AY, 2012, J THORAC DIS, V4, P390, DOI 10.3978/j.issn.2072-1439.2012.07.12; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Frappart PO, 2009, P NATL ACAD SCI USA, V106, P1880, DOI 10.1073/pnas.0806882106; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Gershon TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007491; Gorlin RJ, 2004, GENET MED, V6, P530, DOI 10.1097/01.GIM.0000144188.15902.C4; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Harrison W, 2014, ONCOGENE, V33, P2432, DOI 10.1038/onc.2013.199; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; HSIANG YH, 1989, CANCER RES, V49, P5077; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Joost S, 2012, CANCER RES, V72, P88, DOI 10.1158/0008-5472.CAN-10-4621; Karnani N, 2011, GENE DEV, V25, P621, DOI 10.1101/gad.2029711; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kaufmann WK, 2007, CELL CYCLE, V6, P1460; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Kudo K, 2012, ONCOGENE, V31, P4718, DOI 10.1038/onc.2011.610; Lauth M, 2007, CURR OPIN INVEST DR, V8, P457; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Liu PJ, 2009, CELL CYCLE, V8, P125, DOI 10.4161/cc.8.1.7528; Liu Y, 2012, CELL DEATH DIFFER, V19, P1602, DOI 10.1038/cdd.2012.38; Liu Y, 2011, CELL DEATH DIFFER, V18, P841, DOI 10.1038/cdd.2010.151; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Ma CX, 2011, TRENDS MOL MED, V17, P88, DOI 10.1016/j.molmed.2010.10.009; Mazumdar T, 2011, ONCOTARGET, V2, P638; Mazumdar T, 2011, CANCER RES, V71, P5904, DOI 10.1158/0008-5472.CAN-10-4173; Mazumdar T, 2011, CANCER RES, V71, P1092, DOI 10.1158/0008-5472.CAN-10-2315; Meng E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107142; Mori Y, 2006, ONCOLOGY-BASEL, V70, P378, DOI 10.1159/000098111; Moukharskaya J, 2012, HEMATOL ONCOL CLIN N, V26, P507, DOI 10.1016/j.hoc.2012.03.002; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Palle K, 2011, CELL CYCLE, V10, P1625, DOI 10.4161/cc.10.10.15617; Paul P, 2013, ONCOTARGET, V4, P1149, DOI 10.18632/oncotarget.1074; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Petermann E, 2006, MOL CELL BIOL, V26, P3319, DOI 10.1128/MCB.26.8.3319-3326.2006; Ping XL, 2001, J INVEST DERMATOL, V116, P614, DOI 10.1046/j.1523-1747.2001.01301.x; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Regairaz M, 2011, J CELL BIOL, V195, P739, DOI 10.1083/jcb.201104003; ROBINSON JR, 1969, INT J APPL RADIAT IS, V20, P531, DOI 10.1016/0020-708X(69)90007-6; Roos-Mattjus P, 2003, J BIOL CHEM, V278, P24428, DOI 10.1074/jbc.M301544200; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sarosiek KA, 2013, MOL CELL, V51, P751, DOI 10.1016/j.molcel.2013.08.048; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Shao RG, 1997, CANCER RES, V57, P4029; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; ten Haaf A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-298; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhu GD, 2013, ONCOL REP, V30, P904, DOI 10.3892/or.2013.2534; Zinkel SS, 2007, CELL, V130, P9, DOI 10.1016/j.cell.2007.06.035; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	73	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31513	31525		10.1074/jbc.M114.606483	http://dx.doi.org/10.1074/jbc.M114.606483			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25253693	hybrid, Green Published			2022-12-28	WOS:000344549900053
J	Kwan, HY; Fu, XQ; Liu, B; Chao, XJ; Chan, CL; Cao, HH; Su, T; Tse, AKW; Fong, WF; Yu, ZL				Kwan, Hiu Yee; Fu, Xiuqiong; Liu, Bin; Chao, Xiaojuan; Chan, Chi Leung; Cao, Huihui; Su, Tao; Tse, Anfernee Kai Wing; Fong, Wang Fun; Yu, Zhi-Ling			Subcutaneous Adipocytes Promote Melanoma Cell Growth by Activating the Akt Signaling Pathway ROLE OF PALMITIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA-CARBOXYLASE-ALPHA; CANCER-CELLS; FATTY-ACIDS; MALIGNANT-MELANOMA; SYNTHASE; OBESITY; METABOLISM; PROLIFERATION; IDENTIFICATION; INHIBITION	Tumorigenesis involves constant communication between tumor cells and neighboring normal cells such as adipocytes. The canonical function of adipocytes is to store triglyceride and release fatty acids for other tissues. This study was aimed to find out if adipocytes promoted melanoma cell growth and to investigate the underlying mechanism. Here we isolated adipocytes from inguinal adipose tissue in mice and co-cultured with melanoma cells. We found that the co-cultured melanoma had higher lipid accumulation compared with mono-cultured melanoma. In addition, fluorescently labeled fatty acid BODIPY (R) FLC16 signal was detected in melanoma co-cultured with the adipocytes that had been loaded with the fluorescent dye, suggesting that the adipocytes provide fatty acids to melanoma cells. Compared with mono-cultured melanoma, co-cultured melanoma cells had a higher proliferation and phospho-Akt (Ser-473 and Thr-450) expression. Overexpression of Akt mutants in melanoma cells reduced the co-culture-enhanced proliferation. A lipidomic study showed that the co-cultured melanoma had an elevated palmitic acid level. Interestingly, we found that palmitic acid stimulated melanoma cell proliferation, changed the cell cycle distribution, and increased phospho-Akt (Ser-473 and Thr-450) and PI3K but not phospho-PTEN (phosphophosphatase and tensin homolog) expressions. More importantly, the palmitic acid-stimulated proliferation was further enhanced in the Akt-overexpressed melanoma cells and was reduced by LY294002 or knockdown of endogenous Akt or overexpression of Akt mutants. We also found that palmitic acid-pretreated B16F10 cells were grown to a significantly larger tumor in mice compared with control cells. Taken together, we suggest that adipocytes may serve as an exogenous source of palmitic acid that promotes melanoma cell growth by activating Akt.	[Tse, Anfernee Kai Wing; Fong, Wang Fun; Yu, Zhi-Ling] Hong Kong Baptist Univ, Sch Chinese Med, Ctr Canc & Inflammat Res, Kowloon Tong, Hong Kong, Peoples R China; [Liu, Bin] Guangzhou Med Univ, Guangzhou Inst Cardiovasc Dis, Guangzhou Key Lab Cardiovasc Dis, Guangzhou, Guangdong, Peoples R China; [Liu, Bin] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China	Hong Kong Baptist University; Guangzhou Medical University; Guangzhou Medical University	Kwan, HY (corresponding author), Hong Kong Baptist Univ, Sch Chinese Med, 7 Baptist Univ Rd, Kowloon Tong, Hong Kong, Peoples R China.	hykwan@hkbu.edu.hk; zlyu@hkbu.edu.hk		Yu, Zhiling/0000-0002-2979-9608; Tse, Kai Wing/0000-0002-0046-9808; Liu, Bin/0000-0003-2184-4723; KWAN, Hiu Yee/0000-0002-6088-7323; Fu, Xiu-Qiong/0000-0002-1458-9720	Research Grant Council of SAR of Hong Kong under GRF [HKBU262512, HKBU260613]; Hong Kong Baptist University [FRG2/13-14/016, FRG1/13-14/062, FRG2/12-13/039, FRG2/13-14/030]; Shenzhen STIC Grant [JCYJ20120829154222473]	Research Grant Council of SAR of Hong Kong under GRF; Hong Kong Baptist University; Shenzhen STIC Grant	This work was supported in part by the Research Grant Council of SAR of Hong Kong under GRF (HKBU262512) and Hong Kong Baptist University Grants FRG2/13-14/016 and FRG1/13-14/062 and by Shenzhen STIC Grant JCYJ20120829154222473 (to Z.-L. Y.). This work was also supported by Research Grant Council of SAR of Hong Kong under GRF (HKBU260613) and Hong Kong Baptist University Grant FRG2/12-13/039 and FRG2/13-14/030 (to H. Y. K.).	Abaffy T, 2013, METABOLOMICS, V9, P998, DOI 10.1007/s11306-013-0523-z; Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Ahmadian M, 2007, FUTURE LIPIDOL, V2, P229, DOI 10.2217/17460875.2.2.229; Amemori Sadahiro, 2007, Am J Physiol Gastrointest Liver Physiol, V292, pG923; Bai JN, 1997, BIOCHEMISTRY-US, V36, P8840, DOI 10.1021/bi970145r; Brandon EL, 2009, CANCER BIOL THER, V8, P1871, DOI 10.4161/cbt.8.19.9650; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; D'Esposito V, 2012, DIABETOLOGIA, V55, P2811, DOI 10.1007/s00125-012-2629-7; Dennis LK, 2008, ANN EPIDEMIOL, V18, P214, DOI 10.1016/j.annepidem.2007.09.003; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Ellerhorst JA, 2010, ONCOL REP, V23, P901, DOI 10.3892/or_00000713; Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005; Furuya Y, 1997, ANTICANCER RES, V17, P4589; Gazi E, 2007, J LIPID RES, V48, P1846, DOI 10.1194/jlr.M700131-JLR200; Hardy S, 2005, J BIOL CHEM, V280, P13285, DOI 10.1074/jbc.M410922200; Harvey AE, 2011, ANN NY ACAD SCI, V1229, P45, DOI 10.1111/j.1749-6632.2011.06096.x; Jung JI, 2015, INT J CANCER, V136, P258, DOI 10.1002/ijc.28983; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Kushiro K, 2012, CANCER MICROENVIRON, V5, P73, DOI 10.1007/s12307-011-0087-2; Kushiro K, 2011, CLIN EXP METASTAS, V28, P877, DOI 10.1007/s10585-011-9418-4; Kwan HY, 2013, J PROTEOME RES, V12, P1387, DOI 10.1021/pr3010327; Louie SM, 2013, BBA-MOL CELL BIOL L, V1831, P1566, DOI 10.1016/j.bbalip.2013.07.008; Madhunapantula Subbarao V, 2011, Enzyme Res, V2011, P327923, DOI 10.4061/2011/327923; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Nieman KM, 2013, BBA-MOL CELL BIOL L, V1831, P1533, DOI 10.1016/j.bbalip.2013.02.010; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Peng G, 2011, ENDOCRINOLOGY, V152, P2206, DOI 10.1210/en.2010-1369; Pizer ES, 1996, CANCER RES, V56, P745; Prados J, 2010, EXP DERMATOL, V19, P363, DOI 10.1111/j.1600-0625.2009.00914.x; Proebstle TM, 1996, EUR J CANCER, V32A, P1664, DOI 10.1016/0959-8049(95)00534-X; Pu J, 2011, J LIPID RES, V52, P1319, DOI 10.1194/jlr.M011254; Ralph SJ, 2010, MOL ASPECTS MED, V31, P29, DOI 10.1016/j.mam.2009.12.006; Roberts DL, 2010, ANNU REV MED, V61, P301, DOI 10.1146/annurev.med.080708.082713; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Seguin F, 2012, BRIT J CANCER, V107, P977, DOI 10.1038/bjc.2012.355; Sergentanis TN, 2013, EUR J CANCER, V49, P642, DOI 10.1016/j.ejca.2012.08.028; Vinciguerra M, 2008, GASTROENTEROLOGY, V134, P268, DOI 10.1053/j.gastro.2007.10.010; Wang X, 2011, FREE RADICAL BIO MED, V51, P539, DOI 10.1016/j.freeradbiomed.2011.04.019; Wang XL, 2006, DIABETES, V55, P2301, DOI 10.2337/db05-1574; Wang Z, 2014, J NEUROSCI RES, V92, P574, DOI 10.1002/jnr.23342; Wangari-Talbot Janet, 2013, Frontiers in Genetics, V3, P330, DOI 10.3389/fgene.2012.00330; Yajima I, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/354191	49	50	51	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30525	30537		10.1074/jbc.M114.593210	http://dx.doi.org/10.1074/jbc.M114.593210			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25228694	hybrid, Green Published			2022-12-28	WOS:000344549700031
J	Lee, HK; Lee, DS; Park, SJ; Cho, KH; Bae, HS; Park, JC				Lee, Hye-Kyung; Lee, Dong-Seol; Park, Su-Jin; Cho, Kwang-Hee; Bae, Hyun-Sook; Park, Joo-Cheol			Nuclear Factor I-C (NFIC) Regulates Dentin Sialophosphoprotein (DSPP) and E-cadherin via Control of Kruppel-like Factor 4 (KLF4) During Dentinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TOOTH ROOT DEVELOPMENT; MATRIX PROTEIN-1 DMP1; ODONTOBLAST DIFFERENTIATION; PULP CELLS; EXPRESSION; CANCER; ROLES; OVEREXPRESSION; ODONTOGENESIS	Odontoblasts are a type of terminally differentiated matrix-secreting cells. A number of molecular mechanisms are involved in the differentiation of odontoblasts. Several studies demonstrated that Kruppel-like factor 4 (KLF4) promotes odontoblast differentiation via control of dentin sialophosphoprotein (DSPP). Because nuclear factor I-C (NFIC) is also known to control DSPP, we investigated the relationship between NFIC and KLF4 during odontoblast differentiation. Klf4 mRNA expression was significantly decreased in Nfic(-/-) pulp cells compared with wild type cells. In immunohistochemistry assays, dentin matrix protein 1 (Dmp1), and DSP protein expression was barely observed in Nfic(-/-) odontoblasts and dentin matrix. Nfic bound directly to the Klf4 promoter and stimulated Klf4 transcriptional activity, thereby regulating Dmp1 and DSPP expression during odontoblast differentiation. Nfic or Klf4 overexpression promoted mineralized nodule formation in MDPC-23 cells. In addition, Nfic overexpression also decreased Slug luciferase activity but augmented E-cadherin promoter activity via up-regulation of Klf4 in odontoblasts. Our study reveals important signaling pathways during dentinogenesis: the Nfic-Klf4-Dmp1-Dspp and the Nfic-Klf4-E-cadherin pathways in odontoblasts. Our results indicate the important role of NFIC in regulating KLF4 during dentinogenesis.	[Lee, Hye-Kyung; Lee, Dong-Seol; Park, Su-Jin; Park, Joo-Cheol] Seoul Natl Univ, Sch Dent, Dept Oral Histol Dev Biol, Seoul 110749, South Korea; [Lee, Hye-Kyung; Lee, Dong-Seol; Park, Su-Jin; Park, Joo-Cheol] Seoul Natl Univ, Sch Dent, Dent Res Inst, Seoul 110749, South Korea; [Cho, Kwang-Hee; Bae, Hyun-Sook] Namseoul Univ, Dept Dent Hyg, Cheonan 331707, Chung Nam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Namseoul University	Park, JC (corresponding author), Seoul Natl Univ, Sch Dent, Dept Oral Histol Dev Biol, 101 Daehagro, Seoul 110749, South Korea.	jcapark@snu.ac.kr	Park, Joo Cheol/D-6437-2012; Lee, Dong-Seol/GLN-3829-2022	Park, Joo Cheol/0000-0002-3162-7557; LEE, HYE KYUNG/0000-0002-7785-5942	National Research Foundation of Korea [NRF-2013R1A2A2A01010911, NRF-2013037491, NRF-2013M3A9B2076480]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea Grants NRF-2013R1A2A2A01010911, NRF-2013037491, and NRF-2013M3A9B2076480.	Abe S, 2012, CELL BIOL INT, V36, P927, DOI 10.1042/CBI20110506; Arana-Chavez VE, 2004, INT J BIOCHEM CELL B, V36, P1367, DOI 10.1016/j.biocel.2004.01.006; AranaChavez VE, 1997, ANAT REC, V248, P332, DOI 10.1002/(SICI)1097-0185(199707)248:3<332::AID-AR5>3.0.CO;2-R; Bandyopadhyay S, 1998, J BIOL CHEM, V273, P392, DOI 10.1074/jbc.273.1.392; Chaudhry AZ, 1999, J BIOL CHEM, V274, P7072, DOI 10.1074/jbc.274.11.7072; Chaudhry AZ, 1998, J BIOL CHEM, V273, P18538, DOI 10.1074/jbc.273.29.18538; Chen Z, 2009, ARCH ORAL BIOL, V54, P403, DOI 10.1016/j.archoralbio.2009.02.003; Couble ML, 2000, CALCIFIED TISSUE INT, V66, P129, DOI 10.1007/PL00005833; del Barrio MG, 2002, DEVELOPMENT, V129, P1583; Diekwisch T, 1989, Acta Histochem Suppl, V37, P209; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Gibson MP, 2013, J BIOL CHEM, V288, P7204, DOI 10.1074/jbc.M112.445775; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Heymann R, 2002, AM J PATHOL, V160, P2123, DOI 10.1016/S0002-9440(10)61161-3; Hosoya A, 2006, J HISTOCHEM CYTOCHEM, V54, P1371, DOI 10.1369/jhc.6A6980.2006; Iida K, 2013, J DENT RES, V92, P905, DOI 10.1177/0022034513502204; Kwon A, 2012, J DENT RES, V91, P506, DOI 10.1177/0022034512443367; Lee DS, 2014, STEM CELLS, V32, P2467, DOI 10.1002/stem.1733; Lee DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029160; Lee DS, 2009, J BIOL CHEM, V284, P17293, DOI 10.1074/jbc.M109.009084; LESOT H, 1982, DIFFERENTIATION, V21, P133, DOI 10.1111/j.1432-0436.1982.tb01206.x; Lin H, 2013, J CELL PHYSIOL, V228, P2076, DOI 10.1002/jcp.24377; Lin H, 2011, J ENDODONT, V37, P948, DOI 10.1016/j.joen.2011.03.030; Liu H, 2013, J BIOL CHEM, V288, P9261, DOI 10.1074/jbc.M112.433730; Liu YN, 2012, MOL CELL BIOL, V32, P941, DOI 10.1128/MCB.06306-11; MINA M, 1987, ARCH ORAL BIOL, V32, P123, DOI 10.1016/0003-9969(87)90055-0; Narayanan K, 2001, P NATL ACAD SCI USA, V98, P4516, DOI 10.1073/pnas.081075198; Nilsson J, 2010, CANCER RES, V70, P2020, DOI 10.1158/0008-5472.CAN-09-1677; Oh HJ, 2012, J CELL BIOCHEM, V113, P877, DOI 10.1002/jcb.23421; Park JC, 2007, J PERIODONTOL, V78, P1795, DOI 10.1902/jop.2007.060363; Qin C, 2007, J DENT RES, V86, P1134, DOI 10.1177/154405910708601202; SLAVKIN HC, 1976, DEV BIOL, V50, P428, DOI 10.1016/0012-1606(76)90163-9; Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003; ten Cate JM, 1998, CARIES RES, V32, P141, DOI 10.1159/000016444; Tiwari N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057329; Wang X, 2011, ONCOGENE, V30, P1901, DOI 10.1038/onc.2010.563; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546	39	30	33	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28225	28236		10.1074/jbc.M114.568691	http://dx.doi.org/10.1074/jbc.M114.568691			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25138274	Green Published, hybrid			2022-12-28	WOS:000343765400019
J	Brumshtein, B; Esswein, SR; Landau, M; Ryan, CM; Whitelegge, JP; Phillips, ML; Cascio, D; Sawaya, MR; Eisenberg, DS				Brumshtein, Boris; Esswein, Shannon R.; Landau, Meytal; Ryan, Christopher M.; Whitelegge, Julian P.; Phillips, Martin L.; Cascio, Duilio; Sawaya, Michael R.; Eisenberg, David S.			Formation of Amyloid Fibers by Monomeric Light Chain Variable Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Antibody; Multiple Myeloma; Protein Aggregation; X-ray Crystallography; Bence-Jones Proteins; Light Chain Amyloidosis; Light Chain Variable Domains; Systemic Amyloidosis	BENCE-JONES PROTEIN; IN-VITRO; 3-DIMENSIONAL STRUCTURE; SYSTEMIC AMYLOIDOSES; MOLECULAR-STRUCTURE; FIBRIL FORMATION; DIMER INTERFACE; IMMUNOGLOBULIN; CRYSTAL; TRANSTHYRETIN	Background: Amyloid fibers are protein aggregates associated with numerous pathologies. Results: Mcg light chain variable domains form amyloid fibers through monomers. Conclusion: This light chain variable domain monomer is the fundamental unit required to form amyloid fibers. Significance: Understanding the molecular mechanism of Mcg light chain amyloid fiber formation has implications for treating systemic amyloidosis. Systemic light chain amyloidosis is a lethal disease characterized by excess immunoglobulin light chains and light chain fragments composed of variable domains, which aggregate into amyloid fibers. These fibers accumulate and damage organs. Some light chains induce formation of amyloid fibers, whereas others do not, making it unclear what distinguishes amyloid formers from non-formers. One mechanism by which sequence variation may reduce propensity to form amyloid fibers is by shifting the equilibrium toward an amyloid-resistant quaternary structure. Here we identify the monomeric form of the Mcg immunoglobulin light chain variable domain as the quaternary unit required for amyloid fiber assembly. Dimers of Mcg variable domains remain stable and soluble, yet become prone to assemble into amyloid fibers upon disassociation into monomers.	[Brumshtein, Boris; Esswein, Shannon R.; Landau, Meytal; Phillips, Martin L.; Cascio, Duilio; Sawaya, Michael R.; Eisenberg, David S.] UCLA, Howard Hughes Med Inst, Inst Genom & Prote, Dept Biol Chem,DOE, Los Angeles, CA 90095 USA; [Brumshtein, Boris; Esswein, Shannon R.; Landau, Meytal; Phillips, Martin L.; Cascio, Duilio; Sawaya, Michael R.; Eisenberg, David S.] UCLA, Howard Hughes Med Inst, Inst Genom & Prote, Dept Chem & Biochem,DOE, Los Angeles, CA 90095 USA; [Ryan, Christopher M.; Whitelegge, Julian P.] UCLA, David Geffen Sch Med, Pasarow Mass Spectrometry Lab, NPI,Semel Inst, Los Angeles, CA 90025 USA	Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Eisenberg, DS (corresponding author), UCLA, Howard Hughes Med Inst, Inst Genom & Prote, Dept Biol Chem,DOE, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu	Landau, Meytal/J-3075-2012; Landau, Meytal/AAF-3479-2021	Landau, Meytal/0000-0002-1743-3430; Landau, Meytal/0000-0002-1743-3430; Sawaya, Michael/0000-0003-0874-9043; Esswein, Shannon/0000-0002-5142-0190	National Institutes of Health [AG-029430]; National Science Foundation [MCB-0958111]; Amyloidosis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029430, R01AG048120, RF1AG048120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Amyloidosis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG-029430 (to D. S. E.). This work was also supported by National Science Foundation Grant MCB-0958111.; Recipient of a fellowship from the Amyloidosis Foundation.	Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Baden EM, 2009, CURR PROTEIN PEPT SC, V10, P500, DOI 10.2174/138920309789351949; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; BERNIER GM, 1963, NATURE, V200, P223, DOI 10.1038/200223b0; Blancas-Mejia LM, 2013, ANNU REV BIOCHEM, V82, P745, DOI 10.1146/annurev-biochem-072611-130030; Bodi K, 2009, AMYLOID, V16, P1, DOI 10.1080/13506120802676781; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bourne PC, 2002, ACTA CRYSTALLOGR D, V58, P815, DOI 10.1107/S0907444902004183; BUXBAUM J, 1992, HEMATOL ONCOL CLIN N, V6, P323, DOI 10.1016/S0889-8588(18)30347-2; BUXBAUM J, 1986, J CLIN INVEST, V78, P798, DOI 10.1172/JCI112643; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P370; COLMAN PM, 1977, J MOL BIOL, V116, P73, DOI 10.1016/0022-2836(77)90119-X; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; DAHLIN DC, 1950, AM J PATHOL, V26, P581; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Edmundson A B, 1969, ANL Rep, P283; EDMUNDSON AB, 1993, PROTEINS, V16, P246, DOI 10.1002/prot.340160304; EDMUNDSON AB, 1984, MOL IMMUNOL, V21, P561, DOI 10.1016/0161-5890(84)90041-5; EDMUNDSON AB, 1976, FED PROC, V35, P2119; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; ELY KR, 1989, J MOL BIOL, V210, P601, DOI 10.1016/0022-2836(89)90135-6; EPP O, 1975, BIOCHEMISTRY-US, V14, P4943, DOI 10.1021/bi00693a025; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; FIRCA JR, 1978, BIOCHEMISTRY-US, V17, P148, DOI 10.1021/bi00594a022; GEDDES AJ, 1968, J MOL BIOL, V32, P343, DOI 10.1016/0022-2836(68)90014-4; GLENNER GG, 1970, BIOCHEM BIOPH RES CO, V41, P1287, DOI 10.1016/0006-291X(70)90227-5; GLENNER GG, 1973, BRIT J HAEMATOL, V24, P533, DOI 10.1111/j.1365-2141.1973.tb01679.x; GLENNER GG, 1971, SCIENCE, V174, P712, DOI 10.1126/science.174.4010.712; Guo ZF, 2006, P NATL ACAD SCI USA, V103, P8042, DOI 10.1073/pnas.0602607103; Hanson BL, 2002, J MOL RECOGNIT, V15, P297, DOI 10.1002/jmr.591; Hernandez-Santoyo A, 2010, J MOL BIOL, V396, P280, DOI 10.1016/j.jmb.2009.11.038; HOBBS JR, 1973, P ROY SOC MED, V66, P705, DOI 10.1177/003591577306600751; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Jones H. B., 1848, PHILOS T R SOC LOND, V138, P55; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; KISHIDA F, 1975, J BIOCHEM, V77, P481, DOI 10.1093/oxfordjournals.jbchem.a130749; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lavatelli F, 2008, MOL CELL PROTEOMICS, V7, P1570, DOI 10.1074/mcp.M700545-MCP200; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Makino DL, 2007, ACTA CRYSTALLOGR D, V63, P780, DOI 10.1107/S0907444907021981; MARCHALONIS JJ, 1989, FASEB J, V3, P2469, DOI 10.1096/fasebj.3.13.2509274; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Olsen KE, 1998, BIOCHEM BIOPH RES CO, V251, P642, DOI 10.1006/bbrc.1998.9508; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace C N, 1986, Methods Enzymol, V131, P266; Peterson FC, 2010, STRUCTURE, V18, P563, DOI 10.1016/j.str.2010.02.012; Qin ZJ, 2007, BIOCHEMISTRY-US, V46, P3521, DOI 10.1021/bi061716v; RICHARDSON JS, 1977, NATURE, V268, P495, DOI 10.1038/268495a0; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; STEVENS FJ, 1995, BIOCHEMISTRY-US, V34, P10697, DOI 10.1021/bi00034a001; STEVENS FJ, 1980, P NATL ACAD SCI-BIOL, V77, P1144, DOI 10.1073/pnas.77.2.1144; Terzyan SS, 2003, J MOL RECOGNIT, V16, P83, DOI 10.1002/jmr.610; Vrana JA, 2009, BLOOD, V114, P4957, DOI 10.1182/blood-2009-07-230722; Wall J, 1999, METHOD ENZYMOL, V309, P204	63	29	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27513	27525		10.1074/jbc.M114.585638	http://dx.doi.org/10.1074/jbc.M114.585638			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25138218	hybrid, Green Published			2022-12-28	WOS:000342852800014
J	Kim, Y; Kim, H; Park, H; Park, D; Lee, H; Lee, YS; Choe, J; Kim, YM; Jeoung, D				Kim, Youngmi; Kim, Hyuna; Park, Hyunmi; Park, Deokbum; Lee, Hansoo; Lee, Yun Sil; Choe, Jongseon; Kim, Young Myeong; Jeoung, Dooil			miR-326-Histone Deacetylase-3 Feedback Loop Regulates the Invasion and Tumorigenic and Angiogenic Response to Anti-cancer Drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Gene Expression; Histone Deacetylase 3 (HDAC3); MicroRNA (miRNA); Tumor Metastases; Anti-cancer Drug Resistance; Feedback Loop; miR-326	CANCER/TESTIS ANTIGEN CAGE; HISTONE DEACETYLASE; CELL-PROLIFERATION; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; GENE-EXPRESSION; LUNG-CANCER; HDAC3; RESISTANCE; PACLITAXEL	Histone modification is known to be associated with multidrug resistance phenotypes. Cancer cell lines that are resistant or have been made resistant to anti-cancer drugs showed lower expression levels of histone deacetylase-3 (HDAC3), among the histone deacetylase(s), than cancer cell lines that were sensitive to anti-cancer drugs. Celastrol and Taxol decreased the expression of HDAC3 in cancer cell lines sensitive to anti-cancer drugs. HDAC3 negatively regulated the invasion, migration, and anchorage-independent growth of cancer cells. HDAC3 conferred sensitivity to anti-cancer drugs in vitro and in vivo. TargetScan analysis predicted miR-326 as a negative regulator of HDAC3. ChIP assays and luciferase assays showed a negative feedback loop between HDAC3 and miR-326. miR-326 decreased the apoptotic effect of anti-cancer drugs, and the miR-326 inhibitor increased the apoptotic effect of anti-cancer drugs. miR-326 enhanced the invasion and migration potential of cancer cells. The miR-326 inhibitor negatively regulated the tumorigenic, metastatic, and angiogenic potential of anti-cancer drug-resistant cancer cells. HDAC3 showed a positive feedback loop with miRNAs such as miR-200b, miR-217, and miR-335. miR-200b, miR-217, and miR-335 negatively regulated the expression of miR-326 and the invasion and migration potential of cancer cells while enhancing the apoptotic effect of anti-cancer drugs. TargetScan analysis predicted miR-200b and miR-217 as negative regulators of cancer-associated gene, a cancer/testis antigen, which is known to regulate the response to anti-cancer drugs. HDAC3 and miR-326 acted upstream of the cancer-associated gene. Thus, we show that the miR-326-HDAC3 feedback loop can be employed as a target for the development of anti-cancer therapeutics.	[Kim, Youngmi; Kim, Hyuna; Park, Hyunmi; Park, Deokbum; Jeoung, Dooil] Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon 200701, South Korea; [Lee, Hansoo] Kangwon Natl Univ, Dept Biol Sci, Coll Nat Sci, Chunchon 200701, South Korea; [Choe, Jongseon; Kim, Young Myeong] Kangwon Natl Univ, Grad Sch Med, Chunchon 200701, South Korea; [Lee, Yun Sil] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Ewha Womans University	Jeoung, D (corresponding author), Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon 200701, South Korea.	jeoungd@kangwon.ac.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850	National Research Foundation from the BK21 Plus Program [2012H1B8A2025495, 2014R1A2A2A01002448, 2012R1A1A3009993]; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1320160]	National Research Foundation from the BK21 Plus Program; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea	This work was supported by National Research Foundation Grants 2012H1B8A2025495, 2014R1A2A2A01002448, and 2012R1A1A3009993, a grant from the BK21 Plus Program, and by National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea Grant 1320160.	Aghdassi A, 2012, GUT, V61, P439, DOI 10.1136/gutjnl-2011-300060; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Bardai FH, 2011, J NEUROSCI, V31, P1746, DOI 10.1523/JNEUROSCI.5704-10.2011; Bitarte N, 2011, STEM CELLS, V29, P1661, DOI 10.1002/stem.741; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chae S, 2012, AM J PHYSIOL-GASTR L, V302, pG1016, DOI 10.1152/ajpgi.00449.2011; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen ZL, 2013, CELL SIGNAL, V25, P2693, DOI 10.1016/j.cellsig.2013.08.032; Cheng WW, 2012, FEBS J, V279, P2047, DOI 10.1111/j.1742-4658.2012.08589.x; El-Khoury V, 2007, BRIT J CANCER, V97, P562, DOI 10.1038/sj.bjc.6603914; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Jin W, 2010, BREAST CANCER RES TR, V124, P39, DOI 10.1007/s10549-009-0683-8; Kannaiyan R, 2011, APOPTOSIS, V16, P1028, DOI 10.1007/s10495-011-0629-6; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Kim HC, 2010, CELL MOL LIFE SCI, V67, P3499, DOI 10.1007/s00018-010-0388-5; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kim Y, 2013, J BIOL CHEM, V288, P36502, DOI 10.1074/jbc.M113.502047; Kim Y, 2010, J BIOL CHEM, V285, P25957, DOI 10.1074/jbc.M109.095950; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Li YG, 2013, CARCINOGENESIS, V34, P1601, DOI 10.1093/carcin/bgt065; Li YH, 2013, BLOOD, V121, P499, DOI 10.1182/blood-2012-07-444729; Liang ZX, 2010, BIOCHEM PHARMACOL, V79, P817, DOI 10.1016/j.bcp.2009.10.017; Liu CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051436; Liu ZX, 2013, J BIOL CHEM, V288, P4334, DOI 10.1074/jbc.M112.419168; Mahlknecht U, 2004, J IMMUNOL, V173, P3979, DOI 10.4049/jimmunol.173.6.3979; Mahlknecht U, 1999, GENOMICS, V56, P197, DOI 10.1006/geno.1998.5645; Noh JH, 2013, CANCER LETT, V335, P455, DOI 10.1016/j.canlet.2013.03.003; Ott PA, 2013, CANCER CHEMOTH PHARM, V71, P183, DOI 10.1007/s00280-012-1995-7; Park D, 2014, BMB REP, V47, P227, DOI 10.5483/BMBRep.2014.47.4.128; Por E, 2010, J BIOL CHEM, V285, P14475, DOI 10.1074/jbc.M109.084400; Sankar N, 2008, ONCOGENE, V27, P5717, DOI 10.1038/onc.2008.181; Scarola M, 2010, CANCER RES, V70, P6925, DOI 10.1158/0008-5472.CAN-10-0141; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tan ZQ, 2014, MOL CELL BIOCHEM, V386, P223, DOI 10.1007/s11010-013-1860-y; To KKW, 2008, MOL CANCER RES, V6, P151, DOI 10.1158/1541-7786.MCR-07-0175; Uo T, 2009, J NEUROSCI, V29, P2824, DOI 10.1523/JNEUROSCI.6186-08.2009; Wang HQ, 2013, TUMOR BIOL, V34, P3101, DOI 10.1007/s13277-013-0878-9; Williams LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083991; Xu R, 2011, CANCER LETT, V306, P151, DOI 10.1016/j.canlet.2011.02.042; Xu R, 2009, ANTICANCER RES, V29, P261; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang XN, 2011, MOL CELL, V41, P371, DOI 10.1016/j.molcel.2011.01.020; Zhang XW, 2012, CANCER CELL, V22, P506, DOI 10.1016/j.ccr.2012.09.003; Zhao JJ, 2010, BLOOD, V115, P2630, DOI 10.1182/blood-2009-09-243147; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160; Zhou JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068469	49	34	34	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					28019	28039		10.1074/jbc.M114.578229	http://dx.doi.org/10.1074/jbc.M114.578229			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25138213	hybrid, Green Published			2022-12-28	WOS:000342852800054
J	Reissner, C; Stahn, J; Breuer, D; Klose, M; Pohlentz, G; Mormann, M; Missler, M				Reissner, Carsten; Stahn, Johanna; Breuer, Dorothee; Klose, Martin; Pohlentz, Gottfried; Mormann, Michael; Missler, Markus			Dystroglycan Binding to alpha-Neurexin Competes with Neurexophilin-1 and Neuroligin in the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Adhesion; Autism; Disulfide; Glycomics; Molecular Modeling; Site-directed Mutagenesis	CONGENITAL MUSCULAR-DYSTROPHY; PROTEIN-STRUCTURE PREDICTION; EXCITATORY SYNAPSE FORMATION; CELL-SURFACE PROTEINS; CRYSTAL-STRUCTURE; LAMININ-BINDING; INHIBITORY SYNAPSES; BETA-NEUREXINS; ENDOPLASMIC-RETICULUM; LATROTOXIN RECEPTOR	Background: Extracellular matrix dystroglycan has essential functions at the neuromuscular junction and at inhibitory synapses in the brain. Results: Brain dystroglycan competes with neurexophilin-1 and neuroligins for binding to presynaptic -neurexins. Conclusion: Competition between -neurexin ligands in combination with alternative splicing determines formation of important trans-synaptic complexes. Significance: This is the first analysis of binding interference in -neurexin multiplexes. -Neurexins (-Nrxn) are mostly presynaptic cell surface molecules essential for neurotransmission that are linked to neuro-developmental disorders as autism or schizophrenia. Several interaction partners of -Nrxn are identified that depend on alternative splicing, including neuroligins (Nlgn) and dystroglycan (DAG). The trans-synaptic complex with Nlgn1 was extensively characterized and shown to partially mediate -Nrxn function. However, the interactions of -Nrxn with DAG, neurexophilins (Nxph1) and Nlgn2, ligands that occur specifically at inhibitory synapses, are incompletely understood. Using site-directed mutagenesis, we demonstrate the exact binding epitopes of DAG and Nxph1 on Nrxn1 and show that their binding is mutually exclusive. Identification of an unusual cysteine bridge pattern and complex type glycans in Nxph1 ensure binding to the second laminin/neurexin/sex hormone binding (LNS2) domain of Nrxn1, but this association does not interfere with Nlgn binding at LNS6. DAG, in contrast, interacts with both LNS2 and LNS6 domains without inserts in splice sites SS#2 or SS#4 mostly via LARGE (like-acetylglucosaminyltransferase)-dependent glycans attached to the mucin region. Unexpectedly, binding of DAG at LNS2 prevents interaction of Nlgn at LNS6 with or without splice insert in SS#4, presumably by sterically hindering each other in the u-form conformation of -Nrxn. Thus, expression of DAG and Nxph1 together with alternative splicing in Nrxn1 may prevent or facilitate formation of distinct trans-synaptic NrxnNlgn complexes, revealing an unanticipated way to contribute to the identity of synaptic subpopulations.	[Reissner, Carsten; Stahn, Johanna; Breuer, Dorothee; Klose, Martin; Missler, Markus] Univ Munster, Inst Anat & Mol Neurobiol, D-48149 Munster, Germany; [Pohlentz, Gottfried; Mormann, Michael] Univ Munster, Inst Med Phys & Biophys, D-48149 Munster, Germany; [Missler, Markus] Cells Mot, Cluster Excellence EXC 1003, D-48149 Munster, Germany	University of Munster; University of Munster	Missler, M (corresponding author), Univ Munster, Inst Anat & Mol Neurobiol, Vesaliusweg 2-4, D-48149 Munster, Germany.	markus.missler@uni-muenster.de	Mormann, Michael/T-4860-2017	Mormann, Michael/0000-0002-7428-7329; Reissner, Carsten/0000-0002-5496-9971; Missler, Markus/0000-0001-8008-984X; Stahn, Jochen/0000-0002-6711-0592	Deutsche Forschungsgemeinschaft [SFB492-TPA16, SFB629-TPB11, 492-Z2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in whole or in parts, by Deutsche Forschungsgemeinschaft Grants SFB492-TPA16 (to M. Missler), SFB629-TPB11 (M. Missler), and 492-Z2 (to M. Mormann).	Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Batista-Brito R, 2008, CEREB CORTEX, V18, P2306, DOI 10.1093/cercor/bhm258; Batta G, 2009, FEBS J, V276, P2875, DOI 10.1111/j.1742-4658.2009.07011.x; BENHAM CJ, 1993, PROTEIN SCI, V2, P41; Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581; Born G, 2014, P NATL ACAD SCI USA, V111, pE1274, DOI 10.1073/pnas.1312112111; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Bulleid NJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013219; Chang CEA, 2008, P NATL ACAD SCI USA, V105, P7456, DOI 10.1073/pnas.0800452105; Cheek S, 2006, J MOL BIOL, V359, P215, DOI 10.1016/j.jmb.2006.03.017; Chen F, 2011, STRUCTURE, V19, P779, DOI 10.1016/j.str.2011.03.012; Chen WT, 2013, J AM CHEM SOC, V135, P9877, DOI 10.1021/ja4040472; Chen X, 2008, NAT STRUCT MOL BIOL, V15, P50, DOI 10.1038/nsmb1350; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Comim CM, 2013, MOL NEUROBIOL, V48, P71, DOI 10.1007/s12035-013-8415-9; Comoletti D, 2008, CHEM-BIOL INTERACT, V175, P150, DOI 10.1016/j.cbi.2008.04.040; Comoletti D, 2010, STRUCTURE, V18, P1044, DOI 10.1016/j.str.2010.06.005; De Rosa MC, 2011, J MOL GRAPH MODEL, V29, P1015, DOI 10.1016/j.jmgm.2011.04.008; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dudanova I, 2007, J COMP NEUROL, V502, P261, DOI 10.1002/cne.21305; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; Fairless R, 2008, J NEUROSCI, V28, P12969, DOI 10.1523/JNEUROSCI.5294-07.2008; Flint J, 2005, J BIOL CHEM, V280, P23718, DOI 10.1074/jbc.M501551200; GEE SH, 1993, J BIOL CHEM, V268, P14972; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Grewal PK, 2002, BBA-GEN SUBJECTS, V1573, P216, DOI 10.1016/S0304-4165(02)00387-2; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Harrison D, 2007, J BIOL CHEM, V282, P11573, DOI 10.1074/jbc.M610657200; Harrison R, 2012, GLYCOBIOLOGY, V22, P662, DOI 10.1093/glycob/cws002; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; Hussain NK, 2005, SCIENCE, V307, P1207, DOI 10.1126/science.1110011; IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Iijima T, 2011, CELL, V147, P1601, DOI 10.1016/j.cell.2011.11.028; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2010, J BIOL CHEM, V285, P31208, DOI 10.1074/jbc.M110.116343; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Koehnke J, 2008, STRUCTURE, V16, P410, DOI 10.1016/j.str.2007.12.024; Koehnke J, 2008, P NATL ACAD SCI USA, V105, P1873, DOI 10.1073/pnas.0711701105; Koehnke J, 2010, NEURON, V67, P61, DOI 10.1016/j.neuron.2010.06.001; Leone P, 2010, EMBO J, V29, P2461, DOI 10.1038/emboj.2010.123; Levi S, 2002, J NEUROSCI, V22, P4274, DOI 10.1523/JNEUROSCI.22-11-04274.2002; Lui L, 2010, J NEUROSCI RES, V88, P837, DOI 10.1002/jnr.22258; Matsuda K, 2011, EUR J NEUROSCI, V33, P1447, DOI 10.1111/j.1460-9568.2011.07638.x; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Miller MT, 2011, STRUCTURE, V19, P767, DOI 10.1016/j.str.2011.03.011; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J NEUROSCI, V18, P3630; Missler M, 1998, J BIOL CHEM, V273, P34716, DOI 10.1074/jbc.273.52.34716; Montanaro F, 2003, NEURON, V37, P193, DOI 10.1016/S0896-6273(03)00032-1; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Mormann M, 2008, ANAL BIOANAL CHEM, V392, P831, DOI 10.1007/s00216-008-2258-7; Nakagawa N, 2013, GLYCOBIOLOGY, V23, P1066, DOI 10.1093/glycob/cwt043; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Neue K, 2011, J PROTEOME RES, V10, P2248, DOI 10.1021/pr101082c; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Patzke H, 2000, MOL CELL NEUROSCI, V15, P561, DOI 10.1006/mcne.2000.0853; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Petrenko AG, 1996, J NEUROSCI, V16, P4360; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Pribiag H, 2014, P NATL ACAD SCI USA, V111, P6810, DOI 10.1073/pnas.1321774111; PUSCHEL AW, 1995, J NEUROSCI, V15, P2849; Reichelt AC, 2012, NEUROPHARMACOLOGY, V62, P1519, DOI 10.1016/j.neuropharm.2011.01.024; Reissner C, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-213; Reissner C, 2008, P NATL ACAD SCI USA, V105, P15124, DOI 10.1073/pnas.0801639105; REZNIK M, 2012, PLOS ONE, V7, P37894; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rozic G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018579; Rudenko G, 1999, CELL, V99, P93, DOI 10.1016/S0092-8674(00)80065-3; Rudenko G, 2001, TRENDS BIOCHEM SCI, V26, P363, DOI 10.1016/S0968-0004(01)01832-1; Saito F, 2008, FEBS LETT, V582, P439, DOI 10.1016/j.febslet.2008.01.006; Sasaki T, 2006, EMBO J, V25, P80, DOI 10.1038/sj.emboj.7600912; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Satz JS, 2010, J NEUROSCI, V30, P14560, DOI 10.1523/JNEUROSCI.3247-10.2010; Saura CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019430; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Simons KT, 1999, PROTEINS, P171; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sons MS, 2006, NEUROSCIENCE, V138, P433, DOI 10.1016/j.neuroscience.2005.11.040; Stalnaker SH, 2011, J BIOL CHEM, V286, P21180, DOI 10.1074/jbc.M110.203281; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Striegel AR, 2012, J NEUROSCI, V32, P1253, DOI 10.1523/JNEUROSCI.4652-11.2012; Suckow AT, 2008, ENDOCRINOLOGY, V149, P6006, DOI 10.1210/en.2008-0274; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Sugita S, 1998, J BIOL CHEM, V273, P32715, DOI 10.1074/jbc.273.49.32715; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Tanaka H, 2012, CELL REPORTS, V2, P101, DOI 10.1016/j.celrep.2012.06.009; Tanaka H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019411; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Treutlein B, 2014, P NATL ACAD SCI USA, V111, pE1291, DOI 10.1073/pnas.1403244111; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Waite A, 2012, TRENDS NEUROSCI, V35, P487, DOI 10.1016/j.tins.2012.04.004; Wizemann H, 2003, J MOL BIOL, V332, P635, DOI 10.1016/S0022-2836(03)00848-9; Xu Jinbo, 2003, J Bioinform Comput Biol, V1, P95, DOI 10.1142/S0219720003000186; YOON HJ, 2013, PLOS CURR, V5, DOI DOI 10.1371/CURRENTS.MD.3756B4A389974DFF21C0CF13508D3F7B; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Zhang C, 2010, NEURON, V66, P403, DOI 10.1016/j.neuron.2010.04.008	119	43	45	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27585	27603		10.1074/jbc.M114.595413	http://dx.doi.org/10.1074/jbc.M114.595413			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25157101	hybrid, Green Published			2022-12-28	WOS:000342852800020
J	Bing, YT; Zhu, SY; Yu, GZ; Li, T; Liu, WJ; Li, CS; Wang, YT; Qi, HL; Guo, T; Yuan, YF; He, YM; Liu, ZS; Liu, QY				Bing, Yuntao; Zhu, Siying; Yu, Guozheng; Li, Ting; Liu, Weijun; Li, Changsheng; Wang, Yitao; Qi, Haolong; Guo, Tao; Yuan, Yufeng; He, Yueming; Liu, Zhisu; Liu, Quanyan			Glucocorticoid-induced S-Adenosylmethionine Enhances the Interferon Signaling Pathway by Restoring STAT1 Protein Methylation in Hepatitis B Virus-infected Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE ADENOSYLTRANSFERASE; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; LIVER-CANCER; ALPHA; INHIBITION; THERAPY; TRANSCRIPTION; ACTIVATION; SYNTHETASE	Patients with chronic hepatitis B usually exhibit a low response to treatment with interferon alpha (IFN-alpha). An alternative approach to increase the response rate of IFN-alpha might be to immunologically stimulate the host with glucocorticoids (GCs) before treatment with IFN-alpha, but the underlying mechanism remains unclear. We hypothesized that the GCs enhance IFN signaling by inducing S-adenosylmethionine (AdoMet) when hepatitis B virus (HBV) replication was effectively suppressed by IFN-alpha. Here, we investigated the effect of GCs and IFN-alpha on AdoMet production and methionine adenosyltransferase 1A (MAT1A) expression in vitro. Furthermore, we determined whether post-transcriptional regulation is involved in HBV-repressed MAT1A expression and AdoMet production induced by dexamethasone (Dex). We found that AdoMet homeostasis was disrupted by Dex and that Dex directly regulated MAT1A expression by enhancing the binding of the glucocorticoid receptor (GR) to the glucocorticoid-response element (GRE) of the MAT1A promoter. HBV reduced AdoMet production by increasing methylation at GRE sites within the MAT1A promoter. The X protein of hepatitis B virus led to hypermethylation in the MAT1A promoter by recruiting DNA methyltransferase 1, and it inhibited GR binding to the GRE in the MAT1A promoter. Dex could increase an antiviral effect by inducing AdoMet production via a positive feedback loop when HBV is effectively suppressed by IFN-alpha, and the mechanism that involves Dex-induced AdoMet could increase STAT1 methylation rather than STAT1 phosphorylation. These findings provide a possible mechanism by which GC-induced AdoMet enhances the antiviral activity of IFN-alpha by restoring STAT1 methylation in HBV-infected cells.	[Bing, Yuntao; Zhu, Siying; Yu, Guozheng; Li, Ting; Liu, Weijun; Li, Changsheng; Wang, Yitao; Qi, Haolong; Guo, Tao; Yuan, Yufeng; He, Yueming; Liu, Zhisu; Liu, Quanyan] Wuhan Univ, Zhongnan Hosp, Digest Dis Res Ctr, Dept Gen Surg, Wuhan 430071, Peoples R China	Wuhan University	Liu, ZS (corresponding author), Wuhan Univ, Zhongnan Hosp, Digest Dis Res Ctr, Dept Gen Surg, Donghu Rd 169, Wuhan 430071, Peoples R China.	spss2005@126.com; lqy@whu.edu.cn		Bing, Yuntao/0000-0002-0187-133X	National Natural Science Foundation of China [30872491/C160402, 81372552, 81172349/H1617]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 30872491/C160402, 81372552, and 81172349/H1617.	Anstee QM, 2012, J HEPATOL, V57, P1097, DOI 10.1016/j.jhep.2012.04.041; Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1; Bhattacharyya S, 2011, P NATL ACAD SCI USA, V108, P9554, DOI 10.1073/pnas.1017296108; Bonello N, 2013, J THEOR BIOL, V336, P87, DOI 10.1016/j.jtbi.2013.07.019; Cai JX, 1998, CANCER RES, V58, P1444; Cai JX, 1996, HEPATOLOGY, V24, P1090; Chen JL, 2013, HEPATOLOGY, V57, P470, DOI 10.1002/hep.26064; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Feld JJ, 2011, GASTROENTEROLOGY, V140, P830, DOI 10.1053/j.gastro.2010.09.010; Ferir G, 2008, REV MED VIROL, V18, P19, DOI 10.1002/rmv.554; Filipowicz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015492; FOSTER GR, 1993, HEPATOLOGY, V17, P757, DOI 10.1002/hep.1840170502; FREZZA M, 1990, GASTROENTEROLOGY, V99, P211, DOI 10.1016/0016-5085(90)91250-A; Garcia-Trevijano ER, 2000, FASEB J, V14, P2511, DOI 10.1096/fj.00-0121com; Gil B, 1997, ENDOCRINOLOGY, V138, P1251, DOI 10.1210/en.138.3.1251; Grillo MA, 2005, AMINO ACIDS, V28, P357, DOI 10.1007/s00726-005-0197-6; HAYATA T, 1991, HEPATOLOGY, V13, P1022, DOI 10.1002/hep.1840130603; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Li JP, 2010, AM J PATHOL, V176, P2456, DOI 10.2353/ajpath.2010.090810; Li J, 2010, ANTIVIR RES, V85, P463, DOI 10.1016/j.antiviral.2009.10.011; Li YK, 2013, J BIOL CHEM, V288, P20927, DOI 10.1074/jbc.M112.440115; Liao JY, 2000, P NATL ACAD SCI USA, V97, P5267, DOI 10.1073/pnas.97.10.5267; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu QY, 2011, J BIOL CHEM, V286, P17168, DOI 10.1074/jbc.M110.167783; Locarnini S, 2004, SEMIN LIVER DIS, V24, P3, DOI 10.1055/s-2004-828672; Lu SC, 2005, ALCOHOL, V35, P227, DOI 10.1016/j.alcohol.2005.03.011; Lu SC, 2012, PHYSIOL REV, V92, P1515, DOI 10.1152/physrev.00047.2011; Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev; Mellerup M. T., 2005, COCHRANE DB SYST REV, V3; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; NORDEEN SK, 1990, MOL ENDOCRINOL, V4, P1866, DOI 10.1210/mend-4-12-1866; Park IY, 2007, GASTROENTEROLOGY, V132, P1476, DOI 10.1053/j.gastro.2007.01.034; Qin B, 2000, Zhonghua Gan Zang Bing Za Zhi, V8, P158; RAKELA J, 1983, GASTROENTEROLOGY, V84, P956; Rosmorduc O, 1999, J GEN VIROL, V80, P1253, DOI 10.1099/0022-1317-80-5-1253; Sun DX, 2006, J HEPATOL, V45, P636, DOI 10.1016/j.jhep.2006.05.019; Wang JH, 2009, PROTEOMICS, V9, P1672, DOI 10.1002/pmic.200800621; WONG DKH, 1993, ANN INTERN MED, V119, P312, DOI 10.7326/0003-4819-119-4-199308150-00011	39	14	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.589689	http://dx.doi.org/10.1074/jbc.M114.589689			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25271158	Green Published, hybrid			2022-12-28	WOS:000345335000022
J	Chavez, JC; Ferreira, JJ; Butler, A; Beltran, JLDL; Trevino, CL; Darszon, A; Salkoff, L; Santi, CM				Cesar Chavez, Julio; Ferreira, Juan Jose; Butler, Alice; De La Vega Beltran, Jose Luis; Trevino, Claudia L.; Darszon, Alberto; Salkoff, Lawrence; Santi, Celia M.			SLO3 K+ Channels Control Calcium Entry through CATSPER Channels in Sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Calcium Channel; pH Regulation; Potassium Channel; Sperm; Spermatozoa	SEA-URCHIN SPERM; CHLORTETRACYCLINE FLUORESCENCE ASSAY; MOUSE SPERM; ACROSOME REACTION; HUMAN SPERMATOZOA; INTRACELLULAR PH; NA+/H+ EXCHANGER; BOVINE SPERM; INTERNAL PH; MEMBRANE HYPERPOLARIZATION	Here we show how a sperm-specific potassium channel (SLO3) controls Ca2+ entry into sperm through a sperm-specific Ca2+ channel, CATSPER, in a totally unanticipated manner. The genetic deletion of either of those channels confers male infertility in mice. During sperm capacitation SLO3 hyperpolarizes the sperm, whereas CATSPER allows Ca2+ entry. These two channels may be functionally connected, but it had not been demonstrated that SLO3-dependent hyperpolarization is required for Ca2+ entry through CATSPER channels, nor has a functional mechanism linking the two channels been shown. In this study we show that Ca2+ entry through CATSPER channels is deficient in Slo3 mutant sperm lacking hyperpolarization; we also present evidence supporting the hypothesis that SLO3 channels activate CATSPER channels indirectly by promoting a rise in intracellular pH through a voltage-dependent mechanism. This mechanism may work through a Na+/H+ exchanger (sNHE) and/or a bicarbonate transporter, which utilizes the inward driving force of the Na+ gradient, rendering it intrinsically voltage-dependent. In addition, the sperm-specific Na+/H+ exchanger (sNHE) possess a putative voltage sensor that might be activated by membrane hyperpolarization, thus increasing the voltage sensitivity of internal alkalization.	[Cesar Chavez, Julio; Ferreira, Juan Jose; Butler, Alice; Salkoff, Lawrence; Santi, Celia M.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Cesar Chavez, Julio; De La Vega Beltran, Jose Luis; Trevino, Claudia L.; Darszon, Alberto] UNAM, Inst Biotecnol, Cuernavaca 62210, Morelos, Mexico	Washington University (WUSTL); Universidad Nacional Autonoma de Mexico	Santi, CM (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	santiC@wustl.edu		Darszon, Alberto/0000-0002-2502-0505; Ferreira, Juan/0000-0001-8175-9067; Trevino, Claudia L/0000-0002-7281-0534; Chavez, Julio/0000-0002-7375-9531	National Institutes of Health [R01 HD069631, R01HD038082]; Consejo Nacional de Ciencia y Tecnologia (CONACyT-Mexico) [128566]; Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico (DGAPA/UNAM) [IN225406, IN202212-3]; Alexander von Humboldt Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069631, R01HD038082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Ciencia y Tecnologia (CONACyT-Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico (DGAPA/UNAM)(Universidad Nacional Autonoma de Mexico); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HD069631 (to C. M. S.) and R01HD038082 (to Pablo Visconti subcontract to A. D.). This work was also supported by Consejo Nacional de Ciencia y Tecnologia (CONACyT-Mexico) Grant 128566 (to A. D. and C. L. T.); Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico (DGAPA/UNAM) Grants IN225406 (to A. D.) and IN202212-3 (to C. L. T.); and a grant from the Alexander von Humboldt Foundation (to C. L. T.).	ACOTT TS, 1984, BIOL REPROD, V30, P926, DOI 10.1095/biolreprod30.4.926; Arnoult C, 1999, P NATL ACAD SCI USA, V96, P6757, DOI 10.1073/pnas.96.12.6757; Arnoult C, 1996, J CELL BIOL, V134, P637, DOI 10.1083/jcb.134.3.637; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; BABCOCK DF, 1987, J BIOL CHEM, V262, P15041; BABCOCK DF, 1983, P NATL ACAD SCI-BIOL, V80, P1327, DOI 10.1073/pnas.80.5.1327; BALDI E, 1991, J ANDROL, V12, P323; Breitbart H, 2003, CELL MOL BIOL, V49, P321; Brenker C, 2014, ELIFE, V3, DOI 10.7554/eLife.01438; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; CARR DW, 1989, BIOL REPROD, V41, P907, DOI 10.1095/biolreprod41.5.907; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chavez JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060578; DASGUPTA S, 1993, J REPROD FERTIL, V99, P135; Demarco IA, 2003, J BIOL CHEM, V278, P7001, DOI 10.1074/jbc.M206284200; Donowitz M, 2013, MOL ASPECTS MED, V34, P236, DOI 10.1016/j.mam.2012.05.001; Florman HM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P55; Garcia MA, 1999, MOL REPROD DEV, V52, P189, DOI 10.1002/(SICI)1098-2795(199902)52:2<189::AID-MRD10>3.0.CO;2-D; GARCIASOTO J, 1987, DEV BIOL, V120, P112, DOI 10.1016/0012-1606(87)90109-6; GATTI JL, 1993, J REPROD FERTIL, V98, P439, DOI 10.1530/jrf.0.0980439; GIROUXWIDEMANN V, 1991, MOL REPROD DEV, V29, P157, DOI 10.1002/mrd.1080290211; GONZALEZMARTINEZ M, 1987, FEBS LETT, V218, P247, DOI 10.1016/0014-5793(87)81055-4; GONZALEZMARTINEZ MT, 1992, DEV BIOL, V150, P193, DOI 10.1016/0012-1606(92)90018-C; Hamamah S, 1998, HUM REPROD, V13, P20, DOI 10.1093/humrep/13.suppl_4.20; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Ho HC, 2002, DEV BIOL, V250, P208, DOI 10.1006/dbio.2002.0797; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; LEE HC, 1986, J BIOL CHEM, V261, P6026; Lishko PV, 2010, J PHYSIOL-LONDON, V588, P4667, DOI 10.1113/jphysiol.2010.194142; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Liu Tao, 2010, Front Biosci (Elite Ed), V2, P566, DOI 10.2741/e115; Lopez-Gonzalez I, 2014, MOL HUM REPROD, V20, P619, DOI 10.1093/molehr/gau029; De La Vega-Beltran JL, 2012, J BIOL CHEM, V287, P44384, DOI 10.1074/jbc.M112.393488; Mannowetz N, 2013, ELIFE, V2, DOI 10.7554/eLife.01009; Marquez B, 2007, BIOL REPROD, V76, P660, DOI 10.1095/biolreprod.106.055038; Munoz-Garay C, 2001, DEV BIOL, V234, P261, DOI 10.1006/dbio.2001.0196; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Nishigaki T, 2006, BIOTECHNIQUES, V41, P191, DOI 10.2144/000112220; Nishigaki T, 2014, BIOCHEM BIOPH RES CO, V450, P1149, DOI 10.1016/j.bbrc.2014.05.100; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Santi CM, 2013, CURR TOP DEV BIOL, V102, P385, DOI 10.1016/B978-0-12-416024-8.00014-3; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; SUAREZ SS, 1993, P NATL ACAD SCI USA, V90, P4660, DOI 10.1073/pnas.90.10.4660; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VREDENBURGHWILBERG WL, 1995, MOL REPROD DEV, V40, P490, DOI 10.1002/mrd.1080400413; Waldegger S, 2003, PFLUG ARCH EUR J PHY, V446, P143, DOI 10.1007/s00424-003-1048-5; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; WARD CR, 1984, DEV BIOL, V104, P287, DOI 10.1016/0012-1606(84)90084-8; WARD CR, 1994, MOL REPROD DEV, V39, P423, DOI 10.1002/mrd.1080390411; Wennemuth G, 2000, J BIOL CHEM, V275, P21210, DOI 10.1074/jbc.M002068200; Woo AL, 2002, MOL REPROD DEV, V62, P348, DOI 10.1002/mrd.90002; Xia JS, 2007, BIOL REPROD, V77, P551, DOI 10.1095/biolreprod.107.061358; Xia JS, 2009, BIOL REPROD, V80, P1092, DOI 10.1095/biolreprod.108.074039; Zeng XH, 2013, J GEN PHYSIOL, V142, P305, DOI 10.1085/jgp.201311011; Zeng XH, 2011, P NATL ACAD SCI USA, V108, P5879, DOI 10.1073/pnas.1100240108; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044; ZENG Y, 1995, DEV BIOL, V171, P554, DOI 10.1006/dbio.1995.1304	59	52	54	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32266	32275		10.1074/jbc.M114.607556	http://dx.doi.org/10.1074/jbc.M114.607556			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25271166	Green Published, hybrid			2022-12-28	WOS:000345314700052
J	Henningham, A; Yamaguchi, M; Aziz, RK; Kuipers, K; Buffalo, CZ; Dahesh, S; Choudhury, B; Van Vleet, J; Yamaguchi, Y; Seymour, LM; Ben Zakour, NL; He, LJ; Smith, HV; Grimwood, K; Beatson, SA; Ghosh, P; Walker, MJ; Nizet, V; Cole, JN				Henningham, Anna; Yamaguchi, Masaya; Aziz, Ramy K.; Kuipers, Kirsten; Buffalo, Cosmo Z.; Dahesh, Samira; Choudhury, Biswa; Van Vleet, Jeremy; Yamaguchi, Yuka; Seymour, Lisa M.; Ben Zakour, Nouri L.; He, Lingjun; Smith, Helen V.; Grimwood, Keith; Beatson, Scott A.; Ghosh, Partho; Walker, Mark J.; Nizet, Victor; Cole, Jason N.			Mutual Exclusivity of Hyaluronan and Hyaluronidase in Invasive Group A Streptococcus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Hyaluronan; Hyaluronate; Infectious Disease; Streptococcus Pyogenes (S; Pyogenes); Group A Streptococcus; Hyaluronate Lyase; Hyaluronic acid Capsule; Invasive Disease; Nonencapsulated	INHIBITOR C4B-BINDING PROTEIN; ACID CAPSULE; BINDING-PROTEIN; FIBRINOGEN; VIRULENCE; GENE; PLASMINOGEN; EXPRESSION; PYOGENES; DISEASE	A recent analysis of group A Streptococcus (GAS) invasive infections in Australia has shown a predominance of M4 GAS, a serotype recently reported to lack the antiphagocytic hyaluronic acid (HA) capsule. Here, we use molecular genetics and bioinformatics techniques to characterize 17 clinical M4 isolates associated with invasive disease in children during this recent epidemiology. All M4 isolates lacked HA capsule, and whole genome sequence analysis of two isolates revealed the complete absence of the hasABC capsule biosynthesis operon. Conversely, M4 isolates possess a functional HA-degrading hyaluronate lyase (HylA) enzyme that is rendered nonfunctional in other GAS through a point mutation. Transformation with a plasmid expressing hasABC restored partial encapsulation in wild-type (WT) M4 GAS, and full encapsulation in an isogenic M4 mutant lacking HylA. However, partial encapsulation reduced binding to human complement regulatory protein C4BP, did not enhance survival in whole human blood, and did not increase virulence of WT M4 GAS in a mouse model of systemic infection. Bioinformatics analysis found no hasABC homologs in closely related species, suggesting that this operon was a recent acquisition. These data showcase a mutually exclusive interaction of HA capsule and active HylA among strains of this leading human pathogen.	[Henningham, Anna; Yamaguchi, Masaya; Kuipers, Kirsten; Dahesh, Samira; Yamaguchi, Yuka; Nizet, Victor; Cole, Jason N.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Aziz, Ramy K.] Univ Calif San Diego, Syst Biol Res Grp, La Jolla, CA 92093 USA; [Buffalo, Cosmo Z.; Ghosh, Partho] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Choudhury, Biswa; Van Vleet, Jeremy] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Henningham, Anna; Seymour, Lisa M.; Ben Zakour, Nouri L.; Beatson, Scott A.; Walker, Mark J.; Cole, Jason N.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Henningham, Anna; Seymour, Lisa M.; Ben Zakour, Nouri L.; Beatson, Scott A.; Walker, Mark J.; Cole, Jason N.] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia; [Yamaguchi, Masaya] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Suita, Osaka 5650871, Japan; [Aziz, Ramy K.] Cairo Univ, Dept Microbiol & Immunol, Fac Pharm, Cairo 11562, Egypt; [Kuipers, Kirsten] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Lab Pediat Infect Dis, NL-6500 HC Nijmegen, Netherlands; [He, Lingjun] San Diego State Univ, Dept Math & Stat, San Diego, CA 92182 USA; [Smith, Helen V.] Queensland Hlth Forens & Sci Serv, Coopers Plains, Qld 4108, Australia; [Grimwood, Keith] Queensland Childrens Med Res Inst, Herston, Qld 4029, Australia; [Nizet, Victor] Rady Childrens Hosp, San Diego, CA 92123 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Queensland; University of Queensland; Osaka University; Egyptian Knowledge Bank (EKB); Cairo University; Radboud University Nijmegen; California State University System; San Diego State University; Queensland Health; Rady Childrens Hospital San Diego	Cole, JN (corresponding author), Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.	jncole@ucsd.edu	Henningham, Anna/C-7355-2017; Beatson, Scott/B-6985-2013; Yamaguchi, Masaya/I-8156-2019; ZAKOUR, Nouri L BEN/B-9338-2011; Kuipers, Kirsten/G-5069-2016; Nizet, Victor/AAF-3190-2019; Aziz, Ramy/B-2918-2009	Henningham, Anna/0000-0002-0554-6593; Beatson, Scott/0000-0002-1806-3283; Yamaguchi, Masaya/0000-0001-6218-7112; ZAKOUR, Nouri L BEN/0000-0002-6949-1755; Nizet, Victor/0000-0003-3847-0422; Buffalo, Cosmo/0000-0002-8187-4660; Grimwood, Keith/0000-0003-3174-9834; Aziz, Ramy/0000-0002-4448-7100; Smith, Helen/0000-0003-4308-9335; Walker, Mark/0000-0001-7423-2769	National Institutes of Health [AI077780, AI48176]; National Health and Medical Research Council of Australia [514639, APP1033258, 565526]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096837, R01AI077780, R21AI048176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077780 and AI48176 (to V. N.) and National Health and Medical Research Council of Australia Grants 514639 and APP1033258 (to J. N. C.) and 565526 (to M. J. W.).	Agarwal V, 2012, J IMMUNOL, V189, P3575, DOI 10.4049/jimmunol.1102934; Ashbaugh CD, 2000, CELL MICROBIOL, V2, P283, DOI 10.1046/j.1462-5822.2000.00050.x; Baker JR, 2002, BIOCHEM J, V365, P317, DOI 10.1042/BJ20020149; Beres SB, 2006, P NATL ACAD SCI USA, V103, P7059, DOI 10.1073/pnas.0510279103; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bessen DE, 2002, INFECT IMMUN, V70, P1159, DOI 10.1128/IAI.70.3.1159-1167.2002; Blom AM, 2000, J IMMUNOL, V164, P5328, DOI 10.4049/jimmunol.164.10.5328; Blom AM, 2008, VACCINE, V26, pI49, DOI 10.1016/j.vaccine.2008.11.049; Caldeira NGS, 2013, J MED MICROBIOL, V62, P655, DOI 10.1099/jmm.0.052357-0; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; Carlsson F, 2003, J EXP MED, V198, P1057, DOI 10.1084/jem.20030543; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Cole JN, 2012, J BACTERIOL, V194, P6154, DOI 10.1128/JB.01317-12; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cole JN, 2010, MBIO, V1, DOI 10.1128/mBio.00191-10; Coleman JL, 1999, J LAB CLIN MED, V134, P567, DOI 10.1016/S0022-2143(99)90095-1; Courtney HS, 1997, INFECT IMMUN, V65, P2472, DOI 10.1128/IAI.65.6.2472-2474.1997; Creti R, 2012, EUR J CLIN MICROBIOL, V31, P233, DOI 10.1007/s10096-011-1298-7; Cywes C, 2000, J CLIN INVEST, V106, P995, DOI 10.1172/JCI10195; Dahesh S, 2012, VIRULENCE, V3, P566, DOI 10.4161/viru.21933; Dale JB, 1996, INFECT IMMUN, V64, P1495, DOI 10.1128/IAI.64.5.1495-1501.1996; DEANGELIS PL, 1993, J BIOL CHEM, V268, P19181; DOUGHERTY BA, 1992, J EXP MED, V175, P1291, DOI 10.1084/jem.175.5.1291; FABER V, 1954, ACTA PATHOL MIC SC, V35, P159; Facklam R, 1999, EMERG INFECT DIS, V5, P247, DOI 10.3201/eid0502.990209; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Flores AR, 2012, MBIO, V3, DOI 10.1128/mBio.00413-12; FOLEY MJ, 1959, J EXP MED, V110, P617, DOI 10.1084/jem.110.4.617; Guo XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094156; Hair PS, 2012, MOL IMMUNOL, V50, P253, DOI 10.1016/j.molimm.2012.01.010; Hoang LMN, 2005, CLIN INFECT DIS, V40, pE38, DOI 10.1086/427875; Hollands A, 2010, J INFECT DIS, V202, P11, DOI 10.1086/653124; Hollands A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004102; HORSTMANN RD, 1992, INFECT IMMUN, V60, P5036, DOI 10.1128/IAI.60.12.5036-5041.1992; Hynes W, 2009, MICROB PATHOGENESIS, V47, P308, DOI 10.1016/j.micpath.2009.09.008; Hynes WL, 2000, FEMS MICROBIOL LETT, V184, P109, DOI 10.1016/S0378-1097(00)00029-X; Ikebe T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000832; Jenkins HT, 2006, J BIOL CHEM, V281, P3690, DOI 10.1074/jbc.M511563200; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; LIN B, 1994, J BIOL CHEM, V269, P30113; Lithgow A, 2014, J PAEDIATR CHILD H, V50, P687, DOI 10.1111/jpc.12601; Maamary PG, 2012, FASEB J, V26, P4675, DOI 10.1096/fj.12-212142; Macheboeuf P, 2011, NATURE, V472, P64, DOI 10.1038/nature09967; MACLENNAN AP, 1956, J GEN MICROBIOL, V14, P134, DOI 10.1099/00221287-14-1-134; MACLENNAN AP, 1956, J GEN MICROBIOL, V15, P485, DOI 10.1099/00221287-15-3-485; MARCUM JA, 1983, COMP BIOCHEM PHYS B, V75, P389, DOI 10.1016/0305-0491(83)90345-0; Margarit I, 2009, FASEB J, V23, P3100, DOI 10.1096/fj.09-131458; Moses AE, 1997, INFECT IMMUN, V65, P64, DOI 10.1128/IAI.65.1.64-71.1997; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Oliver MA, 2008, VACCINE, V26, pI75, DOI 10.1016/j.vaccine.2008.11.054; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Pence MA, 2010, J INNATE IMMUN, V2, P587, DOI 10.1159/000317672; Persson Jenny, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020047; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; Ramachandran V, 2004, J BACTERIOL, V186, P7601, DOI 10.1128/JB.186.22.7601-7609.2004; Ravins M, 2000, J INFECT DIS, V182, P1702, DOI 10.1086/317635; Sanderson-Smith ML, 2007, J BACTERIOL, V189, P1435, DOI 10.1128/JB.01218-06; Schrager HM, 1998, J CLIN INVEST, V101, P1708, DOI 10.1172/JCI2121; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Stollerman GH, 2008, CLIN INFECT DIS, V46, P1038, DOI 10.1086/529194; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; WANG H, 1995, MICROB PATHOGENESIS, V18, P153, DOI 10.1016/S0882-4010(95)90013-6; WESSELS MR, 1994, P NATL ACAD SCI USA, V91, P12238, DOI 10.1073/pnas.91.25.12238; WESSELS MR, 1991, P NATL ACAD SCI USA, V88, P8317, DOI 10.1073/pnas.88.19.8317; WESSELS MR, 1994, INFECT IMMUN, V62, P433, DOI 10.1128/IAI.62.2.433-441.1994; Whitehead BD, 2011, EPIDEMIOL INFECT, V139, P623, DOI 10.1017/S0950268810001378	70	22	22	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32303	32315		10.1074/jbc.M114.602847	http://dx.doi.org/10.1074/jbc.M114.602847			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25266727	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000345314700055
J	Schild, F; Kieffer-Jaquinod, S; Palencia, A; Cobessi, D; Sarret, G; Zubieta, C; Jourdain, A; Dumas, R; Forge, V; Testemale, D; Bourguignon, J; Hugouvieux, V				Schild, Florie; Kieffer-Jaquinod, Sylvie; Palencia, Andres; Cobessi, David; Sarret, Geraldine; Zubieta, Chloe; Jourdain, Agnes; Dumas, Renaud; Forge, Vincent; Testemale, Denis; Bourguignon, Jacques; Hugouvieux, Veronique			Biochemical and Biophysical Characterization of the Selenium-binding and Reducing Site in Arabidopsis thaliana Homologue to Mammals Selenium-binding Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Plant Biochemistry; Protein Chemical Modification; Proteomics; Selenium; X-ray Absorption Spectroscopy	GLUTATHIONE-PEROXIDASE; CIRCULAR-DICHROISM; GENE-EXPRESSION; LOLIGO-VULGARIS; POOR SURVIVAL; HUMAN HEALTH; PLANTS; PEPTIDES; CANCER; SELENOPROTEINS	Background: The selenium-binding site in selenium-binding protein (SBP) homologues was not identified. Results: The Arabidopsis thaliana SBP1 selenium-binding site was characterized as a R-S-Se(II)-S-R-type complex involving Cys(21) and Cys(22). Conclusion: This is the first identification of the selenium-binding site in any SBP. Significance: It is an important step toward a better understanding of the link between selenium binding and function of SBP. The function of selenium-binding protein 1 (SBP1), present in almost all organisms, has not yet been established. In mammals, SBP1 is known to bind the essential element selenium but the binding site has not been identified. In addition, the SBP family has numerous potential metal-binding sites that may play a role in detoxification pathways in plants. In Arabidopsis thaliana, AtSBP1 over-expression increases tolerance to two toxic compounds for plants, selenium and cadmium, often found as soil pollutants. For a better understanding of AtSBP1 function in detoxification mechanisms, we investigated the chelating properties of the protein toward different ligands with a focus on selenium using biochemical and biophysical techniques. Thermal shift assays together with inductively coupled plasma mass spectrometry revealed that AtSBP1 binds selenium after incubation with selenite (SeO<sub arrange="stack">3<sup arrange="stack">2-) with a ligand to protein molar ratio of 1:1. Isothermal titration calorimetry confirmed the 1:1 stoichiometry and revealed an unexpectedly large value of binding enthalpy suggesting a covalent bond between selenium and AtSBP1. Titration of reduced Cys residues and comparative mass spectrometry on AtSBP1 and the purified selenium-AtSBP1 complex identified Cys(21) and Cys(22) as being responsible for the binding of one selenium. These results were validated by site-directed mutagenesis. Selenium K-edge x-ray absorption near edge spectroscopy performed on the selenium-AtSBP1 complex demonstrated that AtSBP1 reduced SeO<sub arrange="stack">3<sup arrange="stack">2- to form a R-S-Se(II)-S-R-type complex. The capacity of AtSBP1 to bind different metals and selenium is discussed with respect to the potential function of AtSBP1 in detoxification mechanisms and selenium metabolism.	[Schild, Florie; Zubieta, Chloe; Jourdain, Agnes; Dumas, Renaud; Bourguignon, Jacques; Hugouvieux, Veronique] Univ Grenoble Alpes, Inst Rech Technol & Sci Vivant, Lab Physiol Cellulaire & Vegetale, CEA,CNRS UMR5168,INRA USC1359, F-38000 Grenoble, France; [Kieffer-Jaquinod, Sylvie] Univ Grenoble Alpes, Inst Rech Technol & Sci Vivant, Lab Biol Grande Echelle, CEA,INSERM, F-38000 Grenoble, France; [Palencia, Andres] European Mol Biol Lab Outstn, F-38042 Grenoble, France; [Palencia, Andres] Univ Grenoble Alpes EMBL CNRS, Unit Virus Host Cell Interact, F-38042 Grenoble, France; [Cobessi, David] Univ Grenoble Alpes, CEA, CNRS, Direct Sci Vivant,Inst Biol Struct, F-38044 Grenoble, France; [Sarret, Geraldine] Univ Grenoble Alpes, CNRS, F-38041 Grenoble, France; [Sarret, Geraldine] IRD, ISTerre, F-38041 Grenoble, France; [Forge, Vincent] Univ Grenoble Alpes, Lab Chim & Biol Met, CEA, CNRS,Inst Rech Technol & Sci Vivant, F-38000 Grenoble, France; [Testemale, Denis] Univ Grenoble Alpes, CNRS, Inst NEEL, F-38042 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Hugouvieux, V (corresponding author), Univ Grenoble Alpes, Inst Rech Technol & Sci Vivant, Lab Physiol Cellulaire & Vegetale, CEA,CNRS UMR5168,INRA USC1359, 17 Rue Martyrs, F-38000 Grenoble, France.	Veronique.hugouvieux@cea.fr	Palencia, Andrés/F-4257-2017; Sarret, Geraldine/I-2797-2016; Dumas, Renaud/E-1835-2011; BM30, Beamline FAME/G-9313-2012	Palencia, Andrés/0000-0002-1805-319X; Sarret, Geraldine/0000-0002-1709-3456; Zubieta, Chloe/0000-0003-4558-9333; Bourguignon, jacques/0000-0001-7517-0600; kieffer-jaquinod, Sylvie/0000-0003-1281-758X; dumas, renaud/0000-0003-1404-3274	Rhone-Alpes region; Biologie et Amelioration des Plantes Department of Institut National de la Recherche Agronomique; CEA Toxicology program	Rhone-Alpes region(Region Auvergne-Rhone-Alpes); Biologie et Amelioration des Plantes Department of Institut National de la Recherche Agronomique; CEA Toxicology program	This work was supported by the Rhone-Alpes region, the Biologie et Amelioration des Plantes Department of Institut National de la Recherche Agronomique, and the CEA Toxicology program.	Agalou A, 2005, FUNCT PLANT BIOL, V32, P881, DOI 10.1071/FP05090; Agalou A, 2006, FUNCT PLANT BIOL, V33, P847, DOI 10.1071/FP05312; Ansong E, 2014, MOL NUTR FOOD RES, V58, P117, DOI 10.1002/mnfr.201300543; BANSAL MP, 1990, CARCINOGENESIS, V11, P2071, DOI 10.1093/carcin/11.11.2071; Behne D, 2001, ANNU REV NUTR, V21, P453, DOI 10.1146/annurev.nutr.21.1.453; Brazier MW, 2008, J BIOL CHEM, V283, P12831, DOI 10.1074/jbc.M709820200; CHAFFOTTE AF, 1992, BIOCHEMISTRY-US, V31, P9694, DOI 10.1021/bi00155a024; Chen GA, 2004, J PATHOL, V202, P321, DOI 10.1002/path.1524; Cohen SD, 1997, TOXICOL APPL PHARM, V143, P1, DOI 10.1006/taap.1996.8074; Crepin T, 2010, J VIROL, V84, P9096, DOI 10.1128/JVI.00995-10; Dian C, 2011, MOL MICROBIOL, V79, P1260, DOI 10.1111/j.1365-2958.2010.07517.x; Dupierris V, 2009, BIOINFORMATICS, V25, P1980, DOI 10.1093/bioinformatics/btp301; Dutilleul C, 2008, PLANT PHYSIOL, V147, P239, DOI 10.1104/pp.107.114033; Ellis DR, 2003, CURR OPIN PLANT BIOL, V6, P273, DOI 10.1016/S1369-5266(03)00030-X; Fang WF, 2010, CARCINOGENESIS, V31, P1360, DOI 10.1093/carcin/bgq114; Feng RW, 2013, ENVIRON EXP BOT, V87, P58, DOI 10.1016/j.envexpbot.2012.09.002; Flemetakis E, 2002, MOL PLANT MICROBE IN, V15, P313, DOI 10.1094/MPMI.2002.15.4.313; Fu LH, 2002, J BIOL CHEM, V277, P25983, DOI 10.1074/jbc.M202912200; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; Hartleib J, 2001, BIOCHEM J, V353, P579, DOI 10.1042/0264-6021:3530579; Huang C, 2012, CLIN CANCER RES, V18, P3042, DOI 10.1158/1078-0432.CCR-12-0183; Hugouvieux V, 2009, PLANT PHYSIOL, V151, P768, DOI 10.1104/pp.109.144808; Jeong JY, 2009, BIOCHEM BIOPH RES CO, V379, P583, DOI 10.1016/j.bbrc.2008.12.110; Kanazawa T, 2008, AM J MED GENET B, V147B, P686, DOI 10.1002/ajmg.b.30664; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kim H, 2006, PROTEOMICS, V6, P3466, DOI 10.1002/pmic.200500629; Krittanai C, 1997, ANAL BIOCHEM, V253, P57, DOI 10.1006/abio.1997.2366; Lai B, 2003, BIOCHEMISTRY-US, V42, P785, DOI 10.1021/bi026960a; LANFEAR J, 1993, CARCINOGENESIS, V14, P335, DOI 10.1093/carcin/14.3.335; Mattow J, 2006, ELECTROPHORESIS, V27, P1683, DOI 10.1002/elps.200500703; Mehdi Y, 2013, MOLECULES, V18, P3292, DOI 10.3390/molecules18033292; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Noctor G, 2012, PLANT CELL ENVIRON, V35, P454, DOI 10.1111/j.1365-3040.2011.02400.x; Ogasawara Y, 2005, P NATL ACAD SCI USA, V102, P1012, DOI 10.1073/pnas.0409042102; Ogasawara Y, 2001, P NATL ACAD SCI USA, V98, P9494, DOI 10.1073/pnas.171320998; Pal R, 2010, APPL BIOCHEM BIOTECH, V160, P945, DOI 10.1007/s12010-009-8565-4; Pilon-Smits EAH, 2009, CURR OPIN PLANT BIOL, V12, P267, DOI 10.1016/j.pbi.2009.04.009; Pilon-Smits EAH, 2009, CURR OPIN BIOTECH, V20, P207, DOI 10.1016/j.copbio.2009.02.001; Pohl NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007774; Pons T, 2003, CURR MED CHEM, V10, P505, DOI 10.2174/0929867033368204; Porat A, 2000, J BIOL CHEM, V275, P14457, DOI 10.1074/jbc.275.19.14457; Proux O, 2005, PHYS SCRIPTA, VT115, P970; Raucci R, 2011, BBA-PROTEINS PROTEOM, V1814, P513, DOI 10.1016/j.bbapap.2011.02.006; Sarret G, 2005, APPL ENVIRON MICROB, V71, P2331, DOI 10.1128/AEM.71.5.2331-2337.2005; Sarry JE, 2006, PROTEOMICS, V6, P2180, DOI 10.1002/pmic.200500543; Sawada K, 2004, BIOSCI BIOTECH BIOCH, V68, P873, DOI 10.1271/bbb.68.873; Scharff EI, 2001, STRUCTURE, V9, P493, DOI 10.1016/S0969-2126(01)00610-4; Silvers AL, 2010, CLIN CANCER RES, V16, P2009, DOI 10.1158/1078-0432.CCR-09-2801; Song LS, 2006, DEV COMP IMMUNOL, V30, P265, DOI 10.1016/j.dci.2005.04.001; Sors TG, 2005, PHOTOSYNTH RES, V86, P373, DOI 10.1007/s11120-005-5222-9; Sutherland DEK, 2011, METALLOMICS, V3, P444, DOI 10.1039/c0mt00102c; Suzuki M, 2008, J BIOL CHEM, V283, P25936, DOI 10.1074/jbc.M803773200; Suzuki N, 2002, PLANT J, V32, P165, DOI 10.1046/j.1365-313X.2002.01412.x; TAINER J A, 1992, Current Opinion in Biotechnology, V3, P378, DOI 10.1016/0958-1669(92)90166-G; TAINER JA, 1991, CURR OPIN BIOTECH, V2, P582, DOI 10.1016/0958-1669(91)90084-I; Terry N, 2000, ANNU REV PLANT PHYS, V51, P401, DOI 10.1146/annurev.arplant.51.1.401; Van Hoewyk D, 2013, ANN BOT-LONDON, V112, P965, DOI 10.1093/aob/mct163; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; White PJ, 2004, J EXP BOT, V55, P1927, DOI 10.1093/jxb/erh192; Xia YJ, 2011, HUM PATHOL, V42, P1620, DOI 10.1016/j.humpath.2011.01.008; Zhang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063702; Zhu YG, 2009, TRENDS PLANT SCI, V14, P436, DOI 10.1016/j.tplants.2009.06.006	62	21	21	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31765	31776		10.1074/jbc.M114.571208	http://dx.doi.org/10.1074/jbc.M114.571208			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25274629	hybrid, Green Published			2022-12-28	WOS:000345314700009
J	Gondo, A; Shinotsuka, T; Morita, A; Abe, Y; Yasui, M; Nuriya, M				Gondo, Asako; Shinotsuka, Takanori; Morita, Ayaka; Abe, Yoichiro; Yasui, Masato; Nuriya, Mutsuo			Sustained Down-regulation of beta-Dystroglycan and Associated Dysfunctions of Astrocytic Endfeet in Epileptic Cerebral Cortex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; LIPID RAFTS; BRAIN; AQUAPORIN-4; MEMBRANE; MODEL; WATER; COMPLEX; SYSTEM; MICRODOMAINS	Epilepsy is characterized by the abnormal activation of neurons in the cerebral cortex, but the molecular and cellular mechanisms contributing to the development of recurrent seizures are largely unknown. Recently, the critical involvement of astrocytes in the pathophysiology of epilepsy has been proposed. However, the nature of plastic modulations of astrocytic proteins in the epileptic cortex remains poorly understood. In this study, we utilized the zero magnesium in vitro model of epilepsy and examined the potential molecular changes of cortical astrocytes, focusing specifically on endfeet, where specialized biochemical compartments exist. We find that the continuous epileptic activation of neurons for 1 h decreases the expression level of beta-dystroglycan (beta DG) in acute cortical brain slices prepared from mice. This change is completely abolished by the pharmacological blockade of NMDA-type glutamate receptors as well as by matrix metalloproteinase inhibitors. Consistent with the highly specialized localization of beta DG at astrocytic endfeet, where it plays a pivotal role in anchoring endfeet-enriched proteins in astrocytes, the down-regulation of beta DG is accompanied by a decrease in the expression of AQP4 but not laminin. Importantly, this down-regulation of beta DG persists for at least 1 h, even after the apparent recovery of neuronal activation. Finally, we show that the down-regulation of beta DG is associated with the dysfunction of the endfeet at the blood-brain interface as a diffusion barrier. These results suggest that the sustained down-regulation of beta DG leads to dysfunctions of astrocytic endfeet in the epileptic cerebral cortex and may contribute to the pathogenesis of epilepsy.	[Gondo, Asako; Shinotsuka, Takanori; Morita, Ayaka; Abe, Yoichiro; Yasui, Masato; Nuriya, Mutsuo] Keio Univ, Sch Med, Dept Pharmacol, Tokyo 1608582, Japan; [Gondo, Asako] Tokyo Med Univ, Dept Nephrol & Dialysis, Tokyo 1600023, Japan; [Morita, Ayaka] Yokohama Natl Univ, Coll Engn, Yokohama, Kanagawa 2408501, Japan; [Nuriya, Mutsuo] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan	Keio University; Tokyo Medical University; Yokohama National University; Yokohama National University	Nuriya, M (corresponding author), Keio Univ, Sch Med, Dept Pharmacol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	mnuriya@z2.keio.jp	Abe, Yoichiro/J-5576-2013; Nuriya, Mutsuo/J-5928-2013; Abe, Yoichiro/AAN-8801-2020	Abe, Yoichiro/0000-0001-6163-8794; Nuriya, Mutsuo/0000-0002-5689-8222; Abe, Yoichiro/0000-0001-6163-8794	Grants-in-Aid for Scientific Research [14J07414] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Alvestad S, 2013, EPILEPSY RES, V105, P30, DOI 10.1016/j.eplepsyres.2013.01.006; Ambrosini E, 2008, MOL CELL NEUROSCI, V37, P480, DOI 10.1016/j.mcn.2007.11.003; ARAM JA, 1988, J NEUROSCI METH, V23, P211, DOI 10.1016/0165-0270(88)90005-2; Badea T, 2001, J NEUROBIOL, V48, P215, DOI 10.1002/neu.1052; Beaumont TL, 2012, J NEUROSCI, V32, P14389, DOI 10.1523/JNEUROSCI.3408-12.2012; Crunelli V, 2013, J PHYSIOL-LONDON, V591, P775, DOI 10.1113/jphysiol.2012.243378; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; DREIER JP, 1990, NEUROSCI LETT, V119, P68, DOI 10.1016/0304-3940(90)90757-Z; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Eid T, 2005, P NATL ACAD SCI USA, V102, P1193, DOI 10.1073/pnas.0409308102; Fort PE, 2008, GLIA, V56, P597, DOI 10.1002/glia.20633; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Gomez-Gonzalo M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000352; Hibino H, 2007, EUR J NEUROSCI, V26, P2539, DOI 10.1111/j.1460-9568.2007.05876.x; Iliff JJ, 2013, STROKE, V44, pS93, DOI 10.1161/STROKEAHA.112.678698; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Lee DJ, 2012, EXP NEUROL, V235, P246, DOI 10.1016/j.expneurol.2012.02.002; Li YJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-80; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Noel G, 2009, J BIOL CHEM, V284, P19694, DOI 10.1074/jbc.M109.010090; Noell S, 2011, EUR J NEUROSCI, V33, P2179, DOI 10.1111/j.1460-9568.2011.07688.x; Nuriya M, 2013, CEREB CORTEX, V23, P2118, DOI 10.1093/cercor/bhs198; Nuriya M, 2013, J NEUROSCI, V33, P3692, DOI 10.1523/JNEUROSCI.3050-12.2013; Pisani A, 2004, EPILEPSIA, V45, P719, DOI 10.1111/j.0013-9580.2004.02204.x; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Shinotsuka T, 2014, BIOCHEM BIOPH RES CO, V444, P171, DOI 10.1016/j.bbrc.2014.01.035; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; VILAGI I, 1991, EPILEPSY RES, V8, P102, DOI 10.1016/0920-1211(91)90077-S; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yoshioka M, 2005, J CHILD NEUROL, V20, P385, DOI 10.1177/08830738050200041901; Yuste R, 2010, DENDRITIC SPINES	36	20	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30279	30288		10.1074/jbc.M114.588384	http://dx.doi.org/10.1074/jbc.M114.588384			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25228692	Green Published, hybrid			2022-12-28	WOS:000344549700012
J	Karst, JC; Enguene, VYN; Cannella, SE; Subrini, O; Hessel, A; Debard, S; Ladant, D; Chenal, A				Karst, Johanna C.; Enguene, V. Yvette Ntsogo; Cannella, Sara E.; Subrini, Orso; Hessel, Audrey; Debard, Sylvain; Ladant, Daniel; Chenal, Alexandre			Calcium, Acylation, and Molecular Confinement Favor Folding of Bordetella pertussis Adenylate Cyclase CyaA Toxin into a Monomeric and Cytotoxic Form	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; TARGET-CELLS; HEMOLYTIC ACTIVITIES; MEMBRANE TRANSLOCATION; CATALYTIC DOMAIN; RTX PROTEINS; CALMODULIN; PURIFICATION; SECRETION; BINDING	The adenylate cyclase (CyaA) toxin, a multidomain protein of 1706 amino acids, is one of the major virulence factors produced by Bordetella pertussis, the causative agent of whooping cough. CyaA is able to invade eukaryotic target cells in which it produces high levels of cAMP, thus altering the cellular physiology. Although CyaA has been extensively studied by various cellular and molecular approaches, the structural and functional states of the toxin remain poorly characterized. Indeed, CyaA is a large protein and exhibits a pronounced hydrophobic character, making it prone to aggregation into multimeric forms. As a result, CyaA has usually been extracted and stored in denaturing conditions. Here, we define the experimental conditions allowing CyaA folding into a monomeric and functional species. We found that CyaA forms mainly multimers when refolded by dialysis, dilution, or buffer exchange. However, a significant fraction of monomeric, folded protein could be obtained by exploiting molecular confinement on size exclusion chromatography. Folding of CyaA into a monomeric form was found to be critically dependent upon the presence of calcium and post-translational acylation of the protein. We further show that the monomeric preparation displayed hemolytic and cytotoxic activities suggesting that the monomer is the genuine, physiologically active form of the toxin. We hypothesize that the structural role of the post-translational acylation in CyaA folding may apply to other RTX toxins.	[Karst, Johanna C.; Enguene, V. Yvette Ntsogo; Cannella, Sara E.; Subrini, Orso; Hessel, Audrey; Debard, Sylvain; Ladant, Daniel; Chenal, Alexandre] Inst Pasteur, CNRS UMR 3528, Unite Biochim Interact Macromol, Dept Biol Struct & Chim, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ladant, D (corresponding author), Inst Pasteur, CNRS URA 3528, Unite Biochim Interact Macromol, 28 Rue Dr Roux, F-75724 Paris 15, France.	daniel.ladant@pasteur.fr; alexandre.chenal@pasteur.fr	Chenal, Alexandre/C-2240-2009	Chenal, Alexandre/0000-0002-4959-1003; LADANT, Daniel/0000-0003-1955-548X; NTSOGO, YVETTE/0000-0003-0096-3192	Agence Nationale de la Recherche, program Jeunes Chercheurs [ANR-09-JCJC-0012]; Institut Pasteur Projet Transversal de Recherche PTR [374]; Jacob class of Pasteur-Paris University International Ph.D. Program from Institut Pasteur; CNRS (UMR 3528, Biologie Structurale et Agents Infectieux)	Agence Nationale de la Recherche, program Jeunes Chercheurs(French National Research Agency (ANR)); Institut Pasteur Projet Transversal de Recherche PTR; Jacob class of Pasteur-Paris University International Ph.D. Program from Institut Pasteur; CNRS (UMR 3528, Biologie Structurale et Agents Infectieux)	This work was supported by the Agence Nationale de la Recherche, program Jeunes Chercheurs (Grant ANR-09-JCJC-0012), the Institut Pasteur Projet Transversal de Recherche PTR#374, the Jacob class of Pasteur-Paris University International Ph.D. Program from Institut Pasteur, and CNRS (UMR 3528, Biologie Structurale et Agents Infectieux).	BARRY EM, 1991, J BACTERIOL, V173, P720, DOI 10.1128/jb.173.2.720-726.1991; Basler M, 2007, J BIOL CHEM, V282, P12419, DOI 10.1074/jbc.M611226200; Bauche C, 2006, J BIOL CHEM, V281, P16914, DOI 10.1074/jbc.M601594200; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BELLALOU J, 1990, INFECT IMMUN, V58, P3242, DOI 10.1128/IAI.58.10.3242-3247.1990; BENZ R, 1994, J BIOL CHEM, V269, P27231; Bumba L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000901; Carbonetti NH, 2010, FUTURE MICROBIOL, V5, P455, DOI 10.2217/FMB.09.133; Chenal A, 2010, BIOPHYS J, V99, P3744, DOI 10.1016/j.bpj.2010.10.016; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Cheung GYC, 2009, MICROB PATHOGENESIS, V46, P36, DOI 10.1016/j.micpath.2008.10.005; Dadaglio G, 2003, INT IMMUNOL, V15, P1423, DOI 10.1093/intimm/dxg144; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Eby JC, 2010, J BIOL CHEM, V285, P10662, DOI 10.1074/jbc.M109.089219; Fiser R, 2007, J BIOL CHEM, V282, P2808, DOI 10.1074/jbc.M609979200; GENTILE F, 1990, J BIOL CHEM, V265, P10686; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; GLASER P, 1988, MOL MICROBIOL, V2, P19, DOI 10.1111/j.1365-2958.1988.tb00003.x; GORDON VM, 1989, J BIOL CHEM, V264, P14792; Gray MC, 2004, MOL MICROBIOL, V53, P1709, DOI 10.1111/j.1365-2958.2004.04227.x; Guermonprez P, 1999, J IMMUNOL, V162, P1910; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; Herlax V, 2007, BIOCHEMISTRY-US, V46, P5177, DOI 10.1021/bi0618013; Heveker N, 1997, EUR J BIOCHEM, V243, P643, DOI 10.1111/j.1432-1033.1997.00643.x; Hewlett EL, 2006, MOL MICROBIOL, V59, P447, DOI 10.1111/j.1365-2958.2005.04958.x; HEWLETT EL, 1976, P NATL ACAD SCI USA, V73, P1926, DOI 10.1073/pnas.73.6.1926; HEWLETT EL, 1991, J BIOL CHEM, V266, P17503; HEWLETT EL, 1989, J BIOL CHEM, V264, P19379; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; Karst Johanna C, 2012, Methods Mol Biol, V896, P163, DOI 10.1007/978-1-4614-3704-8_10; Karst JC, 2012, J BIOL CHEM, V287, P9200, DOI 10.1074/jbc.M111.316166; Karst JC, 2010, BIOCHEMISTRY-US, V49, P318, DOI 10.1021/bi9016389; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LADANT D, 1986, J BIOL CHEM, V261, P6264; Lieutaud P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S25; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Masin J, 2005, BIOCHEMISTRY-US, V44, P12759, DOI 10.1021/bi050459b; MASURE HR, 1990, BIOCHEMISTRY-US, V29, P140, DOI 10.1021/bi00453a017; Meier R, 2007, J BIOL CHEM, V282, P31477, DOI 10.1074/jbc.M704942200; Paccani SR, 2011, J EXP MED, V208, P1317, DOI 10.1084/jem.20101558; Preville X, 2005, CANCER RES, V65, P641; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; ROGEL A, 1989, EMBO J, V8, P2755, DOI 10.1002/j.1460-2075.1989.tb08417.x; ROGEL A, 1992, J BIOL CHEM, V267, P22599; ROSE T, 1995, J BIOL CHEM, V270, P26370, DOI 10.1074/jbc.270.44.26370; SAKAMOTO H, 1992, J BIOL CHEM, V267, P13598; Saron MF, 1997, P NATL ACAD SCI USA, V94, P3314, DOI 10.1073/pnas.94.7.3314; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; SEBO P, 1991, GENE, V104, P19, DOI 10.1016/0378-1119(91)90459-O; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Sotomayor Perez AC, 2010, J MOL BIOL, V397, P534, DOI 10.1016/j.jmb.2010.01.031; Sotomayor-Perez Ana Cristina, 2012, Methods Mol Biol, V896, P331, DOI 10.1007/978-1-4614-3704-8_22; Sotomayor-Perez AC, 2011, J BIOL CHEM, V286, P16997, DOI 10.1074/jbc.M110.210393; Sotomayor-Perez AC, 2013, J AM CHEM SOC, V135, P11929, DOI 10.1021/ja404790f; Subrini O, 2013, J BIOL CHEM, V288, P32585, DOI 10.1074/jbc.M113.508838; Szilvay GR, 2009, BIOCHEMISTRY-US, V48, P11273, DOI 10.1021/bi901447j; Uribe KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067648; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Veneziano R, 2013, P NATL ACAD SCI USA, V110, P20473, DOI 10.1073/pnas.1312975110; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Vojtova-Vodolanova J, 2009, FASEB J, V23, P2831, DOI 10.1096/fj.09-131250; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x; Westrop GD, 1996, GENE, V180, P91, DOI 10.1016/S0378-1119(96)00412-X	70	39	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30702	30716		10.1074/jbc.M114.580852	http://dx.doi.org/10.1074/jbc.M114.580852			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231985	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000344549700046
J	Snyder, M; Huang, JY; Huang, XY; Zhang, JJ				Snyder, Marylynn; Huang, Jianyun; Huang, Xin-Yun; Zhang, J. Jillian			A Signal Transducer and Activator of Transcription 3 center dot Nuclear Factor kappa B (Stat3 center dot NF kappa B) Complex Is Necessary for the Expression of Fascin in Metastatic Breast Cancer Cells in Response to Interleukin (IL)-6 and Tumor Necrosis Factor (TNF)-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Stat3; Transcription Regulation; Tumor Metastasis; Tumor Necrosis Factor (TNF); Fascin; NF KappaB	EPITHELIAL-MESENCHYMAL TRANSITION; STAT3; TARGET; ROLES; GENE; GROWTH; INFLAMMATION; MIGRATION; MICE; DIFFERENTIATION	Background: IL-6/Stat3 promote breast cancer metastasis through regulation of the fascin gene. Results: In addition to IL-6, TNF-alpha induces binding of a Stat3NF kappa B complex to the fascin promoter to induce transcription. Conclusion: Both NF kappa B and Stat3 are required for cytokine-induced fascin expression and cell migration. Significance: Identification of proteins critical for breast cancer metastasis will reveal drug targets. IL-6 mediated activation of Stat3 is a major signaling pathway in the process of breast cancer metastasis. One important mechanism by which the IL-6/Stat3 pathway promotes metastasis is through transcriptional regulation of the actin-bundling protein fascin. In this study, we further analyzed the transcriptional regulation of the fascin gene promoter. We show that in addition to IL-6, TNF-alpha increases Stat3 and NF kappa B binding to the fascin promoter to induce its expression. We also show that NFB is required for Stat3 recruitment to the fascin promoter in response to IL-6. Furthermore, Stat3 and NFB form a protein complex in response to cytokine stimulation. Finally, we demonstrate that an overlapping STAT/NF kappa B site in a highly conserved 160-bp region of the fascin promoter is sufficient and necessary to induce transcription in response to IL-6 and TNF-alpha.	[Snyder, Marylynn; Huang, Jianyun; Huang, Xin-Yun; Zhang, J. Jillian] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA	Cornell University	Zhang, JJ (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, 1300 York Ave, New York, NY 10065 USA.	jjz2002@med.cornell.edu			National Institutes of Health [CA136837]; NATIONAL CANCER INSTITUTE [R01CA136837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA136837 (to X. Y. H.).	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Barbieri I, 2010, CANCER RES, V70, P2558, DOI 10.1158/0008-5472.CAN-09-2840; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Besser D, 1999, MOL CELL BIOL, V19, P1401; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bros M, 2003, J IMMUNOL, V171, P1825, DOI 10.4049/jimmunol.171.4.1825; Carbone C, 2012, EXPERT OPIN THER TAR, V16, pS1, DOI 10.1517/14728222.2011.645806; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Faggioli L, 1996, EUR J BIOCHEM, V239, P624, DOI 10.1111/j.1432-1033.1996.0624u.x; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Hashimoto Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005130; Heinrich PC, 1998, Z ERNAHRUNGSWISS, V37, P43; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Lerner L, 2003, GENE DEV, V17, P2564, DOI 10.1101/gad.1135003; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Ramadoss S, 2011, MOL CELL BIOL, V31, P924, DOI 10.1128/MCB.00576-10; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Said NABM, 2011, CELLS TISSUES ORGANS, V193, P85, DOI 10.1159/000320360; Santos CI, 2011, BBA-REV CANCER, V1816, P38, DOI 10.1016/j.bbcan.2011.03.003; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; Shen YH, 2004, MOL CELL BIOL, V24, P407, DOI 10.1128/MCB.24.1.407-419.2004; Snyder M, 2008, J BIOL CHEM, V283, P3791, DOI 10.1074/jbc.M706976200; Snyder M, 2011, J BIOL CHEM, V286, P38886, DOI 10.1074/jbc.M111.286245; Snyder M, 2011, FEBS LETT, V585, P148, DOI 10.1016/j.febslet.2010.11.030; Snyder M, 2010, J BIOL CHEM, V285, P23639, DOI 10.1074/jbc.M110.101063; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang XK, 1999, MOL CELL BIOL, V19, P7138	42	51	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					30082	30089		10.1074/jbc.M114.591719	http://dx.doi.org/10.1074/jbc.M114.591719			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25213863	Green Published, hybrid			2022-12-28	WOS:000344370800048
J	Markadieu, N; Rios, K; Spiller, BW; McDonald, WH; Welling, PA; Delpire, E				Markadieu, Nicolas; Rios, Kerri; Spiller, Benjamin W.; McDonald, W. Hayes; Welling, Paul A.; Delpire, Eric			Short Forms of Ste20-related Proline/Alanine-rich Kinase (SPAK) in the Kidney Are Created by Aspartyl Aminopeptidase (Dnpep)-mediated Proteolytic Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-2CL(-) COTRANSPORTER; SUBSTRATE-SPECIFICITY; CL-COTRANSPORTER; ACTIVATION; PROLINE; OSR1; IDENTIFICATION; INSIGHTS; DITHIOTHREITOL; INHIBITOR	The Ste20-related kinase SPAK regulates sodium, potassium, and chloride transport in a variety of tissues. Recently, SPAK fragments, which lack the catalytic domain and are inhibitory to Na+ transporters, have been detected in kidney. It has been hypothesized that the fragments originate from alternative translation start sites, but their precise origin is unknown. Here, we demonstrate that kidney lysate possesses proteolytic cleavage activity toward SPAK. Ion exchange and size exclusion chromatography combined with mass spectrometry identified the protease as aspartyl aminopeptidase. The presence of the protease was verified in the active fractions, and recombinant aspartyl aminopeptidase recapitulated the cleavage pattern observed with kidney lysate. Identification of the sites of cleavage by mass spectrometry allowed us to test the function of the smaller fragments and demonstrate their inhibitory action toward the Na+-K+-2Cl(-) cotransporter, NKCC2.	[Markadieu, Nicolas; Rios, Kerri; Delpire, Eric] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37232 USA; [Spiller, Benjamin W.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; [McDonald, W. Hayes] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA; [Welling, Paul A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University System of Maryland; University of Maryland Baltimore	Delpire, E (corresponding author), Vanderbilt Univ, Sch Med, Dept Anesthesiol, T-4202 Med Ctr North,1161 21st Ave, South Nashville, TN 37232 USA.	eric.delpire@vanderbilt.edu	McDonald, W. Hayes/B-4109-2016	McDonald, W. Hayes/0000-0002-3510-426X	National Institutes of Health [DK093501, GM081778]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063049, R01DK093501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK093501 (to E. D. and P. A. W.) and GM081778 (to B. W. S.).	[Anonymous], PHYSL REV, V92, P1577; Bylander JE, 2007, BIOL CHEM, V388, P1163, DOI 10.1515/BC.2007.156; Chen YY, 2012, J BIOL CHEM, V287, P13356, DOI 10.1074/jbc.M112.347518; Chow KM, 2009, BIOCHEMISTRY-US, V48, P2868, DOI 10.1021/bi8016125; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; Correa LM, 2000, DEV BIOL, V225, P124, DOI 10.1006/dbio.2000.9825; Cousins RJ, 2000, J NUTR, V130, p1384S, DOI 10.1093/jn/130.5.1384S; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; FRANK G, 1974, EUR J BIOCHEM, V44, P317; Franzetti B, 2002, EMBO J, V21, P2132, DOI 10.1093/emboj/21.9.2132; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gagnon KB, 2011, CELL PHYSIOL BIOCHEM, V28, P1219, DOI 10.1159/000335854; Geng Y, 2009, J BIOL CHEM, V284, P14020, DOI 10.1074/jbc.M900142200; Gondzik V, 2012, AM J PHYSIOL-CELL PH, V303, pC936, DOI 10.1152/ajpcell.00395.2011; Grimm PR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.402800; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Krezel A, 2001, J INORG BIOCHEM, V84, P77, DOI 10.1016/S0162-0134(00)00212-9; Lin SH, 2011, P NATL ACAD SCI USA, V108, P17538, DOI 10.1073/pnas.1107452108; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Martinez MN, 2012, J LIPID RES, V53, P379, DOI 10.1194/jlr.M019752; McCormick JA, 2011, CELL METAB, V14, P352, DOI 10.1016/j.cmet.2011.07.009; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Park HJ, 2013, AM J PHYSIOL-RENAL, V305, pF1687, DOI 10.1152/ajprenal.00211.2013; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Puente XS, 2004, GENOME RES, V14, P609, DOI 10.1101/gr.1946304; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Ranaldi G, 2002, AM J PHYSIOL-RENAL, V283, pF1365, DOI 10.1152/ajprenal.00094.2002; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; San-Cristobal P, 2009, P NATL ACAD SCI USA, V106, P4384, DOI 10.1073/pnas.0813238106; Schwacke JH, 2013, HYPERTENSION, V61, P690, DOI 10.1161/HYPERTENSIONAHA.111.00318; Tamura T, 2000, ARCH BIOCHEM BIOPHYS, V379, P261, DOI 10.1006/abbi.2000.1869; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Villa F, 2007, EMBO REP, V8, P839, DOI 10.1038/sj.embor.7401048; Wilk S, 1998, J BIOL CHEM, V273, P15961, DOI 10.1074/jbc.273.26.15961; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Wolf G, 1997, EXP NEPHROL, V5, P364; Yang SS, 2010, J AM SOC NEPHROL, V21, P1868, DOI 10.1681/ASN.2009121295; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Yokoyama R, 2006, FEBS J, V273, P192, DOI 10.1111/j.1742-4658.2005.05057.x	46	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29273	29284		10.1074/jbc.M114.604009	http://dx.doi.org/10.1074/jbc.M114.604009			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25164821	Green Published, hybrid			2022-12-28	WOS:000344141000041
J	Rajan, R; Osterman, AK; Gast, AT; Mondragon, A				Rajan, Rakhi; Osterman, Amy K.; Gast, Alexandra T.; Mondragon, Alfonso			Biochemical Characterization of the Topoisomerase Domain of Methanopyrus kandleri Topoisomerase V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI DNA TOPOISOMERASE; VACCINIA TOPOISOMERASE; COVALENT CATALYSIS; HYPERTHERMOPHILIC PROKARYOTE; MUTATIONAL ANALYSIS; REPAIR ACTIVITIES; CRYSTAL-STRUCTURE; MECHANISM; IB; RESIDUES	Topoisomerases are ubiquitous enzymes that modify the topological state of DNA inside the cell and are essential for several cellular processes. Topoisomerase V is the sole member of the type IC topoisomerase subtype. The topoisomerase domain has a unique fold among topoisomerases, and the putative active site residues show a distinct arrangement. The present study was aimed at identifying the roles of the putative active site residues in the DNA cleavage/religation process. Residues Arg-131, Arg144, His-200, Glu-215, Lys-218, and Tyr-226 were mutated individually to a series of conservative and non-conservative amino acids, and the DNA relaxation activity at different pH values, times, and enzyme concentrations was compared with wild-type activity. The results suggest that Arg-144 is essential for protein stability because any substitution at this position was deleterious and that Arg-131 and His-200 are involved in transition state stabilization. Glu-215 reduces the DNA binding ability of topoisomerase V, especially in shorter fragments with fewer helix-hairpin-helix DNA binding motifs. Finally, Lys-218 appears to play a direct role in catalysis but not in charge stabilization of the protein-DNA intermediate complex. The results suggest that although catalytically important residues are oriented in different fashions in the active sites of type IB and type IC topoisomerases, similar amino acids play equivalent roles in both of these subtypes of enzymes, showing convergent evolution of the catalytic mechanism.	[Rajan, Rakhi; Osterman, Amy K.; Gast, Alexandra T.; Mondragon, Alfonso] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Mondragon, A (corresponding author), Northwestern Univ, Dept Mol Biosci, 2205 Tech Dr, Evanston, IL 60208 USA.	a-mondragon@northwestern.edu	Rajan, Rakhi/K-2477-2016	Tarabochia-Gast, Alexandra/0000-0001-7691-179X	National Institutes of Health [R01GM51350]; American Heart Association [10POST2600325]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM51350 (to A. M.). This work was also supported by American Heart Association Grant 10POST2600325 (to R. R.).	Baker NM, 2009, NUCLEIC ACIDS RES, V37, P693, DOI 10.1093/nar/gkn1009; Belova GI, 2002, J BIOL CHEM, V277, P4959, DOI 10.1074/jbc.M110131200; Belova GI, 2001, P NATL ACAD SCI USA, V98, P6015, DOI 10.1073/pnas.111040498; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Changela A, 2001, NATURE, V411, P1077, DOI 10.1038/35082615; Changela A, 2007, J MOL BIOL, V368, P105, DOI 10.1016/j.jmb.2007.01.065; Cheng CH, 1997, J BIOL CHEM, V272, P8263, DOI 10.1074/jbc.272.13.8263; DOMANICO PL, 1991, J INORG BIOCHEM, V42, P87, DOI 10.1016/0162-0134(91)80035-G; Forterre P, 2006, TRENDS BIOTECHNOL, V24, P245, DOI 10.1016/j.tibtech.2006.04.006; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Koster DA, 2008, NUCLEIC ACIDS RES, V36, P2301, DOI 10.1093/nar/gkn035; Krogh BO, 2000, MOL CELL, V5, P1035, DOI 10.1016/S1097-2765(00)80268-3; Krogh BO, 2002, J BIOL CHEM, V277, P5711, DOI 10.1074/jbc.C100681200; Perry K, 2002, J BIOL CHEM, V277, P13237, DOI 10.1074/jbc.M112019200; Perry K, 2006, MOL CELL, V23, P343, DOI 10.1016/j.molcel.2006.06.015; Perry K, 2010, STRUCTURE, V18, P127, DOI 10.1016/j.str.2009.10.020; Petersen BO, 1996, J MOL BIOL, V263, P181, DOI 10.1006/jmbi.1996.0568; Petersen BO, 1997, J BIOL CHEM, V272, P3891, DOI 10.1074/jbc.272.7.3891; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rajan R, 2013, NUCLEIC ACIDS RES, V41, P657, DOI 10.1093/nar/gks1017; Rajan R, 2010, STRUCTURE, V18, P829, DOI 10.1016/j.str.2010.03.006; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Seol Y, 2012, P NATL ACAD SCI USA, V109, P16125, DOI 10.1073/pnas.1206480109; SLESAREV AI, 1994, J BIOL CHEM, V269, P3295; SLESAREV AI, 1993, NATURE, V364, P735, DOI 10.1038/364735a0; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; STIVERS JT, 1994, BIOCHEMISTRY-US, V33, P15449, DOI 10.1021/bi00255a027; STIVERS JT, 1994, BIOCHEMISTRY-US, V33, P327, DOI 10.1021/bi00167a043; Taneja B, 2006, EMBO J, V25, P398, DOI 10.1038/sj.emboj.7600922; Taneja B, 2007, P NATL ACAD SCI USA, V104, P14670, DOI 10.1073/pnas.0701989104; Tian LG, 2005, STRUCTURE, V13, P513, DOI 10.1016/j.str.2005.02.001; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang JC, 2009, ANNU REV BIOCHEM, V78, P31, DOI 10.1146/annurev.biochem.78.030107.090101; WITTSCHIEBEN J, 1994, J BIOL CHEM, V269, P29978; Wittschieben J, 1997, NUCLEIC ACIDS RES, V25, P3001, DOI 10.1093/nar/25.15.3001; Yang Z, 2001, J BIOL CHEM, V276, P677, DOI 10.1074/jbc.M007593200; Zhang ZT, 2011, P NATL ACAD SCI USA, V108, P6939, DOI 10.1073/pnas.1100300108; Zhu CX, 1997, J BIOL CHEM, V272, P16206, DOI 10.1074/jbc.272.26.16206; Zhu CX, 2000, J BIOL CHEM, V275, P5318, DOI 10.1074/jbc.275.8.5318; Zhu CX, 1998, J BIOL CHEM, V273, P8783, DOI 10.1074/jbc.273.15.8783	41	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28898	28909		10.1074/jbc.M114.590711	http://dx.doi.org/10.1074/jbc.M114.590711			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25135643	Green Published, hybrid			2022-12-28	WOS:000344141000013
J	Sobradillo, D; Hernandez-Morales, M; Ubierna, D; Moyer, MP; Nunez, L; Villalobos, C				Sobradillo, Diego; Hernandez-Morales, Miriam; Ubierna, Daniel; Moyer, Mary P.; Nunez, Luca; Villalobos, Carlos			A Reciprocal Shift in Transient Receptor Potential Channel 1 (TRPC1) and Stromal Interaction Molecule 2 (STIM2) Contributes to Ca2+ Remodeling and Cancer Hallmarks in Colorectal Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CALCIUM-ENTRY; ION CHANNELS; ORAI1; PROLIFERATION; EXPRESSION; TARGET; INHIBITION; MIGRATION; STORES; TUMORS	We have investigated the molecular basis of intracellular Ca2+ handling in human colon carcinoma cells (HT29) versus normal human mucosa cells (NCM460) and its contribution to cancer features. We found that Ca2+ stores in colon carcinoma cells are partially depleted relative to normal cells. However, resting Ca2+ levels, agonist-induced Ca2+ increases, store-operated Ca2+ entry (SOCE), and store-operated currents (I-SOC) are largely enhanced in tumor cells. Enhanced SOCE and depleted Ca2+ stores correlate with increased cell proliferation, invasion, and survival characteristic of tumor cells. Normal mucosa cells displayed small, inward Ca2+ release-activated Ca2+ currents (I-CRAC) mediated by ORAI1. In contrast, colon carcinoma cells showed mixed currents composed of enhanced I-CRAC plus a nonselective ISOC mediated by TRPC1. Tumor cells display increased expression of TRPC1, ORAI1, ORAI2, ORAI3, and STIM1. In contrast, STIM2 protein was nearly depleted in tumor cells. Silencing data suggest that enhanced ORAI1 and TRPC1 contribute to enhanced SOCE and differential store-operated currents in tumor cells, whereas ORAI2 and -3 are seemingly less important. In addition, STIM2 knockdown decreases SOCE and Ca2+ store content in normal cells while promoting apoptosis resistance. These data suggest that loss of STIM2 may underlie Ca2+ store depletion and apoptosis resistance in tumor cells. We conclude that a reciprocal shift in TRPC1 and STIM2 contributes to Ca2+ remodeling and tumor features in colon cancer.	[Sobradillo, Diego; Hernandez-Morales, Miriam; Ubierna, Daniel; Villalobos, Carlos] CSIC, Inst Mol Biol & Genet IBGM, Valladolid 47003, Spain; [Moyer, Mary P.] INCELL Corp, San Antonio, TX 78249 USA; [Nunez, Luca] Univ Valladolid, Dept Biochem & Mol Biol & Physiol, Valladolid 47003, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid	Villalobos, C (corresponding author), Inst Mol Biol & Genet, C Sanz & Fores 3, Valladolid 47003, Spain.	carlosv@ibgm.uva.es	Hernández-Morales, M/AAC-7682-2019; nunez, lucia/AAG-8018-2019; Villalobos, Carlos/M-9839-2017	Hernández-Morales, M/0000-0001-6487-1735; Villalobos, Carlos/0000-0002-0429-3846; Nunez, Lucia/0000-0002-9638-5747; DEL BOSQUE FERNANDEZ, DAVID/0000-0002-5204-1010	Ministerio de Economia y Competitividad, Spain [BFU2009-08967, BFU2012-37146]; Regional Government of Castilla y Leon, Spain [VA145U13]; Spanish National Research Council	Ministerio de Economia y Competitividad, Spain; Regional Government of Castilla y Leon, Spain; Spanish National Research Council	This work was supported in part by Grants BFU2009-08967 and BFU2012-37146 from Ministerio de Economia y Competitividad, Spain (to C. V.), and Ref VA145U13 from Regional Government of Castilla y Leon, Spain (to L. N.).; Supported by the JAE program from the Spanish National Research Council.	Alcarraz-Vizan G, 2014, BBA-GEN SUBJECTS, V1840, P1634, DOI 10.1016/j.bbagen.2013.12.024; Alicia S, 2008, CELL CALCIUM, V44, P479, DOI 10.1016/j.ceca.2008.03.001; Ashida S, 2012, CLIN CANCER RES, V18, P1578, DOI 10.1158/1078-0432.CCR-11-2535; Ay AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072889; Aydar E, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-23; Aytes A, 2012, MOL CARCINOGEN, V51, P746, DOI 10.1002/mc.20843; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Bell N, 2013, BBA-MOL CELL RES, V1833, P643, DOI 10.1016/j.bbamcr.2012.11.025; Bergmeier W, 2013, CHANNELS, V7, P379, DOI 10.4161/chan.24302; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Chen YF, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-23; Chen YF, 2011, P NATL ACAD SCI USA, V108, P15225, DOI 10.1073/pnas.1103315108; Cheng KT, 2013, CURR TOP MEMBR, V71, P149, DOI 10.1016/B978-0-12-407870-3.00007-X; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Ding X, 2010, JNCI-J NATL CANCER I, V102, P1052, DOI 10.1093/jnci/djq217; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Golovina VA, 2001, AM J PHYSIOL-HEART C, V280, pH746, DOI 10.1152/ajpheart.2001.280.2.H746; Gusev K, 2003, J GEN PHYSIOL, V122, P81, DOI 10.1085/jgp.200308815; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; HOTH M, 1993, ANN NY ACAD SCI, V707, P198, DOI 10.1111/j.1749-6632.1993.tb38053.x; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Jiang HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067637; Kim MS, 2009, J BIOL CHEM, V284, P9733, DOI 10.1074/jbc.M808097200; Lehen'kyi V, 2011, ADV EXP MED BIOL, V704, P929, DOI 10.1007/978-94-007-0265-3_48; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Liu HL, 2011, EXP MOL PATHOL, V91, P753, DOI 10.1016/j.yexmp.2011.09.005; Madsen CP, 2012, AM J PHYSIOL-CELL PH, V303, pC625, DOI 10.1152/ajpcell.00287.2011; McAndrew D, 2011, MOL CANCER THER, V10, P448, DOI 10.1158/1535-7163.MCT-10-0923; Motiani RK, 2013, PFLUG ARCH EUR J PHY, V465, P1249, DOI 10.1007/s00424-013-1254-8; Motiani RK, 2013, FASEB J, V27, P63, DOI 10.1096/fj.12-213801; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Nilius B, 2007, BBA-MOL BASIS DIS, V1772, P805, DOI 10.1016/j.bbadis.2007.02.002; Nunez L, 2006, J PHYSIOL-LONDON, V571, P57, DOI 10.1113/jphysiol.2005.100586; Pani B, 2006, MOL BIOL CELL, V17, P4446, DOI 10.1091/mbc.E06-03-0251; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pigozzi D, 2006, CELL CALCIUM, V39, P401, DOI 10.1016/j.ceca.2006.01.003; Prevarskaya N, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0097; Rao JN, 2012, AM J PHYSIOL-CELL PH, V303, pC308, DOI 10.1152/ajpcell.00120.2012; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Ruano Y, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-39; Saul S, 2014, EUR J PHARMACOL, V739, P49, DOI 10.1016/j.ejphar.2013.10.071; Schindl R, 2009, P NATL ACAD SCI USA, V106, P19623, DOI 10.1073/pnas.0907714106; Skopin A, 2013, BIOCHIMIE, V95, P347, DOI 10.1016/j.biochi.2012.10.004; Smaili SS, 2013, CURR MOL MED, V13, P252; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Takahashi Y, 2007, BIOCHEM BIOPH RES CO, V356, P45, DOI 10.1016/j.bbrc.2007.02.107; Valero RA, 2008, CELL CALCIUM, V44, P259, DOI 10.1016/j.ceca.2007.12.002; Vanden Abeele F, 2003, CELL CALCIUM, V33, P357, DOI 10.1016/S0143-4160(03)00049-6; Wang XT, 2000, AM J PATHOL, V157, P1549, DOI 10.1016/S0002-9440(10)64792-X; Yang N, 2013, CANCER LETT, V330, P163, DOI 10.1016/j.canlet.2012.11.040; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoshida J, 2012, BIOCHEM PHARMACOL, V84, P1592, DOI 10.1016/j.bcp.2012.09.021; Zeng B, 2013, CURR CANCER DRUG TAR, V13, P103, DOI 10.2174/156800913804486629; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200	60	78	80	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28765	28782		10.1074/jbc.M114.581678	http://dx.doi.org/10.1074/jbc.M114.581678			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25143380	hybrid, Green Published			2022-12-28	WOS:000344141000002
J	Hersch, SJ; Elgamal, S; Katz, A; Ibba, M; Navarre, WW				Hersch, Steven J.; Elgamal, Sara; Katz, Assaf; Ibba, Michael; Navarre, William Wiley			Translation Initiation Rate Determines the Impact of Ribosome Stalling on Bacterial Protein Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR-P; FACTOR EF-P; ESCHERICHIA-COLI; CODON USAGE; CRYSTAL-STRUCTURE; GENE-EXPRESSION; SEQUENCE; PROLINE; POXA; SECM	Ribosome stalling during translation can be caused by a number of characterized mechanisms. However, the impact of elongation stalls on protein levels is variable, and the reasons for this are often unclear. To investigate this relationship, we examined the bacterial translation elongation factor P (EF-P), which plays a critical role in rescuing ribosomes stalled at specific amino acid sequences including polyproline motifs. In previous proteomic analyses of both Salmonella and Escherichia coli efp mutants, it was evident that not all proteins containing a polyproline motif were dependent on EF-P for efficient expression in vivo. The alpha- and beta-subunits of ATP synthase, AtpA and AtpD, are translated from the same mRNA transcript, and both contain a PPG motif; however, proteomic analysis revealed that AtpD levels are strongly dependent on EF-P, whereas AtpA levels are independent of EF-P. Using these model proteins, we systematically determined that EF-P dependence is strongly influenced by elements in the 5'-untranslated region of the mRNA. By mutating either the Shine-Dalgarno sequence or the start codon, we find that EF-P dependence correlates directly with the rate of translation initiation where strongly expressed proteins show the greatest dependence on EF-P. Our findings demonstrate that polyproline-induced stalls exert a net effect on protein levels only if they limit translation significantly more than initiation. This model can be generalized to explain why sequences that induce pauses in translation elongation to, for example, facilitate folding do not necessarily exact a penalty on the overall production of the protein.	[Hersch, Steven J.; Navarre, William Wiley] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Elgamal, Sara; Katz, Assaf; Ibba, Michael] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University of Toronto; University System of Ohio; Ohio State University	Ibba, M (corresponding author), Ohio State Univ, Dept Microbiol, 484 West 12th Ave, Columbus, OH 43210 USA.	ibba.1@osu.edu; william.navarre@utoronto.ca	Elgamal, Sara/GQH-4293-2022; Katz, Assaf/K-7130-2018; Katz, Assaf/R-7504-2019	Katz, Assaf/0000-0001-5481-7399; Elgamal, Sara/0000-0003-2274-9891; Hersch, Steven/0000-0001-6186-0133; Navarre, William/0000-0002-9293-9220	National Institutes of Health [GM065183]; Natural Sciences and Engineering Research Council of Canada [RGPIN 386286-10]; Vanier Canada Graduate Scholarship from Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Vanier Canada Graduate Scholarship from Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065183. This work was also supported by Natural Sciences and Engineering Research Council of Canada Grant RGPIN 386286-10 (to W. W. N.) and a Vanier Canada Graduate Scholarship from Natural Sciences and Engineering Research Council of Canada (to S. J. H.).	Angov E, 2011, BIOTECHNOL J, V6, P650, DOI 10.1002/biot.201000332; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; Bullwinkle TJ, 2013, J BIOL CHEM, V288, P4416, DOI 10.1074/jbc.M112.438879; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Chartier M, 2012, BIOINFORMATICS, V28, P1438, DOI 10.1093/bioinformatics/bts149; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; Choi S, 2011, PROTEINS, V79, P1688, DOI 10.1002/prot.22992; Chu D, 2014, EMBO J, V33, P21, DOI 10.1002/embj.201385651; Ciandrini L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002866; Corcoran CP, 2012, MOL MICROBIOL, V84, P428, DOI 10.1111/j.1365-2958.2012.08031.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; Elgamal S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004553; Fredrick K, 2010, CELL, V141, P227, DOI 10.1016/j.cell.2010.03.033; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Giudice E, 2013, TRENDS BIOCHEM SCI, V38, P403, DOI 10.1016/j.tibs.2013.06.002; GOLDMAN E, 1995, J MOL BIOL, V245, P467, DOI 10.1006/jmbi.1994.0038; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hanawa-Suetsugu K, 2004, P NATL ACAD SCI USA, V101, P9595, DOI 10.1073/pnas.0308667101; Hersch SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00180-13; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ito K, 2010, BIOCHEM BIOPH RES CO, V393, P1, DOI 10.1016/j.bbrc.2010.01.073; Kemp AJ, 2013, MOL MICROBIOL, V87, P284, DOI 10.1111/mmi.12096; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Ma J, 2002, J BACTERIOL, V184, P5733, DOI 10.1128/JB.184.20.5733-5745.2002; Novoa EM, 2012, TRENDS GENET, V28, P574, DOI 10.1016/j.tig.2012.07.006; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peil L, 2013, P NATL ACAD SCI USA, V110, P15265, DOI 10.1073/pnas.1310642110; Peil L, 2012, NAT CHEM BIOL, V8, P695, DOI [10.1038/NCHEMBIO.1001, 10.1038/nchembio.1001]; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Qing GL, 2003, J MOL MICROB BIOTECH, V6, P133, DOI 10.1159/000077244; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; Sussman JK, 1996, MOL MICROBIOL, V21, P347, DOI 10.1046/j.1365-2958.1996.6371354.x; Takahashi S, 2013, J AM CHEM SOC, V135, P13096, DOI 10.1021/ja405967h; Tanner DR, 2009, J BIOL CHEM, V284, P34809, DOI 10.1074/jbc.M109.039040; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Urban Johannes H., 2009, V540, P301, DOI 10.1007/978-1-59745-558-9_22; Vimberg V, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-100; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Yap MN, 2011, MOL MICROBIOL, V81, P540, DOI 10.1111/j.1365-2958.2011.07713.x; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zou SB, 2012, J BACTERIOL, V194, P413, DOI 10.1128/JB.05864-11; Zou SB, 2011, VIRULENCE, V2, P147, DOI 10.4161/viru.2.2.15039	61	37	37	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28160	28171		10.1074/jbc.M114.593277	http://dx.doi.org/10.1074/jbc.M114.593277			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25148683	Green Published, hybrid			2022-12-28	WOS:000343765400013
J	Petkau, K; Parsons, BD; Duggal, A; Foley, E				Petkau, Kristina; Parsons, Brendon D.; Duggal, Aashna; Foley, Edan			A Deregulated Intestinal Cell Cycle Program Disrupts Tissue Homeostasis without Affecting Longevity in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT MIDGUT REGENERATION; STEM-CELLS; MULTIPLE PATHWAYS; HOST-DEFENSE; GUT IMMUNITY; DUAL OXIDASE; PROLIFERATION; MELANOGASTER; EGFR; MICROBIOTA	Recent studies illuminate a complex relationship between the control of stem cell division and intestinal tissue organization in the model system Drosophila melanogaster. Host and microbial signals drive intestinal proliferation to maintain an effective epithelial barrier. Although it is widely assumed that proliferation induces dysplasia and shortens the life span of the host, the phenotypic consequences of deregulated intestinal proliferation for an otherwise healthy host remain unexplored. To address this question, we genetically isolated and manipulated the cell cycle programs of adult stem cells and enterocytes. Our studies revealed that cell cycle alterations led to extensive cell death and morphological disruptions. Despite the extensive tissue damage, we did not observe an impact on longevity, suggesting a remarkable degree of plasticity in intestinal function.	[Petkau, Kristina; Parsons, Brendon D.; Duggal, Aashna; Foley, Edan] Univ Alberta, Dept Med Microbiol & Immunol, Inst Virol, Edmonton, AB T6G 2S2, Canada	University of Alberta	Foley, E (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada.	efoley@ualberta.ca			NICHD, National Institutes of Health; Canada Foundation for Innovation; Alberta Science and Research Investment Program	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Science and Research Investment Program	Transgenic flies were provided by Bruno Lemaitre, Bruce Edgar, Christian Lehner, and Pernille Rorth. The anti-Dl, anti-Prospero, and anti-Armadillo monoclonal antibodies were obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of NICHD, National Institutes of Health, and maintained by The University of Iowa Department of Biology (Iowa City, IA). Infrastructure funds were provided by the Canada Foundation for Innovation and the Alberta Science and Research Investment Program. We are grateful to Brittany Fraser for assistance with cell counting and to John Walsh, David Bond, and Andrew Simmonds for comments on the manuscript. We acknowledge the microscopy support from Dr. Stephen Ogg and the Faculty of Medicine and Dentistry Core Imaging Cell Imaging Centre of the University of Alberta.	Amcheslavsky A, 2011, J CELL BIOL, V193, P695, DOI 10.1083/jcb.201103018; Ayyaz A, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00098; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Bond D, 2012, J BIOL CHEM, V287, P27359, DOI 10.1074/jbc.M112.378018; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Chatterjee M, 2009, J CELL PHYSIOL, V220, P664, DOI 10.1002/jcp.21808; Chen VL, 2014, GUT MICROBES, V5, P129, DOI 10.4161/gmic.27289; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cordero JB, 2012, DEVELOPMENT, V139, P4524, DOI 10.1242/dev.078261; Cordero JB, 2012, EMBO J, V31, P3901, DOI 10.1038/emboj.2012.248; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Ferrandon D, 2013, CURR OPIN IMMUNOL, V25, P59, DOI 10.1016/j.coi.2012.11.008; GARTNER LP, 1973, INT J RADIAT BIOL, V23, P23, DOI 10.1080/09553007314550031; Guntermann S, 2011, J BIOL CHEM, V286, P30284, DOI 10.1074/jbc.M111.220285; Guo Z, 2013, J CELL BIOL, V201, P945, DOI 10.1083/jcb.201302049; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Jiang HQ, 2011, EXP CELL RES, V317, P2780, DOI 10.1016/j.yexcr.2011.07.020; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jiang HQ, 2009, DEVELOPMENT, V136, P483, DOI 10.1242/dev.026955; Kannan K, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00288; Kapuria S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003045; Karpac J, 2009, AGING CELL, V8, P288, DOI 10.1111/j.1474-9726.2009.00476.x; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Lee WJ, 2013, ANNU REV CELL DEV BI, V29, P571, DOI 10.1146/annurev-cellbio-101512-122333; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Li ZH, 2013, DEV CELL, V24, P133, DOI 10.1016/j.devcel.2012.12.010; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; Liu W, 2010, J CELL BIOCHEM, V109, P992, DOI 10.1002/jcb.22482; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Montiel-Castro AJ, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00070; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Park JS, 2009, AGING-US, V1, P637, DOI 10.18632/aging.100054; Quan ZH, 2013, J CELL SCI, V126, P3884, DOI 10.1242/jcs.125294; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Stronach B, 2005, DEV DYNAM, V232, P575, DOI 10.1002/dvdy.20283; Takashima S, 2008, NATURE, V454, P651, DOI 10.1038/nature07156; Takashima S, 2012, STEM CELL REV REP, V8, P597, DOI 10.1007/s12015-012-9351-1; Takashima S, 2011, DEV BIOL, V353, P161, DOI 10.1016/j.ydbio.2011.01.039; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Xu N, 2011, DEV BIOL, V354, P31, DOI 10.1016/j.ydbio.2011.03.018	61	26	26	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28719	28729		10.1074/jbc.M114.578708	http://dx.doi.org/10.1074/jbc.M114.578708			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25170078	hybrid, Green Published			2022-12-28	WOS:000343765400059
J	Kasim, M; Benko, E; Winkelmann, A; Mrowka, R; Staudacher, JJ; Persson, PB; Scholz, H; Meier, JC; Fahling, M				Kasim, Mumtaz; Benko, Edgar; Winkelmann, Aline; Mrowka, Ralf; Staudacher, Jonas J.; Persson, Pontus B.; Scholz, Holger; Meier, Jochen C.; Faehling, Michael			Shutdown of Achaete-scute Homolog-1 Expression by Heterogeneous Nuclear Ribonucleoprotein (hnRNP)-A2/B1 in Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE CHARACTERIZATION; MESSENGER-RNA; LUNG-CANCER; HNRNP A2/B1; HIPPOCAMPAL-NEURONS; PRONEURAL GENES; NEUROBLASTOMA; TRANSCRIPTION; DIFFERENTIATION; PROTEIN	The basic helix-loop-helix transcription factor hASH1, encoded by the ASCL1 gene, plays an important role in neurogenesis and tumor development. Recent findings indicate that local oxygen tension is a critical determinant for the progression of neuroblastomas. Here we investigated the molecular mechanisms underlying the oxygen-dependent expression of hASH1 in neuroblastoma cells. Exposure of human neuroblastoma-derived Kelly cells to 1% O-2 significantly decreased ASCL1 mRNA and hASH1 protein levels. Using reporter gene assays, we show that the response of hASH1 to hypoxia is mediated mainly by post-transcriptional inhibition via the ASCL1 mRNA 5'- and 3'-UTRs, whereas additional inhibition of the ASCL1 promoter was observed under prolonged hypoxia. By RNA pulldown experiments followed by MALDI/TOF-MS analysis, we identified heterogeneous nuclear ribonucleoprotein (hnRNP)-A2/B1 and hnRNP-R as interactors binding directly to the ASCL1 mRNA 5'- and 3'-UTRs and influencing its expression. We further demonstrate that hnRNP-A2/B1 is a key positive regulator of ASCL1, findings that were also confirmed by analysis of a large compilation of gene expression data. Our data suggest that a prominent down-regulation of hnRNP-A2/B1 during hypoxia is associated with the post-transcriptional suppression of hASH1 synthesis. This novel post-transcriptional mechanism for regulating hASH1 levels will have important implications in neural cell fate development and disease.	[Kasim, Mumtaz; Benko, Edgar; Staudacher, Jonas J.; Persson, Pontus B.; Scholz, Holger; Faehling, Michael] Charite, Inst Vegetat Physiol, D-10117 Berlin, Germany; [Winkelmann, Aline; Meier, Jochen C.] Max Delbruck Ctr Mol Med, RNA Editing & Hyperexcitabil Disorders Helmholtz, D-13125 Berlin, Germany; [Mrowka, Ralf] Univ Klinikum Jena, Klin Innere Med 3, AG Expt Nephrol, D-07743 Jena, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Friedrich Schiller University of Jena	Fahling, M (corresponding author), Charite, Inst Vegetat Physiol, D-10117 Berlin, Germany.	michael.faehling@charite.de	Mrowka, Ralf/AAW-1480-2021; Fähling, Michael/E-5018-2011; Staudacher, Jonas Jaromir/AAM-6134-2020	Mrowka, Ralf/0000-0002-0991-3418; Staudacher, Jonas Jaromir/0000-0001-5697-2798; Fahling, Michael/0000-0003-1079-5049; Meier, Jochen/0000-0001-5574-3336; Persson, Pontus/0000-0003-0926-2878	Deutsche Forschungsgemeinschaft [FA845/2-2]; Bundesministerium fur Bildung und Forschung BMBF ERA-Net NEURON II project CIPRESS	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung BMBF ERA-Net NEURON II project CIPRESS	This work was supported by Deutsche Forschungsgemeinschaft Grant FA845/2-2 (to M. F.) and the Bundesministerium fur Bildung und Forschung BMBF ERA-Net NEURON II project CIPRESS (to J. C. M.).	Agostini F, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks968; Axelson H, 2004, CANCER LETT, V204, P171, DOI 10.1016/S0304-3835(03)00453-1; BALL DW, 1993, P NATL ACAD SCI USA, V90, P5648, DOI 10.1073/pnas.90.12.5648; Bannai H, 2004, J BIOL CHEM, V279, P53427, DOI 10.1074/jbc.M409732200; Bellucci M, 2011, NAT METHODS, V8, P444, DOI 10.1038/nmeth.1611; Benko E, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00001; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bhattacharjee RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053036; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; Castro DS, 2011, CELL CYCLE, V10, P4026, DOI 10.4161/cc.10.23.18578; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Cau E, 2002, DEVELOPMENT, V129, P1871; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; DeGregori J, 2006, CURR MOL MED, V6, P739; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Eichler SA, 2009, EUR J NEUROSCI, V30, P1077, DOI 10.1111/j.1460-9568.2009.06903.x; Elmi M, 2010, MOL CELL NEUROSCI, V45, P121, DOI 10.1016/j.mcn.2010.06.003; Fahling M, 2006, J BIOL CHEM, V281, P26089, DOI 10.1074/jbc.M604939200; Fahling M, 2009, J CELL MOL MED, V13, P2770, DOI 10.1111/j.1582-4934.2009.00875.x; Fahling M, 2009, J BIOL CHEM, V284, P4255, DOI 10.1074/jbc.M807354200; Fahling M, 2006, J BIOL CHEM, V281, P9279, DOI 10.1074/jbc.M510925200; Forstera B, 2010, BRAIN, V133, P3778, DOI 10.1093/brain/awq298; Fukuda A, 2009, J BIOL CHEM, V284, P23472, DOI 10.1074/jbc.M109.013656; Garayoa M, 2003, AM J RESP CELL MOL, V28, P80, DOI 10.1165/rcmb.4880; Gestblom C, 1999, LAB INVEST, V79, P67; Goodarzi H, 2012, NATURE, V485, P264, DOI 10.1038/nature11013; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Holmquist L, 2006, ADV EXP MED BIOL, V587, P179; Horton S, 1999, MOL CELL NEUROSCI, V14, P355, DOI 10.1006/mcne.1999.0791; Huang J, 2008, CELL MOL BIOL LETT, V13, P303, DOI 10.2478/s11658-008-0002-0; Isogai E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019297; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; JURASKA JM, 1982, J COMP NEUROL, V212, P208, DOI 10.1002/cne.902120210; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Khazipov R, 2001, J NEUROSCI, V21, P9770, DOI 10.1523/JNEUROSCI.21-24-09770.2001; Kosari F, 2014, ONCOGENE, V33, P3776, DOI 10.1038/onc.2013.359; Liu J, 2010, INT J GYNECOL CANCER, V20, P1109, DOI 10.1111/IGC.0b013e3181ea74ad; Liu YC, 2010, J HISTOCHEM CYTOCHEM, V58, P695, DOI 10.1369/jhc.2010.955021; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; Lo LC, 1998, DEVELOPMENT, V125, P609; Marin O, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001834; Nakagawara A, 2004, CANCER LETT, V204, P213, DOI 10.1016/S0304-3835(03)00457-9; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Powell LM, 2008, CURR OPIN GENET DEV, V18, P411, DOI 10.1016/j.gde.2008.07.012; RAKIC P, 1994, PROG BRAIN RES, V102, P227; Salama-Cohen P, 2005, MOL BIOL CELL, V16, P339, DOI 10.1091/mbc.e04-05-0438; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Soderholm H, 1999, BIOCHEM BIOPH RES CO, V256, P557, DOI 10.1006/bbrc.1999.0314; Sriuranpong V, 2002, MOL CELL BIOL, V22, P3129, DOI 10.1128/MCB.22.9.3129-3139.2002; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tauler J, 2010, CANCER RES, V70, P7137, DOI 10.1158/0008-5472.CAN-10-0860; Teicher BA, 2014, BIOCHEM PHARMACOL, V87, P211, DOI 10.1016/j.bcp.2013.09.014; Torii MA, 1999, DEVELOPMENT, V126, P443; Wang L, 2011, WORLD J GASTROENTERO, V17, P1434, DOI 10.3748/wjg.v17.i11.1434; Wilkinson G, 2013, NEUROSCIENCE, V253, P256, DOI 10.1016/j.neuroscience.2013.08.029; Winkelmann A, 2014, J CLIN INVEST, V124, P696, DOI 10.1172/JCI71472; Yao LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078439; Zhou J, 2001, BREAST CANCER RES TR, V66, P217, DOI 10.1023/A:1010631915831	61	5	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26973	26988		10.1074/jbc.M114.579391	http://dx.doi.org/10.1074/jbc.M114.579391			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25124043	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000342853900027
J	Sharp, T; Wang, JB; Li, X; Cao, HJ; Gao, S; Moreno, M; Gao, ACS				Sharp, Thad; Wang, Jianbo; Li, Xiao; Cao, Huojun; Gao, Shan; Moreno, Myriam; Amendt, Brad A.			A Pituitary Homeobox 2 (Pitx2):microRNA-200a-3p: beta-catenin Pathway Converts Mesenchymal Cells to Amelogenin-expressing Dental Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMELOBLAST-LINEAGE CELLS; STEM-CELLS; TOOTH MORPHOGENESIS; IN-VITRO; GENE-EXPRESSION; MIR-200 FAMILY; DIFFERENTIAL REGULATION; PROGENITOR CELLS; LEF-1 PROMOTER; CUTTING-EDGE	Pitx2, Wnt/beta-catenin signaling, and microRNAs (miRs) play a critical role in the regulation of dental stem cells during embryonic development. In this report, we have identified a Pitx2: beta-catenin regulatory pathway involved in epithelial cell differentiation and conversion of mesenchymal cells to amelogenin expressing epithelial cells via miR-200a. Pitx2 and beta-catenin are expressed in the labial incisor cervical loop or epithelial stem cell niche, with decreased expression in the differentiating ameloblast cells of the mouse lower incisor. Bioinformatics analyses reveal that miR-200a-3p expression is activated in the pre-ameloblast cells to enhance epithelial cell differentiation. We demonstrate that Pitx2 activates miR-200a-3p expression and miR-200a-3p reciprocally represses Pitx2 and beta-catenin expression. Pitx2 and beta-catenin interact to synergistically activate gene expression during odontogenesis and miR-200a-3p attenuates their expression and directs differentiation. To understand how this mechanism controls cell differentiation and cell fate, oral epithelial and odontoblast mesenchymal cells were reprogrammed by a two-step induction method using Pitx2 and miR-200a-3p. Conversion to amelogenin expressing dental epithelial cells involved an up-regulation of the stem cell marker Sox2 and proliferation genes and decreased expression of mesenchymal markers. E-cadherin expression was increased as well as ameloblast specific factors. The combination of Pitx2, a regulator of dental stem cells and miR-200a converts mesenchymal cells to a fully differentiated dental epithelial cell type. This pathway and reprogramming can be used to reprogram mesenchymal or oral epithelial cells to dental epithelial (ameloblast) cells, which can be used in tissue repair and regeneration studies.	[Sharp, Thad; Li, Xiao; Moreno, Myriam; Amendt, Brad A.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Wang, Jianbo; Cao, Huojun; Gao, Shan] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Amendt, Brad A.] Univ Iowa, Carver Coll Med, Craniofacial Anomalies Res Ctr, Iowa City, IA 52242 USA	University of Iowa; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Iowa	Gao, ACS (corresponding author), Univ Iowa, Carver Coll Med, Craniofacial Anomalies Res Ctr, 1-675 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	brad-amendt@uiowa.edu	cao, huojun/M-5431-2017; Li, Xiao/X-3429-2019	Li, Xiao/0000-0001-8527-4438; Amendt, Brad A./0000-0001-6524-1006; Cao, Huojun/0000-0003-4428-8686	University of Iowa College of Dentistry; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013941] Funding Source: NIH RePORTER	University of Iowa College of Dentistry; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank the University of Iowa College of Dentistry for support and preclinical studies, the University of Iowa Carver College of Medicine Bioinformatics and RNA sequencing core. We thank Steven Eliason (University of Iowa, Carver College of Medicine) and Dr. Liu Hong (University of Iowa, College of Dentistry) for technical support.	Amen M, 2008, NUCLEIC ACIDS RES, V36, P462, DOI 10.1093/nar/gkm1047; Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bei M, 2009, CURR OPIN GENET DEV, V19, P504, DOI 10.1016/j.gde.2009.09.002; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cao H, 2010, J DENT RES, V89, P779, DOI 10.1177/0022034510369304; Cao HJ, 2013, DEVELOPMENT, V140, P3348, DOI 10.1242/dev.089193; Cao HJ, 2010, DEV BIOL, V347, P289, DOI 10.1016/j.ydbio.2010.08.031; Cha KB, 2004, MECH DEVELOP, V121, P183, DOI 10.1016/j.mod.2003.12.002; Chavez MG, 2014, JOVE-J VIS EXP, DOI 10.3791/51266; Chavez MG, 2013, TISSUE ENG PART C-ME, V19, DOI [10.1089/ten.TEC.2012.0232, 10.1089/ten.tec.2012.0232]; CHEN LS, 1992, ARCH ORAL BIOL, V37, P771, DOI 10.1016/0003-9969(92)90110-T; Chen SY, 2013, DEVELOPMENT, V140, P255, DOI 10.1242/dev.083139; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; Cui L, 2013, J CLIN INVEST, V123, P1647, DOI 10.1172/JCI65048; Cui XM, 2005, DEV BIOL, V278, P193, DOI 10.1016/j.ydbio.2004.10.023; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DenBesten PK, 2005, ARCH ORAL BIOL, V50, P689, DOI 10.1016/j.archoralbio.2004.12.008; FARGES JC, 1991, ARCH ORAL BIOL, V36, P737, DOI 10.1016/0003-9969(91)90040-2; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gay I, 2014, J PERIODONTAL RES, V49, P110, DOI 10.1111/jre.12086; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gronthos S, 2011, METHODS MOL BIOL, V698, P107, DOI 10.1007/978-1-60761-999-4_9; Hanks CT, 1998, EUR J ORAL SCI, V106, P260, DOI 10.1111/j.1600-0722.1998.tb02185.x; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Harada H, 2004, ARCH HISTOL CYTOL, V67, P1, DOI 10.1679/aohc.67.1; Harada H, 2002, DEVELOPMENT, V129, P1533; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Hu JKH, 2014, GENESIS, V52, P79, DOI 10.1002/dvg.22732; Hynes K, 2014, STEM CELLS DEV, V23, P1084, DOI 10.1089/scd.2013.0111; Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Jheon AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024536; Karpowicz P, 2009, J NEUROSCI, V29, P3885, DOI 10.1523/JNEUROSCI.0037-09.2009; Kawano S, 2004, J DENT RES, V83, P129, DOI 10.1177/154405910408300209; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Li CY, 2012, DEV BIOL, V366, P357, DOI 10.1016/j.ydbio.2012.03.012; LIMEBACK H, 1987, BIOCHEM CELL BIOL, V65, P698, DOI 10.1139/o87-092; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Liu F, 2010, J DENT RES, V89, P318, DOI 10.1177/0022034510363373; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Liu W, 2003, DEVELOPMENT, V130, P6375, DOI 10.1242/dev.00849; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maas R, 1997, CRIT REV ORAL BIOL M, V8, P4, DOI 10.1177/10454411970080010101; Martinez NJ, 2010, CELL STEM CELL, V7, P31, DOI 10.1016/j.stem.2010.06.011; Matsumura T, 1998, INT J DEV BIOL, V42, P1137; Menicanin D, 2014, STEM CELLS DEV, V23, P1001, DOI 10.1089/scd.2013.0490; Menicanin D, 2010, STEM CELLS DEV, V19, P1501, DOI 10.1089/scd.2009.0492; Michon F, 2010, DEV BIOL, V340, P355, DOI 10.1016/j.ydbio.2010.01.019; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Morotomi T, 2005, ARCH ORAL BIOL, V50, P695, DOI 10.1016/j.archoralbio.2004.12.006; Mucchielli ML, 1997, DEV BIOL, V189, P275, DOI 10.1006/dbio.1997.8672; Mustonen T, 2002, DEV BIOL, V248, P281, DOI 10.1006/dbio.2002.0734; NAKAHORI Y, 1991, GENOMICS, V9, P264, DOI 10.1016/0888-7543(91)90251-9; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; Noramly S, 1999, DEVELOPMENT, V126, P3509; Peters H, 1999, TRENDS GENET, V15, P59, DOI 10.1016/S0168-9525(98)01662-X; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sasaki T, 2005, DEV BIOL, V278, P130, DOI 10.1016/j.ydbio.2004.10.021; Sharpe PT, 2005, SCI AM, V293, P34, DOI 10.1038/scientificamerican0805-34; Shi S, 2005, Orthod Craniofac Res, V8, P191, DOI 10.1111/j.1601-6343.2005.00331.x; SNEAD ML, 1985, BIOCHEM BIOPH RES CO, V129, P812, DOI 10.1016/0006-291X(85)91964-3; St Amand TR, 2000, DEV BIOL, V217, P323, DOI 10.1006/dbio.1999.9547; Stockinger A, 2001, J CELL BIOL, V154, P1185, DOI 10.1083/jcb.200104036; Tabata MJ, 1996, ARCH ORAL BIOL, V41, P1019, DOI 10.1016/S0003-9969(96)00087-8; Tabata MJ, 2003, J HISTOCHEM CYTOCHEM, V51, P1673, DOI 10.1177/002215540305101211; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thesleff I, 1996, CURR OPIN CELL BIOL, V8, P844, DOI 10.1016/S0955-0674(96)80086-X; Thesleff I., 2009, TOOTH ORGANOGENESIS; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Tummers M, 2003, DEVELOPMENT, V130, P1049, DOI 10.1242/dev.00332; Tummers M, 2008, EVOL DEV, V10, P187, DOI 10.1111/j.1525-142X.2008.00226.x; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; Venugopalan SR, 2008, HUM MOL GENET, V17, P3643, DOI 10.1093/hmg/ddn258; Wang XP, 2007, PLOS BIOL, V5, P1324, DOI 10.1371/journal.pbio.0050159; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xia HP, 2010, J BIOL CHEM, V285, P36995, DOI 10.1074/jbc.M110.133744; Yen AHH, 2006, EXPERT OPIN BIOL TH, V6, P9, DOI 10.1517/14712598.6.1.9; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; ZEICHNERDAVID M, 1995, INT J DEV BIOL, V39, P69; Zhang YD, 2005, CELL RES, V15, P301, DOI 10.1038/sj.cr.7290299; Zhang ZC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024608, 10.1371/journal.pone.0028817]; Zhang ZC, 2010, J BIOL CHEM, V285, P34718, DOI 10.1074/jbc.M110.126441	96	33	37	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27327	27341		10.1074/jbc.M114.575654	http://dx.doi.org/10.1074/jbc.M114.575654			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122764	Green Published, hybrid			2022-12-28	WOS:000342853900053
J	Tang, MF; Li, YJ; Zhang, XY; Deng, TT; Zhou, ZF; Ma, WB; Zhou, SY				Tang, Mengfan; Li, Yujing; Zhang, Xiya; Deng, Tingting; Zhou, Zhifen; Ma, Wenbin; Zhou Songyang			Structural Maintenance of Chromosomes Flexible Hinge Domain Containing 1 (SMCHD1) Promotes Non-homologous End Joining and Inhibits Homologous Recombination Repair upon DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; DNA Damage; DNA Damage Response; DNA Recombination; DNA Repair; Signal Transduction	DOUBLE-STRAND BREAKS; INACTIVE X-CHROMOSOME; HISTONE H2AX; TUMOR-SUPPRESSOR; UBIQUITIN MARK; BRCA1; 53BP1; PROTEINS; GENOME; CELLS	Background: The role of SMCHD1 in DNA damage response is largely unknown. Results: SMCHD1 recruitment to DNA damage foci is regulated by 53BP1. Knocking out SMCHD1 compromised cell survival, and decreased the efficiency of non-homologous end joining (NHEJ) while elevating the efficiency of homologous recombination (HR). Conclusion: SMCHD1 regulates both NHEJ and HR. Significance: Our findings should further understanding of how cells adopt different repair pathways. Structural maintenance of chromosomes flexible hinge domain containing 1 (SMCHD1) has been shown to be involved in gene silencing and DNA damage. However, the exact mechanisms of how SMCHD1 participates in DNA damage remains largely unknown. Here we present evidence that SMCHD1 recruitment to DNA damage foci is regulated by 53BP1. Knocking out SMCHD1 led to aberrant H2AX foci accumulation and compromised cell survival upon DNA damage, demonstrating the critical role of SMCHD1 in DNA damage repair. Following DNA damage induction, SMCHD1 depletion resulted in reduced 53BP1 foci and increased BRCA1 foci, as well as less efficient non-homologous end joining (NHEJ) and elevated levels of homologous recombination (HR). Taken together, these results suggest an important function of SMCHD1 in promoting NHEJ and repressing HR repair in response to DNA damage.	[Tang, Mengfan; Li, Yujing; Zhang, Xiya; Deng, Tingting; Zhou, Zhifen; Ma, Wenbin; Zhou Songyang] Sun Yat Sen Univ, Sch Life Sci, SYSU Baylor Coll Med Joint Res Ctr Biomed Sci, Key Lab Gene Engn,Minist Educ,State Key Lab Bioco, Guangzhou 510275, Guangdong, Peoples R China; [Zhou Songyang] Baylor Coll Med, Verna & Marrs Dept Biochem & Mol Biol, Houston, TX 77030 USA	Sun Yat Sen University; Baylor College of Medicine	Ma, WB (corresponding author), Sun Yat Sen Univ, Sch Life Sci, SYSU Baylor Coll Med Joint Res Ctr Biomed Sci, Key Lab Gene Engn,Minist Educ,State Key Lab Bioco, Guangzhou 510275, Guangdong, Peoples R China.	mawenbin@mail.sysu.edu.cn; songyang@bcm.edu	Li, yujing/GQA-4109-2022; Li, Yujing/L-2221-2019	Li, Yujing/0000-0002-3223-769X; Zhou, Zhifen/0000-0003-2737-6764; Ma, Wenbin/0000-0001-8774-7593	NIGMS National Institutes of Health [GM095599]; Welch Foundation [Q-1673]; CPRIT [RP130135]; CDMRP [BC123368]; National Basic Research Program (973 Program) [2012CB911201]; National Natural Science Foundation [91019020, 81330055, 91213302, 31171397, 31271533, 31371508]; Introduced Innovative R&D Team of Guangdong Province [201001Y0104687244]; "985" project foundation of Sun Yat-sen University [33000-3281303]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095599] Funding Source: NIH RePORTER	NIGMS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); CPRIT; CDMRP(United States Department of Defense); National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Introduced Innovative R&D Team of Guangdong Province; "985" project foundation of Sun Yat-sen University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by NIGMS National Institutes of Health Grant GM095599, the Welch Foundation Q-1673, CPRIT RP130135, and CDMRP BC123368. This work was also funded by the National Basic Research Program (973 Program) (2012CB911201), the National Natural Science Foundation (91019020, 81330055, 91213302, 31171397, 31271533, and 31371508) and Introduced Innovative R&D Team of Guangdong Province (201001Y0104687244) and "985" project foundation of Sun Yat-sen University (33000-3281303).	Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Bohmdorfer G, 2011, PLANT J, V67, P420, DOI 10.1111/j.1365-313X.2011.04604.x; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chankova SG, 2007, RADIAT ENVIRON BIOPH, V46, P409, DOI 10.1007/s00411-007-0123-2; Chapman JR, 2012, J CELL SCI, V125, P3529, DOI 10.1242/jcs.105353; Coker H, 2014, J CELL SCI, V127, P1869, DOI 10.1242/jcs.140020; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daley JM, 2014, MOL CELL BIOL, V34, P1380, DOI 10.1128/MCB.01639-13; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Fernandez-Capetillo O, 2008, MOL CELL, V31, P303, DOI 10.1016/j.molcel.2008.07.004; Foray N, 1999, ONCOGENE, V18, P7334, DOI 10.1038/sj.onc.1203165; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gatti M, 2012, CELL CYCLE, V11, P2538, DOI 10.4161/cc.20919; Gendrel AV, 2013, MOL CELL BIOL, V33, P3150, DOI 10.1128/MCB.00145-13; Graumann PL, 2009, CHROMOSOME RES, V17, P265, DOI 10.1007/s10577-008-9014-x; Grolimund L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3848; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-8; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; Leong HS, 2013, CANCER RES, V73, P1591, DOI 10.1158/0008-5472.CAN-12-3019; Li L, 2005, J CELL BIOCHEM, V94, P298, DOI 10.1002/jcb.20355; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Lottersberger F, 2013, P NATL ACAD SCI USA, V110, P2146, DOI 10.1073/pnas.1222617110; Lou ZK, 2005, ADV EXP MED BIOL, V570, P425, DOI 10.1007/1-4020-3764-3_15; Lowndes NF, 2005, CURR BIOL, V15, pR99, DOI 10.1016/j.cub.2005.01.029; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao ZY, 2007, P NATL ACAD SCI USA, V104, P13068, DOI 10.1073/pnas.0702410104; Massah S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097535; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Mazon G, 2010, CELL, V142, DOI 10.1016/j.cell.2010.08.006; Moynahan ME, 2001, CANCER RES, V61, P4842; Nozawa RS, 2013, NAT STRUCT MOL BIOL, V20, P566, DOI 10.1038/nsmb.2532; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; Petrini JHJ, 2003, TRENDS CELL BIOL, V13, P458, DOI 10.1016/S0962-8924(03)00170-3; Pinto DMS, 2010, SUBCELL BIOCHEM, V50, P55, DOI 10.1007/978-90-481-3471-7_4; Schubert V, 2009, CYTOGENET GENOME RES, V124, P202, DOI 10.1159/000218126; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Zhang JR, 2005, MOL CANCER RES, V3, P531, DOI 10.1158/1541-7786.MCR-05-0192	53	10	10	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34024	34032		10.1074/jbc.M114.601179	http://dx.doi.org/10.1074/jbc.M114.601179			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25294876	Green Published, hybrid			2022-12-28	WOS:000346077600029
J	Lu, L; Zheng, L; Si, Y; Luo, WY; Dujardin, G; Kwan, T; Potochick, NR; Thompson, SR; Schneider, DA; King, PH				Lu, Liang; Zheng, Lei; Si, Ying; Luo, Wenyi; Dujardin, Gwendal; Kwan, Thaddaeus; Potochick, Nicholas R.; Thompson, Sunnie R.; Schneider, David A.; King, Peter H.			Hu Antigen R (HuR) Is a Positive Regulator of the RNA-binding Proteins TDP-43 and FUS/TLS IMPLICATIONS FOR AMYOTROPHIC LATERAL SCLEROSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig Disease); Astrocyte; Neuron; RNA Processing; RNA Splicing; 3 Untranslated Region	NUCLEAR FACTOR TDP-43; MESSENGER-RNA; MOTOR-NEURONS; TRANSLATIONAL CONTROL; STRESS GRANULES; RICH ELEMENTS; WIDE ANALYSIS; UP-REGULATION; CFTR EXON-9; STABILITY	Background: RNA processing abnormalities have been linked to amyotrophic lateral sclerosis (ALS). Results: HuR promotes the expression of the ALS-associated TDP-43 and FUS/TLS RNA-binding proteins. Conclusion: Through its regulation of TDP-43 and FUS/TLS, HuR potentially impacts a wide range of molecular and cellular phenotypes. Significance: A network of proteins exists to maintain RNA processing, and ALS-associated abnormalities may stem from disruption of this network. Posttranscriptional gene regulation is governed by a network of RNA-binding proteins (RBPs) that interact with regulatory elements in the mRNA to modulate multiple molecular processes, including splicing, RNA transport, RNA stability, and translation. Mounting evidence indicates that there is a hierarchy within this network whereby certain RBPs cross-regulate other RBPs to coordinate gene expression. HuR, an RNA-binding protein we linked previously to aberrant VEGF mRNA metabolism in models of SOD1-associated amyotrophic lateral sclerosis, has been identified as being high up in this hierarchy, serving as a regulator of RNA regulators. Here we investigated the role of HuR in regulating two RBPs, TDP-43 and FUS/TLS, that have been linked genetically to amyotrophic lateral sclerosis. We found that HuR promotes the expression of both RBPs in primary astrocytes and U251 cells under normal and stressed (hypoxic) conditions. For TDP-43, we found that HuR binds to the 3 untranslated region (UTR) and regulates its expression through translational efficiency rather than RNA stability. With HuR knockdown, there was a shift of TDP-43 and FUS mRNAs away from polysomes, consistent with translational silencing. The TDP-43 splicing function was attenuated upon HuR knockdown and could be rescued by ectopic TDP-43 lacking the 3 UTR regulatory elements. Finally, conditioned medium from astrocytes in which HuR or TDP-43 was knocked down produced significant motor neuron and cortical neuron toxicity in vitro. These findings indicate that HuR regulates TDP-43 and FUS/TLS expression and that loss of HuR-mediated RNA processing in astrocytes can alter the molecular and cellular landscape to produce a toxic phenotype.	[Lu, Liang; Zheng, Lei; Si, Ying; Luo, Wenyi; Kwan, Thaddaeus; King, Peter H.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Lu, Liang; King, Peter H.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [King, Peter H.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Potochick, Nicholas R.; Thompson, Sunnie R.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Schneider, David A.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Lu, Liang; King, Peter H.] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35294 USA; [Dujardin, Gwendal] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Buenos Aires	Lu, L (corresponding author), Sparks Ctr, Dept Neurol, Suite 260,1720 7th Ave S, Birmingham, AL 35233 USA.	luliang@uab.edu; pking@uab.edu	Dujardin, Gwendal/K-7464-2015	Dujardin, Gwendal/0000-0003-4320-6351; King, Peter/0000-0001-9391-7464; Schneider, David/0000-0003-0635-5091; Thompson, Sunnie/0000-0002-7338-8822	NINDS, National Intitutes of Health [NS064133, R21NS081743, R21NS085497, NS057664]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI102187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS057664, R21NS081743, R01NS064133, R21NS085497] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003035] Funding Source: NIH RePORTER	NINDS, National Intitutes of Health; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by NINDS, National Intitutes of Health Grants NS064133, R21NS081743, and R21NS085497 (to P. H. K.) and NS057664 (to L. L.). This work was also supported by a Merit Review award from the Department of Veterans Affairs (to P. H. K.).	Abdelmohsen K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Avendano-Vazquez SE, 2012, GENE DEV, V26, P1679, DOI 10.1101/gad.194829.112; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bi FF, 2013, P NATL ACAD SCI USA, V110, P4069, DOI 10.1073/pnas.1218497110; Blackburn D, 2009, GLIA, V57, P1251, DOI 10.1002/glia.20848; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2012, TRENDS BIOCHEM SCI, V37, P237, DOI 10.1016/j.tibs.2012.03.003; Buratti E, 2011, FEBS J, V278, P3530, DOI 10.1111/j.1742-4658.2011.08257.x; Burkhart RA, 2013, RNA BIOL, V10, P1312, DOI 10.4161/rna.25274; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Dassi E, 2013, NUCLEIC ACIDS RES, V41, P3201, DOI 10.1093/nar/gkt017; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Dujardin G, 2010, NUCLEIC ACIDS RES, V38, P7273, DOI 10.1093/nar/gkq573; Durie D, 2011, ONCOGENE, V30, P1460, DOI 10.1038/onc.2010.527; Fallini C, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-17; Fialcowitz EJ, 2005, J BIOL CHEM, V280, P22406, DOI 10.1074/jbc.M500618200; Filippova N, 2012, J BIOL CHEM, V287, P32277, DOI 10.1074/jbc.M112.353912; Filippova N, 2011, MOL CANCER RES, V9, P648, DOI 10.1158/1541-7786.MCR-10-0325; Gorospe M, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00007; Haidet-Phillips AM, 2013, EXP NEUROL, V250, P250, DOI 10.1016/j.expneurol.2013.10.004; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Henics T, 1999, J BIOL CHEM, V274, P17318, DOI 10.1074/jbc.274.24.17318; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Iguchi Y, 2009, J BIOL CHEM, V284, P22059, DOI 10.1074/jbc.M109.012195; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; King P. H, 2000, NUCLEIC ACIDS RES, V28, pE20; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Li XD, 2012, SPACE, P60; Li XL, 2009, J NEUROCHEM, V108, P1032, DOI 10.1111/j.1471-4159.2008.05856.x; Lin WJ, 2007, J BIOL CHEM, V282, P19958, DOI 10.1074/jbc.M702281200; Lin WJ, 2011, MOL CELL BIOL, V31, P3196, DOI 10.1128/MCB.05073-11; Lu L, 2007, J NEUROSCI, V27, P7929, DOI 10.1523/JNEUROSCI.1877-07.2007; Lu L, 2009, J BIOL CHEM, V284, P33989, DOI 10.1074/jbc.M109.067918; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Mansfield KD, 2009, BIOL CELL, V101, P169, DOI 10.1042/BC20080055; Meisner N.-C., 2011, PROPERTIES REGULATOR, P106; Meisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14; Meng Z, 2008, J CELL PHYSIOL, V217, P172, DOI 10.1002/jcp.21486; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Nabors LB, 2001, CANCER RES, V61, P2154; Nabors LLB, 2003, CANCER RES, V63, P4181; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Pagani F, 2000, J BIOL CHEM, V275, P21041, DOI 10.1074/jbc.M910165199; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Sama RRK, 2013, J CELL PHYSIOL, V228, P2222, DOI 10.1002/jcp.24395; Simone LE, 2013, CURR OPIN GENET DEV, V23, P35, DOI 10.1016/j.gde.2012.12.006; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Srikantan S, 2012, FRONT BIOSCI-LANDMRK, V17, P189, DOI 10.2741/3921; Suswam EA, 2005, INT J CANCER, V113, P911, DOI 10.1002/ijc.20675; Suswam EA, 2013, J NEURO-ONCOL, V113, P195, DOI 10.1007/s11060-013-1112-8; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Vaccaro A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002806; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yang CX, 2014, P NATL ACAD SCI USA, V111, pE1121, DOI 10.1073/pnas.1322641111; Zhou YQ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003895	70	26	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31792	31804		10.1074/jbc.M114.573246	http://dx.doi.org/10.1074/jbc.M114.573246			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25239623	Green Published, hybrid			2022-12-28	WOS:000345314700011
J	Chen, SR; Zhu, LH; Chen, H; Wen, L; Laumet, G; Pan, HL				Chen, Shao-Rui; Zhu, Lihong; Chen, Hong; Wen, Lei; Laumet, Geoffroy; Pan, Hui-Lin			Increased Spinal Cord Na+-K+-2Cl(-) Cotransporter-1 (NKCC1) Activity Contributes to Impairment of Synaptic Inhibition in Paclitaxel-induced Neuropathic Pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL NEUROPATHY; ACTIN POLYMERIZATION; CHLORIDE HOMEOSTASIS; SURFACE EXPRESSION; RECEPTOR-ACTIVITY; MITOTIC KINESIN; NERVOUS-SYSTEM; UP-REGULATION; A-FIBER; RAT	Microtubule-stabilizing agents, such as paclitaxel (Taxol), are effective chemotherapy drugs for treating many cancers, and painful neuropathy is a major dose-limiting adverse effect. Cation-chloride cotransporters, such as Na+-K+-2Cl(-) cotransporter-1 (NKCC1) and K+-Cl- cotransporter-2 (KCC2), critically influence spinal synaptic inhibition by regulating intracellular chloride concentrations. Here we show that paclitaxel treatment in rats significantly reduced GABA-induced membrane hyperpolarization and caused a depolarizing shift in GA BA reversal potential of dorsal horn neurons. However, paclitaxel had no significant effect on AMPA or NMDA receptor-mediated glutamatergic input from primary afferents to dorsal horn neurons. Paclitaxel treatment significantly increased protein levels, but not mRNA levels, of NKCC1 in spinal cords. Inhibition of NKCC1 with bumetanide reversed the paclitaxel effect on GABA-mediated hyperpolarization and GABA reversal potentials. Also, intrathecal bumetanide significantly attenuated hyperalgesia and allodynia induced by paclitaxel. Co-immunoprecipitation revealed that NKCC1 interacted with beta-tubulin and beta-actin in spinal cords. Remarkably, paclitaxel increased NKCC1 protein levels at the plasma membrane and reduced NKCC1 levels in the cytosol of spinal cords. In contrast, treatment with an actin-stabilizing agent had no significant effect on NKCC1 protein levels in the plasma membrane or cytosolic fractions of spinal cords. In addition, inhibition of the motor protein dynein blocked paclitaxel-induced subcellular redistribution of NKCC1, whereas inhibition of kinesin-5 mimicked the paclitaxel effect. Our findings suggest that increased NKCC1 activity contributes to diminished spinal synaptic inhibition and neuropathic pain caused by paclitaxel. Paclitaxel disrupts intracellular NKCC1 trafficking by interfering with microtubule dynamics and associated motor proteins.	[Chen, Shao-Rui; Zhu, Lihong; Chen, Hong; Wen, Lei; Laumet, Geoffroy; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Ctr Neurosci & Pain Res, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org	Laumet, Geoffroy/O-7480-2019; Zhu, Li/GXH-9801-2022	Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [NS073935]; N. G. and Helen T. Hawkins endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS073935. This work was also supported by the N. G. and Helen T. Hawkins endowment (to H.-L.P.).	Baas PW, 2013, BRAIN, V136, P2937, DOI 10.1093/brain/awt153; Boehmerle W, 2006, P NATL ACAD SCI USA, V103, P18356, DOI 10.1073/pnas.0607240103; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Cavaletti G, 2000, NEUROTOXICOLOGY, V21, P389, DOI 10.1046/j.1529-8027.2001.01008-5.x; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen J, 2006, J NEURO-ONCOL, V76, P85, DOI 10.1007/s11060-005-4171-7; Chen SR, 2014, J PHARMACOL EXP THER, V350, P301, DOI 10.1124/jpet.114.215855; Chen SR, 2003, J PHARMACOL EXP THER, V307, P676, DOI 10.1124/jpet.103.055905; Choi WS, 2005, CIRC RES, V97, P363, DOI 10.1161/01.RES.0000179535.06458.f8; COLLOT M, 1984, P NATL ACAD SCI-BIOL, V81, P788, DOI 10.1073/pnas.81.3.788; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; DEBRABANDER M, 1981, P NATL ACAD SCI-BIOL, V78, P5608; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Delpy A, 2008, J PHYSIOL-LONDON, V586, P1059, DOI 10.1113/jphysiol.2007.146993; Dina OA, 2001, NEUROSCIENCE, V108, P507, DOI 10.1016/S0306-4522(01)00425-0; Galan A, 2005, NEUROSCIENCE, V133, P245, DOI 10.1016/j.neuroscience.2005.02.025; Grisold W., 2006, NEUROL ONCOL, V14, P45; Hannaert P, 2002, N-S ARCH PHARMACOL, V365, P193, DOI 10.1007/s00210-001-0521-y; Haque SA, 2004, CELL MOTIL CYTOSKEL, V58, P10, DOI 10.1002/cm.10176; Heng YW, 2012, J CELL SCI, V125, P1579, DOI 10.1242/jcs.096818; Holzinger A, 2009, METHODS MOL BIOL, V586, P71, DOI 10.1007/978-1-60761-376-3_4; Ikeda K, 1997, HEARING RES, V107, P1, DOI 10.1016/S0378-5955(97)00009-9; Jakab RL, 2011, AM J PHYSIOL-GASTR L, V300, pG82, DOI 10.1152/ajpgi.00245.2010; Kapitein LC, 2010, CURR BIOL, V20, P290, DOI 10.1016/j.cub.2009.12.052; Lee JJ, 2006, J CLIN ONCOL, V24, P1633, DOI 10.1200/JCO.2005.04.0543; Li DP, 2002, J PHYSIOL-LONDON, V543, P807, DOI 10.1113/jphysiol.2002.020644; LIPTON RB, 1989, NEUROLOGY, V39, P368, DOI 10.1212/WNL.39.3.368; Liu X, 2013, P NATL ACAD SCI USA, V110, P11976, DOI 10.1073/pnas.1306180110; Loewen ME, 2009, AM J PHYSIOL-HEART C, V296, pH71, DOI 10.1152/ajpheart.00260.2008; Matsumoto M, 2006, J PHARMACOL EXP THER, V318, P735, DOI 10.1124/jpet.106.103614; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Myers KA, 2007, J CELL BIOL, V178, P1081, DOI 10.1083/jcb.200702074; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; Polomano RC, 2001, PAIN MED, V2, P8, DOI 10.1046/j.1526-4637.2001.002001008.x; Price TJ, 2006, BRAIN RES, V1112, P146, DOI 10.1016/j.brainres.2006.07.012; Reynolds A, 2007, J PHYSIOL-LONDON, V582, P507, DOI 10.1113/jphysiol.2007.129718; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Rowinsky E K, 1993, J Natl Cancer Inst Monogr, P107; Saunders AM, 2007, CURR BIOL, V17, pR453, DOI 10.1016/j.cub.2007.05.001; Scripture CD, 2006, CURR NEUROPHARMACOL, V4, P165, DOI 10.2174/157015906776359568; SHPETNER HS, 1988, J CELL BIOL, V107, P1001, DOI 10.1083/jcb.107.3.1001; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Snyder JP, 2001, P NATL ACAD SCI USA, V98, P5312, DOI 10.1073/pnas.051309398; Valensin S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-196; Walter WJ, 2012, P NATL ACAD SCI USA, V109, P5289, DOI 10.1073/pnas.1116315109; Xiao WH, 2008, PAIN, V135, P262, DOI 10.1016/j.pain.2007.06.001; Ye ZY, 2012, J NEUROSCI, V32, P8560, DOI 10.1523/JNEUROSCI.1346-12.2012; Yoon SY, 2005, CELL MOTIL CYTOSKEL, V60, P181, DOI 10.1002/cm.20057; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947; Zhang LL, 2007, J NEUROPHYSIOL, V98, P266, DOI 10.1152/jn.00288.2007; Zhao YL, 2012, J BIOL CHEM, V287, P25073, DOI 10.1074/jbc.M112.378737; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777; Zhou HY, 2012, J BIOL CHEM, V287, P33853, DOI 10.1074/jbc.M112.395830	60	30	31	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31111	31120		10.1074/jbc.M114.600320	http://dx.doi.org/10.1074/jbc.M114.600320			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25253692	Green Published, hybrid			2022-12-28	WOS:000344549900020
J	Louw-du Toit, R; Hapgood, JP; Africander, D				Louw-du Toit, Renate; Hapgood, Janet P.; Africander, Donita			Medroxyprogesterone Acetate Differentially Regulates Interleukin (IL)-12 and IL-10 in a Human Ectocervical Epithelial Cell Line in a Glucocorticoid Receptor (GR)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FEMALE GENITAL-TRACT; HERPES-SIMPLEX-VIRUS; NF-KAPPA-B; HORMONAL CONTRACEPTION; GENE-EXPRESSION; TNF-ALPHA; SYNTHETIC PROGESTINS; REPRODUCTIVE-TRACT; SEX-HORMONES	Medroxyprogesterone acetate (MPA), designed to mimic the actions of the endogenous hormone progesterone (P-4), is extensively used by women as a contraceptive and in hormone replacement therapy. However, little is known about the steroid receptor-mediated molecular mechanisms of action of MPA in the female genital tract. In this study, we investigated the regulation of the pro-inflammatory cytokine, interleukin (IL)-12, and the anti-inflammatory cytokine IL-10, by MPA versus P-4, in an in vitro cell culture model of the female ectocervical environment. This study shows that P-4 and MPA significantly increase the expression of the IL-12p40 and IL-12p35 genes, whereas IL-10 gene expression is suppressed in a dose-dependent manner. Moreover, these effects were abrogated when reducing the glucocorticoid receptor (GR) levels with siRNA. Using a combination of chromatin immunoprecipitation (ChIP), siRNA, and re-ChIP assays, we show that recruitment of the P-4- and MPA-bound GR to the IL-12p40 promoter requires CCAAT enhancer-binding protein (C/EBp)-beta and nuclear factor kappa B (NF kappa B), although recruitment to the IL-10 promoter requires signal transducer and activator of transcription (STAT)-3. These results suggest that both P-4 and MPA may modulate inflammation in the ectocervix via this genomic mechanism.	[Louw-du Toit, Renate; Africander, Donita] Univ Stellenbosch, Dept Biochem, ZA-7602 Matieland, South Africa; [Hapgood, Janet P.] Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, South Africa	Stellenbosch University; University of Cape Town	Africander, D (corresponding author), Univ Stellenbosch, Dept Biochem, Private Bag X1, ZA-7602 Matieland, South Africa.	drho@sun.ac.za	Hapgood, Janet P/P-2549-2018	Hapgood, Janet P/0000-0002-4414-4861; Africander, Donita/0000-0002-3429-7100	Medical Research Council, the National Research Foundation in South Africa; Stellenbosch University	Medical Research Council, the National Research Foundation in South Africa; Stellenbosch University	This work was supported by grants from the Medical Research Council, the National Research Foundation in South Africa, and Stellenbosch University (to D. A.).	Adcock IM, 2001, IMMUNOL CELL BIOL, V79, P376, DOI 10.1046/j.1440-1711.2001.01025.x; Africander D, 2013, BIOCHEM BIOPH RES CO, V433, P305, DOI 10.1016/j.bbrc.2013.02.086; Africander D, 2011, CONTRACEPTION, V84, P423, DOI 10.1016/j.contraception.2011.06.006; Africander D, 2011, STEROIDS, V76, P636, DOI 10.1016/j.steroids.2011.03.001; Africander DJ, 2014, J STEROID BIOCHEM, V143, P404, DOI 10.1016/j.jsbmb.2014.05.007; Arambasic J, 2010, IUBMB LIFE, V62, P227, DOI 10.1002/iub.313; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Avenant C, 2010, BIOCHEMISTRY-US, V49, P972, DOI 10.1021/bi901956s; Baeten JM, 2001, AM J OBSTET GYNECOL, V185, P380, DOI 10.1067/mob.2001.115862; Bailie R, 1997, S AFR MED J, V87, P302; Bamberger CM, 1999, J CLIN ENDOCR METAB, V84, P4055, DOI 10.1210/jc.84.11.4055; Barousse MM, 2007, AM J REPROD IMMUNOL, V58, P159, DOI 10.1111/j.1600-0897.2007.00504.x; Becker C, 2001, J IMMUNOL, V167, P2608, DOI 10.4049/jimmunol.167.5.2608; Benkhart EM, 2000, J IMMUNOL, V165, P1612, DOI 10.4049/jimmunol.165.3.1612; Benki S, 2004, J INFECT DIS, V189, P2192, DOI 10.1086/421298; Birrell SN, 2007, FASEB J, V21, P2285, DOI 10.1096/fj.06-7518com; Blish CA, 2011, AM J REPROD IMMUNOL, V65, P302, DOI 10.1111/j.1600-0897.2010.00930.x; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Brabin L, 2002, AIDS PATIENT CARE ST, V16, P211, DOI 10.1089/10872910252972267; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao SJ, 2002, J IMMUNOL, V169, P5715, DOI 10.4049/jimmunol.169.10.5715; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.0.CO;2-I; Chang HD, 2007, ANN NY ACAD SCI, V1109, P40, DOI 10.1196/annals.1398.006; Crowley-Nowick PA, 2000, J INFECT DIS, V181, P939, DOI 10.1086/315311; Cummins JE, 2006, AIDS RES HUM RETROV, V22, P788, DOI 10.1089/aid.2006.22.788; CUMMINS JE, 2000, AIDS REV, V2, P144; Davidson NJ, 1998, J IMMUNOL, V161, P3143; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Elovitz MA, 2008, J MATERN-FETAL NEO M, V21, P223, DOI 10.1080/14767050801923680; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Fichorova RN, 2004, JAIDS-J ACQ IMM DEF, V37, pS184, DOI 10.1097/00126334-200410013-00010; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Gayo A, 1998, J NEUROIMMUNOL, V85, P122, DOI 10.1016/S0165-5728(97)00262-2; Ghanem KG, 2005, J INFECT DIS, V191, P358, DOI 10.1086/427190; Govender Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096497; Gravitt P, 2010, SEX HORMONES AND IMMUNITY TO INFECTION, P257, DOI 10.1007/978-3-642-02155-8_10; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; Gumbi PP, 2008, J VIROL, V82, P8529, DOI 10.1128/JVI.00183-08; Hapgood JP, 2013, ENDOCRINOLOGY, V154, P985, DOI 10.1210/en.2013-1066; Hapgood JP, 2004, TRENDS PHARMACOL SCI, V25, P554, DOI 10.1016/j.tips.2004.09.005; Heckel MC, 2011, CELL IMMUNOL, V266, P143, DOI 10.1016/j.cellimm.2010.09.010; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Hel Z, 2010, ENDOCR REV, V31, P79, DOI 10.1210/er.2009-0018; Hickey DK, 2011, J REPROD IMMUNOL, V88, P185, DOI 10.1016/j.jri.2011.01.005; Huijbregts RPH, 2013, ENDOCRINOLOGY, V154, P1282, DOI 10.1210/en.2012-1850; Ildgruben AK, 2003, OBSTET GYNECOL, V102, P571, DOI 10.1016/S0029-7844(03)00618-5; Jeannin P, 1996, J IMMUNOL, V156, P3159; Johansson-Haque K, 2008, J MOL ENDOCRINOL, V41, P239, DOI 10.1677/JME-08-0015; John M, 1998, AM J RESP CRIT CARE, V157, P256, DOI 10.1164/ajrccm.157.1.9703079; Kelly RW, 1997, HUM REPROD, V12, P677, DOI 10.1093/humrep/12.4.677; Kim MH, 2009, PROSTATE, V69, P1435, DOI 10.1002/pros.20993; Kleinschmidt I, 2007, CONTRACEPTION, V75, P461, DOI 10.1016/j.contraception.2007.02.002; Kleynhans L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024639; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Koubovec D, 2005, MOL CELL ENDOCRINOL, V242, P23, DOI 10.1016/j.mce.2005.07.001; Koubovec D, 2004, MOL CELL ENDOCRINOL, V221, P75, DOI 10.1016/j.mce.2004.03.006; KREISS J, 1994, J INFECT DIS, V170, P1597, DOI 10.1093/infdis/170.6.1597; Kremer KN, 2007, J IMMUNOL, V178, P1581, DOI 10.4049/jimmunol.178.3.1581; KUBE D, 1995, CYTOKINE, V7, P1, DOI 10.1006/cyto.1995.1001; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kurebayashi J, 2003, THYROID, V13, P249, DOI 10.1089/105072503321582042; Langlais D, 2012, MOL CELL, V47, P38, DOI 10.1016/j.molcel.2012.04.021; Lannan EA, 2012, ENDOCRINOLOGY, V153, P3701, DOI 10.1210/en.2012-1020; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Ludwig Kirsten, 2011, Genes Cancer, V2, P20, DOI 10.1177/1947601911402680; Ma W, 2004, J IMMUNOL, V172, P318, DOI 10.4049/jimmunol.172.1.318; Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; MacDonald EM, 2007, BIOL REPROD, V77, P1049, DOI 10.1095/biolreprod.107.063933; Mirani M, 2002, J IMMUNOL, V169, P6361, DOI 10.4049/jimmunol.169.11.6361; Miscia S, 2002, CELL GROWTH DIFFER, V13, P13; Morrison C, 2014, JAIDS-J ACQ IMM DEF, V66, P109, DOI 10.1097/QAI.0000000000000103; Morrison CS, 2012, AIDS, V26, P497, DOI 10.1097/QAD.0b013e32834fa13d; Morrison CS, 2010, AIDS, V24, P1778, DOI 10.1097/QAD.0b013e32833a2537; Morrison CS, 2004, SEX TRANSM DIS, V31, P561, DOI 10.1097/01.olq.0000137904.56037.70; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Mostad SB, 2000, J INFECT DIS, V181, P58, DOI 10.1086/315188; Mozo L, 2004, CLIN EXP ALLERGY, V34, P406, DOI 10.1111/j.1365-2222.2004.01824.x; Ochiel DO, 2008, CURR WOMENS HEALTH R, V4, P102, DOI 10.2174/157340408784246395; Ou XM, 2006, J BIOL CHEM, V281, P21512, DOI 10.1074/jbc.M600250200; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; Quayle AJ, 2002, J REPROD IMMUNOL, V57, P61, DOI 10.1016/S0165-0378(02)00019-0; Quinn TC, 2005, SCIENCE, V308, P1582, DOI 10.1126/science.1112489; Reichelderfer PS, 2000, AIDS, V14, P2101, DOI 10.1097/00002030-200009290-00005; Roberts L, 2012, BEST PRACT RES CL OB, V26, P441, DOI 10.1016/j.bpobgyn.2012.02.002; Robertson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064831; Robinson K, 2006, J AM COLL SURGEONS, V202, P788, DOI 10.1016/j.jamcollsurg.2006.01.007; Ronacher K, 2009, MOL CELL ENDOCRINOL, V299, P219, DOI 10.1016/j.mce.2008.10.008; Roos AB, 2012, J ENDOCRINOL, V212, P291, DOI 10.1530/JOE-11-0369; Rowland TL, 1998, IMMUNOPHARMACOLOGY, V40, P11, DOI 10.1016/S0162-3109(98)00010-1; Saba E, 2013, MUCOSAL IMMUNOL, V6, P1081, DOI 10.1038/mi.2013.2; Sambrook J., 1989, MOL CLONING LAB MANU, V3, P18; Shiraki M, 2004, LAB INVEST, V84, P1491, DOI 10.1038/labinvest.3700175; Shrier LA, 2003, J ADOLESCENT HEALTH, V32, P183, DOI 10.1016/S1054-139X(02)00536-0; Skjolaas KA, 2002, VET IMMUNOL IMMUNOP, V87, P79, DOI 10.1016/S0165-2427(02)00122-8; Smit J, 2001, BMC HEALTH SERV RES, V1, DOI 10.1186/1472-6963-1-4; Speroff L., 2010, CLIN GUIDE CONTRACEP, P217; Stanczyk FZ, 2013, ENDOCR REV, V34, P171, DOI 10.1210/er.2012-1008; STEIN B, 1993, MOL CELL BIOL, V13, P7191, DOI 10.1128/MCB.13.11.7191; Tomasicchio M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062895; Trinchieri G, 1995, RES IMMUNOL, V146, P423, DOI 10.1016/0923-2494(96)83011-2; Unterberger C, 2008, MOL IMMUNOL, V45, P3230, DOI 10.1016/j.molimm.2008.02.020; Verhoog NJD, 2011, J BIOL CHEM, V286, P19297, DOI 10.1074/jbc.M110.193672; Visser J, 1998, BLOOD, V91, P4255, DOI 10.1182/blood.V91.11.4255.411a03_4255_4264; Watford WT, 2003, CYTOKINE GROWTH F R, V14, P361, DOI 10.1016/S1359-6101(03)00043-1; Watson DC, 2012, CLIN VACCINE IMMUNOL, V19, P823, DOI 10.1128/CVI.00030-12; Webster JC, 1999, TRENDS ENDOCRIN MET, V10, P396, DOI 10.1016/S1043-2760(99)00186-1; Wira CR, 2010, AM J REPROD IMMUNOL, V63, P544, DOI 10.1111/j.1600-0897.2010.00842.x; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Wira CR, 2005, AM J REPROD IMMUNOL, V53, P65, DOI 10.1111/j.1600-0897.2004.00248.x; Yang C, 2011, BRIT J PHARMACOL, V164, P1661, DOI 10.1111/j.1476-5381.2011.01465.x; Yates MA, 2010, J NEUROIMMUNOL, V220, P136, DOI 10.1016/j.jneuroim.2010.01.013; Yilma AN, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/520174; Zhou L, 2004, MOL CELL BIOL, V24, P2385, DOI 10.1128/MCB.24.6.2385-2396.2004	115	24	24	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31136	31149		10.1074/jbc.M114.587311	http://dx.doi.org/10.1074/jbc.M114.587311			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25202013	hybrid, Green Published			2022-12-28	WOS:000344549900022
J	Qu, H; Tu, YZ; Guan, JL; Xiao, GZ; Wu, CY				Qu, Hong; Tu, Yizeng; Guan, Jun-Lin; Xiao, Guozhi; Wu, Chuanyue			Kindlin-2 Tyrosine Phosphorylation and Interaction with Src Serve as a Regulatable Switch in the Integrin Outside-in Signaling Circuit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CELL-MATRIX ADHESION; EXTRACELLULAR-MATRIX; ADAPTER PROTEIN; GROWTH-FACTOR; PAXILLIN; TRANSDUCTION; CYTOSKELETON; ACTIVATION; BINDING	Integrin-mediated cell-extracellular matrix (ECM) adhesion is critical for control of intracellular signaling; however, the mechanisms underlying this "outside-in" signaling are incompletely understood. Here we show that depletion of kindlin-2 impairs integrin outside-in signaling. Kindlin-2 is tyrosine-phosphorylated upon cell-ECM adhesion. Furthermore, kindlin-2 binds Src in a cell-ECM adhesion-regulatable fashion. At the molecular level, the kindlin-2 . Src interaction is mediated by the kindlin-2 F0 and the Src SH2 and SH3 domains center dot Src activation increases kindlin-2 tyrosine phosphorylation and the kindlin-2 . Src interaction. Conversely, inhibition of Src reduces kindlin-2 tyrosine phosphorylation and diminishes the kindlin-2 center dot Src interaction. Finally, disruption of the kindlin-2 center dot Src interaction, unlike depletion of kindlin-2, impairs neither cell-ECM adhesion nor cell-ECM adhesion-induced focal adhesion kinase Tyr-397 phosphorylation. However, it markedly inhibits cell-ECM adhesion-induced paxillin tyrosine phosphorylation, cell migration, and proliferation. These results suggest that kindlin-2 tyrosine phosphorylation and interaction with Src serve as a regulatable switch downstream of focal adhesion kinase in the integrin outside-in signaling circuit, relaying signals from cell-ECM adhesion to paxillin that control cell migration and proliferation.	[Qu, Hong; Tu, Yizeng; Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Guan, Jun-Lin] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45267 USA; [Xiao, Guozhi] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; University of Cincinnati; Rush University	Wu, CY (corresponding author), Univ Pittsburgh, Dept Pathol, 707B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	carywu@pitt.edu			National Institutes of Health [GM65188]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM65188 (to C. W.).	BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; BIBBINS KB, 1993, MOL CELL BIOL, V13, P7278, DOI 10.1128/MCB.13.12.7278; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; GUAN JL, 1991, CELL REGUL, V2, P951, DOI 10.1091/mbc.2.11.951; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; Hall JE, 2011, INT REV CEL MOL BIO, V288, P185, DOI 10.1016/B978-0-12-386041-5.00005-4; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Katz E, 2007, INT J BIOCHEM CELL B, V39, P715, DOI 10.1016/j.biocel.2006.11.004; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kohno M, 1999, J AM SOC NEPHROL, V10, P2495; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; LaFlamme SE, 1997, MATRIX BIOL, V16, P153, DOI 10.1016/S0945-053X(97)90003-2; LaFlamme SE, 1996, SEMIN CANCER BIOL, V7, P111, DOI 10.1006/scbi.1996.0016; Lai-Cheong JE, 2010, INT J BIOCHEM CELL B, V42, P595, DOI 10.1016/j.biocel.2009.10.015; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Plow EF, 2009, CURR OPIN HEMATOL, V16, P323, DOI 10.1097/MOH.0b013e32832ea389; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0; Rosado JA, 2004, J BIOL CHEM, V279, P1665, DOI 10.1074/jbc.M307963200; Schaller MD, 2000, J CELL BIOL, V150, pF9, DOI 10.1083/jcb.150.1.F9; Schaller MD, 1997, J BIOL CHEM, V272, P25319, DOI 10.1074/jbc.272.40.25319; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; THOMAS SM, 1995, NATURE, V376, P267, DOI 10.1038/376267a0; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; TURNER CE, 1991, J CELL BIOL, V115, P201, DOI 10.1083/jcb.115.1.201; TWAMLEYSTEIN GM, 1993, P NATL ACAD SCI USA, V90, P7696, DOI 10.1073/pnas.90.16.7696; Wu CY, 2005, J CELL SCI, V118, P659, DOI 10.1242/jcs.01639; Ye F, 2014, FRONT MED-PRC, V8, P6, DOI 10.1007/s11684-014-0317-3; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001	54	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31001	31013		10.1074/jbc.M114.580811	http://dx.doi.org/10.1074/jbc.M114.580811			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25237194	Green Published, hybrid			2022-12-28	WOS:000344549900011
J	Tecleab, A; Zhang, XL; Sebti, SM				Tecleab, Awet; Zhang, Xiaolei; Sebti, Said M.			Ral GTPase Down-regulation Stabilizes and Reactivates p53 to Inhibit Malignant Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENIC RAS; TUMOR-SUPPRESSOR; K-RAS; ACTIVATION; PHOSPHORYLATION; MUTATIONS; CANCER; SENESCENCE; GENE; REQUIREMENTS	Ral GTPases are critical effectors of Ras, yet the molecular mechanism by which they induce malignant transformation is not well understood. In this study, we found the expression of K-Ras, RalB, and sometimes RalA, but not AKT1/2 and c-Raf, to be required for maintaining low levels of p53 in human cancer cells that harbor mutant K-Ras and wild-type p53. Down-regulation of K-Ras, RalB, and sometimes RalA increases p53 protein levels and results in a p53-dependent up-regulation of the expression of p21(WAF). K-Ras, RalA, and RalB depletion increases p53 stability as demonstrated by ataxia telangiectasia-mutated kinase activation, increased Ser-15 phosphorylation, and a significant (up to 6-fold) increase in p53 half-life. Furthermore, depletion of K-Ras and RalB inhibits anchorage-independent growth and invasion and interferes with cell cycle progression in a p53-dependent manner. Depletion of RalA inhibits invasion in a p53-dependent manner. Thus, expression of K-Ras and RalB and possibly RalA proteins is critical for maintaining low levels of p53, and down-regulation of these GTPases reactivates p53 by significantly enhancing its stability, and this contributes to suppression of malignant transformation.	[Tecleab, Awet; Zhang, Xiaolei; Sebti, Said M.] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, Tampa, FL 33612 USA; [Tecleab, Awet; Sebti, Said M.] Univ S Florida, Dep Oncol Sci, Tampa, FL 33612 USA; [Tecleab, Awet; Sebti, Said M.] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Sebti, SM (corresponding author), 12902 Magnolia Dr,SRB3-DRDIS, Tampa, FL 33612 USA.	said.sebti@moffitt.org		Zhang, Xiaolei/0000-0003-2395-2453	Cancer Center support [NIH P30-CA 76292]; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	Cancer Center support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Sebti laboratory, Maria Balasis, Norbert Berndt, Aslamuzzaman Kazi, and Hua Yang as well as Rasa Hamilton (Moffitt Cancer Center),for carefully reviewing the manuscript- and for their comments. We thank Dr. handong Chen (Moffitt Cancer Center) for valuable comments. We also thank members of the Flow Cytometer Core Facility at the Moffitt Cancer Center and Research Institute jiff assisting with the cell cycle experiments. We also thank the Dr David Shibata laboratory for providing us with the isogenic cell lines HCT116 and HKH2 The core facilities at the Moffitt Cancer Center are supported partially by the Cancer Center support grant NIH P30-CA 76292.	Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; de Bruyn KMT, 2000, J BIOL CHEM, V275, P29761, DOI 10.1074/jbc.M001160200; De Ruiter ND, 2001, MOL CELL BIOL, V21, P8225, DOI 10.1128/MCB.21.23.8225-8235.2001; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Ferro E, 2010, CELL SIGNAL, V22, P1804, DOI 10.1016/j.cellsig.2010.05.010; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gille H, 1999, J BIOL CHEM, V274, P22033, DOI 10.1074/jbc.274.31.22033; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Ha L, 2007, P NATL ACAD SCI USA, V104, P10968, DOI 10.1073/pnas.0611638104; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henry DO, 2000, MOL CELL BIOL, V20, P8084, DOI 10.1128/MCB.20.21.8084-8092.2000; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HOLLSTEIN MC, 1990, P NATL ACAD SCI USA, V87, P9958, DOI 10.1073/pnas.87.24.9958; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Kodama M, 2010, MOL CELL BIOL, V30, P1620, DOI 10.1128/MCB.00810-09; Lee SH, 2009, NEOPLASIA, V11, P22, DOI 10.1593/neo.81006; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lim KH, 2010, MOL CELL BIOL, V30, P508, DOI 10.1128/MCB.00916-08; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Lowe SW, 1999, ENDOCR-RELAT CANCER, V6, P45, DOI 10.1677/erc.0.0060045; Martin Timothy D, 2012, Small GTPases, V3, P126, DOI 10.4161/sgtp.19571; Martin TD, 2012, J BIOL CHEM, V287, P14827, DOI 10.1074/jbc.M112.344986; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Oxford G, 2005, CANCER RES, V65, P7111, DOI 10.1158/0008-5472.CAN-04-1957; Raj D, 2008, CARCINOGENESIS, V29, P194, DOI 10.1093/carcin/bgm219; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Rebhun JF, 2000, J BIOL CHEM, V275, P13406, DOI 10.1074/jbc.C000085200; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Ries SJ, 2000, NAT MED, V6, P1128, DOI 10.1038/80466; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wolthuis RMF, 1998, CURR BIOL, V8, P471, DOI 10.1016/S0960-9822(98)70183-6; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126	51	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31296	31309		10.1074/jbc.M114.565796	http://dx.doi.org/10.1074/jbc.M114.565796			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25210032	Green Published, hybrid			2022-12-28	WOS:000344549900034
J	Langlois, S; Xiang, X; Young, K; Cowan, BJ; Penuela, S; Cowan, KN				Langlois, Stephanie; Xiang, Xiao; Young, Kelsey; Cowan, Bryce J.; Penuela, Silvia; Cowan, Kyle N.			Pannexin 1 and Pannexin 3 Channels Regulate Skeletal Muscle Myoblast Proliferation and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEINS; C6 GLIOMA-CELLS; KERATINOCYTE DIFFERENTIATION; ATP; HEMICHANNELS; ACTIVATION; MEMBRANE; RELEASE; FAMILY; INFLAMMASOME	Pannexins constitute a family of three glycoproteins (Panx1, -2, and -3) forming single membrane channels. Recent work demonstrated that Panx1 is expressed in skeletal muscle and involved in the potentiation of contraction. However, Panxs functions in skeletal muscle cell differentiation, and proliferation had yet to be assessed. We show here that Panx1 and Panx3, but not Panx2, are present in human and rodent skeletal muscle, and their various species are differentially expressed in fetal versus adult human skeletal muscle tissue. Panx1 levels were very low in undifferentiated human primary skeletal muscle cells and myoblasts (HSMM) but increased drastically during differentiation and became the main Panx expressed in differentiated cells. Using HSMM, we found that Panx1 expression promotes this process, whereas it was impaired in the presence of probenecid or carbenoxolone. As for Panx3, its lower molecular weight species were prominent in adult skeletal muscle but very low in the fetal tissue and in undifferentiated skeletal muscle cells and myoblasts. Its overexpression (similar to 43-kDa species) induced HSMM differentiation and also inhibited their proliferation. On the other hand, a similar to 70-kDa immunoreactive species of Panx3, likely glycosylated, sialylated, and phosphorylated, was highly expressed in proliferative myoblasts but strikingly down-regulated during their differentiation. Reduction of its endogenous expression using two Panx3 shRNAs significantly inhibited HSMM proliferation without triggering their differentiation. In summary, our results demonstrate that Panx1 and Panx3 are co-expressed in human skeletal muscle myoblasts and play a pivotal role in dictating the proliferation and differentiation status of these cells.	[Langlois, Stephanie; Cowan, Kyle N.] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Surg, Div Paediat Surg, Ottawa, ON K1H 8L1, Canada; [Langlois, Stephanie; Xiang, Xiao; Young, Kelsey; Cowan, Kyle N.] Childrens Hosp Eastern Ontario, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada; [Xiang, Xiao; Cowan, Kyle N.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8L1, Canada; [Cowan, Bryce J.] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 4E8, Canada; [Penuela, Silvia] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of British Columbia; Western University (University of Western Ontario)	Cowan, KN (corresponding author), Childrens Hosp Eastern Ontario, 401 Smyth Rd,Rm 3370, Ottawa, ON K1H 8L1, Canada.	kcowan@cheo.on.ca	Penuela, Silvia/A-6961-2010	Penuela, Silvia/0000-0003-4829-5517; Xiang, Xiao/0000-0002-3969-1668; Cowan, Kyle/0000-0003-0109-7716	Department of Surgery at the Children's Hospital of Eastern Ontario; Research Institute of the Children's Hospital of Eastern Ontario	Department of Surgery at the Children's Hospital of Eastern Ontario; Research Institute of the Children's Hospital of Eastern Ontario	This work was supported by grants from the Department of Surgery at the Children's Hospital of Eastern Ontario and the Research Institute of the Children's Hospital of Eastern Ontario.	Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Araya R, 2004, BRAIN RES REV, V47, P174, DOI 10.1016/j.brainresrev.2004.06.003; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bond SR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00058; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Buvinic S, 2009, J BIOL CHEM, V284, P34490, DOI 10.1074/jbc.M109.057315; Celetti SJ, 2010, J CELL SCI, V123, P1363, DOI 10.1242/jcs.056093; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Cowan KN, 2012, CELL COMMUN ADHES, V19, P45, DOI 10.3109/15419061.2012.712575; Ednie AR, 2012, COMPR PHYSIOL, V2, P1269, DOI 10.1002/cphy.c110044; Filigheddu N, 2007, MOL BIOL CELL, V18, P986, DOI 10.1091/mbc.E06-05-0402; Gulbransen BD, 2012, NAT REV GASTRO HEPAT, V9, P625, DOI 10.1038/nrgastro.2012.138; Ishikawa M, 2014, J BIOL CHEM, V289, P2839, DOI 10.1074/jbc.M113.523241; Ishikawa M, 2011, J CELL BIOL, V193, P1257, DOI 10.1083/jcb.201101050; Iwamoto T, 2010, J BIOL CHEM, V285, P18948, DOI 10.1074/jbc.M110.127027; Jorquera G, 2013, J CELL SCI, V126, P1189, DOI 10.1242/jcs.116855; Lai CPK, 2009, ONCOGENE, V28, P4402, DOI 10.1038/onc.2009.283; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2014, CHANNELS, V8, P124, DOI 10.4161/chan.27422; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Porter GA, 2002, J BIOL CHEM, V277, P28942, DOI 10.1074/jbc.M203961200; Prochnow N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051767; Proulx A, 1997, DEV GENET, V20, P133, DOI 10.1002/(SICI)1520-6408(1997)20:2<133::AID-DVG6>3.0.CO;2-8; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Riquelme MA, 2013, NEUROPHARMACOLOGY, V75, P594, DOI 10.1016/j.neuropharm.2013.03.022; Ryten M, 2002, J CELL BIOL, V158, P345, DOI 10.1083/jcb.200202025; Shestopalov VI, 2008, CELL MOL LIFE SCI, V65, P376, DOI 10.1007/s00018-007-7200-1; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Turmel P, 2011, MOL REPROD DEV, V78, P124, DOI 10.1002/mrd.21280	39	41	43	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30717	30731		10.1074/jbc.M114.572131	http://dx.doi.org/10.1074/jbc.M114.572131			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25239622	hybrid, Green Published			2022-12-28	WOS:000344549700047
J	Wang, HY; Wang, X; Chen, GN; Zhang, XM; Tang, XB; Park, D; Cucinotta, FA; Yu, DS; Deng, XM; Dynan, WS; Doetsch, PW; Wang, Y				Wang, Hongyan; Wang, Xiang; Chen, Guangnan; Zhang, Xiangming; Tang, Xiaobing; Park, Dongkyoo; Cucinotta, Francis A.; Yu, David S.; Deng, Xingming; Dynan, William S.; Doetsch, Paul W.; Wang, Ya			RETRACTED: Distinct Roles of Ape1 Protein, an Enzyme Involved in DNA Repair, in High or Low Linear Energy Transfer Ionizing Radiation-induced Cell Killing (Retracted article. See vol. 295, pg. 6249, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							DOUBLE-STRAND BREAKS; ACCELERATED HEAVY-IONS; LIGASE-IV; END; DAMAGE; ENDONUCLEASE; PATHWAY; BINDING; REF-1; ATM	High linear energy transfer ( LET) radiation from space heavy charged particles or a heavier ion radiotherapy machine kills more cells than low LET radiation, mainly because high LET radiation-induced DNA damage is more difficult to repair. Relative biological effectiveness (RBE) is the ratio of the effects generated by high LET radiation to low LET radiation. Previously, our group and others demonstrated that the cell-killing RBE is involved in the interference of high LET radiation with non-homologous end joining but not homologous recombination repair. This effect is attributable, in part, to the small DNA fragments (<= 40 bp) directly produced by high LET radiation, the size of which prevents Ku protein from efficiently binding to the two ends of one fragment at the same time, thereby reducing non-homologous end joining efficiency. Here we demonstrate that Ape1, an enzyme required for processing apurinic/apyrimidinic ( known as abasic) sites, is also involved in the generation of small DNA fragments during the repair of high LET radiation-induced base damage, which contributes to the higher RBE of high LET radiation-induced cell killing. This discovery opens a new direction to develop approaches for either protecting astronauts from exposure to space radiation or benefiting cancer patients by sensitizing tumor cells to high LET radiotherapy.	[Wang, Hongyan; Wang, Xiang; Chen, Guangnan; Zhang, Xiangming; Tang, Xiaobing; Park, Dongkyoo; Yu, David S.; Deng, Xingming; Dynan, William S.; Doetsch, Paul W.; Wang, Ya] Emory Univ, Dept Radiat Oncol, Sch Med, Atlanta, GA 30322 USA; [Wang, Hongyan; Wang, Xiang; Chen, Guangnan; Zhang, Xiangming; Tang, Xiaobing; Park, Dongkyoo; Yu, David S.; Deng, Xingming; Dynan, William S.; Doetsch, Paul W.; Wang, Ya] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Cucinotta, Francis A.] Univ Nevada, Dept Hlth Phys & Diagnost Sci, Las Vegas, NV 89154 USA	Emory University; Emory University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Wang, Y (corresponding author), Emory Univ, Div Expt Radiat Oncol, Dept Radiat Oncol, Winship Canc Inst, 1365 Clifton Rd NE,Rm C5090, Atlanta, GA 30322 USA.	ywang94@emory.edu	Cucinotta, Francis/AAZ-5941-2020	Dynan, William/0000-0002-4045-5662	National Institutes of Health [P30CA138292]; National Aeronautics and Space Administration [NNX11AC39G]; NATIONAL CANCER INSTITUTE [P30CA138292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P30CA138292. This work was also supported by National Aeronautics and Space Administration Grant NNX11AC39G.	Asaithamby A, 2011, P NATL ACAD SCI USA, V108, P8293, DOI 10.1073/pnas.1016045108; AUFDERHEIDE E, 1987, INT J RADIAT BIOL, V51, P779, DOI 10.1080/09553008714551071; BADIE C, 1995, CANCER RES, V55, P1232; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Blaisdell JO, 2001, RADIAT PROT DOSIM, V97, P25, DOI 10.1093/oxfordjournals.rpd.a006634; BRENNER DJ, 1992, INT J RADIAT BIOL, V61, P737, DOI 10.1080/09553009214551591; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Erzberger JP, 1999, J MOL BIOL, V290, P447, DOI 10.1006/jmbi.1999.2888; Fung H, 2011, J BIOL CHEM, V286, P4968, DOI 10.1074/jbc.M110.146498; Georgakilas AG, 2004, NUCLEIC ACIDS RES, V32, P5609, DOI 10.1093/nar/gkh871; GOODHEAD DT, 1980, INT J RADIAT BIOL, V37, P135, DOI 10.1080/09553008014550201; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Lind BK, 2003, RADIAT RES, V160, P366, DOI 10.1667/0033-7587(2003)160[0366:RRDMBO]2.0.CO;2; Malyarchuk S, 2009, DNA REPAIR, V8, P1343, DOI 10.1016/j.dnarep.2009.08.008; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Okayasu R, 2006, RADIAT RES, V165, P59, DOI 10.1667/RR3489.1; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; RYDBERG B, 1994, RADIAT RES, V139, P133, DOI 10.2307/3578657; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Sutherland BM, 2000, P NATL ACAD SCI USA, V97, P103, DOI 10.1073/pnas.97.1.103; Svilar D, 2012, JOVE-J VIS EXP, DOI 10.3791/4168; Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang HC, 2001, NUCLEIC ACIDS RES, V29, P1653, DOI 10.1093/nar/29.8.1653; Wang HY, 2008, DNA REPAIR, V7, P725, DOI 10.1016/j.dnarep.2008.01.010; Wang HY, 2010, NUCLEIC ACIDS RES, V38, P3245, DOI 10.1093/nar/gkq069; Wang HY, 2009, INT J RADIAT ONCOL, V74, P1236, DOI 10.1016/j.ijrobp.2008.12.089; Wang HY, 2005, J CELL PHYSIOL, V202, P492, DOI 10.1002/jcp.20141; WARD JF, 1981, RADIAT RES, V86, P185, DOI 10.2307/3575500; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; XANTHOUDAKIS S, 1994, P NATL ACAD SCI USA, V91, P23, DOI 10.1073/pnas.91.1.23; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Yoo S, 1999, NUCLEIC ACIDS RES, V27, P4679, DOI 10.1093/nar/27.24.4679; Zafar F, 2010, RADIAT RES, V173, P27, DOI 10.1667/RR1910.1; Zeitlin C, 2013, SCIENCE, V340, P1080, DOI 10.1126/science.1235989; Zheng ZM, 2012, CANCER RES, V72, P1221, DOI 10.1158/0008-5472.CAN-11-2785	42	7	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30635	30644		10.1074/jbc.M114.604959	http://dx.doi.org/10.1074/jbc.M114.604959			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25210033	hybrid, Green Published			2022-12-28	WOS:000344549700040
J	Khazaei, MR; Girouard, MP; Alchini, R; Tone, SO; Shimada, T; Bechstedt, S; Cowan, M; Guillet, D; Wiseman, PW; Brouhard, G; Cloutier, JF; Fournier, AE				Khazaei, Mohamad R.; Girouard, Marie-Pier; Alchini, Ricardo; Tone, Stephan Ong; Shimada, Tadayuki; Bechstedt, Susanne; Cowan, Mitra; Guillet, Dominique; Wiseman, Paul W.; Brouhard, Gary; Cloutier, Jean Francois; Fournier, Alyson E.			Collapsin Response Mediator Protein 4 Regulates Growth Cone Dynamics through the Actin and Microtubule Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Axon; Cell Biology; Cytoskeleton; Microfilaments; Microtubule; Neurodevelopment; Neuroscience; CRMP; Growth Cone	AXON OUTGROWTH INHIBITION; F-ACTIN; NEURITE OUTGROWTH; SHORT-STOP; HIPPOCAMPAL-NEURONS; BINDING PROTEIN; MOTOR-NEURONS; GUIDANCE CUE; PHOSPHORYLATION; CRMP-2	Background: Intricate regulation of the growth cone cytoskeleton controls growth cone dynamics. Results: Loss of CRMP4 disrupts growth cone cytoskeletal dynamics, growth cone expansion, and axon growth. Conclusion: CRMP4 regulates both the actin and microtubule growth cone cytoskeleton. Significance: CRMP4 plays a critical role in regulating cytoskeletal dynamics underlying growth cone properties. Coordinated control of the growth cone cytoskeleton underlies axon extension and guidance. Members of the collapsin response mediator protein (CRMP) family of cytosolic phosphoproteins regulate the microtubule and actin cytoskeleton, but their roles in regulating growth cone dynamics remain largely unexplored. Here, we examine how CRMP4 regulates the growth cone cytoskeleton. Hippocampal neurons from CRMP4-/- mice exhibited a selective decrease in axon extension and reduced growth cone area, whereas overexpression of CRMP4 enhanced the formation and length of growth cone filopodia. Biochemically, CRMP4 can impact both microtubule assembly and F-actin bundling in vitro. Through a structure function analysis of CRMP4, we found that the effects of CRMP4 on axon growth and growth cone morphology were dependent on microtubule assembly, whereas filopodial extension relied on actin bundling. Intriguingly, anterograde movement of EB3 comets, which track microtubule protrusion, slowed significantly in neurons derived from CRMP4-/- mice, and rescue of microtubule dynamics required CRMP4 activity toward both the actin and microtubule cytoskeleton. Together, this study identified a dual role for CRMP4 in regulating the actin and microtubule growth cone cytoskeleton.	[Khazaei, Mohamad R.; Girouard, Marie-Pier; Alchini, Ricardo; Tone, Stephan Ong; Cloutier, Jean Francois; Fournier, Alyson E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Shimada, Tadayuki] Tokyo Metropolitan Inst Med Sci, Neural Plast Project, Setagaya Ku, Tokyo 1568506, Japan; [Bechstedt, Susanne; Brouhard, Gary] McGill Univ, Dept Biol, Montreal, PQ H3G 0B1, Canada; [Guillet, Dominique; Wiseman, Paul W.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Wiseman, Paul W.] McGill Univ, Dept Chem, Montreal, PQ H3A 2K6, Canada; [Cowan, Mitra] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ H2X 0A9, Canada	McGill University; Tokyo Metropolitan Institute of Medical Science; McGill University; McGill University; McGill University; Universite de Montreal	Fournier, AE (corresponding author), McGill Univ, Montreal Neurol Inst, BT-109,3801 Rue Univ, Montreal, PQ H3A 2B4, Canada.	alyson.fournier@mcgill.ca	Brouhard, Gary/AAZ-7789-2021		Canadian Institutes of Health Research; McGill Program in Neuroengineering; Canada Research Chair	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McGill Program in Neuroengineering; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by grants from the Canadian Institutes of Health Research and the McGill Program in Neuroengineering and by a Canada Research Chair (to A. E. F.).	Alabed YZ, 2007, J NEUROSCI, V27, P1702, DOI 10.1523/JNEUROSCI.5055-06.2007; Alabed YZ, 2010, J NEUROSCI, V30, P5635, DOI 10.1523/JNEUROSCI.6154-09.2010; Alves-Silva J, 2012, J NEUROSCI, V32, P9143, DOI 10.1523/JNEUROSCI.0416-12.2012; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Aylsworth A, 2009, EXP CELL RES, V315, P2856, DOI 10.1016/j.yexcr.2009.06.014; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brot S, 2010, J NEUROSCI, V30, P10639, DOI 10.1523/JNEUROSCI.0059-10.2010; Buck KB, 2002, J NEUROSCI, V22, P9358; Chae YC, 2009, CELL SIGNAL, V21, P1818, DOI 10.1016/j.cellsig.2009.07.017; Challacombe JF, 1996, J CELL SCI, V109, P2031; Challacombe JF, 1997, J NEUROSCI, V17, P3085; Cohan CS, 2001, CELL MOTIL CYTOSKEL, V48, P109, DOI 10.1002/1097-0169(200102)48:2<109::AID-CM1002>3.0.CO;2-G; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; EDWARDS RA, 1995, CELL MOTIL CYTOSKEL, V32, P1, DOI 10.1002/cm.970320102; Fournier AE, 2000, METHOD ENZYMOL, V325, P473; Fu XQ, 2013, J NEUROSCI, V33, P709, DOI 10.1523/JNEUROSCI.4603-12.2013; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; Gordon-Weeks PR, 2014, J NEUROCHEM, V129, P206, DOI 10.1111/jnc.12502; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Heo K, 2006, CELL SIGNAL, V18, P2182, DOI 10.1016/j.cellsig.2006.05.006; Higurashi M, 2012, DEV NEUROBIOL, V72, P1528, DOI 10.1002/dneu.22017; Hur EM, 2012, TRENDS NEUROSCI, V35, P164, DOI 10.1016/j.tins.2011.11.002; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Lee S, 2000, J NEUROSCI, V20, P1096, DOI 10.1523/JNEUROSCI.20-03-01096.2000; Lee S, 2002, DEVELOPMENT, V129, P1195; Lee S, 2007, DEVELOPMENT, V134, P1767, DOI 10.1242/dev.02842; Lin PC, 2011, J BIOL CHEM, V286, P41466, DOI 10.1074/jbc.M111.283580; Maniar TA, 2012, NAT NEUROSCI, V15, P48, DOI 10.1038/nn.2970; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; MORIMURA R, 2013, J PEDIATR ONCOL NURS, V30, P911, DOI DOI 10.1002/DNEU.22117; Nagai J, 2012, NEUROSCI LETT, V519, P56, DOI 10.1016/j.neulet.2012.05.020; Niisato E, 2012, DEV NEUROBIOL, V72, P1447, DOI 10.1002/dneu.22007; Paul C. A., 2008, CSH PROTOC, V2008; Prokop A, 1998, J CELL BIOL, V143, P1283, DOI 10.1083/jcb.143.5.1283; Quach TT, 2000, GENE, V242, P175, DOI 10.1016/S0378-1119(99)00528-4; Quach TT, 2004, MOL CELL NEUROSCI, V25, P433, DOI 10.1016/j.mcn.2003.11.006; Quinn CC, 2003, J NEUROSCI, V23, P2815; Rembutsu M, 2008, BIOCHEMISTRY-US, V47, P2153, DOI 10.1021/bi702030w; Rosslenbroich V, 2005, EXP CELL RES, V310, P434, DOI 10.1016/j.yexcr.2005.08.005; Sanchez-Soriano N, 2009, J CELL SCI, V122, P2534, DOI 10.1242/jcs.046268; Stepanova T, 2003, J NEUROSCI, V23, P2655; Tanaka H, 2012, DEV BIOL, V370, P223, DOI 10.1016/j.ydbio.2012.07.032; Tone SO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014345; Vitriol EA, 2012, NEURON, V73, P1068, DOI 10.1016/j.neuron.2012.03.005; Wang LH, 1996, J NEUROSCI, V16, P6197; Wang LH, 1997, J NEUROCHEM, V69, P2261; Williamson T, 1996, P NATL ACAD SCI USA, V93, P15221, DOI 10.1073/pnas.93.26.15221; Yang SY, 2013, J BIOL CHEM, V288, P274, DOI 10.1074/jbc.M112.427971; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yuasa-Kawada J, 2003, EUR J NEUROSCI, V17, P2329, DOI 10.1046/j.1460-9568.2003.02664.x	56	43	45	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					30133	30143		10.1074/jbc.M114.570440	http://dx.doi.org/10.1074/jbc.M114.570440			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25225289	Green Published, hybrid			2022-12-28	WOS:000344370800052
J	Lai, RPJ; Hock, M; Radzimanowski, J; Tonks, P; Hulsik, DL; Effantin, G; Seilly, DJ; Dreja, H; Kliche, A; Wagner, R; Barnett, SW; Tumba, N; Morris, L; LaBranche, CC; Montefiori, DC; Seaman, MS; Heeney, JL; Weissenhorn, W				Lai, Rachel P. J.; Hock, Miriam; Radzimanowski, Jens; Tonks, Paul; Hulsik, David Lutje; Effantin, Gregory; Seilly, David J.; Dreja, Hanna; Kliche, Alexander; Wagner, Ralf; Barnett, Susan W.; Tumba, Nancy; Morris, Lynn; LaBranche, Celia C.; Montefiori, David C.; Seaman, Michael S.; Heeney, Jonathan L.; Weissenhorn, Winfried			A Fusion Intermediate gp41 Immunogen Elicits Neutralizing Antibodies to HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						AIDS; Membrane Fusion; Protein Conformation; Vaccine Development; X-ray Scattering; HIV-1; HIV-1 gp41	HUMAN-IMMUNODEFICIENCY-VIRUS; PROXIMAL EXTERNAL REGION; HUMAN MONOCLONAL-ANTIBODIES; SCATTERING DATA-ANALYSIS; B-CELL RESPONSES; ENVELOPE GLYCOPROTEIN; TYPE-1 HIV-1; BROAD NEUTRALIZATION; RATIONAL DESIGN; MEDIATED FUSION	Background: HIV-1 gp41 MPER is a target for inducing broadly neutralizing antibodies. Results: Gp41(int) folds into a compact elongated structure that induces neutralizing antibodies upon immunization. Conclusion: Presentation of gp41(int) in a lipid environment is beneficial to induce neutralizing antibodies. Significance: Membrane-anchored gp41(int) is a promising antigen to improve breadth and potency of anti-gp41 antibody responses. The membrane-proximal external region (MPER) of the human immunodeficiency virus, type 1 (HIV-1) envelope glycoprotein subunit gp41 is targeted by potent broadly neutralizing antibodies 2F5, 4E10, and 10E8. These antibodies recognize linear epitopes and have been suggested to target the fusion intermediate conformation of gp41 that bridges viral and cellular membranes. Anti-MPER antibodies exert different degrees of membrane interaction, which is considered to be the limiting factor for the generation of such antibodies by immunization. Here we characterize a fusion intermediate conformation of gp41 (gp41(int)-Cys) and show that it folds into an elongated approximate to 12-nm-long extended structure based on small angle x-ray scattering data. Gp41(int)-Cys was covalently linked to liposomes via its C-terminal cysteine and used as immunogen. The gp41(int)-Cys proteoliposomes were administered alone or in prime-boost regimen with trimeric envelope gp140(CA018) in guinea pigs and elicited high anti-gp41 IgG titers. The sera interacted with a peptide spanning the MPER region, demonstrated competition with broadly neutralizing antibodies 2F5 and 4E10, and exerted modest lipid binding, indicating the presence of MPER-specific antibodies. Although the neutralization potency generated solely by gp140(CA018) was higher than that induced by gp41(int)-Cys, the majority of animals immunized with gp41(int)-Cys proteoliposomes induced modest breadth and potency in neutralizing tier 1 pseudoviruses and replication-competent simian/human immunodeficiency viruses in the TZM-bl assay as well as responses against tier 2 HIV-1 in the A3R5 neutralization assay. Our data thus demonstrate that liposomal gp41 MPER formulation can induce neutralization activity, and the strategy serves to improve breadth and potency of such antibodies by improved vaccination protocols.	[Lai, Rachel P. J.; Tonks, Paul; Seilly, David J.; Dreja, Hanna; Heeney, Jonathan L.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Hock, Miriam; Radzimanowski, Jens; Hulsik, David Lutje; Effantin, Gregory; Weissenhorn, Winfried] Univ Grenoble Alpes, UVHCI, F-38000 Grenoble, France; [Hock, Miriam; Radzimanowski, Jens; Hulsik, David Lutje; Effantin, Gregory; Weissenhorn, Winfried] CNRS, UVHCI, F-38000 Grenoble, France; [Kliche, Alexander; Wagner, Ralf] Univ Regensburg, Inst Med Microbiol & Hyg, D-93053 Regensburg, Germany; [Barnett, Susan W.] Novartis Vaccines & Diagnost Inc, Cambridge, MA 02139 USA; [Tumba, Nancy; Morris, Lynn] Natl Inst Communicable Dis, Ctr HIV & Sexually Transmitted Infect, ZA-2131 Johannesburg, South Africa; [LaBranche, Celia C.; Montefiori, David C.] Duke Univ, Dept Surg, Med Ctr, Durham, NC 27710 USA; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02115 USA	University of Cambridge; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); University of Regensburg; Novartis; National Institute for Communicable Diseases (NICD); Duke University; Harvard University; Beth Israel Deaconess Medical Center	Heeney, JL (corresponding author), Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England.	jlh66@cam.ac.uk; weissenhorn@embl.fr	Morris, Lynn/V-3941-2018	Morris, Lynn/0000-0003-3961-7828; Lai, Rachel/0000-0003-3418-850X; Heeney, Jonathan/0000-0003-2702-1621	Bill and Melinda Gates Foundation [38637]; Comprehensive Antibody-Vaccine Immune Monitoring Consortium [38619]; Sidaction; Labex Grenoble Alliance for Integrated Structural Cell Biology (GRAL) [ANR-10-LABX-49-01]; Agence nationale de recherche sur le sida et les hepatites virales	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Comprehensive Antibody-Vaccine Immune Monitoring Consortium; Sidaction; Labex Grenoble Alliance for Integrated Structural Cell Biology (GRAL); Agence nationale de recherche sur le sida et les hepatites virales(ANRSFrench National Research Agency (ANR))	This work was supported in part by the Bill and Melinda Gates Foundation-funded Consortium of AIDS Vaccine Discovery (Grant 38637), the Comprehensive Antibody-Vaccine Immune Monitoring Consortium (Grant 38619), and Sidaction (to W. W.).; Supported by Labex Grenoble Alliance for Integrated Structural Cell Biology (GRAL) Grant ANR-10-LABX-49-01.; Supported by a postdoctoral fellowship from the Agence nationale de recherche sur le sida et les hepatites virales.	Alam SM, 2008, J VIROL, V82, P115, DOI 10.1128/JVI.00927-07; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Arnold GF, 2009, J VIROL, V83, P5087, DOI 10.1128/JVI.00184-09; Bar KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002721; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Behrendt R, 2012, INTERVIROLOGY, V55, P252, DOI 10.1159/000324483; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Bonsignori M, 2009, J IMMUNOL, V183, P2708, DOI 10.4049/jimmunol.0901068; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; BUITING AMJ, 1992, RES IMMUNOL, V143, P541, DOI 10.1016/0923-2494(92)80066-T; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Caffrey M, 1997, J MOL BIOL, V271, P819, DOI 10.1006/jmbi.1997.1217; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen J, 2014, J VIROL, V88, P1249, DOI 10.1128/JVI.02664-13; Chen Y, 2013, J IMMUNOL, V191, P1260, DOI 10.4049/jimmunol.1300770; Choudhry V, 2006, BIOCHEM BIOPH RES CO, V348, P1107, DOI 10.1016/j.bbrc.2006.07.163; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; Cole KS, 1997, J VIROL, V71, P5069, DOI 10.1128/JVI.71.7.5069-5079.1997; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Dawood R, 2013, AIDS, V27, P717, DOI 10.1097/QAD.0b013e32835cfca5; Decroix N, 2001, SCAND J IMMUNOL, V53, P401, DOI 10.1046/j.1365-3083.2001.00894.x; Dennison SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027824; Dey AK, 2012, VACCINE, V30, P2749, DOI 10.1016/j.vaccine.2012.02.027; Dimitrov AS, 2007, BIOCHEMISTRY-US, V46, P1398, DOI 10.1021/bi062245f; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Eckhart L, 1996, J GEN VIROL, V77, P2001, DOI 10.1099/0022-1317-77-9-2001; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; FORTIN A, 1993, IMMUNOBIOLOGY, V188, P316, DOI 10.1016/S0171-2985(11)80239-1; FREUDENBERG MA, 1989, INFECTION, V17, P322, DOI 10.1007/BF01650719; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Frey G, 2010, NAT STRUCT MOL BIOL, V17, P1486, DOI 10.1038/nsmb.1950; Guenaga J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016074; Haynes BF, 2010, NAT STRUCT MOL BIOL, V17, P543, DOI 10.1038/nsmb0510-543; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hinz A, 2009, VIROLOGY, V390, P221, DOI 10.1016/j.virol.2009.05.015; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Hulsik DL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003202; Jain S, 2010, VACCINE, V28, P7070, DOI 10.1016/j.vaccine.2010.08.009; Joyce JG, 2002, J BIOL CHEM, V277, P45811, DOI 10.1074/jbc.M205862200; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kim M, 2007, VACCINE, V25, P5102, DOI 10.1016/j.vaccine.2006.09.071; Kim M, 2011, NAT STRUCT MOL BIOL, V18, P1235, DOI 10.1038/nsmb.2154; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kusov YY, 2007, ANTIVIR RES, V73, P101, DOI 10.1016/j.antiviral.2006.08.003; Lai RPJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035083; Law M, 2007, J VIROL, V81, P4272, DOI 10.1128/JVI.02536-06; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liang XP, 1999, VACCINE, V17, P2862, DOI 10.1016/S0264-410X(99)00125-5; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liao MF, 2000, PEPTIDES, V21, P463, DOI 10.1016/S0196-9781(00)00179-0; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Luo M, 2006, VACCINE, V24, P435, DOI 10.1016/j.vaccine.2005.08.006; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mantis NJ, 2001, VACCINE, V19, P3990, DOI 10.1016/S0264-410X(01)00115-3; Marusic C, 2001, J VIROL, V75, P8434, DOI 10.1128/JVI.75.18.8434-8439.2001; Matoba N, 2006, VACCINE, V24, P5047, DOI 10.1016/j.vaccine.2006.03.045; McGaughey GB, 2003, BIOCHEMISTRY-US, V42, P3214, DOI 10.1021/bi026952u; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Merk A, 2013, CURR OPIN STRUC BIOL, V23, P268, DOI 10.1016/j.sbi.2013.03.007; Meyerson JR, 2013, P NATL ACAD SCI USA, V110, P513, DOI 10.1073/pnas.1214810110; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Munoz-Barroso I, 1999, J VIROL, V73, P6089; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1995, J VIROL, V69, P6678, DOI 10.1128/JVI.69.11.6678-6686.1995; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Ni JH, 2004, BIOORGAN MED CHEM, V12, P3141, DOI 10.1016/j.bmc.2004.04.008; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Ofek G, 2010, J VIROL, V84, P2955, DOI 10.1128/JVI.02257-09; Oster AM, 2011, AIDS, V25, P2157, DOI 10.1097/QAD.0b013e32834bfde9; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pastori C, 2012, VIROLOGY, V431, P1, DOI 10.1016/j.virol.2012.05.005; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Pietzsch J, 2010, J VIROL, V84, P5032, DOI 10.1128/JVI.00154-10; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Reardon PN, 2014, P NATL ACAD SCI USA, V111, P1391, DOI 10.1073/pnas.1309842111; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Samygina VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067145; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Scherer EM, 2007, AIDS, V21, P2131, DOI 10.1097/QAD.0b013e3282a4a632; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Shen XY, 2009, J VIROL, V83, P3617, DOI 10.1128/JVI.02631-08; Singh H, 2011, AIDS, V25, P1247, DOI 10.1097/QAD.0b013e32834785cf; Srivastava IK, 2002, J VIROL, V76, P2835, DOI 10.1128/JVI.76.6.2835-2847.2002; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Strasz N, 2014, AIDS RES HUM RETROV, V30, P498, DOI [10.1089/aid.2013.0191, 10.1089/AID.2013.0191]; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Toukam DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038068; Verkoczy L, 2010, P NATL ACAD SCI USA, V107, P181, DOI 10.1073/pnas.0912914107; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018233; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 1996, EMBO J, V15, P1507, DOI 10.1002/j.1460-2075.1996.tb00494.x; Weissenhorn W, 1997, P NATL ACAD SCI USA, V94, P6065, DOI 10.1073/pnas.94.12.6065; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Ye L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014813; Yi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072205; Zhang HT, 2004, J VIROL, V78, P8342, DOI 10.1128/jvi.78.15.8342-8348.2004; Zhou MK, 2012, VACCINE, V30, P1911, DOI 10.1016/j.vaccine.2012.01.026; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	117	26	30	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29912	29926		10.1074/jbc.M114.569566	http://dx.doi.org/10.1074/jbc.M114.569566			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25160627	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000344370800034
J	Spencer, ALM; Bagai, I; Becker, DF; Zuiderweg, ERP; Ragsdale, SW				Spencer, Andrea L. M.; Bagai, Ireena; Becker, Donald F.; Zuiderweg, Erik R. P.; Ragsdale, Stephen W.			Protein/Protein Interactions in the Mammalian Heme Degradation Pathway HEME OXYGENASE-2, CYTOCHROME P450 REDUCTASE, AND BILIVERDIN REDUCTASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytochrome P450; Electron Transfer Complex; Enzyme Kinetics; Enzyme Mechanism; Heme Oxygenase; Nuclear Magnetic Resonance (NMR); Protein; Protein Interaction	THIOL/DISULFIDE REDOX SWITCH; OXYGENASE SYSTEM; PROTEIN INTERACTIONS; REGULATORY MOTIFS; CYSTEINE RESIDUES; CARBON-MONOXIDE; IX-ALPHA; BINDING; GENE; FORM	Background: Heme oxygenase, cytochrome P450 reductase, and biliverdin reductase are the key enzymes in heme degradation. Results: Specific electrostatic and hydrophobic interactions form the binding interface between heme oxygenase and cytochrome P450 reductase. Conclusion: Heme oxygenase binds cytochrome P450 reductase dynamically and biliverdin reductase very weakly. Significance: Characterizing interactions among proteins involved in heme degradation are crucial to understanding heme homeostasis. Heme oxygenase (HO) catalyzes the rate-limiting step in the O-2-dependent degradation of heme to biliverdin, CO, and iron with electrons delivered from NADPH via cytochrome P450 reductase (CPR). Biliverdin reductase (BVR) then catalyzes conversion of biliverdin to bilirubin. We describe mutagenesis combined with kinetic, spectroscopic (fluorescence and NMR), surface plasmon resonance, cross-linking, gel filtration, and analytical ultracentrifugation studies aimed at evaluating interactions of HO-2 with CPR and BVR. Based on these results, we propose a model in which HO-2 and CPR form a dynamic ensemble of complex(es) that precede formation of the productive electron transfer complex. The H-1-N-15 TROSY NMR spectrum of HO-2 reveals specific residues, including Leu-201, near the heme face of HO-2 that are affected by the addition of CPR, implicating these residues at the HO/CPR interface. Alanine substitutions at HO-2 residues Leu-201 and Lys-169 cause a respective 3- and 22-fold increase in K-m values for CPR, consistent with a role for these residues in CPR binding. Sedimentation velocity experiments confirm the transient nature of the HO-2CPR complex (K-d = 15.1 m). Our results also indicate that HO-2 and BVR form a very weak complex that is only captured by cross-linking. For example, under conditions where CPR affects the H-1-N-15 TROSY NMR spectrum of HO-2, BVR has no effect. Fluorescence quenching experiments also suggest that BVR binds HO-2 weakly, if at all, and that the previously reported high affinity of BVR for HO is artifactual, resulting from the effects of free heme (dissociated from HO) on BVR fluorescence.	[Spencer, Andrea L. M.; Ragsdale, Stephen W.] Univ Michigan, Cellular & Mol Biol Training Program, Ann Arbor, MI 48103 USA; [Bagai, Ireena; Zuiderweg, Erik R. P.; Ragsdale, Stephen W.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48103 USA; [Becker, Donald F.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Lincoln	Zuiderweg, ERP (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	zuiderwe@umich.edu; sragsdal@umich.edu			National Institutes of Health [HL 102662A, P30GM103335, GM061068, T32GM007215]; National Science Foundation [DBI-0619764]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010266, R01HL102662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315, T32GM007215, R01GM061068, P30GM103335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 102662A (to S. W. R.) and P30GM103335 and GM061068 (to D. B.). This work was also supported by National Science Foundation Grant DBI-0619764 (to D. B.). The stipend for A. L. M. S. was supported in part by National Institutes of Health Grant T32GM007215.	Ahmad Z, 2002, J BIOL CHEM, V277, P9226, DOI 10.1074/jbc.M108239200; Andresen C, 2012, NUCLEIC ACIDS RES, V40, P6353, DOI 10.1093/nar/gks263; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Bianchetti CM, 2007, J BIOL CHEM, V282, P37624, DOI 10.1074/jbc.M707396200; Carrington A., 1967, INTRO MAGNETIC RESON; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Crowley PB, 2003, ACCOUNTS CHEM RES, V36, P723, DOI 10.1021/ar0200955; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; ENOCH HG, 1979, J BIOL CHEM, V254, P8976; Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1; GODDARD TD, 2008, SPARKY 3 VERSION 3 1; Hanafy KA, 2013, CURR PHARM DESIGN, V19, P2771; Hayashi S, 2004, GENE, V336, P241, DOI 10.1016/j.gene.2004.04.002; Higashimoto Y, 2005, J BIOL CHEM, V280, P729, DOI 10.1074/jbc.M406203200; Higashimoto Y, 2008, BIOCHEM BIOPH RES CO, V367, P852, DOI 10.1016/j.bbrc.2008.01.016; Huang TJ, 2001, ANTIOXID REDOX SIGN, V3, P685, DOI 10.1089/15230860152543023; Huber WJ, 2009, DRUG METAB DISPOS, V37, P857, DOI 10.1124/dmd.108.025023; Ishikawa K, 1998, J BIOL CHEM, V273, P4317, DOI 10.1074/jbc.273.8.4317; ISHIKAWA K, 1995, J BIOL CHEM, V270, P6345, DOI 10.1074/jbc.270.11.6345; Jansen T, 2010, J MOL CELL CARDIOL, V49, P186, DOI 10.1016/j.yjmcc.2010.04.011; Kenaan C, 2011, BIOCHEMISTRY-US, V50, P3957, DOI 10.1021/bi1020748; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; KUTTY RK, 1981, J BIOL CHEM, V256, P3956; Lerner-Marmarosh N, 2005, P NATL ACAD SCI USA, V102, P7109, DOI 10.1073/pnas.0502173102; Lerner-Marmarosh N, 2008, P NATL ACAD SCI USA, V105, P6870, DOI 10.1073/pnas.0800750105; Linnenbaum M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035483; Liu Y, 2000, J BIOL CHEM, V275, P5297, DOI 10.1074/jbc.275.8.5297; Maines MD, 2005, ANTIOXID REDOX SIGN, V7, P1761, DOI 10.1089/ars.2005.7.1761; Maines MD, 2004, ANTIOXID REDOX SIGN, V6, P797, DOI 10.1089/1523086041798105; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MAINES MD, 1993, MOL CELL NEUROSCI, V4, P389, DOI 10.1006/mcne.1993.1049; Maines MD, 2001, J PHARMACOL EXP THER, V296, P1091; Marohnic CC, 2006, J BIOL CHEM, V281, P35975, DOI 10.1074/jbc.M607095200; Matsui T, 2010, ACCOUNTS CHEM RES, V43, P240, DOI 10.1021/ar9001685; MCCOUBREY WK, 1994, EUR J BIOCHEM, V222, P597, DOI 10.1111/j.1432-1033.1994.tb18902.x; McCoubrey WK, 1997, EUR J BIOCHEM, V247, P725, DOI 10.1111/j.1432-1033.1997.00725.x; Miralem T, 2005, J BIOL CHEM, V280, P17084, DOI 10.1074/jbc.M413121200; ONO T, 1975, J BIOL CHEM, V250, P1571; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; QUENOUILLE MH, 1956, BIOMETRIKA, V43, P353; Sambrook J., 2001, MOL CLONING LAB MANU; Sassa S, 2004, ANTIOXID REDOX SIGN, V6, P819, DOI 10.1089/ars.2004.6.819; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sedlak TW, 2009, P NATL ACAD SCI USA, V106, P5171, DOI 10.1073/pnas.0813132106; Strobel Henry W., 1995, P225; Sugishima M, 2014, P NATL ACAD SCI USA, V111, P2524, DOI 10.1073/pnas.1322034111; Tanford C, 1963, PHYS CHEM MACROMOLEC; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Tudor C, 2008, BIOCHEM J, V413, P405, DOI 10.1042/BJ20080018; Ubbink M, 2009, FEBS LETT, V583, P1060, DOI 10.1016/j.febslet.2009.02.046; Varfaj F, 2012, J BIOL CHEM, V287, P35181, DOI 10.1074/jbc.M112.378042; Wang JL, 2003, J BIOL CHEM, V278, P20069, DOI 10.1074/jbc.M300989200; WILLIAMS CH, 1962, J BIOL CHEM, V237, P587; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; Yi L, 2009, J BIOL CHEM, V284, P20556, DOI 10.1074/jbc.M109.015651; YOSHIDA T, 1980, FEBS LETT, V115, P278, DOI 10.1016/0014-5793(80)81186-0; Zuiderweg ERP, 2012, RSC BIOMOL SCI, V25, P216, DOI 10.1039/9781849735391-00216; ZUIDERWEG ERP, 1981, EUR J BIOCHEM, V118, P95, DOI 10.1111/j.1432-1033.1981.tb05490.x	64	28	30	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29836	29858		10.1074/jbc.M114.582783	http://dx.doi.org/10.1074/jbc.M114.582783			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25196843	Green Published, hybrid			2022-12-28	WOS:000344370800029
J	Wang, L; Dai, W; Lu, L				Wang, Ling; Dai, Wei; Lu, Luo			Osmotic Stress-induced Phosphorylation of H2AX by Polo-like Kinase 3 Affects Cell Cycle Progression in Human Corneal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Cornea; Epithelial Cell; H2A Histone Family; Member X (H2AFX); Phosphorylation; Signaling	DOUBLE-STRAND BREAKS; DNA TOPOISOMERASE-I; SERINE/THREONINE KINASE; HYPEROSMOTIC STRESS; PLK3 FUNCTIONS; HISTONE H2AX; ACTIVATION; APOPTOSIS; PATHWAY; ATM	Background: To study Plk3-activated H2AX affecting hyperosmotic stress-induced cell fate. Results: Plk3 directly catalyzed H2AX in hyperosmotic stress-induced cells, resulting in an accumulation of G(2)/M phase, altered population in the G(1) and S phases, and increased apoptosis. Conclusion: Hyperosmotic stress-activated Plk3 elicited H2AX, which regulates cell cycle progression and cell fate. Significance: Plk3-mediated H2AX in stress-induced cells plays important roles to determine cell growth and death. Increased concentrations of extracellular solutes affect cell function and fate by stimulating cellular responses, such as evoking MAPK cascades, altering cell cycle progression, and causing apoptosis. Our study results here demonstrate that hyperosmotic stress induced H2AX phosphorylation (H2AX) by an unrevealed kinase cascade involving polo-like kinase 3 (Plk3) in human corneal epithelial (HCE) cells. We found that hyperosmotic stress induced DNA-double strand breaks and increased H2AX in HCE cells. Phosphorylation of H2AX at serine 139 was catalyzed by hyperosmotic stress-induced activation of Plk3. Plk3 directly interacted with H2AX and was colocalized with H2AX in the nuclei of hyperosmotic stress-induced cells. Suppression of Plk3 activity by overexpression of a kinase-silencing mutant or by knocking down Plk3 mRNA effectively reduced H2AX in hyperosmotic stress-induced cells. This was consistent with results that show H2AX was markedly suppressed in the Plk3(-/-) knock-out mouse corneal epithelial layer in response to hyperosmotic stimulation. The effect of hyperosmotic stress-activated Plk3 and increased H2AX in cell cycle progression showed an accumulation of G(2)/M phase, altered population in G(1) and S phases, and increased apoptosis. Our results for the first time reveal that hyperosmotic stress-activated Plk3 elicited H2AX. This Plk3-mediated activation of H2AX subsequently regulates the cell cycle progression and cell fate.	[Wang, Ling; Lu, Luo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA 90502 USA; [Dai, Wei] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York University	Lu, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, 1124 W Carson St,H-H Bldg, Torrance, CA 90502 USA.	lluou@ucla.edu		Dai, Wei/0000-0003-0169-8327	National Institutes of Health [EY 022364, CA074229]; NATIONAL CANCER INSTITUTE [R01CA074229, R01CA150512] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022364] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported, in whole or in part, by National Institutes of Health Grants EY 022364 (to L. L.) and CA074229 (to W.D.).	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Bahassi EM, 2006, MUTAT RES-FUND MOL M, V596, P166, DOI 10.1016/j.mrfmmm.2005.12.002; Bahassi EM, 2002, ONCOGENE, V21, P6633, DOI 10.1038/sj.onc.1205850; Bin OY, 1997, J BIOL CHEM, V272, P28646, DOI 10.1074/jbc.272.45.28646; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Corrales RM, 2008, CORNEA, V27, P574, DOI 10.1097/ICO.0b013e318165b19e; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; DEUTSCH C, 1982, BIOCHIM BIOPHYS ACTA, V721, P262, DOI 10.1016/0167-4889(82)90078-7; DONOHUE PJ, 1995, J BIOL CHEM, V270, P10351, DOI 10.1074/jbc.270.17.10351; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Foulks GN, 2007, SURV OPHTHALMOL, V52, P369, DOI 10.1016/j.survophthal.2007.04.009; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; Huang ZB, 2004, J PHYSIOL-LONDON, V558, P181, DOI 10.1113/jphysiol.2004.065540; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Ito T, 2005, AM J PHYSIOL-REG I, V289, pR432, DOI 10.1152/ajpregu.00027.2004; Jiang N, 2006, J BIOL CHEM, V281, P10577, DOI 10.1074/jbc.M513156200; Kurose A, 2005, CYTOM PART A, V68A, P1, DOI 10.1002/cyto.a.20186; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Li B, 1996, J BIOL CHEM, V271, P19402, DOI 10.1074/jbc.271.32.19402; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lunn JA, 2007, J BIOL CHEM, V282, P10370, DOI 10.1074/jbc.M607780200; Mitono H, 2005, J APPL PHYSIOL, V99, P902, DOI 10.1152/japplphysiol.00156.2005; Nakamura Y, 1998, NAT MED, V4, P1231, DOI 10.1038/3207; Pehrson JR, 1998, NUCLEIC ACIDS RES, V26, P2837, DOI 10.1093/nar/26.12.2837; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Sheikh-Hamad D, 2004, AM J PHYSIOL-RENAL, V287, pF1102, DOI 10.1152/ajprenal.00225.2004; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P174, DOI 10.1093/nar/22.2.174; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Wang L, 2008, J BIOL CHEM, V283, P25928, DOI 10.1074/jbc.M801326200; Wang L, 2007, J BIOL CHEM, V282, P32121, DOI 10.1074/jbc.M702791200; Wang L, 2007, INVEST OPHTH VIS SCI, V48, P652, DOI 10.1167/iovs.06-1007; Wang L, 2011, INVEST OPHTH VIS SCI, V52, P3200, DOI 10.1167/iovs.10-6485; Wang L, 2011, J BIOL CHEM, V286, P1951, DOI 10.1074/jbc.M110.166009; WEST MHP, 1980, BIOCHEMISTRY-US, V19, P3238, DOI 10.1021/bi00555a022; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Westphal CH, 1997, CURR BIOL, V7, pR789, DOI 10.1016/S0960-9822(06)00406-4; Wu SG, 1998, NEPHRON, V78, P28, DOI 10.1159/000044878; Xie SQ, 2005, ONCOGENE, V24, P277, DOI 10.1038/sj.onc.1208218; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Xie SQ, 2001, J BIOL CHEM, V276, P36194, DOI 10.1074/jbc.M104157200; Xu DZ, 2010, J BIOL CHEM, V285, P38944, DOI 10.1074/jbc.M110.160325; Yu SP, 2000, P NATL ACAD SCI USA, V97, P9360, DOI 10.1073/pnas.97.17.9360	51	16	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29827	29835		10.1074/jbc.M114.597161	http://dx.doi.org/10.1074/jbc.M114.597161			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25202016	hybrid, Green Published			2022-12-28	WOS:000344370800028
J	Zhao, XQ; Zhu, LL; Chang, Q; Jiang, CY; You, Y; Luo, TM; Jia, XM; Lin, X				Zhao, Xue-Qiang; Zhu, Le-Le; Chang, Qing; Jiang, Changying; You, Yun; Luo, Tianming; Jia, Xin-Ming; Lin, Xin			C-type Lectin Receptor Dectin-3 Mediates Trehalose 6,6 '-Dimycolate (TDM)-induced Mincle Expression through CARD9/Bcl10/MALT1-dependent Nuclear Factor (NF)-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Innate Immunity; Lectin; NF-kappa B (NF-B); NF-B Transcription Factor; Signal Transduction	NF-KAPPA-B; INNATE IMMUNE; ANTIFUNGAL IMMUNITY; CANDIDA-ALBICANS; CORD FACTOR; SYK KINASE; CELLS; RECOGNITION; INFECTION; RESPONSES	Background: Recent studies suggest that Mincle expression is induced by Dectin-3-mediated signaling in response to TDM stimulation. Results: Deficiency in Dectin-3 and the CARD9-Bcl10-Malt1 complex are defective for TDM-induced NF-B activation and Mincle. Conclusion: Dectin-3- and CARD9/Bcl10/Malt1-dependent NF-B activation plays an essential role for TDM-induced Mincle expression. Significance: This study provides the molecular insight for designing adjuvants that stimulate the immune system. Previous studies indicate that both Dectin-3 (also called MCL or Clec4d) and Mincle (also called Clec4e), two C-type lectin receptors, can recognize trehalose 6,6-dimycolate (TDM), a cell wall component from mycobacteria, and induce potent innate immune responses. Interestingly, stimulation of Dectin-3 by TDM can also induce Mincle expression, which may enhance the host innate immune system to sense Mycobacterium infection. However, the mechanism by which Dectin-3 induces Mincle expression is not fully defined. Here, we show that TDM-induced Mincle expression is dependent on Dectin-3-mediated NF-B, but not nuclear factor of activated T-cells (NFAT), activation, and Dectin-3 induces NF-B activation through the CARD9-BCL10-MALT1 complex. We found that bone marrow-derived macrophages from Dectin-3-deficient mice were severely defective in the induction of Mincle expression in response to TDM stimulation. This defect is correlated with the failure of TDM-induced NF-B activation in Dectin-3-deficient bone marrow-derived macrophages. Consistently, inhibition of NF-B, but not NFAT, impaired TDM-induced Mincle expression, whereas NF-B, but not NFAT, binds to the Mincle promoter. Dectin-3-mediated NF-B activation is dependent on the CARD9-Bcl10-MALT1 complex. Finally, mice deficient for Dectin-3 or CARD9 produced much less proinflammatory cytokines and keyhole limpet hemocyanin (KLH)-specific antibodies after immunization with an adjuvant containing TDM. Overall, this study provides the mechanism by which Dectin-3 induces Mincle expression in response to Mycobacterium infection, which will have significant impact to improve adjuvant and design vaccine for antimicrobial infection.	[Zhao, Xue-Qiang; Jiang, Changying; You, Yun; Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Zhao, Xue-Qiang; Jiang, Changying; You, Yun; Lin, Xin] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Zhu, Le-Le; Jia, Xin-Ming] Tongji Univ, Sch Med, Dept Immunol, Shanghai 200092, Peoples R China; [Chang, Qing; Luo, Tianming] Tsinghua Univ, Sch Med, Inst Immunol, Beijing 100084, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tongji University; Tsinghua University	Jia, XM (corresponding author), Tongji Univ, Sch Med, Dept Immunol, Shanghai 200092, Peoples R China.	jiaxm@tongji.edu.cn; xllin@mdanderson.org	ZHU, LELE/AAP-9075-2020; Jiang, Changying/AAL-3711-2020	ZHU, LELE/0000-0002-1732-8753; Jiang, Changying/0000-0003-3778-4438; CHANG, QING/0000-0002-9259-7734	Shanghai Basic Research Program [12JC1408401]; National Institutes of Health [R01 AI050848, R01 GM065899]; Center for Inflammation and Cancer of the MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065899] Funding Source: NIH RePORTER	Shanghai Basic Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Inflammation and Cancer of the MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by The Shanghai Basic Research Program Grant 12JC1408401 (to X. M. J.) and National Institutes of Health Grants R01 AI050848 and R01 GM065899 and a pilot grant from the Center for Inflammation and Cancer of the MD Anderson Cancer Center (to X. L.).	Arce I, 2004, EUR J IMMUNOL, V34, P210, DOI 10.1002/eji.200324230; Behler F, 2012, J IMMUNOL, V189, P3121, DOI 10.4049/jimmunol.1201399; Blonska M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004273; Blonska M, 2012, J IMMUNOL, V188, P3160, DOI 10.4049/jimmunol.1102943; Desel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053531; Drummond RA, 2011, EUR J IMMUNOL, V41, P276, DOI 10.1002/eji.201041252; Feinberg H, 2013, J BIOL CHEM, V288, P28457, DOI 10.1074/jbc.M113.497149; Gorjestani S, 2012, J BIOL CHEM, V287, P44143, DOI 10.1074/jbc.M112.414276; Graham LM, 2012, J BIOL CHEM, V287, P25964, DOI 10.1074/jbc.M112.384164; Graham LM, 2009, CYTOKINE, V48, P148, DOI 10.1016/j.cyto.2009.07.010; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Kerscher B, 2013, INT IMMUNOL, V25, P271, DOI 10.1093/intimm/dxt006; Kingeter LM, 2012, CELL MOL IMMUNOL, V9, P105, DOI 10.1038/cmi.2011.58; Lang R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00005; Liu XK, 2013, J EXP MED, V210, P1575, DOI 10.1084/jem.20122327; Lobato-Pascual A, 2013, EUR J IMMUNOL, V43, P3167, DOI 10.1002/eji.201343752; Marakalala MJ, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/567571; Masumoto M, 1999, J IMMUNOL, V163, P5039; Matsunaga I, 2009, J EXP MED, V206, P2865, DOI 10.1084/jem.20092533; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Nurieva RI, 2012, J BIOL CHEM, V287, P11234, DOI 10.1074/jbc.M111.324046; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Shenderov K, 2013, J IMMUNOL, V190, P5722, DOI 10.4049/jimmunol.1203343; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Vautier S, 2012, CYTOKINE, V58, P89, DOI 10.1016/j.cyto.2011.08.031; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Zhu LL, 2013, IMMUNITY, V39, P324, DOI 10.1016/j.immuni.2013.05.017	34	72	75	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					30052	30062		10.1074/jbc.M114.588574	http://dx.doi.org/10.1074/jbc.M114.588574			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25202022	Green Published, hybrid			2022-12-28	WOS:000344370800045
J	Da-Re, C; von Stockum, S; Biscontin, A; Millino, C; Cisotto, P; Zordan, MA; Zeviani, M; Bernardi, P; De Pitta, C; Costa, R				Da-Re, Caterina; von Stockum, Sophia; Biscontin, Alberto; Millino, Caterina; Cisotto, Paola; Zordan, Mauro A.; Zeviani, Massimo; Bernardi, Paolo; De Pitta, Cristiano; Costa, Rodolfo			Leigh Syndrome in Drosophila melanogaster MORPHOLOGICAL AND BIOCHEMICAL CHARACTERIZATION OF Surf1 POST-TRANSCRIPTIONAL SILENCING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; DROSOPHILA-MELANOGASTER HOMOLOG; COMPLEX-I; FUNCTIONAL-CHARACTERIZATION; TRANSLATIONAL REGULATION; BINDING PROTEIN; GENE-EXPRESSION; SURF1 GENE; MUTATIONS; DEFECTS	Leigh Syndrome (LS) is the most common early-onset, progressive mitochondrial encephalopathy usually leading to early death. The single most prevalent cause of LS is occurrence of mutations in the SURF1 gene, and LSSurf1 patients show a ubiquitous and specific decrease in the activity of mitochondrial respiratory chain complex IV (cytochrome c oxidase, COX). SURF1 encodes an inner membrane mitochondrial protein involved in COX assembly. We established a Drosophila melanogaster model of LS based on the post-transcriptional silencing of CG9943, the Drosophila homolog of SURF1. Knockdown of Surf1 was induced ubiquitously in larvae and adults, which led to lethality; in the mesodermal derivatives, which led to pupal lethality; or in the central nervous system, which allowed survival. A biochemical characterization was carried out in knockdown individuals, which revealed that larvae unexpectedly displayed defects in all complexes of the mitochondrial respiratory chain and in the F-ATP synthase, while adults had a COX-selective impairment. Silencing of Surf1 expression in Drosophila S2R(+) cells led to selective loss of COX activity associated with decreased oxygen consumption and respiratory reserve. We conclude that Surf1 is essential for COX activity and mitochondrial function in D. melanogaster, thus providing a new tool that may help clarify the pathogenic mechanisms of LS.	[Da-Re, Caterina; Biscontin, Alberto; Cisotto, Paola; Zordan, Mauro A.; De Pitta, Cristiano; Costa, Rodolfo] Univ Padua, Dept Biol, I-35121 Padua, Italy; [von Stockum, Sophia; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Millino, Caterina] Univ Padua, CRIBI Biotechnol Ctr, I-35121 Padua, Italy; [Zeviani, Massimo] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge CB2 0XY, England	University of Padua; University of Padua; University of Padua; University of Cambridge	De Pitta, C (corresponding author), Univ Padua, Dept Biol, Viale Giuseppe Colombo 3, I-35121 Padua, Italy.	cristiano.depitta@unipd.it; rodolfo.costa@unipd.it	Zeviani, Massimo/AAU-2632-2021; Bernardi, Paolo/C-3656-2008; De Pitta, Cristiano/AAY-7302-2020	Zeviani, Massimo/0000-0002-9067-5508; Bernardi, Paolo/0000-0001-9187-3736; De Pitta, Cristiano/0000-0001-8013-8162; Biscontin, Alberto/0000-0003-1492-7715	University of Padova (Progetto Strategico di Ateneo: "Models of Mitochondrial Diseases"); Fondazione CARIPLO: Scientific Research in Biomedicine ("MITGEN: Definition and Characterization of Disease Genes in Mitochondrial Disorders"); Telethon Project ("MitMed: a Multicenter Consortium for the Identification and Characterization of Nuclear Genes Responsible for Human Mitochondrial Disorders") [GGP11011]; Medical Research Council [MC_UP_1002/1] Funding Source: researchfish; MRC [MC_UP_1002/1] Funding Source: UKRI	University of Padova (Progetto Strategico di Ateneo: "Models of Mitochondrial Diseases"); Fondazione CARIPLO: Scientific Research in Biomedicine ("MITGEN: Definition and Characterization of Disease Genes in Mitochondrial Disorders"); Telethon Project ("MitMed: a Multicenter Consortium for the Identification and Characterization of Nuclear Genes Responsible for Human Mitochondrial Disorders")(Fondazione Telethon); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by grants from the University of Padova (Progetto Strategico di Ateneo: 2008: "Models of Mitochondrial Diseases") (to P. B. and R. C.); Fondazione CARIPLO: Scientific Research in Biomedicine 2011 ("MITGEN: Definition and Characterization of Disease Genes in Mitochondrial Disorders") (to M. Z. and R. C.); Telethon Project N. GGP11011 ("MitMed: a Multicenter Consortium for the Identification and Characterization of Nuclear Genes Responsible for Human Mitochondrial Disorders") (to M. Z. and R. C.).	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038; Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Baumbach J, 2014, CELL METAB, V19, P331, DOI 10.1016/j.cmet.2013.12.004; Bestwick M, 2010, MOL CELL BIOL, V30, P4480, DOI 10.1128/MCB.00228-10; Boistau B. M., 2005, BIOINFORMATICS, V19, P185; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bruno C, 2002, J CHILD NEUROL, V17, P233, DOI 10.1177/088307380201700318; Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309; Chen JQ, 2009, BBA-MOL CELL RES, V1793, P1540, DOI 10.1016/j.bbamcr.2009.06.001; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Da-Re C, 2014, EMBO REP, V15, P586, DOI 10.1002/embr.201337972; Da-Re C, 2014, J BIOL CHEM, V289, P7448, DOI 10.1074/jbc.M113.543926; Deepa SS, 2013, FASEB J, V27, P1371, DOI 10.1096/fj.12-221879; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Dieteren CEJ, 2008, J BIOL CHEM, V283, P34753, DOI 10.1074/jbc.M807323200; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; DIMAURO S, 1988, J BIOENERG BIOMEMBR, V20, P353, DOI 10.1007/BF00769637; Farina L, 2002, AM J NEURORADIOL, V23, P1095; Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Flockhart IT, 2012, NUCLEIC ACIDS RES, V40, pD715, DOI 10.1093/nar/gkr953; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4; Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761; Giuliani G, 2014, NUCLEIC ACIDS RES, V42, P1970, DOI 10.1093/nar/gkt1118; Herrmann JM, 2005, GENE, V354, P43, DOI 10.1016/j.gene.2005.03.017; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Lazarou M, 2009, FEBS J, V276, P6701, DOI 10.1111/j.1742-4658.2009.07384.x; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; Lin AL, 2013, J CEREBR BLOOD F MET, V33, P1605, DOI 10.1038/jcbfm.2013.116; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Nijtmans LGJ, 2001, FEBS LETT, V498, P46, DOI 10.1016/S0014-5793(01)02447-4; Oliveira MT, 2011, J BIOL CHEM, V286, P40649, DOI 10.1074/jbc.M111.289983; Pequignot MO, 2001, HUM MUTAT, V17, P374, DOI 10.1002/humu.1112.abs; Poyau A, 1999, FEBS LETT, V462, P416, DOI 10.1016/S0014-5793(99)01571-9; Reinhold R, 2011, HUM MOL GENET, V20, P2379, DOI 10.1093/hmg/ddr145; Rinaldi T, 2010, FEMS YEAST RES, V10, P1006, DOI 10.1111/j.1567-1364.2010.00685.x; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sales G, 2013, NUCLEIC ACIDS RES, V41, pW89, DOI 10.1093/nar/gkt386; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Suthammarak W, 2010, J BIOL CHEM, V285, P40724, DOI 10.1074/jbc.M110.159608; Taanman JW, 1997, J BIOENERG BIOMEMBR, V29, P151, DOI 10.1023/A:1022638013825; Tiranti V, 1999, ANN NEUROL, V46, P161, DOI 10.1002/1531-8249(199908)46:2<161::AID-ANA4>3.0.CO;2-O; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0; Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006; Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541; YAO KM, 1994, J NEUROCHEM, V63, P41; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zara V, 2009, FEBS J, V276, P1900, DOI 10.1111/j.1742-4658.2009.06916.x; Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259; Zeviani M, 1999, ITAL J NEUROL SCI, V20, P401; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804; Zordan MA, 2006, GENETICS, V172, P229, DOI 10.1534/genetics.105.049072	64	15	15	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29235	29246		10.1074/jbc.M114.602938	http://dx.doi.org/10.1074/jbc.M114.602938			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25164807	Green Published, hybrid			2022-12-28	WOS:000344141000038
J	Poirier, V; Bach, H; Av-Gay, Y				Poirier, Valerie; Bach, Horacio; Av-Gay, Yossef			Mycobacterium tuberculosis Promotes Anti-apoptotic Activity of the Macrophage by PtpA Protein-dependent Dephosphorylation of Host GSK3 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; INFECTION; CELL; ACTIVATION; PHAGOSOME; PHOSPHORYLATION; ACIDIFICATION; INHIBITION; BIOGENESIS; RECEPTOR	Mycobacterium tuberculosis tyrosine phosphatase PtpA inhibits two key cellular events in macrophages required for the elimination of invading organisms, phagosome acidification, and maturation. Kinome analysis revealed multiple PtpA-dependent changes to the phosphorylation status of macrophage proteins upon M. tuberculosis infection. Among those proteins we show that PtpA dephosphorylates GSK3 alpha on amino acid Tyr(279), which leads to modulation of GSK3 alpha anti-apoptotic activity, promoting pathogen survival early during infection.	[Poirier, Valerie; Bach, Horacio; Av-Gay, Yossef] Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC V6H 3Z6, Canada	University of British Columbia	Av-Gay, Y (corresponding author), Univ British Columbia, Dept Med, Div Infect Dis, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada.	yossi@mail.ubc.ca	Av-Gay, Yossef/H-5128-2019	Av-Gay, Yossef/0000-0002-9547-0237	Canadian Institutes of Health Research Operating Grant [MOP-106622]	Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Operating Grant MOP-106622 (to Y. A.-G.).	ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Bach H, 2006, INFECT IMMUN, V74, P6540, DOI 10.1128/IAI.01106-06; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DOLIN PJ, 1994, B WORLD HEALTH ORGAN, V72, P213; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Fratazzi C, 1997, J IMMUNOL, V158, P4320; Hackam DJ, 1997, J BIOL CHEM, V272, P29810, DOI 10.1074/jbc.272.47.29810; Hestvik ALK, 2005, FEMS MICROBIOL REV, V29, P1041, DOI 10.1016/j.femsre.2005.04.013; Hestvik ALK, 2003, INFECT IMMUN, V71, P5514, DOI 10.1128/IAI.71.10.5514-5522.2003; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; HOFLACK B, 1985, P NATL ACAD SCI USA, V82, P4428, DOI 10.1073/pnas.82.13.4428; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Karim AF, 2011, J BIOL CHEM, V286, P40307, DOI 10.1074/jbc.M111.266239; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Oddo M, 1998, J IMMUNOL, V160, P5448; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Pelech S., 2002, SCI STKE, V162, ppe50; PLYTE SE, 1992, BIOCHIM BIOPHYS ACTA, V1114, P147, DOI 10.1016/0304-419X(92)90012-N; Poirier V, 2012, MICROBES INFECT, V14, P1211, DOI 10.1016/j.micinf.2012.07.001; Riendeau CJ, 2003, INFECT IMMUN, V71, P254, DOI 10.1128/IAI.71.1.254-259.2003; SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x; Wang ZB, 2005, CELL BIOL INT, V29, P489, DOI 10.1016/j.cellbi.2005.04.001; Wong D, 2013, TRENDS MICROBIOL, V21, P100, DOI 10.1016/j.tim.2012.09.002; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; XU SM, 1994, J IMMUNOL, V153, P2568; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406	34	38	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29376	29385		10.1074/jbc.M114.582502	http://dx.doi.org/10.1074/jbc.M114.582502			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25187516	Green Published, hybrid			2022-12-28	WOS:000344141000049
J	Goncalves, VL; Vicente, JB; Pinto, L; Romao, CV; Frazao, C; Sarti, P; Giuffre, A; Teixeira, M				Goncalves, Vera L.; Vicente, Joao B.; Pinto, Liliana; Romao, Celia V.; Frazao, Carlos; Sarti, Paolo; Giuffre, Alessandro; Teixeira, Miguel			Flavodiiron Oxygen Reductase from Entamoeba histolytica MODULATION OF SUBSTRATE PREFERENCE BY TYROSINE 271 AND LYSINE 53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE REDUCTASE; FLAVO-DIIRON PROTEIN; ESCHERICHIA-COLI FLAVORUBREDOXIN; PARASITE GIARDIA-INTESTINALIS; ENTERICA SEROVAR TYPHIMURIUM; CYTOCHROME-C-OXIDASE; MOORELLA-THERMOACETICA; ENTAMOEBA-HISTOLYTICA; DESULFOVIBRIO-GIGAS; ACTIVE-SITE	Flavodiiron proteins (FDPs) are a family of enzymes endowed with bona fide oxygen- and/or nitric-oxide reductase activity, although their substrate specificity determinants remain elusive. After a comprehensive comparison of available three-dimensional structures, particularly of FDPs with a clear preference toward either O-2 or NO, two main differences were identified near the diiron active site, which led to the construction of site-directed mutants of Tyr(271) and Lys(53) in the oxygen reducing Entamoeba histolytica EhFdp1. The biochemical and biophysical properties of these mutants were studied by UV-visible and electron paramagnetic resonance (EPR) spectroscopies coupled to potentiometry. Their reactivity with O-2 and NO was analyzed by stopped-flow absorption spectroscopy and amperometric methods. These mutations, whereas keeping the overall properties of the redox cofactors, resulted in increased NO reductase activity and faster inactivation of the enzyme in the reaction with O-2, pointing to a role of the mutated residues in substrate selectivity.	[Goncalves, Vera L.; Pinto, Liliana; Romao, Celia V.; Frazao, Carlos; Teixeira, Miguel] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2781901 Oeiras, Portugal; [Goncalves, Vera L.; Vicente, Joao B.] Univ Lisbon, Res Inst Med iMed ULisboa, Metab & Genet Grp, Fac Pharm, P-1649003 Lisbon, Portugal; [Vicente, Joao B.] Univ Lisbon, Fac Pharm, Dept Biochem & Human Biol, P-1649003 Lisbon, Portugal; [Sarti, Paolo] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Sarti, Paolo] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Sarti, Paolo; Giuffre, Alessandro] CNR, Inst Biol Mol Med & Nanobiotechnol, I-00185 Rome, Italy	Universidade Nova de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR)	Vicente, JB (corresponding author), Univ Lisbon, Inst Med & Pharmaceut Sci iMed ULisboa, Metab & Genet Grp, Ave Prof Gama Pinto, P-1649003 Lisbon, Portugal.	joaovicente@ff.ul.pt; miguel@itqb.unl.pt	Romao, Celia V/G-7013-2011; Giuffrè, Alessandro/K-4341-2015; Teixeira, Miguel/A-9098-2011; Teixeira, Miguel/M-1509-2019; Vicente, Joao B/L-8732-2016; iMed.ULisboa, MetGen/B-5293-2014; Frazao, Carlos/C-1965-2008	Romao, Celia V/0000-0002-9474-2405; Giuffrè, Alessandro/0000-0001-5301-0681; Teixeira, Miguel/0000-0003-4124-6237; Teixeira, Miguel/0000-0003-4124-6237; Frazao, Carlos/0000-0002-7725-1671; Vicente, Joao/0000-0001-5244-8059; Sarti, Paolo/0000-0002-8219-4827	Portuguese Fundacao para a Ciencia e Tecnologia [PTDC/QUI-BIQ/111080/2009, PTDC/SAU-MIC/111447/2009]; Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (PNR-CNR Aging Program) [PTDC/QUI-BIQ/111080/2009, PTDC/SAU-MIC/111447/2009, SFRH/BPD/94050/2013]; Fondo per gli Investimenti della Ricerca di Base [RBIN06E9Z8, PRIN 20107Z8XBW_005]; Fundacao para a Ciencia e Tecnologia-Consiglio Nazionale delle Ricerche Portugal-Italy bilateral project; Federation of the European Biochemical Societies	Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (PNR-CNR Aging Program); Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Fundacao para a Ciencia e Tecnologia-Consiglio Nazionale delle Ricerche Portugal-Italy bilateral project; Federation of the European Biochemical Societies	This work was supported by the Portuguese Fundacao para a Ciencia e Tecnologia project Grants PTDC/QUI-BIQ/111080/2009 and PTDC/SAU-MIC/111447/2009 (to J. B. V. and M. T.), Grants SFRH/BPD/94050/2013 (to C. V. R.), PEST-OE/EQB/LA0004/2013, PEST-OE/SAU/UI4013/2011 from the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (PNR-CNR Aging Program 2012-2014 (to A. G.), Fondo per gli Investimenti della Ricerca di Base Grants RBIN06E9Z8 and PRIN 20107Z8XBW_005 (to P. S.), and grants from the Fundacao para a Ciencia e Tecnologia-Consiglio Nazionale delle Ricerche Portugal-Italy bilateral project (to A. G. and M. T.), and a Federation of the European Biochemical Societies short-term fellowship (to J. B. V.).	Allahverdiyeva Y, 2011, J BIOL CHEM, V286, P24007, DOI 10.1074/jbc.M111.223289; Baptista JM, 2012, J BACTERIOL, V194, P3611, DOI 10.1128/JB.00140-12; Beckman JS, 1996, METHODS NITRIC OXIDE, P61; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Caranto JD, 2014, J AM CHEM SOC, V136, P7981, DOI 10.1021/ja5022443; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Di Matteo A, 2008, J BIOL CHEM, V283, P4061, DOI 10.1074/jbc.M705605200; Ducluzeau AL, 2009, TRENDS BIOCHEM SCI, V34, P9, DOI 10.1016/j.tibs.2008.10.005; Ermakova M, 2013, FEBS LETT, V587, P82, DOI 10.1016/j.febslet.2012.11.006; Fang H, 2012, J BIOL INORG CHEM, V17, P1231, DOI 10.1007/s00775-012-0938-4; FISCHER DS, 1964, CLIN CHEM, V10, P21, DOI 10.1016/0009-8981(64)90210-4; Frazao C, 2000, NAT STRUCT BIOL, V7, P1041; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gomes CM, 2002, J BIOL CHEM, V277, P25273, DOI 10.1074/jbc.M203886200; Gomes CM, 2000, BIOCHEMISTRY-US, V39, P16230, DOI 10.1021/bi001844y; Goncalves VL, 2011, BIOENERGETIC PROCESSES OF CYANOBACTERIA: FROM EVOLUTIONARY SINGULARITY TO ECOLOGICAL DIVERSITY, P631, DOI 10.1007/978-94-007-0388-9_22; Goncalves VL, 2011, BIOCHEM SOC T, V39, P216, DOI 10.1042/BST0390216; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; HOSLER JP, 1995, BIOCHEMISTRY-US, V34, P7586, DOI 10.1021/bi00023a004; Justino MC, 2005, J BIOL CHEM, V280, P2636, DOI 10.1074/jbc.M411070200; Kurtz DM, 2007, DALTON T, P4115, DOI 10.1039/b710047g; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Mills PC, 2008, MICROBIOL-SGM, V154, P1218, DOI 10.1099/mic.0.2007/014290-0; Mills PC, 2005, BIOCHEM SOC T, V33, P198, DOI 10.1042/BST0330198; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Pfitzner U, 1998, J BIOENERG BIOMEMBR, V30, P89, DOI 10.1023/A:1020515713103; Rodrigues R, 2006, J BACTERIOL, V188, P2745, DOI 10.1128/JB.188.8.2745-2751.2006; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saraiva LM, 2004, ADV MICROB PHYSIOL, V49, P77, DOI 10.1016/S0065-2911(04)49002-X; Seedorf H, 2007, FEBS J, V274, P1588, DOI 10.1111/j.1742-4658.2007.05706.x; Silaghi-Dumitrescu R, 2005, BIOCHEMISTRY-US, V44, P6492, DOI 10.1021/bi0473049; Silaghi-Dumitrescu R, 2003, BIOCHEMISTRY-US, V42, P2806, DOI 10.1021/bi027253k; Silaghi-Dumitrescu R, 2005, BIOCHEMISTRY-US, V44, P3572, DOI 10.1021/bi0477337; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Smutna T, 2009, EUKARYOT CELL, V8, P47, DOI 10.1128/EC.00276-08; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; SUSIN S, 1993, J BIOL CHEM, V268, P20958; Thomas D. D., 2010, NITRIC OXIDE BIOL PA, P3; Vicente J. B., 2011, ENCY INORGANIC BIOIN, P1; Vicente JB, 2005, J BIOL CHEM, V280, P34599, DOI 10.1074/jbc.M506349200; Vicente JB, 2008, METHOD ENZYMOL, V437, P47, DOI 10.1016/S0076-6879(07)37003-1; Vicente JB, 2008, METHOD ENZYMOL, V437, P21, DOI 10.1016/S0076-6879(07)37002-X; Vicente JB, 2008, METHOD ENZYMOL, V437, P3, DOI 10.1016/S0076-6879(07)37001-8; Vicente JB, 2012, EUKARYOT CELL, V11, P1112, DOI 10.1128/EC.00149-12; Vicente JB, 2009, ARCH BIOCHEM BIOPHYS, V488, P9, DOI 10.1016/j.abb.2009.06.011; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Zhang PP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005331; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	50	16	16	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28260	28270		10.1074/jbc.M114.579086	http://dx.doi.org/10.1074/jbc.M114.579086			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25151360	hybrid, Green Published			2022-12-28	WOS:000343765400022
J	Jia, N; Barclay, WS; Roberts, K; Yen, HL; Chan, RWY; Lam, AKY; Air, G; Peiris, JSM; Dell, A; Nicholls, JM; Haslam, SM				Jia, Nan; Barclay, Wendy S.; Roberts, Kim; Yen, Hui-Ling; Chan, Renee W. Y.; Lam, Alfred K. Y.; Air, Gillian; Peiris, J. S. Malik; Dell, Anne; Nicholls, John M.; Haslam, Stuart M.			Glycomic Characterization of Respiratory Tract Tissues of Ferrets IMPLICATIONS FOR ITS USE IN INFLUENZA VIRUS INFECTION STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A H7N9 VIRUS; RECEPTOR SPECIFICITY; AVIAN INFLUENZA; MASS-SPECTROMETRY; SIALIC-ACID; GUINEA-PIG; TRANSMISSION; HEMAGGLUTININ; GLYCAN; MODEL	The initial recognition between influenza virus and the host cell is mediated by interactions between the viral surface protein hemagglutinin and sialic acid-terminated glycoconjugates on the host cell surface. The sialic acid residues can be linked to the adjacent monosaccharide by alpha 2-3- or alpha 2-6-type glycosidic bonds. It is this linkage difference that primarily defines the species barrier of the influenza virus infection with alpha 2-3 binding being associated with avian influenza viruses and alpha 2-6 binding being associated with human strains. The ferret has been extensively used as an animal model to study the transmission of influenza. To better understand the validity of this model system, we undertook glycomic characterization of respiratory tissues of ferret, which allows a comparison of potential viral receptors to be made between humans and ferrets. To complement the structural analysis, lectin staining experiments were performed to characterize the regional distributions of glycans along the respiratory tract of ferrets. Finally, the binding between the glycans identified and the hemagglutinins of different strains of influenza viruses was assessed by glycan array experiments. Our data indicated that the respiratory tissues of ferret heterogeneously express both alpha 2-3- and alpha 2-6-linked sialic acids. However, the respiratory tissues of ferret also expressed the Sda epitope (NeuAc alpha 2-3( GalNAc beta 1-4) Gal beta 1-4GlcNAc) and sialylated N,N'-diacetyllactosamine(NeuAc alpha 2-6GalNAc beta 1-4GlcNAc), which have not been observed in the human respiratory tract surface epithelium. The presence of the Sda epitope reduces potential binding sites for avian viruses and thus may have implications for the usefulness of the ferret in the study of influenza virus infection.	[Jia, Nan; Dell, Anne; Haslam, Stuart M.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Barclay, Wendy S.; Roberts, Kim] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Infect Dis, London W2 1PG, England; [Yen, Hui-Ling; Chan, Renee W. Y.; Peiris, J. S. Malik] Univ Hong Kong, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China; [Lam, Alfred K. Y.] Griffith Univ, Dept Pathol, Nathan, Qld 4111, Australia; [Air, Gillian] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73126 USA; [Nicholls, John M.] Univ Hong Kong, Dept Pathol, Pokfulam, Hong Kong, Peoples R China	Imperial College London; Imperial College London; University of Hong Kong; Griffith University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Hong Kong	Nicholls, JM (corresponding author), Univ Hong Kong, Dept Pathol, Pokfulam, Hong Kong, Peoples R China.	nicholls@pathology.hku.hk; s.haslam@imperial.ac.uk	Yen, Hui-Ling/C-4501-2009; Jia, Nan/AAG-2775-2020; Yen, Hui-Ling/GNH-5083-2022; Chan, Renee Wan Yi/AAA-6598-2020; Lam, Alfred/C-1652-2008; Peiris, Joseph Sriyal Malik/C-4380-2009; Nicholls, John Malcolm/C-4375-2009	Yen, Hui-Ling/0000-0003-2493-3609; Jia, Nan/0000-0002-6317-269X; Chan, Renee Wan Yi/0000-0001-6485-0926; Lam, Alfred/0000-0003-2771-564X; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Air, Gillian/0000-0001-5724-3108; Nicholls, John Malcolm/0000-0001-7217-7444; Dell, Anne/0000-0003-1380-2347; Barclay, Wendy/0000-0002-3948-0895	Wellcome Trust [082098]; Biotechnology and Biological Sciences Research Council [BB/K016164/1, BB/F008309/1]; University Grants Committee from Government of the Hong Kong Special Administrative Region [AoE/M-12/96]; BBSRC [BB/F008309/1, BB/K016164/1] Funding Source: UKRI; National Centre for the Replacement [G1000033/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050933] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University Grants Committee from Government of the Hong Kong Special Administrative Region; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Centre for the Replacement; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grant 082098 from the Wellcome Trust (to S. M. H., A. D., and J. N.), Grants BB/K016164/1 and BB/F008309/1 from the Biotechnology and Biological Sciences Research Council (to A. D. and S. M. H.), and Area of Excellence Scheme of the University Grants Committee Grant AoE/M-12/96 from the Government of the Hong Kong Special Administrative Region.	Air GM, 2012, INFLUENZA OTHER RESP, V6, P245, DOI 10.1111/j.1750-2659.2011.00304.x; BASARAB O, 1969, BRIT J EXP PATHOL, V50, P612; Bateman AC, 2010, J BIOL CHEM, V285, P34016, DOI 10.1074/jbc.M110.115998; Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Belser JA, 2009, ADV VIRUS RES, V73, P55, DOI 10.1016/S0065-3527(09)73002-7; Bern M, 2013, MOL CELL PROTEOMICS, V12, P996, DOI 10.1074/mcp.O112.026377; Chan MCW, 2013, LANCET RESP MED, V1, P534, DOI 10.1016/S2213-2600(13)70138-3; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Cohen J, 2012, SCIENCE, V335, P512, DOI 10.1126/science.335.6068.512; Crusat M, 2013, VIROLOGY, V447, P326, DOI 10.1016/j.virol.2013.08.010; de Vries RP, 2014, J VIROL, V88, P768, DOI 10.1128/JVI.02690-13; DELL A, 1991, CARBOHYD RES, V209, P33, DOI 10.1016/0008-6215(91)80143-B; DRZENIEK R, 1966, BIOCHIM BIOPHYS ACTA, V128, P547, DOI 10.1016/0926-6593(66)90015-4; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Francis T, 1938, J EXP MED, V68, P789, DOI 10.1084/jem.68.6.789; GALILI U, 1991, P NATL ACAD SCI USA, V88, P7401, DOI 10.1073/pnas.88.16.7401; Gambaryan A, 2005, VIROLOGY, V334, P276, DOI 10.1016/j.virol.2005.02.003; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Klisch K, 2008, GLYCOBIOLOGY, V18, P42, DOI 10.1093/glycob/cwm113; Kolarich D, 2013, MOL CELL PROTEOMICS, V12, P991, DOI 10.1074/mcp.O112.026492; Kreijtz JHCM, 2013, VACCINE, V31, P4995, DOI 10.1016/j.vaccine.2013.06.071; Lee CL, 2009, J BIOL CHEM, V284, P15084, DOI 10.1074/jbc.M807960200; LEIGH MW, 1989, BIOCHEMISTRY-US, V28, P9440, DOI 10.1021/bi00450a029; LEIGH MW, 1995, VACCINE, V13, P1468, DOI 10.1016/0264-410X(95)00004-K; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; MALAGOLINI N, 1994, GLYCOCONJUGATE J, V11, P89, DOI 10.1007/BF00731148; MANNING DD, 1990, J AM VET MED ASSOC, V197, P84; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; North SJ, 2010, METHOD ENZYMOL, V478, P27, DOI 10.1016/S0076-6879(10)78002-2; POTTER CW, 1972, BRIT J EXP PATHOL, V53, P153; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; Roberts KL, 2011, J GEN VIROL, V92, P1822, DOI 10.1099/vir.0.031203-0; SERAFINICESSI F, 1983, BIOCHEM J, V215, P483, DOI 10.1042/bj2150483; Shelton H, 2013, J GEN VIROL, V94, P1220, DOI 10.1099/vir.0.050526-0; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Van Poucke S, 2013, INFLUENZA OTHER RESP, V7, P151, DOI 10.1111/j.1750-2659.2012.00376.x; Walther T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003223; Xu LL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-253; Xu R, 2013, SCIENCE, V342, P1230, DOI 10.1126/science.1243761; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07; Yen HL, 2011, P NATL ACAD SCI USA, V108, P14264, DOI 10.1073/pnas.1111000108	45	64	64	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28489	28504		10.1074/jbc.M114.588541	http://dx.doi.org/10.1074/jbc.M114.588541			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25135641	Green Published, hybrid			2022-12-28	WOS:000343765400040
J	Gao, YZ; Yao, JH; Poudel, S; Romer, E; Abu-Niaaj, L; Leffak, M				Gao, Yanzhe; Yao, Jianhong; Poudel, Sumeet; Romer, Eric; Abu-Niaaj, Lubna; Leffak, Michael			Protein Phosphatase 2A and Cdc7 Kinase Regulate the DNA Unwinding Element-binding Protein in Replication Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA SYNTHETASE COMPLEXES; XENOPUS EGG EXTRACTS; S-PHASE; SACCHAROMYCES-CEREVISIAE; PHOSPHORYLATION SITES; SEQUENTIAL ACTION; BUDDING YEAST; MCM PROTEINS; CANCER-CELLS; IN-VITRO	The DNA unwinding element (DUE)-binding protein (DUE-B) binds to replication origins coordinately with the minichromosome maintenance (MCM) helicase and the helicase activator Cdc45 in vivo, and loads Cdc45 onto chromatin in Xenopus egg extracts. Human DUE-B also retains the aminoacyl-tRNA proofreading function of its shorter orthologs in lower organisms. Here we report that phosphorylation of the DUE-B unstructured C-terminal domain unique to higher organisms regulates DUE-B intermolecular binding. Gel filtration analyses show that unphosphorylated DUE-B forms multiple high molecular weight (HMW) complexes. Several aminoacyl-tRNA synthetases and Mcm2-7 proteins were identified by mass spectrometry of the HMW complexes. Aminoacyl-tRNA synthetase binding is RNase A sensitive, whereas interaction with Mcm2-7 is nuclease resistant. Unphosphorylated DUE-B HMW complex formation is decreased by PP2A inhibition or direct DUE-B phosphorylation, and increased by inhibition of Cdc7. These results indicate that the state of DUE-B phosphorylation is maintained by the equilibrium between Cdc7-dependent phosphorylation and PP2A-dependent dephosphorylation, each previously shown to regulate replication initiation. Alanine mutation of the DUE-B C-terminal phosphorylation target sites increases MCM binding but blocks Cdc45 loading in vivo and inhibits cell division. In egg extracts alanine mutation of the DUE-B C-terminal phosphorylation sites blocks Cdc45 loading and inhibits DNA replication. The effects of DUE-B C-terminal phosphorylation reveal a novel S phase kinase regulatory mechanism for Cdc45 loading and MCM helicase activation.	[Gao, Yanzhe; Yao, Jianhong; Poudel, Sumeet; Romer, Eric; Abu-Niaaj, Lubna; Leffak, Michael] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Leffak, M (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.	Michael.Leffak@wright.edu	Gao, Yanzhe/B-6417-2017; Abu-Niaaj, Lubna/T-2433-2019	Abu-Niaaj, Lubna/0000-0003-1434-259X	National Institutes of Health from the NIGMS [GM53819]; Wright State University Biomedical Sciences Ph.D. Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053819] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wright State University Biomedical Sciences Ph.D. Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM53819 from the NIGMS (to M. L.).; Supported by the Wright State University Biomedical Sciences Ph.D. Program.	Aladjem MI, 1998, SCIENCE, V281, P1005, DOI 10.1126/science.281.5379.1005; Balestrini A, 2010, NAT CELL BIOL, V12, P484, DOI 10.1038/ncb2050; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Casper JM, 2005, J BIOL CHEM, V280, P13071, DOI 10.1074/jbc.M404754200; Charych DH, 2008, J CELL BIOCHEM, V104, P1075, DOI 10.1002/jcb.21698; Chen XM, 2013, NUCLEIC ACIDS RES, V41, P6460, DOI 10.1093/nar/gkt368; Cho WH, 2006, P NATL ACAD SCI USA, V103, P11521, DOI 10.1073/pnas.0604990103; Chong JPJ, 1997, METHOD ENZYMOL, V283, P549; Chou DM, 2002, J BIOL CHEM, V277, P40520, DOI 10.1074/jbc.M207226200; Chowdhury A, 2010, MOL CELL BIOL, V30, P1495, DOI 10.1128/MCB.00710-09; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Evrin C, 2013, NUCLEIC ACIDS RES, V41, P3162, DOI 10.1093/nar/gkt043; Fernandez-Cid A, 2013, MOL CELL, V50, P577, DOI 10.1016/j.molcel.2013.03.026; Gambus A, 2011, J BIOL CHEM, V286, P11855, DOI 10.1074/jbc.M110.199521; Ghosh M, 2006, MOL CELL BIOL, V26, P5270, DOI 10.1128/MCB.02137-05; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Hausmann CD, 2008, FEMS MICROBIOL REV, V32, P705, DOI 10.1111/j.1574-6976.2008.00119.x; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Hoang ML, 2007, MOL CELL BIOL, V27, P7594, DOI 10.1128/MCB.00997-07; Ishimi Y, 2003, EUR J BIOCHEM, V270, P1089, DOI 10.1046/j.1432-1033.2003.03440.x; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kemp M, 2006, THESIS WRIGHT STATE; Kemp M, 2007, J BIOL CHEM, V282, P10441, DOI 10.1074/jbc.M609632200; Kim JH, 2014, TOP CURR CHEM, V344, P119, DOI 10.1007/128_2013_479; Krasinska L, 2011, MOL CELL, V44, P437, DOI 10.1016/j.molcel.2011.10.007; Kumagai A, 2011, J CELL BIOL, V193, P995, DOI 10.1083/jcb.201102003; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Lebofsky Ronald, 2009, V521, P229, DOI [10.1007/978-1-60327-817-5_13, 10.1007/978-1-60327-815-7_13]; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Lin XH, 1998, P NATL ACAD SCI USA, V95, P14693, DOI 10.1073/pnas.95.25.14693; Liu GQ, 2007, MOL CELL BIOL, V27, P7828, DOI 10.1128/MCB.01276-07; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Montagnoli A, 2008, NAT CHEM BIOL, V4, P357, DOI 10.1038/nchembio.90; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Petersen P, 2006, MOL CELL BIOL, V26, P1997, DOI 10.1128/MCB.26.5.1997-2011.2006; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Ruzzene M, 2002, BIOCHEM J, V364, P41, DOI 10.1042/bj3640041; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	47	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35987	36000		10.1074/jbc.M114.589119	http://dx.doi.org/10.1074/jbc.M114.589119			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25258324	Green Published, hybrid			2022-12-28	WOS:000346897900029
J	Vorobyeva, AG; Lee, R; Miller, S; Longen, C; Sharoni, M; Kandelwal, PJ; Kim, FJ; Marenda, DR; Saunders, AJ				Vorobyeva, Anna G.; Lee, Randall; Miller, Sean; Longen, Charles; Sharoni, Michal; Kandelwal, Preeti J.; Kim, Felix J.; Marenda, Daniel R.; Saunders, Aleister J.			Cyclopamine Modulates gamma-Secretase-mediated Cleavage of Amyloid Precursor Protein by Altering Its Subcellular Trafficking and Lysosomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; CHOLESTEROL TRANSPORT; INTRACELLULAR DOMAIN; BETA-AMYLOIDOGENESIS; SYNAPTIC PLASTICITY; CELL-SURFACE; COMPLEX; DROSOPHILA; NOTCH	Alzheimer disease (AD) is a progressive neurodegenerative disease leading to memory loss. Numerous lines of evidence suggest that amyloid-beta (A beta), a neurotoxic peptide, initiates a cascade that results in synaptic dysfunction, neuronal death, and eventually cognitive deficits. A beta is generated by the proteolytic processing of the amyloid precursor protein (APP), and alterations to this processing can result in Alzheimer disease. Using in vitro and in vivo models, we identified cyclopamine as a novel regulator of gamma-secretase-mediated cleavage of APP. We demonstrate that cyclopamine decreases A beta generation by altering APP retrograde trafficking. Specifically, cyclopamine treatment reduced APP-C-terminal fragment (CTF) delivery to the trans-Golgi network where gamma-secretase cleavage occurs. Instead, cyclopamine redirects APP-CTFs to the lysosome. These data demonstrate that cyclopamine treatment decreases gamma-secretase-mediated cleavage of APP. In addition, cyclopamine treatment decreases the rate of APP-CTF degradation. Together, our data demonstrate that cyclopamine alters APP processing and A beta generation by inducing changes in APP subcellular trafficking and APP-CTF degradation.	[Vorobyeva, Anna G.; Lee, Randall; Miller, Sean; Sharoni, Michal; Kandelwal, Preeti J.; Marenda, Daniel R.; Saunders, Aleister J.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Longen, Charles; Kim, Felix J.] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA; [Marenda, Daniel R.; Saunders, Aleister J.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19102 USA; [Saunders, Aleister J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA	Drexel University; Drexel University; Drexel University; Drexel University	Saunders, AJ (corresponding author), Drexel Univ, Dept Biol, 3245 Chestnut St, Philadelphia, PA 19104 USA.	Aleister.Saunders@drexel.edu		Saunders, Aleister/0000-0002-7298-7823	National Institutes of Health [R01NS057295]; Drexel University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Drexel University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS057295. This work was also supported by Drexel University funding (to A. J. S.).	Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Bar EE, 2008, EXPERT OPIN INV DRUG, V17, P185, DOI 10.1517/13543784.17.2.185; Barthet G, 2011, FASEB J, V25, P2937, DOI 10.1096/fj.11-183806; Bodovitz S, 1996, J BIOL CHEM, V271, P4436; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Burg VK, 2013, J NEUROSCI, V33, P16072, DOI 10.1523/JNEUROSCI.1506-13.2013; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chakraborty R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020799; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Costa RM, 2005, TRENDS NEUROSCI, V28, P429, DOI 10.1016/j.tins.2005.05.003; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Dahlhaus M, 2008, J NEUROSCI, V28, P10794, DOI 10.1523/JNEUROSCI.1348-08.2008; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Fossgreen A, 1998, P NATL ACAD SCI USA, V95, P13703, DOI 10.1073/pnas.95.23.13703; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Frears ER, 1999, NEUROREPORT, V10, P1699, DOI 10.1097/00001756-199906030-00014; GANDY S, 1994, INT REV NEUROBIOL, V36, P29, DOI 10.1016/S0074-7742(08)60302-5; GANDY S, 1994, BIOCHIMIE, V76, P300, DOI 10.1016/0300-9084(94)90162-7; GANDY S, 1994, NEUROBIOL AGING, V15, P253, DOI 10.1016/0197-4580(94)90125-2; Ghribi O, 2006, EXP NEUROL, V200, P460, DOI 10.1016/j.expneurol.2006.03.019; GOLDE TE, 1993, ANN NY ACAD SCI, V695, P103, DOI 10.1111/j.1749-6632.1993.tb23036.x; Guo M, 2003, HUM MOL GENET, V12, P2669, DOI 10.1093/hmg/ddg292; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Jiang ST, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-6; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Jimenez-Sanchez M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2212; Kalman Janos, 2005, Orv Hetil, V146, P1903; Karaca I, 2014, J BIOL CHEM, V289, P16761, DOI 10.1074/jbc.M113.535500; KEELER RF, 1978, LIPIDS, V13, P708, DOI 10.1007/BF02533750; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lane RF, 2013, J NEUROSCI, V33, P7099, DOI 10.1523/JNEUROSCI.5270-12.2013; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lee ST, 2014, J AGR FOOD CHEM, V62, P7355, DOI 10.1021/jf5005622; Levin-Allerhand J A, 2002, J Nutr Health Aging, V6, P315; Levin-Allerhand JA, 2002, J ALZHEIMERS DIS, V4, P449; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Palma V, 2004, DEVELOPMENT, V131, P337, DOI 10.1242/dev.00930; Palmert M R, 1990, Adv Neurol, V51, P181; Palmert M R, 1989, Prog Clin Biol Res, V317, P971; Pappolla MA, 2003, NEUROLOGY, V61, P199, DOI 10.1212/01.WNL.0000070182.02537.84; Runz H, 2002, J NEUROSCI, V22, P1679, DOI 10.1523/JNEUROSCI.22-05-01679.2002; Sarajarvi T, 2011, MOL CELL BIOL, V31, P2326, DOI 10.1128/MCB.05015-11; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Selkoe DJ, 2003, NEUROCHEM RES, V28, P1705, DOI 10.1023/A:1026065122854; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Takasugi N, 2002, J BIOL CHEM, V277, P50198, DOI 10.1074/jbc.M205352200; Tanzi RE, 2005, NAT NEUROSCI, V8, P977, DOI 10.1038/nn0805-977; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tanzi RE, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006296; vandenHeuvel M, 1996, TRENDS CELL BIOL, V6, P451, DOI 10.1016/0962-8924(96)84934-8; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang LF, 2009, MOLECULES, V14, P3589, DOI 10.3390/molecules14093589; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Xiang Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2669; Yao ZX, 2002, FASEB J, V16, P1677, DOI 10.1096/fj.02-0285fje; Zhang C, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-15	76	7	7	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33258	33274		10.1074/jbc.M114.591792	http://dx.doi.org/10.1074/jbc.M114.591792			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25281744	Green Published, hybrid			2022-12-28	WOS:000345636600018
J	Koharudin, LMI; Wu, Y; DeLucia, M; Mehrens, J; Gronenborn, AM; Ahn, J				Koharudin, Leonardus M. I.; Wu, Ying; DeLucia, Maria; Mehrens, Jennifer; Gronenborn, Angela M.; Ahn, Jinwoo			Structural Basis of Allosteric Activation of Sterile alpha Motif and Histidine-Aspartate Domain-containing Protein 1 (SAMHD1) by Nucleoside Triphosphates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES SYNDROME; RESTRICTION FACTOR SAMHD1; IMMUNODEFICIENCY-VIRUS TYPE-1; DNTP TRIPHOSPHOHYDROLASE; HIV-1 INFECTION; INHIBITION; PHOSPHORYLATION; REPLICATION; MACROPHAGES; REGULATOR	Sterile alpha motif and histidine-aspartate domain-containing protein 1 (SAMHD1) plays a critical role in inhibiting HIV infection, curtailing the pool of dNTPs available for reverse transcription of the viral genome. Recent structural data suggested a compelling mechanism for the regulation of SAMHD1 enzymatic activity and revealed dGTP-induced association of two inactive dimers into an active tetrameric enzyme. Here, we present the crystal structures of SAMHD1 catalytic core (residues 113-626) tetramers, complexed with mixtures of nucleotides, including dGTP/dATP, dGTP/dCTP, dGTP/dTTP, and dGTP/dUTP. The combined structural and biochemical data provide insight into dNTP promiscuity at the secondary allosteric site and how enzymatic activity is modulated. In addition, we present biochemical analyses of GTP-induced SAMHD1 full-length tetramerization and the structure of SAMHD1 catalytic core tetramer in complex with GTP/dATP, revealing the structural basis of GTP-mediated SAMHD1 activation. Altogether, the data presented here advance our understanding of SAMHD1 function during cellular homeostasis.	Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Host Prot Interact, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gronenborn, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA.	amg100@pitt.edu; jia12@pitt.edu		Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [P50GM82251]; University of Pittsburgh School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh School of Medicine(University of Pittsburgh); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P50GM82251 (to A. M. G. and J. A.). This work was also supported in part by start-up funds from the University of Pittsburgh School of Medicine (to J. A.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amie SM, 2013, J BIOL CHEM, V288, P25001, DOI 10.1074/jbc.C113.493619; Amie SM, 2013, VIROLOGY, V436, P247, DOI 10.1016/j.virol.2012.11.010; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; DeLucia M, 2013, J BIOL CHEM, V288, P19116, DOI 10.1074/jbc.M113.469007; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Gelais CS, 2014, J VIROL, V88, P5834, DOI 10.1128/JVI.00155-14; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Hansen EC, 2014, P NATL ACAD SCI USA, V111, pE1843, DOI 10.1073/pnas.1401706111; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Kim ET, 2013, J VIROL, V87, P12949, DOI 10.1128/JVI.02291-13; Kondo N, 2004, J BIOCHEM, V136, P221, DOI 10.1093/jb/mvh115; Kondo N, 2007, ACTA CRYSTALLOGR D, V63, P230, DOI 10.1107/S0907444906049262; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Leshinsky-Silver E, 2011, EUR J HUM GENET, V19, P287, DOI 10.1038/ejhg.2010.213; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miazzi C, 2014, J BIOL CHEM, V289, P18339, DOI 10.1074/jbc.M114.571091; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Pan XY, 2013, CELL RES, V23, P876, DOI 10.1038/cr.2013.74; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Ramantani G, 2011, J CHILD NEUROL, V26, P1425, DOI 10.1177/0883073811408310; Ramesh V, 2010, DEV MED CHILD NEUROL, V52, P725, DOI 10.1111/j.1469-8749.2010.03727.x; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; Sze A, 2013, J MOL BIOL, V425, P4981, DOI 10.1016/j.jmb.2013.10.022; Thiele H, 2010, HUM MUTAT, V31, pE1836, DOI 10.1002/humu.21357; Vorontsov II, 2014, J BIOL CHEM, V289, P2815, DOI 10.1074/jbc.M113.524207; Vorontsov II, 2011, J BIOL CHEM, V286, P33158, DOI 10.1074/jbc.M111.250456; Welbourn S, 2013, J VIROL, V87, P11516, DOI 10.1128/JVI.01642-13; White TE, 2013, VIROLOGY, V436, P81, DOI 10.1016/j.virol.2012.10.029; Wu L., 2013, ISRN BIOCH, V728392, P1, DOI [10.1155/2013/728392, DOI 10.1155/2013/728392]; Xin BZ, 2011, P NATL ACAD SCI USA, V108, P5372, DOI 10.1073/pnas.1014265108; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Zhu CF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3722	52	53	54	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.591958	http://dx.doi.org/10.1074/jbc.M114.591958			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25288794	Green Published, hybrid			2022-12-28	WOS:000345335000020
J	Okada, M; Matsuzawa, A; Yoshimura, A; Ichijo, H				Okada, Masahiro; Matsuzawa, Atsushi; Yoshimura, Akihiko; Ichijo, Hidenori			The Lysosome Rupture-activated TAK1-JNK Pathway Regulates NLRP3 Inflammasome Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-1 SIGNALING PATHWAY; I-KAPPA-B; OXIDATIVE STRESS; KINASE CASCADE; CELL-DEATH; APOPTOSIS; PHOSPHORYLATION; TRANSLOCATION; MITOCHONDRIA; CRYSTALS	Lysosome rupture triggers NLRP3 inflammasome activation in macrophages. However, the underlying mechanism is not fully understood. Here we showed that the TAK1-JNK pathway, a MAPK signaling pathway, is activated through lysosome rupture and that this activation is necessary for the complete activation of the NLRP3 inflammasome through the oligomerization of an adapter protein, apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC). We also revealed that the activation of the TAK1-JNK pathway is sustained through Ca2+ ions and that calcium/calmodulin-dependent protein kinase type II functions upstream of the TAK1-JNK pathway and specifically regulates lysosome rupture-induced NLRP3 inflammasome activation. These data suggest a novel role for the TAK1-JNK pathway as a critical regulator of NLRP3 inflammasome activation.	[Okada, Masahiro; Matsuzawa, Atsushi; Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Bunkyo Ku, Tokyo 1130033, Japan; [Okada, Masahiro; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Matsuzawa, Atsushi] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Hlth Chem, Aoba Ku, Sendai, Miyagi 9808578, Japan	University of Tokyo; Keio University; Tohoku University	Matsuzawa, A (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Hlth Chem, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	matsushi@m.tohoku.ac.jp	Matsuzawa, Atsushi/GLU-1387-2022; Yoshimura, Akihiko/K-5515-2013	Ichijo, Hidenori/0000-0002-5005-6438; Matsuzawa, Atsushi/0000-0001-8303-3905	KAKENHI from Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Global Center of Education and Research for Chemical Biology of the Diseases; Global Center of Excellence Program (GCOE) Program; Strategic Research Program for Brain Sciences by MEXT; Advanced Research for Medical Products Mining Programme of the National Institute of Bio-medical Innovation; Funding Program for Next Generation World-leading Researchers; Nagase Science and Technology Foundation; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation; Grants-in-Aid for Scientific Research [26114009] Funding Source: KAKEN	KAKENHI from Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Education and Research for Chemical Biology of the Diseases; Global Center of Excellence Program (GCOE) Program; Strategic Research Program for Brain Sciences by MEXT; Advanced Research for Medical Products Mining Programme of the National Institute of Bio-medical Innovation; Funding Program for Next Generation World-leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nagase Science and Technology Foundation; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI from Japan Society for the Promotion of Science (JSPS) and Ministry of Education, Culture, Sports, Science and Technology (MEXT), by the Global Center of Education and Research for Chemical Biology of the Diseases, by the Global Center of Excellence Program (GCOE) Program, by the "Understanding of Molecular and Environmental Bases for Brain Health" study conducted under the Strategic Research Program for Brain Sciences by MEXT, by the Advanced Research for Medical Products Mining Programme of the National Institute of Bio-medical Innovation, by the Funding Program for Next Generation World-leading Researchers, by the Nagase Science and Technology Foundation, by the Astellas Foundation for Research on Metabolic Disorders, and by the Takeda Science Foundation.	Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Giamarellos-Bourboulis EJ, 2009, ANN RHEUM DIS, V68, P273, DOI 10.1136/ard.2007.082222; Gong YN, 2010, CELL RES, V20, P1289, DOI 10.1038/cr.2010.135; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hung YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3111; Irie T, 2000, FEBS LETT, V467, P160, DOI 10.1016/S0014-5793(00)01146-7; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kwak JH, 2008, J BIOL CHEM, V283, P19816, DOI 10.1074/jbc.M802285200; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Park S, 2013, J IMMUNOL, V191, P4358, DOI 10.4049/jimmunol.1301170; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Triantafilou K, 2013, J CELL SCI, V126, P2903, DOI 10.1242/jcs.124388; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Uchimoto T, 1999, APOPTOSIS, V4, P357, DOI 10.1023/A:1009695221038; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zhong ZY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2608; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	43	123	136	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.579961	http://dx.doi.org/10.1074/jbc.M114.579961			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25288801	Green Published, hybrid			2022-12-28	WOS:000345335000044
J	Kolic, J; Spigelman, AF; Smith, AM; Fox, JEM; MacDonald, PE				Kolic, Jelena; Spigelman, Aliya F.; Smith, Alannah M.; Fox, Jocelyn E. Manning; MacDonald, Patrick E.			Insulin Secretion Induced by Glucose-dependent Insulinotropic Polypeptide Requires Phosphatidylinositol 3-Kinase gamma in Rodent and Human beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Exocytosis; Insulin; Pancreatic Islet; Phosphatidylinositide 3-Kinase (PI 3-Kinase); Ras-related C3 Botulinum Toxin Substrate 1 (Rac1); Type 2 Diabetes	GLUCAGON-LIKE PEPTIDE-1; GASTRIC-INHIBITORY POLYPEPTIDE; PHOSPHOINOSITIDE 3-KINASE; FUNCTIONAL EXPRESSION; INCRETIN HORMONES; RHEUMATOID-ARTHRITIS; SIGNALING PATHWAYS; GRANULE EXOCYTOSIS; GLP-1 RECEPTOR; GROWTH-FACTOR	Background: PI3K is implicated in insulin secretion and actin remodeling and is activated by glucose-dependent insulinotropic polypeptide (GIP). Results: GIP activates Ras-related-C3 botulinum toxin substrate-1 (Rac1), induces actin remodeling, and amplifies -cell insulin secretion in a PI3K-dependent manner. Conclusion: Insulin secretion induced by GIP requires PI3K. Significance: Understanding the -cell signaling pathway will help us understand -cell dysfunction in diabetes. PI3K, a G-protein-coupled type 1B phosphoinositol 3-kinase, exhibits a basal glucose-independent activity in -cells and can be activated by the glucose-dependent insulinotropic polypeptide (GIP). We therefore investigated the role of the PI3K catalytic subunit (p110) in insulin secretion and -cell exocytosis stimulated by GIP. We inhibited p110 with AS604850 (1 mol/liter) or knocked it down using an shRNA adenovirus or siRNA duplex in mouse and human islets and -cells. Inhibition of PI3K blunted the exocytotic and insulinotropic response to GIP receptor activation, whereas responses to the glucagon-like peptide-1 or the glucagon-like peptide-1 receptor agonist exendin-4 were unchanged. Downstream, we find that GIP, much like glucose stimulation, activates the small GTPase protein Rac1 to induce actin remodeling. Inhibition of PI3K blocked these effects of GIP. Although exendin-4 could also stimulate actin remodeling, this was not prevented by p110 inhibition. Finally, forced actin depolymerization with latrunculin B restored the exocytotic and secretory responses to GIP during PI3K inhibition, demonstrating that the loss of GIP-induced actin depolymerization was indeed limiting insulin exocytosis.	Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2E1, Canada; [MacDonald, Patrick E.] Univ Alberta, Alberta Diabet Inst, Edmonton, AB T6G 2E1, Canada	University of Alberta; University of Alberta	MacDonald, PE (corresponding author), Univ Alberta, Alberta Diabet Inst, LKS Ctr Rm 6-126, Edmonton, AB T6G 2E1, Canada.	pmacdonald@ualberta.ca		Kolic, Jelena/0000-0003-4151-1280; Spigelman, Aliya F/0000-0001-6188-2041; MacDonald, Patrick/0000-0002-5439-6288	Canadian Diabetes Association; Alberta Diabetes Foundation; University of Alberta; Alberta Innovates-Health Solutions; Canadian Institutes of Health Research	Canadian Diabetes Association; Alberta Diabetes Foundation; University of Alberta(University of Alberta); Alberta Innovates-Health Solutions; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The work was supported by an operating grant to PEM from the Canadian Diabetes Association. Human islet isolations were funded in part by the Alberta Diabetes Foundation and the University of Alberta.; Supported by studentships Alberta Innovates-Health Solutions and the Canadian Institutes of Health Research.	Asahara S, 2013, DIABETOLOGIA, V56, P1088, DOI 10.1007/s00125-013-2849-5; Barnett A, 2007, EXPERT OPIN PHARMACO, V8, P2593, DOI 10.1517/14656566.8.15.2593; Becattini B, 2011, P NATL ACAD SCI USA, V108, pE854, DOI 10.1073/pnas.1106698108; Bernstein HG, 1998, CELL MOL BIOL, V44, P973; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Calanna S, 2013, DIABETES CARE, V36, P3346, DOI 10.2337/dc13-0465; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; DILLON JS, 1993, ENDOCRINOLOGY, V133, P1907, DOI 10.1210/en.133.4.1907; Drucker DJ, 2013, DIABETES, V62, P3316, DOI 10.2337/db13-0822; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Edwards CMB, 2004, J ROY SOC MED, V97, P270, DOI 10.1258/jrsm.97.6.270; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; GREMLICH S, 1995, DIABETES, V44, P1202, DOI 10.2337/diabetes.44.10.1202; Holst JJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE199, DOI 10.1152/ajpendo.00545.2003; HOLZ GG, 1993, NATURE, V361, P362, DOI 10.1038/361362a0; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Jung ID, 2004, EUR J BIOCHEM, V271, P1557, DOI 10.1111/j.1432-1033.2004.04066.x; Kalwat MA, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.73; Kaneko K, 2010, CELL METAB, V12, P619, DOI 10.1016/j.cmet.2010.11.005; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Knop FK, 2007, DIABETES, V56, P1951, DOI 10.2337/db07-0100; Kobayashi N, 2011, P NATL ACAD SCI USA, V108, P5753, DOI 10.1073/pnas.1016430108; Kolic J, 2013, DIABETOLOGIA, V56, P1339, DOI 10.1007/s00125-013-2882-4; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; Li LX, 2006, ENDOCRINOLOGY, V147, P3318, DOI 10.1210/en.2006-0155; MacDonald PE, 2004, ENDOCRINOLOGY, V145, P4078, DOI 10.1210/en.2004-0028; MacDonald PE, 2002, DIABETES, V51, pS434, DOI 10.2337/diabetes.51.2007.S434; McClenaghan NH, 2006, J ENDOCRINOL, V190, P889, DOI 10.1677/joe.1.06949; Merrins MJ, 2008, J PHYSIOL-LONDON, V586, P5367, DOI 10.1113/jphysiol.2008.158477; MOJSOV S, 1987, J CLIN INVEST, V79, P616, DOI 10.1172/JCI112855; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; PEDERSON RA, 1976, ENDOCRINOLOGY, V99, P780, DOI 10.1210/endo-99-3-780; Pigeau GM, 2009, DIABETES, V58, P2084, DOI 10.2337/db08-1371; Randis TM, 2008, EUR J IMMUNOL, V38, P1215, DOI 10.1002/eji.200838266; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Seino S, 2009, DIABETES OBES METAB, V11, P180, DOI 10.1111/j.1463-1326.2009.01108.x; Song WJ, 2011, CELL METAB, V13, P308, DOI 10.1016/j.cmet.2011.02.002; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Straub SG, 1998, DIABETES, V47, P758, DOI 10.2337/diabetes.47.5.758; Straub SG, 1996, BIOCHEM BIOPH RES CO, V224, P369, DOI 10.1006/bbrc.1996.1035; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Trumper A, 2001, MOL ENDOCRINOL, V15, P1559, DOI 10.1210/me.15.9.1559; USDIN TB, 1993, ENDOCRINOLOGY, V133, P2861, DOI 10.1210/en.133.6.2861; Vilsboll T, 2001, DIABETES, V50, P609, DOI 10.2337/diabetes.50.3.609; Vilsboll Tina, 2007, Ugeskr Laeger, V169, P2101; VOLZ A, 1995, FEBS LETT, V373, P23, DOI 10.1016/0014-5793(95)01006-Z; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Weiss-Haljiti C, 2004, J BIOL CHEM, V279, P43273, DOI 10.1074/jbc.M402924200; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wymann MP, 2013, ANN NY ACAD SCI, V1280, P44, DOI 10.1111/nyas.12037; Yabe D, 2011, PROG BIOPHYS MOL BIO, V107, P248, DOI 10.1016/j.pbiomolbio.2011.07.010	59	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32109	32120		10.1074/jbc.M114.577510	http://dx.doi.org/10.1074/jbc.M114.577510			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25288806	Green Published, hybrid			2022-12-28	WOS:000345314700039
J	Hendrayani, SF; Al-Khalaf, HH; Aboussekhra, A				Hendrayani, Siti-Fauziah; Al-Khalaf, Huda H.; Aboussekhra, Abdelilah			The Cytokine IL-6 Reactivates Breast Stromal Fibroblasts through Transcription Factor STAT3-dependent Up-regulation of the RNA-binding Protein AUF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-ASSOCIATED FIBROBLASTS; MESSENGER-RNA; TRANSFORMING GROWTH-FACTOR-BETA-1; TUMOR-SUPPRESSOR; GROWTH-FACTOR; FACTOR SNAIL; STAT3; INTERLEUKIN-6; CARCINOMA; EXPRESSION	The development and spread of mammary carcinomas require synergetic interplay between tumor cells and their microenvironment through paracrine secretions, which are still not well defined. We have shown here that interleukin-6 (IL-6), either recombinant or secreted from highly invasive breast cancer cells, down-regulates the tumor suppressor proteins p16(INK4A), p21(WAF1), and p53 and activates breast stromal fibroblasts in a paracrine manner. The formation of myofibroblasts requires p16(INK4A) down-regulation and the activation of the JAK2/STAT3 pathway. Indeed, the transcription factor STAT3 positively controls the expression of the three major myofibroblast markers, SDF-1, alpha-smooth muscle actin (alpha-SMA), and TGF-beta 1, and mediates IL-6-related down-regulation of p16(INK4A), p21(WAF1), and p53 as well as the activation of stromal fibroblasts. Importantly, these effects were mediated through STAT3-dependent up-regulation of the mRNA-binding protein AUF1, whose promoter contains three canonical STAT3 binding sites. AUF1 binds the SDF-1, alpha-SMA, TGF-beta 1, and IL-6 mRNAs and reduces their turnover. Consequently, specific AUF1 down-regulation inhibits IL-6-dependent activation of breast stromal fibroblasts, whereas AUF1 ectopic expression of p37(AUF1) activated these cells and enhanced their paracrine induction of epithelial-to-mesenchymal transition in breast cancer cells, which shows a non-cell-autonomous oncogenic function of AUF1. Together, these results demonstrate a major role of IL-6 in activating breast stromal fibroblasts through STAT3-dependent AUF1 induction.	[Hendrayani, Siti-Fauziah; Al-Khalaf, Huda H.; Aboussekhra, Abdelilah] King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, Riyadh 11211, Saudi Arabia; [Al-Khalaf, Huda H.] King Abdulaziz City Sci & Technol, Joint Ctr Genom Res, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center	Aboussekhra, A (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, MBC 03,POB 3354, Riyadh 11211, Saudi Arabia.	aboussekhra@kfshrc.edu.sa	Alkhalaf, Huda/Z-5701-2019		King Abdulaziz City for Science and Technology under National Comprehensive Plan for Science and Technology [11-BIO1435-20]	King Abdulaziz City for Science and Technology under National Comprehensive Plan for Science and Technology	This work was performed under Research Advisory Council Proposal 2120034 and was supported in part by a King Abdulaziz City for Science and Technology Grant 11-BIO1435-20, under National Comprehensive Plan for Science and Technology.	Abdelmohsen K, 2012, NUCLEIC ACIDS RES, V40, P11531, DOI 10.1093/nar/gks930; Aboussekhra A, 2011, INT J DEV BIOL, V55, P841, DOI 10.1387/ijdb.113362aa; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Al-Ansari MM, 2013, ONCOGENE, V32, P2356, DOI 10.1038/onc.2012.270; Al-Khalaf HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021111; Al-Mohanna MA, 2007, NUCLEIC ACIDS RES, V35, P223, DOI 10.1093/nar/gkl1075; Albini A, 2008, CANCER METAST REV, V27, P75, DOI 10.1007/s10555-007-9111-x; Allen M, 2011, J PATHOL, V223, P162, DOI 10.1002/path.2803; Bar J, 2009, ONCOGENE, V28, P933, DOI 10.1038/onc.2008.445; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chang Q, 2013, NEOPLASIA, V15, P848, DOI 10.1593/neo.13706; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Dethlefsen C, 2013, BREAST CANCER RES TR, V138, P657, DOI 10.1007/s10549-013-2488-z; Dolled-Filhart M, 2003, CLIN CANCER RES, V9, P594; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gouble A, 2002, CANCER RES, V62, P1489; Groner B, 2008, SEMIN CELL DEV BIOL, V19, P341, DOI 10.1016/j.semcdb.2008.06.005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hawsawi NM, 2008, CANCER RES, V68, P2717, DOI 10.1158/0008-5472.CAN-08-0192; Jablonka S, 2001, HUM MOL GENET, V10, P497, DOI 10.1093/hmg/10.5.497; Kiaris H, 2005, CANCER RES, V65, P1627, DOI 10.1158/0008-5472.CAN-04-3791; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lieblein JC, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-302; Moskovits N, 2006, CANCER RES, V66, P10671, DOI 10.1158/0008-5472.CAN-06-2323; Niu GL, 2005, MOL CELL BIOL, V25, P7432, DOI 10.1128/MCB.25.17.7432-7440.2005; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; RONNOVJESSEN L, 1995, J CLIN INVEST, V95, P859, DOI 10.1172/JCI117736; RONNOVJESSEN L, 1993, LAB INVEST, V68, P696; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Sriuranpong V, 2003, CANCER RES, V63, P2948; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; TAMM I, 1989, J EXP MED, V170, P1649, DOI 10.1084/jem.170.5.1649; Trimis G, 2008, HUM MOL GENET, V17, P3596, DOI 10.1093/hmg/ddn252; Trojanowicz B, 2009, ENDOCR-RELAT CANCER, V16, P857, DOI 10.1677/ERC-08-0234; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Wang WG, 2005, EMBO REP, V6, P158, DOI 10.1038/sj.embor.7400346; Xu J, 2013, CANCER LETT, V335, P380, DOI 10.1016/j.canlet.2013.02.054; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zucconi BE, 2011, FRONT BIOSCI-LANDMRK, V16, P2307, DOI 10.2741/3855	50	50	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					30962	30976		10.1074/jbc.M114.594044	http://dx.doi.org/10.1074/jbc.M114.594044			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25231991	Green Published, hybrid			2022-12-28	WOS:000344549900008
J	Jasinski-Bergner, S; Stehle, F; Gonschorek, E; Kalich, J; Schulz, K; Huettelmaier, S; Braun, J; Seliger, B				Jasinski-Bergner, Simon; Stehle, Franziska; Gonschorek, Evamaria; Kalich, Jana; Schulz, Kristin; Huettelmaier, Stefan; Braun, Juliane; Seliger, Barbara			Identification of 14-3-3 beta Gene as a Novel miR-152 Target Using a Proteome-based Approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-CELL PROLIFERATION; RT-PCR; HLA-C; MICRORNA; EXPRESSION; PROTEINS; CANCER; SUPPRESSOR; QUANTIFICATION; 14-3-3-SIGMA	Recent studies demonstrated that miR-152 overexpression down-regulates the nonclassical human leukocyte antigen (HLA) class I molecule HLA-G in human tumors thereby contributing to their immune surveillance. Using two-dimensional gel electrophoresis followed by MALDI-TOF mass spectrometry, the protein expression profile of HLA-G(+), miR-152(low) cells, and their miR-152-overexpressing (miR(high)) counterparts was compared leading to the identification of 24 differentially expressed proteins. These were categorized according to their function and localization demonstrating for most of them an important role in the initiation and progression of tumors. The novel miR-152 target 14-3-3 protein beta/alpha/YWHAB (14-3-3 beta) is down-regulated upon miR-152 overexpression, although its overexpression was often found in tumors of distinct origin. The miR-152-mediated reduction of the 14-3-3 beta expression was accompanied by an up-regulation of BAX protein expression resulting in a pro-apoptotic phenotype. In contrast, the reconstitution of 14-3-3 beta expression in miR-152(high) cells increased the expression of the anti-apoptotic BCL2 gene, enhances the proliferative activity in the presence of the cytostatic drug paclitaxel, and causes resistance to apoptosis induced by this drug. By correlating clinical microarray data with the patients' outcome, a link between 1.4-3-3 beta and HLA-G expression was found, which could be associated with poor prognosis and overall survival of patients with tumors. Because miR-152 controls both the expression of 14-3-3 beta and HLA-G, it exerts a dual role in tumor cells by both altering the immunogenicity and the tumorigenicity.	[Jasinski-Bergner, Simon; Stehle, Franziska; Gonschorek, Evamaria; Kalich, Jana; Schulz, Kristin; Seliger, Barbara] Univ Halle Wittenberg, Inst Med Immunol, D-06112 Halle, Germany; [Huettelmaier, Stefan; Braun, Juliane] Univ Halle Wittenberg, Inst Mol Med, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Seliger, B (corresponding author), Univ Halle Wittenberg, Inst Med Immunol, Magdeburger Str 2, D-06112 Halle, Germany.	barbara.seliger@uk-halle.de	Hüttelmaier, Stefan/AAQ-1203-2021	Braun, Juliane/0000-0002-2491-5788; Seliger, Barbara/0000-0002-5544-4958	Deutsche Forschungsgemeinschaft [GRK 1591]; Mildred Scheel Cancer Research Foundation; Else Kroener Fresenius Foundation; intramural Roux program of the Martin Luther University Halle-Wittenberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Mildred Scheel Cancer Research Foundation; Else Kroener Fresenius Foundation; intramural Roux program of the Martin Luther University Halle-Wittenberg	This work was supported by Deutsche Forschungsgemeinschaft Grant GRK 1591, the Mildred Scheel Cancer Research Foundation, the Else Kroener Fresenius Foundation, and the intramural Roux program of the Martin Luther University Halle-Wittenberg.	Almeida CR, 2006, J IMMUNOL, V177, P6904, DOI 10.4049/jimmunol.177.10.6904; Almeida CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024927; Amiot L, 2011, CELL MOL LIFE SCI, V68, P417, DOI 10.1007/s00018-010-0583-4; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bonelli P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/361020; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Braun J, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku127; Bukur J, 2003, CANCER RES, V63, P4107; Bukur J, 2012, SEMIN CANCER BIOL, V22, P350, DOI 10.1016/j.semcancer.2012.03.003; Bukur J, 2010, J BIOL CHEM, V285, P30419, DOI 10.1074/jbc.M109.094284; Cai MY, 2009, CLIN CANCER RES, V15, P4686, DOI 10.1158/1078-0432.CCR-09-0463; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Diao S, 2010, PROTEOMICS, V10, P3723, DOI 10.1002/pmic.201000050; Dunker K, 2008, TISSUE ANTIGENS, V72, P137, DOI 10.1111/j.1399-0039.2008.01090.x; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Herrmann F, 2003, IMMUNOGENETICS, V55, P379, DOI 10.1007/s00251-003-0597-2; Kohn M, 2010, RNA, V16, P1420, DOI 10.1261/rna.2152710; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lichtenfels R, 2001, ELECTROPHORESIS, V22, P1801, DOI 10.1002/1522-2683(200105)22:9<1801::AID-ELPS1801>3.0.CO;2-I; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Liu TA, 2011, AM J PATHOL, V179, P2698, DOI 10.1016/j.ajpath.2011.08.010; Manaster I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033395; Minamida S, 2011, ANAL BIOANAL CHEM, V401, P245, DOI 10.1007/s00216-011-5057-5; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Neal CL, 2010, EXPERT OPIN THER TAR, V14, P1343, DOI 10.1517/14728222.2010.531011; Nishimura Y, 2013, BRIT J CANCER, V108, P1324, DOI 10.1038/bjc.2013.65; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Pavan L, 2003, CARCINOGENESIS, V24, P1325, DOI 10.1093/carcin/bgg074; Sanfiorenzo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054596; Seliger B, 2007, CLIN CANCER RES, V13, P27, DOI 10.1158/1078-0432.CCR-06-0824; Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1; Stehle F, 2013, J BIOL CHEM, V288, P16334, DOI 10.1074/jbc.M112.437962; Takihara Y, 2000, CARCINOGENESIS, V21, P2073, DOI 10.1093/carcin/21.11.2073; Tsuruta T, 2011, CANCER RES, V71, P6450, DOI 10.1158/0008-5472.CAN-11-0364; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Xiang Y, 2014, ONCOGENE, V33, P378, DOI 10.1038/onc.2012.575; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhao J, 2011, SEMIN CELL DEV BIOL, V22, P705, DOI 10.1016/j.semcdb.2011.09.012; Zhu C, 2013, PROSTATE, V73, P1082, DOI 10.1002/pros.22656; Zhu XM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.002	53	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31121	31135		10.1074/jbc.M114.556290	http://dx.doi.org/10.1074/jbc.M114.556290			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25228695	Green Published, hybrid			2022-12-28	WOS:000344549900021
J	Brandt, U; Schurmann, M; Steinbuchel, A				Brandt, Ulrike; Schuermann, Marc; Steinbuechel, Alexander			Mercaptosuccinate Dioxygenase, a Cysteine Dioxygenase Homologue, from Variovorax paradoxus Strain B4 Is the Key Enzyme of Mercaptosuccinate Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUANTUM DOTS; PURIFICATION; IDENTIFICATION; INTERMEDIATE; ACTIVATION; CATABOLISM; EXPRESSION; MECHANISM; DPN7(T); PLANTS	The versatile thiol mercaptosuccinate has a wide range of applications, e.g. in quantum dot research or in bioimaging. Its metabolism is investigated in Variovorax paradoxus strain B4, which can utilize this compound as the sole source of carbon and sulfur. Proteomic studies of strain B4 resulted in the identification of a putative mercaptosuccinate dioxygenase, a cysteine dioxygenase homologue, possibly representing the key enzyme in the degradation of mercaptosuccinate. Therefore, the putative mercaptosuccinate dioxygenase was heterologously expressed, purified, and characterized in this study. The results clearly demonstrated that the enzyme utilizes mercaptosuccinate with concomitant consumption of oxygen. Thus, the enzyme is designated as mercaptosuccinate dioxygenase. Succinate and sulfite were verified as the final reaction products. The enzyme showed an apparent K-m of 0.4 mM, and a specific activity (V-max) of 20.0 mu mol min(-1) mg(-1) corresponding to a k(cat) of 7.7 s(-1). Furthermore, the enzyme was highly specific for mercaptosuccinate, no activity was observed with cysteine, dithiothreitol, 2-mercaptoethanol, and 3-mercaptopropionate. These structurally related thiols did not have an inhibitory effect either. Fe(II) could clearly be identified as metal cofactor of the mercaptosuccinate dioxygenase with a content of 0.6 mol of Fe(II)/mol of enzyme. The recently proposed hypothesis for the degradation pathway of mercaptosuccinate based on proteome analyses could be strengthened in the present study. (i) Mercaptosuccinate is first converted to sulfinosuccinate by this mercaptosuccinate dioxygenase; (ii) sulfinosuccinate is spontaneously desulfinated to succinate and sulfite; and (iii) whereas succinate enters the central metabolism, sulfite is detoxified by the previously identified putative molybdopterin oxidoreductase.	[Brandt, Ulrike; Schuermann, Marc; Steinbuechel, Alexander] Univ Munster, Inst Mol Microbiol & Biotechnol, D-48149 Munster, Germany; [Steinbuechel, Alexander] King Abdulaziz Univ, Fac Biol, Jeddah 21413, Saudi Arabia	University of Munster; King Abdulaziz University	Steinbuchel, A (corresponding author), Univ Munster, Inst Mol Microbiol & Biotechnol, D-48149 Munster, Germany.	steinbu@uni-muenster.de						Bach LG, 2013, J COLLOID INTERF SCI, V394, P132, DOI 10.1016/j.jcis.2012.11.068; Belimov AA, 2009, NEW PHYTOL, V181, P413, DOI 10.1111/j.1469-8137.2008.02657.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt U, 2014, APPL MICROBIOL BIOT, V98, P6039, DOI 10.1007/s00253-014-5811-7; Britton HTS, 1931, J CHEM SOC, P1456, DOI 10.1039/jr9310001456; Bruland N, 2009, J BIOL CHEM, V284, P660, DOI 10.1074/jbc.M806762200; Carbajal-Rodriguez I, 2011, J BACTERIOL, V193, P527, DOI 10.1128/JB.00793-10; Chai SC, 2005, J BIOL CHEM, V280, P9865, DOI 10.1074/jbc.M413733200; CHENEY GE, 1959, J PHYS CHEM-US, V63, P2055, DOI 10.1021/j150582a018; Dominy JE, 2006, J BACTERIOL, V188, P5561, DOI 10.1128/JB.00291-06; Driggers CM, 2013, J MOL BIOL, V425, P3121, DOI 10.1016/j.jmb.2013.05.028; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Filby G., 1974, U.S. Patent, Patent No. [US3950404A, 3950404]; Fu T, 2010, J NANOSCI NANOTECHNO, V10, P1741, DOI 10.1166/jnn.2010.2049; Ghaderi S, 2012, J NANOSCI NANOTECHNO, V12, P4928, DOI 10.1166/jnn.2012.4907; Levin EJ, 2007, STRUCTURE, V15, P1040, DOI 10.1016/j.str.2007.06.019; McCoy JG, 2006, P NATL ACAD SCI USA, V103, P3084, DOI 10.1073/pnas.0509262103; Mubbeler JH, 2006, INT J SYST EVOL MICR, V56, P1305, DOI 10.1099/ijs.0.64126-0; Pawelec M, 2004, DALTON T, P292, DOI 10.1039/b311053b; Pierce BS, 2007, BIOCHEMISTRY-US, V46, P8569, DOI 10.1021/bi700662d; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Rizvi Sarwat B, 2012, Int J Nanomedicine, V7, P3915, DOI 10.2147/IJN.S28577; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Satola B, 2013, APPL MICROBIOL BIOT, V97, P541, DOI 10.1007/s00253-012-4585-z; Schurmann M, 2013, J BACTERIOL, V195, P1538, DOI 10.1128/JB.02105-12; Schurmann M, 2011, J BACTERIOL, V193, P3078, DOI 10.1128/JB.00049-11; Simmons CR, 2008, BIOCHEMISTRY-US, V47, P11390, DOI 10.1021/bi801546n; Simmons CR, 2006, J BIOL CHEM, V281, P18723, DOI 10.1074/jbc.M601555200; Simmons CR, 2006, PROTEIN EXPRES PURIF, V47, P74, DOI 10.1016/j.pep.2005.10.025; SMITH GF, 1952, ANALYST, V77, P418, DOI 10.1039/an9527700418; SORBO B, 1987, METHOD ENZYMOL, V143, P3; Souness RJ, 2013, BIOCHEMISTRY-US, V52, P7606, DOI 10.1021/bi400661a; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Stipanuk MH, 2009, AMINO ACIDS, V37, P55, DOI 10.1007/s00726-008-0202-y; Stipanuk MH, 2011, AMINO ACIDS, V41, P91, DOI 10.1007/s00726-010-0518-2; Tchesnokov EP, 2012, BIOCHEMISTRY-US, V51, P257, DOI 10.1021/bi201597w; YAMAGUCHI K, 1978, J BIOCHEM-TOKYO, V83, P479, DOI 10.1093/oxfordjournals.jbchem.a131935; Ye S, 2007, J BIOL CHEM, V282, P3391, DOI 10.1074/jbc.M609337200	40	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30800	30809		10.1074/jbc.M114.579730	http://dx.doi.org/10.1074/jbc.M114.579730			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25228698	Green Published, hybrid			2022-12-28	WOS:000344549700054
J	Oganesyan, V; Peng, L; Damschroder, MM; Cheng, L; Sadowska, A; Tkaczyk, C; Sellman, BR; Wu, H; Dall'Acqua, WF				Oganesyan, Vaheh; Peng, Li; Damschroder, Melissa M.; Cheng, Li; Sadowska, Agnieszka; Tkaczyk, Christine; Sellman, Bret R.; Wu, Herren; Dall'Acqua, William F.			Mechanisms of Neutralization of a Human Anti-alpha-toxin Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody; Crystal Structure; Infectious Disease; Mutagenesis; Staphylococcus aureus (S; aureus); Fab; Alpha Toxin	STAPHYLOCOCCUS-AUREUS; PASSIVE-IMMUNIZATION; HEMOLYSIN; MUTAGENESIS; SEVERITY; BINDING	Background: MEDI4893 is an anti--toxin (AT) antibody currently in clinical trial in the field of Staphylococcus aureus-mediated diseases. Results: Structure/function studies of MEDI4893 reveal its epitope and mechanisms of action. Conclusion: MEDI4893 recognizes a novel epitope and exhibits a possible dual neutralization mechanism. Significance: Understanding the molecular basis of AT/MEDI4893 interaction has important implications to design potent antibodies targeting Staphylococcus aureus. MEDI4893 is a neutralizing human monoclonal antibody that targets -toxin (AT) and is currently undergoing evaluation in the field of Staphylococcus aureus-mediated diseases. We have solved the crystal structure of MEDI4893 Fab bound to monomeric AT at a resolution of 2.56 and further characterized its epitope using various engineered AT variants. We have found that MEDI4893 recognizes a novel epitope in the so-called rim domain of AT and exerts its neutralizing effect through a dual mechanism. In particular, MEDI4893 not only sterically blocks binding of AT to its cell receptor but also prevents it from adopting a lytic heptameric trans-membrane conformation.	[Oganesyan, Vaheh; Peng, Li; Damschroder, Melissa M.; Cheng, Li; Wu, Herren; Dall'Acqua, William F.] Medimmune Inc, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA; [Sadowska, Agnieszka; Tkaczyk, Christine; Sellman, Bret R.] Medimmune Inc, Dept Infect Dis, Gaithersburg, MD 20878 USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune	Oganesyan, V (corresponding author), Medimmune Inc, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA.	oganesyanv@medimmune.com; dallacquaw@medimmune.com		Damschroder, Melissa/0000-0001-9453-6532				Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; de Kraker MEA, 2011, ANTIMICROB AGENTS CH, V55, P1598, DOI 10.1128/AAC.01157-10; Folettit D, 2013, J MOL BIOL, V425, P1641, DOI 10.1016/j.jmb.2013.02.008; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Gouaux E, 1997, PROTEIN SCI, V6, P2631; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menzies BE, 1996, INFECT IMMUN, V64, P1839, DOI 10.1128/IAI.64.5.1839-1841.1996; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oganesyan V, 2013, ACTA CRYSTALLOGR F, V69, P302, DOI 10.1107/S1744309113002881; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Powers ME, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003871; Ragle BE, 2010, ANTIMICROB AGENTS CH, V54, P298, DOI 10.1128/AAC.00973-09; Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Tkaczyk C, 2012, CLIN VACCINE IMMUNOL, V19, P377, DOI 10.1128/CVI.05589-11; Tkaczyk C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075103; WALKER B, 1995, J BIOL CHEM, V270, P23065, DOI 10.1074/jbc.270.39.23065; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208	28	61	69	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29874	29880		10.1074/jbc.M114.601328	http://dx.doi.org/10.1074/jbc.M114.601328			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25210036	hybrid, Green Published			2022-12-28	WOS:000344370800031
J	Liu, XM; He, FX; Pang, RR; Zhao, D; Qiu, W; Shan, K; Zhang, J; Lu, YL; Li, Y; Wang, YW				Liu, Xiaomei; He, Fengxia; Pang, Rongrong; Zhao, Dan; Qiu, Wen; Shan, Kai; Zhang, Jing; Lu, Yanlai; Li, Yan; Wang, Yingwei			Interleukin-17 (IL-17)-induced MicroRNA 873 (miR-873) Contributes to the Pathogenesis of Experimental Autoimmune Encephalomyelitis by Targeting A20 Ubiquitin-editing Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ZINC-FINGER PROTEIN; MULTIPLE-SCLEROSIS; CELLS; INFLAMMATION; EXPRESSION; RESPONSES; TNFAIP3; IL-17	Interleukin 17 (IL-17), produced mainly by T helper 17 (Th17) cells, is increasingly recognized as a key regulator in various autoimmune diseases, including human multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). Although several microRNAs (miRNAs) with aberrant expression have been shown to contribute to the pathogenesis of MS and EAE, the mechanisms underlying the regulation of abnormal miRNA expression in astrocytes upon IL-17 stimulation remain unclear. In the present study, we detected the changes of miRNA expression profiles both in the brain tissue of EAE mice and in cultured mouse primary astrocytes stimulated with IL-17 and identified miR-873 as one of the co-up-regulated miRNAs in vivo and in vitro. The overexpression of miR-873, demonstrated by targeting A20 (TNF alpha-induced protein 3, TNFAIP3), remarkably reduced the A20 level and promoted NF-kappa B activation in vivo and in vitro as well as increasing the production of inflammatory cytokines and chemokines (i.e. IL-6, TNF-alpha, MIP-2, and MCP-1/5). More importantly, silencing the endogenous miR-873 or A20 gene with lentiviral vector of miR-873 sponge (LV-miR-873 sponge) or short hairpin RNA (shRNA) of A20 (LV-A20 shRNA) in vivo significantly lessened or aggravated inflammation and demyelination in the central nervous system (CNS) of EAE mice, respectively. Taken together, these findings indicate that miR-873 induced by IL-17 stimulation promotes the production of inflammatory cytokines and aggravates the pathological process of EAE mice through the A20/NF-kappa B pathway, which provides a new insight into the mechanism of inflammatory damage in MS.	[Liu, Xiaomei; He, Fengxia; Pang, Rongrong; Zhao, Dan; Qiu, Wen; Shan, Kai; Zhang, Jing; Lu, Yanlai; Li, Yan; Wang, Yingwei] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University	Wang, YW (corresponding author), Nanjing Med Univ, Dept Microbiol & Immunol, Hanzhong Rd 140, Nanjing 210029, Jiangsu, Peoples R China.	wangyw1508@njmu.edu.cn	Shan, Kai/GSJ-6217-2022	Li, Yan/0000-0003-0420-4222; He, Fengxia/0000-0002-1695-3127	Jiangsu Province Key Laboratory of Neurodegeneration Grant [SJ11KF07]; National Natural Science Foundation of China [81072402]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Jiangsu Province Key Laboratory of Neurodegeneration Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by Jiangsu Province Key Laboratory of Neurodegeneration Grant SJ11KF07) and National Natural Science Foundation of China Grant 81072402 as well as the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brambilla R, 2009, J IMMUNOL, V182, P2628, DOI 10.4049/jimmunol.0802954; Creeke PI, 2013, THER ADV NEUROL DISO, V6, P3, DOI 10.1177/1756285612469264; de Faria Omar Jr., 2013, Frontiers in Genetics, V3, P311, DOI 10.3389/fgene.2012.00311; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Fenoglio C, 2012, INT J MOL SCI, V13, P13227, DOI 10.3390/ijms131013227; Garofalo M, 2011, ANNU REV PHARMACOL, V51, P25, DOI 10.1146/annurev-pharmtox-010510-100517; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Guerau-de-Arellano M, 2011, BRAIN, V134, P3575, DOI 10.1093/brain/awr262; Hanieh H, 2013, EUR J IMMUNOL, V43, P2771, DOI 10.1002/eji.201343486; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hemdan NY, 2010, AUTOIMMUN REV, V9, P785, DOI 10.1016/j.autrev.2010.07.003; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Iborra M, 2012, AUTOIMMUN REV, V11, P305, DOI 10.1016/j.autrev.2010.07.002; Junker A, 2011, NAT REV NEUROL, V7, P56, DOI 10.1038/nrneurol.2010.179; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lescher J, 2012, J NEUROIMMUNOL, V246, P27, DOI 10.1016/j.jneuroim.2012.02.012; Liu LS, 2012, J BIOL CHEM, V287, P16410, DOI 10.1074/jbc.M111.319566; Liu XM, 2006, J BIOL CHEM, V281, P17432, DOI 10.1074/jbc.M513490200; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Martinelli-Boneschi F, 2012, NEUROSCI LETT, V508, P4, DOI 10.1016/j.neulet.2011.11.006; Marwaha AK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00129; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Meares GP, 2012, GLIA, V60, P771, DOI 10.1002/glia.22307; Mor E, 2011, NUCLEIC ACIDS RES, V39, P3710, DOI 10.1093/nar/gkq1325; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; Musone SL, 2011, GENES IMMUN, V12, P176, DOI 10.1038/gene.2010.64; Nagpal JK, 2010, CURR MOL MED, V10, P503, DOI 10.2174/156652410791608216; Nakahama T, 2013, P NATL ACAD SCI USA, V110, P11964, DOI 10.1073/pnas.1311087110; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Qin HW, 2008, J IMMUNOL, V181, P3167, DOI 10.4049/jimmunol.181.5.3167; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Thamilarasan M, 2012, AUTOIMMUN REV, V11, P174, DOI 10.1016/j.autrev.2011.05.009; Waschbisch A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024604; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; Zepp J, 2011, TRENDS IMMUNOL, V32, P232, DOI 10.1016/j.it.2011.02.007; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815	47	54	58	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28971	28986		10.1074/jbc.M114.577429	http://dx.doi.org/10.1074/jbc.M114.577429			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25183005	hybrid, Green Published			2022-12-28	WOS:000344141000018
J	Meiselbach, H; Vogel, N; Langlhofer, G; Stangl, S; Schleyer, B; Bahnassawy, L; Sticht, H; Breitinger, HG; Becker, CM; Villmann, C				Meiselbach, Heike; Vogel, Nico; Langlhofer, Georg; Stangl, Sabine; Schleyer, Barbara; Bahnassawy, Lamia'a; Sticht, Heinrich; Breitinger, Hans-Georg; Becker, Cord-Michael; Villmann, Carmen			Single Expressed Glycine Receptor Domains Reconstitute Functional Ion Channels without Subunit-specific Desensitization Behavior	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FEBRILE SEIZURES PLUS; CYS-LOOP RECEPTOR; CHROMOSOMAL LOCALIZATION; ACETYLCHOLINE-RECEPTOR; GENERALIZED EPILEPSY; FRAMESHIFT MUTATION; ALPHA-1; HYPEREKPLEXIA; DETERMINES; GENE	Cys loop receptors are pentameric arrangements of independent subunits that assemble into functional ion channels. Each subunit shows a domain architecture. Functional ion channels can be reconstituted even from independent, nonfunctional subunit domains, as shown previously for GlyR alpha 1 receptors. Here, we demonstrate that this reconstitution is not restricted to alpha 1 but can be transferred to other members of the Cys loop receptor family. A nonfunctional GlyR subunit, truncated at the intracellular TM3-4 loop by a premature stop codon, can be complemented by co-expression of the missing tail portion of the receptor. Compared with alpha 1 subunits, rescue by domain complementation was less efficient when GlyR alpha 3 or the GABA(A/C) subunit rho 1 was used. If truncation disrupted an alternative splicing cassette within the intracellular TM3-4 loop of alpha 3 subunits, which also regulates receptor desensitization, functional rescue was not possible. When alpha 3 receptors were restored by complementation using domains with and without the spliced insert, no difference in desensitization was found. In contrast, desensitization properties could even be transferred between alpha 1/alpha 3 receptor chimeras harboring or lacking the alpha 3 splice cassette proving that functional rescue depends on the integrity of the alternative splicing cassette in alpha 3. Thus, an intact alpha 3 splicing cassette in the TM3-4 loop environment is indispensable for functional rescue, and the quality of receptor restoration can be assessed from desensitization properties.	[Meiselbach, Heike; Sticht, Heinrich] Univ Erlangen Nurnberg, Emil Fischer Ctr, D-91054 Erlangen, Germany; [Vogel, Nico; Stangl, Sabine; Becker, Cord-Michael; Villmann, Carmen] Univ Erlangen Nurnberg, Emil Fischer Ctr, Inst Biochem, D-91054 Erlangen, Germany; [Langlhofer, Georg; Schleyer, Barbara; Villmann, Carmen] Univ Wurzburg, Inst Clin Neurobiol, D-97078 Wurzburg, Germany; [Bahnassawy, Lamia'a; Breitinger, Hans-Georg] German Univ Cairo, Dept Biochem, Cairo 11835, Egypt	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Wurzburg; Egyptian Knowledge Bank (EKB); German University in Cairo	Villmann, C (corresponding author), Univ Wurzburg, Inst Clin Neurobiol, Versbacherstr 5, D-97078 Wurzburg, Germany.	Villmann_C@ukw.de	Breitinger, Hans-Georg/ABD-3247-2021	Breitinger, Hans-Georg/0000-0003-0111-3528; Langlhofer, Georg/0000-0003-4386-8777; Sticht, Heinrich/0000-0001-5644-045X	Deutsche Forschungsgemeinschaft [VI586, BR 1507]; Johannes and Frieda Marohn Stiftung.; Graduate School of Life Science, Wurzburg, Germany; Science and Technology Development Fund [1785]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Johannes and Frieda Marohn Stiftung.; Graduate School of Life Science, Wurzburg, Germany; Science and Technology Development Fund(Science and Technology Development Fund (STDF))	This work was supported in part by Deutsche Forschungsgemeinschaft Grant VI586 and the Johannes and Frieda Marohn Stiftung.; Supported by the Graduate School of Life Science, Wurzburg, Germany.; Supported by Deutsche Forschungsgemeinschaft Grant BR 1507 and Science and Technology Development Fund Grant 1785.	Accelrys Inc, 2005, DS VIEWERPRO SUIT 6; Bedwell DM, 1997, NAT MED, V3, P1280, DOI 10.1038/nm1197-1280; Bode A, 2013, J BIOL CHEM, V288, P33745, DOI 10.1074/jbc.M113.509240; Breitinger HG, 2009, J BIOL CHEM, V284, P28624, DOI 10.1074/jbc.M109.043174; Breitinger HG, 2002, J NEUROCHEM, V83, P30, DOI 10.1046/j.1471-4159.2002.01109.x; BUCKWALTER MS, 1994, HUM MOL GENET, V3, P2025, DOI 10.1093/hmg/3.11.2025; Chen XB, 2009, MOL MEMBR BIOL, V26, P321, DOI 10.1080/09687680903120319; Cheng MHY, 2007, PROTEINS, V68, P581, DOI 10.1002/prot.21435; Enz R, 1996, J NEUROSCI, V16, P4479; FINERMOORE J, 1984, P NATL ACAD SCI-BIOL, V81, P155, DOI 10.1073/pnas.81.1.155; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Han L, 2013, ACS CHEM NEUROSCI, V4, P1361, DOI 10.1021/cn400097j; Han L, 2013, ACS CHEM NEUROSCI, V4, P248, DOI 10.1021/cn300177g; Harkin LA, 2002, AM J HUM GENET, V70, P530, DOI 10.1086/338710; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huang RQ, 2007, BIOCHEMISTRY-US, V46, P11484, DOI 10.1021/bi701093j; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Kang JQ, 2009, J NEUROSCI, V29, P2845, DOI 10.1523/JNEUROSCI.4772-08.2009; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; Kling C, 1997, NEUROSCIENCE, V78, P411, DOI 10.1016/S0306-4522(96)00567-2; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; MALOSIO ML, 1991, J BIOL CHEM, V266, P2048; MATZENBACH B, 1994, J BIOL CHEM, V269, P2607; Melzer N, 2010, J BIOL CHEM, V285, P3730, DOI 10.1074/jbc.M109.030460; Nicholas K. B., 1997, EMBNEW NEWS, V4, P97; Nikolic Z, 1998, J BIOL CHEM, V273, P19708, DOI 10.1074/jbc.273.31.19708; Nys M, 2013, BIOCHEM PHARMACOL, V86, P1042, DOI 10.1016/j.bcp.2013.07.001; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; Sanchez R, 2000, METH MOL B, V143, P97; Schaefer N, 2013, BRIT J PHARMACOL, V170, P933, DOI 10.1111/bph.12335; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripos Inc, 2002, SYB 6 9 REL 7 0A; Tsai CH, 2004, NEUROLOGY, V63, P893, DOI 10.1212/01.WNL.0000138566.65519.67; Unterer B, 2012, J BIOL CHEM, V287, P39205, DOI 10.1074/jbc.M112.376053; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Villmann C, 2009, J NEUROSCI, V29, P2440, DOI 10.1523/JNEUROSCI.4400-08.2009; Vogel N, 2009, J BIOL CHEM, V284, P36128, DOI 10.1074/jbc.M109.043448; Yevenes GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023886; Yevenes GE, 2008, P NATL ACAD SCI USA, V105, P20523, DOI 10.1073/pnas.0806257105; Yevenes GE, 2006, J BIOL CHEM, V281, P39300, DOI 10.1074/jbc.M608272200	45	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29135	29147		10.1074/jbc.M114.559138	http://dx.doi.org/10.1074/jbc.M114.559138			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25143388	hybrid, Green Published			2022-12-28	WOS:000344141000030
J	Zhao, Y; Ling, F; Griffin, TM; He, T; Towner, R; Ruan, H; Sun, XH				Zhao, Ying; Ling, Flora; Griffin, Timothy M.; He, Ting; Towner, Rheal; Ruan, Hong; Sun, Xiao-Hong			Up-regulation of the Sirtuin 1 (Sirt1) and Peroxisome Proliferator-activated Receptor gamma Coactivator-1 alpha (PGC-1 alpha) Genes in White Adipose Tissue of Id1 Protein-deficient Mice IMPLICATIONS IN THE PROTECTION AGAINST DIET AND AGE-INDUCED GLUCOSE INTOLERANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; PPAR-GAMMA; BROWN FAT; DIFFERENTIATION; INHIBITOR; ADIPOGENESIS; ADIPOCYTES; EXPRESSION; BALANCE; OBESITY	Id1, a helix-loop-helix (HLH) protein that inhibits the function of basic HLH E protein transcription factors in lymphoid cells, has been implicated in diet-and age-induced obesity by unknown mechanisms. Here we show that Id1-deficient mice are resistant to a high fat diet- and age-induced obesity, as revealed by reduced weight gain and body fat, increased lipid oxidation, attenuated hepatosteatosis, lower levels of lipid droplets in brown adipose tissue, and smaller white adipocytes after a high fat diet feeding or in aged animals. Id1 deficiency improves glucose tolerance, lowers serum insulin levels, and reduces TNF alpha gene expression in white adipose tissue. Id1 deficiency also increased expression of Sirtuin 1 and peroxisome proliferator-activated receptor gamma coactivator 1 alpha, regulators of mitochondrial biogenesis and energy expenditure, in the white adipose tissue. This effect was accompanied by the elevation of several genes encoding proteins involved in oxidative phosphorylation and fatty acid oxidation, such as cytochrome c, medium-chain acyl-CoA dehydrogenase, and adipocyte protein 2. Moreover, the phenotype for Id1 deficiency was similar to that of mice expressing an E protein dominant-positive construct, ET2, suggesting that the balance between Id and E proteins plays a role in regulating lipid metabolism and insulin sensitivity.	[Zhao, Ying; Ling, Flora; Sun, Xiao-Hong] Oklahoma Med Res Fdn, Program Immunobiol & Canc Res, Oklahoma City, OK 73104 USA; [Griffin, Timothy M.] Oklahoma Med Res Fdn, Program Free Radical Biol & Aging, Oklahoma City, OK 73104 USA; [He, Ting; Towner, Rheal] Oklahoma Med Res Fdn, Adv Magnet Resonance Ctr, Oklahoma City, OK 73104 USA; [Ling, Flora; Sun, Xiao-Hong] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Griffin, Timothy M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Ruan, Hong] Rutgers State Univ, Dept Physiol & Biophys, Piscataway, NJ 08854 USA	Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Rutgers State University New Brunswick	Sun, XH (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	sunx@omrf.org	Griffin, Timothy M./V-8838-2019	Griffin, Timothy M./0000-0001-8840-9940; Towner, Rheal/0000-0001-7368-8983; Sun, Xiao-Hong/0000-0003-0572-2662	National Institutes of Health [AI56129]; Oklahoma Center for Adult Stem Cell Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for Adult Stem Cell Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI56129 (to X.-H. S.). This work was also supported by the Oklahoma Center for Adult Stem Cell Research.	Akerfeldt MC, 2011, DIABETES, V60, P2506, DOI 10.2337/db11-0083; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Cochrane SW, 2009, BLOOD, V113, P1016, DOI 10.1182/blood-2008-06-164996; Cutchins A, 2012, ARTERIOSCL THROM VAS, V32, P317, DOI 10.1161/ATVBAHA.111.234856; Doran AC, 2008, CIRC RES, V103, P624, DOI 10.1161/CIRCRESAHA.108.175893; Fasshauer M, 2000, J BIOL CHEM, V275, P25494, DOI 10.1074/jbc.M004046200; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Garteiser P, 2013, METABOLISM, V62, P1686, DOI 10.1016/j.metabol.2013.06.009; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; Langin D, 2010, BBA-MOL CELL BIOL L, V1801, P372, DOI 10.1016/j.bbalip.2009.09.008; Li XL, 2013, ACTA BIOCH BIOPH SIN, V45, P51, DOI 10.1093/abbs/gms108; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Moldes M, 1997, MOL CELL BIOL, V17, P1796, DOI 10.1128/MCB.17.4.1796; Murad JM, 2010, J BIOL CHEM, V285, P24164, DOI 10.1074/jbc.M110.128744; Nieto-Vazquez Iria, 2008, Archives of Physiology and Biochemistry, V114, P183, DOI [10.1080/13813450802181047, 10.1080/13813450802181047 ]; Pan DN, 2009, CELL, V137, P73, DOI 10.1016/j.cell.2009.01.051; Park KW, 2008, MOL ENDOCRINOL, V22, P2038, DOI 10.1210/me.2007-0454; Peng X, 2012, AM J PHYSIOL-CELL PH, V303, pC267, DOI 10.1152/ajpcell.00365.2011; Perry SS, 2007, BLOOD, V110, P2351, DOI 10.1182/blood-2007-01-069914; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Satyanarayana A, 2012, FASEB J, V26, P309, DOI 10.1096/fj.11-190892; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Spiegelman BM, 2000, INT J OBESITY, V24, pS8, DOI 10.1038/sj.ijo.0801492; Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665; Sun XH, 2004, ADV IMMUNOL, V84, P43, DOI 10.1016/S0065-2776(04)84002-1; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Yang TL, 2006, TRENDS ENDOCRIN MET, V17, P186, DOI 10.1016/j.tem.2006.04.002; Yang YZ, 2006, J BIOL CHEM, V281, P34989, DOI 10.1074/jbc.M608078200; Zhang XM, 2007, J BIOL CHEM, V282, P33284, DOI 10.1074/jbc.M705089200; Zhao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055552	47	17	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29112	29122		10.1074/jbc.M114.571679	http://dx.doi.org/10.1074/jbc.M114.571679			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25190816	Green Published, hybrid			2022-12-28	WOS:000344141000028
J	Inamori, K; Willer, T; Hara, Y; Venzke, D; Anderson, ME; Clarke, NF; Guicheney, P; Bonnemann, CG; Moore, SA; Campbell, KP				Inamori, Kei-ichiro; Willer, Tobias; Hara, Yuji; Venzke, David; Anderson, Mary E.; Clarke, Nigel F.; Guicheney, Pascale; Boennemann, Carsten G.; Moore, Steven A.; Campbell, Kevin P.			Endogenous Glucuronyltransferase Activity of LARGE or LARGE2 Required for Functional Modification of alpha-Dystroglycan in Cells and Tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG-SYNDROME; HUMAN LARGE GENE; LAMININ-BINDING; ABNORMAL GLYCOSYLATION; LARGE FAMILY; MUTATIONS; GLYCOSYLTRANSFERASES; EXPRESSION; ISPD	Mutations in the LARGE gene have been identified in congenital muscular dystrophy (CMD) patients with brain abnormalities. Both LARGE and its paralog, LARGE2 (also referred to as GYLTL1B) are bifunctional glycosyltransferases with xylosyltransferase (Xyl-T) and glucuronyltransferase (GlcA-T) activities, and are capable of forming polymers consisting of [-3Xyl-alpha 1,3GlcA beta 1-] repeats. LARGE-dependent modification of alpha-dystroglycan (alpha-DG) with these polysaccharides is essential for the ability of alpha-DG to act as a receptor for ligands in the extracellular matrix. Here we report on the endogenous enzymatic activities of LARGE and LARGE2 in mice and humans, using a newly developed assay for GlcA-T activity. We show that normal mouse and human cultured cells have endogenous LARGE GlcA-T, and that this activity is absent in cells from the Large(myd) (Large-deficient) mouse model of muscular dystrophy, as well as in cells from CMD patients with mutations in the LARGE gene. We also demonstrate that GlcA-T activity is significant in the brain, heart, and skeletal muscle of wild-type and Large2(-/-) mice, but negligible in the corresponding tissues of the Large(myd) mice. Notably, GlcA-T activity is substantial, though reduced, in the kidneys of both the Large(myd) and Large2(-/-) mice, consistent with the observation of alpha-DG/laminin binding in these contexts. This study is the first to test LARGE activity in samples as small as cryosections and, moreover, provides the first direct evidence that not only LARGE, but also LARGE2, is vital to effective functional modification of alpha-DG in vivo.	[Inamori, Kei-ichiro; Willer, Tobias; Hara, Yuji; Venzke, David; Anderson, Mary E.; Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Dept Mol Physiol & Biophys,Dept Internal Med, Roy J & Lucille A Carver Coll Med,Dept Neurol, Iowa City, IA 52242 USA; [Inamori, Kei-ichiro] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Glycopathol, Sendai, Miyagi 9818558, Japan; [Clarke, Nigel F.] Univ Sydney, Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW 2006, Australia; [Guicheney, Pascale] Fac Med Pierre & Marie Curie, INSERM, U1166, Inst Cardiometab & Nutr,ICAN, Paris, France; [Guicheney, Pascale] Univ Paris 06, UMR S1166, Univ Sorbonne, Paris, France; [Boennemann, Carsten G.] NINDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; [Moore, Steven A.] Univ Iowa, Dept Pathol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; Tohoku Medical & Pharmaceutical University; University of Sydney; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Iowa	Campbell, KP (corresponding author), Univ Iowa, Howard Hughes Med Inst, Dept Mol Physiol & Biophys,Dept Internal Med, Roy J & Lucille A Carver Coll Med,Dept Neurol, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Guicheney, Pascale/D-1034-2017; Inamori, Kei-ichiro/ABA-2926-2020	Guicheney, Pascale/0000-0002-7663-2050; Inamori, Kei-ichiro/0000-0002-5947-3633; Moore, Steven/0000-0002-6353-7900; Campbell, Kevin/0000-0003-2066-5889	Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [1 U54 NS053672]; Muscular Dystrophy Association; American Recovery and Reinvestment Act (ARRA) Go Grant [1 RC2 NS069521-01]; Grants-in-Aid for Scientific Research [25670149] Funding Source: KAKEN; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003129, RC2NS069521, U54NS053672] Funding Source: NIH RePORTER	Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center(Ohio State University); Muscular Dystrophy Association(Muscular Dystrophy Association); American Recovery and Reinvestment Act (ARRA) Go Grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant (1 U54 NS053672, to K. P. C., S. A. M., and T. W.), the Muscular Dystrophy Association, and an American Recovery and Reinvestment Act (ARRA) Go Grant (1 RC2 NS069521-01, to K. P. C. and T. W.).	Ashikov A, 2013, GLYCOBIOLOGY, V23, P303, DOI 10.1093/glycob/cws153; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Barbaric Ivana, 2007, Briefings in Functional Genomics & Proteomics, V6, P91, DOI 10.1093/bfgp/elm008; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2005, HUM MOL GENET, V14, P657, DOI 10.1093/hmg/ddi062; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Buysse K, 2013, HUM MOL GENET, V22, P1746, DOI 10.1093/hmg/ddt021; Clarke NF, 2011, EUR J HUM GENET, V19, P452, DOI 10.1038/ejhg.2010.212; DURBEEJ M, 1995, J CELL BIOL, V130, P79, DOI 10.1083/jcb.130.1.79; Fujimura K, 2005, BIOCHEM BIOPH RES CO, V329, P1162, DOI 10.1016/j.bbrc.2005.02.082; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Grewal PK, 2005, GLYCOBIOLOGY, V15, P912, DOI 10.1093/glycob/cwi094; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Hara Y, 2011, NEW ENGL J MED, V364, P939, DOI 10.1056/NEJMoa1006939; Inamori K, 2013, GLYCOBIOLOGY, V23, P295, DOI 10.1093/glycob/cws152; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Jarad G, 2011, AM J PHYSIOL-RENAL, V300, pF811, DOI 10.1152/ajprenal.00725.2010; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2009, HUM MOL GENET, V18, P621, DOI 10.1093/hmg/ddn387; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Lommel M, 2010, NEUROLOGY, V74, P157, DOI 10.1212/WNL.0b013e3181c919d6; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2008, NEUROMUSCULAR DISORD, V18, P45, DOI 10.1016/j.nmd.2007.08.002; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Peyrard M, 1999, P NATL ACAD SCI USA, V96, P598, DOI 10.1073/pnas.96.2.598; Roscioli T, 2012, NAT GENET, V44, P581, DOI 10.1038/ng.2253; Sasaki K, 1997, P NATL ACAD SCI USA, V94, P14294, DOI 10.1073/pnas.94.26.14294; Stevens E, 2013, AM J HUM GENET, V92, P354, DOI 10.1016/j.ajhg.2013.01.016; Takahashi S, 2001, GLYCOBIOLOGY, V11, P37, DOI 10.1093/glycob/11.1.37; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269; Vajsar J, 2006, NEUROMUSCULAR DISORD, V16, P132, DOI 10.1016/j.nmd.2005.11.012; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Vogtlander NPJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005979; Vuillaumier-Barrot S, 2012, AM J HUM GENET, V91, P1135, DOI 10.1016/j.ajhg.2012.10.009; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Wright KM, 2012, NEURON, V76, P931, DOI 10.1016/j.neuron.2012.10.009; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Zhang WL, 2003, CLIN BIOCHEM, V36, P339, DOI 10.1016/S0009-9120(03)00036-5; Zhang WL, 2002, BIOCHEM J, V361, P153, DOI 10.1042/0264-6021:3610153; Zhang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019080	48	12	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28138	28148		10.1074/jbc.M114.597831	http://dx.doi.org/10.1074/jbc.M114.597831			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25138275	Green Published, hybrid			2022-12-28	WOS:000343765400011
J	Podolski, M; Mahamdeh, M; Howard, J				Podolski, Marija; Mahamdeh, Mohammed; Howard, Jonathon			Stu2, the Budding Yeast XMAP215/Dis1 Homolog, Promotes Assembly of Yeast Microtubules by Increasing Growth Rate and Decreasing Catastrophe Frequency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TUBULIN-BINDING; PLUS-END; DYNAMICS; POLYMERASE; PROTEINS; PURIFICATION; MECHANISMS; REVEALS; COMPLEX	Stu2 is the budding yeast member of the XMAP215/Dis1 family of microtubule polymerases. It is essential in cell division, allowing proper spindle orientation and metaphase chromosome alignment, as well as spindle elongation during anaphase. Despite Stu2 having a phenotype that suggests it promotes microtubule growth, like the other members of the XMAP215/Dis1 family, previous studies with purified Stu2 indicate only that it antagonizes microtubule growth. One potential explanation for these contradictory findings is that the assays were performed with mammalian brain tubulin, which may not be the right substrate to test the activity of Stu2 given that yeast and brain tubulins are quite divergent in sequence and that the vertebrate tubulins are subject to many post-translational modifications. To test this possibility, we reconstituted the activity of Stu2 with purified budding yeast tubulin. We found that Stu2 accelerated microtubule growth in yeast tubulin by severalfold, similar to the acceleration reported for XMAP215 in porcine brain tubulin. Furthermore, Stu2 accelerated polymerization in yeast tubulin to a much greater extent than in porcine brain tubulin, and the concentration of Stu2 required to reach 50% maximum activity in yeast tubulin was nearly 2 orders of magnitude lower than that in porcine brain tubulin. We conclude that Stu2 is a microtubule polymerase, like its relatives, and that its activity is considerably higher in yeast tubulin compared with mammalian brain tubulin. The biochemical properties of Stu2 reported here account for many of the phenotypes of Stu2 observed in cells.	[Podolski, Marija; Mahamdeh, Mohammed; Howard, Jonathon] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA	Yale University	Howard, J (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06511 USA.	jonathon.howard@yale.edu	Howard, Jonathon/D-4229-2011; Mahamdeh, Mohammed/AAG-6530-2019; Howard, Jonathon/J-7492-2016	Howard, Jonathon/0000-0003-0086-1196; Howard, Jonathon/0000-0003-0086-1196	National Institutes of Health [R01 GM110386]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM110386 (to J. H.).	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Al-Bassam J, 2006, J CELL BIOL, V172, P1009, DOI 10.1083/jcb.200511010; Al-Bassam J, 2011, TRENDS CELL BIOL, V21, P604, DOI 10.1016/j.tcb.2011.06.007; Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Alper JB, 2013, BIOPHYS J, V104, P1989, DOI 10.1016/j.bpj.2013.03.041; Ayaz P, 2012, SCIENCE, V337, P857, DOI 10.1126/science.1221698; BARNES G, 1992, MOL BIOL CELL, V3, P29, DOI 10.1091/mbc.3.1.29; Bormuth V, 2007, J MICROSC-OXFORD, V226, P1, DOI 10.1111/j.1365-2818.2007.01756.x; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Cassimeris L, 2010, METHOD CELL BIOL, V97, P1; DAVIS A, 1993, BIOCHEMISTRY-US, V32, P8823, DOI 10.1021/bi00085a013; FIELD DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4041, DOI 10.1073/pnas.81.13.4041; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Gell C, 2011, METHODS MOL BIOL, V777, P15, DOI 10.1007/978-1-61779-252-6_2; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Howard J., 2001, MECH MOTOR PROTEINS; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kosco KA, 2001, MOL BIOL CELL, V12, P2870, DOI 10.1091/mbc.12.9.2870; Luduena RF, 1998, INT REV CYTOL, V178, P207; NEFF NF, 1983, CELL, V33, P211, DOI 10.1016/0092-8674(83)90350-1; SCHATZ PJ, 1986, MOL CELL BIOL, V6, P3711, DOI 10.1128/MCB.6.11.3711; Severin F, 2001, J CELL BIOL, V153, P435, DOI 10.1083/jcb.153.2.435; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Takeshita N, 2013, J CELL SCI, V126, P5400, DOI 10.1242/jcs.129841; van Breugel M, 2003, J CELL BIOL, V161, P359, DOI 10.1083/jcb.200211097; van der Vaart B, 2009, BIOCHEM SOC T, V37, P1007, DOI 10.1042/BST0371007; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; Widlund PO, 2012, MOL BIOL CELL, V23, P4393, DOI 10.1091/mbc.E12-06-0444; Widlund PO, 2011, P NATL ACAD SCI USA, V108, P2741, DOI 10.1073/pnas.1016498108; Williams RC, 1999, ANAL BIOCHEM, V275, P265, DOI 10.1006/abio.1999.4326; Zanic M, 2013, NAT CELL BIOL, V15, P688, DOI 10.1038/ncb2744	36	42	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28087	28093		10.1074/jbc.M114.584300	http://dx.doi.org/10.1074/jbc.M114.584300			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25172511	hybrid, Green Published			2022-12-28	WOS:000343765400003
J	Qi, YY; Marlin, MC; Liang, ZM; Berry, WL; Janknecht, R; Zhou, J; Wang, ZH; Lu, GD; Li, GP				Qi, Yaoyao; Marlin, M. Caleb; Liang, Zhimin; Berry, William L.; Janknecht, Ralf; Zhou, Jie; Wang, Zonghua; Lu, Guodong; Li, Guangpu			Distinct Biochemical and Functional Properties of Two Rab5 Homologs from the Rice Blast Fungus Magnaporthe oryzae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL GTPASE RAB5; EARLY ENDOCYTIC PATHWAY; MEMBRANE-FUSION; ENDOSOME FUSION; RECYCLING ENDOSOMES; NEURITE OUTGROWTH; IN-VITRO; TRAFFICKING; EEA1; EFFECTOR	Rab5 is a key regulator of early endocytosis by promoting early endosomal fusion and motility. In this study, we have unexpectedly found distinct properties of the two Rab5 homologs (MoRab5A and MoRab5B) from Magnaporthe oryzae, a pathogenic fungus in plants whose infection causes rice blast disease. Like mammalian Rab5, MoRab5A and MoRab5B can bind to several Rab5 effectors in a GTP-dependent manner, including EEA1, Rabenosyn-5, and Rabaptin-5. However, MoRab5A shows distinct binding characteristics in the sense that both the wild-type and the GTP hydrolysis-defective constitutively active mutant bind the effectors equally well in GST pull-down assays, suggesting that MoRab5A is defective in GTP hydrolysis and mostly in the GTP-bound conformation in the cell. Indeed, GTP hydrolysis assays indicate that MoRab5A GTPase activity is dramatically lower than MoRab5B and human Rab5 and is insensitive to RabGAP5 stimulation. We have further identified a Pro residue in the switch I region largely responsible for the distinct MoRab5A properties by characterization of MoRab5A and MoRab5B chimeras and mutagenesis. The differences between MoRab5A and MoRab5B extend to their functions in the cell. Although they both target to early endosomes, only MoRab5B closely resembles human Rab5 in promoting early endosome fusion and stimulating fluid phase endocytosis. In contrast, MoRab5A correlates with another related early endosomal Rab, Rab22, in terms of the presence of the switch I Pro residue and the blocked GTPase activity. Our data thus identify MoRab5B as the Rab5 ortholog and suggest that MoRab5A specializes to perform a non-redundant function in endosomal sorting.	[Qi, Yaoyao; Zhou, Jie; Wang, Zonghua; Lu, Guodong] Fujian Agr & Forestry Univ, Key Lab Biopesticides & Chem Biol, Minist Educ, Fuzhou 350002, Fujian, Peoples R China; [Qi, Yaoyao; Marlin, M. Caleb; Liang, Zhimin; Li, Guangpu] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Berry, William L.; Janknecht, Ralf] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Janknecht, Ralf; Li, Guangpu] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73104 USA	Fujian Agriculture & Forestry University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Lu, GD (corresponding author), Fujian Agr & Forestry Univ, Key Lab Biopesticides & Chem Biol, Minist Educ, Fuzhou 350002, Fujian, Peoples R China.	gdlufafu@163.com; guangpu-li@ouhsc.edu	Li, Guangpu/GRS-5397-2022	Marlin, M. Caleb/0000-0003-0453-5355; Berry, William/0000-0002-1661-5443; Janknecht, Ralf/0000-0003-1741-1562	National Institutes of Health [R01GM074692]; NSFC [31328002, 31070124]; China Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM074692, NSFC Grants 31328002 and 31070124, and a scholarship from the China Scholarship Council.	Atkinson HA, 2002, FUNGAL GENET BIOL, V37, P233, DOI 10.1016/S1087-1845(02)00535-2; Balaji K, 2012, J CELL SCI, V125, P5887, DOI 10.1242/jcs.113688; BARBIERI MA, 1994, J BIOL CHEM, V269, P18720; Berry WL, 2014, INT J ONCOL, V44, P1341, DOI 10.3892/ijo.2014.2279; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Diekmann Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002217; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; Elias M, 2012, J CELL SCI, V125, P2500, DOI 10.1242/jcs.101378; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Kauppi M, 2002, J CELL SCI, V115, P899; Klopper TH, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-71; Kummel D, 2014, CURR OPIN CELL BIOL, V29, P61, DOI 10.1016/j.ceb.2014.04.007; Li G., 2012, YPT RAB GTPASES INTR, P3; LI GP, 1993, J BIOL CHEM, V268, P24475; LI GP, 1993, ARCH BIOCHEM BIOPHYS, V304, P471, DOI 10.1006/abbi.1993.1377; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Magadan JG, 2006, MOL CELL BIOL, V26, P2595, DOI 10.1128/MCB.26.7.2595-2614.2006; MARINO MP, 2003, LENTIVIRUS GENE ENG, P43; Mishra A, 2010, P NATL ACAD SCI USA, V107, P10866, DOI 10.1073/pnas.1000843107; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Simpson JC, 2004, J CELL SCI, V117, P6297, DOI 10.1242/jcs.01560; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; STEINMAN RM, 1974, J CELL BIOL, V63, P949, DOI 10.1083/jcb.63.3.949; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Wang L, 2011, MOL BIOL CELL, V22, P3853, DOI 10.1091/mbc.E11-03-0277; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; Zacchi P, 1998, J CELL BIOL, V140, P1039, DOI 10.1083/jcb.140.5.1039; Zhu HP, 2009, MOL BIOL CELL, V20, P4720, DOI 10.1091/mbc.E09-06-0453	38	7	9	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28299	28309		10.1074/jbc.M114.591503	http://dx.doi.org/10.1074/jbc.M114.591503			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25164815	Green Published, hybrid			2022-12-28	WOS:000343765400025
J	Belardinelli, JM; Larrouy-Maumus, G; Jones, V; de Carvalho, LPS; McNeil, MR; Jackson, M				Belardinelli, Juan Manuel; Larrouy-Maumus, Gerald; Jones, Victoria; de Carvalho, Luiz Pedro Sorio; McNeil, Michael R.; Jackson, Mary			Biosynthesis and Translocation of Unsulfated Acyltrehaloses in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycolipid; Mycobacteria; Polyketide; Transporter; Tuberculosis; Chp2; MmpL10; Acyltransferase; Acyltrehalose	SULFOLIPID-1 BIOSYNTHESIS; OUTER-MEMBRANE; LIPID-BILAYER; FATTY-ACIDS; T-CELLS; VIRULENCE; INHIBITION; SULFATIDE; ANTIGEN; PROTEIN	Background: The biogenesis of 2,3-diacyltrehaloses (DAT) and penta-acyltrehaloses (PAT) found in the outer membrane of Mycobacterium tuberculosis is ill defined. Results: DAT synthesis is cytosolic. Chp2-mediated transesterification reactions between DAT substrates yield PAT on the periplasmic face of the membrane. Conclusion: DAT and PAT biosynthesis is topologically split across the membrane. Significance: DAT and PAT biosynthesis and transport are coupled and dependent on the MmpL10 transporter. A number of species-specific polymethyl-branched fatty acid-containing trehalose esters populate the outer membrane of Mycobacterium tuberculosis. Among them, 2,3-diacyltrehaloses (DAT) and penta-acyltrehaloses (PAT) not only play a structural role in the cell envelope but also contribute to the ability of M. tuberculosis to multiply and persist in the infected host, promoting the intracellular survival of the bacterium and modulating host immune responses. The nature of the machinery, topology, and sequential order of the reactions leading to the biosynthesis, assembly, and export of these complex glycolipids to the cell surface are the object of the present study. Our genetic and biochemical evidence corroborates a model wherein the biosynthesis and translocation of DAT and PAT to the periplasmic space are coupled and topologically split across the plasma membrane. The formation of DAT occurs on the cytosolic face of the plasma membrane through the action of PapA3, FadD21, and Pks3/4; that of PAT occurs on the periplasmic face via transesterification reactions between DAT substrates catalyzed by the acyltransferase Chp2 (Rv1184c). The integral membrane transporter MmpL10 is essential for DAT to reach the cell surface, and its presence in the membrane is required for Chp2 to be active. Disruption of mmpL10 or chp2 leads to an important build-up of DAT inside the cells and to the formation of a novel form of unsulfated acyltrehalose esterified with polymethyl-branched fatty acids normally found in sulfolipids that is translocated to the cell surface.	[Belardinelli, Juan Manuel; Jones, Victoria; McNeil, Michael R.; Jackson, Mary] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Larrouy-Maumus, Gerald; de Carvalho, Luiz Pedro Sorio] Natl Inst Med Res, MRC, Div Mycobacterial Res, London NW7 1AA, England	Colorado State University; MRC National Institute for Medical Research	Jackson, M (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Mary.Jackson@colostate.edu	McNeil, Michael/G-3325-2019; Belardinelli, Juan Manuel/N-7335-2019; Jackson, Mary/D-5345-2017	Belardinelli, Juan Manuel/0000-0003-1336-9141; Jackson, Mary/0000-0002-9212-0258; Larrouy-Maumus, Gerald/0000-0001-6614-8698; Sorio de Carvalho, Luiz Pedro/0000-0003-2875-4552	National Institutes of Health, NIAID [AI063054]; Medical Research Council (MRC) [MC_UP_A253_1111]; MRC [U117533887]; MRC [MR/J006874/1, MC_UP_A253_1111] Funding Source: UKRI; Medical Research Council [MC_UP_A253_1111] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063054] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant AI063054. This work was supported by funds from the Medical Research Council (MRC) to L.P.S.d.C. (MC_UP_A253_1111). The MRC Biomedical NMR Centre, NIMR, Mill Hill, is funded by MRC Grant-in-aid U117533887.	Alexeyev MF, 1999, J MOL BIOL, V285, P1503, DOI 10.1006/jmbi.1998.2412; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Bansal-Mutalik R, 2014, P NATL ACAD SCI USA, V111, P4958, DOI 10.1073/pnas.1403078111; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Berg S, 2005, J BIOL CHEM, V280, P5651, DOI 10.1074/jbc.M411418200; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; BROZNA JP, 1991, INFECT IMMUN, V59, P2542, DOI 10.1128/IAI.59.8.2542-2548.1991; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Daffe M, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0021-2013; Deshayes C, 2010, MOL MICROBIOL, V78, P989, DOI 10.1111/j.1365-2958.2010.07385.x; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; Dubey VS, 2002, MOL MICROBIOL, V45, P1451, DOI 10.1046/j.1365-2958.2002.03119.x; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Gilmore SA, 2012, ACS CHEM BIOL, V7, P863, DOI 10.1021/cb200311s; GOREN MB, 1976, P NATL ACAD SCI USA, V73, P2510, DOI 10.1073/pnas.73.7.2510; GOREN MB, 1990, HDB LIPID RES, V6, P363; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Guerin ME, 2009, J BIOL CHEM, V284, P21613, DOI 10.1074/jbc.M109.003947; Hatzios SK, 2009, J BIOL CHEM, V284, P12745, DOI 10.1074/jbc.M809088200; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hsieh JM, 2010, PROTEIN SCI, V19, P868, DOI 10.1002/pro.365; HUSSEINI H, 1952, AM REV TUBERC PULM, V65, P655; Jackson M, 2001, Methods Mol Med, V54, P59, DOI 10.1385/1-59259-147-7:059; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; KATO M, 1974, INFECT IMMUN, V10, P733, DOI 10.1128/IAI.10.4.733-741.1974; Kumar P, 2007, P NATL ACAD SCI USA, V104, P11221, DOI 10.1073/pnas.0611649104; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; Layre E, 2011, J LIPID RES, V52, P1098, DOI 10.1194/jlr.M013482; Lee KS, 2007, FEMS MICROBIOL LETT, V267, P121, DOI 10.1111/j.1574-6968.2006.00553.x; Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056; Lynett J, 2007, MICROBIOL-SGM, V153, P3133, DOI 10.1099/mic.0.2007/007864-0; Mederle I, 2002, INFECT IMMUN, V70, P303, DOI 10.1128/IAI.70.1.303-314.2002; Murakami S, 2008, CURR OPIN STRUC BIOL, V18, P459, DOI 10.1016/j.sbi.2008.06.007; PABST MJ, 1988, J IMMUNOL, V140, P634; Passemar C, 2014, CELL MICROBIOL, V16, P195, DOI 10.1111/cmi.12214; Rezwan M, 2007, J MICROBIOL METH, V68, P32, DOI 10.1016/j.mimet.2006.05.016; Rousseau C, 2003, INFECT IMMUN, V71, P4684, DOI 10.1128/IAI.71.8.4684-4690.2003; Rousseau C, 2003, CELL MICROBIOL, V5, P405, DOI 10.1046/j.1462-5822.2003.00289.x; Saavedra R, 2001, CLIN DIAGN LAB IMMUN, V8, P1081, DOI 10.1128/CDLI.8.6.1-91-1088.2001; Seeliger JC, 2012, J BIOL CHEM, V287, P7990, DOI 10.1074/jbc.M111.315473; Seidel M, 2007, GLYCOBIOLOGY, V17, P210, DOI 10.1093/glycob/cwl066; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Sonden B, 2005, MOL MICROBIOL, V58, P426, DOI 10.1111/j.1365-2958.2005.04847.x; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Sulzenbacher G, 2006, EMBO J, V25, P1436, DOI 10.1038/sj.emboj.7601048; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190; ZHANG L, 1991, J IMMUNOL, V146, P2730; ZHANG L, 1988, INFECT IMMUN, V56, P2876, DOI 10.1128/IAI.56.11.2876-2883.1988; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	55	51	53	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27952	27965		10.1074/jbc.M114.581199	http://dx.doi.org/10.1074/jbc.M114.581199			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25124040	Green Published, hybrid			2022-12-28	WOS:000342852800049
J	Goodman, MF				Goodman, Myron F.			The Discovery of Error-prone DNA Polymerase V and Its Unique Regulation by RecA and ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOS-INDUCED MUTAGENESIS; ESCHERICHIA-COLI; UV MUTAGENESIS; ABASIC LESIONS; Y-FAMILY; PROTEIN; UMUD; PURIFICATION; BYPASS; REPLICATION	My career pathway has taken a circuitous route, beginning with a Ph.D. degree in electrical engineering from The Johns Hopkins University, followed by five postdoctoral years in biology at Hopkins and culminating in a faculty position in biological sciences at the University of Southern California. My startup package in 1973 consisted of $2,500, not to be spent all at once, plus an ancient Packard scintillation counter that had a series of rapidly flashing light bulbs to indicate a radioactive read-out in counts/minute. My research pathway has been similarly circuitous. The discovery of Escherichia coli DNA polymerase V (pol V) began with an attempt to identify the mutagenic DNA polymerase responsible for copying damaged DNA as part of the well known SOS regulon. Although we succeeded in identifying a DNA polymerase, one that was induced as part of the SOS response, we actually rediscovered DNA polymerase II, albeit in a new role. A decade later, we discovered a new polymerase, pol V, whose activity turned out to be regulated by bound molecules of RecA protein and ATP. This Reflections article describes our research trajectory, includes a review of key features of DNA damage-induced SOS mutagenesis leading us to pol V, and reflects on some of the principal researchers who have made indispensable contributions to our efforts.	[Goodman, Myron F.] Univ So Calif, Mol & Computat Sect, Dept Biol Sci, Los Angeles, CA 90089 USA; [Goodman, Myron F.] Univ So Calif, Mol & Computat Sect, Dept Chem, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Goodman, MF (corresponding author), Univ So Calif, Mol & Computat Sect, Dept Biol Sci, Los Angeles, CA 90089 USA.	mgoodman@usc.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012259] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES012259] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BONNER CA, 1988, J BIOL CHEM, V263, P18946; BONNER CA, 1990, P NATL ACAD SCI USA, V87, P7663, DOI 10.1073/pnas.87.19.7663; BRIDGES BA, 1985, MUTAT RES, V150, P133, DOI 10.1016/0027-5107(85)90110-1; Bruck I, 1996, J BIOL CHEM, V271, P10767, DOI 10.1074/jbc.271.18.10767; BURCKHARDT SE, 1988, P NATL ACAD SCI USA, V85, P1811, DOI 10.1073/pnas.85.6.1811; Corzett CH, 2013, GENETICS, V194, P409, DOI 10.1534/genetics.113.151837; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; Creighton S, 1995, METHOD ENZYMOL, V262, P232; DUTREIX M, 1989, J BACTERIOL, V171, P2415, DOI 10.1128/jb.171.5.2415-2423.1989; ECHOLS H, 1990, MUTAT RES, V236, P301, DOI 10.1016/0921-8777(90)90013-U; Erdem AL, 2014, ELIFE, V3, DOI 10.7554/eLife.02384; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; IWASAKI H, 1990, J BACTERIOL, V172, P6268, DOI 10.1128/jb.172.11.6268-6273.1990; Jiang QF, 2009, NATURE, V460, P359, DOI 10.1038/nature08178; KATO T, 1977, MOL GEN GENET, V156, P121, DOI 10.1007/BF00283484; KENYON CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2819, DOI 10.1073/pnas.77.5.2819; KITAGAWA Y, 1985, P NATL ACAD SCI USA, V82, P4336, DOI 10.1073/pnas.82.13.4336; NOHMI T, 1988, P NATL ACAD SCI USA, V85, P1816, DOI 10.1073/pnas.85.6.1816; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Patel M, 2010, CRIT REV BIOCHEM MOL, V45, P171, DOI 10.3109/10409238.2010.480968; PERRY KL, 1985, P NATL ACAD SCI USA, V82, P4331, DOI 10.1073/pnas.82.13.4331; Pham P, 2002, P NATL ACAD SCI USA, V99, P11061, DOI 10.1073/pnas.172197099; Radman M, 1974, MOL ENV ASPECTS MUTA, P128; RAJAGOPALAN M, 1992, P NATL ACAD SCI USA, V89, P10777, DOI 10.1073/pnas.89.22.10777; RANDALL SK, 1987, J BIOL CHEM, V262, P6864; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; Reuven NB, 1998, MOL CELL, V2, P191, DOI 10.1016/S1097-2765(00)80129-X; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; SCHEUERMANN RH, 1984, P NATL ACAD SCI-BIOL, V81, P7747, DOI 10.1073/pnas.81.24.7747; Schlacher K, 2005, MOL CELL, V17, P561, DOI 10.1016/j.molcel.2005.01.006; Schlacher K, 2006, NATURE, V442, P883, DOI 10.1038/nature05042; SHINAGAWA H, 1988, P NATL ACAD SCI USA, V85, P1806, DOI 10.1073/pnas.85.6.1806; STEINBORN G, 1978, MOL GEN GENET, V165, P87, DOI 10.1007/BF00270380; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Tang MJ, 1998, P NATL ACAD SCI USA, V95, P9755, DOI 10.1073/pnas.95.17.9755; Walker GC, 1998, P NATL ACAD SCI USA, V95, P10348, DOI 10.1073/pnas.95.18.10348; WEIGLE JJ, 1953, P NATL ACAD SCI USA, V39, P628, DOI 10.1073/pnas.39.7.628; WICKNER RB, 1972, J BIOL CHEM, V247, P489; WITKIN EM, 1967, P NATL ACAD SCI USA, V57, P1275, DOI 10.1073/pnas.57.5.1275; WITKIN EM, 1969, ANNU REV MICROBIOL, V23, P487, DOI 10.1146/annurev.mi.23.100169.002415; WOODGATE R, 1989, P NATL ACAD SCI USA, V86, P7301, DOI 10.1073/pnas.86.19.7301; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S	42	9	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26772	26782		10.1074/jbc.X114.607374	http://dx.doi.org/10.1074/jbc.X114.607374			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25160630	Green Published, hybrid			2022-12-28	WOS:000342853900010
J	Hassinen, A; Kellokumpu, S				Hassinen, Antti; Kellokumpu, Sakari			Organizational Interplay of Golgi N-Glycosyltransferases Involves Organelle Microenvironment-Dependent Transitions between Enzyme Homo-and Heteromers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX-FORMATION; KIN RECOGNITION; MEDIAL-GOLGI; GLYCOSYLATION; RETENTION; DOMAIN; FORM; OLIGOSACCHARIDES; OLIGOMERIZATION; LOCALIZATION	Glycosylation of proteins and lipids takes place in the Golgi apparatus by the consecutive actions of functionally distinct glycosidases and glycosyltransferases. Current evidence indicates that they function as enzyme homomers and/or heteromers in the living cell. Here we investigate their organizational interplay and show that glycosyltransferase homomers are assembled in the endoplasmic reticulum. Upon transport to the Golgi, the majority of homomers are disassembled to allow the formation of enzyme heteromers between sequentially acting medial Golgi enzymes GnT-I and GnT-II or trans-Golgi enzymes GalT-I and ST6Gal-I. This transition is driven by the acidic Golgi environment, as it was markedly inhibited by raising Golgi luminal pH with chloroquine. Our FRAP ( fluorescence recovery after photobleaching) measurements showed that the complexes remain mobile Golgi membrane constituents that can relocate to the endoplasmic reticulum or to the scattered Golgi mini-stacks upon brefeldin A or nocodazole treatment, respectively. During this relocation, heteromers undergo a reverse transition back to enzyme homomers. These data unveil an unprecedented organizational interplay between Golgi N-glycosyltransferases that involves dynamic and organelle microenvironment-driven transitions between enzyme homomers and heteromers during their trafficking within the early secretory compartments.	[Hassinen, Antti; Kellokumpu, Sakari] Univ Oulu, Fac Biochem & Mol Med, FI-90220 Oulu, Finland	University of Oulu	Kellokumpu, S (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Aapistie 7, FI-90220 Oulu, Finland.	sakari.kellokumpu@oulu.fi		Hassinen, Antti/0000-0001-9491-2868	Finnish Glycoscience Graduate School; University of Oulu; Magnus Ehrnrooth Foundation; Emil Aaltonen Foundation; Finnish Cultural Foundation	Finnish Glycoscience Graduate School; University of Oulu; Magnus Ehrnrooth Foundation; Emil Aaltonen Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was supported by the Finnish Glycoscience Graduate School, The University of Oulu, Magnus Ehrnrooth Foundation, Emil Aaltonen Foundation, and the Finnish Cultural Foundation.	Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Banfield DK, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005264; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Burchell J, 1999, GLYCOBIOLOGY, V9, P1307, DOI 10.1093/glycob/9.12.1307; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Cummings R.D., 2009, PRINCIPLES GLYCAN RE, P387; Dayhoff JE, 2010, J MOL BIOL, V395, P860, DOI 10.1016/j.jmb.2009.10.052; de Graffenried CL, 2004, CURR OPIN CELL BIOL, V16, P356, DOI 10.1016/j.ceb.2004.06.007; DUNPHY WG, 1985, CELL, V40, P463, DOI 10.1016/0092-8674(85)90161-8; Emr S, 2009, J CELL BIOL, V187, P449, DOI 10.1083/jcb.200909011; Flugel D, 2012, BLOOD, V119, P1292, DOI 10.1182/blood-2011-08-375014; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Giraudo CG, 2003, J BIOL CHEM, V278, P40262, DOI 10.1074/jbc.M305455200; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Gleeson PA, 1998, HISTOCHEM CELL BIOL, V109, P517, DOI 10.1007/s004180050252; Glick BS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005215; Hart Gerald W., 1992, Current Opinion in Cell Biology, V4, P1017, DOI 10.1016/0955-0674(92)90134-X; Hashimoto K, 2010, J MOL BIOL, V399, P196, DOI 10.1016/j.jmb.2010.03.059; Hassinen A, 2011, J BIOL CHEM, V286, P38329, DOI 10.1074/jbc.M111.277681; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Jackson CL, 2009, J CELL SCI, V122, P443, DOI 10.1242/jcs.032581; Jungmann J, 1998, EMBO J, V17, P423, DOI 10.1093/emboj/17.2.423; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Maccioni HJF, 2011, J NEUROCHEM, V117, P589, DOI 10.1111/j.1471-4159.2011.07232.x; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; NILSSON T, 1993, FEBS LETT, V330, P1, DOI 10.1016/0014-5793(93)80906-B; Nilsson T, 2009, FEBS LETT, V583, P3764, DOI 10.1016/j.febslet.2009.10.064; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Opat AS, 2000, J BIOL CHEM, V275, P11836, DOI 10.1074/jbc.275.16.11836; Ouzzine M, 2000, J BIOL CHEM, V275, P28254; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Rivinoja A, 2006, J CELL PHYSIOL, V208, P167, DOI 10.1002/jcp.20653; Sasai K, 2001, J BIOL CHEM, V276, P759, DOI 10.1074/jbc.M004972200; Schoberer J, 2013, PLANT PHYSIOL, V161, P1737, DOI 10.1104/pp.112.210757; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Tu LN, 2010, CELL MOL LIFE SCI, V67, P29, DOI 10.1007/s00018-009-0126-z; Ungar D, 2009, SEMIN CELL DEV BIOL, V20, P762, DOI 10.1016/j.semcdb.2009.03.004; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; WEISZ OA, 1993, J CELL BIOL, V122, P1185, DOI 10.1083/jcb.122.6.1185; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; Yang W, 1997, CELL BIOL INT, V21, P223, DOI 10.1006/cbir.1997.0138; Yen TY, 2003, J BIOL CHEM, V278, P45864, DOI 10.1074/jbc.M303851200	51	35	37	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26937	26948		10.1074/jbc.M114.595058	http://dx.doi.org/10.1074/jbc.M114.595058			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25135644	Green Published, hybrid			2022-12-28	WOS:000342853900024
J	Krishnan, S; Liu, F; Abrol, R; Hodges, J; Goddard, WA; Prasadarao, NV				Krishnan, Subramanian; Liu, Fan; Abrol, Ravinder; Hodges, Jacqueline; Goddard, William A., III; Prasadarao, Nemani V.			The Interaction of N-Glycans in Fc gamma Receptor I alpha-Chain with Escherichia coli K1 Outer Membrane Protein A for Entry into Macrophages EXPERIMENTAL AND COMPUTATIONAL ANALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORCE-FIELD; TRANSMEMBRANE DOMAIN; PATHOGENS; DYNAMICS	Neonatal meningitis, caused by Escherichia coli K1, is a serious central nervous system disease. We have established that macrophages serve as permissive niches for E. coli K1 to multiply in the host and for attaining a threshold level of bacterial load, which is a prerequisite for the onset of the disease. Here, we demonstrate experimentally that three N-glycans in Fc gamma RIa interact with OmpA of E. coli K1 for binding to and entering the macrophages. Adoptive transfer of Fc gamma RIa(-/-) bone marrow-derived macrophages transfected with Fc gamma RIa into Fc gamma RIa(-/-) newborn mice renders them susceptible to E. coli K1-induced meningitis. In contrast, mice that received bone marrow-derived macrophages transfected with Fc gamma RIa in which N-glycosylation sites 1, 4, and 5 are mutated to alanines exhibit resistance to E. coli K1 infection. Our molecular dynamics and simulation studies predict that N-glycan 5 exhibits strong binding at the barrel site of OmpA formed by loops 3 and 4, whereas N-glycans 1 and 4 interact with loops 1, 3, and 4 of OmpA at tip regions. Molecular modeling data also suggest no role for the IgG binding site in the invasion process. In agreement, experimental mutations in IgG binding site had no effect on the E. coli K1 entry into macrophages in vitro or on the onset of meningitis in newborn mice. Together, this integration of experimental and computational studies reveals how the N-glycans in Fc gamma RIa interact with the OmpA of E. coli K1 for inducing the disease pathogenesis.	[Krishnan, Subramanian; Hodges, Jacqueline; Prasadarao, Nemani V.] Univ So Calif, Childrens Hosp Los Angeles, Div Infect Dis, Los Angeles, CA 90027 USA; [Krishnan, Subramanian; Hodges, Jacqueline; Prasadarao, Nemani V.] Univ So Calif, Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Prasadarao, Nemani V.] Univ So Calif, Childrens Hosp Los Angeles, Dept Surg, Los Angeles, CA 90027 USA; [Liu, Fan; Abrol, Ravinder; Goddard, William A., III] CALTECH, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA; [Abrol, Ravinder] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA	Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; California Institute of Technology; Cedars Sinai Medical Center	Goddard, WA (corresponding author), CALTECH, Mat & Proc Simulat Ctr, Mail Code 139-74, Pasadena, CA 91125 USA.	wag@wag.caltech.edu; pnemani@chla.usc.edu	Krishnan, Subramanian/K-5032-2019; Abrol, Ravinder/R-3458-2019; Hodges, Jacqueline/GMW-4043-2022	Abrol, Ravinder/0000-0001-7333-6793; Krishnan, Subramanian/0000-0001-5780-7452	National Institutes of Health [N5731 15, A140567]; Defense University Research Instruments Program; National Science Foundation Caltech Science and Engineering of Materials; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040567, R01AI040567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense University Research Instruments Program; National Science Foundation Caltech Science and Engineering of Materials; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants N5731 15 and A140567 (to N. V. P. and W. A. G.). This work was also supported by Defense University Research Instruments Program and National Science Foundation Caltech Science and Engineering of Materials.	Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Datta D, 2003, PROTEINS, V50, P213, DOI 10.1002/prot.10257; Drayman N, 2013, CELL HOST MICROBE, V14, P63, DOI 10.1016/j.chom.2013.05.005; Drevets DA, 2004, CLIN MICROBIOL REV, V17, P323, DOI 10.1128/CMR.17.2.323-347.2004; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krishnan S, 2014, MICROBES INFECT, V16, P540, DOI 10.1016/j.micinf.2014.06.002; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Lu JH, 2011, J BIOL CHEM, V286, P40608, DOI 10.1074/jbc.M111.257550; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Mehlert A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002618; Mittal R, 2011, J BIOL CHEM, V286, P2183, DOI 10.1074/jbc.M110.178236; Pascal TA, 2010, J BIOL CHEM, V285, P37753, DOI 10.1074/jbc.M110.122804; Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983; Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Shanmuganathan MV, 2014, MICROBES INFECT, V16, P134, DOI 10.1016/j.micinf.2013.10.013; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; WEISER JN, 1991, INFECT IMMUN, V59, P2252, DOI 10.1128/IAI.59.7.2252-2258.1991	32	11	11	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					30937	30949		10.1074/jbc.M114.599407	http://dx.doi.org/10.1074/jbc.M114.599407			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25231998	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000344549900006
J	Lee, HS; Oh, SJ; Lee, KH; Lee, YS; Ko, E; Kim, KE; Kim, HC; Kim, S; Song, PH; Kim, YI; Kim, C; Han, S				Lee, Hyo Seon; Oh, Seung Ja; Lee, Kwang-Hoon; Lee, Yoon-Sook; Ko, Eun; Kim, Kyung Eun; Kim, Hyung-chan; Kim, Seokkyun; Song, Paul H.; Kim, Yong-In; Kim, Chungho; Han, Sangyeul			Gln-362 of Angiopoietin-2 Mediates Migration of Tumor and Endothelial Cells through Association with alpha 5 beta 1 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEASE-2; TIE2 RECEPTOR; ANGIOGENESIS; CANCER; PATHWAY; INVASION; ALPHA-V-BETA-3; VASCULATURE; METASTASIS; EXPRESSION	Angiopoietin-2 (Ang-2) not only regulates angiogenesis by binding to its well known receptor Tie2 on endothelial cells but also controls sprouting of Tie2-negative angiogenic endothelial cells and invasion of Tie2-negative non-endothelial cells by binding to integrins. However, the molecular mechanism of the Ang-2/ integrin association has been unclear. In this study, we found that the Gln-362 residue of Ang-2 was essential for binding to alpha 5 beta 1 integrin. A Q362E Ang-2 mutant, which still bound to Tie2, failed to associate with alpha 5 beta 1 integrin and was unable to activate the integrin downstream signaling of focal adhesion kinase. In addition, unlike wild-type Ang-2, the Q362E Ang-2 mutant was defective in mediating invasion of Tie2-negative glioma or Tie2-positive endothelial cells. Furthermore, the tailpiece domain of the alpha 5 subunit in alpha 5 beta 1 integrin was critical for binding to Ang-2. Taken together, these results provide a novel insight into the mechanism of integrin regulation by Ang-2, which contributes to tumor invasion and endothelial cell migration in a Tie2-independent manner.	[Lee, Hyo Seon; Oh, Seung Ja; Lee, Kwang-Hoon; Lee, Yoon-Sook; Ko, Eun; Kim, Kyung Eun; Kim, Hyung-chan; Kim, Seokkyun; Song, Paul H.; Kim, Chungho; Han, Sangyeul] Samsung Elect Co Ltd, Samsung Adv Inst Technol, Bio Therapeut Lab, Suwon 443803, Gyeonggi Do, South Korea; [Kim, Yong-In] Samsung Elect Co Ltd, Samsung Adv Inst Technol, Well Aging Ctr, Suwon 443803, South Korea; [Kim, Chungho] Korea Univ, Sch Life Sci & Biotechnol, Seoul 736707, South Korea	Samsung; Samsung Electronics; Samsung; Samsung Electronics; Korea University	Kim, C (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea.	chungho@korea.ac.kr; sangyeul.han@samsung.com	Oh, Seung Ja/ABC-6168-2021	Oh, Seung Ja/0000-0002-4572-0656				Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Barton WA, 2005, STRUCTURE, V13, P825, DOI 10.1016/j.str.2005.03.009; Barton WA, 2006, NAT STRUCT MOL BIOL, V13, P524, DOI 10.1038/nsmb1101; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; Cascone T, 2012, J CLIN ONCOL, V30, P441, DOI 10.1200/JCO.2011.38.7621; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Daly C, 2013, CANCER RES, V73, P108, DOI 10.1158/0008-5472.CAN-12-2064; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Eklund L, 2013, EXP CELL RES, V319, P1271, DOI 10.1016/j.yexcr.2013.03.011; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gerald D, 2013, CANCER RES, V73, P1649, DOI 10.1158/0008-5472.CAN-12-4697; Hu B, 2006, CANCER RES, V66, P775, DOI 10.1158/0008-5472.CAN-05-1149; Hu B, 2003, P NATL ACAD SCI USA, V100, P8904, DOI 10.1073/pnas.1533394100; Imanishi Y, 2011, J BIOL CHEM, V286, P29249, DOI 10.1074/jbc.M111.235689; Imanishi Y, 2007, CANCER RES, V67, P4254, DOI 10.1158/0008-5472.CAN-06-4100; Kim HZ, 2009, BBA-MOL CELL RES, V1793, P772, DOI 10.1016/j.bbamcr.2009.01.018; Leow CC, 2012, INT J ONCOL, V40, P1321, DOI 10.3892/ijo.2012.1366; Lewis CE, 2011, CANCER CELL, V19, P431, DOI 10.1016/j.ccr.2011.03.016; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; Schulz P, 2011, FASEB J, V25, P3325, DOI 10.1096/fj.11-182287; Sfiligoi C, 2003, INT J CANCER, V103, P466, DOI 10.1002/ijc.10851; Thomas M, 2010, J BIOL CHEM, V285, P23842, DOI 10.1074/jbc.M109.097543; Thurston G., 2011, United States Patent, Patent No. [US2011/0027286A1, 20110027286]; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037	27	24	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31330	31340		10.1074/jbc.M114.572594	http://dx.doi.org/10.1074/jbc.M114.572594			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25237190	Green Published, hybrid			2022-12-28	WOS:000344549900037
J	Nichols, WA; Henderson, BJ; Yu, C; Parker, RL; Richards, CI; Lester, HA; Miwa, JM				Nichols, Weston A.; Henderson, Brandon J.; Yu, Caroline; Parker, Rell L.; Richards, Christopher I.; Lester, Henry A.; Miwa, Julie M.			Lynx1 Shifts alpha 4 beta 2 Nicotinic Receptor Subunit Stoichiometry by Affecting Assembly in the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED UP-REGULATION; ACETYLCHOLINE-RECEPTORS; IN-VIVO; PROTOTOXIN LYNX1; CELL-SURFACE; TRAFFICKING; CHAPERONE; AGONIST; MODULATION; PLASTICITY	Glycosylphosphatidylinositol-anchored neurotoxin-like receptor binding proteins, such as lynx modulators, are topologically positioned to exert pharmacological effects by binding to the extracellular portion of nAChRs. These actions are generally thought to proceed when both lynx and the nAChRs are on the plasma membrane. Here, we demonstrate that lynx1 also exerts effects on alpha 4 beta 2 nAChRs within the endoplasmic reticulum. Lynx1 affects assembly of nascent alpha 4 and beta 2 subunits and alters the stoichiometry of the receptor population that reaches the plasma membrane. Additionally, these data suggest that lynx1 shifts nAChR stoichiometry to low sensitivity (alpha 4)(3)(beta 2)(2) pentamers primarily through this interaction in the endoplasmic reticulum, rather than solely via direct modulation of activity on the plasma membrane. To our knowledge, these data represent the first test of the hypothesis that a lynx family member, or indeed any glycosylphosphatidylinositol-anchored protein, could act within the cell to alter assembly of a multisubunit protein.	[Nichols, Weston A.; Henderson, Brandon J.; Yu, Caroline; Parker, Rell L.; Lester, Henry A.; Miwa, Julie M.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Richards, Christopher I.] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; [Miwa, Julie M.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	California Institute of Technology; University of Kentucky; Lehigh University	Miwa, JM (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	jmm312@lehigh.edu		Parker, Rell/0000-0002-4538-1818; Henderson, Brandon/0000-0003-0381-028X; Miwa, Julie/0000-0002-4418-3756	National Institutes of Health [DA033831, NS034407, EY018502, MH088550]; Tobacco-related Disease Research Program (TRDRP) [19KT-0032]; NATIONAL EYE INSTITUTE [R21EY018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034407, R01NS034407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA033831] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-related Disease Research Program (TRDRP)(University of California System); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA033831, NS034407, EY018502, and MH088550. This work was also supported by Tobacco-related Disease Research Program (TRDRP) Grant 19KT-0032.	Alexander JK, 2010, J NEUROSCI, V30, P10112, DOI 10.1523/JNEUROSCI.6344-09.2010; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Cha BY, 2004, J CELL SCI, V117, P3353, DOI 10.1242/jcs.01180; Drenan RM, 2008, MOL PHARMACOL, V73, P27, DOI 10.1124/mol.107.039180; Gault L., 2013, ALZHEIMERS DEMENT, V9, P138; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Harvey A., 2014, U. S. Patent, Patent No. [20,140,031,395 A1, 20140031395]; Hauser TA, 2009, BIOCHEM PHARMACOL, V78, P803, DOI 10.1016/j.bcp.2009.05.030; Henderson BJ, 2014, J GEN PHYSIOL, V143, P51, DOI 10.1085/jgp.201311102; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Kanner R., 2010, U. S. Patent, Patent No. [20,100,190,819 A1, 20100190819]; Khiroug SS, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-141; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lester HA, 2009, AAPS J, V11, P167, DOI 10.1208/s12248-009-9090-7; Lieberman JA, 2013, NEUROPSYCHOPHARMACOL, V38, P968, DOI 10.1038/npp.2012.259; Lyukmanova EN, 2011, J BIOL CHEM, V286, P10618, DOI 10.1074/jbc.M110.189100; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Miwa JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043302; Miwa JM, 2012, PHYSIOLOGY, V27, P187, DOI 10.1152/physiol.00002.2012; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Moss FJ, 2009, J GEN PHYSIOL, V134, P489, DOI 10.1085/jgp.200910314; Nashmi R, 2003, J NEUROSCI, V23, P11554; Nashmi R, 2007, J NEUROSCI, V27, P8202, DOI 10.1523/JNEUROSCI.2199-07.2007; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Prickaerts J, 2012, NEUROPHARMACOLOGY, V62, P1099, DOI 10.1016/j.neuropharm.2011.10.024; Putman D., 2013, Patent No. [WO 2013169889 A1, 2013169889]; Richards CI, 2011, J BIOL CHEM, V286, P31241, DOI 10.1074/jbc.M111.256024; Srinivasan R, 2014, PHARMACOL RES, V83, P20, DOI 10.1016/j.phrs.2014.02.005; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Tekinay AB, 2009, P NATL ACAD SCI USA, V106, P4477, DOI 10.1073/pnas.0813109106; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; Wang Y, 2009, J NEUROSCI, V29, P12625, DOI 10.1523/JNEUROSCI.1776-09.2009; Whiteaker P, 1998, MOL PHARMACOL, V53, P950	42	46	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31423	31432		10.1074/jbc.M114.573667	http://dx.doi.org/10.1074/jbc.M114.573667			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25193667	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000344549900045
J	Wang, Y; Kavran, JM; Chen, Z; Karukurichi, KR; Leahy, DJ; Cole, PA				Wang, Yun; Kavran, Jennifer M.; Chen, Zan; Karukurichi, Kannan R.; Leahy, Daniel J.; Cole, Philip A.			Regulation of S-Adenosylhomocysteine Hydrolase by Lysine Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-HOMOCYSTEINE HYDROLASE; EXPRESSED PROTEIN LIGATION; METHYLATION METABOLISM; SIGNAL-TRANSDUCTION; METHIONINE CYCLE; KEY ENZYME; HISTONE H3; INHIBITOR; DEFICIENCY; ADENOSYLMETHIONINE	S-Adenosylhomocysteine hydrolase (SAHH) is an NAD(+)-dependent tetrameric enzyme that catalyzes the breakdown of S-adenosylhomocysteine to adenosine and homocysteine and is important in cell growth and the regulation of gene expression. Loss of SAHH function can result in global inhibition of cellular methyltransferase enzymes because of high levels of S-adenosylhomocysteine. Prior proteomics studies have identified two SAHH acetylation sites at Lys(401) and Lys(408) but the impact of these post-translational modifications has not yet been determined. Here we use expressed protein ligation to produce semisynthetic SAHH acetylated at Lys(401) and Lys(408) and show that modification of either position negatively impacts the catalytic activity of SAHH. X-ray crystal structures of 408-acetylated SAHH and dually acetylated SAHH have been determined and reveal perturbations in the C-terminal hydrogen bonding patterns, a region of the protein important for NAD(+) binding. These crystal structures along with mutagenesis data suggest that such hydrogen bond perturbations are responsible for SAHH catalytic inhibition by acetylation. These results suggest how increased acetylation of SAHH may globally influence cellular methylation patterns.	[Wang, Yun; Chen, Zan; Karukurichi, Kannan R.; Leahy, Daniel J.; Cole, Philip A.] Johns Hopkins Sch Med, Deptartment Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Kavran, Jennifer M.; Leahy, Daniel J.] Johns Hopkins Sch Med, Deptartment Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Cole, PA (corresponding author), 725 N Wolfe St,316 Hunterian Bldg, Baltimore, MD 21205 USA.	pcole@jhmi.edu	Chen, Zan/D-3531-2019	Chen, Zan/0000-0001-9925-872X	National Institutes of Health; Flight Attendant Medical Research Institute Foundation; NATIONAL CANCER INSTITUTE [R01CA090466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099321, R37GM062437, R01GM099092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health and the Flight Attendant Medical Research Institute Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albaugh BN, 2011, J BIOL CHEM, V286, P24694, DOI 10.1074/jbc.M111.251579; Arbely E, 2011, P NATL ACAD SCI USA, V108, P8251, DOI 10.1073/pnas.1105028108; AULTRICHE DB, 1994, J BIOL CHEM, V269, P31472; Baric I, 2005, J INHERIT METAB DIS, V28, P885, DOI 10.1007/s10545-005-0192-9; Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; Baric I, 2009, J INHERIT METAB DIS, V32, P459, DOI 10.1007/s10545-009-1146-4; BITONTI AJ, 1990, BIOCHEM PHARMACOL, V40, P601, DOI 10.1016/0006-2952(90)90562-Y; Bjursell MK, 2011, AM J HUM GENET, V89, P507, DOI 10.1016/j.ajhg.2011.09.004; Bolduc D, 2013, ELIFE, V2, DOI 10.7554/eLife.00691; Buist NRM, 2006, J INHERIT METAB DIS, V29, P538, DOI 10.1007/s10545-006-0240-0; Cai S, 2007, BIOORGAN MED CHEM, V15, P7281, DOI 10.1016/j.bmc.2007.08.029; Cai SM, 2010, BIOCHEMISTRY-US, V49, P8434, DOI 10.1021/bi1007595; Chalker JM, 2012, ANGEW CHEM INT EDIT, V51, P1835, DOI 10.1002/anie.201106432; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 2012, MOL CELL PROTEOMICS, V11, P1048, DOI 10.1074/mcp.M112.019547; CHIANG PK, 1979, BIOCHEM PHARMACOL, V28, P1897, DOI 10.1016/0006-2952(79)90642-7; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clarke S., 2001, HOMOCYSTEINE HLTH DI; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Dayal S, 2001, CIRC RES, V88, P1203, DOI 10.1161/hh1101.092180; De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703; DELAHABA G, 1959, J BIOL CHEM, V234, P603; Dhall A, 2011, ACS CHEM BIOL, V6, P987, DOI 10.1021/cb200142c; Di Cerbo V, 2014, ELIFE, V3, DOI 10.7554/eLife.01632; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evertts AG, 2013, J BIOL CHEM, V288, P12142, DOI 10.1074/jbc.M112.428318; Flavell RR, 2009, ACCOUNTS CHEM RES, V42, P107, DOI 10.1021/ar800129c; Galloway SE, 2008, J VIROL, V82, P12280, DOI 10.1128/JVI.01225-08; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Herrmann W, 2005, CLIN CHEM, V51, P891, DOI 10.1373/clinchem.2004.044453; HOFFMAN DR, 1980, J BIOL CHEM, V255, P822; Huang R, 2010, J AM CHEM SOC, V132, P9986, DOI 10.1021/ja103954u; Huang Y, 2010, MOL BIOSYST, V6, P683, DOI 10.1039/b920120c; Jabs K, 2006, METABOLISM, V55, P252, DOI 10.1016/j.metabol.2005.08.025; Karukurichi KR, 2010, J AM CHEM SOC, V132, P1222, DOI 10.1021/ja909466d; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Lammers M, 2010, NAT CHEM BIOL, V6, P331, DOI 10.1038/nchembio.342; Leal JF, 2008, CARCINOGENESIS, V29, P2089, DOI 10.1093/carcin/bgn198; Lee KM, 2011, J MED CHEM, V54, P930, DOI 10.1021/jm1010836; Lee Y, 2011, J AM CHEM SOC, V133, P19807, DOI 10.1021/ja2066175; Li FP, 2011, ANGEW CHEM INT EDIT, V50, P9611, DOI 10.1002/anie.201103754; LIU S, 1992, ANTIVIR RES, V19, P247, DOI 10.1016/0166-3542(92)90083-H; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Loehrer FMT, 2001, ATHEROSCLEROSIS, V154, P147, DOI 10.1016/S0021-9150(00)00449-4; Malanovic N, 2008, J BIOL CHEM, V283, P23989, DOI 10.1074/jbc.M800830200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER MW, 1994, EMBO J, V13, P1806, DOI 10.1002/j.1460-2075.1994.tb06449.x; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Nicolas E, 2003, MOL CELL BIOL, V23, P1614, DOI 10.1128/MCB.23.5.1614-1622.2003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMER JL, 1979, J BIOL CHEM, V254, P1217; Perna AF, 2009, SEMIN DIALYSIS, V22, P351, DOI 10.1111/j.1525-139X.2009.00579.x; Piotukh K, 2011, J AM CHEM SOC, V133, P17536, DOI 10.1021/ja205630g; Poirier LA, 2001, METABOLISM, V50, P1014, DOI 10.1053/meta.2001.25655; Saeed M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046174; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Still AJ, 2013, J BIOL CHEM, V288, P26209, DOI 10.1074/jbc.M113.483396; Tarrant MK, 2012, NAT CHEM BIOL, V8, P262, DOI [10.1038/NCHEMBIO.771, 10.1038/nchembio.771]; Tehlivets O, 2004, FEBS LETT, V577, P501, DOI 10.1016/j.febslet.2004.10.057; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Turner MA, 1998, NAT STRUCT BIOL, V5, P369, DOI 10.1038/nsb0598-369; Turner MA, 2000, CELL BIOCHEM BIOPHYS, V33, P101, DOI 10.1385/CBB:33:2:101; WOLOS JA, 1993, J IMMUNOL, V151, P526; Yang XD, 2003, BIOCHEMISTRY-US, V42, P1900, DOI 10.1021/bi0262350; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Yuan CS, 1996, J BIOL CHEM, V271, P28009, DOI 10.1074/jbc.271.45.28009; YUAN CS, 1993, J BIOL CHEM, V268, P17030; Yuan H, 2012, EMBO J, V31, P58, DOI 10.1038/emboj.2011.382; Zheng H, 2013, MOL CELL BIOL, V33, P4960, DOI 10.1128/MCB.00874-13; Zhou JB, 2011, BLOOD, V118, P2830, DOI 10.1182/blood-2010-07-294827	79	21	22	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31361	31372		10.1074/jbc.M114.597153	http://dx.doi.org/10.1074/jbc.M114.597153			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25248746	Green Published, hybrid			2022-12-28	WOS:000344549900040
J	Baranova, NS; Inforzato, A; Briggs, DC; Tilakaratna, V; Enghild, JJ; Thakar, D; Milner, CM; Day, AJ; Richter, RP				Baranova, Natalia S.; Inforzato, Antonio; Briggs, David C.; Tilakaratna, Viranga; Enghild, Jan J.; Thakar, Dhruv; Milner, Caroline M.; Day, Anthony J.; Richter, Ralf P.			Incorporation of Pentraxin 3 into Hyaluronan Matrices Is Tightly Regulated and Promotes Matrix Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-STIMULATED GENE-6; INTER-ALPHA-INHIBITOR; QUARTZ-CRYSTAL MICROBALANCE; CELL-OOCYTE COMPLEXES; AMYLOID-P COMPONENT; C-REACTIVE PROTEIN; EXTRACELLULAR-MATRIX; TRYPSIN-INHIBITOR; HUMAN TSG-6; PERICELLULAR MATRIX	Mammalian oocytes are surrounded by a highly hydrated hyaluronan ( HA)-rich extracellular matrix with embedded cumulus cells, forming the cumulus cell.oocyte complex (COC) matrix. The correct assembly, stability, and mechanical properties of this matrix, which are crucial for successful ovulation, transport of the COC to the oviduct, and its fertilization, depend on the interaction between HA and specific HA-organizing proteins. Although the proteins inter-alpha-inhibitor (I alpha I), pentraxin 3 (PTX3), and TNF-stimulated gene-6 (TSG-6) have been identified as being critical for COC matrix formation, its supramolecular organization and the molecular mechanism of COC matrix stabilization remain unknown. Here we used films of end-grafted HA as a model system to investigate the molecular interactions involved in the formation and stabilization of HA matrices containing TSG-6, I alpha I, and PTX3. We found that PTX3 binds neither to HA alone nor to HA films containing TSG-6. This long pentraxin also failed to bind to products of the interaction between I alpha I, TSG-6, and HA, among which are the covalent heavy chain (HC).HA and HC.TSG-6 complexes, despite the fact that both I alpha I and TSG-6 are ligands of PTX3. Interestingly, prior encounter with I alpha I was required for effective incorporation of PTX3 into TSG-6-loaded HA films. Moreover, we demonstrated that this ternary protein mixture made of I alpha I, PTX3, and TSG-6 is sufficient to promote formation of a stable (i.e. cross-linked) yet highly hydrated HA matrix. We propose that this mechanism is essential for correct assembly of the COC matrix and may also have general implications in other inflammatory processes that are associated with HA cross-linking.	[Baranova, Natalia S.; Richter, Ralf P.] CIC biomaGUNE, Donostia San Sebastian 20009, Spain; [Inforzato, Antonio] Humanitas Clin & Res Ctr, I-20089 Rozzano, Italy; [Tilakaratna, Viranga; Day, Anthony J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Milner, Caroline M.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Enghild, Jan J.] Univ Aarhus, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Thakar, Dhruv; Richter, Ralf P.] Univ Grenoble Alpes, Dept Mol Chem, F-38000 Grenoble, France; [Thakar, Dhruv; Richter, Ralf P.] CNRS, F-38000 Grenoble, France; [Richter, Ralf P.] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany	CIC biomaGUNE; IRCCS Humanitas Research Hospital; University of Manchester; University of Manchester; Aarhus University; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Max Planck Society	Day, AJ (corresponding author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg, Manchester M13 9PT, Lancs, England.	anthony.day@manchester.ac.uk	Thakar, Dhruv/N-4065-2017; Richter, Ralf Peter/B-3343-2013; Inforzato, Antonio/ABG-4513-2020; Day, Anthony/O-1658-2015; biomaGUNE, CIC/J-9136-2014	Thakar, Dhruv/0000-0002-5276-6732; Richter, Ralf Peter/0000-0003-3071-2837; Inforzato, Antonio/0000-0001-8110-0027; Day, Anthony/0000-0002-1415-3134; biomaGUNE, CIC/0000-0001-7690-0660; Enghild, Jan Johannes/0000-0001-9292-9172; Briggs, David/0000-0002-9793-7339; Baranova, Natalia/0000-0002-3086-9124	AIRC Special Program Molecular Clinical Oncology 5 per mille [99629]; European Commission (ERC project HIIS); Arthritis Research UK [18472, 19489]; Medical Research Council [G0701180]; European Commission [FP7-HEALTH-2011-ADITEC-No280873]; Spanish Ministry of Economy and Competitiveness (MINECO) [MAT2011-24306, RYC2009-04275]; European Research Council [306435]; MRC [G0701180] Funding Source: UKRI; Versus Arthritis [19489, 18472] Funding Source: researchfish	AIRC Special Program Molecular Clinical Oncology 5 per mille(Fondazione AIRC per la ricerca sul cancro); European Commission (ERC project HIIS); Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Versus Arthritis(Versus Arthritis)	Supported by the AIRC Special Program Molecular Clinical Oncology 5 per mille (project 99629) and the European Commission (ERC project HIIS and FP7-HEALTH-2011-ADITEC-No280873).; Supported by Arthritis Research UK Grants 18472 and 19489 and Medical Research Council Grant G0701180.; Supported by Spanish Ministry of Economy and Competitiveness (MINECO) Grants MAT2011-24306 and RYC2009-04275 and European Research Council Starting Grant 306435.	Baranova NS, 2013, J BIOL CHEM, V288, P29642, DOI 10.1074/jbc.M113.477422; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Blom AM, 1999, J BIOL CHEM, V274, P298, DOI 10.1074/jbc.274.1.298; Blundell CD, 2005, J BIOL CHEM, V280, P18189, DOI 10.1074/jbc.M414343200; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; Carrette O, 2001, BIOL REPROD, V65, P301, DOI 10.1095/biolreprod65.1.301; Carton I, 2010, ANAL CHEM, V82, P9275, DOI 10.1021/ac102495q; Chang MY, 2012, J BIOL CHEM, V287, P14122, DOI 10.1074/jbc.M111.324988; Cohen M, 2003, BIOPHYS J, V85, P1996, DOI 10.1016/S0006-3495(03)74627-X; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Day A. J., 2005, HYALURONAN, P675; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Eisele NB, 2013, BIOPHYS J, V105, P1860, DOI 10.1016/j.bpj.2013.09.006; Eisele NB, 2012, BIOMACROMOLECULES, V13, P2322, DOI 10.1021/bm300577s; Eisele NB, 2010, EMBO REP, V11, P366, DOI 10.1038/embor.2010.34; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Fulop C, 1997, GENE, V202, P95, DOI 10.1016/S0378-1119(97)00459-9; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; He H, 2013, J BIOL CHEM, V288, P25792, DOI 10.1074/jbc.M113.479584; HEDMAN K, 1979, J CELL BIOL, V81, P83, DOI 10.1083/jcb.81.1.83; Higman VA, 2014, J BIOL CHEM, V289, P5619, DOI 10.1074/jbc.M113.542357; Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u; Ievoli E, 2011, MATRIX BIOL, V30, P330, DOI 10.1016/j.matbio.2011.05.002; Inforzato A, 2011, TISSUE ANTIGENS, V77, P271, DOI 10.1111/j.1399-0039.2011.01645.x; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Inforzato A, 2012, ADV EXP MED BIOL, V946, P1, DOI 10.1007/978-1-4614-0106-3_1; Inforzato A, 2010, J BIOL CHEM, V285, P17681, DOI 10.1074/jbc.M109.085639; Kahmann JD, 1997, PROTEIN EXPRES PURIF, V9, P315, DOI 10.1006/prep.1996.0694; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; Lauer ME, 2013, J BIOL CHEM, V288, P205, DOI 10.1074/jbc.M112.403998; Leali D, 2012, ARTERIOSCL THROM VAS, V32, P696, DOI 10.1161/ATVBAHA.111.243998; LEE GW, 1993, J IMMUNOL, V150, P1804; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Mahoney DJ, 2001, J BIOL CHEM, V276, P22764, DOI 10.1074/jbc.M100666200; Maina V, 2009, J LEUKOCYTE BIOL, V86, P123, DOI 10.1189/jlb.0608345; Mantovani A, 2003, VACCINE, V21, pS43, DOI 10.1016/S0264-410X(03)00199-3; Mantovani A, 2013, ANN NY ACAD SCI, V1285, P1, DOI 10.1111/nyas.12043; Moalli F, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/830421; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P1008, DOI 10.1210/en.2002-220435; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; Reviakine I, 2011, ANAL CHEM, V83, P8838, DOI 10.1021/ac201778h; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Richter RP, 2007, J AM CHEM SOC, V129, P5306, DOI 10.1021/ja068768s; Richter RP, 2005, LANGMUIR, V21, P299, DOI 10.1021/la0478402; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Russell DL, 2006, SEMIN REPROD MED, V24, P217, DOI 10.1055/s-2006-948551; Sabri S, 2000, J CELL SCI, V113, P1589; Salier JP, 1996, BIOCHEM J, V315, P1, DOI 10.1042/bj3150001; SALUSTRI A, 1992, DEV BIOL, V151, P541, DOI 10.1016/0012-1606(92)90192-J; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Salustri A., 1998, ROLE HYALURONAN OVUL; Sanggaard KW, 2006, BIOCHEMISTRY-US, V45, P7661, DOI 10.1021/bi060106s; Sanggaard KW, 2010, J BIOL CHEM, V285, P21988, DOI 10.1074/jbc.M109.041046; Sanggaard KW, 2008, J BIOL CHEM, V283, P33919, DOI 10.1074/jbc.M804240200; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Sato H, 2001, BIOCHEM BIOPH RES CO, V281, P1154, DOI 10.1006/bbrc.2001.4475; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045; Smith ML, 2003, BIOPHYS J, V85, P637, DOI 10.1016/S0006-3495(03)74507-X; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Wolny PM, 2010, J BIOL CHEM, V285, P30170, DOI 10.1074/jbc.M110.137562; Yoshihara Y, 2008, OSTEOARTHR CARTILAGE, V16, P1343, DOI 10.1016/j.joca.2008.04.004; Yoshioka S, 2000, ENDOCRINOLOGY, V141, P4114, DOI 10.1210/en.141.11.4114; ZHULINA EB, 1990, J COLLOID INTERF SCI, V137, P495, DOI 10.1016/0021-9797(90)90423-L; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	82	49	49	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30481	30498		10.1074/jbc.M114.568154	http://dx.doi.org/10.1074/jbc.M114.568154			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25190808	Green Published, hybrid			2022-12-28	WOS:000344549700028
J	Abdulla, A; Zhang, Y; Hsu, FN; Xiaoli, AM; Zhao, XP; Yang, EST; Ji, JY; Yang, FJ				Abdulla, Arian; Zhang, Yi; Hsu, Fu-Ning; Xiaoli, Alus M.; Zhao, Xiaoping; Yang, Ellen S. T.; Ji, Jun-Yuan; Yang, Fajun			Regulation of Lipogenic Gene Expression by Lysine-specific Histone Demethylase-1 (LSD1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Lipid Metabolism; Lipogenesis; Sirtuin 1 (SIRT1); Transcription; Triglyceride; LSD1; SREBP1	ELEMENT-BINDING PROTEIN-1A; LEUCINE ZIPPER PROTEIN; LIPID-METABOLISM; TRANSCRIPTION FACTORS; SIRT1 DEACETYLATES; SREBP FAMILY; PHOSPHORYLATION; METHYLATION; MECHANISMS; TARGET	Background: SREBP-1 plays a critical role in maintaining lipid homeostasis by activating lipogenic gene transcription. Results: LSD1 is required for SREBP1-mediated gene expression through multiple mechanisms in mammalian cells. Conclusion: LSD1 is a novel regulator of lipid metabolism. Significance: LSD1 is a potential target for treating diseases with aberrant lipid homeostasis. Dysregulation of lipid homeostasis is a common feature of several major human diseases, including type 2 diabetes and cardiovascular disease. However, because of the complex nature of lipid metabolism, the regulatory mechanisms remain poorly defined at the molecular level. As the key transcriptional activators of lipogenic genes, such as fatty acid synthase (FAS), sterol regulatory element-binding proteins (SREBPs) play a pivotal role in stimulating lipid biosynthesis. Several studies have shown that SREBPs are regulated by the NAD(+)-dependent histone deacetylase SIRT1, which forms a complex with the lysine-specific histone demethylase LSD1. Here, we show that LSD1 plays a role in regulating SREBP1-mediated gene expression. Multiple lines of evidence suggest that LSD1 is required for SREBP1-dependent activation of the FAS promoter in mammalian cells. LSD1 knockdown decreases SREBP-1a at the transcription level. Although LSD1 affects nuclear SREBP-1 abundance indirectly through SIRT1, it is also required for SREBP1 binding to the FAS promoter. As a result, LSD1 knockdown decreases triglyceride levels in hepatocytes. Taken together, these results show that LSD1 plays a role in regulating lipogenic gene expression, suggesting LSD1 as a potential target for treating dysregulation of lipid metabolism.	[Abdulla, Arian; Zhang, Yi; Xiaoli, Alus M.; Zhao, Xiaoping; Yang, Ellen S. T.; Yang, Fajun] Albert Einstein Coll Med, Dept Med & Dev & Mol Biol, Diabet Res & Training Ctr, Bronx, NY 10461 USA; [Hsu, Fu-Ning; Ji, Jun-Yuan] Texas A&M Univ, Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA	Yeshiva University; Albert Einstein College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Yang, FJ (corresponding author), Albert Einstein Coll Med, Dept Med & Dev & Mol Biol, 1301 Morris Pk Ave, Bronx, NY 10461 USA.	fajun.yang@einstein.yu.edu	Abdulla, Arian/AAK-7722-2020	Abdulla, Arian/0000-0001-5024-030X; Ji, Jun-yuan/0000-0002-4483-4336	National Institutes of Health [R01-DK093623, P60-DK020541]; American Diabetes Association [7-11-BS-173]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093623, R01DK095013, R01DK098439, P60DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG023475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK093623 and P60-DK020541 (to the Einstein Diabetes Center). This work was also supported by American Diabetes Association Grant 7-11-BS-173.	Abdulla Arian, 2013, J Biochem Pharmacol Res, V1, P56; Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bengoechea-Alonso MT, 2009, J BIOL CHEM, V284, P5885, DOI 10.1074/jbc.M807906200; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Castoreno AB, 2005, P NATL ACAD SCI USA, V102, P13129, DOI 10.1073/pnas.0506716102; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Choi WI, 2008, J BIOL CHEM, V283, P29341, DOI 10.1074/jbc.M802477200; Chuang JY, 2011, FREE RADICAL BIO MED, V51, P2309, DOI 10.1016/j.freeradbiomed.2011.10.001; Dif N, 2006, BIOCHEM J, V400, P179, DOI 10.1042/BJ20060499; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; Forneris F, 2008, TRENDS BIOCHEM SCI, V33, P181, DOI 10.1016/j.tibs.2008.01.003; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Hino S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1755; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mulligan P, 2011, MOL CELL, V42, P689, DOI 10.1016/j.molcel.2011.04.020; Musri MM, 2010, J BIOL CHEM, V285, P30034, DOI 10.1074/jbc.M110.151209; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Shaw M, 1997, FEBS LETT, V416, P307, DOI 10.1016/S0014-5793(97)01235-0; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Stavropoulos P, 2006, NAT STRUCT MOL BIOL, V13, P626, DOI 10.1038/nsmb1113; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Xiaoli, 2013, TRENDS CARDIOVAS MED, V23, P269, DOI 10.1016/j.tcm.2013.03.002; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; You M, 2008, AM J PHYSIOL-GASTR L, V294, pG892, DOI 10.1152/ajpgi.00575.2007; Zhang CK, 2005, BIOCHEM J, V386, P161, DOI 10.1042/BJ20041514; Zhang Yi, 2013, J Biochem Pharmacol Res, V1, P51; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462; Zingg JM, 2013, BIOFACTORS, V39, P101, DOI 10.1002/biof.1072	51	28	28	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29937	29947		10.1074/jbc.M114.573659	http://dx.doi.org/10.1074/jbc.M114.573659			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25190802	Green Published, hybrid			2022-12-28	WOS:000344370800036
J	Tinajero-Trejo, M; Denby, KJ; Sedelnikova, SE; Hassoubah, SA; Mann, BE; Poole, RK				Tinajero-Trejo, Mariana; Denby, Katie J.; Sedelnikova, Svetlana E.; Hassoubah, Shahira A.; Mann, Brian E.; Poole, Robert K.			Carbon Monoxide-releasing Molecule-3 (CORM-3; Ru(CO)(3)Cl(Glycinate)) as a Tool to Study the Concerted Effects of Carbon Monoxide and Nitric Oxide on Bacterial Flavohemoglobin Hmp APPLICATIONS AND PITFALLSPITFALLS*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbon Monoxide; Escherichia coli (E; coli); Hemoglobin; Microbiology; Nitric Oxide	COLI FLAVOHAEMOGLOBIN HMP; HEME OXYGENASE-1/CARBON MONOXIDE; ESCHERICHIA-COLI; NITROSATIVE STRESS; THERAPEUTIC APPLICATIONS; FLUORESCENT-PROBE; METAL-CARBONYLS; LIVING CELLS; RESPIRATION; PROTECTION	Background: CO-releasing molecules (CO-RMs) are used to study biological interactions with this toxic gas. Results: CORM-3 inhibits the NO detoxification activity of the E. coli flavohemoglobin Hmp in vivo but not in vitro. Conclusion: CO-RMs must be used with regard to their chemistry in biological studies. Significance: CORM-3 is a useful tool to study concerted effects of NO and CO in vivo. CO and NO are small toxic gaseous molecules that play pivotal roles in biology as gasotransmitters. During bacterial infection, NO, produced by the host via the inducible NO synthase, exerts critical antibacterial effects while CO, generated by heme oxygenases, enhances phagocytosis of macrophages. In Escherichia coli, other bacteria and fungi, the flavohemoglobin Hmp is the most important detoxification mechanism converting NO and O-2 to the ion nitrate (NO<sub arrange="stack">3<sup arrange="stack">-). The protoheme of Hmp binds not only O-2 and NO, but also CO so that this ligand is expected to be an inhibitor of NO detoxification in vivo and in vitro. CORM-3 (Ru(CO)(3)Cl(glycinate)) is a metal carbonyl compound extensively used and recently shown to have potent antibacterial properties. In this study, attenuation of the NO resistance of E. coli by CORM-3 is demonstrated in vivo. However, polarographic measurements showed that CO gas, but not CORM-3, produced inhibition of the NO detoxification activity of Hmp in vitro. Nevertheless, CO release from CORM-3 in the presence of soluble cellular compounds is demonstrated by formation of carboxy-Hmp. We show that the inability of CORM-3 to inhibit the activity of purified Hmp is due to slow release of CO in protein solutions alone i.e. when sodium dithionite, widely used in previous studies of CO release from CORM-3, is excluded. Finally, we measure intracellular CO released from CORM-3 by following the formation of carboxy-Hmp in respiring cells. CORM-3 is a tool to explore the concerted effects of CO and NO in vivo.	[Tinajero-Trejo, Mariana; Denby, Katie J.; Sedelnikova, Svetlana E.; Hassoubah, Shahira A.; Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Mann, Brian E.] Univ Sheffield, Dept Chem, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield	Tinajero-Trejo, M (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	m.tinajero-trejo@sheffield.ac.uk	Hassoubah, Shahira/AAY-6659-2020	Hassoubah, Shahira/0000-0003-3089-3682	Consejo Nacional de Ciencia y Tecnologia (Mexico) [99171]; Consejo Estatal de Ciencia, Tecnologia e Innovacion de Michoacan [007]; UK Biotechnology and Biological Sciences Research Council [BB/HO16805/1]; BBSRC [BB/H016805/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H016805/1] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Estatal de Ciencia, Tecnologia e Innovacion de Michoacan; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Consejo Nacional de Ciencia y Tecnologia (Mexico) through Grant Number 99171 and Consejo Estatal de Ciencia, Tecnologia e Innovacion de Michoacan through Grant Number 007 (to M. T.-T.) and the UK Biotechnology and Biological Sciences Research Council through Grant Number BB/HO16805/1 (to R. K. P.).	Alcaraz MJ, 2008, CURR PHARM DESIGN, V14, P465, DOI 10.2174/138161208783597362; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boczkowski J, 2006, TRENDS BIOCHEM SCI, V31, P614, DOI 10.1016/j.tibs.2006.09.001; Chung SW, 2008, J CLIN INVEST, V118, P239, DOI 10.1172/JCI32730; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; Clarke MJ, 2002, COORDIN CHEM REV, V232, P69, DOI 10.1016/S0010-8545(02)00025-5; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; Davidge KS, 2009, ADV MICROB PHYSIOL, V56, P85, DOI 10.1016/S0065-2911(09)05603-3; Davidge KS, 2009, J BIOL CHEM, V284, P4516, DOI 10.1074/jbc.M808210200; Desmard M, 2012, ANTIOXID REDOX SIGN, V16, P153, DOI 10.1089/ars.2011.3959; Desmard M, 2009, FASEB J, V23, P1023, DOI 10.1096/fj.08-122804; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; Forrester MT, 2012, FREE RADICAL BIO MED, V52, P1620, DOI 10.1016/j.freeradbiomed.2012.01.028; Franke A, 2013, EUR J INORG CHEM, P460, DOI 10.1002/ejic.201201111; Gardner AM, 2002, J BIOL CHEM, V277, P8166, DOI 10.1074/jbc.M110470200; Gardner PR, 2006, J INORG BIOCHEM, V100, P542, DOI 10.1016/j.jinorgbio.2005.12.012; Gardner PR, 2000, J BIOL CHEM, V275, P31581, DOI 10.1074/jbc.M004141200; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gardner PR, 1997, J BIOL CHEM, V272, P25071, DOI 10.1074/jbc.272.40.25071; Gardner PR, 1998, J BIOL CHEM, V273, P26528, DOI 10.1074/jbc.273.41.26528; Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698; Hausladen A., 1998, ARCH PHYSIOL BIOCHEM, V2, P83; Hernandez-Urzua E, 2003, J BIOL CHEM, V278, P34975, DOI 10.1074/jbc.M303629200; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030; IOANNIDIS N, 1992, BIOCHEM J, V288, P649, DOI 10.1042/bj2880649; Jesse HE, 2013, BBA-PROTEINS PROTEOM, V1834, P1693, DOI 10.1016/j.bbapap.2013.04.019; Johnson TR, 2007, DALTON T, P1500, DOI 10.1039/b613629j; Johnson TR, 2003, ANGEW CHEM INT EDIT, V42, P3722, DOI 10.1002/anie.200301634; Kalnenieks U, 1998, FEMS MICROBIOL LETT, V168, P91; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; KEILIN D, 1966, HIST CELL RESPIRATIO; Kim SO, 1999, FEBS LETT, V445, P389, DOI 10.1016/S0014-5793(99)00157-X; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Mann BE, 2010, TOP ORGANOMETAL CHEM, V32, P247, DOI 10.1007/978-3-642-13185-1_10; MARKS GS, 1991, TRENDS PHARMACOL SCI, V12, P185, DOI 10.1016/0165-6147(91)90544-3; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; McLean S, 2013, ANTIOXID REDOX SIGN, V19, P1999, DOI 10.1089/ars.2012.5103; McLean S, 2012, ANAL BIOCHEM, V427, P36, DOI 10.1016/j.ab.2012.04.026; Michel BW, 2012, J AM CHEM SOC, V134, P15668, DOI 10.1021/ja307017b; Mills CE, 2001, BIOCHEM J, V353, P207, DOI 10.1042/0264-6021:3530207; Motterlini R, 2005, EXPERT OPIN INV DRUG, V14, P1305, DOI 10.1517/13543784.14.11.1305; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Nobre LS, 2007, ANTIMICROB AGENTS CH, V51, P4303, DOI 10.1128/AAC.00802-07; Otterbein LE, 2005, CELL MOL BIOL, V51, P433, DOI 10.1170/T647; Park SS, 2012, ANAL CHEM, V84, P1792, DOI 10.1021/ac2031628; Poole RK, 1996, J BACTERIOL, V178, P5487, DOI 10.1128/jb.178.18.5487-5492.1996; Poole RK, 2000, MOL MICROBIOL, V36, P775, DOI 10.1046/j.1365-2958.2000.01889.x; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; POOLE RK, 1994, P ROY SOC B-BIOL SCI, V255, P251, DOI 10.1098/rspb.1994.0036; POOLE RK, 1986, J GEN MICROBIOL, V132, P1525; Roberts GP, 2004, MICROBIOL MOL BIOL R, V68, P453, DOI 10.1128/MMBR.68.3.453-473.2004; Romao CC, 2012, CHEM SOC REV, V41, P3571, DOI 10.1039/c2cs15317c; Ryan R.R., 1981, INORG CHEM, P47; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Saavedra JE, 1996, J MED CHEM, V39, P4361, DOI 10.1021/jm960616s; Schatzschneider U, 2011, INORG CHIM ACTA, V374, P19, DOI 10.1016/j.ica.2011.02.068; Shekhawat GS, 2010, J EXP BOT, V61, P2255, DOI 10.1093/jxb/erq074; Stevanin TM, 2005, INFECT IMMUN, V73, P3322, DOI 10.1128/IAI.73.6.3322-3329.2005; Stevanin TM, 2000, J BIOL CHEM, V275, P35868, DOI 10.1074/jbc.M002471200; Takaki S, 2010, INTENS CARE MED, V36, P42, DOI 10.1007/s00134-009-1575-4; Thorup C, 1999, AM J PHYSIOL-RENAL, V277, pF882, DOI 10.1152/ajprenal.1999.277.6.F882; Tinajero-Trejo Mariana, 2013, F1000Prime Rep, V5, P28, DOI 10.12703/P5-28; Vinogradov SN, 2013, BBA-PROTEINS PROTEOM, V1834, P1789, DOI 10.1016/j.bbapap.2013.03.021; Wang J, 2012, ANGEW CHEM INT EDIT, V51, P9652, DOI 10.1002/anie.201203684; Wilson JL, 2013, ANTIOXID REDOX SIGN, V19, P497, DOI 10.1089/ars.2012.4784; Wilson JL, 2012, CURR PHARM BIOTECHNO, V13, P760; Xue L, 2000, P NATL ACAD SCI USA, V97, P1851, DOI 10.1073/pnas.97.4.1851	68	20	21	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29471	29482		10.1074/jbc.M114.573444	http://dx.doi.org/10.1074/jbc.M114.573444			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25193663	Green Published, hybrid			2022-12-28	WOS:000344370800002
J	Lauer, ME; Hascall, VC; Green, DE; DeAngelis, PL; Calabro, A				Lauer, Mark E.; Hascall, Vincent C.; Green, Dixy E.; DeAngelis, Paul L.; Calabro, Anthony			Irreversible Heavy Chain Transfer to Chondroitin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; FACTOR-STIMULATED GENE-6; ALPHA-TRYPSIN INHIBITOR; SMOOTH-MUSCLE-CELLS; CHEMOENZYMATIC SYNTHESIS; EXTRACELLULAR-MATRIX; OOCYTE COMPLEXES; PROTEIN TSG-6; HYALURONAN; TNF	We have recently demonstrated that the transfer of heavy chains (HCs) from inter-alpha-inhibitor, via the enzyme TSG-6 (tumor necrosis factor-stimulated gene 6), to hyaluronan (HA) oligosaccharides is an irreversible event in which subsequent swapping of HCs between HA molecules does not occur. We now describe our results of HC transfer experiments to chondroitin sulfate A, chemically desulfated chondroitin, chemoenzymatically synthesized chondroitin, unsulfated heparosan, heparan sulfate, and alginate. Of these potential HC acceptors, only chemically desulfated chondroitin and chemoenzymatically synthesized chondroitin were HC acceptors. The kinetics of HC transfer to chondroitin was similar to HA. At earlier time points, HCs were more widely distributed among the different sizes of chondroitin chains. As time progressed, the HCs migrated to lower molecular weight chains of chondroitin. Our interpretation is that TSG-6 swaps the HCs from the larger, reversible sites on chondroitin chains, which function as HC acceptors, onto smaller chondroitin chains, which function as irreversible HC acceptors. HCs transferred to smaller chondroitin chains were unable to be swapped off the smaller chondroitin chains and transferred to HA. HCs transferred to high molecular weight HA were unable to be swapped onto chondroitin. We also present data that although chondroitin was a HC acceptor, HA was the preferred acceptor when chondroitin and HA were in the same reaction mixture.	[Lauer, Mark E.; Hascall, Vincent C.; Calabro, Anthony] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Green, Dixy E.; DeAngelis, Paul L.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73126 USA	Cleveland Clinic Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Lauer, ME (corresponding author), Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA.	lauerm1@ccf.org			National Institutes of Health, NHLBI [P01HL107147, 1RO1HL113325-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147, R01HL113325] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI Awards P01HL107147 and 1RO1HL113325-01A1.	Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Chi LL, 2008, J AM CHEM SOC, V130, P2617, DOI 10.1021/ja0778500; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Evanko SP, 2009, J HISTOCHEM CYTOCHEM, V57, P1041, DOI 10.1369/jhc.2009.953802; Fulop C, 1997, GENE, V202, P95, DOI 10.1016/S0378-1119(97)00459-9; Jing W, 2004, J BIOL CHEM, V279, P42345, DOI 10.1074/jbc.M402744200; Kota DJ, 2013, DIABETES, V62, P2048, DOI 10.2337/db12-0931; Lauer ME, 2013, J BIOL CHEM, V288, P205, DOI 10.1074/jbc.M112.403998; Lauer ME, 2013, J BIOL CHEM, V288, P423, DOI 10.1074/jbc.M112.389882; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lin QM, 2013, ACTA PHARMACOL SIN, V34, P784, DOI 10.1038/aps.2012.199; Ly M, 2011, NAT CHEM BIOL, V7, P827, DOI 10.1038/nchembio.673; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Qi Y, 2014, J INVEST DERMATOL, V134, P526, DOI 10.1038/jid.2013.328; Roddy GW, 2011, STEM CELLS, V29, P1572, DOI 10.1002/stem.708; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Sanggaard KW, 2010, J BIOL CHEM, V285, P21988, DOI 10.1074/jbc.M109.041046; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Sismey-Ragatz AE, 2007, J BIOL CHEM, V282, P28321, DOI 10.1074/jbc.M701599200; Swaidani S, 2013, J BIOL CHEM, V288, P412, DOI 10.1074/jbc.M112.389874; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Tracy BS, 2007, J BIOL CHEM, V282, P337, DOI 10.1074/jbc.M607569200; Tsukahara S, 2006, BIOCHEM J, V398, P595, DOI 10.1042/BJ20060027; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Wang N, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt142; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043768; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Yang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100285	30	4	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29171	29179		10.1074/jbc.M114.600809	http://dx.doi.org/10.1074/jbc.M114.600809			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25135638	Green Published, hybrid			2022-12-28	WOS:000344141000033
J	Zhang, AL; He, X; Zhang, L; Yang, L; Woodman, P; Li, W				Zhang, Aili; He, Xin; Zhang, Ling; Yang, Lin; Woodman, Philip; Li, Wei			Biogenesis of Lysosome-related Organelles Complex-1 Subunit 1 (BLOS1) Interacts with Sorting Nexin 2 and the Endosomal Sorting Complex Required for Transport-I (ESCRT-I) Component TSG101 to Mediate the Sorting of Epidermal Growth Factor Receptor into Endosomal Compartments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERMANSKY-PUDLAK-SYNDROME; PROTEIN TRAFFICKING; DOWN-REGULATION; BLOC-1; DYSBINDIN; DEFICIENCY; DEGRADATION; MATURATION; MACHINERY; RETROMER	Biogenesis of lysosome-related organelles complex-1 (BLOC-1) is a component of the molecular machinery required for the biogenesis of specialized organelles and lysosomal targeting of cargoes via the endosomal to lysosomal trafficking pathway. BLOS1, one subunit of BLOC-1, is implicated in lysosomal trafficking of membrane proteins. We found that the degradation and trafficking of epidermal growth factor receptor (EGFR) were delayed in BLOS1 knockdown cells, which were rescued through BLOS1 overexpression. A key feature to the delayed EGFR degradation is the accumulation of endolysosomes in BLOS1 knockdown cells or BLOS1 knock-out mouse embryonic fibroblasts. BLOS1 interacted with SNX2 (a retromer subunit) and TSG101 (an endosomal sorting complex required for transport subunit-I) to mediate EGFR lysosomal trafficking. These results suggest that coordination of the endolysosomal trafficking proteins is important for proper targeting of EGFR to lysosomes.	[Zhang, Aili; He, Xin; Yang, Lin; Li, Wei] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China; [Zhang, Aili] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Zhang, Ling; Woodman, Philip] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Manchester	Li, W (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, 1 West Beichen Rd, Beijing 100101, Peoples R China.	wli@genetics.ac.cn			National Natural Science Foundation of China [31230046, 31471333, 91332116]; Chinese Academy of Sciences [KJZD-EW-L08]; Biotechnology and Biological Sciences Research Council [BB/I012109/1, BB/H531600/1] Funding Source: researchfish; Medical Research Council [G0701140] Funding Source: researchfish; BBSRC [BB/I012109/1, BB/H531600/1] Funding Source: UKRI; MRC [G0701140] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by National Natural Science Foundation of China Grants 31230046, 31471333, and 91332116 and by Chinese Academy of Sciences Grant KJZD-EW-L08.	Bache KG, 2006, MOL BIOL CELL, V17, P2513, DOI 10.1091/mbc.E05-10-0915; Bishop N, 2002, J CELL BIOL, V157, P91, DOI 10.1083/jcb.200112080; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Cheli VT, 2010, HUM MOL GENET, V19, P861, DOI 10.1093/hmg/ddp555; Cui YY, 2010, J CELL SCI, V123, P3727, DOI 10.1242/jcs.069732; Cullinane AR, 2011, AM J HUM GENET, V88, P778, DOI 10.1016/j.ajhg.2011.05.009; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; Gullapalli A, 2004, MOL BIOL CELL, V15, P2143, DOI 10.1091/mbc.E03-09-0711; Hah J.H., 2005, J NEUROSCI, V25, P10546; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Izouvelelvis A., 2013, BIOMED RES INT; Ji YY, 2009, P NATL ACAD SCI USA, V106, P19593, DOI 10.1073/pnas.0904289106; Larimore J, 2014, J BIOL CHEM, V289, P14291, DOI 10.1074/jbc.M114.553750; Lee HH, 2012, J BIOL CHEM, V287, P5882, DOI 10.1074/jbc.M111.325746; Lemnron M.A., 2010, CELL, V141, P1117; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Li Wei, 2007, Journal of Genetics and Genomics, V34, P669, DOI 10.1016/S1673-8527(07)60076-9; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Luzio JP, 2009, BIOCHEM SOC T, V37, P1019, DOI 10.1042/BST0371019; Madala SK, 2012, AM J RESP CELL MOL, V46, P380, DOI 10.1165/rcmb.2011-0237OC; Malerod L, 2007, TRAFFIC, V8, P1617, DOI 10.1111/j.1600-0854.2007.00630.x; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009325; McDonald JH, 2013, J MICROSC-OXFORD, V252, P295, DOI 10.1111/jmi.12093; Morgan NV, 2006, AM J HUM GENET, V78, P160, DOI 10.1086/499338; Peng JY, 2014, SCI CHINA LIFE SCI, V57, P59, DOI 10.1007/s11427-013-4588-8; Peter ATJ, 2013, J CELL BIOL, V201, P97, DOI 10.1083/jcb.201210038; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; Schmidt O, 2012, CURR BIOL, V22, pR116, DOI 10.1016/j.cub.2012.01.028; Scott I, 2014, J BIOL CHEM, V289, P2864, DOI 10.1074/jbc.M113.521641; Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066; Sitaram A, 2012, MOL BIOL CELL, V23, P3178, DOI 10.1091/mbc.E11-06-0509; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Stefani F, 2011, CURR BIOL, V21, P1245, DOI 10.1016/j.cub.2011.06.028; Swank RT, 1998, PIGM CELL RES, V11, P60, DOI 10.1111/j.1600-0749.1998.tb00713.x; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Wang H, 2014, J BIOL CHEM, V289, P29060, DOI 10.1074/jbc.M114.590927; Wei AH, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12051; Yang Q, 2012, TRAFFIC, V13, P1160, DOI 10.1111/j.1600-0854.2012.01375.x; Zhou B, 2011, BIOSCIENCE REP, V31, P151, DOI 10.1042/BSR20100110	42	36	37	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29180	29194		10.1074/jbc.M114.576561	http://dx.doi.org/10.1074/jbc.M114.576561			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25183008	Green Published, hybrid			2022-12-28	WOS:000344141000034
J	Chen, C; Tao, T; Wen, C; He, WQ; Qiao, YN; Gao, YQ; Chen, X; Wang, P; Chen, CP; Zhao, W; Chen, HQ; Ye, AP; Peng, YJ; Zhu, MS				Chen, Chen; Tao, Tao; Wen, Cheng; He, Wei-Qi; Qiao, Yan-Ning; Gao, Yun-Qian; Chen, Xin; Wang, Pei; Chen, Cai-Ping; Zhao, Wei; Chen, Hua-Qun; Ye, An-Pei; Peng, Ya-Jing; Zhu, Min-Sheng			Myosin Light Chain Kinase (MLCK) Regulates Cell Migration in a Myosin Regulatory Light Chain Phosphorylation-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CONTRACTION; MEMBRANE TENSION; RHO-KINASE; EXTRACELLULAR-MATRIX; ADHESION DYNAMICS; ACTIN CONNECTION; CA2+ SENSITIVITY; DISTINCT ROLES; IN-VIVO; MOTILITY	Myosin light chain kinase (MLCK) has long been implicated in the myosin phosphorylation and force generation required for cell migration. Here, we surprisingly found that the deletion of MLCK resulted in fast cell migration, enhanced protrusion formation, and no alteration of myosin light chain phosphorylation. The mutant cells showed reduced membrane tether force and fewer membrane F-actin filaments. This phenotype was rescued by either kinase-dead MLCK or five-DFRXXL motif, a MLCK fragment with potent F-actin-binding activity. Pull-down and co-immunoprecipitation assays showed that the absence of MLCK led to attenuated formation of transmembrane complexes, including myosin II, integrins and fibronectin. We suggest that MLCK is not required for myosin phosphorylation in a migrating cell. A critical role of MLCK in cell migration involves regulating the cell membrane tension and protrusion necessary for migration, thereby stabilizing the membrane skeleton through F-actin-binding activity. This finding sheds light on a novel regulatory mechanism of protrusion during cell migration.	[Chen, Chen; Tao, Tao; He, Wei-Qi; Qiao, Yan-Ning; Gao, Yun-Qian; Chen, Xin; Wang, Pei; Chen, Cai-Ping; Zhao, Wei; Peng, Ya-Jing; Zhu, Min-Sheng] Nanjing Univ, Model Anim Res Ctr, Key Lab Model Anim Dis Study, Minist Educ, Nanjing 210061, Jiangsu, Peoples R China; [Wen, Cheng; Ye, An-Pei] Peking Univ, Sch Elect Engn & Comp Sci, Key Lab Phys & Chem Nanodevices, Minist Educ, Beijing 100871, Peoples R China; [Chen, Hua-Qun; Zhu, Min-Sheng] Nanjing Normal Univ, Sch Life Sci, Nanjing 210009, Jiangsu, Peoples R China	Nanjing University; Peking University; Nanjing Normal University	Peng, YJ (corresponding author), Nanjing Univ, Model Anim Res Ctr, Key Lab Model Anim Dis Study, Minist Educ, 12 Xue Fu Rd, Nanjing 210061, Jiangsu, Peoples R China.	pengyj@nicemice.cn; zhums@nju.edu.cn	Chen, Caiping/HII-8998-2022; He, Weiqi/I-7935-2013; Ye, Anpei/E-2765-2016; He, Weiqi/L-2502-2019	He, Weiqi/0000-0003-3137-8420; He, Weiqi/0000-0003-3137-8420; Chen, Chen/0000-0001-7075-8501; Chen, Xin/0000-0003-3304-8943; Qiao, Yanning/0000-0002-8092-4662	National Basic Research Program of China (973 Program) [2014CB964701]; National Natural Science Foundation of China [31371356, 31200824, 31330034]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program, 2014CB964701) and the National Natural Science Foundation of China (31371356, 31200824, and 31330034).	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Batchelder EL, 2011, P NATL ACAD SCI USA, V108, P11429, DOI 10.1073/pnas.1010481108; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Betapudi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008560; Blue EK, 2002, AM J PHYSIOL-CELL PH, V282, pC451, DOI 10.1152/ajpcell.00333.2001; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Chew TL, 2002, J CELL BIOL, V156, P543, DOI 10.1083/jcb.200110161; Connell LE, 2006, J CELL SCI, V119, P2269, DOI 10.1242/jcs.02926; Cramer LP, 2013, CURR OPIN CELL BIOL, V25, P591, DOI 10.1016/j.ceb.2013.05.001; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Dai JW, 1998, J NEUROSCI, V18, P6681; Davidson LA, 2006, CURR BIOL, V16, P833, DOI 10.1016/j.cub.2006.03.038; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; HOLZAPFEL G, 1983, EXP CELL RES, V148, P117, DOI 10.1016/0014-4827(83)90192-1; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Katoh K, 2001, AM J PHYSIOL-CELL PH, V280, pC1669, DOI 10.1152/ajpcell.2001.280.6.C1669; Kenagy RD, 1997, CIRCULATION, V96, P3555; Komatsu S, 2004, J CELL BIOL, V165, P243, DOI 10.1083/jcb.200309056; Kudryashov DS, 1999, FEBS LETT, V463, P67, DOI 10.1016/S0014-5793(99)01591-4; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Li YJ, 2009, COLLOID SURFACE B, V70, P169, DOI 10.1016/j.colsurfb.2008.11.012; Lieber AD, 2013, CURR BIOL, V23, P1409, DOI 10.1016/j.cub.2013.05.063; Lin PJ, 1999, J BIOL CHEM, V274, P5987, DOI 10.1074/jbc.274.9.5987; Liu SC, 2000, J CELL SCI, V113, P3563; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mizuno Y, 2008, AM J PHYSIOL-CELL PH, V295, pC358, DOI 10.1152/ajpcell.90645.2007; Niggli V, 2006, BIOCHEM BIOPH RES CO, V343, P602, DOI 10.1016/j.bbrc.2006.03.022; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Okeyo KO, 2009, J BIOMECH, V42, P2540, DOI 10.1016/j.jbiomech.2009.07.002; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Schiller HB, 2013, EMBO REP, V14, P509, DOI 10.1038/embor.2013.49; Sellers JR, 1991, CURR OPIN CELL BIOL, V3, P98, DOI 10.1016/0955-0674(91)90171-T; SELLERS JR, 1981, J BIOL CHEM, V256, P3137; Sheetz MP, 1996, TRENDS CELL BIOL, V6, P85, DOI 10.1016/0962-8924(96)80993-7; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Smith AF, 1998, AM J PHYSIOL-CELL PH, V274, pC1188, DOI 10.1152/ajpcell.1998.274.5.C1188; Smith L, 1999, J BIOL CHEM, V274, P29433, DOI 10.1074/jbc.274.41.29433; Smith L, 2002, J BIOL CHEM, V277, P35597, DOI 10.1074/jbc.M206483200; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; TANSEY MG, 1994, J BIOL CHEM, V269, P9912; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Traynor D, 2007, J CELL SCI, V120, P2318, DOI 10.1242/jcs.007732; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; WORD RA, 1991, AM J PHYSIOL, V260, pC861, DOI 10.1152/ajpcell.1991.260.4.C861; Yang CX, 2006, CELL RES, V16, P367, DOI 10.1038/sj.cr.7310047; Zhang WC, 2008, FEBS J, V275, P2489, DOI 10.1111/j.1742-4658.2008.06393.x; Zhang WC, 2010, J BIOL CHEM, V285, P5522, DOI 10.1074/jbc.M109.062836	73	38	41	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28478	28488		10.1074/jbc.M114.567446	http://dx.doi.org/10.1074/jbc.M114.567446			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25122766	Green Published, hybrid			2022-12-28	WOS:000343765400039
J	El Hiani, Y; Linsdell, P				El Hiani, Yassine; Linsdell, Paul			Metal Bridges Illuminate Transmembrane Domain Movements during Gating of the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE CHARGES; WILD-TYPE; PORE; REGIONS; ROLES; PYROPHOSPHATE; SEGMENT; MODEL	Opening and closing of the cystic fibrosis transmembrane conductance regulator are controlled by ATP binding and hydrolysis by the cytoplasmic nucleotide-binding domains. Different conformational changes in the channel pore have been described during channel opening and closing; however, the relative importance of these changes to the process of gating the pore is not known. We have used patch clamp recording to identify high affinity Cd2+ bridges formed between pairs of pore-lining cysteine residues introduced into different transmembrane alpha-helices (TMs). Seven Cd2+ bridges were identified forming between cysteines in TMs 6 and 12. Interestingly, each of these Cd2+ bridges apparently formed only in closed channels, and their formation stabilized the closed state. In contrast, a single Cd2+ bridge identified between cysteines in TMs 1 and 12 stabilized the channel open state. Analysis of the pattern of Cd2+ bridge formation in different channel states suggests that lateral separation and convergence of different TMs, rather than relative rotation or translation of different TMs, is the key conformational change that causes the channel pore to open and close.	[El Hiani, Yassine; Linsdell, Paul] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 4R2, Canada	Dalhousie University	Linsdell, P (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, POB 15000, Halifax, NS B3H 4R2, Canada.	paul.linsdell@dal.ca		El Hiani, Yassine/0000-0002-1251-5066; Linsdell, Paul/0000-0001-6257-6273	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	Bai YH, 2011, J GEN PHYSIOL, V138, P495, DOI 10.1085/jgp.201110705; Bai YH, 2010, J GEN PHYSIOL, V136, P293, DOI 10.1085/jgp.201010480; Beck EJ, 2008, J BIOL CHEM, V283, P4957, DOI 10.1074/jbc.M702235200; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; CARSON MR, 1995, J BIOL CHEM, V270, P20466, DOI 10.1074/jbc.270.35.20466; Choi LS, 2013, BIOPHYS J, V105, P356, DOI 10.1016/j.bpj.2013.04.046; Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; El Hiani Y, 2012, BIOPHYS J, V103, P1719, DOI 10.1016/j.bpj.2012.09.020; El Hiani Y, 2010, J BIOL CHEM, V285, P32126, DOI 10.1074/jbc.M110.113332; Gao X, 2013, BIOPHYS J, V104, P786, DOI 10.1016/j.bpj.2012.12.048; Ge N, 2004, J BIOL CHEM, V279, P55283, DOI 10.1074/jbc.M411935200; GUNDERSON KL, 1994, J BIOL CHEM, V269, P19349; Henrion U, 2012, P NATL ACAD SCI USA, V109, P8552, DOI 10.1073/pnas.1116938109; Holstead RG, 2011, J MEMBRANE BIOL, V243, P15, DOI 10.1007/s00232-011-9388-0; Hwang TC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009498; Li MS, 2009, BRIT J PHARMACOL, V157, P1065, DOI 10.1111/j.1476-5381.2009.00258.x; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Linsdell P, 2014, PFLUG ARCH EUR J PHY, V466, P2243, DOI 10.1007/s00424-014-1501-7; Linsdell P, 2014, MOL MEMBR BIOL, V31, P1, DOI 10.3109/09687688.2013.868055; Lubamba B, 2012, CLIN BIOCHEM, V45, P1132, DOI 10.1016/j.clinbiochem.2012.05.034; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Qian F, 2011, PFLUG ARCH EUR J PHY, V462, P559, DOI 10.1007/s00424-011-0998-2; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; Wang WY, 2014, PFLUG ARCH EUR J PHY, V466, P477, DOI 10.1007/s00424-013-1317-x; Wang WY, 2012, J BIOL CHEM, V287, P32136, DOI 10.1074/jbc.M112.385096; Wang WY, 2012, J BIOL CHEM, V287, P10156, DOI 10.1074/jbc.M112.342972; Wang WY, 2012, BBA-BIOMEMBRANES, V1818, P851, DOI 10.1016/j.bbamem.2011.12.025; Wang WY, 2011, J GEN PHYSIOL, V138, P165, DOI 10.1085/jgp.201110605; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327	33	8	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28149	28159		10.1074/jbc.M114.593103	http://dx.doi.org/10.1074/jbc.M114.593103			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25143385	Green Published, hybrid			2022-12-28	WOS:000343765400012
J	Mahajan, K; Lawrence, HR; Lawrence, NJ; Mahajan, NP				Mahajan, Kiran; Lawrence, Harshani R.; Lawrence, Nicholas J.; Mahajan, Nupam P.			ACK1 Tyrosine Kinase Interacts with Histone Demethylase KDM3A to Regulate the Mammary Tumor Oncogene HOXA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURGICAL ADJUVANT BREAST; BOWEL PROJECT P-1; ANDROGEN RECEPTOR; ESTROGEN-RECEPTOR; TAMOXIFEN RESISTANCE; PROSTATE-CANCER; DASATINIB BMS-354825; PHOSPHORYLATION; ACTIVATION; MECHANISMS	Hormone therapy with the selective estrogen-receptor modulator tamoxifen provides a temporary relief for patients with estrogen receptor alpha (ER)-positive breast cancers. However, a subset of patients exhibiting overexpression of the HER2 receptor tyrosine kinase displays intrinsic resistance to tamoxifen therapy. Therefore, elucidating the mechanisms promoting the estrogen (E-2)-independent ER-regulated gene transcription in tamoxifen-resistant breast tumors is essential to identify new therapeutic avenues to overcome drug resistance and ameliorate poor prognosis. The non-receptor tyrosine kinase, ACK1 (also known as TNK2), has emerged as a major integrator of signaling from various receptor tyrosine kinases including HER2. We have uncovered that heregulin-mediated ACK1 activation promoted ER activity in the presence of tamoxifen, which was significantly down-regulated upon ACK1 knockdown or inhibition of ACK1 by small molecule inhibitors, AIM-100 or Dasatinib. We report that ACK1 phosphorylates the ER co-activator, KDM3A, a H3K9 demethylase, at an evolutionary conserved tyrosine 1114 site in a heregulin-dependent manner, even in the presence of tamoxifen. Consistent with this finding, ACK1 activation resulted in a significant decrease in the deposition of dimethyl H3K9 epigenetic marks. Conversely, inhibition of ACK1 by AIM-100 or Dasatinib restored dimethyl H3K9 methylation marks and caused transcriptional suppression of the ER-regulated gene HOXA1. Thus, by its ability to regulate the epigenetic activity of an ER co-activator KDM3A, ACK1 modulates HOXA1 expression in the absence of E-2, conferring tamoxifen resistance. These data reveal a novel therapeutic option, suppression of ACK1 signaling by AIM-100 or Dasatinib, to mitigate HOXA1 up-regulation in breast cancer patients displaying tamoxifen resistance.	[Mahajan, Kiran; Lawrence, Harshani R.; Lawrence, Nicholas J.; Mahajan, Nupam P.] Univ S Florida, H Lee Moffitt Canc Ctr, Drug Discovery Dept, Tampa, FL 33682 USA; [Mahajan, Kiran; Lawrence, Harshani R.; Lawrence, Nicholas J.; Mahajan, Nupam P.] Univ S Florida, Dept Oncol Sci, Coll Med, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Mahajan, K (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Drug Discovery Dept, 12902 Magnolia Dr, Tampa, FL 33682 USA.	kiran.mahajan@moffitt.org; nupam.mahajan@moffitt.org	Mahajan, Kiran/ABA-3013-2020	Mahajan, Kiran/0000-0001-7192-396X	Department of Defense [W81XWH-12-1-0248, W81XWH-14-1-0002, W81XWH-14-1-0003]; NCI, National Institutes of Health [1R01CA135328]; NATIONAL CANCER INSTITUTE [R01CA135328, P30CA076292] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Department of Defense Grant W81XWH-12-1-0248 (to K. M.) and by NCI, National Institutes of Health Grant 1R01CA135328 and Department of Defense Grants W81XWH-14-1-0002 and W81XWH-14-1-0003 (to N. P. M.).	BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Brock A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007048; Buchwald M, 2013, ONCOGENE, V32, P4913, DOI 10.1038/onc.2012.515; Chen HX, 2003, J MAMMARY GLAND BIOL, V8, P159, DOI 10.1023/A:1025996707117; Cho HS, 2012, INT J CANCER, V131, pE179, DOI 10.1002/ijc.26501; Clarke R, 2001, PHARMACOL REV, V53, P25; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; GOTTARDIS MM, 1988, CANCER RES, V48, P5183; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Holst F, 2007, NAT GENET, V39, P655, DOI 10.1038/ng2006; Hopp TA, 2004, CLIN CANCER RES, V10, P7490, DOI 10.1158/1078-0432.CCR-04-1114; HOWELL A, 1995, LANCET, V345, P29, DOI 10.1016/S0140-6736(95)91156-1; Johnston SRD, 1997, ANTI-CANCER DRUG, V8, P911, DOI 10.1097/00001813-199711000-00002; Li JN, 2010, NAT CHEM BIOL, V6, P291, DOI [10.1038/NCHEMBIO.332, 10.1038/nchembio.332]; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Liu XF, 2004, J BIOL CHEM, V279, P15050, DOI 10.1074/jbc.M311932200; Liu Y, 2010, ONCOGENE, V29, P3208, DOI 10.1038/onc.2010.103; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Mahajan K, 2013, CANCER LETT, V338, P185, DOI 10.1016/j.canlet.2013.04.004; Mahajan K, 2012, NAT STRUCT MOL BIOL, V19, P930, DOI 10.1038/nsmb.2356; Mahajan K, 2012, J BIOL CHEM, V287, P22112, DOI 10.1074/jbc.M112.357384; Mahajan K, 2012, J CELL PHYSIOL, V227, P3178, DOI 10.1002/jcp.24065; Mahajan K, 2012, AM J PATHOL, V180, P1386, DOI 10.1016/j.ajpath.2011.12.028; Mahajan K, 2010, PROSTATE, V70, P1274, DOI 10.1002/pros.21163; Mahajan K, 2010, J CELL PHYSIOL, V224, P327, DOI 10.1002/jcp.22162; Mahajan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009646; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Massarweh S, 2007, CLIN CANCER RES, V13, P1950, DOI 10.1158/1078-0432.CCR-06-2540; Mellinghoff IK, 2004, CANCER CELL, V6, P517, DOI 10.1016/j.ccr.2004.09.031; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Robertson SC, 2000, TRENDS GENET, V16, P368, DOI 10.1016/S0168-9525(00)02077-1; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Skorski T, 2002, NAT REV CANCER, V2, P351, DOI 10.1038/nrc799; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zhang X, 2003, J BIOL CHEM, V278, P7580, DOI 10.1074/jbc.M212050200	53	40	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28179	28191		10.1074/jbc.M114.584425	http://dx.doi.org/10.1074/jbc.M114.584425			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25148682	hybrid, Green Published			2022-12-28	WOS:000343765400015
J	Abicht, HK; Scharer, MA; Quade, N; Ledermann, R; Mohorko, E; Capitani, G; Hennecke, H; Glockshuber, R				Abicht, Helge K.; Schaerer, Martin A.; Quade, Nick; Ledermann, Raphael; Mohorko, Elisabeth; Capitani, Guido; Hennecke, Hauke; Glockshuber, Rudi			How Periplasmic Thioredoxin TlpA Reduces Bacterial Copper Chaperone ScoI and Cytochrome Oxidase Subunit II (CoxB) Prior to Metallation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRADYRHIZOBIUM-JAPONICUM TLPA; DISULFIDE BOND FORMATION; C-OXIDASE; PARACOCCUS-DENITRIFICANS; SEQUENCE ALIGNMENT; RESPIRATORY-CHAIN; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; REDOX PROPERTIES; PROTEIN	Two critical cysteine residues in the copper-A site (Cu-A) on subunit II (CoxB) of bacterial cytochrome c oxidase lie on the periplasmic side of the cytoplasmic membrane. As the periplasm is an oxidizing environment as compared with the reducing cytoplasm, the prediction was that a disulfide bond formed between these cysteines must be eliminated by reduction prior to copper insertion. We show here that a periplasmic thioredoxin (TlpA) acts as a specific reductant not only for the Cu2+ transfer chaperone ScoI but also for CoxB. The dual role of TlpA was documented best with high-resolution crystal structures of the kinetically trapped TlpA-ScoI and TlpA-CoxB mixed disulfide intermediates. They uncovered surprisingly disparate contact sites on TlpA for each of the two protein substrates. The equilibrium of CoxB reduction by TlpA revealed a thermodynamically favorable reaction, with a less negative redox potential of CoxB (E-0' = -231 mV) as compared with that of TlpA (E-0' = -256 mV). The reduction of CoxB by TlpA via disulfide exchange proved to be very fast, with a rate constant of 8.4 x 10(4) M-1 s(-1) that is similar to that found previously for ScoI reduction. Hence, TlpA is a physiologically relevant reductase for both ScoI and CoxB. Although the requirement of ScoI for assembly of the Cu-A-CoxB complex may be bypassed in vivo by high environmental Cu2+ concentrations, TlpA is essential in this process because only reduced CoxB can bind copper ions.	[Abicht, Helge K.; Schaerer, Martin A.; Quade, Nick; Mohorko, Elisabeth; Glockshuber, Rudi] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Abicht, Helge K.; Ledermann, Raphael; Hennecke, Hauke] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Schaerer, Martin A.; Capitani, Guido] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Hennecke, H (corresponding author), ETH, Inst Microbiol, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland.	hennecke@micro.biol.ethz.ch	Ledermann, Raphael/B-4301-2018	Ledermann, Raphael/0000-0003-4612-1708; Abicht, Helge/0000-0003-3960-5763	Promedica Foundation, Chur, Switzerland [GHDE KXQ7-DZZ (1276/M)]; ETH Zurich; Swiss National Foundation for Scientific Research	Promedica Foundation, Chur, Switzerland; ETH Zurich(ETH Zurich); Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF))	This project was funded by the Promedica Foundation, Chur, Switzerland (grant GHDE KXQ7-DZZ (1276/M) to H. K. A.). Other financial support came from the ETH Zurich and the Swiss National Foundation for Scientific Research.	Abriata LA, 2008, NAT CHEM BIOL, V4, P599, DOI 10.1038/nchembio.110; Afonine PV, 2010, J APPL CRYSTALLOGR, V43, P669, DOI 10.1107/S0021889810015608; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banci L, 2011, FEBS J, V278, P2244, DOI 10.1111/j.1742-4658.2011.08141.x; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; BOTT M, 1990, MOL MICROBIOL, V4, P2147, DOI 10.1111/j.1365-2958.1990.tb00576.x; Brzezinski P, 2008, J BIOENERG BIOMEMBR, V40, P521, DOI 10.1007/s10863-008-9181-7; Buhler D, 2010, J BIOL CHEM, V285, P15704, DOI 10.1074/jbc.M109.085217; Capitani G, 2001, J MOL BIOL, V311, P1037, DOI 10.1006/jmbi.2001.4913; Chacon KN, 2012, J AM CHEM SOC, V134, P16401, DOI 10.1021/ja307276z; Cheng ZY, 2011, CHEM REV, V111, P5768, DOI 10.1021/cr100006x; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Duarte JM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-334; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finder VH, 2010, J MOL BIOL, V396, P9, DOI 10.1016/j.jmb.2009.12.016; Herrmann JM, 2014, ANTIOXID REDOX SIGN, V21, P438, DOI 10.1089/ars.2014.5841; Herrmann JM, 2009, BBA-MOL CELL RES, V1793, P71, DOI 10.1016/j.bbamcr.2008.05.001; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Jaksch M, 2001, HUM MOL GENET, V10, P3025, DOI 10.1093/hmg/10.26.3025; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Kaila VRI, 2010, CHEM REV, V110, P7062, DOI 10.1021/cr1002003; Koepke J, 2009, BBA-BIOENERGETICS, V1787, P635, DOI 10.1016/j.bbabio.2009.04.003; Kojer K, 2014, BBA-PROTEINS PROTEOM, V1844, P1383, DOI 10.1016/j.bbapap.2014.02.004; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LOFERER H, 1993, EMBO J, V12, P3373, DOI 10.1002/j.1460-2075.1993.tb06011.x; LOFERER H, 1995, J BIOL CHEM, V270, P26178, DOI 10.1074/jbc.270.44.26178; LOFERER H, 1994, EUR J BIOCHEM, V223, P339, DOI 10.1111/j.1432-1033.1994.tb18999.x; Mattatall NR, 2000, J BIOL CHEM, V275, P28802, DOI 10.1074/jbc.M002741200; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mohorko E, 2012, FEBS LETT, V586, P4094, DOI 10.1016/j.febslet.2012.10.026; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; REGENSBURGER B, 1983, ARCH MICROBIOL, V135, P103, DOI 10.1007/BF00408017; Richter OMH, 2009, BBA-BIOENERGETICS, V1787, P626, DOI 10.1016/j.bbabio.2009.02.020; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Rossmann R, 1997, FEBS LETT, V406, P249, DOI 10.1016/S0014-5793(97)00270-6; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Salviati L, 2002, BIOCHEM J, V363, P321, DOI 10.1042/0264-6021:3630321; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Serventi F, 2012, J BIOL CHEM, V287, P38812, DOI 10.1074/jbc.M112.406173; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Stirnimann CU, 2006, CELL MOL LIFE SCI, V63, P1642, DOI 10.1007/s00018-006-6055-1; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; Williams JC, 2005, J BIOL CHEM, V280, P15202, DOI 10.1074/jbc.M410705200	50	27	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.607127	http://dx.doi.org/10.1074/jbc.M114.607127			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25274631	Green Published, hybrid			2022-12-28	WOS:000345335000004
J	Bonvin, P; Dunn, SM; Rousseau, F; Dyer, DP; Shaw, J; Power, CA; Handel, TM; Proudfoot, AEI				Bonvin, Pauline; Dunn, Steven M.; Rousseau, Francois; Dyer, Douglas P.; Shaw, Jeffrey; Power, Christine A.; Handel, Tracy M.; Proudfoot, Amanda E. I.			Identification of the Pharmacophore of the CC Chemokine-binding Proteins Evasin-1 and-4 Using Phage Display	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Migration; Chemokine; Chemotaxis; Epitope Mapping; Phage Display; Chemokine Binding Protein; Pharmacophore	GLYCOSAMINOGLYCAN BINDING; ANTIINFLAMMATORY ACTIVITY; ESCHERICHIA-COLI; STRUCTURAL BASIS; DECOY RECEPTOR; INHIBITOR VCCI; INTERFACES; VIRUS; SITE; SEQUESTRATION	Background: The selectivity profiles of the closely related chemokine-binding proteins Evasin-1 and -4 differ. Results: Using phage display, we identified the N-terminal region of Evasin-4 as key for the interaction with CC chemokines. Conclusion: Evasin-1 and -4 use different domains for target binding. Significance: Phage display allowed rapid insight into their different selectivities, which could aid rational design of inhibitory proteins. To elucidate the ligand-binding surface of the CC chemokine-binding proteins Evasin-1 and Evasin-4, produced by the tick Rhipicephalus sanguineus, we sought to identify the key determinants responsible for their different chemokine selectivities by expressing Evasin mutants using phage display. We first designed alanine mutants based on the Evasin-1CCL3 complex structure and an in silico model of Evasin-4 bound to CCL3. The mutants were displayed on M13 phage particles, and binding to chemokine was assessed by ELISA. Selected variants were then produced as purified proteins and characterized by surface plasmon resonance analysis and inhibition of chemotaxis. The method was validated by confirming the importance of Phe-14 and Trp-89 to the inhibitory properties of Evasin-1 and led to the identification of a third crucial residue, Asn-88. Two amino acids, Glu-16 and Tyr-19, were identified as key residues for binding and inhibition of Evasin-4. In a parallel approach, we identified one clone (Y28Q/N60D) that showed a clear reduction in binding to CCL3, CCL5, and CCL8. It therefore appears that Evasin-1 and -4 use different pharmacophores to bind CC chemokines, with the principal binding occurring through the C terminus of Evasin-1, but through the N-terminal region of Evasin-4. However, both proteins appear to target chemokine N termini, presumably because these domains are key to receptor signaling. The results also suggest that phage display may offer a useful approach for rapid investigation of the pharmacophores of small inhibitory binding proteins.	[Bonvin, Pauline; Dunn, Steven M.; Shaw, Jeffrey; Power, Christine A.; Proudfoot, Amanda E. I.] Merck Serono Geneva Res Ctr, CH-1202 Geneva, Switzerland; [Bonvin, Pauline; Rousseau, Francois; Proudfoot, Amanda E. I.] NovImmune SA, Geneva, Switzerland; [Dyer, Douglas P.; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Merck KGaA; EMD Serono Inc.; NovImmune SA; University of California System; University of California San Diego	Proudfoot, AEI (corresponding author), Merck Serono Geneva Res Ctr, 9 Chemin Mines, CH-1202 Geneva, Switzerland.	amandapf@orange.fr	Dyer, Douglas/L-9679-2019; Dyer, Douglas/J-2675-2015	Dyer, Douglas/0000-0001-5567-6241; Dyer, Douglas/0000-0001-5567-6241	European Union [HEALTH-F4-2011-281608 TIMER]; NIAID, National Institutes of Health [RO1AI37113]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037113] Funding Source: NIH RePORTER	European Union(European Commission); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the European Union Seventh Framework Programme (FP7-2007-2013) Grant HEALTH-F4-2011-281608 TIMER (to P. B. and A. E. I. P.) and NIAID, National Institutes of Health Grant RO1AI37113 (to T. M. H.).	Alcami A, 2009, ADV EXP MED BIOL, V666, P167; Alejo A, 2006, P NATL ACAD SCI USA, V103, P5995, DOI 10.1073/pnas.0510462103; Alexander JM, 2002, CELL, V111, P343, DOI 10.1016/S0092-8674(02)01007-3; Alexander-Brett JM, 2007, J EXP MED, V204, P3157, DOI 10.1084/jem.20071677; Bahar MW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040005; Beck CG, 2001, J BIOL CHEM, V276, P43270, DOI 10.1074/jbc.M106305200; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Chevigne A, 2011, BIOCHEM PHARMACOL, V82, P1438, DOI 10.1016/j.bcp.2011.07.091; Crowley PB, 2005, PROTEINS, V59, P231, DOI 10.1002/prot.20417; Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; Deruaz M, 2013, FEBS J, V280, P4876, DOI 10.1111/febs.12463; Dey B, 2012, MOL CELL BIOCHEM, V365, P279, DOI 10.1007/s11010-012-1269-z; Dias JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008514; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Fra AM, 2003, J IMMUNOL, V170, P2279, DOI 10.4049/jimmunol.170.5.2279; Frauenschuh A, 2007, J BIOL CHEM, V282, P27250, DOI 10.1074/jbc.M704706200; Hammers CM, 2014, J INVEST DERMATOL, V134, DOI 10.1038/jid.2013.521; Kuo NW, 2014, J BIOL CHEM, V289, P6592, DOI 10.1074/jbc.M113.538991; Lalani AS, 1998, VIROLOGY, V250, P173, DOI 10.1006/viro.1998.9340; Magistrelli G, 2005, BIOCHEM BIOPH RES CO, V334, P370, DOI 10.1016/j.bbrc.2005.06.091; Menten P, 1999, J CLIN INVEST, V104, pR1, DOI 10.1172/JCI7318; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Pakianathan DR, 1997, BIOCHEMISTRY-US, V36, P9642, DOI 10.1021/bi970593z; Pande J, 2010, BIOTECHNOL ADV, V28, P849, DOI 10.1016/j.biotechadv.2010.07.004; Proudfoot AEI, 2000, METH MOL B, V138, P75; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; Rebollo IR, 2013, METHODS, V60, P46, DOI 10.1016/j.ymeth.2012.12.008; Ruiz-Arguello MB, 2008, J VIROL, V82, P917, DOI 10.1128/JVI.02111-07; Saha RP, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-11; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Seet BT, 2001, P NATL ACAD SCI USA, V98, P9008, DOI 10.1073/pnas.171069398; Sidhu SS, 2007, CURR OPIN STRUC BIOL, V17, P481, DOI 10.1016/j.sbi.2007.08.007; Smith P, 2005, J EXP MED, V202, P1319, DOI 10.1084/jem.20050955; Sticht H, 1999, BIOCHEMISTRY-US, V38, P5995, DOI 10.1021/bi990065i; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Van Berkel V, 2000, J VIROL, V74, P6741, DOI 10.1128/JVI.74.15.6741-6747.2000; Webb LMC, 2004, FASEB J, V18, P571, DOI 10.1096/fj.03-0485fje; White GE, 2011, MOL PHARMACOL, V80, P328, DOI 10.1124/mol.111.071985; Xue XG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002162; Zhang L, 2006, P NATL ACAD SCI USA, V103, P13985, DOI 10.1073/pnas.0602142103; Zipfel PF, 2013, MOL IMMUNOL, V56, P152, DOI 10.1016/j.molimm.2013.05.222	43	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31846	31855		10.1074/jbc.M114.599233	http://dx.doi.org/10.1074/jbc.M114.599233			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25266725	Green Published, hybrid			2022-12-28	WOS:000345314700016
J	Neau, DB; Bender, G; Boeglin, WE; Bartlett, SG; Brash, AR; Newcomer, ME				Neau, David B.; Bender, Gunes; Boeglin, William E.; Bartlett, Sue G.; Brash, Alan R.; Newcomer, Marcia E.			Crystal Structure of a Lipoxygenase in Complex with Substrate THE ARACHIDONIC ACID-BINDING SITE OF 8R-LIPOXYGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arachidonic Acid (AA) (ARA); Eicosanoid Biosynthesis; Lipid Signaling; Lipoxygenase Pathway; Protein Structure; X-ray Crystallography	ACTIVE-SITE; ARACHIDONIC-ACID; FATTY-ACIDS; INHIBITION; OXYGENATION; SPECIFICITY; MODEL; STEREOSPECIFICITY; 8R-LIPOXYGENASE; DETERMINANTS	Background: Lipoxygenases (LOX) catalyze the oxygenation of polyunsaturated fatty acids but generate distinct products from a common substrate. Results: We report the first structure of a LOX-substrate complex. Conclusion: The structure provides a context for understanding product specificity in enzymes that metabolize arachidonic acid. Significance: With roles in the production of potent lipid mediators, LOX are targets for drug design. Lipoxygenases (LOX) play critical roles in mammalian biology in the generation of potent lipid mediators of the inflammatory response; consequently, they are targets for the development of isoform-specific inhibitors. The regio- and stereo-specificity of the oxygenation of polyunsaturated fatty acids by the enzymes is understood in terms of the chemistry, but structural observation of the enzyme-substrate interactions is lacking. Although several LOX crystal structures are available, heretofore the rapid oxygenation of bound substrate has precluded capture of the enzyme-substrate complex, leaving a gap between chemical and structural insights. In this report, we describe the 2.0 angstrom resolution structure of 8R-LOX in complex with arachidonic acid obtained under anaerobic conditions. Subtle rearrangements, primarily in the side chains of three amino acids, allow binding of arachidonic acid in a catalytically competent conformation. Accompanying experimental work supports a model in which both substrate tethering and cavity depth contribute to positioning the appropriate carbon at the catalytic machinery.	[Bender, Gunes; Bartlett, Sue G.; Newcomer, Marcia E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Neau, David B.] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Northeastern Collaborat Access Team, Argonne, IL 60439 USA; [Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA	Louisiana State University System; Louisiana State University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Vanderbilt University	Newcomer, ME (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	newcomer@lsu.edu			Nation Institute of General Medical Sciences from the National Institutes of Health [P41 GM103403]; U. S. Department of Energy [DE-AC02-06CH11357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, P01GM015431, P50GM015431] Funding Source: NIH RePORTER	Nation Institute of General Medical Sciences from the National Institutes of Health; U. S. Department of Energy(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work includes research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by a grant from the Nation Institute of General Medical Sciences (P41 GM103403) from the National Institutes of Health. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U. S. Department of Energy Office of Science by Argonne National Laboratory, was supported by the U. S. Department of Energy under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; Berry H, 1997, FEBS LETT, V408, P324, DOI 10.1016/S0014-5793(97)00453-5; Borngraber S, 1999, J BIOL CHEM, V274, P37345, DOI 10.1074/jbc.274.52.37345; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; Brash AR, 2012, LIPIDS, V47, P101, DOI 10.1007/s11745-011-3612-7; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Chen C, 2014, APPL ENVIRON MICROB, V80, P3992, DOI 10.1128/AEM.00215-14; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; Dewal MB, 2013, BIOCHEMISTRY-US, V52, P6559, DOI 10.1021/bi400444y; Eek P, 2012, J BIOL CHEM, V287, P22377, DOI 10.1074/jbc.M112.343285; EGMOND MR, 1972, BIOCHEM BIOPH RES CO, V48, P1055, DOI 10.1016/0006-291X(72)90815-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Garreta A, 2013, FASEB J, V27, P4811, DOI 10.1096/fj.13-235952; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; HAMBERG M, 1967, J BIOL CHEM, V242, P5329; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Klinman JP, 2007, ACCOUNTS CHEM RES, V40, P325, DOI 10.1021/ar6000507; Knapp MJ, 2001, J AM CHEM SOC, V123, P2931, DOI 10.1021/ja003855k; Kobe MJ, 2014, J BIOL CHEM, V289, P8562, DOI 10.1074/jbc.M113.543777; KUHL PW, 1994, BIOCHEM J, V298, P171, DOI 10.1042/bj2980171; KUHN H, 1990, J BIOL CHEM, V265, P16300; LiCata VJ, 1997, BIOPHYS CHEM, V64, P225, DOI 10.1016/S0301-4622(96)02204-1; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Marangoni A. G., 2003, ENZYME KINETICS MODE, P184; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; Neau DB, 2007, ACTA CRYSTALLOGR F, V63, P972, DOI 10.1107/S1744309107050993; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; Oldham ML, 2005, J BIOL CHEM, V280, P39545, DOI 10.1074/jbc.M506675200; Peng S, 2003, J AM CHEM SOC, V125, P8988, DOI 10.1021/ja035977t; Schneider C, 2000, ANAL BIOCHEM, V287, P186, DOI 10.1006/abio.2000.4847; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Szegletes T, 1999, BIOCHEMISTRY-US, V38, P122, DOI 10.1021/bi9813577; Willemoes M, 2003, ARCH BIOCHEM BIOPHYS, V413, P17, DOI 10.1016/S0003-9861(03)00085-7; Xu S, 2012, STRUCTURE, V20, P1490, DOI 10.1016/j.str.2012.06.003; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9; Ziegler J, 2009, J BIOL CHEM, V284, P26758, DOI 10.1074/jbc.M109.030957	44	46	47	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31905	31913		10.1074/jbc.M114.599662	http://dx.doi.org/10.1074/jbc.M114.599662			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25231982	Green Published, hybrid			2022-12-28	WOS:000345314700021
J	Herlihey, FA; Moynihan, PJ; Clarke, AJ				Herlihey, Francesca A.; Moynihan, Patrick J.; Clarke, Anthony J.			The Essential Protein for Bacterial Flagella Formation FlgJ Functions as a beta-N-Acetylglucosaminidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-ASSISTED CATALYSIS; PEPTIDOGLYCAN HYDROLASE FLGJ; CIRCULAR-DICHROISM SPECTRA; ESCHERICHIA-COLI; LYTIC TRANSGLYCOSYLASES; SALMONELLA-TYPHIMURIUM; RHODOBACTER-SPHAEROIDES; STRUCTURAL PROTEINS; SECONDARY STRUCTURE; ROD FORMATION	The flagellum is a major virulence factor of motile pathogenic bacteria. This structure requires more than 50 proteins for its biogenesis and function, one of which is FlgJ. Homologs of FlgJ produced by the beta- and gamma-proteobacteria, such as Salmonella enterica, Vibrio spp., and both Sphingomonas sp. and Pseudomonas spp. are bifunctional, possessing an N-terminal domain responsible for proper rod assembly and a C-terminal domain possessing peptidoglycan lytic activity. Despite the amount of research conducted on FlgJ from these and other bacteria over the past 15 years, no biochemical analysis had been conducted on any FlgJ and consequently confusion exists as to whether the enzyme is a peptidoglycan hydrolase or a lytic transglycosylase. In this study, we present the development of a novel assay for glycoside lytic enzymes and its use to provide the first enzymatic characterization of the lytic domain of FlgJ from S. enterica as the model enzyme. Surprisingly, FlgJ functions as neither a muramidase nor a lytic transglycosylases but rather as a beta-N-acetylglucosaminidase. As such, FlgJ represents the first autolysin with this activity to be characterized from a Gram-negative bacterium. At its optimal pH of 4.0, the Michaelis-Menten parameters of K-m and k(cat) for FlgJ from S. enterica were determined to be 0.64 +/- 0.18 mg ml(-1) and 0.13 +/- 0.016 s(-1), respectively, using purified PG as substrate. Its catalytic residues were identified as Glu(184) and Glu(223).	[Herlihey, Francesca A.; Moynihan, Patrick J.; Clarke, Anthony J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Clarke, AJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	a.clarke@exec.uoguelph.ca	Moynihan, Patrick J/I-3393-2013	Moynihan, Patrick J/0000-0003-4182-6223	Canadian Institutes of Health Research Team [TGC114045]; Ontario Graduate Scholarship from the Province of Ontario	Canadian Institutes of Health Research Team(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship from the Province of Ontario	This work was supported by Canadian Institutes of Health Research Team Grant TGC114045 (to A. J. C.) and an Ontario Graduate Scholarship (to P. J. M.) from the Province of Ontario.	Apel D, 2008, BBA-BIOMEMBRANES, V1778, P1851, DOI 10.1016/j.bbamem.2007.07.005; Bai XH, 2014, J BIOL CHEM, V289, P23403, DOI 10.1074/jbc.M114.579714; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Berger CN, 2009, ISME J, V3, P261, DOI 10.1038/ismej.2008.95; Blackburn NT, 2002, BIOCHEMISTRY-US, V41, P1001, DOI 10.1021/bi011833k; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Blackburn NT, 2000, ANAL BIOCHEM, V284, P388, DOI 10.1006/abio.2000.4707; Bublitz M, 2009, MOL MICROBIOL, V71, P1509, DOI 10.1111/j.1365-2958.2009.06619.x; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CLARKE AJ, 1993, ANAL BIOCHEM, V212, P344, DOI 10.1006/abio.1993.1339; Das M, 1998, FEMS MICROBIOL LETT, V165, P239, DOI 10.1016/S0378-1097(98)00283-3; de la Mora J, 2007, J BACTERIOL, V189, P7998, DOI 10.1128/JB.01073-07; de la Mora J, 2012, J BACTERIOL, V194, P4513, DOI 10.1128/JB.00460-12; Demchick P, 1996, J BACTERIOL, V178, P768, DOI 10.1128/jb.178.3.768-773.1996; Dijkstra AJ, 1996, J BACTERIOL, V178, P5555, DOI 10.1128/jb.178.19.5555-5562.1996; Drouillard S, 1997, BIOCHEM J, V328, P945, DOI 10.1042/bj3280945; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Fujii M, 2008, J MOL BIOL, V379, P273, DOI 10.1016/j.jmb.2008.04.012; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; HARSHEY RM, 1994, P NATL ACAD SCI USA, V91, P8631, DOI 10.1073/pnas.91.18.8631; HASH JH, 1967, J BACTERIOL, V93, P1201, DOI 10.1128/JB.93.3.1201-1202.1967; Hashimoto W, 2009, BIOCHEM BIOPH RES CO, V381, P16, DOI 10.1016/j.bbrc.2009.01.186; Hirano T, 2001, J MOL BIOL, V312, P359, DOI 10.1006/jmbi.2001.4963; HOLTJE JV, 1975, J BACTERIOL, V124, P1067; Inagaki N, 2009, GENE, V447, P61, DOI 10.1016/j.gene.2009.08.004; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; KUBORI T, 1992, J MOL BIOL, V226, P433, DOI 10.1016/0022-2836(92)90958-M; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lood R, 2014, ANTIMICROB AGENTS CH, V58, P3073, DOI 10.1128/AAC.00115-14; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Maruyama Y, 2010, J BASIC MICROB, V50, P311, DOI 10.1002/jobm.200900249; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Moens S, 1996, CRIT REV MICROBIOL, V22, P67, DOI 10.3109/10408419609106456; Moynihan PJ, 2010, J BIOL CHEM, V285, P13264, DOI 10.1074/jbc.M110.107086; Nambu T, 1999, J BACTERIOL, V181, P1555, DOI 10.1128/JB.181.5.1555-1561.1999; Nambu T, 2006, GENES GENET SYST, V81, P381, DOI 10.1266/ggs.81.381; Pfeffer JM, 2013, J BIOL CHEM, V288, P2605, DOI 10.1074/jbc.M112.436352; Reid CW, 2004, FEBS LETT, V574, P73, DOI 10.1016/j.febslet.2004.08.006; Roure S, 2012, MOL MICROBIOL, V86, P845, DOI 10.1111/mmi.12019; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 1999, PROTEIN SCI, V8, P370; Suzuki H, 1998, J STRUCT BIOL, V124, P104, DOI 10.1006/jsbi.1998.4048; SUZUKI T, 1978, J BACTERIOL, V133, P904, DOI 10.1128/JB.133.2.904-915.1978; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; van Heijenoort J, 2011, MICROBIOL MOL BIOL R, V75, P636, DOI 10.1128/MMBR.00022-11; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Viollier PH, 2003, MOL MICROBIOL, V49, P331, DOI 10.1046/j.1365-2958.2003.03576.x; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Yokoi KJ, 2008, GENE, V416, P66, DOI 10.1016/j.gene.2008.03.004; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456	53	43	43	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31029	31042		10.1074/jbc.M114.603944	http://dx.doi.org/10.1074/jbc.M114.603944			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25248745	hybrid, Green Published			2022-12-28	WOS:000344549900013
J	Park, S; Li, CM; Haeseleer, F; Palczewski, K; Ames, JB				Park, Saebomi; Li, Congmin; Haeseleer, Francoise; Palczewski, Krzysztof; Ames, James B.			Structural Insights into Activation of the Retinal L-type Ca2+ Channel (Cav1.4) by Ca2+-binding Protein 4 (CaBP4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATIONARY NIGHT BLINDNESS; CALPASTATIN DOMAIN L; CALCIUM-BINDING; APO-CALMODULIN; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; NMR STRUCTURE; TROPONIN-C; IQ MOTIF; MUTATIONS	CaBP4 modulates Ca2+- dependent activity of L-type voltage-gated Ca2+ channels (Cav1.4) in retinal photoreceptor cells. Mg2+ binds to the first and third EF-hands (EF1 and EF3), and Ca2+ binds to EF1, EF3, and EF4 of CaBP4. Here we present NMR structures of CaBP4 in both Mg2+-bound and Ca2+-bound states and model the CaBP4 structural interaction with Cav1.4. CaBP4 contains an unstructured N-terminal region (residues 1-99) and four EF-hands in two separate lobes. The N-lobe consists of EF1 and EF2 in a closed conformation with either Mg2+ or Ca2+ bound at EF1. The C-lobe binds Ca2+ at EF3 and EF4 and exhibits a Ca2+-induced closed-to-open transition like that of calmodulin. Exposed residues in Ca2+-bound CaBP4 (Phe(137), Glu(168), Leu(207), Phe(214), Met(251), Phe(264), and Leu(268)) make contacts with the IQ motif in Cav1.4, and the Cav1.4 mutant Y1595E strongly impairs binding to CaBP4. We conclude that CaBP4 forms a collapsed structure around the IQ motif in Cav1.4 that we suggest may promote channel activation by disrupting an interaction between IQ and the inhibitor of Ca2+-dependent inactivation domain.	[Park, Saebomi; Li, Congmin; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Haeseleer, Francoise] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Cleveland Ctr Membrane & Struct Biol, Dept Pharmacol, Cleveland, OH 44106 USA	University of California System; University of California Davis; University of Washington; University of Washington Seattle; Case Western Reserve University	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, One Shields Ave, Davis, CA 95616 USA.	jbames@ucdavis.edu			National Institutes of Health [EY012347, RR11973, EY020850]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR011973] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012347, P30EY001730, R01EY020850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY012347 and RR11973 (University of California Davis NMR Facility) (to J.B.A.) and EY020850 (to F.H.).	Atkinson RA, 2001, NAT STRUCT BIOL, V8, P853, DOI 10.1038/nsb1001-853; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Badger J, 1999, PROTEINS, V35, P25, DOI 10.1002/(SICI)1097-0134(19990401)35:1<25::AID-PROT3>3.3.CO;2-M; Bijveld MMC, 2013, OPHTHALMOLOGY, V120, P2072, DOI 10.1016/j.ophtha.2013.03.002; Chagot B, 2011, J MOL BIOL, V406, P106, DOI 10.1016/j.jmb.2010.11.046; Chang SL, 2003, J AM CHEM SOC, V125, P11379, DOI 10.1021/ja034064w; Clore GM, 1998, CURR OPIN CHEM BIOL, V2, P564, DOI 10.1016/S1367-5931(98)80084-7; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fallon JL, 2009, P NATL ACAD SCI USA, V106, P5135, DOI 10.1073/pnas.0807487106; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Feldkamp MD, 2011, STRUCTURE, V19, P733, DOI 10.1016/j.str.2011.02.009; Findeisen F, 2013, J MOL BIOL, V425, P3217, DOI 10.1016/j.jmb.2013.06.024; Finley NL, 2004, BIOCHEMISTRY-US, V43, P11371, DOI 10.1021/bi049672i; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haeseleer F, 2013, INVEST OPHTH VIS SCI, V54, P1214, DOI 10.1167/iovs.12-11319; HERZBERG O, 1988, J MOL BIOL, V203, P761, DOI 10.1016/0022-2836(88)90208-2; Hoda JC, 2006, J NEUROCHEM, V96, P1648, DOI 10.1111/j.1471-4159.2006.03678.x; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; Lange OF, 2012, P NATL ACAD SCI USA, V109, P10873, DOI 10.1073/pnas.1203013109; Li CM, 2009, J BIOL CHEM, V284, P2472, DOI 10.1074/jbc.M806513200; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Littink KW, 2009, INVEST OPHTH VIS SCI, V50, P2344, DOI 10.1167/iovs.08-2553; Lodha N, 2010, ADV EXP MED BIOL, V664, P549, DOI 10.1007/978-1-4419-1399-9_63; Maeda T, 2005, INVEST OPHTH VIS SCI, V46, P4320, DOI 10.1167/iovs.05-0478; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; Minobe E, 2011, J BIOL CHEM, V286, P39013, DOI 10.1074/jbc.M111.242248; MONCRIEF ND, 1990, J MOL EVOL, V30, P522, DOI 10.1007/BF02101108; MUHANDIRAM DR, 1993, J MAGN RESON SER B, V102, P317, DOI 10.1006/jmrb.1993.1102; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Park S, 2014, BIOMOL NMR ASSIGN, V8, P361, DOI 10.1007/s12104-013-9517-z; Park S, 2011, PROTEIN SCI, V20, P1356, DOI 10.1002/pro.662; Park S, 2010, BIOMOL NMR ASSIGN, V4, P159, DOI 10.1007/s12104-010-9235-8; Regus-Leidig H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086769; Schmitz F, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00026; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Senguen FT, 2012, BIOCHEMISTRY-US, V51, P6182, DOI 10.1021/bi300698h; Shaltiel L, 2012, J BIOL CHEM, V287, P36312, DOI 10.1074/jbc.M112.392811; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Sun W, 2014, FEBS LETT, V588, P665, DOI 10.1016/j.febslet.2014.01.019; Swindells MB, 1996, NAT STRUCT BIOL, V3, P501, DOI 10.1038/nsb0696-501; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Tomaselli S, 2007, PROTEINS, V69, P177, DOI 10.1002/prot.21517; Uversky Vladimir N., 2007, V408, P69; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Wutz K, 2002, EUR J HUM GENET, V10, P449, DOI 10.1038/sj.ejhg.5200828; Yang PS, 2014, NAT CHEM BIOL, V10, P231, DOI [10.1038/NCHEMBIO.1436, 10.1038/nchembio.1436]; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Zeitz C, 2006, AM J HUM GENET, V79, P657, DOI 10.1086/508067; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	56	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31262	31273		10.1074/jbc.M114.604439	http://dx.doi.org/10.1074/jbc.M114.604439			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25258313	Green Published, hybrid			2022-12-28	WOS:000344549900031
J	Shahpasandzadeh, H; Popova, B; Kleinknecht, A; Fraser, PE; Outeiro, TF; Braus, GH				Shahpasandzadeh, Hedieh; Popova, Blagovesta; Kleinknecht, Alexandra; Fraser, Paul E.; Outeiro, Tiago F.; Braus, Gerhard H.			Interplay between Sumoylation and Phosphorylation for Protection against alpha-Synuclein Inclusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODIFIER SUMO MODIFICATION; LEWY BODIES; RAT MODEL; IN-VIVO; PROTEIN; UBIQUITIN; YEAST; AGGREGATION; TOXICITY; DEGRADATION	Parkinson disease is associated with the progressive loss of dopaminergic neurons from the substantia nigra. The pathological hallmark of the disease is the accumulation of intracytoplasmic inclusions known as Lewy bodies that consist mainly of post-translationally modified forms of alpha-synuclein. Whereas phosphorylation is one of the major modifications of alpha-synuclein in Lewy bodies, sumoylation has recently been described. The interplay between alpha-synuclein phosphorylation and sumoylation is poorly understood. Here, we examined the interplay between these modifications as well as their impact on cell growth and inclusion formation in yeast. We found that alpha-synuclein is sumoylated in vivo at the same sites in yeast as in human cells. Impaired sumoylation resulted in reduced yeast growth combined with an increased number of cells with inclusions, suggesting that this modification plays a protective role. In addition, inhibition of sumoylation prevented autophagy-mediated aggregate clearance. A defect in alpha-synuclein sumoylation could be suppressed by serine 129 phosphorylation by the human G protein-coupled receptor kinase 5 (GRK5) in yeast. Phosphorylation reduced foci formation, alleviated yeast growth inhibition, and partially rescued autophagic alpha-synuclein degradation along with the promotion of proteasomal degradation, resulting in aggregate clearance in the absence of a small ubiquitin-like modifier. These findings suggest a complex interplay between sumoylation and phosphorylation in alpha-synuclein aggregate clearance, which may open new horizons for the development of therapeutic strategies for Parkinson disease.	[Shahpasandzadeh, Hedieh; Popova, Blagovesta; Kleinknecht, Alexandra; Braus, Gerhard H.] Univ Gottingen, Inst Microbiol & Genet, Dept Mol Microbiol & genet, D-37077 Gottingen, Germany; [Shahpasandzadeh, Hedieh; Popova, Blagovesta; Kleinknecht, Alexandra; Outeiro, Tiago F.; Braus, Gerhard H.] Ctr Nanoscale Microscopy & Mol Physiol Brain, D-37073 Gottingen, Germany; [Fraser, Paul E.] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5T 2S8, Canada; [Fraser, Paul E.] Univ Toronto, Dept Med Biophys, Toronto, ON M5T 2S8, Canada; [Outeiro, Tiago F.] Univ Med Ctr Gottingen, Dept Neurodegenerat & Restorat Res, D-37073 Gottingen, Germany	University of Gottingen; University of Toronto; University of Toronto; University of Gottingen	Braus, GH (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Mol Microbiol & genet, D-37077 Gottingen, Germany.	gbraus@gwdg.de	Outeiro, Tiago/M-8106-2019; Outeiro, Tiago F/C-1067-2008; Outeiro, Tiago/L-7351-2019; Braus, Gerhard/ABC-6293-2021; Braus, Gerhard H/G-3999-2012	Outeiro, Tiago F/0000-0003-1679-1727; Outeiro, Tiago/0000-0003-1679-1727; Braus, Gerhard/0000-0002-3117-5626; Braus, Gerhard H/0000-0002-3117-5626; Popova, Blagovesta/0000-0001-6323-374X	Deutsche Forschungsgemeinschaft Research Center Nanoscale Microscopy and Molecular Physiology of the Brain; Cluster of Excellence	Deutsche Forschungsgemeinschaft Research Center Nanoscale Microscopy and Molecular Physiology of the Brain; Cluster of Excellence	This work was supported by the Cluster of Excellence and Deutsche Forschungsgemeinschaft Research Center Nanoscale Microscopy and Molecular Physiology of the Brain.	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; [Anonymous], 1991, Methods Enzymol, V194, P1; Arawaka S, 2006, J NEUROSCI, V26, P9227, DOI 10.1523/JNEUROSCI.0341-06.2006; Basso E, 2013, MOL NEUROBIOL, V48, P854, DOI 10.1007/s12035-013-8473-z; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Bergeron M, 2014, NEUROSCIENCE, V256, P72, DOI 10.1016/j.neuroscience.2013.09.061; Biggins S, 2001, GENETICS, V159, P453; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; Dadke S, 2007, NAT CELL BIOL, V9, P80, DOI 10.1038/ncb1522; Dieckhoff P, 2004, MOL MICROBIOL, V51, P1375, DOI 10.1046/j.1365-2958.2003.03910.x; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; Droescher M, 2011, J BIOL CHEM, V286, P18731, DOI 10.1074/jbc.M111.235978; DUBIEL W, 1992, J BIOL CHEM, V267, P22699; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Eckermann K, 2013, NEUROMOL MED, V15, P737, DOI 10.1007/s12017-013-8259-5; Ellis CE, 2001, J BIOL CHEM, V276, P3879, DOI 10.1074/jbc.M010316200; Forno LS, 1996, ADV NEUROL, V69, P217; Franssens V, 2010, CELL DEATH DIFFER, V17, P746, DOI 10.1038/cdd.2009.203; Freichel C, 2007, NEUROBIOL AGING, V28, P1421, DOI 10.1016/j.neurobiolaging.2006.06.013; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Janer A, 2010, HUM MOL GENET, V19, P181, DOI 10.1093/hmg/ddp478; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Jones EW, 2002, METHOD ENZYMOL, V351, P127; Kametaka S, 1996, GENE, V178, P139, DOI 10.1016/0378-1119(96)00354-X; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Krumova P, 2013, CELL MOL LIFE SCI, V70, P2123, DOI 10.1007/s00018-012-1158-3; Krumova P, 2011, J CELL BIOL, V194, P49, DOI 10.1083/jcb.201010117; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; McFarland NR, 2009, J NEUROPATH EXP NEUR, V68, P515, DOI 10.1097/NEN.0b013e3181a24b53; Mukherjee S, 2009, J BIOL CHEM, V284, P21296, DOI 10.1074/jbc.M109.011494; Mullen JR, 2010, MOL CELL BIOL, V30, P3737, DOI 10.1128/MCB.01649-09; Nonaka T, 2005, BIOCHEMISTRY-US, V44, P361, DOI 10.1021/bi0485528; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Petroi D, 2012, J BIOL CHEM, V287, P27567, DOI 10.1074/jbc.M112.361865; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Reynolds MR, 2007, BIOCHEMISTRY-US, V46, P7325, DOI 10.1021/bi700430y; Rott R, 2008, J BIOL CHEM, V283, P3316, DOI 10.1074/jbc.M704809200; Rott R, 2011, P NATL ACAD SCI USA, V108, P18666, DOI 10.1073/pnas.1105725108; Sakamoto M, 2009, BIOCHEM BIOPH RES CO, V384, P378, DOI 10.1016/j.bbrc.2009.04.130; Salvi M, 2012, BIOCHEM BIOPH RES CO, V418, P156, DOI 10.1016/j.bbrc.2011.12.152; Sancenon V, 2012, HUM MOL GENET, V21, P2432, DOI 10.1093/hmg/dds058; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; SIKORSKI RS, 1989, GENETICS, V122, P19; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Soustelle C, 2004, MOL CELL BIOL, V24, P5130, DOI 10.1128/MCB.24.12.5130-5143.2004; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Wang SX, 2012, P NATL ACAD SCI USA, V109, P16119, DOI 10.1073/pnas.1206286109; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Waxman EA, 2011, J NEUROSCI RES, V89, P231, DOI 10.1002/jnr.22537; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yao Q, 2011, J BIOL CHEM, V286, P27342, DOI 10.1074/jbc.M111.220848; Zabrocki P, 2005, FEBS J, V272, P1386, DOI 10.1111/j.1742-4658.2005.04571.x; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	82	58	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31224	31240		10.1074/jbc.M114.559237	http://dx.doi.org/10.1074/jbc.M114.559237			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25231978	hybrid, Green Published			2022-12-28	WOS:000344549900028
J	Hayashi, Y; Nemoto-Sasaki, Y; Tanikawa, T; Oka, S; Tsuchiya, K; Zama, K; Mitsutake, S; Sugiura, T; Yamashita, A				Hayashi, Yasuhiro; Nemoto-Sasaki, Yoko; Tanikawa, Takashi; Oka, Saori; Tsuchiya, Kiyoto; Zama, Kouta; Mitsutake, Susumu; Sugiura, Takayuki; Yamashita, Atsushi			Sphingomyelin Synthase 2, but Not Sphingomyelin Synthase 1, Is Involved in HIV-1 Envelope-mediated Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE RECEPTORS; TYROSINE KINASE; CELL-LINE; ENTRY; CCR5; CD4; INFECTION; DOMAINS; BINDS	Membrane fusion between the viral envelope and plasma membranes of target cells has previously been correlated with HIV-1 infection. Lipids in the plasma membrane, including sphingomyelin, may be crucially involved in HIV-1 infection; however, the role of lipid-metabolic enzymes in membrane fusion remains unclear. In this study, we examined the roles of sphingomyelin synthase (SMS) in HIV-1 Env-mediated membrane fusion using a cell-cell fusion assay with HIV-1 mimetics and their target cells. We employed reconstituted cells as target cells that stably express Sms1 or Sms2 in Sms-deficient cells. Fusion susceptibility was similar to 5-fold higher in Sms2-expressing cells (not in Sms1-expressing cells) than in Sms-deficient cells. The enhancement of fusion susceptibility observed in Sms2-expressing cells was reversed and reduced by Sms2 knockdown. We also found that catalytically nonactive Sms2 promoted membrane fusion susceptibility. Moreover, SMS2 co-localized and was constitutively associated with the HIV receptor co-receptor complex in the plasma membrane. In addition, HIV-1 Env treatment resulted in a transient increase in nonreceptor tyrosine kinase (Pyk2) phosphorylation in Sms2-expressing and catalytically nonactive Sms2-expressing cells. We observed that F-actin polymerization in the region of membrane fusion was more prominent in Sms2-expressing cells than Sms-deficient cells. Taken together, our research provides insight into a novel function of SMS2 which is the regulation of HIV-1 Env-mediated membrane fusion via actin rearrangement.	[Hayashi, Yasuhiro; Nemoto-Sasaki, Yoko; Tanikawa, Takashi; Oka, Saori; Sugiura, Takayuki; Yamashita, Atsushi] Teikyo Univ, Fac Pharma Sci, Itabashi Ku, Tokyo 1738605, Japan; [Tsuchiya, Kiyoto] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Shinjuku Ku, Tokyo 1628655, Japan; [Zama, Kouta] Hokkaido Univ, Fac Adv Life Sci, Dept Biomembrane & Biofunct Chem, Sapporo, Hokkaido 0010021, Japan; [Mitsutake, Susumu] Saga Univ, Fac Agr, Dept Appl Biochem & Food Sci, Saga 8408502, Japan	Teikyo University; National Center for Global Health & Medicine - Japan; Hokkaido University; Saga University	Yamashita, A (corresponding author), Teikyo Univ, Fac Pharma Sci, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	ayamashi@pharm.teikyo-u.ac.jp	Tsuchiya, Kiyoto/L-8650-2013; Mitsutake, Susumu/A-4082-2012	Tsuchiya, Kiyoto/0000-0002-8233-6653; Yamashita, Atsushi/0000-0002-2544-2134	Japan Society for the Promotion of Science [25860055, 24590095]; Ministry of Education, Culture, Sports, and Technology; Grants-in-Aid for Scientific Research [25860055] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Young Scientists (B) 25860055 (to Y. H.) and for Scientific Research (C) 24590095 (to A. Y.) from the Japan Society for the Promotion of Science and in part by Ministry of Education, Culture, Sports, and Technology-supported program for the Strategic Research Foundation at Private Universities.	Abe M, 2012, MOL CELL BIOL, V32, P1396, DOI 10.1128/MCB.06113-11; Anand AR, 2009, BLOOD, V114, P3588, DOI 10.1182/blood-2009-02-206342; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Asano S, 2012, MOL CELL BIOL, V32, P3242, DOI 10.1128/MCB.00121-12; Astier A, 1997, J BIOL CHEM, V272, P228; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Barrero-Villar M, 2009, J CELL SCI, V122, P103, DOI 10.1242/jcs.035873; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Chen YG, 1997, J CELL BIOL, V138, P495, DOI 10.1083/jcb.138.3.495; Chiantia S, 2006, BIOPHYS J, V90, P4500, DOI 10.1529/biophysj.106.081026; de Curtis I, 2012, J CELL SCI, V125, P4435, DOI 10.1242/jcs.108266; Finnegan CM, 2007, J VIROL, V81, P5294, DOI 10.1128/JVI.02553-06; Finnegan CM, 2004, P NATL ACAD SCI USA, V101, P15452, DOI 10.1073/pnas.0402874101; FLORKIEWICZ RZ, 1984, SCIENCE, V225, P721, DOI 10.1126/science.6087454; Fuortes M, 1999, J CLIN INVEST, V104, P327, DOI 10.1172/JCI6018; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Godlee C, 2013, J CELL BIOL, V203, P717, DOI 10.1083/jcb.201307100; Ha KD, 2012, BBA-MOL CELL BIOL L, V1821, P1078, DOI 10.1016/j.bbalip.2012.04.004; Hug P, 2000, J VIROL, V74, P6377, DOI 10.1128/JVI.74.14.6377-6385.2000; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Iyengar S, 1998, J VIROL, V72, P5251, DOI 10.1128/JVI.72.6.5251-5255.1998; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jenkinson S, 2003, J BIOMOL SCREEN, V8, P463, DOI 10.1177/1087057103255747; Ji CH, 2006, J BIOMOL SCREEN, V11, P65, DOI 10.1177/1087057105282959; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Keogh RJ, 2002, BIOCHEM BIOPH RES CO, V290, P1470, DOI 10.1006/bbrc.2002.6350; Koot M, 1996, J INFECT DIS, V173, P349, DOI 10.1093/infdis/173.2.349; Lee C, 2003, J LEUKOCYTE BIOL, V74, P676, DOI 10.1189/jlb.0503206; Li ZQ, 2012, ARTERIOSCL THROM VAS, V32, P1577, DOI 10.1161/ATVBAHA.112.251538; Liu Y, 2004, J VIROL, V78, P4120, DOI 10.1128/JVI.78.8.4120-4133.2004; Liu Y., 2009, SCI SIGNAL, V2, P1; Lord C., 2013, COLD SPRING HARBOR P, V5, P1; Maeda K, 2008, J MOL BIOL, V381, P956, DOI 10.1016/j.jmb.2008.06.041; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Roberts PC, 1999, J VIROL, V73, P10447, DOI 10.1128/JVI.73.12.10447-10457.1999; Rucker J, 1997, METHOD ENZYMOL, V288, P118; Shimizu T, 2004, CURR MICROBIOL, V48, P182, DOI 10.1007/s00284-003-4101-x; Speck RF, 1997, J VIROL, V71, P7136, DOI 10.1128/JVI.71.9.7136-7139.1997; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Tsuchiya K., 2013, SCI REP, V3, P1, DOI DOI 10.1038/SREP01173; Vieira CR, 2010, CHEM BIOL, V17, P766, DOI 10.1016/j.chembiol.2010.05.023; Xiao XD, 1999, P NATL ACAD SCI USA, V96, P7496, DOI 10.1073/pnas.96.13.7496; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Yeang C, 2008, BBA-MOL CELL BIOL L, V1781, P610, DOI 10.1016/j.bbalip.2008.07.002; Zama K, 2012, CHEM PHYS LIPIDS, V165, P760, DOI 10.1016/j.chemphyslip.2012.09.003	48	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30842	30856		10.1074/jbc.M114.574285	http://dx.doi.org/10.1074/jbc.M114.574285			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231990	Green Published, hybrid			2022-12-28	WOS:000344549700058
J	Nakanishi-Matsui, M; Sekiya, M; Yano, S; Futai, M				Nakanishi-Matsui, Mayumi; Sekiya, Mizuki; Yano, Shio; Futai, Masamitsu			Inhibition of F-1-ATPase Rotational Catalysis by the Carboxyl-terminal Domain of the epsilon Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ATP SYNTHASE; ESCHERICHIA-COLI; F-1 SECTOR; GAMMA-SUBUNIT; MECHANISM; COMPLEX; BINDING; FOF1	Escherichia coli ATP synthase (F0F1) couples catalysis and proton transport through subunit rotation. The epsilon subunit, an endogenous inhibitor, lowers F-1-ATPase activity by decreasing the rotation speed and extending the duration of the inhibited state (Sekiya, M., Hosokawa, H., Nakanishi-Matsui, M., Al-Shawi, M. K., Nakamoto, R. K., and Futai, M. (2010) Single molecule behavior of inhibited and active states of Escherichia coli ATP synthase F-1 rotation. J. Biol. Chem. 285, 42058-42067). In this study, we constructed a series of epsilon subunits truncated successively from the carboxyl-terminal domain (helix 1/loop 2/helix 2) and examined their effects on rotational catalysis (ATPase activity, average rotation rate, and duration of inhibited state). As expected, the epsilon subunit lacking helix 2 caused about 1/2-fold reduced inhibition, and that without loop 2/helix 2 or helix 1/loop 2/helix 2 showed a further reduced effect. Substitution of epsilon Ser(108) in loop 2 and epsilon Tyr(114) in helix 2, which possibly interact with the beta and gamma subunits, respectively, decreased the inhibitory effect. These results suggest that the carboxyl-terminal domain of the epsilon subunit plays a pivotal role in the inhibition of F-1 rotation through interaction with other subunits.	[Nakanishi-Matsui, Mayumi; Sekiya, Mizuki; Yano, Shio; Futai, Masamitsu] Iwate Med Univ, Fac Pharmaceut Sci, Dept Biochem, Yahaba, Iwate 0283694, Japan	Iwate Medical University	Nakanishi-Matsui, M (corresponding author), Iwate Med Univ, Fac Pharmaceut Sci, Dept Biochem, Nishitokuta 2-1-1, Yahaba, Iwate 0283694, Japan.	nakanim@iwate-med.ac.jp			Japan Society for the Promotion of Science KAKENHI [24590086]; Terumo Life Science Foundation; Japan Foundation for Applied Enzymology; Hayashi Memorial Foundation for Female Natural Scientists	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Terumo Life Science Foundation(Terumo Life Science Foundation); Japan Foundation for Applied Enzymology; Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists)	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant 24590086, the Terumo Life Science Foundation, and the Japan Foundation for Applied Enzymology. This work was also supported by a grant from the Hayashi Memorial Foundation for Female Natural Scientists (to M. N.-M.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; AlShawi MK, 1997, J BIOL CHEM, V272, P2300; Andrews SH, 2001, BIOCHEMISTRY-US, V40, P10664, DOI 10.1021/bi0155697; Bilyard T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0023; Borsch M, 2013, BIOCHEM SOC T, V41, P1219, DOI 10.1042/BST20130101; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulygin VV, 2004, J BIOL CHEM, V279, P35616, DOI 10.1074/jbc.M405012200; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Cipriano DJ, 2002, J BIOL CHEM, V277, P16782, DOI 10.1074/jbc.M201349200; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; Futai M., 2004, HDB ATPASES BIOCH CE, P237; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Kashiwagi S, 2008, BIOCHEM BIOPH RES CO, V365, P227, DOI 10.1016/j.bbrc.2007.10.157; Kato-Yamada Y, 1999, J BIOL CHEM, V274, P33991, DOI 10.1074/jbc.274.48.33991; KUKI M, 1988, J BIOL CHEM, V263, P17437; Nakanishi-Matsui M, 2006, J BIOL CHEM, V281, P4126, DOI 10.1074/jbc.M510090200; Nakanishi-Matsui M, 2007, J BIOL CHEM, V282, P20698, DOI 10.1074/jbc.M700551200; Nakanishi-Matsui M, 2013, IUBMB LIFE, V65, P247, DOI 10.1002/iub.1134; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; Nakanishi-Matsui M, 2010, BIOCHEM BIOPH RES CO, V395, P173, DOI 10.1016/j.bbrc.2010.03.127; Oka H, 2014, BIOCHEM BIOPH RES CO, V446, P889, DOI 10.1016/j.bbrc.2014.03.021; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Peskova YB, 2000, BIOCHEMISTRY-US, V39, P11830, DOI 10.1021/bi0013694; Schulenberg B, 1999, J BIOL CHEM, V274, P28351, DOI 10.1074/jbc.274.40.28351; Sekiya M, 2012, J BIOL CHEM, V287, P22771, DOI 10.1074/jbc.M112.374868; Sekiya M, 2010, J BIOL CHEM, V285, P42058, DOI 10.1074/jbc.M110.176701; Sekiya M, 2009, J BIOL CHEM, V284, P22401, DOI 10.1074/jbc.M109.009019; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Uhlin U, 1997, STRUCTURE, V5, P1219, DOI 10.1016/S0969-2126(97)00272-4; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; WILKENS S, 1995, NAT STRUCT BIOL, V2, P961, DOI 10.1038/nsb1195-961; Wilkens S, 1998, J BIOL CHEM, V273, P26645, DOI 10.1074/jbc.273.41.26645; Xiong H, 1998, BIOCHEMISTRY-US, V37, P16423, DOI 10.1021/bi981522i	36	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30822	30831		10.1074/jbc.M114.578872	http://dx.doi.org/10.1074/jbc.M114.578872			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25228697	Green Published, hybrid			2022-12-28	WOS:000344549700056
J	Koo, AJ; Thireault, C; Zemelis, S; Poudel, AN; Zhang, T; Kitaoka, N; Brandizzi, F; Matsuura, H; Howe, GA				Koo, Abraham J.; Thireault, Caitlin; Zemelis, Starla; Poudel, Arati N.; Zhang, Tong; Kitaoka, Naoki; Brandizzi, Federica; Matsuura, Hideyuki; Howe, Gregg A.			Endoplasmic Reticulum-associated Inactivation of the Hormone Jasmonoyl-L-Isoleucine by Multiple Members of the Cytochrome P450 94 Family in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytochrome P450; Fatty Acid Oxidation; Plant Biochemistry; Plant Hormone; Stress Response; Jasmonate	TRANSCRIPTION FACTOR; PLANT DEVELOPMENT; SPLICE VARIANT; AMINO-ACID; GROWTH; DEFENSE; BIOSYNTHESIS; CATABOLISM; REPRESSION; RESPONSES	Background: Accumulation of the plant hormone jasmonoyl-l-isoleucine (JA-Ile) is tightly controlled to prevent overactivation of defense responses. Results: Cytochrome P450 94s (CYP94s) with distinct tissue expression patterns localize to ER and oxidize JA-Ile to a dicarboxy derivative that fails to assemble JA-Ile co-receptor complexes. Conclusion: Sequential CYP94-catalyzed oxidations block receptor activation and signaling. Significance: P450s inactivate fatty acid-derived signals in both plants and animals. The plant hormone jasmonate (JA) controls diverse aspects of plant immunity, growth, and development. The amplitude and duration of JA responses are controlled in large part by the intracellular level of jasmonoyl-l-isoleucine (JA-Ile). In contrast to detailed knowledge of the JA-Ile biosynthetic pathway, little is known about enzymes involved in JA-Ile metabolism and turnover. Cytochromes P450 (CYP) 94B3 and 94C1 were recently shown to sequentially oxidize JA-Ile to hydroxy (12OH-JA-Ile) and dicarboxy (12COOH-JA-Ile) derivatives. Here, we report that a third member (CYP94B1) of the CYP94 family also participates in oxidative turnover of JA-Ile in Arabidopsis. In vitro studies showed that recombinant CYP94B1 converts JA-Ile to 12OH-JA-Ile and lesser amounts of 12COOH-JA-Ile. Consistent with this finding, metabolic and physiological characterization of CYP94B1 loss-of-function and overexpressing plants demonstrated that CYP94B1 and CYP94B3 coordinately govern the majority (>95%) of 12-hydroxylation of JA-Ile in wounded leaves. Analysis of CYP94-promoter-GUS reporter lines indicated that CYP94B1 and CYP94B3 serve unique and overlapping spatio-temporal roles in JA-Ile homeostasis. Subcellular localization studies showed that CYP94s involved in conversion of JA-Ile to 12COOH-JA-Ile reside on endoplasmic reticulum (ER). In vitro studies further showed that 12COOH-JA-Ile, unlike JA-Ile, fails to promote assembly of COI1-JAZ co-receptor complexes. The double loss-of-function mutant of CYP94B3 and ILL6, a JA-Ile amidohydrolase, displayed a JA profile consistent with the collaborative action of the oxidative and the hydrolytic pathways in JA-Ile turnover. Collectively, our results provide an integrated view of how multiple ER-localized CYP94 and JA amidohydrolase enzymes attenuate JA signaling during stress responses.	[Koo, Abraham J.; Thireault, Caitlin; Zemelis, Starla; Brandizzi, Federica; Howe, Gregg A.] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; [Howe, Gregg A.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Kitaoka, Naoki; Matsuura, Hideyuki] Hokkaido Univ, Res Fac Agr, Div Appl Biosci, Sapporo, Hokkaido 0608589, Japan; [Koo, Abraham J.; Poudel, Arati N.; Zhang, Tong] Univ Missouri, Div Biochem, Columbia, MO 65211 USA; [Koo, Abraham J.; Poudel, Arati N.; Zhang, Tong] Univ Missouri, Interdisciplinary Plant Grp, Columbia, MO 65211 USA; [Poudel, Arati N.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA	Michigan State University; Michigan State University; Hokkaido University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Koo, AJ (corresponding author), Univ Missouri, Div Biochem, Columbia, MO 65211 USA.	kooaj@missouri.edu	Koo, Abraham J/H-9721-2017; /ABM-4447-2022; Howe, Gregg A/N-1887-2014	/0000-0002-5725-9510; Howe, Gregg A/0000-0002-9218-979X; Koo, Abraham/0000-0003-2162-2987; Kitaoka, Naoki/0000-0003-4031-1455	National Institutes of Health [GM57795]; Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U. S. Department of Energy [DE-FG02-91ER20021]; Food for the 21st Century Program, University of Missouri; Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE Office of Science) [BER DE-FC02-07ER64494]; National Science Foundation (NSF) [MCB1243792]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U. S. Department of Energy(United States Department of Energy (DOE)); Food for the 21st Century Program, University of Missouri; Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE Office of Science)(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant No. GM57795 (to G. A. H.) and the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U. S. Department of Energy (Grant No. DE-FG02-91ER20021) for partial support of A. J. K. and C. T.; Supported by the Food for the 21st Century Program, University of Missouri (to A. J. K.).; Supported by the Department of Energy (DOE) Great Lakes Bioenergy Research Center (DOE Office of Science BER DE-FC02-07ER64494) and National Science Foundation (NSF) (MCB1243792).	BARTEL B, 1995, SCIENCE, V268, P1745, DOI 10.1126/science.7792599; Bell EM, 2012, P NATL ACAD SCI USA, V109, P21146, DOI 10.1073/pnas.1210789109; BENVENISTE I, 1978, PHYTOCHEMISTRY, V17, P359, DOI 10.1016/S0031-9422(00)89316-4; Bhosale R, 2013, PLANT CELL, V25, P2865, DOI 10.1105/tpc.113.112268; Brandizzi F, 2003, PLANT J, V34, P269, DOI 10.1046/j.1365-313X.2003.01728.x; Brandizzi F, 2002, NAT REV MOL CELL BIO, V3, P520, DOI 10.1038/nrm861; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Campanella JJ, 2003, COMP FUNCT GENOM, V4, P584, DOI 10.1002/cfg.340; Campos ML, 2014, J CHEM ECOL, V40, P657, DOI 10.1007/s10886-014-0468-3; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Chung HS, 2009, PHYTOCHEMISTRY, V70, P1547, DOI 10.1016/j.phytochem.2009.08.022; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Fonseca S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086182; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Froehlich JE, 2001, PLANT PHYSIOL, V125, P306, DOI 10.1104/pp.125.1.306; Glauser G, 2008, J BIOL CHEM, V283, P16400, DOI 10.1074/jbc.M801760200; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; GOLDBERG MW, 1995, CURR OPIN CELL BIOL, V7, P301, DOI 10.1016/0955-0674(95)80083-2; Guranowski A, 2007, FEBS LETT, V581, P815, DOI 10.1016/j.febslet.2007.01.049; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; Heitz T, 2012, J BIOL CHEM, V287, P6296, DOI 10.1074/jbc.M111.316364; Helliwell CA, 2001, PLANT J, V28, P201, DOI 10.1046/j.1365-313X.2001.01150.x; Herde Marco, 2013, Methods Mol Biol, V1011, P51, DOI 10.1007/978-1-62703-414-2_5; Hsieh HL, 2000, GENE DEV, V14, P1958; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kitaoka N, 2014, PHYTOCHEMISTRY, V99, P6, DOI 10.1016/j.phytochem.2013.12.019; Kitaoka N, 2011, PLANT CELL PHYSIOL, V52, P1757, DOI 10.1093/pcp/pcr110; Koo AJK, 2006, J BIOL CHEM, V281, P33511, DOI 10.1074/jbc.M607854200; Koo AJK, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00019; Koo AJK, 2011, P NATL ACAD SCI USA, V108, P9298, DOI 10.1073/pnas.1103542108; Koo AJK, 2009, PHYTOCHEMISTRY, V70, P1571, DOI 10.1016/j.phytochem.2009.07.018; Koo AJK, 2009, PLANT J, V59, P974, DOI 10.1111/j.1365-313X.2009.03924.x; KRAMELL R, 1988, TETRAHEDRON, V44, P5791, DOI 10.1016/S0040-4020(01)81437-X; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Moreno JE, 2013, PLANT PHYSIOL, V162, P1006, DOI 10.1104/pp.113.218164; Nakamura Y, 2011, PLANT PHYSIOL, V155, P1226, DOI 10.1104/pp.110.168617; Nakata M, 2013, PLANT CELL, V25, P1641, DOI 10.1105/tpc.113.111112; Noir S, 2013, PLANT PHYSIOL, V161, P1930, DOI 10.1104/pp.113.214908; OKUDA KI, 1994, J LIPID RES, V35, P361; Pinot F, 2011, FEBS J, V278, P195, DOI 10.1111/j.1742-4658.2010.07948.x; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Sasaki-Sekimoto Y, 2013, PLANT PHYSIOL, V163, P291, DOI 10.1104/pp.113.220129; Schaller A, 2009, PHYTOCHEMISTRY, V70, P1532, DOI 10.1016/j.phytochem.2009.07.032; Schilmiller AL, 2007, PLANT PHYSIOL, V143, P812, DOI 10.1104/pp.106.092916; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shyu C, 2012, PLANT CELL, V24, P536, DOI 10.1105/tpc.111.093005; Song SS, 2014, CURR OPIN PLANT BIOL, V21, P112, DOI 10.1016/j.pbi.2014.07.005; Song SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003653; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Ullmann-Zeunert L, 2013, PLANT J, V75, P417, DOI 10.1111/tpj.12210; Vanstraelen M, 2012, ANNU REV CELL DEV BI, V28, P463, DOI 10.1146/annurev-cellbio-101011-155741; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Werck-Reichhart D. l., 2009, CYTOCHROMES P450 ARA, P1; Westfall CS, 2012, SCIENCE, V336, P1708, DOI 10.1126/science.1221863; Widemann Emilie, 2013, J Biol Chem, V288, P31701, DOI 10.1074/jbc.M113.499228; Withers J, 2012, P NATL ACAD SCI USA, V109, P20148, DOI 10.1073/pnas.1210054109; Woldemariam MG, 2012, PLANT J, V72, P758, DOI 10.1111/j.1365-313X.2012.05117.x; Yamamoto K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02556; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Yang DL, 2012, P NATL ACAD SCI USA, V109, pE1192, DOI 10.1073/pnas.1201616109; YOSHIHARA T, 1989, AGR BIOL CHEM TOKYO, V53, P2835, DOI 10.1080/00021369.1989.10869712; Zhang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003699	67	69	75	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29728	29738		10.1074/jbc.M114.603084	http://dx.doi.org/10.1074/jbc.M114.603084			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25210037	Green Published, hybrid			2022-12-28	WOS:000344370800021
J	Korboukh, VK; Lee, CA; Acevedo, A; Vignuzzi, M; Xiao, YH; Arnold, JJ; Hemperly, S; Graci, JD; August, A; Andino, R; Cameron, CE				Korboukh, Victoria K.; Lee, Cheri A.; Acevedo, Ashley; Vignuzzi, Marco; Xiao, Yinghong; Arnold, Jamie J.; Hemperly, Stephen; Graci, Jason D.; August, Avery; Andino, Raul; Cameron, Craig E.			RNA Virus Population Diversity, an Optimum for Maximal Fitness and Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Poliovirus; RNA Polymerase; RNA Virus; Viral Polymerase; Viral Replication	POLYMERASE 3D(POL); POLIOVIRUS PATHOGENESIS; LETHAL MUTAGENESIS; FIDELITY; REPLICATION; MECHANISMS; RIBAVIRIN; DYNAMICS; CLEAVAGE; DNA	Background: Viral RNA polymerase nucleotide incorporation fidelity contributes to pathogenesis. Results: A poliovirus mutator strain and its polymerase have been characterized. Conclusion: Pathogenesis requires optimal polymerase fidelity; not all mutations in a viral genome are linked to polymerase fidelity. Significance: Mutator and antimutator phenotypes can be harnessed for the development of viral prophylaxis and antiviral therapies. The ability of an RNA virus to exist as a population of genetically distinct variants permits the virus to overcome events during infections that would otherwise limit virus multiplication or drive the population to extinction. Viral genetic diversity is created by the ribonucleotide misincorporation frequency of the viral RNA-dependent RNA polymerase (RdRp). We have identified a poliovirus (PV) RdRp derivative (H273R) possessing a mutator phenotype. GMP misincorporation efficiency for H273R RdRp in vitro was increased by 2-3-fold that manifested in a 2-3-fold increase in the diversity of the H273R PV population in cells. Circular sequencing analysis indicated that some mutations were RdRp-independent. Consistent with the population genetics theory, H273R PV was driven to extinction more easily than WT in cell culture. Furthermore, we observed a substantial reduction in H273R PV virulence, measured as the ability to cause paralysis in the cPVR mouse model. Reduced virulence correlated with the inability of H273R PV to sustain replication in tissues/organs in which WT persists. Despite the attenuated phenotype, H273R PV was capable of replicating in mice to levels sufficient to induce a protective immune response, even when the infecting dose used was insufficient to elicit any visual signs of infection. We conclude that optimal RdRp fidelity is a virulence determinant that can be targeted for viral attenuation or antiviral therapies, and we suggest that the RdRp may not be the only source of mutations in a RNA virus genome.	[Korboukh, Victoria K.; Lee, Cheri A.; Arnold, Jamie J.; Hemperly, Stephen; Graci, Jason D.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [August, Avery] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Acevedo, Ashley; Vignuzzi, Marco; Xiao, Yinghong; Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California San Francisco	Cameron, CE (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, 201 Althouse Lab, University Pk, PA 16802 USA.	cec9@psu.edu	Xiao, Yinghong/AAM-1231-2020	Vignuzzi, Marco/0000-0002-4400-771X; Xiao, Yinghong/0000-0002-6850-6521	National Institutes of Health from NIAID [R01 AI045818]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045818, P01AI091575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007810] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI045818 from NIAID (to C. E. C.).	Acevedo A, 2014, NATURE, V505, P686, DOI 10.1038/nature12861; Anderson JP, 2004, ANNU REV MICROBIOL, V58, P183, DOI 10.1146/annurev.micro.58.030603.123649; Arnold JJ, 2005, J BIOL CHEM, V280, P25706, DOI 10.1074/jbc.M503444200; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Arnold JJ, 2000, J BIOL CHEM, V275, P5329, DOI 10.1074/jbc.275.8.5329; Bull JJ, 2007, J VIROL, V81, P2930, DOI 10.1128/JVI.01624-06; Cameron CE, 2009, CURR OPIN STRUC BIOL, V19, P768, DOI 10.1016/j.sbi.2009.10.012; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Crotty S, 2002, J GEN VIROL, V83, P1707, DOI 10.1099/0022-1317-83-7-1707; Delaney S, 2012, FREE RADICAL RES, V46, P420, DOI 10.3109/10715762.2011.653968; Domingo E, 2005, ARCH VIROL, P59; Gnadig NF, 2012, P NATL ACAD SCI USA, V109, pE2294, DOI 10.1073/pnas.1204022109; Gohara DW, 2000, J BIOL CHEM, V275, P25523, DOI 10.1074/jbc.M002671200; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Graci JD, 2008, FUTURE VIROL, V3, P553, DOI 10.2217/17460794.3.6.553; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; Hong Zhi, 2002, Prog Drug Res, V59, P41; Korneeva VS, 2007, J BIOL CHEM, V282, P16135, DOI 10.1074/jbc.M610090200; Li ZW, 2014, WIRES RNA, V5, P335, DOI 10.1002/wrna.1214; Lou DI, 2013, P NATL ACAD SCI USA, V110, P19872, DOI 10.1073/pnas.1319590110; Moustafa IM, 2011, J MOL BIOL, V410, P159, DOI 10.1016/j.jmb.2011.04.078; Oh HS, 2009, J VIROL, V83, P9370, DOI 10.1128/JVI.02076-08; Pariente N, 2001, J VIROL, V75, P9723, DOI 10.1128/JVI.75.20.9723-9730.2001; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; Racaniello VR, 2006, VIROLOGY, V344, P9, DOI 10.1016/j.virol.2005.09.015; Rozen-Gagnon K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003877; Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003565; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726; Weeks SA, 2012, J BIOL CHEM, V287, P31618, DOI 10.1074/jbc.C112.401471; Whitton JL, 2005, NAT REV MICROBIOL, V3, P765, DOI 10.1038/nrmicro1284; Yang XR, 2010, BIOCHEMISTRY-US, V49, P9361, DOI 10.1021/bi100833r	33	76	77	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29531	29544		10.1074/jbc.M114.592303	http://dx.doi.org/10.1074/jbc.M114.592303			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25213864	Green Published, hybrid			2022-12-28	WOS:000344370800006
J	Wang, SL; Lei, T; Zhang, K; Zhao, WX; Fang, L; Lai, BC; Han, J; Xiao, L; Wang, NP				Wang, Shaolan; Lei, Ting; Zhang, Kang; Zhao, Wenxiang; Fang, Li; Lai, Baochang; Han, Jie; Xiao, Lei; Wang, Nanping			Xenobiotic Pregnane X Receptor (PXR) Regulates Innate Immunity via Activation of NLRP3 Inflammasome in Vascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellular Immune Response; Endothelial Cell; Innate Immunity; Nod-like Receptor (NLR); Pattern Recognition Receptor (PRR); Toll-like Receptor (TLR); Transcription Factor; Xenobiotic	DRUG-METABOLISM; MACULAR DEGENERATION; STRESS; INFECTIONS; DEFENSES; PROMOTER; DISEASE; ELEMENT; BINDING; HEALTH	Background: Xenobiotics activate nuclear receptor PXR for detoxification and clearance. However, a role of PXR in regulating innate immunity remains unknown. Results: PXR induced NLRP3 expression and triggered inflammasome activation in vascular ECs. Conclusion: PXR plays an important role in the activation of NLRP3 inflammasome in response to xenobiotics. Significance: Our findings revealed a novel mechanism of innate immunity. Pregnane X receptor (PXR) is a member of nuclear receptor superfamily and responsible for the detoxification of xenobiotics. Our previously study demonstrated that PXR is expressed in endothelial cells (ECs) and acts as a master regulator of detoxification genes to protect ECs against xenobiotics. Vascular endothelial cells are key sentinel cells to sense the pathogens and xenobiotics. In this study, we examined the potential function of PXR in the regulation of innate immunity in vasculatures. Treatments with PXR agonists or overexpression of a constitutively active PXR in cultured ECs increased gene expression of the key pattern recognition receptors, including Toll-like receptors (TLR-2, -4, -9) and NOD-like receptors (NOD-1 and -2 and NLRP3). In particular, PXR agonism triggered the activation of NLRP3 inflammasome and the ensuing cleavage and maturation of caspase-1 and interleukin-1 (IL-1). Conversely, selective antagonism or gene silencing of PXR abrogated NLRP3 inflammasome activation. In addition, we identified NLRP3 as a transcriptional target of PXR by using the promoter-reporter and ChIP assays. In summary, our findings revealed a novel regulatory mechanism of innate immune by PXR, which may act as a master transcription factor controlling the convergence between the detoxification of xenobiotics and the innate immunity against them.	[Wang, Shaolan; Lei, Ting; Zhang, Kang; Zhao, Wenxiang; Lai, Baochang; Han, Jie; Xiao, Lei; Wang, Nanping] Xi An Jiao Tong Univ, Cardiovasc Res Ctr, Sch Med, Xian 710061, Peoples R China; [Fang, Li; Wang, Nanping] Peking Univ, Inst Cardiovasc Sci, Beijing 100191, Peoples R China	Xi'an Jiaotong University; Peking University	Wang, NP (corresponding author), Xi An Jiao Tong Univ, Cardiovasc Res Ctr, Sch Med, 76 W Yanta Rd, Xian 710061, Peoples R China.	nanpingwang2003@yahoo.com	Wang, Nanping/G-1818-2011	Wang, Nanping/0000-0002-8528-8132	National Science Foundation of China [81220108005, 31430045]; Ministry of Science and Technology [2010CB912502]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by grants from the National Science Foundation of China (81220108005 and 31430045) and the Ministry of Science and Technology (2010CB912502).	Anderson JP, 2008, GENES IMMUN, V9, P721, DOI 10.1038/gene.2008.66; Cunha A, 2012, NAT REV IMMUNOL, V12, DOI 10.1038/nri3237; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Gao J, 2012, TRENDS PHARMACOL SCI, V33, P552, DOI 10.1016/j.tips.2012.07.003; Hariparsad N, 2009, NUCLEIC ACIDS RES, V37, P1160, DOI 10.1093/nar/gkn1047; Jacobs MN, 2005, TOXICOL APPL PHARM, V209, P123, DOI 10.1016/j.taap.2005.03.015; Mai JT, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-61; Marneros AG, 2013, CELL REP, V4, P945, DOI 10.1016/j.celrep.2013.08.002; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Mitchell JA, 2007, BIOCHEM SOC T, V35, P1449, DOI 10.1042/BST0351449; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Opitz B, 2009, THROMB HAEMOSTASIS, V102, P1103, DOI 10.1160/TH09-05-0323; Qiao Y, 2012, FEBS LETT, V586, P1022, DOI 10.1016/j.febslet.2012.02.045; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schuetz EG, 1998, MOL PHARMACOL, V54, P1113, DOI 10.1124/mol.54.6.1113; Sonoda J, 2003, CURR DRUG METAB, V4, P59, DOI 10.2174/1389200033336739; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Swales KE, 2012, CARDIOVASC RES, V93, P674, DOI 10.1093/cvr/cvr330; Vladimer GI, 2013, CURR OPIN MICROBIOL, V16, P23, DOI 10.1016/j.mib.2012.11.008; Wang XH, 2013, P NATL ACAD SCI USA, V110, P13174, DOI 10.1073/pnas.1312065110; Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753; Xia M, 2014, AM J PATHOL, V184, P1617, DOI 10.1016/j.ajpath.2014.01.032; Xiao H, 2013, CIRCULATION, V128, P632, DOI 10.1161/CIRCULATIONAHA.113.002714; Xiao L, 2014, AM J PHYSIOL-HEART C, V306, pH317, DOI 10.1152/ajpheart.00182.2013; Yin Y, 2009, INT J IMMUNOPATH PH, V22, P311, DOI 10.1177/039463200902200208; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283	26	37	41	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					30075	30081		10.1074/jbc.M114.578781	http://dx.doi.org/10.1074/jbc.M114.578781			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25202020	Green Published, hybrid			2022-12-28	WOS:000344370800047
J	Chu, BCH; Otten, R; Krewulak, KD; Mulder, FAA; Vogel, HJ				Chu, Byron C. H.; Otten, Renee; Krewulak, Karla D.; Mulder, Frans A. A.; Vogel, Hans J.			The Solution Structure, Binding Properties, and Dynamics of the Bacterial Siderophore-binding Protein FepB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-RESONANCE EXPERIMENTS; ESCHERICHIA-COLI; CROSS-SATURATION; MULTIDIMENSIONAL NMR; FERRIC ENTEROBACTIN; NUCLEOTIDE-SEQUENCE; BETA-CYCLODEXTRIN; TRANSPORT PROTEIN; DIPOLAR COUPLINGS; CRYSTAL-STRUCTURE	The periplasmic binding protein (PBP) FepB plays a key role in transporting the catecholate siderophore ferric enterobactin from the outer to the inner membrane in Gram-negative bacteria. The solution structures of the 34-kDa apo- and holo-FepB from Escherichia coli, solved by NMR, represent the first solution structures determined for the type III class of PBPs. Unlike type I and II PBPs, which undergo large "Venus flytrap" conformational changes upon ligand binding, both forms of FepB maintain similar overall folds; however, binding of the ligand is accompanied by significant loop movements. Reverse methyl cross-saturation experiments corroborated chemical shift perturbation results and uniquely defined the binding pocket for gallium enterobactin (GaEnt). NMR relaxation experiments indicated that a flexible loop (residues 225-250) adopted a more rigid and extended conformation upon ligand binding, which positioned residues for optimal interactions with the ligand and the cytoplasmic membrane ABC transporter (FepCD), respectively. In conclusion, this work highlights the pivotal role that structural dynamics plays in ligand binding and transporter interactions in type III PBPs.	[Chu, Byron C. H.; Krewulak, Karla D.; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada; [Otten, Renee; Mulder, Frans A. A.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Mulder, Frans A. A.] Univ Aarhus, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark; [Mulder, Frans A. A.] Univ Aarhus, Dept Chem, DK-8000 Aarhus C, Denmark	University of Calgary; University of Groningen; Aarhus University; Aarhus University	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Biochem Res Grp, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca	Mulder, Frans AA/C-7158-2017	Mulder, Frans AA/0000-0001-9427-8406; Otten, Renee/0000-0001-7342-6131; Krewulak, Karla/0000-0003-0300-4122	Canadian Institutes of Health Research; Alberta Innovates Health Solutions	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions	This work was supported by an operating grant from the Canadian Institutes of Health Research (Novel Alternatives to Antibiotics program).; Recipient of a Scientist Award from Alberta Innovates Health Solutions.	Abergel RJ, 2008, J AM CHEM SOC, V130, P11524, DOI 10.1021/ja803524w; Abergel RJ, 2006, J AM CHEM SOC, V128, P8920, DOI 10.1021/ja062046j; Andre I, 2002, ANAL BIOCHEM, V305, P195, DOI 10.1006/abio.2002.5661; Annamalai R, 2004, J BACTERIOL, V186, P3578, DOI 10.1128/JB.186.11.3578-3589.2004; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Bermejo GA, 2010, BIOCHEMISTRY-US, V49, P1893, DOI 10.1021/bi902045p; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Chou JJ, 2000, J BIOMOL NMR, V18, P217, DOI 10.1023/A:1026563923774; Chu BC, 2010, BIOMETALS, V23, P601, DOI 10.1007/s10534-010-9361-x; Chu BCH, 2013, J BIOL CHEM, V288, P31409, DOI 10.1074/jbc.M113.490441; Chu BCH, 2011, BIOL CHEM, V392, P39, DOI 10.1515/BC.2011.012; Coudevylle N, 2010, J BIOL CHEM, V285, P41646, DOI 10.1074/jbc.M110.123331; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Eletsky A, 2001, J BIOMOL NMR, V20, P177, DOI 10.1023/A:1011265430149; ELKINS MF, 1989, J BACTERIOL, V171, P5443, DOI 10.1128/jb.171.10.5443-5451.1989; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Felder CB, 1999, AAPS PHARMSCI, V1; Fischbach MA, 2006, NAT CHEM BIOL, V2, P132, DOI 10.1038/nchembio771; Gardner KH, 1997, J AM CHEM SOC, V119, P7599, DOI 10.1021/ja9706514; Gardner KH, 1997, BIOCHEMISTRY-US, V36, P1389, DOI 10.1021/bi9624806; GEEN H, 1991, J MAGN RESON, V93, P93, DOI 10.1016/0022-2364(91)90034-Q; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P2648, DOI 10.1021/bi9726584; Gifford JL, 2011, J BIOMOL NMR, V50, P71, DOI 10.1007/s10858-011-9495-3; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; Grigg JC, 2010, J BIOL CHEM, V285, P34579, DOI 10.1074/jbc.M110.172924; Grigg JC, 2010, J BIOL CHEM, V285, P11162, DOI 10.1074/jbc.M109.097865; GRZESIEK S, 1993, J AM CHEM SOC, V115, P4369, DOI 10.1021/ja00063a068; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Ho WW, 2007, J BIOL CHEM, V282, P35796, DOI 10.1074/jbc.M706761200; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang H, 2012, J AM CHEM SOC, V134, P3864, DOI 10.1021/ja2111306; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Hwang PM, 2001, J BIOMOL NMR, V20, P83, DOI 10.1023/A:1011226512421; Kandt C, 2006, BIOCHEMISTRY-US, V45, P13284, DOI 10.1021/bi061280j; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Kneller, 2003, SPARKY 3; Krewulak K. D., 2009, HDB METALLOPROTEINS; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Krewulak KD, 2005, BIOMETALS, V18, P375, DOI 10.1007/s10534-005-3712-z; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Li N, 2012, J BIOL CHEM, V287, P8912, DOI 10.1074/jbc.M111.316034; LIU J, 1989, J BACTERIOL, V171, P791, DOI 10.1128/jb.171.2.791-798.1989; Liu M, 2008, BIOPHYS CHEM, V138, P42, DOI 10.1016/j.bpc.2008.09.001; LLINAS M, 1973, BIOCHEMISTRY-US, V12, P3836, DOI 10.1021/bi00744a007; LOOMIS LD, 1991, INORG CHEM, V30, P906, DOI 10.1021/ic00005a008; MAO B, 1982, J BIOL CHEM, V257, P1131; Mattle D, 2010, J MOL BIOL, V404, P220, DOI 10.1016/j.jmb.2010.09.005; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Muller A, 2006, ANGEW CHEM INT EDIT, V45, P5132, DOI 10.1002/anie.200601198; Orekhov VY, 2003, J BIOMOL NMR, V27, P165, DOI 10.1023/A:1024944720653; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Otten R, 2010, J AM CHEM SOC, V132, P2952, DOI 10.1021/ja907706a; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Peacock RS, 2006, BIOMETALS, V19, P127, DOI 10.1007/s10534-005-5420-0; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Peuckert F, 2009, ANGEW CHEM INT EDIT, V48, P7924, DOI 10.1002/anie.200902495; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; ROHRBACH MR, 1995, J BACTERIOL, V177, P7186, DOI 10.1128/jb.177.24.7186-7193.1995; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SHARFF AJ, 1993, BIOCHEMISTRY-US, V32, P10553, DOI 10.1021/bi00091a004; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shimada I, 2009, PROG NUCL MAG RES SP, V54, P123, DOI 10.1016/j.pnmrs.2008.07.001; Skrynnikov NR, 2000, J MOL BIOL, V295, P1265, DOI 10.1006/jmbi.1999.3430; Sobolev V, 2005, NUCLEIC ACIDS RES, V33, pW39, DOI 10.1093/nar/gki398; Sprencel C, 2000, J BACTERIOL, V182, P5359, DOI 10.1128/JB.182.19.5359-5364.2000; Stockner T, 2005, BIOPHYS J, V89, P3362, DOI 10.1529/biophysj.105.069443; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; Takahashi H, 2006, J BIOMOL NMR, V34, P167, DOI 10.1007/s10858-006-0008-8; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Takeda M, 2003, J BIOL CHEM, V278, P43550, DOI 10.1074/jbc.M308199200; Tamiola K, 2012, BIOCHEM SOC T, V40, P1014, DOI 10.1042/BST20120171; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Tjandra N, 1997, NAT STRUCT BIOL, V4, P732, DOI 10.1038/nsb0997-732; TOLMAN JR, 1995, P NATL ACAD SCI USA, V92, P9279, DOI 10.1073/pnas.92.20.9279; Trakhanov S, 2005, BIOCHEMISTRY-US, V44, P6597, DOI 10.1021/bi047302o; Tugarinov V, 2005, P NATL ACAD SCI USA, V102, P622, DOI 10.1073/pnas.0407792102; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Usher KC, 2001, P NATL ACAD SCI USA, V98, P10676, DOI 10.1073/pnas.181353398; Venters RA, 1996, J MOL BIOL, V264, P1101, DOI 10.1006/jmbi.1996.0699; Watts RE, 2012, INFECT IMMUN, V80, P333, DOI 10.1128/IAI.05594-11; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zawadzka AM, 2009, P NATL ACAD SCI USA, V106, P21854, DOI 10.1073/pnas.0904793106; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022; Zhu G, 1999, J BIOMOL NMR, V13, P77, DOI 10.1023/A:1008398227519	93	27	28	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29219	29234		10.1074/jbc.M114.564021	http://dx.doi.org/10.1074/jbc.M114.564021			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25173704	Green Published, hybrid			2022-12-28	WOS:000344141000037
J	Clausen, JD; Holdensen, AN; Andersen, JP				Clausen, Johannes D.; Holdensen, Anne Nyholm; Andersen, Jens Peter			Critical Roles of Interdomain Interactions for Modulatory ATP Binding to Sarcoplasmic Reticulum Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-PUMP; FUNCTIONAL CONSEQUENCES; PHOSPHOENZYME INTERMEDIATE; CRYSTAL-STRUCTURES; DOMAIN RESIDUES; TRANSPORT SITES; CATALYTIC SITE; CA-2+-ATPASE; NUCLEOTIDES; MECHANISM	ATP has dual roles in the reaction cycle of sarcoplasmic reticulum Ca2+-ATPase. Upon binding to the Ca(2)E1 state, ATP phosphorylates the enzyme, and by binding to other conformational states in a non-phosphorylating modulatory mode ATP stimulates the dephosphorylation and other partial reaction steps of the cycle, thereby ensuring a high rate of Ca2+ transport under physiological conditions. The present study elucidates the mechanism underlying the modulatory effect on dephosphorylation. In the intermediate states of dephosphorylation the A-domain residues Ser(186) and Asp(203) interact with Glu(439) (N-domain) and Arg(678) (P-domain), respectively. Single mutations to these residues abolish the stimulation of dephosphorylation by ATP. The double mutation swapping Asp(203) and Arg(678) rescues ATP stimulation, whereas this is not the case for the double mutation swapping Ser(186) and Glu(439). By taking advantage of the ability of wild type and mutant Ca2+-ATPases to form stable complexes with aluminum fluoride (E2.AlF) and beryllium fluoride (E2.BeF) as analogs of the E2.P phosphoryl transition state and E2P ground state, respectively, of the dephosphorylation reaction, the mutational effects on ATP binding to these intermediates are demonstrated. In the wild type Ca2+-ATPase, the ATP affinity of the E2.P phosphoryl transition state is higher than that of the E2P ground state, thus explaining the stimulation of dephosphorylation by nucleotide-induced transition state stabilization. We find that the Asp(203)-Arg(678) and Ser(186)-Glu(439) interdomain bonds are critical, because they tighten the interaction with ATP in the E2.P phosphoryl transition state. Moreover, ATP binding and the Ser(186)-Glu(439) bond are mutually exclusive in the E2P ground state.	[Clausen, Johannes D.; Holdensen, Anne Nyholm; Andersen, Jens Peter] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Clausen, Johannes D.; Holdensen, Anne Nyholm] Aarhus Univ, Ctr Membrane Pumps Cells & Disease PUMPKIN, Danish Natl Res Fdn, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Danmarks Grundforskningsfond	Andersen, JP (corresponding author), Ole Worms Alle 4,Bldg 1160, DK-8000 Aarhus C, Denmark.	jpa@fi.au.dk		Andersen, Jens Peter/0000-0003-0654-4300	Lundbeck Foundation; Danish Medical Research Council; Novo Nordisk Foundation; Danish National Research Foundation (PUMPKIN Centre); Lundbeck Foundation [R93-2011-8682] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation (PUMPKIN Centre)(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden)	This work was supported in part by grants from the Lundbeck Foundation (to J. D. C.), the Danish Medical Research Council (to J. P. A.), the Novo Nordisk Foundation (to J. P. A.), and the Danish National Research Foundation (PUMPKIN Centre).	ANDERSEN JP, 1985, BIOCHIM BIOPHYS ACTA, V815, P9, DOI 10.1016/0005-2736(85)90467-5; ANDERSEN JP, 1989, J BIOL CHEM, V264, P21018; ARIKI M, 1980, BIOCHEMISTRY-US, V19, P2001, DOI 10.1021/bi00550a042; BODLEY AL, 1987, J BIOL CHEM, V262, P13997; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; CHAMPEIL P, 1986, BIOCHEMISTRY-US, V25, P7623, DOI 10.1021/bi00371a053; CHAMPEIL P, 1988, J BIOL CHEM, V263, P12288; CHAMPEIL P, 1986, J BIOL CHEM, V261, P6372; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Clausen JD, 2007, J BIOL CHEM, V282, P20686, DOI 10.1074/jbc.M702365200; Clausen JD, 2013, EMBO J, V32, P3231, DOI 10.1038/emboj.2013.250; Clausen JD, 2011, J BIOL CHEM, V286, P11792, DOI 10.1074/jbc.M110.206094; Clausen JD, 2008, J BIOL CHEM, V283, P35703, DOI 10.1074/jbc.M806795200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; Liu XY, 2009, J BIOL CHEM, V284, P25190, DOI 10.1074/jbc.M109.034140; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MARUYAMA K, 1989, J BIOL CHEM, V264, P13038; McIntosh DB, 1999, J BIOL CHEM, V274, P25227, DOI 10.1074/jbc.274.36.25227; McIntosh DB, 2004, J BIOL CHEM, V279, P32515, DOI 10.1074/jbc.M403242200; MCINTOSH DB, 1983, BIOCHEMISTRY-US, V22, P2867, DOI 10.1021/bi00281a015; McIntosh DB, 1996, J BIOL CHEM, V271, P25778, DOI 10.1074/jbc.271.42.25778; Miyauchi Y, 2006, J BIOL CHEM, V281, P22882, DOI 10.1074/jbc.M601966200; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PICK U, 1982, J BIOL CHEM, V257, P6111; SCOFANO HM, 1979, J BIOL CHEM, V254, P227; SEEBREGTS CJ, 1989, J BIOL CHEM, V264, P2043; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; VILSEN B, 1991, J BIOL CHEM, V266, P16157; VILSEN B, 1989, J BIOL CHEM, V264, P21024; WAKABAYASHI S, 1990, BIOCHEMISTRY-US, V29, P7309, DOI 10.1021/bi00483a022; WAKABAYASHI S, 1986, J BIOL CHEM, V261, P9762	47	3	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29123	29134		10.1074/jbc.M114.571687	http://dx.doi.org/10.1074/jbc.M114.571687			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25193668	Green Published, hybrid			2022-12-28	WOS:000344141000029
J	Lawrence, SA; Titus, SA; Ferguson, J; Heineman, AL; Taylor, SM; Moran, RG				Lawrence, Scott A.; Titus, Steven A.; Ferguson, Jennifer; Heineman, Amy L.; Taylor, Shirley M.; Moran, Richard G.			Mammalian Mitochondrial and Cytosolic Folylpolyglutamate Synthetase Maintain the Subcellular Compartmentalization of Folates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMATE SYNTHETASE; ONE-CARBON METABOLISM; CHINESE-HAMSTER CELLS; SACCHAROMYCES-CEREVISIAE; LEUKEMIA-CELL; CANCER-CELLS; METHOTREXATE; GLYCINE; TRANSPORT; SERINE	Folylpoly-gamma-glutamate synthetase (FPGS) catalyze the addition of multiple glutamates to tetrahydrofolate derivatives. Two mRNAs for the fpgs gene direct isoforms of FPGS to the cytosol and to mitochondria in mouse and human tissues. We sought to clarify the functions of these two compartmentalized isoforms. Stable cell lines were created that express cDNAs for the mitochondrial and cytosolic isoforms of human FPGS under control of a doxycycline-inducible promoter in the AUXB1 cell line. AUXB1 are devoid of endogenous FPGS activity due to a premature translational stop at codon 432 in the fpgs gene. Loss of folates was not measurable from these doxycycline-induced cells or from parental CHO cells over the course of three CHO cell generations. Likewise, there was no detectable transfer of folate polyglutamates either from the cytosol to mitochondria, or from mitochondria to the cytosol. The cell line expressing cytosolic FPGS required exogenous glycine but not thymidine or purine, whereas cells expressing the mitochondrial isoform required exogenous thymidine and purine but not glycine for optimal growth and survival. We concluded that mitochondrial FPGS is required because folate polyglutamates are not substrates for transport across the mitochondrial membrane in either direction and that polyglutamation not only traps folates in the cytosol, but also in the mitochondrial matrix.	[Lawrence, Scott A.; Moran, Richard G.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; [Taylor, Shirley M.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Titus, Steven A.; Ferguson, Jennifer; Heineman, Amy L.; Taylor, Shirley M.; Moran, Richard G.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Moran, RG (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, 401 Coll St, Richmond, VA 23298 USA.	rmoran@vcu.edu			National Institutes of Health-NCI Cancer Center Grant [P30 CA016059]; NATIONAL CANCER INSTITUTE [R01CA039687, P30CA016059] Funding Source: NIH RePORTER	National Institutes of Health-NCI Cancer Center Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Professor Andrew Bognar for critical review of this manuscript. We also thank Dr. Kellie Archer for assistance with statistical analysis supported by the VCU Massey Cancer Center Biostatistics Shared Resource with funding from National Institutes of Health-NCI Cancer Center Grant P30 CA016059.	Ahmed AU, 2009, INT REV CEL MOL BIO, V273, P49, DOI 10.1016/S1937-6448(08)01802-9; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; BARLOWE C K, 1988, Biofactors, V1, P171; Blakley R. L., 1969, THE BIOCHEMISTRY OF; Chen ZS, 2003, CANCER RES, V63, P4048; CHU EHY, 1972, P NATL ACAD SCI USA, V69, P3459, DOI 10.1073/pnas.69.11.3459; Dotzlaf J, 2007, HYBRIDOMA, V26, P155, DOI 10.1089/hyb.2007.004; Drake JC, 1996, BIOCHEM PHARMACOL, V51, P1349, DOI 10.1016/0006-2952(96)00057-3; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; FREEMANTLE SJ, 1995, J BIOL CHEM, V270, P9579, DOI 10.1074/jbc.270.16.9579; FRY DW, 1982, J BIOL CHEM, V257, P1890; GOLDMAN ID, 1968, J BIOL CHEM, V243, P5007; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Kastanos EK, 1997, BIOCHEMISTRY-US, V36, P14956, DOI 10.1021/bi971610n; Kruh GD, 2003, ONCOGENE, V22, P7537, DOI 10.1038/sj.onc.1206953; Lamers Y, 2009, J NUTR, V139, P666, DOI 10.3945/jn.108.103580; Lawrence SA, 2011, J BIOL CHEM, V286, P31480, DOI 10.1074/jbc.M111.272187; Li Y, 2000, J BACTERIOL, V182, P2886, DOI 10.1128/JB.182.10.2886-2892.2000; LIN BF, 1993, J BIOL CHEM, V268, P21674; LIN BF, 1994, J BIOL CHEM, V269, P9705; LOWE KE, 1993, J BIOL CHEM, V268, P21665; MCBURNEY MW, 1974, CELL, V2, P173, DOI 10.1016/0092-8674(74)90091-9; MCCLOSKEY DE, 1991, J BIOL CHEM, V266, P6181; Moran DM, 2014, MOL CANCER THER, V13, P1611, DOI 10.1158/1535-7163.MCT-13-0649; Perchiniak E, 2007, BIOCHEMISTRY-US, V46, P1557, DOI 10.1021/bi062191+; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; Qi H, 1999, ADV ENZYME REGUL, V39, P263, DOI 10.1016/S0065-2571(98)00023-5; RATANASTHIEN K, 1974, J CLIN PATHOL, V27, P875, DOI 10.1136/jcp.27.11.875; Sanghani SP, 1999, J BIOL CHEM, V274, P27018, DOI 10.1074/jbc.274.38.27018; SHANE B, 1989, VITAM HORM, V45, P263; SIROTNAK FM, 1978, BIOCHEM PHARMACOL, V27, P1821, DOI 10.1016/0006-2952(78)90025-4; Sun XL, 1998, P NATL ACAD SCI USA, V95, P6647, DOI 10.1073/pnas.95.12.6647; Sun XL, 2001, J MOL BIOL, V310, P1067, DOI 10.1006/jmbi.2001.4815; TAYLOR RT, 1982, ARCH BIOCHEM BIOPHYS, V217, P609, DOI 10.1016/0003-9861(82)90543-4; Tedeschi PM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.393; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Titus SA, 2000, J BIOL CHEM, V275, P36811, DOI 10.1074/jbc.M005163200; Visentin M, 2014, ANNU REV PHYSIOL, V76, P251, DOI 10.1146/annurev-physiol-020911-153251; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhao RB, 2000, J BIOL CHEM, V275, P26599, DOI 10.1074/jbc.M002580200; Zhao RB, 2011, ANNU REV NUTR, V31, P177, DOI 10.1146/annurev-nutr-072610-145133	41	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29386	29396		10.1074/jbc.M114.593244	http://dx.doi.org/10.1074/jbc.M114.593244			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25164808	Green Published, hybrid			2022-12-28	WOS:000344141000050
J	Tanno, M; Kuno, A; Ishikawa, S; Miki, T; Kouzu, H; Yano, T; Murase, H; Tobisawa, T; Ogasawara, M; Horio, Y; Miura, T				Tanno, Masaya; Kuno, Atsushi; Ishikawa, Satoko; Miki, Takayuki; Kouzu, Hidemichi; Yano, Toshiyuki; Murase, Hiromichi; Tobisawa, Toshiyuki; Ogasawara, Makoto; Horio, Yoshiyuki; Miura, Tetsuji			Translocation of Glycogen Synthase Kinase-3 beta (GSK-3 beta), a Trigger of Permeability Transition, Is Kinase Activity-dependent and Mediated by Interaction with Voltage-dependent Anion Channel 2 (VDAC2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; REPERFUSION INJURY; ALZHEIMERS-DISEASE; PROTEIN IMPORT; CYCLOPHILIN-D; SIGNALING PATHWAYS; CANCER-CELLS; MITOCHONDRIA; ACTIVATION; PROTECTION	Glycogen synthase kinase-3 beta (GSK-3 beta) is a major positive regulator of the mitochondrial permeability transition pore (mPTP), a principle trigger of cell death, under the condition of oxidative stress. However, the mechanism by which cytosolic GSK-3 beta translocates to mitochondria, promoting mPTP opening, remains unclear. Here we addressed this issue by analyses of the effect of site-directed mutations in GSK-3 beta on mitochondrial translocation and protein/protein interactions upon oxidative stress. H9c2 cardiomyoblasts were transfected with GFP-tagged GSK-3 beta (WT), a mutant GSK-3 beta insensitive to inhibitory phosphorylation (S9A), or kinase-deficient GSK-3 beta (K85R). Time lapse observation revealed that WT and S9A translocated from the cytosol to the mitochondria more promptly than did K85R after exposure to oxidative stress. H2O2 increased the density of nine spots on two-dimensional gel electrophoresis of anti-GSK-3 beta-immunoprecipitates by more than 3-fold. MALDI-TOF/MS analysis revealed that one of the spots contained voltage-dependent anion channel 2 (VDAC2). Knockdown of VDAC2, but not VDAC1 or VDAC3, by siRNA attenuated both the mitochondrial translocation of GSK-3 beta and mPTP opening under stress conditions. The mitochondrial translocation of GSK-3 beta was attenuated also when Lys-15, but not Arg-4 or Arg-6, in the N-terminal domain of GSK-3 beta was replaced with alanine. The oxidative stress-induced mitochondrial translocation of GSK-3 beta was associated with an increase in cell death, which was suppressed by lithium chloride (LiCl), a GSK-3 beta inhibitor. These results demonstrate that GSK-3 beta translocates from the cytosol to mitochondria in a kinase activity- and VDAC2-dependent manner in which an N-terminal domain of GSK-3 beta may function as a mitochondrial targeting sequence.	[Tanno, Masaya; Kuno, Atsushi; Ishikawa, Satoko; Miki, Takayuki; Kouzu, Hidemichi; Yano, Toshiyuki; Murase, Hiromichi; Tobisawa, Toshiyuki; Ogasawara, Makoto; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Chuo Ku, Sapporo, Hokkaido 0608543, Japan; [Kuno, Atsushi; Horio, Yoshiyuki] Sapporo Med Univ, Sch Med, Dept Pharmacol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan	Sapporo Medical University; Sapporo Medical University	Miura, T (corresponding author), Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Chuo Ku, S1 W16, Sapporo, Hokkaido 0608543, Japan.	miura@sapmed.ac.jp	Kouzu, Hidemichi/AAZ-3810-2020	Kouzu, Hidemichi/0000-0001-7815-1464; KUNO, ATSUSHI/0000-0001-6873-1297; Horio, Yoshiyuki/0000-0002-5021-5929	Japanese Society for the Promotion of Science [23501086, 26461133]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japanese Society for the Promotion of Science Grants-in-aid for Scientific Research 23501086 and 26461133.	Argaud Laurent, 2005, J Mol Cell Cardiol, V38, P367, DOI 10.1016/j.yjmcc.2004.12.001; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chen B, 2013, BIOCHEM BIOPH RES CO, V437, P526, DOI 10.1016/j.bbrc.2013.06.103; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Chiara F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.184; Clarke SJ, 2002, J BIOL CHEM, V277, P34793, DOI 10.1074/jbc.M202191200; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Das S, 2008, CIRC RES, V103, P983, DOI 10.1161/CIRCRESAHA.108.178970; Di Lisa F, 2006, CARDIOVASC RES, V70, P191, DOI 10.1016/j.cardiores.2006.01.016; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Eckert GP, 2012, MOL NEUROBIOL, V46, P136, DOI 10.1007/s12035-012-8271-z; Eom TY, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-14; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; Goni-Oliver P, 2011, NEUROCHEM INT, V59, P97, DOI 10.1016/j.neuint.2011.03.021; Guo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054914; Halestrap AP, 2010, BIOCHEM SOC T, V38, P841, DOI 10.1042/BST0380841; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Hermans AN, 1997, BBA-BIOMEMBRANES, V1330, P83, DOI 10.1016/S0005-2736(97)00143-0; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Juhaszova M, 2009, CIRC RES, V104, P1240, DOI 10.1161/CIRCRESAHA.109.197996; King TD, 2008, NEUROTOX RES, V14, P367, DOI 10.1007/BF03033861; Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957; Liao RL, 2007, CIRC RES, V101, P1069, DOI 10.1161/CIRCRESAHA.107.165621; Miki T, 2009, DIABETES, V58, P2863, DOI 10.2337/db09-0158; Miura T, 2012, CARDIOVASC RES, V94, P181, DOI 10.1093/cvr/cvr302; Miura T, 2010, CARDIOVASC RES, V88, P7, DOI 10.1093/cvr/cvq206; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Masahiro N, 2007, J MOL CELL CARDIOL, V43, P564, DOI 10.1016/j.yjmcc.2007.08.010; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Ohori K, 2008, AM J PHYSIOL-HEART C, V295, pH2079, DOI 10.1152/ajpheart.00092.2008; Omura T, 1998, J BIOCHEM-TOKYO, V123, P1010; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pedretti S, 2011, BASIC RES CARDIOL, V106, P355, DOI 10.1007/s00395-011-0152-5; Perez-Gracia E, 2008, ACTA NEUROPATHOL, V116, P261, DOI 10.1007/s00401-008-0370-6; Phukan S, 2010, BRIT J PHARMACOL, V160, P1, DOI 10.1111/j.1476-5381.2010.00661.x; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Rasola A, 2010, P NATL ACAD SCI USA, V107, P726, DOI 10.1073/pnas.0912742107; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Shinohara Y, 2000, EUR J BIOCHEM, V267, P6067, DOI 10.1046/j.1432-1327.2000.01687.x; Suh DH, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00041; Wang Z, 2013, FREE RADICAL BIO MED, V65, P849, DOI 10.1016/j.freeradbiomed.2013.08.169; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yanagita T, 2007, NEUROPHARMACOLOGY, V53, P881, DOI 10.1016/j.neuropharm.2007.08.018; Yano T, 2011, HYPERTENSION, V57, P110, DOI 10.1161/HYPERTENSIONAHA.110.158469; Yoo BC, 2001, ELECTROPHORESIS, V22, P172, DOI 10.1002/1522-2683(200101)22:1<172::AID-ELPS172>3.0.CO;2-P	56	63	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29285	29296		10.1074/jbc.M114.563924	http://dx.doi.org/10.1074/jbc.M114.563924			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25187518	Green Published, hybrid			2022-12-28	WOS:000344141000042
J	Helmann, JD				Helmann, John D.			Specificity of Metal Sensing: Iron and Manganese Homeostasis in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							LYME-DISEASE PATHOGEN; UPTAKE REGULATOR FUR; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; OXIDATIVE-STRESS; STREPTOCOCCUS-PNEUMONIAE; DEINOCOCCUS-RADIODURANS; TRANSPORT REGULATOR; TRANSCRIPTIONAL REGULATORS; METALLOREGULATORY PROTEIN	Metalloregulatory proteins allow cells to sense metal ions and appropriately adjust the expression of metal uptake, storage, and efflux pathways. Bacillus subtilis provides a model for the coordinate regulation of iron and manganese homeostasis that involves three key regulators: Fur senses iron sufficiency, MntR senses manganese sufficiency, and PerR senses the intracellular Fe/Mn ratio. Here, I review the structural and physiological bases of selective metal perception, the effects of non-cognate metals, and mechanisms that may serve to coordinate iron and manganese homeostasis.	Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA	Cornell University	Helmann, JD (corresponding author), Cornell Univ, Dept Microbiol, Wing Hall, Ithaca, NY 14853 USA.	jdh9@cornell.edu		Helmann, John/0000-0002-3832-3249	National Institutes of Health [GM059323]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM059323 (to J. D. H.). This is the third article in the Thematic Minireview series "Metals in Biology 2014."	Aguirre JD, 2013, J BIOL CHEM, V288, P8468, DOI 10.1074/jbc.M112.433540; Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; Anjem A, 2012, J BIOL CHEM, V287, P15544, DOI 10.1074/jbc.M111.330365; Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x; Bsat N, 1998, MOL MICROBIOL, V29, P189, DOI 10.1046/j.1365-2958.1998.00921.x; Carpenter BM, 2009, INFECT IMMUN, V77, P2590, DOI 10.1128/IAI.00116-09; Caza M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00080; Chazarreta-Cifre L, 2011, J BACTERIOL, V193, P4043, DOI 10.1128/JB.05103-11; CHEN L, 1995, MOL MICROBIOL, V18, P295, DOI 10.1111/j.1365-2958.1995.mmi_18020295.x; CHEN L, 1995, P NATL ACAD SCI USA, V92, P8190, DOI 10.1073/pnas.92.18.8190; Cotruvo JA, 2012, METALLOMICS, V4, P1020, DOI 10.1039/c2mt20142a; Culotta VC, 2013, ANTIOXID REDOX SIGN, V19, P933, DOI 10.1089/ars.2012.5093; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; DAILEY HA, 1987, ANN NY ACAD SCI, V514, P81, DOI 10.1111/j.1749-6632.1987.tb48763.x; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; DeWitt MA, 2007, J MOL BIOL, V365, P1257, DOI 10.1016/j.jmb.2006.10.080; Duarte V, 2010, MOL BIOSYST, V6, P316, DOI 10.1039/b915042k; Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12; Faulkner MJ, 2012, J BACTERIOL, V194, P1226, DOI 10.1128/JB.06566-11; Faulkner MJ, 2011, ANTIOXID REDOX SIGN, V15, P175, DOI 10.1089/ars.2010.3682; Fillat MF, 2014, ARCH BIOCHEM BIOPHYS, V546, P41, DOI 10.1016/j.abb.2014.01.029; FISHER S, 1973, J BACTERIOL, V113, P1373, DOI 10.1128/JB.113.3.1373-1380.1973; Fuangthong M, 2002, J BACTERIOL, V184, P3276, DOI 10.1128/JB.184.12.3276-3286.2002; Gaballa A, 1998, J BACTERIOL, V180, P5815, DOI 10.1128/JB.180.22.5815-5821.1998; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Gaballa A, 2007, MOL MICROBIOL, V66, P164, DOI 10.1111/j.1365-2958.2007.05905.x; Gaballa A, 2012, NUCLEIC ACIDS RES, V40, P3585, DOI 10.1093/nar/gkr1280; Glasfeld A, 2003, NAT STRUCT BIOL, V10, P652, DOI 10.1038/nsb951; Guedon E, 2003, MOL MICROBIOL, V48, P495, DOI 10.1046/j.1365-2958.2003.03445.x; Guedon E, 2003, MOL MICROBIOL, V49, P1477, DOI 10.1046/j.1365-2958.2003.03648.x; Guerra AJ, 2012, ARCH BIOCHEM BIOPHYS, V519, P210, DOI 10.1016/j.abb.2011.11.021; Haas M, 2001, MICROBIOL-SGM, V147, P1783, DOI 10.1099/00221287-147-7-1783; HANTKE K, 1987, MOL GEN GENET, V210, P135, DOI 10.1007/BF00337769; Helmann JD, 2007, MOL MICROBIOLOGY HEA, V6, P37; Herbig AF, 2001, MOL MICROBIOL, V41, P849, DOI 10.1046/j.1365-2958.2001.02543.x; Hider RC, 2013, DALTON T, V42, P3220, DOI 10.1039/c2dt32149a; Hohle TH, 2012, MOL MICROBIOL, V84, P766, DOI 10.1111/j.1365-2958.2012.08057.x; Ikeda JS, 2005, J BACTERIOL, V187, P912, DOI 10.1128/JB.187.3.912-922.2005; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jacquamet L, 2009, MOL MICROBIOL, V73, P20, DOI 10.1111/j.1365-2958.2009.06753.x; Jakubovics NS, 2009, MOL MICROBIOL, V72, P1, DOI 10.1111/j.1365-2958.2009.06637.x; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Keyer K, 1997, J BIOL CHEM, V272, P27652, DOI 10.1074/jbc.272.44.27652; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kliegman JI, 2006, BIOCHEMISTRY-US, V45, P3493, DOI 10.1021/bi0524215; Lawson RJ, 2004, BIOCHEMISTRY-US, V43, P12390, DOI 10.1021/bi049131t; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Lee JW, 2006, J BIOL CHEM, V281, P23567, DOI 10.1074/jbc.M603968200; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Li CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021983; Lisher JP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00091; Lisher JP, 2013, BIOCHEMISTRY-US, V52, P7689, DOI 10.1021/bi401132w; Ma Z, 2013, ENCY INORGANIC BIOIN; Ma Z, 2012, MOL MICROBIOL, V86, P1144, DOI 10.1111/mmi.12049; Ma Z, 2011, NUCLEIC ACIDS RES, V39, P9130, DOI 10.1093/nar/gkr625; Ma Z, 2011, NUCLEIC ACIDS RES, V39, P5036, DOI 10.1093/nar/gkr095; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Martin JE, 2011, MOL MICROBIOL, V80, P319, DOI 10.1111/j.1365-2958.2011.07593.x; McGuire AM, 2013, BIOCHEMISTRY-US, V52, P701, DOI 10.1021/bi301550t; Merchant AT, 2014, MOL ORAL MICROBIOL, V29, P1, DOI 10.1111/omi.12039; Merchant SS, 2012, ADV MICROB PHYSIOL, V60, P91, DOI 10.1016/B978-0-12-398264-3.00002-4; Miller AF, 2012, FEBS LETT, V586, P585, DOI 10.1016/j.febslet.2011.10.048; Moore CM, 2005, CURR OPIN MICROBIOL, V8, P188, DOI 10.1016/j.mib.2005.02.007; Moore CM, 2005, MOL MICROBIOL, V57, P27, DOI 10.1111/j.1365-2958.2005.04642.x; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Parent A, 2013, ANGEW CHEM INT EDIT, V52, P10339, DOI 10.1002/anie.201304021; Parker MJ, 2014, BIOCHEMISTRY-US, V53, P766, DOI 10.1021/bi401056e; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Puri S, 2010, P NATL ACAD SCI USA, V107, P10691, DOI 10.1073/pnas.1002342107; Que Q, 2000, MOL MICROBIOL, V35, P1454, DOI 10.1046/j.1365-2958.2000.01811.x; Rosch JW, 2009, MOL MICROBIOL, V72, P12, DOI 10.1111/j.1365-2958.2009.06638.x; Sankaran B, 2009, J BACTERIOL, V191, P6936, DOI 10.1128/JB.00287-09; Schmitt MP, 2002, J BACTERIOL, V184, P6882, DOI 10.1128/JB.184.24.6882-6892.2002; Sen KI, 2006, BIOCHEMISTRY-US, V45, P4295, DOI 10.1021/bi052288g; Sevcenco AM, 2011, METALLOMICS, V3, P1324, DOI 10.1039/c1mt00154j; Sharma A, 2013, P NATL ACAD SCI USA, V110, P5945, DOI 10.1073/pnas.1303376110; Shin JH, 2011, P NATL ACAD SCI USA, V108, P5045, DOI 10.1073/pnas.1017744108; Smaidone GT, 2012, J BACTERIOL, V194, P2586, DOI 10.1128/JB.05567-11; Smaldone GT, 2012, J BACTERIOL, V194, P2594, DOI 10.1128/JB.05990-11; Sobota JM, 2014, J BACTERIOL, V196, P1980, DOI 10.1128/JB.01573-14; Stoll KE, 2009, BIOCHEMISTRY-US, V48, P10308, DOI 10.1021/bi900980g; Tabares LC, 2013, J BIOL CHEM, V288, P5050, DOI 10.1074/jbc.C112.444992; Traore DAK, 2009, NAT CHEM BIOL, V5, P53, DOI 10.1038/nchembio.133; Troxell B, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00059; Tu WY, 2012, J BACTERIOL, V194, P932, DOI 10.1128/JB.06195-11; VASANTHA N, 1979, J GEN MICROBIOL, V112, P329, DOI 10.1099/00221287-112-2-329; Veyrier FJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002261; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; You CH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-57; Zeth K, 2012, BIOCHEM J, V445, P297, DOI 10.1042/BJ20120514; Zuber P, 2009, ANNU REV MICROBIOL, V63, P575, DOI 10.1146/annurev.micro.091208.073241	93	85	85	4	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28112	28120		10.1074/jbc.R114.587071	http://dx.doi.org/10.1074/jbc.R114.587071			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25160631	hybrid, Green Published			2022-12-28	WOS:000343765400007
J	Scholl, ZN; Yang, WT; Marszalek, PE				Scholl, Zackary N.; Yang, Weitao; Marszalek, Piotr E.			Chaperones Rescue Luciferase Folding by Separating Its Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANICAL UNFOLDING PATHWAYS; SUBSTRATE-BINDING PROPERTIES; PHOTINUS-PYRALIS LUCIFERASE; ATOMIC-FORCE MICROSCOPY; STRUCTURE-BASED MODELS; FIREFLY LUCIFERASE; STRUCTURAL BASIS; PROTEIN-STRUCTURE; SWISS-MODEL; LANDSCAPE	Over the last 50 years, significant progress has been made toward understanding how small single-domain proteins fold. However, very little is known about folding mechanisms of medium and large multidomain proteins that predominate the proteomes of all forms of life. Large proteins frequently fold cotranslationally and/or require chaperones. Firefly (Photinus pyralis) luciferase (Luciferase, 550 residues) has been a model of a cotranslationally folding protein whose extremely slow refolding (approximately days) is catalyzed by chaperones. However, the mechanism by which Luciferase misfolds and how chaperones assist Luciferase refolding remains unknown. Here we combine single-molecule force spectroscopy (atomic force microscopy (AFM)/single-molecule force spectroscopy) with steered molecular dynamic computer simulations to unravel the mechanism of chaperone-assisted Luciferase refolding. Our AFM and steered molecular dynamic results show that partially unfolded Luciferase, with the N-terminal domain remaining folded, can refold robustly without chaperones. Complete unfolding causes Luciferase to get trapped in very stable non-native configurations involving interactions between N- and C-terminal residues. However, chaperones allow the completely unfolded Luciferase to refold quickly in AFM experiments, strongly suggesting that chaperones are able to sequester non-natively contacting residues. More generally, we suggest that many chaperones, rather than actively promoting the folding, mimic the ribosomal exit tunnel and physically separate protein domains, allowing them to fold in a cotranslational-like sequential process.	[Scholl, Zackary N.; Yang, Weitao] Duke Univ, Ctr Biol Inspired Mat & Mat Syst, Program Computat Biol & Bioinformat, Durham, NC 27705 USA; [Yang, Weitao] Duke Univ, Ctr Biol Inspired Mat & Mat Syst, Dept Chem, Durham, NC 27705 USA; [Marszalek, Piotr E.] Duke Univ, Dept Mech Engn & Mat Sci, Ctr Biol Inspired Mat & Mat Syst, Durham, NC 27705 USA	Duke University; Duke University; Duke University	Marszalek, PE (corresponding author), Duke Univ, Dept Mech Engn & Mat Sci, Ctr Biol Inspired Mat & Mat Syst, Durham, NC 27705 USA.	pemar@duke.edu	Yang, Weitao/C-1109-2008	Yang, Weitao/0000-0001-5576-2828	National Science Foundation [1106401]; NSF [MCB-1052208]; Kimberly-Clark Corporation	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Kimberly-Clark Corporation	This work was supported by National Science Foundation Graduate Research Fellowship Program Grant 1106401 (to Z. N. S.) and by NSF Grant MCB-1052208 (to P. E. M. and W. Y.).; Supported by the Kimberly-Clark Corporation. To whom correspondence should be addressed: Dept. of Mechanical Engineering and Materials Science, Center for Biologically Inspired Materials and Material Systems, Duke University, Durham, NC 27705. Tel.: 919-660-5381; E-mail: pemar@duke.edu.	Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592; Bertz M, 2008, J MOL BIOL, V378, P447, DOI 10.1016/j.jmb.2008.02.025; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Chang KH, 1997, BIOCHEMISTRY-US, V36, P15650, DOI 10.1021/bi971262p; Clark PL, 2004, TRENDS BIOCHEM SCI, V29, P527, DOI 10.1016/j.tibs.2004.08.008; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Clementi C, 2008, CURR OPIN STRUC BIOL, V18, P10, DOI 10.1016/j.sbi.2007.10.005; DELUCA M, 1974, BIOCHEMISTRY-US, V13, P921, DOI 10.1021/bi00702a015; DENBURG JL, 1969, ARCH BIOCHEM BIOPHYS, V134, P381, DOI 10.1016/0003-9861(69)90297-5; Dietz H, 2006, P NATL ACAD SCI USA, V103, P1244, DOI 10.1073/pnas.0509217103; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Eaton WA, 2000, ANNU REV BIOPH BIOM, V29, P327, DOI 10.1146/annurev.biophys.29.1.327; Englander SW, 2007, Q REV BIOPHYS, V40, P287, DOI 10.1017/S0033583508004654; FERSHT A, 1999, STRUCTURE MECH PROTE, P1; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; Frydman J, 1999, NAT STRUCT BIOL, V6, P697, DOI 10.1038/10754; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Herbst R, 1998, BIOCHEMISTRY-US, V37, P6586, DOI 10.1021/bi972928i; Herbst R, 1997, J BIOL CHEM, V272, P7099, DOI 10.1074/jbc.272.11.7099; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim M, 2010, BIOPHYS J, V98, P3086, DOI 10.1016/j.bpj.2010.02.054; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kleinkauf H, 1996, EUR J BIOCHEM, V236, P335, DOI 10.1111/j.1432-1033.1996.00335.x; Lammert H, 2009, PROTEINS, V77, P881, DOI 10.1002/prot.22511; LEE RT, 1970, ARCH BIOCHEM BIOPHYS, V141, P38, DOI 10.1016/0003-9861(70)90103-7; Lee W, 2010, J BIOL CHEM, V285, P38167, DOI 10.1074/jbc.M110.179697; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Ozawa T, 2001, ANAL CHEM, V73, P2516, DOI 10.1021/ac0013296; Peng Q, 2008, P NATL ACAD SCI USA, V105, P1885, DOI 10.1073/pnas.0706775105; Pirchi M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1504; Porter LL, 2012, P NATL ACAD SCI USA, V109, P9420, DOI 10.1073/pnas.1202604109; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Sapra KT, 2009, ANGEW CHEM INT EDIT, V48, P8306, DOI 10.1002/anie.200904361; Schueler-Furman O, 2005, SCIENCE, V310, P638, DOI 10.1126/science.1112160; SCHUMACHER RJ, 1994, J BIOL CHEM, V269, P9493; Shank EA, 2010, NATURE, V465, P637, DOI 10.1038/nature09021; Stigler J, 2011, SCIENCE, V334, P512, DOI 10.1126/science.1207598; Svetlov MS, 2006, PROTEIN SCI, V15, P242, DOI 10.1110/ps.051752506; Wang WQ, 2001, BIOCHEM BIOPH RES CO, V282, P28, DOI 10.1006/bbrc.2001.4539; Wolynes PG, 2005, Q REV BIOPHYS, V38, P405, DOI 10.1017/S0033583505004075; Zheng WJ, 2006, P NATL ACAD SCI USA, V103, P7664, DOI 10.1073/pnas.0510426103; Zheng WJ, 2003, P NATL ACAD SCI USA, V100, P13253, DOI 10.1073/pnas.2235686100; Zhou HX, 2001, BIOCHEMISTRY-US, V40, P11289, DOI 10.1021/bi0155504	50	22	22	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28607	28618		10.1074/jbc.M114.582049	http://dx.doi.org/10.1074/jbc.M114.582049			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25160632	hybrid, Green Published			2022-12-28	WOS:000343765400049
J	Hanisch, FG; Bonar, D; Schloerer, N; Schroten, H				Hanisch, Franz-Georg; Bonar, David; Schloerer, Nils; Schroten, Horst			Human Trefoil Factor 2 Is a Lectin That Binds alpha-GlcNAc-capped Mucin Glycans with Antibiotic Activity against Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycomics; Glycosylation; Helicobacter pylori; Lectin; Mucin; Mucin-type O-Glycans; Trefoil Factor Family 2 (TFF2)	PANCREATIC SPASMOLYTIC POLYPEPTIDE; DAMAGED GASTRIC-MUCOSA; O-LINKED GLYCANS; N-ACETYLGLUCOSAMINE; FAMILY FACTOR-2; HUMAN STOMACH; CELL MUCIN; EXPRESSION; TFF2; PEPTIDES	Background: Trefoil factor 2 (TFF2) forms complexes with MUC6 and is concertedly secreted by deep gastric glands. Results: TFF2 is a lectin that binds to -GlcNAc-capped MUC6 O-glycans with antibiotic activity against Helicobacter pylori. Conclusion: There may be a functional link between mucin glycans and TFF2 in H. pylori defense. Significance: The findings impact in development of defense strategies against H. pylori and in TFF2 receptor-mediated cell signaling. Helicobacter pylori infection is the major cause of gastric cancer and remains an important health care challenge. The trefoil factor peptides are a family of small highly conserved proteins that are claimed to play essential roles in cytoprotection and epithelial repair within the gastrointestinal tract. H. pylori colocalizes with MUC5AC at the gastric surface epithelium, but not with MUC6 secreted in concert with TFF2 by deep gastric glands. Both components of the gastric gland secretome associate non-covalently and show increased expression upon H. pylori infection. Although blood group active O-glycans of the Lewis-type form the basis of H. pylori adhesion to the surface mucin layer and to epithelial cells, 1,4-GlcNAc-capped O-glycans on gastric mucins were proposed to inhibit H. pylori growth as a natural antibiotic. We show here that the gastric glycoform of TFF2 is a calcium-independent lectin, which binds with high specificity to O-linked 1,4-GlcNAc-capped hexasaccharides on human and porcine stomach mucin. The structural assignments of two hexasaccharide isomers and the binding active glycotope were based on mass spectrometry, linkage analysis, H-1 nuclear magnetic resonance spectroscopy, glycan inhibition, and lectin competition of TFF2-mucin binding. Neoglycolipids derived from the C3/C6-linked branches of the two isomers revealed highly specific TFF2 binding to the 6-linked trisaccharide in GlcNAc1-4Gal1-4GlcNAc1-6(Fuc1-2Gal1-3)GalNAc-ol(Structure 1). Supposedly, lectin TFF2 is involved in protection of gastric epithelia via a functional relationship to defense against H. pylori launched by antibiotic 1,4-GlcNAc-capped mucin glycans. Lectin-carbohydrate interaction may have also an impact on more general functional aspects of TFF members by mediating their binding to cell signaling receptors.	[Hanisch, Franz-Georg; Bonar, David] Univ Cologne, Inst Biochem 2, Fac Med, D-50931 Cologne, Germany; [Hanisch, Franz-Georg] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Schloerer, Nils] Univ Cologne, Inst Organ Chem, D-50939 Cologne, Germany; [Schroten, Horst] Heidelberg Univ, Univ Childrens Hosp, D-68167 Mannheim, Germany	University of Cologne; University of Cologne; University of Cologne; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hanisch, FG (corresponding author), Univ Cologne, Inst Biochem 2, Fac Med, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	franz.hanisch@uni-koeln.de	Schloerer, Nils E/C-3868-2013; Schloerer, Nils/AAA-5176-2021	Schloerer, Nils E/0000-0002-0990-9582; Schloerer, Nils/0000-0002-0990-9582	Deutsche Forschungsgemeinschaft [HA 2092/21-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant HA 2092/21-1 (to F. G. H.).	ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; Breloy I, 2012, J BIOL CHEM, V287, P18275, DOI 10.1074/jbc.M111.280297; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Colomb F, 2014, SPR CARB CH, V40, P596, DOI 10.1039/9781849739986-00596; Ding SZ, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-18; Ferreira B, 2006, J HISTOCHEM CYTOCHEM, V54, P585, DOI 10.1369/jhc.5A6836.2006; Fox JG, 2007, AM J PATHOL, V171, P1520, DOI 10.2353/ajpath.2007.070249; GAJHEDE M, 1993, STRUCTURE, V1, P253, DOI 10.1016/0969-2126(93)90014-8; Gott P, 1996, EUR J HUM GENET, V4, P308; HANBY AM, 1993, GASTROENTEROLOGY, V105, P1110, DOI 10.1016/0016-5085(93)90956-D; HANISCH FG, 1992, EUR J BIOCHEM, V205, P527, DOI 10.1111/j.1432-1033.1992.tb16809.x; HANISCH FG, 1993, EUR J BIOCHEM, V217, P645, DOI 10.1111/j.1432-1033.1993.tb18288.x; Hanisch FG, 2013, GLYCOBIOLOGY, V23, P2, DOI 10.1093/glycob/cws131; Hanisch Franz-Georg, 2009, V534, P107, DOI 10.1007/978-1-59745-022-5_8; Hoffmann W, 2002, INT REV CYTOL, V213, P147; Jiang P, 2014, ONCOL LETT, V7, P1525, DOI 10.3892/ol.2014.1904; JORGENSEN KH, 1982, REGUL PEPTIDES, V3, P207, DOI 10.1016/0167-0115(82)90126-4; Karasawa F, 2012, J CLIN INVEST, V122, P923, DOI 10.1172/JCI59087; Kawakubo M, 2004, SCIENCE, V305, P1003, DOI 10.1126/science.1099250; Kobayashi M, 2009, GLYCOBIOLOGY, V19, P453, DOI 10.1093/glycob/cwp004; Kouznetsova I, 2007, CELL PHYSIOL BIOCHEM, V20, P899, DOI 10.1159/000110450; Kurt-Jones EA, 2007, INFECT IMMUN, V75, P471, DOI 10.1128/IAI.02039-05; May FEB, 2000, GUT, V46, P454, DOI 10.1136/gut.46.4.454; Muller S, 2002, J BIOL CHEM, V277, P26103, DOI 10.1074/jbc.M202921200; Nakayama J, 1999, P NATL ACAD SCI USA, V96, P8991, DOI 10.1073/pnas.96.16.8991; Ota H, 2006, HISTOCHEM CELL BIOL, V126, P617, DOI 10.1007/s00418-006-0197-y; Otto W, 2005, CELL MOL LIFE SCI, V62, P2939, DOI 10.1007/s00018-005-5482-8; Phillipson M, 2008, AM J PHYSIOL-GASTR L, V295, pG806, DOI 10.1152/ajpgi.90252.2008; PLAYFORD RJ, 1995, GASTROENTEROLOGY, V108, P108, DOI 10.1016/0016-5085(95)90014-4; Rossez Y, 2012, GLYCOBIOLOGY, V22, P1193, DOI 10.1093/glycob/cws072; STOLL MS, 1990, EUR J BIOCHEM, V189, P499, DOI 10.1111/j.1432-1033.1990.tb15515.x; Sturmer R, 2014, CELL PHYSIOL BIOCHEM, V33, P895, DOI 10.1159/000358662; Suzuki K, 2006, SCAND J GASTROENTERO, V41, P1390, DOI 10.1080/00365520600792077; Thim L, 2002, EUR J CLIN INVEST, V32, P519, DOI 10.1046/j.1365-2362.2002.01014.x; TOMASETTO C, 1990, EMBO J, V9, P407, DOI 10.1002/j.1460-2075.1990.tb08125.x; Van den Brink GR, 2000, GUT, V46, P601, DOI 10.1136/gut.46.5.601; Xia HHX, 2004, J CLIN PATHOL, V57, P861, DOI 10.1136/jcp.2003.015487	37	42	43	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27363	27375		10.1074/jbc.M114.597757	http://dx.doi.org/10.1074/jbc.M114.597757			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25124036	hybrid, Green Published			2022-12-28	WOS:000342852800001
J	Yadav, T; Carrasco, B; Serrano, E; Alonso, JC				Yadav, Tribhuwan; Carrasco, Begona; Serrano, Ester; Alonso, Juan C.			Roles of Bacillus subtilis DprA and SsbA in RecA-mediated Genetic Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; DNA Recombination; DNA Transformation; DNA-Protein Interaction; Protein-DNA Interaction	SINGLE-STRANDED-DNA; HELICOBACTER-PYLORI DPRA; HOMOLOGOUS RECOMBINATION; ESCHERICHIA-COLI; INCOMING DNA; PROTEIN; TRANSFORMATION; EXCHANGE; BINDING; MECHANISM	Background: ATP-bound RecA cannot catalyze DNA recombination without crucial accessory factors. Results: DprA facilitates RecA assembly onto SsbA- or SsbB-coated single-stranded DNA, but only DprA and SsbA enable RecAATP to mediate strand exchange. Conclusion: RecAATP transition to an active state requires DprA and SsbA. Significance: DprA and SsbA may serve as a two-component mediator during chromosomal transformation. Bacillus subtilis competence-induced RecA, SsbA, SsbB, and DprA are required to internalize and to recombine single-stranded (ss) DNA with homologous resident duplex. RecA, in the ATPMg(2+)-bound form (RecAATP), can nucleate and form filament onto ssDNA but is inactive to catalyze DNA recombination. We report that SsbA or SsbB bound to ssDNA blocks the RecA filament formation and fails to activate recombination. DprA facilitates RecA filamentation; however, the filaments cannot engage in DNA recombination. When ssDNA was preincubated with SsbA, but not SsbB, DprA was able to activate DNA strand exchange dependent on RecAATP. This work demonstrates that RecAATP, in concert with SsbA and DprA, catalyzes DNA strand exchange, and SsbB is an accessory factor in the reaction. In contrast, RecAdATP efficiently catalyzes strand exchange even in the absence of single-stranded binding proteins or DprA, and addition of the accessory factors marginally improved it. We proposed that the RecA-bound nucleotide (ATP and to a lesser extent dATP) might dictate the requirement for accessory factors.	[Yadav, Tribhuwan; Carrasco, Begona; Serrano, Ester; Alonso, Juan C.] CSIC, Ctr Nacl Biotecnol, Dept Microbial Biotechnol, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Alonso, JC (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Microbial Biotechnol, Darwin Str 3, Madrid 28049, Spain.	jcalonso@cnb.csic.es	Serrano, Ester/Q-1730-2018; Alonso, Juan Carlos/D-2595-2009	Serrano, Ester/0000-0001-5075-2954; Alonso, Juan Carlos/0000-0002-5178-7179; Carrasco, Begona/0000-0002-5671-1296; Yadav, Tribhuwan/0000-0003-3571-9907	Ministerio de Economia y Competitividad, Direccion General de Investigacion [FU2012-39879-C02-01]; Comunidad de Madrid [S2009MAT-1507]; International Fellowship Programme of La Caixa Foundation (La Caixa/Centro Nacional de Biotecnologia)	Ministerio de Economia y Competitividad, Direccion General de Investigacion; Comunidad de Madrid(Comunidad de Madrid); International Fellowship Programme of La Caixa Foundation (La Caixa/Centro Nacional de Biotecnologia)	This work was supported in part by the Ministerio de Economia y Competitividad, Direccion General de Investigacion FU2012-39879-C02-01 and by Comunidad de Madrid Grant S2009MAT-1507 (to J. C. A.).; Supported by the International Fellowship Programme of La Caixa Foundation (La Caixa/Centro Nacional de Biotecnologia). Present address: Dept. of Molecular Biophysics and Biochemistry, School of Medicine, Yale University, New Haven, CT 06510.	Attaiech L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002156; Ayora S, 2002, J BIOL CHEM, V277, P35969, DOI 10.1074/jbc.M204467200; Ayora S, 2002, J MOL BIOL, V316, P35, DOI 10.1006/jmbi.2001.5336; Bazemore LR, 1997, J BIOL CHEM, V272, P14672, DOI 10.1074/jbc.272.23.14672; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Berge M, 2003, MOL MICROBIOL, V50, P527, DOI 10.1046/j.1365-2958.2003.03702.x; Brimacombe CA, 2014, MOL MICROBIOL, V92, P1260, DOI 10.1111/mmi.12628; Carrasco B, 2005, NUCLEIC ACIDS RES, V33, P3942, DOI 10.1093/nar/gki713; Carrasco B, 2008, DNA REPAIR, V7, P990, DOI 10.1016/j.dnarep.2008.03.019; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chiesa M, 2012, NANO LETT, V12, P1275, DOI 10.1021/nl2037547; Claverys JP, 2009, FEMS MICROBIOL REV, V33, P643, DOI 10.1111/j.1574-6976.2009.00164.x; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Dwivedi GR, 2013, NUCLEIC ACIDS RES, V41, P3274, DOI 10.1093/nar/gkt024; Grove DE, 2012, BIOCHEM BIOPH RES CO, V424, P40, DOI 10.1016/j.bbrc.2012.06.059; Ha T, 2012, ANNU REV BIOPHYS, V41, P295, DOI 10.1146/annurev-biophys-042910-155351; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Kidane D, 2012, CRIT REV BIOCHEM MOL, V47, P531, DOI 10.3109/10409238.2012.729562; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.biochem.63.1.991; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kramer N, 2007, MOL MICROBIOL, V65, P454, DOI 10.1111/j.1365-2958.2007.05799.x; Lioy VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030282; Lisboa J, 2014, NUCLEIC ACIDS RES, V42, P7395, DOI 10.1093/nar/gku349; LOVETT CM, 1985, J BIOL CHEM, V260, P3305; Manfredi C, 2008, J BIOL CHEM, V283, P24837, DOI 10.1074/jbc.M802002200; Mortier-Barriere I, 2007, CELL, V130, P824, DOI 10.1016/j.cell.2007.07.038; Ngo KV, 2013, J BIOL CHEM, V288, P21351, DOI 10.1074/jbc.M113.459230; Quevillon-Cheruel S, 2012, P NATL ACAD SCI USA, V109, pE2466, DOI 10.1073/pnas.1205638109; RADDING CM, 1991, J BIOL CHEM, V266, P5355; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Sinha S, 2012, J BACTERIOL, V194, P5245, DOI 10.1128/JB.00671-12; Steffen SE, 2002, J BIOL CHEM, V277, P14493, DOI 10.1074/jbc.M112444200; Steffen SE, 1999, J BIOL CHEM, V274, P25990, DOI 10.1074/jbc.274.37.25990; Takeuchi N, 2014, G3-GENES GENOM GENET, V4, P325, DOI 10.1534/g3.113.009845; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; VLAI I, 2014, NUCLEIC ACIDS RES, V42, P2295; Voloshin ON, 2004, MOL CELL, V15, P846, DOI 10.1016/j.molcel.2004.09.010; Wang W, 2014, NUCLEIC ACIDS RES, V42, P3478, DOI 10.1093/nar/gkt1334; Yadav T, 2013, J BIOL CHEM, V288, P22437, DOI 10.1074/jbc.M113.478347; Yadav T, 2012, NUCLEIC ACIDS RES, V40, P5546, DOI 10.1093/nar/gks173; YANCEYWRONA JE, 1995, CURR BIOL, V5, P1149, DOI 10.1016/S0960-9822(95)00231-4	42	31	36	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27640	27652		10.1074/jbc.M114.577924	http://dx.doi.org/10.1074/jbc.M114.577924			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25138221	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000342852800024
J	Artigas, N; Urena, C; Rodriguez-Carballo, E; Rosa, JL; Ventura, F				Artigas, Natalia; Urena, Carlos; Rodriguez-Carballo, Edgardo; Luis Rosa, Jose; Ventura, Francesc			Mitogen-activated Protein Kinase (MAPK)-regulated Interactions between Osterix and Runx2 Are Critical for the Transcriptional Osteogenic Program	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST-SPECIFIC EXPRESSION; CLEIDOCRANIAL DYSPLASIA; OSTEOCALCIN GENE; BONE-FORMATION; CELL-DIFFERENTIATION; SIGNALING PATHWAYS; PROXIMAL PROMOTER; FACTOR OSF2/CBFA1; P38; PHOSPHORYLATION	The transcription factors Runx2 and Osx (Osterix) are required for osteoblast differentiation and bone formation. Runx2 expression occurs at early stages of osteochondroprogenitor determination, followed by Osx induction during osteoblast maturation. We demonstrate that coexpression of Osx and Runx2 leads to cooperative induction of expression of the osteogenic genes Col1a1, Fmod, and Ibsp. Functional interaction of Osx and Runx2 in the regulation of these promoters is mediated by enhancer regions with adjacent Sp1 and Runx2 DNA-binding sites. These enhancers allow formation of a cooperative transcriptional complex, mediated by the binding of Osx and Runx2 to their specific DNA promoter sequences and by the protein-protein interactions between them. We also identified the domains involved in the interaction between Osx and Runx2. These regions contain the amino acids in Osx and Runx2 known to be phosphorylated by p38 and ERK MAPKs. Inhibition of p38 and ERK kinase activities or mutation of their known phosphorylation sites in Osx or Runx2 strongly disrupts their physical interaction and cooperative transcriptional effects. Altogether, our results provide a molecular description of a mechanism for Osx and Runx2 transcriptional cooperation that is subject to further regulation by MAPK-activating signals during osteogenesis.	[Artigas, Natalia; Urena, Carlos; Rodriguez-Carballo, Edgardo; Luis Rosa, Jose; Ventura, Francesc] Univ Barcelona, Inst Invest Biomed Bellvitge IDIBELL, Dept Ciencies Fisiol 2, E-08907 Lhospitalet De Llobregat, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Ventura, F (corresponding author), Univ Barcelona, IDIBELL, Dept Ciencies Fisiol 2, C Feixa Llarga S-N, E-08907 Lhospitalet De Llobregat, Spain.	fventura@ub.edu	Ventura, Francesc/ABG-2285-2020; Ventura, Francesc/K-9700-2014; Rosa, Jose Luis/K-6685-2014	Ventura, Francesc/0000-0001-9673-9405; Ventura, Francesc/0000-0001-9673-9405; Rosa, Jose Luis/0000-0002-6161-5688; Artigas, Natalia/0000-0003-3290-2052; Urena Martin, Carlos/0000-0002-7130-9705; Rodriguez-Carballo, Eddie/0000-0003-4321-508X	Ministry of Education, Spain [BFU2011-24254]; La Marato de TV3; Instituto de Salud Carlos III [RETIC RD06/0020]; University of Barcelona	Ministry of Education, Spain(Spanish Government); La Marato de TV3; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); University of Barcelona	This work was supported in part by Ministry of Education, Spain Grant BFU2011-24254, La Marato de TV3, and Instituto de Salud Carlos III Grant RETIC RD06/0020.; Recipient of a fellowship from the University of Barcelona.	Baek WY, 2010, BONE, V46, P920, DOI 10.1016/j.bone.2009.12.007; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Chen F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024638; Cheng AX, 2010, J BONE MINER RES, V25, P2404, DOI 10.1002/jbmr.174; Choi YH, 2011, BIOCHEM BIOPH RES CO, V415, P472, DOI 10.1016/j.bbrc.2011.10.097; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Franceschi RT, 2003, CONNECT TISSUE RES, V44, P109, DOI 10.1080/03008200390152188; Ge CX, 2012, J BONE MINER RES, V27, P538, DOI 10.1002/jbmr.561; Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hinoi E, 2006, J BIOL CHEM, V281, P18015, DOI 10.1074/jbc.M600603200; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200; Jin HL, 2009, HUM MOL GENET, V18, P2729, DOI 10.1093/hmg/ddp205; Ortuno MJ, 2013, BONE, V52, P548, DOI 10.1016/j.bone.2012.11.007; Ortuno MJ, 2010, J BIOL CHEM, V285, P31985, DOI 10.1074/jbc.M110.123612; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kawate H, 2007, J STEROID BIOCHEM, V105, P46, DOI 10.1016/j.jsbmb.2006.11.020; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Kim S, 2003, GENE DEV, V17, P1979, DOI 10.1101/gad.1119303; Kim Y, 2007, J CELL PHYSIOL, V211, P253, DOI 10.1002/jcp.20933; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Lapunzina P, 2010, AM J HUM GENET, V87, P110, DOI 10.1016/j.ajhg.2010.05.016; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lee HW, 2008, J BONE MINER RES, V23, P1227, DOI 10.1359/JBMR.080325; Lee KE, 2013, GENET MOL RES, V12, P4567, DOI 10.4238/2013.October.15.5; Lee KN, 2012, J BIOL CHEM, V287, P18888, DOI 10.1074/jbc.M111.311878; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Liu TJ, 2007, J CELL PHYSIOL, V211, P728, DOI 10.1002/jcp.20988; Liu TM, 2013, TISSUE ENG PART B-RE, V19, P254, DOI [10.1089/ten.TEB.2012.0527, 10.1089/ten.teb.2012.0527]; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Niger C, 2011, BONE, V49, P683, DOI 10.1016/j.bone.2011.07.027; Nishimura R, 2012, J BIOL CHEM, V287, P33179, DOI 10.1074/jbc.M111.337063; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Paredes R, 2004, MOL CELL BIOL, V24, P8847, DOI 10.1128/MCB.24.20.8847-8861.2004; Pelletier N, 2002, ONCOGENE, V21, P2729, DOI 10.1038/sj.onc.1205367; Roca H, 2005, J BIOL CHEM, V280, P30845, DOI 10.1074/jbc.M503942200; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Sinha KM, 2014, J BONE MINER RES, V29, P855, DOI 10.1002/jbmr.2103; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; Timpson NJ, 2009, HUM MOL GENET, V18, P1510, DOI 10.1093/hmg/ddp052; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	53	87	89	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27105	27117		10.1074/jbc.M114.576793	http://dx.doi.org/10.1074/jbc.M114.576793			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122769	Green Published, hybrid			2022-12-28	WOS:000342853900037
J	Bianchini, E; Testoni, S; Gentile, A; Cali, T; Ottolini, D; Villa, A; Brini, M; Betto, R; Mascarello, F; Nissen, P; Sandona, D; Sacchetto, R				Bianchini, Elisa; Testoni, Stefania; Gentile, Arcangelo; Cali, Tito; Ottolini, Denis; Villa, Antonello; Brini, Marisa; Betto, Romeo; Mascarello, Francesco; Nissen, Poul; Sandona, Dorianna; Sacchetto, Roberta			Inhibition of Ubiquitin Proteasome System Rescues the Defective Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA1) Protein Causing Chianina Cattle Pseudomyotonia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TWITCH SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; BRODY-DISEASE; CONGENITAL PSEUDOMYOTONIA; CRYSTAL-STRUCTURE; CALCIUM-PUMP; CA2+ ATPASE; COS-1 CELLS; DEGRADATION; MUTATION	A missense mutation in ATP2A1 gene, encoding sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA1) protein, causes Chianina cattle congenital pseudomyotonia, an exercise-induced impairment of muscle relaxation. Skeletal muscles of affected cattle are characterized by a selective reduction of SERCA1 in sarcoplasmic reticulum membranes. In this study, we provide evidence that the ubiquitin proteasome system is involved in the reduced density of mutated SERCA1. The treatment with MG132, an inhibitor of ubiquitin proteasome system, rescues the expression level and membrane localization of the SERCA1 mutant in a heterologous cellular model. Cells co-transfected with the Ca2+-sensitive probe aequorin show that the rescued SERCA1 mutant exhibits the same ability of wild type to maintain Ca(2+)homeostasis within cells. These data have been confirmed by those obtained ex vivo on adult skeletal muscle fibers from a biopsy from a pseudomyotonia-affected subject. Our data show that the mutation generates a protein most likely corrupted in proper folding but not in catalytic activity. Rescue of mutated SERCA1 to sarcoplasmic reticulum membrane can re-establish resting cytosolic Ca2+ concentration and prevent the appearance of pathological signs of cattle pseudomyotonia.	[Bianchini, Elisa; Sandona, Dorianna] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Cali, Tito; Ottolini, Denis; Brini, Marisa] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Testoni, Stefania] Univ Padua, Dept Anim Med Prod & Hlth, I-35020 Padua, Italy; [Mascarello, Francesco; Sacchetto, Roberta] Univ Padua, Dept Comparat Biomed & Food Sci, I-35020 Padua, Italy; [Gentile, Arcangelo] Univ Bologna, Dept Vet Med Sci, I-40064 Bologna, Italy; [Villa, Antonello] Univ Milano Bicocca, Consorzio MIA, I-20900 Monza, Italy; [Betto, Romeo] Consiglio Nazl Ric Padova, Inst Neurosci, I-35131 Padua, Italy; [Nissen, Poul] Aarhus Univ, Dept Mol Biol & Genet, Ctr Membrane Pumps Cells & Dis, DK-8000 Aarhus, Denmark	University of Padua; University of Padua; University of Padua; University of Padua; University of Bologna; University of Milano-Bicocca; Aarhus University	Sandona, D (corresponding author), Univ Padua, Dept Biomed Sci, Via Ugo Bassi 58-B, I-35131 Padua, Italy.	dorianna.sandona@unipd.it; roberta.sacchetto@unipd.it	Calì, Tito/K-5064-2016; Brini, Marisa/K-5189-2016; sandona, dorianna/AAB-9480-2020	Calì, Tito/0000-0002-8901-1659; Nissen, Poul/0000-0003-0948-6628; Brini, Marisa/0000-0001-5141-0243; Villa, Antonello/0000-0002-3820-8072	University of Padova [2009 CPDA091413]; Italian Telethon Foundation [GEP12058]	University of Padova; Italian Telethon Foundation(Fondazione Telethon)	This work was supported by grants from the University of Padova (Progetto Ateneo 2009 CPDA091413) (to F. M.) and the Italian Telethon Foundation (Project GEP12058) (to D. S.).	Assereto S, 2006, AM J PHYSIOL-CELL PH, V290, pC577, DOI 10.1152/ajpcell.00434.2005; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; BRODY IA, 1969, NEW ENGL J MED, V281, P187, DOI 10.1056/NEJM196907242810403; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Daiho T, 1999, J BIOL CHEM, V274, P23910, DOI 10.1074/jbc.274.34.23910; Drogemuller C, 2008, GENOMICS, V92, P474, DOI 10.1016/j.ygeno.2008.07.014; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.bb.18.060189.002001; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Grunberg W, 2010, NEUROMUSCULAR DISORD, V20, P467, DOI 10.1016/j.nmd.2010.04.010; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; KARPATI G, 1986, ANN NEUROL, V20, P38, DOI 10.1002/ana.410200108; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Murgiano L, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-186; Odermatt A, 1996, NAT GENET, V14, P191, DOI 10.1038/ng1096-191; Odermatt A, 2000, HUM GENET, V106, P482, DOI 10.1007/s004390000297; Sacchetto R, 2005, J BIOL CHEM, V280, P7147, DOI 10.1074/jbc.M413574200; Sacchetto R, 2009, AM J PATHOL, V174, P565, DOI 10.2353/ajpath.2009.080659; Sacchetto R, 2012, J STRUCT BIOL, V178, P38, DOI 10.1016/j.jsb.2012.02.008; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Testoni S, 2008, VET REC, V163, P254, DOI 10.1136/vr.163.8.252; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Voermans NC, 2012, NEUROMUSCULAR DISORD, V22, P944, DOI 10.1016/j.nmd.2012.03.012; Zhu L, 2006, J BIOL CHEM, V281, P22289, DOI 10.1074/jbc.M602664200	31	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33073	33082		10.1074/jbc.M114.576157	http://dx.doi.org/10.1074/jbc.M114.576157			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25288803	Green Published, hybrid			2022-12-28	WOS:000345636600002
J	Shibata, T; Nakashima, F; Honda, K; Lu, YJ; Kondo, T; Ushida, Y; Aizawa, K; Suganuma, H; Oe, S; Tanaka, H; Takahashi, T; Uchida, K				Shibata, Takahiro; Nakashima, Fumie; Honda, Kazuya; Lu, Yu-Jhang; Kondo, Tatsuhiko; Ushida, Yusuke; Aizawa, Koichi; Suganuma, Hiroyuki; Oe, Sho; Tanaka, Hiroshi; Takahashi, Takashi; Uchida, Koji			Toll-like Receptors as a Target of Food-derived Anti-inflammatory Compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SESQUITERPENE LACTONES; BRASSICA-OLERACEA; CABBAGE EXTRACT; INNATE IMMUNITY; INHIBITION; ENZYMES; SULFORAPHANE; INDUCTION; CELLS	Toll-like receptors (TLRs) play a key role in linking pathogen recognition with the induction of innate immunity. They have been implicated in the pathogenesis of chronic inflammatory diseases, representing potential targets for prevention/treatment. Vegetable-rich diets are associated with the reduced risk of several inflammatory disorders. In the present study, based on an extensive screening of vegetable extracts for TLR-inhibiting activity in HEK293 cells co-expressing TLR with the NF-kappa B reporter gene, we found cabbage and onion extracts to be the richest sources of a TLR signaling inhibitor. To identify the active substances, we performed activity-guiding separation of the principal inhibitors and identified 3-methylsulfinylpropyl isothiocyanate (iberin) from the cabbage and quercetin and quercetin 4'-O-beta-glucoside from the onion, among which iberin showed the most potent inhibitory effect. It was revealed that iberin specifically acted on the dimerization step of TLRs in the TLR signaling pathway. To gain insight into the inhibitory mechanism of TLR dimerization, we developed a novel probe combining an isothiocyanate-reactive group and an alkyne functionality for click chemistry and detected the probe bound to the TLRs in living cells, suggesting that iberin disrupts dimerization of the TLRs via covalent binding. Furthermore, we designed a variety of iberin analogues and found that the inhibition potency was influenced by the oxidation state of the sulfur. Modeling studies of the iberin analogues showed that the oxidation state of sulfur might influence the global shape of the isothiocyanates. These findings establish the TLR dimerization step as a target of food-derived anti-inflammatory compounds.	[Shibata, Takahiro; Nakashima, Fumie; Honda, Kazuya; Lu, Yu-Jhang; Kondo, Tatsuhiko; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Ushida, Yusuke; Aizawa, Koichi; Suganuma, Hiroyuki] Kagome Co Ltd, Div Res & Dev, Nasushiobara 3292762, Japan; [Oe, Sho; Tanaka, Hiroshi; Takahashi, Takashi] Tokyo Inst Technol, Grad Sch Sci & Engn, Tokyo 1528552, Japan	Nagoya University; Kagome Co., Ltd.; Tokyo Institute of Technology	Uchida, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	Tanaka, Hiroshi/I-2402-2012; Shibata, Takahiro/I-6872-2014	Ushida, Yusuke/0000-0003-4117-929X; Lu, Yu-Jhang/0000-0002-8867-6958; Shibata, Takahiro/0000-0003-3194-607X; Uchida, Koji/0000-0003-3894-5299; Suganuma, Hiroyuki/0000-0001-6596-9881	Ministry of Education, Culture, Sports, Science, and Technology in Japan	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (to T. S. and K. U.).	Ahn YH, 2010, P NATL ACAD SCI USA, V107, P9590, DOI 10.1073/pnas.1004104107; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Brennan P, 1998, BIOCHEM PHARMACOL, V55, P965, DOI 10.1016/S0006-2952(97)00535-2; Chuanphongpanich Sarunya, 2006, Chiang Mai Journal of Science, V33, P223; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Comalada M, 2006, BIOCHEM PHARMACOL, V72, P1010, DOI 10.1016/j.bcp.2006.07.016; Carvalho Camilo Amaro de, 2011, Arq. Gastroenterol., V48, P276, DOI 10.1590/S0004-28032011000400011; Dinkova-Kostova AT, 2001, P NATL ACAD SCI USA, V98, P3404, DOI 10.1073/pnas.051632198; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Gillet LCJ, 2008, MOL CELL PROTEOMICS, V7, P1241, DOI 10.1074/mcp.M700505-MCP200; Haddad JJ, 2005, MOL IMMUNOL, V42, P987, DOI 10.1016/j.molimm.2004.09.029; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; HANTKE K, 1973, EUR J BIOCHEM, V34, P284, DOI 10.1111/j.1432-1033.1973.tb02757.x; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Jadhav U, 2007, INT J MOL MED, V19, P353; Komatsu W, 2002, NUTR CANCER, V43, P82, DOI 10.1207/S15327914NC431_10; Komatsu W, 1998, LIPIDS, V33, P499, DOI 10.1007/s11745-998-0233-7; Koo JE, 2013, BIOCHEM BIOPH RES CO, V434, P600, DOI 10.1016/j.bbrc.2013.03.123; Lee JY, 2011, J AGR FOOD CHEM, V59, P857, DOI 10.1021/jf1033587; Lee JY, 2006, MOL CELLS, V21, P174; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Mas S, 2007, NUTR CANCER, V58, P107, DOI 10.1080/01635580701308257; Morimitsu Y, 2002, J BIOL CHEM, V277, P3456, DOI 10.1074/jbc.M110244200; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Rungeler P, 1999, BIOORGAN MED CHEM, V7, P2343, DOI 10.1016/S0968-0896(99)00195-9; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Sargeant LA, 2001, EUR J CLIN NUTR, V55, P342, DOI 10.1038/sj.ejcn.1601162; SCHULTZ O.-E, 1954, ARCH PHARM BER DEUTSCH PHARM GES, V287, P404, DOI 10.1002/ardp.19542870707; Siedle B, 2004, J MED CHEM, V47, P6042, DOI 10.1021/jm049937r; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Staack R, 1998, TOXICOL APPL PHARM, V149, P17, DOI 10.1006/taap.1997.8340; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; STOEWSAND GS, 1995, FOOD CHEM TOXICOL, V33, P537, DOI 10.1016/0278-6915(95)00017-V; Takeuchi O, 2001, INT IMMUNOPHARMACOL, V1, P625, DOI 10.1016/S1567-5769(01)00010-8; Talalay P, 2001, J NUTR, V131, p3027S, DOI 10.1093/jn/131.11.3027S; TALALAY P, 1988, P NATL ACAD SCI USA, V85, P8261, DOI 10.1073/pnas.85.21.8261; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; Vazquez-Prieto MA, 2010, MOL ASPECTS MED, V31, P540, DOI 10.1016/j.mam.2010.09.009; Wadsworth TL, 1999, BIOCHEM PHARMACOL, V57, P941, DOI 10.1016/S0006-2952(99)00002-7; Wang W, 2005, J AGR FOOD CHEM, V53, P1417, DOI 10.1021/jf048153j; Youn HS, 2008, BIOCHEM PHARMACOL, V75, P494, DOI 10.1016/j.bcp.2007.08.033; Youn HS, 2006, BIOCHEM PHARMACOL, V72, P62, DOI 10.1016/j.bcp.2006.03.022; Youn HS, 2010, J IMMUNOL, V184, P411, DOI 10.4049/jimmunol.0803988; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; ZHANG YS, 1994, CANCER RES, V54, pS1976	52	35	35	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.585901	http://dx.doi.org/10.1074/jbc.M114.585901			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25294874	hybrid, Green Published			2022-12-28	WOS:000345335000031
J	Traini, M; Quinn, CM; Sandoval, C; Johansson, E; Schroder, K; Kockx, M; Meikle, PJ; Jessup, W; Kritharides, L				Traini, Mathew; Quinn, Carmel M.; Sandoval, Cecilia; Johansson, Erik; Schroder, Kate; Kockx, Maaike; Meikle, Peter J.; Jessup, Wendy; Kritharides, Leonard			Sphingomyelin Phosphodiesterase Acid-like 3A (SMPDL3A) Is a Novel Nucleotide Phosphodiesterase Regulated by Cholesterol in Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-E; FUNCTIONAL-CHARACTERIZATION; ATHEROSCLEROTIC LESIONS; DISULFIDE BOND; ECTO-APYRASE; SECRETION; GENE; EXPRESSION; RECEPTOR; CD39	Cholesterol-loaded foam cell macrophages are prominent in atherosclerotic lesions and play complex roles in both inflammatory signaling and lipid metabolism, which are underpinned by large scale reprogramming of gene expression. We performed a microarray study of primary human macrophages that showed that transcription of the sphingomyelin phosphodiesterase acid-like 3A (SMPDL3A) gene is up-regulated after cholesterol loading. SMPDL3A protein expression in and secretion from primary macrophages are stimulated by cholesterol loading, liver X receptor ligands, and cyclic AMP, and N-glycosylated SMPDL3A protein is detectable in circulating blood. We demonstrate for the first time that SMPDL3A is a functional phosphodiesterase with an acidic pH optimum. We provide evidence that SMPDL3A is not an acid sphingomyelinase but unexpectedly is active against nucleotide diphosphate and triphosphate substrates at acidic and neutral pH. SMPDL3A is a major source of nucleotide phosphodiesterase activity secreted by liver X receptor-stimulated human macrophages. Extracellular nucleotides such as ATP may activate pro-inflammatory responses in immune cells. Increased expression and secretion of SMPDL3A by cholesterol-loaded macrophage foam cells in lesions may decrease local concentrations of pro-inflammatory nucleotides and potentially represent a novel anti-inflammatory axis linking lipid metabolism with purinergic signaling in atherosclerosis.	[Traini, Mathew; Johansson, Erik; Kockx, Maaike; Jessup, Wendy; Kritharides, Leonard] Univ Sydney, ANZAC Res Inst, Atherosclerosis Lab, Sydney, NSW 2139, Australia; [Quinn, Carmel M.; Sandoval, Cecilia] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia; [Schroder, Kate] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Meikle, Peter J.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Kritharides, Leonard] Concord Repatriat Gen Hosp, Dept Cardiol, Concord, NSW 2139, Australia	University of Sydney; ANZAC Research Institute; University of New South Wales Sydney; University of Queensland; Baker Heart and Diabetes Institute; Concord Repatriation General Hospital	Traini, M (corresponding author), Concord Repatriat Gen Hosp, ANZAC Res Inst, Atherosclerosis Lab, Hosp Rd, Concord, NSW 2139, Australia.	mathew.traini@sydney.edu.au	Research Institute, ANZAC/CAE-9030-2022; Ekanayake, Kanchana/P-8817-2016; Schroder, Kate/C-6132-2008; Meikle, Peter J/B-4023-2009; Kritharides, Leonard/AAQ-2720-2020	Schroder, Kate/0000-0001-9261-3805; Traini, Mathew/0000-0002-9423-5294; Meikle, Peter/0000-0002-2593-4665	National Heart Foundation postdoctoral fellowship; National Health and Medical Research Council of Australia Program; Principal Research fellowship grants	National Heart Foundation postdoctoral fellowship(National Heart Foundation of Australia); National Health and Medical Research Council of Australia Program(National Health and Medical Research Council (NHMRC) of Australia); Principal Research fellowship grants	This work was supported in part by a National Heart Foundation postdoctoral fellowship (to M. T.), National Health and Medical Research Council of Australia Program (to W. J, and L. K.), and Principal Research fellowship grants.	Airola MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105830; Baek AE, 2013, FASEB J, V27, P4419, DOI 10.1096/fj.13-234625; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Beer M, 2011, METHODS MOL BIOL, V755, P417, DOI 10.1007/978-1-61779-163-5_35; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Devlin CM, 2008, ARTERIOSCL THROM VAS, V28, P1723, DOI 10.1161/ATVBAHA.108.173344; Duan RD, 2003, J BIOL CHEM, V278, P38528, DOI 10.1074/jbc.M305437200; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; FERLINZ K, 1994, BIOCHEM J, V301, P855, DOI 10.1042/bj3010855; Ferlinz K, 1997, EUR J BIOCHEM, V243, P511, DOI 10.1111/j.1432-1033.1997.511_1a.x; Ferrari D, 1997, J IMMUNOL, V159, P1451; Fornoni A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002231; Guns PJDF, 2010, BRIT J PHARMACOL, V159, P326, DOI 10.1111/j.1476-5381.2009.00497.x; Hechler B, 2008, CIRCULATION, V118, P754, DOI 10.1161/CIRCULATIONAHA.108.788927; Hide I, 2000, J NEUROCHEM, V75, P965, DOI 10.1046/j.1471-4159.2000.0750965.x; Im SS, 2011, CIRC RES, V108, P996, DOI 10.1161/CIRCRESAHA.110.226878; Jenkins RW, 2010, J BIOL CHEM, V285, P35706, DOI 10.1074/jbc.M110.125609; Jones I, 2008, MOL GENET METAB, V95, P152, DOI 10.1016/j.ymgme.2008.08.004; KANSAS GS, 1991, J IMMUNOL, V146, P2235; Knowles AF, 2011, PURINERG SIGNAL, V7, P21, DOI 10.1007/s11302-010-9214-7; Kockx M, 2007, CIRC RES, V101, P607, DOI 10.1161/CIRCRESAHA.107.157198; Kockx M, 2012, BIOCHEM J, V447, P51, DOI 10.1042/BJ20111891; Kockx M, 2009, J BIOL CHEM, V284, P24144, DOI 10.1074/jbc.M109.032615; Kolzer M, 2004, BIOL CHEM, V385, P1193, DOI 10.1515/BC.2004.154; KOONIN EV, 1994, PROTEIN SCI, V3, P356; KRITHARIDES L, 1995, ARTERIOSCL THROM VAS, V15, P276, DOI 10.1161/01.ATV.15.2.276; Lansmann S, 2003, EUR J BIOCHEM, V270, P1076, DOI 10.1046/j.1432-1033.2003.03435.x; Leal DBR, 2005, BBA-GEN SUBJECTS, V1721, P9, DOI 10.1016/j.bbagen.2004.09.006; Lee CY, 2007, BIOCHEMISTRY-US, V46, P14969, DOI 10.1021/bi700817g; Li D, 2012, ARTERIOSCL THROM VAS, V32, pE81, DOI 10.1161/ATVBAHA.111.239095; Liao H, 2010, J BIOL CHEM, V285, P14791, DOI 10.1074/jbc.M110.116905; Masuishi Y, 2013, J PROTEOME RES, V12, P4617, DOI 10.1021/pr4004807; Meikle PJ, 2011, ARTERIOSCL THROM VAS, V31, P2723, DOI 10.1161/ATVBAHA.111.234096; Moos MPW, 2005, ARTERIOSCL THROM VAS, V25, P2386, DOI 10.1161/01.ATV.0000187470.31662.fe; Mulero JJ, 1999, J BIOL CHEM, V274, P20064, DOI 10.1074/jbc.274.29.20064; Naghavi M, 2002, ATHEROSCLEROSIS, V164, P27, DOI 10.1016/S0021-9150(02)00018-7; Noto PB, 2012, MOL PHARMACOL, V82, P719, DOI 10.1124/mol.112.078865; Oorni K, 2005, ARTERIOSCL THROM VAS, V25, P1678, DOI 10.1161/01.ATV.0000168912.42941.60; Pehkonen P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-50; Perisic L, 2013, ARTERIOSCL THROM VAS, V33, P2432, DOI 10.1161/ATVBAHA.113.301743; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Piscopiello M, 2013, INT J CARDIOL, V168, P2863, DOI 10.1016/j.ijcard.2013.03.084; PONTING CP, 1994, PROTEIN SCI, V3, P359; Puig O, 2011, CIRC-CARDIOVASC GENE, V4, P595, DOI 10.1161/CIRCGENETICS.111.960773; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; Schissel SL, 1998, J BIOL CHEM, V273, P2738, DOI 10.1074/jbc.273.5.2738; Schissel SL, 1996, J BIOL CHEM, V271, P18431, DOI 10.1074/jbc.271.31.18431; Schmidt M, 2013, PHARMACOL REV, V65, P670, DOI 10.1124/pr.110.003707; Seto M, 2004, PROTEIN SCI, V13, P3172, DOI 10.1110/ps.04966204; Shashkin P, 2005, CURR PHARM DESIGN, V11, P3061, DOI 10.2174/1381612054865064; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Vaccaro AM, 1999, NEUROCHEM RES, V24, P307, DOI 10.1023/A:1022530508763; Wright KO, 2002, J UROLOGY, V168, P2645, DOI 10.1016/S0022-5347(05)64236-X; Yegutkin GG, 2012, FASEB J, V26, P3875, DOI 10.1096/fj.12-205658; Zeidan YH, 2010, CURR MOL MED, V10, P454, DOI 10.2174/156652410791608225; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	61	27	30	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.612341	http://dx.doi.org/10.1074/jbc.M114.612341			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25288789	hybrid, Green Published			2022-12-28	WOS:000345335000042
J	Tsukamoto, S; Huang, YH; Umeda, D; Yamada, S; Yamashita, S; Kumazoe, M; Kim, Y; Murata, M; Yamada, K; Tachibana, H				Tsukamoto, Shuntaro; Huang, Yuhui; Umeda, Daisuke; Yamada, Shuhei; Yamashita, Shuya; Kumazoe, Motofumi; Kim, Yoonhee; Murata, Motoki; Yamada, Koji; Tachibana, Hirofumi			67-kDa Laminin Receptor-dependent Protein Phosphatase 2A (PP2A) Activation Elicits Melanoma-specific Antitumor Activity Overcoming Drug Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEA POLYPHENOL EGCG; SIGNALING PATHWAYS; TUMOR-SUPPRESSOR; KINASE-C; INHIBITION; CANCER; BRAF; EPIGALLOCATECHIN-3-GALLATE; PROGRESSION; EXPRESSION	The Ras/Raf/MEK/ERK pathway has been identified as a major, druggable regulator of melanoma. Mutational activation of BRAF is the most prevalent genetic alteration in human melanoma, resulting in constitutive melanoma hyperproliferation. A selective BRAF inhibitor showed remarkable clinical activity in patients with mutated BRAF. Unfortunately, most patients acquire resistance to the BRAF inhibitor, highlighting the urgent need for new melanoma treatment strategies. Green tea polyphenol (-)-epigallocatechin-3-O-gallate (EGCG) inhibits cell proliferation independently of BRAF inhibitor sensitivity, suggesting that increased understanding of the anti-melanoma activity of EGCG may provide a novel therapeutic target. Here, by performing functional genetic screening, we identified protein phosphatase 2A (PP2A) as a critical factor in the suppression of melanoma cell proliferation. We demonstrated that tumor-overexpressed 67-kDa laminin receptor (67LR) activates PP2A through adenylate cyclase/cAMP pathway eliciting inhibitions of oncoproteins and activation of tumor suppressor Merlin. Activating 67LR/PP2A pathway leading to melanoma-specific mTOR inhibition shows strong synergy with the BRAF inhibitor PLX4720 in the drug-resistant melanoma. Moreover, SET, a potent inhibitor of PP2A, is overexpressed on malignant melanoma. Silencing of SET enhances 67LR/PP2A signaling. Collectively, activation of 67LR/PP2A signaling may thus be a novel rational strategy for melanoma-specific treatment.	[Tsukamoto, Shuntaro; Huang, Yuhui; Umeda, Daisuke; Yamada, Shuhei; Yamashita, Shuya; Kumazoe, Motofumi; Kim, Yoonhee; Murata, Motoki; Yamada, Koji; Tachibana, Hirofumi] Kyushu Univ, Dept Biosci & Biotechnol, Div Appl Biol Chem, Fac Agr, Fukuoka 8128581, Japan; [Tachibana, Hirofumi] Kyushu Univ, Food Funct Design Res Ctr, Fukuoka 8128581, Japan	Kyushu University; Kyushu University	Tachibana, H (corresponding author), Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Fukuoka 8128581, Japan.	tatibana@agr.kyushu-u.ac.jp		Umeda, Daisuke/0000-0001-6301-9938; Kumazoe, Motofumi/0000-0002-3002-2994	Japan Society for the Promotion of Science [22228002]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-aid for Scientific Research (S) Grant 22228002 (to H. T.) and Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science DC2 (to S. T.) and DC1 (to Y. H.).	AlSaleh W, 1997, J PATHOL, V181, P287, DOI 10.1002/(SICI)1096-9896(199703)181:3<287::AID-PATH762>3.0.CO;2-W; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; CHOCHUNG YS, 1990, CANCER RES, V50, P7093; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deng W, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2011.00950.x; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; HOLZMAYER TA, 1992, NUCLEIC ACIDS RES, V20, P711, DOI 10.1093/nar/20.4.711; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Kiss A, 2013, FEBS J, V280, P612, DOI 10.1111/j.1742-4658.2012.08498.x; Kitano K, 1997, BIOPHYS CHEM, V65, P157, DOI 10.1016/S0301-4622(96)02254-5; Kumazoe M, 2013, J CLIN INVEST, V123, P787, DOI 10.1172/JCI64768; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Marquette A, 2011, NAT STRUCT MOL BIOL, V18, P584, DOI 10.1038/nsmb.2022; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Merkel S, 2006, TRANSPL P, V38, P714, DOI 10.1016/j.transproceed.2006.01.044; Murray LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043295; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Nihal M, 2005, INT J CANCER, V114, P513, DOI 10.1002/ijc.20785; Patel V, 2008, CLIN CANCER RES, V14, P1002, DOI 10.1158/1078-0432.CCR-07-1497; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Qin JC, 2008, CANCER RES, V68, P4150, DOI 10.1158/0008-5472.CAN-08-0839; Salama AKS, 2013, CLIN CANCER RES, V19, P4326, DOI 10.1158/1078-0432.CCR-13-0779; Sanjuan X, 1996, J PATHOL, V179, P376, DOI 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V; Scheiman J, 2010, MOL THER, V18, P63, DOI 10.1038/mt.2009.199; Singh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025224; Stamenkovic I, 2010, CURR PROTEIN PEPT SC, V11, P471, DOI 10.2174/138920310791824011; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Takizawa N, 2002, FEBS LETT, V515, P127, DOI 10.1016/S0014-5793(02)02451-1; Tay KH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.79; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Tsukamoto S, 2012, BIOCHEM J, V443, P525, DOI 10.1042/BJ20111837; Umeda D, 2008, J BIOL CHEM, V283, P3050, DOI 10.1074/jbc.M707892200; Viacava P, 1997, J PATHOL, V182, P36, DOI 10.1002/(SICI)1096-9896(199705)182:1<36::AID-PATH802>3.0.CO;2-W; Watanabe Y, 2012, EXP THER MED, V4, P205, DOI 10.3892/etm.2012.587; Zhang Qingxiu, 2012, Enzyme Res, V2012, P659649, DOI 10.1155/2012/659649	40	51	51	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.604983	http://dx.doi.org/10.1074/jbc.M114.604983			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25294877	Green Published, hybrid			2022-12-28	WOS:000345335000024
J	Hothersall, JD; Alexander, A; Samson, AJ; Moffat, C; Bollan, KA; Connolly, CN				Hothersall, J. Daniel; Alexander, Amy; Samson, Andrew J.; Moffat, Christopher; Bollan, Karen A.; Connolly, Christopher N.			5-Hydroxytryptamine (5-HT) Cellular Sequestration during Chronic Exposure Delays 5-HT3 Receptor Resensitization due to Its Subsequent Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Intestine; Ion Channel; Membrane Trafficking; Pharmacology; Receptor Desensitization; Receptor Internalization; Selective Serotonin Reuptake Inhibitor (SSRI); Serotonin; Serotonin Transporter; 5-HT3	IRRITABLE-BOWEL-SYNDROME; SEROTONIN TRANSPORTER; SURFACE EXPRESSION; RAT ILEUM; INTERNALIZATION; ANTAGONISTS; CELLS; DESENSITIZATION; ACTIVATION; INHIBITION	Background: Altered levels of 5-HT are thought to contribute to cognitive and gastrointestinal dysfunction. Results: Intracellular accumulation of 5-HT leads to a prolonged loss of 5-HT3 receptor function. Conclusion: 5-HT3 receptor desensitization is maintained by a chronic release of 5-HT. Significance: Prolonged 5-HT3 receptor dysfunction may result from the clinical use of selective serotonin reuptake inhibitors or pathologically raised 5-HT levels. The serotonergic synapse is dynamically regulated by serotonin (5-hydroxytryptamine (5-HT)) with elevated levels leading to the down-regulation of the serotonin transporter and a variety of 5-HT receptors, including the 5-HT type-3 (5-HT3) receptors. We report that recombinantly expressed 5-HT3 receptor binding sites are reduced by chronic exposure to 5-HT (IC50 of 154.0 +/- 45.7 m, t(1/2) = 28.6 min). This is confirmed for 5-HT3 receptor-induced contractions in the guinea pig ileum, which are down-regulated after chronic, but not acute, exposure to 5-HT. The loss of receptor function does not involve endocytosis, and surface receptor levels are unaltered. The rate and extent of down-regulation is potentiated by serotonin transporter function (IC50 of 2.3 +/- 1.0 m, t(1/2) = 3.4 min). Interestingly, the level of 5-HT uptake correlates with the extent of down-regulation. Using TX-114 extraction, we find that accumulated 5-HT remains soluble and not membrane-bound. This cytoplasmically sequestered 5-HT is readily releasable from both COS-7 cells and the guinea pig ileum. Moreover, the 5-HT level released is sufficient to prevent recovery from receptor desensitization in the guinea pig ileum. Together, these findings suggest the existence of a novel mechanism of down-regulation where the chronic release of sequestered 5-HT prolongs receptor desensitization.	[Hothersall, J. Daniel; Alexander, Amy; Samson, Andrew J.; Moffat, Christopher; Bollan, Karen A.; Connolly, Christopher N.] Univ Dundee, Med Res Inst, Dundee DD1 9SY, Scotland	University of Dundee	Connolly, CN (corresponding author), Univ Dundee, Med Res Inst, Div Neurosci, Dundee DD1 9SY, Scotland.	c.n.connolly@dundee.ac.uk		Connolly, Christopher/0000-0002-0445-8874; Samson, Andrew James/0000-0002-4842-5126	Wellcome Trust [085141]; Anonymous Trust; Biotechnology and Biological Sciences Research Council [C18896] Funding Source: researchfish; Medical Research Council [1314783] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Anonymous Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by The Wellcome Trust (to C. N. C.; Ref. 085141) and the Anonymous Trust.	Aapro Matti S, 2007, Ther Clin Risk Manag, V3, P1009; Ahern GP, 2011, CURR OPIN PHARMACOL, V11, P29, DOI 10.1016/j.coph.2011.02.004; Bearcroft CP, 1998, GUT, V42, P42, DOI 10.1136/gut.42.1.42; Bertrand PP, 2008, AM J PHYSIOL-GASTR L, V295, pG1228, DOI 10.1152/ajpgi.90375.2008; Bertrand RL, 2011, ENDOCRINOLOGY, V152, P36, DOI 10.1210/en.2010-0377; Bhattacharyya S, 2002, P NATL ACAD SCI USA, V99, P14470, DOI 10.1073/pnas.212517999; Boyd GW, 2002, MOL CELL NEUROSCI, V21, P38, DOI 10.1006/mcne.2002.1160; Chanrion B, 2007, P NATL ACAD SCI USA, V104, P8119, DOI 10.1073/pnas.0610964104; Chen JJ, 2001, J NEUROSCI, V21, P6348, DOI 10.1523/JNEUROSCI.21-16-06348.2001; Chen JX, 1998, AM J PHYSIOL-GASTR L, V275, pG433, DOI 10.1152/ajpgi.1998.275.3.G433; Connolly CN, 2004, BIOCHEM SOC T, V32, P529, DOI 10.1042/BST0320529; CRAIG DA, 1990, N-S ARCH PHARMACOL, V342, P9; Faerber L, 2007, EUR J PHARMACOL, V560, P1, DOI 10.1016/j.ejphar.2007.01.028; Freeman SL, 2006, GASTROENTEROLOGY, V131, P97, DOI 10.1053/j.gastro.2006.04.013; Galligan JJ, 2002, NEUROGASTROENT MOTIL, V14, P611, DOI 10.1046/j.1365-2982.2002.00363.x; Guthrie CR, 2005, J PHARMACOL EXP THER, V313, P1003, DOI 10.1124/jpet.104.081919; Hagbom M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002115; HANLEY HG, 1977, ARCH GEN PSYCHIAT, V34, P521; Hansen MB, 2008, ACTA PHYSIOL, V193, P311, DOI 10.1111/j.1748-1716.2008.01870.x; Hothersall JD, 2013, BRIT J PHARMACOL, V169, P1252, DOI 10.1111/bph.12204; Huang J, 2004, BRAIN RES, V1028, P156, DOI 10.1016/j.brainres.2004.09.009; Ilegems E, 2004, J BIOL CHEM, V279, P53346, DOI 10.1074/jbc.M407467200; Jimenez-Trejo F, 2012, REPRODUCTION, V144, P677, DOI 10.1530/REP-12-0145; Kittler K, 2010, EUR J PHARMACOL, V629, P63, DOI 10.1016/j.ejphar.2009.12.010; Kondaurova EM, 2012, NEUROSCI LETT, V522, P52, DOI 10.1016/j.neulet.2012.06.015; Lau T, 2009, NEUROCHEM INT, V54, P271, DOI 10.1016/j.neuint.2008.12.004; Lee SL, 1999, AM J PHYSIOL-LUNG C, V277, pL282, DOI 10.1152/ajplung.1999.277.2.L282; Linder AE, 2008, J PHARMACOL EXP THER, V325, P714, DOI 10.1124/jpet.107.135699; Liu HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024928; Liu YL, 2011, AM J RESP CELL MOL, V44, P548, DOI 10.1165/rcmb.2010-0078OC; Lummis SCR, 2013, NEUROPHARMACOLOGY, V73, P241, DOI 10.1016/j.neuropharm.2013.05.010; McKinnon NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035563; Mercado CP, 2011, CURR OPIN PHARMACOL, V11, P23, DOI 10.1016/j.coph.2011.01.006; Minami M, 2003, PHARMACOL THERAPEUT, V99, P149, DOI 10.1016/S0163-7258(03)00057-3; Mnie-Filali O, 2010, CELL SIGNAL, V22, P501, DOI 10.1016/j.cellsig.2009.11.004; Muchatuta Neil A, 2009, Ther Clin Risk Manag, V5, P21; Niesler B, 2011, CURR OPIN PHARMACOL, V11, P81, DOI 10.1016/j.coph.2011.01.011; Riad M, 2004, J NEUROSCI, V24, P5420, DOI 10.1523/JNEUROSCI.0950-04.2004; Rojas C, 2010, EUR J PHARMACOL, V626, P193, DOI 10.1016/j.ejphar.2009.10.002; Schlag BD, 2004, J PHARMACOL EXP THER, V310, P865, DOI 10.1124/jpet.104.067306; Spiller R, 2008, CURR OPIN PHARMACOL, V8, P709, DOI 10.1016/j.coph.2008.07.003; Stratz C, 2008, THROMB HAEMOSTASIS, V99, P784, DOI 10.1160/TH07-10-0630; Tao-Cheng JH, 1999, NEUROSCIENCE, V94, P821, DOI 10.1016/S0306-4522(99)00373-5; Turvill JL, 2000, BRIT J PHARMACOL, V130, P1031, DOI 10.1038/sj.bjp.0703414; Vikenes K, 1999, CIRCULATION, V100, P483, DOI 10.1161/01.CIR.100.5.483; Wade PR, 1996, J NEUROSCI, V16, P2352; Wesseldijk F, 2008, ANESTH ANALG, V106, P1862, DOI 10.1213/ane.0b013e318172c2f4; Whalen EJ, 2000, BRAIN RES, V873, P302, DOI 10.1016/S0006-8993(00)02526-9; Yasuda M, 2013, BRIT J PHARMACOL, V168, P1388, DOI 10.1111/bph.12019	49	5	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32020	32029		10.1074/jbc.M114.594796	http://dx.doi.org/10.1074/jbc.M114.594796			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25281748	Green Published, hybrid			2022-12-28	WOS:000345314700031
J	Basu, S; Sladecek, S; Pemble, H; Wittmann, T; Slotman, JA; van Cappellen, W; Brenner, HR; Galjart, N				Basu, Sreya; Sladecek, Stefan; Pemble, Hayley; Wittmann, Torsten; Slotman, Johan A.; van Cappellen, Wiggert; Brenner, Hans-Rudolf; Galjart, Niels			Acetylcholine Receptor (AChR) Clustering Is Regulated Both by Glycogen Synthase Kinase 3 beta (GSK3 beta)-dependent Phosphorylation and the Level of CLIP-associated Protein 2 (CLASP2) Mediating the Capture of Microtubule Plus-ends	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROMUSCULAR-JUNCTION; INNERVATED MUSCLE; CELL CORTEX; AGRIN; EB1; DYNAMICS; ACTIN; EXPRESSION; GSK3-BETA; APPARATUS	The postsynaptic apparatus of the neuromuscular junction (NMJ) traps and anchors acetylcholine receptors (AChRs) at high density at the synapse. We have previously shown that microtubule (MT) capture by CLASP2, a MT plus-end-tracking protein (+TIP), increases the size and receptor density of AChR clusters at the NMJ through the delivery of AChRs and that this is regulated by a pathway involving neuronal agrin and several postsynaptic kinases, including GSK3. Phosphorylation by GSK3 has been shown to cause CLASP2 dissociation from MT ends, and nine potential phosphorylation sites for GSK3 have been mapped on CLASP2. How CLASP2 phosphorylation regulates MT capture at the NMJ and how this controls the size of AChR clusters are not yet understood. To examine this, we used myotubes cultured on agrin patches that induce AChR clustering in a two-dimensional manner. We show that expression of a CLASP2 mutant, in which the nine GSK3 target serines are mutated to alanine (CLASP2-9XS/9XA) and are resistant to GSK3 beta-dependent phosphorylation, promotes MT capture at clusters and increases AChR cluster size, compared with myotubes that express similar levels of wild type CLASP2 or that are noninfected. Conversely, myotubes expressing a phosphomimetic form of CLASP2 (CLASP2-8XS/D) show enrichment of immobile mutant CLASP2 in clusters, but MT capture and AChR cluster size are reduced. Taken together, our data suggest that both GSK3 beta-dependent phosphorylation and the level of CLASP2 play a role in the maintenance of AChR cluster size through the regulated capture and release of MT plus-ends.	[Basu, Sreya; Sladecek, Stefan; Brenner, Hans-Rudolf] Univ Basel, Inst Physiol, Dept Biomed, CH-4056 Basel, Switzerland; [Basu, Sreya; Galjart, Niels] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands; [Pemble, Hayley; Wittmann, Torsten] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Slotman, Johan A.; van Cappellen, Wiggert] Erasmus MC, Opt Imaging Ctr, NL-3015 GE Rotterdam, Netherlands	University of Basel; Erasmus University Rotterdam; Erasmus MC; University of California System; University of California San Francisco; Erasmus University Rotterdam; Erasmus MC	Brenner, HR (corresponding author), Inst Physiol, Dept Biomed, Klingelbergstr 50, CH-4056 Basel, Switzerland.	Hans-Rudolf.Brenner@unibas.ch; n.galjart@erasmusmc.nl	Galjart, Niels/D-1146-2010; Wittmann, Torsten/F-9833-2013	Galjart, Niels/0000-0003-1964-3607; Wittmann, Torsten/0000-0001-9134-691X; Slotman, Johan A./0000-0001-9705-9620	Swiss National Science Foundation; Swiss Foundation for Research on Muscle Diseases; Netherlands Organization for Scientific Research CW [70059011]; ZonMW Grant [91208002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079139] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Foundation for Research on Muscle Diseases; Netherlands Organization for Scientific Research CW; ZonMW Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Swiss National Science Foundation, The Swiss Foundation for Research on Muscle Diseases, the Netherlands Organization for Scientific Research CW Grant 70059011, and ZonMW Grant 91208002 (to N. G.).	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Al-Bassam J, 2011, TRENDS CELL BIOL, V21, P604, DOI 10.1016/j.tcb.2011.06.007; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; Chen YW, 2014, J NEUROSCI, V34, P2413, DOI 10.1523/JNEUROSCI.3226-13.2014; Cohen I, 1997, MOL CELL NEUROSCI, V9, P237, DOI 10.1006/mcne.1997.0623; Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321; Drabek K, 2006, CURR BIOL, V16, P2259, DOI 10.1016/j.cub.2006.09.065; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Geng L, 2008, CHEM-BIOL INTERACT, V175, P108, DOI 10.1016/j.cbi.2008.04.017; HALL ZW, 1981, J CELL BIOL, V90, P789, DOI 10.1083/jcb.90.3.789; Jones G, 1997, P NATL ACAD SCI USA, V94, P2654, DOI 10.1073/pnas.94.6.2654; Jones G, 1996, P NATL ACAD SCI USA, V93, P5985, DOI 10.1073/pnas.93.12.5985; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kishi M, 2005, J CELL BIOL, V169, P355, DOI 10.1083/jcb.200411012; Kumar P, 2012, J BIOL CHEM, V287, P17050, DOI 10.1074/jbc.M111.316661; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Lin S, 2008, J NEUROSCI, V28, P3333, DOI 10.1523/JNEUROSCI.5590-07.2008; Maurer SP, 2014, CURR BIOL, V24, P372, DOI 10.1016/j.cub.2013.12.042; McMahan Uel J., 1992, Current Opinion in Cell Biology, V4, P869, DOI 10.1016/0955-0674(92)90113-Q; Meier T, 1997, J NEUROSCI, V17, P6534; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Patel K, 2012, CYTOSKELETON, V69, P155, DOI 10.1002/cm.21005; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt N, 2012, J CELL BIOL, V198, P421, DOI 10.1083/jcb.201111130; Schmidt N, 2011, J CELL BIOL, V195, P1171, DOI 10.1083/jcb.201107083; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Sugiyama JE, 1997, J CELL BIOL, V139, P181, DOI 10.1083/jcb.139.1.181; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; Wittmann T, 2005, J CELL BIOL, V169, P929, DOI 10.1083/jcb.200412114; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006	33	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30857	30867		10.1074/jbc.M114.589457	http://dx.doi.org/10.1074/jbc.M114.589457			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231989	hybrid, Green Published			2022-12-28	WOS:000344549700059
J	Fristedt, R; Williams-Carrier, R; Merchant, SS; Barkan, A				Fristedt, Rikard; Williams-Carrier, Rosalind; Merchant, Sabeeha S.; Barkan, Alice			A Thylakoid Membrane Protein Harboring a DnaJ-type Zinc Finger Domain Is Required for Photosystem I Accumulation in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA CHLOROPLASTS; ALGA CHLAMYDOMONAS-REINHARDTII; CYTOCHROME B(6)F COMPLEX; BIOGENESIS FACTOR CYO1; PSI-G SUBUNIT; DISULFIDE-ISOMERASE; MOLECULAR CHAPERONE; MAIZE; BINDING; GENE	Photosystem I ( PSI) is a large pigment-protein complex and one of the two photosystems that drive electron transfer in oxygenic photosynthesis. We identified a nuclear gene required specifically for the accumulation of PSI in a forward genetic analysis of chloroplast biogenesis in maize. This gene, designated psa2, belongs to the "GreenCut" gene set, a group of genes found in green algae and plants but not in non-photosynthetic organisms. Disruption of the psa2 ortholog in Arabidopsis likewise resulted in the specific loss of PSI proteins. PSA2 harbors a conserved domain found in DnaJ chaperones where it has been shown to form a zinc finger and to have protein-disulfide isomerase activity. Accordingly, PSA2 exhibited protein-disulfide reductase activity in vitro. PSA2 localized to the thylakoid lumen and was found in a similar to 250-kDa complex harboring the peripheral PSI protein PsaG but lacking several core PSI subunits. PSA2 mRNA is coexpressed with mRNAs encoding various proteins involved in the biogenesis of the photosynthetic apparatus with peak expression preceding that of genes encoding structural components. PSA2 protein abundance was not decreased in the absence of PSI but was reduced in the absence of the PSI assembly factor Ycf3. These findings suggest that a complex harboring PSA2 and PsaG mediates thiol transactions in the thylakoid lumen that are important for the assembly of PSI.	[Fristedt, Rikard; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Fristedt, Rikard; Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Barkan, Alice] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Oregon	Barkan, A (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	abarkan@uoregon.edu			United States Department of Energy [DE-FC02-02ER63421]; National Science Foundation [IOS-0922560]; WennerGren Foundation; Direct For Biological Sciences [0922560] Funding Source: National Science Foundation	United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); WennerGren Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by United States Department of Energy Cooperative Agreement DE-FC02-02ER63421 (to David Eisenberg at UCLA), National Science Foundation Grant IOS-0922560 (to A. B.), and a postdoctoral fellowship from the WennerGren Foundation (to R. F.).	Albus CA, 2010, PLANT CELL, V22, P2838, DOI 10.1105/tpc.110.073908; Amann K, 2004, PLANT CELL, V16, P3084, DOI 10.1105/tpc.104.024935; Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Banecki B, 1996, J BIOL CHEM, V271, P14840, DOI 10.1074/jbc.271.25.14840; BARKAN A, 1994, EMBO J, V13, P3170, DOI 10.1002/j.1460-2075.1994.tb06616.x; Boudreau E, 1997, EMBO J, V16, P6095, DOI 10.1093/emboj/16.20.6095; Brutnell TP, 1999, PLANT CELL, V11, P849, DOI 10.1105/tpc.11.5.849; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Cai WH, 2010, PLANT PHYSIOL, V154, P109, DOI 10.1104/pp.110.159558; Celedon JM, 2013, BBA-MOL CELL RES, V1833, P341, DOI 10.1016/j.bbamcr.2012.06.028; Chi W, 2012, PHILOS T R SOC B, V367, P3420, DOI 10.1098/rstb.2012.0065; Dall'Osto L, 2013, PLANT CELL, V25, P591, DOI 10.1105/tpc.112.108621; DECROUYCHANEL A, 1995, J BIOL CHEM, V270, P22669, DOI 10.1074/jbc.270.39.22669; Feiz L., 2014, PLANT J IN PRESS; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Fristedt R, 2014, PLANT PHYSIOL, V164, P201, DOI 10.1104/pp.113.228338; Fristedt R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024565; Fristedt R, 2009, PLANT CELL, V21, P3950, DOI 10.1105/tpc.109.069435; Fromme P, 2003, FEBS LETT, V555, P40, DOI 10.1016/S0014-5793(03)01124-4; Grossman AR, 2010, PHOTOSYNTH RES, V106, P3, DOI 10.1007/s11120-010-9555-7; Jarvi S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00434; Jarvi S, 2011, BIOCHEM J, V439, P207, DOI 10.1042/BJ20102155; Jensen PE, 2002, J BIOL CHEM, V277, P2798, DOI 10.1074/jbc.M110448200; Joliot P, 2005, P NATL ACAD SCI USA, V102, P4913, DOI 10.1073/pnas.0501268102; Kargul J, 2003, J BIOL CHEM, V278, P16135, DOI 10.1074/jbc.M300262200; Karpowicz SJ, 2011, J BIOL CHEM, V286, P21427, DOI 10.1074/jbc.M111.233734; Krech K, 2012, PLANT PHYSIOL, V159, P579, DOI 10.1104/pp.112.196642; Lezhneva L, 2004, PLANT J, V37, P174, DOI 10.1046/j.1365-313X.2003.01952.x; Lezhneva L, 2008, J BIOL CHEM, V283, P24608, DOI 10.1074/jbc.M803869200; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Liu J, 2012, PLANT CELL, V24, P4992, DOI 10.1105/tpc.112.106542; Lu Y, 2011, PLANT CELL, V23, P1861, DOI 10.1105/tpc.111.085456; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; Maple J, 2004, CURR BIOL, V14, P776, DOI 10.1016/j.cub.2004.04.031; Meurer J, 1998, EMBO J, V17, P5286, DOI 10.1093/emboj/17.18.5286; Muranaka A, 2012, J PLANT PHYSIOL, V169, P1212, DOI 10.1016/j.jplph.2012.04.001; Naver H, 2001, PLANT CELL, V13, P2731, DOI 10.1105/tpc.010253; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Ozawa S, 2010, J BIOL CHEM, V285, P20072, DOI 10.1074/jbc.M109.098954; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7; Roose JL, 2014, J BIOL CHEM, V289, P23776, DOI 10.1074/jbc.M114.589085; Rosgaard L, 2005, FEBS J, V272, P4002, DOI 10.1111/j.1742-4658.2005.04824.x; Ruf S, 1997, J CELL BIOL, V139, P95, DOI 10.1083/jcb.139.1.95; Schottler MA, 2011, J PLANT PHYSIOL, V168, P1452, DOI 10.1016/j.jplph.2010.12.009; Schwenkert S, 2010, BIOCHEM J, V425, P207, DOI 10.1042/BJ20091290; SELMANREIMER S, 1981, BIOCHEMISTRY-US, V20, P5476, DOI 10.1021/bi00522a020; Shimada H, 2007, PLANT CELL, V19, P3157, DOI 10.1105/tpc.107.051714; Stern DB, 2004, TRENDS PLANT SCI, V9, P293, DOI 10.1016/j.tplants.2004.04.001; Stockel J, 2006, PLANT PHYSIOL, V141, P870, DOI 10.1104/pp.106.078147; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; Tanz SK, 2012, PLANT J, V69, P743, DOI 10.1111/j.1365-313X.2011.04833.x; Tomizioli M, 2014, MOL CELL PROTEOMICS, V13, P2147, DOI 10.1074/mcp.M114.040923; Varotto C, 2002, PLANT PHYSIOL, V129, P616, DOI 10.1104/pp.002089; Voelker R, 1995, MOL GEN GENET, V249, P507, DOI 10.1007/BF00290576; VOELKER R, 1995, EMBO J, V14, P3905, DOI 10.1002/j.1460-2075.1995.tb00062.x; Watkins KP, 2011, PLANT CELL, V23, P1082, DOI 10.1105/tpc.111.084335; Williams-Carrier R, 2010, PLANT J, V63, P167, DOI 10.1111/j.1365-313X.2010.04231.x; Yabe T, 2004, PLANT CELL, V16, P993, DOI 10.1105/tpc.020511; Zoschke R, 2013, PLANT CELL, V25, P2265, DOI 10.1105/tpc.113.111567; Zygadlo A, 2006, J BIOL CHEM, V281, P10548, DOI 10.1074/jbc.M512687200; Zygadlo A, 2005, BBA-BIOENERGETICS, V1708, P154, DOI 10.1016/j.bbabio.2005.02.003	65	41	44	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30657	30667		10.1074/jbc.M114.587758	http://dx.doi.org/10.1074/jbc.M114.587758			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25228689	hybrid, Green Published			2022-12-28	WOS:000344549700042
J	Dayan, O; Ben-Yona, A; Kanner, BI				Dayan, Oshrat; Ben-Yona, Assaf; Kanner, Baruch I.			The Aromatic and Charge Pairs of the Thin Extracellular Gate of the gamma-Aminobutyric Acid Transporter GAT-1 Are Differently Impacted by Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN; NEUROTRANSMITTER TRANSPORTERS; XENOPUS OOCYTES; SUBTYPE-A; SODIUM; IDENTIFICATION; SITE; EXPRESSION; GLUTAMATE; HOMOLOG	GAT-1 is a sodium-and chloride-coupled GABA transporter and a member of the neurotransmitter: sodium: symporters, which are crucial for synaptic transmission. The structure of bacterial homologue LeuT shows a thin extracellular gate consisting of a charge and an aromatic pair. Here we addressed the question of whether mutation of the aromatic and charge pair residues of GAT-1 has similar consequences. In contrast to charge pair mutants, significant radioactive GABA transport was retained by mutants of the aromatic pair residue Phe-294. Moreover, the magnitude of maximal transport currents induced by GABA by these mutants was comparable with those by wild type GAT-1. However, the apparent affinity of the non-conserved mutants for GABA was reduced up to 20-fold relative to wild type. The voltage dependence of the sodium-dependent transient currents of the Phe-294 mutants was similar to that of the wild type. On the other hand, the conserved charge pair mutant D451E exhibited a right-shifted voltage dependence, indicating an increased apparent affinity for sodium. In further contrast to D451E, whereas the extracellular aqueous accessibility of an endogenous cysteine residue to a membrane-impermeant sulfhydryl reagent was increased relative to wild type, this was not the case for the aromatic pair mutants. Our data indicate that, in contrast to the charge pair, the aromatic pair is not essential for gating. Instead they are compatible with the idea that they serve to diminish dissociation of the substrate from the binding pocket.	[Dayan, Oshrat; Ben-Yona, Assaf; Kanner, Baruch I.] Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Hadassah Med Sch, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Hadassah Med Sch, POB 12272, IL-91120 Jerusalem, Israel.	baruch.kanner@mail.huji.ac.il			Israel Science Foundation [804/11]; Rosetrees Trust	Israel Science Foundation(Israel Science Foundation); Rosetrees Trust(Rosetrees Trust)	This work was supported by Grant 804/11 from the Israel Science Foundation and by a grant from the Rosetrees Trust.	Ben-Yona A, 2012, J BIOL CHEM, V287, P7159, DOI 10.1074/jbc.M111.323634; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Bennett ER, 1997, J BIOL CHEM, V272, P1203, DOI 10.1074/jbc.272.2.1203; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Golovanevsky V, 1999, J BIOL CHEM, V274, P23020, DOI 10.1074/jbc.274.33.23020; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; KANNER BI, 1994, J EXP BIOL, V196, P237; KAVANAUGH MP, 1992, J BIOL CHEM, V267, P22007; KEYNAN S, 1988, BIOCHEMISTRY-US, V27, P12, DOI 10.1021/bi00401a003; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lu CC, 1999, J GEN PHYSIOL, V114, P429, DOI 10.1085/jgp.114.3.429; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Nelson N, 1998, J NEUROCHEM, V71, P1785; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Wang H, 2012, EMBO REP, V13, P861, DOI 10.1038/embor.2012.110; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	29	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28172	28178		10.1074/jbc.M114.589721	http://dx.doi.org/10.1074/jbc.M114.589721			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25143384	Green Published, hybrid			2022-12-28	WOS:000343765400014
J	Tang, W; Strachan, RT; Lefkowitz, RJ; Rockman, HA				Tang, Wei; Strachan, Ryan T.; Lefkowitz, Robert J.; Rockman, Howard A.			Allosteric Modulation of beta-Arrestin-biased Angiotensin II Type 1 Receptor Signaling by Membrane Stretch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; TERNARY COMPLEX MODEL; 7-TRANSMEMBRANE RECEPTORS; MECHANICAL-STRESS; ADRENERGIC-RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; CONFORMATIONAL-CHANGES; CARDIAC-HYPERTROPHY; CRYSTAL-STRUCTURE; SHEAR-STRESS	It has recently been appreciated that the angiotensin II type 1 receptor (AT1R), a prototypic member of the G protein-coupled receptor superfamily, also functions as a mechanosensor. Specifically, mechanical stretch activates the AT1R to promote downstream signaling mediated exclusively by the multifunctional scaffold protein, beta-arrestin, in a manner consistent with previously identified beta-arrestin-biased ligands. However, the ligand-independent mechanism by which mechanical stretch promotes beta-arrestin-biased signaling remains unknown. Implicit in the concept of biased agonism (i.e. the ability of an agonist to activate a subset of receptor-mediated signaling pathways) is the notion that distinct active conformations of the receptor mediate differential activation of signaling pathways. Here we determined whether mechanical stretch stabilizes distinct beta-arrestin-activating conformations of the AT1R by using beta-arrestin2-biased agonists as conformational probes in pharmacological and biophysical assays. When tested at cells expressing the AT1R fused to beta-arrestin (AT1R-beta-arrestin2), we found that osmotic stretch increased the binding affinity and potency of the beta-arrestin-biased agonist TRV120023, with no effect on the balanced agonist AngII. In addition, the effect of osmotic stretch on ERK activation was markedly augmented in cells expressing the AT1R-beta-arrestin2 fusion compared with the wild type AT1R and completely blocked in cells expressing the AT1R-G(q) fusion. Biophysical experiments with an intramolecular BRET beta-arrestin2 biosensor revealed that osmotic stretch and TRV120023 activate AT1Rs to stabilize beta-arrestin2 active conformations that differ from those stabilized by the AT1R activated by angiotensin II. Together, these data support a novel ligand-independent mechanism whereby mechanical stretch allosterically stabilizes specific beta-arrestin-biased active conformations of the AT1R and has important implications for understanding pathophysiological AT1R signaling.	[Tang, Wei; Strachan, Ryan T.; Lefkowitz, Robert J.; Rockman, Howard A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Rockman, Howard A.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Rockman, Howard A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Strachan, Ryan T.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Rockman, HA (corresponding author), Duke Univ, DUMC 3104,Rm 226 CARL Bldg, Durham, NC 27710 USA.	h.rockman@duke.edu	Lefkowitz, Robert/AAW-2649-2021		National Institutes of Health [HL56687, HL75443, HL16037, HL70631, T32 HL007101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075443, R01HL070631, R01HL016037, R37HL016037, T32HL007101, R01HL056687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL56687 and HL75443 (to H. A. R.), HL16037 and HL70631 (to R. J. L.), and T32 HL007101 to (W. T.).	Barauna VG, 2013, BIOCHEM BIOPH RES CO, V434, P647, DOI 10.1016/j.bbrc.2013.04.005; Barnett-Norris J, 2005, LIFE SCI, V77, P1625, DOI 10.1016/j.lfs.2005.05.040; BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Charest PG, 2005, EMBO REP, V6, P334, DOI 10.1038/sj.embor.7400373; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; COTECCHIA S, 1990, P NATL ACAD SCI USA, V87, P2896, DOI 10.1073/pnas.87.8.2896; Daniels D, 2005, ENDOCRINOLOGY, V146, P5552, DOI 10.1210/en.2005-0774; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Deupi X, 2007, ADV PROTEIN CHEM, V74, P137, DOI 10.1016/S0065-3231(07)74004-4; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Fork C, 2011, BIOCHEM J, V436, P305, DOI 10.1042/BJ20101904; GERWINS P, 1990, MOL PHARMACOL, V38, P660; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Johnson AK, 1996, CLIN EXP PHARMACOL P, V23, P183, DOI 10.1111/j.1440-1681.1996.tb02594.x; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Schnitzler MMY, 2011, CURR OPIN PHARMACOL, V11, P112, DOI 10.1016/j.coph.2010.11.003; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Nair KS, 2002, CURR BIOL, V12, P421, DOI 10.1016/S0960-9822(02)00691-7; Nilius B, 2012, TRENDS NEUROSCI, V35, P477, DOI 10.1016/j.tins.2012.04.002; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Onaran HO, 2012, NAT CHEM BIOL, V8, P674, DOI 10.1038/nchembio.1024; Osol G, 2002, AM J PHYSIOL-HEART C, V283, pH2260, DOI 10.1152/ajpheart.00634.2002; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rajagopal S, 2011, MOL PHARMACOL, V80, P367, DOI 10.1124/mol.111.072801; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rakesh K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000769; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Sanni SJ, 2010, BRIT J PHARMACOL, V161, P150, DOI 10.1111/j.1476-5381.2010.00875.x; Schleifenbaum J, 2014, CIRC RES, V115, P263, DOI 10.1161/CIRCRESAHA.115.302882; Scimia MC, 2012, NATURE, V488, P394, DOI 10.1038/nature11263; Seifert R, 1999, TRENDS PHARMACOL SCI, V20, P383, DOI 10.1016/S0165-6147(99)01368-1; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; Storch U, 2012, AM J PHYSIOL-HEART C, V302, pH1241, DOI 10.1152/ajpheart.00818.2011; Strachan RT, 2014, J BIOL CHEM, V289, P14211, DOI 10.1074/jbc.M114.548131; Swaminath G, 2003, J BIOL CHEM, V278, P352, DOI 10.1074/jbc.M206424200; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Yasuda N, 2008, EMBO REP, V9, P179, DOI 10.1038/sj.embor.7401157; Zablocki D, 2013, CIRC RES, V113, P1192, DOI 10.1161/CIRCRESAHA.113.302501; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	54	39	40	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28271	28283		10.1074/jbc.M114.585067	http://dx.doi.org/10.1074/jbc.M114.585067			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25170081	hybrid, Green Published			2022-12-28	WOS:000343765400023
J	Messenger, SW; Falkowski, MA; Thomas, DDH; Jones, EK; Hong, WJ; Gaisano, HY; Boulis, NM; Groblewski, GE				Messenger, Scott W.; Falkowski, Michelle A.; Thomas, Diana D. H.; Jones, Elaina K.; Hong, Wanjin; Gaisano, Herbert Y.; Boulis, Nicholas M.; Groblewski, Guy E.			Vesicle Associated Membrane Protein 8 (VAMP8)-mediated Zymogen Granule Exocytosis Is Dependent on Endosomal Trafficking via the Constitutive-Like Secretory Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endosome; Exocytosis; Intracellular Trafficking; Pancreas; SNARE Proteins	REGULATED EXOCYTOSIS; NEUROTRANSMITTER RELEASE; AMYLASE SECRETION; FUNCTIONAL-ROLE; ACINAR-CELLS; SNARE; IDENTIFICATION; VAMP8; EXPRESSION; DISTINCT	Acinar cell zymogen granules (ZG) express 2 isoforms of the vesicle-associated membrane protein family (VAMP2 and -8) thought to regulate exocytosis. Expression of tetanus toxin to cleave VAMP2 in VAMP8 knock-out (-/-) acini confirmed that VAMP2 and -8 are the primary VAMPs for regulated exocytosis, each contributing approximate to 50% of the response. Analysis of VAMP8(-/-) acini indicated that although stimulated secretion was significantly reduced, a compensatory increase in constitutive secretion maintained total secretion equivalent to wild type (WT). Using a perifusion system to follow secretion over time revealed VAMP2 mediates an early rapid phase peaking and falling within 2-3 min, whereas VAMP8 controls a second prolonged phase that peaks at 4 min and slowly declines over 20 min to support the protracted secretory response. VAMP8(-/-) acini show increased expression of the endosomal proteins Ti-VAMP7 (2-fold) and Rab11a (4-fold) and their redistribution from endosomes to ZGs. Expression of GDP-trapped Rab11a-S25N inhibited secretion exclusively from the VAMP8 but not the VAMP2 pathway. VAMP8(-/-) acini also showed a >90% decrease in the early endosomal proteins Rab5/D52/EEA1, which control anterograde trafficking in the constitutive-like secretory pathway. In WT acini, short term (14-16 h) culture also results in a >90% decrease in Rab5/D52/EEA1 and a complete loss of the VAMP8 pathway, whereas VAMP2-secretion remains intact. Remarkably, rescue of Rab5/D52/EEA1 expression restored the VAMP8 pathway. Expressed D52 shows extensive colocalization with Rab11a and VAMP8 and partially copurifies with ZG fractions. These results indicate that robust trafficking within the constitutive-like secretory pathway is required for VAMP8- but not VAMP2-mediated ZG exocytosis.	[Messenger, Scott W.; Falkowski, Michelle A.; Thomas, Diana D. H.; Jones, Elaina K.; Groblewski, Guy E.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA; [Hong, Wanjin] Natl Univ Singapore, Inst Mol & Cellular Biol, Singapore 138673, Singapore; [Gaisano, Herbert Y.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Gaisano, Herbert Y.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Boulis, Nicholas M.] Georgia Inst Technol, Dept Neurosurg, Atlanta, GA 30322 USA	University of Wisconsin System; University of Wisconsin Madison; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; University of Toronto; University of Toronto; University System of Georgia; Georgia Institute of Technology	Groblewski, GE (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	groby@nutrisci.wisc.edu		Jones, Elaina/0000-0002-0691-4933	National Institutes of Health [DK07088]; United States Department of Agriculture/HATCH Grant [WIS01583]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK098108, R01DK070888, T32DK007665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture/HATCH Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK07088 (to G. E. G.). This work was also supported by United States Department of Agriculture/HATCH Grant WIS01583 (to G. E. G.).	Aikawa Y, 2006, MOL BIOL CELL, V17, P2113, DOI 10.1091/mbc.E06-01-0074; Antonin W, 2000, MOL BIOL CELL, V11, P3289, DOI 10.1091/mbc.11.10.3289; ARVAN P, 1991, J BIOL CHEM, V266, P14171; Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; Azouz NP, 2014, J IMMUNOL, V192, P4043, DOI 10.4049/jimmunol.1302196; Baetz NW, 2013, MOL BIOL CELL, V24, P643, DOI 10.1091/mbc.E12-09-0659; Baumler MD, 2010, AM J PHYSIOL-GASTR L, V299, pG338, DOI 10.1152/ajpgi.00165.2010; Behrendorff N, 2011, J BIOL CHEM, V286, P29627, DOI 10.1074/jbc.M111.265199; Castle AM, 2002, J CELL SCI, V115, P2963; Castle JD, 1996, J CELL SCI, V109, P2591; Chaudhuri A, 2007, AM J PHYSIOL-GASTR L, V292, pG1403, DOI 10.1152/ajpgi.00478.2005; Chen XQ, 2003, J BIOL CHEM, V278, P50053, DOI 10.1074/jbc.M309910200; Chen XQ, 2008, MOL CELL PROTEOMICS, V7, P2323, DOI 10.1074/mcp.M700575-MCP200; Chen Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1209, DOI 10.1152/ajpcell.00159.2005; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Cosen-Binker LI, 2008, J CLIN INVEST, V118, P2535, DOI 10.1172/JCI34672; Falkowski MA, 2011, AM J PHYSIOL-GASTR L, V301, pG306, DOI 10.1152/ajpgi.00108.2011; FujitaYoshigaki J, 1996, J BIOL CHEM, V271, P13130, DOI 10.1074/jbc.271.22.13130; Gaisano HY, 2009, GASTROENTEROLOGY, V136, P2040, DOI 10.1053/j.gastro.2009.04.023; GAISANO HY, 1994, J BIOL CHEM, V269, P17062; Groblewski GE, 1998, J BIOL CHEM, V273, P22738, DOI 10.1074/jbc.273.35.22738; Groblewski GE, 1999, AM J PHYSIOL-GASTR L, V276, pG219, DOI 10.1152/ajpgi.1999.276.1.G219; Hoekstra D, 2004, J CELL SCI, V117, P2183, DOI 10.1242/jcs.01217; Huang AY, 2001, J BIOL CHEM, V276, P22296, DOI 10.1074/jbc.M100211200; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jones LC, 2012, J PHYSIOL-LONDON, V590, P545, DOI 10.1113/jphysiol.2011.222091; KAWABATA SI, 1988, EUR J BIOCHEM, V172, P17, DOI 10.1111/j.1432-1033.1988.tb13849.x; Loo LS, 2009, EUR J IMMUNOL, V39, P3520, DOI 10.1002/eji.200939378; LOWE ME, 1992, J BIOL CHEM, V267, P17069; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Masedunskas A, 2008, TRAFFIC, V9, P1801, DOI 10.1111/j.1600-0854.2008.00798.x; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; Messenger SW, 2014, CELL CALCIUM, V55, P369, DOI 10.1016/j.ceca.2014.03.003; Messenger SW, 2013, AM J PHYSIOL-GASTR L, V305, pG439, DOI 10.1152/ajpgi.00143.2013; Mullock BM, 2000, MOL BIOL CELL, V11, P3137, DOI 10.1091/mbc.11.9.3137; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; Oishi Y, 2006, HISTOCHEM CELL BIOL, V125, P273, DOI 10.1007/s00418-005-0068-y; PADFIELD PJ, 1995, AM J PHYSIOL-GASTR L, V269, pG647, DOI 10.1152/ajpgi.1995.269.5.G647; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Pickett JA, 2007, BIOCHEM BIOPH RES CO, V359, P599, DOI 10.1016/j.bbrc.2007.05.128; Pocard T, 2007, J CELL SCI, V120, P3309, DOI 10.1242/jcs.007948; Polgar J, 2002, BLOOD, V100, P1081, DOI 10.1182/blood.V100.3.1081; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Rodriguez-Pineiro AM, 2012, J PROTEOME RES, V11, P1879, DOI 10.1021/pr2010988; Sabbatini ME, 2008, J BIOL CHEM, V283, P23884, DOI 10.1074/jbc.M800754200; Scheuber A, 2006, P NATL ACAD SCI USA, V103, P16562, DOI 10.1073/pnas.0603511103; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Sengupta D, 1996, EUR J CELL BIOL, V70, P306; Shahheydari H, 2014, MOL BIOL REP, V41, P4565, DOI 10.1007/s11033-014-3327-y; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Teng Q, 2005, GENE THER, V12, P108, DOI 10.1038/sj.gt.3302400; Thomas DDH, 2004, AM J PHYSIOL-GASTR L, V287, pG253, DOI 10.1152/ajpgi.00033.2004; Thomas DDH, 2001, J BIOL CHEM, V276, P28866, DOI 10.1074/jbc.M102214200; Thomas DDH, 2010, AM J PHYSIOL-CELL PH, V298, pC725, DOI 10.1152/ajpcell.00455.2009; Thorn Peter, 2012, Commun Integr Biol, V5, P61; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Wang CC, 2007, MOL BIOL CELL, V18, P1056, DOI 10.1091/mbc.E06-10-0974; Weng N, 2007, J BIOL CHEM, V282, P9635, DOI 10.1074/jbc.M611108200; Williams JA, 2008, CURR OPIN GASTROEN, V24, P573, DOI 10.1097/MOG.0b013e32830b110c; Yoshimura K, 1998, EUR J MORPHOL, V36, P198; YOSHIMURA K, 1991, JPN J PHYSIOL, V41, P443, DOI 10.2170/jjphysiol.41.443; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zhang Z, 2013, J NEUROSCI, V33, P9169, DOI 10.1523/JNEUROSCI.0301-13.2013; Zhu D, 2012, CELL METAB, V16, P238, DOI 10.1016/j.cmet.2012.07.001	65	15	16	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					28040	28053		10.1074/jbc.M114.593913	http://dx.doi.org/10.1074/jbc.M114.593913			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25138214	hybrid, Green Published			2022-12-28	WOS:000342852800055
J	Saen-oon, S; Lee, SG; Jez, JM; Guallar, V				Saen-oon, Suwipa; Lee, Soon Goo; Jez, Joseph M.; Guallar, Victor			An Alternative Mechanism for the Methylation of Phosphoethanolamine Catalyzed by Plasmodium falciparum Phosphoethanolamine Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computer Modeling; Crystallography; Enzyme Mechanism; Mutagenesis; Protein Structure	N-METHYLTRANSFERASE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; PHOSPHOCHOLINE BIOSYNTHESIS; PHOSPHOLIPID-METABOLISM; MOLECULAR-MECHANICS; PRODUCT SPECIFICITY; FORCE-FIELD; PATHWAY; PROTEIN; INTEGRATION	Background: In Plasmodium, phosphoethanolamine methyltransferase (PfPMT) is essential for normal growth and development. Results: Computational, biochemical, and structural studies suggest catalytic and structural roles for Asp-128 in PfPMT. Conclusion: Asp-128 is critical for specific methylation of phosphoethanolamine and not other phosphobases. Significance: This work provides new insight on the evolution of multiple substrate activity in PMT from different organisms. The phosphobase methylation pathway catalyzed by the phosphoethanolamine methyltransferase in Plasmodium falciparum (PfPMT), the malaria parasite, offers an attractive target for anti-parasitic drug development. PfPMT methylates phosphoethanolamine (pEA) to phosphocholine for use in membrane biogenesis. Quantum mechanics and molecular mechanics (QM/MM) calculations tested the proposed reaction mechanism for methylation of pEA involving the previously identified Tyr-19-His-132 dyad, which indicated an energetically unfavorable mechanism. Instead, the QM/MM calculations suggested an alternative mechanism involving Asp-128. The reaction coordinate involves the stepwise transfer of a proton to Asp-128 via a bridging water molecule followed by a typical S(n)2-type methyl transfer from S-adenosylmethionine to pEA. Functional analysis of the D128A, D128E, D128Q, and D128N PfPMT mutants shows a loss of activity with pEA but not with the final substrate of the methylation pathway. X-ray crystal structures of the PfPMT-D128A mutant in complex with S-adenosylhomocysteine and either pEA or phosphocholine reveal how mutation of Asp-128 disrupts a hydrogen bond network in the active site. The combined QM/MM, biochemical, and structural studies identify a key role for Asp-128 in the initial step of the phosphobase methylation pathway in Plasmodium and provide molecular insight on the evolution of multiple activities in the active site of the PMT.	[Saen-oon, Suwipa; Guallar, Victor] Joint Barcelona Supercomp Ctr, Ctr Genom Regulat, Inst Res, Biomed Res Program, Barcelona 08034, Spain; [Lee, Soon Goo; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Guallar, Victor] Catalan Inst Res & Adv Studies, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); Washington University (WUSTL); ICREA	Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu; victor.guallar@bsc.es	Guallar, Victor/B-1579-2013	Guallar, Victor/0000-0002-4580-1114; saen-oon, suwipa/0000-0002-4101-245X; Lee, Soon Goo/0000-0002-1541-8587	National Institutes of Health [AI-097119]; Barcelona Supercomputer Center; Spanish Ministry of Education and Science [CTQ2013-48287];  [DE-AC02-06CH11357]; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barcelona Supercomputer Center; Spanish Ministry of Education and Science(Spanish Government); ; ICREA(ICREA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-097119 (to the Jez laboratory). This work was also supported by funds from the Barcelona Supercomputer Center and the Spanish Ministry of Education and Science through Project CTQ2013-48287 (to the Guallar laboratory). Portions of this work were carried out at the Argonne National Laboratory Structural Biology Center of the Advanced Photon Source, a national user facility operated by the University of Chicago for the Department of Energy Office of Biological and Environmental Research and supported by Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bobenchik AM, 2013, P NATL ACAD SCI USA, V110, P18262, DOI 10.1073/pnas.1313965110; Bobenchik AM, 2011, FEMS MICROBIOL REV, V35, P609, DOI 10.1111/j.1574-6976.2011.00267.x; Brendza KM, 2007, BIOCHEM J, V404, P439, DOI 10.1042/BJ20061815; Calas M, 2000, J MED CHEM, V43, P505, DOI 10.1021/jm9911027; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hu P, 2006, J AM CHEM SOC, V128, P1272, DOI 10.1021/ja056153+; Hunter WN, 2009, J BIOL CHEM, V284, P11749, DOI 10.1074/jbc.R800072200; Hur S, 2003, P NATL ACAD SCI USA, V100, P12015, DOI 10.1073/pnas.1534873100; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Lee SG, 2014, TRENDS PARASITOL, V30, P241, DOI 10.1016/j.pt.2014.03.001; Lee SG, 2013, STRUCTURE, V21, P1778, DOI 10.1016/j.str.2013.07.023; Lee SG, 2012, BIOORG MED CHEM LETT, V22, P4990, DOI 10.1016/j.bmcl.2012.06.032; Lee SG, 2012, J BIOL CHEM, V287, P1426, DOI 10.1074/jbc.M111.315267; Lee SG, 2011, J BIOL CHEM, V286, P38060, DOI 10.1074/jbc.M111.290619; Liscombe DK, 2012, NAT PROD REP, V29, P1238, DOI 10.1039/c2np20029e; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNeil SD, 2001, P NATL ACAD SCI USA, V98, P10001, DOI 10.1073/pnas.171228998; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nuccio ML, 2000, J BIOL CHEM, V275, P14095, DOI 10.1074/jbc.275.19.14095; Palavalli LH, 2006, BIOCHEMISTRY-US, V45, P6056, DOI 10.1021/bi060199d; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schapira Matthieu, 2011, Curr Chem Genomics, V5, P85, DOI 10.2174/1875397301005010085; Schmidt T, 2014, J PHYS CHEM B, V118, P5882, DOI 10.1021/jp5028564; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Velichkova P, 2006, J PHYS CHEM B, V110, P16, DOI 10.1021/jp055120d; Velichkova P, 2005, J PHYS CHEM B, V109, P8216, DOI 10.1021/jp0443254; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wengelnik K, 2002, SCIENCE, V295, P1311, DOI 10.1126/science.1067236; Witola WH, 2008, J BIOL CHEM, V283, P27636, DOI 10.1074/jbc.M804360200; Zhang X, 2008, P NATL ACAD SCI USA, V105, P5728, DOI 10.1073/pnas.0801788105; Zhang XD, 2006, P NATL ACAD SCI USA, V103, P16141, DOI 10.1073/pnas.0607503103; Zhang YK, 2003, J PHYS CHEM B, V107, P4459, DOI 10.1021/jp022525e; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	43	10	10	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33815	33825		10.1074/jbc.M114.611319	http://dx.doi.org/10.1074/jbc.M114.611319			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25288796	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000346077600009
J	Hall, J; Reschke, S; Cao, HN; Leimkuhler, S; Hille, R				Hall, James; Reschke, Stefan; Cao, Hongnan; Leimkuehler, Silke; Hille, Russ			The Reductive Half-reaction of Xanthine Dehydrogenase from Rhodobacter capsulatus THE ROLE OF GLU(232) IN CATALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Glutamate; Glutamine; Isotope Effect; Ultraviolet-visible Spectroscopy (UV-visible Spectroscopy); Xanthine; Xanthine Dehydrogenase; Xanthine Oxidase; pH Dependence	CRYSTAL-STRUCTURES; SUBSTRATE ORIENTATION; ACTIVE-SITE; OXIDASE; MECHANISM; SPECIFICITY; IDENTIFICATION; OXIDOREDUCTASE; HYDROXYLATION; RESIDUES	Background: Kinetic characterization of wild-type xanthine dehydrogenase and variants. Results: Comparison of the pH dependence of both k(red) and k(red)/K-d, as well as k(cat) and k(cat)/K-m. Conclusion: Ionized Glu(232) of wild-type enzyme plays an important role in catalysis by discriminating against the monoanionic form of xanthine. Significance: Examining the contributions of Glu(232) to catalysis is essential for understanding the mechanism of xanthine dehydrogenase. The kinetic properties of an E232Q variant of the xanthine dehydrogenase from Rhodobacter capsulatus have been examined to ascertain whether Glu(232) in wild-type enzyme is protonated or unprotonated in the course of catalysis at neutral pH. We find that k(red), the limiting rate constant for reduction at high [xanthine], is significantly compromised in the variant, a result that is inconsistent with Glu(232) being neutral in the active site of the wild-type enzyme. A comparison of the pH dependence of both k(red) and k(red)/K-d from reductive half-reaction experiments between wild-type and enzyme and the E232Q variant suggests that the ionized Glu(232) of wild-type enzyme plays an important role in catalysis by discriminating against the monoanionic form of substrate, effectively increasing the pK(a) of substrate by two pH units and ensuring that at physiological pH the neutral form of substrate predominates in the Michaelis complex. A kinetic isotope study of the wild-type R. capsulatus enzyme indicates that, as previously determined for the bovine and chicken enzymes, product release is principally rate-limiting in catalysis. The disparity in rate constants for the chemical step of the reaction and product release, however, is not as great in the bacterial enzyme as compared with the vertebrate forms. The results indicate that the bacterial and bovine enzymes catalyze the chemical step of the reaction to the same degree and that the faster turnover observed with the bacterial enzyme is due to a faster rate constant for product release than is seen with the vertebrate enzyme.	[Hall, James; Cao, Hongnan; Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Reschke, Stefan; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, Dept Mol Enzymol, D-14476 Potsdam, Germany	University of California System; University of California Riverside; University of Potsdam	Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, 1462 Boyce Hall, Riverside, CA 92521 USA.	Russ.Hille@ucr.edu		Cao, Hongnan/0000-0003-2496-1298; Leimkuhler, Silke/0000-0003-3238-2122; Hall, James/0000-0002-9843-7520	U.S. Department of Energy [DE-FG02-13ER16411]; Deutsche Forschungsgemeinschaft Cluster of Excellence "Unifying Concepts in Catalysis"	U.S. Department of Energy(United States Department of Energy (DOE)); Deutsche Forschungsgemeinschaft Cluster of Excellence "Unifying Concepts in Catalysis"(German Research Foundation (DFG))	This work was supported by U.S. Department of Energy Grant DE-FG02-13ER16411 (to R. H.) and by funds from the Deutsche Forschungsgemeinschaft Cluster of Excellence "Unifying Concepts in Catalysis" (to S. L.).	Aguey-Zinsou KF, 2003, J AM CHEM SOC, V125, P15352, DOI 10.1021/ja037940e; BRAY RC, 1979, BIOCHEM J, V177, P357, DOI 10.1042/bj1770357; Cao HN, 2010, J BIOL CHEM, V285, P28044, DOI 10.1074/jbc.M110.128561; Choi EY, 2004, J INORG BIOCHEM, V98, P841, DOI 10.1016/j.jinorgbio.2003.11.010; DARDENNE SC, 1990, BIOCHEMISTRY-US, V29, P9046, DOI 10.1021/bi00490a023; Dietzel U, 2009, J BIOL CHEM, V284, P8759, DOI 10.1074/jbc.M808114200; EDMONDSON D, 1973, J BIOL CHEM, V248, P6135; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Hille R, 2005, ARCH BIOCHEM BIOPHYS, V433, P107, DOI 10.1016/j.abb.2004.08.012; HILLE R, 1995, FASEB J, V9, P995, DOI 10.1096/fasebj.9.11.7649415; Hille R, 2013, DALTON T, V42, P3029, DOI 10.1039/c2dt32376a; Hille R, 2011, COORDIN CHEM REV, V255, P1179, DOI 10.1016/j.ccr.2010.11.034; Huber R, 1996, P NATL ACAD SCI USA, V93, P8846, DOI 10.1073/pnas.93.17.8846; Ilich P, 1997, INORG CHIM ACTA, V263, P87, DOI 10.1016/S0020-1693(97)05654-5; Kalimuthu P, 2011, J PHYS CHEM B, V115, P2655, DOI 10.1021/jp111809f; Kim JH, 1996, J BIOL CHEM, V271, P6771, DOI 10.1074/jbc.271.12.6771; Kulikowska E, 2004, ACTA BIOCHIM POL, V51, P493; Leimkuhler S, 1998, MOL MICROBIOL, V27, P853, DOI 10.1046/j.1365-2958.1998.00733.x; Leimkuhler S, 2004, J BIOL CHEM, V279, P40437, DOI 10.1074/jbc.M405778200; Leimkuhler S, 2003, J BIOL CHEM, V278, P20802, DOI 10.1074/jbc.M303091200; McCrudden F H, 1905, URIC ACID; MCWHIRTER RB, 1991, J BIOL CHEM, V266, P23724; Metz S, 2009, J AM CHEM SOC, V131, P14885, DOI 10.1021/ja9045394; Neumann M, 2008, FEBS J, V275, P5678, DOI 10.1111/j.1742-4658.2008.06694.x; NORTHROP DB, 1975, BIOCHEMISTRY-US, V14, P2644, DOI 10.1021/bi00683a013; Okamoto K, 2004, P NATL ACAD SCI USA, V101, P7931, DOI 10.1073/pnas.0400973101; Okamoto K, 2010, J AM CHEM SOC, V132, P17080, DOI 10.1021/ja1077574; Pauff JM, 2007, J BIOL CHEM, V282, P12785, DOI 10.1074/jbc.M700364200; Pauff JM, 2009, J BIOL CHEM, V284, P8751, DOI 10.1074/jbc.M804517200; SIMON H, 1966, ANGEW CHEM INT EDIT, V5, P920, DOI 10.1002/anie.196609201; Truglio JJ, 2002, STRUCTURE, V10, P115, DOI 10.1016/S0969-2126(01)00697-9; Xia M, 1999, J BIOL CHEM, V274, P3323, DOI 10.1074/jbc.274.6.3323; Yamaguchi Y, 2007, J BIOCHEM, V141, P513, DOI 10.1093/jb/mvm053	33	6	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32121	32130		10.1074/jbc.M114.603456	http://dx.doi.org/10.1074/jbc.M114.603456			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25258317	Green Published, hybrid			2022-12-28	WOS:000345314700040
J	Zhang, WL; Mottillo, EP; Zhao, JW; Gartung, A; VanHecke, GC; Lee, JF; Maddipati, KR; Xu, HY; Ahn, YH; Proia, RL; Granneman, JG; Lee, MJ				Zhang, Wenliang; Mottillo, Emilio P.; Zhao, Jiawei; Gartung, Allison; VanHecke, Garrett C.; Lee, Jen-Fu; Maddipati, Krishna R.; Xu, Haiyan; Ahn, Young-Hoon; Proia, Richard L.; Granneman, James G.; Lee, Menq-Jer			Adipocyte Lipolysis-stimulated Interleukin-6 Production Requires Sphingosine Kinase 1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipose Tissue; AP1 Transcription Factor (AP-1); c-Jun N-terminal Kinase (JNK); Inflammation; Interleukin 6 (IL-6); Lipolysis; Beta 3 Adrenergic Receptor; Hormone-sensitive Lipase; Sphingosine Kinase	HORMONE-SENSITIVE LIPASE; SUBCUTANEOUS ADIPOSE-TISSUE; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; FATTY-ACIDS; SPHINGOSINE-1-PHOSPHATE; OBESITY; INFLAMMATION; RECEPTOR; 1-PHOSPHATE	Adipocyte lipolysis can increase the production of inflammatory cytokines such as interleukin-6 (IL-6) that promote insulin resistance. However, the mechanisms that link lipolysis with inflammation remain elusive. Acute activation of (3)-adrenergic receptors (ADRB3) triggers lipolysis and up-regulates production of IL-6 in adipocytes, and both of these effects are blocked by pharmacological inhibition of hormone-sensitive lipase. We report that stimulation of ADRB3 induces expression of sphingosine kinase 1 (SphK1) and increases sphingosine 1-phosphate production in adipocytes in a manner that also depends on hormone-sensitive lipase activity. Mechanistically, we found that adipose lipolysis-induced SphK1 up-regulation is mediated by the c-Jun N-terminal kinase (JNK)/activating protein-1 signaling pathway. Inhibition of SphK1 by sphingosine kinase inhibitor 2 diminished the ADRB3-induced IL-6 production both in vitro and in vivo. Induction of IL-6 by ADRB3 activation was suppressed by siRNA knockdown of Sphk1 in cultured adipocytes and was severely attenuated in Sphk1 null mice. Conversely, ectopic expression of SphK1 increased IL-6 expression in adipocytes. Collectively, these data demonstrate that SphK1 is a critical mediator in lipolysis-triggered inflammation in adipocytes.	[Zhang, Wenliang; Mottillo, Emilio P.; Zhao, Jiawei; Gartung, Allison; Lee, Jen-Fu; Maddipati, Krishna R.; Granneman, James G.; Lee, Menq-Jer] Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA; [Zhang, Wenliang; Zhao, Jiawei; Gartung, Allison; Lee, Jen-Fu; Maddipati, Krishna R.; Lee, Menq-Jer] Wayne State Univ, Bioact Lipid Res Program, Detroit, MI 48202 USA; [Mottillo, Emilio P.; Granneman, James G.] Wayne State Univ, Ctr Integrat Metab & Endocrine Res, Detroit, MI 48202 USA; [VanHecke, Garrett C.; Ahn, Young-Hoon] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [Granneman, James G.] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48202 USA; [Lee, Menq-Jer] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48202 USA; [Lee, Menq-Jer] Wayne State Univ, Cardiovasc Res Inst, Detroit, MI 48202 USA; [Xu, Haiyan] Brown Univ, Dept Med, Alpert Med Sch, Providence, RI 02912 USA; [Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20814 USA	Wayne State University; Wayne State University; Wayne State University; Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Brown University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Granneman, JG (corresponding author), Wayne State Univ, Sch Med, Ctr Integrat Metab & Endocrine Res, 540 E Canfield Ave,Lande 103, Detroit, MI 48201 USA.	jgranne@med.wayne.edu; Menqjer.lee@wayne.edu	Maddipati, Krishna Rao/H-3569-2019; Maddipati, Krishna Rao/G-1859-2011; Proia, Richard L/A-7908-2012; LEE, JEN-FU/GRO-3670-2022	Maddipati, Krishna Rao/0000-0003-1445-791X; Maddipati, Krishna Rao/0000-0003-1445-791X; Proia, Richard/0000-0003-0456-1270	National Institutes of Health [HL-071071, DK-076229, DK-062292]; Intramural Research Program of the National Institutes of Health, NIDDK; Michigan Diabetes Research and Training Center (National Institutes of Health) [5P600-DK020572]; Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK020572, R01DK062292, ZIADK056014, R56DK062292, ZIADK056015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Michigan Diabetes Research and Training Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health Grants HL-071071 (to M.-J. L.), DK-076229 and DK-062292 (to J. G. G.), the Intramural Research Program of the National Institutes of Health, NIDDK (to R. L. P.), and by a Pilot and Feasibility Grant from the Michigan Diabetes Research and Training Center (National Institutes of Health Grant 5P600-DK020572) (to M. L.).; Supported by a doctoral research award from the Canadian Institutes of Health Research.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Andersson CX, 2008, DIABETES-METAB RES, V24, P595, DOI 10.1002/dmrr.889; Bachmaier K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030742; Baker DA, 2010, J IMMUNOL, V185, P2570, DOI 10.4049/jimmunol.1000644; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Bezaire V, 2009, P NUTR SOC, V68, P350, DOI 10.1017/S0029665109990279; Claus TH, 2005, J PHARMACOL EXP THER, V315, P1396, DOI 10.1124/jpet.105.086926; Das Arghya, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P23; Ebdrup S, 2007, J MED CHEM, V50, P5449, DOI 10.1021/jm0607653; Eckel RH, 2004, CIRCULATION, V110, P2968, DOI 10.1161/01.CIR.0000140086.88453.9A; Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hla T, 1999, BIOCHEM PHARMACOL, V58, P201; Hsu A, 2012, INT J ONCOL, V40, P1619, DOI 10.3892/ijo.2012.1379; Hu W, 2009, J LIPID RES, V50, P1852, DOI 10.1194/jlr.M800635-JLR200; Igarashi Y, 1998, ACTA BIOCHIM POL, V45, P299, DOI 10.18388/abp.1998_4226; Jiao P, 2011, OBESITY, V19, P483, DOI 10.1038/oby.2010.200; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Mottillo EP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1188, DOI 10.1152/ajpendo.00051.2007; Mottillo EP, 2012, J BIOL CHEM, V287, P25038, DOI 10.1074/jbc.M112.374041; Mottillo EP, 2011, AM J PHYSIOL-ENDOC M, V301, pE122, DOI 10.1152/ajpendo.00039.2011; Mottillo EP, 2010, BBA-MOL CELL BIOL L, V1801, P1048, DOI 10.1016/j.bbalip.2010.04.012; Muradashvili N, 2014, AM J PHYSIOL-CELL PH, V307, pC169, DOI 10.1152/ajpcell.00305.2013; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Ross JS, 2013, J BIOL CHEM, V288, P22193, DOI 10.1074/jbc.M113.477786; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Skoura A, 2011, ARTERIOSCL THROM VAS, V31, P81, DOI 10.1161/ATVBAHA.110.213496; Spiegel S, 1999, J LEUKOCYTE BIOL, V65, P341, DOI 10.1002/jlb.65.3.341; Strom K, 2009, FASEB J, V23, P2307, DOI 10.1096/fj.08-120923; Szczepankiewicz BG, 2006, J MED CHEM, V49, P3563, DOI 10.1021/jm060199b; Turpeinen T, 2010, J PHARMACOL EXP THER, V333, P310, DOI 10.1124/jpet.109.157438; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wang J, 2014, AM J PHYSIOL-ENDOC M, V306, pE756, DOI 10.1152/ajpendo.00549.2013; Zhang WL, 2013, PROSTAG OTH LIPID M, V106, P62, DOI 10.1016/j.prostaglandins.2013.06.001	46	48	51	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32178	32185		10.1074/jbc.M114.601096	http://dx.doi.org/10.1074/jbc.M114.601096			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25253697	Green Published, hybrid			2022-12-28	WOS:000345314700045
J	Beard, WA; Shock, DD; Batra, VK; Prasad, R; Wilson, SH				Beard, William A.; Shock, David D.; Batra, Vinod K.; Prasad, Raiendra; Wilson, Samuel H.			Substrate-induced DNA Polymerase beta Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; ACTIVE-SITE; NUCLEOTIDE INCORPORATION; SUBDOMAIN MOTIONS; KINETIC ANALYSES; GASTRIC-CANCER; INDUCED FIT; MECHANISM; FIDELITY; EFFICIENCY	DNA polymerases and substrates undergo conformational changes upon forming protein-ligand complexes. These conformational adjustments can hasten or deter DNA synthesis and influence substrate discrimination. From structural comparison of binary DNA and ternary DNA-dNTP complexes of DNA polymerase beta, several side chains have been implicated in facilitating formation of an active ternary complex poised for chemistry. Site-directed mutagenesis of these highly conserved residues (Asp-192, Arg-258, Phe-272, Glu-295, and Tyr-296) and kinetic characterization provides insight into the role these residues play during correct and incorrect insertion as well as their role in conformational activation. The catalytic efficiencies for correct nucleotide insertion for alanine mutants were wild type similar to R258A > F272A similar to Y296A > E295A > D192A. Because the efficiencies for incorrect insertion were affected to about the same extent for each mutant, the effects on fidelity were modest (< 5-fold). The R258A mutant exhibited an increase in the single- turnover rate of correct nucleotide insertion. This suggests that the wild-type Arg-258 side chain generates a population of non-productive ternary complexes. Structures of binary and ternary substrate complexes of the R258A mutant and a mutant associated with gastric carcinomas, E295K, provide molecular insight into intermediate structural conformations not appreciated previously. Although the R258A mutant crystal structures were similar to wild-type enzyme, the open ternary complex structure of E295K indicates that Arg-258 stabilizes a nonproductive conformation of the primer terminus that would decrease catalysis. Significantly, the open E295K ternary complex binds two metal ions indicating that metal binding cannot overcome the modified interactions that have interrupted the closure of the N-subdomain.	[Beard, William A.; Shock, David D.; Batra, Vinod K.; Prasad, Raiendra; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, NIH, 111 T W Alexander Dr,POB 12233,MD F1-12, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293	National Institutes of Health [P41 GM-103311]; NATIONAL CANCER INSTITUTE [U19CA105010, U19CA177547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050158, Z01ES050161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. K. Bebenek and B. D. Freudenthal for critical reading of the manuscript and valuable discussions. Molecular graphics images were produced using the Chimera package from the Resource for Biocomputing; Visualization, and Informatics at the University of California, San Francisco (Supported by National Institutes of Health Grant P41 GM-103311).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahn J, 1997, BIOCHEMISTRY-US, V36, P1100, DOI 10.1021/bi961653o; Bakhtina M, 2005, BIOCHEMISTRY-US, V44, P5177, DOI 10.1021/bi047664w; Bakhtina M, 2007, BIOCHEMISTRY-US, V46, P5463, DOI 10.1021/bi700084w; Bakhtina M, 2009, BIOCHEMISTRY-US, V48, P3197, DOI 10.1021/bi802119f; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 1996, J BIOL CHEM, V271, P12141, DOI 10.1074/jbc.271.21.12141; Beard WA, 2004, J BIOL CHEM, V279, P31921, DOI 10.1074/jbc.M404016200; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beard WA, 2002, J BIOL CHEM, V277, P47393, DOI 10.1074/jbc.M210036200; Beard WA, 2002, J BIOL CHEM, V277, P8235, DOI 10.1074/jbc.M107286200; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Beard WA, 2014, BIOCHEMISTRY-US, V53, P2768, DOI 10.1021/bi500139h; Beard WA, 2010, MUTAT RES-GEN TOX EN, V703, P18, DOI 10.1016/j.mrgentox.2010.07.013; Beard WA, 2009, J BIOL CHEM, V284, P31680, DOI 10.1074/jbc.M109.029843; Bebenek K, 2010, NUCLEIC ACIDS RES, V38, P5419, DOI 10.1093/nar/gkq261; Berg BJV, 2001, J BIOL CHEM, V276, P3408, DOI 10.1074/jbc.M002884200; Berlow RB, 2012, J MOL BIOL, V419, P171, DOI 10.1016/j.jmb.2012.03.013; Bienstock RJ, 2014, DNA REPAIR, V22, P77, DOI 10.1016/j.dnarep.2014.07.003; Bose-Basu B, 2004, BIOCHEMISTRY-US, V43, P8911, DOI 10.1021/bi049641n; Cavanaugh NA, 2010, J BIOL CHEM, V285, P24457, DOI 10.1074/jbc.M110.132407; DATE T, 1991, BIOCHEMISTRY-US, V30, P5286, DOI 10.1021/bi00235a023; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Donigan KA, 2012, J BIOL CHEM, V287, P23830, DOI 10.1074/jbc.M111.324947; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; Dunlap CA, 2002, BIOCHEMISTRY-US, V41, P11226, DOI 10.1021/bi025837g; Eckenroth BE, 2013, J BIOL CHEM, V288, P34850, DOI 10.1074/jbc.M113.510891; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Freudenthal BD, 2012, STRUCTURE, V20, P1829, DOI 10.1016/j.str.2012.08.008; Garcia-Diaz M, 2005, NAT STRUCT MOL BIOL, V12, P97, DOI 10.1038/nsmb876; Iwanaga A, 1999, MUTAT RES-DNA REPAIR, V435, P121, DOI 10.1016/S0921-8777(99)00036-1; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim SJ, 2003, J BIOL CHEM, V278, P5072, DOI 10.1074/jbc.M208472200; Kirby TW, 2012, NUCLEIC ACIDS RES, V40, P2974, DOI 10.1093/nar/gkr1218; Koag MC, 2014, NUCLEIC ACIDS RES, V42, P8755, DOI 10.1093/nar/gku554; Lang TM, 2007, MOL CELL BIOL, V27, P5587, DOI 10.1128/MCB.01883-06; Li SX, 1999, BIOCHEMISTRY-US, V38, P4800, DOI 10.1021/bi9827058; Mejia E, 2014, DNA REPAIR, V18, P1, DOI 10.1016/j.dnarep.2014.03.001; Menge KL, 1995, BIOCHEMISTRY-US, V34, P15934, DOI 10.1021/bi00049a008; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Moon AF, 2014, NAT STRUCT MOL BIOL, V21, P253, DOI 10.1038/nsmb.2766; Osheroff WP, 1999, J BIOL CHEM, V274, P20749, DOI 10.1074/jbc.274.30.20749; Osheroff WP, 2000, J BIOL CHEM, V275, P28033; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patterson TA, 2000, PROTEIN EXPRES PURIF, V18, P100, DOI 10.1006/prep.1999.1167; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radhakrishnan R, 2006, BIOCHEMISTRY-US, V45, P15142, DOI 10.1021/bi061353z; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; Sucato CA, 2007, BIOCHEMISTRY-US, V46, P461, DOI 10.1021/bi061517b; Towle-Weicksel JB, 2014, J BIOL CHEM, V289, P16541, DOI 10.1074/jbc.M114.561878; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Wu S, 2014, CHEM REV, V114, P2759, DOI 10.1021/cr3005179; Yang LJ, 2002, J MOL BIOL, V317, P651, DOI 10.1006/jmbi.2002.5450; Yang LJ, 2004, BIOPHYS J, V86, P3392, DOI 10.1529/biophysj.103.036012	58	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31411	31422		10.1074/jbc.M114.607432	http://dx.doi.org/10.1074/jbc.M114.607432			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25261471	Green Published, hybrid			2022-12-28	WOS:000344549900044
J	Miyanaga, A; Cieslak, J; Shinohara, Y; Kudo, F; Eguchi, T				Miyanaga, Akimasa; Cieslak, Jolanta; Shinohara, Yuji; Kudo, Fumitaka; Eguchi, Tadashi			The Crystal Structure of the Adenylation Enzyme VinN Reveals a Unique beta-Amino Acid Recognition Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASE; ACYL-AMP LIGASE; MYCOBACTERIUM-TUBERCULOSIS; STARTER UNIT; SUBSTRATE-SPECIFICITY; CONFERRING CODE; BIOSYNTHESIS; DOMAINS; MODEL; ANTIBIOTICS	Adenylation enzymes play important roles in the biosynthesis and degradation of primary and secondary metabolites. Mechanistic insights into the recognition of alpha-amino acid substrates have been obtained for alpha-amino acid adenylation enzymes. The Asp residue is invariant and is essential for the stabilization of the alpha-amino group of the substrate. In contrast, the beta-amino acid recognition mechanism of adenylation enzymes is still unclear despite the importance of beta-amino acid activation for the biosynthesis of various natural products. Herein, we report the crystal structure of the stand-alone adenylation enzyme VinN, which specifically activates (2S, 3S)-3-methylaspartate (3-MeAsp) in vicenistatin biosynthesis. VinN has an overall structure similar to that of other adenylation enzymes. The structure of the complex with 3-MeAsp revealed that a conserved Asp(230) residue is used in the recognition of the beta-amino group of 3-MeAsp similar to alpha-amino acid adenylation enzymes. A mutational analysis and structural comparison with alpha-amino acid adenylation enzymes showed that the substrate-binding pocket of VinN has a unique architecture to accommodate 3-MeAsp as a beta-amino acid substrate. Thus, the VinN structure allows the first visualization of the interaction of an adenylation enzyme with a beta-amino acid and provides new mechanistic insights into the selective recognition of beta-amino acids in this family of enzymes.	[Miyanaga, Akimasa; Kudo, Fumitaka] Tokyo Inst Technol, Dept Chem, Meguro Ku, Tokyo 1528551, Japan; [Cieslak, Jolanta; Shinohara, Yuji; Eguchi, Tadashi] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Eguchi, T (corresponding author), Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, 2-12-1 O Okayama, Tokyo 1528551, Japan.	eguchi@cms.titech.ac.jp	Miyanaga, Akimasa/C-1472-2015; Kudo, Fumitaka/C-9216-2015; Eguchi, Tadashi/B-9339-2015	Miyanaga, Akimasa/0000-0003-2219-6051; Kudo, Fumitaka/0000-0002-4788-0063; Eguchi, Tadashi/0000-0002-7830-7104	Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Nagase Science and Technology Foundation; Takeda Science Foundation	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nagase Science and Technology Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants-in-aid for scientific research in innovative areas from the Japanese Ministry of Education, Culture, Sports, Science and Technology, grants-in-aid for young scientists (B) from the Japan Society for the Promotion of Science, the Nagase Science and Technology Foundation, and the Takeda Science Foundation.	Amagai K, 2013, CHEMBIOCHEM, V14, P1998, DOI 10.1002/cbic.201300370; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chen CY, 2009, P NATL ACAD SCI USA, V106, P3764, DOI 10.1073/pnas.0900266106; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; DeLano W.L, PYMOL MOL GRAPHICS S; Drake EJ, 2010, BIOCHEMISTRY-US, V49, P9292, DOI 10.1021/bi101226n; Du LQ, 2008, BIOCHEMISTRY-US, V47, P11473, DOI 10.1021/bi801363b; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eppelmann K, 2002, BIOCHEMISTRY-US, V41, P9718, DOI 10.1021/bi0259406; Fortin PD, 2007, NATURE, V448, P824, DOI 10.1038/nature06068; Goyal A, 2006, ACTA CRYSTALLOGR F, V62, P350, DOI 10.1107/S1744309106005938; Goyal A, 2012, J MOL BIOL, V416, P221, DOI 10.1016/j.jmb.2011.12.031; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Herbst DA, 2013, J BIOL CHEM, V288, P1991, DOI 10.1074/jbc.M112.420182; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hughes AJ, 2011, CHEM BIOL, V18, P165, DOI 10.1016/j.chembiol.2010.12.014; Jorgensen H, 2009, CHEM BIOL, V16, P1109, DOI 10.1016/j.chembiol.2009.09.014; Khayatt BI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062136; Kudo F, 2014, NAT PROD REP, V31, P1056, DOI 10.1039/c4np00007b; Lee TV, 2010, J BIOL CHEM, V285, P2415, DOI 10.1074/jbc.M109.071324; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maruyama C, 2012, NAT CHEM BIOL, V8, P791, DOI [10.1038/NCHEMBIO.1040, 10.1038/nchembio.1040]; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; Mootz HD, 1997, J BACTERIOL, V179, P6843, DOI 10.1128/jb.179.21.6843-6850.1997; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishio M, 2014, PHYS CHEM CHEM PHYS, V16, P12648, DOI 10.1039/c4cp00099d; Rachid S, 2007, J BIOL CHEM, V282, P21810, DOI 10.1074/jbc.M703439200; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Rouhiainen L, 2004, APPL ENVIRON MICROB, V70, P686, DOI 10.1128/AEM.70.2.686-692.2004; SHINDO K, 1993, J ANTIBIOT, V46, P1076, DOI 10.7164/antibiotics.46.1076; Shinohara Y, 2011, J AM CHEM SOC, V133, P18134, DOI 10.1021/ja208927r; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stevens BW, 2006, BIOCHEMISTRY-US, V45, P15495, DOI 10.1021/bi061788m; Takaishi M, 2013, J ANTIBIOT, V66, P691, DOI 10.1038/ja.2013.76; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Thirlway J, 2012, ANGEW CHEM INT EDIT, V51, P7181, DOI 10.1002/anie.201202043; Udwary DW, 2007, P NATL ACAD SCI USA, V104, P10376, DOI 10.1073/pnas.0700962104; Uguru GC, 2004, J AM CHEM SOC, V126, P5032, DOI 10.1021/ja048778y; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Van Lanen SG, 2006, J BIOL CHEM, V281, P29633, DOI 10.1074/jbc.M605887200; Villiers BRM, 2009, CHEMBIOCHEM, V10, P671, DOI 10.1002/cbic.200800553; Wackler B, 2012, CHEMBIOCHEM, V13, P1798, DOI 10.1002/cbic.201200187; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200	48	32	32	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31448	31457		10.1074/jbc.M114.602326	http://dx.doi.org/10.1074/jbc.M114.602326			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25246523	Green Published, hybrid			2022-12-28	WOS:000344549900047
J	Onish, C; Mori-Kimachi, S; Hirade, T; Abe, M; Taketani, T; Suzumiya, J; Sugimoto, T; Yamaguchi, S; Kapur, R; Fukuda, S				Onish, Chie; Mori-Kimachi, Satomi; Hirade, Tomohiro; Abe, Mariko; Taketani, Takeshi; Suzumiya, Junji; Sugimoto, Toshitsugu; Yamaguchi, Seiji; Kapur, Reuben; Fukuda, Seiji			Internal Tandem Duplication Mutations in FLT3 Gene Augment Chernotaxis to Cxcl12 Protein by Blocking the Down-regulation of the Rho-associated Kinase via the Cxcl12/Cxcr4 Signaling Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA STEM-CELLS; CHEMOKINE RECEPTOR; CXCR4; EXPRESSION; INHIBITOR; MIGRATION; SURVIVAL; ADHESION; BEHAVIOR; MODEL	Internal tandem duplication mutations in the Flt3 gene (ITD-FLT3) enhance cell migration toward the chemokine Cxcl12, which is highly expressed in the therapy-protective bone marrow niche, providing a potential mechanism underlying the poor prognosis of ITD-FLT3(+) acute myeloid leukemia. We aimed to investigate the mechanisms linking ITD-FLT3 to increased cell migration toward Cxcl12. Classification of the expression of Cxcl12-regulated genes in ITD-FLT3(+) cells demonstrated that the enhanced migration of ITD-FLT3(+) cells toward Cxcl12 was associated with the differential expression of genes downstream of Cxcl12/Cxcr4, which are functionally distinct from those expressed in ITD-FLT3(-) cells but are independent of the Cxcr4 expression levels. Among these differentially regulated genes, the expression of Rock] in the ITD-FLT3(+) cells that migrated toward Cxcl12 was significantly higher than in ITD-FLT3(-) cells that migrated toward Cxcl12. In ITD-FLT3(-) cells, Rock1 expression and Mypt1 phosphorylation were transiently up-regulated but were subsequently down-regulated by Cxcl12. In contrast, the presence of ITD-FLT3 blocked the Cxcl12-induced down-regulation of Rock1 and early Mypt1 dephosphorylation. Likewise, the FLT3 ligand counteracted the Cxcl12-induced down-regulation of Rock1 in ITD-FLT3(-) cells, which coincided with enhanced cell migration toward Cxcl12. Rock1 antagonists or Rock1 shRNA abolished the enhanced migration of ITD-FLT3(+) cells toward Cxcl12. Our findings demonstrate that ITD-FLT3 increases cell migration toward Cxcl12 by antagonizing the down-regulation of Rock1 expression. These findings suggest that the aberrant modulation of Rock1 expression and activity induced by ITD-FLT3 may enhance acute myeloid leukemia cell chemotaxis to the therapy-protective bone marrow niche, where Cxcl12 is abundantly expressed.	[Onish, Chie; Suzumiya, Junji] Shimane Univ, Sch Med, Dept Oncol Hematol, Izumo, Shimane 6938501, Japan; [Mori-Kimachi, Satomi; Hirade, Tomohiro; Abe, Mariko; Yamaguchi, Seiji; Fukuda, Seiji] Shimane Univ, Sch Med, Dept Pediat, Izumo, Shimane 6938501, Japan; [Sugimoto, Toshitsugu] Shimane Univ, Sch Med, Dept Internal Med 1, Izumo, Shimane 6938501, Japan; [Taketani, Takeshi] Shimane Univ Hosp, Div Blood Transfus, Izumo, Shimane 6938501, Japan; [Kapur, Reuben] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Kapur, Reuben] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	Shimane University; Shimane University; Shimane University; Shimane University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Onish, C (corresponding author), Shimane Univ, Sch Med, Dept Oncol Hematol, Izumo, Shimane 6938501, Japan.	mikami@med.shimane-u.ac.jp; sfukuda@med.shimane-u.ac.jp		mori, satomi/0000-0002-8026-6954	Medical and Pharmaceutical Research Fund; Sankyo Biomedical Research Foundation; Mitsubishi Mother and Pharma Research Foundation; Japanese Leukemia Research Fund; Naito Foundation [20390298, 25461 593]; Japanese Society for the Promotion of Science [24791064]; NATIONAL CANCER INSTITUTE [R01CA173852, R01CA134777] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077177] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25461593] Funding Source: KAKEN	Medical and Pharmaceutical Research Fund; Sankyo Biomedical Research Foundation; Mitsubishi Mother and Pharma Research Foundation; Japanese Leukemia Research Fund; Naito Foundation(Naito Memorial Foundation); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research support funds from the Medical and Pharmaceutical Research Fund, the Sankyo Biomedical Research Foundation, the Mitsubishi Mother and Pharma Research Foundation, the Japanese Leukemia Research Fund, the Naito Foundation, Grants-in-aid for Scientific Research 20390298 and 25461 593 (to S. F.), and Grant-in-aid for Young Investigators 24791064 (to C.O.) from the Japanese Society for the Promotion of Science.	Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Basu S, 2005, BLOOD, V106, P485, DOI 10.1182/blood-2004-10-4145; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Choi YH, 2014, MOL CANCER RES, V12, P38, DOI 10.1158/1541-7786.MCR-12-0334; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Fiedler W, 2003, BLOOD, V102, P2763, DOI 10.1182/blood-2002-10-2998; Fukuda S, 2005, BLOOD, V105, P3117, DOI 10.1182/blood-2004-04-1440; Fukuda S, 2009, BLOOD, V114, P394, DOI 10.1182/blood-2008-11-188714; Fukumoto Y, 2013, CIRC J, V77, P2619, DOI 10.1253/circj.CJ-13-0443; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jacobi A, 2010, EXP HEMATOL, V38, P180, DOI 10.1016/j.exphem.2009.12.003; Ji Z, 2014, J IMMUNOL, V193, P2157, DOI 10.4049/jimmunol.1302702; Kelly LM, 2002, BLOOD, V99, P310, DOI 10.1182/blood.V99.1.310; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Mali RS, 2011, CANCER CELL, V20, P357, DOI 10.1016/j.ccr.2011.07.016; Mohle R, 2000, BRIT J HAEMATOL, V110, P563, DOI 10.1046/j.1365-2141.2000.02157.x; Moyer RA, 2007, LAB INVEST, V87, P807, DOI 10.1038/labinvest.3700595; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Rombouts EJC, 2004, BLOOD, V104, P550, DOI 10.1182/blood-2004-02-0566; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Smith BD, 2004, BLOOD, V103, P3669, DOI 10.1182/blood-2003-11-3775; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Struckhoff AP, 2010, J CELL SCI, V123, P401, DOI 10.1242/jcs.052167; Tavor S, 2004, CANCER RES, V64, P2817, DOI 10.1158/0008-5472.CAN-03-3693; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Vicente-Manzanares M, 2002, J IMMUNOL, V168, P400, DOI 10.4049/jimmunol.168.1.400; Voermans C, 2002, LEUKEMIA, V16, P650, DOI 10.1038/sj.leu.2402431; Wijtmans M, 2012, EUR J MED CHEM, V51, P184, DOI 10.1016/j.ejmech.2012.02.041; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311	32	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31053	31065		10.1074/jbc.M114.568287	http://dx.doi.org/10.1074/jbc.M114.568287			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25237195	hybrid, Green Published			2022-12-28	WOS:000344549900015
J	Abe, K; Tani, K; Fujiyoshi, Y				Abe, Kazuhiro; Tani, Kazutoshi; Fujiyoshi, Yoshinori			Systematic Comparison of Molecular Conformations of H+,K+-ATPase Reveals an Important Contribution of the A-M2 Linker for the Luminal Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-POTASSIUM PUMP; CRYSTAL-STRUCTURE; GASTRIC H+,K+-ATPASE; STRUCTURAL BASIS; ION-TRANSPORT; BETA-SUBUNIT; K+-ATPASE; H,K-ATPASE; BINDING; NA+	GastricH(+),K+-ATPase, an ATP-driven proton pump responsible for gastric acidification, is a molecular target for anti-ulcer drugs. Here we show its cryo-electron microscopy ( EM) structure in an E2P analog state, bound to magnesium fluoride (MgF), and its K+-competitive antagonist SCH28080, determined at 7 angstrom resolution by electron crystallography of two-dimensional crystals. Systematic comparison with other E2P-related cryo-EM structures revealed that the molecular conformation in the (SCH)E2.MgF state is remarkably distinguishable. Although the azimuthal position of the A domain of the (SCH)E2.MgF state is similar to that in the E2.AlF (aluminum fluoride) state, in which the transmembrane luminal gate is closed, the arrangement of transmembrane helices in the (SCH)E2.MgF state shows a luminal-open conformation imposed on by bound SCH28080 at its luminal cavity, based on observations of the structure in the SCH28080-bound E2.BeF (beryllium fluoride) state. The molecular conformation of the (SCH)E2.MgF state thus represents a mixed overall structure in which its cytoplasmic and luminal half appear to be independently modulated by a phosphate analog and an antagonist bound to the respective parts of the enzyme. Comparison of the molecular conformations revealed that the linker region connecting the A domain and the transmembrane helix 2 (A-M2 linker) mediates the regulation of luminal gating. The mechanistic rationale underlying luminal gating observed in H+,K+-ATPase is consistent with that observed in sarcoplasmic reticulum Ca2+-ATPase and other P-type ATPases and is most likely conserved for the P-type ATPase family in general.	[Abe, Kazuhiro; Tani, Kazutoshi; Fujiyoshi, Yoshinori] Nagoya Univ, Cellular & Struct Physiol Inst, Nagoya, Aichi 4648601, Japan; [Abe, Kazuhiro; Fujiyoshi, Yoshinori] Nagoya Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Abe, K (corresponding author), Nagoya Univ, Cellular & Struct Physiol Inst, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	kabe@cespi.nagoya-u.ac.jp	Tani, Kazutoshi/B-3705-2008; Abe, Kazuhiro/D-7662-2013	Tani, Kazutoshi/0000-0003-4835-154X; Abe, Kazuhiro/0000-0003-2681-5921	New Energy and Industrial Technology Development Organization (NEDO); National Institute of Biomedical Innovation; METI, Japan; Grants-in-Aid for Scientific Research [26440024] Funding Source: KAKEN	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); METI, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for Scientific Research (S), New Energy and Industrial Technology Development Organization (NEDO), and the National Institute of Biomedical Innovation (to Y. F.), grants-in-aid for Scientific Research (C) (to K. T.), and grants-in-aid for Young Scientist (A) and Platform for Drug Design, Discovery, and Development from METI, Japan (to K. A.).	Abe K, 2005, J BIOCHEM, V138, P293, DOI 10.1093/jb/mvi127; Abe K, 2002, BIOCHEMISTRY-US, V41, P2438, DOI 10.1021/bi015622r; Abe K, 2012, P NATL ACAD SCI USA, V109, P18401, DOI 10.1073/pnas.1212294109; Abe K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1154; Abe K, 2010, J STRUCT BIOL, V170, P60, DOI 10.1016/j.jsb.2009.12.008; Abe K, 2009, EMBO J, V28, P1637, DOI 10.1038/emboj.2009.102; AGARD DA, 1983, J MOL BIOL, V167, P849, DOI 10.1016/S0022-2836(83)80114-4; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Andersson M, 2014, NAT STRUCT MOL BIOL, V21, P43, DOI 10.1038/nsmb.2721; Bublitz M, 2010, CURR OPIN STRUC BIOL, V20, P431, DOI 10.1016/j.sbi.2010.06.007; CHANG H, 1977, BIOCHIM BIOPHYS ACTA, V464, P313, DOI 10.1016/0005-2736(77)90006-2; CHOW DC, 1995, J EXP BIOL, V198, P1; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Durr KL, 2009, J BIOL CHEM, V284, P20147, DOI 10.1074/jbc.M109.005769; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARLEY RA, 1985, J BIOL CHEM, V260, P3899; FUJIYOSHI Y, 1991, ULTRAMICROSCOPY, V38, P241, DOI 10.1016/0304-3991(91)90159-4; Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)90004-1; GANSER AL, 1973, BIOCHIM BIOPHYS ACTA, V307, P169, DOI 10.1016/0005-2736(73)90035-7; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Gyobu N, 2004, J STRUCT BIOL, V146, P325, DOI 10.1016/j.jsb.2004.01.012; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; KEELING DJ, 1989, J BIOL CHEM, V264, P5545; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; McIntosh DB, 2008, BIOCHEMISTRY-US, V47, P6386, DOI 10.1021/bi800290q; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Nyblom M, 2013, SCIENCE, V342, P123, DOI 10.1126/science.1243352; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; POST RL, 1972, J BIOL CHEM, V247, P6530; RABON EC, 1990, ANNU REV PHYSIOL, V52, P321; RABON EC, 1990, J BIOL CHEM, V265, P19594; SACHS G, 1976, J BIOL CHEM, V251, P7690; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shin JM, 2009, PFLUG ARCH EUR J PHY, V457, P609, DOI 10.1007/s00424-008-0495-4; Shin JM, 2005, BIOCHEMISTRY-US, V44, P16321, DOI 10.1021/bi051342q; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Tani K, 1996, ULTRAMICROSCOPY, V65, P31, DOI 10.1016/S0304-3991(96)00052-6; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2013, CURR OPIN STRUC BIOL, V23, P507, DOI 10.1016/j.sbi.2013.06.005; VANDERHIJDEN HTWM, 1991, BIOCHIM BIOPHYS ACTA, V1061, P141, DOI 10.1016/0005-2736(91)90278-G; WOLOSIN JM, 1985, AM J PHYSIOL, V248, pG595, DOI 10.1152/ajpgi.1985.248.6.G595; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Yang F, 2013, MICROSCOPY-JPN, V62, P597, DOI 10.1093/jmicro/dft038; YEH LA, 1990, MEMBRANE BIOCHEM, V9, P129, DOI 10.3109/09687689009025835	52	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30590	30601		10.1074/jbc.M114.584623	http://dx.doi.org/10.1074/jbc.M114.584623			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231997	Green Published, hybrid			2022-12-28	WOS:000344549700036
J	Jansen, S; Collins, A; Golden, L; Sokolova, O; Goode, BL				Jansen, Silvia; Collins, Agnieszka; Golden, Leslie; Sokolova, Olga; Goode, Bruce L.			Structure and Mechanism of Mouse Cyclase-associated Protein (CAP1) in Regulating Actin Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACANTHAMOEBA ACTOPHORIN ADF/COFILIN; FILAMENT TURNOVER; IN-VIVO; F-ACTIN; SRV2/CYCLASE-ASSOCIATED PROTEIN; SRV2/CAP COMPLEX; PORCINE BRAIN; COFILIN; PROFILIN; MONOMERS	Srv2/CAP is a conserved actin-binding protein with important roles in driving cellular actin dynamics in diverse animal, fungal, and plant species. However, there have been conflicting reports about whether the activities of Srv2/CAP are conserved, particularly between yeast and mammalian homologs. Yeast Srv2 has two distinct functions in actin turnover: its hexameric N-terminal-half enhances cofilin-mediated severing of filaments, while its C-terminal-half catalyzes dissociation of cofilin from ADP-actin monomers and stimulates nucleotide exchange. Here, we dissected the structure and function of mouse CAP1 to better understand its mechanistic relationship to yeast Srv2. Although CAP1 has a shorter N-terminal oligomerization sequence compared with Srv2, we find that the N-terminal-half of CAP1 (N-CAP1) forms hexameric structures with six protrusions, similar to N-Srv2. Further, N-CAP1 autonomously binds to F-actin and decorates the sides and ends of filaments, altering F-actin structure and enhancing cofilin-mediated severing. These activities depend on conserved surface residues on the helical-folded domain. Moreover, N-CAP1 enhances yeast cofilin-mediated severing, and conversely, yeast N-Srv2 enhances human cofilin-mediated severing, highlighting the mechanistic conservation between yeast and mammals. Further, we demonstrate that the C-terminal actin-binding beta-sheet domain of CAP1 is sufficient to catalyze nucleotide-exchange of ADP-actin monomers, while in the presence of cofilin this activity additionally requires the WH2 domain. Thus, the structures, activities, and mechanisms of mouse and yeast Srv2/CAP homologs are remarkably well conserved, suggesting that the same activities and mechanisms underlie many of the diverse actin-based functions ascribed to Srv2/CAP homologs in different organisms.	[Jansen, Silvia; Collins, Agnieszka; Golden, Leslie; Goode, Bruce L.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA; [Sokolova, Olga] Moscow MV Lomonosov State Univ, Fac Biol, Moscow 119991, Russia	Brandeis University; Lomonosov Moscow State University	Goode, BL (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, 415 South St, Waltham, MA 02454 USA.	goode@brandeis.edu	Sokolova, Olga S/G-7794-2016		Russian Scientific Foundation [14-14-00234]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063691] Funding Source: NIH RePORTER	Russian Scientific Foundation(Russian Science Foundation (RSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Chen Xu for assistance with the Morgani electron microscope. The three-dimensional reconstruction of N-CAP1 was accomplished with grant support from the Russian Scientific Foundation (Project 14-14-00234) (to O. S.).	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/S0960-9822(03)00907-2; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Blanchoin L, 1998, J BIOL CHEM, V273, P25106, DOI 10.1074/jbc.273.39.25106; Brieher W, 2013, MOL BIOL CELL, V24, P2299, DOI 10.1091/mbc.E12-09-0694; Chaudhry F, 2014, CYTOSKELETON, V71, P351, DOI 10.1002/cm.21170; Chaudhry F, 2013, MOL BIOL CELL, V24, P31, DOI 10.1091/mbc.E12-08-0589; Chaudhry F, 2010, CYTOSKELETON, V67, P120, DOI 10.1002/cm.20429; Elam WA, 2013, FEBS LETT, V587, P1215, DOI 10.1016/j.febslet.2013.01.062; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Graziano BR, 2013, J CELL BIOL, V201, P595, DOI 10.1083/jcb.201212059; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MABUCHI I, 1983, J CELL BIOL, V97, P1612, DOI 10.1083/jcb.97.5.1612; MACIVER SK, 1991, J CELL BIOL, V115, P1611, DOI 10.1083/jcb.115.6.1611; Makkonen M, 2013, J BIOL CHEM, V288, P984, DOI 10.1074/jbc.M112.435719; Mattila PK, 2004, MOL BIOL CELL, V15, P5158, DOI 10.1091/mbc.E04-06-0444; McCullough BR, 2008, J MOL BIOL, V381, P550, DOI 10.1016/j.jmb.2008.05.055; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; MINTZER KA, 1994, CELL SIGNAL, V6, P681, DOI 10.1016/0898-6568(94)90050-7; Moriyama K, 2002, BIOCHEM J, V365, P147, DOI 10.1042/BJ20020231; NISHIDA E, 1984, J BIOCHEM-TOKYO, V95, P399, DOI 10.1093/oxfordjournals.jbchem.a134620; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P1160, DOI 10.1021/bi00326a015; Normoyle KPM, 2012, J BIOL CHEM, V287, P35722, DOI 10.1074/jbc.M112.396051; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Ono S, 2013, J CELL SCI, V126, P3249, DOI 10.1242/jcs.128231; Quintero-Monzon O, 2009, J BIOL CHEM, V284, P10923, DOI 10.1074/jbc.M808760200; Shima F, 2000, MOL CELL BIOL, V20, P26, DOI 10.1128/MCB.20.1.26-33.2000; Suarez C, 2011, CURR BIOL, V21, P862, DOI 10.1016/j.cub.2011.03.064; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004	36	39	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30732	30742		10.1074/jbc.M114.601765	http://dx.doi.org/10.1074/jbc.M114.601765			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25228691	Green Published, hybrid			2022-12-28	WOS:000344549700048
J	Thwaites, T; Nogueira, AT; Campeotto, I; Silva, AP; Grieshaber, SS; Carabeo, RA				Thwaites, Tristan; Nogueira, Ana T.; Campeotto, Ivan; Silva, Ana P.; Grieshaber, Scott S.; Carabeo, Rey A.			The Chlamydia Effector TarP Mimics the Mammalian Leucine-Aspartic Acid Motif of Paxillin to Subvert the Focal Adhesion Kinase during Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; TRACHOMATIS; PROTEIN; RECRUITMENT; BINDING; ENTRY; IDENTIFICATION; INCLUSION; COMPLEX; FAMILY	Host cell signal transduction pathways are often targets of bacterial pathogens, especially during the process of invasion when robust actin remodeling is required. We demonstrate that the host cell focal adhesion kinase (FAK) was necessary for the invasion by the obligate intracellular pathogen Chlamydia caviae. Bacterial adhesion triggered the transient recruitment of FAK to the plasma membrane to mediate a Cdc42-and Arp2/3-dependent actin assembly. FAK recruitment was via binding to a domain within the virulence factor TarP that mimicked the LD2 motif of the FAK binding partner paxillin. Importantly, bacterial two-hybrid and quantitative imaging assays revealed a similar level of interaction between paxillin-LD2 and TarP-LD. The conserved leucine residues within the L(D/E) XLLXXL motif were essential to the recruitment of FAK, Cdc42, p34(Arc), and actin to the plasma membrane. In the absence of FAK, TarP-LD-mediated F-actin assembly was reduced, highlighting the functional relevance of this interaction. Together, the data indicate that a prokaryotic version of the paxillin LD2 domain targets the FAK signaling pathway, with TarP representing the first example of an LD-containing Type III virulence effector.	[Thwaites, Tristan; Nogueira, Ana T.; Campeotto, Ivan; Carabeo, Rey A.] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; [Thwaites, Tristan; Nogueira, Ana T.; Silva, Ana P.; Carabeo, Rey A.] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Bacteriol Sect,Programme Microbiol, Aberdeen AB25 2ZD, Scotland; [Grieshaber, Scott S.] Univ Florida, Sch Dent, Dept Oral Biol, Gainesville, FL 32610 USA	Imperial College London; University of Aberdeen; State University System of Florida; University of Florida	Carabeo, RA (corresponding author), Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland.	r.carabeo@abdn.ac.uk		Teixeira Nogueira, Ana/0000-0002-0476-3676; CARABEO, REY/0000-0002-5708-5493; Campeotto, Ivan/0000-0002-0814-619X	Medical Research Council; University of Aberdeen Knowledge Exchange and Transfer Fund; Medical Research Council studentship; Fundacao para a Ciencia e a Tecnologia studentship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065545] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Aberdeen Knowledge Exchange and Transfer Fund; Medical Research Council studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para a Ciencia e a Tecnologia studentship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Medical Research Council and the University of Aberdeen Knowledge Exchange and Transfer Fund (to R. A. C.).; Supported by a Medical Research Council studentship.; Supported by a Fundacao para a Ciencia e a Tecnologia studentship.	Beatty WL, 2008, INFECT IMMUN, V76, P2872, DOI 10.1128/IAI.00129-08; Boehm M, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00017; Boncompain G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086196; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Campellone KG, 2004, J CELL BIOL, V164, P407, DOI 10.1083/jcb.200306032; Carabeo RA, 2004, TRAFFIC, V5, P418, DOI 10.1111/j.1398-9219.2004.00184.x; Carabeo RA, 2002, INFECT IMMUN, V70, P3793, DOI 10.1128/IAI.70.7.3793-3803.2002; Carabeo R, 2011, CELL MICROBIOL, V13, P1460, DOI 10.1111/j.1462-5822.2011.01651.x; Carabeo RA, 2007, CELL MICROBIOL, V9, P2278, DOI 10.1111/j.1462-5822.2007.00958.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clifton DR, 2005, INFECT IMMUN, V73, P3860, DOI 10.1128/IAI.73.7.3860-3868.2005; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Coombes BK, 2002, CELL MICROBIOL, V4, P447, DOI 10.1046/j.1462-5822.2002.00203.x; Dumoux M, 2012, TRAFFIC, V13, P1612, DOI 10.1111/tra.12002; Elwell CA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000021; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; Gurumurthy RK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000651; Hackstadt T, 1998, CURR OPIN MICROBIOL, V1, P82, DOI 10.1016/S1369-5274(98)80146-X; Hall JE, 2011, INT REV CEL MOL BIO, V288, P185, DOI 10.1016/B978-0-12-386041-5.00005-4; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Iwanicki MP, 2008, J CELL SCI, V121, P895, DOI 10.1242/jcs.020941; Jewett TJ, 2006, P NATL ACAD SCI USA, V103, P15599, DOI 10.1073/pnas.0603044103; Jiwani S, 2013, J BACTERIOL, V195, P708, DOI 10.1128/JB.01768-12; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Kumar Yadunanda, 2008, Commun Integr Biol, V1, P175; Lane BJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000014; Laurin M, 2014, GENE DEV, V28, P533, DOI 10.1101/gad.236349.113; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Molleken K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003325; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; MOULDER JW, 1985, MICROBIOL REV, V49, P298, DOI 10.1128/MMBR.49.3.298-337.1985; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ouellette SP, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00112; Ouellette SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016783; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Scheswohl Danielle M, 2008, J Mol Signal, V3, P1, DOI 10.1186/1750-2187-3-1; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Subtil A, 2004, J CELL SCI, V117, P3923, DOI 10.1242/jcs.01247; Thomas JW, 1999, J BIOL CHEM, V274, P36684, DOI 10.1074/jbc.274.51.36684; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Tomar A, 2009, J CELL SCI, V122, P1852, DOI 10.1242/jcs.046870; Wade R, 2006, BIOCHEM J, V393, P565, DOI 10.1042/BJ20051241; Wang AY, 2010, J BACTERIOL, V192, P2809, DOI 10.1128/JB.01462-09; Wong ARC, 2012, MBIO, V3, DOI 10.1128/mBio.00250-11; WYRICK PB, 1994, MICROB PATHOGENESIS, V17, P159, DOI 10.1006/mpat.1994.1062	52	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30426	30442		10.1074/jbc.M114.604876	http://dx.doi.org/10.1074/jbc.M114.604876			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25193659	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000344549700024
J	Ugarte-Uribe, B; Muller, HM; Otsuki, M; Nickel, W; Garcia-Saez, AJ				Ugarte-Uribe, Begona; Mueller, Hans-Michael; Otsuki, Miki; Nickel, Walter; Garcia-Saez, Ana J.			Dynamin-related Protein 1 (Drp1) Promotes Structural Intermediates of Membrane Division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL FISSION; CONFORMATIONAL-CHANGES; PEROXISOMAL FISSION; CRYSTAL-STRUCTURE; MIDDLE DOMAIN; GTPASE; FIS1; MFF; RECRUITMENT; MID51	Drp1 is a dynamin-like GTPase that mediates mitochondrial and peroxisomal division in a process dependent on self-assembly and coupled to GTP hydrolysis. Despite the link between Drp1 malfunction and human disease, the molecular details of its membrane activity remain poorly understood. Here we reconstituted and directly visualized Drp1 activity in giant unilamellar vesicles. We quantified the effect of lipid composition and GTP on membrane binding and remodeling activity by fluorescence confocal microscopy and flow cytometry. In contrast to other dynamin relatives, Drp1 bound to both curved and flat membranes even in the absence of nucleotides. We also found that Drp1 induced membrane tubulation that was stimulated by cardiolipin. Moreover, Drp1 promoted membrane tethering dependent on the intrinsic curvature of the membrane lipids and on GTP. Interestingly, Drp1 concentrated at membrane contact surfaces and, in the presence of GTP, formed discrete clusters on the vesicles. Our findings support a role of Drp1 not only in the formation of lipid tubes but also on the stabilization of tightly apposed membranes, which are intermediate states in the process of mitochondrial fission.	[Ugarte-Uribe, Begona; Otsuki, Miki; Garcia-Saez, Ana J.] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany; [Ugarte-Uribe, Begona; Garcia-Saez, Ana J.] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Mueller, Hans-Michael; Nickel, Walter] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Ruprecht Karls University Heidelberg	Garcia-Saez, AJ (corresponding author), Interfac Inst Biochem, Hoppe Seyler Str 4, D-72076 Tubingen, Germany.	ana.garcia@uni-tuebingen.de	Saez, Ana J. Garcia/U-1611-2019	Muller, Hans-Michael/0000-0002-2384-7285	Max Planck Society; German Cancer Research Center; German Ministry for Education and Research (BMBF) [N.0312040]	Max Planck Society(Max Planck Society); German Cancer Research Center(Helmholtz Association); German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Max Planck Society, by the German Cancer Research Center, and by German Ministry for Education and Research (BMBF) Grant N.0312040.	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bhar D, 2006, J BIOL CHEM, V281, P17312, DOI 10.1074/jbc.M513530200; Bleicken S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035910; Bossy B, 2010, J ALZHEIMERS DIS, V20, pS513, DOI 10.3233/JAD-2010-100552; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Bustillo-Zabalbeitia I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102738; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Guo T, 2007, J CELL BIOL, V177, P289, DOI 10.1083/jcb.200609072; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Itoyama A, 2013, BIOL OPEN, V2, P998, DOI 10.1242/bio.20135298; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kobayashi S, 2007, EXP CELL RES, V313, P1675, DOI 10.1016/j.yexcr.2007.02.028; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lackner LL, 2009, SCIENCE, V325, P874, DOI 10.1126/science.1176921; LEE YC, 1993, BIOPHYS J, V65, P1429, DOI 10.1016/S0006-3495(93)81206-2; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Lewis RNAH, 2000, BIOPHYS J, V79, P1455, DOI 10.1016/S0006-3495(00)76397-1; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Loson OC, 2014, STRUCTURE, V22, P367, DOI 10.1016/j.str.2014.01.001; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Macdonald PJ, 2014, MOL BIOL CELL, V25, P1905, DOI 10.1091/mbc.E14-02-0728; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Morlot S, 2013, ANNU REV BIOPHYS, V42, P629, DOI 10.1146/annurev-biophys-050511-102247; Morlot S, 2012, CELL, V151, P619, DOI 10.1016/j.cell.2012.09.017; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Neumann S, 2013, J BIOL CHEM, V288, P25119, DOI 10.1074/jbc.M113.490474; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2013, J BIOL CHEM, V288, P27584, DOI 10.1074/jbc.M113.479873; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Rappoport JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002416; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Schrader M, 2012, BBA-MOL BASIS DIS, V1822, P1343, DOI 10.1016/j.bbadis.2011.12.014; Schumann U, 2008, TRENDS CELL BIOL, V18, P253, DOI 10.1016/j.tcb.2008.04.002; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Sever S, 2006, EMBO J, V25, P4163, DOI 10.1038/sj.emboj.7601298; Shnyrova AV, 2013, SCIENCE, V339, P1433, DOI 10.1126/science.1233920; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Strack S, 2012, J BIOL CHEM, V287, P10990, DOI 10.1074/jbc.M112.342105; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Temmerman K, 2009, J LIPID RES, V50, P1245, DOI 10.1194/jlr.D800043-JLR200; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Wenger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071835; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	75	44	44	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30645	30656		10.1074/jbc.M114.575779	http://dx.doi.org/10.1074/jbc.M114.575779			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25237193	Green Published, hybrid			2022-12-28	WOS:000344549700041
J	Bucker, R; Heroven, AK; Becker, J; Dersch, P; Wittmann, C				Buecker, Rene; Heroven, Ann Kathrin; Becker, Judith; Dersch, Petra; Wittmann, Christoph			The Pyruvate-Tricarboxylic Acid Cycle Node A FOCAL POINT OF VIRULENCE CONTROL IN THE ENTERIC PATHOGEN YERSINIA PSEUDOTUBERCULOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Bacterial Metabolism; Bacterial Pathogenesis; Gene Expression; Pyruvate; Systems Biology; Tricarboxylic Acid Cycle (TCA Cycle) (Krebs Cycle); Metabolic Flux Analysis; Yersinia	ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; METABOLIC-RESPONSES; CHROMOSOMAL GENES; LYSINE PRODUCTION; SECRETION SYSTEM; EXPRESSION; FLUX; CARBON; PROTEIN	Background:Yersinia pseudotuberculosis is a human pathogen and the ancestor of Y. pestis. Results: The pyruvate-tricarboxylic acid cycle node in the carbon core metabolism of Y. pseudotuberculosis is a focal point of its virulence control system. Conclusion: Mutants genetically perturbed at this metabolic control point are less virulent in mouse infection studies. Significance: Learning how pathogenic traits are controlled is crucial for finding novel drug targets against the pathogen. Despite our increasing knowledge of the specific pathogenicity factors in bacteria, the contribution of metabolic processes to virulence is largely unknown. Here, we elucidate a tight connection between pathogenicity and core metabolism in the enteric pathogen Yersinia pseudotuberculosis by integrated transcriptome and [C-13]fluxome analysis of the wild type and virulence-regulator mutants. During aerobic growth on glucose, Y. pseudotuberculosis reveals an unusual flux distribution with a high level of secreted pyruvate. The absence of the transcriptional and post-transcriptional regulators RovA, CsrA, and Crp strongly perturbs the fluxes of carbon core metabolism at the level of pyruvate metabolism and the tricarboxylic acid (TCA) cycle, and these perturbations are accompanied by transcriptional changes in the corresponding enzymes. Knock-outs of regulators of this metabolic branch point and of its central enzyme, pyruvate kinase (pykF), result in mutants with significantly reduced virulence in an oral mouse infection model. In summary, our work identifies the pyruvate-TCA cycle node as a focal point for controlling the host colonization and virulence of Yersinia.	[Buecker, Rene; Becker, Judith; Wittmann, Christoph] Univ Saarland, Inst Syst Biotechnol, D-66123 Saarbrucken, Germany; [Buecker, Rene] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Engn, D-38106 Braunschweig, Germany; [Heroven, Ann Kathrin; Dersch, Petra] Helmholtz Ctr Infect Res, Dept Mol Infect Biol, D-38124 Braunschweig, Germany	Saarland University; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research	Wittmann, C (corresponding author), Univ Saarland, Inst Syst Biotechnol, Campus A1-5, D-66123 Saarbrucken, Germany.	christoph.wittmann@uni-saarland.de		Wittmann, Christoph/0000-0002-7952-985X	Deutsche Forschungsgemeinschaft (Host-Adapted Metabolism of Bacterial Pathogens) [SPP 1316]	Deutsche Forschungsgemeinschaft (Host-Adapted Metabolism of Bacterial Pathogens)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Host-Adapted Metabolism of Bacterial Pathogens) Grant SPP 1316.	Abernathy J, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-5; Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Ansong C, 2013, MOL BIOSYST, V9, P44, DOI 10.1039/c2mb25287b; Antoniewicz MR, 2007, METAB ENG, V9, P68, DOI 10.1016/j.ymben.2006.09.001; Atkinson S, 2008, MOL MICROBIOL, V69, P137, DOI 10.1111/j.1365-2958.2008.06268.x; Atkinson S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001250; Becker J, 2005, APPL ENVIRON MICROB, V71, P8587, DOI 10.1128/AEM.71.12.8587-8596.2005; Becker J, 2013, BIOTECHNOL BIOENG, V110, P3013, DOI 10.1002/bit.24963; Becker J, 2009, APPL ENVIRON MICROB, V75, P7866, DOI 10.1128/AEM.01942-09; Becker J, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-8; BOLIN I, 1982, INFECT IMMUN, V37, P506; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bottone EJ, 1997, CLIN MICROBIOL REV, V10, P257, DOI 10.1128/CMR.10.2.257; Bowden SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013871; Brown T.A., 2002, GENOMES, V2nd; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chubukov V, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.66; Commichau FM, 2006, CURR OPIN MICROBIOL, V9, P167, DOI 10.1016/j.mib.2006.01.001; Dacheux D, 2002, INFECT IMMUN, V70, P3973, DOI 10.1128/IAI.70.7.3973-3977.2002; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dauner M, 2001, BIOTECHNOL BIOENG, V76, P132, DOI 10.1002/bit.1153; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Dube P, 2009, CURR TOP MICROBIOL, V337, P61, DOI 10.1007/978-3-642-01846-6_3; Emmerling M, 2002, J BACTERIOL, V184, P152, DOI 10.1128/JB.184.1.152-164.2002; Evans MR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-58; FERRARIS RP, 1990, AM J PHYSIOL, V259, pG822, DOI 10.1152/ajpgi.1990.259.5.G822; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gohler AK, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-197; Heesemann J, 2006, CURR OPIN MICROBIOL, V9, P55, DOI 10.1016/j.mib.2005.10.018; Heroven AK, 2004, MOL MICROBIOL, V53, P871, DOI 10.1111/j.1365-2958.2004.04162.x; Heroven AK, 2008, MOL MICROBIOL, V68, P1179, DOI 10.1111/j.1365-2958.2008.06218.x; Heroven AK, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00158; Heroven AK, 2012, RNA BIOL, V9, P379, DOI 10.4161/rna.19333; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Hofreuter D, 2008, CELL HOST MICROBE, V4, P425, DOI 10.1016/j.chom.2008.10.002; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; Jahn S, 2013, BBA-MOL CELL RES, V1833, P2879, DOI 10.1016/j.bbamcr.2013.07.011; Jalava K, 2006, J INFECT DIS, V194, P1209, DOI 10.1086/508191; Kiefer P, 2004, APPL ENVIRON MICROB, V70, P229, DOI 10.1128/AEM.70.1.229-239.2004; Kohlstedt M, 2010, APPL MICROBIOL BIOT, V88, P1065, DOI 10.1007/s00253-010-2854-2; Kromer JO, 2005, ANAL BIOCHEM, V340, P171, DOI 10.1016/j.ab.2005.01.027; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Link H, 2013, NAT BIOTECHNOL, V31, P357, DOI 10.1038/nbt.2489; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; Luttmann D, 2009, MOL MICROBIOL, V72, P978, DOI 10.1111/j.1365-2958.2009.06704.x; Mercado-Lubo R, 2009, INFECT IMMUN, V77, P1397, DOI 10.1128/IAI.01335-08; Meza E, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-127; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Monk IR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-96; Motin VL, 2004, J BACTERIOL, V186, P6298, DOI 10.1128/JB.186.18.6298-6305.2004; Nagel G, 2001, MOL MICROBIOL, V41, P1249, DOI 10.1046/j.1365-2958.2001.02522.x; Neidhardt F. C., 1990, PHYSL BACTERIAL CELL, P133; Pradel E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004029; Quek LE, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-25; Revelles O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066386; Rimhanen-Finne R, 2009, EPIDEMIOL INFECT, V137, P342, DOI 10.1017/S0950268807000155; Sambrook J., 2001, MOL CLONING LAB MANU; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Schilling O, 2007, APPL ENVIRON MICROB, V73, P499, DOI 10.1128/AEM.02084-06; Schmid A, 2009, J BIOL CHEM, V284, P12165, DOI 10.1074/jbc.M900773200; Siddiquee KA, 2004, APPL MICROBIOL BIOT, V63, P407, DOI 10.1007/s00253-003-1357-9; Silver JD, 2009, BIOSTATISTICS, V10, P352, DOI 10.1093/biostatistics/kxn042; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; SPIRO S, 1991, TRENDS BIOCHEM SCI, V16, P310, DOI 10.1016/0968-0004(91)90125-F; SUZUKI T, 1969, BIOCHIM BIOPHYS ACTA, V191, P559, DOI 10.1016/0005-2744(69)90349-0; Trotter EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025501; Valgepea K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-166; van Rijsewijk BRBH, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.9; Vanderpool CK, 2007, CURR OPIN MICROBIOL, V10, P146, DOI 10.1016/j.mib.2007.03.011; Vanderpool CK, 2007, J BACTERIOL, V189, P2238, DOI 10.1128/JB.01689-06; Walker J., 2002, PROTEIN PROTOCOLS HD, P3; Wittmann C, 2004, APPL ENVIRON MICROB, V70, P7277, DOI 10.1128/AEM.70.12.7277-7287.2004; Wittmann C, 2003, BIOTECHNOL LETT, V25, P377, DOI 10.1023/A:1022402212537; Wittmann C, 2002, ANAL BIOCHEM, V307, P379, DOI 10.1016/S0003-2697(02)00030-1; Wittmann C, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-6; Yang YH, 2003, INST MATH S, V40, P403; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Young GM, 2000, INFECT IMMUN, V68, P4323, DOI 10.1128/IAI.68.7.4323-4326.2000; Yu J, 2013, INFECT IMMUN, V81, P4053, DOI 10.1128/IAI.00880-13; Zhan LJ, 2008, INFECT IMMUN, V76, P5028, DOI 10.1128/IAI.00370-08	88	45	46	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					30114	30132		10.1074/jbc.M114.581348	http://dx.doi.org/10.1074/jbc.M114.581348			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25164818	Green Published, hybrid			2022-12-28	WOS:000344370800051
J	Castro, NE; Kato, M; Park, JT; Natarajan, R				Castro, Nancy E.; Kato, Mitsuo; Park, Jung Tak; Natarajan, Rama			Transforming Growth Factor beta 1 (TGF-beta 1) Enhances Expression of Profibrotic Genes through a Novel Signaling Cascade and MicroRNAs in Renal Mesangial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; INDUCED COLLAGEN EXPRESSION; NUCLEAR-PROTEIN 1; DIABETIC-NEPHROPATHY; NF-Y; EXTRACELLULAR-MATRIX; DIFFERENTIAL EXPRESSION; UP-REGULATION; SELF-RENEWAL; LET-7	Increased expression of transforming growth factor-beta 1 (TGF-beta 1) in glomerular mesangial cells (MC) augments extracellular matrix accumulation and hypertrophy during the progression of diabetic nephropathy (DN), a debilitating renal complication of diabetes. MicroRNAs (miRNAs) play key roles in the pathogenesis of DN by modulating the actions of TGF-beta 1 to enhance the expression of profibrotic genes like collagen. In this study, we found a significant decrease in the expression of miR-130b in mouse MC treated with TGF-beta 1. In parallel, there was a down-regulation in miR-130b host gene 2610318N02RIK (RIK), suggesting host gene-dependent expression of this miRNA. TGF-beta receptor 1 (TGF-beta R1) was identified as a target of miR-130b. Interestingly, the RIK promoter contains three NF-Y binding sites and was regulated by NF-YC. Furthermore, NF-YC expression was inhibited by TGF-beta 1, suggesting that a signaling cascade, involving TGF-beta 1-induced decreases in NF-YC, RIK, and miR-130b, may upregulate TGF-beta R1 to augment expression of TGF-beta 1 target fibrotic genes. miR-130b was down-regulated, whereas TGF-beta R1, as well as the profibrotic genes collagen type IV alpha 1 (Col4a1), Col12a1, CTGF, and PAI-1 were up-regulated not only in mouse MC treated with TGF-beta 1 but also in the glomeruli of streptozotocin-injected diabetic mice, supporting in vivo relevance. Together, these results demonstrate a novel miRNA-and host gene-mediated amplifying cascade initiated by TGF-beta 1 that results in the up-regulation of profibrotic factors, such as TGF-beta R1 and collagens associated with the progression of DN.	[Castro, Nancy E.; Kato, Mitsuo; Park, Jung Tak; Natarajan, Rama] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet, Duarte, CA 91010 USA; [Castro, Nancy E.; Kato, Mitsuo; Park, Jung Tak; Natarajan, Rama] City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Diabet Res, Duarte, CA 91010 USA; [Park, Jung Tak] City Hope Natl Med Ctr, Beckman Res Inst, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA; [Natarajan, Rama] Yonsei Univ, Dept Internal Med, Coll Med, Seoul 120752, South Korea	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Yonsei University; Yonsei University Health System	Natarajan, R (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet, 1500 E Duarte Rd, Duarte, CA 91010 USA.	RNatarajan@coh.org	Kato, Mitsuo/D-5411-2009	Park, Jung Tak/0000-0002-2325-8982	National Institutes of Health [DK081705, DK058191]; National Institutes of Health, NIDDK [DK081705]; American Diabetes Association [ADA-7-10-MI-07]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058191, R01DK081705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK081705 and DK058191 (to R. N.) and a Diversity Supplement from National Institutes of Health, NIDDK, Grant DK081705 (to support N. C.). This work was also supported by American Diabetes Association mentor-based postdoctoral fellowship ADA-7-10-MI-07 (to N. C.).	Alvarez ML, 2013, DIABETES RES CLIN PR, V99, P1, DOI 10.1016/j.diabres.2012.10.010; Badal SS, 2015, PEDIATR NEPHROL, V30, P727, DOI 10.1007/s00467-014-2867-7; Baricos WH, 1999, J AM SOC NEPHROL, V10, P790; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Basile V, 2006, J BIOL CHEM, V281, P2347, DOI 10.1074/jbc.M507712200; Brennan EP, 2013, J AM SOC NEPHROL, V24, P627, DOI 10.1681/ASN.2012060550; Chen PY, 2012, CELL REP, V2, P1684, DOI 10.1016/j.celrep.2012.10.021; Dangi-Garimella S, 2011, ONCOGENE, V30, P1002, DOI 10.1038/onc.2010.485; Deshpande SD, 2013, DIABETES, V62, P3151, DOI 10.2337/db13-0305; Dolfini D, 2013, CELL DEATH DIFFER, V20, P676, DOI 10.1038/cdd.2013.13; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hut QH, 2002, J BIOL CHEM, V277, P37191, DOI 10.1074/jbc.M205985200; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jiang Z, 2003, BIOCHEM BIOPH RES CO, V309, P961, DOI 10.1016/j.bbrc.2003.08.102; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kao CY, 1999, J BIOL CHEM, V274, P23043, DOI 10.1074/jbc.274.33.23043; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2014, NAT REV NEPHROL, V10, P517, DOI 10.1038/nrneph.2014.116; Kato M, 2013, FREE RADICAL BIO MED, V64, P85, DOI 10.1016/j.freeradbiomed.2013.06.009; Kato M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003389; Kato M, 2010, J BIOL CHEM, V285, P34004, DOI 10.1074/jbc.M110.165027; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim BH, 2013, J SURG ONCOL, V107, P505, DOI 10.1002/jso.23271; Lan HY, 2012, CLIN EXP PHARMACOL P, V39, P731, DOI 10.1111/j.1440-1681.2011.05663.x; Lee EK, 2011, MOL CELL BIOL, V31, P626, DOI 10.1128/MCB.00894-10; LI XY, 1992, NUCLEIC ACIDS RES, V20, P1087, DOI 10.1093/nar/20.5.1087; Liu AM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000825; Ly LL, 2013, AM J CANCER RES, V3, P339; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Manni I, 2001, J BIOL CHEM, V276, P5570, DOI 10.1074/jbc.M006052200; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Natarajan R, 2012, J CARDIOVASC TRANSL, V5, P413, DOI 10.1007/s12265-012-9368-5; Park JM, 2013, BIORESOURCE TECHNOL, V135, P1, DOI 10.1016/j.biortech.2013.03.132; Poncelet AC, 2001, J BIOL CHEM, V276, P6983, DOI 10.1074/jbc.M006442200; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Reeves WB, 2000, P NATL ACAD SCI USA, V97, P7667, DOI 10.1073/pnas.97.14.7667; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; REITH W, 1994, P NATL ACAD SCI USA, V91, P554, DOI 10.1073/pnas.91.2.554; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Scheffer AR, 2014, WORLD J UROL, V32, P353, DOI 10.1007/s00345-012-1010-2; Seo JY, 2009, AM J NEPHROL, V30, P481, DOI 10.1159/000242477; SHARMA K, 1995, DIABETES, V44, P1139, DOI 10.2337/diabetes.44.10.1139; Tsuchida K, 2003, KIDNEY INT, V63, P2000, DOI 10.1046/j.1523-1755.2003.00009.x; Tzur G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007511; Vickers MM, 2012, CLIN EXP METASTAS, V29, P123, DOI 10.1007/s10585-011-9435-3; Wang B, 2014, KIDNEY INT, V85, P352, DOI 10.1038/ki.2013.372; Wiebe MS, 2000, GENE, V246, P383, DOI 10.1016/S0378-1119(00)00086-X; YAMAMOTO T, 1993, P NATL ACAD SCI USA, V90, P1814, DOI 10.1073/pnas.90.5.1814; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; ZIYADEH FN, 1993, AM J KIDNEY DIS, V22, P736, DOI 10.1016/S0272-6386(12)80440-9	55	73	81	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29001	29013		10.1074/jbc.M114.600783	http://dx.doi.org/10.1074/jbc.M114.600783			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25204661	hybrid, Green Published			2022-12-28	WOS:000344141000020
J	Chung, FZ; Sahasrabuddhe, AA; Ma, KY; Chen, XF; Basrur, V; Lim, MS; Elenitoba-Johnson, KSJ				Chung, Fu-Zon; Sahasrabuddhe, Anagh A.; Ma, Kaiyu; Chen, Xiaofei; Basrur, Venkatesha; Lim, Megan S.; Elenitoba-Johnson, Kojo S. J.			Fbxo45 Inhibits Calcium-sensitive Proteolysis of N-cadherin and Promotes Neuronal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE COMPLEX; STRUCTURAL BASIS; SYNAPTIC ACTIVITY; CELL MOTILITY; DEGRADATION; ADHESION; PROTEIN; DOMAIN; ORGANIZATION; RECOGNITION	Fbxo45 is an atypical E3 ubiquitin ligase, which specifically targets proteins for ubiquitin-mediated degradation. Fbxo45 ablation results in defective neuronal differentiation and abnormal formation of neural connections; however, the mechanisms underlying these defects are poorly understood. Using an unbiased mass spectrometry-based proteomic screen, we show here that N-cadherin is a novel interactor of Fbxo45. N-cadherin specifically interacts with Fbxo45 through two consensus motifs overlapping the site of calcium-binding and dimerization of the cadherin molecule. N-cadherin interaction with Fbxo45 is significantly abrogated by calcium treatment. Surprisingly, Fbxo45 depletion by RNAi-mediated silencing results in enhanced proteolysis of N-cadherin. Conversely, ectopic expression of Fbxo45 results in decreased proteolysis of N-cadherin. Fbxo45 depletion results in dramatic reduction in N-cadherin expression, impaired neuronal differentiation, and diminished formation of neuronal processes. Our studies reveal an unanticipated role for an F-box protein that inhibits proteolysis in the regulation of a critical biological process.	[Chung, Fu-Zon; Sahasrabuddhe, Anagh A.; Ma, Kaiyu; Chen, Xiaofei; Basrur, Venkatesha; Lim, Megan S.; Elenitoba-Johnson, Kojo S. J.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Lim, Megan S.; Elenitoba-Johnson, Kojo S. J.] Univ Michigan, Sch Med, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Elenitoba-Johnson, Kojo S. J.] Univ Michigan, Sch Med, Prot Folding Dis Initiat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Elenitoba-Johnson, KSJ (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 2037 BSRB 109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	kojoelen@umich.edu		Sahasrabuddhe, Anagh/0000-0002-3040-0019; Elenitoba-Johnson, Kojo/0000-0002-1082-1545; Lim, Megan/0000-0002-0415-2867	National Institutes of Health [R01 DE119249, R01 CA136905, R01 CA140806]; NATIONAL CANCER INSTITUTE [R01CA136905, R01CA140806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DE119249, R01 CA136905 (to K. S. J. E.-J.), and R01 CA140806 (to M. S. L.).	Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Filippakopoulos P, 2010, J MOL BIOL, V401, P389, DOI 10.1016/j.jmb.2010.06.017; Foster MW, 2013, NITRIC OXIDE-BIOL CH, V34, P37, DOI 10.1016/j.niox.2013.02.079; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; INUZUKA H, 1991, NEURON, V7, P69, DOI 10.1016/0896-6273(91)90075-B; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kaido M, 2009, GENES CELLS, V14, P1067, DOI 10.1111/j.1365-2443.2009.01335.x; Kawauchi T, 2012, INT J MOL SCI, V13, P4564, DOI 10.3390/ijms13044564; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Kowalczyk Andrew P, 2012, Subcell Biochem, V60, P197, DOI 10.1007/978-94-007-4186-7_9; Kuang ZH, 2010, J CELL BIOL, V190, P129, DOI 10.1083/jcb.200912087; Kuang ZH, 2009, J MOL BIOL, V386, P662, DOI 10.1016/j.jmb.2008.12.078; Lelievre EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033206; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Marrs GS, 2009, MOL CELL NEUROSCI, V40, P390, DOI 10.1016/j.mcn.2008.12.007; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; Nishiya T, 2011, J BIOL CHEM, V286, P9009, DOI 10.1074/jbc.M110.190678; Qian LW, 2008, J VIROL, V82, P11902, DOI 10.1128/JVI.01042-08; Ratheesh A, 2012, NAT REV MOL CELL BIO, V13, P673, DOI 10.1038/nrm3431; Reines A, 2012, J NEUROSCI, V32, P6323, DOI 10.1523/JNEUROSCI.0916-12.2012; Sahasrabuddhe AA, 2015, ONCOGENE, V34, P445, DOI 10.1038/onc.2013.571; Sahasrabuddhe AA, 2011, CELL CYCLE, V10, P1322, DOI 10.4161/cc.10.8.15372; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Su HX, 2013, STEM CELL RES, V10, P338, DOI 10.1016/j.scr.2013.01.003; Suzuki SC, 2008, DEV GROWTH DIFFER, V50, pS119, DOI 10.1111/j.1440-169X.2008.01002.x; Tada H, 2010, J BIOL CHEM, V285, P3840, DOI 10.1074/jbc.M109.046284; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tran NL, 2002, J BIOL CHEM, V277, P32905, DOI 10.1074/jbc.M200300200; Vunnam N, 2011, BBA-PROTEINS PROTEOM, V1814, P1841, DOI 10.1016/j.bbapap.2011.08.002; Vunnam N, 2011, BIOCHEMISTRY-US, V50, P8437, DOI 10.1021/bi200902s; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009; Wu CL, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-16; Xu X, 2001, J CELL BIOL, V154, P217, DOI 10.1083/jcb.200105047; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Zhang JN, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-7	38	15	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28448	28459		10.1074/jbc.M114.561241	http://dx.doi.org/10.1074/jbc.M114.561241			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25143387	Green Published, hybrid			2022-12-28	WOS:000343765400037
J	Liu, ZY; Galemmo, RA; Fraser, KB; Moehle, MS; Sen, S; Volpicelli-Daley, LA; DeLucas, LJ; Ross, LJ; Valiyaveettil, J; Moukha-Chafiq, O; Pathak, AK; Ananthan, S; Kezar, H; White, EL; Gupta, V; Maddry, JA; Suto, MJ; West, AB				Liu, Zhiyong; Galemmo, Robert A., Jr.; Fraser, Kyle B.; Moehle, Mark S.; Sen, Saurabh; Volpicelli-Daley, Laura A.; DeLucas, Lawrence J.; Ross, Larry J.; Valiyaveettil, Jacob; Moukha-Chafiq, Omar; Pathak, Ashish K.; Ananthan, Subramaniam; Kezar, Hollis; White, E. Lucile; Gupta, Vandana; Maddry, Joseph A.; Suto, Mark J.; West, Andrew B.			Unique Functional and Structural Properties of the LRRK2 Protein ATP-binding Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPEAT KINASE 2; DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; NEURONAL TOXICITY; P-GLYCOPROTEIN; GTPASE DOMAIN; ACTIVE STATE; INHIBITOR; MUTANT	Pathogenic mutations in the LRRK2 gene can cause late-onset Parkinson disease. The most common mutation, G2019S, resides in the kinase domain and enhances activity. LRRK2 possesses the unique property of cis-autophosphorylation of its own GTPase domain. Because high-resolution structures of the human LRRK2 kinase domain are not available, we used novel high-throughput assays that measured both cis-autophosphorylation and trans-peptide phosphorylation to probe the ATP-binding pocket. We disclose hundreds of commercially available activity-selective LRRK2 kinase inhibitors. Some compounds inhibit cis-autophosphorylation more strongly than trans-peptide phosphorylation, and other compounds inhibit G2019S-LRRK2 more strongly than WT-LRRK2. Through exploitation of structure-activity relationships revealed through high-throughput analyses, we identified a useful probe inhibitor, SRI-29132 (11). SRI-29132 is exquisitely selective for LRRK2 kinase activity and is effective in attenuating proinflammatory responses in macrophages and rescuing neurite retraction phenotypes in neurons. Furthermore, the compound demonstrates excellent potency, is highly blood-brain barrier-permeant, but suffers from rapid first-pass metabolism. Despite the observed selectivity of SRI-29132, docking models highlighted critical interactions with residues conserved in many protein kinases, implying a unique structural configuration for the LRRK2 ATP-binding pocket. Although the human LRRK2 kinase domain is unstable and insoluble, we demonstrate that the LRRK2 homolog from ameba can be mutated to approximate some aspects of the human LRRK2 ATP-binding pocket. Our results provide a rich resource for LRRK2 small molecule inhibitor development. More broadly, our results provide a precedent for the functional interrogation of ATP-binding pockets when traditional approaches to ascertain structure prove difficult.	[Liu, Zhiyong; Fraser, Kyle B.; Moehle, Mark S.; Sen, Saurabh; Volpicelli-Daley, Laura A.; West, Andrew B.] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Dept Neurol, Birmingham, AL 35294 USA; [Liu, Zhiyong] Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Dept Optometry, Birmingham, AL 35294 USA; [Galemmo, Robert A., Jr.; DeLucas, Lawrence J.; Ross, Larry J.; Valiyaveettil, Jacob; Moukha-Chafiq, Omar; Pathak, Ashish K.; Ananthan, Subramaniam; Kezar, Hollis; White, E. Lucile; Gupta, Vandana; Maddry, Joseph A.; Suto, Mark J.] So Res Inst, Drug Discovery Div, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	West, AB (corresponding author), Civitan Int Res Bldg,5th Floor,1719 6th Ave S, Birmingham, AL USA.	abwest@uab.edu	Moehle, Mark/GNH-1825-2022	Moehle, Mark/0000-0002-8023-1313; West, Andrew/0000-0002-3034-4061; Pathak, Ashish/0000-0003-0143-7979	NINDS, National Institutes of Health [R01NS064934]; Alabama Drug Discovery Alliance; UAB Center for Clinical and Translational Science Grant [UL1R00165]; American Parkinson Disease Association; Southern Research Strategic Investment Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064934] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alabama Drug Discovery Alliance; UAB Center for Clinical and Translational Science Grant; American Parkinson Disease Association; Southern Research Strategic Investment Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NINDS, National Institutes of Health Grant R01NS064934. This work was also supported by the Alabama Drug Discovery Alliance, by the UAB Center for Clinical and Translational Science Grant UL1R00165, by John A. and Ruth R. Jurenko, by the American Parkinson Disease Association, and by the Southern Research Strategic Investment Fund.	Andres-Mateos E, 2009, J NEUROSCI, V29, P15846, DOI 10.1523/JNEUROSCI.4357-09.2009; Baptista MAS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080705; Choi HG, 2012, ACS MED CHEM LETT, V3, P658, DOI 10.1021/ml300123a; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Covy JP, 2009, BIOCHEM BIOPH RES CO, V378, P473, DOI 10.1016/j.bbrc.2008.11.048; Daher JPL, 2014, P NATL ACAD SCI USA, V111, P9289, DOI 10.1073/pnas.1403215111; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Franzini M, 2013, BIOORG MED CHEM LETT, V23, P1967, DOI 10.1016/j.bmcl.2013.02.043; Gilsbach BK, 2012, P NATL ACAD SCI USA, V109, P10322, DOI 10.1073/pnas.1203223109; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Hakimi M, 2011, J NEURAL TRANSM, V118, P795, DOI 10.1007/s00702-011-0653-2; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Lemaire S, 2007, ANTIMICROB AGENTS CH, V51, P2748, DOI 10.1128/AAC.00090-07; Liao JL, 2014, P NATL ACAD SCI USA, V111, P4055, DOI 10.1073/pnas.1323285111; Liu M, 2011, BIOCHEMISTRY-US, V50, P9399, DOI 10.1021/bi201173d; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Misra S, 1999, P NATL ACAD SCI USA, V96, P5814, DOI 10.1073/pnas.96.10.5814; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Ramsden N, 2011, ACS CHEM BIOL, V6, P1021, DOI 10.1021/cb2002413; Ray S, 2014, J BIOL CHEM, V289, P13042, DOI 10.1074/jbc.M113.537811; Ray S, 2012, FUTURE MED CHEM, V4, P1701, DOI [10.4155/fmc.12.110, 10.4155/FMC.12.110]; Reith AD, 2012, BIOORG MED CHEM LETT, V22, P5625, DOI 10.1016/j.bmcl.2012.06.104; Santner AA, 2012, BIOCHEMISTRY-US, V51, P7250, DOI 10.1021/bi300653m; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Sheng DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000914; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Stafa K, 2014, HUM MOL GENET, V23, P2055, DOI 10.1093/hmg/ddt600; Thevenet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021519; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Treiber DK, 2013, CHEM BIOL, V20, P745, DOI 10.1016/j.chembiol.2013.06.001; Vallotton P, 2007, CYTOM PART A, V71A, P889, DOI 10.1002/cyto.a.20462; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Webber PJ, 2011, J MOL BIOL, V412, P94, DOI 10.1016/j.jmb.2011.07.033; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Zhang JW, 2012, BIOORG MED CHEM LETT, V22, P1864, DOI 10.1016/j.bmcl.2012.01.084; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	45	21	21	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.602318	http://dx.doi.org/10.1074/jbc.M114.602318			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25228699	hybrid, Green Published			2022-12-28	WOS:000345335000045
J	Takahashi, S; Nagano, S; Nogawa, T; Kanoh, N; Uramoto, M; Kawatani, M; Shimizu, T; Miyazawa, T; Shiro, Y; Osada, H				Takahashi, Shunji; Nagano, Shingo; Nogawa, Toshihiko; Kanoh, Naoki; Uramoto, Masakazu; Kawatani, Makoto; Shimizu, Takeshi; Miyazawa, Takeshi; Shiro, Yoshitsugu; Osada, Hiroyuki			Structure-Function Analyses of Cytochrome P450revI Involved in Reveromycin A Biosynthesis and Evaluation of the Biological Activity of Its Substrate, Reveromycin T	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CANCER CELLS; ESCHERICHIA-COLI; SPIROFUNGIN; INHIBITION; GROWTH; BONE	Numerous cytochrome P450s are involved in secondary metabolite biosynthesis. The biosynthetic gene cluster for reveromycin A (RM-A), which is a promising lead compound with anti-osteoclastic activity, also includes a P450 gene, revI. To understand the roles of P450revI, we comprehensively characterized the enzyme by genetic, kinetic, and structural studies. The revI gene disruptants (Delta revI) resulted in accumulation of reveromycin T (RM-T), and revI gene complementation restored RM-A production, indicating that the physiological substrate of P450revI is RM-T. Indeed, the purified P450revI catalyzed the C18-hydroxylation of RM-T more efficiently than the other RM derivatives tested. Moreover, the 1.4 angstrom resolution co-crystal structure of P450revI with RM-T revealed that the substrate binds the enzyme with a folded compact conformation for C18-hydroxylation. To address the structure-enzyme activity relationship, site-directed mutagenesis was performed in P450revI. R190A and R81A mutations, which abolished salt bridge formation with C1 and C24 carboxyl groups of RM-T, respectively, resulted in significant loss of enzyme activity. The interaction between Arg(190) and the C1 carboxyl group of RM-T elucidated why P450revI was unable to catalyze both RM-T 1-methyl ester and RM-T 1-ethyl ester. Moreover, the accumulation of RM-T in Delta revI mutants enabled us to characterize its biological activity. Our results show that RM-T had stronger anticancer activity and isoleucyl-tRNA synthetase inhibition than RM-A. However, RM-Tshowed much less anti-osteoclastic activity than RM-A, indicating that hemisuccinate moiety is important for the activity. Structure-based P450revI engineering for novel hydroxylation and subsequent hemisuccinylation will help facilitate the development of RM derivatives with antiosteoclast activity.	[Takahashi, Shunji; Nogawa, Toshihiko; Osada, Hiroyuki] RIKEN, Ctr Sustainable Resource Sci, Chem Biol Grp, Wako, Saitama 3510198, Japan; [Takahashi, Shunji; Uramoto, Masakazu; Kawatani, Makoto; Shimizu, Takeshi; Miyazawa, Takeshi; Osada, Hiroyuki] RIKEN, Antibiot Lab, Wako, Saitama 3510198, Japan; [Nagano, Shingo] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808582, Japan; [Nagano, Shingo; Shiro, Yoshitsugu] RIKEN, SPring Ctr 8, Biomet Sci Lab, Sayo, Hyogo 6795148, Japan; [Kanoh, Naoki] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan	RIKEN; RIKEN; Tottori University; RIKEN; Tohoku University	Takahashi, S (corresponding author), RIKEN, Ctr Sustainable Resource Sci, Chem Biol Grp, Wako, Saitama 3510198, Japan.	shunjitaka@riken.jp; snagano@bio.tottori-u.ac.jp	Nogawa, Toshihiko/ABG-2652-2020; Takahashi, Shunji/GLT-3245-2022; Osada, Hiroyuki/N-4305-2014; Kanoh, Naoki/F-5765-2010; Takahashi, Shunji/N-6921-2015; Osada, Hiroyuki/AAY-6254-2020; Shiro, Yoshitsugu Y/J-3757-2014; Nogawa, Toshihiko/C-4095-2017	Takahashi, Shunji/0000-0003-1684-9298; Kanoh, Naoki/0000-0002-4382-3715; Takahashi, Shunji/0000-0003-1684-9298; Shiro, Yoshitsugu Y/0000-0003-0695-8327; Kawatani, Makoto/0000-0002-9571-4916; Nogawa, Toshihiko/0000-0003-1270-5270	Japan Society for the Promotion of Science (JSPS) KAKENHI [24248022, 24380052]; science and technology research promotion program for agriculture, forestry, fisheries, and the food industry; Ministry of Economy, Trade, and Industry (METI), Japan	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); science and technology research promotion program for agriculture, forestry, fisheries, and the food industry; Ministry of Economy, Trade, and Industry (METI), Japan	This work was partially supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 24248022 (to H. O.) and 24380052 (to S. T.) by the science and technology research promotion program for agriculture, forestry, fisheries, and the food industry and by a grant for the "project focused on developing key technology of discovering and manufacturing drugs for next-generation treatment and diagnosis" from the Ministry of Economy, Trade, and Industry (METI), Japan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Guengerich FP, 2002, NAT REV DRUG DISCOV, V1, P359, DOI 10.1038/nrd792; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hiraoka K, 2008, CANCER SCI, V99, P1595, DOI 10.1111/j.1349-7006.2008.00880.x; Holtzel A, 1998, J ANTIBIOT, V51, P699; Jiang J, 2009, BIOCHEMISTRY-US, V48, P6431, DOI 10.1021/bi900766w; KOSHINO H, 1992, J ANTIBIOT, V45, P1420, DOI 10.7164/antibiotics.45.1420; Li SY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.410340; Marjanovic J, 2007, ANGEW CHEM INT EDIT, V46, P8854, DOI 10.1002/anie.200702440; Miyamoto Y, 2002, J BIOL CHEM, V277, P28810, DOI 10.1074/jbc.M203827200; Muguruma H, 2005, CLIN CANCER RES, V11, P8822, DOI 10.1158/1078-0432.CCR-05-1335; Nogawa T, 2013, J ANTIBIOT, V66, P247, DOI 10.1038/ja.2012.115; OMURA T, 1964, J BIOL CHEM, V239, P2370; Onaka H, 2003, J ANTIBIOT, V56, P950, DOI 10.7164/antibiotics.56.950; Osada H, 1997, BIOORGAN MED CHEM, V5, P193, DOI 10.1016/S0968-0896(96)00207-6; OSADA H, 1991, J ANTIBIOT, V44, P259, DOI 10.7164/antibiotics.44.259; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shimizu T, 2000, ORG LETT, V2, P2153, DOI 10.1021/ol0060634; Shimizu T, 2005, ORG LETT, V7, P5573, DOI 10.1021/ol052039k; Shimizu T, 2002, BIOORG MED CHEM LETT, V12, P3363, DOI 10.1016/S0960-894X(02)00782-5; Shimizu T., 2001, SYNTHESIS-STUTTGART, DOI [10.1055/s-2001-14564, DOI 10.1055/S-2001-14564]; Shimizu T, 2008, BIOORG MED CHEM LETT, V18, P3756, DOI 10.1016/j.bmcl.2008.05.054; Sugimoto H, 2008, BIOCHEMISTRY-US, V47, P4017, DOI 10.1021/bi7023767; Takahashi S, 2011, NAT CHEM BIOL, V7, P461, DOI [10.1038/NCHEMBIO.583, 10.1038/nchembio.583]; Takahashi S, 2010, J BACTERIOL, V192, P2839, DOI 10.1128/JB.01557-09; Tanaka M, 2012, J DENT RES, V91, P771, DOI 10.1177/0022034512451026; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Usui T, 2000, BIOPROBES, P125; Woo JT, 2006, P NATL ACAD SCI USA, V103, P4729, DOI 10.1073/pnas.0505663103; Yano A, 2008, P NATL ACAD SCI USA, V105, P15541, DOI 10.1073/pnas.0805354105	35	13	13	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.598391	http://dx.doi.org/10.1074/jbc.M114.598391			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25258320	hybrid, Green Published			2022-12-28	WOS:000345335000005
J	Yanamala, N; Kapralov, AA; Djukic, M; Peterson, J; Mao, GW; Klein-Seetharaman, J; Stoyanovsky, DA; Stursa, J; Neuzil, J; Kagan, VE				Yanamala, Naveena; Kapralov, Alexander A.; Djukic, Mirjana; Peterson, Jim; Mao, Gaowei; Klein-Seetharaman, Judith; Stoyanovsky, Detcho A.; Stursa, Jan; Neuzil, Jiri; Kagan, Valerian E.			Structural Re-arrangement and Peroxidase Activation of Cytochrome c by Anionic Analogues of Vitamin E, Tocopherol Succinate and Tocopherol Phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIOLIPIN-CONTAINING MEMBRANES; CELL-DEATH; MOLECULAR-MECHANISM; FOLDING PATHWAY; BINDING SITES; IN-VIVO; CANCER; APOPTOSIS; MITOCHONDRIA; DAMAGE	Cytochrome c is a multifunctional hemoprotein in the mitochondrial intermembrane space whereby its participation in electron shuttling between respiratory complexes III and IV is alternative to its role in apoptosis as a peroxidase activated by interaction with cardiolipin (CL), and resulting in selective CL peroxidation. The switch from electron transfer to peroxidase function requires partial unfolding of the protein upon binding of CL, whose specific features combine negative charges of the two phosphate groups with four hydrophobic fatty acid residues. Assuming that other endogenous small molecule ligands with a hydrophobic chain and a negatively charged functionality may activate cytochrome c into a peroxidase, we investigated two hydrophobic anionic analogues of vitamin E, alpha-tocopherol succinate (alpha-TOS) and alpha-tocopherol phosphate (alpha-TOP), as potential inducers of peroxidase activity of cytochrome c. NMR studies and computational modeling indicate that they interact with cytochrome c at similar sites previously proposed for CL. Absorption spectroscopy showed that both analogues effectively disrupt the Fe-S(Met(80)) bond associated with unfolding of cytochrome c. We found that alpha-TOS and alpha-TOP stimulate peroxidase activity of cytochrome c. Enhanced peroxidase activity was also observed in isolated rat liver mitochondria incubated with alpha-TOS and tBOOH. Amitochondria-targeted derivative of TOS, triphenylphosphonium-TOS (mito-VES), was more efficient in inducing H2O2-dependent apoptosis in mouse embryonic cytochrome c(+/+) cells than in cytochrome c(-/-) cells. Essential for execution of the apoptotic program peroxidase activation of cytochrome c by alpha-TOS may contribute to its known anti-cancer pharmacological activity.	[Yanamala, Naveena; Kapralov, Alexander A.; Djukic, Mirjana; Mao, Gaowei; Stoyanovsky, Detcho A.; Kagan, Valerian E.] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA 15260 USA; [Yanamala, Naveena; Kapralov, Alexander A.; Djukic, Mirjana; Peterson, Jim; Mao, Gaowei; Stoyanovsky, Detcho A.; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15260 USA; [Kagan, Valerian E.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Kagan, Valerian E.] Univ Pittsburgh, Dept Radiat Oncol, Pittsburgh, PA 15260 USA; [Kagan, Valerian E.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Klein-Seetharaman, Judith] Univ Warwick, Sch Med, Div Metab & Vasc Hlth, Coventry CV4 7AL, W Midlands, England; [Stursa, Jan] Univ Hosp, Biomed Res Ctr, Hradec Kralove 569810, Czech Republic; [Neuzil, Jiri] Acad Sci Czech Republ, Inst Biotechnol, Prague 14220, Czech Republic; [Neuzil, Jiri] Griffith Univ, Sch Med Sci, Southport, Qld 4222, Australia	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Warwick; University Hospital Hradec Kralove; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Griffith University	Kagan, VE (corresponding author), Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Dept Environm & Occupat Hlth, Bridgeside Point 100 Technol Dr,Suite 350, Pittsburgh, PA 15219 USA.	kagan@pitt.edu	Djukic, Mirjana M/N-2645-2016; Yanamala, Naveena/AAA-6729-2022; Neuzil, Jiri/H-7204-2014; mao, gaowei/A-8142-2015	Djukic, Mirjana M/0000-0003-0177-1205; Neuzil, Jiri/0000-0002-2478-2460; mao, gaowei/0000-0001-6090-8131; Peterson, James/0000-0002-7300-5887; Stoyanovsky, Detcho/0000-0001-5591-4780; Kapralov, Oleksandr/0000-0002-3006-916X; Yanamala, Naveena/0000-0002-4454-4240; Kagan, Valerian E./0000-0002-7245-1885	National Institutes of Health [HL114453, U19 AIO68021, ES 020693, ES 021068]; National Institute for Occupational Safety and Health [OH008282]; Human Frontier Science Program [HFSP-RGP0013/2014]; Australian Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH008282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021068, R01ES020693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Human Frontier Science Program(Human Frontier Science Program); Australian Research Council(Australian Research Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL114453, U19 AIO68021, ES 020693, and ES 021068, by National Institute for Occupational Safety and Health Grant OH008282, and by Human Frontier Science Program Grant HFSP-RGP0013/2014.; Supported in part by the Australian Research Council.	Abner Erin L, 2011, Curr Aging Sci, V4, P158; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN, P40; Azzi A, 2007, FREE RADICAL BIO MED, V43, P16, DOI 10.1016/j.freeradbiomed.2007.03.013; Battistuzzi G, 2012, BIOCHEMISTRY-US, V51, P5967, DOI 10.1021/bi3007302; Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; Belikova NA, 2009, J AM CHEM SOC, V131, P11288, DOI 10.1021/ja904343c; Biswas S, 2012, J CONTROL RELEASE, V159, P393, DOI 10.1016/j.jconrel.2012.01.009; Borisenko GG, 2004, J BIOL CHEM, V279, P23453, DOI 10.1074/jbc.M400119200; Carraway AD, 1996, INORG CHEM, V35, P6885, DOI 10.1021/ic960434o; Chattopadhyay K, 2003, BIOCHEMISTRY-US, V42, P14606, DOI 10.1021/bi0351662; Davies MJ, 2011, J CLIN BIOCHEM NUTR, V48, P8, DOI 10.3164/jcbn.11-006FR; DEJONGH HHJ, 1995, FEBS LETT, V360, P255, DOI 10.1016/0014-5793(95)00115-P; Dolara P, 2012, EUR J NUTR, V51, P769, DOI 10.1007/s00394-012-0389-2; Dong LF, 2008, ONCOGENE, V27, P4324, DOI 10.1038/onc.2008.69; Dong LF, 2011, J BIOL CHEM, V286, P3717, DOI 10.1074/jbc.M110.186643; Droghetti E, 2006, BIOPHYS J, V91, P3022, DOI 10.1529/biophysj.106.079749; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Evans HM, 1922, SCIENCE, V56, P650, DOI 10.1126/science.56.1458.650; Gianello R, 2007, INT J TOXICOL, V26, P475, DOI 10.1080/10915810701620556; Goddard D., 2008, SPARKY 3; Golli F, 2010, BIOFACTORS, V36, P33, DOI 10.1002/biof.75; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; KAGAN VE, 1989, ANN NY ACAD SCI, V570, P121; Kapralov AA, 2007, BIOCHEMISTRY-US, V46, P14232, DOI 10.1021/bi701237b; Kawai C, 2005, J BIOL CHEM, V280, P34709, DOI 10.1074/jbc.M412532200; Kogure K, 2003, CANCER LETT, V192, P19, DOI 10.1016/S0304-3835(02)00683-3; Krishna MMG, 2007, PROTEIN SCI, V16, P1946, DOI 10.1110/ps.072922307; Krishna MMG, 2006, J MOL BIOL, V359, P1410, DOI 10.1016/j.jmb.2006.04.035; Lacombe ML, 2009, BIOCHIMIE, V91, P779, DOI 10.1016/j.biochi.2009.02.006; LIEWALD F, 1990, CYTOMETRY, V11, P341, DOI 10.1002/cyto.990110305; Liu JH, 2008, BIOCHEMISTRY-US, V47, P4518, DOI 10.1021/bi701962c; Liu WX, 2003, PROTEIN SCI, V12, P2104, DOI 10.1110/ps.03211303; Maity H, 2006, PROTEINS, V63, P349, DOI 10.1002/prot.20756; Maity H, 2005, P NATL ACAD SCI USA, V102, P4741, DOI 10.1073/pnas.0501043102; Marques HM, 2007, DALTON T, P4371, DOI 10.1039/b710940g; Munro OQ, 1996, INORG CHEM, V35, P3752, DOI 10.1021/ic9502842; Munteanu A, 2004, BIOCHEM BIOPH RES CO, V318, P311, DOI 10.1016/j.bbrc.2004.04.028; Myung SK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f10; Negis Y, 2009, NUTR CANCER, V61, P875, DOI 10.1080/01635580903285197; Neuzil J, 2001, BRIT J CANCER, V84, P87, DOI 10.1054/bjoc.2000.1559; Neuzil J, 2007, MOL PHARMACOL, V71, P1185, DOI 10.1124/mol.106.030122; Niki E, 2012, ANN NUTR METAB, V61, P207, DOI 10.1159/000343106; Nishio K, 2011, FREE RADICAL BIO MED, V50, P1794, DOI 10.1016/j.freeradbiomed.2011.03.021; Oellerich S, 2002, J PHYS CHEM B, V106, P6566, DOI 10.1021/jp013841g; PACKER L, 1991, AM J CLIN NUTR, V53, pS1050, DOI 10.1093/ajcn/53.4.1050S; Pallotti F, 2007, METHOD CELL BIOL, V80, P3, DOI 10.1016/S0091-679X(06)80001-4; Paradies G, 2009, CELL CALCIUM, V45, P643, DOI 10.1016/j.ceca.2009.03.012; Prasad S, 2002, BBA-PROTEIN STRUCT M, V1596, P63, DOI 10.1016/S0167-4838(02)00205-4; Ralph SJ, 2011, PHARM RES-DORDR, V28, P2695, DOI 10.1007/s11095-011-0566-7; Rezk BM, 2007, FRONT BIOSCI-LANDMRK, V12, P2013, DOI 10.2741/2206; Ricciarelli R, 2001, FASEB J, V15, P2314, DOI 10.1096/fj.01-0258rev; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Rodriguez-Enriquez S, 2012, BBA-BIOENERGETICS, V1817, P1597, DOI 10.1016/j.bbabio.2012.05.005; Rohlena J, 2011, ANTIOXID REDOX SIGN, V15, P2951, DOI 10.1089/ars.2011.3990; Rumbley JN, 2002, BIOCHEMISTRY-US, V41, P13894, DOI 10.1021/bi026543y; RYTOMAA M, 1995, J BIOL CHEM, V270, P3197, DOI 10.1074/jbc.270.7.3197; RYTOMAA M, 1994, J BIOL CHEM, V269, P1770; Samhan-Arias AK, 2012, BBA-BIOMEMBRANES, V1818, P2413, DOI 10.1016/j.bbamem.2012.03.014; Sanghera N, 2000, PROTEIN SCI, V9, P1194, DOI 10.1110/ps.9.6.1194; Shiau CW, 2006, J BIOL CHEM, V281, P11819, DOI 10.1074/jbc.M511015200; Sinibaldi F, 2008, BIOCHEMISTRY-US, V47, P6928, DOI 10.1021/bi800048v; TAPPEL AL, 1970, AM J CLIN NUTR, V23, P1137; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tyurina YY, 2014, NAT CHEM, V6, P542, DOI [10.1038/NCHEM.1924, 10.1038/nchem.1924]	67	15	17	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.601377	http://dx.doi.org/10.1074/jbc.M114.601377			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25278024	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000345335000009
J	Frank, DJ; Madrona, Y; de Montellano, PRO				Frank, Daniel J.; Madrona, Yarrow; de Montellano, Paul R. Ortiz			Cholesterol Ester Oxidation by Mycobacterial Cytochrome P450	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIOXYGEN COMPLEX; WILD-TYPE; MACROPHAGES; SUBSTRATE; BINDING; SYSTEM; CAVITY; SPIN	Mycobacteria share a common cholesterol degradation pathway initiated by oxidation of the alkyl side chain by enzymes of cytochrome P450 (CYP) families 125 and 142. Structural and sequence comparisons of the two enzyme families revealed two insertions into the N-terminal region of the CYP125 family (residues 58-67 and 100-109 in the CYP125A1 sequence) that could potentially sterically block the oxidation of the longer cholesterol ester molecules. Catalytic assays revealed that only CYP142 enzymes are able to oxidize cholesteryl propionate, and although CYP125 enzymes could oxidize cholesteryl sulfate, they were much less efficient at doing so than the CYP142 enzymes. The crystal structure of CYP142A2 in complex with cholesteryl sulfate revealed a substrate tightly fit into a smaller active site than was previously observed for the complex of CYP125A1 with 4-cholesten-3-one. We propose that the larger CYP125 active site allows for multiple binding modes of cholesteryl sulfate, the majority of which trigger the P450 catalytic cycle, but in an uncoupled mode rather than one that oxidizes the sterol. In contrast, the more unhindered and compact CYP142 structure enables enzymes of this family to readily oxidize cholesteryl esters, thus providing an additional source of carbon for mycobacterial growth.	[Frank, Daniel J.; Madrona, Yarrow; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Univ Calif San Francisco, 600 16th St,N576D, San Francisco, CA 94158 USA.	Ortiz@cgl.ucsf.edu	Frank, Daniel/G-5821-2010	Frank, Daniel/0000-0003-0063-7557; Frank, Daniel/0000-0002-9774-5580	Office of Science, Office of Basic Energy Sciences, of the U. S. Department of Energy [DE-ACO2-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025515, R37GM025515] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the U. S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Christopher Waddling for tireless work in maintaining and improving the University of California at San Francisco macromolecular structure facility and in particular, the in-house x-ray generator, where data for the cholesteryl sulfate bound CYP142A2 crystal structure was collected. This publication also includes work performed at the Advanced Light Source (ALS) in Berkeley, CA. ALS is a national user facility supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U. S. Department of Energy under Contract DE-ACO2-05CH11231. We thank Drs. Clinton Nishida, Debashree Basudhar, and other members of the Ortiz de Montellano laboratory for technical assistance and useful discussions.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; FISHER MT, 1985, J AM CHEM SOC, V107, P5018, DOI 10.1021/ja00303a045; Garcia-Fernandez E, 2013, ENVIRON MICROBIOL, V15, P2342, DOI 10.1111/1462-2920.12108; Johnston JB, 2010, J BIOL CHEM, V285, P36352, DOI 10.1074/jbc.M110.161117; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim C, 2000, BIOORG CHEM, V28, P306, DOI 10.1006/bioo.2000.1187; KLANSEK JJ, 1995, J LIPID RES, V36, P2261; KONDO E, 1974, JPN J MED SCI BIOL, V27, P59, DOI 10.7883/yoken1952.27.59; KONDO E, 1976, JPN J MED SCI BIOL, V29, P123, DOI 10.7883/yoken1952.29.123; LOIDA PJ, 1993, BIOCHEMISTRY-US, V32, P11530, DOI 10.1021/bi00094a009; Madrona Y, 2013, BIOCHEMISTRY-US, V52, P5039, DOI 10.1021/bi4006946; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLean KJ, 2010, FUTURE MED CHEM, V2, P1339, DOI [10.4155/fmc.10.216, 10.4155/FMC.10.216]; Nagano S, 2005, J BIOL CHEM, V280, P22102, DOI 10.1074/jbc.M501732200; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; OMURA T, 1964, J BIOL CHEM, V239, P2379; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Ouellet H, 2011, BIOORG MED CHEM LETT, V21, P332, DOI 10.1016/j.bmcl.2010.11.007; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; Ouellet H, 2010, ARCH BIOCHEM BIOPHYS, V493, P82, DOI 10.1016/j.abb.2009.07.011; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Schmidtke P, 2011, BIOINFORMATICS, V27, P3276, DOI 10.1093/bioinformatics/btr550; SLIGAR SG, 1976, BIOCHEMISTRY-US, V15, P5399, DOI 10.1021/bi00669a029; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; World Health Organization, 2014, WHO FACT SHEETS TUB; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344	32	20	22	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30417	30425		10.1074/jbc.M114.602771	http://dx.doi.org/10.1074/jbc.M114.602771			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25210044	Green Published, hybrid			2022-12-28	WOS:000344549700023
J	Vizcarra, CL; Bor, B; Quinlan, ME				Vizcarra, Christina L.; Bor, Batbileg; Quinlan, Margot E.			The Role of Formin Tails in Actin Nucleation, Processive Elongation, and Filament Bundling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGY-2 DOMAIN; MOLECULAR-BASIS; ATP-ACTIN; ADP-ACTIN; CAPPUCCINO; SPIRE; MECHANISM; MICROTUBULES; PROTEINS; PROFILIN	Formins are multidomain proteins that assemble actin in a wide variety of biological processes. They both nucleate and remain processively associated with growing filaments, in some cases accelerating filament growth. The well conserved formin homology 1 and 2 domains were originally thought to be solely responsible for these activities. Recently a role in nucleation was identified for the Diaphanous autoinhibitory domain ( DAD), which is C-terminal to the formin homology 2 domain. The C-terminal tail of the Drosophila formin Cappuccino ( Capu) is conserved among FMN formins but distinct from other formins. It does not have a DAD domain. Nevertheless, we find that Capu-tail plays a role in filament nucleation similar to that described for mDia1 and other formins. Building on this, replacement of Capu-tail with DADs from other formins tunes nucleation activity. Capu-tail has low-affinity interactions with both actin monomers and filaments. Removal of the tail reduces actin filament binding and bundling. Furthermore, when the tail is removed, we find that processivity is compromised. Despite decreased processivity, the elongation rate of filaments is unchanged. Again, replacement of Capu-tail with DADs from other formins tunes the processive association with the barbed end, indicating that this is a general role for formin tails. Our data show a role for the Capu-tail domain in assembling the actin cytoskeleton, largely mediated by electrostatic interactions. Because of its multifunctionality, the formin tail is a candidate for regulation by other proteins during cytoskeletal rearrangements.	[Vizcarra, Christina L.; Quinlan, Margot E.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Bor, Batbileg] Univ Calif Los Angeles, Mol Biol Interdept PhD Program, Los Angeles, CA 90095 USA; [Quinlan, Margot E.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Quinlan, ME (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles E Young Dr E, Los Angeles, CA 90095 USA.	margot@chem.ucla.edu	Bor, Batbileg/AAY-8795-2021	Bor, Batbileg/0000-0002-1797-1730	National Institutes of Health [F32GM087857, R01GM096133]; Whitcome fellowship (UCLA); Burroughs-Welcome Fund Career Award in the Biomedical Sciences; March of Dimes Foundation [1-FY12-442]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087857, R01GM096133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitcome fellowship (UCLA); Burroughs-Welcome Fund Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health National Research Service Award Postdoctoral Fellowship F32GM087857 (to C. L. V.) and National Institutes of Health Grant R01GM096133 (to M. E. Q.). This work was also supported by a Whitcome fellowship (UCLA) (to B. B.), by a Burroughs-Welcome Fund Career Award in the Biomedical Sciences (to M. E. Q.), and by March of Dimes Foundation Grant 1-FY12-442 (to M. E. Q.).	Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bois J. S., 2007, THESIS CALTECH; Bor B, 2012, MOL BIOL CELL, V23, P3801, DOI 10.1091/mbc.E12-04-0288; Breitsprecher D, 2012, SCIENCE, V336, P1164, DOI 10.1126/science.1218062; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; EMMONS S, 1995, GENE DEV, V9, P2482, DOI 10.1101/gad.9.20.2482; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Heimsath EG, 2012, J BIOL CHEM, V287, P3087, DOI 10.1074/jbc.M111.312207; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kupi T, 2013, EUR BIOPHYS J BIOPHY, V42, P757, DOI 10.1007/s00249-013-0922-0; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Mouilleron S, 2008, EMBO J, V27, P3198, DOI 10.1038/emboj.2008.235; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otomo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012896; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Paul AS, 2009, J BIOL CHEM, V284, P12533, DOI 10.1074/jbc.M808587200; Pechlivanis M, 2009, J BIOL CHEM, V284, P25324, DOI 10.1074/jbc.M109.030320; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinlan ME, 2013, DEVELOPMENT, V140, P4417, DOI 10.1242/dev.097337; Ramabhadran V, 2013, J BIOL CHEM, V288, P26847, DOI 10.1074/jbc.M113.472415; Rosales-Nieves AE, 2006, NAT CELL BIOL, V8, P367, DOI 10.1038/ncb1385; Roth-Johnson EA, 2014, J BIOL CHEM, V289, P4395, DOI 10.1074/jbc.M113.499921; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Scott BJ, 2011, MOL BIOL CELL, V22, P3826, DOI 10.1091/mbc.E11-06-0492; Smith MB, 2010, CYTOSKELETON, V67, P693, DOI 10.1002/cm.20481; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Thompson ME, 2013, NAT STRUCT MOL BIOL, V20, P111, DOI 10.1038/nsmb.2462; Tu DQ, 2012, P NATL ACAD SCI USA, V109, pE3424, DOI 10.1073/pnas.1203035109; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Zeth K, 2011, J BIOL CHEM, V286, P30732, DOI 10.1074/jbc.M111.257782; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057; Zuchero J Bradley, 2007, Methods Mol Biol, V370, P213	53	26	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30602	30613		10.1074/jbc.M114.588368	http://dx.doi.org/10.1074/jbc.M114.588368			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25246531	hybrid, Green Published			2022-12-28	WOS:000344549700037
J	Chu, NK; Shabbir, W; Bove-Fenderson, E; Araman, C; Lemmens-Gruber, R; Harris, DA; Becker, CFW				Chu, Nam K.; Shabbir, Waheed; Bove-Fenderson, Erin; Araman, Can; Lemmens-Gruber, Rosa; Harris, David A.; Becker, Christian F. W.			A C-terminal Membrane Anchor Affects the Interactions of Prion Proteins with Lipid Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Liposome; Prion; Protein Aggregation; Protein Chemistry; Protein Conformation; lipid-Protein Interactions; Membrane Anchor; Pore Formation; Protein Semisynthesis	GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR; CELLULAR MEMBRANES; CULTURED-CELLS; CONVERSION; BINDING; PRPSC; RECOMBINANT; SEMISYNTHESIS; FLUORESCENCE; PENETRATION	Background: Membrane attachment of PrP via a GPI anchor is critical for conversion into PrPSc. Results: Semisynthetic membrane-anchored PrP variants are generated and analyzed in different lipid environments. Conclusion: A membrane anchor drastically changes PrP interactions with membranes and enables pore formation. Significance: Membrane-induced conformational changes and pore formation of PrP play a role in the conversion into PrPSc and its toxic effects. Membrane attachment via a C-terminal glycosylphosphatidylinositol anchor is critical for conversion of PrPC into pathogenic PrPSc. Therefore the effects of the anchor on PrP structure and function need to be deciphered. Three PrP variants, including full-length PrP (residues 23-231, FL_PrP), N-terminally truncated PrP (residues 90-231, T_PrP), and PrP missing its central hydrophobic region (105-125, CR_PrP), were equipped with a C-terminal membrane anchor via a semisynthesis strategy. Analyses of the interactions of lipidated PrPs with phospholipid membranes demonstrated that C-terminal membrane attachment induces a different binding mode of PrP to membranes, distinct from that of non-lipidated PrPs, and influences the biochemical and conformational properties of PrPs. Additionally, fluorescence-based assays indicated pore formation by lipidated CR_PrP, a variant that is known to be highly neurotoxic in transgenic mice. This finding was supported by using patch clamp electrophysiological measurements of cultured cells. These results provide new evidence for the role of the membrane anchor in PrP-lipid interactions, highlighting the importance of the N-terminal and the central hydrophobic domain in these interactions.	[Chu, Nam K.; Araman, Can; Becker, Christian F. W.] Univ Vienna, Fac Chem, Inst Biol Chem, A-1090 Vienna, Austria; [Shabbir, Waheed; Lemmens-Gruber, Rosa] Univ Vienna, Dept Pharmacol & Toxicol, A-1090 Vienna, Austria; [Bove-Fenderson, Erin; Harris, David A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	University of Vienna; University of Vienna; Boston University	Becker, CFW (corresponding author), Univ Vienna, Fac Chem, Inst Biol Chem, Wahringer Str 38, A-1090 Vienna, Austria.	christian.becker@univie.ac.at	Becker, Christian F/A-4891-2010; Chu, Nam/AAY-8247-2021	Becker, Christian F/0000-0002-8890-7082; Lemmens-Gruber, Rosa/0000-0002-4817-6748; Harris, David/0000-0002-6985-5790; Araman, Can/0000-0002-6961-5607; Chu, Nam/0000-0001-9717-5007	National Institutes of Health [R01 NS065244]; Deutsche Forschungsgemeinschaft (DFG) [BE3270/6-1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065244, R01NS040975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS065244 (to D. A. H.). This work was also supported by Deutsche Forschungsgemeinschaft (DFG) Grant BE3270/6-1 (to C. F. W. B.).	Aguzzi A, 2000, CELL DEATH DIFFER, V7, P889, DOI 10.1038/sj.cdd.4400737; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Baron GS, 2003, J BIOL CHEM, V278, P14883, DOI 10.1074/jbc.M210840200; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Becker CFW, 2008, ANGEW CHEM INT EDIT, V47, P8215, DOI 10.1002/anie.200802161; Biasini E, 2013, J NEUROSCI, V33, P2408, DOI 10.1523/JNEUROSCI.3406-12.2013; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Breydo L, 2007, BIOCHEMISTRY-US, V46, P852, DOI 10.1021/bi061923v; Butko P, 1996, BIOCHEMISTRY-US, V35, P11355, DOI 10.1021/bi960970s; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Christensen HM, 2009, J NEUROCHEM, V108, P44, DOI 10.1111/j.1471-4159.2008.05719.x; Chu NK, 2009, METHOD ENZYMOL, V462, P177, DOI 10.1016/S0076-6879(09)62009-7; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Critchley P, 2004, BIOCHEM BIOPH RES CO, V313, P559, DOI 10.1016/j.bbrc.2003.12.004; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Eberl H, 2004, J BIOL CHEM, V279, P25058, DOI 10.1074/jbc.M400952200; EFTINK MR, 1991, METHOD BIOCHEM ANAL, V35, P127; Garg P, 2013, BBA-BIOMEMBRANES, V1828, P732, DOI 10.1016/j.bbamem.2012.08.006; Gerlach H, 2010, NAT CHEM BIOL, V6, P46, DOI [10.1038/NCHEMBIO.268, 10.1038/nchembio.268]; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; Goold R, 2013, J CELL SCI, V126, P3552, DOI 10.1242/jcs.120477; Halevy R, 2003, PEPTIDES, V24, P1753, DOI 10.1016/j.peptides.2003.08.019; Herce HD, 2007, P NATL ACAD SCI USA, V104, P20805, DOI 10.1073/pnas.0706574105; Hicks MR, 2006, FEBS J, V273, P1285, DOI 10.1111/j.1742-4658.2006.05152.x; Hornemann S, 1997, FEBS LETT, V413, P277, DOI 10.1016/S0014-5793(97)00921-6; Katz M, 2003, BIOCHEM J, V375, P405, DOI 10.1042/BJ20030784; Kim JI, 2009, FEBS LETT, V583, P3671, DOI 10.1016/j.febslet.2009.10.049; LANGNER M, 1993, CHEM PHYS LIPIDS, V65, P23, DOI 10.1016/0009-3084(93)90078-H; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Mingeot-Leclercq MP, 2002, CHEM PHYS LIPIDS, V120, P57, DOI 10.1016/S0009-3084(02)00108-1; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Olschewski D, 2007, CHEM BIOL, V14, P994, DOI 10.1016/j.chembiol.2007.08.007; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Priola SA, 2009, PRION, V3, P134, DOI 10.4161/pri.3.3.9771; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raja SM, 1999, BIOPHYS J, V76, P1469, DOI 10.1016/S0006-3495(99)77307-8; Robinson PJ, 2010, BIOPHYS J, V98, P1520, DOI 10.1016/j.bpj.2009.12.4304; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; Sanghera N, 2011, CHEM BIOL, V18, P1422, DOI 10.1016/j.chembiol.2011.08.016; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Solomon IH, 2011, J BIOL CHEM, V286, P14724, DOI 10.1074/jbc.M110.214973; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; Stern O, 1919, PHYS Z, V20, P183; Turnbaugh JA, 2012, J NEUROSCI, V32, P8817, DOI 10.1523/JNEUROSCI.1103-12.2012; Turnbaugh JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025675; Vogt TCB, 1999, J BIOL CHEM, V274, P29115, DOI 10.1074/jbc.274.41.29115; Wadia JS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003314; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, BIOCHEMISTRY-US, V49, P8169, DOI 10.1021/bi101146v; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Westergard L, 2011, J NEUROSCI, V31, P14005, DOI 10.1523/JNEUROSCI.1243-11.2011	59	23	23	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					30144	30160		10.1074/jbc.M114.587345	http://dx.doi.org/10.1074/jbc.M114.587345			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25217642	Green Published, hybrid			2022-12-28	WOS:000344370800053
J	Dahal, RA; Pramod, AB; Sharma, B; Krout, D; Foster, JD; Cha, JH; Cao, JJ; Newman, AH; Lever, JR; Vaughan, RA; Henry, LK				Dahal, Rejwi Acharya; Pramod, Akula Bala; Sharma, Babita; Krout, Danielle; Foster, James D.; Cha, Joo Hwan; Cao, Jianjing; Newman, Amy Hauck; Lever, John R.; Vaughan, Roxanne A.; Henry, L. Keith			Computational and Biochemical Docking of the Irreversible Cocaine Analog RTI 82 Directly Demonstrates Ligand Positioning in the Dopamine Transporter Central Substrate-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Addiction; Dopamine Transporter; Molecular Docking; Molecular Dynamics; Monoamine Transporter; Photoaffinity Labeling; SCAM; Topane	HUMAN SEROTONIN TRANSPORTERS; TRANSMEMBRANE DOMAIN-I; ACID METHYL-ESTERS; NEUROTRANSMITTER TRANSPORTERS; MONOAMINE TRANSPORTERS; MOLECULAR-DYNAMICS; CONFORMATIONAL-CHANGES; PHOTOAFFINITY LIGANDS; IMPLICATES PROXIMITY; LEUCINE TRANSPORTER	Background: Cocaine interaction with DAT was assessed using the irreversible binding cocaine analog RTI 82. Results: Molecular modeling and peptide mapping identify adduction of RTI 82 to Phe-319 and Phe-320 of rat DAT and human DAT, respectively. Conclusion: Tropane-based pharmacophores bind to DAT in the central substrate site. Significance: Mapping the cocaine-binding site reveals new insights for medication discovery. The dopamine transporter (DAT) functions as a key regulator of dopaminergic neurotransmission via re-uptake of synaptic dopamine (DA). Cocaine binding to DAT blocks this activity and elevates extracellular DA, leading to psychomotor stimulation and addiction, but the mechanisms by which cocaine interacts with DAT and inhibits transport remain incompletely understood. Here, we addressed these questions using computational and biochemical methodologies to localize the binding and adduction sites of the photoactivatable irreversible cocaine analog 3-(p-chlorophenyl)tropane-2-carboxylic acid, 4-azido-3-iodophenylethyl ester ([I-125]RTI 82). Comparative modeling and small molecule docking indicated that the tropane pharmacophore of RTI 82 was positioned in the central DA active site with an orientation that juxtaposed the aryliodoazide group for cross-linking to rat DAT Phe-319. This prediction was verified by focused methionine substitution of residues flanking this site followed by cyanogen bromide mapping of the [I-125]RTI 82-labeled mutants and by the substituted cysteine accessibility method protection analyses. These findings provide positive functional evidence linking tropane pharmacophore interaction with the core substrate-binding site and support a competitive mechanism for transport inhibition. This synergistic application of computational and biochemical methodologies overcomes many uncertainties inherent in other approaches and furnishes a schematic framework for elucidating the ligand-protein interactions of other classes of DA transport inhibitors.	[Dahal, Rejwi Acharya; Pramod, Akula Bala; Sharma, Babita; Krout, Danielle; Foster, James D.; Vaughan, Roxanne A.; Henry, L. Keith] Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58203 USA; [Cha, Joo Hwan; Cao, Jianjing; Newman, Amy Hauck] NIDA, Med Chem Sect, Intramural Res Program, Baltimore, MD 21224 USA; [Lever, John R.] Harry S Truman Mem Vet Hosp, Res Serv, Columbia, MO 65201 USA; [Lever, John R.] Univ Missouri, Dept Radiol, Radiopharmaceut Sci Inst, Columbia, MO 65211 USA; [Lever, John R.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA	University of North Dakota Grand Forks; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Vaughan, RA (corresponding author), 501 N Columbia Rd,Stop 9037, Grand Forks, ND 58202 USA.	roxanne.vaughan@med.und.edu; keith.henry@med.und.edu			National Institutes of Health Grants from the INBRE Program of the NCRR; NIDA-Intramural Research Program; COBRE Program of the NCRR [DA027845, P20 RR017699]; ND EPSCoR IIG [P20 RR016741]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027845, ZIADA000389] Funding Source: NIH RePORTER	National Institutes of Health Grants from the INBRE Program of the NCRR; NIDA-Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); COBRE Program of the NCRR; ND EPSCoR IIG; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants from the INBRE Program of the NCRR and the NIDA-Intramural Research Program (to A. H. N.), Grants DA027845 (to L. K. H. and R. A. V.), P20 RR017699 (to University of North Dakota) from the COBRE Program of the NCRR, and Grant P20 RR016741 from ND EPSCoR IIG (to R. A. V. and J. D. F.).	Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; Barker EL, 1999, J NEUROSCI, V19, P4705; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Bisgaard H, 2011, NEUROPHARMACOLOGY, V60, P182, DOI 10.1016/j.neuropharm.2010.08.021; Boja JW, 1998, SYNAPSE, V30, P9, DOI 10.1002/(SICI)1098-2396(199809)30:1<9::AID-SYN2>3.3.CO;2-P; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Caplan DA, 2008, BIOPHYS J, V95, P4613, DOI 10.1529/biophysj.108.139741; CARROLL FI, 1992, J MED CHEM, V35, P1813, DOI 10.1021/jm00088a017; CARROLL FI, 1991, J MED CHEM, V34, P2719, DOI 10.1021/jm00113a008; CARROLL FI, 1994, J MED CHEM, V37, P2865, DOI 10.1021/jm00044a007; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Chen NH, 2004, J NEUROCHEM, V89, P750, DOI 10.1111/j.1471-4159.2004.02409.x; Chen NH, 2001, J NEUROCHEM, V77, P1116, DOI 10.1046/j.1471-4159.2001.00312.x; Chen R, 2005, J NEUROCHEM, V94, P352, DOI 10.1111/j.1471-4159.2005.03199.x; Combs SA, 2013, NAT PROTOC, V8, P1277, DOI 10.1038/nprot.2013.074; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W. L, 2013, PYMOL MOL GRAPHICS S; Desai RI, 2005, J NEUROSCI, V25, P1889, DOI 10.1523/JNEUROSCI.4778-04.2005; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Felts B, 2014, J BIOL CHEM, V289, P1825, DOI 10.1074/jbc.M113.504654; Ferrer JV, 1998, P NATL ACAD SCI USA, V95, P9238, DOI 10.1073/pnas.95.16.9238; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Gabrielsen M, 2012, J MOL MODEL, V18, P1073, DOI 10.1007/s00894-011-1133-1; Gaffaney JD, 2014, NEUROCHEM INT, V73, P16, DOI 10.1016/j.neuint.2013.11.003; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Geurink PP, 2012, TOP CURR CHEM, V324, P85, DOI 10.1007/128_2011_286; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Hahn MK, 2007, ANNU REV PHARMACOL, V47, P401, DOI 10.1146/annurev.pharmtox.47.120505.105242; Henry LK, 2007, MOL INTERV, V7, P306, DOI 10.1124/mi.7.6.4; Henry LK, 2011, J BIOL CHEM, V286, P30823, DOI 10.1074/jbc.M111.250308; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hill ER, 2011, NEUROPHARMACOLOGY, V61, P112, DOI 10.1016/j.neuropharm.2011.03.014; Huang XQ, 2009, J PHYS CHEM B, V113, P15057, DOI 10.1021/jp900963n; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Indarte M, 2008, PROTEINS, V70, P1033, DOI 10.1002/prot.21598; Itokawa M, 2000, MOL PHARMACOL, V57, P1093; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; Koldso H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002246; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kurian MA, 2011, LANCET NEUROL, V10, P54, DOI 10.1016/S1474-4422(10)70269-6; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lee SH, 2000, MOL PHARMACOL, V57, P883; LEVER JR, 1993, J LABELLED COMPD RAD, V33, P1131, DOI 10.1002/jlcr.2580331207; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Lin ZC, 2000, MOL PHARMACOL, V58, P1581, DOI 10.1124/mol.58.6.1581; Lin ZC, 1999, MOL PHARMACOL, V56, P434, DOI 10.1124/mol.56.2.434; Lin ZC, 2002, MOL PHARMACOL, V61, P885, DOI 10.1124/mol.61.4.885; Loland CJ, 2008, MOL PHARMACOL, V73, P813, DOI 10.1124/mol.107.039800; Loland CJ, 2012, BIOL PSYCHIAT, V72, P405, DOI 10.1016/j.biopsych.2012.03.022; MADRAS BK, 1989, MOL PHARMACOL, V36, P518; Madras BK, 1996, SYNAPSE, V24, P340; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; MCELVAIN JS, 1992, BIOCHEM PHARMACOL, V43, P2189, DOI 10.1016/0006-2952(92)90178-L; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Meltzer PC, 1997, J MED CHEM, V40, P2661, DOI 10.1021/jm9703045; Merchant BA, 2012, J MOL GRAPH MODEL, V38, P1, DOI 10.1016/j.jmgm.2012.05.007; Mereu M, 2013, PSYCHOPHARMACOLOGY, V229, P415, DOI 10.1007/s00213-013-3232-4; MISSALE C, 1985, J NEUROCHEM, V45, P51, DOI 10.1111/j.1471-4159.1985.tb05473.x; MOE, 2012, MOL OP ENV; Parnas ML, 2008, MOL PHARMACOL, V73, P1141, DOI 10.1124/mol.107.043679; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Piscitelli CL, 2012, EMBO J, V31, P228, DOI 10.1038/emboj.2011.353; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; Plenge P, 2007, EUR J PHARMACOL, V567, P1, DOI 10.1016/j.ejphar.2007.03.055; Plenge P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371765; Pramod AB, 2013, MOL ASPECTS MED, V34, P197, DOI 10.1016/j.mam.2012.07.002; QUACPAC, 2011, OPENEYE SCI SOFTW; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Runyon S.P., 2008, DOPAMINE TRANSPORTER, P125; Schmitt KC, 2013, J PHARMACOL EXP THER, V346, P2, DOI 10.1124/jpet.111.191056; Schmitt KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025790; Sen N, 2005, NEUROPHARMACOLOGY, V49, P780, DOI 10.1016/j.neuropharm.2005.08.014; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, CHANNELS, V2, P380, DOI 10.4161/chan.2.5.6904; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Tanda G, 2013, PSYCHOPHARMACOLOGY, V229, P307, DOI 10.1007/s00213-013-3109-6; Tanda G, 2009, ADV PHARMACOL, V57, P253, DOI 10.1016/S1054-3589(08)57007-4; Torres GE, 2007, CURR OPIN NEUROBIOL, V17, P304, DOI 10.1016/j.conb.2007.05.002; Ukairo OT, 2005, J PHARMACOL EXP THER, V314, P575, DOI 10.1124/jpet.105.085829; Vaughan RA, 1996, J BIOL CHEM, V271, P21672, DOI 10.1074/jbc.271.35.21672; Vaughan RA, 1999, J NEUROSCI, V19, P630; Vaughan RA, 2001, MOL PHARMACOL, V59, P1157, DOI 10.1124/mol.59.5.1157; Vaughan RA, 2007, J BIOL CHEM, V282, P8915, DOI 10.1074/jbc.M610633200; Velazquez-Sanchez C, 2010, EUR NEUROPSYCHOPHARM, V20, P501, DOI 10.1016/j.euroneuro.2010.03.005; WALL SC, 1993, MOL PHARMACOL, V43, P264; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; Wang H, 2012, NAT STRUCT MOL BIOL, V19, P212, DOI 10.1038/nsmb.2215; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Wu XH, 2003, MOL PHARMACOL, V63, P653, DOI 10.1124/mol.63.3.653; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zdravkovic I, 2012, BBA-BIOMEMBRANES, V1818, P337, DOI 10.1016/j.bbamem.2011.10.031; Zhan CG, 2005, J COMPUT CHEM, V26, P980, DOI 10.1002/jcc.20241; Zhao CF, 2012, BIOPHYS J, V103, P878, DOI 10.1016/j.bpj.2012.07.044; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	109	20	20	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29712	29727		10.1074/jbc.M114.571521	http://dx.doi.org/10.1074/jbc.M114.571521			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25179220	Green Published, hybrid			2022-12-28	WOS:000344370800020
J	Field, MS; Kamynina, E; Agunloye, OC; Liebenthal, RP; Lamarre, SG; Brosnan, ME; Brosnan, JT; Stover, PJ				Field, Martha S.; Kamynina, Elena; Agunloye, Olufunmilayo C.; Liebenthal, Rebecca P.; Lamarre, Simon G.; Brosnan, Margaret E.; Brosnan, John T.; Stover, Patrick J.			Nuclear Enrichment of Folate Cofactors and Methylenetetrahydrofolate Dehydrogenase 1 (MTHFD1) Protect de Novo Thymidylate Biosynthesis during Folate Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Compartmentalization; DNA Synthesis; Folate; Homocysteine; Nucleoside; Nucleotide Metabolism; MTHFD1; One-carbon Metabolism; Uracil	HYDROXYMETHYLTRANSFERASE; RISK; COMPETITION; METABOLISM; MODIFIER; CHOLINE; DIETARY; FORMATE; MICE	Background: MTHFD1 is the primary source of one-carbon units for thymidylate synthesis. Results: MTHFD1 localizes to the nucleus in folate deficiency and S- and G(2)/M phases in mammalian cells to support de novo thymidylate biosynthesis. Conclusion: MTHFD1 nuclear localization explains the incorporation of formate into thymidylate during de novo thymidylate biosynthesis. Significance: Nuclear localization of MTHFD1 protects DNA by limiting uracil misincorporation into DNA. Folate-mediated one-carbon metabolism is a metabolic network of interconnected pathways that is required for the de novo synthesis of three of the four DNA bases and the remethylation of homocysteine to methionine. Previous studies have indicated that the thymidylate synthesis and homocysteine remethylation pathways compete for a limiting pool of methylenetetrahydrofolate cofactors and that thymidylate biosynthesis is preserved in folate deficiency at the expense of homocysteine remethylation, but the mechanisms are unknown. Recently, it was shown that thymidylate synthesis occurs in the nucleus, whereas homocysteine remethylation occurs in the cytosol. In this study we demonstrate that methylenetetrahydrofolate dehydrogenase 1 (MTHFD1), an enzyme that generates methylenetetrahydrofolate from formate, ATP, and NADPH, functions in the nucleus to support de novo thymidylate biosynthesis. MTHFD1 translocates to the nucleus in S-phase MCF-7 and HeLa cells. During folate deficiency mouse liver MTHFD1 levels are enriched in the nucleus >2-fold at the expense of levels in the cytosol. Furthermore, nuclear folate levels are resistant to folate depletion when total cellular folate levels are reduced by >50% in mouse liver. The enrichment of folate cofactors and MTHFD1 protein in the nucleus during folate deficiency in mouse liver and human cell lines accounts for previous metabolic studies that indicated 5,10-methylenetetrahydrofolate is preferentially directed toward de novo thymidylate biosynthesis at the expense of homocysteine remethylation during folate deficiency.	[Field, Martha S.; Kamynina, Elena; Agunloye, Olufunmilayo C.; Liebenthal, Rebecca P.; Stover, Patrick J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Lamarre, Simon G.; Brosnan, Margaret E.; Brosnan, John T.] Mem Univ Newfoundland, Dept Biochem, St John, NF A1B 3X9, Canada	Cornell University; Memorial University Newfoundland	Stover, PJ (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	pjs13@cornell.edu	Lamarre, Simon/A-5674-2008	Lamarre, Simon/0000-0001-7038-4626; Field, Martha/0000-0001-7547-5180	National Institutes of Health [R37DK58144]; Canadian Institutes of Health Research/Research and Development Corporation (RDC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058144] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research/Research and Development Corporation (RDC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R37DK58144 (to P. J. S.).; Supported by a grant from Canadian Institutes of Health Research/Research and Development Corporation (RDC).	Anderson DD, 2012, J BIOL CHEM, V287, P7051, DOI 10.1074/jbc.M111.333120; Anderson DD, 2012, J BIOL CHEM, V287, P4790, DOI 10.1074/jbc.M111.302174; Anderson DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005839; Ash JA, 2013, NEUROTOXICOL TERATOL, V38, P79, DOI 10.1016/j.ntt.2013.05.002; Beaudin AE, 2012, AM J CLIN NUTR, V95, P109, DOI 10.3945/ajcn.111.020305; Beaudin AE, 2011, AM J CLIN NUTR, V93, P789, DOI 10.3945/ajcn.110.002766; Beaudin AE, 2009, BIRTH DEFECTS RES A, V85, P274, DOI 10.1002/bdra.20553; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; DebRoy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070062; Field MS, 2013, J NUTR, V143, P41, DOI 10.3945/jn.112.169821; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Fox JT, 2009, J BIOL CHEM, V284, P31097, DOI 10.1074/jbc.M109.015800; Fox JT, 2009, J BIOL CHEM, V284, P31085, DOI 10.1074/jbc.M109.035576; Girgis S, 1998, GENE, V210, P315, DOI 10.1016/S0378-1119(98)00085-7; GREEN JM, 1988, BIOCHEMISTRY-US, V27, P8014, DOI 10.1021/bi00421a007; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Lamarre SG, 2013, CLIN CHEM LAB MED, V51, P571, DOI 10.1515/cclm-2012-0552; Lamarre SG, 2012, AM J PHYSIOL-ENDOC M, V302, pE61, DOI 10.1152/ajpendo.00345.2011; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; MacFarlane AJ, 2011, CANCER RES, V71, P2098, DOI 10.1158/0008-5472.CAN-10-1886; MacFarlane AJ, 2011, CARCINOGENESIS, V32, P427, DOI 10.1093/carcin/bgq270; MacFarlane AJ, 2009, J BIOL CHEM, V284, P1533, DOI 10.1074/jbc.M808281200; Pangilinan F, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-62; Scotti M, 2013, WIRES SYST BIOL MED, V5, P343, DOI 10.1002/wsbm.1209; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Stover PJ, 1997, J BIOL CHEM, V272, P1842, DOI 10.1074/jbc.272.3.1842; Suh JR, 2001, ANNU REV NUTR, V21, P255, DOI 10.1146/annurev.nutr.21.1.255; Suh JR, 2000, J BIOL CHEM, V275, P35646, DOI 10.1074/jbc.M005864200; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Wang YC, 2014, INT J CANCER, V134, P799, DOI 10.1002/ijc.28420; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200	31	51	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29642	29650		10.1074/jbc.M114.599589	http://dx.doi.org/10.1074/jbc.M114.599589			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25213861	hybrid, Green Published			2022-12-28	WOS:000344370800014
J	Kacprzyk-Stokowiec, A; Kulma, M; Traczyk, G; Kwiatkowska, K; Sobota, A; Dadlez, M				Kacprzyk-Stokowiec, Aleksandra; Kulma, Magdalena; Traczyk, Gabriela; Kwiatkowska, Katarzyna; Sobota, Andrzej; Dadlez, Michal			Crucial Role of Perfringolysin O D1 Domain in Orchestrating Structural Transitions Leading to Membrane-perforating Pores A HYDROGEN-DEUTERIUM EXCHANGE STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSIN; STAPHYLOCOCCAL ALPHA-HEMOLYSIN; THIOL-ACTIVATED CYTOLYSIN; MASS-SPECTROMETRY; CLOSTRIDIUM-PERFRINGENS; CONFORMATIONAL-CHANGES; STREPTOLYSIN-O; THETA-TOXIN; MECHANISM; PREPORE	Perfringolysin O(PFO) is a toxic protein that binds to cholesterol-containing membranes, oligomerizes, and forms a beta-barrel transmembrane pore, leading to cell lysis. Previous studies have uncovered the sequence of events in this multistage structural transition to a considerable detail, but the underlying molecular mechanisms are not yet fully understood. By measuring hydrogen-deuterium exchange patterns of peptide bond amide protons monitored by mass spectrometry (MS), we have mapped structural changes in PFO and its variant bearing a point mutation during incorporation to the lipid environment. We have defined all regions that undergo structural changes caused by the interaction with the lipid environment both in wild-type PFO, thus providing new experimental constraints for molecular modeling of the pore formation process, and in a point mutant, W165T, for which the pore formation process is known to be inefficient. We have demonstrated that point mutation W165T causes destabilization of protein solution structure, strongest for domain D1, which interrupts the pathway of structural transitions in other domains necessary for proper oligomerization in the membrane. In PFO, the strongest changes accompanying binding to the membrane focus in D1; the C-terminal part of D4; and strands beta 1, beta 4, and beta 5 of D3. These changes were much weaker for PFOl(ipo)(W165T) where substantial stabilization was observed only in D4 domain. In this study, the application of hydrogen-deuterium exchange analysis monitored by MS provided new insight into conformational changes of PFO associated with the membrane binding, oligomerization, and lytic pore formation.	[Kacprzyk-Stokowiec, Aleksandra; Kulma, Magdalena; Dadlez, Michal] Polish Acad Sci, Dept Biophys, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Traczyk, Gabriela; Kwiatkowska, Katarzyna; Sobota, Andrzej] Polish Acad Sci, Nencki Inst Expt Biol, Dept Cell Biol, PL-02093 Warsaw, Poland; [Dadlez, Michal] Warsaw Univ, Inst Genet & Biotechnol, Dept Biol, PL-02185 Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Warsaw	Dadlez, M (corresponding author), Polish Acad Sci, Dept Biophys, Inst Biochem & Biophys, 5A Pawinskiego St, PL-02106 Warsaw, Poland.	michald@ibb.waw.pl	Kwiatkowska, Katarzyna/R-4087-2016; Kwiatkowska, Katarzyna/ABE-9713-2021	Kwiatkowska, Katarzyna/0000-0002-0550-8394; Dadlez, Michal/0000-0001-8811-5176; Traczyk, Gabriela/0000-0003-2065-440X	Foundation for Polish Science TEAM Program [TEAM/2011-7/1]; Centre of Preclinical Research and Technology Grant [POIG.02.02.00- 14-024/08-00]; NanoFun [POIGT.02.02.00-00-025/09-00]	Foundation for Polish Science TEAM Program; Centre of Preclinical Research and Technology Grant; NanoFun	This work was supported by Foundation for Polish Science TEAM Program Grant TEAM/2011-7/1, Centre of Preclinical Research and Technology Grant POIG.02.02.00- 14-024/08-00, and NanoFun Grant POIGT.02.02.00-00-025/09-00.	Bourdeau RW, 2009, J BIOL CHEM, V284, P14645, DOI 10.1074/jbc.M807631200; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; Dang TX, 2005, J STRUCT BIOL, V150, P100, DOI 10.1016/j.jsb.2005.02.003; delosToyos JR, 1996, INFECT IMMUN, V64, P480, DOI 10.1128/IAI.64.2.480-484.1996; Dowd KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002787; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Hebling CM, 2010, ANAL CHEM, V82, P5415, DOI 10.1021/ac100962c; Heuck AP, 2007, J BIOL CHEM, V282, P22629, DOI 10.1074/jbc.M703207200; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Hotze EM, 2012, J BIOL CHEM, V287, P24534, DOI 10.1074/jbc.M112.380139; Hotze EM, 2012, BBA-BIOMEMBRANES, V1818, P1028, DOI 10.1016/j.bbamem.2011.07.036; Hotze EM, 2002, J BIOL CHEM, V277, P11597, DOI 10.1074/jbc.M111039200; Hotze EM, 2001, J BIOL CHEM, V276, P8261, DOI 10.1074/jbc.M009865200; IWAMOTO M, 1987, EUR J BIOCHEM, V167, P425, DOI 10.1111/j.1432-1033.1987.tb13355.x; Kaltashov IA, 2013, PROTEIN SCI, V22, P530, DOI 10.1002/pro.2238; Koshy SS, 2013, BIOCHEMISTRY-US, V52, P8833, DOI 10.1021/bi401261b; Kulma M, 2010, BBA-BIOMEMBRANES, V1798, P471, DOI 10.1016/j.bbamem.2009.12.004; Kupniewska-Kozak A, 2010, J MOL BIOL, V403, P52, DOI 10.1016/j.jmb.2010.08.027; Kwiatkowska K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-64; Miles G, 2002, PROTEIN SCI, V11, P1813, DOI 10.1110/ps.0204002; Morgan CR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010876; NAKAMURA M, 1995, BIOCHEMISTRY-US, V34, P6513, DOI 10.1021/bi00019a032; NELSON GJ, 1967, J LIPID RES, V8, P374; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Palmer M, 1998, EMBO J, V17, P1598, DOI 10.1093/emboj/17.6.1598; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Rossjohn J, 2007, J MOL BIOL, V367, P1227, DOI 10.1016/j.jmb.2007.01.042; SALO P, 1993, INFECT IMMUN, V61, P2822, DOI 10.1128/IAI.61.7.2822-2826.1993; Schuerch DW, 2005, P NATL ACAD SCI USA, V102, P12537, DOI 10.1073/pnas.0500558102; Sellman BR, 1997, MOL MICROBIOL, V23, P551, DOI 10.1046/j.1365-2958.1997.d01-1876.x; Shakor ABA, 2004, J BIOL CHEM, V279, P36778, DOI 10.1074/jbc.M402170200; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; Sitkiewicz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076353; Solovyova AS, 2004, BIOPHYS J, V87, P540, DOI 10.1529/biophysj.104.039974; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; TWETEN RK, 1988, INFECT IMMUN, V56, P3235, DOI 10.1128/IAI.56.12.3235-3240.1988; WALKER B, 1992, J BIOL CHEM, V267, P21782; Walzthoeni T, 2013, CURR OPIN STRUC BIOL, V23, P252, DOI 10.1016/j.sbi.2013.02.008	43	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28738	28752		10.1074/jbc.M114.577981	http://dx.doi.org/10.1074/jbc.M114.577981			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25164812	hybrid, Green Published			2022-12-28	WOS:000343765400061
J	Ali, M; Chernova, TA; Newnam, GP; Yin, LM; Shanks, J; Karpova, TS; Lee, A; Laur, O; Subramanian, S; Kim, D; McNally, JG; Seyfried, NT; Chernoff, YO; Wilkinson, KD				Ali, Moiez; Chernova, Tatiana A.; Newnam, Gary P.; Yin, Luming; Shanks, John; Karpova, Tatiana S.; Lee, Andrew; Laur, Oskar; Subramanian, Sindhu; Kim, Dami; McNally, James G.; Seyfried, Nicholas T.; Chernoff, Yury O.; Wilkinson, Keith D.			Stress-dependent Proteolytic Processing of the Actin Assembly Protein Lsb1 Modulates a Yeast Prion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Endoplasmic Reticulum (ER); Prion; Proteasome; Ubiquitylation (Ubiquitination); Rsp5; Sup35; Heat Shock	TAIL-ANCHORED PROTEINS; DAMAGED PROTEINS; IN-VIVO; CYTOSKELETON; AGGREGATION; SEGREGATION; PROTEASOME; UBIQUITINATION; INHERITANCE; ACTIVATION	Background: Thermal stress affects inheritance of prion amyloids in budding yeast. Results: Heat shock-induced processing of actin assembly protein Lsb1 is involved in yeast prion inheritance. Conclusion: Components of the actin cytoskeleton affect prion dynamics in response to heat shock. Significance: Understanding the mechanisms of aggregate segregation in response to stress may present new opportunities for pharmacological interventions aimed at protein aggregation disorders. Yeast prions are self-propagating amyloid-like aggregates of Q/N-rich protein that confer heritable traits and provide a model of mammalian amyloidoses. [PSI+] is a prion isoform of the translation termination factor Sup35. Propagation of [PSI+] during cell division under normal conditions and during the recovery from damaging environmental stress depends on cellular chaperones and is influenced by ubiquitin proteolysis and the actin cytoskeleton. The paralogous yeast proteins Lsb1 and Lsb2 bind the actin assembly protein Las17 (a yeast homolog of human Wiskott-Aldrich syndrome protein) and participate in the endocytic pathway. Lsb2 was shown to modulate maintenance of [PSI+] during and after heat shock. Here, we demonstrate that Lsb1 also regulates maintenance of the Sup35 prion during and after heat shock. These data point to the involvement of Lsb proteins in the partitioning of protein aggregates in stressed cells. Lsb1 abundance and cycling between actin patches, endoplasmic reticulum, and cytosol is regulated by the Guided Entry of Tail-anchored proteins pathway and Rsp5-dependent ubiquitination. Heat shock-induced proteolytic processing of Lsb1 is crucial for prion maintenance during stress. Our findings identify Lsb1 as another component of a tightly regulated pathway controlling protein aggregation in changing environments.	[Ali, Moiez; Chernova, Tatiana A.; Yin, Luming; Shanks, John; Lee, Andrew; Subramanian, Sindhu; Kim, Dami; Seyfried, Nicholas T.; Wilkinson, Keith D.] Emory Univ, Dept Biochem, Sch Med, Atlanta, GA 30322 USA; [Newnam, Gary P.; Chernoff, Yury O.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Newnam, Gary P.; Chernoff, Yury O.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Karpova, Tatiana S.; McNally, James G.] NCI, Ctr Canc Res Core Fluorescence Imaging Facil, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA; [Laur, Oskar] Emory Univ, Div Microbiol, Yerkes Res Ctr, Atlanta, GA 30329 USA; [Chernoff, Yury O.] St Petersburg State Univ, Lab Amyloid Biol, St Petersburg 199034, Russia	Emory University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Emory University; Saint Petersburg State University	Chernova, TA (corresponding author), 1510 Clifton Rd, Atlanta, GA 30322 USA.	tcherno@emory.edu; genekdw@emory.edu	Chernova, Tatiana/AAR-5007-2020; Chernoff, Yury O/J-2833-2014	Chernova, Tatiana/0000-0003-1966-0159; Chernoff, Yury/0000-0002-8934-9051; Karpova, Tatiana/0000-0001-6025-2128	National Institutes of Health [GM093294]; St. Petersburg State University [1.50.2218.2013]; NATIONAL CANCER INSTITUTE [ZICBC011574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Petersburg State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM093294 (to K. D. W., T. A. C., and Y. O. C.) and Project 1.50.2218.2013 from St. Petersburg State University (to Y. O. C.).	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Allen KD, 2007, J BIOL CHEM, V282, P3004, DOI 10.1074/jbc.M609597200; Bailleul-Winslett PA, 2000, GENE EXPRESSION, V9, P145; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; Chernoff YO, 2007, FEBS LETT, V581, P3695, DOI 10.1016/j.febslet.2007.04.075; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Chernova TA, 2014, FEMS MICROBIOL REV, V38, P326, DOI 10.1111/1574-6976.12053; Chernova TA, 2011, MOL CELL, V43, P242, DOI 10.1016/j.molcel.2011.07.001; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Evangelista M, 2000, J CELL BIOL, V148, P353, DOI 10.1083/jcb.148.2.353; Fasken MB, 2008, J BIOL CHEM, V283, P27130, DOI 10.1074/jbc.M803649200; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Ghahramani S., 2000, FUNDAMENTALS PROBABI; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Guarente L, 2010, CELL, V140, P176, DOI 10.1016/j.cell.2010.01.015; Gupta R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100159; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; Hernebring M, 2006, P NATL ACAD SCI USA, V103, P7700, DOI 10.1073/pnas.0510944103; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Howard GC, 2012, YEAST, V29, P93, DOI 10.1002/yea.1919; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; James P, 1996, GENETICS, V144, P1425; Kabani M, 2014, MOL MICROBIOL, V92, P507, DOI 10.1111/mmi.12572; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kaminska J, 2011, EUR J CELL BIOL, V90, P1016, DOI 10.1016/j.ejcb.2011.08.002; Kiktev DA, 2012, MOL CELL BIOL, V32, P4960, DOI 10.1128/MCB.00875-12; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Li LM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002973; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Liu BD, 2011, CELL, V147, P959, DOI 10.1016/j.cell.2011.11.018; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Newnam G. P., 2011, J MOL BIOL; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Nystrom T, 2014, CURR OPIN MICROBIOL, V18, P61, DOI 10.1016/j.mib.2014.02.003; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Rape M, 2004, BBA-MOL CELL RES, V1695, P209, DOI 10.1016/j.bbamcr.2004.09.022; Rieder S E, 2001, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0307s07; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shcherbik N, 2003, CURR BIOL, V13, P1227, DOI 10.1016/S0960-9822(03)00457-3; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Smethurst D. G., 2011, FEMS YEAST RES, V408, P432; Sontag EM, 2014, CURR OPIN CELL BIOL, V26, P139, DOI 10.1016/j.ceb.2013.12.006; Spiess M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061147; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; Tessarz P, 2009, MOL CELL BIOL, V29, P3738, DOI 10.1128/MCB.00201-09; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; Weinberg J, 2012, TRENDS CELL BIOL, V22, P1, DOI 10.1016/j.tcb.2011.09.001; Zhou CK, 2011, CELL, V147, P1186, DOI 10.1016/j.cell.2011.11.002	64	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27625	27639		10.1074/jbc.M114.582429	http://dx.doi.org/10.1074/jbc.M114.582429			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25143386	Green Published, hybrid			2022-12-28	WOS:000342852800023
J	Mehmeti, I; Lortz, S; Elsner, M; Lenzen, S				Mehmeti, Ilir; Lortz, Stephan; Elsner, Matthias; Lenzen, Sigurd			Peroxiredoxin 4 Improves Insulin Biosynthesis and Glucose-induced Insulin Secretion in Insulin-secreting INS-1E Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; PANCREATIC BETA-CELLS; ANTIOXIDATIVE DEFENSE STATUS; UNFOLDED PROTEIN RESPONSE; ENZYME GENE-EXPRESSION; OXIDATIVE STRESS; LOCALIZED PEROXIREDOXIN; DISULFIDE FORMATION; DIABETES-MELLITUS; HYDROGEN-PEROXIDE	Oxidative folding of (pro) insulin is crucial for its assembly and biological function. This process takes place in the endoplasmic reticulum (ER) and is accomplished by protein disulfide isomerase and ER oxidoreductin 1 beta, generating stoichiometric amounts of hydrogen peroxide (H2O2) as byproduct. During insulin resistance in the prediabetic state, increased insulin biosynthesis can overwhelm the ER antioxidative and folding capacity, causing an imbalance in the ER redox homeostasis and oxidative stress. Peroxiredoxin 4 (Prdx4), an ER-specific antioxidative peroxidase can utilize luminal H2O2 as driving force for reoxidizing protein disulfide isomerase family members, thus efficiently contributing to disulfide bond formation. Here, we examined the functional significance of Prdx4 on beta-cell function with emphasis on insulin content and secretion during stimulation with nutrient secretagogues. Overexpression of Prdx4 in glucose-responsive insulin-secreting INS-1E cells significantly metabolized luminal H2O2 and improved the glucose-induced insulin secretion, which was accompanied by the enhanced proinsulin mRNA transcription and insulin content. This beta-cell beneficial effect was also observed upon stimulation with the nutrient insulin secretagogue combination of leucine plus glutamine, indicating that the effect is not restricted to glucose. However, knockdown of Prdx4 had no impact on H2O2 metabolism or beta-cell function due to the fact that Prdx4 expression is negligibly low in pancreatic beta-cells. Moreover, we provide evidence that the constitutively low expression of Prdx4 is highly susceptible to hyperoxidation in the presence of high glucose. Overall, these data suggest an important role of Prdx4 in maintaining insulin levels and improving the ER folding capacity also under conditions of a high insulin requirement.	[Mehmeti, Ilir; Lortz, Stephan; Elsner, Matthias; Lenzen, Sigurd] Hannover Med Sch, Inst Clin Biochem, D-30623 Hannover, Germany	Hannover Medical School	Lenzen, S (corresponding author), Hannover Med Sch, Inst Clin Biochem, D-30623 Hannover, Germany.	lenzen.sigurd@mh-hannover.de	Elsner, Matthias/Q-1229-2017	Mehmeti, Ilir/0000-0003-1923-0837; Lortz, Stephan/0000-0002-3392-8978	European Union (BetaBAT) [277713]	European Union (BetaBAT)	This work was supported by a grant from the European Union (BetaBAT, Grant 277713) in the Framework Programme 7.	Appenzeller-Herzog C., 2008, EMBO J, V27, P2977; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Awazawa M, 2014, MOL CELL BIOL, V34, P1290, DOI 10.1128/MCB.01647-13; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bast A, 2002, DIABETOLOGIA, V45, P867, DOI 10.1007/s00125-002-0846-1; Cao ZB, 2011, J BIOL CHEM, V286, P42257, DOI 10.1074/jbc.M111.298810; Ding Y, 2010, ANTIOXID REDOX SIGN, V13, P1477, DOI 10.1089/ars.2010.3137; Goodge KA, 2000, SEMIN CELL DEV BIOL, V11, P235, DOI 10.1006/scdb.2000.0172; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Gurgul-Convey E, 2011, J MOL MED, V89, P785, DOI 10.1007/s00109-011-0747-1; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Iuchi Y, 2009, BIOCHEM J, V419, P149, DOI 10.1042/BJ20081526; Kakihana T, 2012, ANTIOXID REDOX SIGN, V16, P763, DOI 10.1089/ars.2011.4238; Karala AR, 2009, ANTIOXID REDOX SIGN, V11, P963, DOI 10.1089/ARS.2008.2326; Khoo C, 2011, ENDOCRINOLOGY, V152, P2599, DOI 10.1210/en.2010-1420; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mehmeti I, 2012, FREE RADICAL BIO MED, V53, P1451, DOI 10.1016/j.freeradbiomed.2012.08.010; Mehmeti I, 2011, MOL CELL ENDOCRINOL, V332, P88, DOI 10.1016/j.mce.2010.09.017; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nabeshima A, 2013, ANTIOXID REDOX SIGN, V19, P1983, DOI 10.1089/ars.2012.4946; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Oka OBV, 2013, BBA-MOL CELL RES, V1833, P2425, DOI 10.1016/j.bbamcr.2013.02.007; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Paula FMM, 2013, MOL CELL ENDOCRINOL, V374, P56, DOI 10.1016/j.mce.2013.04.009; Ramming Thomas, 2013, Int J Cell Biol, V2013, P180906, DOI 10.1155/2013/180906; Ramming T, 2014, FREE RADICAL BIO MED, V70, P106, DOI 10.1016/j.freeradbiomed.2014.01.018; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Rhee SG, 2010, MOL CELLS, V29, P539, DOI 10.1007/s10059-010-0082-3; Ron D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013177; Saaranen MJ, 2010, ANTIOXID REDOX SIGN, V12, P15, DOI 10.1089/ars.2009.2674; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; SCHUIT FC, 1991, BIOCHEM BIOPH RES CO, V178, P1182, DOI 10.1016/0006-291X(91)91017-7; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Van Lommel L, 2006, DIABETES, V55, P3214, DOI 10.2337/db06-0774; Wang L, 2014, ANTIOXID REDOX SIGN, V20, P545, DOI 10.1089/ars.2013.5236; Wang X, 2012, BIOCHEM J, V441, P113, DOI 10.1042/BJ20110380; Wolf G, 2010, J ENDOCRINOL, V207, P163, DOI 10.1677/JOE-09-0455; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zito E, 2013, ANTIOXID REDOX SIGN, V18, P1666, DOI 10.1089/ars.2012.4966; Zito E, 2012, MOL CELL, V48, P39, DOI 10.1016/j.molcel.2012.08.010; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	51	39	41	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26904	26913		10.1074/jbc.M114.568329	http://dx.doi.org/10.1074/jbc.M114.568329			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122762	Green Published, hybrid			2022-12-28	WOS:000342853900021
J	Kari, J; Olsen, J; Borch, K; Cruys-Bagger, N; Jensen, K; Westh, P				Kari, Jeppe; Olsen, Johan; Borch, Kim; Cruys-Bagger, Nicolaj; Jensen, Kenneth; Westh, Peter			Kinetics of Cellobiohydrolase (Cel7A) Variants with Lowered Substrate Affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI CELLOBIOHYDROLASE; CRYSTALLINE CELLULOSE DEGRADATION; REAL-TIME MEASUREMENTS; ENZYMATIC-HYDROLYSIS; PROCESSIVE ACTION; LIGNOCELLULOSIC BIOMASS; GLYCOSIDE HYDROLASES; SERRATIA-MARCESCENS; INSOLUBLE CELLULOSE; AROMATIC RESIDUES	Cellobiohydrolases are exo-active glycosyl hydrolases that processively convert cellulose to soluble sugars, typically cellobiose. They effectively break down crystalline cellulose and make up a major component in industrial enzyme mixtures used for deconstruction of lignocellulosic biomass. Identification of the rate-limiting step for cellobiohydrolases remains controversial, and recent reports have alternately suggested either association (on-rate) or dissociation (off-rate) as the overall bottleneck. Obviously, this uncertainty hampers both fundamental mechanistic understanding and rational design of enzymes with improved industrial applicability. To elucidate the role of on-and off-rates, respectively, on the overall kinetics, we have expressed a variant in which a tryptophan residue (Trp-38) in the middle of the active tunnel has been replaced with an alanine. This mutation weakens complex formation, and the population of substrate-bound W38A was only about half of the wild type. Nevertheless, the maximal, steady-state rate was twice as high for the variant enzyme. It is argued that these opposite effects on binding and activity can be reconciled if the rate-limiting step is after the catalysis (i.e. in the dissociation process).	[Kari, Jeppe; Olsen, Johan; Cruys-Bagger, Nicolaj; Westh, Peter] Roskilde Univ, Dept Sci Syst & Models, Res Unit Funct Biomat, DK-4000 Roskilde, Denmark; [Borch, Kim; Jensen, Kenneth] Novozymes AS, DK-2880 Bagsvaerd, Denmark	Roskilde University; Novozymes	Westh, P (corresponding author), Roskilde Univ, NSM, Res Unit Funct Biomat, 1 Univ Vej, DK-4000 Roskilde, Denmark.	pwesth@ruc.dk	Jensen, Kenneth/G-3638-2011; Olsen, Johan/A-5599-2016; Westh, Peter/AAR-9731-2021; Kari, Jeppe/AAP-6649-2021	Jensen, Kenneth/0000-0001-6286-5577; Olsen, Johan/0000-0002-1383-8318; Kari, Jeppe/0000-0003-3792-3856; Westh, Peter/0000-0002-6185-0637				ABUJA PM, 1988, EUR BIOPHYS J BIOPHY, V15, P339, DOI 10.1007/BF00254721; Alasepp K, 2014, LANGMUIR, V30, P7134, DOI 10.1021/la500161e; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Beckham GT, 2014, CURR OPIN BIOTECH, V27, P96, DOI 10.1016/j.copbio.2013.12.002; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Cruys-Bagger N, 2014, ANAL BIOCHEM, V447, P162, DOI 10.1016/j.ab.2013.11.024; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; Cruys-Bagger N, 2013, FEBS J, V280, P3952, DOI 10.1111/febs.12397; Cruys-Bagger N, 2012, BIOTECHNOL BIOENG, V109, P3199, DOI 10.1002/bit.24593; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Eriksson T, 2002, APPL BIOCHEM BIOTECH, V101, P41, DOI 10.1385/ABAB:101:1:41; Fox JM, 2013, NAT CHEM BIOL, V9, P356, DOI 10.1038/nchembio.1227; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; GhattyVenkataKrishna PK, 2013, BIOPHYS J, V104, P904, DOI 10.1016/j.bpj.2012.12.052; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Igarashi K, 2006, FEBS J, V273, P2869, DOI 10.1111/j.1742-4658.2006.05299.x; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Jorgensen H, 2007, BIOFUEL BIOPROD BIOR, V1, P119, DOI 10.1002/bbb.4; Kiehna SE, 2007, CHEM COMMUN, P4026, DOI 10.1039/b711431a; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; Knott BC, 2014, J AM CHEM SOC, V136, P321, DOI 10.1021/ja410291u; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; Kostylev M, 2014, BIOTECHNOL BIOENG, V111, P664, DOI 10.1002/bit.25139; Kostylev M, 2013, BIOCHEMISTRY-US, V52, P5656, DOI 10.1021/bi400358v; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Larsen J, 2008, CHEM ENG TECHNOL, V31, P765, DOI 10.1002/ceat.200800048; Laughrey ZR, 2008, J AM CHEM SOC, V130, P14625, DOI 10.1021/ja803960x; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Maurer SA, 2012, IND ENG CHEM RES, V51, P11389, DOI 10.1021/ie3008538; Monschein M, 2013, BIORESOURCE TECHNOL, V128, P679, DOI 10.1016/j.biortech.2012.10.129; Murphy L, 2010, ANAL BIOCHEM, V404, P140, DOI 10.1016/j.ab.2010.04.020; Nakamura A, 2014, J AM CHEM SOC, V136, P4584, DOI 10.1021/ja4119994; Nakamura A, 2013, J BIOL CHEM, V288, P13503, DOI 10.1074/jbc.M113.452623; Olsen SN, 2011, APPL BIOCHEM BIOTECH, V163, P626, DOI 10.1007/s12010-010-9068-z; Palonen H, 1999, APPL ENVIRON MICROB, V65, P5229; Parsiegla G, 2000, BIOCHEMISTRY-US, V39, P11238, DOI 10.1021/bi001139p; Parsiegla G, 2008, J MOL BIOL, V375, P499, DOI 10.1016/j.jmb.2007.10.039; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Shang BZ, 2013, J BIOL CHEM, V288, P29081, DOI 10.1074/jbc.M113.497412; Sorlie M, 2012, BIOCATAL BIOTRANSFOR, V30, P353, DOI 10.3109/10242422.2012.676282; STAHLBERG J, 1991, BIO-TECHNOL, V9, P286, DOI 10.1038/nbt0391-286; Taylor CB, 2013, J PHYS CHEM B, V117, P4924, DOI 10.1021/jp401410h; Taylor CB, 2012, J BIOL CHEM, V287, P3147, DOI 10.1074/jbc.M111.270389; Teeri TT, 1997, TRENDS BIOTECHNOL, V15, P160, DOI 10.1016/S0167-7799(97)01032-9; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Vuong TV, 2009, APPL ENVIRON MICROB, V75, P6655, DOI 10.1128/AEM.01260-09; Wahlstrom R, 2014, BIOTECHNOL BIOENG, V111, P726, DOI 10.1002/bit.25144; Watanabe T, 2003, BIOCHEM J, V376, P237, DOI 10.1042/BJ20030419; Westh P., 2014, PCT International Patent Appl., Patent No. [WO/2014/064115, 2014064115]; Wilson David B, 2012, Methods Mol Biol, V908, P93, DOI 10.1007/978-1-61779-956-3_9; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200; Zhang S, 2000, EUR J BIOCHEM, V267, P3101, DOI 10.1046/j.1432-1327.2000.01315.x; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282	67	50	50	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.604264	http://dx.doi.org/10.1074/jbc.M114.604264			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25271162	Green Published, hybrid			2022-12-28	WOS:000345335000006
J	Banzawa, N; Saito, S; Imagawa, T; Kashio, M; Takahashi, K; Tominaga, M; Ohta, T				Banzawa, Nagako; Saito, Shigeru; Imagawa, Toshiaki; Kashio, Makiko; Takahashi, Kenji; Tominaga, Makoto; Ohta, Toshio			Molecular Basis Determining Inhibition/Activation of Nociceptive Receptor TRPA1 Protein A SINGLE AMINO ACID DICTATES SPECIES-SPECIFIC ACTIONS OF THE MOST POTENT MAMMALIAN TRPA1 ANTAGONIST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Imaging; Dorsal Root Ganglia; Neuron; Pain; Patch Clamp; Transient Receptor Potential Channels (TRP Channels)	ACTIVATED ION-CHANNEL; ANKYRIN 1 TRPA1; MOUSE TRPA1; CAPSAICIN RECEPTOR; COLD; PAIN; SENSITIVITY; HEAT; IDENTIFICATION; TRPV1	Background: Nociceptive TRPA1 is an important drug discovery target for identification of analgesics. Results: A967079, one of the most potent mammalian TRPA1 antagonists, showed marked species differences. Conclusion: A single amino acid was responsible for inhibitory/stimulatory actions of A967079. Significance: The present data provide novel insight in the search for analgesics targeting TRPA1. The transient receptor potential ankyrin 1 (TRPA1) is a Ca2+-permeable, nonselective cation channel mainly expressed in a subset of nociceptive neurons. TRPA1 functions as a cellular sensor detecting mechanical, chemical, and thermal stimuli. Because TRPA1 is considered to be a key player in nociception and inflammatory pain, TRPA1 antagonists have been developed as analgesic agents. Recently, by utilizing species differences, we identified the molecular basis of the antagonistic action of A967079, one of the most potent mammalian TRPA1 antagonists. Here, we show a unique effect of A967079 on TRPA1 from diverse vertebrate species, i.e. it acts as an agonist but not as an antagonist for chicken and frog TRPA1s. By characterizing chimeric channels of human and chicken TRPA1s, as well as point mutants, we found that a single specific amino acid residue located within the putative fifth transmembrane domain was involved in not only the stimulatory but also the inhibitory actions of A967079. AP18, structurally related to A967079, exerted similar pharmacological properties to A967079. Our findings and previous reports on species differences in the sensitivity to TRPA1 antagonists supply useful information in the search for novel analgesic medicines targeting TRPA1.	[Banzawa, Nagako; Takahashi, Kenji; Ohta, Toshio] Tottori Univ, Fac Agr, Dept Vet Pharmacol, Tottori 6808553, Japan; [Saito, Shigeru; Kashio, Makiko; Tominaga, Makoto] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Natl Inst Physiol Sci, Okazaki, Aichi 4448787, Japan; [Imagawa, Toshiaki] Hokkaido Univ, Dept Chem, Biol Chem Lab, Fac Sci, Sapporo, Hokkaido 0600810, Japan	Tottori University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Hokkaido University	Ohta, T (corresponding author), Tottori Univ, Fac Agr, Dept Vet Pharmacol, Tottori 6808553, Japan.	tohta@muses.tottori-u.ac.jp	Saito, Shigeru/B-4698-2015	Kashio, Makiko/0000-0001-6404-2339; Saito, Shigeru/0000-0002-6237-8979	KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [22380160, 26292150, 24580426]	KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or part, by a KAKENHI, Grants-in-aid for Scientific Research (B) 22380160 and 26292150 (to T. O.), and Grant-in-aid for Scientific Research (C) 24580426 (to K. T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Altier C, 2004, TRENDS PHARMACOL SCI, V25, P465, DOI 10.1016/j.tips.2004.07.004; Andrade EL, 2012, PHARMACOL THERAPEUT, V133, P189, DOI 10.1016/j.pharmthera.2011.10.008; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bang S, 2009, J GEN PHYSIOL, V133, P257, DOI 10.1085/jgp.200810138; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Caspani O, 2009, J GEN PHYSIOL, V133, P245, DOI 10.1085/jgp.200810136; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen J, 2008, J NEUROSCI, V28, P5063, DOI 10.1523/JNEUROSCI.0047-08.2008; Chen J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3501; Chen J, 2011, PAIN, V152, P1165, DOI 10.1016/j.pain.2011.01.049; Chen J, 2009, J GEN PHYSIOL, V133, P623, DOI 10.1085/jgp.200910246; da Costa DSM, 2010, PAIN, V148, P431, DOI 10.1016/j.pain.2009.12.002; de la Roche J, 2013, J BIOL CHEM, V288, P20280, DOI 10.1074/jbc.M113.479337; DeFalco J, 2010, BIOORG MED CHEM LETT, V20, P276, DOI 10.1016/j.bmcl.2009.10.113; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kim D, 2007, J NEUROSCI, V27, P6500, DOI 10.1523/JNEUROSCI.0623-07.2007; Klement G, 2013, BIOPHYS J, V104, P798, DOI 10.1016/j.bpj.2013.01.008; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Kurganov E, 2014, PFLUG ARCH EUR J PHY, V466, P1873, DOI 10.1007/s00424-013-1420-z; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; McGaraughty S, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-14; Miura S, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-7; Nagatomo K, 2008, P NATL ACAD SCI USA, V105, P17373, DOI 10.1073/pnas.0809769105; Nagatomo K, 2010, BIOPHYS J, V99, P3609, DOI 10.1016/j.bpj.2010.10.014; Nakatsuka K, 2013, J MOL NEUROSCI, V51, P754, DOI 10.1007/s12031-013-0060-2; Ogawa H, 2012, NEUROSCIENCE, V218, P335, DOI 10.1016/j.neuroscience.2012.05.044; Ohkita M, 2012, J BIOL CHEM, V287, P2388, DOI 10.1074/jbc.M111.305698; Ohta T, 2008, J BIOL CHEM, V283, P9377, DOI 10.1074/jbc.M709377200; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Ro JY, 2009, PAIN, V144, P270, DOI 10.1016/j.pain.2009.04.021; Saito S, 2014, MOL BIOL EVOL, V31, P708, DOI 10.1093/molbev/msu001; Saito S, 2012, J BIOL CHEM, V287, P30743, DOI 10.1074/jbc.M112.362194; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Zhang XF, 2008, EUR J NEUROSCI, V27, P605, DOI 10.1111/j.1460-9568.2008.06030.x; Zhou YM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3399	45	25	25	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31927	31939		10.1074/jbc.M114.586891	http://dx.doi.org/10.1074/jbc.M114.586891			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25271161	hybrid, Green Published			2022-12-28	WOS:000345314700023
J	de Diego, I; Veillard, F; Sztukowska, MN; Guevara, T; Potempa, B; Pomowski, A; Huntington, JA; Potempa, J; Gomis-Ruth, FX				de Diego, Inaki; Veillard, Florian; Sztukowska, Maryta N.; Guevara, Tibisay; Potempa, Barbara; Pomowski, Anja; Huntington, James A.; Potempa, Jan; Xavier Gomis-Rueth, F.			Structure and Mechanism of Cysteine Peptidase Gingipain K (Kgp), a Major Virulence Factor of Porphyromonas gingivalis in Periodontitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cysteine Protease; Enzyme Catalysis; Microbial Pathogenesis; Protease Inhibitor; X-ray Crystallography; Oral Pathogen	ACTIVE-SITE; CRYSTAL-STRUCTURE; LYS-GINGIPAIN; PROTEINASE; ARG; FEATURES; PACKING; BINDING; CRYSTALLOGRAPHY; INHIBITORS	Cysteine peptidases are key proteolytic virulence factors of the periodontopathogen Porphyromonas gingivalis, which causes chronic periodontitis, the most prevalent dysbiosis-driven disease in humans. Two peptidases, gingipain K (Kgp) and R (RgpA and RgpB), which differ in their selectivity after lysines and arginines, respectively, collectively account for 85% of the extracellular proteolytic activity of P. gingivalis at the site of infection. Therefore, they are promising targets for the design of specific inhibitors. Although the structure of the catalytic domain of RgpB is known, little is known about Kgp, which shares only 27% sequence identity. We report the high resolution crystal structure of a competent fragment of Kgp encompassing the catalytic cysteine peptidase domain and a downstream immunoglobulin superfamily-like domain, which is required for folding and secretion of Kgp in vivo. The structure, which strikingly resembles a tooth, was serendipitously trapped with a fragment of a covalent inhibitor targeting the catalytic cysteine. This provided accurate insight into the active site and suggested that catalysis may require a catalytic triad, Cys(477)-His(444)-Asp(388), rather than the cysteine-histidine dyad normally found in cysteine peptidases. In addition, a 20--long solvent-filled interior channel traverses the molecule and links the bottom of the specificity pocket with the molecular surface opposite the active site cleft. This channel, absent in RgpB, may enhance the plasticity of the enzyme, which would explain the much lower activity in vitro toward comparable specific synthetic substrates. Overall, the present results report the architecture and molecular determinants of the working mechanism of Kgp, including interaction with its substrates.	[de Diego, Inaki; Guevara, Tibisay; Xavier Gomis-Rueth, F.] Spanish Res Council Consejo Super Invest, Mol Biol Inst Barcelona, Proteolysis Lab, Barcelona 08028, Catalonia, Spain; [Veillard, Florian; Sztukowska, Maryta N.; Potempa, Barbara; Potempa, Jan] Univ Louisville, Sch Dent, Sch Med, Louisville, KY 40202 USA; [Potempa, Jan] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Pomowski, Anja; Huntington, James A.] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Wellcome Trust, Cambridge CB2 0XY, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Louisville; Jagiellonian University; University of Cambridge; Wellcome Trust Sanger Institute	Potempa, J (corresponding author), Univ Louisville, Sch Dent, Sch Med, Louisville, KY 40202 USA.	jspote01@louisville.edu; fxgr@ibmb.csic.es	Potempa, Jan/AAA-6850-2021; de Diego Martinez, Iñaki/AAB-4712-2019	de Diego Martinez, Iñaki/0000-0002-6156-4032; Guevara Puig, Tibisay/0000-0002-1366-8507; Potempa, Jan/0000-0002-3600-7461; Veillard, Florian/0000-0003-1248-2396; Gomis-Ruth, F. Xavier/0000-0002-6848-6874	National Institutes of Health [DE09761/DE/NIDCR]; Polish National Science Center [UMO-2012/04/A/NZ1/00051]; Ministry of Science and Higher Education of Poland [2137/7.PR-EU/2011/2]; European Union [FP7-HEALTH-2010-261460, FP7-PEOPLE-2011-ITN-290246, FP7-HEALTH-2012-306029-2, POIG.02.01.00-12-064/08]; Spanish Ministry of Economy and Competitiveness [BFU2012-32862, BIO2013-49320-EXP]; Spanish Ministry of Science and Education [CSD2006-00015]; National Government of Catalonia [2014SGR9]; European Synchrotron Radiation Facility (Grenoble, France); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE009761] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish National Science Center; Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland); European Union(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Science and Education(Spanish Government); National Government of Catalonia; European Synchrotron Radiation Facility (Grenoble, France); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE09761/DE/NIDCR. This work was also supported by Polish National Science Center Grant UMO-2012/04/A/NZ1/00051; Ministry of Science and Higher Education of Poland Grant 2137/7.PR-EU/2011/2; European Union Grants FP7-HEALTH-2010-261460 "Gums&Joints," FP7-PEOPLE-2011-ITN-290246 "RAPID," FP7-HEALTH-2012-306029-2 "TRIGGER," and POIG.02.01.00-12-064/08; Spanish Ministry of Economy and Competitiveness Grants BFU2012-32862 and BIO2013-49320-EXP; Spanish Ministry of Science and Education Grant CSD2006-00015; and National Government of Catalonia Grant 2014SGR9. Funding for data collection was provided in part by the European Synchrotron Radiation Facility (Grenoble, France).	Aravind L, 2002, PROTEINS, V46, P355, DOI 10.1002/prot.10060; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Brochu V, 2001, ORAL MICROBIOL IMMUN, V16, P79, DOI 10.1034/j.1399-302x.2001.016002079.x; Carranza C., 1999, AFMB ACTIVITY REPORT, P89; Chen JM, 1998, FEBS LETT, V441, P361, DOI 10.1016/S0014-5793(98)01574-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHEN ZX, 1992, J BIOL CHEM, V267, P18896; Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Curtis MA, 2002, INFECT IMMUN, V70, P6968, DOI 10.1128/IAI.70.12.6968-6975.2002; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Dall E, 2013, P NATL ACAD SCI USA, V110, P10940, DOI 10.1073/pnas.1300686110; de Diego I, 2013, J BIOL CHEM, V288, P14287, DOI 10.1074/jbc.M112.444927; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Discipio RG, 1996, IMMUNOLOGY, V87, P660, DOI 10.1046/j.1365-2567.1996.478594.x; DRENTH J, 1976, BIOCHEMISTRY-US, V15, P3731, DOI 10.1021/bi00662a014; Dubin G, 2013, CURR PHARM DESIGN, V19, P1090, DOI 10.2174/13816128130611; DUNITZ JD, 1994, SCIENCE, V264, P670, DOI 10.1126/science.264.5159.670; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frydrych I, 2008, J CELL BIOCHEM, V103, P1646, DOI 10.1002/jcb.21550; Guarne A, 2000, J MOL BIOL, V302, P1227, DOI 10.1006/jmbi.2000.4115; Haffajee Anne D, 2003, Ann Periodontol, V8, P115, DOI 10.1902/annals.2003.8.1.115; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Harding MM, 2000, ACTA CRYSTALLOGR D, V56, P857, DOI 10.1107/S0907444900005849; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hede K, 2014, NATURE, V509, pS2, DOI 10.1038/509S2a; Hildebrand PW, 2008, BIOPHYS J, V94, P1945, DOI 10.1529/biophysj.107.110395; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ishida Y, 2008, ARCH ORAL BIOL, V53, P538, DOI 10.1016/j.archoralbio.2008.01.004; JIA ZC, 1995, J BIOL CHEM, V270, P5527, DOI 10.1074/jbc.270.10.5527; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kataoka S, 2014, FASEB J, V28, P3564, DOI 10.1096/fj.14-252130; Kokkinidis M, 2012, ADV PROTEIN CHEM STR, V87, P181, DOI 10.1016/B978-0-12-398312-1.00007-X; Kurita-Ochiai T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/595981; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee C, 2000, P NATL ACAD SCI USA, V97, P7727, DOI 10.1073/pnas.97.14.7727; Li N, 2011, MOL MICROBIOL, V81, P1358, DOI 10.1111/j.1365-2958.2011.07768.x; Li N, 2010, MOL MICROBIOL, V76, P861, DOI 10.1111/j.1365-2958.2010.07123.x; Maixner F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099994; Mallorqui-Fernandez N, 2008, J BIOL CHEM, V283, P2871, DOI 10.1074/jbc.M708481200; Maresz KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003627; Marrero A, 2012, ANGEW CHEM INT EDIT, V51, P3340, DOI 10.1002/anie.201108015; Matesanz-Perez P, 2013, J CLIN PERIODONTOL, V40, P227, DOI 10.1111/jcpe.12026; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; May M, 2014, NATURE, V509, pS4, DOI 10.1038/509S4a; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mittl PRE, 2006, CURR OPIN STRUC BIOL, V16, P769, DOI 10.1016/j.sbi.2006.10.014; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Page R C, 1998, Ann Periodontol, V3, P108, DOI 10.1902/annals.1998.3.1.108; Pathirana RD, 2007, INFECT IMMUN, V75, P1436, DOI 10.1128/IAI.01627-06; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PIKE R, 1994, J BIOL CHEM, V269, P406; Pike RN, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P2337, DOI 10.1016/B978-0-12-382219-2.00521-4; Polgar L, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1773, DOI 10.1016/B978-0-12-382219-2.00405-1; Potempa J, 1997, BIOL CHEM, V378, P223, DOI 10.1515/bchm.1997.378.3-4.223; POTEMPA J, 1995, INFECT IMMUN, V63, P1176, DOI 10.1128/IAI.63.4.1176-1182.1995; Potempa J, 1996, ACTA BIOCHIM POL, V43, P455; Potempa Jan, 2005, V12, P132, DOI 10.1159/000081693; Potempa Jan, 2007, Curr Protoc Protein Sci, VChapter 21, DOI 10.1002/0471140864.ps2120s49; Puente XS, 1997, BIOCHEM J, V322, P947, DOI 10.1042/bj3220947; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Richardson J. S., 1989, PREDICTION PROTEIN S, P1; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; ROBERTUS JD, 1972, BIOCHEMISTRY-US, V11, P2439, DOI 10.1021/bi00763a009; Rose A, 2014, NUCLEIC ACIDS RES, V42, pD347, DOI 10.1093/nar/gkt1062; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schulenburg C, 2013, TOP CURR CHEM, V337, P41, DOI 10.1007/128_2012_411; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SHAW ELLIOTT, 1965, BIOCHEMISTRY, V4, P2219, DOI 10.1021/bi00886a039; Sztukowska M, 2004, MOL MICROBIOL, V54, P1393, DOI 10.1111/j.1365-2958.2004.04357.x; Sztukowska M, 2012, BIOL CHEM, V393, P971, DOI 10.1515/hsz-2012-0175; Takano K, 2003, PROTEIN ENG, V16, P5, DOI 10.1093/proeng/gzg001; Tang YQ, 2011, ADV EXP MED BIOL, V712, P15, DOI 10.1007/978-1-4419-8414-2_2; Tilakaratne A, 2014, OPEN DENT J, V8, P109, DOI 10.2174/1874210601408010109; Trillo-Muyo S, 2013, ACTA CRYSTALLOGR D, V69, P464, DOI 10.1107/S0907444912050135; Vidossich P, 2014, J PHYS CHEM B, V118, P2924, DOI 10.1021/jp4123425; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; WILLIAMS MA, 1994, PROTEIN SCI, V3, P1224, DOI 10.1002/pro.5560030808; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F	88	54	55	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32291	32302		10.1074/jbc.M114.602052	http://dx.doi.org/10.1074/jbc.M114.602052			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25266723	Green Published, hybrid			2022-12-28	WOS:000345314700054
J	Eckert, ESP; Reckmann, I; Hellwig, A; Rohling, S; El-Battari, A; Wieland, FT; Popoff, V				Eckert, Elias S. P.; Reckmann, Ingeborg; Hellwig, Andrea; Roehling, Simone; El-Battari, Assou; Wieland, Felix T.; Popoff, Vincent			Golgi Phosphoprotein 3 Triggers Signal-mediated Incorporation of Glycosyltransferases into Coatomer-coated (COPI) Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; TRANSMEMBRANE DOMAINS; TUMOR PROGRESSION; POOR-PROGNOSIS; PROTEIN; GOLPH3; LOCALIZATION; TRANSPORT; RETENTION; BINDING	Newly synthesized membrane and secreted proteins undergo a series of posttranslational modifications in the Golgi apparatus, including attachment of carbohydrate moieties. The final structure of so-formed glycans is determined by the order of execution of the different glycosylation steps, which seems intimately related to the spatial distribution of glycosyltransferases and glycosyl hydrolases within the Golgi apparatus. How cells achieve an accurate localization of these enzymes is not completely understood but might involve dynamic processes such as coatomer-coated (COPI) vesicle-mediated trafficking. In yeast, this transport is likely to be regulated by vacuolar protein sorting 74 (Vps74p), a peripheral Golgi protein able to interact with COPI coat as well as with a binding motif present in the cytosolic tails of some mannosyltransferases. Recently, Golgi phosphoprotein 3 (GOLPH3), the mammalian homolog of Vps74, has been shown to control the Golgi localization of core 2 N-acetyl-glucosamine- transferase 1. Here, we highlight a role of GOLPH3 in the spatial localization of alpha-2,6-sialyltransferase 1. We show, for the first time, that GOLPH3 supports incorporation of both core 2N-acetylglucosamine-transferase 1 and alpha-2,6-sialyltransferase 1 into COPI vesicles. Depletion of GOLPH3 altered the subcellular localization of these enzymes. In contrast, galactosyltransferase, an enzyme that does not interact with GOLPH3, was neither incorporated into COPI vesicles nor was dependent on GOLPH3 for proper localization.	[Eckert, Elias S. P.; Reckmann, Ingeborg; Roehling, Simone; Wieland, Felix T.; Popoff, Vincent] Heidelberg Univ, Heidelberg Univ Biochem Ctr BZH, INF 328, D-69120 Heidelberg, Germany; [Hellwig, Andrea] Heidelberg Univ, Interdisciplinary Ctr Neurosci IZN, INF 364, D-69120 Heidelberg, Germany; [El-Battari, Assou] Aix Marseille Univ, INSERM, UMR 911, Ctr Rech Oncobiol & Oncopharmacol CR02, F-13284 Marseille, France	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Popoff, V (corresponding author), Heidelberg Univ, Heidelberg Univ Biochem Ctr BZH, INF 328, D-69120 Heidelberg, Germany.	vincent.popoff@espci.org			Federation of the Societies of Biochemistry and Molecular Biology (FEBS)	Federation of the Societies of Biochemistry and Molecular Biology (FEBS)	Supported by a Federation of the Societies of Biochemistry and Molecular Biology (FEBS) long term fellowship. To whom correspondence should be addressed. E-mail: vincent.popoff@espci.org.	Adolf F, 2013, TRAFFIC, V14, P922, DOI 10.1111/tra.12084; Ali MF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.346528; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Cheong FY, 2010, TRAFFIC, V11, P1180, DOI 10.1111/j.1600-0854.2010.01092.x; COLLEY KJ, 1992, J BIOL CHEM, V267, P7784; DAHDAL RY, 1993, J BIOL CHEM, V268, P26310; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; El-Battari A, 2003, GLYCOBIOLOGY, V13, P941, DOI 10.1093/glycob/cwg117; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; Faulstich D, 1996, J CELL BIOL, V135, P53, DOI 10.1083/jcb.135.1.53; Fenteany FH, 2005, J BIOL CHEM, V280, P5423, DOI 10.1074/jbc.M412396200; Franco M, 1996, J BIOL CHEM, V271, P1573, DOI 10.1074/jbc.271.3.1573; Glick BS, 1997, FEBS LETT, V414, P177, DOI 10.1016/S0014-5793(97)00984-8; Gommel D, 1999, FEBS LETT, V447, P179, DOI 10.1016/S0014-5793(99)00246-X; Hatakeyama S, 2010, INT J CANCER, V127, P1052, DOI 10.1002/ijc.25117; Hill CAS, 2005, CANCER LETT, V217, P105, DOI 10.1016/j.canlet.2004.06.038; Hu BS, 2013, TUMOR BIOL, V34, P515, DOI 10.1007/s13277-012-0576-z; Hua X, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-127; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Jackson CL, 2009, J CELL SCI, V122, P443, DOI 10.1242/jcs.032581; Kunigou O, 2011, ONCOL REP, V26, P1337, DOI 10.3892/or.2011.1413; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Li H, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-168; Li XY, 2011, J NEURO-ONCOL, V105, P159, DOI 10.1007/s11060-011-0573-x; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Maccioni HJF, 2011, J NEUROCHEM, V117, P589, DOI 10.1111/j.1471-4159.2011.07232.x; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; MASIBAY AS, 1993, J BIOL CHEM, V268, P9908; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; Nakashima-Kamimura N, 2005, J CELL SCI, V118, P5357, DOI 10.1242/jcs.02645; Ng MM, 2013, MOL BIOL CELL, V24, P796, DOI 10.1091/mbc.E12-07-0525; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Pereira NA, 2014, J BIOL CHEM, V289, P14762, DOI 10.1074/jbc.M114.548305; Popoff V., 2011, COLD SPRING HARB PER, V3; Quintero CA, 2008, BIOCHEM J, V412, P19, DOI 10.1042/BJ20071725; Reinhard C, 2003, P NATL ACAD SCI USA, V100, P8253, DOI 10.1073/pnas.1432391100; Sahlmuller MC, 2011, TRAFFIC, V12, P682, DOI 10.1111/j.1600-0854.2011.01177.x; Schaub BE, 2006, MOL BIOL CELL, V17, P5153, DOI 10.1091/mbc.E06-08-0665; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Serafini Tito, 1992, V219, P286; Shimodaira K, 1997, CANCER RES, V57, P5201; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Tu LN, 2012, TRAFFIC, V13, P1496, DOI 10.1111/j.1600-0854.2012.01403.x; Tu LN, 2010, CELL MOL LIFE SCI, V67, P29, DOI 10.1007/s00018-009-0126-z; Wang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045622; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zeng ZL, 2012, CLIN CANCER RES, V18, P4059, DOI 10.1158/1078-0432.CCR-11-3156; Zerfaoui M, 2002, GLYCOBIOLOGY, V12, P15, DOI 10.1093/glycob/12.1.15; Zhou JX, 2012, J NEURO-ONCOL, V110, P195, DOI 10.1007/s11060-012-0970-9	58	48	48	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31319	31329		10.1074/jbc.M114.608182	http://dx.doi.org/10.1074/jbc.M114.608182			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25246532	Green Published, hybrid			2022-12-28	WOS:000344549900036
J	Zhang, XY; Ji, F; Wang, N; Chen, LL; Tian, T; Lu, W				Zhang, Xiao-Yan; Ji, Fang; Wang, Ning; Chen, Lin-Lin; Tian, Tian; Lu, Wei			Glycine Induces Bidirectional Modifications in N-Methyl-D-aspartate Receptor-mediated Synaptic Responses in Hippocampal CA1 Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-ATPASE; NA+-ATPASE; ENTEROCOCCUS-HIRAE; SUBUNIT ROTATION; ROTOR RING; THERMUS-THERMOPHILUS; TORQUE GENERATION; PROTEOLIPID RING; ROTARY MECHANISM; MOLECULAR MOTOR	Glycine can persistently potentiate or depress AMPA responses through differential actions on two binding sites: NMDA and glycine receptors. Whether glycine can induce long-lasting modifications in NMDA responses, however, remains unknown. Here, we report that glycine induces long-term potentiation (LTP) or long-term depression (LTD) of NMDA responses (Gly-LTPNMDA or Gly-LTDNMDA) in a dose-dependent manner in hippocampal CA1 neurons. These modifications of NMDA responses depend on NMDAR activation. In addition, the induction of Gly-LTPNMDA requires binding of glycine with NMDARs, whereas Gly-LTDNMDA requires that glycine bind with both sites on NMDARs and GlyRs. Moreover, activity-dependent exocytosis and endocytosis of postsynaptic NMDARs underlie glycine-induced bidirectional modification of NMDA excitatory postsynaptic currents. Thus, we conclude that glycine at different levels induces bidirectional plasticity of NMDA responses through differentially regulating NMDA receptor trafficking. Our present findings reveal important functions of the two glycine binding sites in gating the direction of synaptic plasticity in NMDA responses.	[Zhang, Xiao-Yan; Ji, Fang; Wang, Ning; Chen, Lin-Lin; Tian, Tian; Lu, Wei] Nanjing Med Univ, Dept Neurobiol, Nanjing 210029, Jiangsu, Peoples R China; [Wang, Ning; Lu, Wei] Southeast Univ, Inst Life Sci, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China; [Lu, Wei] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China; Nantong University	Lu, W (corresponding author), Nanjing Med Univ, Dept Neurobiol, Nanjing 210029, Jiangsu, Peoples R China.	lu@njmu.edu.cn			National Natural Science Foundation of China (NSFC) [31025011]; Major State Basic Research Program of China [2013CB733801]; Doctoral Fund of the Ministry of Education of China [20103234110004]; Open Research Fund of State Key Laboratory of Bioelectronics, Southeast University	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major State Basic Research Program of China(National Basic Research Program of China); Doctoral Fund of the Ministry of Education of China(Ministry of Education, China); Open Research Fund of State Key Laboratory of Bioelectronics, Southeast University	This work was supported by National Natural Science Foundation of China (NSFC) Grant 31025011, Major State Basic Research Program of China Grant 2013CB733801, the Doctoral Fund of the Ministry of Education of China Grant 20103234110004, and the Open Research Fund of State Key Laboratory of Bioelectronics, Southeast University (to W.L.).	Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bilyard T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0023; Bowman EJ, 2005, J BIOENERG BIOMEMBR, V37, P431, DOI 10.1007/s10863-005-9485-9; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Cook GM, 2003, J BACTERIOL, V185, P4442, DOI 10.1128/JB.185.15.4442-4449.2003; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Furuike S, 2008, SCIENCE, V319, P955, DOI 10.1126/science.1151343; Furuike S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1215; Halir R., 1998, P 6 INT C CENTR EUR; Hayashi K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218103; Hirata T, 2000, J BIOL CHEM, V275, P386, DOI 10.1074/jbc.275.1.386; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Imamura H, 2005, P NATL ACAD SCI USA, V102, P17929, DOI 10.1073/pnas.0507764102; Ishmukhametov R, 2010, EMBO J, V29, P3911, DOI 10.1038/emboj.2010.259; KAKINUMA Y, 1994, J BIOCHEM-TOKYO, V116, P1302, DOI 10.1093/oxfordjournals.jbchem.a124679; Maher MJ, 2009, EMBO J, V28, P3771, DOI 10.1038/emboj.2009.310; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Marshansky V, 2014, BBA-BIOENERGETICS, V1837, P857, DOI 10.1016/j.bbabio.2014.01.018; Minagawa Y, 2013, J BIOL CHEM, V288, P32700, DOI 10.1074/jbc.M113.506329; Mizutani K, 2011, P NATL ACAD SCI USA, V108, P13474, DOI 10.1073/pnas.1103287108; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Murata T, 2005, J BIOENERG BIOMEMBR, V37, P411, DOI 10.1007/s10863-005-9481-0; Murata T, 2000, J BIOL CHEM, V275, P13415, DOI 10.1074/jbc.275.18.13415; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murata T, 1997, J BIOL CHEM, V272, P24885, DOI 10.1074/jbc.272.40.24885; Murata T, 1999, J BIOCHEM, V125, P414, DOI 10.1093/oxfordjournals.jbchem.a022302; Murata T, 2008, P NATL ACAD SCI USA, V105, P8607, DOI 10.1073/pnas.0800992105; Nagamatsu Y, 2013, J MOL BIOL, V425, P2699, DOI 10.1016/j.jmb.2013.04.022; Nakano M, 2008, J BIOL CHEM, V283, P20789, DOI 10.1074/jbc.M801276200; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishio K, 2002, P NATL ACAD SCI USA, V99, P13448, DOI 10.1073/pnas.202149599; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 1999, BIOCHEM BIOPH RES CO, V260, P597, DOI 10.1006/bbrc.1999.0885; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Panke O, 2001, BIOPHYS J, V81, P1220, DOI 10.1016/S0006-3495(01)75780-3; Pogoryelov D, 2010, NAT CHEM BIOL, V6, P891, DOI 10.1038/NCHEMBIO.457; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Soga N, 2012, J BIOL CHEM, V287, P9633, DOI 10.1074/jbc.M111.335356; Stewart AG, 2014, CURR OPIN STRUC BIOL, V25, P40, DOI 10.1016/j.sbi.2013.11.013; Stewart AG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1693; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; Toei M, 2013, J BIOL CHEM, V288, P25717, DOI 10.1074/jbc.M113.482455; Toyabe S, 2011, P NATL ACAD SCI USA, V108, P17951, DOI 10.1073/pnas.1106787108; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P898, DOI 10.1073/pnas.031564198; Ueno H, 2005, P NATL ACAD SCI USA, V102, P1333, DOI 10.1073/pnas.0407857102; Ueno H, 2010, BIOPHYS J, V98, P2014, DOI 10.1016/j.bpj.2010.01.011; Usukura E, 2012, J BIOL CHEM, V287, P1884, DOI 10.1074/jbc.M111.305938; Wachter A, 2011, P NATL ACAD SCI USA, V108, P3924, DOI 10.1073/pnas.1011581108; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI 10.1038/NCHEMBIO.443; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yokoyama K, 2005, J BIOENERG BIOMEMBR, V37, P405, DOI 10.1007/s10863-005-9480-1; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504	63	14	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31200	31223		10.1074/jbc.M114.570630	http://dx.doi.org/10.1074/jbc.M114.570630			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25231980	Green Published, hybrid			2022-12-28	WOS:000344549900027
J	Suzuki, J; Imanishi, E; Nagata, S				Suzuki, Jun; Imanishi, Eiichi; Nagata, Shigekazu			Exposure of Phosphatidylserine by Xk-related Protein Family Members during Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID SCRAMBLASE; CASPASE CLEAVAGE; DNA-DEGRADATION; PANNEXIN 1; FIND-ME; IDENTIFICATION; CLEARANCE; CELLS; GENE; ACTIVATION	Apoptotic cells expose phosphatidylserine (PtdSer) on their surface as an "eat me" signal. Mammalian Xk-related (Xkr) protein 8, which is predicted to contain six transmembrane regions, and its Caenorhabditis elegans homolog CED-8 promote apoptotic PtdSer exposure. The mouse and human Xkr families consist of eight and nine members, respectively. Here, we found that mouse Xkr family members, with the exception of Xkr2, are localized to the plasma membrane. When Xkr8-deficient cells, which do not expose PtdSer during apoptosis, were transformed by Xkr family members, the transformants expressing Xkr4, Xkr8, or Xkr9 responded to apoptotic stimuli by exposing cell surface PtdSer and were efficiently engulfed by macrophages. Like Xkr8, Xkr4 and Xkr9 were found to possess a caspase recognition site in the C-terminal region and to require its direct cleavage by caspases for their function. Site-directed mutagenesis of the amino acid residues conserved among CED-8, Xkr4, Xkr8, and Xkr9 identified several essential residues in the second transmembrane and second cytoplasmic regions. Real time PCR analysis indicated that unlike Xkr8, which is ubiquitously expressed, Xkr4 and Xkr9 expression is tissue-specific.	[Suzuki, Jun; Imanishi, Eiichi; Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Nagata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.	snagata@mfour.med.kyoto-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426	Japan Society for the Promotion of Science; Takeda Science Foundation; Grants-in-Aid for Scientific Research [22000013] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for specially promoted research from the Japan Society for the Promotion of Science (to S. N.) and by a grant-in-aid for young scientists (B) from the Japan Society for the Promotion of Science and a research grant from the Takeda Science Foundation (to J. S.).	Alonso-Perez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045356; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Bullen TF, 2006, LAB INVEST, V86, P1052, DOI 10.1038/labinvest.3700464; Calenda G, 2006, GENE, V370, P6, DOI 10.1016/j.gene.2005.10.037; Castoldi E, 2011, BLOOD, V117, P4399, DOI 10.1182/blood-2011-01-332502; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen YZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3726; Coleman JA, 2013, BBA-MOL CELL BIOL L, V1831, P555, DOI 10.1016/j.bbalip.2012.10.006; Crawford ED, 2011, ANNU REV BIOCHEM, V80, P1055, DOI 10.1146/annurev-biochem-061809-121639; Cusack CL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2910; FUKUNAGA R, 1990, J BIOL CHEM, V265, P14008; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Han C, 2014, NEURON, V81, P544, DOI 10.1016/j.neuron.2013.11.021; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2005, P NATL ACAD SCI USA, V102, P16886, DOI 10.1073/pnas.0508599102; HO MF, 1994, CELL, V77, P869, DOI 10.1016/0092-8674(94)90136-8; Kunzelmann K, 2014, PFLUG ARCH EUR J PHY, V466, P407, DOI 10.1007/s00424-013-1305-1; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; McCarty JS, 1999, BIOCHEM BIOPH RES CO, V264, P181, DOI 10.1006/bbrc.1999.1498; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nagata S, 2005, ANNU REV IMMUNOL, V23, P853, DOI 10.1146/annurev.immunol.23.021704.115811; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Neto LRP, 2012, ANIM GENET, V43, P785, DOI 10.1111/j.1365-2052.2012.02330.x; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Rivera A, 2013, BLOOD CELL MOL DIS, V50, P80, DOI 10.1016/j.bcmd.2012.10.002; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Shiraishi T, 2004, BIOCHEM BIOPH RES CO, V322, P197, DOI 10.1016/j.bbrc.2004.07.098; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Toda S, 2012, MOL CELL BIOL, V32, P118, DOI 10.1128/MCB.05993-11; TUCKER KA, 1987, BLOOD, V70, P372; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Meer G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004671; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Yamaguchi H, 2014, ELIFE, V3, DOI 10.7554/eLife.02172; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	49	88	91	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30257	30267		10.1074/jbc.M114.583419	http://dx.doi.org/10.1074/jbc.M114.583419			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231987	Green Published, hybrid			2022-12-28	WOS:000344549700010
J	Morisse, S; Michelet, L; Bedhomme, M; Marchand, CH; Calvaresi, M; Trost, P; Fermani, S; Zaffagnini, M; Lemaire, SD				Morisse, Samuel; Michelet, Laure; Bedhomme, Mariette; Marchand, Christophe H.; Calvaresi, Matteo; Trost, Paolo; Fermani, Simona; Zaffagnini, Mirko; Lemaire, Stephane D.			Thioredoxin- dependent Redox Regulation of Chloroplastic Phosphoglycerate Kinase from Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chlamydomonas; Chloroplast; Disulfide; Photosynthesis; Redox Signaling; Thiol; Thioredoxin; Calvin-Benson Cycle; Phosphoglycerate Kinase	OXIDATION-REDUCTION PROPERTIES; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; FERREDOXIN/THIOREDOXIN SYSTEM; 3-PHOSPHOGLYCERATE KINASE; PHOTOSYNTHETIC ORGANISMS; ESCHERICHIA-COLI; PROTEIN; GLUTAREDOXINS; GLUTATHIONYLATION; PURIFICATION	Background: Chloroplastic PGK is a putative target of thioredoxin identified by redox proteomics. Results:Chlamydomonas PGK1 is regulated by TRX-f via oxidoreduction of the Cys(227)-Cys(361) disulfide bond. Conclusion:Chlamydomonas PGK1 is a potentially new light-modulated Calvin-Benson cycle enzyme. Significance: The complex redox regulation of the Calvin-Benson cycle and its evolution are further expanded. In photosynthetic organisms, thioredoxin-dependent redox regulation is a well established mechanism involved in the control of a large number of cellular processes, including the Calvin-Benson cycle. Indeed, 4 of 11 enzymes of this cycle are activated in the light through dithiol/disulfide interchanges controlled by chloroplastic thioredoxin. Recently, several proteomics-based approaches suggested that not only four but all enzymes of the Calvin-Benson cycle may withstand redox regulation. Here, we characterized the redox features of the Calvin-Benson enzyme phosphoglycerate kinase (PGK1) from the eukaryotic green alga Chlamydomonas reinhardtii, and we show that C. reinhardtii PGK1 (CrPGK1) activity is inhibited by the formation of a single regulatory disulfide bond with a low midpoint redox potential (-335 mV at pH 7.9). CrPGK1 oxidation was found to affect the turnover number without altering the affinity for substrates, whereas the enzyme activation appeared to be specifically controlled by f-type thioredoxin. Using a combination of site-directed mutagenesis, thiol titration, mass spectrometry analyses, and three-dimensional modeling, the regulatory disulfide bond was shown to involve the not strictly conserved Cys(227) and Cys(361). Based on molecular mechanics calculation, the formation of the disulfide is proposed to impose structural constraints in the C-terminal domain of the enzyme that may lower its catalytic efficiency. It is therefore concluded that CrPGK1 might constitute an additional light-modulated Calvin-Benson cycle enzyme with a low activity in the dark and a TRX-dependent activation in the light. These results are also discussed from an evolutionary point of view.	[Morisse, Samuel; Michelet, Laure; Bedhomme, Mariette; Marchand, Christophe H.; Lemaire, Stephane D.] CNRS, Inst Biol Physicochim, Lab Biol Mol & Cellulaire Eucaryotes, UMR8226, F-75005 Paris, France; [Morisse, Samuel; Michelet, Laure; Bedhomme, Mariette; Marchand, Christophe H.; Lemaire, Stephane D.] Univ Paris 06, Sorbonne Univ, UMR8226, Lab Biol Mol & Cellulaire Eucaryotes,Inst Biol Ph, F-75005 Paris, France; [Trost, Paolo; Zaffagnini, Mirko] Univ Bologna, Dept Pharm & Biotechnol, Lab Plant Redox Biol, I-40126 Bologna, Italy; [Calvaresi, Matteo; Fermani, Simona] Univ Bologna, Dept Chem G Ciamician, I-40126 Bologna, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Bologna; University of Bologna	Zaffagnini, M (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Lab Plant Redox Biol, Via Irnerio 42, I-40126 Bologna, Italy.	mirko.zaffagnini3@unibo.it; stephane.lemaire@ibpc.fr	Lemaire, Stéphane D/A-3530-2008; Calvaresi, Matteo/ABG-6570-2021; MARCHAND, Christophe H/B-5854-2008	Lemaire, Stéphane D/0000-0001-6442-0547; Calvaresi, Matteo/0000-0002-9583-2146; MARCHAND, Christophe H/0000-0002-0729-3841; Zaffagnini, Mirko/0000-0001-5115-0859; Trost, Paolo/0000-0002-6347-8701	PRIN; ANR [12-BSV5-0019 REDPRO2]; LABEX DYNAMO [ANR-LABX11-0011]; FARB2012 University of Bologna	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); ANR(French National Research Agency (ANR)); LABEX DYNAMO; FARB2012 University of Bologna	This work was supported in part by PRIN 2008 and 2009 (to M. Z. and P. T.), ANR Grant 12-BSV5-0019 REDPRO2 (to C. H. M. and S. D. L.), LABEX DYNAMO ANR-LABX11-0011 (to C. H. M. and S. D. L.), and FARB2012 University of Bologna (to M. Z. and S. F.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arsova B, 2010, PLANT CELL, V22, P1498, DOI 10.1105/tpc.109.071001; Astier J, 2011, PLANT SCI, V181, P527, DOI 10.1016/j.plantsci.2011.02.011; Balmer Y, 2006, P NATL ACAD SCI USA, V103, P2988, DOI 10.1073/pnas.0511040103; Balmer Y, 2004, PHOTOSYNTH RES, V79, P275, DOI 10.1023/B:PRES.0000017207.88257.d4; Balmer Y, 2001, BIOCHEMISTRY-US, V40, P15444, DOI 10.1021/bi011646m; BANKS RD, 1979, NATURE, V279, P773, DOI 10.1038/279773a0; Bosco MB, 2012, PROTIST, V163, P188, DOI 10.1016/j.protis.2011.07.001; Bentahir M, 2000, J BIOL CHEM, V275, P11147, DOI 10.1074/jbc.275.15.11147; Buchanan BB, 2012, BBA-GEN SUBJECTS, V1820, P1822, DOI 10.1016/j.bbagen.2012.07.006; Chibani K, 2010, PHOTOSYNTH RES, V104, P75, DOI 10.1007/s11120-009-9501-8; Cliff MJ, 2010, J AM CHEM SOC, V132, P6507, DOI 10.1021/ja100974t; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Collin V, 2003, J BIOL CHEM, V278, P23747, DOI 10.1074/jbc.M302077200; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DAVIES GJ, 1994, ACTA CRYSTALLOGR D, V50, P202, DOI 10.1107/S0907444993011138; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fermani S, 2007, P NATL ACAD SCI USA, V104, P11109, DOI 10.1073/pnas.0611636104; FIFIS T, 1978, BIOCHEM J, V175, P311, DOI 10.1042/bj1750311; Gontero B, 2012, BIOCHEM SOC T, V40, P995, DOI 10.1042/BST20120097; Hirasawa M, 1998, ARCH BIOCHEM BIOPHYS, V350, P127, DOI 10.1006/abbi.1997.0499; Hirasawa M, 1999, BIOCHEMISTRY-US, V38, P5200, DOI 10.1021/bi982783v; Kato H, 2013, PHYSIOL PLANTARUM, V148, P371, DOI 10.1111/j.1399-3054.2012.01684.x; Kobayashi D, 2003, PLANT CELL PHYSIOL, V44, P269, DOI 10.1093/pcp/pcg048; Lemaire SD, 2003, FEBS LETT, V543, P87, DOI 10.1016/S0014-5793(03)00416-2; Lemaire SD, 2007, CURR GENET, V51, P343, DOI 10.1007/s00294-007-0128-z; Lindahl M, 2011, ANTIOXID REDOX SIGN, V14, P2581, DOI 10.1089/ars.2010.3551; Marri L, 2005, PLANT PHYSIOL, V139, P1433, DOI 10.1104/pp.105.068445; Marri L, 2014, BIOCHIMIE, V97, P228, DOI 10.1016/j.biochi.2013.10.018; Marri L, 2009, MOL PLANT, V2, P259, DOI 10.1093/mp/ssn061; Michelet L, 2008, J BIOL CHEM, V283, P21571, DOI 10.1074/jbc.M802331200; Michelet L, 2006, PHOTOSYNTH RES, V89, P225, DOI 10.1007/s11120-006-9096-2; Michelet L, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00470; Mora-Garcia S, 1998, J BIOL CHEM, V273, P16273, DOI 10.1074/jbc.273.26.16273; Morisse S, 2014, ANTIOXID REDOX SIGN, V21, P1271, DOI 10.1089/ars.2013.5632; Navrot N, 2011, J PROTEOMICS, V74, P1450, DOI 10.1016/j.jprot.2011.03.008; Nee G, 2009, FEBS LETT, V583, P2827, DOI 10.1016/j.febslet.2009.07.035; NISHIZAWA AN, 1981, J BIOL CHEM, V256, P6119; Rouhier N, 2005, ANTIOXID REDOX SIGN, V7, P919, DOI 10.1089/ars.2005.7.919; Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811; Ruelland E, 1999, TRENDS PLANT SCI, V4, P136, DOI 10.1016/S1360-1385(99)01391-6; Schroter Y, 2010, PROTEOMICS, V10, P2191, DOI 10.1002/pmic.200900678; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Smith CD, 2011, BIOCHEM BIOPH RES CO, V412, P203, DOI 10.1016/j.bbrc.2011.07.045; Sparla F, 2004, J MOL BIOL, V340, P1025, DOI 10.1016/j.jmb.2004.06.005; Sparla F, 2005, PLANT PHYSIOL, V138, P2210, DOI 10.1104/pp.105.062117; Sparla F, 2002, J BIOL CHEM, V277, P44946, DOI 10.1074/jbc.M206873200; Tanou G, 2012, PLANT J, V72, P585, DOI 10.1111/j.1365-313X.2012.05100.x; Trost P, 2006, PHOTOSYNTH RES, V89, P263, DOI 10.1007/s11120-006-9099-z; Tsukamoto Y, 2013, PLANT CELL PHYSIOL, V54, P484, DOI 10.1093/pcp/pct002; WATSON HC, 1982, EMBO J, V1, P1635, DOI 10.1002/j.1460-2075.1982.tb01366.x; Young TA, 2007, J MOL BIOL, V368, P1438, DOI 10.1016/j.jmb.2007.02.077; Yu MD, 2012, CURR OPIN PLANT BIOL, V15, P424, DOI 10.1016/j.pbi.2012.03.005; Zaffagnini M, 2008, J BIOL CHEM, V283, P8868, DOI 10.1074/jbc.M709567200; Zaffagnini M, 2012, PLANT SCI, V185, P86, DOI 10.1016/j.plantsci.2012.01.005; Zaffagnini M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014142; Zaffagnini M, 2012, ANTIOXID REDOX SIGN, V16, P567, DOI 10.1089/ars.2011.4255; Zerrad L, 2011, J BIOL CHEM, V286, P14040, DOI 10.1074/jbc.M110.206813	58	28	28	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					30012	30024		10.1074/jbc.M114.597997	http://dx.doi.org/10.1074/jbc.M114.597997			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25202015	Green Published, hybrid			2022-12-28	WOS:000344370800042
J	Saa, P; Yakovleva, O; de Castro, J; Vasilyeva, I; De Paoli, SH; Simak, J; Cervenakova, L				Saa, Paula; Yakovleva, Oksana; de Castro, Jorge; Vasilyeva, Irina; De Paoli, Silvia H.; Simak, Jan; Cervenakova, Larisa			First Demonstration of Transmissible Spongiform Encephalopathy-associated Prion Protein (PrPTSE) in Extracellular Vesicles from Plasma of Mice Infected with Mouse-adapted Variant Creutzfeldt-Jakob Disease by in Vitro Amplification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISFOLDING CYCLIC AMPLIFICATION; CHRONIC WASTING DISEASE; MESENCHYMAL STEM-CELLS; NEURODEGENERATIVE DISEASES; SELECTIVE EXTERNALIZATION; TRANSFERRIN RECEPTOR; NEUROBLASTOMA-CELLS; CEREBROSPINAL-FLUID; PROTEOMIC ANALYSIS; ENDOTHELIAL-CELLS	The development of variant Creutzfeldt-Jakob disease (vCJD) in three recipients of non-leukoreduced red blood cells from asymptomatic donors who subsequently developed the disease has confirmed existing concerns about the possible spread of transmissible spongiform encephalopathies (TSEs) via blood products. In addition, the presence of disease-associated misfolded prion protein (PrPTSE), generally associated with infectivity, has been demonstrated in the blood of vCJD patients. However, its origin and distribution in this biological fluid are still unknown. Various studies have identified cellular prion protein (PrPC) among the protein cargo in human blood-circulating extracellular vesicles released from endothelial cells and platelets, and exosomes isolated from the conditioned media of TSE-infected cells have caused the disease when injected into experimental mice. In this study, we demonstrate the detection of PrPTSE in extracellular vesicles isolated from plasma samples collected during the preclinical and clinical phases of the disease from mice infected with mouse-adapted vCJD and confirm the presence of the exosomal marker Hsp70 in these preparations.	[Saa, Paula; Yakovleva, Oksana; de Castro, Jorge; Vasilyeva, Irina; Cervenakova, Larisa] Amer Natl Red Cross, Holland Lab, Biomed Serv, Transmissible Dis Dept, Rockville, MD 20855 USA; [De Paoli, Silvia H.; Simak, Jan] US FDA, Lab Cellular Hematol, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA	American Red Cross; US Food & Drug Administration (FDA)	Saa, P (corresponding author), Amer Natl Red Cross, Holland Lab, Biomed Serv, Transmissible Dis Dept, 15601 Crabbs Branch Way, Rockville, MD 20855 USA.	Paula.Saa@redcross.org	Saa, Paula/AAB-6607-2019; Simak, Jan/C-1153-2011	Saa, Paula/0000-0001-6077-4532; Simak, Jan/0000-0001-8910-7362	American National Red Cross; Fondation Alliance BioSecure	American National Red Cross; Fondation Alliance BioSecure	This study was supported by research funding from the American National Red Cross (to L. C.) and the Fondation Alliance BioSecure (to P. S.).	Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Akimov S, 2008, J VIROL, V82, P10959, DOI 10.1128/JVI.01085-08; Akimov S, 2009, FOLIA NEUROPATHOL, V47, P205; Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Andreoletti O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002782; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Bannach O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036620; Bard MP, 2004, AM J RESP CELL MOL, V31, P114, DOI 10.1165/rcmb.2003-0238OC; Brandel JP, 2009, ANN NEUROL, V65, P249, DOI 10.1002/ana.21583; Brouckova A, 2009, THROMB HAEMOSTASIS, V102, P966, DOI 10.1160/TH09-02-0074; Brown P, 2001, J LAB CLIN MED, V137, P5, DOI 10.1067/mlc.2001.111951; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Castro-Seoane R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002538; Cervenakova L, 2003, TRANSFUSION, V43, P1687, DOI 10.1046/j.0041-1132.2003.00586.x; Cervenakova L, 2003, ELECTROPHORESIS, V24, P853, DOI 10.1002/elps.200390107; Cervenakova L, 2011, TRANSFUSION, V51, P1755, DOI 10.1111/j.1537-2995.2010.03041.x; Cheng L, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23743; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Coleman BM, 2012, FASEB J, V26, P4160, DOI 10.1096/fj.11-202077; Dabaghian R, 2008, PRION, V2, P170, DOI 10.4161/pri.2.4.8068; de Marco MF, 2010, J PATHOL, V222, P380, DOI 10.1002/path.2767; Dorsey K, 2009, TRANSFUSION, V49, P977, DOI 10.1111/j.1537-2995.2008.02056.x; Douet JY, 2014, EMERG INFECT DIS, V20, P114, DOI 10.3201/eid2001.130353; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Ecroyd H, 2004, BIOL REPROD, V71, P993, DOI 10.1095/biolreprod.104.029801; Edgeworth JA, 2011, LANCET, V377, P487, DOI 10.1016/S0140-6736(10)62308-2; Elder AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080203; Epple LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042064; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fevrier B, 2005, TRAFFIC, V6, P10, DOI 10.1111/j.1600-0854.2004.00247.x; Fujihara A, 2009, FEBS J, V276, P2841, DOI 10.1111/j.1742-4658.2009.07007.x; Gill ON, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5675; Gonzalez-Begne M, 2009, J PROTEOME RES, V8, P1304, DOI 10.1021/pr800658c; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Haney MJ, 2012, NANOMEDICINE-UK, V7, P815, DOI [10.2217/NNM.11.156, 10.2217/nnm.11.156]; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Jackson GS, 2014, JAMA NEUROL, V71, P421, DOI 10.1001/jamaneurol.2013.6001; Jackson GS, 2014, BLOOD, V123, P452, DOI 10.1182/blood-2013-11-539239; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Kalani A, 2014, MOL NEUROBIOL, V49, P590, DOI 10.1007/s12035-013-8544-1; Kalra H, 2013, PROTEOMICS, V13, P3354, DOI 10.1002/pmic.201300282; Knight R, 2010, TRANSFUS APHER SCI, V43, P387, DOI 10.1016/j.transci.2010.09.003; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathivanan S, 2010, MOL CELL PROTEOMICS, V9, P197, DOI 10.1074/mcp.M900152-MCP200; Mattei V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005057; McCutcheon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023169; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; PAN BT, 1984, J BIOL CHEM, V259, P9776; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Peden A, 2010, HAEMOPHILIA, V16, P296, DOI 10.1111/j.1365-2516.2009.02181.x; Porto-Carreiro I, 2005, BLOOD CELL MOL DIS, V35, P143, DOI 10.1016/j.bcmd.2005.06.013; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ritchie AJ, 2013, BRIT J HAEMATOL, V163, P678, DOI 10.1111/bjh.12543; Robertson C, 2006, BLOOD, V107, P3907, DOI 10.1182/blood-2005-02-0802; Rubenstein R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066352; Rubenstein R, 2011, J VIROL, V85, P9031, DOI 10.1128/JVI.05111-11; Rubenstein R, 2010, J GEN VIROL, V91, P1883, DOI 10.1099/vir.0.020164-0; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Safar JG, 2006, P NATL ACAD SCI USA, V103, P11312, DOI 10.1073/pnas.0604021103; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Schneider A, 2013, CELL TISSUE RES, V352, P33, DOI 10.1007/s00441-012-1428-2; Silva CJ, 2013, BIOCHEMISTRY-US, V52, P2139, DOI 10.1021/bi3016795; Simak J, 2002, TRANSFUSION, V42, P334, DOI 10.1046/j.1537-2995.2002.00072.x; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Sun DM, 2010, MOL THER, V18, P1606, DOI 10.1038/mt.2010.105; Surgucheva I, 2012, BIOCHEMISTRY-US, V51, P4743, DOI 10.1021/bi300478w; Tadokoro H, 2013, J BIOL CHEM, V288, P34343, DOI 10.1074/jbc.M113.480822; Tasaki M, 2010, BIOCHEM BIOPH RES CO, V400, P559, DOI 10.1016/j.bbrc.2010.08.101; Tattum MH, 2010, TRANSFUSION, V50, P996, DOI 10.1111/j.1537-2995.2010.02595.x; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Terry LA, 2009, J VIROL, V83, P12552, DOI 10.1128/JVI.00311-09; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vascellari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048969; Veith NM, 2009, EUR J CELL BIOL, V88, P45, DOI 10.1016/j.ejcb.2008.08.001; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Vella LJ, 2008, VET IMMUNOL IMMUNOP, V124, P385, DOI 10.1016/j.vetimm.2008.04.002; Vella LJ, 2008, EUR BIOPHYS J BIOPHY, V37, P323, DOI 10.1007/s00249-007-0246-z; Vingtdeux V., 2012, FRONT PHYSIOL, V3, P1; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wadsworth JDF, 2011, J PATHOL, V223, P511, DOI 10.1002/path.2821; Wik L, 2012, PRION, V6, DOI 10.4161/pri.22588; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	95	40	41	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29247	29260		10.1074/jbc.M114.589564	http://dx.doi.org/10.1074/jbc.M114.589564			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25157106	Green Published, hybrid			2022-12-28	WOS:000344141000039
J	Campeotto, I; Percy, MG; MacDonald, JT; Forster, A; Freemont, PS; Grundling, A				Campeotto, Ivan; Percy, Matthew G.; MacDonald, James T.; Foerster, Andreas; Freemont, Paul S.; Gruendling, Angelika			Structural and Mechanistic Insight into the Listeria monocytogenes Two-enzyme Lipoteichoic Acid Synthesis System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHESIS; SYNTHASE; MODEL	Lipoteichoic acid (LTA) is an important cell wall component required for proper cell growth in many Gram-positive bacteria. In Listeria monocytogenes, two enzymes are required for the synthesis of this polyglycerolphosphate polymer. The LTA primase LtaP(Lm) initiates LTA synthesis by transferring the first glycerolphosphate (GroP) subunit onto the glycolipid anchor and the LTA synthase LtaS(Lm) extends the polymer by the repeated addition of GroP subunits to the tip of the growing chain. Here, we present the crystal structures of the enzymatic domains of LtaP(Lm) and LtaS(Lm). Although the enzymes share the same fold, substantial differences in the cavity of the catalytic site and surface charge distribution contribute to enzyme specialization. The eLtaS(Lm) structure was also determined in complex with GroP revealing a second GroP binding site. Mutational analysis confirmed an essential function for this binding site and allowed us to propose a model for the binding of the growing chain.	[Campeotto, Ivan; Percy, Matthew G.; Gruendling, Angelika] Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, London SW7 2AZ, England; [Campeotto, Ivan; Percy, Matthew G.; Gruendling, Angelika] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [MacDonald, James T.; Foerster, Andreas; Freemont, Paul S.] Univ London Imperial Coll Sci Technol & Med, Struct Biol Ctr, London SW7 2AZ, England	Imperial College London; Imperial College London; Imperial College London	Freemont, PS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, South Kensington Campus,Sir Ernst Chain Bldg, London SW7 2AZ, England.	p.freemont@imperial.ac.uk; a.grundling@imperial.ac.uk		MacDonald, James/0000-0001-9675-4429; Grundling, Angelika/0000-0002-6235-8687; Freemont, Paul/0000-0002-5658-8486; Campeotto, Ivan/0000-0002-0814-619X; Forster, Andreas/0000-0003-1472-3990	European Research Council [260371]; MRC [MR/J006874/1, G0800777] Funding Source: UKRI; Medical Research Council [G0800777] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by European Research Council Grant 260371 (to A. G.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antelmann H, 2005, PROTEOMICS, V5, P3684, DOI 10.1002/pmic.200401218; Bergfors T, 2003, J STRUCT BIOL, V142, P66, DOI 10.1016/S1047-8477(03)00039-X; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fisher W, 1990, BACTERIAL PHOSPHOGLY; Grundling A, 2004, P NATL ACAD SCI USA, V101, P12318, DOI 10.1073/pnas.0404924101; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; HETHER NW, 1983, J BACTERIOL, V156, P809, DOI 10.1128/JB.156.2.809-817.1983; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karatsa-Dodgson M, 2010, J BACTERIOL, V192, P5341, DOI 10.1128/JB.00453-10; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KOCH HU, 1984, EUR J BIOCHEM, V138, P357, DOI 10.1111/j.1432-1033.1984.tb07923.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lu D, 2009, P NATL ACAD SCI USA, V106, P1584, DOI 10.1073/pnas.0809020106; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oku Y, 2009, J BACTERIOL, V191, P141, DOI 10.1128/JB.01221-08; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Percy MG, 2014, ANNU REV MICROBIOL, V68, P81, DOI 10.1146/annurev-micro-091213-112949; Powers ME, 2011, J BACTERIOL, V193, P340, DOI 10.1128/JB.01052-10; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Reichmann NT, 2011, FEMS MICROBIOL LETT, V319, P97, DOI 10.1111/j.1574-6968.2011.02260.x; Richter SG, 2013, P NATL ACAD SCI USA, V110, P3531, DOI 10.1073/pnas.1217337110; Schirner K, 2009, EMBO J, V28, P830, DOI 10.1038/emboj.2009.25; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; TARON DJ, 1983, J BACTERIOL, V154, P1110, DOI 10.1128/JB.154.3.1110-1116.1983; UCHIKAWA KI, 1986, J BACTERIOL, V168, P115, DOI 10.1128/jb.168.1.115-122.1986; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Webb AJ, 2009, MOL MICROBIOL, V74, P299, DOI 10.1111/j.1365-2958.2009.06829.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wormann ME, 2011, J BACTERIOL, V193, P5279, DOI 10.1128/JB.00369-11; Wormann ME, 2011, MOL MICROBIOL, V79, P566, DOI 10.1111/j.1365-2958.2010.07472.x	43	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28054	28069		10.1074/jbc.M114.590570	http://dx.doi.org/10.1074/jbc.M114.590570			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25128528	hybrid, Green Published			2022-12-28	WOS:000343765400001
J	Meneses, E; Mittermaier, A				Meneses, Erick; Mittermaier, Anthony			Electrostatic Interactions in the Binding Pathway of a Transient Protein Complex Studied by NMR and Isothermal Titration Calorimetry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Isothermal Titration Calorimetry (ITC); Ligand-binding Protein; Nuclear Magnetic Resonance; Protein Dynamic; Src Homology 3 Domain (SH3 Domain); Carr-Purcell-Meiboom-Gill (CPMG) Relaxation Dispersion	NUCLEAR-MAGNETIC-RESONANCE; RECEPTOR-ALPHA CHAIN; SH3 DOMAIN; BIMOLECULAR KINETICS; ENCOUNTER COMPLEXES; HYDROPHOBIC CORE; EXCITED-STATES; TIME-SCALE; ASSOCIATION; BARSTAR	Background: Electrostatic interactions are known accelerate binding in protein complexes with long lifetimes (minutes to hours). Results: NMR and calorimetry were used to characterize binding kinetics in short lived (approximate to 1 ms) protein-peptide complexes. Conclusion: Electrostatic enhancement is much less and basal (electrostatic-free) association rates are greater than previously observed. Significance: Electrostatics may play different roles in short lived and long lived protein complexes. Much of our knowledge of protein binding pathways is derived from extremely stable complexes that interact very tightly, with lifetimes of hours to days. Much less is known about weaker interactions and transient complexes because these are challenging to characterize experimentally. Nevertheless, these types of interactions are ubiquitous in living systems. The combination of NMR relaxation dispersion Carr-Purcell-Meiboom-Gill (CPMG) experiments and isothermal titration calorimetry allows the quantification of rapid binding kinetics for complexes with submillisecond lifetimes that are difficult to study using conventional techniques. We have used this approach to investigate the binding pathway of the Src homology 3 (SH3) domain from the Fyn tyrosine kinase, which forms complexes with peptide targets whose lifetimes are on the order of about a millisecond. Long range electrostatic interactions have been shown to play a critical role in the binding pathways of tightly binding complexes. The role of electrostatics in the binding pathways of transient complexes is less well understood. Similarly to previously studied tight complexes, we find that SH3 domain association rates are enhanced by long range electrostatics, whereas short range interactions are formed late in the docking process. However, the extent of electrostatic association rate enhancement is several orders of magnitudes less, whereas the electrostatic-free basal association rate is significantly greater. Thus, the SH3 domain is far less reliant on electrostatic enhancement to achieve rapid association kinetics than are previously studied systems. This suggests that there may be overall differences in the role played by electrostatics in the binding pathways of extremely stable versus transient complexes.	[Meneses, Erick; Mittermaier, Anthony] McGill Univ, Dept Chem, Montreal, PQ H3A 0B8, Canada	McGill University	Mittermaier, A (corresponding author), McGill Univ, Dept Chem, 801 Sherbrooke St W,Rm 322, Montreal, PQ H3A 0B8, Canada.	anthony.mittermaier@mcgill.ca	Mittermaier, Anthony/R-3210-2017	Mittermaier, Anthony/0000-0002-3767-1225	McGill University; Groupe de Recherche Axe sur la Structure des Proteines (GRASP)	McGill University; Groupe de Recherche Axe sur la Structure des Proteines (GRASP)	NMR experiments were recorded at the Quebec/Eastern Canada High Field NMR Facility, supported by McGill University and Groupe de Recherche Axe sur la Structure des Proteines (GRASP).	ALBERTY RA, 1958, J PHYS CHEM-US, V62, P154, DOI 10.1021/j150560a005; Alsallaq R, 2008, PROTEINS, V71, P320, DOI 10.1002/prot.21679; Alsallaq R, 2007, STRUCTURE, V15, P215, DOI 10.1016/j.str.2007.01.005; ALTSCHUH D, 1992, BIOCHEMISTRY-US, V31, P6298, DOI 10.1021/bi00142a019; BENNAIM A, 1974, J PHYS CHEM-US, V78, P170, DOI 10.1021/j100595a600; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; BOLZANI R, 1979, Bollettino Societa Italiana Biologia Sperimentale, V55, P1618; BUCKLE AM, 1994, BIOCHEMISTRY-US, V33, P8878, DOI 10.1021/bi00196a004; Camacho CJ, 2000, BIOPHYS J, V78, P1094, DOI 10.1016/S0006-3495(00)76668-9; Camacho CJ, 1999, BIOPHYS J, V76, P1166, DOI 10.1016/S0006-3495(99)77281-4; Cantor C., 1980, BIOPHYSICAL CHEM 3, P892; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Demers JP, 2009, J AM CHEM SOC, V131, P4355, DOI 10.1021/ja808255d; Di Nardo AA, 2003, J MOL BIOL, V333, P641, DOI 10.1016/j.jmb.2003.08.035; Docherty H, 2007, J PHYS CHEM B, V111, P8993, DOI 10.1021/jp0678249; Efron B., 1986, STAT SCI, V1, P54, DOI [10.1214/ss/1177013815, DOI 10.1214/SS/1177013815]; England P, 1997, BIOCHEMISTRY-US, V36, P164, DOI 10.1021/bi961419y; ESCOBAR L, 1993, BIOCHEMISTRY-US, V32, P6982, DOI 10.1021/bi00078a024; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; Feng SB, 1995, P NATL ACAD SCI USA, V92, P12408, DOI 10.1073/pnas.92.26.12408; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; Gabdoulline RR, 2002, CURR OPIN STRUC BIOL, V12, P204, DOI 10.1016/S0959-440X(02)00311-1; Hansen DF, 2008, J PHYS CHEM B, V112, P5898, DOI 10.1021/jp074793o; Hansen DF, 2008, J AM CHEM SOC, V130, P2667, DOI 10.1021/ja078337p; Ishima R, 2005, J BIOMOL NMR, V32, P41, DOI 10.1007/s10858-005-3593-z; Janin J, 1997, PROTEINS, V28, P153, DOI 10.1002/(SICI)1097-0134(199706)28:2<153::AID-PROT4>3.0.CO;2-G; Jucovic M, 1996, P NATL ACAD SCI USA, V93, P2343, DOI 10.1073/pnas.93.6.2343; LUZ Z, 1963, J CHEM PHYS, V39, P366, DOI 10.1063/1.1734254; MACOMBER RS, 1992, J CHEM EDUC, V69, P375, DOI 10.1021/ed069p375; Mayer BJ, 2001, J CELL SCI, V114, P1253; MELANDER W, 1977, ARCH BIOCHEM BIOPHYS, V183, P200, DOI 10.1016/0003-9861(77)90434-9; Millet O, 2000, J AM CHEM SOC, V122, P2867, DOI 10.1021/ja993511y; Mittermaier A, 2004, PROTEIN SCI, V13, P1088, DOI 10.1110/ps.03502504; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; NORTHRUP SH, 1993, BIOCHEMISTRY-US, V32, P6613, DOI 10.1021/bi00077a014; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pilling M., 1995, REACTION KINETICS, P146; Radic Z, 1997, J BIOL CHEM, V272, P23265, DOI 10.1074/jbc.272.37.23265; SCHREIBER G, 1993, BIOCHEMISTRY-US, V32, P5145, DOI 10.1021/bi00070a025; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; SEGUR JB, 1951, IND ENG CHEM, V43, P2117, DOI 10.1021/ie50501a040; Shen BJ, 1996, EUR J BIOCHEM, V240, P252, DOI 10.1111/j.1432-1033.1996.0252h.x; Smith AJ, 1997, METHOD ENZYMOL, V289, P419; SOMMER J, 1982, J MOL BIOL, V159, P721, DOI 10.1016/0022-2836(82)90110-3; STONE SR, 1989, BIOCHEMISTRY-US, V28, P6857, DOI 10.1021/bi00443a012; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Sydor JR, 1998, BIOCHEMISTRY-US, V37, P14292, DOI 10.1021/bi980764f; SZABO A, 1982, J CHEM PHYS, V77, P4484, DOI 10.1063/1.444397; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Taylor MG, 1998, PROTEIN SCI, V7, P1857, DOI 10.1002/pro.5560070902; Vallurupalli P, 2007, P NATL ACAD SCI USA, V104, P18473, DOI 10.1073/pnas.0708296104; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; Volkov AN, 2010, J BIOMOL NMR, V48, P225, DOI 10.1007/s10858-010-9452-6; WALLIS R, 1995, BIOCHEMISTRY-US, V34, P13751, DOI 10.1021/bi00042a005; WALLIS R, 1995, BIOCHEMISTRY-US, V34, P13743, DOI 10.1021/bi00042a004; Wang YH, 1997, P NATL ACAD SCI USA, V94, P1657, DOI 10.1073/pnas.94.5.1657; Wendt H, 1997, BIOCHEMISTRY-US, V36, P204, DOI 10.1021/bi961672y; WHERLAND S, 1976, P NATL ACAD SCI USA, V73, P2950, DOI 10.1073/pnas.73.9.2950; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Xu D, 1997, J MOL BIOL, V265, P68, DOI 10.1006/jmbi.1996.0712; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zarrine-Afsar A, 2006, PROTEIN SCI, V15, P162, DOI 10.1110/ps.051829106; Zhou HX, 1997, BIOPHYS J, V73, P2441, DOI 10.1016/S0006-3495(97)78272-9; Zhou HX, 2001, BIOPOLYMERS, V59, P427, DOI 10.1002/1097-0282(200111)59:6<427::AID-BIP1047>3.0.CO;2-7	68	17	17	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27911	27923		10.1074/jbc.M114.553354	http://dx.doi.org/10.1074/jbc.M114.553354			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25122758	hybrid, Green Published			2022-12-28	WOS:000342852800046
J	Takase, R; Mikami, B; Kawai, S; Murata, K; Hashimoto, W				Takase, Ryuichi; Mikami, Bunzo; Kawai, Shigeyuki; Murata, Kousaku; Hashimoto, Wataru			Structure-based Conversion of the Coenzyme Requirement of a Short-chain Dehydrogenase/Reductase Involved in Bacterial Alginate Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; KETOL-ACID REDUCTOISOMERASE; NUCLEOTIDE SPECIFICITY; MOLECULAR-IDENTIFICATION; FORMATE DEHYDROGENASE; XYLITOL DEHYDROGENASE; COFACTOR SPECIFICITY; ESCHERICHIA-COLI; BINDING-SITE; REDUCTASE	The alginate-assimilating bacterium, Sphingomonas sp. strain A1, degrades the polysaccharides to monosaccharides through four alginate lyase reactions. The resultant monosaccharide, which is nonenzymatically converted to 4-deoxy-L-erythro-5-hexoseulose uronate (DEH), is further metabolized to 2-keto-3-deoxy-D-gluconate by NADPH-dependent reductase A1-R in the short-chain dehydrogenase/reductase (SDR) family. A1-R-deficient cells produced another DEH reductase, designated A1-R', with a preference for NADH. Here, we show the identification of a novel NADH-dependent DEH reductase A1-R' in strain A1, structural determination of A1-R' by x-ray crystallography, and structure-based conversion of a coenzyme requirement inSDRenzymes, A1-R and A1-R'. A1-R' was purified from strain A1 cells and enzymatically characterized. Except for the coenzyme requirement, there was no significant difference in enzyme characteristics between A1-R and A1-R'. Crystal structures of A1-R' and A1-R'-NAD(+) complex were determined at 1.8 and 2.7 angstrom resolutions, respectively. Because of a 64% sequence identity, overall structures of A1-R' and A1-R were similar, although a difference in the coenzyme-binding site (particularly the nucleoside ribose 2' region) was observed. Distinct from A1-R, A1-R' included a negatively charged, shallower binding site. These differences were caused by amino acid residues on the two loops around the site. The A1-R' mutant with the two A1-R-typed loops maintained potent enzyme activity with specificity for NADPH rather than NADH, demonstrating that the two loops determine the coenzyme requirement, and loop exchange is a promising method for conversion of coenzyme requirement in the SDR family.	[Takase, Ryuichi; Kawai, Shigeyuki; Murata, Kousaku; Hashimoto, Wataru] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Appl Struct Biol, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Hashimoto, W (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan.	whasimot@kais.kyoto-u.ac.jp		Takase, Ryuichi/0000-0002-7423-9407	Japan Society for the Promotion of Science; Program for Promotion of Basic Research Activities for Innovative Biosciences of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists; Grants-in-Aid for Scientific Research [26660062] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic Research Activities for Innovative Biosciences of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Japan Society for the Promotion of Science (to K. M. and W. H.), the Program for Promotion of Basic Research Activities for Innovative Biosciences of Japan (to K. M.), the Targeted Proteins Research Program (to W. H.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and research fellowships from the Japan Society for the Promotion of Science for Young Scientists (to R. T.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banta S, 2002, PROTEIN ENG, V15, P131, DOI 10.1093/protein/15.2.131; Baroni S, 2012, BIOCHEMISTRY-US, V51, P3819, DOI 10.1021/bi300078p; BERNARD N, 1995, BIOCHEM BIOPH RES CO, V208, P895, DOI 10.1006/bbrc.1995.1419; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinkmann-Chen S, 2013, P NATL ACAD SCI USA, V110, P10946, DOI 10.1073/pnas.1306073110; Capone M, 2011, FEBS J, V278, P2460, DOI 10.1111/j.1742-4658.2011.08172.x; CHEN RD, 1995, P NATL ACAD SCI USA, V92, P11666, DOI 10.1073/pnas.92.25.11666; Chen RD, 1996, P NATL ACAD SCI USA, V93, P12171, DOI 10.1073/pnas.93.22.12171; CLERMONT S, 1993, BIOCHEMISTRY-US, V32, P10178, DOI 10.1021/bi00089a038; Dambe TR, 2006, BIOCHEMISTRY-US, V45, P10030, DOI 10.1021/bi052589q; DeLano W.L, PYMOL MOL GRAPHICS S; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; Ehrensberger AH, 2006, STRUCTURE, V14, P567, DOI 10.1016/j.str.2005.11.016; Elmore CL, 2002, J BIOL CHEM, V277, P48960, DOI 10.1074/jbc.M210173200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enquist-Newman M, 2014, NATURE, V505, P239, DOI 10.1038/nature12771; Eppink MHM, 1999, J MOL BIOL, V292, P87, DOI 10.1006/jmbi.1999.3015; GACESA P, 1988, CARBOHYD POLYM, V8, P161, DOI 10.1016/0144-8617(88)90001-X; Galkin A, 1997, PROTEIN ENG, V10, P687, DOI 10.1093/protein/10.6.687; Hashimoto W, 2000, J BACTERIOL, V182, P4572, DOI 10.1128/JB.182.16.4572-4577.2000; Hashimoto W, 2005, BIOSCI BIOTECH BIOCH, V69, P673, DOI 10.1271/bbb.69.673; Hashimoto Wataru, 2010, Bioeng Bugs, V1, P97, DOI 10.4161/bbug.1.2.10322; Hisano T, 1996, BIOCHEM BIOPH RES CO, V220, P979, DOI 10.1006/bbrc.1996.0526; Hoelsch K, 2013, APPL MICROBIOL BIOT, V97, P2473, DOI 10.1007/s00253-012-4142-9; Hoffmann F, 2007, DRUG METAB REV, V39, P87, DOI 10.1080/03602530600969440; Holmberg N, 1999, PROTEIN ENG, V12, P851, DOI 10.1093/protein/12.10.851; Hsieh JY, 2006, J BIOL CHEM, V281, P23237, DOI 10.1074/jbc.M603451200; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; Kaup B, 2004, APPL MICROBIOL BIOT, V64, P333, DOI 10.1007/s00253-003-1470-9; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; KIMBARA K, 1989, J BACTERIOL, V171, P2740, DOI 10.1128/jb.171.5.2740-2747.1989; Kristan K, 2007, J BIOTECHNOL, V129, P123, DOI 10.1016/j.jbiotec.2006.11.025; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lerchner A, 2013, BIOTECHNOL BIOENG, V110, P2803, DOI 10.1002/bit.24956; Colin VL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/601834; Marohnic CC, 2003, BIOCHEMISTRY-US, V42, P11170, DOI 10.1021/bi034819b; Medina M, 2001, J BIOL CHEM, V276, P11902, DOI 10.1074/jbc.M009287200; Miller SP, 2006, SCIENCE, V314, P458, DOI 10.1126/science.1133479; Moat AG, 1987, PYRIDINE NUCLEOTID B, P1; Momma K, 2000, J BACTERIOL, V182, P3998, DOI 10.1128/JB.182.14.3998-4004.2000; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nedjma M, 2001, ANAL BIOCHEM, V291, P290, DOI 10.1006/abio.2001.5032; Nishitani Y, 2012, BIOCHEMISTRY-US, V51, P3622, DOI 10.1021/bi300194f; Ochiai A, 2006, RES MICROBIOL, V157, P642, DOI 10.1016/j.resmic.2006.02.006; Ochiai A, 2009, J BIOL CHEM, V284, P10181, DOI 10.1074/jbc.M807799200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Persson B, 2013, CHEM-BIOL INTERACT, V202, P111, DOI 10.1016/j.cbi.2012.11.009; Petschacher B, 2005, BIOCHEM J, V385, P75, DOI 10.1042/BJ20040363; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Rane MJ, 1997, ARCH BIOCHEM BIOPHYS, V338, P83, DOI 10.1006/abbi.1996.9802; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; RUVKUN GB, 1981, NATURE, V289, P85, DOI 10.1038/289085a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; Serov AE, 2002, BIOCHEM J, V367, P841, DOI 10.1042/BJ20020379; Shiraishi N, 1998, ARCH BIOCHEM BIOPHYS, V358, P104, DOI 10.1006/abbi.1998.0827; Stokstad E, 2012, SCIENCE, V335, P273, DOI 10.1126/science.335.6066.273; Takase R, 2010, BBA-PROTEINS PROTEOM, V1804, P1925, DOI 10.1016/j.bbapap.2010.05.010; Takeda H, 2011, ENERG ENVIRON SCI, V4, P2575, DOI 10.1039/c1ee01236c; Tomita T, 2006, BIOCHEM BIOPH RES CO, V347, P502, DOI 10.1016/j.bbrc.2006.06.131; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vertes A., 2010, BIOMASS BIOFUELS STR, P1; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Watanabe S, 2005, J BIOL CHEM, V280, P10340, DOI 10.1074/jbc.M409443200; Watanabe S, 2007, J BIOTECHNOL, V130, P316, DOI 10.1016/j.jbiotec.2007.04.019; Yaoi T, 1996, J BIOCHEM-TOKYO, V119, P1014; Yoon HJ, 2000, PROTEIN EXPRES PURIF, V19, P84, DOI 10.1006/prep.2000.1226; Zhang L, 1999, BIOCHEMISTRY-US, V38, P11440, DOI 10.1021/bi991101g; Zheng HY, 2013, BIOCHEMISTRY-US, V52, P5876, DOI 10.1021/bi400821s	70	35	35	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33198	33214		10.1074/jbc.M114.585661	http://dx.doi.org/10.1074/jbc.M114.585661			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25288804	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000345636600014
J	Huang, YP; Nokhrin, S; Hassanzadeh-Ghassabeh, G; Yu, CH; Yang, HJ; Barry, AN; Tonelli, M; Markley, JL; Muyldermans, S; Dmitriev, OY; Lutsenko, S				Huang, Yiping; Nokhrin, Sergiy; Hassanzadeh-Ghassabeh, Gholamreza; Yu, Corey H.; Yang, Haojun; Barry, Amanda N.; Tonelli, Marco; Markley, John L.; Muyldermans, Serge; Dmitriev, Oleg Y.; Lutsenko, Svetlana			Interactions between Metal-binding Domains Modulate Intracellular Targeting of Cu(I)-ATPase ATP7B, as Revealed by Nanobody Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPPER-TRANSPORTING ATPASE; WILSONS-DISEASE PROTEIN; N-TERMINAL DOMAIN; FUNCTIONAL-PROPERTIES; TRAFFICKING; RELAXATION; MENKES; SITES; CELLS; MUTATIONS	The biologically and clinically important membrane transporters are challenging proteins to study because of their low level of expression, multidomain structure, and complex molecular dynamics that underlies their activity. ATP7B is a copper transporter that traffics between the intracellular compartments in response to copper elevation. The N-terminal domain of ATP7B (N-ATP7B) is involved in binding copper, but the role of this domain in trafficking is controversial. To clarify the role of N-ATP7B, we generated nanobodies that interact with ATP7B in vitro and in cells. In solution NMR studies, nanobodies revealed the spatial organization of N-ATP7B by detecting transient functionally relevant interactions between metal-binding domains 1-3. Modulation of these interactions by nanobodies in cells enhanced relocalization of the endogenous ATP7B toward the plasma membrane linking molecular and cellular dynamics of the transporter. Stimulation of ATP7B trafficking by nanobodies in the absence of elevated copper provides direct evidence for the important role of N-ATP7B structural dynamics in regulation of ATP7B localization in a cell.	[Huang, Yiping; Yang, Haojun; Barry, Amanda N.; Lutsenko, Svetlana] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Nokhrin, Sergiy; Yu, Corey H.; Dmitriev, Oleg Y.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Hassanzadeh-Ghassabeh, Gholamreza; Muyldermans, Serge] Vrije Univ Brussel, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Hassanzadeh-Ghassabeh, Gholamreza] VIB, Nanobody Serv Facil, B-1050 Brussels, Belgium; [Tonelli, Marco; Markley, John L.] Univ Wisconsin, Dept Biochem, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA	Johns Hopkins University; University of Saskatchewan; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); University of Wisconsin System; University of Wisconsin Madison	Dmitriev, OY (corresponding author), 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	Oleg.Dmitriev@usask.ca; Lutsenko@jhmi.edu	Muyldermans, Serge/AAC-7374-2019; Muyldermans, Serge V/C-6418-2016; Dmitriev, Oleg/AAB-7830-2019	Muyldermans, Serge/0000-0002-3678-3575; Muyldermans, Serge V/0000-0002-3678-3575; Barry, Amanda/0000-0002-7992-0322	National Institutes of Health [GM067166]; Canadian Institutes of Health Research; Saskatchewan Health Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166, P41GM103399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM067166 (to S. L.) and the Canadian Institutes of Health Research and Saskatchewan Health Research Foundation grants (to O. D.).	Achila D, 2006, P NATL ACAD SCI USA, V103, P5729, DOI 10.1073/pnas.0504472103; Altintas I, 2013, J CONTROL RELEASE, V165, P110, DOI 10.1016/j.jconrel.2012.11.007; Banci L, 2008, BIOCHEMISTRY-US, V47, P7423, DOI 10.1021/bi8004736; Banci L, 2009, BIOCHEMISTRY-US, V48, P7849, DOI 10.1021/bi901003k; Banci L, 2009, J BIOL CHEM, V284, P9354, DOI 10.1074/jbc.M805981200; Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Braiterman LT, 2014, P NATL ACAD SCI USA, V111, pE1364, DOI 10.1073/pnas.1314161111; Cater MA, 2004, BIOCHEM J, V380, P805, DOI 10.1042/BJ20031804; Cater MA, 2007, BIOCHEM J, V401, P143, DOI 10.1042/BJ20061055; Dayie KT, 1996, ANNU REV PHYS CHEM, V47, P243, DOI 10.1146/annurev.physchem.47.1.243; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiDonato M, 1997, J BIOL CHEM, V272, P33279, DOI 10.1074/jbc.272.52.33279; DiDonato M, 2000, BIOCHEMISTRY-US, V39, P1890, DOI 10.1021/bi992222j; Dmitriev O, 2006, P NATL ACAD SCI USA, V103, P5302, DOI 10.1073/pnas.0507416103; Dolgova NV, 2013, BIOCHEM J, V454, P147, DOI 10.1042/BJ20121656; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Forbes JR, 1999, J BIOL CHEM, V274, P12408, DOI 10.1074/jbc.274.18.12408; Hasan NM, 2012, J BIOL CHEM, V287, P36041, DOI 10.1074/jbc.M112.370403; Hasan NM, 2012, CURR TOP MEMBR, V69, P137, DOI 10.1016/B978-0-12-394390-3.00006-9; Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/nnm.13.86, 10.2217/NNM.13.86]; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LeShane ES, 2010, J BIOL CHEM, V285, P6327, DOI 10.1074/jbc.M109.074633; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; Morgan CT, 2004, J BIOL CHEM, V279, P36363, DOI 10.1074/jbc.M404553200; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Petris MJ, 2002, J BIOL CHEM, V277, P46736, DOI 10.1074/jbc.M208864200; Pilankatta Rajendra, 2011, J Biol Chem, V286, P7389, DOI 10.1074/jbc.M110.171454; Ries J, 2012, NAT METHODS, V9, P582, DOI [10.1038/NMETH.1991, 10.1038/nmeth.1991]; Tsay MJ, 2004, BBA-MOL BASIS DIS, V1688, P78, DOI 10.1016/j.bbadis.2003.11.001; Tsivkovskii R, 2002, J BIOL CHEM, V277, P976, DOI 10.1074/jbc.M109368200; Vanderwerf SM, 2001, J BIOL CHEM, V276, P36289, DOI 10.1074/jbc.M102055200; Walker JM, 2002, J BIOL CHEM, V277, P27953, DOI 10.1074/jbc.M203845200; Yatsunyk LA, 2007, J BIOL CHEM, V282, P8622, DOI 10.1074/jbc.M609533200; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022; Zhu JJ, 2012, BIOCHEM J, V448, P73, DOI 10.1042/BJ20120537	37	29	29	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.580845	http://dx.doi.org/10.1074/jbc.M114.580845			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25253690	Green Published, hybrid			2022-12-28	WOS:000345335000025
J	Kannike, K; Sepp, M; Zuccato, C; Cattaneo, E; Timmusk, T				Kannike, Kaja; Sepp, Mari; Zuccato, Chiara; Cattaneo, Elena; Timmusk, Toenis			Forkhead Transcription Factor FOXO3a Levels Are Increased in Huntington Disease Because of Overactivated Positive Autofeedback Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN STRIATAL CELLS; GROWTH-FACTOR-I; 3-NITROPROPIONIC ACID; NUCLEAR TRANSLOCATION; NEUROTROPHIC FACTOR; OXIDATIVE-STRESS; HIPPOCAMPAL-NEURONS; MITOCHONDRIAL TOXIN; SIGNALING PATHWAYS; MUTANT HUNTINGTIN	Huntington disease (HD) is a fatal autosomal dominant neurodegenerative disorder caused by an increased number of CAG repeats in the HTT gene coding for huntingtin. Decreased neurotrophic support and increased mitochondrial and excitotoxic stress have been reported in HD striatal and cortical neurons. The members of the class O forkhead (FOXO) transcription factor family, including FOXO3a, act as sensor proteins that are activated upon decreased survival signals and/or increased cellular stress. Using immunocytochemical screening in mouse striatal Hdh(7/7) (wild type), Hdh(7/109) (heterozygous for HD mutation), and Hdh(109/109) (homozygous for HD mutation) cells, we identified FOXO3a as a differentially regulated transcription factor in HD. We report increased nuclear FOXO3a levels in mutant Hdh cells. Additionally, we show that treatment with mitochondrial toxin 3-nitropropionic acid results in enhanced nuclear localization of FOXO3a in wild type Hdh7/7 cells and in rat primary cortical neurons. Furthermore, mRNA levels of Foxo3a are increased in mutant Hdh cells compared with wild type cells and in 3-nitropropionic acid-treated primary neurons compared with untreated neurons. A similar increase was observed in the cortex of R6/2 mice and HD patient post-mortem caudate tissue compared with controls. Using chromatin immunoprecipitation and reporter assays, we demonstrate that FOXO3a regulates its own transcription by binding to the conserved response element in Foxo3a promoter. Altogether, the findings of this study suggest that FOXO3a levels are increased in HD cells as a result of overactive positive feedback loop.	[Kannike, Kaja; Sepp, Mari; Timmusk, Toenis] Tallinn Univ Technol, Dept Gene Technol, EE-12618 Tallinn, Estonia; [Zuccato, Chiara; Cattaneo, Elena] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; [Zuccato, Chiara; Cattaneo, Elena] Univ Milan, Ctr Stem Cell Res, I-20133 Milan, Italy	Tallinn University of Technology; University of Milan; University of Milan	Timmusk, T (corresponding author), Akadeemia Tee 15, EE-12618 Tallinn, Estonia.	tonis.timmusk@ttu.ee	Sepp, Mari/F-5987-2012; Timmusk, Tonis/H-4889-2015	Sepp, Mari/0000-0003-1733-8385; Timmusk, Tonis/0000-0002-1015-3348; CATTANEO, ELENA/0000-0002-0755-4917; ZUCCATO, CHIARA/0000-0003-1771-3392; Nurm, Kaja/0000-0002-0739-0414	Wellcome Trust [067952]; Estonian Ministry of Education and Research [0140143]; Estonian Science Foundation [7257, 8844]; Estonian Academy of Sciences;  [IUT19-18]	Wellcome Trust(Wellcome TrustEuropean Commission); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation; Estonian Academy of Sciences; 	This work was supported by Wellcome Trust Grant 067952, Estonian Ministry of Education and Research Targeted Funding Grant 0140143 and Institutional Research Funding Grant IUT19-18, Estonian Science Foundation Grants 7257 and 8844, and funds from the Estonian Academy of Sciences.	Al-Mubarak B, 2009, CHANNELS, V3, P233; Apostol BL, 2006, HUM MOL GENET, V15, P273, DOI 10.1093/hmg/ddi443; Bahia PK, 2012, J NEUROCHEM, V123, P182, DOI 10.1111/j.1471-4159.2012.07877.x; Barthelemy C, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-48; BEAL MF, 1993, J NEUROSCI, V13, P4181; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; BROUILLET E, 1995, P NATL ACAD SCI USA, V92, P7105, DOI 10.1073/pnas.92.15.7105; Browne SE, 2006, ANTIOXID REDOX SIGN, V8, P2061, DOI 10.1089/ars.2006.8.2061; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calnan DR, 2012, AGING-US, V4, P462, DOI 10.18632/aging.100471; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Colin E, 2005, EUR J NEUROSCI, V21, P1478, DOI 10.1111/j.1460-9568.2005.03985.x; Davila D, 2012, CELL DEATH DIFFER, V19, P1677, DOI 10.1038/cdd.2012.49; Davila D, 2008, MOL BIOL CELL, V19, P2014, DOI 10.1091/mbc.E07-08-0811; Dick O, 2010, J BIOL CHEM, V285, P19354, DOI 10.1074/jbc.M110.127654; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Ferrer I, 2000, NEUROPATH APPL NEURO, V26, P424, DOI 10.1046/j.1365-2990.2000.00267.x; Fujino K, 2013, NEUROSCI LETT, V557, P148, DOI 10.1016/j.neulet.2013.10.050; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gines S, 2003, J BIOL CHEM, V278, P50514, DOI 10.1074/jbc.M309348200; Gines S, 2010, J BIOL CHEM, V285, P21537, DOI 10.1074/jbc.M109.084202; Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003; Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Ju TC, 2011, J CELL BIOL, V194, P209, DOI 10.1083/jcb.201105010; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kittur N, 2006, RNA, V12, P2057, DOI 10.1261/rna.249306; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Lee JM, 2007, PLOS GENET, V3, P1397, DOI 10.1371/journal.pgen.0030135; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lutzner N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042166; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mojsilovic-Petrovic J, 2009, J NEUROSCI, V29, P8236, DOI 10.1523/JNEUROSCI.1805-09.2009; Neri C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00015; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Palfi SP, 1996, J NEUROSCI, V16, P3019; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Perrin V, 2009, EXP NEUROL, V215, P191, DOI 10.1016/j.expneurol.2008.10.008; Pino E, 2014, HUM MOL GENET, V23, P1435, DOI 10.1093/hmg/ddt530; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Puranam KL, 2006, BIOCHEM BIOPH RES CO, V341, P607, DOI 10.1016/j.bbrc.2006.01.007; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sepp M, 2012, HUM MOL GENET, V21, P2873, DOI 10.1093/hmg/dds112; Sipione S, 2002, HUM MOL GENET, V11, P1953, DOI 10.1093/hmg/11.17.1953; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Tang TS, 2005, P NATL ACAD SCI USA, V102, P2602, DOI 10.1073/pnas.0409402102; Tourette C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001895; Valenza M, 2005, J NEUROSCI, V25, P9932, DOI 10.1523/JNEUROSCI.3355-05.2005; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Zhao Y, 2011, J MOL CELL BIOL, V3, P276, DOI 10.1093/jmcb/mjr013; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x; Zhu WW, 2004, MOL BRAIN RES, V126, P45, DOI 10.1016/j.molbrainres.2004.03.019; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	68	32	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.612424	http://dx.doi.org/10.1074/jbc.M114.612424			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25271153	Green Published, hybrid			2022-12-28	WOS:000345335000038
J	Lin, L; Long, LK; Hatch, MM; Hoffman, DA				Lin, Lin; Long, Laura K.; Hatch, Michael M.; Hoffman, Dax A.			DPP6 Domains Responsible for Its Localization and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Intracellular Trafficking; Membrane Trafficking; Neuron; Potassium Channel; dpp6; kv4; 2; Neuronal Excitability	CA1 PYRAMIDAL NEURONS; IV-RELATED PROTEIN; POTASSIUM CHANNELS; DENDRITIC EXCITABILITY; HIPPOCAMPAL-NEURONS; K+ CHANNELS; DIPEPTIDYL; KV4.2; MODULATION; MEMBRANE	Dipeptidyl peptidase-like protein 6 (DPP6) is an auxiliary subunit of the Kv4 family of voltage-gated K+ channels known to enhance channel surface expression and potently accelerate their kinetics. DPP6 is a single transmembrane protein, which is structurally remarkable for its large extracellular domain. Included in this domain is a cysteine-rich motif, the function of which is unknown. Here we show that this cysteine-rich domain of DPP6 is required for its export from the ER and expression on the cell surface. Disulfide bridges formed at C349/C356 and C465/C468 of the cysteine-rich domain are necessary for the enhancement of Kv4.2 channel surface expression but not its interaction with Kv4.2 subunits. The short intracellular N-terminal and transmembrane domains of DPP6 associates with and accelerates the recovery from inactivation of Kv4.2, but the entire extracellular domain is necessary to enhance Kv4.2 surface expression and stabilization. Our findings show that the cysteine-rich domain of DPP6 plays an important role in protein folding of DPP6 that is required for transport of DPP6/Kv4.2 complexes out of the ER.	[Lin, Lin; Long, Laura K.; Hatch, Michael M.; Hoffman, Dax A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Neurophysiol & Biophys Sect, Program Dev Neurosci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Lin, L (corresponding author), 35 Lincoln Dr,MSC 3715,Bldg 35,Room 3C-908, Bethesda, MD 20892 USA.	linl2@mail.nih.gov	Hoffman, Dax/E-5155-2011	Hoffman, Dax/0000-0001-6999-2157	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008755] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Buzanskas ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094802; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Cheng HC, 2003, J BIOL CHEM, V278, P24600, DOI 10.1074/jbc.M303424200; Cheng HC, 1998, J BIOL CHEM, V273, P24207, DOI 10.1074/jbc.273.37.24207; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; De Meester I, 1999, IMMUNOL TODAY, V20, P367, DOI 10.1016/S0167-5699(99)01486-3; Foeger NC, 2012, J BIOL CHEM, V287, P9640, DOI 10.1074/jbc.M111.324574; Gorrell MD, 2001, SCAND J IMMUNOL, V54, P249, DOI 10.1046/j.1365-3083.2001.00984.x; Hasdemir B, 2005, J CELL BIOL, V171, P459, DOI 10.1083/jcb.200506005; Hildebrandt M, 2000, ADV EXP MED BIOL, V477, P197; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Jerng HH, 2005, J PHYSIOL-LONDON, V568, P767, DOI 10.1113/jphysiol.2005.087858; Jerng HH, 2004, BIOPHYS J, V87, P2380, DOI 10.1529/biophysj.104.042358; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Kim J, 2008, J NEUROPHYSIOL, V100, P1835, DOI 10.1152/jn.90261.2008; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Kin Y, 2001, J BIOCHEM-TOKYO, V129, P289, DOI 10.1093/oxfordjournals.jbchem.a002856; Liao C, 2013, EUR J MED GENET, V56, P484, DOI 10.1016/j.ejmg.2013.06.008; Lin L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3270; LOSTER K, 1995, BIOCHEM BIOPH RES CO, V217, P341, DOI 10.1006/bbrc.1995.2782; Maffie J, 2008, J PHYSIOL-LONDON, V586, P5609, DOI 10.1113/jphysiol.2008.161620; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Nadal MS, 2006, BRAIN RES, V1094, P1, DOI 10.1016/j.brainres.2006.03.106; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Nadin BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060831; Nadin BM, 2010, J NEUROSCI, V30, P8551, DOI 10.1523/JNEUROSCI.5489-09.2010; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; Ren XM, 2005, MOL CELL NEUROSCI, V29, P320, DOI 10.1016/j.mcn.2005.02.003; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; Shah MM, 2010, TRENDS NEUROSCI, V33, P307, DOI 10.1016/j.tins.2010.03.002; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; Sun W, 2011, NEURON, V71, P1102, DOI 10.1016/j.neuron.2011.08.008; Sun YF, 2014, G3-GENES GENOM GENET, V4, P1167, DOI 10.1534/g3.114.011338; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; YOKOTANI N, 1993, HUM MOL GENET, V2, P1037, DOI 10.1093/hmg/2.7.1037; Zagha E, 2005, J BIOL CHEM, V280, P18853, DOI 10.1074/jbc.M410613200	37	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32153	32165		10.1074/jbc.M114.578070	http://dx.doi.org/10.1074/jbc.M114.578070			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25190807	hybrid, Green Published			2022-12-28	WOS:000345314700043
J	Matsumura, R; Tsuchiya, Y; Tokuda, I; Matsuo, T; Sato, M; Node, K; Nishida, E; Akashi, M				Matsumura, Ritsuko; Tsuchiya, Yoshiki; Tokuda, Isao; Matsuo, Takahiro; Sato, Miho; Node, Koichi; Nishida, Eisuke; Akashi, Makoto			The Mammalian Circadian Clock Protein Period Counteracts Cryptochrome in Phosphorylation Dynamics of Circadian Locomotor Output Cycles Kaput (CLOCK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Circadian Clock; Circadian Rhythm; Clock Gene; Gene Expression; Phosphorylation	TRANSCRIPTIONAL ACTIVATORS; GENE-EXPRESSION; ROLES; MECHANISM; RHYTHMS; MPER1; CRY1	Background: The role of the circadian clock component Period (PER) remains unclear. Results: PER1 and PER2, but not PER3, protected CLOCK phosphorylation against Cryptochrome (CRY). Conclusion: PER may counteract CRY function via the protection of CLOCK phosphorylation. Significance: Detailed understanding of the control mechanism of CLOCK phosphorylation may reveal the true role of PER in the molecular clock machinery. The circadian transcription factor CLOCK exhibits a circadian oscillation in its phosphorylation levels. Although it remains unclear whether this phosphorylation contributes to circadian rhythm generation, it has been suggested to be involved in transcriptional activity, intracellular localization, and degradative turnover of CLOCK. Here, we obtained direct evidence that CLOCK phosphorylation may be essential for autonomous circadian oscillation in clock gene expression. Importantly, we found that the circadian transcriptional repressors Cryptochrome (CRY) and Period (PER) showed an opposite effect on CLOCK phosphorylation; CRY impaired BMAL1-dependent CLOCK phosphorylation, whereas PER protected the phosphorylation against CRY. Interestingly, unlike PER1 and PER2, PER3 did not exert a protective action, which correlates with the phenotypic differences among mice lacking the Per genes. Further studies on the regulatory mechanism of CLOCK phosphorylation would thus lead to elucidation of the mechanism of CRY-mediated transcriptional repression and an understanding of the true role of PER in the negative feedback system.	[Matsumura, Ritsuko; Matsuo, Takahiro; Sato, Miho; Akashi, Makoto] Yamaguchi Univ, Res Inst Time Studies, Yamaguchi 7538511, Japan; [Tsuchiya, Yoshiki; Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; [Tokuda, Isao] Ritsumeikan Univ, Dept Mech Engn, Kusatsu 5258577, Japan; [Node, Koichi] Saga Univ, Dept Cardiovasc Med, Saga 8498501, Japan	Yamaguchi University; Kyoto University; Ritsumeikan University; Saga University	Akashi, M (corresponding author), Yamaguchi Univ, Res Inst Time Studies, 1677-1 Yoshida, Yamaguchi 7538511, Japan.	akashima@yamaguchi-u.ac.jp	Matsumura, Ritsuko/AAS-7122-2020		Nakajima Foundation; Naito Foundation; Takeda Science Foundation; Japan Society for the Promotion of Science	Nakajima Foundation; Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by fellowships from the Nakajima Foundation, the Naito Foundation, the Takeda Science Foundation, and the Japan Society for the Promotion of Science.	Akashi M, 2006, MOL BIOL CELL, V17, P555, DOI 10.1091/mbc.E05-05-0396; Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Akashi M, 2000, GENE DEV, V14, P645; Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; Akashi M, 2014, CELL REP, V7, P1056, DOI 10.1016/j.celrep.2014.03.072; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Baker CL, 2010, CELL CYCLE, V9, P231; Becker-Weimann S, 2004, BIOPHYS J, V87, P3023, DOI 10.1529/biophysj.104.040824; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; Dardente H, 2007, BIOCHEM J, V402, P525, DOI 10.1042/BJ20060827; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Froy O, 2002, CURR BIOL, V12, P147, DOI 10.1016/S0960-9822(01)00656-X; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; Hida A, 2000, GENOMICS, V65, P224, DOI 10.1006/geno.2000.6166; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee HM, 2011, P NATL ACAD SCI USA, V108, P16451, DOI 10.1073/pnas.1107178108; Matsumura R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04032; Partch CL, 2006, P NATL ACAD SCI USA, V103, P10467, DOI 10.1073/pnas.0604138103; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Schmalen I, 2014, CELL, V157, P1203, DOI 10.1016/j.cell.2014.03.057; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Spengler ML, 2009, CELL CYCLE, V8, P4138, DOI 10.4161/cc.8.24.10273; Tamaru T, 2003, GENES CELLS, V8, P973, DOI 10.1046/j.1365-2443.2003.00686.x; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshitane H, 2009, MOL CELL BIOL, V29, P3675, DOI 10.1128/MCB.01864-08; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zhu HS, 2001, CURR BIOL, V11, P1945, DOI 10.1016/S0960-9822(01)00601-7	32	18	20	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32064	32072		10.1074/jbc.M114.578278	http://dx.doi.org/10.1074/jbc.M114.578278			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25271155	Green Published, hybrid			2022-12-28	WOS:000345314700035
J	Tian, LL; Chen, JM; Chen, ML; Gui, CE; Zhong, CQ; Hong, LX; Xie, CC; Wu, XR; Yang, LR; Ahmad, V; Han, JH				Tian, Lili; Chen, Jianming; Chen, Mingliang; Gui, Chloe; Zhong, Chuan-qi; Hong, Lixin; Xie, Changchuan; Wu, Xiurong; Yang, Lirong; Ahmad, Vakil; Han, Jiahuai			The p38 Pathway Regulates Oxidative Stress Tolerance by Phosphorylation of Mitochondrial Protein IscU	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Iron-Sulfur Protein; Mitochondrial Aconitase; Oxidative Stress; p38; p38 MAPK	MAP KINASE; IRON; BIOSYNTHESIS; METABOLISM; ACTIVATION	Background: The p38 pathway is an evolutionarily conserved signaling pathway that responds to a variety of stresses. Results: dIscU can be phosphorylated by dMK2, thereby impacting mitochondrial respiratory complex I activity. Conclusion: Iron-sulfur cluster protein IscU phosphorylation by MK2 downstream of p38 signaling may regulate oxidative stress tolerance. Significance: IscU is a novel substrate of MK2, mechanistically connecting the p38 pathway and mitochondria iron-sulfur clusters for the first time. The p38 pathway is an evolutionarily conserved signaling pathway that responds to a variety of stresses. However, the underlying mechanisms are largely unknown. In the present study, we demonstrate that p38b is a major p38 MAPK involved in the regulation of oxidative stress tolerance in addition to p38a and p38c in Drosophila. We further show the importance of MK2 as a p38-activated downstream kinase in resistance to oxidative stresses. Furthermore, we identified the iron-sulfur cluster scaffold protein IscU as a new substrate of MK2 both in Drosophila cells and in mammalian cells. These results imply a new mechanistic connection between the p38 pathway and mitochondria iron-sulfur clusters.	[Tian, Lili; Zhong, Chuan-qi; Hong, Lixin; Xie, Changchuan; Wu, Xiurong; Ahmad, Vakil; Han, Jiahuai] Xiamen Univ, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China; [Tian, Lili; Zhong, Chuan-qi; Hong, Lixin; Xie, Changchuan; Wu, Xiurong; Ahmad, Vakil; Han, Jiahuai] Xiamen Univ, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China; [Chen, Jianming; Chen, Mingliang; Yang, Lirong] SOA, Inst Oceanog 3, Key Lab Marine Biogenet Resources, Xiamen 361005, Fujian, Peoples R China; [Gui, Chloe] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	Xiamen University; Xiamen University; State Oceanic Administration; University of Toronto	Chen, JM (corresponding author), SOA, Inst Oceanog 3, Key Lab Marine Biogenet Resources, 184 Univ Rd, Xiamen 361005, Fujian, Peoples R China.	chenjm@xmu.edu.cn	xie, chang/GYJ-2493-2022; Han, J/G-4671-2010		National Science Foundation [31171366]; Marine Public Welfare Project [201005022]; China Ocean Mineral Resources RD Association [DY125-15-T-03]	National Science Foundation(National Science Foundation (NSF)); Marine Public Welfare Project; China Ocean Mineral Resources RD Association	This work was supported by National Science Foundation Grant 31171366, Marine Public Welfare Project 201005022, and Grant DY125-15-T-03 from the China Ocean Mineral Resources R&D Association.	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Cai WK, 2011, MOL BIOL CELL, V22, P3231, DOI 10.1091/mbc.E11-05-0400; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chen JM, 2010, P NATL ACAD SCI USA, V107, P20774, DOI 10.1073/pnas.1009223107; Craig CR, 2004, EMBO REP, V5, P1058, DOI 10.1038/sj.embor.7400282; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kurata S, 2000, J BIOL CHEM, V275, P23413, DOI 10.1074/jbc.C000308200; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Nordin A, 2011, HUM GENET, V129, P371, DOI 10.1007/s00439-010-0931-3; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; ROBERTSON HM, 1988, GENETICS, V118, P461; Ronkina N, 2010, BIOCHEM PHARMACOL, V80, P1915, DOI 10.1016/j.bcp.2010.06.021; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; STOKOE D, 1993, BIOCHEM J, V296, P843, DOI 10.1042/bj2960843; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Wu XR, 2012, MOL CELL PROTEOMICS, V11, P1640, DOI 10.1074/mcp.M112.019091	20	11	11	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31856	31865		10.1074/jbc.M114.589093	http://dx.doi.org/10.1074/jbc.M114.589093			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25204651	hybrid, Green Published			2022-12-28	WOS:000345314700017
J	Wang, ZQ; Liu, SM; Kakizaki, M; Hirose, Y; Ishikawa, Y; Funato, H; Yanagisawa, M; Yu, YH; Liu, QH				Wang, Zhiqiang; Liu, Shimeng; Kakizaki, Miyo; Hirose, Yuuki; Ishikawa, Yukiko; Funato, Hiromasa; Yanagisawa, Masashi; Yu, Yonghao; Liu, Qinghua			Orexin/Hypocretin Activates mTOR Complex 1 (mTORC1) via an Erk/Akt-independent and Calcium-stimulated Lysosome v-ATPase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; G Protein-coupled Receptor (GPCR); Lysosome; mTOR Complex (mTORC); Neuropeptide; Rag GTPase; Vacuolar ATPase; OX1R Or OX2R; Orexin	SIGNAL-REGULATED KINASE; OX1 OREXIN RECEPTORS; RIBOSOMAL S6 KINASE; TUBEROUS SCLEROSIS; AMINO-ACIDS; G-PROTEIN; PHOSPHOLIPASE-C; RAG GTPASES; CA2+ INFLUX; FACTOR-I	Background: Narcolepsy is caused by deficiency of neuropeptide orexin/hypocretin, of which downstream signaling pathways are unclear. Results: Orexin activates the mTOR pathway in the mouse brain and multiple cell lines expressing OX1R or OX2R. Conclusion: Orexin activates mTOR complex 1 (mTORC1) via calcium-stimulated lysosome v-ATPase pathway. Significance: mTORC1 may play a key role in the functions of orexin in physiology and metabolism. The lack of the neuropeptide orexin, also known as hypocretin, results in narcolepsy, a chronic sleep disorder characterized by frequent sleep/cataplexy attacks and rapid eye movement sleep abnormalities. However, the downstream pathways of orexin signaling are not clearly understood. Here, we show that orexin activates the mTOR pathway, a central regulator of cell growth and metabolism, in the mouse brain and multiple recombinant cell lines that express the G protein-coupled receptors (GPCRs), orexin 1 receptor (OX1R) or orexin 2 receptor (OX2R). This orexin/GPCR-stimulated mTOR activation is sensitive to rapamycin, an inhibitor of mTOR complex 1 (mTORC1) but is independent of two well known mTORC1 activators, Erk and Akt. Rather, our studies indicate that orexin activates mTORC1 via extracellular calcium influx and the lysosome pathway involving v-ATPase and Rag GTPases. Moreover, a cytoplasmic calcium transient is sufficient to mimic orexin/GPCR signaling to mTORC1 activation in a v-ATPase-dependent manner. Together, our studies suggest that the mTORC1 pathway functions downstream of orexin/GPCR signaling, which plays a crucial role in many physiological and metabolic processes.	[Wang, Zhiqiang; Liu, Shimeng; Yu, Yonghao; Liu, Qinghua] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Liu, Shimeng] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Kakizaki, Miyo; Hirose, Yuuki; Ishikawa, Yukiko; Funato, Hiromasa; Yanagisawa, Masashi; Liu, Qinghua] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058575, Japan; [Funato, Hiromasa] Toho Univ, Dept Anat, Sch Med, Tokyo 1438540, Japan	University of Texas System; University of Texas Southwestern Medical Center Dallas; Wuhan University; University of Tsukuba; Toho University	Yu, YH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd K3-219, Dallas, TX 75390 USA.	yonghao.yu@utsouthwestern.edu; qinghua.liu@utsouthwestern.edu		Funato, Hiromasa/0000-0002-2787-9700	Welch Foundation [I-1608, I-1800]; American Heart Association [13GRNT16270022]; Cancer Prevention and Research Institute of Texas Grant [CPRIT-R1103]; Japan Society for the Promotion of Science (JSPS KAKENHI) [26253015, 26220207]; Ministry of Education, Culture, Sports, Science and Technology (MEXT KAKENHI) [25460318, 25126725]	Welch Foundation(The Welch Foundation); American Heart Association(American Heart Association); Cancer Prevention and Research Institute of Texas Grant; Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Welch Foundation Grants I-1608 (to Q. L.) and I-1800 (to Y. Y.), American Heart Association Grant 13GRNT16270022 (to Q. L.), Cancer Prevention and Research Institute of Texas Grant CPRIT-R1103 (to Y. Y.), as well as by Grants-in-aid for Scientific Research of the Japan Society for the Promotion of Science (JSPS KAKENHI) Grants 26253015 and 26220207 (to M. Y.) and Grants-in-aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology (MEXT KAKENHI) Grants 25460318 and 25126725 (to H. F.).	Ammoun S, 2006, MOL ENDOCRINOL, V20, P80, DOI 10.1210/me.2004-0389; Ammoun S, 2003, J PHARMACOL EXP THER, V305, P507, DOI 10.1124/jpet.102.048025; Arvisais EW, 2006, J BIOL CHEM, V281, P26904, DOI 10.1074/jbc.M605371200; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Belsham DD, 2004, ENDOCRINOLOGY, V145, P393, DOI 10.1210/en.2003-0946; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Carter ME, 2009, CURR OPIN PHARMACOL, V9, P39, DOI 10.1016/j.coph.2008.12.018; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Conus NM, 1998, J BIOL CHEM, V273, P4776, DOI 10.1074/jbc.273.8.4776; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Crider BP, 2003, J BIOL CHEM, V278, P44281, DOI 10.1074/jbc.M307372200; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Demetriades C, 2014, CELL, V156, P786, DOI 10.1016/j.cell.2014.01.024; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Feng Y, 2014, NEUROSCI LETT, V579, P35, DOI 10.1016/j.neulet.2014.07.014; Forster C, 2000, J BIOL CHEM, V275, P38245, DOI 10.1074/jbc.M006650200; Funato H, 2009, CELL METAB, V9, P64, DOI 10.1016/j.cmet.2008.10.010; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; Graves LM, 1997, J BIOL CHEM, V272, P1920, DOI 10.1074/jbc.272.3.1920; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hannan KM, 2003, BIOCHEM J, V370, P469, DOI 10.1042/BJ20021709; Harlan SM, 2013, CELL METAB, V17, P599, DOI 10.1016/j.cmet.2013.02.017; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ito N, 2013, NAT MED, V19, P101, DOI 10.1038/nm.3019; Jaeschke A, 2002, J CELL BIOL, V159, P217, DOI 10.1083/jcb.jcb.200206108; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; KOJIMA I, 1988, J BIOL CHEM, V263, P16561; Kok SW, 2003, OBES RES, V11, P1147, DOI 10.1038/oby.2003.156; Kukkonen JP, 2013, AM J PHYSIOL-CELL PH, V304, pC2, DOI 10.1152/ajpcell.00227.2012; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lebreton S, 2008, BIOORG MED CHEM LETT, V18, P5879, DOI 10.1016/j.bmcl.2008.07.003; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lund PE, 2000, J BIOL CHEM, V275, P30806, DOI 10.1074/jbc.M002603200; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Mieda M, 2004, P NATL ACAD SCI USA, V101, P4649, DOI 10.1073/pnas.0400590101; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Mignot E, 1998, NEUROLOGY, V50, pS16, DOI 10.1212/WNL.50.2_Suppl_1.S16; Naegele S, 2004, J BIOL CHEM, V279, P46023, DOI 10.1074/jbc.M404945200; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Peltonen HM, 2009, BIOCHEM BIOPH RES CO, V385, P408, DOI 10.1016/j.bbrc.2009.05.077; Poiraudeau S, 1997, J CELL BIOCHEM, V64, P414; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sakurai T, 1998, Cell, V92, P696; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2010, ANN NY ACAD SCI, V1200, P149, DOI 10.1111/j.1749-6632.2010.05513.x; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Sellayah D, 2011, CELL METAB, V14, P478, DOI 10.1016/j.cmet.2011.08.010; Sikder D, 2007, GENE DEV, V21, P2995, DOI 10.1101/gad.1584307; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Wei W, 2014, CELL METAB, V19, P927, DOI 10.1016/j.cmet.2014.03.016; Xia JX, 2009, J PHYSIOL BIOCHEM, V65, P125, DOI 10.1007/BF03179063; Xu YQ, 2012, J BIOL CHEM, V287, P26409, DOI 10.1074/jbc.M112.352229; Yan Y, 2009, BIOCHEM J, V417, P747, DOI 10.1042/BJ20081865; Yuan LB, 2011, ANESTHESIOLOGY, V114, P340, DOI 10.1097/ALN.0b013e318206ff6f; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	69	31	34	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31950	31959		10.1074/jbc.M114.600015	http://dx.doi.org/10.1074/jbc.M114.600015			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25278019	Green Published, hybrid			2022-12-28	WOS:000345314700025
J	Bolos, M; Hu, YL; Young, KM; Foa, L; Small, DH				Bolos, Marta; Hu, Yanling; Young, Kaylene M.; Foa, Lisa; Small, David H.			Neurogenin 2 Mediates Amyloid-beta Precursor Protein-stimulated Neurogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; INTRACELLULAR DOMAIN; PYRAMIDAL NEURONS; BHLH GENES; DIFFERENTIATION; PROLIFERATION; EXPRESSION	Amyloid-beta precursor protein (APP) is well studied for its role in Alzheimer disease, although its normal function remains uncertain. It has been reported that APP stimulates the proliferation and neuronal differentiation of neural stem/progenitor cells (NSPCs). In this study we examined the role of APP in NSPC differentiation. To identify proteins that may mediate the effect of APP on NSPC differentiation, we used a gene array approach to find genes whose expression correlated with APP-induced neurogenesis. We found that the expression of neurogenin 2 (Ngn2), a basic helix-loop-helix transcription factor, was significantly down-regulated in NSPCs from APP knock-out mice (APPKO) and increased in APP transgenic (Tg2576) mice. Ngn2 overexpression in APPKO NSPCs promoted neuronal differentiation, whereas siRNA knockdown of Ngn2 expression in wild-type NSPCs decreased neuronal differentiation. The results demonstrate that APP-stimulated neuronal differentiation of NSPCs is mediated by Ngn2.	[Bolos, Marta; Hu, Yanling; Young, Kaylene M.; Foa, Lisa; Small, David H.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia; [Foa, Lisa] Univ Tasmania, Sch Med, Hobart, Tas 7000, Australia	University of Tasmania; University of Tasmania	Small, DH (corresponding author), Private Bag 23, Hobart, Tas 7001, Australia.	d.h.small@menzies.utas.edu.au	Foa, Lisa/J-7781-2014; Bolos, Marta/J-7620-2014	Foa, Lisa/0000-0003-4131-8341; Young, Kaylene/0000-0002-1686-3463; Bolos, Marta/0000-0003-2652-8607	National Health and Medical Research Council of Australia; BUPA/Alzheimer's Society UK; Multiple Sclerosis Research Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); BUPA/Alzheimer's Society UK; Multiple Sclerosis Research Australia	This work was supported by project grants from the National Health and Medical Research Council of Australia, BUPA/Alzheimer's Society UK and Multiple Sclerosis Research Australia.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Ali F, 2011, DEVELOPMENT, V138, P4267, DOI 10.1242/dev.067900; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Chasseigneaux S, 2012, J NEUROCHEM, V120, P99, DOI 10.1111/j.1471-4159.2011.07584.x; CLARRIS HJ, 1995, DEV BRAIN RES, V88, P87, DOI 10.1016/0165-3806(95)00083-P; COCHRAN E, 1991, AM J PATHOL, V139, P485; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; Dawkins E, 2014, J NEUROCHEM, V129, P756, DOI 10.1111/jnc.12675; Demars MP, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt77; Florio M, 2012, DEVELOPMENT, V139, P2308, DOI 10.1242/dev.075861; Freude KK, 2011, J BIOL CHEM, V286, P24264, DOI 10.1074/jbc.M111.227421; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; GENTLEMAN SM, 1993, PROG BRAIN RES, V96, P237; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hand R, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-30; HAYASHI Y, 1994, BIOCHEM BIOPH RES CO, V205, P936, DOI 10.1006/bbrc.1994.2755; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; Hu YL, 2013, J BIOL CHEM, V288, P18853, DOI 10.1074/jbc.M112.443671; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Joshi P, 2009, DEV BIOL, V335, P1, DOI 10.1016/j.ydbio.2009.07.041; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Lassek M, 2013, J NEUROCHEM, V127, P48, DOI 10.1111/jnc.12358; Lee JA, 2007, ZEBRAFISH, V4, P277, DOI 10.1089/zeb.2007.0516; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Li SQ, 2012, J NEUROSCI, V32, P7791, DOI 10.1523/JNEUROSCI.1309-12.2012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Toledano MA, 2004, J NEUROSCI, V24, P5439, DOI 10.1523/JNEUROSCI.0974-04.2004; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma YC, 2008, NEURON, V58, P65, DOI 10.1016/j.neuron.2008.01.037; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Megason SG, 2002, DEVELOPMENT, V129, P2087; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Octave JN, 2013, J NEUROCHEM, V126, P183, DOI 10.1111/jnc.12239; Porayette P, 2009, J BIOL CHEM, V284, P23806, DOI 10.1074/jbc.M109.026328; Ribes V, 2008, DEV BIOL, V321, P470, DOI 10.1016/j.ydbio.2008.06.003; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; SALBAUM JM, 1994, J EXP ZOOL, V269, P116, DOI 10.1002/jez.1402690205; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Small D H, 1999, J Alzheimers Dis, V1, P275; Small DH, 2014, NEURODEGENER DIS, V13, P96, DOI 10.1159/000353686; SMALL DH, 1994, J NEUROSCI, V14, P2117; SMALL DH, 1992, J NEUROSCI, V12, P4143; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; TABATON M, 1992, BRAIN RES, V593, P299, DOI 10.1016/0006-8993(92)91323-7; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; Vogt DL, 2011, NEUROBIOL AGING, V32, P1725, DOI 10.1016/j.neurobiolaging.2009.09.002; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Wilkinson G, 2013, NEUROSCIENCE, V253, P256, DOI 10.1016/j.neuroscience.2013.08.029; Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215; Yi SH, 2008, MOL THER, V16, P1873, DOI 10.1038/mt.2008.189; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zhou FF, 2012, BBA-MOL CELL RES, V1823, P1233, DOI 10.1016/j.bbamcr.2012.05.011; Zhou ZD, 2011, CELL ADHES MIGR, V5, P280, DOI 10.4161/cam.5.4.16986	64	13	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31253	31261		10.1074/jbc.M114.581918	http://dx.doi.org/10.1074/jbc.M114.581918			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25217641	Green Published, hybrid			2022-12-28	WOS:000344549900030
J	Ikehara, Y; Arai, K; Furukawa, N; Ohno, T; Miyake, T; Fushinobu, S; Nakajima, M; Miyanaga, A; Taguchi, H				Ikehara, Yoko; Arai, Kazuhito; Furukawa, Nayuta; Ohno, Tadashi; Miyake, Tatsuya; Fushinobu, Shinya; Nakajima, Masahiro; Miyanaga, Akimasa; Taguchi, Hayao			The Core of Allosteric Motion in Thermus caldophilus L-Lactate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SUBSTITUTION; BACILLUS-STEAROTHERMOPHILUS; EXTREME THERMOPHILE; NUCLEOTIDE-SEQUENCE; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; TERNARY COMPLEX; HYBRID ENZYMES; AQUATICUS YT-1; ACTIVE-SITE	For Thermus caldophilus L-lactate dehydrogenase (TcLDH), fructose 1,6-bisphosphate (FBP) reduced the pyruvate S-0.5 value 10(3)-fold and increased the V-max value 4-fold at 30 degrees C and pH 7.0, indicating that TcLDH has a much more T state-sided allosteric equilibrium than Thermus thermophilus L-lactate dehydrogenase, which has only two amino acid replacements, A154G and H179Y. The inactive (T) and active (R) state structures of TcLDH were determined at 1.8 and 2.0 angstrom resolution, respectively. The structures indicated that two mobile regions, MR1 (positions 172-185) and MR2 (positions 211-221), form a compact core for allosteric motion, and His(179) of MR1 forms constitutive hydrogen bonds with MR2. The Q4(R) mutation, which comprises the L67E, H68D, E178K, and A235R replacements, increased V-max 4-fold but reduced pyruvate S-0.5 only 5-fold in the reaction without FBP. In contrast, the P2 mutation, comprising the R173Q and R216L replacements, did not markedly increase V-max, but 10(2)-reduced pyruvate S-0.5, and additively increased the FBP-independent activity of the Q4(R) enzyme. The two types of mutation consistently increased the thermal stability of the enzyme. The MR1-MR2 area is a positively charged cluster, and its center approaches another positively charged cluster (N domain cluster) across the Q-axis subunit interface by 5 angstrom, when the enzyme undergoes the T to R transition. Structural and kinetic analyses thus revealed the simple and unique allosteric machinery of TcLDH, where the MR1-MR2 area pivotally moves during the allosteric motion and mediates the allosteric equilibrium through electrostatic repulsion within the protein molecule.	[Ikehara, Yoko; Arai, Kazuhito; Furukawa, Nayuta; Ohno, Tadashi; Miyake, Tatsuya; Nakajima, Masahiro; Taguchi, Hayao] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan; [Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Miyanaga, Akimasa] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Chem, Meguro Ku, Tokyo 1528557, Japan	Tokyo University of Science; University of Tokyo; Tokyo Institute of Technology	Taguchi, H (corresponding author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	htaguchi@rs.noda.tus.ac.jp	Nakajima, Masahiro/J-3566-2019; Fushinobu, Shinya/E-4987-2011; Miyanaga, Akimasa/C-1472-2015	Nakajima, Masahiro/0000-0002-3182-0859; Fushinobu, Shinya/0000-0003-1346-6435; Miyanaga, Akimasa/0000-0003-2219-6051; Taguchi, Hayao/0000-0001-5270-581X	Photon Factory Program Advisory Committee [2004G136, 2006G160]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23580120]	Photon Factory Program Advisory Committee(High Energy Accelerator Research Organization (KEK)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was performed with the approval of Photon Factory Program Advisory Committee Proposals 2004G136 and 2006G160. This work was supported by Grant-in-Aid 23580120 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to H. T.).	Arai K, 2011, J BIOCHEM, V150, P579, DOI 10.1093/jb/mvr100; Arai K, 2010, PROTEINS, V78, P681, DOI 10.1002/prot.22597; Auerbach G, 1998, STRUCTURE, V6, P769, DOI 10.1016/S0969-2126(98)00078-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUR D, 1989, BIOCHEM BIOPH RES CO, V161, P59, DOI 10.1016/0006-291X(89)91559-3; CLARKE AR, 1988, BIOCHEMISTRY-US, V27, P1617, DOI 10.1021/bi00405a034; CLARKE AR, 1986, NATURE, V324, P699, DOI 10.1038/324699a0; CLARKE AR, 1987, BIOCHIM BIOPHYS ACTA, V913, P72, DOI 10.1016/0167-4838(87)90234-2; Colletier JP, 2012, MOL BIOL EVOL, V29, P1683, DOI 10.1093/molbev/mss015; Coquelle N, 2007, J MOL BIOL, V374, P547, DOI 10.1016/j.jmb.2007.09.049; DeLano W.L, PYMOL MOL GRAPHICS S; Dixson M, 1979, ENZYMES, P400; EVENTOFF W, 1977, P NATL ACAD SCI USA, V74, P2677, DOI 10.1073/pnas.74.7.2677; Feldman-Salit A, 2013, J BIOL CHEM, V288, P21295, DOI 10.1074/jbc.M113.458265; Fetler L, 2007, P NATL ACAD SCI USA, V104, P495, DOI 10.1073/pnas.0607641104; Fischer E, 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; Fushinobu S, 1998, J BIOL CHEM, V273, P2971, DOI 10.1074/jbc.273.5.2971; Fushinobu S, 1996, J BIOL CHEM, V271, P25611, DOI 10.1074/jbc.271.41.25611; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; GRAU UM, 1981, J MOL BIOL, V151, P289, DOI 10.1016/0022-2836(81)90516-7; HART KW, 1987, BIOCHIM BIOPHYS ACTA, V914, P294, DOI 10.1016/0167-4838(87)90289-5; HENSEL R, 1983, EUR J BIOCHEM, V135, P359, DOI 10.1111/j.1432-1033.1983.tb07662.x; Holbrook JJ., 1975, ENZYMES, P191; IWATA S, 1994, NAT STRUCT BIOL, V1, P176, DOI 10.1038/nsb0394-176; IWATA S, 1993, J MOL BIOL, V230, P21, DOI 10.1006/jmbi.1993.1122; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOIDE S, 1991, J BIOCHEM-TOKYO, V109, P6; KOIDE S, 1989, J BIOL CHEM, V264, P8676; KOIDE S, 1992, BIOCHEMISTRY-US, V31, P5362, DOI 10.1021/bi00138a017; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUNAI K, 1986, EUR J BIOCHEM, V160, P433, DOI 10.1111/j.1432-1033.1986.tb09991.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACHIDA M, 1985, J BIOL CHEM, V260, P6143; MACHIDA M, 1985, J BIOCHEM, V97, P899, DOI 10.1093/oxfordjournals.jbchem.a135132; MATSUZAWA H, 1988, FEBS LETT, V233, P375, DOI 10.1016/0014-5793(88)80464-2; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; ONO M, 1990, J BIOCHEM-TOKYO, V107, P21, DOI 10.1093/oxfordjournals.jbchem.a123004; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; SAKOWICZ R, 1993, BIOCHEMISTRY-US, V32, P12730, DOI 10.1021/bi00210a023; SCHROEDER G, 1988, BIOCHEM BIOPH RES CO, V152, P1236, DOI 10.1016/S0006-291X(88)80417-0; TAGUCHI H, 1982, J BIOCHEM, V91, P1343, DOI 10.1093/oxfordjournals.jbchem.a133821; TAGUCHI H, 1984, EUR J BIOCHEM, V145, P283, DOI 10.1111/j.1432-1033.1984.tb08550.x; TAGUCHI H, 1992, EUR J BIOCHEM, V209, P993, DOI 10.1111/j.1432-1033.1992.tb17373.x; Uchikoba H, 2002, PROTEINS, V46, P206, DOI 10.1002/prot.1165; WIGLEY DB, 1992, J MOL BIOL, V223, P317, DOI 10.1016/0022-2836(92)90733-Z; WRBA A, 1990, EUR J BIOCHEM, V188, P195, DOI 10.1111/j.1432-1033.1990.tb15388.x	50	6	7	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31550	31564		10.1074/jbc.M114.599092	http://dx.doi.org/10.1074/jbc.M114.599092			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25258319	Green Published, hybrid			2022-12-28	WOS:000344549900056
J	Zhang, YS; Xia, JX; Li, QL; Yao, Y; Fades, G; Gernapudi, R; Duru, N; Kensler, TW; Zhou, Q				Zhang, Yongshu; Xia, Jixiang; Li, Qinglin; Yao, Yuan; Fades, Gabriel; Gernapudi, Ramkishore; Duru, Nadire; Kensler, Thomas W.; Zhou, Qun			NRF2/Long Noncoding RNA ROR Signaling Regulates Mammary Stem Cell Expansion and Protects against Estrogen Genotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; NRF2; KEAP1; IDENTIFICATION; ELECTROPHILE; EXPRESSION; INDUCTION; CYSTEINES; PATHWAY; STRESS	Long noncoding RNAs (lncRNAs) have emerged as key regulators of gene expression in embryonic stem cell (ESC) self-renewal and differentiation. In ESCs, lncRNAs are regulated at the genetic level via transcription factor binding to lncRNA gene promoters. Here we demonstrate that the key cytoprotective transcription factor NRF2 controls lncRNA expression in mammary stem cells. By profiling lncRNAs in wild-type and NRF2 knockdown mammary stem cells, we demonstrate that the lncRNA ROR, a regulator of embryonic stem cell pluripotency, is overexpressed upon NRF2 knockdown. We performed promoter analyses and examined predicted NRF2 binding elements in the ROR promoter using luciferase reporter constructs of a ROR promoter deletion series. Our studies revealed that NRF2 binds to two specific NRF2 response elements flanking the ROR promoter and that these two NRF2 response elements are equally important to suppress ROR transcription. In addition, we identified associated H3K27me3 chromatin modification and EZH2 binding at the ROR promoter that was dependent on NRF2 binding. We observed that NRF2 knockdown or ROR overexpression leads to increased stem cell self-renewal in mammary stem cells. Furthermore, we demonstrate Nrf2 regulation of the mammary stem cell population in vivo. These observations provide further evidence for the critical role of NRF2 in maintaining normal stem cell subpopulations in mammary epithelium.	[Zhang, Yongshu; Xia, Jixiang; Li, Qinglin; Yao, Yuan; Fades, Gabriel; Gernapudi, Ramkishore; Duru, Nadire; Zhou, Qun] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Kensler, Thomas W.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhou, Q (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	qzhou@som.umaryland.edu	Li, Qinglin/K-2570-2015; Kensler, Thomas W/D-8686-2014	Li, Qinglin/0000-0002-4125-1944; Kensler, Thomas W/0000-0002-6676-261X	National Institutes of Health from the NCI [R01 CA157779, 1F31CA183522]; American Cancer Society; NATIONAL CANCER INSTITUTE [T32CA154274, P30CA134274, R01CA157779, F31CA183522, R01CA094076] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA157779 from the NCI (to Q.Z.) and NCI 1F31CA183522 (to G. E.) and the American Cancer Society (to Q.Z.).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Baird L, 2013, P NATL ACAD SCI USA, V110, P15259, DOI 10.1073/pnas.1305687110; Chartoumpekis DV, 2011, DIABETES, V60, P2465, DOI 10.2337/db11-0112; Cuendet M, 2004, MUTAT RES-FUND MOL M, V550, P109, DOI 10.1016/j.mrfmmm.2004.02.005; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dontu G, 2005, J MAMMARY GLAND BIOL, V10, P75, DOI 10.1007/s10911-005-2542-5; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Li QL, 2014, J BIOL CHEM, V289, P1303, DOI 10.1074/jbc.M113.502278; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Yao YA, 2010, BREAST CANCER RES TR, V124, P585, DOI 10.1007/s10549-010-1023-8; Yu SW, 2007, CURR CANCER DRUG TAR, V7, P416; Zhang YS, 2012, J BIOL CHEM, V287, P41514, DOI 10.1074/jbc.M112.404871	30	34	39	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31310	31318		10.1074/jbc.M114.604868	http://dx.doi.org/10.1074/jbc.M114.604868			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25231996	hybrid, Green Published			2022-12-28	WOS:000344549900035
J	Manicki, M; Majewska, J; Ciesielski, S; Schilke, B; Blenska, A; Kominek, J; Marszalek, J; Craig, EA; Dutkiewicz, R				Manicki, Mateusz; Majewska, Julia; Ciesielski, Szymon; Schilke, Brenda; Blenska, Anna; Kominek, Jacek; Marszalek, Jaroslaw; Craig, Elizabeth A.; Dutkiewicz, Rafal			Overlapping Binding Sites of the Frataxin Homologue Assembly Factor and the Heat Shock Protein 70 Transfer Factor on the Isu Iron-Sulfur Cluster Scaffold Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL CYSTEINE DESULFURASE; YEAST FRATAXIN; SACCHAROMYCES-CEREVISIAE; INTERACTING PROTEIN; BACTERIAL FRATAXIN; FRIEDREICH ATAXIA; COCHAPERONE HSCB; CHAPERONE JAC1; IN-VIVO; BIOGENESIS	In mitochondria FeS clusters, prosthetic groups critical for the activity of many proteins, are first assembled on Isu, a 14-kDa scaffold protein, and then transferred to recipient apo-proteins. The assembly process involves interaction of Isu with both Nfs1, the cysteine desulfurase serving as a sulfur donor, and the yeast frataxin homolog (Yfh1) serving as a regulator of desulfurase activity and/or iron donor. Here, based on the results of biochemical experiments with purified wild-type and variant proteins, we report that interaction of Yfh1 with both Nfs1 and Isu are required for formation of a stable tripartite assembly complex. Disruption of either Yfh1-Isu or Nfs1-Isu interactions destabilizes the complex. Cluster transfer to recipient apoprotein is known to require the interaction of Isu with the J-protein/ Hsp70 molecular chaperone pair, Jac1 and Ssq1. Here we show that the Yfh1 interaction with Isu involves the PVK sequence motif, which is also the site key for the interaction of Isu with Hsp70 Ssq1. Coupled with our previous observation that Nfs1 and Jac1 binding to Isu is mutually exclusive due to partially overlapping binding sites, we propose that such mutual exclusivity of cluster assembly factor (Nfs1/Yfh1) and cluster transfer factor (Jac1/Ssq1) binding to Isu has functional consequences for the transition from the assembly process to the transfer process, and thus regulation of the biogenesis of FeS cluster proteins.	[Manicki, Mateusz; Majewska, Julia; Blenska, Anna; Kominek, Jacek; Marszalek, Jaroslaw; Dutkiewicz, Rafal] Univ Gdansk, Intercollegiate Fac Biotechnol, PL-80822 Gdansk, Poland; [Manicki, Mateusz; Majewska, Julia; Blenska, Anna; Kominek, Jacek; Marszalek, Jaroslaw; Dutkiewicz, Rafal] Med Univ Gdansk, PL-80822 Gdansk, Poland; [Majewska, Julia; Ciesielski, Szymon; Schilke, Brenda; Marszalek, Jaroslaw; Craig, Elizabeth A.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; University of Wisconsin System; University of Wisconsin Madison	Marszalek, J (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, PL-80822 Gdansk, Poland.	jaroslaw.marszalek@biotech.ug.edu.pl; ecraig@wisc.edu	Dutkiewicz, Rafal/ABE-6979-2020	Dutkiewicz, Rafal/0000-0003-4150-0450; Kominek, Jacek/0000-0002-1916-0122; Marszalek, Jaroslaw/0000-0002-6978-1189; Ciesielski, Szymon/0000-0002-9041-7162	National Institutes of Health [GM27870]; Polish National Science Center [DEC-2012/06/A/NZ1/00002]; Foundation for Polish Science International [MPD/2010/5]; European Union European Regional Development Fund, Operational Program Innovative Economy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish National Science Center; Foundation for Polish Science International; European Union European Regional Development Fund, Operational Program Innovative Economy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM27870 (to E. A. C), Polish National Science Center Grant DEC-2012/06/A/NZ1/00002 (to J. M.), and Foundation for Polish Science International Ph.D. Projects Grant MPD/2010/5 co-financed by the European Union European Regional Development Fund, Operational Program Innovative Economy 2007-2013 (to J. M.).	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Andrew AJ, 2006, J BIOL CHEM, V281, P14580, DOI 10.1074/jbc.M600842200; Bonomi F, 2011, BIOCHEMISTRY-US, V50, P9641, DOI 10.1021/bi201123z; Bonomi F, 2008, BIOCHEMISTRY-US, V47, P12795, DOI 10.1021/bi801565j; Bridwell-Rabb J, 2014, BIOCHEMISTRY-US, V53, P4904, DOI 10.1021/bi500532e; Bridwell-Rabb J, 2012, BIOCHEMISTRY-US, V51, P2506, DOI 10.1021/bi201628j; Bridwell-Rabb J, 2011, BIOCHEMISTRY-US, V50, P7265, DOI 10.1021/bi200895k; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; Ciesielski SJ, 2012, J MOL BIOL, V417, P1, DOI 10.1016/j.jmb.2012.01.022; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Dutkiewicz R, 2004, J BIOL CHEM, V279, P29167, DOI 10.1074/jbc.M402947200; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Fuzery AK, 2008, BIOCHEMISTRY-US, V47, P9394, DOI 10.1021/bi800502r; Garland SA, 1999, J MOL BIOL, V294, P897, DOI 10.1006/jmbi.1999.3294; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hoff KG, 2003, J BIOL CHEM, V278, P37582, DOI 10.1074/jbc.M305292200; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jaschkowitz K, 2000, BIOCHEMISTRY-US, V39, P3416, DOI 10.1021/bi992147c; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim JH, 2013, J AM CHEM SOC, V135, P8117, DOI 10.1021/ja401950a; Kim JH, 2009, BIOCHEMISTRY-US, V48, P6062, DOI 10.1021/bi9002277; Leidgens S, 2010, HUM MOL GENET, V19, P276, DOI 10.1093/hmg/ddp495; Li HQ, 2013, J BIOL CHEM, V288, P4116, DOI 10.1074/jbc.M112.435263; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Majewska J, 2013, J BIOL CHEM, V288, P29134, DOI 10.1074/jbc.M113.503524; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Martelli A, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00130; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Naamati A, 2009, J BIOL CHEM, V284, P30200, DOI 10.1074/jbc.M109.034694; Nakai Y, 2001, J BIOL CHEM, V276, P8314, DOI 10.1074/jbc.M007878200; Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857; Pandey A, 2012, BIOCHEM J, V448, P171, DOI 10.1042/BJ20120951; Pareek G, 2011, J BIOL CHEM, V286, P19001, DOI 10.1074/jbc.M110.197434; Pastore A, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00020; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Richards TA, 2006, MOL BIOL EVOL, V23, P1341, DOI 10.1093/molbev/msl001; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; SHERMAN F, 1991, METHODS ENZYMOL, V194, P3; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Smith AD, 2001, J AM CHEM SOC, V123, P11103, DOI 10.1021/ja016757n; Stehling O, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011312; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; THORPE GHG, 1985, CLIN CHEM, V31, P1335; Tsai CL, 2011, BIOCHEMISTRY-US, V50, P6478, DOI 10.1021/bi200666h; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Vaubel RA, 2013, MOL CELL NEUROSCI, V55, P50, DOI 10.1016/j.mcn.2012.08.003; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; Voisine C, 2000, MOL CELL BIOL, V20, P3677, DOI 10.1128/MCB.20.10.3677-3684.2000; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Yan R, 2013, J BIOL CHEM, V288, P24777, DOI 10.1074/jbc.M113.480327	62	33	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30268	30278		10.1074/jbc.M114.596726	http://dx.doi.org/10.1074/jbc.M114.596726			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25228696	hybrid, Green Published			2022-12-28	WOS:000344549700011
J	Emperle, M; Rajavelu, A; Reinhardt, R; Jurkowska, RZ; Jeltsch, A				Emperle, Max; Rajavelu, Arumugam; Reinhardt, Richard; Jurkowska, Renata Z.; Jeltsch, Albert			Cooperative DNA Binding and Protein/DNA Fiber Formation Increases the Activity of the Dnmt3a DNA Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cooperativity; DNA Enzyme; DNA Methylation; DNA Methyltransferase; Enzyme Kinetics; Enzyme Mechanism	DE-NOVO METHYLTRANSFERASE; PROCESSIVE METHYLATION; CATALYTIC MECHANISM; INDIVIDUAL CLONES; MODIFIES DNA; SITES; PREFERENCE; ENZYME; DOMAIN; DNA-(CYTOSINE-C5)-METHYLTRANSFERASES	Background: Dnmt3a has been reported to multimerize on DNA and methylate DNA processively, which is contradicting. Results: We show that multimerization of Dnmt3a on DNA increases its activity, but processive DNA methylation is not detectable. Conclusion: Dnmt3a forms enzyme/DNA fibers. Significance: Our results help to understand the mechanism of DNA methylation and the effects of Dnmt3a somatic cancer mutations. The Dnmt3a DNA methyltransferase has been shown to bind cooperatively to DNA and to form large multimeric protein/DNA fibers. However, it has also been reported to methylate DNA in a processive manner, a property that is incompatible with protein/DNA fiber formation. We show here that the DNA methylation rate of Dnmt3a increases more than linearly with increasing enzyme concentration on a long DNA substrate, but not on a short 30-mer oligonucleotide substrate. We also show that addition of a catalytically inactive Dnmt3a mutant, which carries an amino acid exchange in the catalytic center, increases the DNA methylation rate by wild type Dnmt3a on the long substrate but not on the short one. In agreement with this finding, preincubation experiments indicate that stable protein/DNA fibers are formed on the long, but not on the short substrate. In addition, methylation experiments with substrates containing one or two CpG sites did not provide evidence for a processive mechanism over a wide range of enzyme concentrations. These data clearly indicate that Dnmt3a binds to DNA in a cooperative reaction and that the formation of stable protein/DNA fibers increases the DNA methylation rate. Fiber formation occurs at low m concentrations of Dnmt3a, which are in the range of Dnmt3a concentrations in the nucleus of embryonic stem cells. Understanding the mechanism of Dnmt3a is of vital importance because Dnmt3a is a hotspot of somatic cancer mutations one of which has been implicated in changing Dnmt3a processivity.	[Emperle, Max; Rajavelu, Arumugam; Jurkowska, Renata Z.; Jeltsch, Albert] Univ Stuttgart, Inst Biochem, D-70569 Stuttgart, Germany; [Reinhardt, Richard] Max Planck Genomzentrum Koln, D-50829 Cologne, Germany	University of Stuttgart; Max Planck Society	Jurkowska, RZ (corresponding author), Univ Stuttgart, Fac Chem, Inst Biochem, Pfaffenwaldring 55, D-70569 Stuttgart, Germany.	renata.jurkowska@ibc.uni-stuttgart.de; albert.jeltsch@ibc.uni-stuttgart.de	Jurkowska, Renata/AAE-2504-2020; Jeltsch, Albert/O-7404-2014	Jurkowska, Renata/0000-0002-4507-2222; Jeltsch, Albert/0000-0001-6113-9290; Reinhardt, Richard/0000-0001-9376-2132; Rajavelu, Arumugam/0000-0001-6666-8925	Deutsche Forschungsgemeinschaft [JE 252/10]; Bundesministerium fur Bildung und Forschung [FKZ 01GS0805]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by Deutsche Forschungsgemeinschaft Grant JE 252/10 (to A. J.) and Bundesministerium fur Bildung und Forschung Grant FKZ 01GS0805 (to R. R.).	Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Gowher H, 2006, J MOL BIOL, V357, P928, DOI 10.1016/j.jmb.2006.01.035; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Gowher H, 2002, J BIOL CHEM, V277, P20409, DOI 10.1074/jbc.M202148200; Gowher H, 2001, J MOL BIOL, V309, P1201, DOI 10.1006/jmbi.2001.4710; Goyal R, 2006, NUCLEIC ACIDS RES, V34, P1182, DOI 10.1093/nar/gkl002; Handa V, 2005, J MOL BIOL, V348, P1103, DOI 10.1016/j.jmb.2005.02.044; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Holz-Schietinger C, 2012, J BIOL CHEM, V287, P30941, DOI 10.1074/jbc.M112.366625; Holz-Schietinger C, 2011, J BIOL CHEM, V286, P41479, DOI 10.1074/jbc.M111.284687; Holz-Schietinger C, 2010, J BIOL CHEM, V285, P29091, DOI 10.1074/jbc.M110.142513; Jeltsch A, 2014, TRENDS BIOCHEM SCI, V39, P310, DOI 10.1016/j.tibs.2014.05.002; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jurkowska RZ, 2011, J BIOL CHEM, V286, P24200, DOI 10.1074/jbc.M111.254987; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P1589, DOI 10.1002/cbic.201000673; Jurkowska RZ, 2008, NUCLEIC ACIDS RES, V36, P6656, DOI 10.1093/nar/gkn747; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Li BZ, 2011, CELL RES, V21, P1172, DOI 10.1038/cr.2011.92; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Lin IG, 2002, MOL CELL BIOL, V22, P704, DOI 10.1128/MCB.22.3.704-723.2002; Martinez-Rucobo FW, 2013, BBA-GENE REGUL MECH, V1829, P9, DOI 10.1016/j.bbagrm.2012.09.002; McHenry CS, 2011, CURR OPIN CHEM BIOL, V15, P587, DOI 10.1016/j.cbpa.2011.07.018; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Perry JJP, 2010, J BIOL CHEM, V285, P25699, DOI 10.1074/jbc.M110.124941; Rajavelu A, 2012, NUCLEIC ACIDS RES, V40, P569, DOI 10.1093/nar/gkr753; Rathert P, 2007, CHEMBIOCHEM, V8, P202, DOI 10.1002/cbic.200600358; Reither S, 2003, J MOL BIOL, V329, P675, DOI 10.1016/S0022-2836(03)00509-6; RENBAUM P, 1992, FEBS LETT, V313, P243, DOI 10.1016/0014-5793(92)81201-V; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Roth M, 2000, BIOL CHEM, V381, P269, DOI 10.1515/BC.2000.035; Russler-Germain DA, 2014, CANCER CELL, V25, P442, DOI 10.1016/j.ccr.2014.02.010; Seidel R, 2004, NAT STRUCT MOL BIOL, V11, P838, DOI 10.1038/nsmb816; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Urig S, 2002, J MOL BIOL, V319, P1085, DOI 10.1016/S0022-2836(02)00371-6; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Wienholz BL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001106; Wu MS, 2005, EMBO J, V24, P4082, DOI 10.1038/sj.emboj.7600869; Xu J, 2014, P NATL ACAD SCI USA, V111, P2620, DOI 10.1073/pnas.1400150111; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147; Zhang Yingying, 2009, V507, P177, DOI 10.1007/978-1-59745-522-0_14	42	36	36	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29602	29613		10.1074/jbc.M114.572032	http://dx.doi.org/10.1074/jbc.M114.572032			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25147181	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000344370800011
J	Liou, B; Haffey, WD; Greis, KD; Grabowski, GA				Liou, Benjamin; Haffey, Wendy D.; Greis, Kenneth D.; Grabowski, Gregory A.			The LIMP-2/SCARB2 Binding Motif on Acid beta-Glucosidase BASIC AND APPLIED IMPLICATIONS FOR GAUCHER DISEASE AND ASSOCIATED NEURODEGENERATIVE DISEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Inborn Error of Metabolism; Intracellular Trafficking; Lysosomal Storage Disease; Protein Sorting; Enterovirus 71; Glucocerebrosidase; Lysosomal Targeting	MULTIPLE SEQUENCE ALIGNMENT; MACROPHAGE MANNOSE RECEPTOR; MEMBRANE-PROTEINS; GLUCOCEREBROSIDASE MUTATIONS; PARKINSONS-DISEASE; ENTEROVIRUS 71; SAPOSIN-C; MECHANISM; LIMP-2; RECOGNITION	Background: Acid -glucosidase is trafficked to the lysosome by LIMP-2. Results: A unique 11-amino acid sequence on acid -glucosidase was critical for its LIMP-2-dependent targeting to the lysosome. Conclusion: This sequence is essential for oligosaccharide-independent targeting of synthesized acid -glucosidase to the lysosome. Significance: Modification of this sequence has basic/therapeutic implications for Gaucher disease and its comorbidities (e.g. Parkinson disease). The acid -glucosidase (glucocerbrosidase (GCase)) binding sequence to LIMP-2 (lysosomal integral membrane protein 2), the receptor for intracellular GCase trafficking to the lysosome, has been identified. Heterologous expression of deletion constructs, the available GCase crystal structures, and binding and co-localization of identified peptides or mutant GCases were used to identify and characterize a highly conserved 11-amino acid sequence, DSPIIVDITKD, within human GCase. The binding to LIMP-2 is not dependent upon a single amino acid, but the interactions of GCase with LIMP-2 are heavily influenced by Asp(399) and the di-isoleucines, Ile(402) and Ile(403). A single alanine substitution at any of these decreases GCase binding to LIMP-2 and alters its pH-dependent binding as well as diminishing the trafficking of GCase to the lysosome and significantly increasing GCase secretion. Enterovirus 71 also binds to LIMP-2 (also known as SCARB2) on the external surface of the plasma membrane. However, the LIMP-2/SCARB2 binding sequences for enterovirus 71 and GCase are not similar, indicating that LIMP-2/SCARB2 may have multiple or overlapping binding sites with differing specificities. These findings have therapeutic implications for the production of GCase and the distribution of this enzyme that is delivered to various organs.	[Liou, Benjamin; Grabowski, Gregory A.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Liou, Benjamin; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA; [Haffey, Wendy D.; Greis, Kenneth D.] Univ Cincinnati, Med Ctr, Vontz Ctr Mol Studies, Dept Canc Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University of Cincinnati; University of Cincinnati	Grabowski, GA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	greg.grabowski@cchmc.org		Greis, Kenneth/0000-0002-5316-3351	National Institutes of Health [DK 36729]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 36729 (to G. A. G.).	BARRIOCANAL JG, 1986, J BIOL CHEM, V261, P6755; BERGFUSSMAN A, 1993, J BIOL CHEM, V268, P14861; Blanz J, 2010, HUM MOL GENET, V19, P563, DOI 10.1093/hmg/ddp523; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; BRADY RO, 1966, J CLIN INVEST, V45, P1112, DOI 10.1172/JCI105417; Bultron G, 2010, J INHERIT METAB DIS, V33, P167, DOI 10.1007/s10545-010-9055-0; Chen P, 2012, J BIOL CHEM, V287, P6406, DOI 10.1074/jbc.M111.301622; Cullen V, 2011, ANN NEUROL, V69, P940, DOI 10.1002/ana.22400; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; FABBRO D, 1991, J BIOL CHEM, V266, P15021; Gough NR, 1999, J CELL SCI, V112, P4257; Grabowski G. A., 2010, METABOLIC MOL BASES; Grabowski GA, 2006, METABOLIC MOL BASES; Knipper M, 2006, J PHYSIOL-LONDON, V576, P73, DOI 10.1113/jphysiol.2006.116889; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; Kornfeld S., 2001, METABOLIC MOL BASES; Leonova T, 2000, MOL GENET METAB, V70, P281, DOI 10.1006/mgme.2000.3035; Liou B, 2006, J BIOL CHEM, V281, P4242, DOI 10.1074/jbc.M511110200; Liou B, 2012, MOL GENET METAB, V105, P528, DOI 10.1016/j.ymgme.2011.12.002; Lopez G, 2013, MOL GENET METAB, V109, P235, DOI 10.1016/j.ymgme.2013.04.012; Maniwang E, 2013, MOL GENET METAB, V108, P269, DOI 10.1016/j.ymgme.2013.01.012; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Mullin NP, 1997, J BIOL CHEM, V272, P5668, DOI 10.1074/jbc.272.9.5668; OGATA S, 1994, J BIOL CHEM, V269, P5210; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; REITMAN ML, 1981, J BIOL CHEM, V256, P1977; Saftig P, 2010, BIOCHEM SOC T, V38, P1420, DOI 10.1042/BST0381420; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Sardi SP, 2013, P NATL ACAD SCI USA, V110, P3537, DOI 10.1073/pnas.1220464110; Sardi SP, 2012, NEURODEGENER DIS, V10, P195, DOI 10.1159/000335038; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; SORGE J, 1985, P NATL ACAD SCI USA, V82, P7289, DOI 10.1073/pnas.82.21.7289; Sun Y, 2003, J BIOL CHEM, V278, P31918, DOI 10.1074/jbc.M302752200; Velayati A, 2011, HUM MUTAT, V32, P1232, DOI 10.1002/humu.21566; Wang XX, 2012, NAT STRUCT MOL BIOL, V19, P424, DOI 10.1038/nsmb.2255; Westbroek W, 2011, TRENDS MOL MED, V17, P485, DOI 10.1016/j.molmed.2011.05.003; Yamayoshi S, 2011, J VIROL, V85, P4937, DOI 10.1128/JVI.02358-10; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Zachos C, 2012, TRAFFIC, V13, P1113, DOI 10.1111/j.1600-0854.2012.01372.x; Zhao YG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5321	44	13	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					30063	30074		10.1074/jbc.M114.593616	http://dx.doi.org/10.1074/jbc.M114.593616			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25202012	Green Published, hybrid			2022-12-28	WOS:000344370800046
J	Powell, C; Cornblath, E; Goldman, D				Powell, Curtis; Cornblath, Eli; Goldman, Daniel			Zinc-binding Domain-dependent, Deaminase-independent Actions of Apolipoprotein B mRNA-editing Enzyme, Catalytic Polypeptide 2 (Apobec2), Mediate Its Effect on Zebrafish Retina Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; MULLER GLIA; ESCHERICHIA-COLI; TRANSGENIC ZEBRAFISH; CYTIDINE DEAMINASE; SIGNALING PATHWAY; GENE-EXPRESSION; AID; PROTEINS; CELLS	The Apobec/AID family of cytosine deaminases can deaminate cytosine and thereby contribute to adaptive and innate immunity, DNAdemethylation, and the modification of cellular mRNAs. Unique among this family is Apobec2, whose enzymatic activity has been questioned and whose function remains poorly explored. We recently reported that zebrafish Apobec2a and Apobec2b (Apobec2a, 2b) regulate retina regeneration; however, their mechanism of action remained unknown. Here we show that although Apobec2a, 2b lack cytosine deaminase activity, they require a conserved zinc-binding domain to stimulate retina regeneration. Interestingly, we found that human APOBEC2 is able to functionally substitute for Apobec2a, 2b during retina regeneration. By identifying Apobec2-interacting proteins, including ubiquitin-conjugating enzyme 9 (Ubc9); topoisomerase I-binding, arginine/serine-rich, E3 ubiquitin protein ligase (Toporsa); and POU class 6 homeobox 2 (Pou6f2), we uncovered that sumoylation regulates Apobec2 subcellular localization and that nuclear Apobec2 controls Pou6f2 binding to DNA. Importantly, mutations in the zinc-binding domain of Apobec2 diminished its ability to stimulate Pou6f2 binding to DNA, and knockdown of Ubc9 or Pou6f2 suppressed retina regeneration.	Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Goldman, D (corresponding author), Univ Michigan, Mol & Behav Neurosci Inst, Dept Biol Chem, 5045 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	neuroman@umich.edu			National Institutes of Health, NEI [RO1 EY018132, 1R21 EY022707]; University of Michigan Vision Research Training Grant [5T32EY13934-10]; University of Michigan Predoctoral Fellowship; NATIONAL EYE INSTITUTE [T32EY013934, R01EY018132, R21EY022707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); University of Michigan Vision Research Training Grant; University of Michigan Predoctoral Fellowship(University of Michigan System); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NEI, Grants RO1 EY018132 and 1R21 EY022707 (to D. G.). This work was also supported by University of Michigan Vision Research Training Grant 5T32EY13934-10 (to C. P.), and the University of Michigan Predoctoral Fellowship (to C. P.).	Abdouni H, 2013, NUCLEIC ACIDS RES, V41, P5457, DOI 10.1093/nar/gkt212; Anant S, 2001, J BIOL CHEM, V276, P47338, DOI 10.1074/jbc.M104911200; Anant S, 2001, AM J PHYSIOL-CELL PH, V281, pC1904, DOI 10.1152/ajpcell.2001.281.6.C1904; Barreto VM, 2005, J EXP MED, V202, P733, DOI 10.1084/jem.20051378; Bartel P. L., 1997, YEAST 2 HYBRID SYSTE, P29; Chakarova CF, 2007, AM J HUM GENET, V81, P1098, DOI 10.1086/521953; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Cook AL, 2008, PIGM CELL MELANOMA R, V21, P611, DOI 10.1111/j.1755-148X.2008.00510.x; Dancyger AM, 2012, FASEB J, V26, P1517, DOI 10.1096/fj.11-198135; Etard C, 2010, J CELL BIOL, V189, P527, DOI 10.1083/jcb.200912125; Fausett BV, 2008, J NEUROSCI, V28, P1109, DOI 10.1523/JNEUROSCI.4853-07.2008; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Ihara M, 2008, BIOL REPROD, V79, P906, DOI 10.1095/biolreprod.108.070474; Kassen SC, 2007, DEV NEUROBIOL, V67, P1009, DOI 10.1002/dneu.20362; Krzysiak TC, 2012, BIOCHEMISTRY-US, V51, P2008, DOI 10.1021/bi300021s; Lada AG, 2011, BIOCHEMISTRY-MOSCOW+, V76, P131, DOI 10.1134/S0006297911010135; Li XL, 2012, DEVELOPMENT, V139, P4321, DOI 10.1242/dev.081869; Liao W, 1999, BIOCHEM BIOPH RES CO, V260, P398, DOI 10.1006/bbrc.1999.0925; Mikl MC, 2005, MOL CELL BIOL, V25, P7270, DOI 10.1128/MCB.25.16.7270-7277.2005; Nowak M, 2006, MOL BIOL CELL, V17, P5324, DOI 10.1091/mbc.E06-05-0413; Okuyama S, 2012, INT J CANCER, V130, P1294, DOI 10.1002/ijc.26114; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Petersen-Mahrt SK, 2003, J BIOL CHEM, V278, P19583, DOI 10.1074/jbc.C300114200; Powell C, 2013, P NATL ACAD SCI USA, V110, P19814, DOI 10.1073/pnas.1312009110; Powell C, 2012, J NEUROSCI, V32, P1096, DOI 10.1523/JNEUROSCI.5603-11.2012; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Provost E, 2007, GENESIS, V45, P625, DOI 10.1002/dvg.20338; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ramachandran R, 2012, NAT CELL BIOL, V14, P1013, DOI 10.1038/ncb2586; Ramachandran R, 2011, P NATL ACAD SCI USA, V108, P15858, DOI 10.1073/pnas.1107220108; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; Sato Y, 2010, J BIOL CHEM, V285, P7111, DOI 10.1074/jbc.M109.052977; Seong KM, 2012, J BIOCHEM MOL TOXIC, V26, P429, DOI 10.1002/jbt.21438; Terada K, 2010, DEV BIOL, V347, P180, DOI 10.1016/j.ydbio.2010.08.023; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Uchimura Y, 2004, FEBS LETT, V564, P85, DOI 10.1016/S0014-5793(04)00321-7; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Vonica A, 2011, DEV BIOL, V350, P13, DOI 10.1016/j.ydbio.2010.09.016; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Zhou H, 1996, J NEUROSCI, V16, P2261, DOI 10.1523/jneurosci.16-07-02261.1996	44	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28924	28941		10.1074/jbc.M114.603043	http://dx.doi.org/10.1074/jbc.M114.603043			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25190811	hybrid, Green Published			2022-12-28	WOS:000344141000015
J	Gupta, S; Yeeles, JTP; Marians, KJ				Gupta, Sankalp; Yeeles, Joseph T. P.; Marians, Kenneth J.			Regression of Replication Forks Stalled by Leading-strand Template Damage I-BOTH RecG AND RuvAB CATALYZE REGRESSION, BUT RuvC CLEAVES THE HOLLIDAY JUNCTIONS FORMED BY RecG PREFERENTIALLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-III; ESCHERICHIA-COLI; BRANCH MIGRATION; GENETIC-RECOMBINATION; MAMMALIAN-CELLS; PROTEIN; VITRO; RESOLUTION; REPAIR; HELICASE	The orderly progression of replication forks formed at the origin of replication in Escherichia coli is challenged by encounters with template damage, slow moving RNA polymerases, and frozen DNA-protein complexes that stall the fork. These stalled forks are foci for genomic instability and must be reactivated. Many models of replication fork reactivation invoke nascent strand regression as an intermediate in the processing of the stalled fork. We have investigated the replication fork regression activity of RecG and RuvAB, two proteins commonly thought to be involved in the process, using a reconstituted DNA replication system where the replisome is stalled by collision with leading-strand template damage. We find that both RecG and RuvAB can regress the stalled fork in the presence of the replisome and SSB; however, RuvAB generates a completely unwound product consisting of the paired nascent leading and lagging strands, whereas RuvC cleaves the Holliday junction generated by RecG-catalyzed fork regression. We also find that RecG stimulates RuvAB-catalyzed regression, presumably because it is more efficient at generating the initial Holliday junction from the stalled fork.	[Gupta, Sankalp; Yeeles, Joseph T. P.; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu	Gupta, Sankalp/M-1907-2014	Yeeles, Joseph/0000-0002-2255-2119	National Institutes of Health [GM34557]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034557, R01GM034557] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34557 (to K. J. M.).	Abd Wahab S, 2013, J BIOL CHEM, V288, P26397, DOI 10.1074/jbc.M113.500223; Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; Baharoglu Z, 2006, EMBO J, V25, P596, DOI 10.1038/sj.emboj.7600941; Baharoglu Z, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000012; BENNETT RJ, 1993, CELL, V74, P1021, DOI 10.1016/0092-8674(93)90724-5; BENSON FE, 1994, J BIOL CHEM, V269, P5195; Bradley AS, 2011, J BIOL CHEM, V286, P22372, DOI 10.1074/jbc.M111.233908; CASSUTO E, 1980, P NATL ACAD SCI-BIOL, V77, P3962, DOI 10.1073/pnas.77.7.3962; CONNOLLY B, 1991, P NATL ACAD SCI USA, V88, P6063, DOI 10.1073/pnas.88.14.6063; Courcelle J, 2003, SCIENCE, V299, P1064, DOI 10.1126/science.1081328; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Dickman MJ, 2002, EUR J BIOCHEM, V269, P5492, DOI 10.1046/j.1432-1033.2002.03250.x; DUNDERDALE HJ, 1991, NATURE, V354, P506, DOI 10.1038/354506a0; DUNDERDALE HJ, 1994, J BIOL CHEM, V269, P5187; Eggleston AK, 2000, J BIOL CHEM, V275, P26467, DOI 10.1074/jbc.M001496200; Eggleston AK, 1997, CELL, V89, P607, DOI 10.1016/S0092-8674(00)80242-1; FUJIWARA Y, 1976, MUTAT RES, V37, P91, DOI 10.1016/0027-5107(76)90058-0; Gabbai CB, 2010, DNA REPAIR, V9, P202, DOI 10.1016/j.dnarep.2009.12.009; Gregg AV, 2002, MOL CELL, V9, P241, DOI 10.1016/S1097-2765(02)00455-0; GRIEP MA, 1990, BIOCHEMISTRY-US, V29, P9006, DOI 10.1021/bi00490a018; Gupta S, 2014, J BIOL CHEM, V289, P28388, DOI 10.1074/jbc.M114.587907; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Hanawalt P C, 1966, Photochem Photobiol, V5, P1, DOI 10.1111/j.1751-1097.1966.tb05756.x; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; LANE HED, 1975, J MOL BIOL, V97, P99; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; LLOYD RG, 1984, MOL GEN GENET, V194, P303, DOI 10.1007/BF00383532; Manosas M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3368; MARIANS KJ, 1992, ANNU REV BIOCHEM, V61, P673, DOI 10.1146/annurev.bi.61.070192.003325; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; McGlynn P, 2000, NUCLEIC ACIDS RES, V28, P2324, DOI 10.1093/nar/28.12.2324; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798; McGlynn P, 2001, J BIOL CHEM, V276, P41938, DOI 10.1074/jbc.M107945200; McInerney P, 2007, J BIOL CHEM, V282, P25903, DOI 10.1074/jbc.M703777200; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; MINDEN JS, 1985, J BIOL CHEM, V260, P9316; NURSE P, 1991, J BACTERIOL, V173, P6686, DOI 10.1128/jb.173.21.6686-6693.1991; ODONNELL M, 1990, J BIOL CHEM, V265, P1179; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Robu ME, 2004, J BIOL CHEM, V279, P10973, DOI 10.1074/jbc.M312184200; Robu ME, 2001, P NATL ACAD SCI USA, V98, P8211, DOI 10.1073/pnas.131022698; Seigneur M, 2000, MOL MICROBIOL, V38, P565, DOI 10.1046/j.1365-2958.2000.02152.x; SHAH R, 1994, CELL, V79, P853, DOI 10.1016/0092-8674(94)90074-4; SHARPLES GJ, 1990, MOL GEN GENET, V221, P219, DOI 10.1007/BF00261724; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P5100, DOI 10.1073/pnas.76.10.5100; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Skalka A., 1974, MECH RECOMBINATION, P421, DOI [10.1007/978-1-4684-2133-0_37, DOI 10.1007/978-1-4684-2133-0_37]; Suski C, 2008, MOL CELL, V30, P779, DOI 10.1016/j.molcel.2008.04.020; TSANEVA IR, 1992, CELL, V69, P1171, DOI 10.1016/0092-8674(92)90638-S; van Gool AJ, 1998, EMBO J, V17, P1838, DOI 10.1093/emboj/17.6.1838; Whitby MC, 1998, J BIOL CHEM, V273, P19729, DOI 10.1074/jbc.273.31.19729; WHITBY MC, 1993, CELL, V75, P341, DOI 10.1016/0092-8674(93)80075-P; WHITBY MC, 1994, EMBO J, V13, P5220, DOI 10.1002/j.1460-2075.1994.tb06853.x; Whitby MC, 1996, J MOL BIOL, V264, P878, DOI 10.1006/jmbi.1996.0684; WICKNER W, 1973, P NATL ACAD SCI USA, V70, P1764, DOI 10.1073/pnas.70.6.1764; Yeeles JTP, 2013, MOL CELL, V52, P855, DOI 10.1016/j.molcel.2013.10.020; Yeeles JTP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012815; Yeeles JTP, 2011, SCIENCE, V334, P235, DOI 10.1126/science.1209111; ZAVITZ KH, 1991, MOL MICROBIOL, V5, P2869, DOI 10.1111/j.1365-2958.1991.tb01846.x; Zerbib D, 1998, J MOL BIOL, V281, P621, DOI 10.1006/jmbi.1998.1959; Zhang J, 2010, GENETICS, V185, P23, DOI 10.1534/genetics.110.114413	68	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28376	28387		10.1074/jbc.M114.587881	http://dx.doi.org/10.1074/jbc.M114.587881			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25138216	Green Published, hybrid			2022-12-28	WOS:000343765400031
J	Huang, MX; Parker, MJ; Stubbe, J				Huang, Mingxia; Parker, Mackenzie J.; Stubbe, JoAnne			Choosing the Right Metal: Case Studies of Class I Ribonucleotide Reductases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							IRON CHAPERONES PCBP1; ESCHERICHIA-COLI; STREPTOCOCCUS-SANGUINIS; SACCHAROMYCES-CEREVISIAE; SMALL-SUBUNIT; PROTEIN BIOGENESIS; RADICAL FORMATION; MANGANESE; ENZYME; VIVO	Over one-third of all proteins require metallation for function (Waldron, K. J., Rutherford, J. C., Ford, D., and Robinson, N.J. (2009) Nature 460, 823-830). As biochemical studies of most proteins depend on their isolation subsequent to recombinant expression (i.e. they are seldom purified from their host organism), there is no gold standard to assess faithful metallocofactor assembly and associated function. The biosynthetic machinery for metallocofactor formation in the recombinant expression system may be absent, inadequately expressed, or incompatible with a heterologously expressed protein. A combination of biochemical and genetic studies has led to the identification of key proteins involved in biosynthesis and likely repair of the metallocofactor of ribonucleotide reductases in both bacteria and the budding yeast. In this minireview, we will discuss the recent progress in understanding controlled delivery of metal, oxidants, and reducing equivalents for cofactor assembly in ribonucleotide reductases and highlight issues associated with controlling Fe/Mn metallation and avoidance of mismetallation.	[Huang, Mingxia] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Parker, Mackenzie J.; Stubbe, JoAnne] MIT, Dept Chem, Cambridge, MA 02139 USA; [Stubbe, JoAnne] MIT, Dept Biol, Cambridge, MA 02139 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Stubbe, J (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	stubbe@mit.edu		/0000-0001-7174-0485	National Institutes of Health [GM81393, CA125574]; NATIONAL CANCER INSTITUTE [R01CA125574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM81393 (to J. S.) and CA125574 (to M. H.). This is the second article in the Thematic Minireview series "Metals in Biology 2014."	Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; ATKIN CL, 1973, J BIOL CHEM, V248, P7464; ATTA M, 1992, J BIOL CHEM, V267, P20682; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Chabes A, 2000, P NATL ACAD SCI USA, V97, P2474, DOI 10.1073/pnas.97.6.2474; Cotruvo JA, 2008, P NATL ACAD SCI USA, V105, P14383, DOI 10.1073/pnas.0807348105; Cotruvo JA, 2012, METALLOMICS, V4, P1020, DOI 10.1039/c2mt20142a; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Cotruvo JA, 2011, BIOCHEMISTRY-US, V50, P1672, DOI 10.1021/bi101881d; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; Crack JC, 2007, P NATL ACAD SCI USA, V104, P2092, DOI 10.1073/pnas.0609514104; Crona M, 2011, J BIOL CHEM, V286, P33053, DOI 10.1074/jbc.M111.278119; Crump KE, 2014, MOL MICROBIOL, V92, P1243, DOI 10.1111/mmi.12625; Das S, 2009, J BACTERIOL, V191, P4166, DOI 10.1128/JB.01739-08; Frey AG, 2014, P NATL ACAD SCI USA, V111, P8031, DOI 10.1073/pnas.1402732111; Fugate CJ, 2012, J AM CHEM SOC, V134, P9042, DOI 10.1021/ja3012963; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P735, DOI 10.1089/ars.2006.8.735; Hammerstad M, 2014, ACS CHEM BIOL, V9, P526, DOI 10.1021/cb400757h; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hristova D, 2008, BIOCHEMISTRY-US, V47, P3989, DOI 10.1021/bi702408k; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Jiang W, 2008, BIOCHEMISTRY-US, V47, P13736, DOI 10.1021/bi8017625; Jordan A, 1996, J BIOL CHEM, V271, P8779, DOI 10.1074/jbc.271.15.8779; Lanz ND, 2014, BIOCHEMISTRY-US, V53, P4557, DOI 10.1021/bi500432r; Li HR, 2012, BIOCHEMISTRY-US, V51, P1687, DOI 10.1021/bi2019089; Lisher JP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00091; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; Makhlynets O, 2014, J BIOL CHEM, V289, P6259, DOI 10.1074/jbc.M113.533554; Martin JE, 2011, MOL MICROBIOL, V80, P319, DOI 10.1111/j.1365-2958.2011.07593.x; McNaughton RL, 2010, P NATL ACAD SCI USA, V107, P15335, DOI 10.1073/pnas.1009648107; Minnihan EC, 2013, ACCOUNTS CHEM RES, V46, P2524, DOI 10.1021/ar4000407; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Naranuntarat A, 2009, J BIOL CHEM, V284, P22633, DOI 10.1074/jbc.M109.026773; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; OCHIAI EI, 1990, J BIOL CHEM, V265, P15758; Ortigosa AD, 2006, BIOCHEMISTRY-US, V45, P12282, DOI 10.1021/bi0610404; Perlstein DL, 2005, BIOCHEMISTRY-US, V44, P15366, DOI 10.1021/bi051616+; Rhodes DV, 2014, J BIOL CHEM, V289, P6273, DOI 10.1074/jbc.M113.533620; Roca I, 2008, J BACTERIOL, V190, P4849, DOI 10.1128/JB.00185-08; ROVA U, 1995, BIOCHEMISTRY-US, V34, P4267, DOI 10.1021/bi00013a016; Saito Y, 2011, BIOCHEM BIOPH RES CO, V408, P329, DOI 10.1016/j.bbrc.2011.04.033; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; SJOBERG BM, 1977, J BIOL CHEM, V252, P536; Sommerhalter M, 2004, BIOCHEMISTRY-US, V43, P7736, DOI 10.1021/bi049510m; Stubbe JA, 1998, CHEM REV, V98, P2661, DOI 10.1021/cr980059c; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Voegtli WC, 2001, P NATL ACAD SCI USA, V98, P10073, DOI 10.1073/pnas.181336398; Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114; White MF, 2012, CURR OPIN STRUC BIOL, V22, P94, DOI 10.1016/j.sbi.2011.11.004; WILLING A, 1988, EUR J BIOCHEM, V170, P603, DOI 10.1111/j.1432-1033.1988.tb13740.x; Wu C. H, 2007, THESIS MIT; Wu CH, 2007, BIOCHEMISTRY-US, V46, P11577, DOI 10.1021/bi7012454; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Xu P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00125; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08; Zhang Y, 2014, P NATL ACAD SCI USA, V111, pE1695, DOI 10.1073/pnas.1405204111; Zhang Y, 2011, J BIOL CHEM, V286, P41499, DOI 10.1074/jbc.M111.294074; Zhang Y, 2011, BIOCHEMISTRY-US, V50, P5615, DOI 10.1021/bi200348q	61	29	29	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28104	28111		10.1074/jbc.R114.596684	http://dx.doi.org/10.1074/jbc.R114.596684			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25160629	hybrid, Green Published			2022-12-28	WOS:000343765400006
J	Panagos, CG; Thomson, DS; Moss, C; Hughes, AD; Kelly, MS; Liu, Y; Chai, WG; Venkatasamy, R; Spina, D; Page, CP; Hogwood, J; Woods, RJ; Mulloy, B; Bavington, CD; Uhrin, D				Panagos, Charalampos G.; Thomson, Derek S.; Moss, Claire; Hughes, Adam D.; Kelly, Maeve S.; Liu, Yan; Chai, Wengang; Venkatasamy, Radhakrishnan; Spina, Domenico; Page, Clive P.; Hogwood, John; Woods, Robert J.; Mulloy, Barbara; Bavington, Charlie D.; Uhrin, Dusan			Fucosylated Chondroitin Sulfates from the Body Wall of the Sea Cucumber Holothuria forskali CONFORMATION, SELECTIN BINDING, AND BIOLOGICAL ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; FREE-RADICAL DEPOLYMERIZATION; RESIDUAL DIPOLAR COUPLINGS; HUMAN-LEUKOCYTE ELASTASE; STICHOPUS-JAPONICUS; P-SELECTIN; LEWIS-X; ANTICOAGULANT ACTIVITIES; NMR-SPECTROSCOPY; HEPARAN-SULFATE	Fucosylated chondroitin sulfate (fCS) extracted from the sea cucumber Holothuria forskali is composed of the following repeating trisaccharide unit: -> 3)GalNAc beta 4,6S(1 -> 4) [Fuc alpha X(1 -> 3)]GlcA beta(1 ->, where X stands for different sulfation patterns of fucose (X = 3,4S (46%), 2,4S (39%), and 4S (15%)). As revealed by NMR and molecular dynamics simulations, the fCS repeating unit adopts a conformation similar to that of the Le(x) blood group determinant, bringing several sulfate groups into close proximity and creating large negative patches distributed along the helical skeleton of the CS backbone. This may explain the high affinity of fCS oligosaccharides for L-and P-selectins as determined by microarray binding of fCS oligosaccharides prepared by Cu2+-catalyzed Fenton-type and photochemical depolymerization. No binding to E-selectin was observed. fCS poly- and oligosaccharides display low cytotoxicity in vitro, inhibit human neutrophil elastase activity, and inhibit the migration of neutrophils through an endothelial cell layer in vitro. Although the polysaccharide showed some anti-coagulant activity, small oligosaccharide fCS fragments had much reduced anticoagulant properties, with activity mainly via heparin cofactor II. The fCS polysaccharides showed prekallikrein activation comparable with dextran sulfate, whereas the fCS oligosaccharides caused almost no effect. The H. forskali fCS oligosaccharides were also tested in a mouse peritoneal inflammation model, where they caused a reduction in neutrophil infiltration. Overall, the data presented support the action of fCS as an inhibitor of selectin interactions, which play vital roles in inflammation and metastasis progression. Future studies of fCS-selectin interaction using fCS fragments or their mimetics may open new avenues for therapeutic intervention.	[Uhrin, Dusan] Univ Edinburgh, EaStCHEM Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland; [Thomson, Derek S.; Moss, Claire; Bavington, Charlie D.; Uhrin, Dusan] GlycoMar Ltd, European Ctr Marine Biotechnol, Dunstaffnage Marine Lab, Oban PA37 1QA, Argyll, Scotland; [Hughes, Adam D.; Kelly, Maeve S.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban PA37, Argyll, Scotland; [Liu, Yan; Chai, Wengang; Mulloy, Barbara] Univ London Imperial Coll Sci Technol & Med, Glycosci Lab, London W12 0NN, England; [Venkatasamy, Radhakrishnan; Spina, Domenico; Page, Clive P.; Mulloy, Barbara] Kings Coll London, Inst Pharmaceut Sci, Sackler Inst Pulm Pharmacol, London SE1 9NH, England; [Hogwood, John] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England; [Woods, Robert J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Woods, Robert J.] Natl Univ Ireland Galway, Sch Chem, Galway, Ireland	University of Edinburgh; Imperial College London; University of London; King's College London; National Institute for Biological Standards & Control; University System of Georgia; University of Georgia; Ollscoil na Gaillimhe-University of Galway	Uhrin, D (corresponding author), Univ Edinburgh, EaStCHEM Sch Chem, Joseph Black Bldg,Kings Bldg, Edinburgh EH9 3JJ, Midlothian, Scotland.	dusan.uhrin@ed.ac.uk	Liu, Yan/D-9117-2013; Woods, Robert/F-4962-2015	Woods, Robert/0000-0002-2400-6293; Spina, Domenico/0000-0002-6815-1564; Liu, Yan/0000-0002-2566-6867; Page, Clive Peter/0000-0002-9358-3799	Wellcome Trust [093378/Z/10/Z, 099197/Z/Z]; National Institutes of Health from NIGMS [P41-GM103311]; EPSRC [EP/K039717/1, EP/G037604/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G037604/1, EP/K039717/1, GR/S79268/02] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094919, P41GM103311, P41GM103390] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to members of the Glycosciences Laboratory, especially Robert Childs and Angelina Palma, who contributed to the microarray experiment and data analyses for this study. The microarray facility at the Glycosciences Laboratory is supported by Wellcome Trust Grants 093378/Z/10/Z and 099197/Z/Z. The UCSF Chimera package was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41-GM103311 from NIGMS). We thank Prof. Ten Feizi for critical reading of the manuscript.	Azurmendi HF, 2002, BIOPOLYMERS, V63, P89, DOI 10.1002/bip.10015; BARTOLUCCI C, 1995, CARBOHYD RES, V276, P401, DOI 10.1016/0008-6215(95)00179-W; Beccati D, 2010, CARBOHYD POLYM, V82, P699, DOI 10.1016/j.carbpol.2010.05.038; BECHTEL B, 1990, J BIOL CHEM, V265, P2028; BEUTLER JA, 1993, ANTIVIR CHEM CHEMOTH, V4, P167, DOI 10.1177/095632029300400306; Blossom DB, 2008, NEW ENGL J MED, V359, P2674, DOI 10.1056/NEJMoa0806450; Borsig L, 2007, J BIOL CHEM, V282, P14984, DOI 10.1074/jbc.M610560200; Brown RA, 2003, BRIT J PHARMACOL, V139, P845, DOI 10.1038/sj.bjp.0705291; CAEL JJ, 1978, J MOL BIOL, V125, P21, DOI 10.1016/0022-2836(78)90252-8; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Case DA, 2014, AMBER 14; Cesaretti M, 2003, CARBOHYD POLYM, V54, P59, DOI 10.1016/S0144-8617(03)00144-9; Chai WG, 1996, ANAL BIOCHEM, V237, P88, DOI 10.1006/abio.1996.0205; Chai WG, 2003, METHOD ENZYMOL, V362, P160; Chen SG, 2013, BBA-GEN SUBJECTS, V1830, P3054, DOI 10.1016/j.bbagen.2013.01.001; Chen SG, 2011, CARBOHYD POLYM, V83, P688, DOI 10.1016/j.carbpol.2010.08.040; Feizi T, 2013, ANN NY ACAD SCI, V1292, P33, DOI 10.1111/nyas.12210; Fonseca RJC, 2006, THROMB HAEMOSTASIS, V96, P822, DOI 10.1160/TH06-06-0304; Fonseca RJC, 2010, THROMB HAEMOSTASIS, V103, P994, DOI 10.1160/TH09-10-0734; Fonseca RJC, 2009, THROMB HAEMOSTASIS, V102, P829, DOI 10.1160/TH08-11-0773; Galustian C, 2002, IMMUNOLOGY, V105, P350, DOI 10.1046/j.1365-2567.2002.01369.x; Glauser BF, 2008, THROMB HAEMOSTASIS, V100, P420, DOI 10.1160/TH08-04-0210; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Gray E, 2008, THROMB HAEMOSTASIS, V99, P807, DOI 10.1160/TH08-01-0032; Herencia F, 1998, LIFE SCI, V62, pPL115, DOI 10.1016/S0024-3205(97)01188-0; Higashi K, 2012, CARBOHYD POLYM, V87, P1737, DOI 10.1016/j.carbpol.2011.09.087; Huang N, 2013, CARBOHYD RES, V380, P64, DOI 10.1016/j.carres.2013.07.010; Jin L, 2009, GLYCOBIOLOGY, V19, P1185, DOI 10.1093/glycob/cwp105; Kaplan AP, 2002, J ALLERGY CLIN IMMUN, V109, P195, DOI 10.1067/mai.2002.121316; Kariya Y, 2004, CARBOHYD RES, V339, P1339, DOI 10.1016/j.carres.2004.02.025; Kariya Y, 2002, J BIOCHEM, V132, P335; KARIYA Y, 1990, J BIOL CHEM, V265, P5081; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Koenig A, 1998, J CLIN INVEST, V101, P877, DOI 10.1172/JCI1509; Kogelberg H, 1996, BIOCHEMISTRY-US, V35, P1954, DOI 10.1021/bi9521598; LEMIEUX RU, 1980, CAN J CHEM, V58, P631, DOI 10.1139/v80-098; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Lever R, 2000, BRIT J PHARMACOL, V129, P533, DOI 10.1038/sj.bjp.0703099; Li BZ, 2009, BIOCHEM PHARMACOL, V78, P292, DOI 10.1016/j.bcp.2009.04.012; LI JZ, 1988, THROMB HAEMOSTASIS, V59, P435; Lian W, 2013, BBA-GEN SUBJECTS, V1830, P4681, DOI 10.1016/j.bbagen.2013.06.003; Liu Y, 2007, CHEM BIOL, V14, P847, DOI 10.1016/j.chembiol.2007.06.009; Liu Y, 2012, METHODS MOL BIOL, V808, P117, DOI 10.1007/978-1-61779-373-8_8; Luo L, 2013, MAR DRUGS, V11, P399, DOI 10.3390/md11020399; Manzi A., 1995, CURR PROTOC MOL S32, V32; MCCLURE MO, 1992, AIDS RES HUM RETROV, V8, P19, DOI 10.1089/aid.1992.8.19; Melo NM, 2010, AM J PHYSIOL-RENAL, V299, pF1299, DOI 10.1152/ajprenal.00217.2010; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; MILLER KE, 1992, BIOCHEMISTRY-US, V31, P6703, DOI 10.1021/bi00144a009; Moffatt JD, 2004, BRIT J PHARMACOL, V143, P269, DOI 10.1038/sj.bjp.0705926; Mourao PAS, 1996, J BIOL CHEM, V271, P23973, DOI 10.1074/jbc.271.39.23973; Mourao PAS, 2001, THROMB RES, V102, P167, DOI 10.1016/S0049-3848(01)00230-4; Mourao PAS, 1998, BRIT J HAEMATOL, V101, P647, DOI 10.1046/j.1365-2141.1998.00769.x; Mulloy B, 2000, J BIOTECHNOL, V77, P123, DOI 10.1016/S0168-1656(99)00211-4; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; NAGASE H, 1995, BLOOD, V85, P1527, DOI 10.1182/blood.V85.6.1527.bloodjournal8561527; Pacheco RG, 2000, BLOOD COAGUL FIBRIN, V11, P563, DOI 10.1097/00001721-200009000-00009; Panagos C, 2012, CARBOHYD POLYM, V87, P2086, DOI 10.1016/j.carbpol.2011.10.031; Perez S, 1996, GLYCOBIOLOGY, V6, P537, DOI 10.1093/glycob/6.5.537; Petit AC, 2006, CARBOHYD POLYM, V64, P597, DOI 10.1016/j.carbpol.2005.11.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poppe L, 1997, J AM CHEM SOC, V119, P1727, DOI 10.1021/ja9610702; POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4; RIBEIRO AC, 1994, CARBOHYD RES, V255, P225, DOI 10.1016/S0008-6215(00)90981-9; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Sattelle BM, 2010, CARBOHYD RES, V345, P291, DOI 10.1016/j.carres.2009.11.013; Silipo A, 2008, CHEMBIOCHEM, V9, P240, DOI 10.1002/cbic.200700400; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; TERHO TT, 1971, ANAL BIOCHEM, V41, P471, DOI 10.1016/0003-2697(71)90167-9; Turnbull J E, 2001, Methods Mol Biol, V171, P141; van Die I, 2003, GLYCOBIOLOGY, V13, P471, DOI 10.1093/glycob/cwg052; VANDERGRAAF F, 1982, BLOOD, V59, P1225; VIEIRA RP, 1988, J BIOL CHEM, V263, P18176; VIEIRA RP, 1991, J BIOL CHEM, V266, P13530; Volpi N, 1997, CHEM-BIOL INTERACT, V105, P157, DOI 10.1016/S0009-2797(97)00045-8; Wu MY, 2012, CARBOHYD POLYM, V87, P862, DOI 10.1016/j.carbpol.2011.08.082; Wu MY, 2010, FOOD CHEM, V122, P716, DOI 10.1016/j.foodchem.2010.03.042; Wu MY, 2010, CARBOHYD POLYM, V80, P1116, DOI 10.1016/j.carbpol.2010.01.032; Wu N, 2013, CARBOHYD POLYM, V93, P604, DOI 10.1016/j.carbpol.2012.12.044; YOSHIDA K, 1992, TETRAHEDRON LETT, V33, P4959, DOI 10.1016/S0040-4039(00)61245-5; Yu F, 2007, J AM CHEM SOC, V129, P13288, DOI 10.1021/ja075272h; Zierke M, 2013, J AM CHEM SOC, V135, P13464, DOI 10.1021/ja4054702	84	80	84	1	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28284	28298		10.1074/jbc.M114.572297	http://dx.doi.org/10.1074/jbc.M114.572297			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25147180	Green Published, hybrid			2022-12-28	WOS:000343765400024
J	Ting, SY; Schilke, BA; Hayashi, M; Craig, EA				Ting, See-Yeun; Schilke, Brenda A.; Hayashi, Masaya; Craig, Elizabeth A.			Architecture of the TIM23 Inner Mitochondrial Translocon and Interactions with the Matrix Import Motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; PRESEQUENCE TRANSLOCASE; IN-VIVO; SACCHAROMYCES-CEREVISIAE; PREPROTEIN TRANSLOCASE; CROSS-LINKING; J-DOMAIN; COMPLEX; MEMBRANE; HSP70	Translocation of proteins from the cytosol across the mitochondrial inner membrane is driven by action of the matrix-localized multi-subunit import motor, which is associated with the TIM23 translocon. The architecture of the import apparatus is not well understood. Here, we report results of site-specific in vivo photocross-linking along with genetic and coimmunoprecipitation analyses dissecting interactions between import motor subunits and the translocon. The translocon is composed of the two integral membrane proteins Tim23 and Tim17, each containing four membrane-spanning segments. We found that Tim23 having a photoactivatable cross-linker in the matrix exposed loop between transmembrane domains 1 and 2 (loop 1) cross-linked to Tim44. Alterations in this loop destabilized interaction of Tim44 with the translocon. Analogously, Tim17 having a photoactivatable cross-linker in the matrix exposed loop between transmembrane segments 1 and 2 (loop 1) cross-linked to Pam17. Alterations in this loop caused destabilization of the interaction of Pam17 with the translocon. Substitution of individual photoactivatable residues in Tim44 and Pam17 in regions we previously identified as important for translocon association resulted in cross-linking to Tim23 and Tim17, respectively. Our results are consistent with a model in which motor association is achieved via interaction of Tim23 with Tim44, which serves as a scaffold for association of other motor components, and of Tim17 with Pam17. As both Tim44 and Pam17 have been implicated as regulatory subunits of the motor, this positioning is conducive for responding to conformational changes in the translocon upon a translocating polypeptide entering the channel.	[Ting, See-Yeun; Schilke, Brenda A.; Hayashi, Masaya; Craig, Elizabeth A.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Craig, EA (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	ecraig@wisc.edu	Ting, See-Yeun/AAY-6883-2021; Ting, See-Yeun/Y-9684-2019	Ting, See-Yeun/0000-0001-8472-7204; 	National Institutes of Health [GM27870]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM27870 (to E. A. C).	Alder NN, 2008, MOL BIOL CELL, V19, P159, DOI 10.1091/mbc.E07-07-0669; Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Chacinska A, 2010, MOL CELL BIOL, V30, P307, DOI 10.1128/MCB.00749-09; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Chin JW, 2002, CHEMBIOCHEM, V3, P1135, DOI 10.1002/1439-7633(20021104)3:11<1135::AID-CBIC1135>3.0.CO;2-M; D'Silva PR, 2008, MOL BIOL CELL, V19, P424, DOI 10.1091/mbc.E07-08-0748; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; D'Silva PR, 2005, P NATL ACAD SCI USA, V102, P12419, DOI 10.1073/pnas.0505969102; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hutu DP, 2008, MOL BIOL CELL, V19, P2642, DOI 10.1091/mbc.E07-12-1226; James P, 1997, SCIENCE, V275, P387, DOI 10.1126/science.275.5298.387; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; Krimmer T, 2000, MOL CELL BIOL, V20, P5879, DOI 10.1128/MCB.20.16.5879-5887.2000; Krishnamurthy M, 2011, ACS CHEM BIOL, V6, P1321, DOI 10.1021/cb200308e; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Liu QL, 2001, J BIOL CHEM, V276, P6112, DOI 10.1074/jbc.M009519200; Majmudar CY, 2009, J AM CHEM SOC, V131, P14240, DOI 10.1021/ja904378z; Marom M, 2011, BBA-BIOMEMBRANES, V1808, P990, DOI 10.1016/j.bbamem.2010.07.011; Martinez-Caballero S, 2007, J BIOL CHEM, V282, P3584, DOI 10.1074/jbc.M607551200; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meier S, 2005, J BIOL CHEM, V280, P7777, DOI 10.1074/jbc.M412158200; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mokranjac D, 2007, J BIOL CHEM, V282, P18037, DOI 10.1074/jbc.M701895200; Moro F, 2002, J BIOL CHEM, V277, P6874, DOI 10.1074/jbc.M107935200; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Pareek G, 2013, MOL CELL BIOL, V33, P4641, DOI 10.1128/MCB.00876-13; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Popov-Celeketic D, 2008, EMBO J, V27, P1469, DOI 10.1038/emboj.2008.79; Popov-Celeketic D, 2011, EMBO REP, V12, P542, DOI 10.1038/embor.2011.72; Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2001.4336; Ryan KR, 1998, MOL CELL BIOL, V18, P178, DOI 10.1128/MCB.18.1.178; Schilke BA, 2012, GENETICS, V190, P1341, DOI 10.1534/genetics.112.138743; Schiller D, 2008, MOL CELL BIOL, V28, P4424, DOI 10.1128/MCB.00007-08; Schiller D, 2009, INT J BIOCHEM CELL B, V41, P2343, DOI 10.1016/j.biocel.2009.06.011; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; van der Laan M, 2005, MOL CELL BIOL, V25, P7449, DOI 10.1128/MCB.25.17.7449-7458.2005; van der Laan M, 2006, CURR BIOL, V16, P2271, DOI 10.1016/j.cub.2006.10.025; van der Laan M, 2010, BBA-MOL CELL RES, V1803, P732, DOI 10.1016/j.bbamcr.2010.01.013; Wang Q, 2008, J AM CHEM SOC, V130, P6066, DOI 10.1021/ja800894n; Wiedemann N, 2007, J CELL BIOL, V179, P1115, DOI 10.1083/jcb.200709087	46	25	26	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28689	28696		10.1074/jbc.M114.588152	http://dx.doi.org/10.1074/jbc.M114.588152			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25157107	Green Published, hybrid			2022-12-28	WOS:000343765400056
J	Albracht, CD; Rank, KC; Obrzut, S; Rayment, I; Gilbert, SP				Albracht, Clayton D.; Rank, Katherine C.; Obrzut, Steven; Rayment, Ivan; Gilbert, Susan P.			Kinesin-2 KIF3AB Exhibits Novel ATPase Characteristics*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; Intracellular Trafficking; Kinesin; Microtubule; Presteady-state Kinetics; Intraflagellar Transport; Processivity	LEFT-RIGHT ASYMMETRY; SUPERFAMILY PROTEIN; STRUCTURAL MODEL; DIMERIC KINESIN; IFT PARTICLES; MOTOR PROTEIN; NECK LINKER; PATHWAY; TRANSPORT; HYDROLYSIS	Background: KIF3AB is a heterotrimeric plus-end-directed kinesin-2 motor, implicated in intraflagellar transport. Results: KIF3AB shows rate-limiting ADP release upon microtubule collision and an unusual apparent weak ATP affinity observed at microtubuleKIF3AB dissociation. Conclusion: The presteady-state kinetics suggest a novel ATPase mechanism for KIF3AB stepping. Significance: The KIF3AB kinetics reveal the mechanistic diversity that kinesin motors exhibit for cargo transport. KIF3AB is an N-terminal processive kinesin-2 family member best known for its role in intraflagellar transport. There has been significant interest in KIF3AB in defining the key principles that underlie the processivity of KIF3AB in comparison with homodimeric processive kinesins. To define the ATPase mechanism and coordination of KIF3A and KIF3B stepping, a presteady-state kinetic analysis was pursued. For these studies, a truncated murine KIF3AB was generated. The results presented show that microtubule association was fast at 5.7 m(-1) s(-1), followed by rate-limiting ADP release at 12.8 s(-1). ATP binding at 7.5 m(-1) s(-1) was followed by an ATP-promoted isomerization at 84 s(-1) to form the intermediate poised for ATP hydrolysis, which then occurred at 33 s(-1). ATP hydrolysis was required for dissociation of the microtubuleKIF3AB complex, which was observed at 22 s(-1). The dissociation step showed an apparent affinity for ATP that was very weak (K-1/2,K-ATP at 133 m). Moreover, the linear fit of the initial ATP concentration dependence of the dissociation kinetics revealed an apparent second-order rate constant at 0.09 m(-1) s(-1), which is inconsistent with fast ATP binding at 7.5 m(-1) s(-1) and a K-d,K-ATP at 6.1 m. These results suggest that ATP binding per se cannot account for the apparent weak K-1/2,K-ATP at 133 m. The steady-state ATPase K-m,K-ATP, as well as the dissociation kinetics, reveal an unusual property of KIF3AB that is not yet well understood and also suggests that the mechanochemistry of KIF3AB is tuned somewhat differently from homodimeric processive kinesins.	[Gilbert, Susan P.] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA; Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Rank, Katherine C.; Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of Wisconsin System; University of Wisconsin Madison	Rayment, I (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	ivan_rayment@biochem.wisc.edu; sgilbert@rpi.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835	National Institutes of Health [R37-GM54141, R01-GM086351]; National Institutes of Health Training Grant [T32-GM07215]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, R01GM086351, R37GM054141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-GM54141 (to S. P. G) and R01-GM086351 (to I. R.).; Supported by National Institutes of Health Training Grant T32-GM07215.	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Auerbach SD, 2005, J BIOL CHEM, V280, P37048, DOI 10.1074/jbc.M502984200; Behnke-Parks WM, 2011, J BIOL CHEM, V286, P5242, DOI 10.1074/jbc.M110.192930; Brunnbauer M, 2012, MOL CELL, V46, P147, DOI 10.1016/j.molcel.2012.04.005; Brunnbauer M, 2010, P NATL ACAD SCI USA, V107, P10460, DOI 10.1073/pnas.1005177107; Chen CJ, 2012, J BIOL CHEM, V287, P36673, DOI 10.1074/jbc.M112.395590; Chen CJ, 2011, J BIOL CHEM, V286, P29261, DOI 10.1074/jbc.M111.255554; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; Cochran JC, 2006, BIOCHEMISTRY-US, V45, P12334, DOI 10.1021/bi0608562; COLE DG, 1992, J CELL SCI, V101, P291; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; Foster KA, 2001, J BIOL CHEM, V276, P19259, DOI 10.1074/jbc.M008347200; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; GILBERT SP, 1994, BIOCHEMISTRY-US, V33, P1951, DOI 10.1021/bi00173a044; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Goulet A, 2014, P NATL ACAD SCI USA, V111, P1837, DOI 10.1073/pnas.1319848111; Gumy LF, 2013, J NEUROSCI, V33, P11329, DOI 10.1523/JNEUROSCI.5221-12.2013; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; HENSON JH, 1995, DEV BIOL, V171, P182, DOI 10.1006/dbio.1995.1270; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Klenchin VA, 2011, J BIOL CHEM, V286, P18240, DOI 10.1074/jbc.M111.227371; Klumpp LM, 2004, BIOCHEMISTRY-US, V43, P2792, DOI 10.1021/bi035830e; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Krzysiak TC, 2008, J BIOL CHEM, V283, P2078, DOI 10.1074/jbc.M708354200; Krzysiak TC, 2006, EMBO J, V25, P2263, DOI 10.1038/sj.emboj.7601108; Krzysiak TC, 2006, J BIOL CHEM, V281, P39444, DOI 10.1074/jbc.M608056200; Lindhout DA, 2004, BIOPOLYMERS, V75, P367, DOI 10.1002/bip.20150; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; MA YZ, 1995, BIOCHEMISTRY-US, V34, P13242, DOI 10.1021/bi00040a040; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Moyer ML, 1998, BIOCHEMISTRY-US, V37, P800, DOI 10.1021/bi9711184; Muthukrishnan G, 2009, CURR BIOL, V19, P442, DOI 10.1016/j.cub.2009.01.058; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Pan XY, 2006, J CELL BIOL, V174, P1035, DOI 10.1083/jcb.200606003; PATEL SS, 1993, J BIOL CHEM, V268, P10668; PESAVENTO PA, 1994, J CELL BIOL, V127, P1041, DOI 10.1083/jcb.127.4.1041; Rank KC, 2012, J CELL BIOL, V197, P957, DOI 10.1083/jcb.201201132; Rogers SL, 1997, P NATL ACAD SCI USA, V94, P3720, DOI 10.1073/pnas.94.8.3720; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Rosenfeld SS, 2002, J BIOL CHEM, V277, P36731, DOI 10.1074/jbc.M205261200; Rosenfeld SS, 2001, J BIOL CHEM, V276, P40167, DOI 10.1074/jbc.M103899200; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; Rosenfeld SS, 2009, J BIOL CHEM, V284, P32858, DOI 10.1074/jbc.M109.041210; Sardar HS, 2012, J BIOL CHEM, V287, P24894, DOI 10.1074/jbc.M112.376830; Sardar HS, 2010, CURR BIOL, V20, P1648, DOI 10.1016/j.cub.2010.08.001; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Schroeder HW, 2012, BIOPHYS J, V103, P48, DOI 10.1016/j.bpj.2012.05.037; SHAKIR MA, 1993, NEUROREPORT, V4, P891, DOI 10.1097/00001756-199307000-00013; Shastry S, 2010, CURR BIOL, V20, P939, DOI 10.1016/j.cub.2010.03.065; Skiniotis G, 2004, EMBO J, V23, P989, DOI 10.1038/sj.emboj.7600118; STEWART RJ, 1991, P NATL ACAD SCI USA, V88, P8470, DOI 10.1073/pnas.88.19.8470; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; VERNOS I, 1993, DEV BIOL, V157, P232, DOI 10.1006/dbio.1993.1127; Wedaman KP, 1996, J CELL BIOL, V132, P371, DOI 10.1083/jcb.132.3.371; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yang ZH, 1998, MOL BIOL CELL, V9, P249, DOI 10.1091/mbc.9.2.249; Zhang YR, 2004, BIOPHYS J, V87, P1795, DOI 10.1529/biophysj.104.039842	64	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27836	27848		10.1074/jbc.M114.583914	http://dx.doi.org/10.1074/jbc.M114.583914			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25122755	Green Published, hybrid			2022-12-28	WOS:000342852800040
J	Blom, AM; Bergmann, S; Fulde, M; Riesbeck, K; Agarwal, V				Blom, Anna M.; Bergmann, Simone; Fulde, Marcus; Riesbeck, Kristian; Agarwal, Vaibhav			Streptococcus pneumoniae Phosphoglycerate Kinase Is a Novel Complement Inhibitor Affecting the Membrane Attack Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPEPTIDASE O PEPO; BACTERIAL-RESISTANCE; C4B-BINDING PROTEIN; BINDING PROTEIN; EVASION; PLASMINOGEN; MECHANISM; ANTIBODY; SITES	The Gram-positive bacterium Streptococcus pneumoniae is a major human pathogen that causes infections ranging from acute otitis media to life-threatening invasive disease. Pneumococci have evolved several strategies to circumvent the host immune response, in particular the complement attack. The pneumococcal glycolytic enzyme phosphoglycerate kinase (PGK) is both secreted and bound to the bacterial surface and simultaneously binds plasminogen and its tissue plasminogen activator tPA. In the present study we demonstrate that PGK has an additional role in modulating the complement attack. PGK interacted with the membrane attack complex (MAC) components C5, C7, and C9, thereby blocking the assembly and membrane insertion of MAC resulting in significant inhibition of the hemolytic activity of human serum. Recombinant PGK interacted in a dose-dependent manner with these terminal pathway proteins, and the interactions were ionic in nature. In addition, PGK inhibited C9 polymerization both in the fluid phase and on the surface of sheep erythrocytes. Interestingly, PGK bound several MAC proteins simultaneously. Although C5 and C7 had partially overlapping binding sites on PGK, C9 did not compete with either one for PGK binding. Moreover, PGK significantly inhibited MAC deposition via both the classical and alternative pathway at the pneumococcal surface. Additionally, upon activation plasmin(ogen) bound to PGK cleaved the central complement protein C3b thereby further modifying the complement attack. In conclusion, our data demonstrate for the first time to our knowledge a novel pneumococcal inhibitor of the terminal complement cascade aiding complement evasion by this important pathogen.	[Blom, Anna M.; Agarwal, Vaibhav] Lund Univ, Dept Lab Med Malmo, Sect Med Prot Chem, S-20502 Malmo, Sweden; [Bergmann, Simone] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Fulde, Marcus] Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, D-30625 Hannover, Germany; [Riesbeck, Kristian] Lund Univ, Dept Lab Med Malmo, Sect Med Microbiol, S-20502 Malmo, Sweden	Lund University; Braunschweig University of Technology; Hannover Medical School; Lund University	Blom, AM (corresponding author), Lund Univ, Dept Lab Med Malmo, Wallenberg Lab, Floor 4,Inga Marie Nilssons St 53, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/B-9607-2009; Blom, Anna/AFS-7369-2022	Blom, Anna/0000-0002-1348-1734; Riesbeck, Kristian/0000-0001-6274-6965	Swedish Research Council [K2012-66X-14928-09-5]; Foundation of Torsten Soderberg; Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of King Gustav V's 80th Anniversary; Foundation of Knut and Alice Wallenberg; Foundation of Inga-Britt and Arne Lundberg; Foundation of Ake Wiberg; Royal Physiographic Society in Lund; Skane University Hospital; Swedish Society for Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation of Torsten Soderberg; Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of King Gustav V's 80th Anniversary; Foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Foundation of Inga-Britt and Arne Lundberg; Foundation of Ake Wiberg; Royal Physiographic Society in Lund; Skane University Hospital; Swedish Society for Medical Research	This work was supported by grants from the Swedish Research Council (K2012-66X-14928-09-5), Foundations of Torsten Soderberg, Osterlund, Greta and Johan Kock, King Gustav V's 80th Anniversary, Knut and Alice Wallenberg, Inga-Britt and Arne Lundberg, Ake Wiberg, Royal Physiographic Society in Lund, and a grant from the Skane University Hospital.; Recipient of a postdoctoral stipend from the Swedish Society for Medical Research.	Agarwal V, 2014, J BIOL CHEM, V289, P15833, DOI 10.1074/jbc.M113.530212; Agarwal V, 2013, J BIOL CHEM, V288, P6849, DOI 10.1074/jbc.M112.405530; Agarwal V, 2012, J IMMUNOL, V189, P3575, DOI 10.4049/jimmunol.1102934; Agarwal V, 2010, J BIOL CHEM, V285, P23484, DOI 10.1074/jbc.M110.142703; Akesson P, 1996, J BIOL CHEM, V271, P1081, DOI 10.1074/jbc.271.2.1081; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; Berends ETM, 2013, CELL MICROBIOL, V15, P1955, DOI 10.1111/cmi.12170; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Bernardo-Garcia N, 2011, ACTA CRYSTALLOGR F, V67, P1285, DOI 10.1107/S1744309111030922; Blom AM, 2014, CLIN EXP IMMUNOL, V178, P142, DOI 10.1111/cei.12388; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; BRAGA LL, 1992, J CLIN INVEST, V90, P1131, DOI 10.1172/JCI115931; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; Deng JS, 2003, INFECT IMMUN, V71, P6402, DOI 10.1128/IAI.71.11.6402-6410.2003; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; Fernie-King BA, 2001, IMMUNOLOGY, V103, P390, DOI 10.1046/j.1365-2567.2001.01249.x; FRANK MM, 1987, REV INFECT DIS, V9, pS537; Fulde M, 2014, THROMB HAEMOSTASIS, V111, P401, DOI 10.1160/TH13-05-0421; Hadders MA, 2012, CELL REP, V1, P200, DOI 10.1016/j.celrep.2012.02.003; Hallstrom T, 2013, MBIO, V4, DOI 10.1128/mBio.00481-13; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; JOINER K, 1983, J IMMUNOL, V130, P845; JOINER KA, 1984, INFECT IMMUN, V45, P113, DOI 10.1128/IAI.45.1.113-117.1984; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kashyap DR, 2011, NAT MED, V17, P676, DOI 10.1038/nm.2357; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Laursen NS, 2010, P NATL ACAD SCI USA, V107, P3681, DOI 10.1073/pnas.0910565107; MERI S, 1990, J EXP MED, V172, P367, DOI 10.1084/jem.172.1.367; MILIS L, 1993, CLIN EXP IMMUNOL, V92, P114; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; MULLEREBERHARD HJ, 1985, J INVEST DERMATOL, V85, pS47; Nordenfelt P, 2012, J EXP MED, V209, P2367, DOI 10.1084/jem.20120325; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; PARIZADE M, 1994, J EXP MED, V179, P1625, DOI 10.1084/jem.179.5.1625; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; PODACK ER, 1977, J IMMUNOL, V119, P2024; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Skattum L, 2011, MOL IMMUNOL, V48, P1643, DOI 10.1016/j.molimm.2011.05.001; TSCHOPP J, 1993, J IMMUNOL, V151, P2159; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Yu HN, 2005, BBA-GEN SUBJECTS, V1726, P168, DOI 10.1016/j.bbagen.2005.08.003; Zhang ZF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001225; Zipfel PF, 2013, MOL IMMUNOL, V56, P152, DOI 10.1016/j.molimm.2013.05.222	45	30	31	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.610212	http://dx.doi.org/10.1074/jbc.M114.610212			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25281746	Green Published, hybrid			2022-12-28	WOS:000345335000010
J	Weatherspoon-Griffin, N; Yang, DZ; Kong, W; Hua, ZC; Shi, YX				Weatherspoon-Griffin, Natasha; Yang, Dezhi; Kong, Wei; Hua, Zichun; Shi, Yixin			The CpxR/CpxA Two-component Regulatory System Up-regulates the Multidrug Resistance Cascade to Facilitate Escherichia coli Resistance to a Model Antimicrobial Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE ANTIBIOTIC-RESISTANCE; SIGNAL-TRANSDUCTION PATHWAY; CONTROLS EXPRESSION; MARRAB OPERON; EFFLUX PUMP; CPX REGULON; STRESS; PROTEIN; ACTIVATION; REPRESSOR	A genome-wide susceptibility assay was used to identify specific CpxR-dependent genes that facilitate Escherichia coli resistance to a model cationic antimicrobial peptide, protamine. A total of 115 strains from the Keio Collection, each of which contained a deletion at a demonstrated or predicted CpxR/CpxA-dependent locus, were tested for protamine susceptibility. One strain that exhibited high susceptibility carried a deletion of tolC, a gene that encodes the outer membrane component of multiple tripartite multidrug transporters. Concomitantly, two of these efflux systems, AcrAB/TolC and EmrAB/TolC, play major roles in protamine resistance. Activation of the CpxR/CpxA system stimulates mar transcription, suggesting a new regulatory circuit that enhances the multidrug resistance cascade. Tripartite multidrug efflux systems contribute to bacterial resistance to protamine differently from the Tat system. DNase I footprinting analysis demonstrated that the CpxR protein binds to a sequence located in the -35 and -10 regions of mar promoter. This sequence resembles the consensus CpxR binding site, however, on the opposite strand. aroK, a CpxR-dependent gene that encodes a shikimate kinase in the tryptophan biosynthesis pathway, was also found to facilitate protamine resistance. Specific aromatic metabolites from this pathway, such as indole, can stimulate expression of well studied CpxR-dependent genes degP and cpxP, which are not components of the tripartite multidrug transporters. Thus, we propose a novel mechanism for E. coli to modulate resistance to protamine and likely other cationic antimicrobial peptides in which the CpxR/CpxA system up-regulates mar transcription in response to specific aromatic metabolites, subsequently stimulating the multidrug resistance cascade.	[Weatherspoon-Griffin, Natasha; Yang, Dezhi; Shi, Yixin] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Yang, Dezhi; Kong, Wei; Shi, Yixin] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA; [Yang, Dezhi] Inner Mongolia Univ, Coll Life Sci, Hohhot 010021, Inner Mongolia, Peoples R China; [Hua, Zichun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Inner Mongolia University; Nanjing University	Shi, YX (corresponding author), Arizona State Univ, Sch Life Sci, POB 874501, Tempe, AZ 85287 USA.	yixin.shi@asu.edu	Yang, Dezhi/HGB-2668-2022; SHI, YIXIN/M-5751-2019	Yang, Dezhi/0000-0003-4653-9856; 	Basic Research Grant of Major Open Topics from Science and Technology Department of Inner Mongolia Autonomous Region, China [20110905]	Basic Research Grant of Major Open Topics from Science and Technology Department of Inner Mongolia Autonomous Region, China	This work was supported in part by Basic Research Grant of Major Open Topics from Science and Technology Department of Inner Mongolia Autonomous Region, China 20110905 (To Y. S.).	Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Ando T, 1973, Mol Biol Biochem Biophys, V12, P1; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Chubiz LM, 2010, J BACTERIOL, V192, P4786, DOI 10.1128/JB.00371-10; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Wulf P, 1999, J BACTERIOL, V181, P6772, DOI 10.1128/JB.181.21.6772-6778.1999; De Wulf P, 2002, J BIOL CHEM, V277, P26652, DOI 10.1074/jbc.M203487200; Roldan M, 2008, FEMS MICROBIOL REV, V32, P474, DOI 10.1111/j.1574-6976.2008.00107.x; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Gerken H, 2004, MOL MICROBIOL, V54, P620, DOI 10.1111/j.1365-2958.2004.04301.x; Gerken H, 2010, MOL MICROBIOL, V75, P1033, DOI 10.1111/j.1365-2958.2009.07042.x; HACHLER H, 1991, J BACTERIOL, V173, P5532; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hirakawa H, 2003, J BACTERIOL, V185, P1851, DOI 10.1128/JB.185.6.1851-1856.2003; Kato A, 1999, J BACTERIOL, V181, P5516, DOI 10.1128/JB.181.17.5516-5520.1999; Kato A, 2003, P NATL ACAD SCI USA, V100, P4706, DOI 10.1073/pnas.0836837100; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Ma Q, 2009, ENVIRON MICROBIOL, V11, P2735, DOI 10.1111/j.1462-2920.2009.02000.x; Mahoney TF, 2013, J BACTERIOL, V195, P1869, DOI 10.1128/JB.02197-12; MARTIN RG, 1995, P NATL ACAD SCI USA, V92, P5456, DOI 10.1073/pnas.92.12.5456; Martin RG, 1996, J BACTERIOL, V178, P2216, DOI 10.1128/jb.178.8.2216-2223.1996; Martin RG, 1999, MOL MICROBIOL, V34, P431, DOI 10.1046/j.1365-2958.1999.01599.x; Miller J. H, 1972, EXPT MOL GENETICS; MILLER PF, 1994, ANTIMICROB AGENTS CH, V38, P1773, DOI 10.1128/AAC.38.8.1773; Nishino K, 2010, ANTIMICROB AGENTS CH, V54, P2239, DOI 10.1128/AAC.01677-09; Oh JT, 2000, BBA-BIOMEMBRANES, V1463, P43, DOI 10.1016/S0005-2736(99)00177-7; Price NL, 2009, J BACTERIOL, V191, P1798, DOI 10.1128/JB.00798-08; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Randall LP, 2002, RES VET SCI, V72, P87, DOI 10.1053/rvsc.2001.0537; Rosenberg EY, 2003, MOL MICROBIOL, V48, P1609, DOI 10.1046/j.1365-2958.2003.03531.x; Rosner JL, 2013, J BACTERIOL, V195, P1042, DOI 10.1128/JB.01996-12; SEOANE AS, 1995, J BACTERIOL, V177, P3414, DOI 10.1128/jb.177.12.3414-3419.1995; Shi YX, 2004, MOL MICROBIOL, V53, P229, DOI 10.1111/j.1365-2958.2004.04107.x; Sikdar R, 2013, J BACTERIOL, V195, P12, DOI 10.1128/JB.00762-12; SNYDER WB, 1995, J BACTERIOL, V177, P4216, DOI 10.1128/jb.177.15.4216-4223.1995; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; SULAVIK MC, 1995, MOL MED, V1, P436, DOI 10.1007/BF03401581; Warner DM, 2010, MICROBIOL-SGM, V156, P570, DOI 10.1099/mic.0.033415-0; Weatherspoon-Griffin N, 2011, J BIOL CHEM, V286, P5529, DOI 10.1074/jbc.M110.200352; Yamanaka H, 2008, J BACTERIOL, V190, P7693, DOI 10.1128/JB.00853-08; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2	47	59	61	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.565762	http://dx.doi.org/10.1074/jbc.M114.565762			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25294881	Green Published, hybrid			2022-12-28	WOS:000345335000016
J	Balce, DR; Allan, ERO; McKenna, N; Yates, RM				Balce, Dale R.; Allan, Euan R. O.; McKenna, Neil; Yates, Robin M.			gamma-Interferon-inducible Lysosomal Thiol Reductase (GILT) Maintains Phagosomal Proteolysis in Alternatively Activated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cysteine Protease; Lysosome; Macrophage; Oxidation-Reduction (Redox); Proteolysis; Reductase; Phagosome	NADPH OXIDASE ACTIVITY; MHC CLASS-II; PROTEASE ACTIVITY; REACTIVE OXYGEN; CATHEPSIN-S; CYSTEINE PROTEASES; ANTIGEN; THIOREDOXIN; CELLS; REDOX	Background: GILT is known to reduce disulfide bonds in endosomes, lysosomes, and phagosomes. Results: GILT, in addition to reducing disulfide bonds, maintains phagosomal proteolytic activity, particularly in alternatively activated macrophages. Conclusion: GILT maintains activity of cysteine proteases in phagosomes. Significance: These results reveal a novel role for GILT that may affect antigen processing and efficiency of hydrolysis of phagocytosed protein. Although it is known that lysosomal cysteine cathepsins require a reducing environment for optimal activity, it is not firmly established how these enzymes are maintained in their reduced-active state in the acidic and occasionally oxidative environment within phagosomes and lysosomes. -Interferon-inducible lysosomal thiol reductase (GILT) has been the only enzyme described in the endosomes, lysosomes, and phagosomes with the potential to catalyze the reduction of cysteine cathepsins. Our goal in the current study was to assess the effect of GILT on major phagosomal functions with an emphasis on proteolytic efficiency in murine bone marrow-derived macrophages. Assessment of phagosomal disulfide reduction upon internalization of IgG-opsonized experimental particles confirmed a major role for GILT in phagosomal disulfide reduction in both resting and interferon--activated macrophages. Furthermore we observed a decrease in early phagosomal proteolytic efficiency in GILT-deficient macrophages, specifically in the absence of an NADPH oxidase-mediated respiratory burst. This deficiency was more prominent in IL-4-activated macrophages that inherently possess lower levels of NADPH oxidase activity. Finally, we provide evidence that GILT is required for optimal activity of the lysosomal cysteine protease, cathepsin S. In summary, our results suggest a role for GILT in maintaining cysteine cathepsin proteolytic efficiency in phagosomes, particularly in the absence of high NADPH oxidase activity, which is characteristic of alternatively activated macrophages.	[Balce, Dale R.; Allan, Euan R. O.; McKenna, Neil; Yates, Robin M.] Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, Calgary, AB T2N 4N1, Canada; [McKenna, Neil; Yates, Robin M.] Univ Calgary, Dept Biochem & Mol Biol, Fac Med, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Yates, RM (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	rmyates@ucalgary.ca	Yates, Robin/K-5032-2015	Yates, Robin/0000-0003-3122-1845	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Canadian Institutes of Health Research and Natural Sciences and Engineering Research Council of Canada.	ANJANEYULU PSR, 1987, INT J PEPT PROT RES, V30, P117; Balce DR, 2011, BLOOD, V118, P4199, DOI 10.1182/blood-2011-01-328906; Barry ZT, 2012, J BIOL CHEM, V287, P27723, DOI 10.1074/jbc.M111.332684; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Carlson BA, 2009, MOLECULES, V14, P3509, DOI 10.3390/molecules14093509; CARRAWAY KL, 1970, BIOCHIM BIOPHYS ACTA, V200, P564, DOI 10.1016/0005-2795(70)90112-1; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chiang HS, 2011, FREE RADICAL BIO MED, V51, P688, DOI 10.1016/j.freeradbiomed.2011.05.015; Claus V, 1998, J BIOL CHEM, V273, P9842, DOI 10.1074/jbc.273.16.9842; COLLINS DS, 1991, J IMMUNOL, V147, P4054; Fernandez-Boyanapalli RF, 2009, BLOOD, V113, P2047, DOI 10.1182/blood-2008-05-160564; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Goldstein OG, 2008, CANCER IMMUNOL IMMUN, V57, P1461, DOI 10.1007/s00262-008-0483-8; Haque MA, 2002, J EXP MED, V195, P1267, DOI 10.1084/jem.20011853; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Huynh KK, 2007, MICROBIOL MOL BIOL R, V71, P452, DOI 10.1128/MMBR.00003-07; Kerblat I, 1999, IMMUNOLOGY, V97, P62; Kotsias F, 2013, ANTIOXID REDOX SIGN, V18, P714, DOI 10.1089/ars.2012.4557; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; Lim JC, 2008, J BIOL CHEM, V283, P28873, DOI 10.1074/jbc.M804087200; Lockwood TD, 2002, ANTIOXID REDOX SIGN, V4, P681, DOI 10.1089/15230860260220193; Lockwood TD, 2013, METALLOMICS, V5, P110, DOI 10.1039/c2mt20156a; Lockwood TD, 2000, ANTIOXID REDOX SIGN, V2, P851, DOI 10.1089/ars.2000.2.4-851; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; Nunes P, 2013, TRAFFIC, V14, P1118, DOI 10.1111/tra.12115; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; Phipps-Yonas H, 2013, EUR J IMMUNOL, V43, P65, DOI 10.1002/eji.201242379; Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417; PISONI RL, 1990, J CELL BIOL, V110, P327, DOI 10.1083/jcb.110.2.327; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Roilides E, 1997, J IMMUNOL, V158, P322; Rybicka JM, 2012, EMBO J, V31, P932, DOI 10.1038/emboj.2011.440; Rybicka JM, 2010, P NATL ACAD SCI USA, V107, P10496, DOI 10.1073/pnas.0914867107; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Serinkan BF, 2005, CELL DEATH DIFFER, V12, P1141, DOI 10.1038/sj.cdd.4401619; Shrimali RK, 2008, J BIOL CHEM, V283, P20181, DOI 10.1074/jbc.M802559200; Singh R, 2010, SCIENCE, V328, P1394, DOI 10.1126/science.1189176; Sinnathamby G, 2004, J IMMUNOL, V172, P6607, DOI 10.4049/jimmunol.172.11.6607; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; STEPHEN AG, 1993, BIOCHEM J, V291, P345, DOI 10.1042/bj2910345; Tian W, 2008, BLOOD, V112, P3867, DOI 10.1182/blood-2007-11-126029; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; VanderVen BC, 2009, TRAFFIC, V10, P372, DOI [10.1111/j.1600-0854.2008.00877.x, 10.1111/j.1600-0854.2009.00877.x]; Voss EW, 1996, BIOTECHNIQUES, V20, P286; Wang Y, 2007, KIDNEY INT, V72, P290, DOI 10.1038/sj.ki.5002275; Welch JS, 2002, J BIOL CHEM, V277, P42821, DOI 10.1074/jbc.M205873200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yamamoto M, 2003, J CLIN INVEST, V112, P1395, DOI 10.1172/JCI200317700; Yates RM, 2005, TRAFFIC, V6, P413, DOI 10.1111/j.1600-0854.2005.00284.x; Yates Robin A., 2008, V445, P311, DOI 10.1007/978-1-59745-157-4_20; Yates RM, 2013, ANTIOXID REDOX SIGN, V18, P628, DOI 10.1089/ars.2012.4898; Zeng MY, 2013, BLOOD, V121, P3473, DOI 10.1182/blood-2012-10-461913	58	51	51	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31891	31904		10.1074/jbc.M114.584391	http://dx.doi.org/10.1074/jbc.M114.584391			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25253686	hybrid, Green Published			2022-12-28	WOS:000345314700020
J	Holkenbrink, C; Hoiczyk, E; Kahnt, J; Higgs, PI				Holkenbrink, Carina; Hoiczyk, Egbert; Kahnt, Joerg; Higgs, Penelope I.			Synthesis and Assembly of a Novel Glycan Layer in Myxococcus xanthus Spores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gram-negative Bacteria; Membrane Protein; Peptidoglycan; Polysaccharide; Sporulation	BACTERIAL TYROSINE KINASE; ESCHERICHIA-COLI; CELL-WALL; BACILLUS-SUBTILIS; OUTER-MEMBRANE; POLYSACCHARIDE BIOSYNTHESIS; MULTICELLULAR DEVELOPMENT; CONSERVED DOMAIN; SOCIAL MOTILITY; O-ANTIGEN	Myxococcus xanthus is a Gram-negative deltaproteobacterium that has evolved the ability to differentiate into metabolically quiescent spores that are resistant to heat and desiccation. An essential feature of the differentiation processes is the assembly of a rigid, cell wall-like spore coat on the surface of the outer membrane. In this study, we characterize the spore coat composition and describe the machinery necessary for secretion of spore coat material and its subsequent assembly into a stress-bearing matrix. Chemical analyses of isolated spore coat material indicate that the spore coat consists primarily of short 1-4- and 1-3-linked GalNAc polymers that lack significant glycosidic branching and may be connected by glycine peptides. We show that 1-4-linked glucose (Glc) is likely a minor component of the spore coat with the majority of the Glc arising from contamination with extracellular polysaccharides, O-antigen, or storage compounds. Neither of these structures is required for the formation of resistant spores. Our analyses indicate the GalNAc/Glc polymer and glycine are exported by the ExoA-I system, a Wzy-like polysaccharide synthesis and export machinery. Arrangement of the capsular-like polysaccharides into a rigid spore coat requires the NfsA-H proteins, members of which reside in either the cytoplasmic membrane (NfsD, -E, and -G) or outer membrane (NfsA, -B, and -C). The Nfs proteins function together to modulate the chain length of the surface polysaccharides, which is apparently necessary for their assembly into a stress-bearing matrix.	[Holkenbrink, Carina; Kahnt, Joerg; Higgs, Penelope I.] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany; [Hoiczyk, Egbert] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Higgs, Penelope I.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Max Planck Society; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Wayne State University	Higgs, PI (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	pihiggs@wayne.edu	Higgs, Penelope/Y-8862-2019	Higgs, Penelope/0000-0003-4726-3329	Deutsche Forschungsgemeinschaft [HI1593/2-1]; Wayne State University; International Max Planck Research School; National Institutes of Health [GM85024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085024] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wayne State University; International Max Planck Research School; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Deutsche Forschungsgemeinschaft Grant HI1593/2-1 (to P. H.), Wayne State University (to P. H.), and a fellowship from the International Max Planck Research School (to C. H.). This work was also supported, in whole or in part, by National Institutes of Health Grant GM85024 (to E. H.).	Bhat S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027475; Bohlander R. M., 1994, J BACTERIOL, V176, P6295; Bowden MG, 1998, MOL MICROBIOL, V30, P275, DOI 10.1046/j.1365-2958.1998.01060.x; Bui NK, 2009, J BACTERIOL, V191, P494, DOI 10.1128/JB.00608-08; CAMPOS JM, 1975, P NATL ACAD SCI USA, V72, P518, DOI 10.1073/pnas.72.2.518; CHAO L, 1971, J BACTERIOL, V105, P331, DOI 10.1128/JB.105.1.331-338.1971; Chaplin M.F., 1986, MASS SPECTROM, P1; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; DWORKIN M, 1964, SCIENCE, V146, P243, DOI 10.1126/science.146.3641.243; Faille C, 2014, BIOFOULING, V30, P845, DOI 10.1080/08927014.2014.939073; FILER D, 1977, J BACTERIOL, V131, P751, DOI 10.1128/JB.131.3.751-758.1977; Flardh K, 2009, NAT REV MICROBIOL, V7, P36, DOI 10.1038/nrmicro1968; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Gorke B, 2005, MICROBIOL-SGM, V151, P3777, DOI 10.1099/mic.0.28172-0; Guo DC, 1996, J BACTERIOL, V178, P1631, DOI 10.1128/jb.178.6.1631-1639.1996; Guo DC, 2000, J BACTERIOL, V182, P4564, DOI 10.1128/JB.182.16.4564-4571.2000; Higgins D, 2012, FEMS MICROBIOL REV, V36, P131, DOI 10.1111/j.1574-6976.2011.00310.x; Higgs PI, 2002, J BACTERIOL, V184, P1640, DOI 10.1128/JB.184.6.1640-1648.2002; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Julien B, 2000, P NATL ACAD SCI USA, V97, P9098, DOI 10.1073/pnas.97.16.9098; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kameda T, 2005, MACROMOL BIOSCI, V5, P103, DOI 10.1002/mabi.200400142; Kimura Y, 2012, FEMS MICROBIOL LETT, V336, P45, DOI 10.1111/j.1574-6968.2012.02651.x; Kimura Y, 2011, J BACTERIOL, V193, P5853, DOI 10.1128/JB.05750-11; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; KOTTEL RH, 1975, J BACTERIOL, V124, P550, DOI 10.1128/JB.124.1.550-557.1975; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee B, 2010, METHOD ENZYMOL, V471, P253, DOI 10.1016/S0076-6879(10)71014-4; Letain TE, 1997, MOL MICROBIOL, V24, P271, DOI 10.1046/j.1365-2958.1997.3331703.x; Licking E, 2000, J BACTERIOL, V182, P3553, DOI 10.1128/JB.182.12.3553-3558.2000; Lu A, 2005, MOL MICROBIOL, V55, P206, DOI 10.1111/j.1365-2958.2004.04369.x; Luciano J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002268; MacLean L, 2007, CARBOHYD RES, V342, P2474, DOI 10.1016/j.carres.2007.07.023; Maniatis T., 1982, MOL CLONING LAB MANU; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; McKenney PT, 2013, NAT REV MICROBIOL, V11, P33, DOI 10.1038/nrmicro2921; MERKLE RK, 1994, METHOD ENZYMOL, V230, P1; Mio T, 1999, J BIOL CHEM, V274, P424, DOI 10.1074/jbc.274.1.424; Morona JK, 2000, MOL MICROBIOL, V35, P1431, DOI 10.1046/j.1365-2958.2000.01808.x; Muller FD, 2012, MOL MICROBIOL, V83, P486, DOI 10.1111/j.1365-2958.2011.07944.x; Muller FD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-264; Nariya H, 2003, MOL MICROBIOL, V49, P517, DOI 10.1046/j.1365-2958.2003.03572.x; Nelson DE, 2001, J BACTERIOL, V183, P3055, DOI 10.1128/JB.183.10.3055-3064.2001; Niemetz R, 1997, EUR J BIOCHEM, V249, P905, DOI 10.1111/j.1432-1033.1997.00905.x; Niemeyer D, 2001, J BACTERIOL, V183, P5163, DOI 10.1128/JB.183.17.5163-5170.2001; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; ORNDORFF PE, 1980, J BACTERIOL, V141, P914, DOI 10.1128/JB.141.2.914-927.1980; OSBORN MJ, 1972, J BIOL CHEM, V247, P3973; Pallen M, 2002, TRENDS MICROBIOL, V10, P556, DOI 10.1016/S0966-842X(02)02476-9; Shimkets LJ, 2000, PROKARYOTIC DEVELOPMENT, P1; Simunovic V, 2003, J BACTERIOL, V185, P5066, DOI 10.1128/JB.185.17.5066-5075.2003; STEBER J, 1975, ARCH MICROBIOL, V105, P173, DOI 10.1007/BF00447133; Takeda M, 2010, INT J BIOL MACROMOL, V46, P206, DOI 10.1016/j.ijbiomac.2009.12.006; Ueki T, 2005, J BIOL CHEM, V280, P32279, DOI 10.1074/jbc.M507191200; Ueki T, 1996, GENE, V183, P153, DOI 10.1016/S0378-1119(96)00546-X; Wartel M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001728; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351; Wu SS, 1996, J BACTERIOL, V178, P5817, DOI 10.1128/jb.178.19.5817-5821.1996; YORK WS, 1986, METHOD ENZYMOL, V118, P3; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018	64	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32364	32378		10.1074/jbc.M114.595504	http://dx.doi.org/10.1074/jbc.M114.595504			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25271164	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000345314700060
J	Jin, ZC; Berthiaume, JM; Li, QL; Henry, F; Huang, Z; Sadhukhan, S; Gao, P; Tochtrop, GP; Puchowicz, MA; Zhang, GF				Jin, Zhicheng; Berthiaume, Jessica M.; Li, Qingling; Henry, Fabrice; Huang, Zhong; Sadhukhan, Sushabhan; Gao, Peng; Tochtrop, Gregory P.; Puchowicz, Michelle A.; Zhang, Guo-Fang			Catabolism of (2E)-4-Hydroxy-2-nonenal via omega- and omega-1-Oxidation Stimulated by Ketogenic Diet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta-Oxidation; Coenzyme A (CoA); Cytochrome P450; Diet; Fatty Acid Oxidation; Isotopic Tracer; Lipid Peroxidation; Mass Spectrometry (MS); Metabolism; Metabolomics	POLYMERASE-CHAIN-REACTION; HIGH-FAT DIET; RAT-LIVER; GAMMA-HYDROXYBUTYRATE; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION; MASS-SPECTROMETRY; LAURIC ACID; METABOLISM; MICROSOMES	Oxidative stress triggers the peroxidation of -6-polyunsaturated fatty acids to reactive lipid fragments, including (2E)-4-hydroxy-2-nonenal (HNE). We previously reported two parallel catabolic pathways of HNE. In this study, we report a novel metabolite that accumulates in rat liver perfused with HNE or 4-hydroxynonanoic acid (HNA), identified as 3-(5-oxotetrahydro-2-furanyl)propanoyl-CoA. In experiments using a combination of isotopic analysis and metabolomics studies, three catabolic pathways of HNE were delineated following HNE conversion to HNA. (i) HNA is -hydroxylated to 4,9-dihydroxynonanoic acid, which is subsequently oxidized to 4-hydroxynonanedioic acid. This is followed by the degradation of 4-hydroxynonanedioic acid via -oxidation originating from C-9 of HNA breaking down to 4-hydroxynonanedioyl-CoA, 4-hydroxyheptanedioyl-CoA, or its lactone, 2-hydroxyglutaryl-CoA, and 2-ketoglutaric acid entering the citric acid cycle. (ii) -1-hydroxylation of HNA leads to 4,8-dihydroxynonanoic acid (4,8-DHNA), which is subsequently catabolized via two parallel pathways we previously reported. In catabolic pathway A, 4,8-DHNA is catabolized to 4-phospho-8-hydroxynonanoyl-CoA, 3,8-dihydroxynonanoyl-CoA, 6-hydroxyheptanoyl-CoA, 4-hydroxypentanoyl-CoA, propionyl-CoA, and acetyl-CoA. (iii) The catabolic pathway B of 4,8-DHNA leads to 2,6-dihydroxyheptanoyl-CoA, 5-hydroxyhexanoyl-CoA, 3-hydroxybutyryl-CoA, and acetyl-CoA. Both in vivo and in vitro experiments showed that HNE can be catabolically disposed via - and -1-oxidation in rat liver and kidney, with little activity in brain and heart. Dietary experiments showed that - and -1-hydroxylation of HNA in rat liver were dramatically up-regulated by a ketogenic diet, which lowered HNE basal level. HET0016 inhibition and mRNA expression level suggested that the cytochrome P450 4A are main enzymes responsible for the NADPH-dependent - and -1-hydroxylation of HNA/HNE.	[Jin, Zhicheng; Berthiaume, Jessica M.; Li, Qingling; Henry, Fabrice; Huang, Zhong; Puchowicz, Michelle A.; Zhang, Guo-Fang] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Berthiaume, Jessica M.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Sadhukhan, Sushabhan; Gao, Peng; Tochtrop, Gregory P.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Zhang, GF (corresponding author), Case Western Reserve Univ, Dept Nutr, Sch Med, 10900 Euclid Ave,WG 48, Cleveland, OH 44106 USA.	gxz35@case.edu	Sadhukhan, Sushabhan/AAS-7136-2020; Gao, Peng/AAE-2205-2019	Gao, Peng/0000-0002-4311-584X; Sadhukhan, Sushabhan/0000-0002-3302-5875; Jin, Zhicheng/0000-0003-2770-9549	National Institutes of Health (NIH) [R33DK070291, R01ES013925]; NIH, NCI [CA157735]; Case Western Reserve University/Cleveland Clinic CTSA Grant from the National Center for Research Resources (NCRR), a component of the NIH [UL1 RR024989]; NIH Roadmap for Medical Research; National Science Foundation [MCB-084480]; American Heart Association [12GRNT12050453]; Cleveland Mt. Sinai Health Care Foundation; NATIONAL CANCER INSTITUTE [R01CA157735] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013925] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Case Western Reserve University/Cleveland Clinic CTSA Grant from the National Center for Research Resources (NCRR), a component of the NIH; NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); Cleveland Mt. Sinai Health Care Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Roadmap Grants R33DK070291 and R01ES013925 (to Henri Brunengraber) and by NIH, NCI, Grant CA157735 (to G. P. T.). This work was also supported by Case Western Reserve University/Cleveland Clinic CTSA Grant UL1 RR024989 (to G. F. Z.) from the National Center for Research Resources (NCRR), a component of the NIH and NIH Roadmap for Medical Research. This work was also supported by National Science Foundation Grant MCB-084480 (to G. P. T.), American Heart Association Grant 12GRNT12050453 (to G. F. Z.), and a grant from the Cleveland Mt. Sinai Health Care Foundation.	Akude E, 2010, NEUROTOX RES, V17, P28, DOI 10.1007/s12640-009-9074-5; Ando Y, 1998, J NEUROL SCI, V156, P172, DOI 10.1016/S0022-510X(98)00042-2; Bleicher KB, 2001, J BIOCHEM MOL TOXIC, V15, P133, DOI 10.1002/jbt.10; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; BRUNENGRABER H, 1973, J BIOL CHEM, V248, P2656; Butterfield DA, 2011, FREE RADICAL RES, V45, P59, DOI 10.3109/10715762.2010.520014; Calingasan NY, 1999, J NEUROCHEM, V72, P751, DOI 10.1046/j.1471-4159.1999.0720751.x; Choudhary S, 2003, INVEST OPHTH VIS SCI, V44, P2675, DOI 10.1167/iovs.02-0965; Enoiu M, 2002, ARCH BIOCHEM BIOPHYS, V397, P18, DOI 10.1006/abbi.2001.2633; Falletti O, 2007, FREE RADICAL BIO MED, V42, P1258, DOI 10.1016/j.freeradbiomed.2007.01.024; Gioacchini AM, 1999, RAPID COMMUN MASS SP, V13, P1573, DOI 10.1002/(SICI)1097-0231(19990815)13:15<1573::AID-RCM675>3.0.CO;2-Z; Harris SR, 2013, CHEM RES TOXICOL, V26, P213, DOI 10.1021/tx3003643; Harris SR, 2011, J BIOL CHEM, V286, P5895, DOI 10.1074/jbc.M110.196808; Hayashi Seiko, 2005, Drug Metab Pharmacokinet, V20, P14, DOI 10.2133/dmpk.20.14; Johnston JB, 2011, ARCH BIOCHEM BIOPHYS, V507, P86, DOI 10.1016/j.abb.2010.08.011; Kalsotra A, 2005, BIOCHEM BIOPH RES CO, V338, P423, DOI 10.1016/j.bbrc.2005.08.101; Kalsotra A, 2002, DRUG METAB DISPOS, V30, P1022, DOI 10.1124/dmd.30.9.1022; Laurent A, 2000, TOXICOL LETT, V114, P203, DOI 10.1016/S0378-4274(99)00301-X; Li QL, 2014, J LIPID RES, V55, P592, DOI 10.1194/jlr.D045112; Li QL, 2013, FREE RADICAL BIO MED, V58, P35, DOI 10.1016/j.freeradbiomed.2013.01.005; Li QL, 2012, RAPID COMMUN MASS SP, V26, P1355, DOI 10.1002/rcm.6233; Li QL, 2012, FREE RADICAL BIO MED, V52, P1043, DOI 10.1016/j.freeradbiomed.2011.12.022; Mali VR, 2014, EXP BIOL MED, V239, P610, DOI 10.1177/1535370213520109; Manrique C, 2013, ENDOCRINOLOGY, V154, P3632, DOI 10.1210/en.2013-1256; Mattson MP, 2009, EXP GERONTOL, V44, P625, DOI 10.1016/j.exger.2009.07.003; Mobbs CV, 2013, J CHILD NEUROL, V28, P1009, DOI 10.1177/0883073813487596; OKAMOTO K, 1994, INT J CANCER, V58, P825, DOI 10.1002/ijc.2910580613; OKITA RT, 1980, DRUG METAB DISPOS, V8, P147; OKITA RT, 1979, BIOCHEM PHARMACOL, V28, P3385, DOI 10.1016/0006-2952(79)90077-7; Ramana KV, 2006, J BIOL CHEM, V281, P17652, DOI 10.1074/jbc.M600270200; Sadhukhan S, 2014, FREE RADICAL BIO MED, V70, P78, DOI 10.1016/j.freeradbiomed.2014.02.008; Sadhukhan S, 2010, J AM CHEM SOC, V132, P6309, DOI 10.1021/ja100399m; Sanders RJ, 2006, J BIOL CHEM, V281, P13180, DOI 10.1074/jbc.M513481200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharma S., 2013, EPILEPSY RES TREAT, V2013; Siems Werner, 2003, Molecular Aspects of Medicine, V24, P167, DOI 10.1016/S0098-2997(03)00011-6; Simpson AECM, 1997, GEN PHARMACOL-VASC S, V28, P351, DOI 10.1016/S0306-3623(96)00246-7; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Struys EA, 2006, METABOLISM, V55, P353, DOI 10.1016/j.metabol.2005.09.009; TANAKA S, 1990, BIOCHIM BIOPHYS ACTA, V1043, P177, DOI 10.1016/0005-2760(90)90293-7; Theken KN, 2012, AM J PHYSIOL-ENDOC M, V302, pE500, DOI 10.1152/ajpendo.00370.2011; Woolf EC, 2015, J LIPID RES, V56, P5, DOI 10.1194/jlr.R046797; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang GF, 2012, BIOCHEM J, V444, P333, DOI 10.1042/BJ20112046; Zhang GF, 2009, J BIOL CHEM, V284, P33521, DOI 10.1074/jbc.M109.055665; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070663	46	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32327	32338		10.1074/jbc.M114.602458	http://dx.doi.org/10.1074/jbc.M114.602458			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25274632	hybrid, Green Published			2022-12-28	WOS:000345314700057
J	Machida, K; Mikami, S; Masutani, M; Mishima, K; Kobayashi, T; Imataka, H				Machida, Kodai; Mikami, Satoshi; Masutani, Mamiko; Mishima, Kurumi; Kobayashi, Tominari; Imataka, Hiroaki			A Translation System Reconstituted with Human Factors Proves That Processing of Encephalomyocarditis Virus Proteins 2A and 2B Occurs in the Elongation Phase of Translation without Eukaryotic Release Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Protein Expression; Protein Processing; Protein Synthesis; Translation Regulation; Viral Protein; Cell-free System; Reconstitution System	INTERNAL RIBOSOMAL ENTRY; PEPTIDYL-TRANSFER-RNA; AMINO-ACID-SEQUENCE; INITIATION-FACTORS; HUMAN CYTOMEGALOVIRUS; STRUCTURAL BASIS; MESSENGER-RNA; HEPATITIS-C; CLEAVAGE; POLYPROTEIN	Background: The mechanism by which the encephalomyocarditis virus protein 2A-2B is processed into 2A and 2B is unknown. Results: A translation system reconstituted with defined human factors recapitulates 2A-2B processing. Conclusion: 2A-2B processing occurs at the elongation step. Significance: The translation system reconstituted with human factors should be a useful tool for studying eukaryotic protein synthesis mechanisms. The genomic RNA of encephalomyocarditis virus (EMCV) encodes a single polyprotein, and the primary scission of the polyprotein occurs between nonstructural proteins 2A and 2B by an unknown mechanism. To gain insight into the mechanism of 2A-2B processing, we first translated the 2A-2B region in vitro with eukaryotic and prokaryotic translation systems. The 2A-2B processing occurred only in the eukaryotic systems, not in the prokaryotic systems, and the unprocessed 2A-2B protein synthesized by a prokaryotic system remained uncleaved when incubated with a eukaryotic cell extract. These results suggest that 2A-2B processing is a eukaryote-specific, co-translational event. To define the translation factors required for 2A-2B processing, we constituted a protein synthesis system with eukaryotic elongation factors 1 and 2, eukaryotic release factors 1 and 3 (eRF1 and eRF3), aminoacyl-tRNA synthetases, tRNAs, ribosome subunits, and a plasmid template that included the hepatitis C virus internal ribosome entry site. We successfully reproduced 2A-2B processing in the reconstituted system even without eRFs. Our results indicate that this unusual event occurs in the elongation phase of translation.	[Machida, Kodai; Masutani, Mamiko; Mishima, Kurumi; Kobayashi, Tominari; Imataka, Hiroaki] Univ Hyogo, Grad Sch Engn, Dept Mat Sci & Chem, Himeji, Hyogo 6712201, Japan; [Machida, Kodai; Imataka, Hiroaki] Univ Hyogo, Grad Sch Engn, Mol Nanotechnol Res Ctr, Himeji, Hyogo 6712201, Japan; [Mikami, Satoshi] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan	University of Hyogo; University of Hyogo; RIKEN	Imataka, H (corresponding author), Univ Hyogo, Grad Sch Engn, Dept Mat Sci & Chem, Himeji, Hyogo 6712201, Japan.	imataka@eng.u-hyogo.ac.jp		Machida, Kodai/0000-0003-4973-9685	Ministry of Education, Culture, Sports, Science and Technology of Japan [25660082]; Grants-in-Aid for Scientific Research [26116002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas "RNA Regulation" 20112006 and Grant-in-aid for Exploratory Research 25660082 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to H. I.).	Alderete JP, 1999, J VIROL, V73, P8330, DOI 10.1128/JVI.73.10.8330-8337.1999; Alkalaeva EZ, 2006, CELL, V125, P1125, DOI 10.1016/j.cell.2006.04.035; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Bhushan S, 2010, MOL CELL, V40, P138, DOI 10.1016/j.molcel.2010.09.009; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Donnelly MLL, 1997, J GEN VIROL, V78, P13, DOI 10.1099/0022-1317-78-1-13; Doronina VA, 2008, MOL CELL BIOL, V28, P4227, DOI 10.1128/MCB.00421-08; Fang P, 2004, P NATL ACAD SCI USA, V101, P4059, DOI 10.1073/pnas.0400554101; Hahn H, 1996, J VIROL, V70, P6870, DOI 10.1128/JVI.70.10.6870-6875.1996; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; Ito K, 2013, ANNU REV BIOCHEM, V82, P171, DOI 10.1146/annurev-biochem-080211-105026; Ito K, 2012, NUCLEIC ACIDS RES, V40, P10521, DOI 10.1093/nar/gks790; Jackson RJ, 2012, ADV PROTEIN CHEM STR, V86, P45, DOI [10.1016/B978-0-12-386497-0.00002-5, 10.1016/B978-0-12.386497.000002-5]; Janssen Brian D, 2012, Methods Mol Biol, V905, P291, DOI 10.1007/978-1-61779-949-5_19; Janzen DM, 2002, MOL CELL BIOL, V22, P8562, DOI 10.1128/MCB.22.24.8562-8570.2002; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; Kobayashi T, 2007, J VIROL METHODS, V142, P182, DOI 10.1016/j.jviromet.2007.01.026; Kuruma Y, 2012, BIOCHEM J, V442, P631, DOI 10.1042/BJ20111284; Lancaster AM, 2006, RNA, V12, P894, DOI 10.1261/rna.2342306; Machida K, 2012, PROTEIN EXPRES PURIF, V82, P61, DOI 10.1016/j.pep.2011.11.010; Masutani M, 2013, PROTEIN EXPRES PURIF, V87, P5, DOI 10.1016/j.pep.2012.10.001; Mikami S, 2006, PROTEIN EXPRES PURIF, V46, P348, DOI 10.1016/j.pep.2005.09.021; Mikami S, 2008, PROTEIN EXPRES PURIF, V62, P190, DOI 10.1016/j.pep.2008.09.002; Mikami S, 2010, BIOTECHNOL LETT, V32, P897, DOI 10.1007/s10529-010-0251-7; Murakami H, 2006, NAT METHODS, V3, P357, DOI 10.1038/NMETH877; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Nagase T, 2008, DNA RES, V15, P137, DOI 10.1093/dnares/dsn004; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nakatsu Y, 2006, J VIROL METHODS, V137, P152, DOI 10.1016/j.jviromet.2006.05.029; Ohashi H, 2012, METHODS MOL BIOL, V805, P251, DOI 10.1007/978-1-61779-379-0_14; Onouchi H, 2005, GENE DEV, V19, P1799, DOI 10.1101/gad.1317105; PALMENBERG AC, 1990, ANNU REV MICROBIOL, V44, P603, DOI 10.1146/annurev.mi.44.100190.003131; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Pisarev AV, 2007, CELL, V131, P286, DOI 10.1016/j.cell.2007.08.041; Pisarev AV, 2010, MOL CELL, V37, P196, DOI 10.1016/j.molcel.2009.12.034; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Sharma P, 2012, NUCLEIC ACIDS RES, V40, P3143, DOI 10.1093/nar/gkr1176; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Skabkin MA, 2013, MOL CELL, V51, P249, DOI 10.1016/j.molcel.2013.05.026; Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510; Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142; Ying BW, 2005, J BIOL CHEM, V280, P12035, DOI 10.1074/jbc.M500364200	47	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31960	31971		10.1074/jbc.M114.593343	http://dx.doi.org/10.1074/jbc.M114.593343			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25258322	Green Published, hybrid			2022-12-28	WOS:000345314700026
J	Modi, H; Cornu, M; Thorens, B				Modi, Honey; Cornu, Marion; Thorens, Bernard			Glutamine Stimulates Biosynthesis and Secretion of Insulin-like Growth Factor 2 (IGF2), an Autocrine Regulator of Beta Cell Mass and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta Cell (B-cell); Glucose; Glutamine; Insulin; Insulin Secretion; Insulin-like Growth Factor (IGF)	GLUCAGON-LIKE PEPTIDE-1; PANCREATIC-ISLETS; AMINO-ACIDS; FACTOR-II; GLUCOSE; EXPRESSION; RECEPTOR; PROLIFERATION; TRANSLATION; ROLES	Background: An IGF2/IGF1R autocrine loop regulates beta cell glucose competence, proliferation, and apoptosis, and GLP-1 increases IGF1R expression. Results: Glutamine enhances IGF2 biosynthesis, secretion, and IGF2-dependent Akt phosphorylation. Conclusion: Glutamine controls the activity of the IGF2/IGF1R autocrine loop through IGF2 up-regulation. Significance: The IGF2/IGF1R autocrine loop integrates changes in feeding and metabolic state to adapt beta cell mass and function. IGF2 is an autocrine ligand for the beta cell IGF1R receptor and GLP-1 increases the activity of this autocrine loop by enhancing IGF1R expression, a mechanism that mediates the trophic effects of GLP-1 on beta cell mass and function. Here, we investigated the regulation of IGF2 biosynthesis and secretion. We showed that glutamine rapidly and strongly induced IGF2 mRNA translation using reporter constructs transduced in MIN6 cells and primary islet cells. This was followed by rapid secretion of IGF2 via the regulated pathway, as revealed by the presence of mature IGF2 in insulin granule fractions and by inhibition of secretion by nimodipine and diazoxide. When maximally stimulated by glutamine, the amount of secreted IGF2 rapidly exceeded its initial intracellular pool and tolbutamide, and high K+ increased IGF2 secretion only marginally. This indicates that the intracellular pool of IGF2 is small and that sustained secretion requires de novo synthesis. The stimulatory effect of glutamine necessitates its metabolism but not mTOR activation. Finally, exposure of insulinomas or beta cells to glutamine induced Akt phosphorylation, an effect that was dependent on IGF2 secretion, and reduced cytokine-induced apoptosis. Thus, glutamine controls the activity of the beta cell IGF2/IGF1R autocrine loop by increasing the biosynthesis and secretion of IGF2. This autocrine loop can thus integrate changes in feeding and metabolic state to adapt beta cell mass and function.	[Modi, Honey; Cornu, Marion; Thorens, Bernard] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	University of Lausanne	Thorens, B (corresponding author), Univ Lausanne, Ctr Integrat Genom, Genopode Bldg, CH-1015 Lausanne, Switzerland.	Bernard.Thorens@unil.ch		Modi, Hiren/0000-0003-1731-7111	Innovative Medicine Initiative Joint Undertaking Grant [155005]; European Union; Swiss National Science Foundation [3100A0B-128657]; NCCR Frontiers in Genetics; European Research Council	Innovative Medicine Initiative Joint Undertaking Grant; European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Frontiers in Genetics(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by Innovative Medicine Initiative Joint Undertaking Grant 155005 (IMIDIA), resources of which are composed of financial contributions from the European Union's Sevenths Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution; Swiss National Science Foundation (3100A0B-128657), and NCCR Frontiers in Genetics; European Union Seventh Framework Program Integrated Project BetaBat; and European Research Council Advanced Grant INSIGHT.	Alarcon C, 2002, DIABETES, V51, P2496, DOI 10.2337/diabetes.51.8.2496; Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Buchanan CM, 2001, BIOCHEM J, V360, P431, DOI 10.1042/0264-6021:3600431; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; Christiansen J., 2009, J MOL ENDOCRINOL; Cornu M, 2009, ISLETS, V1, P280, DOI 10.4161/isl.1.3.9932; Cornu M, 2010, J BIOL CHEM, V285, P10538, DOI 10.1074/jbc.M109.091116; Cornu M, 2009, DIABETES, V58, P1816, DOI 10.2337/db09-0063; Dai N, 2011, GENE DEV, V25, P1159, DOI 10.1101/gad.2042311; Dalle S, 2011, CELL SIGNAL, V23, P522, DOI 10.1016/j.cellsig.2010.09.014; Demozay D, 2011, DIABETES, V60, P2892, DOI 10.2337/db11-0341; Groenewoud MJ, 2008, DIABETOLOGIA, V51, P1659, DOI 10.1007/s00125-008-1083-z; HALBAN PA, 1982, ENDOCRINOLOGY, V110, P1183, DOI 10.1210/endo-110-4-1183; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Henquin JC, 2006, DIABETES, V55, P3470, DOI 10.2337/db06-0868; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Jorgensen R, 2005, MOL ENDOCRINOL, V19, P812, DOI 10.1210/me.2004-0312; Klinger S, 2008, DIABETES, V57, P584, DOI 10.2337/db07-1414; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Odegaard ML, 2010, J BIOL CHEM, V285, P16530, DOI 10.1074/jbc.M109.092593; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Park S, 2006, J BIOL CHEM, V281, P1159, DOI 10.1074/jbc.M508307200; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Portela-Gomes GM, 2000, J ENDOCRINOL, V165, P245, DOI 10.1677/joe.0.1650245; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Reinecke M, 1995, GEN COMP ENDOCR, V100, P385, DOI 10.1006/gcen.1995.1169; Samocha-Bonet D, 2011, J NUTR, V141, P1233, DOI 10.3945/jn.111.139824; Scharfmann R, 1990, Diabetes Res, V15, P137; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Sookoian S, 2012, WORLD J GASTROENTERO, V18, P3775, DOI 10.3748/wjg.v18.i29.3775; Stancakova A, 2012, DIABETES, V61, P1895, DOI 10.2337/db11-1378; Susini S, 1998, FASEB J, V12, P1173, DOI 10.1096/fasebj.12.12.1173; SWENNE I, 1982, DIABETES, V31, P754, DOI 10.2337/diab.31.9.754; Talbot J, 2012, MOL CELL ENDOCRINOL, V364, P65, DOI 10.1016/j.mce.2012.08.010; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Thorens B, 2013, J INTERN MED, V274, P203, DOI 10.1111/joim.12096; THORENS B, 1993, J CELL BIOL, V123, P1687, DOI 10.1083/jcb.123.6.1687; Tolhurst G, 2011, ENDOCRINOLOGY, V152, P405, DOI 10.1210/en.2010-0956; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Uldry M, 2004, EMBO J, V23, P531, DOI 10.1038/sj.emboj.7600072; USDIN TB, 1993, ENDOCRINOLOGY, V133, P2861, DOI 10.1210/en.133.6.2861; Vetterli L, 2012, MOL BIOL CELL, V23, P3851, DOI 10.1091/mbc.E11-08-0676; Wicksteed B, 2001, J BIOL CHEM, V276, P22553, DOI 10.1074/jbc.M011214200; Wicksteed B, 2007, CELL METAB, V5, P221, DOI 10.1016/j.cmet.2007.02.007; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116	50	26	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31972	31982		10.1074/jbc.M114.587733	http://dx.doi.org/10.1074/jbc.M114.587733			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25271169	Green Published, hybrid			2022-12-28	WOS:000345314700027
J	Chen, XY; Bai, B; Tian, YJ; Du, H; Chen, J				Chen, Xiaoyu; Bai, Bo; Tian, Yanjun; Du, Hui; Chen, Jing			Identification of Serine 348 on the Apelin Receptor as a Novel Regulatory Phosphorylation Site in Apelin-13-induced G Protein-independent Biased Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; ANGIOTENSIN-II RECEPTOR; BETA-ARRESTIN; ORPHAN RECEPTOR; 7-TRANSMEMBRANE RECEPTORS; MOLECULAR DETERMINANTS; CARDIAC CONTRACTILITY; COUPLED RECEPTORS; ACTIVATION; LIGAND	Phosphorylation plays vital roles in the regulation of G protein-coupled receptor (GPCR) functions. The apelin and apelin receptor (APJ) system is involved in the regulation of cardiovascular function and central control of body homeostasis. Here, using tandem mass spectrometry, we first identified phosphorylated serine residues in the C terminus of APJ. To determine the role of phosphorylation sites in APJ-mediated G protein-dependent and -independent signaling and function, we induced a mutation in the C-terminal serine residues and examined their effects on the interaction between APJ with G protein or GRK/beta-arrestin and their downstream signaling. Mutation of serine 348 led to an elimination of both GRK and beta-arrestin recruitment to APJ induced by apelin-13. Moreover, APJ internalization and G protein-independent ERK signaling were also abolished by point mutation at senile 348. In contrast, this mutant at serine residues had no demonstrable impact on apelin-13-induced G protein activation and its intracellular signaling. These findings suggest that mutation of serine 348 resulted in inactive GRK/beta-arrestin. However, there was no change in the active G protein thus, APJ conformation was biased. These results provide important information on the molecular interplay and impact of the APJ function, which may be extrapolated to design novel drugs for cardiac hypertrophy based on this biased signal pathway.	[Chen, Xiaoyu] Shandong Univ Sch Med, Dept Physiol, Jinan 250012, Shandong, Peoples R China; [Bai, Bo; Tian, Yanjun; Chen, Jing] Jining Med Univ, Inst Neurobiol, Jining 272067, Shandong, Peoples R China; [Chen, Jing] Univ Warwick, Warwick Med Sch, Div Translat & Syst Med, Coventry CV4 7AL, W Midlands, England; [Chen, Xiaoyu; Du, Hui] Taishan Med Coll, Dept Physiol, Tai An 271000, Shandong, Peoples R China	Shandong University; Jining Medical University; University of Warwick; Shandong First Medical University & Shandong Academy of Medical Sciences	Bai, B (corresponding author), Jining Med Univ, Inst Neurobiol, Jining 272067, Shandong, Peoples R China.	bbai@mail.jnmc.edu.cn; Jing.Chen@warwick.ac.uk		xiaoyu, chen/0000-0001-7608-0666	National Nature Science Foundation of China [30971081, 31271243, 81070961]; Taishan Scholar Construction Special Fund	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Construction Special Fund	This work was supported by National Nature Science Foundation of China Grants 30971081, 31271243, and 81070961, and the Taishan Scholar Construction Special Fund.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Ashley EA, 2005, CARDIOVASC RES, V65, P73, DOI 10.1016/j.cardiores.2004.08.018; Bai B, 2008, ACTA BIOCH BIOPH SIN, V40, P311, DOI 10.1111/j.1745-7270.2008.00403.x; Blethrow JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000358; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Butcher AJ, 2011, J BIOL CHEM, V286, P11506, DOI 10.1074/jbc.M110.154526; Castan-Laurell I, 2011, ENDOCRINE, V40, P1, DOI 10.1007/s12020-011-9507-9; Chen J, 2004, MOL ENDOCRINOL, V18, P2790, DOI 10.1210/me.2004-0167; Choi BK, 2003, PROTEOMICS, V3, P1955, DOI 10.1002/pmic.200300558; Chun HJ, 2008, J CLIN INVEST, V118, P3343, DOI 10.1172/JCI34871; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; DeWire SM, 2013, J PHARMACOL EXP THER, V344, P708, DOI 10.1124/jpet.112.201616; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Giddings A. S. R., 2010, INT J HIGH THROUGHTP, V1, P39; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Habata Y, 1999, BBA-MOL CELL RES, V1452, P25, DOI 10.1016/S0167-4889(99)00114-7; Hasbi A, 2004, MOL ENDOCRINOL, V18, P1277, DOI 10.1210/me.2003-0440; Hawtin SR, 2005, MOL PHARMACOL, V68, P1172, DOI 10.1124/mol.105.013359; Jia YX, 2006, REGUL PEPTIDES, V133, P147, DOI 10.1016/j.regpep.2005.09.033; Jones BW, 2007, J BIOL CHEM, V282, P12893, DOI 10.1074/jbc.M610854200; Jorgensen R, 2008, MOL PHARMACOL, V73, P349, DOI 10.1124/mol.107.038877; Katugampola SD, 2001, BRIT J PHARMACOL, V132, P1255, DOI 10.1038/sj.bjp.0703939; Kocan M, 2009, METHODS MOL BIOL, V552, P305, DOI 10.1007/978-1-60327-317-6_22; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Kule CE, 2004, REGUL PEPTIDES, V120, P141, DOI 10.1016/j.regpep.2004.03.001; Lee DK, 2010, BIOCHEM BIOPH RES CO, V395, P185, DOI 10.1016/j.bbrc.2010.03.151; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li YL, 2012, CELL SIGNAL, V24, P991, DOI 10.1016/j.cellsig.2011.12.012; Luttrell LM, 2002, J CELL SCI, V115, P455; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Ma P, 2002, NAT REV DRUG DISCOV, V1, P571, DOI 10.1038/nrd884; Masri B, 2002, BIOCHEM BIOPH RES CO, V290, P539, DOI 10.1006/bbrc.2001.6230; Masri B, 2006, J BIOL CHEM, V281, P18317, DOI 10.1074/jbc.M600606200; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Qian HW, 2001, MOL ENDOCRINOL, V15, P1706, DOI 10.1210/me.15.10.1706; Reaux A, 2001, J NEUROCHEM, V77, P1085, DOI 10.1046/j.1471-4159.2001.00320.x; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Scimia MC, 2012, NATURE, V488, P394, DOI 10.1038/nature11263; See HB, 2011, ASSAY DRUG DEV TECHN, V9, P21, DOI 10.1089/adt.2010.0336; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Siddiquee K, 2011, J HYPERTENS, V29, P724, DOI 10.1097/HJH.0b013e32834347de; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Walther C, 2010, J BIOL CHEM, V285, P41578, DOI 10.1074/jbc.M110.162156; Wang CM, 2014, BBA-MOL CELL RES, V1843, P652, DOI 10.1016/j.bbamcr.2013.12.010; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Yue P, 2011, ENDOCRINOLOGY, V152, P59, DOI 10.1210/en.2010-0576; Zimmerman B, 2011, CELL SIGNAL, V23, P648, DOI 10.1016/j.cellsig.2010.11.016	57	42	44	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31173	31187		10.1074/jbc.M114.574020	http://dx.doi.org/10.1074/jbc.M114.574020			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25271156	Green Published, hybrid			2022-12-28	WOS:000344549900025
J	Moll, HP; Lee, A; Minussi, DC; da Silva, CG; Csizmadia, E; Bhasin, M; Ferran, C				Moll, Herwig P.; Lee, Andy; Minussi, Darlan C.; da Silva, Cleide G.; Csizmadia, Eva; Bhasin, Manoj; Ferran, Christiane			A20 Regulates Atherogenic Interferon (IFN)-gamma Signaling in Vascular Cells by Modulating Basal IFN beta Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ENDOTHELIAL-CELLS; GENE-EXPRESSION; ACTIVATION; GAMMA; INDUCTION; ATHEROSCLEROSIS; PROLIFERATION; INHIBITOR; UBIQUITINATION	IFN gamma signaling in endothelial (EC) and smooth muscle cells (SMC) is a key culprit of pathologic vascular remodeling. The impact of NF-kappa B inhibitory protein A20 on IFN gamma signaling in vascular cells remains unknown. In gain-and loss-of-function studies, A20 inversely regulated expression of IFN gamma-induced atherogenic genes in human EC and SMC by modulating STAT1 transcription. In vivo, inadequate A20 expression in A20 heterozygote mice aggravated intimal hyperplasia following partial carotid artery ligation. This outcome uniquely associated with increased levels of Stat1 and super-induction of Ifn gamma-dependent genes. Transcriptome analysis of the aortic media from A20 heterozygote versus wild-type mice revealed increased basal Ifn beta signaling as the likely cause for higher Stat1 transcription. We confirmed higher basal IFN beta levels in A20-silenced human SMC and showed that neutralization or knockdown of IFN beta abrogates heightened STAT1 levels in these cells. Upstream of IFN beta, A20-silenced EC and SMC demonstrated higher levels of phosphorylated/activated TANK-binding kinase-1 (TBK1), a regulator of IFN beta transcription. This suggested that A20 knockdown increased STAT1 transcription by enhancing TBK1 activation and subsequently basal IFN beta levels. Altogether, these results uncover A20 as a key physiologic regulator of atherogenic IFN beta/STAT1 signaling. This novel function of A20 added to its ability to inhibit nuclear factor-kappa B (NF-kappa B) activation solidifies its promise as an ideal therapeutic candidate for treatment and prevention of vascular diseases. In light of recently discovered A20/TNFAIP3 (TNF alpha-induced protein 3) single nucleotide polymorphisms that impart lower A20 expression or function, these results also qualify A20 as a reliable clinical biomarker for vascular risk assessment.	[Moll, Herwig P.; Lee, Andy; Minussi, Darlan C.; da Silva, Cleide G.; Csizmadia, Eva; Ferran, Christiane] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Vasc & Endovasc Surg,Ctr Vasc Biol Res, Boston, MA 02135 USA; [Moll, Herwig P.; Lee, Andy; Minussi, Darlan C.; da Silva, Cleide G.; Csizmadia, Eva; Ferran, Christiane] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Transplant Inst,Dept Surg, Boston, MA 02215 USA; [Ferran, Christiane] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Nephrol,Dept Med, Boston, MA 02215 USA; [Bhasin, Manoj] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Interdisciplinary Med & Biotechnol,Bioinforma, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ferran, C (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Vasc & Endovasc Surg,Ctr Vasc Biol Res, RN 370 F-G,99 Brookline Ave, Boston, MA 02215 USA.	cferran@caregroup.harvard.edu	Moll, Herwig P./H-2836-2019; Angolano, Cleide/AAZ-4154-2021	Moll, Herwig P./0000-0001-6438-9068; Bhasin, Manoj/0000-0001-5172-420X; Conterno Minussi, Darlan/0000-0001-8856-4625	National Institutes of Health [RO1 HL080130, DK063275]; Austrian Science Fund [J3398-BW23]; National Institutes of Health Fellowship from NRSA [T32 HL07734]; National Council for Scientific and Technological Development (CNPq), Brazil; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080130, T32HL007734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063275, R56DK063275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund(Austrian Science Fund (FWF)); National Institutes of Health Fellowship from NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Council for Scientific and Technological Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL080130 and DK063275 (to C. F.).; Supported by the Austrian Science Fund J3398-BW23.; Supported by National Institutes of Health Fellowship T32 HL07734 from NRSA.; Supported by a Science Without Borders fellowship from National Council for Scientific and Technological Development (CNPq), Brazil.	[Anonymous], 2009, J INTERFERON CYTOKIN, V29, P817; Basagoudanavar SH, 2011, J VIROL, V85, P2599, DOI 10.1128/JVI.02213-10; Boonyasrisawat W, 2007, DIABETES, V56, P499, DOI 10.2337/db06-0946; Cheon H, 2013, EMBO J, V32, P2751, DOI 10.1038/emboj.2013.203; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068; Damrauer SM, 2010, ATHEROSCLEROSIS, V211, P404, DOI 10.1016/j.atherosclerosis.2010.03.029; Daniel S, 2004, BLOOD, V104, P2376, DOI 10.1182/blood-2003-02-0635; Dimayuga PC, 2005, ARTERIOSCL THROM VAS, V25, P2528, DOI 10.1161/01.ATV.0000190606.41121.00; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Ferran C, 1998, BLOOD, V91, P2249, DOI 10.1182/blood.V91.7.2249.2249_2249_2258; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008; Gough DJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000361; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; HANSSON GK, 1991, CIRCULATION, V84, P1266, DOI 10.1161/01.CIR.84.3.1266; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Idel S, 2003, P NATL ACAD SCI USA, V100, P14235, DOI 10.1073/pnas.1835672100; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Longo CR, 2003, CIRCULATION, V108, P1113, DOI 10.1161/01.CIR.0000083718.76889.D0; Maelfait J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002570; Meyer O, 2009, JOINT BONE SPINE, V76, P464, DOI 10.1016/j.jbspin.2009.03.012; Niinisalo P, 2010, ANN MED, V42, P55, DOI 10.3109/07853890903321559; Ning SB, 2010, J VIROL, V84, P6130, DOI 10.1128/JVI.00364-10; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Parvatiyar K, 2011, MICROBES INFECT, V13, P209, DOI 10.1016/j.micinf.2010.11.003; Patel VI, 2006, FASEB J, V20, P1418, DOI 10.1096/fj.05-4981com; Paz S, 2006, CELL MOL BIOL, V52, P17, DOI 10.1170/T694; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ranjbaran H, 2007, J IMMUNOL, V178, P592, DOI 10.4049/jimmunol.178.1.592; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Shrikhande GV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014240; Sikorski K, 2011, AM J PHYSIOL-CELL PH, V300, pC1337, DOI 10.1152/ajpcell.00276.2010; Siracuse JJ, 2012, TRANSPLANTATION, V93, P373, DOI 10.1097/TP.0b013e3182419829; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stephan D, 1997, MOL MED, V3, P593, DOI 10.1007/BF03401816; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Suzuki S, 2010, J BIOL CHEM, V285, P4441, DOI 10.1074/jbc.M109.031476; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Tellides G, 2000, NATURE, V403, P207, DOI 10.1038/35003221; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Tu DQ, 2013, CELL REP, V3, P747, DOI 10.1016/j.celrep.2013.01.033; Wang F, 2012, CARDIOVASC RES, V93, P190, DOI 10.1093/cvr/cvr260; Wang JM, 2010, J IMMUNOL, V185, P1720, DOI 10.4049/jimmunol.1000114; Wang X, 2013, ACTA NEUROPATHOL, V126, P711, DOI 10.1007/s00401-013-1183-9; Wang YN, 2007, CIRC RES, V101, P560, DOI 10.1161/CIRCRESAHA.107.151068; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Wrighton CJ, 1996, J EXP MED, V183, P1013, DOI 10.1084/jem.183.3.1013; Yuan C, 2012, J BIOL CHEM, V287, P17006, DOI 10.1074/jbc.M112.341198; Zernecke A, 2010, CARDIOVASC RES, V86, P192, DOI 10.1093/cvr/cvp391; Zohlnhofer D, 2001, MOL CELL, V7, P1059, DOI 10.1016/S1097-2765(01)00239-8	57	17	17	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					30912	30924		10.1074/jbc.M114.591966	http://dx.doi.org/10.1074/jbc.M114.591966			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25217635	Green Published, hybrid			2022-12-28	WOS:000344549900004
J	Klinman, JP; Kohen, A				Klinman, Judith P.; Kohen, Amnon			Evolutionary Aspects of Enzyme Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							THERMOPHILIC ALCOHOL-DEHYDROGENASE; COLI DIHYDROFOLATE-REDUCTASE; PROTEIN DYNAMICS; HYDRIDE-TRANSFER; ESCHERICHIA-COLI; DISTAL MUTATIONS; CHEMICAL STEP; H-TRANSFER; CATALYSIS; MOTIONS	The role of evolutionary pressure on the chemical step catalyzed by enzymes is somewhat enigmatic, in part because chemistry is not rate-limiting for many optimized systems. Herein, we present studies that examine various aspects of the evolutionary relationship between protein dynamics and the chemical step in two paradigmatic enzyme families, dihydrofolate reductases and alcohol dehydrogenases. Molecular details of both convergent and divergent evolution are beginning to emerge. The findings suggest that protein dynamics across an entire enzyme can play a role in adaptation to differing physiological conditions. The growing tool kit of kinetics, kinetic isotope effects, molecular biology, biophysics, and bioinformatics provides means to link evolutionary changes in structure-dynamics function to the vibrational and conformational states of each protein.	[Klinman, Judith P.] Univ Calif Berkeley, Dept Mol & Cell Biol, Dept Chem, Berkeley, CA 94720 USA; [Klinman, Judith P.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Kohen, Amnon] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Iowa	Klinman, JP (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Dept Chem, 229 Stanley Hall, Berkeley, CA 94720 USA.	klinman@berkeley.edu; amnon-kohen@uiowa.edu			National Science Foundation [CHE-1149023]; National Institutes of Health [GM025765, GM65368]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065368, R37GM025765, R01GM025765] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Science Foundation Grant CHE-1149023 (to A. K.) and National Institutes of Health Grants GM025765 (to J. P. K.) and GM65368 (to A. K.). This is the second article in the Thematic Minireview series "Enzyme Evolution."	Adamczyk AJ, 2011, P NATL ACAD SCI USA, V108, P14115, DOI 10.1073/pnas.1111252108; Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; BAHNSON BJ, 1993, BIOCHEMISTRY-US, V32, P5503, DOI 10.1021/bi00072a003; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Breiten B, 2013, J AM CHEM SOC, V135, P15579, DOI 10.1021/ja4075776; Carr CAM, 2014, BIOCHEMISTRY-US, V53, P2212, DOI 10.1021/bi500070q; Ceccarelli C, 2004, BIOCHEMISTRY-US, V43, P5266, DOI 10.1021/bi049736p; CHA Y, 1989, SCIENCE, V243, P1325, DOI 10.1126/science.2646716; Cheatum CM, 2013, TOP CURR CHEM, V337, P1, DOI 10.1007/128_2012_407; Dias CL, 2010, CRYOBIOLOGY, V60, P91, DOI 10.1016/j.cryobiol.2009.07.005; Englander SW, 1996, CURR OPIN STRUC BIOL, V6, P18, DOI 10.1016/S0959-440X(96)80090-X; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; Francis K, 2013, J BIOL CHEM, V288, P35961, DOI 10.1074/jbc.M113.507632; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Hammes-Schiffer S, 2006, ACCOUNTS CHEM RES, V39, P93, DOI 10.1021/ar040199a; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Ruiz-Pernia JJ, 2013, J AM CHEM SOC, V135, P18689, DOI 10.1021/ja410519h; Karlsson A, 2003, CHEM-BIOL INTERACT, V143, P239, DOI 10.1016/S0009-2797(02)00222-3; Klinman J. P., 2009, RS QUANTUM TUNNELING; Klinman JP, 2013, ANNU REV BIOCHEM, V82, P471, DOI 10.1146/annurev-biochem-051710-133623; Klinman JP, 2009, CHEM PHYS LETT, V471, P179, DOI 10.1016/j.cplett.2009.01.038; Knapp MJ, 2002, J AM CHEM SOC, V124, P3865, DOI 10.1021/ja012205t; Kohen A, 1999, NATURE, V399, P496, DOI 10.1038/20981; Liang ZX, 2004, BIOCHEMISTRY-US, V43, P14676, DOI 10.1021/bi049004x; Liang ZX, 2004, J AM CHEM SOC, V126, P9500, DOI 10.1021/ja047087z; Liang ZX, 2004, P NATL ACAD SCI USA, V101, P9556, DOI 10.1073/pnas.0403337101; Liu CT, 2013, P NATL ACAD SCI USA, V110, P10159, DOI 10.1073/pnas.1307130110; Loveridge EJ, 2012, NAT CHEM, V4, P292, DOI 10.1038/nchem.1296; Meadows CW, 2014, J PHYS CHEM B, V118, P6049, DOI 10.1021/jp500825x; Melander L., 1987, REACTION RATES ISOTO; Nagel ZD, 2013, J BIOL CHEM, V288, P14087, DOI 10.1074/jbc.M113.453951; Nagel ZD, 2012, BIOCHEMISTRY-US, V51, P4147, DOI 10.1021/bi3001352; Nagel ZD, 2011, P NATL ACAD SCI USA, V108, P10520, DOI 10.1073/pnas.1104989108; Nagel ZD, 2010, CHEM REV, V110, pPR41, DOI 10.1021/cr1001035; Nagel ZD, 2009, NAT CHEM BIOL, V5, P543, DOI 10.1038/nchembio.204; Papanikolau Y, 2005, ACTA CRYSTALLOGR F, V61, P246, DOI 10.1107/S1744309105002253; Perl D, 2001, J MOL BIOL, V313, P343, DOI 10.1006/jmbi.2001.5050; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Pudney CR, 2013, J AM CHEM SOC, V135, P2512, DOI 10.1021/ja311277k; Radkiewicz JL, 2000, J AM CHEM SOC, V122, P225, DOI 10.1021/ja9913838; Rajagopalan PTR, 2002, BIOCHEMISTRY-US, V41, P12618, DOI 10.1021/bi026369d; Rod TH, 2003, P NATL ACAD SCI USA, V100, P6980, DOI 10.1073/pnas.1230801100; SCHERAGA HA, 1962, J BIOL CHEM, V237, P2506; Sharp K, 2001, PROTEIN SCI, V10, P661, DOI 10.1110/ps.37801; Sikorski RS, 2004, J AM CHEM SOC, V126, P4778, DOI 10.1021/ja031683w; Singh P, 2014, J AM CHEM SOC, V136, P2575, DOI 10.1021/ja411998h; Stojkovic V, 2012, J AM CHEM SOC, V134, P1738, DOI 10.1021/ja209425w; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Villali J, 2010, CURR OPIN CHEM BIOL, V14, P636, DOI 10.1016/j.cbpa.2010.08.007; Wang L, 2006, P NATL ACAD SCI USA, V103, P15753, DOI 10.1073/pnas.0606976103; Wang Z, 2014, J AM CHEM SOC, V136, P8333, DOI 10.1021/ja501936d; Wiegel J., 1998, THERMOPHILES KEYS MO; Wong KF, 2005, P NATL ACAD SCI USA, V102, P6807, DOI 10.1073/pnas.0408343102	55	41	41	1	61	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30205	30212		10.1074/jbc.R114.565515	http://dx.doi.org/10.1074/jbc.R114.565515			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25210031	hybrid, Green Published			2022-12-28	WOS:000344549700004
J	Malt, AL; Cesario, JM; Tang, ZJ; Brown, S; Jeong, JH				Malt, Andre Landin; Cesario, Jeffry M.; Tang, Zuojian; Brown, Stuart; Jeong, Juhee			Identification of a Face Enhancer Reveals Direct Regulation of LIM Homeobox 8 (Lhx8) by Wingless-Int (WNT)/beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; PALATE MESENCHYMAL CELLS; 1ST BRANCHIAL ARCH; NEURAL CREST; CLEFT-PALATE; TGF-BETA; CRANIOFACIAL MORPHOGENESIS; TOOTH DEVELOPMENT; FACIAL PRIMORDIA; MIDFACIAL MORPHOGENESIS	Development of the mammalian face requires a large number of genes that are expressed with spatio-temporal specificity, and transcriptional regulation mediated by enhancers plays a key role in the precise control of gene expression. Using chromatin immunoprecipitation for a histone marker of active enhancers, we generated a genome-wide map of candidate enhancers from the maxillary arch (primordium for the upper jaw) of mouse embryos. Furthermore, we confirmed multiple novel craniofacial enhancers near the genes implicated in human palate defects through functional assays. We characterized in detail one of the enhancers (Lhx8_enh1) located upstream of Lhx8, a key regulatory gene for craniofacial development. Lhx8_enh1 contained an evolutionarily conserved binding site for lymphoid enhancer factor/T-cell factor family proteins, which mediate the transcriptional regulation by the WNT/beta-catenin signaling pathway. We demonstrated in vitro that WNT/beta-catenin signaling was indeed essential for the expression of Lhx8 in the maxillary arch cells and that Lhx8_enh1 was a direct target of the WNT/beta-catenin pathway. Together, we uncovered a molecular mechanism for the regulation of Lhx8, and we provided valuable resources for further investigation into the gene regulatory network of craniofacial development.	[Malt, Andre Landin; Cesario, Jeffry M.; Jeong, Juhee] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA; [Tang, Zuojian; Brown, Stuart] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA	New York University; New York University	Jeong, JH (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, 345 E 24th St,Rm 902D, New York, NY 10010 USA.	jj78@nyu.edu	Brown, Stuart M./A-9880-2016; Malt, Andre Landin/AAO-2509-2021	Brown, Stuart M./0000-0002-0906-9907; Landin Malt, Andre/0000-0002-6655-7333	National Institutes of Health from NIDCR [R00 DE019486]	National Institutes of Health from NIDCR	This work was supported, in whole or in part, by National Institutes of Health Grant R00 DE019486 from NIDCR (to J. J.).	Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; Barlow AJ, 1997, DEVELOPMENT, V124, P391; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Brugmann SA, 2007, DEVELOPMENT, V134, P3283, DOI 10.1242/dev.005132; Cao XM, 2012, BIOCHEM BIOPH RES CO, V427, P366, DOI 10.1016/j.bbrc.2012.09.066; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Chen JQ, 2009, DEV BIOL, V334, P174, DOI 10.1016/j.ydbio.2009.07.015; Cordero DR, 2011, AM J MED GENET A, V155A, P270, DOI 10.1002/ajmg.a.33702; Cotney J, 2013, CELL, V154, P185, DOI 10.1016/j.cell.2013.05.056; Cotney J, 2012, GENOME RES, V22, P1069, DOI 10.1101/gr.129817.111; COULY GF, 1993, DEVELOPMENT, V117, P409; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Denaxa M, 2009, DEV BIOL, V333, P324, DOI 10.1016/j.ydbio.2009.07.001; Dhulipala VC, 2005, BIRTH DEFECTS RES B, V74, P233, DOI 10.1002/bdrb.20043; Ferretti E, 2011, DEV CELL, V21, P627, DOI 10.1016/j.devcel.2011.08.005; Finger JH, 2011, NUCLEIC ACIDS RES, V39, pD835, DOI 10.1093/nar/gkq1132; Fujimori S, 2010, DEV BIOL, V348, P97, DOI 10.1016/j.ydbio.2010.09.009; GREENE RM, 1985, BIOCHEM BIOPH RES CO, V130, P1037, DOI 10.1016/0006-291X(85)91720-6; Greene RM, 2003, J CELL PHYSIOL, V197, P261, DOI 10.1002/jcp.10355; Grigoriou M, 1998, DEVELOPMENT, V125, P2063; He FL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003851; He FL, 2012, FRONT ORAL BIOL, V16, P81, DOI 10.1159/000337619; He FL, 2011, DEV BIOL, V350, P511, DOI 10.1016/j.ydbio.2010.12.021; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hu D, 1999, DEVELOPMENT, V126, P4873; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Iwata J, 2014, DEVELOPMENT, V141, P909, DOI 10.1242/dev.103093; Iwata J, 2012, J BIOL CHEM, V287, P2353, DOI 10.1074/jbc.M111.280974; Iwata J, 2010, J BIOL CHEM, V285, P4975, DOI 10.1074/jbc.M109.035105; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Jeong J, 2012, DEV DYNAM, V241, P1757, DOI 10.1002/dvdy.23867; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jin YR, 2012, DEVELOPMENT, V139, P1821, DOI 10.1242/dev.075796; Kawakami M, 2014, J BIOSCI BIOENG, V117, P664, DOI 10.1016/j.jbiosc.2013.11.015; Kontges G, 1996, DEVELOPMENT, V122, P3229; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Labhart P, 2005, P NATL ACAD SCI USA, V102, P1339, DOI 10.1073/pnas.0409578102; Lan Y, 2004, DEVELOPMENT, V131, P3207, DOI 10.1242/dev.01175; Lan Y, 2006, DEV DYNAM, V235, P1448, DOI 10.1002/dvdy.20723; Le Douarin NM, 2012, CURR OPIN GENET DEV, V22, P381, DOI 10.1016/j.gde.2012.06.001; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu F, 2010, J DENT RES, V89, P318, DOI 10.1177/0022034510363373; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Mandler M, 2001, DEV BIOL, V240, P548, DOI 10.1006/dbio.2001.0490; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Matsuda T, 2001, MECH DEVELOP, V105, P153, DOI 10.1016/S0925-4773(01)00383-5; Matsumoto K, 1996, NEUROSCI LETT, V204, P113, DOI 10.1016/0304-3940(96)12341-7; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Medeiros DM, 2012, DEV BIOL, V371, P121, DOI 10.1016/j.ydbio.2012.08.026; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Nikopensius T, 2011, BIRTH DEFECTS RES A, V91, P218, DOI 10.1002/bdra.20791; NODEN DM, 1978, DEV BIOL, V67, P296, DOI 10.1016/0012-1606(78)90201-4; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; OSUMIYAMASHITA N, 1994, DEV BIOL, V164, P409, DOI 10.1006/dbio.1994.1211; Potchinsky M, 1996, J CELL PHYSIOL, V166, P380, DOI 10.1002/(SICI)1097-4652(199602)166:2<380::AID-JCP16>3.0.CO;2-F; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahimov F, 2012, CLEFT PALATE-CRAN J, V49, P73, DOI 10.1597/10-178; Reid BS, 2011, DEV BIOL, V349, P261, DOI 10.1016/j.ydbio.2010.11.012; Sakabe NJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-238; Sarkar L, 1999, MECH DEVELOP, V85, P197, DOI 10.1016/S0925-4773(99)00095-7; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simoes-Costa M, 2013, GENOME RES, V23, P1069, DOI 10.1101/gr.157586.113; Song LY, 2009, DEVELOPMENT, V136, P3161, DOI 10.1242/dev.037440; Stuhlmiller TJ, 2012, CELL MOL LIFE SCI, V69, P3715, DOI 10.1007/s00018-012-0991-8; Sun Y, 2012, DEV DYNAM, V241, P663, DOI 10.1002/dvdy.23755; Szabo-Rogers HL, 2010, DEV BIOL, V341, P84, DOI 10.1016/j.ydbio.2009.11.021; Trumpp A, 1999, GENE DEV, V13, P3136, DOI 10.1101/gad.13.23.3136; Tucker AS, 1999, DEVELOPMENT, V126, P51; VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2; Vieira AR, 2008, J DENT RES, V87, P119, DOI 10.1177/154405910808700202; Vieira AR, 2005, PLOS GENET, V1, P651, DOI 10.1371/journal.pgen.0010064; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2013, CELL, V152, P895, DOI 10.1016/j.cell.2012.12.041; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang YP, 2011, DEV BIOL, V349, P250, DOI 10.1016/j.ydbio.2010.11.004; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Warner DR, 2003, CELL SIGNAL, V15, P235, DOI 10.1016/S0898-6568(02)00082-7; Washbourne BJ, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-18; Williamson I, 2011, DEV CELL, V21, P17, DOI 10.1016/j.devcel.2011.06.008; WINGENDER E, 1988, NUCLEIC ACIDS RES, V16, P1879, DOI 10.1093/nar/16.5.1879; Yildirim Y, 2014, EUR J HUM GENET, V22, P333, DOI 10.1038/ejhg.2013.138; Yu L, 2005, DEVELOPMENT, V132, P4397, DOI 10.1242/dev.02013; Yu ZL, 2005, TOXICOL SCI, V83, P349, DOI 10.1093/toxsci/kfi030; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang ZC, 2013, J BIOL CHEM, V288, P2485, DOI 10.1074/jbc.M112.402933; Zhao ML, 2013, MOL CELL BIOL, V33, P3099, DOI 10.1128/MCB.00524-13; Zhao YG, 1999, P NATL ACAD SCI USA, V96, P15002, DOI 10.1073/pnas.96.26.15002	102	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30289	30301		10.1074/jbc.M114.592014	http://dx.doi.org/10.1074/jbc.M114.592014			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25190800	hybrid, Green Published			2022-12-28	WOS:000344549700013
J	Pisani, F; Mola, MG; Simone, L; Rosito, S; Alberga, D; Mangiatordi, GF; Lattanzi, G; Nicolotti, O; Frigeri, A; Svelto, M; Nicchia, GP				Pisani, Francesco; Mola, Maria Grazia; Simone, Laura; Rosito, Stefania; Alberga, Domenico; Mangiatordi, Giuseppe Felice; Lattanzi, Gianluca; Nicolotti, Orazio; Frigeri, Antonio; Svelto, Maria; Nicchia, Grazia Paola			Identification of a Point Mutation Impairing the Binding between Aquaporin-4 and Neuromyelitis Optica Autoantibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVISED DIAGNOSTIC-CRITERIA; MOLECULAR-DYNAMICS; ORTHOGONAL ARRAYS; WATER CHANNEL; MULTIPLE-SCLEROSIS; HUMAN-COMPLEMENT; AQP4 POOLS; MECHANISM; ACTIVATION; EXPRESSION	Neuromyelitis optica (NMO) is characterized by the presence of pathogenic autoantibodies (NMO-IgGs) against supra-molecular assemblies of aquaporin-4 (AQP4), known as orthogonal array of particles (OAPs). NMO-IgGs have a polyclonal origin and recognize different conformational epitopes involving extracellular AQP4 loops A, C, and E. Here we hypothesize a pivotal role for AQP4 transmembrane regions (TMs) in epitope assembly. On the basis of multialignment analysis, mutagenesis, NMO-IgG binding, and cytotoxicity assay, we have disclosed the key role of aspartate 69 (Asp(69)) of TM2 for NMO-IgG epitope assembly. Mutation of Asp(69) to histidine severely impairs NMO-IgG binding for 85.7% of the NMO patient sera analyzed here. Although Blue Native-PAGE, total internal reflection fluorescence microscopy, and water transport assays indicate that the OAP Asp(69) mutant is similar in structure and function to the wild type, molecular dynamic simulations have revealed that the (DH)-H-69 mutation has the effect of altering the structural rearrangements of extracellular loop A. In conclusion, Asp(69) is crucial for the spatial control of loop A, the particular molecular conformation of which enables the assembly of NMO-IgG epitopes. These findings provide additional clues for new strategies for NMO treatment and a wealth of information to better approach NMO pathogenesis.	[Pisani, Francesco; Mola, Maria Grazia; Simone, Laura; Rosito, Stefania; Frigeri, Antonio; Svelto, Maria; Nicchia, Grazia Paola] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, I-70126 Bari, Italy; [Pisani, Francesco; Mola, Maria Grazia; Simone, Laura; Rosito, Stefania; Frigeri, Antonio; Svelto, Maria; Nicchia, Grazia Paola] Univ Bari Aldo Moro, Ctr Excellence Comparat Genom, I-70126 Bari, Italy; [Mangiatordi, Giuseppe Felice; Nicolotti, Orazio] Univ Bari Aldo Moro, Dipartimento Farm Sci Farmaco, I-70126 Bari, Italy; [Alberga, Domenico; Lattanzi, Gianluca] Univ Bari Aldo Moro, Dipartimento Interateneo Fis M Merlin, INFN, I-70126 Bari, Italy; [Alberga, Domenico; Lattanzi, Gianluca] Univ Bari Aldo Moro, TIRES, I-70126 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN); Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Nicchia, GP (corresponding author), Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, I-70126 Bari, Italy.	graziapaola.nicchia@uniba.it	PISANI, Francesco/AAC-1749-2019; Lattanzi, Gianluca/E-1753-2011; Svelto, Maria/P-6186-2014; Simone, Laura/B-2093-2017; Mangiatordi, Giuseppe Felice/AAH-9527-2020; frigeri, Antonio/AAC-6336-2022; Mola, Maria Grazia/I-3507-2019; Alberga, Domenico/K-3272-2019; Lattanzi, Gianluca/AAA-3173-2019; Nicolotti, Orazio/F-3209-2012	PISANI, Francesco/0000-0001-8511-117X; Lattanzi, Gianluca/0000-0002-0808-6457; Simone, Laura/0000-0002-3540-4895; Mola, Maria Grazia/0000-0002-4421-9237; Alberga, Domenico/0000-0002-9475-9602; Lattanzi, Gianluca/0000-0002-0808-6457; Nicolotti, Orazio/0000-0001-6533-5539; Svelto, Maria/0000-0002-5584-9541; Frigeri, Antonio/0000-0002-5284-2934; Mangiatordi, Giuseppe Felice/0000-0003-4042-2841	Italian Ministry of University and Research [RBFR12SJA8]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by Italian Ministry of University and Research Project Firb "Futuro in Ricerca" RBFR12SJA8.	ADELMAN SA, 1976, J CHEM PHYS, V64, P2375, DOI 10.1063/1.432526; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; FREEDMAN J, 1977, VOX SANG, V33, P212, DOI 10.1111/j.1423-0410.1977.tb04466.x; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Hinson SR, 2012, P NATL ACAD SCI USA, V109, P1245, DOI 10.1073/pnas.1109980108; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; HUGHESJONES NC, 1977, NATURE, V270, P613, DOI 10.1038/270613a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iorio R, 2013, J AUTOIMMUN, V40, P21, DOI 10.1016/j.jaut.2012.07.008; Jarius S, 2007, NAT CLIN PRACT NEURO, V3, DOI 10.1038/ncpneuro0501; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kalluri SR, 2010, ARCH NEUROL-CHICAGO, V67, P1201, DOI 10.1001/archneurol.2010.269; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Matiello M, 2011, NEUROLOGY, V77, P1149, DOI 10.1212/WNL.0b013e31822f045b; Matiello M, 2013, JAMA NEUROL, V70, P1118, DOI 10.1001/jamaneurol.2013.3124; Mola MG, 2009, ANAL CHEM, V81, P8219, DOI 10.1021/ac901526k; Nelson PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015050; Nicchia GP, 2008, J NEUROCHEM, V105, P2156, DOI 10.1111/j.1471-4159.2008.05302.x; Nicchia GP, 2011, NEUROSCIENCE, V197, P80, DOI 10.1016/j.neuroscience.2011.09.023; Nicchia GP, 2010, NEUROSCIENCE, V168, P903, DOI 10.1016/j.neuroscience.2010.02.008; Nicchia G.P., 2013, WILEY INTERDISCIPLIN; Nicchia GP, 2008, GLIA, V56, P869, DOI 10.1002/glia.20661; Nicchia GP, 2009, GLIA, V57, P1363, DOI 10.1002/glia.20855; Nordlund HR, 2003, FEBS LETT, V555, P449, DOI 10.1016/S0014-5793(03)01302-4; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Phuan PW, 2012, J BIOL CHEM, V287, P13829, DOI 10.1074/jbc.M112.344325; Pisani F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079185; Pisani F, 2011, J BIOL CHEM, V286, P9216, DOI 10.1074/jbc.M110.123000; Pittock SJ, 2013, LANCET NEUROL, V12, P554, DOI 10.1016/S1474-4422(13)70076-0; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ratelade J, 2012, INT J BIOCHEM CELL B, V44, P1519, DOI 10.1016/j.biocel.2012.06.013; Ratelade J, 2012, ACTA NEUROPATHOL, V123, P861, DOI 10.1007/s00401-012-0986-4; Rossi A, 2012, TRAFFIC, V13, P43, DOI 10.1111/j.1600-0854.2011.01299.x; Rossi A, 2010, J BIOL CHEM, V285, P4562, DOI 10.1074/jbc.M109.069245; Schrodinger, 2013, MAESTR VERS 9 5 REL; SCHUMAKER VN, 1986, MOL IMMUNOL, V23, P557, DOI 10.1016/0161-5890(86)90119-7; SLEDGE CR, 1973, J BIOL CHEM, V248, P2818; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74	44	21	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30578	30589		10.1074/jbc.M114.582221	http://dx.doi.org/10.1074/jbc.M114.582221			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25239624	Green Published, hybrid			2022-12-28	WOS:000344549700035
J	Eom, S; Kim, Y; Kim, M; Park, D; Lee, H; Lee, YS; Choe, J; Kim, YM; Jeoung, D				Eom, Sangkyung; Kim, Youngmi; Kim, Misun; Park, Deokbum; Lee, Hansoo; Lee, Yun Sil; Choe, Jongseon; Kim, Young Myeong; Jeoung, Dooil			Transglutaminase II/MicroRNA-218/-181a Loop Regulates Positive Feedback Relationship between Allergic Inflammation and Tumor Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Gene Regulation; Macrophage; Mast Cell; Tumor Metastasis; Allergic Inflammation; Transglutaminase II; MicroRNA-181a; MicroRNA-218	MAST-CELLS; TISSUE TRANSGLUTAMINASE; AIRWAY INFLAMMATION; SKIN INFLAMMATION; CROSS-LINKING; MOUSE MODEL; T-CELLS; EXPRESSION; ASTHMA; ANAPHYLAXIS	Background: The mechanism of transglutaminase II-mediated allergic inflammation-promoted tumor metastasis remains unknown at the molecular level. Results: The transglutaminase II/miR-218/-181a loop regulates allergic inflammation-promoted tumor metastasis. Conclusion: Transglutaminase II mediates a positive feedback between allergic inflammation and tumor metastasis. Significance: Transglutaminase II can be a target for the development of allergy and cancer therapeutics. The molecular mechanism of transglutaminase II (TGaseII)-mediated allergic inflammation remains largely unknown. TGaseII, induced by antigen stimulation, showed an interaction and co-localization with FcERI. TGaseII was necessary for in vivo allergic inflammation, such as triphasic cutaneous reaction, passive cutaneous anaphylaxis, and passive systemic anaphylaxis. TGaseII was necessary for the enhanced metastatic potential of B16F1 melanoma cells by passive systemic anaphylaxis. TGaseII was shown to be a secreted protein. Recombinant TGaseII protein increased the histamine release and -hexosaminidase activity, and enhanced the metastatic potential of B16F1 mouse melanoma cells. Recombinant TGaseII protein induced the activation of EGF receptor and an interaction between EGF receptor and FcERI. Recombinant TGaseII protein displayed angiogenic potential accompanied by allergic inflammation. R2 peptide, an inhibitor of TGaseII, exerted negative effects on in vitro and in vivo allergic inflammation by regulating the expression of TGaseII and FcERI signaling. MicroRNA (miR)-218 and miR-181a, decreased during allergic inflammation, were predicted as negative regulators of TGaseII by microRNA array and TargetScan analysis. miR-218 and miR-181a formed a negative feedback loop with TGaseII and regulated the in vitro and in vivo allergic inflammation. TGaseII was necessary for the interaction between mast cells and macrophages during allergic inflammation. Mast cells and macrophages, activated during allergic inflammation, were responsible for the enhanced metastatic potential of tumor cells that are accompanied by allergic inflammation. In conclusion, the TGaseII/miR-218/-181a feedback loop can be employed for the development of anti-allergy therapeutics.	[Eom, Sangkyung; Kim, Youngmi; Kim, Misun; Park, Deokbum; Jeoung, Dooil] Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon 200701, South Korea; [Lee, Hansoo] Kangwon Natl Univ, Dept Biol Sci, Coll Nat Sci, Chunchon 200701, South Korea; [Choe, Jongseon; Kim, Young Myeong] Kangwon Natl Univ, Grad Sch Med, Chunchon 200701, South Korea; [Lee, Yun Sil] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Ewha Womans University	Jeoung, D (corresponding author), Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon 200701, South Korea.	jeoungd@kangwon.ac.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850	National Research Foundation [2012H1B8A2025495, 2014R1A2A2A01002448, 2012R1A1A3009993]; BK21 Plus program; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1320160]; Kangwon National University [120140305]	National Research Foundation; BK21 Plus program; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea; Kangwon National University	This work was supported by National Research Foundation Grants 2012H1B8A2025495, 2014R1A2A2A01002448, and 2012R1A1A3009993; a grant from the BK21 Plus program; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea, Grant 1320160; and Kangwon National University Grant 120140305.	Abdala-Valencia H, 2012, AM J PHYSIOL-LUNG C, V303, pL642, DOI 10.1152/ajplung.00406.2011; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Byrne AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069246; Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051268; Collison A, 2011, J ALLERGY CLIN IMMUN, V128, P160, DOI 10.1016/j.jaci.2011.04.005; Dardik R, 2005, ARTERIOSCL THROM VAS, V25, P526, DOI 10.1161/01.ATV.0000154137.21230.80; Detoraki A, 2009, J ALLERGY CLIN IMMUN, V123, P1142, DOI 10.1016/j.jaci.2009.01.044; Eom S, 2014, J BIOL CHEM, V289, P12126, DOI 10.1074/jbc.M113.521245; FESUS L, 1985, J BIOL CHEM, V260, P3771; Hallstrand TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008583; Heijink IH, 2007, AM J RESP CELL MOL, V36, P351, DOI 10.1165/rcmb.2006-0160OC; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Hong GU, 2013, CELL SIGNAL, V25, P1514, DOI 10.1016/j.cellsig.2013.03.010; Hur GY, 2009, J CLIN IMMUNOL, V29, P786, DOI 10.1007/s10875-009-9314-8; Janiak A, 2006, MOL BIOL CELL, V17, P1606, DOI 10.1091/mbc.E05-06-0549; Jemima EA, 2014, MOL IMMUNOL, V62, P19, DOI 10.1016/j.molimm.2014.05.007; Jones CP, 2009, STEM CELLS, V27, P3074, DOI 10.1002/stem.222; Kang SK, 2004, J BIOL CHEM, V279, P36593, DOI 10.1074/jbc.M402084200; Kazenwadel J, 2010, BLOOD, V116, P2395, DOI 10.1182/blood-2009-12-256297; Kim DY, 2011, BRIT J PHARMACOL, V162, P210, DOI 10.1111/j.1476-5381.2010.01033.x; Kim Y, 2012, J BIOL CHEM, V287, P25844, DOI 10.1074/jbc.M112.348284; Kim Y, 2011, MOL IMMUNOL, V48, P1035, DOI 10.1016/j.molimm.2011.01.013; Kim Y, 2010, MOL IMMUNOL, V47, P1010, DOI 10.1016/j.molimm.2009.11.017; Lai TS, 2013, AMINO ACIDS, V45, P857, DOI 10.1007/s00726-013-1532-y; Le Cras TD, 2011, AM J PHYSIOL-LUNG C, V300, pL414, DOI 10.1152/ajplung.00346.2010; LORAND L, 1976, P NATL ACAD SCI USA, V73, P4479, DOI 10.1073/pnas.73.12.4479; Loubaki L, 2010, MOL IMMUNOL, V47, P2112, DOI 10.1016/j.molimm.2010.03.011; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Luo XL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010149; Maeda K, 2010, J IMMUNOL, V185, P4252, DOI 10.4049/jimmunol.1001228; Malmhall C, 2014, J ALLERGY CLIN IMMUN, V133, P1429, DOI 10.1016/j.jaci.2013.11.008; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Na YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063451; Oh K, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-35; Oh K, 2011, J EXP MED, V208, P1707, DOI 10.1084/jem.20101457; Olivera A, 2013, IMMUNOL LETT, V150, P89, DOI 10.1016/j.imlet.2013.01.005; Palosuo K, 2003, J ALLERGY CLIN IMMUN, V111, P1386, DOI 10.1067/mai.2003.1498; Park MK, 2012, BIOMOL THER, V20, P380, DOI 10.4062/biomolther.2012.20.4.380; Rabenhorst A, 2012, BLOOD, V120, P2042, DOI 10.1182/blood-2012-03-415638; Sharma A, 2012, J APPL PHYSIOL, V113, P459, DOI 10.1152/japplphysiol.00001.2012; Small EM, 2010, CIRC RES, V107, P1336, DOI 10.1161/CIRCRESAHA.110.227926; Sohn J, 2003, J CLIN INVEST, V111, P121, DOI 10.1172/JCI200315937; Song Y, 2010, J ALLERGY CLIN IMMUN, V126, P1208, DOI 10.1016/j.jaci.2010.09.013; Stumm CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095959; Suh GY, 2006, EXP LUNG RES, V32, P43, DOI 10.1080/01902140600691514; Telci D, 2009, J BIOL CHEM, V284, P29547, DOI 10.1074/jbc.M109.041806; van Mil A, 2012, CARDIOVASC RES, V93, P655, DOI 10.1093/cvr/cvs003; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang Z, 2012, AMINO ACIDS, V42, P939, DOI 10.1007/s00726-011-1008-x; Xie WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058639; Yamada Y, 2014, BIOCHEM BIOPH RES CO, V443, P980, DOI 10.1016/j.bbrc.2013.12.078; Yu SQ, 2011, AM J RHINOL ALLERGY, V25, pE242, DOI 10.2500/ajra.2011.25.3682; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054250, 10.1371/journal.pone.0059667]; Zhang YY, 2013, INT J MOL MED, V31, P797, DOI 10.3892/ijmm.2013.1260	55	22	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29483	29505		10.1074/jbc.M114.603480	http://dx.doi.org/10.1074/jbc.M114.603480			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25202021	Green Published, hybrid			2022-12-28	WOS:000344370800003
J	Liu, ZB; Chen, XX; Wang, Y; Peng, HY; Wang, YA; Jing, YL; Zhang, HB				Liu, Zhibo; Chen, Xinxin; Wang, Ying; Peng, Haiyong; Wang, Yanan; Jing, Yanling; Zhang, Hongbing			PDK4 Protein Promotes Tumorigenesis through Activation of cAMP-response Element-binding Protein (CREB)-Ras Homolog Enriched in Brain (RHEB)-mTORC1 Signaling Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cAMP-response Element-binding Protein (CREB); Cellular Regulation; DNA-Protein Interaction; Mechanistic Target of Rapamycin (mTOR); Warburg Effect; Ras Homolog Enriched in Brain; Pyruvate Dehydrogenase Kinase 4; Signaling; Tumorigenesis	PYRUVATE-DEHYDROGENASE COMPLEX; TUBEROUS SCLEROSIS COMPLEX-1; MAMMALIAN TARGET; GROWTH-CONTROL; UP-REGULATION; RAT MODEL; MTOR; PHOSPHORYLATION; RAPAMYCIN; CANCER	Background: mTOR integrates various intracellular and extracellular signals to regulate cell growth, proliferation, and survival. Results: PDK4 promotes tumorigenesis through activation of the CREB-RHEB-mTORC1 signaling cascade. Conclusion: PDK4 is a novel activator of mTOR signaling. Significance: PDK4 activation of mTORC1 may be targeted for the treatment of mTOR-mediated cancer and other diseases. Mechanistic target of rapamycin (mTOR) integrates multiple extracellular and intracellular signals to regulate cell growth and survival. Hyperactivation of mTOR has been observed in various cancers. Regulation of mTOR activity is thus of importance in physiological processes and tumor development. Here, we present pyruvate dehydrogenase kinase 4 (PDK4) as a novel regulator of mTORC1 signaling. mTORC1 activity was augmented with PDK4 overexpression and reduced by PDK4 suppression in various cell lines. Furthermore, PDK4 bound to cAMP-response element-binding protein (CREB) and prevented its degradation. The enhanced CREB consequently transactivated the expression of Ras homolog enriched in brain (RHEB), a direct key activator of mTORC1, independent of AMP-activated protein kinase or tuberous sclerosis complex protein 2. PDK4 potentiated the mTORC1 effectors hypoxia-inducible factor 1 and pyruvate kinase isozymes M2 and promoted aerobic glycolysis (Warburg effect). Knockdown of PDK4 suppressed the tumor development of cancer cells with activated mTORC1. The abundance of PDK4 dictated the responsiveness of cells to the mTOR inhibitor, rapamycin. Combinatory suppression of mTOR and PDK4 exerted synergistic inhibition on cancer cell proliferation. Therefore, PDK4 promotes tumorigenesis through activation of the CREB-RHEB-mTORC1 signaling cascade.	[Liu, Zhibo; Chen, Xinxin; Wang, Ying; Peng, Haiyong; Wang, Yanan; Jing, Yanling; Zhang, Hongbing] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Physiol, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Liu, Zhibo; Chen, Xinxin; Wang, Ying; Peng, Haiyong; Wang, Yanan; Jing, Yanling; Zhang, Hongbing] Peking Union Med Coll, Grad Sch, Sch Basic Med, Beijing 100005, Peoples R China; [Wang, Ying] Dalian Med Univ, Inst Canc Stem Cell, Dalian 116044, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Dalian Medical University	Zhang, HB (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100005, Peoples R China.	hbzhang@ibms.pumc.edu.cn	Peng, Haiyong/S-8045-2016		National Science and Technology Major Project [2013ZX10002008]; National Basic Research Program of China 973 Program [2011CB965002]; National Natural Science Foundation of China [81101516, 81130085]; Ministry of Education of China 211 Project [B08007]	National Science and Technology Major Project; National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China 211 Project	This work was supported by the National Science and Technology Major Project (2013ZX10002008), the National Basic Research Program of China 973 Program Grant (2011CB965002), the National Natural Science Foundation of China (Grants 81101516 and 81130085), and the Ministry of Education of China 211 Project (B08007).	Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; DEANGELO AB, 1991, FUND APPL TOXICOL, V16, P337, DOI 10.1016/0272-0590(91)90118-N; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guo LJ, 2012, INT J MOL SCI, V13, P3563, DOI 10.3390/ijms13033563; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; KOBAYASHI T, 1995, NAT GENET, V9, P70, DOI 10.1038/ng0195-70; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li Y, 2007, J BIOL CHEM, V282, P35803, DOI 10.1074/jbc.M705231200; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma JH, 2011, J GENET GENOMICS, V38, P533, DOI 10.1016/j.jgg.2011.10.002; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Mu J, 2013, NEUROBIOL DIS, V51, P133, DOI 10.1016/j.nbd.2012.11.003; Peng H, 2013, ONCOGENE, V32, P4702, DOI 10.1038/onc.2012.481; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Stacpoole PW, 1998, ENVIRON HEALTH PERSP, V106, P989, DOI 10.1289/ehp.98106s4989; Stapoole PW, 2008, ADV DRUG DELIVER REV, V60, P1478, DOI 10.1016/j.addr.2008.02.014; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yecies JL, 2011, CANCER RES, V71, P2815, DOI 10.1158/0008-5472.CAN-10-4158; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zheng M, 2011, NAT CELL BIOL, V13, P263, DOI 10.1038/ncb2168; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	43	56	59	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29739	29749		10.1074/jbc.M114.584821	http://dx.doi.org/10.1074/jbc.M114.584821			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25164809	Green Published, hybrid			2022-12-28	WOS:000344370800022
J	Harari, D; Kuhn, N; Abramovich, R; Sasson, K; Zozulya, AL; Smith, P; Schlapschy, M; Aharoni, R; Koster, M; Eilam, R; Skerra, A; Schreiber, G				Harari, Daniel; Kuhn, Nadine; Abramovich, Renne; Sasson, Keren; Zozulya, Alla L.; Smith, Paul; Schlapschy, Martin; Aharoni, Rina; Koester, Mario; Eilam, Raya; Skerra, Arne; Schreiber, Gideon			Enhanced in Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MXA MESSENGER-RNA; IFN-BETA; EXPRESSION; RECEPTOR; BINDING; RESPONSES; CELLS; INDUCTION; REVEALS	IFN beta is a common therapeutic option to treat multiple sclerosis. It is unique among the family of type I IFNs in that it binds to the interferon receptors with high affinity, conferring exceptional biological properties. We have previously reported the generation of an interferon superagonist (dubbed YNS alpha 8) that is built on the backbone of a low affinity IFN alpha but modified to exhibit higher receptor affinity than even for IFN beta. Here, YNS alpha 8 was fused with a 600-residue hydrophilic, unstructured N-terminal polypeptide chain comprising proline, alanine, and serine (PAS) to prolong its plasma half-life via "PASylation." PAS-YNS alpha 8 exhibited a 10-fold increased half-life in both pharmacodynamic and pharmacokinetic assays in a transgenic mouse model harboring the human receptors, notably without any detectable loss in biological potency or bioavailability. This long-lived superagonist conferred significantly improved protection from MOG(35-55)-induced experimental autoimmune encephalomyelitis compared with IFN beta, despite being injected with a 4-fold less frequency and at an overall 16-fold lower dosage. These data were corroborated by FACS measurements showing a decrease of CD11b(+)/CD45(hi) myeloid lineage cells detectable in the CNS, as well as a decrease in IBA(+) cells in spinal cord sections determined by immunohistochemistry for PAS-YNS alpha 8-treated animals. Importantly, PAS-YNS alpha 8 did not induce antibodies upon repeated administration, and its biological efficacy remained unchanged after 21 days of treatment. A striking correlation between increased levels of CD274 (PD-L1) transcripts from spleen-derived CD4(+) cells and improved clinical response to autoimmune encephalomyelitis was observed, indicating that, at least in this mouse model of multiple sclerosis, CD274 may serve as a biomarker to predict the effectiveness of IFN therapy to treat this complex disease.	[Harari, Daniel; Abramovich, Renne; Sasson, Keren; Schreiber, Gideon] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Aharoni, Rina] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Eilam, Raya] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Kuhn, Nadine; Schlapschy, Martin; Skerra, Arne] Tech Univ Munich, Munich Ctr Integrated Prot Sci, D-85350 Freising Weihenstephan, Germany; [Kuhn, Nadine; Schlapschy, Martin; Skerra, Arne] Tech Univ Munich, Lehrstuhl Biol Chem, D-85350 Freising Weihenstephan, Germany; [Skerra, Arne] XL Prot GmbH, D-85354 Freising Weihenstephan, Germany; [Zozulya, Alla L.; Smith, Paul] Merck Serono, MS Platform, CH-1279 Geneva, GE, Switzerland; [Koester, Mario] Helmholtz Ctr Infect Res, Dept Gene Regulat & Differentiat, D-38124 Braunschweig, Germany	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Technical University of Munich; Technical University of Munich; Merck KGaA; EMD Serono Inc.; Helmholtz Association; Helmholtz-Center for Infection Research	Harari, D (corresponding author), Weizmann Inst Sci, Dept Biol Chem, 234 Herzl St, IL-76100 Rehovot, Israel.	daniel.harari@weizmann.ac.il; gideon.schreiber@weizmann.ac.il	Skerra, Arne/A-2269-2013	Skerra, Arne/0000-0002-5717-498X	Merck-KGaA; Leading Edge Cluster m4 Grant - Bundesministerium fur Bildung und Forschung [16EX1022V]	Merck-KGaA(Merck & Company); Leading Edge Cluster m4 Grant - Bundesministerium fur Bildung und Forschung	This work was supported by a research grant from Merck-KGaA (to G. S.) and by the Leading Edge Cluster m<SUP>4</SUP> Grant 16EX1022V funded by the Bundesministerium fur Bildung und Forschung (to A. S.). A. Z. and P. S. were employed by Merck-Serono. A. S. is a member of XL-protein GmbH.	AUSTIMS Research Group, 1989, J NEUROL NEUROSUR PS, V52, P566; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Baker DP, 2006, BIOCONJUGATE CHEM, V17, P179, DOI 10.1021/bc050237q; Baranzini SE, 2013, MULT SCLER J, V19, P1813, DOI 10.1177/1352458513501573; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Begum F, 2010, J NEUROSCI METH, V187, P59, DOI 10.1016/j.jneumeth.2009.12.013; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Calabresi PA, 2014, LANCET NEUROL, V13, P657, DOI 10.1016/S1474-4422(14)70068-7; Croxford AL, 2011, BBA-MOL BASIS DIS, V1812, P177, DOI 10.1016/j.bbadis.2010.06.010; Dhalluin C, 2005, BIOCONJUGATE CHEM, V16, P518, DOI 10.1021/bc049780h; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Esashi E, 2003, J IMMUNOL, V171, P2773, DOI 10.4049/jimmunol.171.6.2773; Fernald GH, 2007, J IMMUNOL, V178, P5076, DOI 10.4049/jimmunol.178.8.5076; Galligan CL, 2010, MULT SCLER J, V16, P1458, DOI 10.1177/1352458510381259; Goldman Myla D, 2010, Ther Adv Neurol Disord, V3, P229, DOI 10.1177/1756285610374117; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Harari D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084259; Heathcote EJ, 2000, NEW ENGL J MED, V343, P1673, DOI 10.1056/NEJM200012073432302; Hesse D, 2009, NEUROLOGY, V73, P372, DOI 10.1212/WNL.0b013e3181b04c98; Hu X, 2012, J CLIN PHARMACOL, V52, P798, DOI 10.1177/0091270011407068; Hundeshagen A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-140; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Kalie E, 2007, J BIOL CHEM, V282, P11602, DOI 10.1074/jbc.M610115200; Karussis D, 2014, J AUTOIMMUN, V48-49, P134, DOI 10.1016/j.jaut.2014.01.022; Lavoie TB, 2011, CYTOKINE, V56, P282, DOI 10.1016/j.cyto.2011.07.019; Levin D, 2011, MOL CELL BIOL, V31, P3252, DOI 10.1128/MCB.05251-11; Liu YW, 2014, NAT MED, V20, P272, DOI 10.1038/nm.3485; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Mahmood I., 2005, INTERSPECIES PHARMAC; Mahurkar S, 2014, AUTOIMMUN REV, V13, P178, DOI 10.1016/j.autrev.2013.10.012; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; MEERMAN HJ, 1994, BIO-TECHNOL, V12, P1107, DOI 10.1038/nbt1194-1107; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Meyniel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038661; Pachner AR, 2003, NEUROLOGY, V61, pS24, DOI 10.1212/01.WNL.0000092361.04511.D0; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; Reuss R, 2013, BIOL-TARGETS THER, V7, P131, DOI 10.2147/BTT.S29948; Rio J, 2006, ANN NEUROL, V59, P344, DOI 10.1002/ana.20740; Roisman LC, 2005, J MOL BIOL, V353, P271, DOI 10.1016/j.jmb.2005.08.042; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schiweck W, 1995, PROTEINS, V23, P561, DOI 10.1002/prot.340230411; Schlapschy M, 2006, PROTEIN ENG DES SEL, V19, P385, DOI 10.1093/protein/gzl018; Schlapschy M, 2013, PROTEIN ENG DES SEL, V26, P489, DOI 10.1093/protein/gzt023; Schwid SR, 2007, CLIN THER, V29, P2031, DOI 10.1016/j.clinthera.2007.09.025; Sellebjerg F, 2008, MULT SCLER J, V14, P615, DOI 10.1177/1352458507085976; Serana F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094794; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; van der Meide PH, 1998, J NEUROIMMUNOL, V84, P14, DOI 10.1016/S0165-5728(97)00207-5; van der Voort LF, 2010, NEUROLOGY, V75, P1228, DOI 10.1212/WNL.0b013e3181f6c556; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Williams GJ, 1998, J INTERF CYTOK RES, V18, P967, DOI 10.1089/jir.1998.18.967	58	51	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29014	29029		10.1074/jbc.M114.602474	http://dx.doi.org/10.1074/jbc.M114.602474			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25193661	Green Published, hybrid			2022-12-28	WOS:000344141000021
J	Jennelle, L; Hunegnaw, R; Dubrovsky, L; Pushkarsky, T; Fitzgerald, ML; Sviridov, D; Popratiloff, A; Brichacek, B; Bukrinsky, M				Jennelle, Lucas; Hunegnaw, Ruth; Dubrovsky, Larisa; Pushkarsky, Tatiana; Fitzgerald, Michael L.; Sviridov, Dmitri; Popratiloff, Anastas; Brichacek, Beda; Bukrinsky, Michael			HIV-1 Protein Nef Inhibits Activity of ATP-binding Cassette Transporter A1 by Targeting Endoplasmic Reticulum Chaperone Calnexin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 ENVELOPE GLYCOPROTEIN; CHOLESTEROL EFFLUX; QUALITY-CONTROL; CLASS-I; INTRACELLULAR TRAFFICKING; EXTRACELLULAR DOMAIN; P-GLYCOPROTEIN; ABCA1; CALRETICULIN; LOCALIZATION	HIV-infected patients are at increased risk of developing atherosclerosis, in part due to an altered high density lipoprotein profile exacerbated by down-modulation and impairment of ATP-binding cassette transporter A1 (ABCA1) activity by the HIV-1 protein Nef. However, the mechanisms of this Nef effect remain unknown. Here, we show that Nef interacts with an endoplasmic reticulum chaperone calnexin, which regulates folding and maturation of glycosylated proteins. Nef disrupted interaction between calnexin and ABCA1 but increased affinity and enhanced interaction of calnexin with HIV-1 gp160. The Nef mutant that did not bind to calnexin did not affect the calnexin- ABCA1 interaction. Interaction with calnexin was essential for functionality of ABCA1, as knockdown of calnexin blocked the ABCA1 exit from the endoplasmic reticulum, reduced ABCA1 abundance, and inhibited cholesterol efflux; the same effects were observed after Nef overexpression. However, the effects of calnexin knockdown and Nef on cholesterol efflux were not additive; in fact, the combined effect of these two factors together did not differ significantly from the effect of calnexin knockdown alone. Interestingly, gp160 and ABCA1 interacted with calnexin differently; although gp160 binding to calnexin was dependent on glycosylation, glycosylation was of little importance for the interaction between ABCA1 and calnexin. Thus, Nef regulates the activity of calnexin to stimulate its interaction with gp160 at the expense of ABCA1. This study identifies a mechanism for Nef-dependent inactivation of ABCA1 and dysregulation of cholesterol metabolism.	[Jennelle, Lucas; Hunegnaw, Ruth; Dubrovsky, Larisa; Pushkarsky, Tatiana; Brichacek, Beda; Bukrinsky, Michael] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20037 USA; [Fitzgerald, Michael L.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Sviridov, Dmitri] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Popratiloff, Anastas] George Washington Ctr Microscopy & Image Anal, Off VP Res, Washington, DC 20037 USA	George Washington University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Baker Heart and Diabetes Institute	Bukrinsky, M (corresponding author), George Washington Univ, Dept Microbiol Immunol & Trop Med, Ross Hall Rm 624,2300 Eye St NW, Washington, DC 20037 USA.	mbukrins@gwu.edu	Sviridov, Dmitri/E-7943-2010		National Institutes of Health [HL093818, HL101274, AI108533];  [5P30AI087714]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112661, R01HL093818, R01HL101274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI087714, R21AI108533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL093818, HL101274, and AI108533 and by Program Grant 5P30AI087714 (to District of Columbia Developmental Center for AIDS Research). This work is part of a dissertation to be presented by R. H. to the Institute for Biomedical Sciences, George Washington University, in partial fulfillment of the requirements for the Ph.D. degree.	Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Asztalos BF, 2010, J INFECT DIS, V202, P614, DOI 10.1086/654817; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Cui HL, 2012, J LIPID RES, V53, P696, DOI 10.1194/jlr.M023119; Danilczyk UG, 2001, J BIOL CHEM, V276, P25532, DOI 10.1074/jbc.M100270200; Desvarieux M, 2013, AIDS, V27, P2603, DOI 10.1097/QAD.0b013e3283634819; Dettenhofer M, 2001, J BIOL CHEM, V276, P5985, DOI 10.1074/jbc.M008933200; Dubrovsky L, 2012, BIOCHEM BIOPH RES CO, V419, P95, DOI 10.1016/j.bbrc.2012.01.137; Feng B, 2002, J BIOL CHEM, V277, P43271, DOI 10.1074/jbc.M207532200; Fu Y, 2013, CELL METAB, V18, P225, DOI 10.1016/j.cmet.2013.07.003; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Giannarelli C, 2011, ATHEROSCLEROSIS, V219, P384, DOI 10.1016/j.atherosclerosis.2011.06.003; Hagmann W, 2002, BIOL CHEM, V383, P1001, DOI 10.1515/BC.2002.107; Jacob D, 2014, BIOCHEM BIOPH RES CO, V444, P19, DOI 10.1016/j.bbrc.2013.12.141; Jiang H, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-69; Land A, 2001, BIOCHIMIE, V83, P783, DOI 10.1016/S0300-9084(01)01314-1; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Leonard JA, 2011, J VIROL, V85, P6867, DOI 10.1128/JVI.00229-11; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; LOO TW, 1994, J BIOL CHEM, V269, P28683; Low H, 2012, JOVE-J VIS EXP, DOI 10.3791/3810; MATSUSHITA S, 1988, J VIROL, V62, P2107, DOI 10.1128/JVI.62.6.2107-2114.1988; Morrow MP, 2010, MOL PHARMACOL, V78, P215, DOI 10.1124/mol.110.065029; Mujawar Z, 2006, PLOS BIOL, V4, P1970, DOI 10.1371/journal.pbio.0040365; Mujawar Z, 2010, BIOCHEMISTRY-US, V49, P8338, DOI 10.1021/bi100466q; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; Okiyoneda T, 2004, MOL BIOL CELL, V15, P563, DOI 10.1091/mbc.E03-06-0379; Okiyoneda T, 2006, BIOCHEM BIOPH RES CO, V347, P67, DOI 10.1016/j.bbrc.2006.06.032; Otteken A, 1996, J BIOL CHEM, V271, P97, DOI 10.1074/jbc.271.1.97; Papadopoulos M, 2007, J BIOL CHEM, V282, P9401, DOI 10.1074/jbc.M610429200; Papandreou MJ, 2010, J BIOL CHEM, V285, P13788, DOI 10.1074/jbc.M109.066670; PARLATI F, 1995, J BIOL CHEM, V270, P244, DOI 10.1074/jbc.270.1.244; PIND S, 1994, J BIOL CHEM, V269, P12784; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; RUSCHE JR, 1987, P NATL ACAD SCI USA, V84, P6924, DOI 10.1073/pnas.84.19.6924; Schindler M, 2005, J VIROL, V79, P5489, DOI 10.1128/JVI.79.9.5489-5498.2005; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; SIMM M, 1995, J VIROL, V69, P4582, DOI 10.1128/JVI.69.7.4582-4586.1995; Suh WK, 1996, J EXP MED, V184, P337, DOI 10.1084/jem.184.2.337; Tamehiro N, 2008, BIOCHEMISTRY-US, V47, P6138, DOI 10.1021/bi800182t; Tanaka AR, 2001, BIOCHEM BIOPH RES CO, V283, P1019, DOI 10.1006/bbrc.2001.4891; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; Vassilakos A, 1996, EMBO J, V15, P1495, DOI 10.1002/j.1460-2075.1996.tb00493.x	46	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28870	28884		10.1074/jbc.M114.583591	http://dx.doi.org/10.1074/jbc.M114.583591			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25170080	Green Published, hybrid			2022-12-28	WOS:000344141000011
J	Ko, E; Choi, H; Kim, B; Kim, M; Park, KN; Bae, IH; Sung, YK; Lee, TR; Shin, DW; Bae, YS				Ko, Eunbi; Choi, Hyun; Kim, Borim; Kim, Minsun; Park, Kkot-Nara; Bae, Il-Hong; Sung, Young Kwan; Lee, Tae Ryong; Shin, Dong Wook; Bae, Yun Soo			Testosterone Stimulates Duox1 Activity through GPRC6A in Skin Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NON-GENOMIC ACTIONS; RECEPTOR ACTIVATION; NADPH OXIDASE; CELL-DEATH; APOPTOSIS; TISSUE; CA2+; GENERATION; EXPRESSION; CASPASE-3	Testosterone is an endocrine hormone with functions in reproductive organs, anabolic events, and skin homeostasis. We report here that GPRC6A serves as a sensor and mediator of the rapid action of testosterone in epidermal keratinocytes. The silencing of GPRC6A inhibited testosterone-induced intracellular calcium ([Ca2+](i)) mobilization and H2O2 generation. These results indicated that a testosterone-GPRC6A complex is required for activation of G(q) protein, IP3 generation, and [Ca2+](i) mobilization, leading to Duox1 activation. H2O2 generation by testosterone stimulated the apoptosis of keratinocytes through the activation of caspase-3. The application of testosterone into three-dimensional skin equivalents increased the apoptosis of keratinocytes between the granular and stratified corneum layers. These results support an understanding of the molecular mechanism of testosterone-dependent apoptosis in which testosterone stimulates H2O2 generation through the activation of Duox1.	[Ko, Eunbi; Kim, Borim; Kim, Minsun; Park, Kkot-Nara; Bae, Yun Soo] Ewha Womans Univ, Dept Life Sci, Yongin 446729, Geyonggi Do, South Korea; [Ko, Eunbi; Kim, Borim; Kim, Minsun; Park, Kkot-Nara; Bae, Yun Soo] Ewha Womans Univ, Program GT5, Yongin 446729, Geyonggi Do, South Korea; [Choi, Hyun; Bae, Il-Hong; Lee, Tae Ryong; Shin, Dong Wook] Amorepacific Corp R&D Ctr, Biosci Res Inst, Yongin 446729, Geyonggi Do, South Korea; [Sung, Young Kwan] Kyungpook Natl Univ, Sch Med, Dept Immunol, Taegu 700422, South Korea	Ewha Womans University; Ewha Womans University; Kyungpook National University	Shin, DW (corresponding author), Amorepacific Corp R&D Ctr, 314-1 Bora Dong, Yongin 446729, Geyonggi Do, South Korea.	biopang@amorepacific.com; baeys@ewha.ac.kr		Bae, Il-Hong/0000-0003-0535-8303	National Research Foundation of Korea (NRF) [2012R1A5A1048236]; Bio & Medical Technology Development Program Grant [2012M3A9B4028785]; Redoxomics Grant - Ministry of Science, ICT & Future Planning [2012M3A9C5048708]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Bio & Medical Technology Development Program Grant; Redoxomics Grant - Ministry of Science, ICT & Future Planning	This work was supported by National Research Foundation of Korea (NRF) Grant 2012R1A5A1048236, Bio & Medical Technology Development Program Grant 2012M3A9B4028785, and Redoxomics Grant 2012M3A9C5048708 funded by the Ministry of Science, ICT & Future Planning.	Abdel-Latif AM, 2009, CLIN EXP DERMATOL, V34, P390, DOI 10.1111/j.1365-2230.2008.03029.x; Aguirre J, 2010, FREE RADICAL BIO MED, V49, P1342, DOI 10.1016/j.freeradbiomed.2010.07.027; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Bito T, 2012, J DERMATOL SCI, V68, P3, DOI 10.1016/j.jdermsci.2012.06.006; Blattermann S, 2012, NAT CHEM BIOL, V8, P631, DOI [10.1038/NCHEMBIO.962, 10.1038/nchembio.962]; Block K, 2012, NAT REV CANCER, V12, P627, DOI 10.1038/nrc3339; Bowles DK, 2007, AM J PHYSIOL-CELL PH, V293, pC805, DOI 10.1152/ajpcell.00127.2007; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Chignalia AZ, 2012, HYPERTENSION, V59, P1263, DOI 10.1161/HYPERTENSIONAHA.111.180620; CHOUDHRY R, 1992, J ENDOCRINOL, V133, P467, DOI 10.1677/joe.0.1330467; De Gendt K, 2012, MOL CELL ENDOCRINOL, V352, P13, DOI 10.1016/j.mce.2011.08.008; Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103; ELIAS PM, 1983, J INVEST DERMATOL, V80, pS44, DOI 10.1038/jid.1983.12; Estrada M, 2006, J BIOL CHEM, V281, P25492, DOI 10.1074/jbc.M603193200; Faure H, 2009, CELL CALCIUM, V46, P323, DOI 10.1016/j.ceca.2009.09.004; Feingold KR, 2012, CLIN DERMATOL, V30, P263, DOI 10.1016/j.clindermatol.2011.08.008; Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gul R, 2012, AM J PHYSIOL-HEART C, V302, pH901, DOI 10.1152/ajpheart.00250.2011; HELLMAN L, 1977, J CLIN ENDOCR METAB, V45, P1224, DOI 10.1210/jcem-45-6-1224; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Joo JH, 2012, ANTIOXID REDOX SIGN, V16, P57, DOI 10.1089/ars.2011.3898; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Ling SH, 2002, ENDOCRINOLOGY, V143, P1119, DOI 10.1210/en.143.3.1119; Loss ES, 2011, LIFE SCI, V89, P577, DOI 10.1016/j.lfs.2011.05.017; Miller FJ, 2010, ANTIOXID REDOX SIGN, V12, P583, DOI 10.1089/ars.2009.2857; Naito A, 2008, INT J MOL MED, V22, P725, DOI 10.3892/ijmm_00000078; Papadopoulou N, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-88; Petry A, 2010, ANTIOXID REDOX SIGN, V13, P467, DOI 10.1089/ars.2009.3026; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Pi M, 2012, ENDOCRINOLOGY, V153, P4608, DOI 10.1210/en.2012-1301; Pi M, 2012, ENDOCRINOLOGY, V153, P2062, DOI 10.1210/en.2011-2117; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Rahman F, 2007, TRENDS ENDOCRIN MET, V18, P371, DOI 10.1016/j.tem.2007.09.004; Rossol M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2339; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Simoncini T, 2003, EUR J ENDOCRINOL, V148, P281, DOI 10.1530/eje.0.1480281; Taieb J, 2003, CLIN CHEM, V49, P1381, DOI 10.1373/49.8.1381; Thiboutot D, 1998, DERMATOLOGY, V196, P38, DOI 10.1159/000017863; Trueb Ralph M, 2009, Int J Trichology, V1, P6, DOI 10.4103/0974-7753.51923; TYMIANSKI M, 1994, J CEREBR BLOOD F MET, V14, P911, DOI 10.1038/jcbfm.1994.122; Ulivieri C, 2010, TISSUE CELL, V42, P339, DOI 10.1016/j.tice.2010.10.004; Vaccari JPD, 2012, DERMATOL SURG, V38, P1033, DOI 10.1111/j.1524-4725.2012.02378.x; Verzola D, 2004, KIDNEY INT, V65, P1252, DOI 10.1111/j.1523-1755.2004.00497.x; Winiarska A, 2006, SKIN PHARMACOL PHYS, V19, P311, DOI 10.1159/000095251; Zouboulis CC, 2007, HORM METAB RES, V39, P85, DOI 10.1055/s-2007-961807; Zouboulis CC, 2004, EXP DERMATOL, V13, P5, DOI 10.1111/j.1600-0625.2004.00255.x	54	27	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28835	28845		10.1074/jbc.M114.583450	http://dx.doi.org/10.1074/jbc.M114.583450			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25164816	Green Published, hybrid			2022-12-28	WOS:000344141000008
J	Suehiro, J; Kanki, Y; Makihara, C; Schadler, K; Miura, M; Manabe, Y; Aburatani, H; Kodama, T; Minami, T				Suehiro, Jun-ichi; Kanki, Yasuharu; Makihara, Chihiro; Schadler, Keri; Miura, Mai; Manabe, Yuuka; Aburatani, Hiroyuki; Kodama, Tatsuhiko; Minami, Takashi			Genome-wide Approaches Reveal Functional Vascular Endothelial Growth Factor (VEGF)-inducible Nuclear Factor of Activated T Cells (NFAT) c1 Binding to Angiogenesis-related Genes in the Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE-1 PROMOTER; SYNDROME CRITICAL REGION-1; CHEMOKINE RECEPTOR CXCR4; TUMOR-GROWTH; THROMBIN; CALCINEURIN; TRANSCRIPTION; EXPRESSION; PATHWAY; BREAST	VEGF is a key regulator of endothelial cell migration, proliferation, and inflammation, which leads to activation of several signaling cascades, including the calcineurin-nuclear factor of activated T cells (NFAT) pathway. NFAT is not only important for immune responses but also for cardiovascular development and the pathogenesis of Down syndrome. By using Down syndrome model mice and clinical patient samples, we showed recently that the VEGF-calcineurin-NFAT signaling axis regulates tumor angiogenesis and tumor metastasis. However, the connection between genome-wide views of NFAT-mediated gene regulation and downstream gene function in the endothelium has not been studied extensively. Here we performed comprehensive mapping of genome-wide NFATc1 binding in VEGF-stimulated primary cultured endothelial cells and elucidated the functional consequences of VEGF-NFATc1-mediated phenotypic changes. A comparison of the NFATc1 ChIP sequence profile and epigenetic histone marks revealed that predominant NFATc1-occupied peaks overlapped with promoter-associated histone marks. Moreover, we identified two novel NFATc1 regulated genes, CXCR7 and RND1. CXCR7 knockdown abrogated SDF-1- and VEGF-mediated cell migration and tube formation. siRNA treatment of RND1 impaired vascular barrier function, caused RhoA hyperactivation, and further stimulated VEGF-mediated vascular outgrowth from aortic rings. Taken together, these findings suggest that dynamic NFATc1 binding to target genes is critical for VEGF-mediated endothelial cell activation. CXCR7 and RND1 are NFATc1 target genes with multiple functions, including regulation of cell migration, tube formation, and barrier formation in endothelial cells.	[Suehiro, Jun-ichi; Kanki, Yasuharu; Makihara, Chihiro; Schadler, Keri; Miura, Mai; Manabe, Yuuka; Minami, Takashi] Univ Tokyo, Res Ctr Adv Sci & Technol, Div Vasc Biol, Tokyo 1538904, Japan; [Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo 1538904, Japan; [Kanki, Yasuharu; Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 1538904, Japan; [Schadler, Keri] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA	University of Tokyo; University of Tokyo; University of Tokyo; University of Pennsylvania; Pennsylvania Medicine	Minami, T (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Div Vasc Biol, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	minami@med.rcast.u-tokyo.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology in Japan; MEXT in Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Leading-edge Research Promotion Fund from the Japan Society for the Promotion of Science (to T. M.) and by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (to T. M.). This work was also supported by a project for developing innovation systems of MEXT in Japan (to T. M.).	Amerongen GPV, 2009, AM J PHYSIOL-HEART C, V296, pH903, DOI 10.1152/ajpheart.00125.2009; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Ghosh K, 2008, P NATL ACAD SCI USA, V105, P11305, DOI 10.1073/pnas.0800835105; Hadri L, 2006, BIOCHEM J, V394, P27, DOI 10.1042/BJ20051387; Kanki Y, 2011, EMBO J, V30, P2582, DOI 10.1038/emboj.2011.173; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Lee BC, 2004, MOL CANCER RES, V2, P327; Luo C, 2006, J BIOL CHEM, V281, P30081, DOI 10.1074/jbc.M605837200; Markowetz F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001034; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; Minami T, 2005, TRENDS CARDIOVAS MED, V15, P174, DOI 10.1016/j.tcm.2005.06.002; Minami T, 2001, J BIOL CHEM, V276, P47632, DOI 10.1074/jbc.M108363200; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Minami T, 2014, J BIOCHEM, V155, P217, DOI 10.1093/jb/mvu006; Minami T, 2006, J BIOL CHEM, V281, P20503, DOI 10.1074/jbc.M513112200; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Oh M, 2010, J BIOL CHEM, V285, P16623, DOI 10.1074/jbc.M109.098236; Oinuma I, 2012, MOL BIOL CELL, V23, P1593, DOI 10.1091/mbc.E11-11-0900; Phoon CKL, 2004, CIRC RES, V95, P92, DOI 10.1161/01.RES.0000133681.99617.28; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Song HH, 2009, J BIOL CHEM, V284, P29109, DOI 10.1074/jbc.M109.041145; Suehiro J, 2010, BLOOD, V115, P2520, DOI 10.1182/blood-2009-07-233478; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tozawa H, 2011, MOL CELL BIOL, V31, P2196, DOI 10.1128/MCB.01430-10; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911	32	50	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29044	29059		10.1074/jbc.M114.555235	http://dx.doi.org/10.1074/jbc.M114.555235			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25157100	hybrid, Green Published			2022-12-28	WOS:000344141000023
J	Jin, YZ; McFie, PJ; Banman, SL; Brandt, C; Stone, SJ				Jin, Youzhi; McFie, Pamela J.; Banman, Shanna L.; Brandt, Curtis; Stone, Scot J.			Diacylglycerol Acyltransferase-2 (DGAT2) and Monoacylglycerol Acyltransferase-2 (MGAT2) Interact to Promote Triacylglycerol Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; ACYL-COA; ENDOPLASMIC-RETICULUM; INSULIN-RESISTANCE; MEMBRANE-FRACTION; LIPID DROPLETS; FAT-ABSORPTION; CACO-2 CELLS; RAT-LIVER; LOCALIZATION	Acyl CoA:1,2-diacylglycerol acyltransferase (DGAT)-2 is an integral membrane protein that catalyzes triacylglycerol (TG) synthesis using diacylglycerol and fatty acyl CoA as substrates. DGAT2 resides in the endoplasmic reticulum (ER), but when cells are incubated with fatty acids, DGAT2 interacts with lipid droplets presumably to catalyze localized TG synthesis for lipid droplet expansion. Previous studies have shown that DGAT2 interacts with proteins that synthesize its fatty acyl CoA substrates. In this study, we provide additional evidence that DGAT2 is present in a protein complex. Using a chemical crosslinker, disuccinimidyl suberate (DSS), we demonstrated that DGAT2 formed a dimer and was also part of a protein complex of similar to 650 kDa, both in membranes and on lipid droplets. Using co-immunoprecipitation experiments and an in situ proximity ligation assay, we found that DGAT2 interacted with monoacylglycerol acyltransferase (MGAT)-2, an enzyme that catalyzes the synthesis of diacylglycerol. Deletion mutagenesis showed that the interaction with MGAT2 was dependent on the two transmembrane domains of DGAT2. No significant interaction of DGAT2 with lipin1, another enzyme that synthesizes diacylglycerol, could be detected. When co-expressed in cells, DGAT2 and MGAT2 co-localized in the ER and on lipid droplets. Co-expression also resulted in increased TG storage compared with expression of DGAT2 or MGAT2 alone. Incubating McArdle rat hepatoma RH7777 cells with 2-monoacylglycerol caused DGAT2 to translocate to lipid droplets. This also led to the formation of large cytosolic lipid droplets, characteristic of DGAT2, but not DGAT1, and indicated that DGAT2 can utilize monoacylglycerol-derived diacylglycerol. These findings suggest that the interaction of DGAT2 and MGAT2 serves to channel lipid substrates efficiently for TG biosynthesis.	[Jin, Youzhi; McFie, Pamela J.; Brandt, Curtis; Stone, Scot J.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Banman, Shanna L.] Univ Saskatchewan, Western Coll Vet Med, Saskatoon, SK S7N 5B4, Canada	University of Saskatchewan; University of Saskatchewan	Stone, SJ (corresponding author), Univ Saskatchewan, Dept Biochem, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	scot.stone@usask.ca			Heart and Stroke Foundation of Saskatchewan; CIHR [FRN 123385]; CFI	Heart and Stroke Foundation of Saskatchewan; CIHR(Canadian Institutes of Health Research (CIHR)); CFI(Canada Foundation for Innovation)	This work was supported in part by a Heart and Stroke Foundation of Saskatchewan Grant-in-Aid, CIHR (FRN 123385) and the CFI.	BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Cao JS, 2007, J LIPID RES, V48, P583, DOI 10.1194/jlr.M600331-JLR200; Cao JS, 2004, J BIOL CHEM, V279, P18878, DOI 10.1074/jbc.M313272200; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Cheng D, 2008, J BIOL CHEM, V283, P29802, DOI 10.1074/jbc.M800494200; Coe NR, 1999, J BIOL CHEM, V274, P36300, DOI 10.1074/jbc.274.51.36300; COLEMAN RA, 1984, J BIOL CHEM, V259, P8934; CUI Z, 1993, J BIOL CHEM, V268, P16655; Gangar A, 2001, J BIOL CHEM, V276, P10290, DOI 10.1074/jbc.M009550200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Ho SY, 2002, J BIOL CHEM, V277, P1816, DOI 10.1074/jbc.M108027200; KENNEDY EP, 1957, ANNU REV BIOCHEM, V26, P119, DOI 10.1146/annurev.bi.26.070157.001003; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lehner R, 1996, PROG LIPID RES, V35, P169, DOI 10.1016/0163-7827(96)00005-7; LEHNER R, 1995, J BIOL CHEM, V270, P13630, DOI 10.1074/jbc.270.23.13630; Levin MC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1772, DOI 10.1152/ajpendo.00158.2007; LEVY E, 1995, FASEB J, V9, P626, DOI 10.1096/fasebj.9.8.7768354; Liu Q, 2012, PROG LIPID RES, V51, P350, DOI 10.1016/j.plipres.2012.06.001; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; McFie PJ, 2011, J LIPID RES, V52, P1760, DOI 10.1194/jlr.D016626; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; Miernyk JA, 2008, PLANT J, V53, P597, DOI 10.1111/j.1365-313X.2007.03316.x; Millar JS, 2006, J LIPID RES, V47, P2297, DOI 10.1194/jlr.M600213-JLR200; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Ren L, 2003, J BIOCHEM BIOPH METH, V57, P143, DOI 10.1016/S0165-022X(03)00105-2; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Seyer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058224; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Xu NY, 2012, J CELL BIOL, V198, P895, DOI 10.1083/jcb.201201139; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Zhang J, 2014, J BIOL CHEM, V289, P10909, DOI 10.1074/jbc.M113.530022	45	45	45	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28237	28248		10.1074/jbc.M114.571190	http://dx.doi.org/10.1074/jbc.M114.571190			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25164810	hybrid, Green Published			2022-12-28	WOS:000343765400020
J	Son, YO; Pratheeshkumar, P; Roy, RV; Hitron, JA; Wang, L; Zhang, Z; Shi, XL				Son, Young-Ok; Pratheeshkumar, Poyil; Roy, Ram Vinod; Hitron, John Andrew; Wang, Lei; Zhang, Zhuo; Shi, Xianglin			RETRACTED: Nrf2/p62 Signaling in Apoptosis Resistance and Its Role in Cadmium-induced Carcinogenesis (Retracted article. See vol. 293, pg. 15455, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							TRANSCRIPTION FACTOR NRF2; OXIDATIVE STRESS; AUTOPHAGY; P62; ACTIVATION; PROTEIN; OVEREXPRESSION; BINDING; TARGET; BCL-2	The cadmium-transformed human lung bronchial epithelial BEAS-2B cells exhibit a property of apoptosis resistance as compared with normal non-transformed BEAS-2B cells. The level of basal reactive oxygen species (ROS) is extremely low in transformed cells in correlation with elevated expressions of both antioxidant enzymes (catalase, SOD1, and SOD2) and antiapoptotic proteins (Bcl-2/Bcl-xL). Moreover, Nrf2 and p62 are highly expressed in these transformed cells. The knockdown of Nrf2 or p62 by siRNA enhances ROS levels and cadmium-induced apoptosis. The binding activities of Nrf2 on the antioxidant response element promoter regions of p62/Bcl-2/Bcl-xL were dramatically increased in the cadmium-exposed transformed cells. Cadmium exposure increased the formation of LC3-II and the frequency of GFP-LC3 punctal cells in non-transformed BEAS-2B cells, whereas these increases are not shown in transformed cells, an indication of autophagy deficiency of transformed cells. Furthermore, the expression levels of Nrf2 and p62 are dramatically increased during chronic long term exposure to cadmium in the BEAS-2B cells as well as antiapoptotic proteins and antioxidant enzymes. These proteins are overexpressed in the tumor tissues derived from xenograft mouse models. Moreover, the colony growth is significantly attenuated in the transformed cells by siRNA transfection specific for Nrf2 or p62. Taken together, this study demonstrates that cadmium-transformed cells have acquired autophagy deficiency, leading to constitutive p62 and Nrf2 overexpression. These overexpressions up-regulate the antioxidant proteins catalase and SOD and the antiapoptotic proteins Bcl-2 and Bcl-xL. The final consequences are decrease in ROS generation, apoptotic resistance, and increased cell survival, proliferation, and tumorigenesis.	[Son, Young-Ok; Pratheeshkumar, Poyil; Roy, Ram Vinod; Wang, Lei; Shi, Xianglin] Univ Kentucky, Coll Med, Ctr Res Environm Dis, Lexington, KY 40536 USA; [Son, Young-Ok; Pratheeshkumar, Poyil; Roy, Ram Vinod; Hitron, John Andrew; Wang, Lei; Zhang, Zhuo; Shi, Xianglin] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Shi, XL (corresponding author), Univ Kentucky, Coll Med, Ctr Res Environm Dis, Lexington, KY 40536 USA.	xshi5@email.uky.edu	Zhang, Zhuo/B-8601-2012; Shi, Xianglin/B-8588-2012; Son, Young-Ok/P-3675-2015; Wang, Lei/E-3063-2012; Son, Youngok/AAB-1380-2021	Son, Youngok/0000-0003-0154-4061	National Institutes of Health [R01 ES015518, R01 CA119028, R01 ES015375, R01 CA116697]; NATIONAL CANCER INSTITUTE [P30CA177558, R01CA116697, R01CA119028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015518, R01ES015375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES015518, R01 CA119028, R01 ES015375, and R01 CA116697.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; [Anonymous], 1993, IARC Monogr Eval Carcinog Risks Hum, V58, P1; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Faroon O., 2012, TOXICOLOGICAL PROFIL; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He XQ, 2008, CHEM RES TOXICOL, V21, P1375, DOI 10.1021/tx800019a; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Ishii T, 1997, BIOCHEM BIOPH RES CO, V232, P33, DOI 10.1006/bbrc.1997.6221; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kitamura H, 2006, HISTOPATHOLOGY, V48, P157, DOI 10.1111/j.1365-2559.2005.02313.x; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; L'Azou B, 2014, TOXICOL RES-UK, V3, P32, DOI 10.1039/c3tx50063b; Lau A, 2013, MOL CELL BIOL, V33, P2436, DOI 10.1128/MCB.01748-12; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Ministry of Industry Thailand, 2013, PRIOR LIST HAZ SUBST, P2556; Nezis IP, 2012, ANTIOXID REDOX SIGN, V17, P786, DOI 10.1089/ars.2011.4394; Niture SK, 2013, FREE RADICAL BIO MED, V57, P119, DOI 10.1016/j.freeradbiomed.2012.12.014; Niture SK, 2012, J BIOL CHEM, V287, P9873, DOI 10.1074/jbc.M111.312694; Orrenius S, 2013, ANNU REV PHARMACOL, V53, P275, DOI 10.1146/annurev-pharmtox-011112-140210; Pi JB, 2008, FREE RADICAL BIO MED, V45, P651, DOI 10.1016/j.freeradbiomed.2008.05.020; Rolland P, 2007, ENDOCR-RELAT CANCER, V14, P73, DOI 10.1677/erc.1.01312; Satarug S, 2010, ENVIRON HEALTH PERSP, V118, P182, DOI 10.1289/ehp.0901234; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Son YO, 2012, TOXICOL APPL PHARM, V264, P153, DOI 10.1016/j.taap.2012.07.028; Son YO, 2011, TOXICOL SCI, V119, P335, DOI 10.1093/toxsci/kfq335; Son YO, 2010, TOXICOL SCI, V113, P127, DOI 10.1093/toxsci/kfp259; Stacy DR, 2006, HEAD NECK-J SCI SPEC, V28, P813, DOI 10.1002/hed.20430; Thompson HGR, 2003, ONCOGENE, V22, P2322, DOI 10.1038/sj.onc.1206325; Wang SH, 2008, CELL MOL LIFE SCI, V65, P3640, DOI 10.1007/s00018-008-8383-9; Wang SH, 2009, TOXICOL SCI, V108, P124, DOI 10.1093/toxsci/kfn266; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023	43	65	75	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28660	28675		10.1074/jbc.M114.595496	http://dx.doi.org/10.1074/jbc.M114.595496			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25157103	Green Published, hybrid			2022-12-28	WOS:000343765400054
J	Otero, JH; Lizak, B; Feige, MJ; Hendershot, LM				Otero, Joel H.; Lizak, Beata; Feige, Matthias J.; Hendershot, Linda M.			Dissection of Structural and Functional Requirements That Underlie the Interaction of ERdj3 Protein with Substrates in the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton Heat Shock Protein (Hsp70); Chaperone DnaJ (DnaJ); Chaperone DnaK (DnaK); Endoplasmic Reticulum (ER); Endoplasmic Reticulum-associated Protein Degradation (ERAD); Protein Folding	ESCHERICHIA-COLI DNAJ; PEPTIDE-BINDING FRAGMENT; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; ATPASE ACTIVITY; YEAST HSP40; HSP70 CHAPERONES; PLASMODIUM-FALCIPARUM; UNFOLDED PROTEINS; COCHAPERONE DNAJ	Background: ERdj3 is a dimeric type I DnaJ co-chaperone for BiP, the ER Hsp70. Results: Mutational analyses revealed the requirements for ERdj3 substrate binding and release in cells. Conclusion: ERdj3 does not rebind substrates after release, which is linked to substrate half-life. Significance: This study provides mechanistic insights into how ERdj3 aids BiP in deciding the fate of nascent ER proteins. ERdj3, a mammalian endoplasmic reticulum (ER) Hsp40/DnaJ family member, binds unfolded proteins, transfers them to BiP, and concomitantly stimulates BiP ATPase activity. However, the requirements for ERdj3 binding to and release from substrates in cells are not well understood. We found that ERdj3 homodimers that cannot stimulate the ATPase activity of BiP (QPD mutants) bound to unfolded ER proteins under steady state conditions in much greater amounts than wild-type ERdj3. This was due to reduced release from these substrates as opposed to enhanced binding, although in both cases dimerization was strictly required for substrate binding. Conversely, heterodimers consisting of one wild-type and one mutant ERdj3 subunit bound substrates at levels comparable with wild-type ERdj3 homodimers, demonstrating that release requires only one protomer to be functional in stimulating BiP ATPase activity. Co-expressing wild-type ERdj3 and a QPD mutant, which each exclusively formed homodimers, revealed that the release rate of wild-type ERdj3 varied according to the relative half-lives of substrates, suggesting that ERdj3 release is an important step in degradation of unfolded client proteins in the ER. Furthermore, pulse-chase experiments revealed that the binding of QPD mutant homodimers remained constant as opposed to increasing, suggesting that ERdj3 does not normally undergo reiterative binding cycles with substrates.	[Otero, Joel H.; Lizak, Beata; Feige, Matthias J.; Hendershot, Linda M.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Hendershot, LM (corresponding author), St Jude Childrens Res Hosp, Dept Tumor Cell Biol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	linda.hendershot@stjude.org	Hendershot, Linda/N-8124-2018	Hendershot, Linda/0000-0002-5473-0274; Feige, Matthias/0000-0001-5435-4312	National Institutes of Health [R01 GM54068]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; Leopoldina - National Academy of Sciences [LPDS 2009-32]; St. Jude Children's Research Hospital; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Leopoldina - National Academy of Sciences; St. Jude Children's Research Hospital; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM54068 (to L. M. H.) and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital.; Funded by the Leopoldina - National Academy of Sciences, Grant LPDS 2009-32, and by the Paul-Barrett endowed fellowship of St. Jude Children's Research Hospital.	Banecki B, 1996, J BIOL CHEM, V271, P14840, DOI 10.1074/jbc.271.25.14840; Barends TRM, 2013, ACTA CRYSTALLOGR D, V69, P1540, DOI 10.1107/S0907444913010640; Botha M, 2007, INT J BIOCHEM CELL B, V39, P1781, DOI 10.1016/j.biocel.2007.02.011; CAPLAN AJ, 1993, MOL BIOL CELL, V4, P555, DOI 10.1091/mbc.4.6.555; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Cuellar J, 2013, J BIOL CHEM, V288, P15065, DOI 10.1074/jbc.M112.430595; CYR DM, 1992, J BIOL CHEM, V267, P20927; Dong M, 2008, MOL BIOL CELL, V19, P2620, DOI 10.1091/mbc.E07-07-0674; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; GAUT JR, 1993, J BIOL CHEM, V268, P7248; Jin Y, 2008, EMBO J, V27, P2873, DOI 10.1038/emboj.2008.207; Jin Y, 2009, BIOCHEMISTRY-US, V48, P41, DOI 10.1021/bi8015923; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Li JZ, 2006, BIOCHEM J, V398, P353, DOI 10.1042/BJ20060618; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; Mapa K, 2010, MOL CELL, V38, P89, DOI 10.1016/j.molcel.2010.03.010; Marcinowski M, 2013, J MOL BIOL, V425, P466, DOI 10.1016/j.jmb.2012.11.030; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Marcus NY, 2007, ARCH BIOCHEM BIOPHYS, V468, P147, DOI 10.1016/j.abb.2007.10.001; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Michels AA, 1999, J BIOL CHEM, V274, P36757, DOI 10.1074/jbc.274.51.36757; Morahan BJ, 2011, EUKARYOT CELL, V10, P1492, DOI 10.1128/EC.05155-11; Nollen EAA, 2000, MOL CELL BIOL, V20, P1083, DOI 10.1128/MCB.20.3.1083-1088.2000; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Qian XG, 2002, BIOCHEM J, V361, P27, DOI 10.1042/0264-6021:3610027; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Shi YY, 2005, J BIOL CHEM, V280, P22761, DOI 10.1074/jbc.M503643200; Skowronek MH, 1998, P NATL ACAD SCI USA, V95, P1574, DOI 10.1073/pnas.95.4.1574; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Vanhove M, 2001, IMMUNITY, V15, P105, DOI 10.1016/S1074-7613(01)00163-7; Vembar SS, 2009, J BIOL CHEM, V284, P32462, DOI 10.1074/jbc.M109.000729; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19307, DOI 10.1074/jbc.270.33.19307; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; Wu YK, 2005, J MOL BIOL, V346, P1005, DOI 10.1016/j.jmb.2004.12.040; Yu M, 2000, J BIOL CHEM, V275, P24984, DOI 10.1074/jbc.M000739200	50	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27504	27512		10.1074/jbc.M114.587147	http://dx.doi.org/10.1074/jbc.M114.587147			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25143379	hybrid, Green Published			2022-12-28	WOS:000342852800013
J	Rosenbaum, EE; Vasiljevic, E; Cleland, SC; Flores, C; Colley, NJ				Rosenbaum, Erica E.; Vasiljevic, Eva; Cleland, Spencer C.; Flores, Carlos; Colley, Nansi Jo			The Gos28 SNARE Protein Mediates Intra-Golgi Transport of Rhodopsin and Is Required for Photoreceptor Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; CYCLOPHILIN HOMOLOG NINAA; MEMBRANE-FUSION; TRANSMEMBRANE DOMAIN; DROSOPHILA-MELANOGASTER; ENDOPLASMIC-RETICULUM; IN-VIVO; PERIPHERAL PHOTORECEPTORS; PARKINSONS-DISEASE; CRYSTAL-STRUCTURE	SNARE proteins play indispensable roles in membrane fusion events in many cellular processes, including synaptic transmission and protein trafficking. Here, we characterize the Golgi SNARE protein, Gos28, and its role in rhodopsin (Rh1) transport through Drosophila photoreceptors. Mutations in gos28 lead to defective Rh1 trafficking and retinal degeneration. We have pinpointed a role for Gos28 in the intra-Golgi transport of Rh1, downstream from alpha-mannosidase-II in the medial-Golgi. We have confirmed the necessity of key residues in Gos28's SNARE motif and demonstrate that its transmembrane domain is not required for vesicle fusion, consistent with Gos28 functioning as a t-SNARE for Rh1 transport. Finally, we show that human Gos28 rescues both the Rh1 trafficking defects and retinal degeneration in Drosophila gos28 mutants, demonstrating the functional conservation of these proteins. Our results identify Gos28 as an essential SNARE protein in Drosophila photoreceptors and provide mechanistic insights into the role of SNAREs in neurodegenerative disease.	Univ Wisconsin, Dept Ophthalmol & Visual Sci, Dept Genet, Madison, WI 53792 USA; Univ Wisconsin, McPherson Eye Res Inst, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Colley, NJ (corresponding author), Dept Ophthalmol & Visual Sci, 600 Highland Ave, Madison, WI 53792 USA.	njcolley@wisc.edu		Vasiljevic, Eva/0000-0001-9751-8305	National Institutes of Health from NEI [EY008768, P30 EY016665]; NIA [AG321762]; NIGMS [T32 GM007507]; Retina Research Foundation; McPherson Eye Research Institute's Walter H. Helmerich Research Chair; M. D. Matthews Research Professorship; Research to Prevent Blindness Foundation; NATIONAL EYE INSTITUTE [P30EY016665, R29EY008768, R01EY008768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007507] Funding Source: NIH RePORTER	National Institutes of Health from NEI; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Retina Research Foundation; McPherson Eye Research Institute's Walter H. Helmerich Research Chair; M. D. Matthews Research Professorship; Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY008768 and P30 EY016665 from NEI (to N. C.), Grant AG321762 from NIA (to E. R.), and T32 GM007507 from NIGMS (to E. R.). This work was also supported by the Retina Research Foundation, the McPherson Eye Research Institute's Walter H. Helmerich Research Chair, M. D. Matthews Research Professorship, and Research to Prevent Blindness Foundation (to N. C.).	Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Burgoyne RD, 2011, NAT CELL BIOL, V13, P8, DOI 10.1038/ncb0111-8; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; COOMBE PE, 1986, J COMP PHYSIOL A, V159, P655, DOI 10.1007/BF00612038; DECOUET HG, 1987, EUR J CELL BIOL, V44, P50; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Eisbach SE, 2013, J MOL MED, V91, P693, DOI 10.1007/s00109-013-1038-9; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Fukasawa M, 2004, P NATL ACAD SCI USA, V101, P4815, DOI 10.1073/pnas.0401183101; Furuya TK, 2012, NEUROSCIENCE, V220, P41, DOI 10.1016/j.neuroscience.2012.06.035; Garcia-Reitbock P, 2010, BRAIN, V133, P2032, DOI 10.1093/brain/awq132; Gerrard SR, 2000, TRAFFIC, V1, P45, DOI 10.1034/j.1600-0854.2000.010108.x; Grote E, 2000, J CELL BIOL, V151, P453, DOI 10.1083/jcb.151.2.453; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; He YH, 2009, J LIPID RES, V50, P398, DOI 10.1194/jlr.M800360-JLR200; Hofmann MW, 2006, J MOL BIOL, V364, P1048, DOI 10.1016/j.jmb.2006.09.077; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Hsiao HY, 2013, DEV BIOL, V381, P482, DOI 10.1016/j.ydbio.2013.07.001; HUBER A, 1990, J BIOL CHEM, V265, P17906; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jun Y, 2007, EMBO J, V26, P4935, DOI 10.1038/sj.emboj.7601915; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kiselev A, 1996, BIOCHEMISTRY-US, V35, P1848, DOI 10.1021/bi951399k; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; Laage R, 2000, J BIOL CHEM, V275, P17481, DOI 10.1074/jbc.M910092199; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARRIVEE DC, 1981, J GEN PHYSIOL, V78, P521, DOI 10.1085/jgp.78.5.521; Maekawa M, 2009, GENES CELLS, V14, P1003, DOI 10.1111/j.1365-2443.2009.01325.x; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; McNew JA, 1998, FEBS LETT, V435, P89, DOI 10.1016/S0014-5793(98)01044-8; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Mukaetova-Ladinska EB, 2009, THESCIENTIFICWORLDJO, V9, P1463, DOI 10.1100/tsw.2009.151; Nagahama M, 1996, J CELL BIOL, V133, P507, DOI 10.1083/jcb.133.3.507; Okamoto T, 2001, CURR PROTOC PROTEIN, DOI [10.1002/0471143030.cb0101s05, DOI 10.1002/0471143030.CB0101S05]; Orci L, 2000, P NATL ACAD SCI USA, V97, P10400, DOI 10.1073/pnas.190292497; Pak W. L., 1975, MUTATIONS AFFECTING, P703; Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899; Petty H. R., 1993, MOL BIOL MEMBRANES S, P7; Prekeris R, 2000, EUR J CELL BIOL, V79, P771, DOI 10.1078/0171-9335-00109; Rohde J, 2003, J BIOL CHEM, V278, P1656, DOI 10.1074/jbc.M209522200; Rosenbaum EE, 2006, NEURON, V49, P229, DOI 10.1016/j.neuron.2005.12.011; Rosenbaum EE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004349; Rosenbaum EE, 2012, VISUAL NEUROSCI, V29, P143, DOI 10.1017/S0952523812000181; Rosenbaum EE, 2011, NEURON, V72, P602, DOI 10.1016/j.neuron.2011.09.016; Roy R, 2004, BIOCHEMISTRY-US, V43, P4964, DOI 10.1021/bi0362875; Roy R, 2006, BIOCHEMISTRY-US, V45, P7654, DOI 10.1021/bi052620o; Rozas JL, 2011, J NEUROSCI, V31, P1106, DOI 10.1523/JNEUROSCI.2011-10.2011; Russell CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043201; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; Siddiqi S, 2010, BIOCHEM J, V429, P391, DOI 10.1042/BJ20100336; Smith R, 2007, J NEUROCHEM, V103, P115, DOI 10.1111/j.1471-4159.2007.04703.x; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; SOLLNER T, 1995, FEBS LETT, V369, P80, DOI 10.1016/0014-5793(95)00594-Y; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; STEPHENSON RS, 1983, SYM SOC EXP BIOL, P477; Subramaniam VN, 1996, SCIENCE, V272, P1161, DOI 10.1126/science.272.5265.1161; SUBRAMANIAM VN, 1995, J CELL SCI, V108, P2405; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tai GH, 2004, MOL BIOL CELL, V15, P4011, DOI 10.1091/mbc.e03-12-0876; Ungermann C, 2005, J CELL SCI, V118, P3819, DOI 10.1242/jcs.02561; Veit M, 2000, MOL CELL NEUROSCI, V15, P408, DOI 10.1006/mcne.1999.0830; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; Vogel K, 1999, BIOCHEM BIOPH RES CO, V258, P407, DOI 10.1006/bbrc.1999.0652; Volchuk A, 2004, MOL BIOL CELL, V15, P1506, DOI 10.1091/mbc.E03-08-0625; Webel R, 2000, J BIOL CHEM, V275, P24752, DOI 10.1074/jbc.M002668200; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wong SH, 1999, MOL BIOL CELL, V10, P119, DOI 10.1091/mbc.10.1.119; Xu Y, 2002, MOL BIOL CELL, V13, P3493, DOI 10.1091/mbc.E02-01-0004; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Zhang T, 2001, J BIOL CHEM, V276, P27480, DOI 10.1074/jbc.M102786200	83	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.585166	http://dx.doi.org/10.1074/jbc.M114.585166			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25261468	Green Published, hybrid			2022-12-28	WOS:000345335000002
J	Luo, L; Yang, J; Liu, DX				Luo, Lu; Yang, Jun; Liu, Dongxiang			Integration and Oligomerization of Bax Protein in Lipid Bilayers Characterized by Single Molecule Fluorescence Study	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; B-cell Lymphoma 2 (Bcl-2) Family; Bax; Lipid Bilayer; Single Molecule Biophysics	OUTER MITOCHONDRIAL-MEMBRANE; CYTOCHROME-C RELEASE; CONFORMATIONAL-CHANGE; BH3 DOMAINS; CELL-DEATH; APOPTOSIS; ACTIVATION; BCL-2; PERMEABILIZATION; INSERTION	Background: The stoichiometry of Bax oligomers on mitochondria and the process of Bax pore formation remain unclear. Results: Bax oligomerization occurs only if tBid is present, and its membrane insertion highly depends on cardiolipin; Bax tends to form tetramer on membrane. Conclusion: Bax pore formation involves two independent steps: Bax oligomerization and membrane insertion. Significance: This study may help elucidate Bax pore formation. Bax is a pro-apoptotic Bcl-2 family protein. The activated Bax translocates to mitochondria, where it forms pore and permeabilizes the mitochondrial outer membrane. This process requires the BH3-only activator protein (i.e. tBid) and can be inhibited by anti-apoptotic Bcl-2 family proteins such as Bcl-x(L). Here by using single molecule fluorescence techniques, we studied the integration and oligomerization of Bax in lipid bilayers. Our study revealed that Bax can bind to lipid membrane spontaneously in the absence of tBid. The Bax pore formation undergoes at least two steps: pre-pore formation and membrane insertion. The activated Bax triggered by tBid or BH3 domain peptide integrates on bilayers and tends to form tetramers, which are termed as pre-pore. Subsequent insertion of the pre-pore into membrane is highly dependent on the composition of cardiolipin in lipid bilayers. Bcl-x(L) can translocate Bax from membrane to solution and inhibit the pore formation. The study of Bax integration and oligomerization at the single molecule level provides new evidences that may help elucidate the pore formation of Bax and its regulatory mechanism in apoptosis.	[Luo, Lu; Liu, Dongxiang] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol 3, Shanghai 201203, Peoples R China; [Luo, Lu; Liu, Dongxiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Yang, Jun] Shanghai Inst Planned Parenthood Res, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Liu, DX (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol 3, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China.	dxl@mail.shcnc.ac.cn			National Science Fund [21472206]; State Key Laboratory of Drug Research	National Science Fund; State Key Laboratory of Drug Research	This work was supported by the National Science Fund (Grant 21472206) and the State Key Laboratory of Drug Research.	Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Blunck R, 2008, P NATL ACAD SCI USA, V105, P20263, DOI 10.1073/pnas.0807056106; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Epand RF, 2002, BIOCHEM J, V367, P849, DOI 10.1042/BJ20020986; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Kushnareva Y, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001394; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P929, DOI 10.1038/cdd.2008.9; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Ortiz A, 1999, BIOPHYS J, V77, P2003, DOI 10.1016/S0006-3495(99)77041-4; Raemy E, 2014, CHEM PHYS LIPIDS, V179, P70, DOI 10.1016/j.chemphyslip.2013.12.002; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Schellenberg B, 2013, MOL CELL, V49, P959, DOI 10.1016/j.molcel.2012.12.022; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Shamas-Din A, 2013, J BIOL CHEM, V288, P22111, DOI 10.1074/jbc.M113.482109; Tan CB, 2006, J BIOL CHEM, V281, P14764, DOI 10.1074/jbc.M602374200; Todt F, 2013, CELL DEATH DIFFER, V20, P333, DOI 10.1038/cdd.2012.131; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xu XP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.210; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhang TJ, 2013, BBA-MOL CELL BIOL L, V1831, P1542, DOI 10.1016/j.bbalip.2013.03.001	35	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31708	31718		10.1074/jbc.M114.583393	http://dx.doi.org/10.1074/jbc.M114.583393			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25288797	Green Published, hybrid			2022-12-28	WOS:000345314700005
J	Kim, MS; Shutov, LP; Gnanasekaran, A; Lin, ZH; Rysted, JE; Ulrich, JD; Usachev, YM				Kim, Man-Su; Shutov, Leonid P.; Gnanasekaran, Aswini; Lin, Zhihong; Rysted, Jacob E.; Ulrich, Jason D.; Usachev, Yuriy M.			Nerve Growth Factor (NGF) Regulates Activity of Nuclear Factor of Activated T-cells (NFAT) in Neurons via the Phosphatidylinositol 3-Kinase (PI3K)-Akt-Glycogen Synthase Kinase 3 beta (GSK3 beta) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; RAT SENSORY NEURONS; TRANSCRIPTION FACTOR; DEPENDENT TRANSCRIPTION; PROSTAGLANDIN E-2; TRK RECEPTORS; IN-VITRO; CALCIUM; CALCINEURIN; INACTIVATION	The Ca2+/calcineurin-dependent transcription factor nuclear factor of activated T-cells (NFAT) plays an important role in regulating many neuronal functions, including excitability, axonal growth, synaptogenesis, and neuronal survival. NFAT can be activated by action potential firing or depolarization that leads to Ca2+/calcineurin-dependent dephosphorylation of NFAT and its translocation to the nucleus. Recent data suggest that NFAT and NFAT-dependent functions in neurons can also be potently regulated by NGF and other neurotrophins. However, the mechanisms of NFAT regulation by neurotrophins are not well understood. Here, we show that in dorsal root ganglion sensory neurons, NGF markedly facilitates NFAT-mediated gene expression induced by mild depolarization. The effects of NGF were not associated with changes in [Ca2+](i) and were independent of phospholipase C activity. Instead, the facilitatory effect of NGF depended on activation of the PI3K/Akt pathway downstream of the TrkA receptor and on inhibition of glycogen synthase kinase 3 beta (GSK3 beta), a protein kinase known to phosphorylate NFAT and promote its nuclear export. Knockdown or knockout of NFATc3 eliminated this facilitatory effect. Simultaneous monitoring of EGFP-NFATc3 nuclear translocation and [Ca2+](i) changes in dorsal root ganglion neurons indicated that NGF slowed the rate of NFATc3 nuclear export but did not affect its nuclear import rate. Collectively, our data suggest that NGF facilitates depolarization-induced NFAT activation by stimulating PI3K/Akt signaling, inactivating GSK3 beta, and thereby slowing NFATc3 export from the nucleus. We propose that NFAT serves as an integrator of neurotrophin action and depolarization-driven calcium signaling to regulate neuronal gene expression.	[Kim, Man-Su; Shutov, Leonid P.; Gnanasekaran, Aswini; Lin, Zhihong; Rysted, Jacob E.; Ulrich, Jason D.; Usachev, Yuriy M.] Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; [Kim, Man-Su] Inje Univ, Coll Pharm, Gimhae 621749, Gyeongnam, South Korea	University of Iowa; Inje University	Kim, MS (corresponding author), Inje Univ, Coll Pharm, Inje Ro 197, Gimhae 621749, Gyeongnam, South Korea.	mansu-kim@inje.ac.kr; yuriy-usachev@uiowa.edu	Gnanasekaran, Aswini/N-1936-2016	Gnanasekaran, Aswini/0000-0002-0035-9553; Rysted, Jacob/0000-0001-5632-4176; Usachev, Yuriy/0000-0002-6948-4627	National Institutes of Health [NS072432, NS087068]; Fraternal Order of Eagles Diabetes Research Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072432, R01NS087068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fraternal Order of Eagles Diabetes Research Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS072432 and NS087068. This work was also supported by the Fraternal Order of Eagles Diabetes Research Center.	Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Benedito AB, 2005, J BIOL CHEM, V280, P2818, DOI 10.1074/jbc.M408741200; Blair LAC, 1999, J NEUROSCI, V19, P1940; Cai YQ, 2013, J PHARMACOL EXP THER, V345, P161, DOI 10.1124/jpet.112.202192; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Eibl JK, 2012, NEUROCHEM INT, V61, P1266, DOI 10.1016/j.neuint.2012.10.008; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Gomez-Sintes R, 2010, J CLIN INVEST, V120, P2432, DOI 10.1172/JCI37873; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Groth RD, 2007, J NEUROCHEM, V102, P1162, DOI 10.1111/j.1471-4159.2007.04632.x; Groth RD, 2003, J NEUROSCI, V23, P8125; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Hudry E, 2012, J NEUROSCI, V32, P3176, DOI 10.1523/JNEUROSCI.6439-11.2012; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jackson JG, 2007, MOL PHARMACOL, V72, P303, DOI 10.1124/mol.107.035048; Jones DM, 2003, J NEUROCHEM, V86, P1116, DOI 10.1046/j.1471-4159.2003.01925.x; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Khasabova IA, 2004, J NEUROSCI, V24, P1744, DOI 10.1523/JNEUROSCI.4298-03.2004; Khasabova IA, 2002, NEUROSCIENCE, V115, P613, DOI 10.1016/S0306-4522(02)00449-9; Kim MS, 2009, J NEUROSCI, V29, P12101, DOI 10.1523/JNEUROSCI.3384-09.2009; KNUSEL B, 1992, J NEUROCHEM, V59, P1987; Kress M, 2004, NEUROSCI LETT, V354, P127, DOI 10.1016/j.neulet.2003.10.003; Li HM, 2012, NAT STRUCT MOL BIOL, V19, P337, DOI 10.1038/nsmb.2238; Linhart O, 2003, NEUROSCIENCE, V118, P69, DOI 10.1016/S0306-4522(02)00960-0; Malin SA, 2006, J NEUROSCI, V26, P8588, DOI 10.1523/JNEUROSCI.1726-06.2006; Marsh HN, 2003, J CELL BIOL, V163, P999, DOI 10.1083/jcb.200309036; Martin KJ, 2011, NEUROPHARMACOLOGY, V61, P148, DOI 10.1016/j.neuropharm.2011.03.021; Meyer RA, 2006, WALL MELZACKS TXB PA, V5, P3; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Nguyen T, 2008, INT J DEV NEUROSCI, V26, P141, DOI 10.1016/j.ijdevneu.2007.10.004; Nieves-Cintron M, 2007, J BIOL CHEM, V282, P3231, DOI 10.1074/jbc.M608822200; Oh SB, 2001, J NEUROSCI, V21, P5027, DOI 10.1523/JNEUROSCI.21-14-05027.2001; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Ozaki Y, 2009, CELL CALCIUM, V45, P209, DOI 10.1016/j.ceca.2008.10.002; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Quadrato G, 2012, P NATL ACAD SCI USA, V109, pE1499, DOI 10.1073/pnas.1202068109; Rossow CF, 2004, CIRC RES, V94, P1340, DOI 10.1161/01.RES.0000128406.08418.34; Schnizler K, 2008, J NEUROSCI, V28, P4904, DOI 10.1523/JNEUROSCI.0233-08.2008; Schwartz N, 2009, NEURON, V62, P655, DOI 10.1016/j.neuron.2009.05.007; Shioda N, 2007, J NEUROCHEM, V102, P1506, DOI 10.1111/j.1471-4159.2007.04600.x; SHUTTLEWORTH TJ, 1991, J BIOL CHEM, V266, P1410; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Stefos GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067470; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Stucky CL, 1996, NEUROSCIENCE, V74, P1111, DOI 10.1016/S0306-4522(96)00264-3; Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659; Svichar N, 1997, NEUROREPORT, V8, P1555, DOI 10.1097/00001756-199705060-00002; THAYER SA, 1988, J NEUROSCI, V8, P4089; THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Ulrich JD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.365197; Usachev YM, 2002, NEURON, V33, P113, DOI 10.1016/S0896-6273(01)00557-8; Usachev YM, 1999, J PHYSIOL-LONDON, V519, P115, DOI 10.1111/j.1469-7793.1999.0115o.x; van der Velden JLJ, 2008, J BIOL CHEM, V283, P358, DOI 10.1074/jbc.M707812200; Vashishta A, 2009, J NEUROSCI, V29, P15331, DOI 10.1523/JNEUROSCI.4873-09.2009; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Watson JJ, 2008, BIODRUGS, V22, P349, DOI 10.2165/0063030-200822060-00002; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; Wood ER, 2004, BIOORG MED CHEM LETT, V14, P953, DOI 10.1016/j.bmcl.2003.12.002; Yan HQ, 2014, BRAIN RES, V1548, P63, DOI 10.1016/j.brainres.2013.12.028; Yang TTC, 2008, MOL CELL BIOL, V28, P3489, DOI 10.1128/MCB.01847-07; Zhang J, 2012, NEURON, V76, P1133, DOI 10.1016/j.neuron.2012.10.019; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zhu JY, 1999, NATURE, V398, P256, DOI 10.1038/18473	75	46	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31349	31360		10.1074/jbc.M114.587188	http://dx.doi.org/10.1074/jbc.M114.587188			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25231981	Green Published, hybrid			2022-12-28	WOS:000344549900039
J	Surlow, BA; Cooley, BM; Needham, PG; Brodsky, JL; Patton-Vogt, J				Surlow, Beth A.; Cooley, Benjamin M.; Needham, Patrick G.; Brodsky, Jeffrey L.; Patton-Vogt, Jana			Loss of Ypk1, the Yeast Homolog to the Human Serum- and Glucocorticoid-induced Protein Kinase, Accelerates Phospholipase B1-mediated Phosphatidylcholine Deacylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; BUDDING YEAST; SPHINGOLIPID HOMEOSTASIS; LOCALIZATION DATABASE; ALZHEIMERS-DISEASE; GENE DISRUPTION; GLOBAL ANALYSIS; IN-VIVO	Ypk1, the yeast homolog of the human serum- and glucocorticoid-induced kinase (Sgk1), affects diverse cellular activities, including sphingolipid homeostasis. We now report that Ypk1 also impacts the turnover of the major phospholipid, phosphatidylcholine (PC). Pulse-chase radiolabeling reveals that a ypk1 Delta mutant exhibits increased PC deacylation and glycerophosphocholine production compared with wild type yeast. Deletion of PLB1, a gene encoding a B-type phospholipase that hydrolyzes PC, in a ypk1 Delta mutant curtails the increased PC deacylation. In contrast to previous data, we find that Plb1 resides in the ER and in the medium. Consistent with a link between Ypk1 and Plb1, the levels of both Plb1 protein and PLB1 message are elevated in a ypk1 Delta strain compared with wild type yeast. Furthermore, deletion of PLB1 in a ypk1 Delta mutant exacerbates phenotypes associated with loss of YPK1, including slowed growth and sensitivity to cell wall perturbation, suggesting that increased Plb1 activity buffers against the loss of Ypk1. Because Plb1 lacks a consensus phosphorylation site for Ypk1, we probed other processes under the control of Ypk1 that might be linked to PC turnover. Inhibition of sphingolipid biosynthesis by the drug myriocin or through utilization of a lcb1-100 mutant results in increased PLB1 expression. Furthermore, we discovered that the increase in PLB1 expression observed upon inhibition of sphingolipid synthesis or loss of Ypk1 is under the control of the Crz1 transcription factor. Taken together, these results suggest a functional interaction between Ypk1 and Plb1 in which altered sphingolipid metabolism up-regulates PLB1 expression via Crz1.	[Surlow, Beth A.; Cooley, Benjamin M.; Patton-Vogt, Jana] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Needham, Patrick G.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Duquesne University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Patton-Vogt, J (corresponding author), Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA.	pattonvogt@duq.edu			National Institutes of Health [R15 GM104876, R01 GM75061, P30 DK79307]; National Science Foundation [MRIDBI-0821401]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061, R15GM104876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R15 GM104876 (to J. P. V.) and R01 GM75061 and P30 DK79307 (to J. L. B.). The purchase of mass spectrometers was supported by National Science Foundation Grant MRIDBI-0821401.	Ausubel F. M., 1999, SHORT PROTOCOLS MOL, P13; Bailey UM, 2012, J PROTEOME RES, V11, P5376, DOI 10.1021/pr300599f; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Bishop AC, 2013, J BIOL CHEM, V288, P33939, DOI 10.1074/jbc.M113.505735; Bishop AC, 2011, EUKARYOT CELL, V10, P1618, DOI 10.1128/EC.05160-11; Breidenbach MA, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015339; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Caro LHP, 1997, YEAST, V13, P1477, DOI 10.1002/(SICI)1097-0061(199712)13:15<1477::AID-YEA184>3.0.CO;2-L; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; COOK SJ, 1989, BIOCHEM J, V263, P581, DOI 10.1042/bj2630581; De Smet CH, 2013, BBA-MOL CELL BIOL L, V1831, P1167, DOI 10.1016/j.bbalip.2013.03.002; Dickson RC, 1997, J BIOL CHEM, V272, P29620, DOI 10.1074/jbc.272.47.29620; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Fernandez-Murray JP, 2005, J BIOL CHEM, V280, P38290, DOI 10.1074/jbc.M507700200; Fisher E, 2005, J BIOL CHEM, V280, P36110, DOI 10.1074/jbc.M507051200; Fonteh AN, 2013, J LIPID RES, V54, P2884, DOI 10.1194/jlr.M037622; Friant S, 2001, EMBO J, V20, P6783, DOI 10.1093/emboj/20.23.6783; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Habeler G, 2002, NUCLEIC ACIDS RES, V30, P80, DOI 10.1093/nar/30.1.80; Hamada K, 1999, J BACTERIOL, V181, P3886, DOI 10.1128/JB.181.13.3886-3889.1999; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; HANSON BA, 1980, J LIPID RES, V21, P309; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Howson R, 2005, COMP FUNCT GENOM, V6, P2, DOI 10.1002/cfg.449; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ikushiro H, 2004, BIOCHEMISTRY-US, V43, P1082, DOI 10.1021/bi035706v; Jacquier N, 2010, J CELL SCI, V123, P2218, DOI 10.1242/jcs.063073; Kajiwara K, 2012, MOL MICROBIOL, V86, P1246, DOI 10.1111/mmi.12056; Kals M, 2005, YEAST, V22, P213, DOI 10.1002/yea.1204; Kolb AR, 2014, MOL BIOL CELL, V25, P276, DOI 10.1091/mbc.E13-07-0394; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Kurabe N, 2013, CANCER SCI, V104, P1295, DOI 10.1111/cas.12221; LEE KS, 1994, J BIOL CHEM, V269, P19725; Lee YJ, 2012, MOL CELL BIOL, V32, P4705, DOI 10.1128/MCB.00897-12; Li XY, 2010, CELL, V143, P639, DOI 10.1016/j.cell.2010.09.048; Liu M, 2012, J CELL SCI, V125, P2428, DOI 10.1242/jcs.100578; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MARTIN TW, 1988, BIOCHIM BIOPHYS ACTA, V962, P282, DOI 10.1016/0005-2760(88)90258-5; Merkel O, 1999, J BIOL CHEM, V274, P28121, DOI 10.1074/jbc.274.40.28121; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Nakano K, 2008, MOL BIOL CELL, V19, P1783, DOI 10.1091/mbc.E07-07-0646; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; Niles BJ, 2014, CELL REP, V6, P541, DOI 10.1016/j.celrep.2013.12.040; Niles BJ, 2012, CELL CYCLE, V11, P3745, DOI 10.4161/cc.21752; Niles BJ, 2012, P NATL ACAD SCI USA, V109, P1536, DOI 10.1073/pnas.1117563109; PATTON JL, 1995, J BACTERIOL, V177, P3379, DOI 10.1128/jb.177.12.3379-3385.1995; Patton-Vogt J, 2007, BBA-MOL CELL BIOL L, V1771, P337, DOI 10.1016/j.bbalip.2006.04.013; Patton-Vogt JL, 1998, GENETICS, V149, P1707; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; Sanchez-Lopez E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.453; Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Sullivan ML, 2003, J HISTOCHEM CYTOCHEM, V51, P545, DOI 10.1177/002215540305100417; Sun T, 2012, J CHROMATOGR B, V897, P1, DOI 10.1016/j.jchromb.2012.03.034; Sun YD, 2000, MOL CELL BIOL, V20, P4411, DOI 10.1128/MCB.20.12.4411-4419.2000; Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209; Tanoue D, 2005, ARCH BIOCHEM BIOPHYS, V437, P29, DOI 10.1016/j.abb.2005.02.030; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Waksman M, 1996, J BIOL CHEM, V271, P2361, DOI 10.1074/jbc.271.5.2361; Whiley L, 2014, NEUROBIOL AGING, V35, P271, DOI 10.1016/j.neurobiolaging.2013.08.001; WITT W, 1984, BIOCHIM BIOPHYS ACTA, V795, P117, DOI 10.1016/0005-2760(84)90111-5; WITT W, 1984, BIOCHIM BIOPHYS ACTA, V795, P108, DOI 10.1016/0005-2760(84)90110-3; Yoshimoto M, 2004, NUCL MED BIOL, V31, P859, DOI 10.1016/j.nucmedbio.2004.05.002; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824; Zhang Meng, 2009, Open Microbiol J, V3, P136, DOI 10.2174/1874285800903010136; Zheng B, 2003, P NATL ACAD SCI USA, V100, P1745, DOI 10.1073/pnas.0337605100; Zhou XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048889	77	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31591	31604		10.1074/jbc.M114.581157	http://dx.doi.org/10.1074/jbc.M114.581157			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25258318	hybrid, Green Published			2022-12-28	WOS:000344549900059
J	Dzialo, MC; Travaglini, KJ; Shen, S; Roy, K; Chanfreau, GF; Loo, JA; Clarke, SG				Dzialo, Maria C.; Travaglini, Kyle J.; Shen, Sean; Roy, Kevin; Chanfreau, Guillaume F.; Loo, Joseph A.; Clarke, Steven G.			Translational Roles of Elongation Factor 2 Protein Lysine Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; METHYLTRANSFERASE; INHIBITION; YEAST; RIBOSOME; IDENTIFICATION; TRANSLOCATION; ANTIBIOTICS	Methylation of various components of the translational machinery has been shown to globally affect protein synthesis. Little is currently known about the role of lysine methylation on elongation factors. Here we show that in Saccharomyces cerevisiae, the product of the EFM3/YJR129C gene is responsible for the trimethylation of lysine 509 on elongation factor 2. Deletion of EFM3 or of the previously described EFM2 increases sensitivity to antibiotics that target translation and decreases translational fidelity. Furthermore, the amino acid sequences of Efm3 and Efm2, as well as their respective methylation sites on EF2, are conserved in other eukaryotes. These results suggest the importance of lysine methylation modification of EF2 in fine tuning the translational apparatus.	[Dzialo, Maria C.; Travaglini, Kyle J.; Shen, Sean; Roy, Kevin; Chanfreau, Guillaume F.; Loo, Joseph A.; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Dzialo, Maria C.; Travaglini, Kyle J.; Shen, Sean; Roy, Kevin; Chanfreau, Guillaume F.; Loo, Joseph A.; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Loo, Joseph A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Loo, Joseph A.] Univ Calif Los Angeles, Dept Energy Inst Genom & Prote, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr East, Los Angeles, CA 90095 USA.	clarke@chem.ucla.edu	Chanfreau, Guillaume/S-7421-2019	Travaglini, Kyle/0000-0003-3164-6448; Roy, Kevin/0000-0001-8799-6207	National Institutes of Health [GM026020, GM007185]; Ruth L. Kirschstein National Research Service Award; UCLA Department of Chemistry and Biochemistry Alumni Undergraduate Summer Research Fellowship; UCLA College Honors Summer Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, T32GM007185, R01GM103479, R01GM061518, R37GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Department of Chemistry and Biochemistry Alumni Undergraduate Summer Research Fellowship; UCLA College Honors Summer Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM026020 (to S. G. C.) and GM007185, a Ruth L. Kirschstein National Research Service Award (to M. C. D.).; Supported by a UCLA Department of Chemistry and Biochemistry Alumni Undergraduate Summer Research Fellowship and a UCLA College Honors Summer Research Fellowship.	Al-Hadid Q, 2014, MOL CELL BIOL, V34, P2903, DOI 10.1128/MCB.01634-13; ALLEN DW, 1962, BIOCHIM BIOPHYS ACTA, V55, P865; BELFIELD GP, 1993, MOL MICROBIOL, V9, P411, DOI 10.1111/j.1365-2958.1993.tb01702.x; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; CARRASCO L, 1973, BIOCHIM BIOPHYS ACTA, V312, P368, DOI 10.1016/0005-2787(73)90381-X; Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje; Chang YQ, 2011, NUCLEIC ACIDS RES, V39, P6380, DOI 10.1093/nar/gkr256; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Couttas TA, 2012, PROTEOMICS, V12, P960, DOI 10.1002/pmic.201100570; CUNDLIFFE E, 1974, P NATL ACAD SCI USA, V71, P30, DOI 10.1073/pnas.71.1.30; Del Rizzo PA, 2014, BBA-GENE REGUL MECH, V1839, P1404, DOI 10.1016/j.bbagrm.2014.06.008; Erce MA, 2012, PROTEOMICS, V12, P564, DOI 10.1002/pmic.201100397; Graille M, 2012, BIOCHIMIE, V94, P1533, DOI 10.1016/j.biochi.2012.01.005; Gulshan K, 2008, MOL CELL BIOL, V28, P5851, DOI 10.1128/MCB.00405-08; Harger JW, 2002, TRENDS BIOCHEM SCI, V27, P448, DOI 10.1016/S0968-0004(02)02149-7; Heurgue-Hamard V, 1998, EMBO J, V17, P808, DOI 10.1093/emboj/17.3.808; Hiramatsu N, 2011, METHOD ENZYMOL, V491, P183, DOI 10.1016/B978-0-12-385928-0.00011-0; Horowitz S, 2014, ACS CHEM BIOL, V9, P1692, DOI 10.1021/cb5001185; Horowitz S, 2013, J AM CHEM SOC, V135, P15536, DOI 10.1021/ja407140k; Jackman JE, 2013, WIRES RNA, V4, P35, DOI 10.1002/wrna.1144; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Jorgensen R, 2004, J BIOL CHEM, V279, P45919, DOI 10.1074/jbc.M406218200; Justice MC, 1998, J BIOL CHEM, V273, P3148, DOI 10.1074/jbc.273.6.3148; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Kirillov S, 1997, FEBS LETT, V406, P223, DOI 10.1016/S0014-5793(97)00261-5; Kurata S, 2013, NUCLEIC ACIDS RES, V41, P264, DOI 10.1093/nar/gks958; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Lipson RS, 2010, ARCH BIOCHEM BIOPHYS, V500, P137, DOI 10.1016/j.abb.2010.05.023; Liu J, 2014, J GENET GENOMICS, V41, P21, DOI 10.1016/j.jgg.2013.10.002; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Ortiz PA, 2006, J BIOL CHEM, V281, P32639, DOI 10.1074/jbc.M607076200; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Plant EP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000517; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Roy S, 2010, J MOL BIOL, V398, P489, DOI 10.1016/j.jmb.2010.03.024; Salas-Marco J, 2005, J MOL BIOL, V348, P801, DOI 10.1016/j.jmb.2005.03.025; Schalch T, 2009, MOL CELL, V34, P36, DOI 10.1016/j.molcel.2009.02.024; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Sharma S, 2013, NUCLEIC ACIDS RES, V41, P9062, DOI 10.1093/nar/gkt679; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Studte P, 2008, MOL MICROBIOL, V69, P1266, DOI 10.1111/j.1365-2958.2008.06358.x; Szczepinska T, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003514; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Vicens Q, 2001, STRUCTURE, V9, P647, DOI 10.1016/S0969-2126(01)00629-3; Wlodarski T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023168; YARMOLINSKY MB, 1959, P NATL ACAD SCI USA, V45, P1721, DOI 10.1073/pnas.45.12.1721; Zhang LL, 2014, BIOCHEM BIOPH RES CO, V451, P229, DOI 10.1016/j.bbrc.2014.07.110; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zhang XT, 2001, J BIOL CHEM, V276, P47844, DOI 10.1074/jbc.M106285200; Zobel-Thropp P, 2000, J BIOL CHEM, V275, P37150, DOI 10.1074/jbc.M001005200; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	57	17	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30511	30524		10.1074/jbc.M114.605527	http://dx.doi.org/10.1074/jbc.M114.605527			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231983	Green Published, hybrid			2022-12-28	WOS:000344549700030
J	Goncalves, A; Margier, M; Roi, S; Collet, X; Niot, I; Goupy, P; Caris-Veyrat, C; Reboul, E				Goncalves, Aurelie; Margier, Marielle; Roi, Stephanie; Collet, Xavier; Niot, Isabelle; Goupy, Pascale; Caris-Veyrat, Catherine; Reboul, Emmanuelle			Intestinal Scavenger Receptors Are Involved in Vitamin K-1 Absorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B TYPE-I; SR-BI; PHYLLOQUINONE VITAMIN-K-1; MENAQUINONE-4 VITAMIN-K-2; CD36 DEFICIENCY; HUMAN PLASMA; CELL-LINE; TRANSPORT; CACO-2; CAROTENOIDS	Vitamin K-1 (phylloquinone) intestinal absorption is thought to be mediated by a carrier protein that still remains to be identified. Apical transport of vitamin K-1 was examined using Caco-2 TC-7 cell monolayers as a model of human intestinal epithelium and in transfected HEK cells. Phylloquinone uptake was then measured ex vivo using mouse intestinal explants. Finally, vitamin K-1 absorption was compared between wild-type mice and mice overexpressing scavenger receptor class B type I (SR-BI) in the intestine and mice deficient in cluster determinant 36 (CD36). Phylloquinone uptake by Caco-2 cells was saturable and was significantly impaired by co-incubation with alpha-tocopherol (and vice versa). Anti-human SR-BI antibodies and BLT1 (a chemical inhibitor of lipid transport via SR-BI) blocked up to 85% of vitamin K-1 uptake. BLT1 also decreased phylloquinone apical efflux by similar to 80%. Transfection of HEK cells with SR-BI and CD36 significantly enhanced vitamin K-1 uptake, which was subsequently decreased by the addition of BLT1 or sulfo-N-succinimidyl oleate (CD36 inhibitor), respectively. Similar results were obtained in mouse intestinal explants. In vivo, the phylloquinone postprandial response was significantly higher, and the proximal intestine mucosa phylloquinone content 4 h after gavage was increased in mice overexpressing SR-BI compared with controls. Phylloquinone postprandial response was also significantly increased in CD36-deficient mice compared with wild-type mice, but their vitamin K-1 intestinal content remained unchanged. Overall, the present data demonstrate for the first time that intestinal scavenger receptors participate in the absorption of dietary phylloquinone.	[Goncalves, Aurelie; Margier, Marielle; Roi, Stephanie; Reboul, Emmanuelle] INRA, UMR Nutr Obes & Risk Thrombosis 1260, F-13385 Marseille, France; [Goncalves, Aurelie; Margier, Marielle; Roi, Stephanie; Reboul, Emmanuelle] INSERM, UMR 1062, F-13385 Marseille, France; [Goncalves, Aurelie; Margier, Marielle; Roi, Stephanie; Reboul, Emmanuelle] Aix Marseille Univ, F-13385 Marseille, France; [Collet, Xavier] Hop Rangueil, INSERM, UPS U1048, F-31432 Toulouse, France; [Niot, Isabelle] Univ Bourgogne Physiol Nutr, INSERM, AgroSup Dijon, UMR 866, F-21000 Dijon, France; [Goupy, Pascale; Caris-Veyrat, Catherine] INRA, UMR Securite & Qualite Prod Origine Vegetale 408, F-84000 Avignon, France; [Goupy, Pascale; Caris-Veyrat, Catherine] Univ Avignon & Pays Vaucluse, F-84000 Avignon, France	INRAE; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; INRAE; Avignon Universite	Reboul, E (corresponding author), Aix Marseille Univ, INRA 1260, INSERM, Fac Med Timone,UMR 1062, 27 Blvd Jean Moulin, F-13385 Marseille 5, France.	Emmanuelle.Reboul@univ-amu.fr	Collet, Xavier/M-6938-2017; GONCALVES, Aurelie/ABC-5817-2021; Reboul, Emmanuelle/K-6637-2017	GONCALVES, Aurelie/0000-0003-0843-4578; Reboul, Emmanuelle/0000-0002-4576-1992	Societe Francaise de Nutrition (Lu/SFN grant)	Societe Francaise de Nutrition (Lu/SFN grant)	This work was supported by a grant from the Societe Francaise de Nutrition (Lu/SFN grant).	Adams J, 2005, AM J HEALTH-SYST PH, V62, P1574, DOI 10.2146/ajhp040357; ARTURSSON P, 1995, EPITHELIA CELL CULTU, P111; Bietrix F, 2006, J BIOL CHEM, V281, P7214, DOI 10.1074/jbc.M508868200; Bolton-Smith C, 2000, BRIT J NUTR, V83, P389; Borel P, 2001, AM J PHYSIOL-GASTR L, V280, pG95, DOI 10.1152/ajpgi.2001.280.1.G95; Borel P, 2013, J NUTR, V143, P448, DOI 10.3945/jn.112.172734; CHANTRET I, 1994, J CELL SCI, V107, P213; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; Goncalves A, 2014, MOL NUTR FOOD RES, V58, P2297, DOI 10.1002/mnfr.201400339; Goncalves A, 2013, J NUTR BIOCHEM, V24, P1751, DOI 10.1016/j.jnutbio.2013.03.004; Goudriaan JR, 2005, J LIPID RES, V46, P2175, DOI 10.1194/jlr.M500112-JLR200; Hanzawa F, 2014, MOL NUTR FOOD RES, V58, P1601, DOI 10.1002/mnfr.201300710; Hirota Y, 2013, J BIOL CHEM, V288, P33071, DOI 10.1074/jbc.M113.477356; HOLLANDER D, 1973, AM J PHYSIOL, V225, P360, DOI 10.1152/ajplegacy.1973.225.2.360; HOLLANDER D, 1977, AM J PHYSIOL, V232, pE69, DOI 10.1152/ajpendo.1977.232.1.E69; Kamao M, 2005, J CHROMATOGR B, V816, P41, DOI 10.1016/j.jchromb.2004.11.003; Kopec RE, 2013, RAPID COMMUN MASS SP, V27, P1393, DOI 10.1002/rcm.6576; Martin A., 2001, APPORTS NUTR CONSEIL, P244; Nieland TJF, 2004, J LIPID RES, V45, P1256, DOI 10.1194/jlr.M300358-JLR200; Nieland TJF, 2002, P NATL ACAD SCI USA, V99, P15422, DOI 10.1073/pnas.222421399; Okano T, 2008, J BIOL CHEM, V283, P11270, DOI 10.1074/jbc.M702971200; Reboul E, 2005, BIOCHEM J, V387, P455, DOI 10.1042/BJ20040554; Reboul E, 2006, J BIOL CHEM, V281, P4739, DOI 10.1074/jbc.M509042200; Reboul E, 2012, BRIT J NUTR, V107, P1296, DOI 10.1017/S0007114511004405; Reboul E, 2011, PROG LIPID RES, V50, P388, DOI 10.1016/j.plipres.2011.07.001; Reboul E, 2011, MOL NUTR FOOD RES, V55, P691, DOI 10.1002/mnfr.201000553; Reboul E, 2009, AM J CLIN NUTR, V89, P177, DOI 10.3945/ajcn.2008.26559; Salvini S, 2002, BRIT J NUTR, V87, P211, DOI 10.1079/BJN2001507; SAUPE J, 1993, AM J CLIN NUTR, V58, P204, DOI 10.1093/ajcn/58.2.204; Shearer MJ, 2014, J LIPID RES, V55, P345, DOI 10.1194/jlr.R045559; Song QX, 2008, J CHROMATOGR B, V875, P541, DOI 10.1016/j.jchromb.2008.10.009; STAGGERS JE, 1990, BIOCHEMISTRY-US, V29, P2028, DOI 10.1021/bi00460a011; Thi TTT, 2011, J BIOL CHEM, V286, P25201, DOI 10.1074/jbc.M111.233551; Thijssen HHW, 2006, BRIT J NUTR, V95, P260, DOI 10.1079/BJN20051630; Thijssen HHW, 1996, BRIT J NUTR, V75, P121, DOI 10.1079/BJN19960115; Traber MG, 2008, NUTR REV, V66, P624, DOI 10.1111/j.1753-4887.2008.00123.x; Tyssandier V, 2003, AM J PHYSIOL-GASTR L, V284, pG913, DOI 10.1152/ajpgi.00410.2002; Willems BAG, 2014, MOL NUTR FOOD RES, V58, P1620, DOI 10.1002/mnfr.201300743; Yu M, 2011, P NATL ACAD SCI USA, V108, P12243, DOI 10.1073/pnas.1109078108	39	42	42	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30743	30752		10.1074/jbc.M114.587659	http://dx.doi.org/10.1074/jbc.M114.587659			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25228690	Green Published, hybrid			2022-12-28	WOS:000344549700049
J	Salzer, R; Herzberg, M; Nies, DH; Joos, F; Rathmann, B; Thielmann, Y; Averhoff, B				Salzer, Ralf; Herzberg, Martin; Nies, Dietrich H.; Joos, Friederike; Rathmann, Barbara; Thielmann, Yvonne; Averhoff, Beate			Zinc and ATP Binding of the Hexameric AAA-ATPase PilF from Thermus thermophilus ROLE IN COMPLEX STABILITY, PILIATION, ADHESION, TWITCHING MOTILITY, AND NATURAL TRANSFORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-UPTAKE; PROTEIN-SECRETION; GENETIC-TRANSFORMATION; EXTREME THERMOPHILE; VIBRIO-CHOLERAE; BACTERIUM; IDENTIFICATION; COMPETENCE; BIOGENESIS; MACHINERY	The traffic AAA-ATPase PilF is essential for pilus biogenesis and natural transformation of Thermus thermophilus HB27. Recently, we showed that PilF forms hexameric complexes containing six zinc atoms coordinated by conserved tetracysteine motifs. Here we report that zinc binding is essential for complex stability. However, zinc binding is neither required for pilus biogenesis nor natural transformation. A number of the mutants did not exhibit any pili during growth at 64 degrees C but still were transformable. This leads to the conclusion that type 4 pili and the DNA translocator are distinct systems. At lower growth temperatures (55 degrees C) the zinc-depleted multiple cysteine mutants were hyperpiliated but defective in pilus-mediated twitching motility. This provides evidence that zinc binding is essential for the role of PilF in pilus dynamics. Moreover, we found that zinc binding is essential for complex stability but dispensable for ATPase activity. In contrast to many polymerization ATPases from mesophilic bacteria, ATP binding is not required for PilF complex formation; however, it significantly increases complex stability. These data suggest that zinc and ATP binding increase complex stability that is important for functionality of PilF under extreme environmental conditions.	[Salzer, Ralf; Averhoff, Beate] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Herzberg, Martin; Nies, Dietrich H.] Univ Halle Wittenberg, Inst Biol Microbiol, D-06120 Halle, Germany; [Joos, Friederike] Max Planck Inst Biophys, Dept Biol Struct, Frankfurt, Germany; [Rathmann, Barbara; Thielmann, Yvonne] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Martin Luther University Halle Wittenberg; Max Planck Society; Max Planck Society	Averhoff, B (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Max von Laue Str 9, D-60438 Frankfurt, Germany.	averhoff@bio.uni-frankfurt.de	Nies, Dietrich H/H-4143-2011; HERZBERG, MARTIN/K-6210-2019	Thielmann, Yvonne/0000-0003-2673-251X; Averhoff, Beate/0000-0003-1460-3649; Herzberg, Martin/0000-0001-7746-0425	Deutsche Forschungsgemeinschaft [AV 9/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (AV 9/6-1).	Averhoff B, 2009, FEMS MICROBIOL REV, V33, P611, DOI 10.1111/j.1574-6976.2008.00160.x; Averhoff Beate, 2008, P119; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulyha I, 2013, DEV CELL, V25, P119, DOI 10.1016/j.devcel.2013.02.017; Burkhardt J, 2012, J BIOL CHEM, V287, P8484, DOI 10.1074/jbc.M111.334912; Burkhardt J, 2011, J BIOL CHEM, V286, P9977, DOI 10.1074/jbc.M110.212688; Camberg JL, 2005, J BACTERIOL, V187, P249, DOI 10.1128/JB.187.1.249-256.2005; Chen I, 2003, FRONT BIOSCI, V8, pS544; Collins RF, 2013, BIOCHEM J, V450, P417, DOI 10.1042/BJ20121599; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Friedrich A, 2001, APPL ENVIRON MICROB, V67, P3140, DOI 10.1128/AEM.67.7.3140-3148.2001; Friedrich A, 2003, APPL ENVIRON MICROB, V69, P3695, DOI 10.1128/AEM.69.7.3695-3700.2003; Friedrich A, 2002, APPL ENVIRON MICROB, V68, P745, DOI 10.1128/AEM.68.2.745-755.2002; HEINONEN JK, 1981, ANAL BIOCHEM, V113, P313, DOI 10.1016/0003-2697(81)90082-8; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; Jakovljevic V, 2008, J BACTERIOL, V190, P2411, DOI 10.1128/JB.01793-07; Keilberg D, 2014, BIOCHEMISTRY-US, V53, P1899, DOI 10.1021/bi500141f; KOYAMA Y, 1986, J BACTERIOL, V166, P338, DOI 10.1128/jb.166.1.338-340.1986; Krause S, 2000, P NATL ACAD SCI USA, V97, P3067, DOI 10.1073/pnas.050578697; Lang E, 2009, MICROBIOL-SGM, V155, P852, DOI 10.1099/mic.0.022640-0; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Lu C, 2013, STRUCTURE, V21, P1707, DOI 10.1016/j.str.2013.06.027; Miertzschke M, 2011, EMBO J, V30, P4185, DOI 10.1038/emboj.2011.291; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nunn D, 1999, TRENDS CELL BIOL, V9, P402, DOI 10.1016/S0962-8924(99)01634-7; OSHIMA T, 1971, J GEN APPL MICROBIOL, V17, P513, DOI 10.2323/jgam.17.513; OSHIMA T, 1974, INT J SYST BACTERIOL, V24, P102, DOI 10.1099/00207713-24-1-102; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Robien MA, 2003, J MOL BIOL, V333, P657, DOI 10.1016/j.jmb.2003.07.015; Rose I, 2011, EXTREMOPHILES, V15, P191, DOI 10.1007/s00792-010-0343-2; Rumszauer J, 2006, FEBS J, V273, P3261, DOI 10.1111/j.1742-4658.2006.05335.x; Salzer R, 2014, FEMS MICROBIOL LETT, V357, P56, DOI 10.1111/1574-6968.12506; Salzer R, 2014, APPL ENVIRON MICROB, V80, P644, DOI 10.1128/AEM.03218-13; Salzer R, 2013, EXTREMOPHILES, V17, P697, DOI 10.1007/s00792-013-0544-6; Schwarzenlander C, 2006, FEBS J, V273, P4210, DOI 10.1111/j.1742-4658.2006.05416.x; Schwarzenlander C, 2009, ENVIRON MICROBIOL, V11, P801, DOI 10.1111/j.1462-2920.2008.01801.x; Seitz P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004066; Seitz P, 2013, P NATL ACAD SCI USA, V110, P17987, DOI 10.1073/pnas.1315647110; Shiue SJ, 2006, EMBO J, V25, P1426, DOI 10.1038/sj.emboj.7601036; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081	42	22	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30343	30354		10.1074/jbc.M114.598656	http://dx.doi.org/10.1074/jbc.M114.598656			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25202014	hybrid, Green Published			2022-12-28	WOS:000344549700017
J	Ghimire-Rijal, S; Lu, X; Myles, DA; Cuneo, MJ				Ghimire-Rijal, Sudipa; Lu, Xun; Myles, Dean A.; Cuneo, Matthew J.			Duplication of Genes in an ATP-binding Cassette Transport System Increases Dynamic Range While Maintaining Ligand Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Carbohydrate Structure; Fluorescence; Substrate Specificity; X-ray Crystallography; Affinity; Functionalization; Mannose-binding Proteins	STRUCTURE VALIDATION; ESCHERICHIA-COLI; PROTEIN; MOLPROBITY; RECEPTORS; STABILITY; EVOLUTION; BACTERIA; GENOME	Background: The functional role of gene duplicates in a bacterial metabolite transport system is unknown. Results: Duplicated genes have similar ligand specificities, but affinities differ by three orders of magnitude. Conclusion: This expands the ability to respond to nutrient stress and maximizes transport of preferentially metabolized substrates. Significance: Functionalization of gene duplicates in transport pathways allows bacteria to adapt to varying nutrient flux. Many bacteria exist in a state of feast or famine where high nutrient availability leads to periods of growth followed by nutrient scarcity and growth stagnation. To adapt to the constantly changing nutrient flux, metabolite acquisition systems must be able to function over a broad range. This, however, creates difficulties as nutrient concentrations vary over many orders of magnitude, requiring metabolite acquisition systems to simultaneously balance ligand specificity and the dynamic range in which a response to a metabolite is elicited. Here we present how a gene duplication of a periplasmic binding protein in a mannose ATP-binding cassette transport system potentially resolves this dilemma through gene functionalization. Determination of ligand binding affinities and specificities of the gene duplicates with fluorescence and circular dichroism demonstrates that although the binding specificity is maintained the K-d values for the same ligand differ over three orders of magnitude. These results suggest that this metabolite acquisition system can transport ligand at both low and high environmental concentrations while preventing saturation with related and less preferentially metabolized compounds. The x-ray crystal structures of the -mannose-bound proteins help clarify the structural basis of gene functionalization and reveal that affinity and specificity are potentially encoded in different regions of the binding site. These studies suggest a possible functional role and adaptive advantage for the presence of two periplasmic-binding proteins in ATP-binding cassette transport systems and a way bacteria can adapt to varying nutrient flux through functionalization of gene duplicates.	[Ghimire-Rijal, Sudipa; Lu, Xun; Myles, Dean A.; Cuneo, Matthew J.] Oak Ridge Natl Lab, Neutron Sci Directorate, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	Cuneo, MJ (corresponding author), Oak Ridge Natl Lab, Biol & Soft Matter Div, Biol & Biomed Sci Grp, Bethel Valley Rd, Oak Ridge, TN 37831 USA.	cuneomj@ornl.gov	myles, dean a/D-5860-2016	myles, dean a/0000-0002-7693-4964; Cuneo, Matthew/0000-0002-1475-6656	United States Department of Energy, Office of Basic Energy Sciences	United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This research was performed at Oak Ridge National Laboratory's Spallation Neutron Source, sponsored by the United States Department of Energy, Office of Basic Energy Sciences.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Botero LM, 2000, APPL ENVIRON MICROB, V66, P15, DOI 10.1128/AEM.66.1.15-22.2000; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chhabra SR, 2003, J BIOL CHEM, V278, P7540, DOI 10.1074/jbc.M211748200; COHEN DS, 1994, PROTEIN SCI, V3, P1253, DOI 10.1002/pro.5560030811; Conners SB, 2005, J BACTERIOL, V187, P7267, DOI 10.1128/JB.187.21.7267-7282.2005; Cuneo MJ, 2009, J BIOL CHEM, V284, P33217, DOI 10.1074/jbc.M109.041624; De Lorimier RM, 2002, PROTEIN SCI, V11, P2655, DOI 10.1110/ps.021860; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FREIRE E, 1990, ANAL CHEM, V62, pA950, DOI 10.1021/ac00217a002; Gebhard S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-254; HARDER W, 1983, ANNU REV MICROBIOL, V37, P1, DOI 10.1146/annurev.mi.37.100183.000245; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; HIGGINS CF, 1981, P NATL ACAD SCI-BIOL, V78, P6038, DOI 10.1073/pnas.78.10.6038; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; KJELLEBERG S, 1993, ANTON LEEUW INT J G, V63, P333, DOI 10.1007/BF00871228; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lefevre P, 1997, J BACTERIOL, V179, P2900, DOI 10.1128/jb.179.9.2900-2906.1997; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Nanavati DA, 2006, APPL ENVIRON MICROB, V72, P1336, DOI 10.1128/AEM.72.2.1336-1345.2006; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; OH BH, 1994, J BIOL CHEM, V269, P4135; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2013, P NATL ACAD SCI USA, V110, P18132, DOI 10.1073/pnas.1311407110; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rigden DJ, 2004, J MOL BIOL, V343, P971, DOI 10.1016/j.jmb.2004.08.077; SCHELLMAN JA, 1987, ANNU REV BIOPHYS BIO, V16, P115, DOI 10.1146/annurev.bb.16.060187.000555; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993	36	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					30090	30100		10.1074/jbc.M114.590992	http://dx.doi.org/10.1074/jbc.M114.590992			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25210043	Green Published, hybrid			2022-12-28	WOS:000344370800049
J	Hoppner, A; Widderich, N; Lenders, M; Bremer, E; Smits, SHJ				Hoeppner, Astrid; Widderich, Nils; Lenders, Michael; Bremer, Erhard; Smits, Sander H. J.			Crystal Structure of the Ectoine Hydroxylase, a Snapshot of the Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biosynthesis; Chemical Biology; Crystal Structure; Dioxygenase; Enzyme Structure; Enzymes	COMPATIBLE SOLUTE ECTOINE; HALOMONAS-ELONGATA; ESCHERICHIA-COLI; TETRAHYDROPYRIMIDINE DERIVATIVES; SPHINGOPYXIS-ALASKENSIS; PSEUDOMONAS-PUTIDA; HALOGENASE SYRB2; HEAT STRESSES; IN-VITRO; BIOSYNTHESIS	Background: 5-Hydroxyectoine is a compatible solute synthesized by the ectoine hydroxylase (EctD), a non-heme containing iron(II) and 2-oxoglutarate-dependent dioxygenase. Results: The structure of EctD was solved in different forms. Conclusion: The architecture of the catalytic core of EctD was revealed. Significance: The crystal structure increases our understanding of the structural-functional relationship in an evolutionary conserved group of enzymes. Ectoine and its derivative 5-hydroxyectoine are compatible solutes that are widely synthesized by bacteria to cope physiologically with osmotic stress. They also serve as chemical chaperones and maintain the functionality of macromolecules. 5-Hydroxyectoine is produced from ectoine through a stereo-specific hydroxylation, an enzymatic reaction catalyzed by the ectoine hydroxylase (EctD). The EctD protein is a member of the non-heme-containing iron(II) and 2-oxoglutarate-dependent dioxygenase superfamily and is evolutionarily well conserved. We studied the ectoine hydroxylase from the cold-adapted marine ultra-microbacterium Sphingopyxis alaskensis (Sa) and found that the purified SaEctD protein is a homodimer in solution. We determined the SaEctD crystal structure in its apo-form, complexed with the iron catalyst, and in a form that contained iron, the co-substrate 2-oxoglutarate, and the reaction product of EctD, 5-hydroxyectoine. The iron and 2-oxoglutarate ligands are bound within the EctD active site in a fashion similar to that found in other members of the dioxygenase superfamily. 5-Hydroxyectoine, however, is coordinated by EctD in manner different from that found in high affinity solute receptor proteins operating in conjunction with microbial import systems for ectoines. Our crystallographic analysis provides a detailed view into the active site of the ectoine hydroxylase and exposes an intricate network of interactions between the enzyme and its ligands that collectively ensure the hydroxylation of the ectoine substrate in a position- and stereo-specific manner.	[Hoeppner, Astrid] Univ Dusseldorf, Xray Facil, D-40225 Dusseldorf, Germany; [Hoeppner, Astrid] Univ Dusseldorf, Crystal Farm, D-40225 Dusseldorf, Germany; [Widderich, Nils; Bremer, Erhard] Univ Marburg, Microbiol Lab, Dept Biol, D-35043 Marburg, Germany; [Widderich, Nils] Max Planck Inst Terr Microbiol, Emeritus Grp RK Thauer, D-35043 Marburg, Germany; [Lenders, Michael; Smits, Sander H. J.] Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany; [Bremer, Erhard] Univ Marburg, LOEWE Ctr Synthet Microbiol, D-35043 Marburg, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Philipps University Marburg; Max Planck Society; Heinrich Heine University Dusseldorf; Philipps University Marburg	Bremer, E (corresponding author), Univ Marburg, Karl von Frisch Str 8, D-35043 Marburg, Germany.	bremer@staff.uni-marburg.de; Sander.Smits@hhu.de		Hoeppner, Astrid/0000-0002-7076-5936	Deutsche Forschungsgemeinschaft [SFB 987]; LOEWE program of the State of Hessen (via the Center for Synthetic Microbiology, Marburg); Max-Planck Institute for Terrestrial Microbiology (Marburg) through the Emeritus Group of R. K. Thauer; Heinrich-Heine-University Dusseldorf and its Institute of Biochemistry; initiative "Fit for Excellence" of the Heinrich-Heine-University; International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology, Marburg, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE program of the State of Hessen (via the Center for Synthetic Microbiology, Marburg); Max-Planck Institute for Terrestrial Microbiology (Marburg) through the Emeritus Group of R. K. Thauer; Heinrich-Heine-University Dusseldorf and its Institute of Biochemistry; initiative "Fit for Excellence" of the Heinrich-Heine-University; International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology, Marburg, Germany	This work was supported in part by Deutsche Forschungsgemeinschaft Grant SFB 987, the LOEWE program of the State of Hessen (via the Center for Synthetic Microbiology, Marburg), the Max-Planck Institute for Terrestrial Microbiology (Marburg) through the Emeritus Group of R. K. Thauer, a contribution by the Fonds der Chemischen Industrie, by the Heinrich-Heine-University Dusseldorf and its Institute of Biochemistry, and by the initiative "Fit for Excellence" of the Heinrich-Heine-University.; Recipient of a Ph.D. fellowship from the International Max Planck Research School for Environmental, Cellular, and Molecular Microbiology, Marburg, Germany.	Abdel-Aziz H, 2013, PHYTOMEDICINE, V20, P585, DOI 10.1016/j.phymed.2013.01.009; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Becker J, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-110; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Borges N, 2002, EXTREMOPHILES, V6, P209, DOI 10.1007/s007920100236; Bourot S, 2000, J BIOL CHEM, V275, P1050, DOI 10.1074/jbc.275.2.1050; Bremer E, 2000, BACTERIAL STRESS RESPONSES, P79; Bursy J, 2008, APPL ENVIRON MICROB, V74, P7286, DOI 10.1128/AEM.00768-08; Bursy J, 2007, J BIOL CHEM, V282, P31147, DOI 10.1074/jbc.M704023200; Diamant S, 2001, J BIOL CHEM, V276, P39586, DOI 10.1074/jbc.M103081200; Doan VT, 2013, APPL MICROBIOL BIOT, V97, P6271, DOI 10.1007/s00253-012-4528-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GALINSKI EA, 1985, EUR J BIOCHEM, V149, P135, DOI 10.1111/j.1432-1033.1985.tb08903.x; Garcia-Estepa R, 2006, J BACTERIOL, V188, P3774, DOI 10.1128/JB.00136-06; Graf R, 2008, CLIN DERMATOL, V26, P326, DOI 10.1016/j.clindermatol.2008.01.002; Grzyska PK, 2010, P NATL ACAD SCI USA, V107, P3982, DOI 10.1073/pnas.0911565107; Hanekop N, 2007, J MOL BIOL, V374, P1237, DOI 10.1016/j.jmb.2007.09.071; Hangasky JA, 2013, METALLOMICS, V5, P287, DOI 10.1039/c3mt20153h; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Helmetag V, 2009, FEBS J, V276, P3669, DOI 10.1111/j.1742-4658.2009.07085.x; Hoeppner A., 2013, ADV TOPICS CRYSTAL G, P3; Hoeppner A, 2014, ACTA CRYSTALLOGR F, V70, P493, DOI 10.1107/S2053230X14004798; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; INBAR L, 1988, J BIOL CHEM, V263, P16014; INBAR L, 1993, EUR J BIOCHEM, V214, P897, DOI 10.1111/j.1432-1033.1993.tb17993.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Khare D, 2010, P NATL ACAD SCI USA, V107, P14099, DOI 10.1073/pnas.1006738107; Knapp S, 1999, EXTREMOPHILES, V3, P191, DOI 10.1007/s007920050116; Knauer SH, 2012, FEBS J, V279, P816, DOI 10.1111/j.1742-4658.2012.08473.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhlmann AU, 2008, APPL ENVIRON MICROB, V74, P4560, DOI 10.1128/AEM.00492-08; Kuhlmann AU, 2002, APPL ENVIRON MICROB, V68, P772, DOI 10.1128/AEM.68.2.772-783.2002; Kuhlmann SI, 2008, BIOCHEMISTRY-US, V47, P9475, DOI 10.1021/bi8006719; Kundu Siddhartha, 2012, BMC Res Notes, V5, P410, DOI 10.1186/1756-0500-5-410; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kurz Matthias, 2008, Saline Syst, V4, P6, DOI 10.1186/1746-1448-4-6; Lecher J, 2009, J MOL BIOL, V389, P58, DOI 10.1016/j.jmb.2009.03.077; Lentzen G, 2006, APPL MICROBIOL BIOT, V72, P623, DOI 10.1007/s00253-006-0553-9; LIPPERT K, 1992, APPL MICROBIOL BIOT, V37, P61; Louis P, 1997, MICROBIOL-UK, V143, P1141, DOI 10.1099/00221287-143-4-1141; LOVENBERG W, 1963, J BIOL CHEM, V238, P3899; Manzanera M, 2002, APPL ENVIRON MICROB, V68, P4328, DOI 10.1128/AEM.68.9.4328-4333.2002; Marini A, 2014, SKIN PHARMACOL PHYS, V27, P57, DOI 10.1159/000351381; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonough MA, 2005, J BIOL CHEM, V280, P41101, DOI 10.1074/jbc.M507528200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mustakhimov II, 2010, J BACTERIOL, V192, P410, DOI 10.1128/JB.00553-09; Ono H, 1999, J BACTERIOL, V181, P91, DOI 10.1128/JB.181.1.91-99.1999; Pastor JM, 2010, BIOTECHNOL ADV, V28, P782, DOI 10.1016/j.biotechadv.2010.06.005; PETERS P, 1990, FEMS MICROBIOL LETT, V71, P157; Prabhu J, 2004, APPL ENVIRON MICROB, V70, P3130, DOI 10.1128/AEM.70.5.3130-3132.2004; Reuter K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010647; Saum SH, 2008, ENVIRON MICROBIOL, V10, P716, DOI 10.1111/j.1462-2920.2007.01494.x; Schnoor M, 2004, BIOCHEM BIOPH RES CO, V322, P867, DOI 10.1016/j.bbrc.2004.07.200; Schwibbert K, 2011, ENVIRON MICROBIOL, V13, P1973, DOI 10.1111/j.1462-2920.2010.02336.x; Stoveken N, 2011, J BACTERIOL, V193, P4456, DOI 10.1128/JB.00345-11; Straganz GD, 2006, CHEMBIOCHEM, V7, P1536, DOI 10.1002/cbic.200600152; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; Strieker M, 2007, ACS CHEM BIOL, V2, P187, DOI 10.1021/cb700012y; Sun H, 2012, CRYOLETTERS, V33, P485; Tanne C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00150; Ting L, 2010, ENVIRON MICROBIOL, V12, P2658, DOI 10.1111/j.1462-2920.2010.02235.x; Widderich N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093809; Widderich N, 2014, J MOL BIOL, V426, P586, DOI 10.1016/j.jmb.2013.10.028; Witt EMHJ, 2011, APPL MICROBIOL BIOT, V91, P113, DOI 10.1007/s00253-011-3211-9; Wong C, 2009, J AM CHEM SOC, V131, P4872, DOI 10.1021/ja8097355; Wong SD, 2013, NATURE, V499, P320, DOI 10.1038/nature12304; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Zhang ZH, 2011, BIOCHEM BIOPH RES CO, V408, P553, DOI 10.1016/j.bbrc.2011.04.059	71	28	30	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29570	29583		10.1074/jbc.M114.576769	http://dx.doi.org/10.1074/jbc.M114.576769			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25172507	hybrid, Green Published			2022-12-28	WOS:000344370800009
J	Kang, HJ; Menlove, K; Ma, JP; Wilkins, A; Lichtarge, O; Wensel, TG				Kang, Hye Jin; Menlove, Kit; Ma, Jianpeng; Wilkins, Angela; Lichtarge, Olivier; Wensel, Theodore G.			Selectivity and Evolutionary Divergence of Metabotropic Glutamate Receptors for Endogenous Ligands and G Proteins Coupled to Phospholipase C or TRP Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein; G Protein-coupled Receptor (GPCR); Metabotropic Glutamate Receptor (mGluR); Signal Transduction; Transient Receptor Potential Channels (TRP Channels)	SIGNAL-TRANSDUCTION; ALLOSTERIC MODULATOR; IBOTENIC ACID; AMINO-ACIDS; ACTIVATION; EXPRESSION; RAT; STIMULATION; SPECIFICITY; PHOSPHATE	Background: Endogenous ligands and G-proteins regulate responses of metabotropic glutamate receptors. Results: l-serine-O-phosphate activates Group III while antagonizing Group I & II. mGluR1 couples to G(i/o) as well as G(q/11). Conclusion: l-Serine-O-phosphate differentially interacts with mGluR. mGluR1 has a bifurcating G-protein coupling. Significance: Defining the interactions of mGluR with endogenous ligands and G-proteins is important for understanding their roles in human neuronal function and for design of therapeutics. To define the upstream and downstream signaling specificities of metabotropic glutamate receptors (mGluR), we have examined the ability of representative mGluR of group I, II, and III to be activated by endogenous amino acids and catalyze activation of G proteins coupled to phospholipase C (PLC), or activation of G(i/o) proteins coupled to the ion channel TRPC4. Fluorescence-based assays have allowed us to observe interactions not previously reported or clearly identified. We have found that the specificity for endogenous amino acids is remarkably stringent. Even at millimolar levels, structurally similar compounds do not elicit significant activation. As reported previously, the clear exception is l-serine-O-phosphate (l-SOP), which strongly activates group III mGluR, especially mGluR4,-6,-8 but not group I or II mGluR. Whereas l-SOP cannot activate mGluR1 or mGluR2, it acts as a weak antagonist for mGluR1 and a potent antagonist for mGluR2, suggesting that co-recognition of l-glutamate and l-SOP arose early in evolution, and was followed later by divergence of group I and group II mGluR versus group III in l-SOP responses. mGluR7 has low affinity and efficacy for activation by both l-glutamate and l-SOP. Molecular docking studies suggested that residue 74 corresponding to lysine in mGluR4 and asparagine in mGluR7 might play a key role, and, indeed, mutagenesis experiments demonstrated that mutating this residue to lysine in mGluR7 enhances the potency of l-SOP. Experiments with pertussis toxin and dominant-negative G(i/o) proteins revealed that mGluR1 couples strongly to TRPC4 through G(i/o), in addition to coupling to PLC through G(q/11).	[Kang, Hye Jin; Menlove, Kit; Ma, Jianpeng; Lichtarge, Olivier; Wensel, Theodore G.] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Ma, Jianpeng; Lichtarge, Olivier; Wensel, Theodore G.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Wilkins, Angela; Lichtarge, Olivier] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Ma, Jianpeng] Rice Univ, Dept Bioengn, Houston, TX 77005 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Rice University	Wensel, TG (corresponding author), Baylor Coll Med, BCM 125, Houston, TX 77030 USA.	twensel@bcm.edu		Kang, Hye Jin/0000-0001-9067-9050; Wensel, Theodore/0000-0003-3518-9352	National Institutes of Health [R01-GM66099, R01-EY11900, R01-EY07981, R01-GM067801, R01-GM079656, T90-DK070109]; National Science Foundation [MCB-0818353, CCF-0905536, DBI-1062455]; Welch Foundation [Q-1512, Q-0035]; NATIONAL EYE INSTITUTE [R01EY011900, R01EY007981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067801, R01GM079656, R01GM066099] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01-GM66099, R01-EY11900, R01-EY07981, R01-GM067801, R01-GM079656, and T90-DK070109, by National Science Foundation Grants MCB-0818353, CCF-0905536, and DBI-1062455, and by the Welch Foundation, Q-1512 and Q-0035.	Antflick JE, 2009, BRAIN RES, V1300, P1, DOI 10.1016/j.brainres.2009.08.087; ARAMORI I, 1992, NEURON, V8, P757, DOI 10.1016/0896-6273(92)90096-V; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conklin BR, 1996, MOL PHARMACOL, V50, P885; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Flor PJ, 1997, NEUROPHARMACOLOGY, V36, P153, DOI 10.1016/S0028-3908(96)00176-1; FOSTER AC, 1982, BRAIN RES, V242, P374, DOI 10.1016/0006-8993(82)90328-6; Francesconi A, 1998, J BIOL CHEM, V273, P5615, DOI 10.1074/jbc.273.10.5615; Frauli M, 2006, NEUROPHARMACOLOGY, V50, P245, DOI 10.1016/j.neuropharm.2005.09.016; Gilliam JC, 2011, VISION RES, V51, P2440, DOI 10.1016/j.visres.2011.10.009; Gomeza J, 1996, MOL PHARMACOL, V50, P923; Gomeza J, 1996, J BIOL CHEM, V271, P2199, DOI 10.1074/jbc.271.4.2199; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Hermit MB, 2004, J BIOL CHEM, V279, P34811, DOI 10.1074/jbc.M404109200; Jeon JP, 2013, CELL CALCIUM, V54, P307, DOI 10.1016/j.ceca.2013.07.006; Jeon JP, 2012, J BIOL CHEM, V287, P17029, DOI 10.1074/jbc.M111.326553; Jin XC, 2010, NEUROPSYCHOPHARMACOL, V35, P2021, DOI 10.1038/npp.2010.82; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KATAOKA H, 1991, J BIOCHEM-TOKYO, V109, P577, DOI 10.1093/oxfordjournals.jbchem.a123422; KLUNK WE, 1991, MOL CHEM NEUROPATHOL, V15, P51, DOI 10.1007/BF03161056; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Miller M, 2011, TRP CHANNELS, P1; Miller M, 2011, J BIOL CHEM, V286, P33436, DOI 10.1074/jbc.M111.274167; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; NICOLETTI F, 1986, NEUROPHARMACOLOGY, V25, P335, DOI 10.1016/0028-3908(86)90262-5; OFFERMANNS S, 1994, MOL PHARMACOL, V45, P890; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; OKAMOTO N, 1994, J BIOL CHEM, V269, P1231; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Rauw GA, 2010, ANAL BIOCHEM, V405, P260, DOI 10.1016/j.ab.2010.06.024; Riccio A, 2014, J NEUROSCI, V34, P3653, DOI 10.1523/JNEUROSCI.2274-13.2014; Rodriguez GJ, 2010, P NATL ACAD SCI USA, V107, P7787, DOI 10.1073/pnas.0914877107; Rosemond E, 2004, MOL PHARMACOL, V66, P834, DOI 10.1124/mol.104.002956; SAUGSTAD JA, 1994, MOL PHARMACOL, V45, P367; SAWAKI K, 1993, ARCH BIOCHEM BIOPHYS, V305, P546, DOI 10.1006/abbi.1993.1459; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; Trabanco AA, 2011, BIOORG MED CHEM LETT, V21, P971, DOI 10.1016/j.bmcl.2010.12.048; Wilkins AD, 2013, BIOINFORMATICS, V29, P2714, DOI 10.1093/bioinformatics/btt489; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Zhang ZX, 2002, J BIOL CHEM, V277, P33727, DOI 10.1074/jbc.M200976200	48	10	10	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29961	29974		10.1074/jbc.M114.574483	http://dx.doi.org/10.1074/jbc.M114.574483			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25193666	Green Published, hybrid			2022-12-28	WOS:000344370800038
J	Liu, L; Trent, CM; Fang, X; Son, NH; Jiang, HF; Blaner, WS; Hu, YY; Yin, YX; Farese, RV; Homma, S; Turnbull, AV; Eriksson, JW; Hu, SL; Ginsberg, HN; Huang, LS; Goldberg, IJ				Liu, Li; Trent, Chad M.; Fang, Xiang; Son, Ni-Huiping; Jiang, HongFeng; Blaner, William S.; Hu, Yunying; Yin, Yu-Xin; Farese, Robert V., Jr.; Homma, Shunichi; Turnbull, Andrew V.; Eriksson, Jan W.; Hu, Shi-Lian; Ginsberg, Henry N.; Huang, Li-Shin; Goldberg, Ira J.			Cardiomyocyte-specific Loss of Diacylglycerol Acyltransferase 1 (DGAT1) Reproduces the Abnormalities in Lipids Found in Severe Heart Failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Animal Model; Cardiac Metabolism; Ceramide; Diacylglycerol; Heart Failure; Lipid; Lipotoxicity; Metabolism; Signal Transduction	KINASE-C-ALPHA; INSULIN-RESISTANCE; SKELETAL-MUSCLE; IN-VIVO; TRIACYLGLYCEROL SYNTHESIS; TRIGLYCERIDE SYNTHESIS; OBESITY RESISTANCE; HEPATIC STEATOSIS; SYNTHESIS ENZYME; MICE	Background: Total body DGAT1 mice have no cardiac phenotype. Results: Cardiomyocyte DGAT1 knock-out mice have increased mortality and accumulation of potentially toxic lipids, which were corrected by intestinal DGAT1 deletion and GLP-1 receptor agonists. Conclusion: Cardiomyocyte DGAT1 deletion produces heart dysfunction and lipid abnormalities. Significance: Lipotoxicity in the heart can be alleviated by changes in intestinal metabolism. Diacylglycerol acyltransferase 1 (DGAT1) catalyzes the final step in triglyceride synthesis, the conversion of diacylglycerol (DAG) to triglyceride. Dgat1(-/-) mice exhibit a number of beneficial metabolic effects including reduced obesity and improved insulin sensitivity and no known cardiac dysfunction. In contrast, failing human hearts have severely reduced DGAT1 expression associated with accumulation of DAGs and ceramides. To test whether DGAT1 loss alone affects heart function, we created cardiomyocyte-specific DGAT1 knock-out (hDgat1(-/-)) mice. hDgat1(-/-) mouse hearts had 95% increased DAG and 85% increased ceramides compared with floxed controls. 50% of these mice died by 9 months of age. The heart failure marker brain natriuretic peptide increased 5-fold in hDgat1(-/-) hearts, and fractional shortening (FS) was reduced. This was associated with increased expression of peroxisome proliferator-activated receptor and cluster of differentiation 36. We crossed hDgat1(-/-) mice with previously described enterocyte-specific Dgat1 knock-out mice (hiDgat1(-/-)). This corrected the early mortality, improved FS, and reduced cardiac ceramide and DAG content. Treatment of hDgat1(-/-) mice with the glucagon-like peptide 1 receptor agonist exenatide also improved FS and reduced heart DAG and ceramide content. Increased fatty acid uptake into hDgat1(-/-) hearts was normalized by exenatide. Reduced activation of protein kinase C (PKC), which is increased by DAG and ceramides, paralleled the reductions in these lipids. Our mouse studies show that loss of DGAT1 reproduces the lipid abnormalities seen in severe human heart failure.	[Liu, Li; Trent, Chad M.; Fang, Xiang; Son, Ni-Huiping; Jiang, HongFeng; Blaner, William S.; Hu, Yunying; Ginsberg, Henry N.; Huang, Li-Shin; Goldberg, Ira J.] Columbia Univ Coll Phys & Surg, Div Prevent Med & Nutr, New York, NY 10032 USA; [Homma, Shunichi; Goldberg, Ira J.] Columbia Univ Coll Phys & Surg, Div Cardiol, New York, NY 10032 USA; [Liu, Li; Yin, Yu-Xin] Peking Univ, Inst Syst Biomed, Hlth Sci Ctr, Beijing 100083, Peoples R China; [Farese, Robert V., Jr.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Fang, Xiang; Hu, Shi-Lian] Anhui Med Univ, Affiliated Prov Hosp, Dept Geriatr, Hefei 230001, Peoples R China; [Turnbull, Andrew V.; Eriksson, Jan W.] Astra Zeneca Co, S-43150 Molndal, Sweden; [Eriksson, Jan W.] Uppsala Univ, Dept Med Sci, S-75105 Uppsala, Sweden; [Goldberg, Ira J.] NYU, Langone Sch Med, Div Endocrinol Diabet & Metab, New York, NY 10016 USA	Columbia University; Columbia University; Peking University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Anhui Medical University; Uppsala University; New York University; NYU Langone Medical Center	Goldberg, IJ (corresponding author), NYU, Langone Med Center, Div Endocrinol Diabet & Metab, 522 First Ave,Smilow 9B, New York, NY 10016 USA.	Ira.Goldberg@nyumc.org	jiang, hongfeng/I-6188-2013; Eriksson, Jan/AAB-5820-2021		National Institutes of Health from the NHLBI [HL45095, HL73029]; National Center for Advancing Translational Sciences [UL1 TR000040]; Heritage Affiliate of the American Heart Association; Department of Human Resources and Social Security of Anhui Province; Anhui Provincial Hospital; China National Major Scientific Program (973 Project) [2010CB912202]; National Natural Science Foundation of China [30930021]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045095, R01HL073029, R37HL045095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC2AA019413] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Heritage Affiliate of the American Heart Association(American Heart Association); Department of Human Resources and Social Security of Anhui Province; Anhui Provincial Hospital; China National Major Scientific Program (973 Project)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL45095 and HL73029 (to I. J. G.) from the NHLBI and Grant UL1 TR000040 from the National Center for Advancing Translational Sciences.; Supported by a predoctoral fellowship from the Heritage Affiliate of the American Heart Association.; Supported by funds from Department of Human Resources and Social Security of Anhui Province and Anhui Provincial Hospital.; Supported by the China National Major Scientific Program (973 Project 2010CB912202) and National Natural Science Foundation of China (Key Project 30930021).	Ables GP, 2012, J LIPID RES, V53, P2364, DOI 10.1194/jlr.M029041; Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Axelsen LN, 2012, BRIT J PHARMACOL, V165, P2736, DOI 10.1111/j.1476-5381.2011.01714.x; Birch AM, 2010, CURR OPIN DRUG DISC, V13, P489; Birch AM, 2009, J MED CHEM, V52, P1558, DOI 10.1021/jm801507v; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chen HC, 2003, J CLIN INVEST, V111, P1715, DOI [10.1172/JCI15859, 10.1172/JCI200315859]; Chen HC, 2003, AM J PHYSIOL-ENDOC M, V284, pE213, DOI 10.1152/ajpendo.00248.2002; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Chokshi A, 2012, CIRCULATION, V125, P2844, DOI 10.1161/CIRCULATIONAHA.111.060889; Denison H, 2013, DIABETES OBES METAB, V15, P136, DOI 10.1111/dom.12002; Dobrzyn A, 2005, AM J PHYSIOL-ENDOC M, V288, pE599, DOI 10.1152/ajpendo.00439.2004; Drosatos K, 2011, AM J PHYSIOL-ENDOC M, V300, pE489, DOI 10.1152/ajpendo.00569.2010; FOLCH J, 1957, J BIOL CHEM, V226, P497; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Hahn HS, 2003, CIRC RES, V93, P1111, DOI 10.1161/01.RES.0000105087.79373.17; Idris Iskandar, 2006, Diab Vasc Dis Res, V3, P172, DOI 10.3132/dvdr.2006.026; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; King AJ, 2010, EUR J PHARMACOL, V637, P155, DOI 10.1016/j.ejphar.2010.03.056; Lee B, 2010, J LIPID RES, V51, P1770, DOI 10.1194/jlr.M002311; Lin HV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054480; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Liu L, 2012, J LIPID RES, V53, P1482, DOI 10.1194/jlr.M024208; Liu L, 2011, J LIPID RES, V52, P732, DOI 10.1194/jlr.M011395; Liu L, 2009, J BIOL CHEM, V284, P36312, DOI 10.1074/jbc.M109.049817; Liu QH, 2011, J MOL CELL CARDIOL, V51, P474, DOI 10.1016/j.yjmcc.2010.10.004; Morrow JP, 2011, CIRCULATION, V124, P2812, DOI 10.1161/CIRCULATIONAHA.111.056309; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Noyan-Ashraf MH, 2013, CIRCULATION, V127, P74, DOI 10.1161/CIRCULATIONAHA.112.091215; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Perman JC, 2011, J CLIN INVEST, V121, P2625, DOI 10.1172/JCI43068; Pineau L, 2010, FEMS YEAST RES, V10, P1035, DOI 10.1111/j.1567-1364.2010.00674.x; PREISS JE, 1987, METHOD ENZYMOL, V141, P294; Rotolo J, 2012, J CLIN INVEST, V122, P1786, DOI 10.1172/JCI59920; Schmitz-Peiffer C, 2000, CELL SIGNAL, V12, P583, DOI 10.1016/S0898-6568(00)00110-8; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Streeper RS, 2012, AGING-US, V4, P13, DOI 10.18632/aging.100424; Szczepaniak LS, 2007, CIRC RES, V101, P759, DOI 10.1161/CIRCRESAHA.107.160457; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Unger RH, 2010, TRENDS ENDOCRIN MET, V21, P345, DOI 10.1016/j.tem.2010.01.009; Ussher JR, 2014, MOL METAB, V3, P507, DOI 10.1016/j.molmet.2014.04.009; Ussher JR, 2012, ENDOCR REV, V33, P187, DOI 10.1210/er.2011-1052; Vamecq J, 2012, CURR DRUG METAB, V13, P1388, DOI 10.2174/138920012803762792; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; Yamamoto T, 2010, EUR J PHARMACOL, V640, P243, DOI 10.1016/j.ejphar.2010.04.050; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Zhao G, 2008, J MED CHEM, V51, P380, DOI 10.1021/jm7013887	52	47	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29881	29891		10.1074/jbc.M114.601864	http://dx.doi.org/10.1074/jbc.M114.601864			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25157099	Green Published, hybrid			2022-12-28	WOS:000344370800032
J	Ma, TM; Paul, BD; Fu, CL; Hu, SH; Zhu, H; Blackshaw, S; Wolosker, H; Snyder, SH				Ma, Ting Martin; Paul, Bindu D.; Fu, Chenglai; Hu, Shaohui; Zhu, Heng; Blackshaw, Seth; Wolosker, Herman; Snyder, Solomon H.			Serine Racemase Regulated by Binding to Stargazin and PSD-95 POTENTIAL N-METHYL-D-ASPARTATE-alpha-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID (NMDA-AMPA) GLUTAMATE NEUROTRANSMISSION CROSS-TALK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme; Ionotropic Glutamate Receptor; Neuron; Neurotransmitter; Synapse; D-Serine; PSD-95; Stargazin	ENDOPLASMIC-RETICULUM; SILENT SYNAPSES; RECEPTORS; PROTEIN; ACTIVATION; APOPTOSIS; EXPRESSION; SUBUNITS; GLYCINE; CELLS	Background: d-Serine, generated by serine racemase (SR), is an endogenous co-agonist for NMDA receptors. Results: SR binds PSD-95 and stargazin, which inhibits SR enzymatic activity. This complex is disrupted by AMPA receptor activation, activating d-serine synthesis. Conclusion: SR/stargazin/PSD-95 interactions mediate NMDA/AMPA receptor cross-talk. Significance: d-Serine may link AMPA and NMDA neurotransmission. d-Serine, an endogenous co-agonist for the glycine site of the synaptic NMDA glutamate receptor, regulates synaptic plasticity and is implicated in schizophrenia. Serine racemase (SR) is the enzyme that converts l-serine to d-serine. In this study, we demonstrate that SR interacts with the synaptic proteins, postsynaptic density protein 95 (PSD-95) and stargazin, forming a ternary complex. SR binds to the PDZ3 domain of PSD-95 through the PDZ domain ligand at its C terminus. SR also binds to the C terminus of stargazin, which facilitates the cell membrane localization of SR and inhibits its activity. AMPA receptor activation internalizes SR and disrupts its interaction with stargazin, therefore derepressing SR activity, leading to more d-serine production and potentially facilitating NMDA receptor activation. These interactions regulate the enzymatic activity as well as the intracellular localization of SR, potentially coupling the activities of NMDA and AMPA receptors. This shuttling of a neurotransmitter synthesizing enzyme between two receptors appears to be a novel mode of synaptic regulation.	[Ma, Ting Martin; Paul, Bindu D.; Fu, Chenglai; Blackshaw, Seth; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Hu, Shaohui; Zhu, Heng; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Wolosker, Herman] Technion Israel Inst Technol, Dept Biochem, IL-31096 Haifa, Israel	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Technion Israel Institute of Technology	Snyder, SH (corresponding author), Johns Hopkins Univ, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu	Fu, Chenglai/H-5330-2018; Hu, Shaohui/AAE-4433-2020	Fu, Chenglai/0000-0003-4300-9948; Wolosker, Herman/0000-0001-5508-9194	National Institutes of Health from USPHS [MH18501]; Technion-Johns Hopkins Collaboration Program; Prince Center for Aging of the Brain; Israel Science Foundation; Legacy Heritage Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018501, R01MH018501] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; Technion-Johns Hopkins Collaboration Program; Prince Center for Aging of the Brain; Israel Science Foundation(Israel Science Foundation); Legacy Heritage Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH18501 from USPHS (to S. H. S.) and grants from Technion-Johns Hopkins Collaboration Program, The Prince Center for Aging of the Brain, the Israel Science Foundation, and the Legacy Heritage Fund (to H. W.).	Akundi RS, 2003, ANN NY ACAD SCI, V1010, P304, DOI 10.1196/annals.1299.053; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Blackburn-Munro G, 2004, NEUROPHARMACOLOGY, V47, P351, DOI 10.1016/j.neuropharm.2004.04.007; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Fujii K, 2006, MOL PSYCHIATR, V11, P150, DOI 10.1038/sj.mp.4001776; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; HASHIMOTO A, 1992, FEBS LETT, V296, P33, DOI 10.1016/0014-5793(92)80397-Y; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; Hikida T, 2008, BIOL PSYCHIAT, V63, P997, DOI 10.1016/j.biopsych.2007.09.025; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Jantas D, 2008, NEUROCHEM INT, V52, P864, DOI 10.1016/j.neuint.2007.10.003; Jeong J. S., 2012, MOL CELL PROTEOMICS, V111; Kang BN, 2010, J NEUROSCI, V30, P93, DOI 10.1523/JNEUROSCI.3974-09.2010; Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Koldobskiy MA, 2010, P NATL ACAD SCI USA, V107, P20947, DOI 10.1073/pnas.1015671107; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kulikov AV, 2007, B EXP BIOL MED+, V144, P626, DOI 10.1007/s10517-007-0390-6; Leem JW, 2010, EXP NEUROL, V224, P321, DOI 10.1016/j.expneurol.2010.02.012; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Ma QP, 1998, PAIN, V77, P49, DOI 10.1016/S0304-3959(98)00081-5; Ma TM, 2013, MOL PSYCHIATR, V18, P557, DOI 10.1038/mp.2012.97; Minami T, 2001, BRAIN RES, V895, P178, DOI 10.1016/S0006-8993(01)02069-8; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Mustafa AK, 2007, P NATL ACAD SCI USA, V104, P2950, DOI 10.1073/pnas.0611620104; Mustafaa AK, 2009, P NATL ACAD SCI USA, V106, P2921, DOI 10.1073/pnas.0813105106; NAARALA J, 1993, FEBS LETT, V330, P222, DOI 10.1016/0014-5793(93)80278-3; Nair VD, 1996, J NEUROCHEM, V66, P2390; Nissenbaum J, 2010, GENOME RES, V20, P1180, DOI 10.1101/gr.104976.110; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sun DD, 1998, AM J PHYSIOL-CELL PH, V275, pC772, DOI 10.1152/ajpcell.1998.275.3.C772; Tao F, 2006, J NEUROSCI RES, V84, P867, DOI 10.1002/jnr.20973; Taubert D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000385; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2006, P NATL ACAD SCI USA, V103, P10064, DOI 10.1073/pnas.0603128103; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wu H., 2012, ANALG RESUSC CURR RE, DOI [10.4172/2324-903X.1000101, DOI 10.4172/2324-903X.1000101]; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Yu XM, 1998, NATURE, V396, P469, DOI 10.1038/24877	52	26	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29631	29641		10.1074/jbc.M114.571604	http://dx.doi.org/10.1074/jbc.M114.571604			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25164819	Green Published, hybrid			2022-12-28	WOS:000344370800013
J	Shi, G; Wu, M; Fang, L; Yu, F; Cheng, SM; Li, JW; Du, JX; Wong, JM				Shi, Guang; Wu, Meng; Fang, Lan; Yu, Fang; Cheng, Shimeng; Li, Jiwen; Du, James X.; Wong, Jiemin			PHD Finger Protein 2 (PHF2) Represses Ribosomal RNA Gene Transcription by Antagonizing PHF Finger Protein 8 (PHF8) and Recruiting Methyltransferase SUV39H1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Histone Methylation; Nucleolus; Ribosomal Ribonucleic Acid (rRNA) (Ribosomal RNA); RNA Polymerase I; Transcription Regulation	POLYMERASE-I TRANSCRIPTION; LINKED MENTAL-RETARDATION; HISTONE DEMETHYLASE; HETEROCHROMATIN FORMATION; EPIGENETIC CONTROL; PLANT HOMEODOMAIN; BINDING; PROMOTER; TRIMETHYLATION; ACETYLATION	Background: PHF2 is a histone demethylase that possesses an H3K4me2/3 binding activity. Results: PHF2 represses rDNA transcription depending on its H3K4me2/3 binding but not demethylase activity and does so by antagonizing PHF8 and recruiting SUV39H1. PHF2 also seems to generally repress Pol II transcription. Conclusion: PHF2 represses rather than activates rDNA transcription. Significance: This work reveals a potential general transcriptional repression function for PHF2. Regulation of rDNA transcription is central to cell growth and proliferation. PHF2 and PHF8 belong to a subfamily of histone demethylases that also possess a PHD domain-dependent di-/trimethylated histone 3 lysine 4 (H3K4me2/3) binding activity and are known to be enriched in the nucleolus. In this study, we show that, unlike PHF8 that activates rDNA transcription, PHF2 inhibits rDNA transcription. Depletion of PHF2 by RNA interference increases and overexpression of PHF2 decreases rDNA transcription, respectively, whereas simultaneous depletion of PHF8 and PHF2 restores the level of rDNA transcription. The inhibition of rDNA transcription by PHF2 depends on its H3K4me2/3 binding activity that is also required for PHF2 association with the promoter of rDNA genes but not its demethylase activity. We provide evidence that PHF2 is likely to repress rDNA transcription by competing with PHF8 for binding of rDNA promoter and by recruiting H3K9me2/3 methyltransferase SUV39H1. We also provide evidence that, whereas PHF8 promotes, PHF2 represses the transcriptional activity of RAR, Oct4, and KLF4 and a few PHF8 target genes tested. Taken together, our study demonstrates a repressive role for PHF2 in transcription by RNA polymerase I and II.	[Wong, Jiemin] E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China; E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China	East China Normal University; East China Normal University	Wong, JM (corresponding author), E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China.	jmweng@bio.ecnu.edu.cn	Wu, Meng/N-9345-2014	Wu, Meng/0000-0001-8436-2209; Wong, Jiemin/0000-0002-5311-842X; Yu, Fang/0000-0001-9010-9461	Ministry of Science and Technology of China [2010CB944903]; National Natural Science Foundation of China [90919025, 30871381, 81272287, 31371504]; Science Technology Commission of Shanghai Municipality [09DJ1400400, 11DZ2260300]; East China Normal University	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); East China Normal University	This study was supported by Ministry of Science and Technology of China Grant 2010CB944903; National Natural Science Foundation of China Grants 90919025, 30871381, 81272287, and 31371504; and Science Technology Commission of Shanghai Municipality Grants 09DJ1400400 and 11DZ2260300.; Supported by the "Fostering Project for National TOP Hundred Doctoral Dissertations" from East China Normal University.	Baba A, 2011, NAT CELL BIOL, V13, P668, DOI 10.1038/ncb2228; BECKMANN H, 1995, SCIENCE, V270, P1506, DOI 10.1126/science.270.5241.1506; Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; Chan DW, 2009, PROTEOMICS, V9, P2343, DOI 10.1002/pmic.200800600; Cong R, 2012, NUCLEIC ACIDS RES, V40, P9441, DOI 10.1093/nar/gks720; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fortschegger K, 2011, EPIGENETICS-US, V6, P4, DOI 10.4161/epi.6.1.13297; Fortschegger K, 2010, MOL CELL BIOL, V30, P3286, DOI 10.1128/MCB.01520-09; Grummt I, 2013, BBA-GENE REGUL MECH, V1829, P393, DOI 10.1016/j.bbagrm.2012.10.004; Haukenes Gunnar, 1998, Methods in Cell Science, V19, P295, DOI 10.1023/A:1009752804126; Horton JR, 2011, J MOL BIOL, V406, P1, DOI 10.1016/j.jmb.2010.12.013; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Li J, 2012, J BIOL CHEM, V287, P10089, DOI 10.1074/jbc.M111.313965; Li JW, 2006, EMBO J, V25, P5735, DOI 10.1038/sj.emboj.7601454; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; McKeown PC, 2009, CHROMOSOMA, V118, P11, DOI 10.1007/s00412-008-0184-2; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Muth V, 2001, EMBO J, V20, P1353, DOI 10.1093/emboj/20.6.1353; Okuno Y, 2013, DIABETES, V62, P1426, DOI 10.2337/db12-0628; Prieto JL, 2005, BIOCHEM SOC T, V33, P1441, DOI 10.1042/BST0331441; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Qiu JH, 2010, CELL RES, V20, P908, DOI 10.1038/cr.2010.81; Russell J, 2006, BIOCHEM SOC SYMP, V73, P203; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; SCHNAPP A, 1991, J BIOL CHEM, V266, P24588; Stender JD, 2012, MOL CELL, V48, P28, DOI 10.1016/j.molcel.2012.07.020; Suganuma T, 2010, CELL RES, V20, P861, DOI 10.1038/cr.2010.110; Tuan JC, 1999, MOL CELL BIOL, V19, P2872; Wei XY, 1999, J CELL BIOL, V146, P543, DOI 10.1083/jcb.146.3.543; Wen H, 2010, J BIOL CHEM, V285, P9322, DOI 10.1074/jbc.C109.097667; Xie WB, 2012, P NATL ACAD SCI USA, V109, P8161, DOI 10.1073/pnas.1201262109; Yang LX, 2013, MOL CELL BIOL, V33, P3835, DOI 10.1128/MCB.00476-13; Yatim A, 2012, MOL CELL, V48, P445, DOI 10.1016/j.molcel.2012.08.022; Zhang H, 2012, BIOMATERIALS, V33, P5047, DOI 10.1016/j.biomaterials.2012.03.061; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460; Zhu ZQ, 2010, CELL RES, V20, P794, DOI 10.1038/cr.2010.75	40	12	13	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29691	29700		10.1074/jbc.M114.571653	http://dx.doi.org/10.1074/jbc.M114.571653			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25204660	Green Published, hybrid			2022-12-28	WOS:000344370800018
J	Hewawasam, GS; Mattingly, M; Venkatesh, S; Zhang, Y; Florens, L; Workman, JL; Gerton, JL				Hewawasam, Geetha S.; Mattingly, Mark; Venkatesh, Swaminathan; Zhang, Ying; Florens, Laurence; Workman, Jerry L.; Gerton, Jennifer L.			Phosphorylation by Casein Kinase 2 Facilitates Psh1 Protein-assisted Degradation of Cse4 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3 VARIANT; CENTROMERE-SPECIFIC HISTONE; E3 UBIQUITIN LIGASE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; HUMAN-CELLS; KINETOCHORE; LOCALIZATION; CK2; OVEREXPRESSION	Cse4 is the centromeric histone H3 variant in budding yeast. Psh1 is an E3 ubiquitin ligase that controls Cse4 levels through proteolysis. Here we report that Psh1 is phosphorylated by the Cka2 subunit of casein kinase 2 (CK2) to promote its E3 activity for Cse4. Deletion of CKA2 significantly stabilized Cse4. Consistent with phosphorylation promoting the activity of Psh1, Cse4 was stabilized in a Psh1 phosphodepleted mutant strain in which the major phosphorylation sites were changed to alanines. Phosphorylation of Psh1 did not control Psh1-Cse4 or Psh1-Ubc3(E2) interactions. Although Cse4 was highly stabilized in a cka2 Delta strain, mislocalization of Cse4 was mild, suggesting that Cse4 misincorporation was prevented by the intact Psh1-Cse4 association. Supporting this idea, Psh1 was also stabilized in a cka2 Delta strain. Collectively our data suggest that phosphorylation is crucial in Psh1-assisted control of Cse4 levels and that the Psh1-Cse4 association itself functions to prevent Cse4 misincorporation.	[Hewawasam, Geetha S.; Mattingly, Mark; Venkatesh, Swaminathan; Zhang, Ying; Florens, Laurence; Workman, Jerry L.; Gerton, Jennifer L.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Gerton, Jennifer L.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Gerton, JL (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jeg@stowers.org		Florens, Laurence/0000-0002-9310-6650; Venkatesh, Swaminathan/0000-0001-9837-1501	National Institutes of Health [R01GM080477]; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM080477. This work was also supported by the Stowers Institute for Medical Research.	Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Amato A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-119; Au WC, 2008, GENETICS, V179, P263, DOI 10.1534/genetics.108.088518; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Block K, 2001, J BIOL CHEM, V276, P41049, DOI 10.1074/jbc.M106453200; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; Coccetti P, 2008, CELL CYCLE, V7, P1391, DOI 10.4161/cc.7.10.5825; Collins KA, 2004, CURR BIOL, V14, P1968, DOI 10.1016/j.cub.2004.10.024; Collins KA, 2007, GENETICS, V175, P513, DOI 10.1534/genetics.106.064410; Furuyama S, 2007, P NATL ACAD SCI USA, V104, P14706, DOI 10.1073/pnas.0706985104; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Haase J, 2013, CURR BIOL, V23, P1939, DOI 10.1016/j.cub.2013.07.083; Hewawasam G, 2010, MOL CELL, V40, P444, DOI 10.1016/j.molcel.2010.10.014; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Hyman AA, 1995, ANNU REV CELL DEV BI, V11, P471, DOI 10.1146/annurev.cb.11.110195.002351; Kim IS, 2014, BIOCHEM BIOPH RES CO, V443, P62, DOI 10.1016/j.bbrc.2013.11.058; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Lacoste N, 2014, MOL CELL, V53, P631, DOI 10.1016/j.molcel.2014.01.018; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; London N, 2012, CURR BIOL, V22, P900, DOI 10.1016/j.cub.2012.03.052; LUDEMANN R, 1993, J BIOL CHEM, V268, P17413; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mishra PK, 2013, GENETICS, V195, P369, DOI 10.1534/genetics.113.155291; Moreno-Moreno O, 2011, CURR BIOL, V21, P1488, DOI 10.1016/j.cub.2011.07.041; Moreno-Moreno O, 2006, NUCLEIC ACIDS RES, V34, P6247, DOI 10.1093/nar/gkl902; Ohkuni K, 2014, GENETICS, V196, P1041, DOI 10.1534/genetics.114.161224; Pardo PS, 1998, ARCH BIOCHEM BIOPHYS, V349, P397, DOI 10.1006/abbi.1997.0466; Peng YT, 2011, MOL BIOL CELL, V22, P2680, DOI 10.1091/mbc.E10-11-0915; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Ranjitkar P, 2010, MOL CELL, V40, P455, DOI 10.1016/j.molcel.2010.09.025; Sadowski M, 2007, BIOCHEM J, V405, P569, DOI 10.1042/BJ20061812; Shivaraju M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.183640; Tomonaga T, 2003, CANCER RES, V63, P3511; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wilson LK, 1997, J BIOL CHEM, V272, P12961, DOI 10.1074/jbc.272.20.12961; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	39	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29297	29309		10.1074/jbc.M114.580589	http://dx.doi.org/10.1074/jbc.M114.580589			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25183013	Green Published, hybrid			2022-12-28	WOS:000344141000043
J	Foster, AW; Osman, D; Robinson, NJ				Foster, Andrew W.; Osman, Deenah; Robinson, Nigel J.			Metal Preferences and Metallation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							C-TERMINAL DOMAIN; ESCHERICHIA-COLI; COPPER CHAPERONE; TRANSCRIPTIONAL ACTIVATOR; INTRACELLULAR MAGNESIUM; MONOTHIOL GLUTAREDOXINS; MOLYBDENUM COFACTOR; ION SELECTIVITY; BINDING SITES; ZINC	The metal binding preferences of most metalloproteins do not match their metal requirements. Thus, metallation of an estimated 30% of metalloenzymes is aided by metal delivery systems, with similar to 25% acquiring preassembled metal cofactors. The remaining similar to 70% are presumed to compete for metals from buffered metal pools. Metallation is further aided by maintaining the relative concentrations of these pools as an inverse function of the stabilities of the respective metal complexes. For example, magnesium enzymes always prefer to bind zinc, and these metals dominate the metalloenzymes without metal delivery systems. Therefore, the buffered concentration of zinc is held at least a million-fold below magnesium inside most cells.	[Robinson, Nigel J.] Univ Durham, Dept Chem, Durham DH1 3LE, England; Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England	Durham University; Durham University	Robinson, NJ (corresponding author), Univ Durham, Dept Chem, South Rd, Durham DH1 3LE, England.	nigel.robinson@durham.ac.uk	Osman, Deenah/AAB-4516-2020; Robinson, Nigel J/J-6363-2012	Osman, Deenah/0000-0002-0251-9231; Robinson, Nigel J/0000-0001-5586-1092	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/K00817X/1, BB/J017787/1]; BBSRC [BB/J017787/1, BB/K00817X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J017787/1, BB/K00817X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) research grants BB/K00817X/1 and BB/J017787/1. This is the first article in the Thematic Minireview series "Metals in Biology 2014."	ALATOSSAVA T, 1985, J BACTERIOL, V162, P413, DOI 10.1128/JB.162.1.413-419.1985; Anbar AD, 2008, SCIENCE, V322, P1481, DOI 10.1126/science.1163100; Andreini C, 2009, BIOINFORMATICS, V25, P2088, DOI 10.1093/bioinformatics/btp256; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Blaby-Haas CE, 2014, J BIOL CHEM, V289, P28129, DOI 10.1074/jbc.R114.592618; Bozym RA, 2006, ACS CHEM BIOL, V1, P103, DOI 10.1021/cb500043a; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Chen W, 2010, BLOOD, V116, P628, DOI 10.1182/blood-2009-12-259614; Chillappagari S, 2010, J BACTERIOL, V192, P2512, DOI 10.1128/JB.00058-10; Chivers PT, 2012, METALLOMICS, V4, P1043, DOI 10.1039/c2mt20139a; Chivers PT, 2002, CHEM BIOL, V9, P1141, DOI 10.1016/S1074-5521(02)00241-7; CIANCAGLINI P, 1990, INT J BIOCHEM, V22, P747; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Dai Y, 1999, J BIOL CHEM, V274, P1193, DOI 10.1074/jbc.274.3.1193; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; Davis AV, 2008, NAT CHEM BIOL, V4, P148, DOI 10.1038/nchembio0308-148; Dodani SC, 2011, P NATL ACAD SCI USA, V108, P5980, DOI 10.1073/pnas.1009932108; Dudev T, 2014, CHEM REV, V114, P538, DOI 10.1021/cr4004665; Fernandes S, 2002, APPL MICROBIOL BIOT, V58, P313, DOI 10.1007/s00253-001-0905-4; Foster AW, 2014, MOL MICROBIOL, V92, P797, DOI 10.1111/mmi.12594; Foster AW, 2012, J BIOL CHEM, V287, P12142, DOI 10.1074/jbc.M111.338301; Frausto da Silva J.J.R., 1991, BIOL CHEM ELEMENTS I; Funk C, 1999, BIOCHEMISTRY-US, V38, P9397, DOI 10.1021/bi990545+; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Grossoehme N, 2011, J BIOL CHEM, V286, P13522, DOI 10.1074/jbc.M111.220012; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Helmann JD, 2014, J BIOL CHEM, V289, P28112, DOI 10.1074/jbc.R114.587071; Hider RC, 2011, BIOMETALS, V24, P1179, DOI 10.1007/s10534-011-9476-8; Higgins KA, 2012, BIOCHEMISTRY-US, V51, P7816, DOI 10.1021/bi300981m; Hoffmann D, 2006, FEBS J, V273, P4516, DOI 10.1111/j.1742-4658.2006.05460.x; Huang CP, 2014, METALLOMICS, V6, P654, DOI 10.1039/c3mt00331k; Huang MX, 2014, J BIOL CHEM, V289, P28104, DOI 10.1074/jbc.R114.596684; Hung HC, 2001, PROTEIN SCI, V10, P34, DOI 10.1110/ps.35201; Imlay JA, 2014, J BIOL CHEM, V289, P28121, DOI 10.1074/jbc.R114.588814; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Jensen PE, 1996, J BIOL CHEM, V271, P16662, DOI 10.1074/jbc.271.28.16662; JOHNSON DA, 1995, INORG CHEM, V34, P5666, DOI 10.1021/ic00126a041; Kaluarachchi H, 2010, NAT PROD REP, V27, P681, DOI 10.1039/b906688h; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Kudva R, 2013, RES MICROBIOL, V164, P505, DOI 10.1016/j.resmic.2013.03.016; Labbe RF, 1999, CLIN CHEM, V45, P2060; Larin D, 1999, J BIOL CHEM, V274, P28497, DOI 10.1074/jbc.274.40.28497; Leech HK, 2003, J BIOL CHEM, V278, P41900, DOI 10.1074/jbc.M306112200; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Ma Z, 2012, MOL MICROBIOL, V86, P1144, DOI 10.1111/mmi.12049; Ma Z, 2011, NUCLEIC ACIDS RES, V39, P9130, DOI 10.1093/nar/gkr625; Ma Z, 2009, BIOCHEMISTRY-US, V48, P3325, DOI 10.1021/bi900115w; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Mapolelo DT, 2013, DALTON T, V42, P3107, DOI 10.1039/c2dt32263c; Maret W, 2004, BIOCHEMISTRY-US, V43, P3301, DOI 10.1021/bi036340p; McNaughton RL, 2010, P NATL ACAD SCI USA, V107, P15335, DOI 10.1073/pnas.1009648107; Mills SA, 2005, BIOCHEMISTRY-US, V44, P13553, DOI 10.1021/bi0507579; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Osman D, 2013, MOL MICROBIOL, V87, P466, DOI 10.1111/mmi.12107; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Padilla-Benavides T, 2014, J BIOL CHEM, V289, P20492, DOI 10.1074/jbc.M114.577668; Patterson CJ, 2013, METALLOMICS, V5, P352, DOI 10.1039/c3mt20241k; Pennella MA, 2006, J MOL BIOL, V356, P1124, DOI 10.1016/j.jmb.2005.12.019; Pope CR, 2013, P NATL ACAD SCI USA, V110, P20491, DOI 10.1073/pnas.1309820110; Portnoy ME, 2001, MOL GENET GENOMICS, V265, P873, DOI 10.1007/s004380100482; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Raimunda D, 2011, BIOMETALS, V24, P467, DOI 10.1007/s10534-010-9404-3; Ranquet C, 2007, J BIOL CHEM, V282, P30442, DOI 10.1074/jbc.M702519200; Reyes-Caballero H, 2011, BIOPHYS CHEM, V156, P103, DOI 10.1016/j.bpc.2011.03.010; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Rowe JL, 2005, J BACTERIOL, V187, P6317, DOI 10.1128/JB.187.18.6317-6323.2005; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Rutherford JC, 1999, J BIOL CHEM, V274, P25827, DOI 10.1074/jbc.274.36.25827; San Francisco B, 2014, J MOL BIOL, V426, P570, DOI 10.1016/j.jmb.2013.10.025; Sandu C, 2002, ARCH MICROBIOL, V178, P465, DOI 10.1007/s00203-002-0474-7; Schalk IJ, 2004, MOL MICROBIOL, V54, P14, DOI 10.1111/j.1365-2958.2004.04241.x; Schubert HL, 1999, BIOCHEMISTRY-US, V38, P10660, DOI 10.1021/bi9906773; Siburt CJP, 2012, BBA-GEN SUBJECTS, V1820, P379, DOI 10.1016/j.bbagen.2011.09.001; Stengel A, 2012, PLANT CELL, V24, P660, DOI 10.1105/tpc.111.093914; Sun GQ, 1999, BIOCHEMISTRY-US, V38, P5659, DOI 10.1021/bi982793w; Suttisansanee U, 2011, J BIOL CHEM, V286, P38367, DOI 10.1074/jbc.M111.251603; Sydor AM, 2014, J BIOL CHEM, V289, P3828, DOI 10.1074/jbc.M113.502781; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; Thorgersen MP, 2007, J BACTERIOL, V189, P7774, DOI 10.1128/JB.00962-07; Tottey S, 2002, J BIOL CHEM, V277, P5490, DOI 10.1074/jbc.M105857200; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Tottey S, 2012, P NATL ACAD SCI USA, V109, P95, DOI 10.1073/pnas.1117515109; Vergnes A, 2006, J BIOL CHEM, V281, P2170, DOI 10.1074/jbc.M505902200; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/nmeth.1368, 10.1038/NMETH.1368]; Waldron KJ, 2010, J BIOL CHEM, V285, P32504, DOI 10.1074/jbc.M110.153080; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wang D, 2012, J INORG BIOCHEM, V111, P173, DOI 10.1016/j.jinorgbio.2012.02.008; Wang D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3613926; WILLIAMS RJP, 1982, FEBS LETT, V140, P3, DOI 10.1016/0014-5793(82)80508-5; Xiao ZG, 2002, CHEM COMMUN, P588, DOI 10.1039/b111180a; Xiao ZG, 2010, NAT PROD REP, V27, P768, DOI 10.1039/b906690j; Yang TY, 2008, J AM CHEM SOC, V130, P3844, DOI 10.1021/ja076277h	100	236	238	2	96	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28095	28103		10.1074/jbc.R114.588145	http://dx.doi.org/10.1074/jbc.R114.588145			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25160626	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000343765400005
J	Kitazume, S; Imamaki, R; Kurimoto, A; Ogawa, K; Kato, M; Yamaguchi, Y; Tanaka, K; Ishida, H; Ando, H; Kiso, M; Hashii, N; Kawasaki, N; Taniguchi, N				Kitazume, Shinobu; Imamaki, Rie; Kurimoto, Ayako; Ogawa, Kazuko; Kato, Masaki; Yamaguchi, Yoshiki; Tanaka, Katsunori; Ishida, Hideharu; Ando, Hiromune; Kiso, Makoto; Hashii, Noritaka; Kawasaki, Nana; Taniguchi, Naoyuki			Interaction of Platelet Endothelial Cell Adhesion Molecule (PECAM) with alpha 2,6-Sialylated Glycan Regulates Its Cell Surface Residency and Anti-apoptotic Role	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cell Adhesion; Endothelial Cell; Lectin; Sialic Acid	N-GLYCOLYLNEURAMINIC ACID; HEPARIN-LIKE MOLECULES; GROWTH-FACTOR; ACETYLNEURAMINIC ACID; SIGNAL-TRANSDUCTION; CD22 LIGANDS; IN-VIVO; RECEPTOR; ANGIOGENESIS; IDENTIFICATION	Background:N-Glycan 2,6-sialylation regulates the cell surface residency of an anti-apoptotic molecule, platelet endothelial cell adhesion molecule (PECAM). Results: An 2,6-sialylated oligosaccharide inhibited the homophilic PECAM interaction and a cluster-type 2,6-sialyl N-glycan probe bound to PECAM-immobilized beads. Conclusion: PECAM is a weak sialic acid binding lectin. Significance: There is a possibility of using a glycan-based method to modulate angiogenesis. The luminal sides of vascular endothelial cells are heavily covered with a so-called glycocalyx, but the precise role of the endothelial glycocalyx remains unclear. Our previous study showed that N-glycan 2,6-sialylation regulates the cell surface residency of an anti-apoptotic molecule, platelet endothelial cell adhesion molecule (PECAM), as well as the sensitivity of endothelial cells toward apoptotic stimuli. As PECAM itself was shown to be modified with biantennary N-glycans having 2,6-sialic acid, we expected that PECAM would possess lectin-like activity toward 2,6-sialic acid to ensure its homophilic interaction. To verify this, a series of oligosaccharides were initially added to observe their inhibitory effects on the homophilic PECAM interaction in vitro. We found that a longer 2,6-sialylated oligosaccharide exhibited strong inhibitory activity. Furthermore, we found that a cluster-type 2,6-sialyl N-glycan probe specifically bound to PECAM-immobilized beads. Moreover, the addition of the 2,6-sialylated oligosaccharide to endothelial cells enhanced the internalization of PECAM as well as the sensitivity to apoptotic stimuli. Collectively, these findings suggest that PECAM is a sialic acid binding lectin and that this binding property supports endothelial cell survival. Notably, our findings that 2,6-sialylated glycans influenced the susceptibility to endothelial cell apoptosis shed light on the possibility of using a glycan-based method to modulate angiogenesis.	[Kitazume, Shinobu; Imamaki, Rie; Kurimoto, Ayako; Ogawa, Kazuko; Taniguchi, Naoyuki] RIKEN, Global Res Cluster, Max Planck Joint Res Ctr, Dis Glyc Team, Wako, Saitama 3510198, Japan; [Kato, Masaki; Yamaguchi, Yoshiki] RIKEN, Global Res Cluster, Max Planck Joint Res Ctr, Struct Glycobiol Team, Wako, Saitama 3510198, Japan; [Tanaka, Katsunori] RIKEN, Biofunct Synthet Chem Lab, Wako, Saitama 3510198, Japan; [Ishida, Hideharu; Ando, Hiromune; Kiso, Makoto] Gifu Univ, Dept Appl Bioorgan Chem, Gifu 5011193, Japan; [Ando, Hiromune; Kiso, Makoto] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto 6068501, Japan; [Hashii, Noritaka; Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Tokyo 1588501, Japan	RIKEN; RIKEN; RIKEN; Gifu University; Kyoto University; National Institute of Health Sciences - Japan	Kitazume, S (corresponding author), RIKEN, Global Res Cluster, Max Planck Joint Res Ctr, Dis Glyc Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	shinobuk@riken.jp	Yamaguchi, Yoshiki/N-5246-2015; Katsunori, Tanaka/AAJ-3284-2020; Taniguchi, Naoyuki/A-7086-2016; Tanaka, Katsunori/N-5072-2015; Taniguchi, Naoyuki/I-4182-2014; Ando, Hiromune/J-8294-2017	Yamaguchi, Yoshiki/0000-0003-0100-5439; Tanaka, Katsunori/0000-0001-6932-4802; Taniguchi, Naoyuki/0000-0001-5889-5968; Ando, Hiromune/0000-0002-0551-0830	Systems Glycobiology Research Project; RIKEN; Ministry of Education Science, Sports and Culture of Japan; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [25460054] Funding Source: KAKEN	Systems Glycobiology Research Project; RIKEN; Ministry of Education Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Systems Glycobiology Research Project and from the strategic programs for R&D of RIKEN (to N. T.), a grant-in-aid for Scientific Research from the Ministry of Education Science, Sports and Culture of Japan (to N. T. and S. K.), and a grant from the Mitsubishi Foundation (to S. K.).	Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Cao GY, 2009, AM J PATHOL, V175, P903, DOI 10.2353/ajpath.2009.090206; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chen ZM, 2009, ARTERIOSCL THROM VAS, V29, P1067, DOI 10.1161/ATVBAHA.109.186692; Collins BE, 2004, P NATL ACAD SCI USA, V101, P6104, DOI 10.1073/pnas.0400851101; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; DeLisser H, 2010, P NATL ACAD SCI USA, V107, P18616, DOI 10.1073/pnas.1004654107; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Fukunaga K, 2003, J CARBOHYD CHEM, V22, P919, DOI 10.1081/CAR-120026602; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gao CJ, 2003, BLOOD, V102, P169, DOI 10.1182/blood-2003-01-0003; Geyer H, 1999, GLYCOBIOLOGY, V9, P915, DOI 10.1093/glycob/9.9.915; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; HANASAKI K, 1994, J BIOL CHEM, V269, P10637; HANASAKI K, 1995, J BIOL CHEM, V270, P7533, DOI 10.1074/jbc.270.13.7533; Hayakawa T, 2001, P NATL ACAD SCI USA, V98, P11399, DOI 10.1073/pnas.191268198; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Lapierre F, 1996, GLYCOBIOLOGY, V6, P355, DOI 10.1093/glycob/6.3.355; Lee RT, 2000, GLYCOCONJUGATE J, V17, P543, DOI 10.1023/A:1011070425430; Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f; Mamdouh Z, 2003, NATURE, V421, P748, DOI 10.1038/nature01300; NAKAGAWA H, 1995, ANAL BIOCHEM, V226, P130, DOI 10.1006/abio.1995.1200; Nakamura K, 2002, GLYCOBIOLOGY, V12, P209, DOI 10.1093/glycob/12.3.209; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Nitschke L, 1999, J EXP MED, V189, P1513, DOI 10.1084/jem.189.9.1513; Osawa M, 2002, J CELL BIOL, V158, P773, DOI 10.1083/jcb.200205049; Park S, 2010, AM J PHYSIOL-CELL PH, V299, pC1468, DOI 10.1152/ajpcell.00246.2010; Pham T, 2009, BLOOD, V114, P5225, DOI 10.1182/blood-2009-05-220400; Presta M, 2003, CURR PHARM DESIGN, V9, P553, DOI 10.2174/1381612033391379; Rolny C, 2002, J BIOL CHEM, V277, P19315, DOI 10.1074/jbc.M111805200; ROSEN SD, 1989, J IMMUNOL, V142, P1895; Sorensen AL, 2009, BLOOD, V114, P1645, DOI 10.1182/blood-2009-01-199414; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Suzuki T, 2006, BIOCHEM J, V400, P33, DOI 10.1042/BJ20060945; TAKAHASHI N, 1995, ANAL BIOCHEM, V226, P139, DOI 10.1006/abio.1995.1201; Tanaka K, 2010, ANGEW CHEM INT EDIT, V49, P8195, DOI 10.1002/anie.201000892; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Walker JA, 2008, IMMUNOLOGY, V123, P314, DOI 10.1111/j.1365-2567.2007.02752.x; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456; Wuhrer M, 2006, RAPID COMMUN MASS SP, V20, P1747, DOI 10.1002/rcm.2509; Yasukawa Z, 2006, GLYCOBIOLOGY, V16, P651, DOI 10.1093/glycob/cwj112; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	48	22	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27604	27613		10.1074/jbc.M114.563585	http://dx.doi.org/10.1074/jbc.M114.563585			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25135639	Green Published, hybrid			2022-12-28	WOS:000342852800021
J	Eriksson, O; Ramstrom, M; Hornaeus, K; Bergquist, J; Mokhtari, D; Siegbahn, A				Eriksson, Oskar; Ramstrom, Margareta; Hornaeus, Katarina; Bergquist, Jonas; Mokhtari, Dariush; Siegbahn, Agneta			The Eph Tyrosine Kinase Receptors EphB2 and EphA2 Are Novel Proteolytic Substrates of Tissue Factor/Coagulation Factor VIIa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION FACTOR VIIA; LIGAND-BINDING DOMAIN; MONOCLONAL-ANTIBODY; ENDOTHELIAL-CELLS; CLEAVAGE; INHIBITION; EXPRESSION; COMPLEX; IDENTIFICATION; ANTICOAGULANT	Tissue factor (TF) binds the serine protease factor VIIa (FVIIa) to form a proteolytically active complex that can trigger coagulation or activate cell signaling. Here we addressed the involvement of tyrosine kinase receptors (RTKs) in TF/FVIIa signaling by antibody array analysis and subsequently found that EphB2 and EphA2 of the Eph RTK family were cleaved in their ectodomains by TF/FVIIa. We used N-terminal Edman sequencing and LC-MS/MS analysis to characterize the cleaved Eph isoforms and identified a key arginine residue at the cleavage site, in agreement with the tryptic serine protease activity of FVIIa. Protease-activated receptor 2 (PAR2) signaling and downstream coagulation activity was non-essential in this context, in further support of a direct cleavage by TF/FVIIa. EphB2 was cleaved by FVIIa concentrations in the subnanomolar range in a number of TF expressing cell types, indicating that the active cellular pool of TF was involved. FVIIa caused potentiation of cell repulsion by the EphB2 ligand ephrin-B1, demonstrating a novel proteolytical event to control Eph-mediated cell segregation. These results define Eph RTKs as novel proteolytical targets of TF/FVIIa and provide new insights into how TF/FVIIa regulates cellular functions independently of PAR2.	[Eriksson, Oskar; Mokhtari, Dariush; Siegbahn, Agneta] Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden; [Ramstrom, Margareta; Hornaeus, Katarina; Bergquist, Jonas] BMC, Dept Chem, SE-75124 Uppsala, Sweden; [Eriksson, Oskar; Ramstrom, Margareta; Hornaeus, Katarina; Bergquist, Jonas; Mokhtari, Dariush; Siegbahn, Agneta] Uppsala Univ, Sci Life Lab, Uppsala, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University	Siegbahn, A (corresponding author), Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden.	agneta.siegbahn@medsci.uu.se	Bergquist, Jonas/C-5894-2015	Ramstrom, Margareta/0000-0003-1471-7291; Bergquist, Jonas/0000-0002-4597-041X	Swedish Research Council [K213-65X11568-18-5, 621-2011-4423]; Swedish Heart and Lung Foundation; Science for Life Laboratory Sweden; Selanders Foundation; Goran Gustafsson Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Science for Life Laboratory Sweden; Selanders Foundation; Goran Gustafsson Foundation	This work was supported in part by Swedish Research Council Grants K213-65X11568-18-5 (to A. S.) and 621-2011-4423 (to J. B.), the Swedish Heart and Lung Foundation, Science for Life Laboratory Sweden, and the Selanders Foundation.; Supported by the Goran Gustafsson Foundation.	Aberg M, 2011, THROMB RES, V127, P141, DOI 10.1016/j.thromres.2010.11.015; Aberg M, 2014, THROMB HAEMOSTASIS, V111, P748, DOI 10.1160/TH13-07-0593; Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Badeanlou L, 2011, NAT MED, V17, P1490, DOI 10.1038/nm.2461; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Belting M, 2004, NAT MED, V10, P502, DOI 10.1038/nm1037; Bergum PW, 2001, J BIOL CHEM, V276, P10063, DOI 10.1074/jbc.M009116200; CALLANDER NS, 1992, CANCER-AM CANCER SOC, V70, P1194, DOI 10.1002/1097-0142(19920901)70:5<1194::AID-CNCR2820700528>3.0.CO;2-E; Cook KM, 2013, ANTIOXID REDOX SIGN, V18, P1987, DOI 10.1089/ars.2012.4807; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Gailani D, 2009, J THROMB HAEMOST, V7, P75, DOI 10.1111/j.1538-7836.2009.03414.x; Goldgur Y, 2009, ACTA CRYSTALLOGR F, V65, P71, DOI 10.1107/S1744309108043078; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Janes PW, 2012, SEMIN CELL DEV BIOL, V23, P43, DOI 10.1016/j.semcdb.2012.01.001; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Kask L, 2014, J PROTEOME RES, V13, P477, DOI 10.1021/pr4006298; Kazanov MD, 2011, J PROTEOME RES, V10, P3642, DOI 10.1021/pr200271w; Kryczka J, 2012, J BIOL CHEM, V287, P36556, DOI 10.1074/jbc.M112.384909; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Lee C, 2006, EXP CELL RES, V312, P2547, DOI 10.1016/j.yexcr.2006.04.022; Lin KT, 2008, J BIOL CHEM, V283, P28969, DOI 10.1074/jbc.M804401200; Liu H, 2014, THROMB HAEMOSTASIS, V112, P151, DOI 10.1160/TH13-12-1034; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; Metcalfe C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110010; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; MORRISSEY JH, 1993, BLOOD, V81, P734; MORRISSEY JH, 1988, THROMB RES, V52, P247, DOI 10.1016/0049-3848(88)90084-9; NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P8701, DOI 10.1021/bi00027a020; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pitulescu ME, 2010, GENE DEV, V24, P2480, DOI 10.1101/gad.1973910; Ramstrom M, 2009, BIOTECHNOL APPL BIOC, V52, P159, DOI [10.1042/BA20080028, 10.1042/BA20080015]; RUF W, 1991, THROMB HAEMOSTASIS, V66, P529; Ruf W, 2011, J THROMB HAEMOST, V9, P306, DOI 10.1111/j.1538-7836.2011.04318.x; Sakamoto A, 2008, CLIN SCI, V114, P643, DOI 10.1042/CS20070339; Shirk RA, 2007, ARTERIOSCL THROM VAS, V27, P1895, DOI 10.1161/ATVBAHA.107.148304; Siegbahn A, 2008, ARTERIOSCL THROM VAS, V28, P135, DOI 10.1161/ATVBAHA.107.155754; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Solanas G, 2011, NAT CELL BIOL, V13, P1100, DOI 10.1038/ncb2298; Stathakis P, 1999, J BIOL CHEM, V274, P8910, DOI 10.1074/jbc.274.13.8910; Sugiyama N, 2013, J CELL BIOL, V201, P467, DOI 10.1083/jcb.201205176; Toschi V, 1997, CIRCULATION, V95, P594, DOI 10.1161/01.CIR.95.3.594; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Wang SD, 2012, ONCOGENE, V31, P5132, DOI 10.1038/onc.2012.16; Zhang Q, 2009, PROTEINS, V77, P559, DOI 10.1002/prot.22468	46	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.599332	http://dx.doi.org/10.1074/jbc.M114.599332			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25281742	Green Published, hybrid			2022-12-28	WOS:000345335000001
J	Johnson, JS; Kono, T; Tong, X; Yamamoto, WR; Zarain-Herzberg, A; Merrins, MJ; Satin, LS; Gilon, P; Evans-Molina, C				Johnson, Justin S.; Kono, Tatsuyoshi; Tong, Xin; Yamamoto, Wataru R.; Zarain-Herzberg, Angel; Merrins, Matthew J.; Satin, Leslie S.; Gilon, Patrick; Evans-Molina, Carmella			Pancreatic and Duodenal Homeobox Protein 1 (Pdx-1) Maintains Endoplasmic Reticulum Calcium Levels through Transcriptional Regulation of Sarco-endoplasmic Reticulum Calcium ATPase 2b (SERCA2b) in the Islet beta Cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE CA2+ CONCENTRATION; INSULIN GENE-TRANSCRIPTION; WOLFRAM-SYNDROME 1; BINDING CHAPERONES; DIABETES-MELLITUS; MAJOR REGULATOR; PLASMA-MEMBRANE; IN-VIVO; STRESS; ACTIVATION	Although the pancreatic duodenal homeobox 1 (Pdx-1) transcription factor is known to play an indispensable role in beta cell development and secretory function, recent data also implicate Pdx-1 in the maintenance of endoplasmic reticulum (ER) health. The sarco-endoplasmic reticulum Ca2+ ATPase 2b (SERCA2b) pump maintains a steep Ca2+ gradient between the cytosol and ER lumen. In models of diabetes, our data demonstrated loss of beta cell Pdx-1 that occurs in parallel with altered SERCA2b expression, whereas in silico analysis of the SERCA2b promoter revealed multiple putative Pdx-1 binding sites. We hypothesized that Pdx-1 loss under inflammatory and diabetic conditions leads to decreased SERCA2b levels and activity with concomitant alterations in ER health. To test this, siRNA-mediated knockdown of Pdx-1 was performed in INS-1 cells. The results revealed reduced SERCA2b expression and decreased ER Ca2+, which was measured using fluorescence lifetime imaging microscopy. Cotransfection of human Pdx-1 with a reporter fused to the human SERCA2 promoter increased luciferase activity 3- to 4-fold relative to an empty vector control, and direct binding of Pdx-1 to the proximal SERCA2 promoter was confirmed by chromatin immunoprecipitation. To determine whether restoration of SERCA2b could rescue ER stress induced by Pdx-1 loss, Pdx1(+/-) mice were fed a high-fat diet. Isolated islets demonstrated an increased spliced-to-total Xbp1 ratio, whereas SERCA2b overexpression reduced the Xbp1 ratio to that of wild-type controls. Together, these results identify SERCA2b as a novel transcriptional target of Pdx-1 and define a role for altered ER Ca2+ regulation in Pdx-1-deficient states.	[Johnson, Justin S.; Evans-Molina, Carmella] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Kono, Tatsuyoshi; Evans-Molina, Carmella] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Tong, Xin; Yamamoto, Wataru R.; Evans-Molina, Carmella] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Evans-Molina, Carmella] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Zarain-Herzberg, Angel] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico; [Merrins, Matthew J.] Univ Wisconsin, Sch Med & Publ Hlth, Div Endocrinol Diabet & Metab, Dept Med, Madison, WI 53705 USA; [Merrins, Matthew J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53705 USA; [Satin, Leslie S.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48105 USA; [Satin, Leslie S.] Univ Michigan, Sch Med, Brehm Ctr Diabet Res, Ann Arbor, MI 48105 USA; [Gilon, Patrick] Catholic Univ Louvain, Inst Rech Expt & Clin, B-1348 Brussels, Belgium; [Evans-Molina, Carmella] Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Universidad Nacional Autonoma de Mexico; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Universite Catholique Louvain; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Evans-Molina, C (corresponding author), Indiana Univ Sch Med, 635 Barnhill Dr,MS 2031A, Indianapolis, IN 46202 USA.	cevansmo@iu.edu	tong, xin/AAE-7096-2021	Yamamoto, Wataru/0000-0003-1158-9781; Merrins, Matthew J./0000-0003-1599-9227; tong, xin/0000-0003-4408-3832; Kono, Tatsuyoshi/0000-0002-7524-6836	National Institutes of Health [R01 DK093954, RO1 DK46409, K01 DK101683]; NIDDK, National Institutes of Health; Veterans Affairs Merit Award [I01BX001733]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093954, K01DK101683, R01DK046409, P30DK097512, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM077229] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK093954 (to C. E. M.), RO1 DK46409 (to L. S. S.), and K01 DK101683 (to M. J. M.) and by an NIDDK, National Institutes of Health research supplement to promote diversity in health-related research (to J. S. J.). This work was also supported by Veterans Affairs Merit Award I01BX001733 (to C. E. M.) and by gifts from the Sigma Beta Sorority, the Ball Brothers Foundation, and the George and Frances Ball Foundation (to C. E. M.).	Abdi H., 2007, ENCY MEAS STATIST, P103; Al-Quobaili F, 2008, INT J MOL MED, V21, P399; Altshuler I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052617; Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; Ardestani A, 2011, J BIOL CHEM, V286, P17144, DOI 10.1074/jbc.M110.210526; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bain JR, 2004, DIABETES, V53, P2190, DOI 10.2337/diabetes.53.9.2190; Banhegyi G, 2007, ANN NY ACAD SCI, V1113, P58, DOI 10.1196/annals.1391.007; Barrett TG, 1997, J MED GENET, V34, P838, DOI 10.1136/jmg.34.10.838; Bedard K, 2005, INT REV CYTOL, V245, P91, DOI 10.1016/S0074-7696(05)45004-4; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chaudhry ZZ, 2013, LAB ANIM-UK, V47, P257, DOI 10.1177/0023677213489548; Chemaly E. R., 2013, J CARDIOVASC DIS DIA, V1, P113; Clausen JD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.397331; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96; Day RN, 2014, METHODS, V66, P200, DOI 10.1016/j.ymeth.2013.06.017; Docherty HM, 2005, BIOCHEM J, V389, P813, DOI 10.1042/BJ20041891; Eizirik DL, 2013, DIABETOLOGIA, V56, P234, DOI 10.1007/s00125-012-2762-3; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Engin F, 2014, SCI REP-UK, V4, DOI 10.1038/srep04054; Evans-Molina C, 2013, DIABETES OBES METAB, V15, P159, DOI 10.1111/dom.12163; Evans-Molina C, 2007, DIABETES, V56, P827, DOI 10.2337/db06-1440; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; Fisher MM, 2013, ENDOCRINOLOGY, V154, P3476, DOI 10.1210/en.2013-1223; Fonseca SG, 2012, NAT CELL BIOL, V14, P1105, DOI 10.1038/ncb2578; Gautier JF, 2008, DIABETES METAB, V34, pS65, DOI 10.1016/S1262-3636(08)73397-4; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Hatanaka M, 2011, HUM MOL GENET, V20, P1274, DOI 10.1093/hmg/ddq568; Hui HX, 2002, EUR J ENDOCRINOL, V146, P129, DOI 10.1530/eje.0.1460129; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Ishihara H, 2004, HUM MOL GENET, V13, P1159, DOI 10.1093/hmg/ddh125; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Jonsson J, 1995, INT J DEV BIOL, V39, P789; Kim SK, 2002, NAT GENET, V30, P430, DOI 10.1038/ng860; Kono T, 2012, MOL ENDOCRINOL, V26, P257, DOI 10.1210/me.2011-1181; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Mahadevan J, 2013, DIABETES, V62, P3582, DOI 10.2337/db13-0357; McKinnon CM, 2001, DIABETOLOGIA, V44, P1203, DOI 10.1007/s001250100628; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Mihailidou C, 2014, BIOCHIMIE, V99, P19, DOI 10.1016/j.biochi.2013.11.003; MONTERO M, 1995, EMBO J, V14, P5467, DOI 10.1002/j.1460-2075.1995.tb00233.x; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; National Research Council, 2011, GUIDE CARE USE LAB A; Ogihara T, 2010, J BIOL CHEM, V285, P5392, DOI 10.1074/jbc.M109.064659; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Park SW, 2010, P NATL ACAD SCI USA, V107, P19320, DOI 10.1073/pnas.1012044107; Qiu Y, 2002, MOL CELL BIOL, V22, P412, DOI 10.1128/MCB.22.2.412-420.2002; Ramadan JW, 2011, CELL CALCIUM, V50, P481, DOI 10.1016/j.ceca.2011.08.005; Ravier MA, 2011, DIABETES, V60, P2533, DOI 10.2337/db10-1543; Riggs AC, 2005, DIABETOLOGIA, V48, P2313, DOI 10.1007/s00125-005-1947-4; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Seijffers R, 1999, ENDOCRINOLOGY, V140, P3311, DOI 10.1210/en.140.7.3311; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; SHENNAN KIJ, 1994, J BIOL CHEM, V269, P18646; Sims EK, 2013, AM J PHYSIOL-ENDOC M, V305, pE1495, DOI 10.1152/ajpendo.00366.2013; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Sturek JM, 2010, J CLIN INVEST, V120, P2575, DOI 10.1172/JCI41280; Takei D, 2006, FEBS LETT, V580, P5635, DOI 10.1016/j.febslet.2006.09.007; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Vandecaetsbeek Ilse, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a004184; Varadi A, 1996, BIOCHEM J, V314, P663, DOI 10.1042/bj3140663; Wang H, 2005, DIABETOLOGIA, V48, P720, DOI 10.1007/s00125-005-1692-8; Yang L, 2013, J MOL MED, V91, P929, DOI 10.1007/s00109-013-1056-7	77	28	29	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.575191	http://dx.doi.org/10.1074/jbc.M114.575191			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25271154	Green Published, hybrid			2022-12-28	WOS:000345335000034
J	Keerthy, HK; Mohan, CD; Siveen, KS; Fuchs, JE; Rangappa, S; Sundaram, MS; Li, F; Girish, KS; Sethi, G; Basappa,; Bender, A; Rangappa, KS				Keerthy, Hosadurga Kumar; Mohan, Chakrabhavi Dhananjaya; Siveen, Kodappully Sivaraman; Fuchs, Julian E.; Rangappa, Shobith; Sundaram, Mahalingam S.; Li, Feng; Girish, Kesturu S.; Sethi, Gautam; Basappa; Bender, Andreas; Rangappa, Kanchugarakoppal Subbegowda			Novel Synthetic Biscoumarins Target Tumor Necrosis Factor-alpha in Hepatocellular Carcinoma in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Therapy; Cell Invasion; Hepatocellular Carcinoma; Inflammatory Bowel Disease (IBD); NF-kappa B (NF-KB); Tumor Necrosis Factor (TNF)	NF-KAPPA-B; MODE-OF-ACTION; TNF-ALPHA; BIOLOGICAL EVALUATION; RHEUMATOID-ARTHRITIS; FORCE-FIELD; CANCER; CURCUMIN; PATHWAY; INHIBITION	Background: TNF--induced NF-B pathway is associated with the progression of several cancers and abrogation of TNF signaling a potential target for cancer treatment. Results: Novel biscoumarin inhibits TNF signaling in vitro and in vivo in IBD model. Conclusion: The lead compound interrupts the trimeric structure of TNF to achieve this effect. Significance: This study introduces a novel TNF inhibitor with the potential to target pro-inflammatory diseases. TNF is a pleotropic cytokine known to be involved in the progression of several pro-inflammatory disorders. Many therapeutic agents have been designed to counteract the effect of TNF in rheumatoid arthritis as well as a number of cancers. In the present study we have synthesized and evaluated the anti-cancer activity of novel biscoumarins in vitro and in vivo. Among new compounds, BIHC was found to be the most cytotoxic agent against the HepG2 cell line while exhibiting less toxicity toward normal hepatocytes. Furthermore, BIHC inhibited the proliferation of various hepatocellular carcinoma (HCC) cells in a dose- and time-dependent manner. Subsequently, using in silico target prediction, BIHC was predicted as a TNF blocker. Experimental validation was able to confirm this hypothesis, where BIHC could significantly inhibit the recombinant mouse TNF- binding to its antibody with an IC50 of 16.5 m. Furthermore, in silico docking suggested a binding mode of BIHC similar to a ligand known to disrupt the native, trimeric structure of TNF, and also validated with molecular dynamics simulations. Moreover, we have demonstrated the down-regulation of p65 phosphorylation and other NF-B-regulated gene products upon BIHC treatment, and on the phenotypic level the compound shows inhibition of CXCL12-induced invasion of HepG2 cells. Also, we demonstrate that BIHC inhibits infiltration of macrophages to the peritoneal cavity and suppresses the activity of TNF- in vivo in mice primed with thioglycollate broth and lipopolysaccharide. We comprehensively validated the TNF- inhibitory efficacy of BIHC in an inflammatory bowel disease mice model.	[Keerthy, Hosadurga Kumar; Basappa] Bangalore Univ, Dept Chem, Biol Chem Lab, Bangalore 560001, Karnataka, India; [Mohan, Chakrabhavi Dhananjaya; Rangappa, Kanchugarakoppal Subbegowda] Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India; [Sundaram, Mahalingam S.; Girish, Kesturu S.] Univ Mysore, Dept Studies Biochem, Mysore 570006, Karnataka, India; [Siveen, Kodappully Sivaraman; Li, Feng; Sethi, Gautam] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore; [Fuchs, Julian E.; Bender, Andreas] Univ Cambridge, Dept Chem, Unilever Ctr Mol Sci Informat, Cambridge CB2 1EW, England; [Rangappa, Shobith] Singapore MIT Alliance Res & Technol Ctr SMART, Interdisciplinary Res Grp Infect Dis, Singapore 138602, Singapore; [Sethi, Gautam] Natl Univ Singapore, Canc Sci Inst Singapore, Yong Loo Lin Sch Med, Singapore 117599, Singapore	Bangalore University; University of Mysore; University of Mysore; National University of Singapore; University of Cambridge; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore	Basappa, (corresponding author), Bangalore Univ, Dept Chem, Biol Chem Lab, Palace Rd, Bangalore 560001, Karnataka, India.	salundibasappa@gmail.com; ab454@cam.ac.uk; rangappaks@yahoo.com	Mohan, Chakrabhavi Dhananjaya/AGO-1276-2022; Bender, Andreas/C-6942-2009; Rangappa, Shobith/AAI-2169-2020; KS, Girish/GWZ-7128-2022; Sethi, Gautam/F-2372-2011	Bender, Andreas/0000-0002-6683-7546; Rangappa, Shobith/0000-0002-9800-7192; Sethi, Gautam/0000-0002-8677-8475; /0000-0001-6121-0771	National University of Singapore (NUS) Academic Research Fund [R-184-000-207-112]; University Grants Commission [41-257-2012-SR]; Vision Group Science and Technology; Department of Science and Technology [SR/FT/LS-142/2012]; University Grants Commission (UGC); Department of Science and Technology (DST); Karnataka University, India	National University of Singapore (NUS) Academic Research Fund; University Grants Commission(University Grants Commission, India); Vision Group Science and Technology; Department of Science and Technology(Department of Science & Technology (India)); University Grants Commission (UGC)(University Grants Commission, India); Department of Science and Technology (DST)(Department of Science & Technology (India)); Karnataka University, India	This work was supported by grants from National University of Singapore (NUS) Academic Research Fund (Grant R-184-000-207-112) (to G. S.). This research was also supported by the University Grants Commission (41-257-2012-SR), Vision Group Science and Technology, and Department of Science and Technology (Grant SR/FT/LS-142/2012) (to Basappa).; Recipient of a Basic Scientific Research (BSR) fellowship from the University Grants Commission (UGC).; Recipient of an INSPIRE fellowship from the Department of Science and Technology (DST).; Recipient of a PAVATE fellowship from Karnataka University, India.	Alli-Akintade L, 2015, J CLIN GASTROENTEROL, V49, pE21, DOI 10.1097/MCG.0000000000000117; [Anonymous], 2013, MOL OP ENV MOE; Askling J, 2009, ARTHRITIS RHEUM-US, V60, P3180, DOI 10.1002/art.24941; Basappa, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039444; Basappa, 2010, CANCER LETT, V297, P231, DOI 10.1016/j.canlet.2010.05.016; Basappa, 2009, GLYCOBIOLOGY, V19, P735, DOI 10.1093/glycob/cwp041; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bharathkumar H, 2014, RSC ADV, V4, P45143, DOI 10.1039/c4ra08713e; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Chen YR, 1998, ONCOGENE, V17, P173, DOI 10.1038/sj.onc.1201941; COOPER HS, 1993, LAB INVEST, V69, P238; Cravotto G, 2003, SYNTHESIS-STUTTGART, P1286; Dasgupta B, 2014, ARTHRIT CARE RES, V66, P1799, DOI 10.1002/acr.22371; Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555; Fauzi FM, 2013, J CHEM INF MODEL, V53, P661, DOI 10.1021/ci3005513; Feuerstein JD, 2014, MAYO CLIN PROC, V89, P1553, DOI 10.1016/j.mayocp.2014.07.002; Fongmoon D, 2007, J BIOL CHEM, V282, P36895, DOI 10.1074/jbc.M707082200; Frisch M.J., 2009, GAUSSIAN 09 REV A02; Fuchs JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053005; Gonzalez-Rey E, 2006, GASTROENTEROLOGY, V130, P1707, DOI 10.1053/j.gastro.2006.01.041; Hagiwara H, 2000, HETEROCYCLES, V53, P549, DOI 10.3987/COM-99-8817; HAWES AS, 1993, ANN SURG, V218, P79, DOI 10.1097/00000658-199307000-00013; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Iqbal M, 2013, PHYTOCHEM REV, V12, P65, DOI 10.1007/s11101-012-9251-7; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kim HY, 2003, J IMMUNOL, V171, P6072, DOI 10.4049/jimmunol.171.11.6072; Kobayashi T, 2014, J PERIODONTOL, V85, P1480, DOI 10.1902/jop.2014.140194; Koutsoukas A, 2013, J CHEM INF MODEL, V53, P1957, DOI 10.1021/ci300435j; Koutsoukas A, 2011, J PROTEOMICS, V74, P2554, DOI 10.1016/j.jprot.2011.05.011; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu J, 2007, PHYTOCHEMISTRY, V68, P1775, DOI 10.1016/j.phytochem.2007.05.001; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mehrabi H, 2010, J IRAN CHEM SOC, V7, P890, DOI 10.1007/BF03246084; NABEL GJ, 1993, GENE DEV, V7, P2063, DOI 10.1101/gad.7.11.2063; Nemchenko A, 2010, CIRC RES, V106, P10, DOI 10.1161/CIRCRESAHA.109.211185; Olivier S, 2006, BIOCHEM PHARMACOL, V72, P1054, DOI 10.1016/j.bcp.2006.07.023; Pettipher ER, 1996, BRIT J PHARMACOL, V117, P1530, DOI 10.1111/j.1476-5381.1996.tb15317.x; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Revanna CN, 2014, MEDCHEMCOMM, V5, P32, DOI 10.1039/c3md00119a; Rungeler P, 1999, BIOORGAN MED CHEM, V7, P2343, DOI 10.1016/S0968-0896(99)00195-9; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Sethi G, 2009, ADV EXP MED BIOL, V647, P37, DOI 10.1007/978-0-387-89520-8_3; Sethi G, 2009, TRENDS PHARMACOL SCI, V30, P313, DOI 10.1016/j.tips.2009.03.004; Shrimali D, 2013, CANCER LETT, V341, P139, DOI 10.1016/j.canlet.2013.08.023; Siddiqui AM, 2006, CRIT CARE MED, V34, P1874, DOI 10.1097/01.CCM.0000221921.71300.BF; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Snir O, 2013, GENES IMMUN, V14, P83, DOI 10.1038/gene.2012.56; Suh HW, 2007, MOL CELL BIOCHEM, V298, P187, DOI 10.1007/s11010-006-9365-6; Takahashi S, 2003, ENDOCR-RELAT CANCER, V10, P403, DOI 10.1677/erc.0.0100403; Tanaka T, 2014, BIOL-TARGETS THER, V8, P141, DOI 10.2147/BTT.S37509; TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041; van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530	59	64	66	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31879	31890		10.1074/jbc.M114.593855	http://dx.doi.org/10.1074/jbc.M114.593855			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25231984	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000345314700019
J	Robinson, LE; Shridar, M; Smith, P; Murrell-Lagnado, RD				Robinson, Lucy E.; Shridar, Mitesh; Smith, Philip; Murrell-Lagnado, Ruth D.			Plasma Membrane Cholesterol as a Regulator of Human and Rodent P2X7 Receptor Activation and Sensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cholesterol Regulation; Inflammation; Ion Channel; Lipid Raft; Mutagenesis; Patch Clamp; Purinergic Receptor; P2X7	ALVEOLAR EPITHELIAL-CELLS; RAT SUBMANDIBULAR-GLAND; LIPID RAFTS; P2X(7) RECEPTOR; PORE FORMATION; CHANNELS; IDENTIFICATION; TRAFFICKING; APOPTOSIS; CERAMIDE	Background: P2X7 receptors are important in inflammation and immunity, but excessive activation results in cell death. Results: Facilitation of P2X7 receptor currents and dilation of the pore are enhanced by cholesterol depletion and reduced by cholesterol loading. Conclusion: Plasma membrane cholesterol destabilizes the open and dilated states of the receptor pore. Significance: Targeting of P2X7 to cholesterol-rich lipid rafts may protect cells from death. P2X7 receptors are nonselective cation channels gated by high extracellular ATP, but with sustained activation, receptor sensitization occurs, whereby the intrinsic pore dilates, making the cell permeable to large organic cations, which eventually leads to cell death. P2X7 receptors associate with cholesterol-rich lipid rafts, but it is unclear how this affects the properties of the receptor channel. Here we show that pore-forming properties of human and rodent P2X7 receptors are sensitive to perturbations of cholesterol levels. Acute depletion of cholesterol with 5 mm methyl--cyclodextrin (MCD) caused a substantial increase in the rate of agonist-evoked pore formation, as measured by the uptake of ethidium dye, whereas cholesterol loading inhibited this process. Patch clamp analysis of P2X7 receptor currents carried by Na+ and N-methyl-d-glucamine (NMDG(+)) showed enhanced activation and current facilitation following cholesterol depletion. This contrasts with the inhibitory effect of methyl--cyclodextrin reported for other P2X subtypes. Mutational analysis suggests the involvement of an N-terminal region and a proximal C-terminal region that comprises multiple cholesterol recognition amino acid consensus (CRAC) motifs, in the cholesterol sensitivity of channel gating. These results reveal cholesterol as a negative regulator of P2X7 receptor pore formation, protecting cells from P2X7-mediated cell death.	[Robinson, Lucy E.; Shridar, Mitesh; Smith, Philip; Murrell-Lagnado, Ruth D.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Murrell-Lagnado, RD (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	rdm1003@cam.ac.uk		Murrell-Lagnado, Ruth/0000-0003-2743-7977; Smith, Philip/0000-0002-2295-7204	Biotechnology and Biological Sciences Research Council [BB/F001320/1]; Department of Pharmacology, University of Cambridge; Marshall Scholarship; BBSRC [BB/F001320/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department of Pharmacology, University of Cambridge; Marshall Scholarship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BB/F001320/1) (to R. D. M. L.).; Funded by the David James Studentship, Department of Pharmacology, University of Cambridge.; Funded by a Marshall Scholarship.	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Adinolfi Elena, 2005, Purinergic Signal, V1, P219, DOI 10.1007/s11302-005-6322-x; Allsopp RC, 2010, J BIOL CHEM, V285, P32770, DOI 10.1074/jbc.M110.148940; Barth K, 2008, INT J BIOCHEM CELL B, V40, P2230, DOI 10.1016/j.biocel.2008.03.001; Barth K, 2007, FEBS J, V274, P3021, DOI 10.1111/j.1742-4658.2007.05830.x; Bernier LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040595; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Boumechache M, 2009, J BIOL CHEM, V284, P13446, DOI 10.1074/jbc.M901255200; Bowie RV, 2012, AM J PHYSIOL-GASTR L, V302, pG781, DOI 10.1152/ajpgi.00002.2011; Browne LE, 2013, J NEUROSCI, V33, P3557, DOI 10.1523/JNEUROSCI.2235-12.2013; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Ferrari D, 1997, J IMMUNOL, V159, P1451; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Furlan-Freguia C, 2011, J CLIN INVEST, V121, P2932, DOI 10.1172/JCI46129; Garcia-Marcos M, 2006, J LIPID RES, V47, P705, DOI 10.1194/jlr.M500408-JLR200; Garcia-Marcos M, 2006, CELL SIGNAL, V18, P2098, DOI 10.1016/j.cellsig.2006.05.008; Garcia-Marcos M, 2006, BBA-BIOMEMBRANES, V1758, P796, DOI 10.1016/j.bbamem.2006.05.008; Gimpl G, 2011, STEROIDS, V76, P216, DOI 10.1016/j.steroids.2010.11.001; Gnanasekaran A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-77; Gonnord P, 2009, FASEB J, V23, P795, DOI 10.1096/fj.08-114637; Gu BJ, 2009, AM J PHYSIOL-CELL PH, V297, pC430, DOI 10.1152/ajpcell.00079.2009; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Huang FC, 2011, CELL IMMUNOL, V271, P480, DOI 10.1016/j.cellimm.2011.08.018; Jiang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC1295, DOI 10.1152/ajpcell.00253.2005; Lalo U, 2011, J BIOL CHEM, V286, P30591, DOI 10.1074/jbc.M111.253153; Lepine S, 2006, BBA-MOL CELL BIOL L, V1761, P73, DOI 10.1016/j.bbalip.2005.10.001; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Li J, 2012, PURINERG SIGNAL, V8, P311, DOI 10.1007/s11302-011-9289-9; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Michel AD, 2007, BRIT J PHARMACOL, V152, P523, DOI 10.1038/sj.bjp.0707417; Miller CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002212; Mishra A, 2011, J CELL SCI, V124, P657, DOI 10.1242/jcs.066977; Mondal M, 2009, MOL BIOL CELL, V20, P581, DOI 10.1091/mbc.E08-07-0785; Moulin M, 2007, APOPTOSIS, V12, P1703, DOI 10.1007/s10495-007-0096-2; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Oddi S, 2011, J NEUROCHEM, V116, P858, DOI 10.1111/j.1471-4159.2010.07041.x; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Qureshi OS, 2007, J CELL SCI, V120, P3838, DOI 10.1242/jcs.010348; Raymond MN, 2006, FEBS LETT, V580, P131, DOI 10.1016/j.febslet.2005.11.066; Robinson LE, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00233; Roger B, 2008, J NEUROSCI, V28, P6393, DOI 10.1523/JNEUROSCI.0696-08.2008; Roger S, 2010, J BIOL CHEM, V285, P17514, DOI 10.1074/jbc.M109.053082; Rokic MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059411; Singh AK, 2012, J BIOL CHEM, V287, P20509, DOI 10.1074/jbc.M112.356261; Solana R, 2012, SEMIN IMMUNOL, V24, P331, DOI 10.1016/j.smim.2012.04.008; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Vial C, 2005, J BIOL CHEM, V280, P30705, DOI 10.1074/jbc.M504256200; Vincent N, 2002, BBA-BIOMEMBRANES, V1567, P157, DOI 10.1016/S0005-2736(02)00611-9; Weinhold K, 2010, CELL MOL LIFE SCI, V67, P2631, DOI 10.1007/s00018-010-0355-1; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Xu XJ, 2012, J CELL SCI, V125, P3776, DOI 10.1242/jcs.099374; Yan ZH, 2008, J GEN PHYSIOL, V132, P563, DOI 10.1085/jgp.200810059; Yang DL, 2011, INVEST OPHTH VIS SCI, V52, P1522, DOI 10.1167/iovs.10-6172; Zhao Q, 2007, PFLUG ARCH EUR J PHY, V455, P181, DOI 10.1007/s00424-007-0271-x; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	58	43	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31983	31994		10.1074/jbc.M114.574699	http://dx.doi.org/10.1074/jbc.M114.574699			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25281740	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000345314700028
J	Sokabe, M; Fraser, CS				Sokabe, Masaaki; Fraser, Christopher S.			Human Eukaryotic Initiation Factor 2 (eIF2)-GTP-Met-tRNA(i) Ternary Complex and eIF3 Stabilize the 43 S Preinitiation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cooperativity; Eukaryotic Translation Initiation; Protein-Protein Interaction; Ribosome; Ribosome Function; RNA-binding Protein; eIF1; eIF1A; eIF2; eIF3	40S RIBOSOMAL-SUBUNIT; START CODON SELECTION; MESSENGER-RNA; MULTIFACTOR COMPLEX; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; TRANSLATION; BINDING; RECOGNITION; RECRUITMENT	Background: 43 S preinitiation complex (PIC) formation is an important step for eukaryotic translation initiation. Results: A thermodynamic framework of human 43 S PIC reveals a complicated network of positive and negative cooperativity among the components. Conclusion: eIF2 and eIF3 play essential roles in stabilizing the 43 S PIC. Significance: Quantitative analysis of initiation complex formation leads to understanding of mechanistic details in translation initiation. The formation of a stable 43 S preinitiation complex (PIC) must occur to enable successful mRNA recruitment. However, the contributions of eIF1, eIF1A, eIF3, and the eIF2-GTP-Met-tRNA(i) ternary complex (TC) in stabilizing the 43 S PIC are poorly defined. We have reconstituted the human 43 S PIC and used fluorescence anisotropy to systematically measure the affinity of eIF1, eIF1A, and eIF3j in the presence of different combinations of 43 S PIC components. Our data reveal a complicated network of interactions that result in high affinity binding of all 43 S PIC components with the 40 S subunit. Human eIF1 and eIF1A bind cooperatively to the 40 S subunit, revealing an evolutionarily conserved interaction. Negative cooperativity is observed between the binding of eIF3j and the binding of eIF1, eIF1A, and TC with the 40 S subunit. To overcome this, eIF3 dramatically increases the affinity of eIF1 and eIF3j for the 40 S subunit. Recruitment of TC also increases the affinity of eIF1 for the 40 S subunit, but this interaction has an important indirect role in increasing the affinity of eIF1A for the 40 S subunit. Together, our data provide a more complete thermodynamic framework of the human 43 S PIC and reveal important interactions between its components to maintain its stability.	[Sokabe, Masaaki; Fraser, Christopher S.] Univ Calif Davis, Coll Biol Sci, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Fraser, CS (corresponding author), Univ Calif Davis, Coll Biol Sci, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	csfraser@ucdavis.edu			National Institutes of Health [RO1 GM092927]; Japan Society for the Promotion of Science (JSPS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM092927 (to C. S. F.). This work was also supported by Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for Research Abroad (to M. S.).	Algire MA, 2002, RNA, V8, P382, DOI 10.1017/S1355838202029527; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Barth-Baus D, 2013, TRANSLATION, V1, DOI 10.4161/trla.24419; BENNE R, 1979, J BIOL CHEM, V254, P3201; Chaudhuri J, 1997, J BIOL CHEM, V272, P7883, DOI 10.1074/jbc.272.12.7883; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Dennis MD, 2009, J BIOL CHEM, V284, P20615, DOI 10.1074/jbc.M109.007658; Dong JS, 2014, GENE DEV, V28, P502, DOI 10.1101/gad.236547.113; DUNCAN R, 1983, J BIOL CHEM, V258, P7228; ElAntak L, 2010, J MOL BIOL, V396, P1097, DOI 10.1016/j.jmb.2009.12.047; Fekete CA, 2005, EMBO J, V24, P3588, DOI 10.1038/sj.emboj.7600821; Fekete CA, 2007, EMBO J, V26, P1602, DOI 10.1038/sj.emboj.7601613; Feoktistova K, 2013, P NATL ACAD SCI USA, V110, P13339, DOI 10.1073/pnas.1303781110; Firczuk H, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.73; Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631; Fraser CS, 2007, MOL CELL, V26, P811, DOI 10.1016/j.molcel.2007.05.019; Fraser CS, 2009, NAT STRUCT MOL BIOL, V16, P397, DOI 10.1038/nsmb.1572; Fraser CS, 2004, J BIOL CHEM, V279, P8946, DOI 10.1074/jbc.M312745200; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Lomakin IB, 2013, NATURE, V500, P307, DOI 10.1038/nature12355; Lorsch JR, 2010, J BIOL CHEM, V285, P21203, DOI 10.1074/jbc.R110.119743; Loughran G, 2012, NUCLEIC ACIDS RES, V40, P2898, DOI 10.1093/nar/gkr1192; Maag D, 2006, J MOL BIOL, V356, P724, DOI 10.1016/j.jmb.2005.11.083; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Majumdar R, 2003, J BIOL CHEM, V278, P6580, DOI 10.1074/jbc.M210357200; Martin-Marcos P, 2014, RNA, V20, P150, DOI 10.1261/rna.042069.113; Martin-Marcos P, 2013, J BIOL CHEM, V288, P27546, DOI 10.1074/jbc.M113.498642; Mathews M. B., 2007, TRANSLATIONAL CONTRO, P87; Nanda JS, 2013, J BIOL CHEM, V288, P5316, DOI 10.1074/jbc.M112.440693; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Nielsen KH, 2006, MOL CELL BIOL, V26, P2984, DOI 10.1128/MCB.26.8.2984-2998.2006; Olsen DS, 2003, EMBO J, V22, P193, DOI 10.1093/emboj/cdg030; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Phan L, 2001, EMBO J, V20, P2954, DOI 10.1093/emboj/20.11.2954; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; Saini AK, 2010, GENE DEV, V24, P97, DOI 10.1101/gad.1871910; Shin BS, 2011, NAT STRUCT MOL BIOL, V18, P1227, DOI 10.1038/nsmb.2133; Sokabe M, 2012, NUCLEIC ACIDS RES, V40, P905, DOI 10.1093/nar/gkr772; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; THOMAS A, 1980, EUR J BIOCHEM, V107, P39, DOI 10.1111/j.1432-1033.1980.tb04621.x; Unbehaun A, 2004, GENE DEV, V18, P3078, DOI 10.1101/gad.1255704; Valasek L, 2001, EMBO J, V20, P891, DOI 10.1093/emboj/20.4.891; WEEKS KM, 1992, BIOCHEMISTRY-US, V31, P10281, DOI 10.1021/bi00157a015; Weisser M, 2013, NAT STRUCT MOL BIOL, V20, P1015, DOI 10.1038/nsmb.2622; Yi L, 2010, ANGEW CHEM INT EDIT, V49, P9417, DOI 10.1002/anie.201003834; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519	51	38	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31827	31836		10.1074/jbc.M114.602870	http://dx.doi.org/10.1074/jbc.M114.602870			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25246524	Green Published, hybrid			2022-12-28	WOS:000345314700014
J	Anne, OS; Bernheim-Groswasser, A				Siton, Orit; Bernheim-Groswasser, Anne			Reconstitution of Actin-based Motility by Vasodilator-stimulated Phosphoprotein (VASP) Depends on the Recruitment of F-actin Seeds from the Solution Produced by Cofilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENA/VASP PROTEINS; LISTERIA-MONOCYTOGENES; STRUCTURAL BASIS; MYOSIN-X; DYNAMICS; COMPLEX; CYTOSKELETON; POLYMERIZATION; NUCLEATION; FILAMENTS	Vasodilator-stimulated phosphoprotein (VASP) is active in many filopodium-based and cytoskeleton reorganization processes. It is not fully understood how VASP directly functions in actin-based motility and how regulatory proteins affect its function. Here, we combine bead motility assay and single filament experiments. In the presence of a bundling component, actin bundles that grow from the surface of WT-VASP-coated beads induced movement of the beads. VASP promotes actin-based movement alone, in the absence of other actin nucleators. We propose that at physiological salt conditions VASP nucleation activity is too weak to promote motility and bundle formation. Rather, VASP recruits F-actin seeds from the solution and promotes their elongation. Cofilin has a crucial role in the nucleation of these F-actin seeds, notably under conditions of unfavorable spontaneous actin nucleation. We explored the role of multiple VASP variants. We found that the VASP-F-actin binding domain is required for the recruitment of F-actin seeds from the solution. We also found that the interaction of profilin-actin complexes with the VASP-proline- rich domain and the binding of the VASP-F-actin binding domain to the side of growing filaments is critical for transforming actin polymerization into motion. At the single filament level, profilin mediates both filament elongation rate and VASP anti-capping activity. Binding of profilin-actin complexes increases the polymerization efficiency by VASP but decreases its efficiency as an anti-capper; binding of free profilin creates the opposite effect. Finally, we found that an additional component such as methylcellulose or fascin is required for actin bundle formation and motility mediated by VASP.	[Bernheim-Groswasser, Anne] Ben Gurion Univ Negev, Dept Chem Engn, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Bernheim-Groswasser, A (corresponding author), Ben Gurion Univ Negev, Dept Chem Engn, IL-84105 Beer Sheva, Israel.	bernheim@bgu.ac.il	Bernheim, Anne/AAM-5969-2020	Bernheim-Groswasser, Anne/0000-0003-3999-6098	Israel Science Foundation [1534/10]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation Grant 1534/10 (to A.B.-G.)	Achard V, 2010, CURR BIOL, V20, P423, DOI 10.1016/j.cub.2009.12.056; Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Applewhite DA, 2007, MOL BIOL CELL, V18, P2579, DOI 10.1091/mbc.e06-11-0990; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bernheim-Groswasser A, 2002, NATURE, V417, P308, DOI 10.1038/417308a; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Brill-Karniely Y, 2009, CHEMPHYSCHEM, V10, P2818, DOI 10.1002/cphc.200900615; Carlier MF, 2007, ANN NY ACAD SCI, V1112, P67, DOI 10.1196/annals.1415.037; CHAKRABORTY T, 1995, EMBO J, V14, P1314, DOI 10.1002/j.1460-2075.1995.tb07117.x; Chereau D, 2006, J STRUCT BIOL, V155, P195, DOI 10.1016/j.jsb.2006.01.012; Danino D, 2001, COLLOID SURFACE A, V183, P113, DOI 10.1016/S0927-7757(01)00543-X; Drees F, 2008, CURR OPIN NEUROBIOL, V18, P53, DOI 10.1016/j.conb.2008.05.007; Ferron F, 2007, EMBO J, V26, P4597, DOI 10.1038/sj.emboj.7601874; Fleming T, 2010, DEV BIOL, V344, P94, DOI 10.1016/j.ydbio.2010.04.025; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gov Nir S, 2012, Bioarchitecture, V2, P11; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; Haviv L, 2006, P NATL ACAD SCI USA, V103, P4906, DOI 10.1073/pnas.0508269103; Huttelmaier S, 1999, FEBS LETT, V451, P68, DOI 10.1016/S0014-5793(99)00546-3; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Ideses Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003297; Irobi E, 2004, EMBO J, V23, P3599, DOI 10.1038/sj.emboj.7600372; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Lin WH, 2010, J BIOL CHEM, V285, P36010, DOI 10.1074/jbc.M110.129841; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; Neidt EM, 2009, J BIOL CHEM, V284, P673, DOI 10.1074/jbc.M804201200; Ono K, 2008, J CELL SCI, V121, P2662, DOI 10.1242/jcs.034215; Ono S, 1997, J BIOL CHEM, V272, P2527; Pasic L, 2008, J BIOL CHEM, V283, P9814, DOI 10.1074/jbc.M710475200; Plastino J, 2004, CURR BIOL, V14, P1766, DOI 10.1016/j.cub.2004.09.054; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Reymann AC, 2011, MOL BIOL CELL, V22, P2541, DOI 10.1091/mbc.E11-01-0052; Samarin S, 2003, J CELL BIOL, V163, P131, DOI 10.1083/jcb.200303191; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; Siton O, 2011, CURR BIOL, V21, P2092, DOI 10.1016/j.cub.2011.11.010; Skoble J, 2001, J CELL BIOL, V155, P89, DOI 10.1083/jcb.200106061; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Suei S, 2011, J MOL BIOL, V413, P573, DOI 10.1016/j.jmb.2011.08.054; Tahirovic S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001644; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Trichet L, 2008, J CELL BIOL, V181, P19, DOI 10.1083/jcb.200710168; Trichet L, 2007, BIOPHYS J, V92, P1081, DOI 10.1529/biophysj.106.091884; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Yoshinaga S, 2012, J NEUROSCI, V32, P11643, DOI 10.1523/JNEUROSCI.0738-12.2012	62	14	14	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31274	31286		10.1074/jbc.M114.586958	http://dx.doi.org/10.1074/jbc.M114.586958			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25246528	hybrid, Green Published			2022-12-28	WOS:000344549900032
J	Bailey, TA; Luan, HT; Tom, E; Bielecki, TA; Mohapatra, B; Ahmad, G; George, M; Kelly, DL; Natarajan, A; Raja, SM; Band, V; Band, H				Bailey, Tameka A.; Luan, Haitao; Tom, Eric; Bielecki, Timothy Alan; Mohapatra, Bhopal; Ahmad, Gulzar; George, Manju; Kelly, David L.; Natarajan, Amarnath; Raja, Srikumar M.; Band, Vimla; Band, Hamid			A Kinase Inhibitor Screen Reveals Protein Kinase C-dependent Endocytic Recycling of ErbB2 in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; INDUCED DOWN-REGULATION; TYROSINE PHOSPHORYLATION; TANESPIMYCIN 17-AAG; DEGRADATIVE PATHWAY; INDUCED APOPTOSIS; HSP90 INHIBITORS; PHOSPHOLIPASE-D; UP-REGULATION; EGF RECEPTOR	ErbB2 overexpression drives oncogenesis in 20-30% cases of breast cancer. Oncogenic potential of ErbB2 is linked to inefficient endocytic traffic into lysosomes and preferential recycling. However, regulation of ErbB2 recycling is incompletely understood. We used a high-content immunofluorescence imaging-based kinase inhibitor screen on SKBR-3 breast cancer cells to identify kinases whose inhibition alters the clearance of cell surface ErbB2 induced by Hsp90 inhibitor 17-AAG. Less ErbB2 clearance was observed with broad-spectrum PKC inhibitor Ro 31-8220. A similar effect was observed with Go 6976, a selective inhibitor of classical Ca2+-dependent PKCs (alpha, beta 1, beta II, and gamma). PKC activation by PMA promoted surface ErbB2 clearance but without degradation, and ErbB2 was observed to move into a juxtanuclear compartment where it colocalized with PKC-alpha and PKC-delta together with the endocytic recycling regulator Arf6. PKC-alpha knockdown impaired the juxtanuclear localization of ErbB2. ErbB2 transit to the recycling compartment was also impaired upon PKC-delta knockdown. PMA-induced Erkphosphorylation was reduced by ErbB2 inhibitor lapatinib, as well as by knockdown of PKC-delta but not that of PKC-alpha. Our results suggest that activation of PKC-alpha and -delta mediates a novel positive feedback loop by promoting ErbB2 entry into the endocytic recycling compartment, consistent with reported positive roles for these PKCs in ErbB2-mediated tumorigenesis. As the endocytic recycling compartment/pericentrion has emerged as a PKC-dependent signaling hub for G-protein-coupled receptors, our findings raise the possibility that oncogenesis by ErbB2 involves previously unexplored PKC-dependent endosomal signaling.	[Bailey, Tameka A.; Luan, Haitao; Tom, Eric; Bielecki, Timothy Alan; Mohapatra, Bhopal; Ahmad, Gulzar; George, Manju; Kelly, David L.; Natarajan, Amarnath; Raja, Srikumar M.; Band, Vimla; Band, Hamid] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Coll Med, Omaha, NE 68198 USA; [Luan, Haitao; Band, Vimla; Band, Hamid] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Coll Med, Omaha, NE 68198 USA; [Tom, Eric; Mohapatra, Bhopal; Band, Hamid] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Coll Med, Omaha, NE 68198 USA; [Kelly, David L.; Natarajan, Amarnath; Raja, Srikumar M.; Band, Vimla; Band, Hamid] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Band, H (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	hband@unmc.edu	Band, Hamid/AAF-4701-2020	Natarajan, Amarnath/0000-0001-5067-0203; Mohapatra, Bhopal/0000-0003-3434-4306; Bielecki, Timothy/0000-0003-4561-0892	National Institutes of Health [CA116552, CA105489, CA99163, CA87986, CA96844, CA144027, CA127239]; Dept. of Defense [W81WH-11-1-0167, W81XWH-07-1-0351, W81XWH-11-1-0171]; NE DHHS [LB506-2014-01]; Nebraska DHHS [LB606-18123-Y3]; Nebraska Center for Nanomedicine-Center for Biomedical Research Excellence (NCN-COBRE) seed grant; NCI Core Support Grant; NCI Institutional Cancer Biology Training Grant [CA009476]; Susan G. Komen Foundation for Cure postdoctoral Fellowship [KG091363]; UNMC Faculty Diversity Scholar award; NATIONAL CANCER INSTITUTE [R01CA096844, P30CA036727, R01CA087986, R01CA105489, R01CA099163, T32CA009476, R01CA127239, R01CA116552, R01CA144027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Defense(United States Department of Defense); NE DHHS; Nebraska DHHS; Nebraska Center for Nanomedicine-Center for Biomedical Research Excellence (NCN-COBRE) seed grant; NCI Core Support Grant; NCI Institutional Cancer Biology Training Grant; Susan G. Komen Foundation for Cure postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); UNMC Faculty Diversity Scholar award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health Grants CA116552, CA105489, CA99163, CA87986, Dept. of Defense Grant W81WH-11-1-0167, NE DHHS LB506-2014-01, and Nebraska DHHS LB606-18123-Y3 (to H. B.); National Institutes of Health Grants CA96844 and CA144027, and Dept. of Defense Grants W81XWH-07-1-0351 and W81XWH-11-1-0171 (to V. B.); National Institutes of Health Grant CA127239 (to A. N.); Nebraska Center for Nanomedicine-Center for Biomedical Research Excellence (NCN-COBRE) seed grant (to S. M. R.); and the NCI Core Support Grant to the UNMC Buffett Cancer Center.; A postdoctoral trainee under the NCI Institutional Cancer Biology Training Grant (CA009476) and a recipient of the Susan G. Komen Foundation for Cure postdoctoral Fellowship (KG091363) and a UNMC Faculty Diversity Scholar award.	Alessi DR, 1997, FEBS LETT, V402, P121, DOI 10.1016/S0014-5793(96)01510-4; Allen-Petersen BL, 2014, ONCOGENE, V33, P1306, DOI 10.1038/onc.2013.59; Alvi F, 2007, CELL MOL LIFE SCI, V64, P263, DOI 10.1007/s00018-006-6363-5; Antonescu CN, 2010, MOL BIOL CELL, V21, P2944, DOI 10.1091/mbc.E10-05-0421; Austin CD, 2004, MOL BIOL CELL, V15, P5268, DOI 10.1091/mbc.E04-07-0591; Bao J, 2000, J BIOL CHEM, V275, P26178, DOI 10.1074/jbc.M002367200; Barr DJ, 2008, J CELL SCI, V121, P3155, DOI 10.1242/jcs.020404; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Baulida J, 1996, J BIOL CHEM, V271, P5251; Becker KP, 2003, J BIOL CHEM, V278, P52747, DOI 10.1074/jbc.M305228200; Beltman J, 1996, J BIOL CHEM, V271, P27018, DOI 10.1074/jbc.271.43.27018; Bonita DP, 1997, MOL CELL BIOL, V17, P4597, DOI 10.1128/MCB.17.8.4597; Cai JJ, 2010, J BIOL CHEM, V285, P6952, DOI 10.1074/jbc.M109.055731; Chung BM, 2009, ONCOGENE, V28, P1821, DOI 10.1038/onc.2009.31; Chung BM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-84; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cortese K, 2013, MOL BIOL CELL, V24, P129, DOI 10.1091/mbc.E12-04-0282; de Diesbach MT, 2010, EXP CELL RES, V316, P3239, DOI 10.1016/j.yexcr.2010.09.001; Feng X, 1998, J BIOL CHEM, V273, P10755, DOI 10.1074/jbc.273.17.10755; Friedman LM, 2005, P NATL ACAD SCI USA, V102, P1915, DOI 10.1073/pnas.0409610102; Gabriel L, 2012, J BIOL CHEM, V287, P32354, DOI 10.1074/jbc.M112.391458; Gordon LI, 2009, J BIOL CHEM, V284, P2080, DOI 10.1074/jbc.M804570200; Han Z, 2000, CELL DEATH DIFFER, V7, P521, DOI 10.1038/sj.cdd.4400681; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Hashizume T, 2008, CELL BIOL INT, V32, P814, DOI 10.1016/j.cellbi.2008.03.012; Helikar T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061757; Henriksen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058148; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Idkowiak-Baldys J, 2009, J BIOL CHEM, V284, P22322, DOI 10.1074/jbc.M109.026765; Kaneko T, 2005, GENES CELLS, V10, P973, DOI 10.1111/j.1365-2443.2005.00895.x; Kasai A, 2005, GENES CELLS, V10, P1175, DOI 10.1111/j.1365-2443.2005.00909.x; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Keshamouni VG, 2002, J BIOL CHEM, V277, P22558, DOI 10.1074/jbc.M202351200; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Lanzetti L, 2008, TRAFFIC, V9, P2011, DOI 10.1111/j.1600-0854.2008.00816.x; Le XF, 2001, ONCOGENE, V20, P8258, DOI 10.1038/sj.onc.1205039; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lerdrup M, 2006, J CELL SCI, V119, P85, DOI 10.1242/jcs.02707; Lerdrup M, 2007, MOL BIOL CELL, V18, P3656, DOI 10.1091/mbc.e07-01-0025; Li-Ping Z., 2010, REPROD BIOL ENDOCRIN, V8, P1; Li-Ping Z., 2010, REPROD BIOL ENDOCRIN, V8, P7827; Liu Y, 2007, BIOCHEM BIOPH RES CO, V354, P505, DOI 10.1016/j.bbrc.2007.01.009; Llado A, 2004, MOL BIOL CELL, V15, P4877, DOI 10.1091/mbc.E04-02-0127; Llado A, 2008, MOL BIOL CELL, V19, P17, DOI 10.1091/mbc.E07-05-0411; Lonne GK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-76; Lu XY, 2012, BIOCHEM PHARMACOL, V83, P995, DOI 10.1016/j.bcp.2011.11.011; Lum MA, 2013, J BIOL CHEM, V288, P27112, DOI 10.1074/jbc.M112.437095; Lum MA, 2013, J BIOL CHEM, V288, P13093, DOI 10.1074/jbc.M112.437061; Magnifico A, 1998, FEBS LETT, V422, P129, DOI 10.1016/S0014-5793(97)01612-8; Magnifico A, 2007, CANCER RES, V67, P5308, DOI 10.1158/0008-5472.CAN-06-3936; Mahlknecht G, 2013, P NATL ACAD SCI USA, V110, P8170, DOI 10.1073/pnas.1302594110; MAIER LA, 1991, CANCER RES, V51, P5361; Marcotte R, 2009, MOL CELL BIOL, V29, P5858, DOI 10.1128/MCB.01731-08; Marx C, 2010, CANCER RES, V70, P3709, DOI 10.1158/0008-5472.CAN-09-3768; Meijer IMJ, 2012, CELL SIGNAL, V24, P1981, DOI 10.1016/j.cellsig.2012.07.006; Melendez AJ, 2001, CURR BIOL, V11, P869, DOI 10.1016/S0960-9822(01)00260-3; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; Modi S, 2011, CLIN CANCER RES, V17, P5132, DOI 10.1158/1078-0432.CCR-11-0072; Mohapatra B, 2013, BBA-MOL CELL RES, V1833, P122, DOI 10.1016/j.bbamcr.2012.10.010; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Munster PN, 2001, CLIN CANCER RES, V7, P2228; Neckers L, 2003, CURR MED CHEM, V10, P733, DOI 10.2174/0929867033457818; Nishimura M, 2009, MOL CELL BIOL, V29, P5529, DOI 10.1128/MCB.00375-09; Nishimura Y, 2006, HISTOCHEM CELL BIOL, V126, P627, DOI 10.1007/s00418-006-0198-x; Norambuena A, 2010, MOL BIOL CELL, V21, P2916, DOI 10.1091/mbc.E10-02-0167; Ohba S, 2010, J NEUROSURG, V112, P33, DOI 10.3171/2009.3.JNS081146; Ouyang XM, 1998, CARCINOGENESIS, V19, P2013, DOI 10.1093/carcin/19.11.2013; Padival AK, 2004, MOL CELL BIOCHEM, V258, P129, DOI 10.1023/B:MCBI.0000012847.86529.07; Park SK, 2001, J CELL BIOL, V154, P1245, DOI 10.1083/jcb.200104025; Pedersen NM, 2008, MOL CANCER RES, V6, P491, DOI 10.1158/1541-7786.MCR-07-0191; Rafn B, 2012, MOL CELL, V45, P764, DOI 10.1016/j.molcel.2012.01.029; Raja SM, 2008, CANCER BIOL THER, V7, P1629; Raja SM, 2011, CANCER BIOL THER, V11, P263, DOI 10.4161/cbt.11.2.13959; Recktenwald CV, 2012, J BIOL CHEM, V287, P24320, DOI 10.1074/jbc.M111.334425; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Rusin A, 2010, ACTA BIOCHIM POL, V57, P23; Salazar G, 2002, MOL BIOL CELL, V13, P1677, DOI 10.1091/mbc.01-08-0403; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Schweitzer JK, 2011, SEMIN CELL DEV BIOL, V22, P39, DOI 10.1016/j.semcdb.2010.09.002; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; Sidiropoulos PNM, 2012, BRAIN, V135, P1395, DOI 10.1093/brain/aws061; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; SORKIN A, 1993, ONCOGENE, V8, P3021; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Standaert ML, 1999, ENDOCRINOLOGY, V140, P2145, DOI 10.1210/en.140.5.2145; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; Tan M, 2006, ONCOGENE, V25, P3286, DOI 10.1038/sj.onc.1209361; Tonetti DA, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/740353; Tong JF, 2009, MOL CELL PROTEOMICS, V8, P2131, DOI 10.1074/mcp.M900148-MCP200; Vuong TT, 2013, EXP CELL RES, V319, P32, DOI 10.1016/j.yexcr.2012.10.010; Ursini-Siegel J, 2007, NAT REV CANCER, V7, P389, DOI 10.1038/nrc2127; Urtreger AJ, 2012, IUBMB LIFE, V64, P18, DOI 10.1002/iub.574; Vaidyanath A, 2011, J CELL MOL MED, V15, P2525, DOI 10.1111/j.1582-4934.2011.01277.x; Vartanian T, 1997, J CELL BIOL, V137, P211, DOI 10.1083/jcb.137.1.211; Wang XQ, 2007, CANCER RES, V67, P9986, DOI 10.1158/0008-5472.CAN-07-1300; Wang ZX, 1999, MOL BIOL CELL, V10, P1621, DOI 10.1091/mbc.10.5.1621; Ware MF, 1997, J BIOL CHEM, V272, P30185, DOI 10.1074/jbc.272.48.30185; Watanabe TM, 2007, BIOPHYS J, V92, P4109, DOI 10.1529/biophysj.106.094649; Waterman H, 1998, J BIOL CHEM, V273, P13819, DOI 10.1074/jbc.273.22.13819; Widakowich C, 2008, ANTI-CANCER AGENT ME, V8, P488, DOI 10.2174/187152008784533062; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Worthylake R, 1999, J BIOL CHEM, V274, P8865, DOI 10.1074/jbc.274.13.8865; Worthylake R, 1997, J BIOL CHEM, V272, P8594, DOI 10.1074/jbc.272.13.8594; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yang XL, 2005, MOL CELL NEUROSCI, V28, P335, DOI 10.1016/j.mcn.2004.10.001; Zeng LL, 2012, ADV EXP MED BIOL, V740, P639, DOI 10.1007/978-94-007-2888-2_28; Zhong CB, 2008, J NEUROSCI, V28, P9111, DOI 10.1523/JNEUROSCI.0381-08.2008; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200; Zhu WL, 2007, CANCER BIOL THER, V6, P1960, DOI 10.4161/cbt.6.12.4979; Zsebik B, 2006, IMMUNOL LETT, V104, P146, DOI 10.1016/j.imlet.2005.11.018; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	116	25	26	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30443	30458		10.1074/jbc.M114.608992	http://dx.doi.org/10.1074/jbc.M114.608992			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25225290	hybrid, Green Published			2022-12-28	WOS:000344549700025
J	Recht, L; Topfer, N; Batushansky, A; Sikron, N; Gibon, Y; Fait, A; Nikoloski, Z; Boussiba, S; Zarka, A				Recht, Lee; Toepfer, Nadine; Batushansky, Albert; Sikron, Noga; Gibon, Yves; Fait, Aaron; Nikoloski, Zoran; Boussiba, Sammy; Zarka, Aliza			Metabolite Profiling and Integrative Modeling Reveal Metabolic Constraints for Carbon Partitioning under Nitrogen Starvation in the Green Algae Haematococcus pluvialis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-AMINOBUTYRATE SHUNT; FLUX BALANCE ANALYSIS; CHLAMYDOMONAS-REINHARDTII; GAS-CHROMATOGRAPHY; ASTAXANTHIN ACCUMULATION; TRANSCRIPTOMIC ANALYSIS; BIOFUEL PRODUCTION; OXIDATIVE STRESS; HIGH IRRADIANCE; HIGHER-PLANTS	The green alga Hematococcus pluvialis accumulates large amounts of the antioxidant astaxanthin under inductive stress conditions, such as nitrogen starvation. The response to nitrogen starvation and high light leads to the accumulation of carbohydrates and fatty acids as well as increased activity of the tricarboxylic acid cycle. Although the behavior of individual pathways has been well investigated, little is known about the systemic effects of the stress response mechanism. Here we present time-resolved metabolite, enzyme activity, and physiological data that capture the metabolic response of H. pluvialis under nitrogen starvation and high light. The data were integrated into a putative genome-scale model of the green alga to in silico test hypotheses of underlying carbon partitioning. The model-based hypothesis testing reinforces the involvement of starch degradation to support fatty acid synthesis in the later stages of the stress response. In addition, our findings support a possible mechanism for the involvement of the increased activity of the tricarboxylic acid cycle in carbon repartitioning. Finally, the in vitro experiments and the in silico modeling presented here emphasize the predictive power of large scale integrative approaches to pinpoint metabolic adjustment to changing environments.	[Recht, Lee; Batushansky, Albert; Sikron, Noga; Fait, Aaron; Boussiba, Sammy; Zarka, Aliza] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol, IL-84990 Sede Boqer, Israel; [Toepfer, Nadine; Nikoloski, Zoran] Max Planck Inst Mol Plant Physiol, Syst Biol & Math Modeling Grp, D-14476 Potsdam, Germany; [Gibon, Yves] Univ Bordeaux, INRA, Bordeaux Metab Facil Bordeaux, UMR Fruit Biol & Pathol 1332, F-33140 Villenave Dornon, France	Ben Gurion University; Max Planck Society; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Boussiba, S (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol, IL-84990 Sede Boqer, Israel.	sammy@bgu.ac.il	Fait, Aaron/M-2869-2015	Fait, Aaron/0000-0002-9073-8441; Gibon, Yves/0000-0001-8161-1089; Nikoloski, Zoran/0000-0003-2671-6763; Zarka, Aliza/0000-0002-7381-254X; Boussiba, Sammy/0000-0001-9707-0811; Topfer, Nadine/0000-0002-3027-5799	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was financially supported by the European Commission's Seventh Framework Program for Research and Technology Development (FP7) projects GIAVAP and BIOFAT.	Amin S, 2009, ENERG CONVERS MANAGE, V50, P1834, DOI 10.1016/j.enconman.2009.03.001; Araujo WL, 2012, PLANT CELL ENVIRON, V35, P1, DOI 10.1111/j.1365-3040.2011.02332.x; Beer LL, 2009, CURR OPIN BIOTECH, V20, P264, DOI 10.1016/j.copbio.2009.06.002; Berges JA, 1996, PLANT PHYSIOL, V110, P689, DOI 10.1104/pp.110.2.689; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; BOROWITZKA MA, 1991, J APPL PHYCOL, V3, P295, DOI 10.1007/BF02392882; Bouche N, 2004, PLANT MOL BIOL, V55, P315, DOI 10.1007/s11103-004-0650-z; Bouche N, 2003, TRENDS CELL BIOL, V13, P607, DOI 10.1016/j.tcb.2003.10.001; Bouche N, 2003, P NATL ACAD SCI USA, V100, P6843, DOI 10.1073/pnas.1037532100; Boussiba S, 1999, BIOTECHNOL LETT, V21, P601, DOI 10.1023/A:1005507514694; BOUSSIBA S, 1991, PLANT CELL PHYSIOL, V32, P1077, DOI 10.1093/oxfordjournals.pcp.a078171; Boussiba S, 2000, PHYSIOL PLANTARUM, V108, P111, DOI 10.1034/j.1399-3054.2000.108002111x./; Bown AW, 1997, PLANT PHYSIOL, V115, P1, DOI 10.1104/pp.115.1.1; Boyle NR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-4; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Chang RL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.52; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; Courchesne NMD, 2009, J BIOTECHNOL, V141, P31, DOI 10.1016/j.jbiotec.2009.02.018; DUGGLEBY RG, 1973, PLANT PHYSIOL, V52, P312, DOI 10.1104/pp.52.4.312; ElSayed AI, 2014, PLANT BIOLOGY, V16, P1, DOI 10.1111/plb.12053; Erban Alexander, 2007, V358, P19, DOI 10.1007/978-1-59745-244-1_2; Fait A, 2008, TRENDS PLANT SCI, V13, P14, DOI 10.1016/j.tplants.2007.10.005; Fait A, 2009, PLANT METABOLIC NETWORKS, P151, DOI 10.1007/978-0-387-78745-9_6; Fan L, 1998, Z NATURFORSCH C, V53, P93; Gibon Y, 2004, PLANT CELL, V16, P3304, DOI 10.1105/tpc.104.025973; Gibon Y, 2009, PLANT CELL ENVIRON, V32, P859, DOI 10.1111/j.1365-3040.2009.01965.x; Goncalves EC, 2013, PLANTA, V238, P895, DOI 10.1007/s00425-013-1946-5; Goyal A, 2007, PLANT PHYSIOL BIOCH, V45, P705, DOI 10.1016/j.plaphy.2007.05.009; Gwak Y, 2014, J EXP BOT, V65, P4317, DOI 10.1093/jxb/eru206; Han DX, 2013, ALGAE-SEOUL, V28, P131, DOI 10.4490/algae.2013.28.2.131; Heinrich R., 1996, REGULATION CELLULAR; HEWITT BR, 1958, NATURE, V182, P246, DOI 10.1038/182246a0; Hockin NL, 2012, PLANT PHYSIOL, V158, P299, DOI 10.1104/pp.111.184333; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Kim DK, 2011, BIOTECHNOL BIOPROC E, V16, P698, DOI 10.1007/s12257-011-0081-z; Lee DY, 2012, MOL CELL PROTEOMICS, V11, P973, DOI 10.1074/mcp.M111.016733; Lemoine Y, 2010, PHOTOSYNTH RES, V106, P155, DOI 10.1007/s11120-010-9583-3; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Li YT, 2010, METAB ENG, V12, P387, DOI 10.1016/j.ymben.2010.02.002; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Ma Z, 2002, J BACTERIOL, V184, P7001, DOI 10.1128/JB.184.24.7001-7012.2002; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Mizuno Y, 2013, BIORESOURCE TECHNOL, V129, P150, DOI 10.1016/j.biortech.2012.11.030; Nunes-Nesi A, 2007, PLANT J, V50, P1093, DOI 10.1111/j.1365-313X.2007.03115.x; Obata T, 2013, METABOLITES, V3, P325, DOI 10.3390/metabo3020325; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; PAUNIER L, 1960, HELV CHIM ACTA, V43, P118, DOI 10.1002/hlca.19600430117; Peled E, 2011, LIPIDS, V46, P851, DOI 10.1007/s11745-011-3579-4; Piques M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.68; Rabbani S, 1998, PLANT PHYSIOL, V116, P1239, DOI 10.1104/pp.116.4.1239; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Rawsthorne S, 2002, PROG LIPID RES, V41, P182, DOI 10.1016/S0163-7827(01)00023-6; Recht L, 2012, APPL MICROBIOL BIOT, V94, P1495, DOI 10.1007/s00253-012-3940-4; Reynolds A.P., 2006, J MATH MODEL ALGORIT, V5, P475, DOI [DOI 10.1007/S10852-005-9022-1, 10.1007/s10852-005-9022-1]; Rismani-Yazdi H, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-74; ROE JH, 1955, J BIOL CHEM, V212, P335; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Rosenberg JN, 2008, CURR OPIN BIOTECH, V19, P430, DOI 10.1016/j.copbio.2008.07.008; Schoefs B, 2001, FEBS LETT, V500, P125, DOI 10.1016/S0014-5793(01)02596-0; Shelp BJ, 1999, TRENDS PLANT SCI, V4, P446, DOI 10.1016/S1360-1385(99)01486-7; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; SIREVAG R, 1972, J BIOL CHEM, V247, P2586; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Studart-Guimaraes C, 2007, PLANT PHYSIOL, V145, P626, DOI 10.1104/pp.107.103101; Sun TH, 2010, J INTEGR PLANT BIOL, V52, P868, DOI 10.1111/j.1744-7909.2010.00993.x; Sweetlove LJ, 2010, TRENDS PLANT SCI, V15, P462, DOI 10.1016/j.tplants.2010.05.006; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Tan S, 1995, J PHYCOL, V31, P897, DOI 10.1111/j.0022-3646.1995.00897.x; Wang SB, 2004, PLANTA, V220, P17, DOI 10.1007/s00425-004-1323-5; Wheeler MCG, 2005, PLANT PHYSIOL, V139, P39, DOI 10.1104/pp.105.065953; Wienkoop S, 2010, MOL BIOSYST, V6, P1018, DOI 10.1039/b920913a; Xiong W, 2010, PLANT PHYSIOL, V154, P1001, DOI 10.1104/pp.110.158956; Xu JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037438; YONG YYR, 1991, PHYCOLOGIA, V30, P257, DOI 10.2216/i0031-8884-30-3-257.1; Zhekisheva M, 2005, J PHYCOL, V41, P819, DOI 10.1111/j.0022-3646.2005.05015.x; Zhekisheva M, 2002, J PHYCOL, V38, P325, DOI 10.1046/j.1529-8817.2002.01107.x	80	79	81	3	96	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30387	30403		10.1074/jbc.M114.555144	http://dx.doi.org/10.1074/jbc.M114.555144			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25183014	Green Published, hybrid			2022-12-28	WOS:000344549700021
J	Arjunan, P; Wang, JJ; Nemeria, NS; Reynolds, S; Brown, I; Chandrasekhar, K; Calero, G; Jordan, F; Furey, W				Arjunan, Palaniappa; Wang, Junjie; Nemeria, Natalia S.; Reynolds, Shelley; Brown, Ian; Chandrasekhar, Krishnamoorthy; Calero, Guillermo; Jordan, Frank; Furey, William			Novel Binding Motif and New Flexibility Revealed by Structural Analyses of a Pyruvate Dehydrogenase-Dihydrolipoyl Acetyltransferase Subcomplex from the Escherichia coli Pyruvate Dehydrogenase Multienzyme Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Metabolism; Protein Assembly; Protein Complex; Pyruvate Dehydrogenase Complex (PDC); X-ray Crystallography; E1p-E2p Binding; Hydrogen; Deuterium (H; D) Exchange Mass Spectrometry	N-TERMINAL DOMAIN; E1 COMPONENT; LIPOYL DOMAIN; REDUCTIVE ACETYLATION; SUBUNIT; PROTEIN; E2; LOOP; DETERMINANTS; SPECIFICITY	Background: The E. coli pyruvate dehydrogenase complex containing E1p, E2p, and E3 components converts pyruvate to acetyl-CoA. Results: The E1p-E2p subcomplex revealed a novel binding motif relative to the only other known example. Conclusion: Tethering of E1p to E2p depends on the (2) or (22) assembly of E1p. Significance: The new tethering mode should affect overall complex assembly in all such complexes from Gram-negative bacteria. The Escherichia coli pyruvate dehydrogenase multienzyme complex contains multiple copies of three enzymatic components, E1p, E2p, and E3, that sequentially carry out distinct steps in the overall reaction converting pyruvate to acetyl-CoA. Efficient functioning requires the enzymatic components to assemble into a large complex, the integrity of which is maintained by tethering of the displaced, peripheral E1p and E3 components to the E2p core through non-covalent binding. We here report the crystal structure of a subcomplex between E1p and an E2p didomain containing a hybrid lipoyl domain along with the peripheral subunit-binding domain responsible for tethering to the core. In the structure, a region at the N terminus of each subunit in the E1p homodimer previously unseen due to crystallographic disorder was observed, revealing a new folding motif involved in E1p-E2p didomain interactions, and an additional, unexpected, flexibility was discovered in the E1p-E2p didomain subcomplex, both of which probably have consequences in the overall multienzyme complex assembly. This represents the first structure of an E1p-E2p didomain subcomplex involving a homodimeric E1p, and the results may be applicable to a large range of complexes with homodimeric E1 components. Results of HD exchange mass spectrometric experiments using the intact, wild type 3-lipoyl E2p and E1p are consistent with the crystallographic data obtained from the E1p-E2p didomain subcomplex as well as with other biochemical and NMR data reported from our groups, confirming that our findings are applicable to the entire E1p-E2p assembly.	[Arjunan, Palaniappa; Chandrasekhar, Krishnamoorthy; Furey, William] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Reynolds, Shelley; Brown, Ian; Calero, Guillermo] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA; [Wang, Junjie; Nemeria, Natalia S.; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA; [Furey, William] Vet Adm Med Ctr, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rutgers State University Newark; Rutgers State University New Brunswick; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Jordan, F (corresponding author), Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA.	frjordan@rutgers.edu; fureyw@pitt.edu	Wang, Junjie/K-7509-2014	Wang, Junjie/0000-0002-0587-2209	National Institutes of Health [GM061791, GM050380]; Veterans Affairs Merit Review; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061791, R01GM050380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM061791 (to W. F.) and GM050380 (to F. J.). This work was also supported by a Veterans Affairs Merit Review (to W. F.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALI ST, 1990, BIOCHEM J, V271, P139, DOI 10.1042/bj2710139; Arjunan P, 2002, BIOCHEMISTRY-US, V41, P5213, DOI 10.1021/bi0118557; Arjunan P, 2004, BIOCHEMISTRY-US, V43, P2405, DOI 10.1021/bi030200y; Arjunan P, 2006, J BIOL CHEM, V281, P15296, DOI 10.1074/jbc.M600656200; Balakrishnan A, 2012, J AM CHEM SOC, V134, P18644, DOI 10.1021/ja3062375; BLEILE DM, 1979, P NATL ACAD SCI USA, V76, P4385, DOI 10.1073/pnas.76.9.4385; Brautigam CA, 2006, STRUCTURE, V14, P611, DOI 10.1016/j.str.2006.01.001; Brautigam CA, 2011, J BIOL CHEM, V286, P23476, DOI 10.1074/jbc.M110.202960; Bricogne G., 2011, BUSTER VERSION 2 10; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chandrasekhar K, 2006, ACTA CRYSTALLOGR D, V62, P1382, DOI 10.1107/S0907444906034408; Chandrasekhar K, 2013, J BIOL CHEM, V288, P15402, DOI 10.1074/jbc.M113.466789; Ciszak EM, 2006, J BIOL CHEM, V281, P648, DOI 10.1074/jbc.M507850200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank RAW, 2005, STRUCTURE, V13, P1119, DOI 10.1016/j.str.2005.04.021; Frank RAW, 2007, J MOL BIOL, V368, P639, DOI 10.1016/j.jmb.2007.01.080; Hamuro Y, 2008, RAPID COMMUN MASS SP, V22, P1041, DOI 10.1002/rcm.3467; Hengeveld AF, 2002, FEBS LETT, V522, P173, DOI 10.1016/S0014-5793(02)02931-9; Hengeveld AF, 2002, BIOCHEMISTRY-US, V41, P7490, DOI 10.1021/bi012172u; Izard T, 1999, P NATL ACAD SCI USA, V96, P1240, DOI 10.1073/pnas.96.4.1240; Jones DD, 2008, BIOCHEM J, V409, P357, DOI 10.1042/BJ20071119; Jones DD, 2000, J MOL BIOL, V295, P289, DOI 10.1006/jmbi.1999.3335; Jones DD, 2001, J MOL BIOL, V305, P49, DOI 10.1006/jmbi.2000.4257; Jordan F, 2003, J AM CHEM SOC, V125, P12732, DOI 10.1021/ja0346126; Jordan F, 2009, J MOL CATAL B-ENZYM, V61, P14, DOI 10.1016/j.molcatb.2009.04.008; Kale S, 2007, J BIOL CHEM, V282, P28106, DOI 10.1074/jbc.M704326200; Kavan D, 2011, INT J MASS SPECTROM, V302, P53, DOI 10.1016/j.ijms.2010.07.030; Mande SS, 1996, STRUCTURE, V4, P277, DOI 10.1016/S0969-2126(96)00032-9; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nakai T, 2008, J BIOCHEM, V143, P747, DOI 10.1093/jb/mvn033; Nambi S, 2012, J BIOL CHEM, V287, P18115, DOI 10.1074/jbc.M111.328112; Nemeria N, 2002, BIOCHEMISTRY-US, V41, P15459, DOI 10.1021/bi0205909; Nemeria NS, 2010, J BIOL CHEM, V285, P11197, DOI 10.1074/jbc.M109.069179; Park YH, 2004, BIOCHEMISTRY-US, V43, P14037, DOI 10.1021/bi049027b; Pascal BD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-156; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; Song JY, 2012, BIOCHEMISTRY-US, V51, P2795, DOI 10.1021/bi201614n; Song JY, 2010, J BIOL CHEM, V285, P4680, DOI 10.1074/jbc.M109.082842; STEPHENS PE, 1983, EUR J BIOCHEM, V133, P481, DOI 10.1111/j.1432-1033.1983.tb07490.x; Wallis NG, 1996, J MOL BIOL, V263, P463, DOI 10.1006/jmbi.1996.0589; Wang JJ, 2014, J BIOL CHEM, V289, P15215, DOI 10.1074/jbc.M113.544080; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; Yi JZ, 1996, J BIOL CHEM, V271, P33192, DOI 10.1074/jbc.271.52.33192	48	13	15	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					30161	30176		10.1074/jbc.M114.592915	http://dx.doi.org/10.1074/jbc.M114.592915			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25210042	hybrid, Green Published			2022-12-28	WOS:000344370800054
J	Czirjak, G; Enyedi, P				Czirjak, Gabor; Enyedi, Peter			The LQLP Calcineurin Docking Site Is a Major Determinant of the Calcium-dependent Activation of Human TRESK Background K+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcineurin; Calcium; Ion Channel; Potassium Channel; Protein Phosphatase 2B (PP2B); K2P; KCNK18; PXIXIT; Two-pore Domain	POTASSIUM CHANNEL; SENSORY NEURONS; NFAT; DOMAIN; BINDING; SUBSTRATE; CURRENTS; PEPTIDE; PHOSPHORYLATION; PHOSPHATASE	Background: Calcium-dependent activation of TRESK is mediated by calcineurin. Results: The sensitivity of human TRESK to calcium is determined by the LQLP calcineurin-docking site. Conclusion: The previously known PQIIIS and the novel LQLP sites cooperate for the regulation. Significance: TRESK-induced hyperpolarization of the membrane potential is influenced by the LQLP-calcineurin interaction. Calcium-dependent activation of human TRESK (TWIK-related spinal cord K+ channel, K2P18.1) depends on direct targeting of calcineurin to the PQIIIS motif. In the present study we demonstrate that TRESK also contains another functionally relevant docking site for the phosphatase, the LQLP amino acid sequence. Combined mutations of the PQIIIS and LQLP motifs were required to eliminate the calcium-dependent regulation of the channel. In contrast to the alanine substitutions of PQIIIS, the mutation of LQLP to AQAP alone did not significantly change the amplitude of TRESK activation evoked by the substantial elevation of cytoplasmic calcium concentration. However, the AQAP mutation slowed down the response to high calcium. In addition, modest elevation of [Ca2+], which effectively regulated the wild type channel, failed to activate TRESK-AQAP. This indicates that the AQAP mutation diminished the sensitivity of TRESK to calcium. Even if PQIIIS was replaced by the PVIVIT sequence of high calcineurin binding affinity, the effect of the AQAP mutation was clearly detected in this TRESK-PVIVIT context. Substitution of the LQLP region with the corresponding fragment of NFAT transcription factor, perfectly matching the previously described LXVP calcineurin-binding consensus sequence, increased the calcium-sensitivity of TRESK-PVIVIT. Thus the enhancement of the affinity of TRESK for calcineurin by the incorporation of PVIVIT could not compensate for or prevent the effects of LQLP sequence modifications, suggesting that the two calcineurin-binding regions play distinct roles in the regulation. Our results indicate that the LQLP site is a fundamental determinant of the calcium-sensitivity of human TRESK.	[Czirjak, Gabor; Enyedi, Peter] Semmelweis Univ, Dept Physiol, H-1444 Budapest, Hungary	Semmelweis University	Czirjak, G (corresponding author), Semmelweis Univ, Dept Physiol, POB 259, H-1444 Budapest, Hungary.	czirjak.gabor@med.semmelweis-univ.hu		Czirjak, Gabor/0000-0002-5485-2327	Hungarian National Research Fund [OTKA K108496]	Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Hungarian National Research Fund (OTKA K108496).	Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; BLUMENTHAL DK, 1986, J BIOL CHEM, V261, P8140; Braun G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028119; Chae YJ, 2010, ANESTHESIOLOGY, V113, P1326, DOI 10.1097/ALN.0b013e3181f90ca5; Czirjak B, 2004, J BIOL CHEM, V279, P18550, DOI 10.1074/jbc.M312229200; Czirjak G, 2008, J BIOL CHEM, V283, P15672, DOI 10.1074/jbc.M800712200; Czirjak G, 2006, J BIOL CHEM, V281, P14677, DOI 10.1074/jbc.M602495200; Czirjak G, 2010, J BIOL CHEM, V285, P14549, DOI 10.1074/jbc.M110.102020; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Dougherty MK, 2009, MOL CELL, V34, P652, DOI 10.1016/j.molcel.2009.06.001; Enyedi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097854; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Garcia-Cozar FJ, 1998, J BIOL CHEM, V273, P23877, DOI 10.1074/jbc.273.37.23877; Grigoriu S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001492; Guo ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087029; Kang D, 2008, BIOCHEM BIOPH RES CO, V367, P609, DOI 10.1016/j.bbrc.2008.01.008; Kang D, 2006, AM J PHYSIOL-CELL PH, V291, pC138, DOI 10.1152/ajpcell.00629.2005; Lafreniere RG, 2010, NAT MED, V16, P1157, DOI 10.1038/nm.2216; Li HM, 2007, J MOL BIOL, V369, P1296, DOI 10.1016/j.jmb.2007.04.032; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Liu J, 1999, J IMMUNOL, V162, P4755; Liu J, 2001, J IMMUNOL, V167, P2677, DOI 10.4049/jimmunol.167.5.2677; Liu P, 2013, J NEUROSCI, V33, P12810, DOI 10.1523/JNEUROSCI.1237-13.2013; Lotshaw DP, 2007, CELL BIOCHEM BIOPHYS, V47, P209, DOI 10.1007/s12013-007-0007-8; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Marsh B, 2012, MOL CELL NEUROSCI, V49, P375, DOI 10.1016/j.mcn.2012.01.002; Martinez-Martinez S, 2006, J BIOL CHEM, V281, P6227, DOI 10.1074/jbc.M513885200; Mathie A, 2010, J PHYSIOL-LONDON, V588, P3149, DOI 10.1113/jphysiol.2010.192344; Mathie A, 2010, J PHARM PHARMACOL, V62, P1089, DOI 10.1111/j.2042-7158.2010.01131.x; Mehta S, 2009, MOL CELL BIOL, V29, P2777, DOI 10.1128/MCB.01197-08; Noel J, 2011, CHANNELS, V5, P400, DOI 10.4161/chan.5.5.16469; Park S, 2000, P NATL ACAD SCI USA, V97, P7130, DOI 10.1073/pnas.97.13.7130; Plant LD, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00021; Rahm AK, 2014, N-S ARCH PHARMACOL, V387, P291, DOI 10.1007/s00210-013-0945-1; Rodriguez A, 2009, MOL CELL, V33, P616, DOI 10.1016/j.molcel.2009.01.030; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Slupe AM, 2013, J BIOL CHEM, V288, P12353, DOI 10.1074/jbc.M113.459677; Thurman CL, 2000, CELL SIGNAL, V12, P629, DOI 10.1016/S0898-6568(00)00106-6; Tulleuda A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-30; Yoo S, 2009, NEUROSCI LETT, V465, P79, DOI 10.1016/j.neulet.2009.08.062; YOSHIDA S, 1992, J PHYSIOL-LONDON, V458, P307, DOI 10.1113/jphysiol.1992.sp019419; Zhou J, 2013, NEUROREPORT, V24, P131, DOI 10.1097/WNR.0b013e32835d8431	44	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29506	29518		10.1074/jbc.M114.577684	http://dx.doi.org/10.1074/jbc.M114.577684			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25202008	Green Published, hybrid			2022-12-28	WOS:000344370800004
J	Koike-Takeshita, A; Mitsuoka, K; Taguchi, H				Koike-Takeshita, Ayumi; Mitsuoka, Kaoru; Taguchi, Hideki			Asp-52 in Combination with Asp-398 Plays a Critical Role in ATP Hydrolysis of Chaperonin GroEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; Chaperone; Protein Aggregation; Protein Folding; Protein Misfolding; Chaperonin; GroEL; GroES	CRYSTAL-STRUCTURE; SUBSTRATE PROTEIN; ESCHERICHIA-COLI; COMPLEXES; RINGS; CYCLE; BINDING; FORMS; TIMER	Background: Chaperonin GroEL(D398A) is known to slow down the ATP hydrolysis. Results: ATPase activity of GroEL(D52A) and GroEL(D52A/D398A) mutants are approximate to 20% and < 0.01% of wild-type GroEL, respectively. Conclusion: Asp-52 plays a critical role for ATP hydrolysis of GroEL. Significance: GroEL(D52A/D398A) forms a stable symmetric GroEL-GroES complex, providing a good model to characterize the complex in detail. The Escherichia coli chaperonin GroEL is a double-ring chaperone that assists protein folding with the aid of GroES and ATP. Asp-398 in GroEL is known as one of the critical residues on ATP hydrolysis because GroEL(D398A) mutant is deficient in ATP hydrolysis (<2% of the wild type) but not in ATP binding. In the archaeal Group II chaperonin, another aspartate residue, Asp-52 in the corresponding E. coli GroEL, in addition to Asp-398 is also important for ATP hydrolysis. We investigated the role of Asp-52 in GroEL and found that ATPase activity of GroEL(D52A) and GroEL(D52A/D398A) mutants was approximate to 20% and <0.01% of wild-type GroEL, respectively, indicating that Asp-52 in E. coli GroEL is also involved in the ATP hydrolysis. GroEL(D52A/D398A) formed a symmetric football-shaped GroEL-GroES complex in the presence of ATP, again confirming the importance of the symmetric complex during the GroEL ATPase cycle. Notably, the symmetric complex of GroEL(D52A/D398A) was extremely stable, with a half-time of approximate to 150 h (approximate to 6 days), providing a good model to characterize the football-shaped complex.	[Koike-Takeshita, Ayumi] Kanagawa Inst Technol, Dept Appl Biosci, Atsugi, Kanagawa 2430292, Japan; [Mitsuoka, Kaoru] AIST, Technol Res Assoc Next Generat Nat Prod Chem, Koto Ku, Tokyo 1350064, Japan; [Taguchi, Hideki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Kanagawa Institute Technology; National Institute of Advanced Industrial Science & Technology (AIST); Tokyo Institute of Technology	Taguchi, H (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, B-56,4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	taguchi@bio.titech.ac.jp	Taguchi, Hideki/B-6946-2009; taguchi, hideki/AAM-2663-2021	Taguchi, Hideki/0000-0002-6612-9339; taguchi, hideki/0000-0002-6612-9339; Mitsuoka, Kaoru/0000-0003-1782-675X	Japan Society for the Promotion of Science [20870035, 19058002, 17049009]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Uehara Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by Grants-in-aid for Scientific Research 20870035 (to A. K.-T.) and 19058002 and 17049009 (to H. T.) from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This work was also supported by a grant from the Takeda Science Foundation (to H. T.) and the Uehara Memorial Foundation (to H. T.).	AZEM A, 1994, SCIENCE, V265, P653, DOI 10.1126/science.7913553; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Chaudhry C, 2004, J MOL BIOL, V342, P229, DOI 10.1016/j.jmb.2004.07.015; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; Grallert H, 2001, J STRUCT BIOL, V135, P95, DOI 10.1006/jsbi.2001.4387; Grason JP, 2008, P NATL ACAD SCI USA, V105, P17339, DOI 10.1073/pnas.0807418105; Jewett AI, 2010, CELL MOL LIFE SCI, V67, P255, DOI 10.1007/s00018-009-0164-6; Kanzaki T, 2008, J BIOL CHEM, V283, P34773, DOI 10.1074/jbc.M805303200; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Koike-Takeshita A, 2006, J BIOL CHEM, V281, P962, DOI 10.1074/jbc.M506298200; Koike-Takeshita A, 2008, J BIOL CHEM, V283, P23774, DOI 10.1074/jbc.M802542200; Koike-Takeshita A, 2014, J MOL BIOL, V426, P3634, DOI 10.1016/j.jmb.2014.08.017; LLORCA O, 1994, FEBS LETT, V345, P181, DOI 10.1016/0014-5793(94)00432-3; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Saibil HR, 2013, J MOL BIOL, V425, P1476, DOI 10.1016/j.jmb.2012.11.028; SCHMIDT M, 1994, SCIENCE, V265, P656, DOI 10.1126/science.7913554; Shomura Y, 2004, J MOL BIOL, V335, P1265, DOI 10.1016/j.jmb.2003.11.028; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1129, DOI 10.3891/acta.chem.scand.07-1129; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; Taguchi H, 2005, J BIOCHEM, V137, P543, DOI 10.1093/jb/mvi069; Taguchi H, 2004, J BIOL CHEM, V279, P45737, DOI 10.1074/jbc.M406795200; TAGUCHI H, 1991, J BIOL CHEM, V266, P22411; TAGUCHI H, 1995, FEBS LETT, V359, P195, DOI 10.1016/0014-5793(95)00041-7; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; Wang J, 2003, J MOL BIOL, V327, P843, DOI 10.1016/S0022-2836(03)00184-0; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yebenes H, 2011, TRENDS BIOCHEM SCI, V36, P424, DOI 10.1016/j.tibs.2011.05.003	38	7	7	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					30005	30011		10.1074/jbc.M114.593822	http://dx.doi.org/10.1074/jbc.M114.593822			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25202010	Green Published, hybrid			2022-12-28	WOS:000344370800041
J	Mobasher, MA; de Toro-Martin, J; Gonzalez-Rodriguez, A; Ramos, S; Letzig, LG; James, LP; Muntane, J; Alvarez, C; Valverde, AM				Ahmed Mobasher, Maysa; de Toro-Martin, Juan; Gonzalez-Rodriguez, Agueda; Ramos, Sonia; Letzig, Lynda G.; James, Laura P.; Muntane, Jordi; Alvarez, Carmen; Valverde, Angela M.			Essential Role of Protein-tyrosine Phosphatase 1B in the Modulation of Insulin Signaling by Acetaminophen in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; RECEPTOR; GLUCOSE; SENSITIVITY; RESISTANCE; KINASE; LIVER; PHOSPHORYLATION; ROSIGLITAZONE; ACTIVATION	Many drugs are associated with the development of glucose intolerance or deterioration in glycemic control in patients with pre-existing diabetes. We have evaluated the cross-talk between signaling pathways activated by acetaminophen (APAP) and insulin signaling in hepatocytes with or without expression of the protein-tyrosine phosphatase 1B (PTP1B) and in wild-type and PTP1B-deficient mice chronically treated with APAP. Human primary hepatocytes, Huh7 hepatoma cells with silenced PTP1B, mouse hepatocytes from wild-type and PTP1B-deficient mice, and a mouse model of chronic APAP treatment were used to examine the mechanisms involving PTP1B in the effects of APAP on glucose homeostasis and hepatic insulin signaling. In APAP-treated human hepatocytes at concentrations that did not induce death, phosphorylation of JNK and PTP1B expression and enzymatic activity were increased. APAP pretreatment inhibited activation of the early steps of insulin signaling and decreased Akt phosphorylation. The effects of APAP in insulin signaling were prevented by suramin, a PTP1B inhibitor, or rosiglitazone that decreased PTP1B levels. Likewise, PTP1B deficiency in human or mouse hepatocytes protected against APAP-mediated impairment in insulin signaling. These signaling pathways were modulated in mice with chronic APAP treatment, resulting in protection against APAP-mediated hepatic insulin resistance and alterations in islet alpha/beta cell ratio in PTP1B(-/-) mice. Our results demonstrate negative cross-talk between signaling pathways triggered by APAP and insulin signaling in hepatocytes, which is in part mediated by PTP1B. Moreover, our in vivo data suggest that chronic use of APAP may be associated with insulin resistance in the liver.	[Ahmed Mobasher, Maysa; Gonzalez-Rodriguez, Agueda; Valverde, Angela M.] UAM, CSIC, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain; [Ahmed Mobasher, Maysa; de Toro-Martin, Juan; Gonzalez-Rodriguez, Agueda; Alvarez, Carmen; Valverde, Angela M.] Inst Salid Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid 28029, Spain; [de Toro-Martin, Juan; Alvarez, Carmen] Univ Complutense Madrid, Fac Farm, Dept Bioquim & Biol Mol 2, Madrid 28034, Spain; [Ramos, Sonia] CSIC, ICTAN, E-28040 Madrid, Spain; [Letzig, Lynda G.; James, Laura P.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Muntane, Jordi] Univ Seville, CSIC, Dept Gen Surg, Inst Biomed Seville,Hosp Univ Virgen del Rocio, Seville 41013, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN); University of Arkansas System; University of Arkansas Medical Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Valverde, AM (corresponding author), Inst Invest Biomed Alberto Sols, C Arturo Duperier 4, Madrid 28029, Spain.	avalverde@iib.uam.es	Álvarez, Carmen/B-2582-2015; Ramos, Sonia/K-4594-2012; Gonzalez-Rodriguez, Agueda/D-7651-2012	Álvarez, Carmen/0000-0003-1874-1045; Ramos, Sonia/0000-0003-2649-2616; Martinez Valverde, Angela/0000-0003-1192-9045; Gonzalez-Rodriguez, Agueda/0000-0001-6559-0847; Gonzalez-Rodriguez, Agueda/0000-0003-2851-2318	Ministerio de Economia y Competitividad [SAF2012-33283, BFU2011-25420, AGL2010-17579]; Comunidad de Madrid Grant [S2010/BMD-2423]; European Foundation for the Study of Diabetes; Amylin Paul Langerhans Grant; Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas); Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas; Instituto de Salud Carlos III [PI09/0185]; Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (Instituto de Salud Carlos III) post-doctoral contract	Ministerio de Economia y Competitividad(Spanish Government); Comunidad de Madrid Grant(Comunidad de Madrid); European Foundation for the Study of Diabetes; Amylin Paul Langerhans Grant; Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas); Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (Instituto de Salud Carlos III) post-doctoral contract	This work was supported by Grants SAF2012-33283, BFU2011-25420, and AGL2010-17579 from the Ministerio de Economia y Competitividad, Comunidad de Madrid Grant S2010/BMD-2423, European Foundation for the Study of Diabetes and Amylin Paul Langerhans Grant, Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas), Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas, and Grant PI09/0185 from Instituto de Salud Carlos III.; Supported by a Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (Instituto de Salud Carlos III) post-doctoral contract.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Alia M, 2006, TOXICOL APPL PHARM, V212, P110, DOI 10.1016/j.taap.2005.07.014; Amacher DE, 2011, TOXICOLOGY, V279, P10, DOI 10.1016/j.tox.2010.10.006; Archuleta TL, 2009, FREE RADICAL BIO MED, V47, P1486, DOI 10.1016/j.freeradbiomed.2009.08.014; Arias E, 2009, NATL VITAL STADISTIC, V62, P1; Bhattarai BR, 2009, BIOORG MED CHEM LETT, V19, P6161, DOI 10.1016/j.bmcl.2009.09.020; Chakkera HA, 2013, TRANSPLANTATION, V95, P647, DOI 10.1097/TP.0b013e31826e592e; Combs AP, 2005, J MED CHEM, V48, P6544, DOI 10.1021/jm0504555; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; D'Apolito M, 2010, J CLIN INVEST, V120, P203, DOI 10.1172/JCI37672; D'Cruz SC, 2012, REPROD SCI, V19, P163, DOI 10.1177/1933719111415547; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fernandez E, 2006, AM J PHYSIOL-ENDOC M, V291, pE913, DOI 10.1152/ajpendo.00638.2005; Fernandez-Millan E, 2013, DIABETOLOGIA, V56, P1098, DOI 10.1007/s00125-013-2862-8; Gonzalez-Rodriguez A, 2007, ENDOCRINOLOGY, V148, P594, DOI 10.1210/en.2006-0644; Gonzalez-Rodriguez A, 2012, AGING CELL, V11, P284, DOI 10.1111/j.1474-9726.2011.00786.x; Gonzalez-Rodriguez A, 2010, DIABETES, V59, P588, DOI 10.2337/db09-0796; Graham GG, 2005, DRUG SAFETY, V28, P227, DOI 10.2165/00002018-200528030-00004; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Habegger KM, 2013, DIABETES, V62, P1453, DOI 10.2337/db12-1116; Haj FG, 2005, J BIOL CHEM, V280, P15038, DOI 10.1074/jbc.M413240200; Hernandez R, 2004, DIABETOLOGIA, V47, P1615, DOI 10.1007/s00125-004-1503-7; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Khandoudi N, 2002, DIABETES, V51, P1507, DOI 10.2337/diabetes.51.5.1507; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kushner JA, 2004, DIABETES, V53, P61, DOI 10.2337/diabetes.53.1.61; Leng SH, 2010, J ENDOCRINOL, V206, P171, DOI 10.1677/JOE-09-0456; McCain DF, 2004, J BIOL CHEM, V279, P14713, DOI 10.1074/jbc.M312488200; Mobasher MA, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.150; Muldrew KL, 2002, DRUG METAB DISPOS, V30, P446, DOI 10.1124/dmd.30.4.446; NEWTON JF, 1986, J PHARMACOL EXP THER, V237, P519; Owen C, 2013, DIABETOLOGIA, V56, P2286, DOI 10.1007/s00125-013-2992-z; Pichard Lydiane, 2006, Methods Mol Biol, V320, P283; Pillon NJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE453, DOI 10.1152/ajpendo.00553.2012; Piwkowska A, 2012, BIOCHEM BIOPH RES CO, V428, P167, DOI 10.1016/j.bbrc.2012.10.033; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Rumack BH, 2004, HEPATOLOGY, V40, P10, DOI 10.1002/hep.20300; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Scheen AJ, 2007, DIABETES METAB, V33, P169, DOI 10.1016/j.diabet.2007.01.003; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; THUMMEL KE, 1993, BIOCHEM PHARMACOL, V45, P1563, DOI 10.1016/0006-2952(93)90295-8; WELDER AA, 1995, TOXICOL APPL PHARM, V133, P328, DOI 10.1006/taap.1995.1158; Wilding JPH, 2012, DIABETES OBES METAB, V14, P973, DOI 10.1111/j.1463-1326.2012.01601.x; Yoon SY, 2010, NEUROBIOL DIS, V40, P449, DOI 10.1016/j.nbd.2010.07.005; Zabolotny JM, 2008, J BIOL CHEM, V283, P14230, DOI 10.1074/jbc.M800061200; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X	47	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29406	29419		10.1074/jbc.M113.539189	http://dx.doi.org/10.1074/jbc.M113.539189			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25204659	hybrid, Green Published			2022-12-28	WOS:000344141000052
J	Kauffenstein, G; Pelletier, J; Lavoie, EG; Kukulski, F; Martin-Satue, M; Dufresne, SS; Frenette, J; Furstenau, CR; Sereda, MJ; Toutain, B; Henrion, D; Sullivan, R; Vial, C; Sevigny, J				Kauffenstein, Gilles; Pelletier, Julie; Lavoie, Elise G.; Kukulski, Filip; Martin-Satue, Mireia; Dufresne, Sebastien S.; Frenette, Jerome; Fuerstenau, Cristina Ribas; Sereda, Michal J.; Toutain, Bertrand; Henrion, Daniel; Sullivan, Robert; Vial, Catherine; Sevigny, Jean			Nucleoside Triphosphate Diphosphohydrolase-1 Ectonucleotidase Is Required for Normal Vas Deferens Contraction and Male Fertility through Maintaining P2X1 Receptor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE REPRODUCTIVE-TRACT; SMOOTH-MUSCLE; GUINEA-PIG; P2X(1) RECEPTOR; PURINERGIC NEUROTRANSMISSION; ECTO-ATPASE; CELLS; MOUSE; ACTIVATION; EXPRESSION	In this work, we report that Entpd1(-/-) mice, deficient for the ectonucleotidase nucleoside triphosphate diphosphohydrolase-1 (NTPDase1), produce smaller litters (27% reduction) compared with wild-type C57BL6 animals. This deficit is linked to reduced in vivo oocyte fertilization by Entpd1(-/-) males (61 +/- 11% versus 88 +/- 7% for Entpd1(-/-)). Normal epididymal sperm count, spermatozoa morphology, capacitation, and motility and reduced ejaculated sperm number (2.4 +/- 0.5 versus 3.7 +/- 0.4 million for Entpd1(-/-)) pointed to vas deferens dysfunction. NTPDase1 was localized by immunofluorescence in the tunica muscularis of the vas deferens. Its absence resulted in a major ATP hydrolysis deficiency, as observed in situ by histochemistry and in primary smooth muscle cell cultures. In vitro, Entpd1(-/-) vas deferens displayed an exacerbated contraction to ATP, a diminished response to its non-hydrolysable analog alpha beta MeATP, and a reduced contraction to electrical field stimulation, suggesting altered P2X1 receptor function with a propensity to desensitize. This functional alteration was accompanied by a 3-fold decrease in P2X1 protein expression in Entpd1(-/-) vas deferens with no variation in mRNA levels. Accordingly, exogenous nucleotidase activity was required to fully preserve P2X1 receptor activation by ATP in vitro. Our study demonstrates that NTPDase1 is required to maintain normal P2X1 receptor functionality in the vas deferens and that its absence leads to impaired peristalsis, reduced spermatozoa concentration in the semen, and, eventually, reduced fertility. This suggests that alteration of NTPDase1 activity affects ejaculation efficacy and male fertility. This work may contribute to unveil a cause of infertility and open new therapeutic potentials.	[Kauffenstein, Gilles; Lavoie, Elise G.; Kukulski, Filip; Martin-Satue, Mireia; Fuerstenau, Cristina Ribas; Sevigny, Jean] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1V 0A6, Canada; [Kauffenstein, Gilles; Pelletier, Julie; Lavoie, Elise G.; Kukulski, Filip; Martin-Satue, Mireia; Dufresne, Sebastien S.; Frenette, Jerome; Fuerstenau, Cristina Ribas; Sullivan, Robert; Sevigny, Jean] Ctr Hosp Univ Quebec, Ctr Rech, Quebec City, PQ G1V 4G2, Canada; [Kauffenstein, Gilles; Toutain, Bertrand; Henrion, Daniel] Univ Angers, CNRS, Unite Mixte Rech 6214, INSERM,U1083, F-49045 Angers, France; [Martin-Satue, Mireia] Univ Barcelona, Fac Med, Dept Patol & Terapeut Expt, Barcelona 08907, Spain; [Dufresne, Sebastien S.; Frenette, Jerome] Univ Laval, Fac Med, Dept Readaptat, Quebec City, PQ G1V 0A6, Canada; [Sereda, Michal J.; Vial, Catherine] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Sullivan, Robert] Univ Laval, Fac Med, Dept Obstet Gynecol & Reprod, Quebec City, PQ G1V 0A6, Canada	Laval University; Laval University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; University of Barcelona; Laval University; University of Leicester; Laval University	Kauffenstein, G (corresponding author), CNRS, UMR 6214, INSERM 1083, UFR Sci Med, Rue Haute Reculee, F-49045 Angers, France.	gilles.kauffenstein@gmail.com; Jean.Sevigny@crchul.ulaval.ca	Dufresne, Sebastien S./AAL-7005-2021; Henrion, Daniel/AAK-1995-2021; Henrion, Daniel/J-8141-2015; Kauffenstein, Gilles/K-2867-2015; Sévigny, Jean/AGH-9323-2022; Henrion, Daniel/N-7023-2015; Sevigny, Jean/E-8039-2012; Toutain, Bertrand/M-1982-2015	Dufresne, Sebastien S./0000-0001-5924-7962; Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; Kauffenstein, Gilles/0000-0003-4994-8305; Sévigny, Jean/0000-0003-2922-1600; Henrion, Daniel/0000-0003-1094-0285; Sevigny, Jean/0000-0003-2922-1600; Toutain, Bertrand/0000-0002-7571-4062; Frenette, Jerome/0000-0002-4308-9418	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Canada; CIHR; Canadian Stroke Network; Fonds de Recherche en Sante du Quebec (FRSQ); CAPES (Brazilian Ministry of Education); Fonds de Recherche du Quebec-Sante (FRQS)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Stroke Network; Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); CAPES (Brazilian Ministry of Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fonds de Recherche du Quebec-Sante (FRQS)	This work was supported by Canadian Institutes of Health Research (CIHR) grants (to J. S.).; Recipient of a fellowship from the Heart and Stroke Foundation of Canada in partnership with the CIHR and the Canadian Stroke Network. To whom correspondence may be addressed: UMR CNRS 6214 - INSERM 1083, UFR Sciences Medicales, Rue Haute de Reculee, 49045 Angers cedex, France. Tel.: 33-2-41-73-58-77; Fax: 33-2-41-73-58-95; E-mail: gilles.kauffenstein@gmail.com.; Recipient of a scholarship from the Fonds de Recherche en Sante du Quebec (FRSQ).; Supported by the CIHR.; Recipient of a fellowship for visiting scholars at the Universite Laval sponsored by CAPES (Brazilian Ministry of Education). Present address: Instituto de Genetica e Bioquimica, Universidade Federal de Uberlandia, Campus Patos de Minas, Patos de Minas-MG 38700-152, Brazil.; Recipient of a "Chercheur National" award from the Fonds de Recherche du Quebec-Sante (FRQS). To whom correspondence may be addressed: Centre de Recherche du CHU de Quebec, CHUL, 2705 Blvd. Laurier, Office T1-49, Quebec G1V 4G2, Canada. Tel. 418-525-4444, ext. 46319; Fax: 418-654-2765; E-mail: Jean.Sevigny@crchul.ulaval.ca.	Adeoya-Osiguwa SA, 2002, MOL REPROD DEV, V63, P245, DOI 10.1002/mrd.90009; Banks FCL, 2010, FERTIL STERIL, V93, P1415, DOI 10.1016/j.fertnstert.2009.02.061; Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BENHAM CD, 1987, NATURE, V328, P275, DOI 10.1038/328275a0; Brain KL, 2002, J PHYSIOL-LONDON, V541, P849, DOI 10.1113/jphysiol.2002.019612; Braun N, 2000, EUR J NEUROSCI, V12, P4357, DOI 10.1046/j.1460-9568.2000.01342.x; Brownhill VR, 1996, N-S ARCH PHARMACOL, V353, P499; Buell G, 1996, BLOOD, V87, P2659, DOI 10.1182/blood.V87.7.2659.bloodjournal8772659; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Burnstock G, 2010, TRENDS PHARMACOL SCI, V31, P131, DOI 10.1016/j.tips.2009.12.002; Dutton JL, 2000, NEUROPHARMACOLOGY, V39, P2054, DOI 10.1016/S0028-3908(00)00058-7; Edwards SE, 2007, REPROD SCI, V14, P655, DOI 10.1177/1933719107306227; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Ennion SJ, 2001, FEBS LETT, V489, P154, DOI 10.1016/S0014-5793(01)02102-0; Erlinge D, 1998, BIOCHEM BIOPH RES CO, V248, P864, DOI 10.1006/bbrc.1998.9083; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; FRENCH AM, 1983, EXPERIENTIA, V39, P264, DOI 10.1007/BF01955295; Green M. C., 1991, HDB GENETICALLY STAN; Hardy TA, 1999, BRIT J PHARMACOL, V126, P1761, DOI 10.1038/sj.bjp.0702514; HARRIS GS, 1972, EUR J PHARMACOL, V19, P137, DOI 10.1016/0014-2999(72)90091-X; Kauffenstein G, 2010, CARDIOVASC RES, V85, P204, DOI 10.1093/cvr/cvp265; Koziak K, 1999, THROMB HAEMOSTASIS, V82, P1538; Kukulski F, 2005, Purinergic Signal, V1, P193, DOI 10.1007/s11302-005-6217-x; Kukulski F, 2011, ADV PHARMACOL, V61, P263, DOI 10.1016/B978-0-12-385526-8.00009-6; Lavoie EG, 2011, AM J PHYSIOL-GASTR L, V300, pG608, DOI 10.1152/ajpgi.00207.2010; Martin-Satue M, 2009, HISTOCHEM CELL BIOL, V131, P615, DOI 10.1007/s00418-008-0551-3; Martin-Satue M, 2010, HISTOCHEM CELL BIOL, V133, P659, DOI 10.1007/s00418-010-0704-z; Moon SK, 2001, AM J PHYSIOL-HEART C, V280, pH2779, DOI 10.1152/ajpheart.2001.280.6.H2779; Morrier A, 2002, CAN J ANIM SCI, V82, P347, DOI 10.4141/A01-045; Mulryan K, 2000, NATURE, V403, P86, DOI 10.1038/47495; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; OLDSCLARKE P, 1993, DEV BIOL, V155, P14, DOI 10.1006/dbio.1993.1002; Picher M, 1996, BIOCHEM PHARMACOL, V51, P1453, DOI 10.1016/0006-2952(96)00086-X; Queiroz G, 2003, J NEUROCHEM, V85, P740, DOI 10.1046/j.1471-4159.2003.01715.x; Rettinger J, 2004, J BIOL CHEM, V279, P6426, DOI 10.1074/jbc.M306987200; Robaye B, 1997, EUR J PHARMACOL, V329, P231, DOI 10.1016/S0014-2999(97)89184-4; Rolf MG, 2001, THROMB HAEMOSTASIS, V85, P303, DOI 10.1055/s-0037-1615684; SNEDDON P, 1984, J PHYSIOL-LONDON, V347, P561, DOI 10.1113/jphysiol.1984.sp015083; SNEDDON P, 1984, EUR J PHARMACOL, V100, P85, DOI 10.1016/0014-2999(84)90318-2; STJARNE L, 1984, NEUROSCIENCE, V13, P21, DOI 10.1016/0306-4522(84)90256-2; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Westfall TD, 1996, BRIT J PHARMACOL, V117, P867, DOI 10.1111/j.1476-5381.1996.tb15273.x; White CW, 2013, P NATL ACAD SCI USA, V110, P20825, DOI 10.1073/pnas.1318624110; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yu WQ, 2013, FASEB J, V27, P1895, DOI 10.1096/fj.12-219006	47	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28629	28639		10.1074/jbc.M114.604082	http://dx.doi.org/10.1074/jbc.M114.604082			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25160621	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000343765400051
J	Sheng, YQ; Li, W; Zhu, F; Liu, KD; Chen, HY; Yao, K; Reddy, K; Lim, DY; Oi, NM; Li, HT; Peng, C; Ma, WY; Bode, AM; Dong, ZM; Dong, ZG				Sheng, Yuqiao; Li, Wei; Zhu, Feng; Liu, Kangdong; Chen, Hanyong; Yao, Ke; Reddy, Kanamata; Lim, Do Young; Oi, Naomi; Li, Haitao; Peng, Cong; Ma, Wei-Ya; Bode, Ann M.; Dong, Ziming; Dong, Zigang			3,6,2 ',4 ',5 '-Pentahydroxyflavone, an Orally Bioavailable Multiple Protein Kinase Inhibitor, Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADVANCED SOLID TUMORS; I PI3K INHIBITOR; AURORA-B-KINASE; PHASE-I; ACQUIRED-RESISTANCE; MET AMPLIFICATION; GROWTH; MUTATION; OVEREXPRESSION; EXPRESSION	Non-small cell lung cancer (NSCLC) is the most lethal cancer, causing more than 150,000 deaths in the United States in 2013. The receptor tyrosine kinase inhibitors such as gefitinib are not perfect clinical therapeutic agents for NSCLC treatment due to primary or acquired tyrosine kinase inhibitor resistance. Herein, 3,6,2',4',5'-pentahydroxyflavone (36245-PHF) was identified as a multiple kinase inhibitor for NSCLC treatment based on the computational screening of a natural products database. 36245-PHF was shown to inhibit PI3K and Aurora A and B kinases and overcome gefitinib-resistant NSCLC growth. Our data clearly showed that 36245-PHF markedly inhibited anchorage-independent growth of gefitinib-resistant NSCLC cell lines and exerted a substantial chemotherapeutic effect following oral administration in a gefitinib-resistant NSCLC xenograft model. The evidence from three different subsequent methodological approaches, in vitro, ex vivo, and in vivo, all confirmed that 36245-PHF as a multiple protein kinase inhibitor. Overall, we identified 36245-PHF as a multiple protein kinase inhibitor and as a novel therapeutic agent to overcome gefitinib-resistant NSCLC growth, which could provide a new option for clinical NSCLC oral treatment.	[Sheng, Yuqiao; Li, Wei; Zhu, Feng; Liu, Kangdong; Chen, Hanyong; Yao, Ke; Reddy, Kanamata; Lim, Do Young; Oi, Naomi; Li, Haitao; Peng, Cong; Ma, Wei-Ya; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Sheng, Yuqiao; Liu, Kangdong; Dong, Ziming] Zhengzhou Univ, Basic Med Coll, Dept Physiol & Pathophysiol, Zhengzhou 450001, Henan, Peoples R China; [Sheng, Yuqiao] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450001, Henan, Peoples R China; [Li, Wei] Cent S Univ, Xiangya Sch Med, Canc Res Inst, Changsha 410078, Hunan, Peoples R China; [Peng, Cong] Cent S Univ, Xiangya Hosp, Changsha 410078, Hunan, Peoples R China	University of Minnesota System; Zhengzhou University; Zhengzhou University; Central South University; Central South University	Dong, ZM (corresponding author), Zhengzhou Univ, 100 Kexue Rd, Zhengzhou 450001, Henan, Peoples R China.	Dongzm@zzu.edu.cn; zgdong@hi.umn.edu	Sheng, Yuqiao/AAT-7522-2020; ZHU, Feng/C-1303-2010	Sheng, Yuqiao/0000-0002-7528-7187; Zhu, Feng/0000-0003-1172-0102	Hormel Foundation; United Soybean Board; National Institutes of Health [CA1661011, CA172457, R37 C081064, CA027502, ES016548]; NATIONAL CANCER INSTITUTE [R21CA172457, P01CA027502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	Hormel Foundation; United Soybean Board; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by The Hormel Foundation, United Soybean Board, and National Institutes of Health Grants CA1661011, CA172457, R37 C081064, CA027502, and ES016548.	Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Carvajal RD, 2006, CLIN CANCER RES, V12, P6869, DOI 10.1158/1078-0432.CCR-06-1405; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Hong DS, 2012, CLIN CANCER RES, V18, P4173, DOI 10.1158/1078-0432.CCR-12-0714; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Kamei H, 1996, CANCER BIOTHER RADIO, V11, P193, DOI 10.1089/cbr.1996.11.193; Kawano O, 2006, LUNG CANCER, V54, P209, DOI 10.1016/j.lungcan.2006.07.006; Li H, 2011, ADV MED SCI-POLAND, V56, P275, DOI 10.2478/v10039-011-0043-x; Li X, 2012, CARCINOGENESIS, V33, P2548, DOI 10.1093/carcin/bgs283; Liu MM, 2012, EUR J MED CHEM, V52, P33, DOI 10.1016/j.ejmech.2012.03.002; Lo Iacono M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-100; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ogawa E, 2008, ANN SURG ONCOL, V15, P547, DOI 10.1245/s10434-007-9653-8; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Shapiro GI, 2014, CLIN CANCER RES, V20, P233, DOI 10.1158/1078-0432.CCR-13-1777; Smith SL, 2005, BRIT J CANCER, V93, P719, DOI 10.1038/sj.bjc.6602779; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Vischioni B, 2006, MOL CANCER THER, V5, P2905, DOI 10.1158/1535-7163.MCT-06-0301; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Wu CC, 2011, BIOCHEM BIOPH RES CO, V405, P168, DOI 10.1016/j.bbrc.2011.01.001; Xie H, 2013, CANCER RES, V73, P716, DOI 10.1158/0008-5472.CAN-12-2784	29	16	17	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28192	28201		10.1074/jbc.M114.593475	http://dx.doi.org/10.1074/jbc.M114.593475			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25122774	Green Published, hybrid			2022-12-28	WOS:000343765400016
J	Abais, JM; Xia, M; Li, GB; Chen, Y; Conley, SM; Gehr, TWB; Boini, KM; Li, PL				Abais, Justine M.; Xia, Min; Li, Guangbi; Chen, Yang; Conley, Sabena M.; Gehr, Todd W. B.; Boini, Krishna M.; Li, Pin-Lan			Nod-like Receptor Protein 3 (NLRP3) Inflammasome Activation and Podocyte Injury via Thioredoxin-Interacting Protein (TXNIP) during Hyperhomocysteinemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNEL BLOCKERS; GLOMERULAR SCLEROSIS; OXIDATIVE STRESS; NADPH OXIDASE; CELL-DEATH; FOLIC-ACID; ER STRESS; EXPRESSION; DAMAGE; GENE	NADPH oxidase-derived reactive oxygen species (ROS) have been reported to activate NLRP3 inflammasomes resulting in podocyte and glomerular injury during hyperhomocysteinemia (hHcys). However, the mechanism by which the inflammasome senses ROS is still unknown in podocytes upon hHcys stimulation. The current study explored whether thioredoxin-interacting protein (TXNIP), an endogenous inhibitor of the antioxidant thioredoxin and ROS sensor, mediates hHcys-induced NLRP3 inflammasome activation and consequent glomerular injury. In cultured podocytes, size exclusion chromatography and confocal microscopy showed that inhibition of TXNIP by siRNA or verapamil prevented Hcys-induced TXNIP protein recruitment to form NLRP3 inflammasomes and abolished Hcys-induced increases in caspase-1 activity and IL-1 beta production. TXNIP inhibition protected podocytes from injury as shown by normal expression levels of podocyte markers, podocin and desmin. In vivo, adult C57BL/6J male mice were fed a folate-free diet for 4 weeks to induce hHcys, and TXNIP was inhibited by verapamil (1 mg/ml in drinking water) or by local microbubble-ultrasound TXNIP shRNA transfection. Evidenced by immunofluorescence and co-immunoprecipitation studies, glomerular inflammasome formation and TXNIP binding to NLRP3 were markedly increased in mice with hHcys but not in TXNIP shRNA-transfected mice or those receiving verapamil. Furthermore, TXNIP inhibition significantly reduced caspase-1 activity and IL-1 beta production in glomeruli of mice with hHcys. Correspondingly, TXNIP shRNA transfection and verapamil attenuated hHcys-induced proteinuria, albuminuria, glomerular damage, and podocyte injury. In conclusion, our results demonstrate that TXNIP binding to NLRP3 is a key signaling mechanism necessary for hHcys-induced NLRP3 inflammasome formation and activation and subsequent glomerular injury.	[Abais, Justine M.; Xia, Min; Li, Guangbi; Chen, Yang; Conley, Sabena M.; Boini, Krishna M.; Li, Pin-Lan] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; [Gehr, Todd W. B.] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Abais, JM (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, 410 N 12th St, Richmond, VA 23298 USA.	pli@vcu.edu			National Institutes of Health [DK54927, HL075316, HL57244, 1F31AG043289-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057244, R01HL075316, R29HL057244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG043289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by Grants DK54927, HL075316, and HL57244 (to P.-L. L.) and 1F31AG043289-01 (to J. M. A.) from the National Institutes of Health.	Abais JM, 2014, FREE RADICAL BIO MED, V67, P211, DOI 10.1016/j.freeradbiomed.2013.10.009; Abais JM, 2013, ANTIOXID REDOX SIGN, V18, P1537, DOI 10.1089/ars.2012.4666; Advani A, 2009, J AM SOC NEPHROL, V20, P730, DOI 10.1681/ASN.2008020142; Al-Gayyar MMH, 2011, BRIT J PHARMACOL, V164, P170, DOI 10.1111/j.1476-5381.2011.01336.x; Bakker PJ, 2014, KIDNEY INT, V85, P1112, DOI 10.1038/ki.2013.503; Benko S, 2008, CYTOKINE, V43, P368, DOI 10.1016/j.cyto.2008.07.013; Boini KM, 2014, BBA-MOL CELL RES, V1843, P836, DOI 10.1016/j.bbamcr.2014.01.033; Boini KM, 2011, AM J PATHOL, V179, P2210, DOI 10.1016/j.ajpath.2011.07.019; Brough D, 2003, J IMMUNOL, V170, P3029, DOI 10.4049/jimmunol.170.6.3029; Cao L, 2013, MICROVASC RES, V89, P146, DOI 10.1016/j.mvr.2013.07.002; Cha-Molstad H, 2012, MOL PHARMACOL, V82, P541, DOI 10.1124/mol.112.078253; Chen JQ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1133, DOI 10.1152/ajpendo.90944.2008; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; FLOEGE J, 1992, LAB INVEST, V67, P486; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARRIS DCH, 1987, KIDNEY INT, V31, P41, DOI 10.1038/ki.1987.6; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Joles JA, 2000, J AM SOC NEPHROL, V11, P669, DOI 10.1681/ASN.V114669; Kalani A, 2014, J MOL NEUROSCI, V52, P202, DOI 10.1007/s12031-013-0122-5; Kang DH, 2003, CURR OPIN NEPHROL HY, V12, P43, DOI 10.1097/00041552-200301000-00008; Kawachi H, 2006, NEPHROLOGY, V11, P274, DOI 10.1111/j.1440-1797.2006.00583.x; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Li NJ, 2002, HYPERTENSION, V39, P443, DOI 10.1161/hy02t2.102992; Li XN, 2009, BIOCHEM BIOPH RES CO, V381, P660, DOI 10.1016/j.bbrc.2009.02.132; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Minn AH, 2005, BIOCHEM BIOPH RES CO, V336, P770, DOI 10.1016/j.bbrc.2005.08.161; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nilsson K, 2007, DEMENT GERIATR COGN, V23, P321, DOI 10.1159/000100927; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Overley-Adamson B, 2014, CANCER BIOL THER, V15, P452, DOI 10.4161/cbt.27820; PELAYO JC, 1988, AM J PHYSIOL, V254, pF425, DOI 10.1152/ajprenal.1988.254.3.F425; Petrilli V, 2007, JOINT BONE SPINE, V74, P571, DOI 10.1016/j.jbspin.2007.04.004; RAIJ L, 1984, KIDNEY INT, V26, P137, DOI 10.1038/ki.1984.147; Schwartz EJ, 2001, J AM SOC NEPHROL, V12, P1677, DOI 10.1681/ASN.V1281677; Sen U, 2010, AM J NEPHROL, V31, P442, DOI 10.1159/000296717; Shah A, 2013, J BIOL CHEM, V288, P6835, DOI 10.1074/jbc.M112.419101; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Xiong J, 2013, J CELL MOL MED, V17, P1598, DOI 10.1111/jcmm.12173; Xu GL, 2012, DIABETES, V61, P848, DOI 10.2337/db11-0955; Yang F, 2014, J CEREBR BLOOD F MET, V34, P660, DOI 10.1038/jcbfm.2013.242; Yi F, 2006, KIDNEY INT, V70, P88, DOI 10.1038/sj.ki.5001517; Yin Y, 2013, FRONT BIOSCI-LANDMRK, V18, P638, DOI 10.2741/4127; Zhang AY, 2004, MICROVASC RES, V67, P159, DOI 10.1016/j.mvr.2003.11.001; Zhang C, 2012, HYPERTENSION, V60, P154, DOI 10.1161/HYPERTENSIONAHA.111.189688; Zhang C, 2011, PFLUG ARCH EUR J PHY, V462, P455, DOI 10.1007/s00424-011-0981-y; Zhang C, 2010, BBA-MOL CELL RES, V1803, P482, DOI 10.1016/j.bbamcr.2009.12.006; Zhang C, 2010, FREE RADICAL BIO MED, V48, P1109, DOI 10.1016/j.freeradbiomed.2010.01.029; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	51	103	110	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27159	27168		10.1074/jbc.M114.567537	http://dx.doi.org/10.1074/jbc.M114.567537			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25138219	Green Published, hybrid			2022-12-28	WOS:000342853900041
J	Schommer, NN; Muto, J; Nizet, V; Gallo, RL				Schommer, Nina N.; Muto, Jun; Nizet, Victor; Gallo, Richard L.			Hyaluronan Breakdown Contributes to Immune Defense against Group A Streptococcus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOFT-TISSUE INFECTIONS; ACID CAPSULE; CD44; SKIN; RECEPTOR; ACTIVATION; ATTACHMENT; VIRULENCE; DISEASE; FORMS	Group A Streptococcus (GAS) commonly infects human skin and occasionally causes severe and life-threatening invasive diseases. The hyaluronan (HA) capsule of GAS has been proposed to protect GAS from host defense by mimicking endogenous HA, a large and abundant glycosaminoglycan in the skin. However, HA is degraded during tissue injury, and the functions of short-chain HA that is generated during infection have not been studied. To examine the impact of the molecular mass of HA on GAS infection, we established infection models in vitro and in vivo in which the size of HA was defined by enzymatic digestion or custom synthesis. We discovered that conversion of high molecular mass HA to low molecular mass HA facilitated GAS phagocytosis by macrophages and limited the severity of infection in mice. In contrast, native high molecular mass HA significantly impaired internalization by macrophages and increased GAS survival in murine blood. Thus, our data demonstrate that GAS virulence can be influenced by the size of HA derived from both the bacterium and host and suggest that high molecular mass HA facilitates GAS deep tissue infections, whereas the generation of short-chain HA can be protective.	[Schommer, Nina N.; Muto, Jun; Gallo, Richard L.] Univ Calif San Diego, Dept Med, Div Dermatol, La Jolla, CA 92093 USA; [Nizet, Victor; Gallo, Richard L.] Univ Calif San Diego, Dept Pediat, Div Pharmacol & Drug Discovery, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Gallo, RL (corresponding author), Univ Calif San Diego, Dept Med, Div Dermatol, La Jolla, CA 92093 USA.	rgallo@ucsd.edu	Nizet, Victor/AAF-3190-2019; Gallo, Richard L/A-8931-2009	Gallo, Richard L/0000-0002-1401-7861; Nizet, Victor/0000-0003-3847-0422	National Institutes of Health Grants [P01HL057345, P01HL107150]; Deutsche Forschungsgemeinschaft Grant [SCHO1340]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345, P01HL107150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780, R01AI083358] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL057345 and P01HL107150 (to R. L. G.). This work was also supported Deutsche Forschungsgemeinschaft Grant SCHO1340 (to N. N. S.).	Betschel SD, 1998, INFECT IMMUN, V66, P1671, DOI 10.1128/IAI.66.4.1671-1679.1998; Cogen AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008557; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Cywes C, 2001, NATURE, V414, P648, DOI 10.1038/414648a; Dicker KT, 2014, ACTA BIOMATER, V10, P1558, DOI 10.1016/j.actbio.2013.12.019; DiNubile MJ, 2004, J ANTIMICROB CHEMOTH, V53, P37, DOI 10.1093/jac/dkh202; Giordano Philip, 2007, Ther Clin Risk Manag, V3, P309, DOI 10.2147/tcrm.2007.3.2.309; HEESEMANN J, 1985, J CLIN MICROBIOL, V22, P168, DOI 10.1128/JCM.22.2.168-175.1985; Hill DR, 2013, J BIOL CHEM, V288, P29090, DOI 10.1074/jbc.M113.468629; Hollands A, 2010, J INFECT DIS, V202, P11, DOI 10.1086/653124; Jackson DG, 2009, IMMUNOL REV, V230, P216, DOI 10.1111/j.1600-065X.2009.00803.x; Kothapalli D, 2008, J BIOL CHEM, V283, P31823, DOI 10.1074/jbc.M802934200; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lin JN, 2011, J CLIN MICROBIOL, V49, P3632, DOI 10.1128/JCM.00531-11; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Muto J, 2014, J CLIN INVEST, V124, P1309, DOI 10.1172/JCI67947; Nathwani D, 2009, INT J ANTIMICROB AG, V34, pS24, DOI 10.1016/S0924-8579(09)70546-1; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Schommer NN, 2011, INFECT IMMUN, V79, P2267, DOI 10.1128/IAI.01142-10; Schrager HM, 1998, J CLIN INVEST, V101, P1708, DOI 10.1172/JCI2121; Scott JE, 1999, P NATL ACAD SCI USA, V96, P4850, DOI 10.1073/pnas.96.9.4850; Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; TAMMI R, 1988, J INVEST DERMATOL, V90, P412, DOI 10.1111/1523-1747.ep12456530; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Vachon E, 2006, BLOOD, V107, P4149, DOI 10.1182/blood-2005-09-3808; WESSELS MR, 1991, P NATL ACAD SCI USA, V88, P8317, DOI 10.1073/pnas.88.19.8317; WHITNACK E, 1981, INFECT IMMUN, V31, P985, DOI 10.1128/IAI.31.3.985-991.1981; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209	31	26	26	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26914	26921		10.1074/jbc.M114.575621	http://dx.doi.org/10.1074/jbc.M114.575621			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122767	Green Published, hybrid			2022-12-28	WOS:000342853900022
J	Xu, JY; You, D; Leng, PQ; Ye, BC				Xu, Jun-Yu; You, Di; Leng, Pei-Qiang; Ye, Bang-Ce			Allosteric Regulation of a Protein Acetyltransferase in Micromonospora aurantiaca by the Amino Acids Cysteine and Arginine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA SYNTHETASE; KINASE-HOMOSERINE DEHYDROGENASE; LYSINE ACETYLATION; ESCHERICHIA-COLI; ASPARTATE KINASE; ARABIDOPSIS-THALIANA; BACILLUS-SUBTILIS; ACT DOMAIN; ENZYMES; METABOLISM	ACT domains (amino acid-binding domains) are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. Seventy proteins with ACT-GCN5-related N-acetyltransferase (GNAT) domain organization were found in actinomycetales. In this study, we investigate the ACT-containing GNAT acetyltransferase, Micau_1670 (MaKat), from Micromonospora aurantiaca ATCC 27029. Arginine and cysteine were identified as ligands by monitoring the conformational changes that occur upon amino acids binding to the ACT domain in the MaKat protein using FRET assay. It was found that MaKat is an amino acid-regulated protein acetyltransferase, whereas arginine and cysteine stimulated the activity of MaKat with regard to acetylation of acetyl-CoA synthetase (Micau_0428). Our research reveals the biochemical characterization of a protein acetyltransferase that contains a fusion of a GNAT domain with an ACT domain and provides a novel signaling pathway for regulating cellular protein acetylation. These findings indicate that acetylation of proteins and acetyltransferase activity may be tightly linked to cellular concentrations of some amino acids in actinomycetales.	[Xu, Jun-Yu; You, Di; Leng, Pei-Qiang; Ye, Bang-Ce] E China Univ Sci & Technol, Lab Biosyst & Microanal, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	East China University of Science & Technology	Ye, BC (corresponding author), E China Univ Sci & Technol, Lab Biosyst & Microanal, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.	bcye@ecust.edu.cn	xu, junyu/AAR-6286-2021	Xu, Jun-Yu/0000-0002-1403-9200	China National Science Foundation [21276079]; Chinese Ministry of Education Grant Specialized Research Fund for the Doctoral Program [20120074110009]; National Key Technologies RD Program [2014AA021502, 2007AA02Z331]; Fundamental Research Funds for the Central Universities; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R34AA021502] Funding Source: NIH RePORTER	China National Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education Grant Specialized Research Fund for the Doctoral Program; National Key Technologies RD Program(National Key Technology R&D Program); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by China National Science Foundation Grant 21276079, Chinese Ministry of Education Grant Specialized Research Fund for the Doctoral Program 20120074110009, National Key Technologies R&D Program Grants 2014AA021502 and 2007AA02Z331, and grants from the Fundamental Research Funds for the Central Universities.	Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Berndsen CE, 2005, METHODS, V36, P321, DOI 10.1016/j.ymeth.2005.03.002; Caldara M, 2008, J BIOL CHEM, V283, P6347, DOI 10.1074/jbc.M705884200; Castano-Cerezo S, 2011, MOL MICROBIOL, V82, P1110, DOI 10.1111/j.1365-2958.2011.07873.x; COSTREJEAN JM, 1977, J BIOL CHEM, V252, P5332; Crosby HA, 2012, J BIOL CHEM, V287, P15590, DOI 10.1074/jbc.M112.352104; Curien G, 2005, J BIOL CHEM, V280, P41178, DOI 10.1074/jbc.M509324200; Curien G, 2007, FEBS J, V274, P164, DOI 10.1111/j.1742-4658.2006.05573.x; Friedmann DR, 2013, FEBS J, V280, P5570, DOI 10.1111/febs.12373; Gardner JG, 2008, J BACTERIOL, V190, P5132, DOI 10.1128/JB.00340-08; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; GRUNDY FJ, 1994, J BACTERIOL, V176, P4527, DOI 10.1128/JB.176.15.4527-4533.1994; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Hirsch AM, 2010, SOIL BIOL BIOCHEM, V42, P536, DOI 10.1016/j.soilbio.2009.11.023; Kim D, 2013, PROTEOMICS, V13, P1726, DOI 10.1002/pmic.201200001; Kim Y, 2000, ANAL BIOCHEM, V280, P308, DOI 10.1006/abio.2000.4546; Lee DW, 2013, PROTEOMICS, V13, P2278, DOI 10.1002/pmic.201200072; Liberles JS, 2005, AMINO ACIDS, V28, P1, DOI 10.1007/s00726-004-0152-y; Mas-Droux C, 2006, PLANT CELL, V18, P1681, DOI 10.1105/tpc.105.040451; NAGY PL, 1995, J BACTERIOL, V177, P1292, DOI 10.1128/jb.177.5.1292-1298.1995; Nambi S, 2013, J BIOL CHEM, V288, P14114, DOI 10.1074/jbc.M113.463992; Nambi S, 2010, J BIOL CHEM, V285, P24313, DOI 10.1074/jbc.M110.118398; Okanishi H, 2013, J PROTEOME RES, V12, P3952, DOI 10.1021/pr400245k; Paris S, 2003, J BIOL CHEM, V278, P5361, DOI 10.1074/jbc.M207379200; Paris S, 2002, PROTEIN EXPRES PURIF, V24, P105, DOI 10.1006/prep.2001.1539; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Tucker AC, 2013, MOL MICROBIOL, V87, P152, DOI 10.1111/mmi.12088; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t; You D, 2014, J BACTERIOL, V196, P3169, DOI 10.1128/JB.01961-14; Zhang C, 2013, APPL MICROBIOL BIOT, V97, P8307, DOI 10.1007/s00253-013-5121-5; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang K, 2013, J PROTEOME RES, V12, P844, DOI 10.1021/pr300912q	38	20	21	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27034	27045		10.1074/jbc.M114.579078	http://dx.doi.org/10.1074/jbc.M114.579078			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25124041	Green Published, hybrid			2022-12-28	WOS:000342853900031
J	Guarino, C; Legowska, M; Epinette, C; Kellenberger, C; Dallet-Choisy, S; Sienczyk, M; Gabant, G; Cadene, M; Zoidakis, J; Vlahou, A; Wysocka, M; Marchand-Adam, S; Jenne, DE; Lesner, A; Gauthier, F; Korkmaz, B				Guarino, Carla; Legowska, Monika; Epinette, Christophe; Kellenberger, Christine; Dallet-Choisy, Sandrine; Sienczyk, Marcin; Gabant, Guillaume; Cadene, Martine; Zoidakis, Jerome; Vlahou, Antonia; Wysocka, Magdalena; Marchand-Adam, Sylvain; Jenne, Dieter E.; Lesner, Adam; Gauthier, Francis; Korkmaz, Brice			New Selective Peptidyl Di(chlorophenyl) Phosphonate Esters for Visualizing and Blocking Neutrophil Proteinase 3 in Human Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; Neutrophil; Protease; Protease Inhibitor; Serine Protease; Activity-based Probes; Inflammatory Diseases; Proteinase 3 (Myeloblastin)	HUMAN-LEUKOCYTE ELASTASE; CRYSTAL-STRUCTURE; WEGENERS-GRANULOMATOSIS; CATHEPSIN-G; ANTIGEN PROTEINASE-3; SURFACE EXPRESSION; ACTIVE-SITE; INHIBITOR; POLYANGIITIS; AUTOANTIGEN	Background: Proteinase 3 activity is poorly controlled by physiological inhibitors, and its biological function is not well understood. Results: We have designed irreversible phosphonate inhibitors based on structural differences between proteinase 3 and elastase. Conclusion: They selectively inhibit proteinase 3 in biological fluids and can act as activity-based probes. Significance: These inhibitors will help clarify proteinase 3 function. The function of neutrophil protease 3 (PR3) is poorly understood despite of its role in autoimmune vasculitides and its possible involvement in cell apoptosis. This makes it different from its structural homologue neutrophil elastase (HNE). Endogenous inhibitors of human neutrophil serine proteases preferentially inhibit HNE and to a lesser extent, PR3. We constructed a single-residue mutant PR3 (I217R) to investigate the S4 subsite preferences of PR3 and HNE and used the best peptide substrate sequences to develop selective phosphonate inhibitors with the structure Ac-peptidyl(P)(O-C6H4-4-Cl)(2). The combination of a prolyl residue at P4 and an aspartyl residue at P2 was totally selective for PR3. We then synthesized N-terminally biotinylated peptidyl phosphonates to identify the PR3 in complex biological samples. These inhibitors resisted proteolytic degradation and rapidly inactivated PR3 in biological fluids such as inflammatory lung secretions and the urine of patients with bladder cancer. One of these inhibitors revealed intracellular PR3 in permeabilized neutrophils and on the surface of activated cells. They hardly inhibited PR3 bound to the surface of stimulated neutrophils despite their low molecular mass, suggesting that the conformation and reactivity of membrane-bound PR3 is altered. This finding is relevant for autoantibody binding and the subsequent activation of neutrophils in granulomatosis with polyangiitis (formerly Wegener disease). These are the first inhibitors that can be used as probes to monitor, detect, and control PR3 activity in a variety of inflammatory diseases.	[Guarino, Carla; Epinette, Christophe; Dallet-Choisy, Sandrine; Marchand-Adam, Sylvain; Gauthier, Francis; Korkmaz, Brice] INSERM U 1100 EA 6305 Ctr Etud Pathol Resp, F-37032 Tours, France; [Guarino, Carla; Epinette, Christophe; Dallet-Choisy, Sandrine; Marchand-Adam, Sylvain; Gauthier, Francis; Korkmaz, Brice] Univ Tours, F-37032 Tours, France; [Legowska, Monika; Wysocka, Magdalena; Lesner, Adam] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland; [Kellenberger, Christine] CNRS, UMR, F-13288 Marseille, France; [Sienczyk, Marcin] Wroclaw Univ Technol, Div Med Chem & Microbiol, Fac Chem, PL-50370 Wroclaw, Poland; [Gabant, Guillaume; Cadene, Martine] UPR4301 CNRS, Ctr Biophys Mol, F-45071 Orleans, France; [Zoidakis, Jerome; Vlahou, Antonia] Acad Athens, Div Biotechnol, Biomed Res Fdn, Athens 11527, Greece; [Guarino, Carla; Jenne, Dieter E.] German Ctr Lung Res DZL, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, D-81377 Munich, Germany; [Guarino, Carla; Jenne, Dieter E.] Max Planck Inst Neurobiol, D-82152 Planegg Martinsried, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Fahrenheit Universities; University of Gdansk; Centre National de la Recherche Scientifique (CNRS); Wroclaw University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Academy of Athens; Max Planck Society	Korkmaz, B (corresponding author), INSERM U 1100 EA 6305 Ctr Etud Pathol Resp, F-37032 Tours, France.	brice.korkmaz@inserm.fr	Zoidakis, Jerome/P-9599-2018; Jenne, Dieter Erich/AAP-1414-2020; Lesner, Adam/M-2732-2019; kellenberger, christine/AAV-9304-2020; Zoidakis, Jerome/AAO-8236-2021	Zoidakis, Jerome/0000-0002-4557-3430; Zoidakis, Jerome/0000-0002-4557-3430; Lesner, Adam/0000-0001-8335-3431; Dallet-Choisy, Sandrine/0000-0002-6530-4107; Vlahou, Antonia/0000-0003-3284-5713; KORKMAZ, BRICE/0000-0002-5159-8706; Wysocka, Magdalena/0000-0003-2216-5597; marchand-adam, sylvain/0000-0002-9522-3738; Cadene, Martine/0000-0003-4936-2662	Ministere de l'Enseignement Superieur et de la Recherche; Region Centre; Fonds Europeen de Developpement Regional (project INFINHI); Polish Ministry of Science and Higher Education [IP2012 0596 72]; European Union [261382]; European Union Commission [601933]; Alexandre von Humboldt Foundation	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Region Centre(Region Centre-Val de Loire); Fonds Europeen de Developpement Regional (project INFINHI); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Union(European Commission); European Union Commission(European Commission); Alexandre von Humboldt Foundation	This work was supported by the Ministere de l'Enseignement Superieur et de la Recherche, the Region Centre, and the Fonds Europeen de Developpement Regional (project INFINHI) and Polish Ministry of Science and Higher Education (project IP2012 0596 72; to M. W.). This work was also supported by European Union Seventh Framework Programme (FP7/2007-2013; to D. E. J.) under Grant 261382 and by European Union Commission (FP7/TransBioBC; to J. Z. and A. V.) under Grant 601933.; Supported by the Alexandre von Humboldt Foundation.	Attucci S, 2006, J PHARMACOL EXP THER, V318, P803, DOI 10.1124/jpet.106.103440; Benson KF, 2003, NAT GENET, V35, P90, DOI 10.1038/ng1224; BODE W, 1986, EMBO J, V5, P2453, DOI 10.1002/j.1460-2075.1986.tb04521.x; BODUSZEK B, 1994, J ENZYM INHIB, V8, P147, DOI 10.3109/14756369409020197; Broemstrup T, 2010, PHYS CHEM CHEM PHYS, V12, P7487, DOI 10.1039/b924117e; Brown CM, 2011, CHEM BIOL, V18, P48, DOI 10.1016/j.chembiol.2010.11.007; CLARK JM, 1980, J CELL BIOL, V84, P102, DOI 10.1083/jcb.84.1.102; CSERNOK E, 1990, AM J PATHOL, V137, P1113; Csernok E, 2013, EXPERT REV CLIN IMMU, V9, P641, DOI 10.1586/1744666X.2013.811052; Derache C, 2012, FEBS J, V279, P4466, DOI 10.1111/febs.12033; Fujinaga M, 1996, J MOL BIOL, V261, P267, DOI 10.1006/jmbi.1996.0458; Gabillet J, 2012, J IMMUNOL, V189, P2574, DOI 10.4049/jimmunol.1200600; Grzywa R, 2013, CURR PHARM DESIGN, V19, P1154; Hajjar E, 2008, PROTEINS, V71, P1655, DOI 10.1002/prot.21853; Hajjar E, 2007, FEBS LETT, V581, P5685, DOI 10.1016/j.febslet.2007.11.029; Hajjar E, 2010, FEBS J, V277, P2238, DOI 10.1111/j.1742-4658.2010.07659.x; HALBWACHSMECARELLI L, 1995, FEBS LETT, V374, P29, DOI 10.1016/0014-5793(95)01073-N; Hink-Schauer C, 2002, J BIOL CHEM, V277, P50923, DOI 10.1074/jbc.M207962200; Hinkofer LC, 2013, J BIOL CHEM, V288, P26635, DOI 10.1074/jbc.M113.495770; Jegot G, 2011, FASEB J, V25, P3019, DOI 10.1096/fj.10-176552; JENNE DE, 1990, NATURE, V346, P520, DOI 10.1038/346520a0; Kallenberg CGM, 2008, J AUTOIMMUN, V30, P29, DOI 10.1016/j.jaut.2007.11.005; Kantari C, 2011, J LEUKOCYTE BIOL, V90, P941, DOI 10.1189/jlb.1210695; Kasperkiewicz P, 2014, P NATL ACAD SCI USA, V111, P2518, DOI 10.1073/pnas.1318548111; Kollner I, 2006, BLOOD, V108, P493, DOI 10.1182/blood-2005-11-4689; Korkmaz B, 2002, J BIOL CHEM, V277, P39074, DOI 10.1074/jbc.M202918200; Korkmaz B, 2005, J IMMUNOL, V175, P3329, DOI 10.4049/jimmunol.175.5.3329; Korkmaz B, 2004, AM J RESP CELL MOL, V30, P801, DOI 10.1165/rcmb.2003-0139OC; Korkmaz B, 2008, NAT PROTOC, V3, P991, DOI 10.1038/nprot.2008.63; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2007, J BIOL CHEM, V282, P1989, DOI 10.1074/jbc.M608700200; Korkmaz B, 2013, INT IMMUNOPHARMACOL, V17, P1198, DOI 10.1016/j.intimp.2013.07.003; Korkmaz B, 2013, SEMIN IMMUNOPATHOL, V35, P411, DOI 10.1007/s00281-013-0362-z; Korkmaz B, 2013, CURR PHARM DESIGN, V19, P966, DOI 10.2174/1381612811319060002; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Korkmaz B, 2009, J BIOL CHEM, V284, P19896, DOI 10.1074/jbc.M901471200; Korkmaz B, 2008, J BIOL CHEM, V283, P35976, DOI 10.1074/jbc.M806754200; OLEKSYSZYN J, 1989, BIOCHEM BIOPH RES CO, V161, P143, DOI 10.1016/0006-291X(89)91572-6; Owen Caroline A, 2008, Int J Chron Obstruct Pulmon Dis, V3, P253; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schreiber A, 2003, J AM SOC NEPHROL, V14, P68, DOI 10.1097/01.ASN.0000040751.83734.D1; Sienczyk M, 2006, BIOORG MED CHEM LETT, V16, P2886, DOI 10.1016/j.bmcl.2006.03.002; Sienczyk M, 2009, CURR MED CHEM, V16, P1673, DOI 10.2174/092986709788186246; Sienczyk M, 2011, BIOORGAN MED CHEM, V19, P1277, DOI 10.1016/j.bmc.2010.12.008; TERVAERT JWC, 1993, ANN RHEUM DIS, V52, P115, DOI 10.1136/ard.52.2.115; TIAN WX, 1982, BIOCHEMISTRY-US, V21, P1028, DOI 10.1021/bi00534a031; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; von Vietinghoff S, 2007, BLOOD, V109, P4487, DOI 10.1182/blood-2006-10-055327; Witko-Sarsat V, 1999, BLOOD, V94, P2487, DOI 10.1182/blood.V94.7.2487.419k07_2487_2496; WOODARD SL, 1994, J IMMUNOL, V153, P5016; Zoidakis J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009449	51	30	31	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31777	31791		10.1074/jbc.M114.591339	http://dx.doi.org/10.1074/jbc.M114.591339			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25288799	Green Published, hybrid			2022-12-28	WOS:000345314700010
J	Fernandez, MA; Klutkowski, JA; Freret, T; Wolfe, MS				Fernandez, Marty A.; Klutkowski, Julia A.; Freret, Taylor; Wolfe, Michael S.			Alzheimer Presenilin-1 Mutations Dramatically Reduce Trimming of Long Amyloid beta-Peptides (A beta) by gamma-Secretase to Increase 42-to-40-Residue A beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYL-TERMINAL FRAGMENT; PRECURSOR PROTEIN; TRANSMEMBRANE DOMAIN; INTRAMEMBRANE PROTEOLYSIS; TALKING POINT; DISEASE; CLEAVAGE; A-BETA-42; MECHANISM; ENDOPROTEOLYSIS	The presenilin-containing gamma-secretase complex produces the amyloid beta-peptide (A beta) through intramembrane proteolysis, and >100 presenilin mutations are associated with familial early-onset Alzheimer disease (AD). The question of whether these mutations result in AD through a gain or a loss of function remains highly controversial. Mutations in presenilins increase ratios of 42- to 40-residue A beta critical to pathogenesis, but other A beta s of 38 - 49 residues are also formed by gamma-secretase. Evidence in cells suggests the protease first cleaves substrate within the transmembrane domain at the E site to form 48- or 49-residue A beta. Subsequent cleavage almost every three residues from the C terminus is thought to occur along two pathways toward shorter secreted forms of A beta: A beta 49 -> A beta 46 -> A beta 43 -> A beta 40 and A beta 48 -> A beta 45 -> A beta 42 -> A beta 38. Here we show that the addition of synthetic long A beta peptides (A beta 45- 49) directly into purified preparations of gamma-secretase leads to the formation of A beta 40 and A beta 42 whether the protease complex is detergent-solubilized or reconstituted into lipid vesicles, and the ratios of products A beta 42 to A beta 40 follow a pattern consistent with the dual-pathway hypothesis. Kinetic analysis of five different AD-causing mutations in presenilin-1 revealed that all result in drastic reduction of normal carboxypeptidase function. Altered trimming of long A beta peptides to A beta 40 and A beta 42 by mutant proteases occurs at multiple levels, independent of the effects on initial endoproteolysis at the E site, all conspiring to increase the critical A beta 42/A beta 40 ratio implicated in A beta pathogenesis. Taken together, these results suggest that specific reduction of carboxypeptidase function of gamma-secretase leads to the gain of toxic A beta 42/A beta 40.	Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Wolfe, MS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, 77 Ave Louis Pasteur,HIM 754, Boston, MA 02115 USA.	mwolfe@partners.org	freret, thomas/B-2068-2012	freret, thomas/0000-0002-4446-4451; Fernandez, Marty/0000-0002-3211-2563	National Institutes of Health [R03 NS081498]; HHMI Gilliam Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS081498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI Gilliam Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R03 NS081498 (to M. S. W.). This work was also supported by an HHMI Gilliam Fellowship (to M. A. F.).	Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Czirr E, 2008, J BIOL CHEM, V283, P17049, DOI 10.1074/jbc.M802912200; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Fukumori A, 2010, J NEUROSCI, V30, P7853, DOI 10.1523/JNEUROSCI.1443-10.2010; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Golde TE, 2013, BBA-BIOMEMBRANES, V1828, P2898, DOI 10.1016/j.bbamem.2013.06.005; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Heilig EA, 2013, J NEUROSCI, V33, P11606, DOI 10.1523/JNEUROSCI.0954-13.2013; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kimberly WT, 2003, BIOCHEMISTRY-US, V42, P137, DOI 10.1021/bi026888g; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lefranc-Jullien S, 2006, J NEUROCHEM, V97, P807, DOI 10.1111/j.1471-4159.2006.03748.x; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Mori K, 2010, PSYCHOGERIATRICS, V10, P117, DOI 10.1111/j.1479-8301.2010.00330.x; Okochi M, 2013, CELL REP, V3, P42, DOI 10.1016/j.celrep.2012.11.028; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Quintero-Monzon O, 2011, BIOCHEMISTRY-US, V50, P9023, DOI 10.1021/bi2007146; Rivkin A, 2010, BIOORG MED CHEM LETT, V20, P2279, DOI 10.1016/j.bmcl.2010.02.008; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shimojo M, 2008, J BIOL CHEM, V283, P16488, DOI 10.1074/jbc.M801279200; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yagishita S, 2008, J BIOL CHEM, V283, P733, DOI 10.1074/jbc.M707103200; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200	36	101	101	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31043	31052		10.1074/jbc.M114.581165	http://dx.doi.org/10.1074/jbc.M114.581165			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25239621	hybrid, Green Published			2022-12-28	WOS:000344549900014
J	Maloney, JA; Bainbridge, T; Gustafson, A; Zhang, S; Kyauk, R; Steiner, P; van der Brug, M; Liu, YC; Ernst, JA; Watts, RJ; Atwal, JK				Maloney, Janice A.; Bainbridge, Travis; Gustafson, Amy; Zhang, Shuo; Kyauk, Roxanne; Steiner, Pascal; van der Brug, Marcel; Liu, Yichin; Ernst, James A.; Watts, Ryan J.; Atwal, Jasvinder K.			Molecular Mechanisms of Alzheimer Disease Protection by the A673T Allele of Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; A-BETA; COMMON VARIANTS; MEMORY DEFICITS; APP MUTATIONS; MOUSE MODEL; GENE; PRESENILIN-1; DEMENTIA; CD2AP	Pathogenic mutations in the amyloid precursor protein (APP) gene have been described as causing early onset familial Alzheimer disease (AD). We recently identified a rare APP variant encoding an alanine-to-threonine substitution at residue 673 (A673T) that confers protection against development of AD (Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., Hoyte, K., Gustafson, A., Liu, Y., Lu, Y., Bhangale, T., Graham, R. R., Huttenlocher, J., Bjornsdottir, G., Andreassen, O. A., Jonsson, E. G., Palotie, A., Behrens, T. W., Magnusson, O. T., Kong, A., Thorsteinsdottir, U., Watts, R. J., and Stefansson, K. (2012) Nature 488, 96-99). The Ala-673 residue lies within the beta-secretase recognition sequence and is part of the amyloid-beta (A beta) peptide cleavage product (position 2 of A beta). We previously demonstrated that the A673T substitution makes APP a less favorable substrate for cleavage by BACE1. In follow-up studies, we confirm that A673T APP shows reduced cleavage by BACE1 in transfected mouse primary neurons and in isogenic human induced pluripotent stem cell-derived neurons. Using a biochemical approach, we show that the A673T substitution modulates the catalytic turnover rate (V-max) of APP by the BACE1 enzyme, without affecting the affinity (K-m) of the APP substrate for BACE1. We also show a reduced level of A beta(1-42) aggregation with A2T A beta peptides, an observation not conserved in A beta(1-40) peptides. When combined in a ratio of 1: 9 A beta(1-42)/A beta(1-40) to mimic physiologically relevant mixtures, A2T retains a trend toward slowed aggregation kinetics. Microglial uptake of the mutant A beta(1-42) peptides correlated with their aggregation level. Cytotoxicity of the mutant A beta peptides was not dramatically altered. Taken together, our findings demonstrate that A673T, a protective allele of APP, reproducibly reduces amyloidogenic processing of APP and also mildly decreases A beta aggregation. These effects could together have an additive or even synergistic impact on the risk of developing AD.	[Maloney, Janice A.; Zhang, Shuo; Kyauk, Roxanne; Steiner, Pascal; Ernst, James A.; Watts, Ryan J.; Atwal, Jasvinder K.] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Bainbridge, Travis; Ernst, James A.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Gustafson, Amy; Liu, Yichin] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [van der Brug, Marcel] Genentech Inc, ITGR Diagnost Discovery, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ernst, JA (corresponding author), Genentech Inc, Dept Prot Chem, 1 DNA Way, San Francisco, CA 94080 USA.	jernst@gene.com; rwatts@gene.com; jatwal@gene.com						Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Carlson C. B., 2014, SOC NEUR ANN M NOV 1; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cruchaga C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031039; Cruts M, 1998, HUM MOL GENET, V7, P43, DOI 10.1093/hmg/7.1.43; De Jonghe C, 2001, HUM MOL GENET, V10, P1665, DOI 10.1093/hmg/10.16.1665; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Fagan AM, 2000, ANN NEUROL, V48, P201, DOI 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X; FERNANDEZMADRID I, 1991, ANN NEUROL, V30, P730, DOI 10.1002/ana.410300516; Fleisher AS, 2013, NEUROBIOL AGING, V34, P1, DOI 10.1016/j.neurobiolaging.2012.04.017; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 2001, NEUROSCI LETT, V306, P203, DOI 10.1016/S0304-3940(01)01910-3; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kauwe JSK, 2007, ANN NEUROL, V61, P446, DOI 10.1002/ana.21099; Kwok JBJ, 2000, ANN NEUROL, V47, P249, DOI 10.1002/1531-8249(200002)47:2<249::AID-ANA18>3.3.CO;2-#; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-19; Tamayev R, 2012, EMBO MOL MED, V4, P171, DOI 10.1002/emmm.201100195; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; Zhou L, 2011, EMBO MOL MED, V3, P291, DOI 10.1002/emmm.201100138	33	137	140	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					30990	31000		10.1074/jbc.M114.589069	http://dx.doi.org/10.1074/jbc.M114.589069			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25253696	Green Published, hybrid			2022-12-28	WOS:000344549900010
J	Sood, R; Minzel, W; Rimon, G; Tal, S; Barki-Harrington, L				Sood, Rapita; Minzel, Waleed; Rimon, Gilad; Tal, Sharon; Barki-Harrington, Liza			Down-regulation of Cyclooxygenase-2 by the Carboxyl Tail of the Angiotensin II Type 1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEGRADATION; PROTEIN; EXPRESSION; BETA-ARRESTIN-2; UBIQUITINATION; ACTIVATION; INTERACTS; KINASE-1; PATHWAYS; AT(1)	The enzyme cyclooxygenase-2 (COX-2) plays an important role in the kidney by up-regulating the production of the vasoconstrictor hormone angiotensin II (AngII), which in turn down-regulates COX-2 expression via activation of the angiotensin II type 1 receptor (AT(1)) receptor. Chemical inhibition of the catalytic activity of COX-2 is a well-established strategy for treating inflammation but little is known of cellular mechanisms that dispose of the protein itself. Here we show that in addition to its indirect negative feedback on COX-2, AT1 also down-regulates the expression of the COX-2 protein via a pathway that does not involve G-protein or beta-arrestin-dependent signaling. Instead, AT(1) enhances the ubiquitination and subsequent degradation of the enzyme in the proteasome through elements in its cytosolic carboxyl tail (CT). We find that a mutant receptor that lacks the last 35 amino acids of its CT (Delta 324) is devoid of its ability to reduce COX-2, and that expression of the CT sequence alone is sufficient to down-regulate COX-2. Collectively these results propose a new role for AT(1) in regulating COX-2 expression in a mechanism that deviates from its canonical signaling pathways. Down-regulation of COX-2 by a short peptide that originates from AT(1) may present as a basis for novel therapeutic means of eliminating excess COX-2 protein.	[Sood, Rapita; Minzel, Waleed; Tal, Sharon; Barki-Harrington, Liza] Univ Haifa, Fac Nat Sci, Dept Human Biol, IL-3498838 Haifa, Israel; [Rimon, Gilad] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, IL-84105 Beer Sheva, Israel	University of Haifa; Ben Gurion University	Barki-Harrington, L (corresponding author), Univ Haifa, Fac Nat Sci, Dept Human Biol, 199 Aba Khoushy Ave Mt Carmel, IL-3498838 Haifa, Israel.	lbarki@psy.haifa.ac.il			United States Israel Binational Science Foundation [2009246]	United States Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by the United States Israel Binational Science Foundation Grant 2009246 (to L.B.H.).	Ali MS, 1997, J BIOL CHEM, V272, P23382, DOI 10.1074/jbc.272.37.23382; Brender S, 2014, BIOCHEM BIOPH RES CO, V451, P319, DOI 10.1016/j.bbrc.2014.07.123; Chen SF, 2013, J BIOL CHEM, V288, P33462, DOI 10.1074/jbc.M113.521799; Cheng HF, 1999, J CLIN INVEST, V103, P953, DOI 10.1172/JCI5505; Daviet L, 1999, J BIOL CHEM, V274, P17058, DOI 10.1074/jbc.274.24.17058; Haddad A, 2012, J BIOL CHEM, V287, P17214, DOI 10.1074/jbc.M111.304220; Harris RC, 2004, ACTA PHYSIOL SCAND, V181, P543, DOI 10.1111/j.1365-201X.2004.01329.x; HARRIS RC, 1994, J CLIN INVEST, V94, P2504, DOI 10.1172/JCI117620; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Mbonye UR, 2009, BMB REP, V42, P552, DOI 10.5483/BMBRep.2009.42.9.552; Neuss H, 2007, J MOL MED-JMM, V85, P961, DOI 10.1007/s00109-007-0197-y; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Spector-Chotiner A, 2014, BIOCHEM BIOPH RES CO, V443, P738, DOI 10.1016/j.bbrc.2013.12.038; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; Wei HJ, 2004, J BIOL CHEM, V279, P48255, DOI 10.1074/jbc.M406205200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Zhang MZ, 2006, P NATL ACAD SCI USA, V103, P16045, DOI 10.1073/pnas.0602176103	21	6	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31473	31479		10.1074/jbc.M114.587576	http://dx.doi.org/10.1074/jbc.M114.587576			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25231994	Green Published, hybrid			2022-12-28	WOS:000344549900049
J	Grenier, K; Kontogiannea, M; Fon, EA				Grenier, Karl; Kontogiannea, Maria; Fon, Edward A.			Short Mitochondrial ARF Triggers Parkin/PINK1-dependent Mitophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Mitophagy; Parkin; Parkinson Disease; PTEN-induced Putative Kinase 1 (PINK1); smARF	PARKINSONS-DISEASE; DAMAGED MITOCHONDRIA; ACTIVATE PARKIN; MITOFUSIN 1; PINK1; UBIQUITIN; NEURONS; DEGRADATION; AUTOPHAGY; P19(ARF)	Background: PINK1 and Parkin promote mitochondrial autophagy upon loss of mitochondrial membrane potential. Results: smARF induces Parkin/PINK1-mitochondrial autophagy in neurons. Conclusion: smARF is upstream of Parkin and PINK1 in mitochondrial autophagy. Significance: Parkin/PINK1-mitochondrial autophagy can be triggered by intrinsic signaling. Parkinson disease (PD) is a complex neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra. Multiple genes have been associated with PD, including Parkin and PINK1. Recent studies have established that the Parkin and PINK1 proteins function in a common mitochondrial quality control pathway, whereby disruption of the mitochondrial membrane potential leads to PINK1 stabilization at the mitochondrial outer surface. PINK1 accumulation leads to Parkin recruitment from the cytosol, which in turn promotes the degradation of the damaged mitochondria by autophagy (mitophagy). Most studies characterizing PINK1/Parkin mitophagy have relied on high concentrations of chemical uncouplers to trigger mitochondrial depolarization, a stimulus that has been difficult to adapt to neuronal systems and one unlikely to faithfully model the mitochondrial damage that occurs in PD. Here, we report that the short mitochondrial isoform of ARF (smARF), previously identified as an alternate translation product of the tumor suppressor p19ARF, depolarizes mitochondria and promotes mitophagy in a Parkin/PINK1-dependent manner, both in cell lines and in neurons. The work positions smARF upstream of PINK1 and Parkin and demonstrates that mitophagy can be triggered by intrinsic signaling cascades.	McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; McGill Univ, Montreal Neurol Inst, McGill Parkinson Program, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Fon, EA (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St,Rm MP038, Montreal, PQ H3A 2B4, Canada.	ted.fon@mcgill.ca			Graduate Student Award from Parkinson Society Canada; Canadian Institutes of Health Research [MOP-62714]	Graduate Student Award from Parkinson Society Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Graduate Student Award from Parkinson Society Canada (to K. G.) and an operating grant (MOP-62714) from the Canadian Institutes of Health Research (to E. A. F.).	Abdouh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031870; Abida WM, 2008, CANCER RES, V68, P352, DOI 10.1158/0008-5472.CAN-07-2069; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Cai Q, 2012, CURR BIOL, V22, P545, DOI 10.1016/j.cub.2012.02.005; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Corti O, 2013, CURR OPIN NEUROBIOL, V23, P100, DOI 10.1016/j.conb.2012.11.002; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Grenier K, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00100; Hulleman E, 2005, ADV CANCER RES, V94, P1, DOI 10.1016/S0065-230X(05)94001-3; Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Koyano F, 2013, GENES CELLS, V18, P672, DOI 10.1111/gtc.12066; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Moore PS, 2010, NAT REV CANCER, V10, P878, DOI 10.1038/nrc2961; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pimkina J, 2009, J BIOL CHEM, V284, P2803, DOI 10.1074/jbc.M804705200; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680; Reef S, 2008, AUTOPHAGY, V4, P866, DOI 10.4161/auto.6691; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Spratt DE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2983; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Van Laar VS, 2011, HUM MOL GENET, V20, P927, DOI 10.1093/hmg/ddq531; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	48	22	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29519	29530		10.1074/jbc.M114.607150	http://dx.doi.org/10.1074/jbc.M114.607150			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25217637	hybrid, Green Published			2022-12-28	WOS:000344370800005
J	Ono, K; Fujimoto, E; Fujimoto, N; Akiyama, M; Satoh, T; Maeda, H; Fujii, N; Tajima, S				Ono, Koji; Fujimoto, Eita; Fujimoto, Norihiro; Akiyama, Minoru; Satoh, Takahiro; Maeda, Hiroki; Fujii, Noriko; Tajima, Shingo			In Vitro Amyloidogenic Peptides of Galectin-7 POSSIBLE MECHANISM OF AMYLOIDOGENESIS OF PRIMARY LOCALIZED CUTANEOUS AMYLOIDOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRIL FORMATION; THIOFLAVIN-T; INTRACELLULAR ACIDIFICATION; P COMPONENT; APOPTOSIS; BETA; SKIN; BETA(2)-MICROGLOBULIN; ACTIVATION; KERATIN	Pathogenesis of primary localized cutaneous amyloidosis (PLCA) is unclear, but pathogenic relationship to keratinocyte apoptosis has been implicated. We have previously identified galectin-7, actin, and cytokeratins as the major constituents of PLCA. Determination of the amyloidogenetic potential of these proteins by thioflavin T (ThT) method demonstrated that galectin-7 molecule incubated at pH 2.0 was capable of binding to the dye, but failed to form amyloid fibrils. When a series of galectin-7 fragments containing beta-strand peptides were prepared to compare their amyloidogenesis, Ser(31)-Gln(67) and Arg(120)-Phe(136) were aggregated to form amyloid fibrils at pH 2.0. The rates of aggregation of Ser(31)-Gln(67) and Arg(120)-Phe(136) were dose-dependent with maximal ThT levels after 3 and 48 h, respectively. Their synthetic analogs, Phe(33)-Lys(65) and Leu(121)-Arg(134), which are both putative tryptic peptides, showed comparable amyloidogenesis. The addition of sonicated fibrous form of Ser(31)-Gln(67) or Phe(33)-Lys(65) to monomeric Ser(31)-Gln(67) or Phe(33)-Lys(65) solution, respectively, resulted in an increased rate of aggregation and extension of amyloid fibrils. Amyloidogenic potentials of Ser(31)-Gln(67) and Phe(33)-Lys(65) were inhibited by actin and cytokeratin fragments, whereas those of Arg(120)-Phe(136) and Leu(121)-Arg(134) were enhanced in the presence of Gly(84)-Arg(113), a putative tryptic peptide of galectin-7. Degraded fragments of the galectin-7 molecule produced by limited trypsin digestion, formed amyloid fibrils after incubation at pH 2.0. These results suggest that the tryptic peptides of galectin-7 released at neutral pH, may lead to amyloid fibril formation of PLCA in the intracellular acidified conditions during keratinocyte apoptosis via regulation by the galectin-7 peptide as well as actin and cytokeratins.	[Ono, Koji; Fujimoto, Eita; Fujimoto, Norihiro; Akiyama, Minoru; Satoh, Takahiro; Tajima, Shingo] Natl Def Med Coll, Dept Dermatol, Tokorozawa, Saitama 3598513, Japan; [Maeda, Hiroki; Fujii, Noriko] Kyoto Univ, Inst Res Reactor, Osaka 5900494, Japan	National Defense Medical College - Japan; Kyoto University	Ono, K (corresponding author), Natl Def Med Coll, Dept Dermatol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	drde998@ndmc.ac.jp						Arita K, 2008, AM J HUM GENET, V82, P73, DOI 10.1016/j.ajhg.2007.09.002; Bernerd F, 1999, P NATL ACAD SCI USA, V96, P11329, DOI 10.1073/pnas.96.20.11329; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; BREATHNACH SM, 1981, BRIT J DERMATOL, V105, P115, DOI 10.1111/j.1365-2133.1981.tb01195.x; Chang YT, 1999, BRIT J DERMATOL, V140, P210, DOI 10.1111/j.1365-2133.1999.02651.x; Choi CY, 2000, J ANIM SCI, V78, P2990; Conus S, 2012, J BIOL CHEM, V287, P21142, DOI 10.1074/jbc.M111.306399; Debela M, 2008, BIOL CHEM, V389, P623, DOI 10.1515/BC.2008.075; Esler WP, 1999, METHOD ENZYMOL, V309, P350; ETO H, 1984, AM J PATHOL, V116, P473; Furumoto H, 1998, J INVEST DERMATOL, V111, P417, DOI 10.1046/j.1523-1747.1998.00294.x; Gendronneau G, 2008, MOL BIOL CELL, V19, P5541, DOI 10.1091/mbc.E08-02-0166; GLENNER GG, 1980, NEW ENGL J MED, V302, P1283, DOI 10.1056/NEJM198006053022305; GOTTLIEB RA, 1995, P NATL ACAD SCI USA, V92, P5965, DOI 10.1073/pnas.92.13.5965; Gottlieb RA, 1996, P NATL ACAD SCI USA, V93, P654, DOI 10.1073/pnas.93.2.654; HASHIMOTO K, 1984, J INVEST DERMATOL, V82, P1, DOI 10.1111/1523-1747.ep12258661; Heenan PJ, 2005, LEVERS HISTOPATHOLOG, V9th, P980; HINTNER H, 1988, J INVEST DERMATOL, V91, P22, DOI 10.1111/1523-1747.ep12463283; Hsu DK, 2006, METHOD ENZYMOL, V417, P256, DOI 10.1016/S0076-6879(06)17018-4; Inoue K, 2000, AMYLOID, V7, P259, DOI 10.3109/13506120009146439; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; JONES JCR, 1982, CELL MOTIL CYTOSKEL, V2, P197, DOI 10.1002/cm.970020302; Jones S, 2003, J MOL BIOL, V325, P249, DOI 10.1016/S0022-2836(02)01227-5; Kagedal K, 2001, FASEB J, V15, P1592, DOI 10.1096/fj.00-0708fje; Kalagala Y., 1992, BIOCHEM BIOPH RES CO, V182, P1440; KOBAYASHI H, 1983, J INVEST DERMATOL, V80, P66, DOI 10.1111/1523-1747.ep12531130; Kozhukh GV, 2002, J BIOL CHEM, V277, P1310, DOI 10.1074/jbc.M108753200; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Kuwabara I, 2002, J BIOL CHEM, V277, P3487, DOI 10.1074/jbc.M109360200; Leonidas DD, 1998, BIOCHEMISTRY-US, V37, P13930, DOI 10.1021/bi981056x; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LI JF, 1995, J BIOL CHEM, V270, P3203, DOI 10.1074/jbc.270.7.3203; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; MADSEN P, 1995, J BIOL CHEM, V270, P5823, DOI 10.1074/jbc.270.11.5823; Magnaldo T, 1998, DIFFERENTIATION, V63, P159, DOI 10.1046/j.1432-0436.1998.6330159.x; Meisenholder GW, 1996, J BIOL CHEM, V271, P16260, DOI 10.1074/jbc.271.27.16260; Miura Y, 2013, EXP DERMATOL, V22, P36, DOI 10.1111/exd.12065; Naiki H, 1999, METHOD ENZYMOL, V309, P305; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nakanishi J, 2010, J INVEST DERMATOL, V130, P944, DOI 10.1038/jid.2009.364; NEWTON JA, 1985, BRIT J DERMATOL, V112, P201, DOI 10.1111/j.1365-2133.1985.tb00084.x; Ohhashi Y, 2004, J BIOL CHEM, V279, P10814, DOI 10.1074/jbc.M310334200; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; Rodriguez J, 2008, J PROTEOME RES, V7, P300, DOI 10.1021/pr0705035; Sasahara K, 2007, BIOCHEMISTRY-US, V46, P3286, DOI 10.1021/bi602403v; SHIRAHAMA T, 1967, J CELL BIOL, V33, P679, DOI 10.1083/jcb.33.3.679; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; Wang HQ, 2003, J BIOL CHEM, V278, P45737, DOI 10.1074/jbc.M300574200; Yamaguchi I, 2001, AMYLOID, V8, P30, DOI 10.3109/13506120108993812; Zhivotovsky B, 1997, BIOCHEM BIOPH RES CO, V230, P481, DOI 10.1006/bbrc.1996.6016	51	7	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29195	29207		10.1074/jbc.M114.592998	http://dx.doi.org/10.1074/jbc.M114.592998			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25172508	hybrid, Green Published			2022-12-28	WOS:000344141000035
J	Torsvik, J; Johansson, BB; Dalva, M; Marie, M; Fjeld, K; Johansson, S; Bjorkoy, G; Saraste, J; Njolstad, PR; Molven, A				Torsvik, Janniche; Johansson, Bente B.; Dalva, Monica; Marie, Michael; Fjeld, Karianne; Johansson, Stefan; Bjorkoy, Geir; Saraste, Jaakko; Njolstad, Pal R.; Molven, Anders			Endocytosis of Secreted Carboxyl Ester Lipase in a Syndrome of Diabetes and Pancreatic Exocrine Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT-DEPENDENT LIPASE; STIMULATED LIPASE; HUMAN-MILK; SUBSTRATE-SPECIFICITY; ACTIVATED LIPASE; CEL GENE; PROTEIN; AUTOPHAGY; MUTATIONS; GLYCOSYLATION	Maturity-onset diabetes of the young, type 8 (MODY8) is characterized by a syndrome of autosomal dominantly inherited diabetes and exocrine pancreatic dysfunction. It is caused by deletion mutations in the last exon of the carboxyl ester lipase (CEL) gene, resulting in a CEL protein with increased tendency to aggregate. In this study we investigated the intracellular distribution of the wild type (WT) and mutant (MUT) CEL proteins in cellular models. We found that both CEL-WT and CEL-MUT were secreted via the endoplasmic reticulum and Golgi compartments. However, their subcellular distributions differed, as only CEL-MUT was observed as an aggregate at the cell surface and inside large cytoplasmic vacuoles. Many of the vacuoles were identified as components of the endosomal system, and after its secretion, the mutant CEL protein was re-internalized, transported to the lysosomes, and degraded. Internalization of CEL-MUT also led to reduced viability of pancreatic acinar and beta cells. These findings may have implications for the understanding of how the acinar-specific CEL-MUT protein causes both exocrine and endocrine pancreatic disease.	[Torsvik, Janniche; Johansson, Bente B.; Dalva, Monica; Fjeld, Karianne; Johansson, Stefan; Njolstad, Pal R.; Molven, Anders] Univ Bergen, KG Jebsen Ctr Diabet Res, Dept Clin Sci, N-5021 Bergen, Norway; [Torsvik, Janniche; Johansson, Bente B.; Dalva, Monica; Fjeld, Karianne; Johansson, Stefan] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Dalva, Monica; Molven, Anders] Univ Bergen, Gade Lab Pathol, Dept Clin Med, N-5021 Bergen, Norway; [Marie, Michael; Saraste, Jaakko] Univ Bergen, Dept Biomed, N-5021 Bergen, Norway; [Marie, Michael; Saraste, Jaakko] Univ Bergen, Mol Imaging Ctr, N-5021 Bergen, Norway; [Bjorkoy, Geir] Univ Coll Sor Trondelag, Dept Technol, Trondheim, Norway; [Bjorkoy, Geir] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Ctr Mol Inflammat Res, N-7034 Trondheim, Norway; [Njolstad, Pal R.] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Molven, Anders] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Molven, A (corresponding author), Univ Bergen, Gade Lab Pathol, Dept Clin Med, N-5021 Bergen, Norway.	anders.molven@gades.uib.no	Johansson, Bente Berg/AAE-7666-2022; Fjeld, Karianne/Q-7122-2018; Johansson, Stefan/C-4394-2011	Fjeld, Karianne/0000-0003-0441-1475; Johansson, Stefan/0000-0002-2298-7008; Bjorkoy, Geir/0000-0003-0031-8361; Johansson, Bente Berg/0000-0001-8893-1915	Translational Fund of the Bergen Medical Research Foundation; KG Jebsen Foundation; University of Bergen; Research Council of Norway; Haukeland University Hospital; Innovest; Western Norway Regional Health Authority	Translational Fund of the Bergen Medical Research Foundation; KG Jebsen Foundation; University of Bergen; Research Council of Norway(Research Council of Norway); Haukeland University Hospital; Innovest; Western Norway Regional Health Authority	This work was supported by grants from the Translational Fund of the Bergen Medical Research Foundation, the KG Jebsen Foundation, the University of Bergen, the Research Council of Norway, Haukeland University Hospital, Innovest, and the Western Norway Regional Health Authority (to A. M. and P. R. N.).	ABOUAKIL N, 1993, J BIOL CHEM, V268, P25755; BERNBACK S, 1990, J CLIN INVEST, V85, P1221, DOI 10.1172/JCI114556; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; BLACKBERG L, 1987, FEBS LETT, V217, P37, DOI 10.1016/0014-5793(87)81237-1; Brown W. J., 1999, CURRENT PROTOCOLS CE; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; BRUNEAU N, 1995, EUR J BIOCHEM, V233, P209, DOI 10.1111/j.1432-1033.1995.209_1.x; Bruneau N, 2000, MICROSC RES TECHNIQ, V49, P329, DOI 10.1002/(SICI)1097-0029(20000515)49:4<329::AID-JEMT2>3.0.CO;2-H; Bruneau N, 2003, MOL BIOL CELL, V14, P2861, DOI 10.1091/mbc.E02-08-0544; Bruneau N, 1997, J BIOL CHEM, V272, P27353, DOI 10.1074/jbc.272.43.27353; Bruneau N, 1998, J CELL SCI, V111, P2665; BRUNEAU N, 1995, J BIOL CHEM, V270, P13524, DOI 10.1074/jbc.270.22.13524; Caillol N, 1997, LIPIDS, V32, P1147, DOI 10.1007/s11745-997-0147-4; Chen N, 2011, J CLIN GASTROENTEROL, V45, P850, DOI 10.1097/MCG.0b013e31822a2ae5; Comte B, 2006, KIDNEY INT, V69, P1048, DOI 10.1038/sj.ki.5000133; DOWNS D, 1994, BIOCHEMISTRY-US, V33, P7979, DOI 10.1021/bi00192a001; FEBBRAIO M, 1990, J BIOL CHEM, V265, P18531; Franceschi C, 2011, J IMMUNOL, V186, P4067, DOI 10.4049/jimmunol.1000408; HANSSON L, 1993, J BIOL CHEM, V268, P26692; Higuchi S, 2002, J HUM GENET, V47, P213, DOI 10.1007/s100380200027; Johansson BB, 2011, J BIOL CHEM, V286, P34593, DOI 10.1074/jbc.M111.222679; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lindquist S, 2002, EUR J BIOCHEM, V269, P759, DOI 10.1046/j.0014-2956.2001.02666.x; LOMBARDO D, 1980, BIOCHIM BIOPHYS ACTA, V611, P136, DOI 10.1016/0005-2744(80)90049-2; LOMBARDO D, 1978, BIOCHIM BIOPHYS ACTA, V527, P142, DOI 10.1016/0005-2744(78)90263-2; LOMBARDO D, 1980, BIOCHIM BIOPHYS ACTA, V611, P147, DOI 10.1016/0005-2744(80)90050-9; Loomes KM, 1999, EUR J BIOCHEM, V266, P105, DOI 10.1046/j.1432-1327.1999.00824.x; Loomes KM, 1997, FEBS LETT, V405, P369, DOI 10.1016/S0014-5793(97)00215-9; LOOMES KM, 1995, EUR J BIOCHEM, V230, P607; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pasqualini E, 2000, BIOCHEM J, V345, P121, DOI 10.1042/0264-6021:3450121; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Raeder H, 2007, DIABETES, V56, P444, DOI 10.2337/db06-0859; Raeder H, 2014, DIABETES, V63, P259, DOI 10.2337/db13-1012; Ragvin A, 2013, PANCREATOLOGY, V13, P29, DOI 10.1016/j.pan.2012.12.059; REUE K, 1991, J LIPID RES, V32, P267; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; ROUDANI S, 1995, BBA-GENE STRUCT EXPR, V1264, P141, DOI 10.1016/0167-4781(95)00141-3; Sannerud R, 2006, MOL BIOL CELL, V17, P1514, DOI 10.1091/mbc.E05-08-0792; Sannerud Ragna, 2008, V457, P253, DOI 10.1007/978-1-59745-261-8_19; Sasikala M, 2012, DIGEST DIS SCI, V57, P1764, DOI 10.1007/s10620-012-2086-7; Teo AKK, 2013, J BIOL CHEM, V288, P5353, DOI 10.1074/jbc.C112.428979; Tjora E, 2013, PANCREAS, V42, P1078, DOI 10.1097/MPA.0b013e3182920e9c; Torsvik J, 2010, HUM GENET, V127, P55, DOI 10.1007/s00439-009-0740-8; Vesterhus M, 2010, PANCREATOLOGY, V10, P467, DOI 10.1159/000266284; Watanabe Y, 2011, J CELL SCI, V124, P2692, DOI 10.1242/jcs.081232; Ying M, 2000, J CELL SCI, V113, P3623; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023	53	27	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29097	29111		10.1074/jbc.M114.574244	http://dx.doi.org/10.1074/jbc.M114.574244			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25160620	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000344141000027
J	Yu, H; Hausinger, RP; Tang, HZ; Xu, P				Yu, Hao; Hausinger, Robert P.; Tang, Hong-Zhi; Xu, Ping			Mechanism of the 6-Hydroxy-3-succinoyl-pyridine 3-Monooxygenase Flavoprotein from Pseudomonas putida S16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTAINING MONO-OXYGENASE; NICOTINE DEGRADATION; HALF-REACTION; STRAIN S16; MONOOXYGENASES; PYRIDINE; FLAVOENZYMES; DERIVATIVES; IDENTIFICATION; 1-HYDROXYLASE	6-Hydroxy-3-succinoyl-pyridine (HSP) 3-monooxygenase (HspB), a flavoprotein essential to the pyrrolidine pathway of nicotine degradation, catalyzes pyridine-ring beta-hydroxylation, resulting in carbon-carbon cleavage and production of 2,5-dihydroxypyridine. Here, we generated His(6)-tagged HspB in Escherichia coli, characterized the properties of the recombinant enzyme, and investigated its mechanism of catalysis. In contrast to conclusions reported previously, the second product of the HspB reaction was shown to be succinate, with isotope labeling experiments providing direct evidence that the newly introduced oxygen atom of succinate is derived from H2O. Phylogenetic analysis reveals that HspB is the most closely related to two p-nitrophenol 4-monooxygenases, and the experimental results exhibit that p-nitrophenol is a substrate of HspB. The reduction of HspB (with maxima at 375 and 460 nm, and a shoulder at 485 nm) by NADH was followed by stopped-flow spectroscopy, and the rate constant for reduction was shown to be stimulated by HSP. Reduced HspB reacts with oxygen to form a C-(4a)-(hydro)peroxyflavin intermediate with an absorbance maximum at similar to 400 nm within the first few milliseconds before converting to the oxidized flavoenzyme species. The formed C-(4a)-hydroperoxyflavin intermediate reacts with HSP to form an intermediate that hydrolyzes to the products 2,5-dihydroxypyridine and succinate. The investigation on the catalytic mechanism of a flavoprotein pyridine-ring beta-position hydroxylase provides useful information for the biosynthesis of pyridine derivatives.	[Yu, Hao; Tang, Hong-Zhi; Xu, Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Yu, Hao; Tang, Hong-Zhi; Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China; [Hausinger, Robert P.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Michigan State University	Xu, P (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China.	pingxu@sjtu.edu.cn		Hausinger, Robert/0000-0002-3643-2054; Xu, Ping/0000-0002-4418-9680	Chinese National Natural Science Foundation [31230002, 31270154, 31121064]; Shanghai Rising-Star Program [13QA1401700]; Shanghai Jiao Tong University	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Shanghai Jiao Tong University	This work was supported in part by grants from the Chinese National Natural Science Foundation Grants 31230002, 31270154, and 31121064, "Shanghai Rising-Star Program" Grant 13QA1401700, and the "Chen Xing" project from Shanghai Jiao Tong University.	BEATY NB, 1981, J BIOL CHEM, V256, P4619; BEATY NB, 1981, J BIOL CHEM, V256, P4611; Brandsch R, 2006, APPL MICROBIOL BIOT, V69, P493, DOI 10.1007/s00253-005-0226-0; Bull JA, 2012, CHEM REV, V112, P2642, DOI 10.1021/cr200251d; Crozier-Reabe K, 2012, INT J MOL SCI, V13, P15601, DOI 10.3390/ijms131215601; Eppink MHM, 1997, J BACTERIOL, V179, P6680, DOI 10.1128/jb.179.21.6680-6687.1997; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Gabriel DW, 2006, MOL PLANT MICROBE IN, V19, P69, DOI 10.1094/MPMI-19-0069; Gadda G., 2012, HDB FLAVOPROTEINS; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; GRETHERBECK S, 1994, MOL MICROBIOL, V13, P929, DOI 10.1111/j.1365-2958.1994.tb00484.x; HARELAND WA, 1975, J BACTERIOL, V121, P272, DOI 10.1128/JB.121.1.272-285.1975; Hill MD, 2010, CHEM-EUR J, V16, P12052, DOI 10.1002/chem.201001100; Hille R, 2005, ARCH BIOCHEM BIOPHYS, V433, P107, DOI 10.1016/j.abb.2004.08.012; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Jimenez JI, 2008, P NATL ACAD SCI USA, V105, P11329, DOI 10.1073/pnas.0802273105; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; Kaiser JP, 1996, MICROBIOL REV, V60, P483, DOI 10.1128/MMBR.60.3.483-498.1996; Kamerbeek NM, 2001, EUR J BIOCHEM, V268, P2547, DOI 10.1046/j.1432-1327.2001.02137.x; Leisch H, 2011, CHEM REV, V111, P4165, DOI 10.1021/cr1003437; Liu CL, 2013, ARKIVOC, P154, DOI 10.3998/ark.5550190.0014.105; Nakano H, 1999, EUR J BIOCHEM, V260, P120, DOI 10.1046/j.1432-1327.1999.00124.x; Pazmino DET, 2010, J BIOTECHNOL, V146, P9, DOI 10.1016/j.jbiotec.2010.01.021; Peng Q, 1997, CANCER-AM CANCER SOC, V79, P2282; Petersen M, 1999, GREEN CHEM, V1, P99, DOI 10.1039/a809538h; Romero E, 2012, BBA-PROTEINS PROTEOM, V1824, P850, DOI 10.1016/j.bbapap.2012.03.004; Shen WJ, 2010, BIORESOURCE TECHNOL, V101, P7516, DOI 10.1016/j.biortech.2010.04.052; Sucharitakul J, 2013, J BIOL CHEM, V288, P35210, DOI 10.1074/jbc.M113.515205; Sun JQ, 2014, APPL MICROBIOL BIOT, V98, P455, DOI 10.1007/s00253-013-4818-9; Tang HZ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003923; Tang HZ, 2011, J BIOL CHEM, V286, P39179, DOI 10.1074/jbc.M111.283929; Treiber N, 2008, J MOL BIOL, V379, P94, DOI 10.1016/j.jmb.2008.03.032; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d; WAN P, 1988, J AM CHEM SOC, V110, P4336, DOI 10.1021/ja00221a038; Wang SN, 2007, MICROBIOL-SGM, V153, P1556, DOI 10.1099/mic.0.2006/005223-0; Wang SN, 2005, ENVIRON SCI TECHNOL, V39, P6877, DOI 10.1021/es0500759; Wei Q, 2010, BIODEGRADATION, V21, P575, DOI 10.1007/s10532-009-9325-4; Wu XF, 2013, CHEM REV, V113, P1, DOI 10.1021/cr300100s; Yu H, 2011, J BACTERIOL, V193, P5541, DOI 10.1128/JB.05663-11; Zhang JJ, 2009, J BACTERIOL, V191, P2703, DOI 10.1128/JB.01566-08	42	23	26	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29158	29170		10.1074/jbc.M114.558049	http://dx.doi.org/10.1074/jbc.M114.558049			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25172510	Green Published, hybrid			2022-12-28	WOS:000344141000032
J	Mehnert, CS; Rampelt, H; Gebert, M; Oeljeklaus, S; Schrempp, SG; Kochbeck, L; Guiard, B; Warscheid, B; van der Laan, M				Mehnert, Carola S.; Rampelt, Heike; Gebert, Michael; Oeljeklaus, Silke; Schrempp, Sandra G.; Kochbeck, Lioba; Guiard, Bernard; Warscheid, Bettina; van der Laan, Martin			The Mitochondrial ADP/ATP Carrier Associates with the Inner Membrane Presequence Translocase in a Stoichiometric Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN; PROTEIN IMPORT; OXIDATIVE-PHOSPHORYLATION; SUPERCOMPLEX ORGANIZATION; YEAST MITOCHONDRIA; TIM23 MACHINERY; CONTACT SITES; ATP SYNTHASE; COMPLEX; MOTOR	The majority of mitochondrial proteins are synthesized with amino-terminal signal sequences. The presequence translocase of the inner membrane (TIM23 complex) mediates the import of these preproteins. The essential TIM23 core complex closely cooperates with partner protein complexes like the presequence translocase-associated import motor and the respiratory chain. The inner mitochondrial membrane also contains a large number of metabolite carriers, but their association with preprotein translocases has been controversial. We performed a comprehensive analysis of the TIM23 interactome based on stable isotope labeling with amino acids in cell culture. Subsequent biochemical studies on identified partner proteins showed that the mitochondrial ADP/ATP carrier associates with the membrane-embedded core of the TIM23 complex in a stoichiometric manner, revealing an unexpected connection of mitochondrial protein biogenesis to metabolite transport. Our data indicate that direct TIM23-AAC coupling may support preprotein import into mitochondria when respiratory activity is low.	[Mehnert, Carola S.; Rampelt, Heike; Gebert, Michael; Schrempp, Sandra G.; Kochbeck, Lioba; van der Laan, Martin] Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Mehnert, Carola S.; Gebert, Michael; Schrempp, Sandra G.] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Oeljeklaus, Silke; Warscheid, Bettina] Univ Freiburg, Fak Biol, Inst Biol 2, D-79104 Freiburg, Germany; [Oeljeklaus, Silke; Warscheid, Bettina; van der Laan, Martin] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany; [Guiard, Bernard] CNRS, Ctr Genet Mol, F-91190 Gif Sur Yvette, France	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	van der Laan, M (corresponding author), Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany.	martin.van.der.laan@biochemie.uni-freiburg.de		van der Laan, Martin/0000-0003-0789-9912; Rampelt, Heike/0000-0002-5458-5652; Warscheid, Bettina/0000-0001-5096-1975	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 746]; Excellence Initiative of the German Federal and State Governments [EXC 294 BIOSS]; Peter and Traudl Engelhorn Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; Peter and Traudl Engelhorn Foundation	This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 746; by the Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS); and by a postdoctoral fellowship of the Peter and Traudl Engelhorn Foundation (to H. R.).	Bohnert M, 2010, CURR BIOL, V20, P1227, DOI 10.1016/j.cub.2010.05.058; Castegna A, 2010, J BIOL CHEM, V285, P17359, DOI 10.1074/jbc.M109.097188; Chacinska A, 2003, EMBO J, V22, P5370, DOI 10.1093/emboj/cdg532; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Chacinska A, 2010, MOL CELL BIOL, V30, P307, DOI 10.1128/MCB.00749-09; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Dienhart MK, 2008, MOL BIOL CELL, V19, P3934, DOI 10.1091/mbc.E08-04-0402; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Dudek J, 2013, BBA-MOL CELL RES, V1833, P274, DOI 10.1016/j.bbamcr.2012.05.028; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Ferramosca A, 2013, BBA-MOL CELL RES, V1833, P494, DOI 10.1016/j.bbamcr.2012.11.014; Gebert M, 2012, J CELL BIOL, V197, P595, DOI 10.1083/jcb.201110047; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Gilkerson RW, 2003, FEBS LETT, V546, P355, DOI 10.1016/S0014-5793(03)00633-1; Giraud MF, 1997, EUR J BIOCHEM, V245, P813, DOI 10.1111/j.1432-1033.1997.00813.x; Gold VAM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5129; Habib SJ, 2007, METHOD CELL BIOL, V80, P761, DOI 10.1016/S0091-679X(06)80035-X; Hess DC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000407; Hutu DP, 2008, MOL BIOL CELL, V19, P2642, DOI 10.1091/mbc.E07-12-1226; Ieva R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3853; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Krayl M, 2007, MOL CELL BIOL, V27, P411, DOI 10.1128/MCB.01391-06; Kunji ERS, 2010, BBA-BIOENERGETICS, V1797, P817, DOI 10.1016/j.bbabio.2010.03.023; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Mick DU, 2012, CELL, V151, P1528, DOI 10.1016/j.cell.2012.11.053; Mokranjac D, 2005, J BIOL CHEM, V280, P23437, DOI 10.1074/jbc.C500135200; Mokranjac D, 2010, BBA-BIOENERGETICS, V1797, P1045, DOI 10.1016/j.bbabio.2010.01.026; Nury H, 2006, ANNU REV BIOCHEM, V75, P713, DOI 10.1146/annurev.biochem.75.103004.142747; Ohlmeier S, 2004, J BIOL CHEM, V279, P3956, DOI 10.1074/jbc.M310160200; Palmieri L, 2000, BBA-BIOENERGETICS, V1459, P363, DOI 10.1016/S0005-2728(00)00173-0; PFANNER N, 1987, CELL, V49, P815, DOI 10.1016/0092-8674(87)90619-2; Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Reif S, 2005, J MOL BIOL, V354, P520, DOI 10.1016/j.jmb.2005.09.054; Saddar S, 2008, J BIOL CHEM, V283, P6677, DOI 10.1074/jbc.M708440200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015; Stoldt S, 2012, MOL BIOL CELL, V23, P2292, DOI 10.1091/mbc.E11-06-0538; STUART RA, 1994, EUR J BIOCHEM, V220, P9, DOI 10.1111/j.1432-1033.1994.tb18593.x; Stuart RA, 2009, METHOD ENZYMOL, V456, P191, DOI 10.1016/S0076-6879(08)04411-X; Stuart RA, 2008, J BIOENERG BIOMEMBR, V40, P411, DOI 10.1007/s10863-008-9168-4; Traba J, 2009, MITOCHONDRION, V9, P79, DOI 10.1016/j.mito.2009.01.001; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; van der Laan M, 2006, CURR BIOL, V16, P2271, DOI 10.1016/j.cub.2006.10.025; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; WACHTER C, 1992, EMBO J, V11, P4787, DOI 10.1002/j.1460-2075.1992.tb05584.x; Wiedemann N, 2007, J CELL BIOL, V179, P1115, DOI 10.1083/jcb.200709087; Wittig I, 2009, BBA-BIOENERGETICS, V1787, P672, DOI 10.1016/j.bbabio.2008.12.016; Wurm CA, 2006, FEBS LETT, V580, P5628, DOI 10.1016/j.febslet.2006.09.012	52	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27352	27362		10.1074/jbc.M114.556498	http://dx.doi.org/10.1074/jbc.M114.556498			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25124039	Green Published, hybrid			2022-12-28	WOS:000342853900055
J	Pawellek, A; McElroy, S; Samatov, T; Mitchell, L; Woodland, A; Ryder, U; Gray, D; Luhrmann, R; Lamond, AI				Pawellek, Andrea; McElroy, Stuart; Samatov, Timur; Mitchell, Lee; Woodland, Andrew; Ryder, Ursula; Gray, David; Luehrmann, Reinhard; Lamond, Angus I.			Identification of Small Molecule Inhibitors of Pre-mRNA Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						High Throughput Screening; RNA; RNA Splicing; Small Molecule; Spliceosome; DDD00107587; Madrasin	NUCLEAR RIBONUCLEOPROTEIN-PARTICLES; IN-VITRO; CAJAL BODIES; HUMAN GENES; SPLICEOSOME; TARGET; PROTEIN; CANCER; CELLS; ASSAY	Background: There is a need for new small molecule pre-mRNA splicing inhibitors as biotools. Results: High throughput screening resulted in the identification of small molecule splicing inhibitors that are active in vitro and in cells. Conclusion: New small molecules for studying pre-mRNA splicing in vitro and in cells are identified. Significance: Small drug-like molecules are identified that modulate splicing in vitro and in cells. Eukaryotic pre-mRNA splicing is an essential step in gene expression for all genes that contain introns. In contrast to transcription and translation, few well characterized chemical inhibitors are available with which to dissect the splicing process, particularly in cells. Therefore, the identification of specific small molecules that either inhibit or modify pre-mRNA splicing would be valuable for research and potentially also for therapeutic applications. We have screened a highly curated library of 71,504 drug-like small molecules using a high throughput in vitro splicing assay. This identified 10 new compounds that both inhibit pre-mRNA splicing in vitro and modify splicing of endogenous pre-mRNA in cells. One of these splicing modulators, DDD00107587 (termed madrasin, i.e. 2-((7methoxy-4-methylquinazolin-2-yl)amino)-5,6-dimethylpyrimidin-4(3H)-one RNAsplicing inhibitor), was studied in more detail. Madrasin interferes with the early stages of spliceosome assembly and stalls spliceosome assembly at the A complex. Madrasin is cytotoxic at higher concentrations, although at lower concentrations it induces cell cycle arrest, promotes a specific reorganization of subnuclear protein localization, and modulates splicing of multiple pre-mRNAs in both HeLa and HEK293 cells.	[Pawellek, Andrea; Ryder, Ursula; Lamond, Angus I.] Univ Dundee, Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland; [McElroy, Stuart; Mitchell, Lee; Woodland, Andrew; Gray, David] Univ Dundee, Drug Discovery Unit, Dundee DD1 5EH, Scotland; [Samatov, Timur; Luehrmann, Reinhard] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	University of Dundee; University of Dundee; Max Planck Society	Lamond, AI (corresponding author), Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dow St, Dundee DD1 5EH, Scotland.	a.i.lamond@dundee.ac.uk	Gray, David W/F-6674-2011	Gray, David W/0000-0001-9512-3828	EU [LSHG-CT-2005-518238]; Wellcome Trust [073980/Z/03/Z]; GRE Strategic Award [097945/B/11/Z]; Biological Chemistry and Drug Discovery Strategic Award [100476/Z/12/Z]; MRC [MC_G0900864] Funding Source: UKRI; Medical Research Council [MC_G0900864] Funding Source: researchfish	EU(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); GRE Strategic Award; Biological Chemistry and Drug Discovery Strategic Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by EU FP6 EURASNET Grant LSHG-CT-2005-518238 and by Wellcome Trust Programme Grant 073980/Z/03/Z, GRE Strategic Award 097945/B/11/Z, and Biological Chemistry and Drug Discovery Strategic Award 100476/Z/12/Z.	Ahn EY, 2008, P NATL ACAD SCI USA, V105, P17103, DOI 10.1073/pnas.0802696105; Albert BJ, 2009, MOL CANCER THER, V8, P2308, DOI 10.1158/1535-7163.MCT-09-0051; Anderson ES, 2012, RNA, V18, P1041, DOI 10.1261/rna.032912.112; Berg MG, 2012, MOL CELL BIOL, V32, P1271, DOI 10.1128/MCB.05788-11; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Brenk R, 2008, CHEMMEDCHEM, V3, P435, DOI 10.1002/cmdc.200700139; Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894; Cioce M, 2006, J CELL BIOL, V175, P401, DOI 10.1083/jcb.200604099; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Dehm SM, 2013, CLIN CANCER RES, V19, P6064, DOI 10.1158/1078-0432.CCR-13-2461; Effenberger KA, 2013, J BIOMOL SCREEN, V18, P1110, DOI 10.1177/1087057113493117; Fan LY, 2011, ACS CHEM BIOL, V6, P582, DOI 10.1021/cb100356k; Gencheva M, 2010, J BIOL CHEM, V285, P35624, DOI 10.1074/jbc.M110.122309; Gendra E, 2007, J BIOL CHEM, V282, P11648, DOI 10.1074/jbc.M611126200; Ghosh AK, 2011, ORG LETT, V13, P66, DOI 10.1021/ol102549a; Hagiwara M, 2005, BBA-PROTEINS PROTEOM, V1754, P324, DOI 10.1016/j.bbapap.2005.09.010; Hasegawa M, 2011, ACS CHEM BIOL, V6, P229, DOI 10.1021/cb100248e; Hernandez-Lopez HR, 2012, BIOCHEM J, V445, P145, DOI 10.1042/BJ20120413; Hirose T, 2003, MOL CELL, V12, P113, DOI 10.1016/S1097-2765(03)00267-3; Jurica MS, 2008, NAT CHEM BIOL, V4, P3, DOI 10.1038/nchembio0108-3; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Krawczak M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/humu.20400; Kuhn AN, 2009, RNA, V15, P153, DOI 10.1261/rna.1332609; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Lim KH, 2011, P NATL ACAD SCI USA, V108, P11093, DOI 10.1073/pnas.1101135108; Machyna M, 2013, WIRES RNA, V4, P17, DOI 10.1002/wrna.1139; MERMOUD JE, 1992, NUCLEIC ACIDS RES, V20, P5263, DOI 10.1093/nar/20.20.5263; Mizui Y, 2004, J ANTIBIOT, V57, P188, DOI 10.7164/antibiotics.57.188; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; O'Brien K, 2008, J BIOL CHEM, V283, P33147, DOI 10.1074/jbc.M805556200; Pacheco TR, 2006, MOL BIOL CELL, V17, P4187, DOI 10.1091/mbc.E06-01-0036; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pilch B, 2001, CANCER RES, V61, P6876; Roybal GA, 2010, NUCLEIC ACIDS RES, V38, P6664, DOI 10.1093/nar/gkq494; Sakai T, 2004, J ANTIBIOT, V57, P180, DOI 10.7164/antibiotics.57.180; Samatov TR, 2012, CHEMBIOCHEM, V13, P640, DOI 10.1002/cbic.201100790; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; Tazi J, 2005, TRENDS BIOCHEM SCI, V30, P469, DOI 10.1016/j.tibs.2005.06.002; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; WATSON JV, 1987, CYTOMETRY, V8, P1, DOI 10.1002/cyto.990080101; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Yokoi A, 2011, FEBS J, V278, P4870, DOI 10.1111/j.1742-4658.2011.08387.x; Yoon SO, 2006, MOL CANCER THER, V5, P2666, DOI 10.1158/1535-7163.MCT-06-0321; Younis I, 2010, MOL CELL BIOL, V30, P1718, DOI 10.1128/MCB.01301-09; ZILLMANN M, 1988, MOL CELL BIOL, V8, P814, DOI 10.1128/MCB.8.2.814	51	49	54	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34683	34698		10.1074/jbc.M114.590976	http://dx.doi.org/10.1074/jbc.M114.590976			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25281741	Green Published, hybrid			2022-12-28	WOS:000346260800025
J	Milde, S; Coleman, MP				Milde, Stefan; Coleman, Michael P.			Identification of Palmitoyltransferase and Thioesterase Enzymes That Control the Subcellular Localization of Axon Survival Factor Nicotinamide Mononucleotide Adenylyltransferase 2 (NMNAT2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE INTERACTIONS; PALMITOYLATION; PROTEIN; TRAFFICKING; DEGENERATION; DEFICITS; MODEL; MICE; TRANSFERASES; EXPRESSION	The NAD-synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) is a critical survival factor for axons and its constant supply from neuronal cell bodies into axons is required for axon survival in primary culture neurites and axon extension in vivo. Recently, we showed that palmitoylation is necessary to target NMNAT2 to post-Golgi vesicles, thereby influencing its protein turnover and axon protective capacity. Here we find that NMNAT2 is a substrate for cytosolic thioesterases APT1 and APT2 and that palmitoylation/depalmitoylation dynamics are on a time scale similar to its short half-life. Interestingly, however, depalmitoylation does not release NMNAT2 from membranes. The mechanism of palmitoylation-independent membrane attachment appears to be mediated by the same minimal domain required for palmitoylation itself. Furthermore, we identify several zDHHC palmitoyltransferases that influence NMNAT2 palmitoylation and subcellular localization, among which a role for zDHHC17 (HIP14) in neuronal NMNAT2 palmitoylation is best supported by our data. These findings shed light on the enzymatic regulation of NMNAT2 palmitoylation and highlight individual thioesterases and palmitoyltransferases as potential targets to modulate NMNAT2-dependent axon survival.	[Milde, Stefan; Coleman, Michael P.] Babraham Inst, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Coleman, MP (corresponding author), Babraham Inst, Babraham Res Campus, Cambridge CB22 3AT, England.	michael.coleman@babraham.ac.uk			Medical Research Council; Biotechnology and Biological Sciences Research Council; BBSRC [BBS/E/B/0000M739, BBS/E/B/000C0417] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0417, BBS/E/B/0000M739] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Medical Research Council studentship (to S. M.) and a Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant (to M. P. C.).	Adibekian A, 2012, J AM CHEM SOC, V134, P10345, DOI 10.1021/ja303400u; Beirowski B, 2008, EUR J NEUROSCI, V28, P1166, DOI 10.1111/j.1460-9568.2008.06426.x; Chamberlain LH, 2013, BIOCHEM SOC T, V41, P62, DOI 10.1042/BST20120243; Charych EI, 2010, J NEUROSCI, V30, P9027, DOI 10.1523/JNEUROSCI.1635-10.2010; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Ferri A, 2003, CURR BIOL, V13, P669, DOI 10.1016/S0960-9822(03)00206-9; Gilley J, 2013, J NEUROSCI, V33, P13410, DOI 10.1523/JNEUROSCI.1534-13.2013; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Greaves J, 2010, J BIOL CHEM, V285, P24629, DOI 10.1074/jbc.M110.119289; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; Hasbani DM, 2006, EXP NEUROL, V202, P93, DOI 10.1016/j.expneurol.2006.05.017; Herincs Z, 2005, J CELL SCI, V118, P1687, DOI 10.1242/jcs.02296; Hirano T, 2009, BBA-MOL CELL BIOL L, V1791, P797, DOI 10.1016/j.bbalip.2009.05.001; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Kong E, 2013, J BIOL CHEM, V288, P9112, DOI 10.1074/jbc.M112.421073; Lau C, 2010, J BIOL CHEM, V285, P18868, DOI 10.1074/jbc.M110.107631; Levy AD, 2011, MOL BIOL CELL, V22, P1930, DOI 10.1091/mbc.E10-10-0824; Liang XQ, 2002, J BIOL CHEM, V277, P33032, DOI 10.1074/jbc.M204607200; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Linder ME, 2013, BIOCHEM SOC T, V41, P29, DOI 10.1042/BST20120328; Mayer PR, 2010, J BIOL CHEM, V285, P40387, DOI 10.1074/jbc.M110.178913; Milde S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02567; Milde S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001539; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Milnerwood AJ, 2013, P NATL ACAD SCI USA, V110, P20296, DOI 10.1073/pnas.1222384110; Rusch M, 2011, ANGEW CHEM INT EDIT, V50, P9838, DOI 10.1002/anie.201102967; Sajadi A, 2004, CURR BIOL, V14, P326, DOI 10.1016//j.cub.2004.01.053; Samsam M, 2003, J NEUROSCI, V23, P2833; Shin JE, 2012, P NATL ACAD SCI USA, V109, pE3696, DOI 10.1073/pnas.1216204109; Singaraja RR, 2011, HUM MOL GENET, V20, P3899, DOI 10.1093/hmg/ddr308; Tian LJ, 2012, J BIOL CHEM, V287, P14718, DOI 10.1074/jbc.M111.335547; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; Wiggins CM, 2011, J CELL SCI, V124, P969, DOI 10.1242/jcs.058438; Wiggins CM, 2010, CELL SIGNAL, V22, P801, DOI 10.1016/j.cellsig.2010.01.004; Xu J, 2012, BLOOD, V119, P1032, DOI 10.1182/blood-2011-06-358960; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702	45	23	23	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.582338	http://dx.doi.org/10.1074/jbc.M114.582338			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25271157	Green Published, hybrid			2022-12-28	WOS:000345335000039
J	Slavi, N; Rubinos, C; Li, LP; Sellitto, C; White, TW; Mathias, R; Srinivas, M				Slavi, Nefeli; Rubinos, Clio; Li, Leping; Sellitto, Caterina; White, Thomas W.; Mathias, Richard; Srinivas, Miduturu			Connexin 46 (Cx46) Gap Junctions Provide a Pathway for the Delivery of Glutathione to the Lens Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(3) CONNEXIN; KNOCKOUT MICE; RAT LENS; CIRCULATION; CHANNELS; PROTEIN; CATARACT; AGE; TRANSPORTER; SELECTIVITY	Maintenance of adequate levels of glutathione (GSH) in the lens nucleus is critical for protection of lens proteins from the effects of oxidative stress and for lens transparency. How GSH is transported to the nucleus is unknown. We show that GSH diffuses to the nucleus from the outer cortex, where a high concentration of the anti-oxidant is established by synthesis or uptake, via the network of gap junctions. Using electrophysiological measurements, we found that channels formed by Cx46 and Cx50, the two connexin isoforms expressed in the lens, were moderately cation-selective (P-Na/P-Cl similar to 5 for Cx46 and similar to 3 for Cx50). Single channel permeation of the larger GSH anion was low but detectable (P-Na/P-GSH similar to 12 for Cx46 and similar to 8 for Cx50), whereas permeation of divalent anion glutathione disulfide (GSSG) was undetectable. Measurement of GSH levels in the lenses from connexin knock-out (KO) mice indicated Cx46, and not Cx50, is necessary for transport of GSH to the core. Levels of GSH in the nucleus were markedly reduced in Cx46 KO, whereas they were unaffected by Cx50 KO. We also show that GSH delivery to the nucleus is not dependent on the lens microcirculation, which is believed to be responsible for extracellular transport of other nutrients to membrane transporters in the core. These results indicate that glutathione diffuses from cortical fiber cells to the nucleus via gap junction channels formed by Cx46. We present a model of GSH diffusion from outer cells to inner fiber cells through gap junctions.	[Slavi, Nefeli; Rubinos, Clio; Srinivas, Miduturu] SUNY Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA; [Slavi, Nefeli; Rubinos, Clio; Srinivas, Miduturu] SUNY Coll Optometry, Grad Ctr Vis Res, New York, NY 10036 USA; [Li, Leping; Sellitto, Caterina; White, Thomas W.; Mathias, Richard] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; SUNY Optometry; State University of New York (SUNY) System; SUNY Optometry; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Srinivas, M (corresponding author), SUNY Coll Optometry, Dept Biol & Vis Sci, 33 W 42nd St, New York, NY 10036 USA.	msrinivas@sunyopt.edu	White, Thomas W./R-3605-2019; White, Thomas/GPG-4026-2022; Rubinos, Clio/ABA-9937-2021	White, Thomas/0000-0002-3285-7434; Rubinos, Clio/0000-0002-1680-2302	National Institutes of Health [EY006391, EY013163, EY13869]; NATIONAL EYE INSTITUTE [R01EY013869, R01EY006391, R01EY013163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY006391 (to R. T. M.), EY013163 (to T. W. W.), and EY13869 (to M. S.).	Baldo GJ, 2001, J GEN PHYSIOL, V118, P447, DOI 10.1085/jgp.118.5.447; BALDO GJ, 1992, BIOPHYS J, V63, P518, DOI 10.1016/S0006-3495(92)81624-7; Bova LM, 2001, INVEST OPHTH VIS SCI, V42, P200; Candia OA, 2012, INVEST OPHTH VIS SCI, V53, P7087, DOI 10.1167/iovs.12-10295; DICKERSON JE, 1993, BIOCHIM BIOPHYS ACTA, V1157, P141, DOI 10.1016/0304-4165(93)90057-F; Donaldson PJ, 2010, INVEST OPHTH VIS SCI, V51, P2303, DOI 10.1167/iovs.10-5350; Ganea E, 2006, CURR EYE RES, V31, P1, DOI 10.1080/02713680500477347; Gao JY, 2013, INVEST OPHTH VIS SCI, V54, P7174, DOI 10.1167/iovs.13-12593; Gao JY, 2011, J GEN PHYSIOL, V137, P507, DOI 10.1085/jgp.201010538; Giblin FJ, 2000, J OCUL PHARMACOL TH, V16, P121, DOI 10.1089/jop.2000.16.121; Goldberg GS, 1999, NAT CELL BIOL, V1, P457, DOI 10.1038/15693; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Gong XH, 1998, P NATL ACAD SCI USA, V95, P15303, DOI 10.1073/pnas.95.26.15303; Gong XH, 1999, DEV GENET, V24, P27, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<27::AID-DVG4>3.0.CO;2-7; HARDING JJ, 1969, BIOCHEM J, V114, pP88; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; KANNAN R, 1995, INVEST OPHTH VIS SCI, V36, P1785; Kannan R, 1996, INVEST OPHTH VIS SCI, V37, P2269; Lim J, 2007, INVEST OPHTH VIS SCI, V48, P5142, DOI 10.1167/iovs.07-0649; LOU MF, 1992, EXP EYE RES, V55, P889, DOI 10.1016/0014-4835(92)90015-K; Lou MF, 2003, PROG RETIN EYE RES, V22, P657, DOI 10.1016/S1350-9462(03)00050-8; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Martinez-Wittinghan FJ, 2003, J CELL BIOL, V161, P969, DOI 10.1083/jcb.200303068; Martinez-Wittinghan FJ, 2004, INVEST OPHTH VIS SCI, V45, P3629, DOI 10.1167/iovs.04-0445; Mathias RT, 2007, J MEMBRANE BIOL, V216, P1, DOI 10.1007/s00232-007-9019-y; Mathias RT, 1997, PHYSIOL REV, V77, P21, DOI 10.1152/physrev.1997.77.1.21; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; RATHBUN WB, 1984, CURR EYE RES, V3, P101, DOI 10.3109/02713688408997190; REDDY VN, 1990, EXP EYE RES, V50, P771, DOI 10.1016/0014-4835(90)90127-G; Shestopalov VI, 2003, J CELL SCI, V116, P4191, DOI 10.1242/jcs.00738; Shi YR, 2011, INVEST OPHTH VIS SCI, V52, P7332, DOI 10.1167/iovs.11-7724; Shi YR, 2009, J CELL SCI, V122, P1607, DOI 10.1242/jcs.045203; Srinivas M, 2005, BIOPHYS J, V88, P1725, DOI 10.1529/biophysj.104.054023; Srinivas M, 1999, J PHYSIOL-LONDON, V517, P673, DOI 10.1111/j.1469-7793.1999.0673s.x; Sweeney MHJ, 2003, EXP EYE RES, V77, P245, DOI 10.1016/S0014-4835(03)00110-6; Sweeney MHJ, 1998, EXP EYE RES, V67, P587, DOI 10.1006/exer.1998.0549; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Truscott RJW, 2000, OPHTHALMIC RES, V32, P185, DOI 10.1159/000055612; TRUSCOTT RJW, 1977, EXP EYE RES, V25, P139, DOI 10.1016/0014-4835(77)90126-9; Wang HZ, 1997, J GEN PHYSIOL, V109, P491, DOI 10.1085/jgp.109.4.491; Wang Z, 2009, EXP EYE RES, V89, P898, DOI 10.1016/j.exer.2009.07.015; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; WHITE TW, 1992, MOL BIOL CELL, V3, P711, DOI 10.1091/mbc.3.7.711	44	42	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.597898	http://dx.doi.org/10.1074/jbc.M114.597898			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25294879	Green Published, hybrid			2022-12-28	WOS:000345335000026
J	Hagemann-Jensen, M; Uhlenbrock, F; Kehlet, S; Andresen, L; Gabel-Jensen, C; Ellgaard, L; Gammelgaard, B; Skov, S				Hagemann-Jensen, Michael; Uhlenbrock, Franziska; Kehlet, Stephanie; Andresen, Lars; Gabel-Jensen, Charlotte; Ellgaard, Lars; Gammelgaard, Bente; Skov, Soren			The Selenium Metabolite Methylselenol Regulates the Expression of Ligands That Trigger Immune Activation through the Lymphocyte Receptor NKG2D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; HISTONE DEACETYLASE INHIBITORS; KETO ACID METABOLITES; C VIRUS-INFECTION; PROTEIN-KINASE-C; ORGANOSELENIUM COMPOUNDS; DEPSIPEPTIDE FR901228; SODIUM SELENITE; IN-VITRO; CHAIN-B	For decades, selenium research has been focused on the identification of active metabolites, which are crucial for selenium chemoprevention of cancer. In this context, the metabolite methylselenol (CH3SeH) is known for its action to selectively kill transformed cells through mechanisms that include increased formation of reactive oxygen species, induction of DNA damage, triggering of apoptosis, and inhibition of angiogenesis. Here we reveal that CH3SeH modulates the cell surface expression of NKG2D ligands. The expression of NKG2D ligands is induced by stress-associated pathways that occur early during malignant transformation and enable the recognition and elimination of tumors by activating the lymphocyte receptor NKG2D. CH3SeH regulated NKG2D ligands both on the transcriptional and the posttranscriptional levels. CH3SeH induced the transcription of MHC class I polypeptide-related sequence MICA/B and ULBP2 mRNA. However, the induction of cell surface expression was restricted to the ligands MICA/B. Remarkably, our studies showed that CH3SeH inhibited ULBP2 surface transport through inhibition of the autophagic transport pathway. Finally, we identified extracellular calcium as being essential for CH3SeH regulation of NKG2D ligands. A balanced cell surface expression of NKG2D ligands is considered to be an innate barrier against tumor development. Therefore, our work indicates that the application of selenium compounds that are metabolized to CH3SeH could improve NKG2D-based immune therapy.	[Hagemann-Jensen, Michael; Uhlenbrock, Franziska; Kehlet, Stephanie; Andresen, Lars; Skov, Soren] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Immunol Lab, DK-1870 Copenhagen, Denmark; [Gabel-Jensen, Charlotte; Gammelgaard, Bente] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, DK-1870 Copenhagen, Denmark; [Ellgaard, Lars] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biol, DK-1870 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Hagemann-Jensen, M (corresponding author), Univ Copenhagen, Immunol Lab, Stigbojlen 7, DK-1870 Frederiksberg, Denmark.	sosk@sund.ku.dk	Ellgaard, Lars/I-9034-2014; Andresen, Lars/O-2271-2019; Hagemann-Jensen, Michael/AAO-8176-2020; Andresen, Lars/K-1287-2012	Ellgaard, Lars/0000-0002-7018-0137; Andresen, Lars/0000-0002-6362-7973; Hagemann-Jensen, Michael/0000-0002-6423-8216; Gammelgaard, Bente/0000-0002-9149-1014; Skov, Soren/0000-0003-0732-0026	European Marie Curie Initial Training Network EngCaBra Project [PITN-GA-2010-264417]; Danish Council for Independent Research/Medical Sciences Projects [DFF-1331-00169, 271-07-0302]	European Marie Curie Initial Training Network EngCaBra Project; Danish Council for Independent Research/Medical Sciences Projects	This study was supported by European Marie Curie Initial Training Network EngCaBra Project PITN-GA-2010-264417 and by Danish Council for Independent Research/Medical Sciences Projects DFF-1331-00169 and 271-07-0302.	Andreadou I, 1996, J MED CHEM, V39, P2040, DOI 10.1021/jm950750x; Andresen L, 2007, J IMMUNOL, V179, P8235, DOI 10.4049/jimmunol.179.12.8235; Andresen L, 2009, J IMMUNOL, V183, P897, DOI 10.4049/jimmunol.0803014; Armeanu S, 2005, CANCER RES, V65, P6321, DOI 10.1158/0008-5472.CAN-04-4252; Asfour IA, 2009, BIOL TRACE ELEM RES, V127, P200, DOI 10.1007/s12011-008-8240-6; Auger J, 2004, J CHROMATOGR A, V1032, P103, DOI 10.1016/j.chroma.2003.11.077; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bauman Y, 2011, CELL HOST MICROBE, V9, P93, DOI 10.1016/j.chom.2011.01.008; Berg SL, 2004, CANCER CHEMOTH PHARM, V54, P85, DOI 10.1007/s00280-004-0766-5; Brozmanova J, 2010, ARCH TOXICOL, V84, P919, DOI 10.1007/s00204-010-0595-8; Byrd JC, 1999, BLOOD, V94, P1401, DOI 10.1182/blood.V94.4.1401.416k30_1401_1408; Castillo K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.421; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Chen YC, 2013, INT J CANCER, V133, P2054, DOI 10.1002/ijc.28224; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Dong Y, 2003, CANCER RES, V63, P52; Dong Y, 2002, CANCER RES, V62, P708; El-Bayoumy K, 2006, CARCINOGENESIS, V27, P1369, DOI 10.1093/carcin/bgi328; ESAKI N, 1979, BIOCHEMISTRY-US, V18, P407, DOI 10.1021/bi00570a003; Fehrenbacher N, 2005, CANCER RES, V65, P2993, DOI 10.1158/0008-5472.CAN-05-0476; Fernandes AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050727; Gabel-Jensen C, 2010, METALLOMICS, V2, P167, DOI 10.1039/b914255j; Gammelgaard B, 2011, ANAL BIOANAL CHEM, V399, P1743, DOI 10.1007/s00216-010-4212-8; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gopalakrishna R, 2002, J NUTR, V132, p3819S, DOI 10.1093/jn/132.12.3819S; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2006, NAT IMMUNOL, V7, P755, DOI 10.1038/ni1350; Gromer S, 2002, J BIOL CHEM, V277, P9701, DOI 10.1074/jbc.M109234200; Gundimeda U, 2008, J BIOL CHEM, V283, P34519, DOI 10.1074/jbc.M807007200; Ip C, 1998, J NUTR, V128, P1845, DOI 10.1093/jn/128.11.1845; Ip C, 2000, CANCER RES, V60, P2882; Ishiguro K, 2008, BIOTECHNIQUES, V45, P465, DOI 10.2144/000112912; Jensen H, 2013, MOL IMMUNOL, V53, P255, DOI 10.1016/j.molimm.2012.08.011; Jiang C, 2001, CANCER RES, V61, P3062; Jiang C, 2000, MOL CARCINOGEN, V29, P236, DOI 10.1002/1098-2744(200012)29:4<236::AID-MC1006>3.0.CO;2-E; Jiang H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.285; Jinushi M, 2003, J IMMUNOL, V171, P5423, DOI 10.4049/jimmunol.171.10.5423; Jinushi M, 2003, INT J CANCER, V104, P354, DOI 10.1002/ijc.10966; Jinushi M, 2003, J IMMUNOL, V170, P1249, DOI 10.4049/jimmunol.170.3.1249; Kaeck M, 1997, BIOCHEM PHARMACOL, V53, P921, DOI 10.1016/S0006-2952(97)00103-2; Kassam S, 2011, CANCER CHEMOTH PHARM, V68, P815, DOI 10.1007/s00280-011-1649-1; KICE JL, 1978, J AM CHEM SOC, V100, P5094, DOI 10.1021/ja00484a031; Klionsky DJ, 2013, AUTOPHAGY, V9, P445, DOI 10.4161/auto.23907; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; KOCHWESER J, 1976, NEW ENGL J MED, V294, P311, DOI 10.1056/NEJM197602052940605; KOCHWESER J, 1976, NEW ENGL J MED, V294, P526, DOI 10.1056/NEJM197603042941005; Lee JI, 2009, CANCER PREV RES, V2, P683, DOI 10.1158/1940-6207.CAPR-09-0047; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li GX, 2008, CARCINOGENESIS, V29, P1005, DOI 10.1093/carcin/bgn007; Li K, 2009, CANCER IMMUNOL IMMUN, V58, P641, DOI 10.1007/s00262-008-0585-3; LIN Y, 1993, BIOCHEM PHARMACOL, V45, P429, DOI 10.1016/0006-2952(93)90080-G; LU JX, 1995, BIOCHEM PHARMACOL, V50, P213, DOI 10.1016/0006-2952(95)00119-K; Lunoe K, 2011, METALLOMICS, V3, P162, DOI 10.1039/c0mt00091d; Micke O, 2003, INT J RADIAT ONCOL, V56, P40, DOI 10.1016/S0360-3016(02)04390-0; Murata M, 2000, JPN J CANCER RES, V91, P1154, DOI 10.1111/j.1349-7006.2000.tb00899.x; Nachmani D, 2010, NAT IMMUNOL, V11, P806, DOI 10.1038/ni.1916; Nian H, 2009, CARCINOGENESIS, V30, P1416, DOI 10.1093/carcin/bgp147; Nuckel H, 2010, LEUKEMIA, V24, P1152, DOI 10.1038/leu.2010.74; OTOOLE D, 1995, J VET DIAGN INVEST, V7, P281, DOI 10.1177/104063879500700225; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Park SH, 2012, TOXICOL LETT, V212, P252, DOI 10.1016/j.toxlet.2012.06.007; Paschen A, 2009, CLIN CANCER RES, V15, P5208, DOI 10.1158/1078-0432.CCR-09-0886; Rajgolikar G, 1998, BREAST CANCER RES TR, V51, P29, DOI 10.1023/A:1006091014092; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Reeves PG, 2005, J NUTR, V135, P2627, DOI 10.1093/jn/135.11.2627; Ren Y, 2009, BMB REP, V42, P599, DOI 10.5483/BMBRep.2009.42.9.599; Roman M, 2014, METALLOMICS, V6, P25, DOI 10.1039/c3mt00185g; Sandor V, 2002, CLIN CANCER RES, V8, P718; Schreiner B, 2005, FASEB J, V19, P118, DOI 10.1096/fj.05-4342fje; Selenius M, 2010, ANTIOXID REDOX SIGN, V12, P867, DOI 10.1089/ars.2009.2884; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Skov S, 2005, CANCER RES, V65, P11136, DOI 10.1158/0008-5472.CAN-05-0599; Skov S, 2003, BLOOD, V101, P1430, DOI 10.1182/blood-2002-07-2073; Spallholz JE, 2001, NUTR CANCER, V40, P34, DOI 10.1207/S15327914NC401_8; Suzuki KT, 2007, BBA-GEN SUBJECTS, V1770, P1053, DOI 10.1016/j.bbagen.2007.03.007; Tal MC, 2009, CURR TOP MICROBIOL, V335, P107, DOI 10.1007/978-3-642-00302-8_5; Talbot S, 2008, BRIT J PHARMACOL, V154, P940, DOI 10.1038/bjp.2008.161; Uhlenbrock F, 2014, J IMMUNOL, V193, P1654, DOI 10.4049/jimmunol.1303275; Vales-Gomez M, 2008, CANCER RES, V68, P1546, DOI 10.1158/0008-5472.CAN-07-2973; Vivier E, 2002, CURR OPIN IMMUNOL, V14, P306, DOI 10.1016/S0952-7915(02)00337-0; Wang ZS, 2002, MOL CARCINOGEN, V34, P113, DOI 10.1002/mc.10056; Wu JD, 2004, J CLIN INVEST, V114, P560, DOI 10.1172/JCI200422206; Yamamoto S, 2008, ANTICANCER RES, V28, P1585; Yan L, 2012, INT J CANCER, V131, P1260, DOI 10.1002/ijc.27355; Zeng HW, 2009, J NUTR, V139, P1613, DOI 10.3945/jn.109.110320	89	26	27	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31576	31590		10.1074/jbc.M114.591537	http://dx.doi.org/10.1074/jbc.M114.591537			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25258323	Green Published, hybrid			2022-12-28	WOS:000344549900058
J	Yang, GB; Yuan, GH; Ye, WD; Cho, KWY; Chen, YP				Yang, Guobin; Yuan, Guohua; Ye, Wenduo; Cho, Ken W. Y.; Chen, YiPing			An Atypical Canonical Bone Morphogenetic Protein (BMP) Signaling Pathway Regulates Msh Homeobox 1 (Msx1) Expression during Odontogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATERAL PLATE MESODERM; GENE-EXPRESSION; CLEFT-PALATE; IN-SITU; TOOTH; TRANSCRIPTION; SMAD4; IDENTIFICATION; ANTAGONISM; DROSOPHILA	Bone morphogenetic protein (BMP) signaling plays an essential role in early tooth development, evidenced by disruption of BMP signaling leading to an early arrested tooth development. Despite being a central mediator of BMP canonical signaling pathway, inactivation of Smad4 in dental mesenchyme does not result in early developmental defects. In the current study, we investigated the mechanism of receptor-activated Smads (R-Smads) and Smad4 in the regulation of the odontogenic gene Msx1 expression in the dental mesenchyme. We showed that the canonical BMP signaling is not operating in the early developing tooth, as assessed by failed activation of the BRE-Gal transgenic allele and the absence of phospho-(p) Smad1/5/8-Smad4 complexes. The absence of pSmad1/5/8-Smad4 complex appeared to be the consequence of saturation of Smad4 by pSmad2/3 in the dental mesenchyme as knockdown of Smad2/3 or overexpression of Smad4 led to the formation of pSmad1/5/8-Smad4 complexes and activation of canonical BMP signaling in dental mesenchymal cells. We showed that Smad1/5 but not Smad4 are required for BMP-induced expression of Msx1 in dental mesenchymal cells. We further presented evidence that in the absence of Smad4, BMPs are still able to induce pSmad1/5/8 nuclear translocation and their binding to the Msx1 promoter directly in dental mesenchymal cells. Our results demonstrate the functional operation of an atypical canonical BMP signaling (Smad4-independent and Smad1/5/8-dependent) pathway in the dental mesenchyme during early odontogenesis, which may have general implication in the development of other organs.	[Yang, Guobin; Yuan, Guohua] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan 430079, Hubei Province, Peoples R China; [Yang, Guobin; Yuan, Guohua] Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Minist Educ, Wuhan 430079, Hubei Province, Peoples R China; [Yang, Guobin; Yuan, Guohua; Ye, Wenduo; Chen, YiPing] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Cho, Ken W. Y.] Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92697 USA	Wuhan University; Wuhan University; Tulane University; University of California System; University of California Irvine	Chen, YP (corresponding author), Tulane Univ, Dept Cell & Mol Biol, 6823 St Charles Ave, New Orleans, LA 70118 USA.	ychen@tulane.edu			National Institutes of Health [R01DE014044, R01DE024152]; National Natural Science Foundation of China [81371105, 81470708]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014044, R01DE024152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE014044 and R01DE024152 (to Y.C.). This work was also supported by National Natural Science Foundation of China Grants 81371105 (to G. Yang) and 81470708 (to G. Yuan).	Bei M, 1998, DEVELOPMENT, V125, P4325; Binato R, 2006, BIOCHEM J, V393, P141, DOI 10.1042/BJ20050327; Candia AF, 1997, DEVELOPMENT, V124, P4467; CHAI Y, 1994, DEV BIOL, V162, P85, DOI 10.1006/dbio.1994.1069; Chen YP, 1996, DEVELOPMENT, V122, P3035; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; DAVIDSON D, 1995, TRENDS GENET, V11, P405, DOI 10.1016/S0168-9525(00)89124-6; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Furtado MB, 2008, GENE DEV, V22, P3037, DOI 10.1101/gad.1682108; Gronroos E, 2012, MOL CELL BIOL, V32, P2904, DOI 10.1128/MCB.00231-12; Gustafsdottir SM, 2005, ANAL BIOCHEM, V345, P2, DOI 10.1016/j.ab.2005.01.018; He FL, 2010, DEV BIOL, V347, P109, DOI 10.1016/j.ydbio.2010.08.014; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Hu B, 2006, TISSUE ENG, V12, P2069, DOI 10.1089/ten.2006.12.2069; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Javier AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042566; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Jia SH, 2013, DEVELOPMENT, V140, P423, DOI 10.1242/dev.081927; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Katsu K, 2013, DEV BIOL, V374, P71, DOI 10.1016/j.ydbio.2012.11.027; Li JY, 2011, DEVELOPMENT, V138, P1977, DOI 10.1242/dev.061341; Li L, 2011, DEV BIOL, V349, P451, DOI 10.1016/j.ydbio.2010.10.023; Martinez CEA, 2002, BIOCHEM BIOPH RES CO, V291, P655, DOI 10.1006/bbrc.2002.6502; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Monteiro RM, 2008, GENESIS, V46, P335, DOI 10.1002/dvg.20402; Nie XG, 2006, INT J DEV BIOL, V50, P511, DOI 10.1387/ijdb.052101.xn; Pacheco MS, 2008, CELLS TISSUES ORGANS, V187, P199, DOI 10.1159/000112640; Park JES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030075; Rajagopal R, 2009, DEV BIOL, V335, P305, DOI 10.1016/j.ydbio.2009.08.027; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shin JO, 2012, HISTOCHEM CELL BIOL, V137, P791, DOI 10.1007/s00418-012-0930-7; Smith AP, 2009, ONCOGENE, V28, P422, DOI 10.1038/onc.2008.395; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tan XH, 2007, J CELL SCI, V120, P2162, DOI 10.1242/jcs.03466; Tong KK, 2013, MOL CELL BIOL, V33, P1925, DOI 10.1128/MCB.01143-12; Tucker AS, 1998, DEV DYNAM, V212, P533, DOI 10.1002/(SICI)1097-0177(199808)212:4<533::AID-AJA6>3.3.CO;2-I; VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2; von Bubnoff A, 2005, DEV BIOL, V281, P210, DOI 10.1016/j.ydbio.2005.02.014; Wang Y, 2012, J DENT RES, V91, P690, DOI 10.1177/0022034512448660; Yamamoto M, 2009, J CELL BIOL, V184, P323, DOI 10.1083/jcb.200808044; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Yang X, 1998, P NATL ACAD SCI USA, V95, P3667, DOI 10.1073/pnas.95.7.3667; Yao LC, 2006, DEVELOPMENT, V133, P4025, DOI 10.1242/dev.02561; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang JH, 2005, DEV BIOL, V284, P311, DOI 10.1016/j.ydbio.2005.05.036; Zhang YD, 2000, DEVELOPMENT, V127, P1431; Zhao X, 2000, MECH DEVELOP, V99, P29, DOI 10.1016/S0925-4773(00)00467-6	50	26	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31492	31502		10.1074/jbc.M114.600064	http://dx.doi.org/10.1074/jbc.M114.600064			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25274628	Green Published, hybrid			2022-12-28	WOS:000344549900051
J	Bookwalter, CS; Kelsen, A; Leung, JM; Ward, GE; Trybus, KM				Bookwalter, Carol S.; Kelsen, Anne; Leung, Jacqueline M.; Ward, Gary E.; Trybus, Kathleen M.			A Toxoplasma gondii Class XIV Myosin, Expressed in Sf9 Cells with a Parasite Co-chaperone, Requires Two Light Chains for Fast Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING-PROTEIN MTIP; NECK REGION; TPR DOMAIN; UCS DOMAIN; MOTOR; TAIL; COMPLEX; UNC-45; DROSOPHILA; MECHANISM	Many diverse myosin classes can be expressed using the baculovirus/Sf9 insect cell expression system, whereas others have been recalcitrant. We hypothesized that most myosins utilize Sf9 cell chaperones, but others require an organism-specific cochaperone. TgMyoA, a class XIVa myosin from the parasite Toxoplasma gondii, is required for the parasite to efficiently move and invade host cells. The T. gondii genome contains one UCS family myosin co-chaperone (TgUNC). TgMyoA expressed in Sf9 cells was soluble and functional only if the heavy and light chain(s) were co-expressed with TgUNC. The tetratricopeptide repeat domain of TgUNC was not essential to obtain functional myosin, implying that there are other mechanisms to recruit Hsp90. Purified TgMyoA heavy chain complexed with its regulatory light chain (TgMLC1) moved actin in a motility assay at a speed of similar to 1.5 mu m/s. When a putative essential light chain (TgELC1) was also bound, TgMyoA moved actin at more than twice that speed (similar to 3.4 mu m/s). This result implies that two light chains bind to and stabilize the lever arm, the domain that amplifies small motions at the active site into the larger motions that propel actin at fast speeds. Our results show that the TgMyoA domain structure is more similar to other myosins than previously appreciated and provide a molecular explanation for how it moves actin at fast speeds. The ability to express milligram quantities of a class XIV myosin in a heterologous system paves the way for detailed structure-function analysis of TgMyoA and identification of small molecule inhibitors.	[Bookwalter, Carol S.; Trybus, Kathleen M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Kelsen, Anne; Leung, Jacqueline M.; Ward, Gary E.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Ward, GE (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Stafford 316, Burlington, VT 05405 USA.	gary.ward@uvm.edu; kathleen.trybus@uvm.edu		Ward, Gary/0000-0003-4138-3055	National Institutes of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI054961, R01AI054961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496, R01GM078097] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Marc-Jan Gubbels for providing the T. gondii cosmid number p559 and Dr. Con Beckers for providing the anti-TgMLC1 antibody. We acknowledge the early efforts of Aoife Heaslip and Michelle Shepard in attempting to express functional TgMyoA in Sf9 cells without the chaperone. We thank Susan Lowey for helpful comments on the manuscript. T. gondii genome sequence information was obtained from the Toxoplasma Genome Database. ToxoDB is a component of the Eukaryotic Pathogen Genomics Resource, a Bioinformatics Resource Center supported by the National Institutes of Allergy and Infectious Diseases; we gratefully acknowledge the staff responsible for developing and maintaining this resource.	Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; BECKINGHAM K, 1991, J BIOL CHEM, V266, P6027; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Bird JE, 2014, P NATL ACAD SCI USA, V111, P12390, DOI 10.1073/pnas.1409459111; Bosch J, 2007, J MOL BIOL, V372, P77, DOI 10.1016/j.jmb.2007.06.016; Chow D, 2002, J BIOL CHEM, V277, P36799, DOI 10.1074/jbc.M204101200; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Douse CH, 2012, J BIOL CHEM, V287, P36968, DOI 10.1074/jbc.M112.379842; Egarter S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091819; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Frenal K, 2008, MYOS SUP MOL MOT, P421; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gazda L, 2013, CELL, V152, P183, DOI 10.1016/j.cell.2012.12.025; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Heaslip AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000720; Heintzelman MB, 1997, J MOL BIOL, V271, P139, DOI 10.1006/jmbi.1997.1167; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Hettmann C, 2000, MOL BIOL CELL, V11, P1385, DOI 10.1091/mbc.11.4.1385; Kinose F, 1996, J CELL BIOL, V134, P895, DOI 10.1083/jcb.134.4.895; Lee CF, 2011, STRUCTURE, V19, P397, DOI 10.1016/j.str.2011.01.002; Leung JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085763; Liu L, 2008, J BIOL CHEM, V283, P13185, DOI 10.1074/jbc.M800757200; LOWEY S, 1993, NATURE, V365, P454, DOI 10.1038/365454a0; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Mishra M, 2005, EUKARYOT CELL, V4, P567, DOI 10.1128/EC.4.3.567-576.2005; Moore JR, 2004, J MUSCLE RES CELL M, V25, P29, DOI 10.1023/B:JURE.0000021394.48560.71; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Ni WM, 2011, J CELL SCI, V124, P3164, DOI 10.1242/jcs.087320; Pato MD, 1996, J BIOL CHEM, V271, P2689, DOI 10.1074/jbc.271.5.2689; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SHEFFIELD HG, 1968, J PARASITOL, V54, P209, DOI 10.2307/3276925; Shi H, 2010, P NATL ACAD SCI USA, V107, P21382, DOI 10.1073/pnas.1013038107; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Srikakulam R, 1999, J BIOL CHEM, V274, P27265, DOI 10.1074/jbc.274.38.27265; Srikakulam R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002137; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Trybus KM, 2000, METHODS, V22, P327, DOI 10.1006/meth.2000.1085; TRYBUS KM, 1994, J BIOL CHEM, V269, P20819; Turley S, 2013, MOL BIOCHEM PARASIT, V190, P56, DOI 10.1016/j.molbiopara.2013.06.004; Tyska MJ, 2002, CELL MOTIL CYTOSKEL, V51, P1, DOI 10.1002/cm.10014; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Warshaw DM, 2000, J BIOL CHEM, V275, P37167, DOI 10.1074/jbc.M006438200; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Yang Y, 2005, J BIOL CHEM, V280, P32061, DOI 10.1074/jbc.M506765200	51	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30832	30841		10.1074/jbc.M114.572453	http://dx.doi.org/10.1074/jbc.M114.572453			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25231988	hybrid, Green Published			2022-12-28	WOS:000344549700057
J	Babbitt, SE; Francisco, BS; Mendez, DL; Lukat-Rodgers, GS; Rodgers, KR; Bretsnyder, EC; Kranz, RG				Babbitt, Shalon E.; Francisco, Brian San; Mendez, Deanna L.; Lukat-Rodgers, Gudrun S.; Rodgers, Kenton R.; Bretsnyder, Eric C.; Kranz, Robert G.			Mechanisms of Mitochondrial Holocytochrome c Synthase and the Key Roles Played by Cysteines and Histidine of the Heme Attachment Site, Cys-XX-Cys-His	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORPHYRIN FORCE-FIELD; RESONANCE RAMAN-SPECTRA; CYTOCHROME-C; SACCHAROMYCES-CEREVISIAE; NICKEL OCTAETHYLPORPHYRIN; APOCYTOCHROME-C; THIOETHER BOND; ISOTOPE SHIFTS; BIOGENESIS; SYNTHETASE	Mitochondrial cytochrome c assembly requires the covalent attachment of heme by thioether bonds between heme vinyl groups and a conserved CXXCH motif of cytochrome c/c(1). The enzyme holocytochrome c synthase (HCCS) binds heme and apocytochrome c substrate to catalyze this attachment, subsequently releasing holocytochrome c for proper folding to its native structure. We address mechanisms of assembly using a functional Escherichia coli recombinant system expressing human HCCS. Human cytochrome c variants with individual cysteine, histidine, double cysteine, and triple cysteine/histidine substitutions (of CXXCH) were co-purified with HCCS. Single and double mutants form a complex with HCCS but not the triple mutant. Resonance Raman and UV-visible spectroscopy support the proposal that heme puckering induced by both thioether bonds facilitate release of holocytochrome c from the complex. His-19 (of CXXCH) supplies the second axial ligand to heme in the complex, the first axial ligand was previously shown to be from HCCS residue His-154. Substitutions of His-19 in cytochrome c to seven other residues (Gly, Ala, Met, Arg, Lys, Cys, and Tyr) were used with various approaches to establish other roles played by His-19. Three roles for His-19 in HCCS-mediated assembly are suggested: (i) to provide the second axial ligand to the heme iron in preparation for covalent attachment; (ii) to spatially position the two cysteinyl sulfurs adjacent to the two heme vinyl groups for thioether formation; and (iii) to aid in release of the holocytochrome c from the HCCS active site. Only H19M is able to carry out these three roles, albeit at lower efficiencies than the natural His-19.	[Babbitt, Shalon E.; Francisco, Brian San; Mendez, Deanna L.; Bretsnyder, Eric C.; Kranz, Robert G.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Lukat-Rodgers, Gudrun S.; Rodgers, Kenton R.] N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58102 USA	Washington University (WUSTL); North Dakota State University Fargo	Kranz, RG (corresponding author), 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	kranz@biology.wustl.edu		Mendez, Deanna/0000-0002-0481-4816	National Institutes of Health [RO1 GM47909, RO1 AI072719]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI072719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM47909 (to R. G. K.) and RO1 AI072719 (to K. R. R.).	Allen JWA, 2011, FEBS J, V278, P4198, DOI 10.1111/j.1742-4658.2011.08231.x; BARRICK D, 1994, BIOCHEMISTRY-US, V33, P6546, DOI 10.1021/bi00187a023; Bernard DG, 2003, J BIOL CHEM, V278, P49732, DOI 10.1074/jbc.M308881200; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; DICKERSON RE, 1971, J BIOL CHEM, V246, P1511; DUMONT ME, 1987, EMBO J, V6, P235, DOI 10.1002/j.1460-2075.1987.tb04744.x; Feissner R, 2003, ANAL BIOCHEM, V315, P90, DOI 10.1016/S0003-2697(02)00658-9; Feissner RE, 2006, MOL MICROBIOL, V60, P563, DOI 10.1111/j.1365-2958.2006.05132.x; Francisco BS, 2011, BIOCHEMISTRY-US, V50, P10974, DOI 10.1021/bi201508t; Frawley ER, 2009, P NATL ACAD SCI USA, V106, P10201, DOI 10.1073/pnas.0903132106; Hamel P, 2009, BBA-MOL CELL RES, V1793, P125, DOI 10.1016/j.bbamcr.2008.06.017; HU SZ, 1993, J AM CHEM SOC, V115, P12446, DOI 10.1021/ja00079a028; Kiryu-Seo S, 2006, EMBO J, V25, P3411, DOI 10.1038/sj.emboj.7601225; Kleingardner JG, 2011, METALLOMICS, V3, P396, DOI 10.1039/c0mt00086h; Kranz R, 1998, MOL MICROBIOL, V29, P383, DOI 10.1046/j.1365-2958.1998.00869.x; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; Leu BM, 2009, J PHYS CHEM B, V113, P2193, DOI 10.1021/jp806574t; LI XY, 1990, J PHYS CHEM-US, V94, P47, DOI 10.1021/j100364a008; LI XY, 1989, J AM CHEM SOC, V111, P7012, DOI 10.1021/ja00200a018; LI XY, 1990, J PHYS CHEM-US, V94, P31, DOI 10.1021/j100364a007; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MURPHY MEP, 1992, J MOL BIOL, V227, P160, DOI 10.1016/0022-2836(92)90689-H; NICHOLLS DG, 2013, BIOENERGETICS; Rosell FI, 2002, BIOCHEMISTRY-US, V41, P7811, DOI 10.1021/bi016060e; San Francisco B, 2013, P NATL ACAD SCI USA, V110, P3221, DOI 10.1073/pnas.1213897109; Schaefer L, 1996, GENOMICS, V34, P166, DOI 10.1006/geno.1996.0261; SORRELL TN, 1989, J AM CHEM SOC, V111, P766, DOI 10.1021/ja00184a074; SPIRO TG, 1990, COORDIN CHEM REV, V100, P541, DOI 10.1016/0010-8545(90)85019-O; Streit BR, 2010, J AM CHEM SOC, V132, P5711, DOI 10.1021/ja9082182; TANAKA Y, 1990, J BIOCHEM-TOKYO, V108, P7, DOI 10.1093/oxfordjournals.jbchem.a123165; Verissimo AF, 2012, BIOCHEM BIOPH RES CO, V424, P130, DOI 10.1016/j.bbrc.2012.06.088; VISCO C, 1985, J BIOL CHEM, V260, P6133; ZOLLNER A, 1992, EUR J BIOCHEM, V207, P1093, DOI 10.1111/j.1432-1033.1992.tb17146.x	33	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28795	28807		10.1074/jbc.M114.593509	http://dx.doi.org/10.1074/jbc.M114.593509			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25170082	Green Published, hybrid			2022-12-28	WOS:000344141000004
J	Liu, CC; Kanekiyo, T; Roth, B; Bu, GJ				Liu, Chia-Chen; Kanekiyo, Takahisa; Roth, Barbara; Bu, Guojun			Tyrosine-based Signal Mediates LRP6 Receptor Endocytosis and Desensitization of Wnt/beta-Catenin Pathway Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						LRP6; Phosphorylation; Lipid Raft; Endocytosis; -Catenin; Wnt	DENSITY-LIPOPROTEIN RECEPTOR; EPIDERMAL-GROWTH-FACTOR; BETA-CATENIN; INTERNALIZATION; CLATHRIN; PROTEIN; DISEASE; CELL; TRANSDUCTION; TRAFFICKING	Background: LRP6 is an essential co-receptor for Wnt/-catenin signaling, which controls various biological pathways. Results: LRP6 tyrosine mutant exhibited longer half-life and increased lipid raft distribution, phosphorylation, and signaling. Conclusion: Clathrin-mediated endocytosis of LRP6 mediates its degradation, whereas caveolae-dependent pathway promotes Wnt/-catenin signaling. Significance: Understanding the molecular mechanisms underlying LRP6 endocytosis and Wnt/-catenin signaling will help the development of therapeutic methods targeting this pathway. Wnt/-catenin signaling orchestrates a number of critical events including cell growth, differentiation, and cell survival during development. Misregulation of this pathway leads to various human diseases, specifically cancers. Endocytosis and phosphorylation of the LDL receptor-related protein 6 (LRP6), an essential co-receptor for Wnt/-catenin signaling, play a vital role in mediating Wnt/-catenin signal transduction. However, its regulatory mechanism is not fully understood. In this study, we define the mechanisms by which LRP6 endocytic trafficking regulates Wnt/-catenin signaling activation. We show that LRP6 mutant with defective tyrosine-based signal in its cytoplasmic tail has an increased cell surface distribution and decreased endocytosis rate. These changes in LRP6 endocytosis coincide with an increased distribution to caveolae, increased phosphorylation, and enhanced Wnt/-catenin signaling. We further demonstrate that treatment of Wnt3a ligands or blocking the clathrin-mediated endocytosis of LRP6 leads to a redistribution of wild-type receptor to lipid rafts. The LRP6 tyrosine mutant also exhibited an increase in signaling activation in response to Wnt3a stimulation when compared with wild-type LRP6, and this activation is suppressed when caveolae-mediated endocytosis is blocked. Our results reveal molecular mechanisms by which LRP6 endocytosis routes regulate its phosphorylation and the strength of Wnt/-catenin signaling, and have implications on how this pathway can be modulated in human diseases.	[Liu, Chia-Chen; Bu, Guojun] Xiamen Univ, Inst Neurosci, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361005, Fujian, Peoples R China; [Liu, Chia-Chen; Kanekiyo, Takahisa; Roth, Barbara; Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Xiamen University; Mayo Clinic	Bu, GJ (corresponding author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	bu.guojun@mayo.edu			National Institutes of Health [R01 AG035355, P01 AG030128]; Alex's Lemonade Stand Foundation Young Investigator Award; NATIONAL INSTITUTE ON AGING [R01AG035355, R01AG027924, P01AG030128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex's Lemonade Stand Foundation Young Investigator Award; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG035355 and P01 AG030128 (to G. B.) and Alex's Lemonade Stand Foundation Young Investigator Award (to T. K.).	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Beer C, 2005, J VIROL, V79, P10776, DOI 10.1128/JVI.79.16.10776-10787.2005; BEGUINOT L, 1984, P NATL ACAD SCI-BIOL, V81, P2384, DOI 10.1073/pnas.81.8.2384; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Boonen RACM, 2009, AGEING RES REV, V8, P71, DOI 10.1016/j.arr.2008.11.003; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Choi SC, 2008, DEV CELL, V15, P49, DOI 10.1016/j.devcel.2008.05.004; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gong Q, 2008, J CELL MOL MED, V12, P126, DOI 10.1111/j.1582-4934.2007.00148.x; HANOVER JA, 1984, CELL, V39, P283, DOI 10.1016/0092-8674(84)90006-0; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Jiang Y, 2012, EMBO J, V31, P2336, DOI 10.1038/emboj.2012.83; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Li YH, 2005, J CELL SCI, V118, P5305, DOI 10.1242/jcs.02651; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; PAPKOFF J, 1987, MOL CELL BIOL, V7, P3978, DOI 10.1128/MCB.7.11.3978; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Wang HY, 2006, CELL SIGNAL, V18, P934, DOI 10.1016/j.cellsig.2005.12.008; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003	42	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27562	27570		10.1074/jbc.M113.533927	http://dx.doi.org/10.1074/jbc.M113.533927			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25143377	hybrid, Green Published			2022-12-28	WOS:000342852800018
J	Cui, HX; Wang, YQ; Huang, HZ; Yu, WJ; Bai, M; Zhang, L; Bryan, BA; Wang, Y; Luo, J; Li, DL; Ma, YL; Liu, MY				Cui, Hengxiang; Wang, Yeqi; Huang, Huizhe; Yu, Wenjie; Bai, Min; Zhang, Long; Bryan, Brad A.; Wang, Yuan; Luo, Jian; Li, Dali; Ma, Yanlin; Liu, Mingyao			GPR126 Protein Regulates Developmental and Pathological Angiogenesis through Modulation of VEGFR2 Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Endothelial Cell; G Protein-coupled Receptor (GPCR); Protein Kinase A (PKA); Vascular Endothelial Growth Factor (VEGF); VEGFR2	HEMATOPOIETIC STEM-CELLS; COUPLED RECEPTOR; ENDOTHELIAL-CELLS; IN-VITRO; ACTIVATION; GENE; ZEBRAFISH; TRANSCRIPTION; MYELINATION; GENERATION	Background: GPR126 plays critical roles in development, but its function in vessels is not well characterized. Results: GPR126 regulates angiogenesis by modulating endothelial cell proliferation and migration via regulation of Vegfr2 expression. Conclusion: GPR126 is important for physiological and pathological angiogenesis. Significance: This finding provides a new functional mechanism for the regulation of angiogenesis. Angiogenesis, the formation of new blood vessels from pre-existing ones, is essential for development, wound healing, and tumor progression. The VEGF pathway plays irreplaceable roles during angiogenesis, but how other signals cross-talk with and modulate VEGF cascades is not clearly elucidated. Here, we identified that Gpr126, an endothelial cell-enriched gene, plays an important role in angiogenesis by regulating endothelial cell proliferation, migration, and tube formation. Knockdown of Gpr126 in the mouse retina resulted in the inhibition of hypoxia-induced angiogenesis. Interference of Gpr126 expression in zebrafish embryos led to defects in intersegmental vessel formation. Finally, we identified that GPR126 regulated the expression of VEGFR2 by targeting STAT5 and GATA2 through the cAMP-PKA-cAMP-response element-binding protein signaling pathway during angiogenesis. Our findings illustrate that GPR126 modulates both physiological and pathological angiogenesis through VEGF signaling, providing a potential target for the treatment of angiogenesis-related diseases.	[Cui, Hengxiang; Yu, Wenjie; Zhang, Long; Wang, Yuan; Luo, Jian; Li, Dali; Liu, Mingyao] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Cui, Hengxiang; Yu, Wenjie; Zhang, Long; Wang, Yuan; Luo, Jian; Li, Dali; Liu, Mingyao] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Bai, Min; Ma, Yanlin] Hainan Med Univ, Affiliated Hosp, Hainan Reprod Med Ctr, Hainan Prov Key Lab Human Reprod Med & Genet Res, Haikou 570102, Peoples R China; [Wang, Yeqi] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Huang, Huizhe] Chongqing Med Univ, Sch Basic Med, Core Facil Zebrafish Res, Chongqing 400016, Peoples R China; [Bryan, Brad A.] Texas Tech Univ, Hlth Sci Ctr, Ctr Excellence Canc Res, El Paso, TX 79905 USA; [Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	East China Normal University; East China Normal University; Hainan Medical University; Yale University; Chongqing Medical University; Texas Tech University System; Texas Tech University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Li, DL (corresponding author), E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China.	dlli@bio.ecnu.edu.cn; mayl1990@foxmail.com; mlliu@bio.ecnu.edu.cn	CUI, Hengxiang/AAO-1326-2021; Ma, Yanlin/CAH-2185-2022; Wang, Yeqi/V-8445-2019; Luo, Jian/H-3362-2016	Ma, Yanlin/0000-0001-9668-0204; Wang, Yeqi/0000-0003-2881-4607; Yu, Wenjie/0000-0002-3013-1218; Li, Dali/0000-0002-0046-8493; Luo, Jian/0000-0003-3583-0154; wang, Yuan/0000-0002-0939-1269; Liu, Mingyao/0000-0001-7339-5048	National Institutes of Health from NHLBI [R15HL098931]; State Key Development Programs of China [2012CB910400, 2010CB945403]; National Natural Science Foundation of China [30800627, 30930055, 31171318]; Science and Technology Commission of Shanghai Municipality [14140900300]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL098931] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); State Key Development Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R15HL098931 from NHLBI. This work was also supported in part by State Key Development Programs of China grants 2012CB910400 and 2010CB945403), National Natural Science Foundation of China Grants 30800627, 30930055, and 31171318, and Science and Technology Commission of Shanghai Municipality Grant 14140900300.	Anderson KD, 2011, P NATL ACAD SCI USA, V108, P2807, DOI 10.1073/pnas.1019761108; Childs S, 2002, DEVELOPMENT, V129, P973; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Cullen M, 2011, P NATL ACAD SCI USA, V108, P5759, DOI 10.1073/pnas.1017192108; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; Dentelli P, 2009, ARTERIOSCL THROM VAS, V29, P114, DOI 10.1161/ATVBAHA.108.172247; Dudley AC, 2005, BIOCHEM J, V390, P427, DOI 10.1042/BJ20050351; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Hidaka M, 1999, P NATL ACAD SCI USA, V96, P7370, DOI 10.1073/pnas.96.13.7370; Jackson TA, 2005, J BIOL CHEM, V280, P29856, DOI 10.1074/jbc.M500335200; Kaur B, 2005, ONCOGENE, V24, P3632, DOI 10.1038/sj.onc.1208317; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; Korpelainen EI, 1999, ONCOGENE, V18, P1, DOI 10.1038/sj.onc.1202288; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Leung T, 2006, BLOOD, V108, P160, DOI 10.1182/blood-2005-09-3706; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Meissner M, 2004, CIRC RES, V94, P324, DOI 10.1161/01.RES.0000113781.08139.81; Minami T, 2001, J BIOL CHEM, V276, P5395, DOI 10.1074/jbc.M008798200; Monk KR, 2011, DEVELOPMENT, V138, P2673, DOI 10.1242/dev.062224; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Nishimori H, 1997, ONCOGENE, V15, P2145, DOI 10.1038/sj.onc.1201542; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Rompler H, 2007, MOL INTERV, V7, P17, DOI 10.1124/mi.7.1.5; Schmidt A, 2007, CIRC RES, V101, P125, DOI 10.1161/CIRCRESAHA.107.148932; Schuringa JJ, 2004, STEM CELLS, V22, P1191, DOI 10.1634/stemcells.2004-0033; STAINIER DYR, 1994, TRENDS CARDIOVAS MED, V4, P207, DOI 10.1016/1050-1738(94)90036-1; Stehlik C, 2004, FEBS LETT, V569, P149, DOI 10.1016/j.febslet.2004.05.038; Sumida H, 2010, BLOOD, V116, P5060, DOI 10.1182/blood-2010-03-272443; Tanaka A, 2010, BLOOD, V115, P4138, DOI 10.1182/blood-2009-05-223057; Tsopanoglou NE, 1999, J BIOL CHEM, V274, P23969, DOI 10.1074/jbc.274.34.23969; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; Waller-Evans H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014047; Wang T, 2005, BLOOD, V105, P2836, DOI 10.1182/blood-2004-07-2878; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Wang YQ, 2011, J BIOL CHEM, V286, P41095, DOI 10.1074/jbc.M111.296806; Xu M, 2003, EMBO J, V22, P893, DOI 10.1093/emboj/cdg094; Yamamizu K, 2009, BLOOD, V114, P3707, DOI 10.1182/blood-2008-12-195750; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yang LV, 2007, MOL CELL BIOL, V27, P1334, DOI 10.1128/MCB.01909-06; Yang XH, 2009, CANCER RES, V69, P1668, DOI 10.1158/0008-5472.CAN-07-6385; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Zeng HY, 2003, J BIOL CHEM, V278, P20738, DOI 10.1074/jbc.M209712200; Zeoli A, 2008, BLOOD, V112, P350, DOI 10.1182/blood-2007-12-128215	50	35	35	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2014	289	50					34871	34885		10.1074/jbc.M114.571000	http://dx.doi.org/10.1074/jbc.M114.571000			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW4OP	25217645	hybrid, Green Published			2022-12-28	WOS:000346260800038
J	Barabas, ME; Mattson, EC; Aboualizadeh, E; Hirschmugl, CJ; Stucky, CL				Barabas, Marie E.; Mattson, Eric C.; Aboualizadeh, Ebrahim; Hirschmugl, Carol J.; Stucky, Cheryl L.			Chemical Structure and Morphology of Dorsal Root Ganglion Neurons from Naive and Inflamed Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; Infrared Spectroscopy (IR Spectroscopy); Lipid; Mechanotransduction; Pain; Transient Receptor Potential Channels (TRP Channels); Transient Receptor Potential Ankyrin 1; Dorsal Root Ganglia; Nociceptor; Sensory Neuron; Complete Freund's Adjuvant	SPATIAL-RESOLUTION PROPERTIES; TRIGEMINAL SENSORY NEURONS; ION-CHANNEL TRPA1; NOCICEPTIVE NEURONS; IN-VIVO; RECEPTOR; ACTIVATION; PAIN; CONTRIBUTES; COLD	Background: Roles of lipids and carbohydrates in sensory transduction are understudied. Results: Localization of lipids and carbohydrates in neuronal subsets is identified and associated with enrichment of endoplasmic reticulum; lipids increased in nociceptors during inflammation but not in TRPA1-deficient neurons. Conclusion: Chemical morphology varies in sensory subpopulations; TRPA1-mediated lipid increases may underlie mechanical sensitization with inflammation. Significance: Lipids and carbohydrates may mediate inflammatory pain. Fourier transform infrared spectromicroscopy provides label-free imaging to detect the spatial distribution of the characteristic functional groups in proteins, lipids, phosphates, and carbohydrates simultaneously in individual DRG neurons. We have identified ring-shaped distributions of lipid and/or carbohydrate enrichment in subpopulations of neurons which has never before been reported. These distributions are ring-shaped within the cytoplasm and are likely representative of the endoplasmic reticulum. The prevalence of chemical ring subtypes differs between large- and small-diameter neurons. Peripheral inflammation increased the relative lipid content specifically in small-diameter neurons, many of which are nociceptive. Because many small-diameter neurons express an ion channel involved in inflammatory pain, transient receptor potential ankyrin 1 (TRPA1), we asked whether this increase in lipid content occurs in TRPA1-deficient (knock-out) neurons. No statistically significant change in lipid content occurred in TRPA1-deficient neurons, indicating that the inflammation-mediated increase in lipid content is largely dependent on TRPA1. Because TRPA1 is known to mediate mechanical and cold sensitization that accompanies peripheral inflammation, our findings may have important implications for a potential role of lipids in inflammatory pain.	[Barabas, Marie E.; Stucky, Cheryl L.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Mattson, Eric C.; Aboualizadeh, Ebrahim; Hirschmugl, Carol J.] Univ Wisconsin, Dept Phys, Milwaukee, WI 53211 USA	Medical College of Wisconsin; University of Wisconsin System; University of Wisconsin Milwaukee	Stucky, CL (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	cstucky@mcw.edu	Aboualizadeh, Ebrahim/K-2559-2019; Barabas, Marie-Elizabeth/AAG-8822-2021	Aboualizadeh, Ebrahim/0000-0002-8577-7403; Barabas, Marie-Elizabeth/0000-0002-4240-6979	National Institutes of Health [NS040538, NS070711]; National Science Foundation (NSF) [CHE-1112433]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070711, R01NS040538] Funding Source: NIH RePORTER; Division Of Chemistry [1112433] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health R01 Grants NS040538 and NS070711 (to C. L. S.). This work was also supported by National Science Foundation (NSF) Grant CHE-1112433 (to C. J. H.).	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Anishkin A, 2014, P NATL ACAD SCI USA, V111, P7898, DOI 10.1073/pnas.1313364111; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Barabas ME, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-9; Barabas ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047988; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Breese NM, 2005, PAIN, V115, P37, DOI 10.1016/j.pain.2005.02.010; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cruz-Orengo L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-30; da Costa DSM, 2010, PAIN, V148, P431, DOI 10.1016/j.pain.2009.12.002; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; Dall'Acqua MC, 2014, LIFE SCI, V105, P7, DOI 10.1016/j.lfs.2014.02.031; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Erdogan H, 1999, PHYS MED BIOL, V44, P2835, DOI 10.1088/0031-9155/44/11/311; Erdogan H, 1999, IEEE T MED IMAGING, V18, P801, DOI 10.1109/42.802758; Fagone P, 2009, J LIPID RES, V50, pS311, DOI 10.1194/jlr.R800049-JLR200; Ferraro JT, 2004, AM J PHYSIOL-CELL PH, V286, pC831, DOI 10.1152/ajpcell.00224.2003; Fessler JA, 1997, IEEE T MED IMAGING, V16, P166, DOI 10.1109/42.563662; Fessler JA, 1996, IEEE T IMAGE PROCESS, V5, P1346, DOI 10.1109/83.535846; Gascon E, 2010, ARCH PHARM RES, V33, P1489, DOI 10.1007/s12272-010-1003-x; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Gnanasekaran A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-77; Gold MS, 1996, P NATL ACAD SCI USA, V93, P1108, DOI 10.1073/pnas.93.3.1108; Hackett MJ, 2013, ACS CHEM NEUROSCI, V4, P1071, DOI 10.1021/cn4000346; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Hjerling-Leffler J, 2007, J NEUROSCI, V27, P2435, DOI 10.1523/JNEUROSCI.5614-06.2007; Kastyak-Ibrahim MZ, 2012, NEUROIMAGE, V60, P376, DOI 10.1016/j.neuroimage.2011.11.069; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LAWSON SN, 1991, J PHYSIOL-LONDON, V435, P41, DOI 10.1113/jphysiol.1991.sp018497; LAWSON SN, 1993, BRAIN RES BULL, V30, P239, DOI 10.1016/0361-9230(93)90250-F; Le Pichon CE, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00021; Lennertz RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043597; Li CX, 2007, BRAIN RES, V1139, P201, DOI 10.1016/j.brainres.2006.12.039; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Martin MC, 2013, NAT METHODS, V10, P861, DOI [10.1038/NMETH.2596, 10.1038/nmeth.2596]; Materazzi S, 2008, P NATL ACAD SCI USA, V105, P12045, DOI 10.1073/pnas.0802354105; Nasse MJ, 2011, NAT METHODS, V8, P413, DOI [10.1038/NMETH.1585, 10.1038/nmeth.1585]; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; Patti GJ, 2012, NAT CHEM BIOL, V8, P232, DOI [10.1038/nchembio.767, 10.1038/NCHEMBIO.767]; Peng XQ, 2004, BRAIN RES, V1026, P185, DOI 10.1016/j.brainres.2004.07.075; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Piomelli D, 2014, NAT NEUROSCI, V17, P164, DOI 10.1038/nn.3612; Poole K, 2015, PFLUG ARCH EUR J PHY, V467, P121, DOI 10.1007/s00424-014-1563-6; Pristera A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040079; Reichling DB, 2009, TRENDS NEUROSCI, V32, P611, DOI 10.1016/j.tins.2009.07.007; RITTER AM, 1992, J NEUROPHYSIOL, V68, P2033, DOI 10.1152/jn.1992.68.6.2033; Sandt C, 2013, J BIOPHOTONICS, V6, P60, DOI 10.1002/jbio.201200139; Stayman JW, 2000, IEEE T MED IMAGING, V19, P601, DOI 10.1109/42.870666; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stuart B., 2004, INFRARED SPECTROSCOP, DOI DOI 10.1111/j.1750-3841.2008.00799.x; Stucky CL, 2009, BRAIN RES REV, V60, P2, DOI 10.1016/j.brainresrev.2008.12.018; Szoke E, 2010, EUR J PHARMACOL, V628, P67, DOI 10.1016/j.ejphar.2009.11.052; Taylor-Clark TE, 2008, MOL PHARMACOL, V73, P274, DOI 10.1124/mol.107.040832; Tyrrell L, 2001, J NEUROSCI, V21, P9629, DOI 10.1523/JNEUROSCI.21-24-09629.2001; Vasquez V, 2014, CELL REP, V6, P70, DOI 10.1016/j.celrep.2013.12.012; Vilceanu D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012177; Wang YL, 2010, AM J PHYSIOL-LUNG C, V298, pL775, DOI 10.1152/ajplung.00327.2009; Xing YH, 2011, J CELL PHYSIOL, V226, P2350, DOI 10.1002/jcp.22579; Xu ZZ, 2013, J NEUROIMMUNE PHARM, V8, P37, DOI 10.1007/s11481-012-9394-8; Zhang YH, 2013, NEUROSCIENCE, V248, P562, DOI 10.1016/j.neuroscience.2013.06.039; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	64	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					34241	34249		10.1074/jbc.M114.570101	http://dx.doi.org/10.1074/jbc.M114.570101			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25271163	Green Published, hybrid			2022-12-28	WOS:000346077600046
J	Cerk, IK; Salzburger, B; Boeszoermenyi, A; Heier, C; Pillip, C; Romauch, M; Schweiger, M; Cornaciu, I; Lass, A; Zimmermann, R; Zechner, R; Oberer, M				Cerk, Ines K.; Salzburger, Barbara; Boeszoermenyi, Andras; Heier, Christoph; Pillip, Christoph; Romauch, Matthias; Schweiger, Martina; Cornaciu, Irina; Lass, Achim; Zimmermann, Robert; Zechner, Rudolf; Oberer, Monika			A Peptide Derived from G(0)/G(1) Switch Gene 2 Acts as Noncompetitive Inhibitor of Adipose Triglyceride Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; ENERGY-METABOLISM; TERMINAL REGION; MESSENGER-RNA; LIPOLYSIS; EXPRESSION; G0S2; TISSUE; MICE; IDENTIFICATION	The protein G(0)/G(1) switch gene 2 (G0S2) is a small basic protein that functions as an endogenous inhibitor of adipose triglyceride lipase (ATGL), a key enzyme in intracellular lipolysis. In this study, we identified a short sequence covering residues Lys-20 to Ala-52 in G0S2 that is still fully capable of inhibiting mouse and human ATGL. We found that a synthetic peptide corresponding to this region inhibits ATGL in a noncompetitive manner in the nanomolar range. This peptide is highly selective for ATGL and does not inhibit other lipases, including hormone-sensitive lipase, monoacylglycerol lipase, lipoprotein lipase, and patatin domain-containing phospholipases 6 and 7. Because increased lipolysis is linked to the development of metabolic disorders, the inhibition of ATGL by G0S2-derived peptides may represent a novel therapeutic tool to modulate lipolysis.	[Cerk, Ines K.; Salzburger, Barbara; Boeszoermenyi, Andras; Heier, Christoph; Pillip, Christoph; Romauch, Matthias; Schweiger, Martina; Cornaciu, Irina; Lass, Achim; Zimmermann, Robert; Zechner, Rudolf; Oberer, Monika] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	University of Graz	Oberer, M (corresponding author), Graz Univ, Inst Mol Biosci, Humboldtstr 50-3, A-8010 Graz, Austria.	m.oberer@uni-graz.at	Lass, Achim/C-3332-2008; Boeszoermenyi, Andras/AAD-9808-2020	Lass, Achim/0000-0002-8190-7151; Boeszoermenyi, Andras/0000-0001-9810-7241; Schweiger, Martina/0000-0002-3419-1007; Zimmermann, Robert/0000-0002-7354-870X; Heier, Christoph/0000-0001-6858-408X; Oberer, Monika/0000-0003-2525-9513; Zechner, Rudolf/0000-0001-5483-1182	DK Molecular Enzymology; Wittgenstein Award [Z136]; Austrian Science Fund [P25193]; Fondation Leducq [12CVD04];  [SFB Lipotox F30]; Austrian Science Fund (FWF) [Z 136, F 3002, W 901] Funding Source: researchfish	DK Molecular Enzymology(Austrian Science Fund (FWF)); Wittgenstein Award(Austrian Science Fund (FWF)); Austrian Science Fund(Austrian Science Fund (FWF)); Fondation Leducq(Leducq Foundation); ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Grant SFB Lipotox F30 (to M. O. and R. Zechner), DK Molecular Enzymology (to M. O., R. Zechner, and R. Zimmermann), Wittgenstein Award Z136 (to R. Zechner), and Grant P25193 (to A. L.) from the Austrian Science Fund, and Grant 12CVD04 from the Fondation Leducq (to M. O. and R. Zechner).	Bachner D, 1998, DEV DYNAM, V213, P398; Choi H, 2014, CELL DEATH DIFFER, V21, P1071, DOI 10.1038/cdd.2014.26; Cornaciu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026349; Cristillo AD, 1997, DNA CELL BIOL, V16, P1449, DOI 10.1089/dna.1997.16.1449; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Ebdrup S, 2004, J MED CHEM, V47, P400, DOI 10.1021/jm031004s; Gray BP, 2014, CHEM REV, V114, P1020, DOI 10.1021/cr400166n; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Heckmann BL, 2014, J BIOL CHEM, V289, P1905, DOI 10.1074/jbc.M113.522011; Heier C, 2010, BBA-MOL CELL BIOL L, V1801, P1063, DOI 10.1016/j.bbalip.2010.06.001; Hirano K, 2009, J ATHEROSCLER THROMB, V16, P702, DOI 10.5551/jat.1669; Hossen MN, 2010, J CONTROL RELEASE, V147, P261, DOI 10.1016/j.jconrel.2010.07.100; Hoy AJ, 2011, ENDOCRINOLOGY, V152, P48, DOI 10.1210/en.2010-0661; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kienesberger PC, 2008, J BIOL CHEM, V283, P5908, DOI 10.1074/jbc.M709598200; Kienesberger PC, 2009, J BIOL CHEM, V284, P30218, DOI 10.1074/jbc.M109.047787; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kioka H, 2014, P NATL ACAD SCI USA, V111, P273, DOI 10.1073/pnas.1318547111; Koczan D, 2005, EUR J DERMATOL, V15, P251; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kumari M, 2012, CELL METAB, V15, P691, DOI 10.1016/j.cmet.2012.04.008; Kusakabe M, 2010, INT J CANCER, V126, P1895, DOI 10.1002/ijc.24947; Kusakabe M, 2009, BIOCHEM BIOPH RES CO, V390, P1283, DOI 10.1016/j.bbrc.2009.10.137; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Li LO, 2010, BBA-MOL CELL BIOL L, V1801, P246, DOI 10.1016/j.bbalip.2009.09.024; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Ma T, 2014, CANCER BIOL THER, V15, P643, DOI 10.4161/cbt.28251; Mayer N, 2013, NAT CHEM BIOL, V9, P785, DOI [10.1038/NCHEMBIO.1359, 10.1038/nchembio.1359]; Mittendorfer B, 2009, OBESITY, V17, P1872, DOI 10.1038/oby.2009.224; Nagy HM, 2014, BBA-MOL CELL BIOL L, V1841, P588, DOI 10.1016/j.bbalip.2014.01.005; Nakamura N, 2006, DNA RES, V13, P169, DOI 10.1093/dnares/dsl006; Nielsen TS, 2014, DIABETES, V63, P847, DOI 10.2337/db13-1838; Nielsen TS, 2012, J CLIN ENDOCR METAB, V97, pE1348, DOI 10.1210/jc.2012-1159; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; RUSSELL L, 1991, DNA CELL BIOL, V10, P581, DOI 10.1089/dna.1991.10.581; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Schweiger M, 2014, METHOD ENZYMOL, V538, P171, DOI 10.1016/B978-0-12-800280-3.00010-4; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; SEVERSON DL, 1984, LIPIDS, V19, P134, DOI 10.1007/BF02534504; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; Tokumaru Y, 2004, CANCER RES, V64, P5982, DOI 10.1158/0008-5472.CAN-04-0993; Unger RH, 2010, TRENDS ENDOCRIN MET, V21, P345, DOI 10.1016/j.tem.2010.01.009; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Wang Y, 2013, ADV CIV ENG, V2013, DOI 10.1155/2013/189105; Welch C, 2009, CANCER RES, V69, P6782, DOI 10.1158/0008-5472.CAN-09-0128; Yamada T, 2014, LEUKEMIA RES, V38, P210, DOI 10.1016/j.leukres.2013.10.006; Yamada T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038280; Yang XY, 2011, J BIOL CHEM, V286, P40477, DOI 10.1074/jbc.M111.257923; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zhang XD, 2014, DIABETES, V63, P934, DOI 10.2337/db13-1422; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	59	27	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.602599	http://dx.doi.org/10.1074/jbc.M114.602599			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25258314	Green Published, hybrid			2022-12-28	WOS:000345335000015
J	Sato, Y; Takaya, A; Mouslim, C; Hughes, KT; Yamamoto, T				Sato, Yoshiharu; Takaya, Akiko; Mouslim, Chakib; Hughes, Kelly T.; Yamamoto, Tomoko			FliT Selectively Enhances Proteolysis of FlhC Subunit in FlhD(4)C(2) Complex by an ATP-dependent Protease, ClpXP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; FLAGELLUM BIOGENESIS; ESCHERICHIA-COLI; REGULATED PROTEOLYSIS; CYTOSKELETAL PROTEIN; STRUCTURAL INSIGHT; BACILLUS-SUBTILIS; MASTER REGULATOR; CHAPERONE CLPX; MU REPRESSOR	We previously reported that the ClpXP ATP-dependent protease specifically recognizes and degrades the flagellar master transcriptional activator complex, FlhD(4)C(2), to negatively control flagellar biogenesis. The flagellum-related protein, FliT, is also a negative regulator of flagellar regulon by inhibiting the binding of FlhD(4)C(2) to the promoter DNA. We have found a novel pathway of FliT inhibition of FlhD(4)C(2) activity connected to ClpXP proteolysis. An in vitro degradation assay using purified proteins shows that FliT selectively increases ClpXP proteolysis of the FlhC subunit in the FlhD(4)C(2) complex. FliT behaves specifically to ClpXP-dependent proteolysis of FlhC. An in vitro interaction assay detects the ternary complex of FliT-FlhD(4)C(2)-ClpX. FliT promotes the affinity of ClpX against FlhD(4)C(2) complex, whereas FliT does not directly interact with ClpX. Thus, FliT interacts with the FlhC in FlhD(4)C(2) complex and increases the presentation of the FlhC recognition region to ClpX. The DNA-bound form of FlhD(4)C(2) complex is resistant to ClpXP proteolysis. We suggest that the role of FliT in negatively controlling the flagellar gene expression involves increasing free molecules of FlhD(4)C(2) sensitive to ClpXP proteolysis by inhibiting the binding to the promoter DNA as well as enhancing the selective proteolysis of FlhC subunit by ClpXP.	[Sato, Yoshiharu; Takaya, Akiko; Yamamoto, Tomoko] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Microbiol & Mol Genet, Chiba 2608675, Japan; [Mouslim, Chakib; Hughes, Kelly T.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Chiba University; Utah System of Higher Education; University of Utah	Hughes, KT (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	kelly.hughes@utah.edu; tomoko-y@faculty.chiba-u.jp	Takaya, Akiko/H-2769-2017	Takaya, Akiko/0000-0003-1726-7150	National Institutes of Health Public Health Service Grant [GM056141]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [26860282, 25253029]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056141] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service Grant; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grant GM056141 (to K. T. H.). This research was also supported in part by Grants-in-aid for Scientific Research 25253029 (to T. Y.) and 26860282 (to Y. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Abdelhakim AH, 2010, P NATL ACAD SCI USA, V107, P2437, DOI 10.1073/pnas.0910905106; Aldridge C, 2010, MOL MICROBIOL, V78, P1416, DOI 10.1111/j.1365-2958.2010.07415.x; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Battesti A, 2013, GENE DEV, V27, P2722, DOI 10.1101/gad.229617.113; Camberg JL, 2012, STRUCTURE, V20, P1128, DOI 10.1016/j.str.2012.06.004; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; Campos A, 2001, MOL MICROBIOL, V39, P567, DOI 10.1046/j.1365-2958.2001.02247.x; Claret L, 2000, J MOL BIOL, V303, P467, DOI 10.1006/jmbi.2000.4149; Claret L, 2002, J MOL BIOL, V321, P185, DOI 10.1016/S0022-2836(02)00600-9; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; GAMER J, 1992, CELL, V69, P833, DOI 10.1016/0092-8674(92)90294-M; Garg SK, 2009, J BACTERIOL, V191, P1268, DOI 10.1128/JB.01289-08; Gonzalez M, 2000, EMBO J, V19, P5251, DOI 10.1093/emboj/19.19.5251; GROISMAN EA, 1991, METHOD ENZYMOL, V204, P180; HUGHES KT, 1988, GENETICS, V119, P9; Imada K, 2010, P NATL ACAD SCI USA, V107, P8812, DOI 10.1073/pnas.1001866107; Jonas K, 2010, ENVIRON MICROBIOL, V12, P524, DOI 10.1111/j.1462-2920.2009.02097.x; Kirstein J, 2009, EMBO MOL MED, V1, P37, DOI 10.1002/emmm.200900002; Kutsukake K, 1999, GENES GENET SYST, V74, P287, DOI 10.1266/ggs.74.287; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Li BQ, 2012, NUCLEIC ACIDS RES, V40, P11073, DOI 10.1093/nar/gks869; Marshall-Batty KR, 2003, J BIOL CHEM, V278, P1612, DOI 10.1074/jbc.M209352200; McGrath PT, 2006, CELL, V124, P535, DOI 10.1016/j.cell.2005.12.033; MEYNELL EW, 1961, J GEN MICROBIOL, V25, P253, DOI 10.1099/00221287-25-2-253; Minamino T, 2012, MOL MICROBIOL, V83, P168, DOI 10.1111/j.1365-2958.2011.07924.x; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; Stewart MW, 2011, EYE REP, V1, P12, DOI [10.4081/eye.2011.e5, 10.1007/978-94-007-0934-8_1]; Sugimoto S, 2010, J BIOL CHEM, V285, P6648, DOI 10.1074/jbc.M109.080739; Takaya A, 2012, MOL MICROBIOL, V83, P1268, DOI 10.1111/j.1365-2958.2012.08007.x; Thibault G, 2006, P NATL ACAD SCI USA, V103, P17724, DOI 10.1073/pnas.0601505103; Thibault G, 2012, J PHYS CHEM B, V116, P6717, DOI 10.1021/jp212024b; Tomoyasu T, 2003, MOL MICROBIOL, V48, P443, DOI 10.1046/j.1365-2958.2003.03437.x; Turgay K, 1998, EMBO J, V17, P6730; Wada T, 2012, MICROBIOL-SGM, V158, P1533, DOI 10.1099/mic.0.056036-0; Wada T, 2011, J BACTERIOL, V193, P1600, DOI 10.1128/JB.01494-10; Wang SY, 2006, J MOL BIOL, V355, P798, DOI 10.1016/j.jmb.2005.11.020; Welty DJ, 1997, J MOL BIOL, V272, P31, DOI 10.1006/jmbi.1997.1193; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; YAMAGUCHI S, 1986, J BACTERIOL, V166, P187, DOI 10.1128/jb.166.1.187-193.1986; Yamamoto S, 2006, J BACTERIOL, V188, P6703, DOI 10.1128/JB.00799-06; Zhou YN, 1998, J BACTERIOL, V180, P1154, DOI 10.1128/JB.180.5.1154-1158.1998; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	45	19	19	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.593749	http://dx.doi.org/10.1074/jbc.M114.593749			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25278020	hybrid, Green Published			2022-12-28	WOS:000345335000050
J	Agrawal, P; Reynolds, J; Chew, S; Lamba, DA; Hughes, RE				Agrawal, Pooja; Reynolds, Joseph; Chew, Shereen; Lamba, Deepak A.; Hughes, Robert E.			DEPTOR Is a Stemness Factor That Regulates Pluripotency of Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Differentiation; Cell Signaling; Embryonic Stem Cell; Mammalian Target of Rapamycin (mTOR); Neurogenesis	PROTEIN-SYNTHESIS; MAMMALIAN TARGET; SELF-RENEWAL; MTOR; RAPAMYCIN; DIFFERENTIATION; GROWTH; ACTIVATION; GENERATION; MECHANISM	Background: DEPTOR is a negative regulator of mTOR activity and thus plays a role in the regulation of cell metabolism and growth. Results: DEPTOR levels decrease upon differentiation of embryonic stem cells, and reduction of DEPTOR levels is sufficient to promote differentiation. Conclusion: DEPTOR is a stemness factor that regulates pluripotency. Significance: Manipulation of DEPTOR activity provides a means of influencing embryonic stem cell renewal and differentiation. The mammalian target of rapamycin (mTOR) pathway regulates stem cell regeneration and differentiation in response to growth factors, nutrients, cellular energetics, and various extrinsic stressors. Inhibition of mTOR activity has been shown to enhance the regenerative potential of pluripotent stem cells. DEPTOR is the only known endogenous inhibitor of all known cellular mTOR functions. We show that DEPTOR plays a key role in maintaining stem cell pluripotency by limiting mTOR activity in undifferentiated embryonic stem cells (ESCs). DEPTOR levels dramatically decrease with differentiation of mouse ESCs, and knockdown of DEPTOR is sufficient to promote ESC differentiation. A strong decrease in DEPTOR expression is also observed during human ESCs differentiation. Furthermore, reduction in DEPTOR level during differentiation is accompanied by a corresponding increase in mTOR complex 1 activity in mouse ESCs. Our data provide evidence that DEPTOR is a novel stemness factor that promotes pluripotency and self-renewal in ESCs by inhibiting mTOR signaling.	[Agrawal, Pooja; Reynolds, Joseph; Chew, Shereen; Lamba, Deepak A.; Hughes, Robert E.] Buck Inst Res Aging, Novato, CA 94945 USA; [Lamba, Deepak A.] Univ Washington, Dept Ophthalmol, Seattle, WA 98104 USA	Buck Institute for Research on Aging; University of Washington; University of Washington Seattle	Lamba, DA (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	dlamba@buckinstitute.org; rhughes@buckinstitute.org		Chew, Shereen/0000-0002-7285-6604	National Institutes of Health [RL1 GM084432]; California Institute for Regenerative Medicine Research Grant [RB4-05785]; California Institute for Regenerative Medicine Research Training Grant [TG2-01155]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine Research Grant; California Institute for Regenerative Medicine Research Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RL1 GM084432 (to R. E. H.). This work was also supported in part by California Institute for Regenerative Medicine Research Grant RB4-05785 (to D. A. L.).; Supported by California Institute for Regenerative Medicine Research Training Grant TG2-01155.	Agrawal P, 2012, J BIOL CHEM, V287, P21164, DOI 10.1074/jbc.M111.328021; Campbell TB, 2009, BLOOD, V114, P3392, DOI 10.1182/blood-2008-12-195214; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Chen TT, 2011, AGING CELL, V10, P908, DOI 10.1111/j.1474-9726.2011.00722.x; Cho YH, 2014, STEM CELLS, V32, P424, DOI 10.1002/stem.1589; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Davey RE, 2006, STEM CELLS, V24, P2538, DOI 10.1634/stemcells.2006-0216; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Easley CA, 2010, CELL REPROGRAM, V12, P263, DOI 10.1089/cell.2010.0011; Fan CD, 2013, J BIOL CHEM, V288, P1674, DOI 10.1074/jbc.M112.416339; Fuchs C, 2012, HUM MOL GENET, V21, P1049, DOI 10.1093/hmg/ddr535; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Jolly LA, 2009, MOL BIOL CELL, V20, P2015, DOI 10.1091/mbc.E08-06-0596; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009; Kapuria S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003045; Kazi AA, 2011, MOL MED, V17, P925, DOI 10.2119/molmed.2011.00070; Kazi AA, 2010, MOL MED, V16, P359, DOI 10.2119/molmed.2009.00168; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; La Torre Anna, 2012, Methods Mol Biol, V884, P229, DOI 10.1007/978-1-61779-848-1_16; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Laplante M, 2012, CELL METAB, V16, P202, DOI 10.1016/j.cmet.2012.07.008; Lee C, 2013, BIOTECHNIQUES, V54, P141, DOI 10.2144/000113999; Lee KW, 2010, STEM CELLS DEV, V19, P557, DOI 10.1089/scd.2009.0147; Liu ML, 2010, J BIOL CHEM, V285, P36387, DOI 10.1074/jbc.M110.169284; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Proud CG, 2009, J MOL CELL BIOL, V1, P61, DOI 10.1093/jmcb/mjp012; Rosner M, 2010, AMINO ACIDS, V38, P223, DOI 10.1007/s00726-008-0230-7; Soliman GA, 2010, J BIOL CHEM, V285, P7866, DOI 10.1074/jbc.M109.096222; Sun P, 2010, DEVELOPMENT, V137, P2461, DOI 10.1242/dev.051466; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Torres J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036405; Wang S, 2013, CELL STEM CELL, V13, P617, DOI 10.1016/j.stem.2013.10.005; Wang ZW, 2012, AM J PHYSIOL-ENDOC M, V303, pE163, DOI 10.1152/ajpendo.00105.2012; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhou JX, 2009, P NATL ACAD SCI USA, V106, P7840, DOI 10.1073/pnas.0901854106; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	44	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31818	31826		10.1074/jbc.M114.565838	http://dx.doi.org/10.1074/jbc.M114.565838			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25258312	hybrid, Green Published			2022-12-28	WOS:000345314700013
J	Nagai, C; Mabashi-Asazuma, H; Nagasawa, H; Nagata, S				Nagai, Chiaki; Mabashi-Asazuma, Hideaki; Nagasawa, Hiromichi; Nagata, Shinji			Identification and Characterization of Receptors for Ion Transport Peptide (ITP) and ITP-like (ITPL) in the Silkworm Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclic GMP (cGMP); G Protein-coupled Receptor (GPCR); Hormone Receptor; Insect; Neuropeptide; Peptide Hormone; Bombyx mori; Deorphanization; G Protein-coupled Receptor; Guanylyl Cyclase; Hormone Receptor; Insect	CRUSTACEAN HYPERGLYCEMIC HORMONE; MOLT-INHIBITING HORMONE; PRAWN MARSUPENAEUS-JAPONICUS; KURUMA PRAWN; NEUROPEPTIDE GENES; PERIPHERAL NEURONS; GUANYLATE-CYCLASE; EXPRESSION; DROSOPHILA; SYSTEM	Ion transport peptide (ITP) and its alternatively spliced variant, ITP-like (ITPL), are insect peptides that belong to the crustacean hyperglycemic hormone family. These peptides modulate the homeostatic mechanisms for regulating energy metabolism, molting, and reproduction and are specifically conserved in ecdysozoans. Many of the details of the molecular mechanisms by which crustacean hyperglycemic hormone family peptides exert pleiotropy remain to be elucidated, including characterization of their receptors. Here we identified three Bombyx mori orphan neuropeptide G protein-coupled receptors (BNGRs), BNGR-A2, -A24, and -A34, as receptors for ITP and ITPL (collectively referred to as ITPs). BNGR-A2 and -A34 and BNGR-A24 respond to recombinant ITPs, respectively, with EC50 values of 1.1-2.6 x 10(-8) m, when expressed in a heterologous expression system. These three candidate BNGRs are expressed at larval B. mori tissues targeted by ITPs, with cGMP elevation observed after exposure to recombinant ITPs. ITPs also increased the cGMP level in B. mori ovary-derived BmN cells via membrane-bound and soluble guanylyl cyclases. The simultaneous knockdown of bngr-A2 and -A34 significantly decreased the response of BmN cells to ITP, whereas knockdown of bngr-A24 led to decreased responses to ITPL. Conversely, transient expression of bngr-A24 potentiated the response of BmN cells to ITPL. An in vitro binding assay showed direct interaction between ITPs and heterologously expressed BNGRs in a ligand-receptor-specific manner. Taken together, these data demonstrate that BNGR-A2 and -A34 are ITP receptors and that BNGR-A24 is an ITPL receptor in B. mori.	[Nagai, Chiaki; Mabashi-Asazuma, Hideaki; Nagasawa, Hiromichi; Nagata, Shinji] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Nagata, S (corresponding author), Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778567, Japan.	shinjin@k.u-tokyo.ac.jp	Nagai-Okatani, Chiaki/L-2883-2018; Mabashi-Asazuma, Hideaki/AAZ-5401-2020	Nagai-Okatani, Chiaki/0000-0003-4084-3128; Mabashi-Asazuma, Hideaki/0000-0001-5302-6536	Japan Society for the Promotion of Science (JSPS) KAKENHI [22-1424]; MEXT KAKENHI [24580157]; NAITO Foundation	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NAITO Foundation(Naito Memorial Foundation)	This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant-in-Aid for JSPS Fellows 22-1424 (to C. N.)), by MEXT KAKENHI (Grant-in-Aid for Scientific Research (C) 24580157 (to S. N.)), and by the NAITO Foundation (to S. N.).	Asazuma H, 2005, ANN NY ACAD SCI, V1040, P215, DOI 10.1196/annals.1327.027; AUDSLEY N, 1992, J EXP BIOL, V173, P261; Audsley N, 2013, PEPTIDES, V41, P74, DOI 10.1016/j.peptides.2012.11.001; Begum K, 2009, INSECT BIOCHEM MOLEC, V39, P717, DOI 10.1016/j.ibmb.2009.08.005; Birse RT, 2006, J NEUROBIOL, V66, P33, DOI 10.1002/neu.20189; Caers Jelle, 2012, Front Endocrinol (Lausanne), V3, P151, DOI 10.3389/fendo.2012.00151; Chan SM, 2003, GEN COMP ENDOCR, V134, P214, DOI 10.1016/S0016-6480(03)00263-6; Chang ES, 2011, GEN COMP ENDOCR, V172, P323, DOI 10.1016/j.ygcen.2011.04.003; Chung JS, 2010, GEN COMP ENDOCR, V166, P447, DOI 10.1016/j.ygcen.2009.12.011; Dai L, 2007, J COMP NEUROL, V500, P353, DOI 10.1002/cne.21192; Dircksen H, 2008, J COMP NEUROL, V509, P23, DOI 10.1002/cne.21715; Dircksen H, 2009, J EXP BIOL, V212, P401, DOI 10.1242/jeb.026112; Drexler AL, 2007, CELL TISSUE RES, V329, P391, DOI 10.1007/s00441-007-0391-9; Endo H, 2000, INSECT BIOCHEM MOLEC, V30, P355, DOI 10.1016/S0965-1748(99)00129-0; GOY MF, 1990, J BIOL CHEM, V265, P20220; Jiang HB, 2013, P NATL ACAD SCI USA, V110, pE3526, DOI 10.1073/pnas.1310676110; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; Johnson EC, 2003, J BIOL CHEM, V278, P52172, DOI 10.1074/jbc.M306756200; Kahsai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011480; Katayama H, 2002, PEPTIDES, V23, P1537, DOI 10.1016/S0196-9781(02)00094-3; Katayama H, 2004, BIOCHEMISTRY-US, V43, P9629, DOI 10.1021/bi049433v; Katayama H, 2003, J BIOL CHEM, V278, P9620, DOI 10.1074/jbc.M212962200; Katayama H, 2004, ZOOL SCI, V21, P1121, DOI 10.2108/zsj.21.1121; Katayama Hidekazu, 2013, Aqua-Bioscience Monographs, V6, P49; KELLER R, 1992, EXPERIENTIA, V48, P439, DOI 10.1007/BF01928162; King DS, 1999, INSECT BIOCHEM MOLEC, V29, P11, DOI 10.1016/S0965-1748(98)00098-8; Lacombe C, 1999, NEUROPEPTIDES, V33, P71, DOI 10.1054/npep.1999.0016; Lee SG, 2007, COMP BIOCHEM PHYS D, V2, P332, DOI 10.1016/j.cbd.2007.08.001; LI XJ, 1991, EMBO J, V10, P3221, DOI 10.1002/j.1460-2075.1991.tb04885.x; Liu HF, 2004, J EXP ZOOL PART A, V301A, P512, DOI 10.1002/jez.a.75; Meredith J, 1996, J EXP BIOL, V199, P1053; MONNIER D, 1992, J BIOL CHEM, V267, P1298; Nagai C, 2009, ANN NY ACAD SCI, V1163, P478, DOI 10.1111/j.1749-6632.2009.04452.x; Nagai C, 2009, PEPTIDES, V30, P507, DOI 10.1016/j.peptides.2008.07.017; Nagata S, 2011, GEN COMP ENDOCR, V172, P90, DOI 10.1016/j.ygcen.2011.03.004; Nakatsuji T, 2009, COMP BIOCHEM PHYS A, V152, P139, DOI 10.1016/j.cbpa.2008.10.012; Overend G, 2012, PEPTIDES, V34, P209, DOI 10.1016/j.peptides.2011.08.019; Poels J, 2009, PEPTIDES, V30, P545, DOI 10.1016/j.peptides.2008.10.012; Ring M, 1998, INSECT BIOCHEM MOLEC, V28, P51, DOI 10.1016/S0965-1748(97)00096-9; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; SEDLMEIER D, 1981, GEN COMP ENDOCR, V45, P82, DOI 10.1016/0016-6480(81)90172-6; Van Loy T, 2010, PEPTIDES, V31, P520, DOI 10.1016/j.peptides.2009.09.023; Wang YJ, 2000, ARCH INSECT BIOCHEM, V45, P129, DOI 10.1002/1520-6327(200011)45:3&lt;129::AID-ARCH4&gt;3.0.CO;2-L; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; Zheng J, 2008, GEN COMP ENDOCR, V155, P780, DOI 10.1016/j.ygcen.2007.10.009; Zmora Nilli, 2009, Saline Syst, V5, P7, DOI 10.1186/1746-1448-5-7	47	40	42	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32166	32177		10.1074/jbc.M114.590646	http://dx.doi.org/10.1074/jbc.M114.590646			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25278025	Green Published, hybrid			2022-12-28	WOS:000345314700044
J	Uotila, LM; Jahan, F; Hinojosa, LS; Melandri, E; Gronholm, M; Gahmberg, CG				Uotila, Liisa M.; Jahan, Farhana; Hinojosa, Laura Soto; Melandri, Emiliano; Gronholm, Mikaela; Gahmberg, Carl G.			Specific Phosphorylations Transmit Signals from Leukocyte beta(2) to beta(1) Integrins and Regulate Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Integrin; Leukocyte; Phosphorylation; Signal Transduction; LFA-1; VLA-4; Transdominant Inhibition	HUMAN T-CELLS; FUNCTION-ASSOCIATED ANTIGEN-1; TRANSENDOTHELIAL MIGRATION; MEDIATED ADHESION; ALPHA-CHAIN; BINDING; MECHANISMS; ACTIVATION; AFFINITY; EXPRESSION	The regulation of integrins expressed on leukocytes must be controlled precisely, and members of different integrin subfamilies have to act in concert to ensure the proper traffic of immune cells to sites of inflammation. The activation of (2) family integrins through the T cell receptor or by chemokines leads to the inactivation of very late antigen 4. The mechanism(s) of this cross-talk has not been known. We have now elucidated in detail how the signals are transmitted from leukocyte function-associated antigen 1 and show that, after its activation, the signaling involves specific phosphorylations of (2) integrin followed by interactions with cytoplasmic signaling proteins. This results in loss of (1) phosphorylation and a decrease in very late antigen 4 binding to its ligand vascular cell adhesion molecule 1. Our results show how a member of one integrin family regulates the activity of another integrin. This is important for the understanding of integrin-mediated processes.	[Uotila, Liisa M.; Jahan, Farhana; Hinojosa, Laura Soto; Melandri, Emiliano; Gronholm, Mikaela; Gahmberg, Carl G.] Univ Helsinki, Div Biochem & Biotechnol, Fac Biol & Environm Sci, FIN-00014 Helsinki, Finland	University of Helsinki	Gahmberg, CG (corresponding author), Univ Helsinki, Div Biochem & Biotechnol, Fac Biol & Environm Sci, Viikinkaari 5 D POB 56, FIN-00014 Helsinki, Finland.	carl.gahmberg@helsinki.fi	Gahmberg, Carl/AAE-1876-2019	Soto Hinojosa, Laura/0000-0002-0868-3083; Gahmberg, Carl/0000-0001-9892-9296; Gronholm, Mikaela/0000-0002-2378-8924; Uotila, Liisa/0000-0003-4743-9013	Academy of Finland; Sigrid Juselius Foundation; Medicinska Understodsforeningen Liv och Halsa; Finska Lakaresallskapet; Wilhelm and Else Stockmann Foundation; Magnus Ehrnrooth Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medicinska Understodsforeningen Liv och Halsa; Finska Lakaresallskapet; Wilhelm and Else Stockmann Foundation; Magnus Ehrnrooth Foundation	This study was supported by the Academy of Finland, by the Sigrid Juselius Foundation, by the Medicinska Understodsforeningen Liv och Halsa, by Finska Lakaresallskapet, by the Wilhelm and Else Stockmann Foundation, and by the Magnus Ehrnrooth Foundation.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Alon R, 2005, J CELL BIOL, V171, P1073, DOI 10.1083/jcb.200503155; ANDERSSON LC, 1979, INT J CANCER, V23, P143, DOI 10.1002/ijc.2910230202; BLYSTONE SD, 1995, J CELL BIOL, V130, P745, DOI 10.1083/jcb.130.3.745; Bonet R, 2013, J MOL BIOL, V425, P3060, DOI 10.1016/j.jmb.2013.05.024; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Chan JR, 2000, J IMMUNOL, V164, P746, DOI 10.4049/jimmunol.164.2.746; Chigaev A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00242; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Craig DH, 2009, AM J PHYSIOL-CELL PH, V296, pC193, DOI 10.1152/ajpcell.00355.2008; Das M, 2014, BBA-BIOMEMBRANES, V1838, P579, DOI 10.1016/j.bbamem.2013.07.017; DRANSFIELD I, 1989, EMBO J, V8, P3759, DOI 10.1002/j.1460-2075.1989.tb08552.x; Fagerholm SC, 2005, J CELL BIOL, V171, P705, DOI 10.1083/jcb.200504016; Fagerholm SC, 2004, TRENDS BIOCHEM SCI, V29, P504, DOI 10.1016/j.tibs.2004.07.005; Gahmberg CG, 2009, BBA-GEN SUBJECTS, V1790, P431, DOI 10.1016/j.bbagen.2009.03.007; Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x; Gahmberg CG, 1997, CURR OPIN CELL BIOL, V9, P643, DOI 10.1016/S0955-0674(97)80117-2; Garcia-Bernal D, 2005, MOL BIOL CELL, V16, P3223, DOI 10.1091/mbc.E04-12-1049; Gonzalez AM, 2010, CELL SIGNAL, V22, P578, DOI 10.1016/j.cellsig.2009.10.009; Gronholm M, 2011, J IMMUNOL, V187, P3613, DOI 10.4049/jimmunol.1100704; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Imai Y, 2010, INT J HEMATOL, V91, P569, DOI 10.1007/s12185-010-0555-3; Kotovuori A, 1999, J IMMUNOL, V162, P6613; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Manevich E, 2007, J BIOL CHEM, V282, P25338, DOI 10.1074/jbc.M700089200; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; NORTAMO P, 1988, SCAND J IMMUNOL, V28, P537, DOI 10.1111/j.1365-3083.1988.tb01485.x; Nurmi SM, 2007, J BIOL CHEM, V282, P968, DOI 10.1074/jbc.M608524200; Porter JC, 1997, J CELL BIOL, V138, P1437, DOI 10.1083/jcb.138.6.1437; Rose DM, 2007, IMMUNOL REV, V218, P126, DOI 10.1111/j.1600-065X.2007.00536.x; Shulman Z, 2012, NAT IMMUNOL, V13, P67, DOI 10.1038/ni.2173; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Suzuki K, 2003, J CELL PHYSIOL, V197, P297, DOI 10.1002/jcp.10354; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101; Uotila LM, 2013, J BIOL CHEM, V288, P33494, DOI 10.1074/jbc.C113.497446; VANKOOYK Y, 1993, J EXP MED, V177, P185, DOI 10.1084/jem.177.1.185; Weber KSC, 1997, J IMMUNOL, V158, P273	41	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32230	32242		10.1074/jbc.M114.588111	http://dx.doi.org/10.1074/jbc.M114.588111			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25278023	Green Published, hybrid			2022-12-28	WOS:000345314700049
J	Xing, GL; Gan, GM; Chen, DD; Sun, MK; Yi, JK; Lv, HH; Han, JH; Xie, W				Xing, Guanglin; Gan, Guangming; Chen, Dandan; Sun, Mingkuan; Yi, Jukang; Lv, Huihui; Han, Junhai; Xie, Wei			Drosophila Neuroligin3 Regulates Neuromuscular Junction Development and Synaptic Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; Electron Microscopy (EM); Glutamate Receptor; Synapse; Synaptic Plasticity	GLUTAMATE-RECEPTOR SUBUNIT; INHIBITORY SYNAPSES; CELL-ADHESION; VESICLE SIZE; PROTEIN; ENDOCYTOSIS; MUTATIONS; NEUREXIN; TRANSMISSION; DOMAIN	Background: Postsynaptic neuroligins play essential roles in synaptic maturation and function. Results:Drosophila Neuroligin3 regulates neuromuscular junction growth, GluRIIA recruitment, synaptic vesicle recycling, and postsynaptic density maturation. Conclusion: This elucidates the in vivo roles of Drosophila Neuroligin3 in development and synaptic differentiation of NMJs. Significance: This highlights that Drosophila can be used to understand and uncover functional diversity in neuroligins. Neuroligins (Nlgs) are a family of cell adhesion molecules thought to be important for synapse maturation and function. Mammalian studies have shown that different Nlgs have different roles in synaptic maturation and function. In Drosophila melanogaster, the roles of Drosophila neuroligin1 (DNlg1), neuroligin2, and neuroligin4 have been examined. However, the roles of neuroligin3 (dnlg3) in synaptic development and function have not been determined. In this study, we used the Drosophila neuromuscular junctions (NMJs) as a model system to investigate the in vivo role of dnlg3. We showed that DNlg3 was expressed in both the CNS and NMJs where it was largely restricted to the postsynaptic site. We generated dnlg3 mutants and showed that these mutants exhibited an increased bouton number and reduced bouton size compared with the wild-type (WT) controls. Consistent with alterations in bouton properties, pre- and postsynaptic differentiations were affected in dnlg3 mutants. This included abnormal synaptic vesicle endocytosis, increased postsynaptic density length, and reduced GluRIIA recruitment. In addition to impaired synaptic development and differentiation, we found that synaptic transmission was reduced in dnlg3 mutants. Altogether, our data showed that DNlg3 was required for NMJ development, synaptic differentiation, and function.	[Xing, Guanglin; Gan, Guangming; Chen, Dandan; Sun, Mingkuan; Yi, Jukang; Lv, Huihui; Han, Junhai; Xie, Wei] Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China	Southeast University - China	Xie, W (corresponding author), Southeast Univ, Inst Life Sci, 2 Sipailou Rd, Nanjing 210096, Jiangsu, Peoples R China.	wei.xie@seu.edu.cn	SUN, Mingkuan/I-7186-2016; Chen, Dandan/X-6286-2019; Sun, Mingkuan/H-6191-2019	SUN, Mingkuan/0000-0002-4511-5894; Sun, Mingkuan/0000-0002-4511-5894; Xing, Guanglin/0000-0002-8258-0293	Natural Science Foundation of China [31171041]; National Basic Research Program (973 Program) [2012CB517903]; Natural Science Foundation of China; Canadian Institutes of Health Research [81161120543]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Natural Science Foundation of China Grant 31171041, National Basic Research Program (973 Program) Grant 2012CB517903, and Natural Science Foundation of China and Canadian Institutes of Health Research Joint Health Research Initiative Program Grant 81161120543 (to W. X.).	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Banovic D, 2010, NEURON, V66, P724, DOI 10.1016/j.neuron.2010.05.020; Blundell J, 2009, GENES BRAIN BEHAV, V8, P114, DOI 10.1111/j.1601-183X.2008.00455.x; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Chen YC, 2012, J NEUROSCI, V32, P16018, DOI 10.1523/JNEUROSCI.1685-12.2012; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; DiAntonio A, 1999, J NEUROSCI, V19, P3023; DiAntonio A, 2006, INT REV NEUROBIOL, V75, P165, DOI 10.1016/S0074-7742(06)75008-5; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; Featherstone DE, 2005, J NEUROSCI, V25, P3199, DOI 10.1523/JNEUROSCI.4201-04.2005; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jedlicka P, 2011, CEREB CORTEX, V21, P357, DOI 10.1093/cercor/bhq100; Koh TW, 2007, J CELL BIOL, V178, P309, DOI 10.1083/jcb.200701030; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Kwon HB, 2012, NAT NEUROSCI, V15, P1667, DOI 10.1038/nn.3256; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Li Y, 2013, J NEUROSCI, V33, P15545, DOI 10.1523/JNEUROSCI.0819-13.2013; Liebl FLW, 2008, BIOINFORM BIOL INSIG, V2, P369; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; Mondin M, 2011, J NEUROSCI, V31, P13500, DOI 10.1523/JNEUROSCI.6439-10.2011; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Poskanzer KE, 2006, NEURON, V50, P49, DOI 10.1016/j.neuron.2006.02.021; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Salazar AM, 2010, J NEUROSCI, V30, P515, DOI 10.1523/JNEUROSCI.2523-09.2010; Sand P, 2006, SCHIZOPHR RES, V82, P277, DOI 10.1016/j.schres.2005.11.003; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; Stevens RJ, 2012, J NEUROSCI, V32, P18054, DOI 10.1523/JNEUROSCI.2668-12.2012; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sun CC, 2011, HUM MOL GENET, V20, P3042, DOI 10.1093/hmg/ddr208; Sun MK, 2011, J NEUROSCI, V31, P687, DOI 10.1523/JNEUROSCI.3854-10.2011; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Verstreken Patrik, 2008, V440, P349, DOI 10.1007/978-1-59745-178-9_26; Verstreken P, 2009, NEURON, V63, P203, DOI 10.1016/j.neuron.2009.06.017; Wang D, 2010, J CELL SCI, V123, P1546, DOI 10.1242/jcs.060251; Wermter AK, 2008, AM J MED GENET B, V147B, P535, DOI 10.1002/ajmg.b.30618; Zeng XK, 2007, FEBS LETT, V581, P2509, DOI 10.1016/j.febslet.2007.04.068; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhao L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003450	51	34	35	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31867	31877		10.1074/jbc.M114.574897	http://dx.doi.org/10.1074/jbc.M114.574897			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25228693	Green Published, hybrid			2022-12-28	WOS:000345314700018
J	Daiho, T; Yamasaki, K; Danko, S; Suzuki, H				Daiho, Takashi; Yamasaki, Kazuo; Danko, Stefania; Suzuki, Hiroshi			Second Transmembrane Helix (M2) and Long Range Coupling in Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; ADP-INSENSITIVE PHOSPHOENZYME; STABLE STRUCTURAL ANALOG; CA2+ TRANSPORT ACTIVITY; CALCIUM-PUMP; CRYSTAL-STRUCTURE; PHOSPHORYLATED INTERMEDIATE; ADENOSINE-TRIPHOSPHATASE; ANGSTROM RESOLUTION; KINETIC-PROPERTIES	The actuator (A) domain of sarco(endo) plasmic reticulum Ca2+-ATPase not only plays a catalytic role but also undergoes large rotational movements that influence the distant transport sites through connections with transmembrane helices M1 and M2. Here we explore the importance of long helix M2 and its junction with the A domain by disrupting the helix structure and elongating with insertions of five glycine residues. Insertions into the membrane region of M2 and the top junctional segment impair Ca2+ transport despite reasonable ATPase activity, indicating that they are uncoupled. These mutants fail to occlude Ca2+. Those at the top segment also exhibited accelerated phosphoenzyme isomerization E1P -> E2P. Insertions into the middle of M2 markedly accelerate E2P hydrolysis and cause strong resistance to inhibition by luminal Ca2+. Insertions along almost the entire M2 region inhibit the dephosphorylated enzyme transition E2 -> E1. The results pinpoint which parts of M2 control cytoplasm gating and which are critical for luminal gating at each stage in the transport cycle and suggest that proper gate function requires appropriate interactions, tension, and/or rigidity in the M2 region at appropriate times for coupling with A domain movements and catalysis.	[Daiho, Takashi; Yamasaki, Kazuo; Danko, Stefania; Suzuki, Hiroshi] Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College	Daiho, T (corresponding author), Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan.	daiho@asahikawa-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [23370058] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research C (to T. D.) and B (to H. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Abe K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1154; Bublitz M, 2010, CURR OPIN STRUC BIOL, V20, P431, DOI 10.1016/j.sbi.2010.06.007; Daiho T, 1999, J BIOL CHEM, V274, P23910, DOI 10.1074/jbc.274.34.23910; Daiho T, 2003, J BIOL CHEM, V278, P39197, DOI 10.1074/jbc.M305200200; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; Daiho T, 2001, J BIOL CHEM, V276, P32771, DOI 10.1074/jbc.M101229200; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Daiho T, 2010, J BIOL CHEM, V285, P24538, DOI 10.1074/jbc.M110.144535; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2009, J BIOL CHEM, V284, P22722, DOI 10.1074/jbc.M109.029702; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1982, J BIOL CHEM, V257, P1289; Einholm AP, 2004, J BIOL CHEM, V279, P15888, DOI 10.1074/jbc.M400158200; Garnett C, 1996, BIOCHEMISTRY-US, V35, P11019, DOI 10.1021/bi960718k; HANEL AM, 1991, BIOCHEMISTRY-US, V30, P11320, DOI 10.1021/bi00111a019; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; NAKAMURA Y, 1984, J BIOL CHEM, V259, P8183; NAKAMURA Y, 1986, J BIOL CHEM, V261, P3090; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PRAGER R, 1979, EUR J BIOCHEM, V97, P239, DOI 10.1111/j.1432-1033.1979.tb13108.x; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Sato K, 2004, J BIOL CHEM, V279, P35595, DOI 10.1074/jbc.M404887200; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; WEBER K, 1969, J BIOL CHEM, V244, P4406; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Xu C, 2008, J BIOL CHEM, V283, P3297, DOI 10.1074/jbc.M706315200; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; Yamasaki K, 2008, J BIOL CHEM, V283, P29144, DOI 10.1074/jbc.M804596200	49	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31241	31252		10.1074/jbc.M114.584086	http://dx.doi.org/10.1074/jbc.M114.584086			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25246522	Green Published, hybrid			2022-12-28	WOS:000344549900029
J	Muthusamy, S; DeMartino, AM; Watson, LJ; Brittian, KR; Zafir, A; Dassanayaka, S; Hong, KU; Jones, SP				Muthusamy, Senthilkumar; DeMartino, Angelica M.; Watson, Lewis J.; Brittian, Kenneth R.; Zafir, Ayesha; Dassanayaka, Sujith; Hong, Kyung U.; Jones, Steven P.			MicroRNA-539 Is Up-regulated in Failing Heart, and Suppresses O-GlcNAcase Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heart Failure; Metabolism; MicroRNA (miRNA); O-GlcNAcylation; Post-transcriptional Regulation; Hexosamine	BETA-N-ACETYLGLUCOSAMINE; NUCLEOCYTOPLASMIC PROTEINS; CARDIOVASCULAR-SYSTEM; MYOCARDIAL-INFARCTION; CARDIAC-HYPERTROPHY; IN-VIVO; GLCNACYLATION; FAILURE; CARDIOMYOCYTES; STRESS	Background: Protein O-GlcNAcylation is nearly ubiquitous; however, regulation of the expression of key enzymes remains unknown. Results: miR-539 is up-regulated in the failing heart, binds to the 3UTR, and negatively regulates O-GlcNAcase expression. Conclusion: Protein O-GlcNAcylation can be regulated by post-transcriptional mechanisms. Significance: miR-539 regulates one of the two enzymes responsible for O-GlcNAcylation in multicellular eukaryotes. Derangements in metabolism and related signaling pathways characterize the failing heart. One such signal, O-linked -N-acetylglucosamine (O-GlcNAc), is an essential post-translational modification regulated by two enzymes, O-GlcNAc transferase and O-GlcNAcase (OGA), which modulate the function of many nuclear and cytoplasmic proteins. We recently reported reduced OGA expression in the failing heart, which is consistent with the pro-adaptive role of increased O-GlcNAcylation during heart failure; however, molecular mechanisms regulating these enzymes during heart failure remain unknown. Using miRNA microarray analysis, we observed acute and chronic changes in expression of several miRNAs. Here, we focused on miR-539 because it was predicted to target OGA mRNA. Indeed, co-transfection of the OGA-3UTR containing reporter plasmid and miR-539 overexpression plasmid significantly reduced reporter activity. Overexpression of miR-539 in neonatal rat cardiomyocytes significantly suppressed OGA expression and consequently increased O-GlcNAcylation; conversely, the miR-539 inhibitor rescued OGA protein expression and restored O-GlcNAcylation. In conclusion, this work identifies the first target of miR-539 in the heart and the first miRNA that regulates OGA. Manipulation of miR-539 may represent a novel therapeutic target in the treatment of heart failure and other metabolic diseases.	Univ Louisville, Inst Mol Cardiol, Louisville, KY 40202 USA; Univ Louisville, Diabet & Obes Ctr, Louisville, KY 40202 USA	University of Louisville; University of Louisville	Jones, SP (corresponding author), 580 South Preston St,321F Delia Baxter Bldg, Louisville, KY 40202 USA.	Steven.P.Jones@Louisville.edu	Watson, Lewis J/F-3688-2011; Hong, Kyung Uk/G-7145-2011; Muthusamy, Senthilkumar/G-7875-2015; Muthusamy, Senthilkumar/Y-1353-2018; Jones, Steven P./D-5092-2009; Dassanayaka, Sujith/E-9812-2015	Watson, Lewis J/0000-0002-8273-7676; Hong, Kyung Uk/0000-0001-6700-9470; Muthusamy, Senthilkumar/0000-0003-1603-9965; Jones, Steven P./0000-0001-5376-8089; 	National Institutes of Health [R01 HL083320, R01 HL094419, P20 RR024489, P01 HL078825, R37 HL055757]; American Heart Association Predoctoral (Great Rivers Affiliate) Fellowship [0815502D]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094419, R01HL083320, P01HL078825, R37HL055757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral (Great Rivers Affiliate) Fellowship(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL083320, R01 HL094419, P20 RR024489, P01 HL078825, and R37 HL055757 (to S. P. J.) and American Heart Association Predoctoral (Great Rivers Affiliate) Fellowship 0815502D (to L. J. W.).	Boglarka L, 2010, AM J PHYSIOL-HEART C, V299, pH1715, DOI 10.1152/ajpheart.00337.2010; Brainard RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083174; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Champattanachai V, 2007, AM J PHYSIOL-CELL PH, V292, pC178, DOI 10.1152/ajpcell.00162.2006; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Deng YQ, 2009, AM J PATHOL, V175, P2089, DOI 10.2353/ajpath.2009.090157; Divakaran V, 2008, CIRC RES, V103, P1072, DOI 10.1161/CIRCRESAHA.108.183087; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Facundo HT, 2012, AM J PHYSIOL-HEART C, V302, pH2122, DOI 10.1152/ajpheart.00775.2011; Greer JJM, 2006, AM J PHYSIOL-HEART C, V291, pH2743, DOI 10.1152/ajpheart.00347.2006; Groves JA, 2013, CELL STRESS CHAPERON, V18, P535, DOI 10.1007/s12192-013-0426-y; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Jacobsen KT, 2011, BIOCHEM BIOPH RES CO, V404, P882, DOI 10.1016/j.bbrc.2010.12.080; Jones SP, 2001, ACTA PHYSIOL SCAND, V173, P139, DOI 10.1046/j.1365-201X.2001.00899.x; Jones SP, 2005, AM J PHYSIOL-HEART C, V288, pH365, DOI 10.1152/ajpheart.00245.2004; Jones SP, 2003, CIRC RES, V93, P697, DOI 10.1161/01.RES.0000097262.21507.DF; Jones SP, 2003, P NATL ACAD SCI USA, V100, P4891, DOI 10.1073/pnas.0837428100; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Laczy B, 2009, AM J PHYSIOL-HEART C, V296, pH13, DOI 10.1152/ajpheart.01056.2008; Lee YN, 2011, BLOOD, V117, P3629, DOI 10.1182/blood-2010-07-293548; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lima VV, 2009, HYPERTENSION, V53, P166, DOI 10.1161/HYPERTENSIONAHA.108.116798; Ma ZY, 2013, AMINO ACIDS, V45, P719, DOI 10.1007/s00726-013-1543-8; Marsh SA, 2011, AMINO ACIDS, V40, P819, DOI 10.1007/s00726-010-0699-8; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Milosevic J, 2012, AM J RESP CELL MOL, V47, P879, DOI 10.1165/rcmb.2011-0377OC; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Ngoh GA, 2008, J PHARMACOL EXP THER, V327, P602, DOI 10.1124/jpet.108.143263; Ngoh GA, 2011, AMINO ACIDS, V40, P895, DOI 10.1007/s00726-010-0728-7; Ngoh GA, 2010, CIRC RES, V107, P171, DOI 10.1161/CIRCRESAHA.110.224675; Ngoh GA, 2009, AM J PHYSIOL-HEART C, V297, pH1711, DOI 10.1152/ajpheart.00553.2009; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Rodriguez-Melendez R, 2001, J NUTR, V131, P1909, DOI 10.1093/jn/131.7.1909; Sansbury BE, 2014, CIRC-HEART FAIL, V7, P634, DOI 10.1161/CIRCHEARTFAILURE.114.001151; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wang K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4596; Watson LJ, 2014, AM J PHYSIOL-HEART C, V306, pH142, DOI 10.1152/ajpheart.00438.2013; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zafir A, 2013, STEM CELLS, V31, P765, DOI 10.1002/stem.1325	52	55	60	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29665	29676		10.1074/jbc.M114.578682	http://dx.doi.org/10.1074/jbc.M114.578682			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25183011	Green Published, hybrid			2022-12-28	WOS:000344370800016
J	Brown, LM; Rogers, KE; Aroonsakool, N; McCammon, JA; Insel, PA				Brown, Loren M.; Rogers, Kathleen E.; Aroonsakool, Nakon; McCammon, J. Andrew; Insel, Paul A.			Allosteric Inhibition of Epac COMPUTATIONAL MODELING AND EXPERIMENTAL VALIDATION TO IDENTIFY ALLOSTERIC SITES AND INHIBITORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUGGABLE HOT-SPOTS; GENE-EXPRESSION; CAMP EPAC; I-TASSER; ACTIVATION; IDENTIFICATION; MECHANISM; PROTEINS; DYNAMICS; RAP1	Epac, a guanine nucleotide exchange factor for the low molecular weight G protein Rap, is an effector of cAMP signaling and has been implicated to have roles in numerous diseases, including diabetes mellitus, heart failure, and cancer. We used a computational molecular modeling approach to predict potential binding sites for allosteric modulators of Epac and to identify molecules that might bind to these regions. This approach revealed that the conserved hinge region of the cyclic nucleotide-binding domain of Epac1 is a potentially druggable region of the protein. Using a bioluminescence resonance energy transfer-based assay (CAMYEL, cAMP sensor using YFP-Epac-Rluc), we assessed the predicted compounds for their ability to bind Epac and modulate its activity. We identified a thiobarbituric acid derivative, 5376753, that allosterically inhibits Epac activity and used Swiss 3T3 and HEK293 cells to test the ability of this compound to modulate the activity of Epac and PKA, as determined by Rap1 activity and vasodilator-stimulated phosphoprotein phosphorylation, respectively. Compound 5376753 selectively inhibited Epac in biochemical and cell migration studies. These results document the utility of a computational approach to identify a domain for allosteric regulation of Epac and a novel compound that prevents the activation of Epac1 by cAMP.	[Brown, Loren M.; Rogers, Kathleen E.; Aroonsakool, Nakon; McCammon, J. Andrew; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [McCammon, J. Andrew] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [McCammon, J. Andrew] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Insel, PA (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pinsel@ucsd.edu	McCammon, J. Andrew/AAG-1832-2021	McCammon, J. Andrew/0000-0003-3065-1456	National Science Foundation [MCB1020765]; National Institutes of Health [GM31749]; Howard Hughes Medical Institute; National Biomedical Computation Resource; Center for Theoretical Biological Physics; National Science Foundation Supercomputer Centers; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM031749] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Biomedical Computation Resource; Center for Theoretical Biological Physics; National Science Foundation Supercomputer Centers(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Paul Sternweis for the pcDNA3 CAMYEL plasmid and Dr. Frank Lezoualc'h for the CE3F4 compound. Work in the JAM group was supported in part by National Science Foundation Grant MCB1020765, National Institutes of Health Grant GM31749, the Howard Hughes Medical Institute, the National Biomedical Computation Resource, the Center for Theoretical Biological Physics, and National Science Foundation Supercomputer Centers. All authors declare that there are no conflicts of interest.	[Anonymous], 2013, SCHROD SUIT 2013 PRO; [Anonymous], 2013, SCHROD REL 2013 3 LI; [Anonymous], 2014, SCHROD REL 2014 1 MA; Baljinnyam E, 2009, AM J PHYSIOL-CELL PH, V297, pC802, DOI 10.1152/ajpcell.00129.2009; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Brenke R, 2009, BIOINFORMATICS, V25, P621, DOI 10.1093/bioinformatics/btp036; Brown LM, 2014, J BIOL CHEM, V289, P8217, DOI 10.1074/jbc.M114.548636; Case DA, 2012, AMBER 12; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; Consonni SV, 2012, P NATL ACAD SCI USA, V109, P3814, DOI 10.1073/pnas.1117599109; Courilleau D, 2012, J BIOL CHEM, V287, P44192, DOI 10.1074/jbc.M112.422956; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Harper SM, 2008, J BIOL CHEM, V283, P6501, DOI 10.1074/jbc.M707849200; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Kozakov D, 2011, P NATL ACAD SCI USA, V108, P13528, DOI 10.1073/pnas.1101835108; Laurent AC, 2012, BIOCHEM SOC T, V40, P51, DOI 10.1042/BST20110642; Lin JH, 2002, J AM CHEM SOC, V124, P5632, DOI 10.1021/ja0260162; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Lorenz R, 2008, PANCREAS, V37, P102, DOI 10.1097/MPA.0b013e318160748f; MARK LC, 1958, J PHARMACOL EXP THER, V123, P70; Matthiesen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024392; Nichols SE, 2012, METHODS MOL BIOL, V819, P93, DOI 10.1007/978-1-61779-465-0_7; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schmidt M, 2013, PHARMACOL REV, V65, P670, DOI 10.1124/pr.110.003707; SIEGBAHN A, 1990, J CLIN INVEST, V85, P916, DOI 10.1172/JCI114519; Srivastava DP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001350; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; Takahashi M, 2008, GENES CELLS, V13, P549, DOI 10.1111/j.1365-2443.2008.01187.x; Tsalkova T, 2009, J BIOL CHEM, V284, P23644, DOI 10.1074/jbc.M109.024950; Ulucan C, 2007, AM J PHYSIOL-HEART C, V293, pH1662, DOI 10.1152/ajpheart.00159.2007; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Yokoyama U, 2008, P NATL ACAD SCI USA, V105, P6386, DOI 10.1073/pnas.0801490105; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	44	23	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29148	29157		10.1074/jbc.M114.569319	http://dx.doi.org/10.1074/jbc.M114.569319			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25183009	Green Published, hybrid			2022-12-28	WOS:000344141000031
J	Hsu, HM; Lee, Y; Hsu, PH; Liu, HW; Chu, CH; Chou, YW; Chen, YR; Chen, SH; Tai, JH				Hsu, Hong-Ming; Lee, Yu; Hsu, Pang-Hung; Liu, Hsing-Wei; Chu, Chien-Hsin; Chou, Ya-Wen; Chen, Yet-Ran; Chen, Shu-Hui; Tai, Jung-Hsiang			Signal Transduction Triggered by Iron to Induce the Nuclear Importation of a Myb3 Transcription Factor in the Parasitic Protozoan Trichomonas vaginalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; AFRICAN-AMERICANS; CELL-GROWTH; PROTEIN; GENE; PHOSPHORYLATION; MECHANISM; PROMOTER; SEQUENCE; IDENTIFICATION	Iron was previously shown to induce rapid nuclear translocation of a Myb3 transcription factor in the protozoan parasite, Trichomonas vaginalis. In the present study, iron was found to induce a transient increase in cellular cAMP, followed by the nuclear influx of Myb3, whereas the latter was also induced by 8-bromo-cyclic AMP. Iron-inducible cAMP production and nuclear influx of Myb3 were inhibited by suramin and SQ22536, respective inhibitors of the G alpha subunit of heterotrimeric G proteins and adenylyl cyclases. In contrast, the nuclear influx of Myb3 induced by iron or 8-bromo-cAMP was delayed or inhibited, respectively, by H89, the inhibitor of protein kinase A. Using liquid chromatography-coupled tandem mass spectrometry, Thr(156) and Lys(143) in Myb3 were found to be phosphorylated and ubiquitinated, respectively. These modifications were induced by iron and inhibited by H89, as shown by immunoprecipitation- coupled Western blotting. Iron-inducible ubiquitination and nuclear influx were aborted in T156A and K143R, but T156D was constitutively ubiquitinated and persistently localized to the nucleus. Myb3 was phosphorylated in vitro by the catalytic subunit of a T. vaginalis protein kinase A, TvPKAc. A transient interaction between TvPKAc and Myb3 and the phosphorylation of both proteins were induced in the parasite shortly after iron or 8-bromo-cAMP treatment. Together, these observations suggest that iron may induce production of cAMP and activation of TvPKAc, which then induces the phosphorylation of Myb3 and subsequent ubiquitination for accelerated nuclear influx. It is conceivable that iron probably exerts a much broader impact on the physiology of the parasite than previously thought to encounter environmental changes.	[Hsu, Hong-Ming; Lee, Yu; Liu, Hsing-Wei; Chu, Chien-Hsin; Tai, Jung-Hsiang] Acad Sinica, Inst Biomed Sci, Div Infect Dis, Taipei 11529, Taiwan; [Chou, Ya-Wen; Chen, Yet-Ran] Acad Sinica, Res Ctr Agr & Biotechnol, Taipei 11529, Taiwan; [Hsu, Pang-Hung] Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelun 20224, Taiwan; [Chen, Shu-Hui] Natl Cheng Kung Univ, Dept Chem, Tainan 70101, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan Ocean University; National Cheng Kung University	Tai, JH (corresponding author), Acad Sinica, Inst Biomed Sci, Div Infect Dis, Taipei 11529, Taiwan.	taijh@gate.sinica.edu.tw	Tai, Jung-Hsiang/S-7019-2018; Chu, Chu/T-6038-2019; Hsu, Pang-Hung/C-5587-2018	Hsu, Pang-Hung/0000-0001-6873-6434; HSU, HONG-MING/0000-0002-7579-5106; Chu, Chien-Hsin/0000-0002-5490-8378	National Science Council [NSC102-2320-B-001-003]; Institute of Biomedical Sciences (IBMS), Academia Sinica	National Science Council(Ministry of Science and Technology, Taiwan); Institute of Biomedical Sciences (IBMS), Academia Sinica	This work was supported by National Science Council Grant NSC102-2320-B-001-003 and Institute of Biomedical Sciences (IBMS), Academia Sinica.	Alderete JF, 1999, INFECT IMMUN, V67, P4298, DOI 10.1128/IAI.67.8.4298-4302.1999; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Chernorudskiy AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004251; Chung WC, 2005, J PHARMACOL EXP THER, V313, P191, DOI 10.1124/jpet.104.078311; Cotch MF, 1998, AM J OBSTET GYNECOL, V178, P374, DOI 10.1016/S0002-9378(98)80028-8; Cui J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000782; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; De Freitas J, 2003, BIOMETALS, V16, P185, DOI 10.1023/A:1020771000746; De Jesus JB, 2007, PROTEOMICS, V7, P1961, DOI 10.1002/pmic.200600797; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Emery AC, 2013, MOL PHARMACOL, V83, P95, DOI 10.1124/mol.112.081760; Figueroa-Angulo EE, 2012, MICROBES INFECT, V14, P1411, DOI 10.1016/j.micinf.2012.09.004; Harlow E., 1998, ANTIBODIES LAB MANUA, P55; Horvathova L, 2012, GENOME BIOL EVOL, V4, P1017, DOI 10.1093/gbe/evs078; Hsu HM, 2014, J BIOL CHEM, V289, P19120, DOI 10.1074/jbc.M114.549410; Hsu HM, 2012, EUKARYOT CELL, V11, P1441, DOI 10.1128/EC.00190-12; Hsu HM, 2009, EUKARYOT CELL, V8, P362, DOI 10.1128/EC.00317-08; Liu W, 2013, BIOTECHNOL APPL BIOC, V60, P623, DOI 10.1002/bab.1110; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Nanda Neha, 2006, Expert Rev Anti Infect Ther, V4, P125, DOI 10.1586/14787210.4.1.125; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Ong SJ, 2007, J BIOL CHEM, V282, P6716, DOI 10.1074/jbc.M610484200; Ong SJ, 2006, EUKARYOT CELL, V5, P391, DOI 10.1128/EC.5.2.391-399.2006; Papanikolaou G, 2005, TOXICOL APPL PHARM, V202, P199, DOI 10.1016/j.taap.2004.06.021; Petrin D, 1998, CLIN MICROBIOL REV, V11, P300, DOI 10.1128/CMR.11.2.300; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Rouault TA, 2009, SCIENCE, V326, P676, DOI 10.1126/science.1181938; Rowley R., 2012, GLOBAL INCIDENCE PRE; Saint Fleur S., 2008, CYTOKINE, V41, P187; Schwebke JR, 2004, CLIN MICROBIOL REV, V17, P794, DOI 10.1128/CMR.17.4.794-803.2004; Secor WE, 2014, AM J TROP MED HYG, V90, P800, DOI 10.4269/ajtmh.13-0723; Shafir SC, 2009, CLIN MICROBIOL REV, V22, P37, DOI 10.1128/CMR.00002-08; Smith A, 2011, RES MICROBIOL, V162, P646, DOI 10.1016/j.resmic.2011.04.007; Sorvillo F, 2001, EMERG INFECT DIS, V7, P927, DOI 10.3201/eid0706.010603; Sutcliffe S, 2007, CANCER EPIDEM BIOMAR, V16, P1573, DOI 10.1158/1055-9965.EPI-07-0134; SUTHANTHIRAN M, 1984, NATURE, V307, P276, DOI 10.1038/307276a0; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Taylor MS, 2004, MOL PHARMACOL, V65, P1111, DOI 10.1124/mol.65.5.1111; Tilley DG, 2011, CIRC RES, V109, P217, DOI 10.1161/CIRCRESAHA.110.231225; Tsai CD, 2002, J BIOL CHEM, V277, P5153, DOI 10.1074/jbc.M110234200; Twu O, 2014, P NATL ACAD SCI USA, V111, P8179, DOI 10.1073/pnas.1321884111; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Van Ho A, 2002, ANNU REV MICROBIOL, V56, P237, DOI 10.1146/annurev.micro.56.012302.160847; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Wei SY, 2012, NUCLEIC ACIDS RES, V40, P449, DOI 10.1093/nar/gkr707; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x; Wosten MMSM, 2000, CELL, V103, P113, DOI 10.1016/S0092-8674(00)00092-1; Xu H, 2010, J PROTEOME RES, V9, P3384, DOI 10.1021/pr100369y; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; Zhou XZ, 1999, CELL MOL LIFE SCI, V56, P788, DOI 10.1007/s000180050026	52	5	5	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29334	29349		10.1074/jbc.M114.599498	http://dx.doi.org/10.1074/jbc.M114.599498			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25183012	Green Published, hybrid			2022-12-28	WOS:000344141000046
J	Truong, LN; Li, YJ; Sun, E; Ang, K; Hwang, PYH; Wu, XH				Truong, Lan N.; Li, Yongjiang; Sun, Emily; Ang, Katrina; Hwang, Patty Yi-Hwa; Wu, Xiaohua			Homologous Recombination Is a Primary Pathway to Repair DNA Double-Strand Breaks Generated during DNA Rereplication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-ANTIGEN; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; CHROMOSOMAL INSTABILITY; PREVENTS REREPLICATION; DAMAGE RESPONSE; END RESECTION; SV40 ORIGIN; LIGASE-III; IN-VITRO	Re-initiation of DNA replication at origins within a given cell cycle would result in DNA rereplication, which can lead to genome instability and tumorigenesis. DNA rereplication can be induced by loss of licensing control at cellular replication origins, or by viral protein-driven multiple rounds of replication initiation at viral origins. DNA double-strand breaks (DSBs) are generated during rereplication, but the mechanisms of how these DSBs are repaired to maintain genome stability and cell viability are poorly understood in mammalian cells. We generated novel EGFP-based DSB repair substrates, which specifically monitor the repair of rereplication-associated DSBs. We demonstrated that homologous recombination (HR) is an important mechanism to repair rereplication-associated DSBs, and sister chromatids are used as templates for such HR-mediated DSB repair. Micro-homology-mediated non-homologous end joining (MMEJ) can also be used but to a lesser extent compared to HR, whereas Ku-dependent classical non-homologous end joining (C-NHEJ) has a minimal role to repair rereplication-associated DSBs. In addition, loss of HR activity leads to severe cell death when rereplication is induced. Therefore, our studies identify HR, the most conservative repair pathway, as the primary mechanism to repair DSBs upon rereplication.	[Truong, Lan N.; Li, Yongjiang; Sun, Emily; Ang, Katrina; Hwang, Patty Yi-Hwa; Wu, Xiaohua] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Wu, XH (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	xiaohwu@scripps.edu			National Institutes of Health [CA102361, GM080677, CA140972, CA102361-07S1, CA140972-03S1]; NIH Training Grant [DK007022-30]; NATIONAL CANCER INSTITUTE [R01CA140972, R01CA102361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA102361, GM080677, CA140972, CA102361-07S1, and CA140972-03S1 (to X. W.) and NIH Training Grant DK007022-30 (to L. N. T.).	Aggarwal P, 2007, GENE DEV, V21, P2908, DOI 10.1101/gad.1586007; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Aladjem MI, 1998, SCIENCE, V281, P1005, DOI 10.1126/science.281.5379.1005; Archambault V, 2005, MOL CELL BIOL, V25, P6707, DOI 10.1128/MCB.25.15.6707-6721.2005; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Avni D, 2003, MOL CELL, V12, P735, DOI 10.1016/S1097-2765(03)00355-1; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; BOTCHAN M, 1980, CELL, V20, P143, DOI 10.1016/0092-8674(80)90242-1; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Davidson IF, 2006, MOL CELL, V24, P433, DOI 10.1016/j.molcel.2006.09.010; DEB S, 1987, J VIROL, V61, P2143, DOI 10.1128/JVI.61.7.2143-2149.1987; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Diffley JFX, 2001, CURR BIOL, V11, pR367, DOI 10.1016/S0960-9822(01)00196-8; Diffley TFX, 1996, GENE DEV, V10, P2819, DOI 10.1101/gad.10.22.2819; Green BM, 2005, MOL BIOL CELL, V16, P421, DOI 10.1091/mbc.e04-09-0833; Hook SS, 2007, CURR OPIN CELL BIOL, V19, P663, DOI 10.1016/j.ceb.2007.10.007; HURWITZ J, 1990, J BIOL CHEM, V265, P18043; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liontos M, 2007, CANCER RES, V67, P10899, DOI 10.1158/0008-5472.CAN-07-2837; Liu E, 2007, J CELL BIOL, V179, P643, DOI 10.1083/jcb.200704138; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; MILLER J, 1984, P NATL ACAD SCI-BIOL, V81, P7534, DOI 10.1073/pnas.81.23.7534; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; MYERS RM, 1980, P NATL ACAD SCI-BIOL, V77, P6491, DOI 10.1073/pnas.77.11.6491; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Neelsen KJ, 2013, GENE DEV, V27, P2537, DOI 10.1101/gad.226373.113; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Pinyol M, 2006, INT J CANCER, V119, P2768, DOI 10.1002/ijc.22146; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Seo J, 2005, ONCOGENE, V24, P8176, DOI 10.1038/sj.onc.1208881; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; STARY A, 1992, J GEN VIROL, V73, P1679, DOI 10.1099/0022-1317-73-7-1679; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; Syu LJ, 1997, J MOL BIOL, V271, P76, DOI 10.1006/jmbi.1997.1156; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; TEGTMEYER P, 1972, J VIROL, V10, P591, DOI 10.1128/JVI.10.4.591-598.1972; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Wang HL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003277; Wang HL, 2012, J BIOL CHEM, V287, P21471, DOI 10.1074/jbc.M112.355354; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Wu XH, 2004, GENE DEV, V18, P1305, DOI 10.1101/gad.1182804; Zhu WG, 2006, MOL CELL BIOL, V26, P4601, DOI 10.1128/MCB.02141-05	61	19	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28910	28923		10.1074/jbc.M114.576488	http://dx.doi.org/10.1074/jbc.M114.576488			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25160628	Green Published, hybrid			2022-12-28	WOS:000344141000014
J	Wang, T; Chen, J				Wang, Tian; Chen, Jeannie			Induction of the Unfolded Protein Response by Constitutive G-protein Signaling in Rod Photoreceptor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; CYCLASE-ACTIVATING PROTEINS; 2 APOPTOTIC PATHWAYS; RETINAL DEGENERATION; TRANSDUCIN ACTIVATION; MACULAR DEGENERATION; OGUCHI-DISEASE; MICE LACKING; MOUSE MODEL; ER STRESS	Phototransduction is a G-protein signal transduction cascade that converts photon absorption to a change in current at the plasma membrane. Certain genetic mutations affecting the proteins in the phototransduction cascade cause blinding disorders in humans. Some of these mutations serve as a genetic source of "equivalent light" that activates the cascade, whereas other mutations lead to amplification of the light response. How constitutive phototransduction causes photoreceptor cell death is poorly understood. We showed that persistent G-protein signaling, which occurs in rod arrestin and rhodopsin kinase knockout mice, caused a rapid and specific induction of the PERK pathway of the unfolded protein response. These changes were not observed in the cGMP-gated channel knock-out rods, an equivalent light condition that mimics light-stimulated channel closure. Thus transducin signaling, but not channel closure, triggers rapid cell death in light damage caused by constitutive phototransduction. Additionally, we show that in the albino light damage model cell death was not associated with increase in global protein ubiquitination or unfolded protein response induction. Taken together, these observations provide novel mechanistic insights into the cell death pathway caused by constitutive phototransduction and identify the unfolded protein response as a potential target for therapeutic intervention.	[Wang, Tian] Univ So Calif, Program Genet Mol & Cellular Biol, Los Angeles, CA 90089 USA; [Wang, Tian; Chen, Jeannie] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Chen, J (corresponding author), 1501 San Pablo St,ZNI Rm 227, Los Angeles, CA 90089 USA.	jeannie@usc.edu			National Institutes of Health [EY12155, EY03040]; Beckman Initiative for Macular Research; NATIONAL EYE INSTITUTE [R01EY012155, P30EY003040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Initiative for Macular Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY12155 (to J. C.) and EY03040 (to Doheny Eye Institute). This work was also supported by funds from the Beckman Initiative for Macular Research (to J. C.).	Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Athanasiou D, 2013, FEBS LETT, V587, P2008, DOI 10.1016/j.febslet.2013.05.020; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Burns ME, 2010, PHYSIOLOGY, V25, P72, DOI 10.1152/physiol.00001.2010; Cachafeiro M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.303; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Chen J, 1999, INVEST OPHTH VIS SCI, V40, P2978; Chen JY, 2006, J NEUROSCI, V26, P11929, DOI 10.1523/JNEUROSCI.3212-06.2006; Chertov AO, 2011, J BIOL CHEM, V286, P34700, DOI 10.1074/jbc.M111.279752; Choudhury S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.34; Concepcion F, 2002, VISION RES, V42, P417, DOI 10.1016/S0042-6989(01)00195-X; Donovan M, 2001, J BIOL CHEM, V276, P23000, DOI 10.1074/jbc.M005359200; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Griciuc A, 2011, TRENDS MOL MED, V17, P442, DOI 10.1016/j.molmed.2011.04.002; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Grimm C, 2000, MOL VIS, V6, P252; Hafezi F, 1997, NAT MED, V3, P346, DOI 10.1038/nm0397-346; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; HOYO N, 2014, PLOS GENET, V0010; Hunter JJ, 2012, PROG RETIN EYE RES, V31, P28, DOI 10.1016/j.preteyeres.2011.11.001; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Kerov V, 2005, J BIOL CHEM, V280, P41069, DOI 10.1074/jbc.M508849200; Kudo T, 2008, CELL DEATH DIFFER, V15, P364, DOI 10.1038/sj.cdd.4402276; Kunte MM, 2012, INVEST OPHTH VIS SCI, V53, P3792, DOI 10.1167/iovs.11-9235; LaVail MM, 1999, INVEST OPHTH VIS SCI, V40, P1020; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Mao W, 2013, J BIOL CHEM, V288, P5257, DOI 10.1074/jbc.M112.430058; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Mitchell P, 1998, OPHTHALMOLOGY, V105, P1359, DOI 10.1016/S0161-6420(98)98013-7; Moaven H, 2013, P NATL ACAD SCI USA, V110, P9463, DOI 10.1073/pnas.1301126110; Mockel A, 2012, J BIOL CHEM, V287, P37483, DOI 10.1074/jbc.M112.386821; Noell W K, 1966, Invest Ophthalmol, V5, P450; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Palczewski K, 2004, BIOCHEM BIOPH RES CO, V322, P1123, DOI 10.1016/j.bbrc.2004.07.122; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; RAPORT CJ, 1994, INVEST OPHTH VIS SCI, V35, P2932; RAPP LM, 1980, VISION RES, V20, P1127, DOI 10.1016/0042-6989(80)90050-4; Roca A, 2004, NEUROSCIENCE, V129, P779, DOI 10.1016/j.neuroscience.2004.08.021; Rzymski T, 2009, CELL CYCLE, V8, P3838, DOI 10.4161/cc.8.23.10086; Salminen A, 2010, MOL MED, V16, P535, DOI 10.2119/molmed.2010.00070; SCHNETKAMP PPM, 1986, J PHYSIOL-LONDON, V373, P25, DOI 10.1113/jphysiol.1986.sp016033; Shinde VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033266; Sui GY, 2013, BRIT J OPHTHALMOL, V97, P389, DOI 10.1136/bjophthalmol-2012-302281; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; Youssef PN, 2011, EYE, V25, P1, DOI 10.1038/eye.2010.149; Zhang Y, 2009, J CELL SCI, V122, P1192, DOI 10.1242/jcs.042531; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201	53	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29310	29321		10.1074/jbc.M114.595207	http://dx.doi.org/10.1074/jbc.M114.595207			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25183010	Green Published, hybrid			2022-12-28	WOS:000344141000044
J	Blin, S; Chatelain, FC; Feliciangeli, S; Kang, D; Lesage, F; Bichet, D				Blin, Sandy; Chatelain, Franck C.; Feliciangeli, Sylvain; Kang, Dawon; Lesage, Florian; Bichet, Delphine			Tandem Pore Domain Halothane-inhibited K+ Channel Subunits THIK1 and THIK2 Assemble and Form Active Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING POTASSIUM CHANNELS; DEAFNESS ASSOCIATED CHANGES; PLASMA-MEMBRANE; FUNCTIONAL EXPRESSION; SUMOYLATION SILENCES; STOICHIOMETRY; NEURONS; BRAIN; CONDUCTANCE; ASSOCIATION	Despite a high level of sequence homology, tandem pore domain halothane-inhibited K+ channel 1 (THIK1) produces background K+ currents, whereas THIK2 is silent. This lack of activity is due to a unique combination of intracellular retention and weak basal activity in the plasma membrane. Here, we designed THIK subunits containing dominant negative mutations (THIK1(DN) and THIK2(DN)). THIK2(DN) mutant inhibits THIK1 currents, whereas THIK1(DN) inhibits an activated form of THIK2 (THIK2-A155P-I158D). In situ proximity ligation assays and Forster/fluorescence resonance energy transfer (FRET) experiments support a physical association between THIK1 and THIK2. Next, we expressed covalent tandems of THIK proteins to obtain expression of pure heterodimers. Td-THIK1-THIK2 (where Td indicates tandem) produces K+ currents of amplitude similar to Td-THIK1-THIK1 but with a noticeable difference in the current kinetics. Unlike Td-THIK2-THIK2 that is mainly detected in the endoplasmic reticulum, Td-THIK1-THIK2 distributes at the plasma membrane, indicating that THIK1 can mask the endoplasmic reticulum retention/retrieval motif of THIK2. Kinetics and unitary conductance of Td-THIK1-THIK2 are intermediate between THIK1 and THIK2. Altogether, these results show that THIK1 and THIK2 form active heteromeric channels, further expanding the known repertoire of K+ channels.	[Blin, Sandy; Chatelain, Franck C.; Feliciangeli, Sylvain; Lesage, Florian; Bichet, Delphine] CNRS, Inst Pharmacol Mol & Cellulaire, LabEx ICST, F-06560 Valbonne, France; [Blin, Sandy; Chatelain, Franck C.; Feliciangeli, Sylvain; Lesage, Florian; Bichet, Delphine] Univ Nice Sophia Antipolis, F-06560 Valbonne, France; [Kang, Dawon] Gyeongsang Natl Univ, Sch Med, Dept Physiol, Jinju 660751, South Korea; [Kang, Dawon] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Jinju 660751, South Korea	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Gyeongsang National University; Gyeongsang National University	Lesage, F (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, LabEx ICST, 660 Route Lucioles, F-06560 Valbonne, France.	lesage@ipmc.cnrs.fr	Lesage, Florian/D-5097-2011; Feliciangeli, Sylvain/Q-1292-2016; Lesage, Florian/P-9780-2019	Lesage, Florian/0000-0002-4406-7106; Feliciangeli, Sylvain/0000-0003-3358-3719; Lesage, Florian/0000-0002-4406-7106; Bichet, Delphine/0000-0002-9601-089X; CHATELAIN, Franck C./0000-0002-8426-8893	Fondation pour la Recherche Medicale (Equipe labellisee FRM); Agence Nationale de la Recherche (Laboratory of Excellence "Ion Channel Science and Therapeutics") [ANR-11-LABX-0015-01]	Fondation pour la Recherche Medicale (Equipe labellisee FRM)(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche (Laboratory of Excellence "Ion Channel Science and Therapeutics")(French National Research Agency (ANR))	This work was supported by the Fondation pour la Recherche Medicale (Equipe labellisee FRM 2011) and by the Agence Nationale de la Recherche (Laboratory of Excellence "Ion Channel Science and Therapeutics" Grant ANR-11-LABX-0015-01).	Aller MI, 2008, NEUROSCIENCE, V151, P1154, DOI 10.1016/j.neuroscience.2007.12.011; Ashmole I, 2001, PFLUG ARCH EUR J PHY, V442, P828, DOI 10.1007/s004240100620; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Chatelain FC, 2013, J BIOL CHEM, V288, P35081, DOI 10.1074/jbc.M113.503318; Chatelain FC, 2012, P NATL ACAD SCI USA, V109, P5499, DOI 10.1073/pnas.1201132109; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Cui YL, 2007, NEUROSCIENCE, V149, P421, DOI 10.1016/j.neuroscience.2007.05.054; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; DUPRAT F, 1995, BIOCHEM BIOPH RES CO, V212, P657, DOI 10.1006/bbrc.1995.2019; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Feliciangeli S, 2007, CELL, V130, P563, DOI 10.1016/j.cell.2007.06.012; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Holt AG, 2006, HEARING RES, V216, P146, DOI 10.1016/j.heares.2006.03.009; Hwang EM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4227; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Kang D, 2014, PFLUG ARCH EUR J PHY, V466, P1289, DOI 10.1007/s00424-013-1358-1; Karpova Tatiana, 2006, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1207s35; Kim D, 2001, BIOCHEM BIOPH RES CO, V284, P923, DOI 10.1006/bbrc.2001.5064; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Lauritzen I, 2003, J BIOL CHEM, V278, P32068, DOI 10.1074/jbc.M302631200; Lesage F, 1996, EMBO J, V15, P6400, DOI 10.1002/j.1460-2075.1996.tb01031.x; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; Liao YJ, 1996, J NEUROSCI, V16, P7137; Lopes CMB, 2001, J BIOL CHEM, V276, P24449, DOI 10.1074/jbc.C100184200; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Marsh B, 2012, MOL CELL NEUROSCI, V49, P375, DOI 10.1016/j.mcn.2012.01.002; Noel J, 2011, CHANNELS, V5, P400, DOI 10.4161/chan.5.5.16469; Plant LD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003431; Rajan S, 2001, J BIOL CHEM, V276, P7302, DOI 10.1074/jbc.M008985200; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Renigunta V, 2014, PFLUG ARCH EUR J PHY, V466, P1735, DOI 10.1007/s00424-013-1404-z; Salinas M, 1999, J BIOL CHEM, V274, P11751, DOI 10.1074/jbc.274.17.11751; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Theilig F, 2008, CELL PHYSIOL BIOCHEM, V21, P63, DOI 10.1159/000113748; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; Wischmeyer E, 1997, MOL CELL NEUROSCI, V9, P194, DOI 10.1006/mcne.1997.0614; Yang WP, 1998, J BIOL CHEM, V273, P19419, DOI 10.1074/jbc.273.31.19419; Yeom M, 2005, BIOCHEM BIOPH RES CO, V326, P321, DOI 10.1016/j.bbrc.2004.11.034; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	49	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28202	28212		10.1074/jbc.M114.600437	http://dx.doi.org/10.1074/jbc.M114.600437			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25148687	Green Published, hybrid			2022-12-28	WOS:000343765400017
J	Mas, C; Norwood, SJ; Bugarcic, A; Kinna, G; Leneva, N; Kovtun, O; Ghai, R; Yanez, LEO; Davis, JL; Teasdale, RD; Collins, BM				Mas, Caroline; Norwood, Suzanne J.; Bugarcic, Andrea; Kinna, Genevieve; Leneva, Natalya; Kovtun, Oleksiy; Ghai, Rajesh; Yanez, Lorena E. Ona; Davis, Jasmine L.; Teasdale, Rohan D.; Collins, Brett M.			Structural Basis for Different Phosphoinositide Specificities of the PX Domains of Sorting Nexins Regulating G-protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOX-HOMOLOGY DOMAIN; MITOCHONDRIAL INHERITANCE; CRYSTAL-STRUCTURE; RGS; ENDOCYTOSIS; NUCLEAR; BINDING; SYSTEM	Sorting nexins (SNXs) or phox homology (PX) domain containing proteins are central regulators of cell trafficking and signaling. A subfamily of PX domain proteins possesses two unique PX-associated domains, as well as a regulator of G protein-coupled receptor signaling (RGS) domain that attenuates G alpha(s)-coupled G protein-coupled receptor signaling. Here we delineate the structural organization of these RGS-PX proteins, revealing a protein family with a modular architecture that is conserved in all eukaryotes. The one exception to this is mammalian SNX19, which lacks the typical RGS structure but preserves all other domains. The PX domain is a sensor of membrane phosphoinositide lipids and we find that specific sequence alterations in the PX domains of the mammalian RGS-PX proteins, SNX13, SNX14, SNX19, and SNX25, confer differential phosphoinositide binding preferences. Although SNX13 and SNX19 PX domains bind the early endosomal lipid phosphatidylinositol 3-phosphate, SNX14 shows no membrane binding at all. Crystal structures of the SNX19 and SNX14 PX domains reveal key differences, with alterations in SNX14 leading to closure of the binding pocket to prevent phosphoinositide association. Our findings suggest a role for alternative membrane interactions in spatial control of RGS-PX proteins in cell signaling and trafficking.	[Mas, Caroline; Norwood, Suzanne J.; Bugarcic, Andrea; Kinna, Genevieve; Leneva, Natalya; Kovtun, Oleksiy; Ghai, Rajesh; Yanez, Lorena E. Ona; Davis, Jasmine L.; Teasdale, Rohan D.; Collins, Brett M.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Queensland	Collins, BM (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	b.collins@imb.uq.edu.au	Collins, Brett/J-1563-2014; Bugarcic, Andrea/AAN-8952-2021; Kovtun, Oleksiy/AAE-5397-2019; Bugarcic, Andrea/D-7986-2013; Teasdale, Rohan/AAD-6698-2019; Teasdale, Rohan D/B-2538-2009; Kovtun, Oleksiy/F-7443-2015; Ghai, Rajesh/D-5903-2012	Collins, Brett/0000-0002-6070-3774; Kovtun, Oleksiy/0000-0001-6374-7863; Teasdale, Rohan/0000-0001-7455-5269; Teasdale, Rohan D/0000-0001-7455-5269; Kovtun, Oleksiy/0000-0001-6374-7863; Ghai, Rajesh/0000-0002-0919-0934; Mas, Caroline/0000-0002-7733-6982; Ona Yanez, Lorena E./0000-0001-5958-9057; Leneva, Natalya/0000-0001-8102-9769; Bugarcic, Andrea/0000-0003-2525-2450	ACRF	ACRF	We acknowledge support from the staff and facilities of the University of Queensland Remote Operation Crystallization and x-ray (UQ ROCX) facility and the Australian Synchrotron. We thank Patricia Walden and Jenny Martin for assistance with x-ray diffraction data collection. Microscopy was performed at the Australian Cancer Research Foundation (ACRF)/Institute for Molecular Bioscience Dynamic Imaging Facility for Cancer Biology established with the support of ACRF.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bin Z, 2004, MOL BIOL CELL, V15, P5538, DOI 10.1091/mbc.E04-06-0446; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Carroll P, 2001, DEV DYNAM, V221, P431, DOI 10.1002/dvdy.1163; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du YS, 2013, BRAIN RES, V1509, P79, DOI 10.1016/j.brainres.2013.03.005; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fisk HA, 1997, J CELL BIOL, V138, P485, DOI 10.1083/jcb.138.3.485; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Follett J, 2014, TRAFFIC, V15, P230, DOI 10.1111/tra.12136; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hao XB, 2011, CELL SIGNAL, V23, P935, DOI 10.1016/j.cellsig.2011.01.022; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098383; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Jean-Baptiste G, 2006, CELL MOL LIFE SCI, V63, P1969, DOI 10.1007/s00018-006-6066-y; Kan A, 2009, ARTHRITIS RHEUM-US, V60, P3314, DOI 10.1002/art.24878; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Koharudin LMI, 2009, J BIOL CHEM, V284, P23697, DOI 10.1074/jbc.M109.008995; Krauss M, 2007, FEBS LETT, V581, P2105, DOI 10.1016/j.febslet.2007.01.089; MCCONNELL SJ, 1992, J CELL BIOL, V118, P385, DOI 10.1083/jcb.118.2.385; MCCONNELL SJ, 1993, SCIENCE, V260, P687, DOI 10.1126/science.8480179; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; Pylypenko O, 2007, EMBO J, V26, P4788, DOI 10.1038/sj.emboj.7601889; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Suh JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002152; Teasdale RD, 2012, BIOCHEM J, V441, P39, DOI 10.1042/BJ20111226; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang Q, 2008, STRUCTURE, V16, P1574, DOI 10.1016/j.str.2008.07.016; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Xing Y, 2004, J BIOL CHEM, V279, P30662, DOI 10.1074/jbc.M404107200; Xu JX, 2013, J BIOL CHEM, V288, P16598, DOI 10.1074/jbc.M112.449306; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757; Zheng B, 2006, P NATL ACAD SCI USA, V103, P16776, DOI 10.1073/pnas.0607974103; Zhou CZ, 2003, J BIOL CHEM, V278, P50371, DOI 10.1074/jbc.M304392200	50	36	39	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28554	28568		10.1074/jbc.M114.595959	http://dx.doi.org/10.1074/jbc.M114.595959			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25148684	hybrid, Green Published			2022-12-28	WOS:000343765400045
J	Rotunno, MS; Auclair, JR; Maniatis, S; Shaffer, SA; Agar, J; Bosco, DA				Rotunno, Melissa S.; Auclair, Jared R.; Maniatis, Stephanie; Shaffer, Scott A.; Agar, Jeffrey; Bosco, Daryl A.			Identification of a Misfolded Region in Superoxide Dismutase 1 That Is Exposed in Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE MODIFICATION; MONOCLONAL-ANTIBODY; DISULFIDE BOND; FAMILIAL ALS; MOUSE MODEL; METAL-IONS; SOD1; MUTANT; AGGREGATION; PROTEIN	Mutations and aberrant post-translational modifications within Cu, Zn-superoxide dismutase (SOD1) cause this otherwise protective enzyme to misfold, leading to amyotrophic lateral sclerosis (ALS). The C4F6 antibody selectively binds misfolded SOD1 in spinal cord tissues from postmortem human ALS cases, as well as from an ALS-SOD1 mouse model, suggesting that the C4F6 epitope reports on a pathogenic conformation that is common to misfolded SOD1 variants. To date, the residues and structural elements that comprise this epitope have not been elucidated. Using a chemical cross-linking and mass spectrometry approach, we identified the C4F6 epitope within several ALS-linked SOD1 variants, as well as an oxidized form of WT SOD1, supporting the notion that a similar misfolded conformation is shared among pathological SOD1 proteins. Exposure of the C4F6 epitope was modulated by the SOD1 electrostatic (loop VII) and zinc binding (loop IV) loops and correlated with SOD1-induced toxicity in a primary microglia activation assay. Site-directed mutagenesis revealed Asp(92) and Asp(96) as key residues within the C4F6 epitope required for the SOD1-C4F6 binding interaction. We propose that stabilizing the functional loops within SOD1 and/or obscuring the C4F6 epitope are viable therapeutic strategies for treating SOD1-mediated ALS.	[Rotunno, Melissa S.; Bosco, Daryl A.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Auclair, Jared R.; Agar, Jeffrey] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Maniatis, Stephanie; Shaffer, Scott A.] Univ Massachusetts, Sch Med, Prote & Mass Spectrometry Facil, Shrewsbury, MA 01545 USA; [Shaffer, Scott A.; Bosco, Daryl A.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Northeastern University; University of Massachusetts System; University of Massachusetts System; University of Massachusetts Worcester	Bosco, DA (corresponding author), Albert Sherman Ctr, Dept Neurol, AS6-1057,368 Plantat Dr, Worcester, MA 01605 USA.	Daryl.Bosco@umassmed.edu		Agar, Jeffery/0000-0003-2645-1873	National Institutes of Health [R01NS067206]; ALS Therapy Alliance/CVS Pharmacy; ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067206, R01NS065263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Therapy Alliance/CVS Pharmacy; ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS067206. This work was also supported by funds from the ALS Therapy Alliance/CVS Pharmacy and the ALS Association (to D. A. B.).	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Auclair JR, 2013, BIOCHEMISTRY-US, V52, P6137, DOI 10.1021/bi4006122; Auclair JR, 2010, P NATL ACAD SCI USA, V107, P21394, DOI 10.1073/pnas.1015463107; Banci L, 2003, BIOCHEMISTRY-US, V42, P9543, DOI 10.1021/bi034324m; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Broering TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061210; Brotherton TE, 2012, P NATL ACAD SCI USA, V109, P5505, DOI 10.1073/pnas.1115009109; Cao XH, 2008, J BIOL CHEM, V283, P16169, DOI 10.1074/jbc.M801522200; Chen XP, 2012, NEUROCHEM RES, V37, P835, DOI 10.1007/s11064-011-0679-8; Coelho T, 2013, J NEUROL, V260, P2802, DOI 10.1007/s00415-013-7051-7; Danielsson J, 2013, P NATL ACAD SCI USA, V110, P3829, DOI 10.1073/pnas.1217306110; Danielsson J, 2011, J BIOL CHEM, V286, P33070, DOI 10.1074/jbc.M111.251223; Ding F, 2008, P NATL ACAD SCI USA, V105, P19696, DOI 10.1073/pnas.0803266105; Durazo A, 2009, J BIOL CHEM, V284, P34382, DOI 10.1074/jbc.M109.052076; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Fujisawa T, 2012, ANN NEUROL, V72, P739, DOI 10.1002/ana.23668; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gros-Louis F, 2010, J NEUROCHEM, V113, P1188, DOI 10.1111/j.1471-4159.2010.06683.x; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Lemire J, 2008, J APPL TOXICOL, V28, P175, DOI 10.1002/jat.1263; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Lynch SM, 2004, BIOCHEMISTRY-US, V43, P16525, DOI 10.1021/bi048831v; Molnar KS, 2009, J BIOL CHEM, V284, P30965, DOI 10.1074/jbc.M109.023945; Panchaud A, 2010, J PROTEOME RES, V9, P2508, DOI 10.1021/pr9011816; Pickles S, 2013, HUM MOL GENET, V22, P3947, DOI 10.1093/hmg/ddt249; Pokrishevsky E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035050; Prudencio M, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-77; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Redler RL, 2014, BIOCHEMISTRY-US, V53, P2423, DOI 10.1021/bi500158w; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rotunno MS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00253; Sasabe J, 2007, EMBO J, V26, P4149, DOI 10.1038/sj.emboj.7601840; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shipp EL, 2003, BIOCHEMISTRY-US, V42, P1890, DOI 10.1021/bi026704y; Sreedharan J, 2013, ANN NEUROL, V74, P309, DOI 10.1002/ana.24012; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; STEINEBACH OM, 1993, TOXICOL APPL PHARM, V118, P245, DOI 10.1006/taap.1993.1030; SUZUMURA A, 1987, J NEUROIMMUNOL, V15, P263, DOI 10.1016/0165-5728(87)90121-4; Svensson AKE, 2006, J MOL BIOL, V364, P1084, DOI 10.1016/j.jmb.2006.09.005; Taylor DM, 2007, J BIOL CHEM, V282, P16329, DOI 10.1074/jbc.M610119200; Tiwari A, 2009, J BIOL CHEM, V284, P27746, DOI 10.1074/jbc.M109.043729; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Ve Velde C., 2008, P NATL ACAD SCI USA, V105, P4022, DOI [DOI 10.1073/PNAS.0712209105, 10.1073/pnas.0712209105]; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919	53	20	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28527	28538		10.1074/jbc.M114.581801	http://dx.doi.org/10.1074/jbc.M114.581801			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25164820	Green Published, hybrid			2022-12-28	WOS:000343765400043
J	Arif, M; Wei, JS; Zhang, Q; Liu, F; Basurto-Islas, G; Grundke-Iqbal, I; Iqbal, K				Arif, Mohammad; Wei, Jianshe; Zhang, Qi; Liu, Fei; Basurto-Islas, Gustavo; Grundke-Iqbal, Inge; Iqbal, Khalid			Cytoplasmic Retention of Protein Phosphatase 2A Inhibitor 2 (I-2(PP2A)) Induces Alzheimer-like Abnormal Hyperphosphorylation of Tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Ca2+; Calmodulin-dependent Protein Kinase (CaMK); Protein Serine; Threonine Phosphatase (PSP); Serine; Threonine Protein Kinase; Tau Protein (Tau)	AMYLOID PRECURSOR PROTEIN; CATALYTIC SUBUNIT; NEUROFIBRILLARY DEGENERATION; NUCLEAR-LOCALIZATION; CELL-PROLIFERATION; PHOSPHORYLATED-TAU; DISEASE BRAIN; DOWN-SYNDROME; SET; MICROTUBULES	Background: In Alzheimer brain, I-2(PP2A) is translocated from the neuronal nucleus to the cytoplasm and promotes abnormal hyperphosphorylation of Tau. Results: Inactivation of nuclear localization signal (NLS) causes retention of I-2(PP2A) in the cell cytoplasm, where it promotes Tau hyperphosphorylation by affecting PP2A signaling. Conclusion: Retention of I-2(PP2A) in cell cytoplasm results in Tau hyperphosphorylation. Significance: The study provides potential tools for investigating Tau-based therapeutics. Abnormal hyperphosphorylation of Tau leads to the formation of neurofibrillary tangles, a hallmark of Alzheimer disease (AD), and related tauopathies. The phosphorylation of Tau is regulated by protein phosphatase 2A (PP2A), which in turn is modulated by endogenous inhibitor 2 (I-2(PP2A)). In AD brain, I-2(PP2A) is translocated from neuronal nucleus to cytoplasm, where it inhibits PP2A activity and promotes abnormal phosphorylation of Tau. Here we describe the identification of a potential nuclear localization signal (NLS) in the C-terminal region of I-2(PP2A) containing a conserved basic motif, (RKR181)-R-179, which is sufficient for directing its nuclear localization. The current study further presents an inducible cell model (Tet-Off system) of AD-type abnormal hyperphosphorylation of Tau by expressing I-2(PP2A) in which the NLS was inactivated by (RKR181)-R-179 AAA along with (KR169)-K-168 AA mutations. In this model, the mutant NLS (mNLS)-I-2(PP2A) (I(2)(PP2A)AA-AAA) was retained in the cell cytoplasm, where it physically interacted with PP2A and inhibited its activity. Inhibition of PP2A was associated with the abnormal hyperphosphorylation of Tau, which resulted in microtubule network instability and neurite outgrowth impairment. Expression of mNLS-I-2(PP2A) activated CAMKII and GSK-3, which are Tau kinases regulated by PP2A. The immunoprecipitation experiments showed the direct interaction of I-2(PP2A) with PP2A and GSK-3 but not with CAMKII. Thus, the cell model provides insights into the nature of the potential NLS and the mechanistic relationship between I-2(PP2A)-induced inhibition of PP2A and hyperphosphorylation of Tau that can be utilized to develop drugs preventing Tau pathology.	[Arif, Mohammad; Wei, Jianshe; Zhang, Qi; Liu, Fei; Basurto-Islas, Gustavo; Grundke-Iqbal, Inge; Iqbal, Khalid] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA	Institute for Basic Research in Developmental Disabilities	Iqbal, K (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, Inge Grundke Iqbal Res Floor,1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	khalid.iqbal.ibr@gmail.com		Basurto-Islas, Gustavo/0000-0002-9401-140X	National Institutes of Health, NIA [AG019158]; New York State Office of People with Developmental Disabilities; NATIONAL INSTITUTE ON AGING [R01AG019158] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); New York State Office of People with Developmental Disabilities; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, NIA, Grant AG019158. This work was also supported by the New York State Office of People with Developmental Disabilities.	ALAFUZOFF I, 1987, ACTA NEUROPATHOL, V74, P209, DOI 10.1007/BF00688184; Alonso AD, 1997, P NATL ACAD SCI USA, V94, P298, DOI 10.1073/pnas.94.1.298; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Alonso AD, 2010, J BIOL CHEM, V285, P30851, DOI 10.1074/jbc.M110.110957; Alonso AD, 2006, P NATL ACAD SCI USA, V103, P8864, DOI 10.1073/pnas.0603214103; Arnaud L, 2011, FEBS LETT, V585, P2653, DOI 10.1016/j.febslet.2011.07.020; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Basurto-Islas G, 2013, J BIOL CHEM, V288, P17495, DOI 10.1074/jbc.M112.446070; Bennecib M, 2001, FEBS LETT, V490, P15, DOI 10.1016/S0014-5793(01)02127-5; Blanchard J, 2010, ACTA NEUROPATHOL, V120, P605, DOI 10.1007/s00401-010-0734-6; Bolognin S, 2012, ACTA NEUROPATHOL, V123, P133, DOI 10.1007/s00401-011-0908-x; Canela N, 2003, J BIOL CHEM, V278, P1158, DOI 10.1074/jbc.M207497200; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen S, 2008, J BIOL CHEM, V283, P10513, DOI 10.1074/jbc.M709852200; Chohan MO, 2006, FEBS LETT, V580, P3973, DOI 10.1016/j.febslet.2006.06.021; Compagnone NA, 2000, MOL ENDOCRINOL, V14, P875, DOI 10.1210/me.14.6.875; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; Facchinetti P, 2014, NEUROBIOL AGING, V35, P958, DOI 10.1016/j.neurobiolaging.2013.08.039; FAVRE B, 1994, J BIOL CHEM, V269, P16311; Fukukawa C, 2005, INT J ONCOL, V26, P751; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; Gong CX, 1996, BRAIN RES, V741, P95, DOI 10.1016/S0006-8993(96)00904-3; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hernandez F, 2010, MOL CELL BIOCHEM, V344, P211, DOI 10.1007/s11010-010-0544-0; Iijima K, 2010, HUM MOL GENET, V19, P2947, DOI 10.1093/hmg/ddq200; Iqbal K, 2005, ACTA NEUROPATHOL, V109, P25, DOI 10.1007/s00401-004-0951-y; Iqbal K, 1998, NEUROBIOL AGING, V19, pS124; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; Katayose Y, 2000, J BIOL CHEM, V275, P9209, DOI 10.1074/jbc.275.13.9209; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Lam BD, 2013, FEBS LETT, V587, P111, DOI 10.1016/j.febslet.2012.11.013; Li B, 2007, ACTA NEUROPATHOL, V113, P501, DOI 10.1007/s00401-007-0207-8; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu GP, 2008, NEUROBIOL AGING, V29, P1348, DOI 10.1016/j.neurobiolaging.2007.03.012; Luo M, 2004, TRAFFIC, V5, P847, DOI 10.1111/j.1600-0854.2004.00227.x; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; Pei JJ, 2003, AM J PATHOL, V163, P845, DOI 10.1016/S0002-9440(10)63445-1; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Qian W, 2010, J ALZHEIMERS DIS, V19, P1221, DOI [10.3233/JAD-2009-1317, 10.3233/JAD-2010-1317]; Qu DB, 2007, J NEUROCHEM, V103, P408, DOI 10.1111/j.1471-4159.2007.04747.x; Sayas CL, 2002, BBA-MOL CELL BIOL L, V1582, P144, DOI 10.1016/S1388-1981(02)00149-X; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Shi JH, 2008, J BIOL CHEM, V283, P28660, DOI 10.1074/jbc.M802645200; Shin KS, 1999, J CELL BIOCHEM, V74, P119, DOI 10.1002/(SICI)1097-4644(19990701)74:1<119::AID-JCB13>3.0.CO;2-7; Singh TJ, 1996, FEBS LETT, V387, P145, DOI 10.1016/0014-5793(96)00485-1; SINGH TJ, 1995, FEBS LETT, V358, P4, DOI 10.1016/0014-5793(94)01383-C; Sironi JJ, 1998, FEBS LETT, V436, P471, DOI 10.1016/S0014-5793(98)01185-5; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Sobral LM, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-32; Sontag JM, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00016; Sun XY, 2012, J BIOL CHEM, V287, P11174, DOI 10.1074/jbc.M111.309070; Tanimukai H, 2005, AM J PATHOL, V166, P1761, DOI 10.1016/S0002-9440(10)62486-8; Tatebayashi Y, 1999, J NEUROSCI, V19, P5245; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Tsujio I, 2005, FEBS LETT, V579, P363, DOI 10.1016/j.febslet.2004.11.097; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Wang XC, 2014, ACTA NEUROPATHOL, V127, P243, DOI 10.1007/s00401-013-1175-9; Wang XC, 2010, FASEB J, V24, P4420, DOI 10.1096/fj.10-158477; Yu G, 2013, NEUROBIOL AGING, V34, P1748, DOI 10.1016/j.neurobiolaging.2012.12.025; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zhu LQ, 2010, J NEUROSCI, V30, P3839, DOI 10.1523/JNEUROSCI.5174-09.2010	73	50	52	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27677	27691		10.1074/jbc.M114.565358	http://dx.doi.org/10.1074/jbc.M114.565358			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25128526	Green Published, hybrid			2022-12-28	WOS:000342852800027
J	Foulcer, SJ; Nelson, CM; Quintero, MV; Kuberan, B; Larkin, J; Dours-Zimmermann, MT; Zimmermann, DR; Apte, SS				Foulcer, Simon J.; Nelson, Courtney M.; Quintero, Maritza V.; Kuberan, Balagurunathan; Larkin, Jonathan; Dours-Zimmermann, Maria T.; Zimmermann, Dieter R.; Apte, Suneel S.			Determinants of Versican-V1 Proteoglycan Processing by the Metalloproteinase ADAMTS5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAMTS; Chondroitin Sulfate; Extracellular Matrix; Glycosaminoglycan; Metalloprotease; Proteoglycan; Proteolytic Enzyme; Aggrecanase; Blocking Antibody; Versican	CREST CELL-MIGRATION; SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX; PROTEOLYTIC CLEAVAGE; AGGRECANASE-1 ADAMTS-4; NONCATALYTIC DOMAINS; CHONDROITIN SULFATE; ARTICULAR-CARTILAGE; CRYSTAL-STRUCTURES; MULTIPLE DOMAINS	Background: The mechanisms of versican proteolysis by ADAMTS proteases are unknown. Results: The ADAMTS5 ancillary domain and specific chondroitin sulfate chains of versican are required for proteolysis. Conclusion: Docking between the ADAMTS5 ancillary domain and CS chains is a major mechanism underlying versican proteolysis. Proteolysis by ADAMTS1 has a similar requirement for GAG chains. Significance: The findings suggest strategies for blocking versican cleavage. Proteolysis of the Glu(441)-Ala(442) bond in the glycosaminoglycan (GAG) domain of the versican-V1 variant by a disintegrin-like and metalloproteinase domain with thrombospondin type 1 motif (ADAMTS) proteases is required for proper embryo morphogenesis. However, the processing mechanism and the possibility of additional ADAMTS-cleaved processing sites are unknown. We demonstrate here that if Glu(441) is mutated, ADAMTS5 cleaves inefficiently at a proximate upstream site but normally does not cleave elsewhere within the GAG domain. Chondroitin sulfate (CS) modification of versican is a prerequisite for cleavage at the Glu(441)-Ala(442) site, as demonstrated by reduced processing of CS-deficient or chondroitinase ABC-treated versican-V1. Site-directed mutagenesis identified the N-terminal CS attachment sites Ser(507) and Ser(525) as essential for processing of the Glu(441)-Ala(442) bond by ADAMTS5. A construct including only these two GAG chains, but not downstream GAG attachment sites, was cleaved efficiently. Therefore, CS chain attachment to Ser(507) and Ser(525) is necessary and sufficient for versican proteolysis by ADAMTS5. Mutagenesis of Glu(441) and an antibody to a peptide spanning Thr(432)-Gly(445) (i.e. containing the scissile bond) reduced versican-V1 processing. ADAMTS5 lacking the C-terminal ancillary domain did not cleave versican, and an ADAMTS5 ancillary domain construct bound versican-V1 via the CS chains. We conclude that docking of ADAMTS5 with two N-terminal GAG chains of versican-V1 via its ancillary domain is required for versican processing at Glu(441)-Ala(442). V1 proteolysis by ADAMTS1 demonstrated a similar requirement for the N-terminal GAG chains and Glu(441). Therefore, versican cleavage can be inhibited substantially by mutation of Glu(441), Ser(507), and Ser(525) or by an antibody to the region of the scissile bond.	[Foulcer, Simon J.; Nelson, Courtney M.; Apte, Suneel S.] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA; [Quintero, Maritza V.; Kuberan, Balagurunathan] Univ Utah, Hlth Sci Ctr, Dept Med Chem, Salt Lake City, UT 84112 USA; [Quintero, Maritza V.; Kuberan, Balagurunathan] Univ Utah, Hlth Sci Ctr, Dept Bioengn, Salt Lake City, UT 84112 USA; [Larkin, Jonathan] GlaxoSmithKline, Expt Med Unit, King Of Prussia, PA 19406 USA; [Dours-Zimmermann, Maria T.; Zimmermann, Dieter R.] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland	Cleveland Clinic Foundation; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; GlaxoSmithKline; University of Zurich; University Zurich Hospital	Apte, SS (corresponding author), Cleveland Clin, Dept Biomed Engn, ND20,9500 Euclid Ave, Cleveland, OH 44195 USA.	aptes@ccf.org		Larkin, Jonathan/0000-0002-1202-9287; Quintero, Maritza/0000-0001-8879-7867; Apte, Suneel/0000-0001-8441-1226; Balagurunathan, Kuberan/0000-0001-9203-8118	National Institutes of Health Program of Excellence in Glycoscience Awards [P01 HL-107147, P01 HL-107152]; Sabrina's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147, P01HL107152] Funding Source: NIH RePORTER	National Institutes of Health Program of Excellence in Glycoscience Awards; Sabrina's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Program of Excellence in Glycoscience Awards P01 HL-107147 (to S. S. A.) and P01 HL-107152 (to B. K.) and by funding from Sabrina's Foundation (to S. A.).	Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Aspberg A, 1999, J BIOL CHEM, V274, P20444, DOI 10.1074/jbc.274.29.20444; ASPBERG A, 1995, P NATL ACAD SCI USA, V92, P10590, DOI 10.1073/pnas.92.23.10590; Bai XM, 1999, J BIOL CHEM, V274, P13017, DOI 10.1074/jbc.274.19.13017; BodeLesniewska B, 1996, J HISTOCHEM CYTOCHEM, V44, P303, DOI 10.1177/44.4.8601689; Brown HM, 2006, DEV BIOL, V300, P699, DOI 10.1016/j.ydbio.2006.10.012; Brown HM, 2010, BIOL REPROD, V83, P549, DOI 10.1095/biolreprod.110.084434; Cattaruzza S, 2002, J BIOL CHEM, V277, P47626, DOI 10.1074/jbc.M206521200; Choocheep K, 2010, J BIOL CHEM, V285, P21114, DOI 10.1074/jbc.M109.096479; Dancevic CM, 2013, J BIOL CHEM, V288, P37267, DOI 10.1074/jbc.M112.418624; DOURSZIMMERMANN MT, 1994, J BIOL CHEM, V269, P32992; Dupuis LE, 2013, J MOL CELL CARDIOL, V60, P50, DOI 10.1016/j.yjmcc.2013.03.010; Dupuis LE, 2011, DEV BIOL, V357, P152, DOI 10.1016/j.ydbio.2011.06.041; Dutt S, 2006, J BIOL CHEM, V281, P12123, DOI 10.1074/jbc.M510834200; Dutt S, 2011, J NEUROSCI, V31, P5262, DOI 10.1523/JNEUROSCI.4897-10.2011; Enomoto H, 2010, DEVELOPMENT, V137, P4029, DOI 10.1242/dev.050591; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Fosang AJ, 2008, NAT CLIN PRACT RHEUM, V4, P420, DOI 10.1038/ncprheum0841; Fushimi K, 2008, J BIOL CHEM, V283, P6706, DOI 10.1074/jbc.M708647200; Gao DC, 2012, CANCER RES, V72, P1384, DOI 10.1158/0008-5472.CAN-11-2905; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Hattori N, 2011, J BIOL CHEM, V286, P34298, DOI 10.1074/jbc.M111.254938; Henderson DJ, 1998, CIRC RES, V83, P523, DOI 10.1161/01.RES.83.5.523; Hering TM, 1997, ARCH BIOCHEM BIOPHYS, V345, P259, DOI 10.1006/abbi.1997.0261; ILIC MZ, 1992, ARCH BIOCHEM BIOPHYS, V294, P115, DOI 10.1016/0003-9861(92)90144-L; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kern CB, 2006, DEV DYNAM, V235, P2238, DOI 10.1002/dvdy.20838; Kern CB, 2010, MATRIX BIOL, V29, P304, DOI 10.1016/j.matbio.2010.01.005; Kischel P, 2010, INT J CANCER, V126, P640, DOI 10.1002/ijc.24812; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; Lark MW, 1997, J CLIN INVEST, V100, P93, DOI 10.1172/JCI119526; LEBARON RG, 1992, J BIOL CHEM, V267, P10003; Lemire JM, 1999, ARTERIOSCL THROM VAS, V19, P1630, DOI 10.1161/01.ATV.19.7.1630; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Longpre JM, 2004, J BIOL CHEM, V279, P33237, DOI 10.1074/jbc.M313151200; Matsumoto K, 2003, J BIOL CHEM, V278, P41205, DOI 10.1074/jbc.M305060200; Matsumoto K, 2006, J BIOL CHEM, V281, P18257, DOI 10.1074/jbc.M510330200; Matthews RT, 2000, J BIOL CHEM, V275, P22695, DOI 10.1074/jbc.M909764199; McCulloch DR, 2009, DEV CELL, V17, P687, DOI 10.1016/j.devcel.2009.09.008; Miwa HE, 2006, MATRIX BIOL, V25, P534, DOI 10.1016/j.matbio.2006.07.004; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Mosyak L, 2008, PROTEIN SCI, V17, P16, DOI 10.1110/ps.073287008; Munteanu SE, 2002, MATRIX BIOL, V21, P429, DOI 10.1016/S0945-053X(02)00034-3; Nandadasa S, 2014, MATRIX BIOL, V35, P34, DOI 10.1016/j.matbio.2014.01.005; Perissinotto D, 2000, DEVELOPMENT, V127, P2823; Ricciardelli C, 2009, CANCER METAST REV, V28, P233, DOI 10.1007/s10555-009-9182-y; Rodriguez-Manzaneque JC, 2002, BIOCHEM BIOPH RES CO, V293, P501; Russell DL, 2003, J BIOL CHEM, V278, P42330, DOI 10.1074/jbc.M300519200; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Schmalfeldt M, 2000, J CELL SCI, V113, P807; Shi SL, 2004, J BIOL CHEM, V279, P12060, DOI 10.1074/jbc.M310091200; SHINOMURA T, 1993, J BIOL CHEM, V268, P14461; Silver DL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000003; Snow HE, 2005, ANAT REC PART A, V282A, P95, DOI 10.1002/ar.a.20151; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200; Tortorella MD, 2000, J BIOL CHEM, V275, P18566, DOI 10.1074/jbc.M909383199; Viapiano MS, 2008, J NEURO-ONCOL, V88, P261, DOI 10.1007/s11060-008-9575-8; Victor XV, 2009, J BIOL CHEM, V284, P25842, DOI 10.1074/jbc.M109.043208; Williams DR, 2005, BIOCHEM BIOPH RES CO, V334, P960, DOI 10.1016/j.bbrc.2005.06.189; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Yang BL, 2003, LIFE SCI, V73, P3399, DOI 10.1016/j.lfs.2003.06.018; Yee AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1751; Zheng XL, 2013, J THROMB HAEMOST, V11, P11, DOI 10.1111/jth.12221; Zheng XL, 2010, HAEMATOL-HEMATOL J, V95, P1555, DOI 10.3324/haematol.2009.019299; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x; ZIMMERMANN DR, 1994, J CELL BIOL, V124, P817, DOI 10.1083/jcb.124.5.817	70	38	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27859	27873		10.1074/jbc.M114.573287	http://dx.doi.org/10.1074/jbc.M114.573287			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25122765	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000342852800042
J	Worth, AJ; Basu, SS; Snyder, NW; Mesaros, C; Blair, IA				Worth, Andrew J.; Basu, Sankha S.; Snyder, Nathaniel W.; Mesaros, Clementina; Blair, Ian A.			Inhibition of Neuronal Cell Mitochondrial Complex I with Rotenone Increases Lipid beta-Oxidation, Supporting Acetyl-Coenzyme A Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; REDUCTIVE CARBOXYLATION; DOPAMINERGIC-NEURONS; FAT UPTAKE; METABOLISM; DYSFUNCTION; STRESS; GLUTAMINE; SPECTROMETRY; GROWTH	Rotenone is a naturally occurring mitochondrial complex I inhibitor with a known association with parkinsonian phenotypes in both human populations and rodent models. Despite these findings, a clear mechanistic link between rotenone exposure and neuronal damage remains to be determined. Here, we report alterations to lipid metabolism in SH-SY5Y neuroblastoma cells exposed to rotenone. The absolute levels of acetylCoA were found to be maintained despite a significant decrease in glucose-derived acetyl-CoA. Furthermore, palmitoyl-CoA levels were maintained, whereas the levels of many of the medium- chain acyl-CoA species were significantly reduced. Additionally, using isotopologue analysis, we found that beta-oxidation of fatty acids with varying chain lengths helped maintain acetylCoA levels. Rotenone also induced increased glutamine utilization for lipogenesis, in part through reductive carboxylation, as has been found previously in other cell types. Finally, palmitoylcarnitine levels were increased in response to rotenone, indicating an increase in fatty acid import. Taken together, these findings show that alterations to lipid and glutamine metabolism play an important compensatory role in response to complex I inhibition by rotenone.	[Blair, Ian A.] Univ Penn, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Blair, IA (corresponding author), Univ Penn, Ctr Canc Pharmacol, 854 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	ianblair@mail.med.upenn.edu		Snyder, Nathaniel/0000-0001-5643-8747	National Institutes of Health Grants [P30ES013508, T32GM008076, T32ES019851]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508, T32ES019851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008076] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30ES013508, T32GM008076, and T32ES019851.	Basu SS, 2012, NAT PROTOC, V7, P1, DOI 10.1038/nprot.2011.421; Basu SS, 2011, CHEM RES TOXICOL, V24, P1630, DOI 10.1021/tx200366j; Basu SS, 2011, ANAL CHEM, V83, P1363, DOI 10.1021/ac1027353; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Cannon JR, 2009, NEUROBIOL DIS, V34, P279, DOI 10.1016/j.nbd.2009.01.016; Chassain C, 2005, EXP NEUROL, V191, P276, DOI 10.1016/j.expneurol.2004.09.017; Daye D, 2012, SEMIN CELL DEV BIOL, V23, P362, DOI 10.1016/j.semcdb.2012.02.002; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DESROSIERS C, 1994, J BIOL CHEM, V269, P27179; Du QQ, 2015, J CHROMATOGR SCI, V53, P79, DOI 10.1093/chromsci/bmu022; Emadi A, 2014, EXP HEMATOL, V42, P247, DOI 10.1016/j.exphem.2013.12.001; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Fan J, 2013, J BIOL CHEM, V288, P31363, DOI 10.1074/jbc.M113.502740; Gameiro PA, 2013, J BIOL CHEM, V288, P12967, DOI 10.1074/jbc.M112.396796; HARTLEY A, 1994, J NEUROCHEM, V63, P1987; Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011; Henchcliffe C, 2008, ANN NY ACAD SCI, V1147, P206, DOI 10.1196/annals.1427.037; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Kim KY, 2012, CURR OPIN LIPIDOL, V23, P201, DOI 10.1097/MOL.0b013e328352dc5d; Kim KY, 2011, J CLIN INVEST, V121, P3701, DOI 10.1172/JCI44736; Lee SH, 2007, METHOD ENZYMOL, V433, P159, DOI 10.1016/S0076-6879(07)33009-7; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lowther J, 2012, BIOCHEM SOC T, V40, P547, DOI 10.1042/BST20110769; Mally J, 1997, J NEUROL SCI, V151, P159, DOI 10.1016/S0022-510X(97)00119-6; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Newman JC, 2012, J BIOL CHEM, V287, P42436, DOI 10.1074/jbc.R112.404863; Pickrell AM, 2013, MOL CELL NEUROSCI, V55, P87, DOI 10.1016/j.mcn.2012.08.002; Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008; Plaitakis A, 2000, J NEUROL, V247, P25, DOI 10.1007/PL00007757; Reitman ZJ, 2014, J BIOL CHEM, V289, P23318, DOI 10.1074/jbc.M114.575183; Shamoto-Nagai M, 2003, J NEUROSCI RES, V74, P589, DOI 10.1002/jnr.10777; Singh G, 2000, ANAL CHEM, V72, P3007, DOI 10.1021/ac000374a; Snyder NW, 2013, JOVE-J VIS EXP, DOI 10.3791/50433; Subramaniam SR, 2013, PROG NEUROBIOL, V106, P17, DOI 10.1016/j.pneurobio.2013.04.004; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Taylor JM, 2013, NEUROCHEM INT, V62, P803, DOI 10.1016/j.neuint.2012.12.016; Varcin M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/624925; Weber CA, 2006, ANN PHARMACOTHER, V40, P935, DOI 10.1345/aph.1G551; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021; Zhang GF, 2011, J BIOL CHEM, V286, P23631, DOI 10.1074/jbc.R110.171405; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI 10.1038/NCHEMBIO.495; Zhou C, 2008, ANN NY ACAD SCI, V1147, P93, DOI 10.1196/annals.1427.023	46	32	32	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26895	26903		10.1074/jbc.M114.591354	http://dx.doi.org/10.1074/jbc.M114.591354			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122772	hybrid, Green Published			2022-12-28	WOS:000342853900020
J	Meng, XF; Dobruchowska, JM; Pijning, T; Lopez, CA; Kamerling, JP; Dijkhuizen, L				Meng, Xiangfeng; Dobruchowska, Justyna M.; Pijning, Tjaard; Lopez, Cesar A.; Kamerling, Johannis P.; Dijkhuizen, Lubbert			Residue Leu(940) Has a Crucial Role in the Linkage and Reaction Specificity of the Glucansucrase GTF180 of the Probiotic Bacterium Lactobacillus reuteri 180	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL-CHARACTERIZATION; 121 REUTERANSUCRASE; GLUCAN PRODUCTS; YOUNG-CHILDREN; ACUTE DIARRHEA; EXOPOLYSACCHARIDES; DEXTRANSUCRASE; STRAINS; ENZYMES; ACID	Highly conserved glycoside hydrolase family 70 glucansucrases are able to catalyze the synthesis of alpha-glucans with different structure from sucrose. The structural determinants of glucansucrase specificity have remained unclear. Residue Leu(940) in domain B of GTF180, the glucansucrase of the probiotic bacterium Lactobacillus reuteri 180, was shown to vary in different glucansucrases and is close to the +1 glucosyl unit in the crystal structure of GTF180-Delta N in complex with maltose. Herein, we show that mutations in Leu(940) of wild-type GTF180-Delta N all caused an increased percentage of (alpha 1 -> 6) linkages and a decreased percentage of (alpha 1 -> 3) linkages in the products. alpha-Glucans with potential different physicochemical properties (containing 67-100% of (alpha 1 -> 6) linkages) were produced by GTF180 and its Leu(940) mutants. Mutant L940W was unable to form (alpha 1 -> 3) linkages and synthesized a smaller and linear glucan polysaccharide with only (alpha 1 -> 6) linkages. Docking studies revealed that the introduction of the large aromatic amino acid residue tryptophan at position 940 partially blocked the binding groove, preventing the isomalto-oligosaccharide acceptor to bind in an favorable orientation for the formation of (alpha 1 -> 3) linkages. Our data showed that the reaction specificity of GTF180 mutant was shifted either to increased polysaccharide synthesis (L940A, L940S, L940E, and L940F) or increased oligosaccharide synthesis (L940W). The L940W mutant is capable of producing a large amount of isomalto-oligosaccharides using released glucose from sucrose as acceptors. Thus, residue Leu(940) in domain B is crucial for linkage and reaction specificity of GTF180. This study provides clear and novel insights into the structure-function relationships of glucansucrase enzymes.	[Meng, Xiangfeng; Dobruchowska, Justyna M.; Kamerling, Johannis P.; Dijkhuizen, Lubbert] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Microbial Physiol, NL-9747 AG Groningen, Netherlands; [Pijning, Tjaard; Lopez, Cesar A.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biophys Chem, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Dijkhuizen, L (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	l.dijkhuizen@rug.nl	Dijkhuizen, Lubbert/E-9454-2014; Pijning, Tjaard/ABA-2929-2021; Pijning, Tjaard/HDO-3704-2022; Dijkhuizen, Lubbert/K-3539-2019; DOBRUCHOWSKA, JUSTYNA/AAY-1409-2021	Pijning, Tjaard/0000-0003-4107-3663; Dijkhuizen, Lubbert/0000-0003-2312-7162; 	Chinese Scholarship Council; European Union [NOVOSIDES FP7-KBBE-2010-4-265854]	Chinese Scholarship Council(China Scholarship Council); European Union(European Commission)	This work was financially supported by the Chinese Scholarship Council (to X. M.), and by European Union project NOVOSIDES FP7-KBBE-2010-4-265854 (to L. D.).	Badel S, 2011, BIOTECHNOL ADV, V29, P54, DOI 10.1016/j.biotechadv.2010.08.011; Brison Y, 2012, J BIOL CHEM, V287, P7915, DOI 10.1074/jbc.M111.305078; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Dobruchowska JM, 2013, GLYCOBIOLOGY, V23, P1084, DOI 10.1093/glycob/cwt048; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Funane K, 2005, FEBS LETT, V579, P4739, DOI 10.1016/j.febslet.2005.07.050; Galle S, 2012, INT J FOOD MICROBIOL, V155, P105, DOI 10.1016/j.ijfoodmicro.2012.01.009; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hellmuth H, 2008, BIOCHEMISTRY-US, V47, P6678, DOI 10.1021/bi800563r; Irague R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077837; Irague R, 2012, BIOMACROMOLECULES, V13, P187, DOI 10.1021/bm201453r; Kaditzky SB, 2008, FOOD BIOTECHNOL, V22, P398, DOI 10.1080/08905430802470235; Kralj S, 2004, MICROBIOL-SGM, V150, P3681, DOI 10.1099/mic.0.27321-0; Kralj S, 2005, APPL ENVIRON MICROB, V71, P3942, DOI 10.1128/AEM.71.7.3942-3950.2005; Kralj S, 2005, BIOCHEMISTRY-US, V44, P9206, DOI 10.1021/bi050447q; Kralj S, 2004, MICROBIOL-SGM, V150, P2099, DOI 10.1099/mic.0.27105-0; Kralj S, 2006, FEBS J, V273, P3735, DOI 10.1111/j.1742-4658.2006.05376.x; Leemhuis H, 2013, J BIOTECHNOL, V163, P250, DOI 10.1016/j.jbiotec.2012.06.037; Leemhuis H, 2012, BIOCATAL BIOTRANSFOR, V30, P366, DOI 10.3109/10242422.2012.676301; MacGregor EA, 1996, FEBS LETT, V378, P263, DOI 10.1016/0014-5793(95)01428-4; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Monchois V, 1999, APPL MICROBIOL BIOT, V52, P660, DOI 10.1007/s002530051575; Monchois V, 2000, APPL ENVIRON MICROB, V66, P1923, DOI 10.1128/AEM.66.5.1923-1927.2000; Monchois V, 1999, FEMS MICROBIOL REV, V23, P131, DOI 10.1016/S0168-6445(98)00041-2; MOOSER G, 1991, J BIOL CHEM, V266, P8916; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Moulis C, 2006, J BIOL CHEM, V281, P31254, DOI 10.1074/jbc.M604850200; Naessens M, 2005, J CHEM TECHNOL BIOT, V80, P845, DOI 10.1002/jctb.1322; Olano-Martin E, 2000, BRIT J NUTR, V83, P247, DOI 10.1017/S0007114500000325; Pijning T, 2012, ACTA CRYSTALLOGR F, V68, P1448, DOI 10.1107/S1744309112044168; Rosenfeldt V, 2002, PEDIATR INFECT DIS J, V21, P411, DOI 10.1097/00006454-200205000-00012; Shornikova AV, 1997, J PEDIATR GASTR NUTR, V24, P399, DOI 10.1097/00005176-199704000-00008; Thompson J, 2001, CARBOHYD RES, V331, P149, DOI 10.1016/S0008-6215(01)00028-3; Tubelius Py, 2005, Environ Health, V4, P25, DOI 10.1186/1476-069X-4-25; Van Geel-Schutten GH, 1999, APPL ENVIRON MICROB, V65, P3008; van Geel-Schutten GH, 1998, APPL MICROBIOL BIOT, V50, P697, DOI 10.1007/s002530051353; van Leeuwen SS, 2008, CARBOHYD RES, V343, P1237, DOI 10.1016/j.carres.2008.01.042; van Leeuwen SS, 2009, BIOMACROMOLECULES, V10, P580, DOI 10.1021/bm801240r; Vujicic-Zagar A, 2010, P NATL ACAD SCI USA, V107, P21406, DOI 10.1073/pnas.1007531107; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035	41	27	34	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.602524	http://dx.doi.org/10.1074/jbc.M114.602524			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25288798	Green Published, hybrid			2022-12-28	WOS:000345335000032
J	Maher, K; Kokelj, BJ; Butinar, M; Mikhaylov, G; Mancek-Keber, M; Stoka, V; Vasiljeva, O; Turk, B; Grigoryev, SA; Kopitar-Jerala, N				Maher, Katarina; Kokelj, Barbara Jeric; Butinar, Miha; Mikhaylov, Georgy; Mancek-Keber, Mateja; Stoka, Veronika; Vasiljeva, Olga; Turk, Boris; Grigoryev, Sergei A.; Kopitar-Jerala, Natasa			A Role for Stefin B (Cystatin B) in Inflammation and Endotoxemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caspase; Inflammasome; Mitochondria; Reactive Oxygen Species (ROS); Sepsis	PROGRESSIVE MYOCLONUS EPILEPSY; NF-KAPPA-B; NLRP3 INFLAMMASOME; CATHEPSIN-L; PATTERN-RECOGNITION; NALP3 INFLAMMASOME; SIGNAL TRANSDUCER; OXIDATIVE STRESS; GENE-EXPRESSION; TUMOR-CELLS	Background: The lack of cysteine cathepsin inhibitor, stefin B (cystatin B), results in progressive myoclonus epilepsy, type 1. Results: Stefin B deficiency in macrophages resulted in increased inflammasome activation. Conclusion: Stefin B-deficient mice are significantly more sensitive to e LPS-induced sepsis due to increased caspase-11 expression and mitochondrial damage. Significance: Stefin B has an important role in limiting the inflammatory response during LPS-induced sepsis. Stefin B (cystatin B) is an endogenous cysteine cathepsin inhibitor, and the loss-of-function mutations in the stefin B gene were reported in patients with Unverricht-Lundborg disease (EPM1). In this study we demonstrated that stefin B-deficient (StB KO) mice were significantly more sensitive to the lethal LPS-induced sepsis and secreted higher amounts of pro-inflammatory cytokines IL-1 and IL-18 in the serum. We further showed that increased caspase-11 gene expression and better pro-inflammatory caspase-1 and -11 activation determined in StB KO bone marrow-derived macrophages resulted in enhanced IL-1 processing. Pretreatment of macrophages with the cathepsin inhibitor E-64d did not affect secretion of IL-1, suggesting that the increased cathepsin activity determined in StB KO bone marrow-derived macrophages is not essential for inflammasome activation. Upon LPS stimulation, stefin B was targeted into the mitochondria, and the lack of stefin B resulted in the increased destabilization of mitochondrial membrane potential and mitochondrial superoxide generation. Collectively, our study demonstrates that the LPS-induced sepsis in StB KO mice is dependent on caspase-11 and mitochondrial reactive oxygen species but is not associated with the lysosomal destabilization and increased cathepsin activity in the cytosol.	[Maher, Katarina; Kokelj, Barbara Jeric; Butinar, Miha; Mikhaylov, Georgy; Stoka, Veronika; Vasiljeva, Olga; Turk, Boris; Kopitar-Jerala, Natasa] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, SI-1000 Ljubljana, Slovenia; [Maher, Katarina; Kokelj, Barbara Jeric; Butinar, Miha; Mikhaylov, Georgy; Stoka, Veronika] Jozef Stefan Int Postgrad Sch, SI-1000 Ljubljana, Slovenia; [Mancek-Keber, Mateja] Natl Inst Chem, Dept Biotechnol, SI-1000 Ljubljana, Slovenia; [Mancek-Keber, Mateja] EN FIST Ctr Excellence, SI-1000 Ljubljana, Slovenia; [Turk, Boris] Ctr Excellence Integrated Approaches Chem & Biol, SI-1000 Ljubljana, Slovenia; [Turk, Boris] Univ Ljubljana, Fac Chem & Chem Technol, Dept Chem & Biochem, SI-1000 Ljubljana, Slovenia; [Maher, Katarina; Grigoryev, Sergei A.] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; National Institute of Chemistry - Slovenia; University of Ljubljana; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kopitar-Jerala, N (corresponding author), Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, SI-1000 Ljubljana, Slovenia.	natasa.kopitar@ijs.si	Stoka, Veronika/AAM-2283-2021	Vasiljeva, Olga/0000-0003-3648-5460; Turk, Boris/0000-0002-9007-5764	Slovenian Research Agency [J3-0612, P-0140]; Commissariat a l'Energie Atomique et aux Energies Alternatives France-Slovenia grant; Slovenian Young Researcher Program; EMBO [ASTF 50-2012]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Commissariat a l'Energie Atomique et aux Energies Alternatives France-Slovenia grant; Slovenian Young Researcher Program; EMBO(European Molecular Biology Organization (EMBO))	This work was supported in part by Slovenian Research Agency Grants J3-0612 (to N. K. J.) and P-0140 (to B. T.) and Commissariat a l'Energie Atomique et aux Energies Alternatives France-Slovenia grant (to N. K. J.).; Supported by the Slovenian Young Researcher Program.; Recipient of EMBO Short Term Scholarship ASTF 50-2012 to visit the College of Medicine, Pennsylvania State University, Hershey, PA 17033.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bird PI, 2009, NAT REV IMMUNOL, V9, P871, DOI 10.1038/nri2671; Broz P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003144; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Bulynko YA, 2006, MOL CELL BIOL, V26, P4172, DOI 10.1128/MCB.00135-06; Butinar M, 2014, ONCOGENE, V33, P3392, DOI 10.1038/onc.2013.314; Ceru S, 2010, J BIOL CHEM, V285, P10078, DOI 10.1074/jbc.M109.034793; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Di Giaimo R, 2002, HUM MOL GENET, V11, P2941, DOI 10.1093/hmg/11.23.2941; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hoegen T, 2011, J IMMUNOL, V187, P5440, DOI 10.4049/jimmunol.1100790; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Houseweart MK, 2003, J NEUROBIOL, V56, P315, DOI 10.1002/neu.10253; Istomina NE, 2003, MOL CELL BIOL, V23, P6455, DOI 10.1128/MCB.23.18.6455-6468.2003; Jabaut J, 2013, FREE RADICAL BIO MED, V60, P233, DOI 10.1016/j.freeradbiomed.2013.01.025; Joensuu T, 2008, EPILEPSIA, V49, P557, DOI 10.1111/j.1528-1167.2007.01422.x; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Karthikeyan RS, 2011, J INFECT DIS, V204, P942, DOI 10.1093/infdis/jir426; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kopitar-Jerala NA, 2005, FEBS LETT, V579, P2149, DOI 10.1016/j.febslet.2005.03.002; Kopitar-Jerala N, 2006, FEBS LETT, V580, P6295, DOI 10.1016/j.febslet.2006.10.055; Lalioti MD, 1997, AM J HUM GENET, V60, P342; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lehtinen MK, 2009, J NEUROSCI, V29, P5910, DOI 10.1523/JNEUROSCI.0682-09.2009; Lenarcic B, 1998, BIOL CHEM, V379, P105; LEW W, 1988, J IMMUNOL, V140, P1895; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Lopez-Castejon G, 2010, J IMMUNOL, V185, P2611, DOI 10.4049/jimmunol.1000436; Luciano-Montalvo C, 2009, PLACENTA, V30, P464, DOI 10.1016/j.placenta.2009.03.003; Maher K, 2014, FEBS LETT, V588, P720, DOI 10.1016/j.febslet.2014.01.015; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nekrasov M, 2012, NAT STRUCT MOL BIOL, V19, P1076, DOI 10.1038/nsmb.2424; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; Popova E. Y., 2012, PLOS ONE, V7; Puren AJ, 1999, P NATL ACAD SCI USA, V96, P2256, DOI 10.1073/pnas.96.5.2256; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Rinne R, 2002, ANN MED, V34, P380, DOI 10.1080/078538902320772124; Rivera-Rivera L, 2012, J NEUROVIROL, V18, P20, DOI 10.1007/s13365-011-0061-2; Schauvliege R, 2002, J BIOL CHEM, V277, P41624, DOI 10.1074/jbc.M207852200; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SCHRECK R, 1992, J VIROL, V66, P6288, DOI 10.1128/JVI.66.11.6288-6293.1992; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Spes A, 2012, BIOL CHEM, V393, P1417, DOI 10.1515/hsz-2012-0213; Tegelberg S, 2012, J NEUROPATH EXP NEUR, V71, P40, DOI 10.1097/NEN.0b013e31823e68e1; Tschopp J, 2011, EUR J IMMUNOL, V41, P1196, DOI 10.1002/eji.201141436; Turk B, 2002, CURR PHARM DESIGN, V8, P1623, DOI 10.2174/1381612023394124; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Wu XY, 2007, CHINESE MED J-PEKING, V120, P893, DOI 10.1097/00029330-200705020-00008; Zhang HL, 2009, J IMMUNOL, V182, P6993, DOI 10.4049/jimmunol.0802502; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	68	42	45	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31736	31750		10.1074/jbc.M114.609396	http://dx.doi.org/10.1074/jbc.M114.609396			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25288807	Green Published, hybrid			2022-12-28	WOS:000345314700007
J	Rivera-Najera, LY; Saab-Rincon, G; Battaglia, M; Amero, C; Pulido, NO; Garcia-Hernandez, E; Solorzano, RM; Reyes, JL; Covarrubias, AA				Rivera-Najera, Lucero Y.; Saab-Rincon, Gloria; Battaglia, Marina; Amero, Carlos; Pulido, Nancy O.; Garcia-Hernandez, Enrique; Solorzano, Rosa M.; Reyes, Jose L.; Covarrubias, Alejandra A.			A Group 6 Late Embryogenesis Abundant Protein from Common Bean Is a Disordered Protein with Extended Helical Structure and Oligomer-forming Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Intrinsically Disordered Protein; Isothermal Titration Calorimetry (ITC); Protein Conformation; Protein Self-assembly; Protein Structure; Stress Response; Plant Biology	ISOTHERMAL TITRATION CALORIMETRY; LEA PROTEINS; POLYPROLINE-II; INTRINSIC DISORDER; CIRCULAR-DICHROISM; DEHYDRATION TOLERANCE; ADENOSINE NUCLEOTIDES; WATER-DEFICIT; PEPTIDES; TEMPERATURE	Background: Late embryogenesis-abundant proteins accumulate under water-deficit and are widely distributed in plants and anhydrobiotic organisms. Results: A common bean group-6 LEA protein shows structural disorder, adopts helicity under water deficit or high molecular crowding, and presents oligomeric forms. Conclusion: PvLEA6 protein adopts different conformations and/or a quaternary structure depending on its environment. Significance: Similar characteristics might be present in different LEA proteins, which could be relevant to their function. Late embryogenesis-abundant proteins accumulate to high levels in dry seeds. Some of them also accumulate in response to water deficit in vegetative tissues, which leads to a remarkable association between their presence and low water availability conditions. A major sub-group of these proteins, also known as typical LEA proteins, shows high hydrophilicity and a high percentage of glycine and other small amino acid residues, distinctive physicochemical properties that predict a high content of structural disorder. Although all typical LEA proteins share these characteristics, seven groups can be distinguished by sequence similarity, indicating structural and functional diversity among them. Some of these groups have been extensively studied; however, others require a more detailed analysis to advance in their functional understanding. In this work, we report the structural characterization of a group 6 LEA protein from a common bean (Phaseolus vulgaris L.) (PvLEA6) by circular dichroism and nuclear magnetic resonance showing that it is a disordered protein in aqueous solution. Using the same techniques, we show that despite its unstructured nature, the addition of trifluoroethanol exhibited an intrinsic potential in this protein to gain helicity. This property was also promoted by high osmotic potentials or molecular crowding. Furthermore, we demonstrate that PvLEA6 protein is able to form soluble homo-oligomeric complexes that also show high levels of structural disorder. The association between PvLEA6 monomers to form dimers was shown to occur in plant cells by bimolecular fluorescence complementation, pointing to the in vivo functional relevance of this association.	[Rivera-Najera, Lucero Y.; Battaglia, Marina; Solorzano, Rosa M.; Reyes, Jose L.; Covarrubias, Alejandra A.] Univ Nacl Autonoma Mexico, Dept Biol Mol Plantas, Cuernavaca 62250, Mor, Mexico; [Saab-Rincon, Gloria] Univ Nacl Autonoma Mexico, Inst Biotecnologia, Dept Ingn Celular & Biocatalisis, Cuernavaca 62250, Morelos, Mexico; [Amero, Carlos] Univ Autonoma Estado Morelos, Ctr Invest Quim, Cuernavaca 62209, Morelos, Mexico; [Pulido, Nancy O.; Garcia-Hernandez, Enrique] Univ Nacl Autonoma Mexico, Inst Quim, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico	Covarrubias, AA (corresponding author), Univ Nacl Autonoma Mexico, Dept Biol Mol Plantas, Inst Biotecnol, Ave Univ 2001, Cuernavaca 62210, Morelos, Mexico.	crobles@ibt.unam.mx	Amero, Carlos/AAE-7733-2020; Amero, Carlos/C-6952-2011; Battaglia, Marina E/AAC-1418-2021; Saab-RIncon, Gloria/AFO-4892-2022	Amero, Carlos/0000-0001-6300-0241; Battaglia, Marina E/0000-0002-4300-4285; Saab-RIncon, Gloria/0000-0002-5251-1000; Garcia-Hernandez, Enrique/0000-0003-4561-4973; Reyes, Jose L./0000-0001-5129-9741	Consejo Nacional de Ciencia y Tecnologia-Mexico [132258]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT-Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico) [IN-208212]; Consejo Nacional de Ciencia y Tecnologia-Mexico Ph.D. fellowship	Consejo Nacional de Ciencia y Tecnologia-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT-Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia-Mexico Ph.D. fellowship	This work was supported in part by Consejo Nacional de Ciencia y Tecnologia-Mexico Grant 132258 and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT-Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico) Grant IN-208212.; Supported by a Consejo Nacional de Ciencia y Tecnologia-Mexico Ph.D. fellowship.	Amara I, 2012, PLANT CELL PHYSIOL, V53, P312, DOI 10.1093/pcp/pcr183; Aruxandei DC, 2011, BIOCHEMISTRY-US, V50, P10990, DOI [10.1021/bi20111oh, 10.1021/bi201110h]; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Battaglia M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00190; Belda-Palazon B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046907; Bewley J. D., 2013, SEEDS PHYSL DEV GERM, P124; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Campos F, 2013, MOL GENET GENOMICS, V288, P503, DOI 10.1007/s00438-013-0768-2; Carrari F, 2004, TRENDS PLANT SCI, V9, P57, DOI 10.1016/j.tplants.2003.12.004; CECCARDI TL, 1994, PROTEIN EXPRES PURIF, V5, P266, DOI 10.1006/prep.1994.1040; Chen K, 2004, P NATL ACAD SCI USA, V101, P15352, DOI 10.1073/pnas.0406657101; Colmenero-Flores JM, 1999, PLANT PHYSIOL, V120, P93, DOI 10.1104/pp.120.1.93; ColmeneroFlores JM, 1997, PLANT MOL BIOL, V35, P393, DOI 10.1023/A:1005802505731; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demchenko AP, 2001, J MOL RECOGNIT, V14, P42, DOI 10.1002/1099-1352(200101/02)14:1<42::AID-JMR518>3.0.CO;2-8; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Duan JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045117; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; GALLY JA, 1962, BIOCHIM BIOPHYS ACTA, V60, P499, DOI 10.1016/0006-3002(62)90869-7; Garay-Arroyo A, 2000, J BIOL CHEM, V275, P5668, DOI 10.1074/jbc.275.8.5668; Gentile F, 2002, J BIOL CHEM, V277, P44050, DOI 10.1074/jbc.M206761200; Georgakopoulou S, 2009, J MOL BIOL, V386, P544, DOI 10.1016/j.jmb.2008.12.053; Gunasekaran K, 2004, J MOL BIOL, V341, P1327, DOI 10.1016/j.jmb.2004.07.002; Hackl EV, 2014, BIOPOLYMERS, V101, P591, DOI 10.1002/bip.22422; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Hincha DK, 2012, BIOCHEM SOC T, V40, P1000, DOI 10.1042/BST20120109; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Hundertmark M, 2012, BIOCHEM BIOPH RES CO, V417, P122, DOI 10.1016/j.bbrc.2011.11.067; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Jeong JK, 2003, BIOCHEM BIOPH RES CO, V300, P29, DOI 10.1016/S0006-291X(02)02769-9; Johnson DE, 2012, J STRUCT BIOL, V180, P201, DOI 10.1016/j.jsb.2012.05.013; KAZUOKA T, 1994, PLANT CELL PHYSIOL, V35, P601, DOI 10.1093/oxfordjournals.pcp.a078635; Keller R., 2004, COMPUTER AIDED RESON, P5; Kjaergaard M, 2010, PROTEIN SCI, V19, P1555, DOI 10.1002/pro.435; Liyanage MR, 2014, METHODS MOL BIOL, V1088, P237, DOI 10.1007/978-1-62703-673-3_16; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; Marion J, 2008, PLANT J, V56, P169, DOI 10.1111/j.1365-313X.2008.03596.x; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Marsh JA, 2012, CURR OPIN STRUC BIOL, V22, P643, DOI 10.1016/j.sbi.2012.08.008; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Moreno-Fonseca LP, 2001, PLANT MOL BIOL, V45, P501, DOI 10.1023/A:1010607223533; Nakayama K, 2007, PLANT PHYSIOL, V144, P513, DOI 10.1104/pp.106.094581; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Park SH, 1997, PROTEIN SCI, V6, P1694, DOI 10.1002/pro.5560060809; Pazos F, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00363; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Pulido NO, 2010, BIOCHEMISTRY-US, V49, P5258, DOI 10.1021/bi1006767; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Rucker AL, 2002, PROTEIN SCI, V11, P980, DOI 10.1110/ps.4550102; Salcedo G, 2014, BBA-BIOENERGETICS, V1837, P44, DOI 10.1016/j.bbabio.2013.08.005; Sasaki K, 2014, PLANT CELL PHYSIOL, V55, P136, DOI 10.1093/pcp/pct164; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shi ZS, 2005, P NATL ACAD SCI USA, V102, P17964, DOI 10.1073/pnas.0507124102; Shi ZS, 2002, P NATL ACAD SCI USA, V99, P9190, DOI 10.1073/pnas.112193999; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Soulages JL, 2003, PLANT PHYSIOL, V131, P963, DOI 10.1104/pp.015891; Soulages JL, 2002, PLANT PHYSIOL, V128, P822, DOI 10.1104/pp.010521; Sun XL, 2013, PLANT CELL, V25, P38, DOI 10.1105/tpc.112.106062; TIFFANY ML, 1969, BIOPOLYMERS, V8, P347, DOI 10.1002/bip.1969.360080306; TIFFANY ML, 1972, BIOPOLYMERS, V11, P2309; TIFFANY ML, 1968, BIOPOLYMERS, V6, P1767, DOI 10.1002/bip.1968.360061212; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Tunnacliffe A, 2010, TOP CURR GENET, V21, P91, DOI 10.1007/978-3-642-12422-8_6; Tweddle JC, 2003, J ECOL, V91, P294, DOI 10.1046/j.1365-2745.2003.00760.x; Uversky VN, 2009, PROTEIN J, V28, P305, DOI 10.1007/s10930-009-9201-4; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Velazquez-Campoy Adrian, 2004, Methods Mol Biol, V261, P35; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wilcox DE, 2008, INORG CHIM ACTA, V361, P857, DOI 10.1016/j.ica.2007.10.032; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145	75	28	28	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31995	32009		10.1074/jbc.M114.583369	http://dx.doi.org/10.1074/jbc.M114.583369			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25271167	Green Published, hybrid			2022-12-28	WOS:000345314700029
J	Yu, SY; Yehia, G; Wang, JF; Stypulkowski, E; Sakamori, R; Jiang, P; Hernandez-Enriquez, B; Tran, TS; Bonder, EM; Guo, W; Gao, N				Yu, Shiyan; Yehia, Ghassan; Wang, Juanfei; Stypulkowski, Ewa; Sakamori, Ryotaro; Jiang, Ping; Hernandez-Enriquez, Berenice; Tran, Tracy S.; Bonder, Edward M.; Guo, Wei; Gao, Nan			Global Ablation of the Mouse Rab11a Gene Impairs Early Embryogenesis and Matrix Metalloproteinase Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Embryo; Matrix Metalloproteinase (MMP); Mouse Genetics; Rab; Trafficking; Rab11; Rab11a; rab11	POLARIZED EPITHELIAL-CELLS; PLASMA-MEMBRANE TRANSPORT; EXTRACELLULAR-MATRIX; E-CADHERIN; RECYCLING ENDOSOMES; MDCK CELLS; ACTIVATED MACROPHAGES; INVADOPODIA FORMATION; GOLGI NETWORK; IN-VIVO	Background: The physiological role of Rab11a in mouse embryogenesis has not been fully studied. Results: Using a Rab11a(null) mouse allele, the transport of multiple membrane-associated and soluble cargos was analyzed in mouse blastocysts and MEFs. Conclusion: Rab11a ablation impairs mouse blastocyst development and the secretion of soluble matrix metalloproteinases. Significance:In vivo functions of Rab11a in mouse fetal development and soluble MMP secretion were uncovered. Rab11a has been conceived as a prominent regulatory component of the recycling endosome, which acts as a nexus in the endo- and exocytotic networks. The precise in vivo role of Rab11a in mouse embryonic development is unknown. We globally ablated Rab11a and examined the phenotypic and molecular outcomes in Rab11a(null) blastocysts and mouse embryonic fibroblasts. Using multiple trafficking assays and complementation analyses, we determined, among multiple important membrane-associated and soluble cargos, the critical contribution of Rab11a vesicular traffic to the secretion of multiple soluble MMPs. Rab11a(null) embryos were able to properly form normal blastocysts but died at peri-implantation stages. Our data suggest that Rab11a critically controls mouse blastocyst development and soluble matrix metalloproteinase secretion.	[Yu, Shiyan; Stypulkowski, Ewa; Sakamori, Ryotaro; Hernandez-Enriquez, Berenice; Tran, Tracy S.; Bonder, Edward M.; Gao, Nan] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA; [Yehia, Ghassan] Rutgers New Jersey Med Sch, Transgen Core Facil, Newark, NJ 07103 USA; [Wang, Juanfei; Guo, Wei] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Jiang, Ping] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania; Cold Spring Harbor Laboratory	Gao, N (corresponding author), Rutgers State Univ, Dept Biol Sci, Rm 206,195 Univ Ave, Newark, NJ 07102 USA.	ngao@andromeda.rutgers.edu	Tran, Tracy/M-2173-2019; Sakamori, Ryotaro/B-4406-2014	Sakamori, Ryotaro/0000-0002-1580-607X; Tran, Tracy/0000-0002-2179-5725	National Institutes of Health [DK085194, DK093809, DK102934, CA17859]; Charles and Johanna Busch Memorial Award [659160]; Rutgers University Faculty Research Grant [281708]; New Jersey Commission on Cancer Research Postdoctoral Fellowship [DFHS13PPC016];  [GM085146]; NATIONAL CANCER INSTITUTE [R21CA178599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102934, K01DK085194, R03DK093809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles and Johanna Busch Memorial Award; Rutgers University Faculty Research Grant; New Jersey Commission on Cancer Research Postdoctoral Fellowship; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK085194, DK093809, DK102934, and CA17859 (to N. G.) and Grant GM085146 (to W. G.). This work was also supported by Charles and Johanna Busch Memorial Award 659160 and by Rutgers University Faculty Research Grant 281708 (to N. G.).; Supported by New Jersey Commission on Cancer Research Postdoctoral Fellowship DFHS13PPC016.	Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Apodaca G, 2012, NAT CELL BIOL, V14, P1235, DOI 10.1038/ncb2635; Baratti-Elbaz C, 1999, MOL ENDOCRINOL, V13, P1751, DOI 10.1210/me.13.10.1751; Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; BEHRENDTSEN O, 1992, DEVELOPMENT, V114, P447; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Bogard N, 2007, DEVELOPMENT, V134, P3413, DOI 10.1242/dev.008466; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chambers R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010994; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Dollar G, 2002, DEVELOPMENT, V129, P517; Eisfeld AJ, 2011, J VIROL, V85, P6117, DOI 10.1128/JVI.00378-11; Fields IC, 2007, J CELL BIOL, V177, P477, DOI 10.1083/jcb.200610047; Gao N, 2010, GENE DEV, V24, P1295, DOI 10.1101/gad.1921510; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; GLASS RH, 1983, J CELL BIOL, V96, P1108, DOI 10.1083/jcb.96.4.1108; Goldenring JR, 1996, AM J PHYSIOL-GASTR L, V270, pG515, DOI 10.1152/ajpgi.1996.270.3.G515; Gorodeski GI, 2007, ENDOCRINOLOGY, V148, P218, DOI 10.1210/en.2006-1120; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gravotta D, 2007, P NATL ACAD SCI USA, V104, P1564, DOI 10.1073/pnas.0610700104; Hanania R, 2012, J BIOL CHEM, V287, P8468, DOI 10.1074/jbc.M111.290676; Herda S, 2012, IMMUNITY, V37, P854, DOI 10.1016/j.immuni.2012.07.012; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Jacob A, 2013, J CELL SCI, V126, P4647, DOI 10.1242/jcs.126573; Kawamura N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2069; Kean MJ, 2009, J CELL SCI, V122, P4089, DOI 10.1242/jcs.052761; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Liu JL, 2009, MOL BIOL CELL, V20, P3763, DOI 10.1091/mbc.E08-09-0967; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; Mattila PE, 2012, TRAFFIC, V13, P433, DOI 10.1111/j.1600-0854.2011.01315.x; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; Nakatsu Y, 2013, J VIROL, V87, P4683, DOI 10.1128/JVI.02189-12; Nishimura N, 2002, P NATL ACAD SCI USA, V99, P6755, DOI 10.1073/pnas.092150699; Oehlke O, 2011, J CELL PHYSIOL, V226, P638, DOI 10.1002/jcp.22388; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Reefman E, 2010, J IMMUNOL, V184, P4852, DOI 10.4049/jimmunol.0803954; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; RudolphOwen LA, 1997, ENDOCRINOLOGY, V138, P4902, DOI 10.1210/en.138.11.4902; Sakamori R, 2014, CANCER RES, V74, P5480, DOI 10.1158/0008-5472.CAN-14-0267; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Sato T, 2014, J CELL SCI, V127, P422, DOI 10.1242/jcs.136903; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Schroder HM, 2013, INT J BIOCHEM CELL B, V45, P1133, DOI 10.1016/j.biocel.2013.02.020; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Solis GP, 2013, MOL BIOL CELL, V24, P2689, DOI 10.1091/mbc.E12-12-0854; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stanley AC, 2012, J LEUKOCYTE BIOL, V92, P1227, DOI 10.1189/jlb.0412191; Stanton JL, 2002, MOL HUM REPROD, V8, P149, DOI 10.1093/molehr/8.2.149; Staun-Ram E, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-56; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Steffen A, 2008, CURR BIOL, V18, P926, DOI 10.1016/j.cub.2008.05.044; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; van Mourik MSM, 2009, J LEUKOCYTE BIOL, V85, P4, DOI 10.1189/jlb.0708395; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang XY, 2000, J BIOL CHEM, V275, P29138, DOI 10.1074/jbc.M004410200; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004; Wiesner C, 2013, J CELL SCI, V126, P2820, DOI 10.1242/jcs.122358; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Xia S, 2004, P NATL ACAD SCI USA, V101, P15207, DOI 10.1073/pnas.0406571101; Yu SY, 2014, EMBO J, V33, P1882, DOI 10.15252/embj.201487888; Zlatkine P, 1997, J CELL SCI, V110, P673	76	26	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32030	32043		10.1074/jbc.M113.538223	http://dx.doi.org/10.1074/jbc.M113.538223			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25271168	Green Published, hybrid			2022-12-28	WOS:000345314700032
J	Benilova, I; Gallardo, R; Ungureanu, AA; Cano, VC; Snellinx, A; Ramakers, M; Bartic, C; Rousseau, F; Schymkowitz, J; De Strooper, B				Benilova, Iryna; Gallardo, Rodrigo; Ungureanu, Andreea-Alexandra; Cano, Virginia Castillo; Snellinx, An; Ramakers, Meine; Bartic, Carmen; Rousseau, Frederic; Schymkowitz, Joost; De Strooper, Bart			The Alzheimer Disease Protective Mutation A2T Modulates Kinetic and Thermodynamic Properties of Amyloid-beta (A beta) Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEIN GENE; APP GENE; HIPPOCAMPAL-NEURONS; FIBRILLAR OLIGOMERS; PATHOGENIC MUTATION; TOTTORI D7N; ENGLISH H6R; N-TERMINUS; PEPTIDE; AMYLOIDOGENESIS	Missense mutations in alanine 673 of the amyloid precursor protein (APP), which corresponds to the second alanine of the amyloid beta (A beta) sequence, have dramatic impact on the risk for Alzheimer disease; A2V is causative, and A2T is protective. Assuming a crucial role of amyloid-A beta in neurodegeneration, we hypothesized that both A2V and A2T mutations cause distinct changes in A beta properties that may at least partially explain these completely different phenotypes. Using human APP-overexpressing primary neurons, we observed significantly decreased A beta production in the A2T mutant along with an enhanced A beta generation in the A2V mutant confirming earlier data from non-neuronal cell lines. More importantly, thioflavin T fluorescence assays revealed that the mutations, while having little effect on A beta 42 peptide aggregation, dramatically change the properties of the A beta 40 pool with A2V accelerating and A2T delaying aggregation of the A beta peptides. In line with the kinetic data, A beta A2T demonstrated an increase in the solubility at equilibrium, an effect that was also observed in all mixtures of the A2T mutant with the wild type A beta 40. We propose that in addition to the reduced beta-secretase cleavage of APP, the impaired propensity to aggregate may be part of the protective effect conferred by A2T substitution. The interpretation of the protective effect of this mutation is thus much more complicated than proposed previously.	[Benilova, Iryna; Snellinx, An; De Strooper, Bart] Univ Leuven, VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [Benilova, Iryna; Snellinx, An; De Strooper, Bart] Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Benilova, Iryna; Snellinx, An; De Strooper, Bart] Univ Leuven, Leuven Inst Neurodegenerat Dis, B-3000 Louvain, Belgium; [Gallardo, Rodrigo; Cano, Virginia Castillo; Ramakers, Meine; Rousseau, Frederic; Schymkowitz, Joost] Univ Leuven, VIB Switch Lab, B-3000 Louvain, Belgium; [Gallardo, Rodrigo; Cano, Virginia Castillo; Ramakers, Meine; Rousseau, Frederic; Schymkowitz, Joost] Univ Leuven, SWITCH Lab, Dept Cellular & Mol Med, B-3000 Louvain, Belgium; [Ungureanu, Andreea-Alexandra; Bartic, Carmen] Univ Leuven, Lab Solid State Phys & Magnetism, B-3000 Louvain, Belgium; [Ungureanu, Andreea-Alexandra; Bartic, Carmen] IMEC, B-3001 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; IMEC	De Strooper, B (corresponding author), Univ Leuven, Ctr Human Genet, VIB Ctr Biol Dis, Herestr 49,Box 602, B-3000 Louvain, Belgium.	bart.destrooper@cme.vib-kuleuven.be	Bartic, Carmen/I-1310-2013; Rousseau, Frederic/J-9044-2016; Schymkowitz, Joost/AAV-3680-2021; Benilova, Iryna/H-6533-2019; de+Strooper, Bart/Z-1638-2019; Bartic, Carmen/AAA-6514-2022; Schymkowitz, Joost/K-7764-2016	Rousseau, Frederic/0000-0002-9189-7399; Bartic, Carmen/0000-0001-9577-2844; Ramakers, Meine/0000-0002-9417-4196; Gallardo, Rodrigo/0000-0003-1584-3564; Schymkowitz, Joost/0000-0003-2020-0168	VIB; University of Leuven; Funds for Scientific Research Flanders; Flanders Institute for Science and Technology; Federal Office for Scientific Affairs of Belgium (Belspo) [P7/16]; KULeuven/Flemish Government	VIB; University of Leuven(KU Leuven); Funds for Scientific Research Flanders; Flanders Institute for Science and Technology; Federal Office for Scientific Affairs of Belgium (Belspo); KULeuven/Flemish Government(KU Leuven)	This work was supported by grants from VIB, University of Leuven, Funds for Scientific Research Flanders, Flanders Institute for Science and Technology, and the Federal Office for Scientific Affairs of Belgium (Belspo), Grant IUAP P7/16, and a Methusalem grant of the KULeuven/Flemish Government (to B. D. S.), and part of this work was done in the frame of ERA-NET NEURON "A beta ID."	Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Broersen K, 2011, PROTEIN ENG DES SEL, V24, P743, DOI 10.1093/protein/gzr020; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Christopeit T, 2005, PROTEIN SCI, V14, P2125, DOI 10.1110/ps.051470405; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Strooper B, 2012, NATURE, V488, P38, DOI 10.1038/488038a; DESTROOPER B, 1995, EMBO J, V14, P4932, DOI 10.1002/j.1460-2075.1995.tb00176.x; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Dubnovitsky A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066101; Eckman CB, 1997, HUM MOL GENET, V6, P2087, DOI 10.1093/hmg/6.12.2087; Giaccone G, 2010, ACTA NEUROPATHOL, V120, P803, DOI 10.1007/s00401-010-0747-1; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Golde TE, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt178; Hardy J, 2014, J INTERN MED, V275, P296, DOI 10.1111/joim.12192; Hashimoto Y, 2014, J NEUROCHEM, V130, P291, DOI 10.1111/jnc.12717; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Hortschansky P, 2005, PROTEIN SCI, V14, P2915, DOI 10.1110/ps.051585905; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kero M, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.09.017; Kim W, 2008, J MOL BIOL, V377, P565, DOI 10.1016/j.jmb.2007.12.079; Kulic L, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.109; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lin SY, 2003, INT J BIOL MACROMOL, V32, P173, DOI 10.1016/S0141-8130(03)00051-5; Meinhardt J, 2007, PROTEIN SCI, V16, P1214, DOI 10.1110/ps.062734207; Miles LA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01302; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Murakami K, 2010, GERIATR GERONTOL INT, V10, pS169, DOI 10.1111/j.1447-0594.2010.00598.x; Ono K, 2010, J BIOL CHEM, V285, P23184, DOI 10.1074/jbc.M109.086496; PEACOCK ML, 1993, NEUROLOGY, V43, P1254, DOI 10.1212/WNL.43.6.1254; Qahwash I, 2003, J BIOL CHEM, V278, P23187, DOI 10.1074/jbc.M213298200; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Teplow DB, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt203; Vandersteen A, 2012, J BIOL CHEM, V287, P36732, DOI 10.1074/jbc.M112.394635; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Zhou L, 2011, EMBO MOL MED, V3, P291, DOI 10.1002/emmm.201100138	45	116	116	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					30977	30989		10.1074/jbc.M114.599027	http://dx.doi.org/10.1074/jbc.M114.599027			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25253695	hybrid, Green Published			2022-12-28	WOS:000344549900009
J	Ziani, W; Maillard, AP; Petit-Hartlein, I; Garnier, N; Crouzy, S; Girard, E; Coves, J				Ziani, Widade; Maillard, Antoine P.; Petit-Haertlein, Isabelle; Garnier, Norbert; Crouzy, Serge; Girard, Eric; Coves, Jacques			The X-ray Structure of NccX from Cupriavidus metallidurans 31A Illustrates Potential Dangers of Detergent Solubilization When Generating and Interpreting Crystal Structures of Membrane Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICKEL RESISTANCE DETERMINANT; HELIX-HELIX INTERACTIONS; MONOAMINE-OXIDASE-A; FORCE-FIELD; CNR COBALT; GXXXG; DOMAIN; DIMERIZATION; ASSOCIATION; SIMULATION	The x-ray structure of NccX, a type II transmembrane metal sensor, from Cupriavidus metallidurans 31A has been determined at a resolution of 3.12 angstrom. This was achieved after solubilization by dodecylphosphocholine and purification in the presence of the detergent. NccX crystal structure did not match the model based on the extensively characterized periplasmic domain of its closest homologue CnrX. Instead, the periplasmic domains of NccX appeared collapsed against the hydrophobic transmembrane segments, leading to an aberrant topology incompatible with membrane insertion. This was explained by a detergent-induced redistribution of the hydrophobic interactions among the transmembrane helices and a pair of hydrophobic patches keeping the periplasmic domains together in the native duller. Molecular dynamics simulations performed with the full-length protein or with the transmembrane segments were used along with in vivo homodimerization assays (TOXCAT) to evaluate the determinants of the interactions between NccX protomers. Taken as a whole, computational and experimental results are in agreement with the structural model of CnrX where a cradle-shaped periplasmic metal sensor domain is anchored into the inner membrane by two N-terminal helices. In addition, they show that the main determinant of NccX dimerization is the periplasmic soluble domain and that the interaction between transmembrane segments is highly dynamic. The present work introduces a new crystal structure for a transmembrane protein and, in line with previous studies, substantiates the use of complementary theoretical and in vivo investigations to rationalize a three-dimensional structure obtained in non-native conditions.	[Ziani, Widade; Maillard, Antoine P.; Petit-Haertlein, Isabelle; Girard, Eric; Coves, Jacques] Univ Grenoble Alpes, CEA, UMR CNRS 5075, Inst Biol Struct, F-38044 Grenoble 9, France; [Garnier, Norbert] Univ Orleans, CNRS UPR4301, Ctr Biophys Mol, F-45071 Orleans 2, France; [Crouzy, Serge] CEA Grenoble, UMR 5249, Lab Chim & Biol Metaux, F-38054 Grenoble 09, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; CEA	Coves, J (corresponding author), Inst Biol Struct, Campus EPN,CS 10090,71 Ave Martyrs, F-38044 Grenoble 9, France.	jacques.coves@ibs.fr	Maillard, Antoine/C-5236-2013	Maillard, Antoine/0000-0002-3658-041X; Garnier, Norbert/0000-0003-1941-1814; Girard, Eric/0000-0002-5758-6095	NIGMS, National Institutes of Health [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Eve de Rosny, Juliette Trepreau, and Adeline Veyret for help during the first steps of purification of NccX. We thank beamline Proxima-1 (Synchrotron SOLEIL, Gif Sur Yvette) for provision of beamtime and Pierre Legrand for data collection, structure determination, and refinement of the reported structure of NccX. We also thank Dr. P. Fuchs (Paris Diderot University) fOr providing useful Python scripts for trajectory analyses with Gromacs. Molecular graphics and analyses were performed with the UCSF Chimera package. Chimera was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (Supported by NIGMS, National Institutes of Health Grant P41-GM103311).	Aci-Seche S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097779; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Blanc E., 2011, BUSTER VERSION 2 11; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHOTHIA C, 1981, J MOL BIOL, V145, P215, DOI 10.1016/0022-2836(81)90341-7; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Cymer F, 2012, BBA-BIOMEMBRANES, V1818, P963, DOI 10.1016/j.bbamem.2011.07.035; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grass G, 2005, BIOMETALS, V18, P437, DOI 10.1007/s10534-005-3718-6; Grass G, 2000, J BACTERIOL, V182, P1390, DOI 10.1128/JB.182.5.1390-1398.2000; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janssen PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010433; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kleiger G, 2002, BIOCHEMISTRY-US, V41, P5990, DOI 10.1021/bi0200763; Lemmon M. A., 1992, BIOCHEMISTRY-US, V31, P12719; Li DF, 2013, NATURE, V497, P521, DOI 10.1038/nature12179; Ma JC, 2004, J MOL BIOL, V338, P103, DOI 10.1016/j.jmb.2004.02.032; Maillard AP, 2014, J MOL BIOL, V426, P2313, DOI 10.1016/j.jmb.2014.04.003; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melnyk RA, 2004, J BIOL CHEM, V279, P16591, DOI 10.1074/jbc.M313936200; MERGEAY M, 1985, J BACTERIOL, V162, P328, DOI 10.1128/JB.162.1.328-334.1985; Monchy S, 2007, J BACTERIOL, V189, P7417, DOI 10.1128/JB.00375-07; Monk BC, 2014, P NATL ACAD SCI USA, V111, P3865, DOI 10.1073/pnas.1324245111; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pompidor G, 2008, FEBS LETT, V582, P3954, DOI 10.1016/j.febslet.2008.10.042; Psachoulia E, 2010, ACCOUNTS CHEM RES, V43, P388, DOI 10.1021/ar900211k; Rodrigues ML, 2006, EMBO J, V25, P5951, DOI 10.1038/sj.emboj.7601439; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Son SY, 2008, P NATL ACAD SCI USA, V105, P5739, DOI 10.1073/pnas.0710626105; Tibazarwa C, 2000, J BACTERIOL, V182, P1399, DOI 10.1128/JB.182.5.1399-1409.2000; Trepreau J, 2014, METALLOMICS, V6, P263, DOI 10.1039/c3mt00248a; Trepreau J, 2011, BIOCHEMISTRY-US, V50, P9036, DOI 10.1021/bi201031q; Trepreau J, 2011, J MOL BIOL, V408, P766, DOI 10.1016/j.jmb.2011.03.014; Tulumello DV, 2012, BBA-BIOMEMBRANES, V1818, P1351, DOI 10.1016/j.bbamem.2012.01.013; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; von Rozycki T, 2009, ANTON LEEUW INT J G, V96, P115, DOI 10.1007/s10482-008-9284-5; Warschawski DE, 2011, BBA-BIOMEMBRANES, V1808, P1957, DOI 10.1016/j.bbamem.2011.03.016; Wassenaar TA, 2014, J CHEM THEORY COMPUT, V10, P676, DOI 10.1021/ct400617g; Wei P, 2011, PROTEIN SCI, V20, P1814, DOI 10.1002/pro.713; Zhou HX, 2013, ANNU REV BIOPHYS, V42, P361, DOI 10.1146/annurev-biophys-083012-130326; Zoonens M, 2013, J AM CHEM SOC, V135, P15174, DOI 10.1021/ja407424v	58	8	8	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31160	31172		10.1074/jbc.M114.586537	http://dx.doi.org/10.1074/jbc.M114.586537			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25258316	Green Published, hybrid			2022-12-28	WOS:000344549900024
J	Banerjee, R				Banerjee, Ruma			Introduction to the Thematic Minireview Series on Enzyme Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review								In this thematic minireview series, the JBC presents five provocative articles on Enzyme Evolution. The reviews discuss stimulating concepts that include the emergence of primordial catalysts at temperatures that were considerably warmer than present day ones and the impact of the cooling environment on the evolution of catalytic fitness and the preservation of catalysis-promoting conformational dynamics. They also discuss the use of Urzymes or invariant modules in enzyme superfamilies as paradigms for understanding the evolution of catalytic efficiency and specificity, the use of bioinformatics approaches to understand the roles of substrate ambiguity and catalytic promiscuity as drivers of evolution, and the challenges associated with assigning catalytic function as the number of superfamily members grows rapidly.	[Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu			National Institutes of Health [DK45776, HL58984, GM112455]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045776, R01DK045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK45776, HL58984, and GM112455 (to R. B.)	Allewell NM, 2012, J BIOL CHEM, V287, P1, DOI 10.1074/jbc.R111.307322; Brown SD, 2014, J BIOL CHEM, V289, P30221, DOI 10.1074/jbc.R114.569350; Carter CW, 2014, J BIOL CHEM, V289, P30213, DOI 10.1074/jbc.R114.567495; Klinman JP, 2014, J BIOL CHEM, V289, P30205, DOI 10.1074/jbc.R114.565515; Pandya C, 2014, J BIOL CHEM, V289, P30229, DOI 10.1074/jbc.R114.572990; Wolfenden R, 2014, J BIOL CHEM, V289, P30198, DOI 10.1074/jbc.R114.567081	6	1	1	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30196	30197		10.1074/jbc.R114.610766	http://dx.doi.org/10.1074/jbc.R114.610766			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25210045	Green Published, hybrid			2022-12-28	WOS:000344549700002
J	Martin, D; Li, Y; Yang, JY; Wang, G; Margariti, A; Jiang, ZX; Yu, H; Zampetaki, A; Hu, YH; Xu, QB; Zeng, LF				Martin, Daniel; Li, Yi; Yang, Junyao; Wang, Gang; Margariti, Andriana; Jiang, Zhixin; Yu, Hui; Zampetaki, Anna; Hu, Yanhua; Xu, Qingbo; Zeng, Lingfang			Unspliced X-box-binding Protein 1 (XBP1) Protects Endothelial Cells from Oxidative Stress through Interaction with Histone Deacetylase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; LAMINAR SHEAR-STRESS; RICTOR-MTOR COMPLEX; NF-KAPPA-B; HEME OXYGENASE-1; TRANSCRIPTION FACTOR; NF-E2-RELATED FACTOR-2; MEDIATED APOPTOSIS; DISTURBED FLOW; ACTIVATION	It is well known that atherosclerosis occurs geographically at branch points where disturbed flow predisposes to the development of plaque via triggering of oxidative stress and inflammatory reactions. In this study, we found that disturbed flow activated anti-oxidative reactions via up-regulating heme oxygenase 1 (HO-1) in an X-box-binding protein 1 (XBP1) and histone deacetylase 3 (HDAC3)-dependent manner. Disturbed flow concomitantly up-regulated the unspliced XBP1 (XBP1u) and HDAC3 in a VEGF receptor and PI3K/Akt-dependent manner. The presence of XBP1 was essential for the up-regulation of HDAC3 protein. Overexpression of XBP1u and/or HDAC3 activated Akt1 phosphorylation, Nrf2 protein stabilization and nuclear translocation, and HO-1 expression. Knockdown of XBP1u decreased the basal level and disturbed flow-induced Akt1 phosphorylation, Nrf2 stabilization, and HO-1 expression. Knockdown of HDAC3 ablated XBP1u-mediated effects. The mammalian target of rapamycin complex 2 (mTORC2) inhibitor, AZD2014, ablated XBP1u or HDAC3 or disturbed flow-mediated Akt1 phosphorylation, Nrf2 nuclear translocation, and HO-1 expression. Neither actinomycin D nor cycloheximide affected disturbed flow-induced up-regulation of Nrf2 protein. Knockdown of Nrf2 abolished XBP1u or HDAC3 or disturbed flow-induced HO-1 up-regulation. Co-immunoprecipitation assays demonstrated that XBP1u physically bound to HDAC3 and Akt1. The region of amino acids 201 to 323 of the HDAC3 protein was responsible for the binding to XBP1u. Double immunofluorescence staining revealed that the interactions between Akt1 and mTORC2, Akt1 and HDAC3, Akt1 and XBP1u, HDAC3, and XBP1u occurred in the cytosol. Thus, we demonstrate that XBP1u and HDAC3 exert a protective effect on disturbed flow-induced oxidative stress via up-regulation of mTORC2-dependent Akt1 phosphorylation and Nrf2-mediated HO-1 expression.	[Martin, Daniel; Li, Yi; Yang, Junyao; Zampetaki, Anna; Hu, Yanhua; Xu, Qingbo; Zeng, Lingfang] Kings Coll London, Cardiovasc Div, London SE5 9NU, England; [Wang, Gang] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Emergency Med, Sch Med, Xian 710004, Peoples R China; [Margariti, Andriana] Queens Univ Belfast, Ctr Med Expt, Sch Med Dent & Biomed Sci, Inst Clin Sci, Belfast BT12 6BL, Antrim, North Ireland; [Jiang, Zhixin] Peoples Liberat Army, Hosp 305, Ctr Lab, Beijing 100017, Peoples R China; [Yu, Hui] Chinese Acad Med Sci, Sino German Lab Mol Med, Key Lab Clin Cardiovasc Genet, Minist Educ,FuWai Hosp, Beijing 100037, Peoples R China	University of London; King's College London; Xi'an Jiaotong University; Queens University Belfast; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Xu, QB (corresponding author), Kings Coll London, Cardiovasc Div, London SE5 9NU, England.	qingbo.xu@kcl.ac.uk; lingfang.zeng@kcl.ac.uk	Margariti, Andriana/AAH-5318-2019	Zampetaki, Anna/0000-0002-7257-8624; Zeng, Lingfang/0000-0002-0390-4561	British Heart Foundation; Oak Foundation; National Natural Science Foundation of China [81300116]; British Heart Foundation [FS/13/18/30207, PG/12/11/29408] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Oak Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); British Heart Foundation(British Heart Foundation)	This work was supported by grants from the British Heart Foundation and the Oak Foundation and National Natural Science Foundation of China Grant 81300116.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Alam S, 2011, J BIOL CHEM, V286, P44211, DOI 10.1074/jbc.M111.242289; Ali F, 2009, J BIOL CHEM, V284, P18882, DOI 10.1074/jbc.M109.009886; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Brouard S, 2002, J BIOL CHEM, V277, P17950, DOI 10.1074/jbc.M108317200; Brunt KR, 2006, ARTERIOSCL THROM VAS, V26, P2027, DOI 10.1161/01.ATV.0000236204.37119.8d; Chen XL, 2003, J BIOL CHEM, V278, P703, DOI 10.1074/jbc.M203161200; Davies Peter F, 2010, Semin Thromb Hemost, V36, P265, DOI 10.1055/s-0030-1253449; De Keulenaer GW, 1998, CIRC RES, V82, P1094, DOI 10.1161/01.RES.82.10.1094; de la Vega L, 2012, MOL CELL, V46, P472, DOI 10.1016/j.molcel.2012.03.003; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Freidja ML, 2011, J HYPERTENS, V29, P102, DOI 10.1097/HJH.0b013e32833db36e; Guo FJ, 2014, CELL SIGNAL, V26, P332, DOI 10.1016/j.cellsig.2013.11.018; Haberzettl P, 2013, REDOX BIOL, V1, P56, DOI 10.1016/j.redox.2012.10.003; Hsieh CY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-12; Hu YH, 2003, CIRCULATION, V108, P3122, DOI 10.1161/01.CIR.0000105722.96112.67; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jazwa A, 2006, FREE RADICAL BIO MED, V40, P1250, DOI 10.1016/j.freeradbiomed.2005.11.016; Jin ZG, 2003, CIRC RES, V93, P354, DOI 10.1161/01.RES.0000089257.94002.96; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kikuchi G, 2005, BIOCHEM BIOPH RES CO, V338, P558, DOI 10.1016/j.bbrc.2005.08.020; Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781; Lin MH, 2014, TOXICOLOGY, V315, P24, DOI 10.1016/j.tox.2013.11.007; Nigro P, 2011, ANTIOXID REDOX SIGN, V15, P1405, DOI 10.1089/ars.2010.3679; Nitenberg A, 2006, DIABETES METAB, V32, p2S28, DOI 10.1016/S1262-3636(06)70482-7; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Pike KG, 2013, BIOORG MED CHEM LETT, V23, P1212, DOI 10.1016/j.bmcl.2013.01.019; Primiano T, 1997, Adv Pharmacol, V38, P293; Rojo AI, 2012, FREE RADICAL BIO MED, V52, P473, DOI 10.1016/j.freeradbiomed.2011.11.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shelton P, 2013, FASEB J, V27, P414, DOI 10.1096/fj.12-217257; SIOW RCM, 1995, FEBS LETT, V368, P239, DOI 10.1016/0014-5793(95)00650-X; Su ZY, 2014, CANCER PREV RES, V7, P319, DOI 10.1158/1940-6207.CAPR-13-0313-T; Wagner CT, 1997, J CLIN INVEST, V100, P589, DOI 10.1172/JCI119569; Warabi E, 2007, FREE RADICAL BIO MED, V42, P260, DOI 10.1016/j.freeradbiomed.2006.10.043; Wiesel P, 2000, CIRCULATION, V102, P3015, DOI 10.1161/01.cir.102.24.3015; Wilson SJ, 2003, VASC PHARMACOL, V40, P109, DOI 10.1016/S1537-1891(02)00340-3; Xiao QZ, 2006, ARTERIOSCL THROM VAS, V26, P2244, DOI 10.1161/01.ATV.0000240251.50215.50; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Zampetaki A, 2010, CIRCULATION, V121, P132, DOI 10.1161/CIRCULATIONAHA.109.890491; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zeng LF, 2013, J BIOL CHEM, V288, P31853, DOI 10.1074/jbc.M113.463745; Zeng LF, 2013, CIRCULATION, V127, P1712, DOI 10.1161/CIRCULATIONAHA.112.001337; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106	44	59	63	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30625	30634		10.1074/jbc.M114.571984	http://dx.doi.org/10.1074/jbc.M114.571984			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25190803	hybrid, Green Published			2022-12-28	WOS:000344549700039
J	Wang, HY; Jin, HN; Beauvais, DM; Rapraeger, AC				Wang, Haiyao; Jin, Haining; Beauvais, DeannaLee M.; Rapraeger, Alan C.			Cytoplasmic Domain Interactions of Syndecan-1 and Syndecan-4 with alpha 6 beta 4 Integrin Mediate Human Epidermal Growth Factor Receptor (HER1 and HER2)-dependent Motility and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE 3-OH KINASE; 6 BETA 4; ALPHA(6)BETA(4) INTEGRIN; CELL-ADHESION; KERATINOCYTE MIGRATION; CARCINOMA INVASION; ALPHA-3-BETA-1 INTEGRIN; ERBB-3 EXPRESSION; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS	Epithelial cells are highly dependent during wound healing and tumorigenesis on the alpha 6 beta 4 integrin and its association with receptor tyrosine kinases. Previous work showed that phosphorylation of the beta 4 subunit upon matrix engagement depends on the matrix receptor syndecan (Sdc)-1 engaging the cytoplasmic domain of the beta 4 integrin and coupling of the integrin to human epidermal growth factor receptor-2 (HER2). In this study, HER2-dependent migration activated by matrix engagement is compared with migration stimulated by EGF. We find that whereas HER2-dependent migration depends on Sdc1, EGF-dependent migration depends on a complex consisting of human epidermal growth factor receptor-1 (HER1, commonly known as EGFR), alpha 6 beta 4, and Sdc4. The two syndecans recognize distinct sites at the extreme C terminus of the beta 4 integrin cytoplasmic domain. The binding motif in Sdc1 is QEEXYX, composed in part by its syndecan-specific variable (V) region and in part by the second conserved (C2) region that it shares with other syndecans. A cell-penetrating peptide containing this sequence competes for HER2-dependent epithelial migration and carcinoma survival, although it is without effect on the EGFR-stimulated mechanism. beta 4 mutants bearing mutations specific for Sdc1 and Sdc4 recognition act as dominant negative mutants to block cell spreading or cell migration that depends on HER2 or EGFR, respectively. The interaction of the alpha 6 beta 4 integrin with the syndecans appears critical for it to be utilized as a signaling platform; migration depends on alpha 3 beta 1 integrin binding to laminin 332 (LN332; also known as laminin 5), whereas antibodies that block alpha 6 beta 4 binding are without effect. These findings indicate that specific syndecan family members are likely to have key roles in alpha 6 beta 4 integrin activation by receptor tyrosine kinases.	[Wang, Haiyao; Jin, Haining; Beauvais, DeannaLee M.; Rapraeger, Alan C.] Univ Wisconsin, Dept Human Oncol, Madison, WI 53705 USA; [Rapraeger, Alan C.] Univ Wisconsin, Wisconsin Inst Med Res, Carbone Canc Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Rapraeger, AC (corresponding author), Wisconsin Inst Med Res, 1111 Highland Ave, Madison, WI 53705 USA.	rapraeger@humonc.wisc.edu			National Institutes of Health from NCI [P30 CA014520]; NATIONAL CANCER INSTITUTE [R01CA163662, P30CA014520, R01CA109010] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the University of Wisconsin Carbone Cancer Center for the use of its shared services, supported by National Institutes of Health Grant P30 CA014520 from NCI.	Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Amin DN, 2006, CANCER RES, V66, P2173, DOI 10.1158/0008-5472.CAN-05-3387; Araki E, 2009, MOL BIOL CELL, V20, P3012, DOI 10.1091/mbc.E08-09-0977; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Bachy S, 2008, J CELL PHYSIOL, V214, P238, DOI 10.1002/jcp.21184; Bertotti A, 2006, J CELL BIOL, V175, P993, DOI 10.1083/jcb.200605114; Bon G, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1651; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Bruns CJ, 2000, CANCER RES, V60, P2926; Byron A, 2009, J CELL SCI, V122, P4009, DOI 10.1242/jcs.056770; Carulli S, 2012, J BIOL CHEM, V287, P12204, DOI 10.1074/jbc.M111.300061; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; de Pereda JM, 2009, EMBO J, V28, P1180, DOI 10.1038/emboj.2009.48; Dutta U, 2008, CANCER RES, V68, P8779, DOI 10.1158/0008-5472.CAN-08-2125; Egles C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010528; ELENIUS K, 1991, J CELL BIOL, V114, P585, DOI 10.1083/jcb.114.3.585; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Folgiero V, 2007, CANCER RES, V67, P1645, DOI 10.1158/0008-5472.CAN-06-2980; Folgiero V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001592; Frijns E, 2012, MOL BIOL CELL, V23, P1475, DOI 10.1091/mbc.E11-11-0957; Frijns E, 2010, J BIOL CHEM, V285, P37650, DOI 10.1074/jbc.M110.138818; Gambaletta D, 2000, J BIOL CHEM, V275, P10604, DOI 10.1074/jbc.275.14.10604; Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417; Germain EC, 2009, MOL BIOL CELL, V20, P56, DOI 10.1091/mbc.E08-06-0646; Giancotti FG, 2007, TRENDS PHARMACOL SCI, V28, P506, DOI 10.1016/j.tips.2007.08.004; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Goldfinger LE, 1998, J CELL BIOL, V141, P255, DOI 10.1083/jcb.141.1.255; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hopkinson SB, 2000, MOL BIOL CELL, V11, P277, DOI 10.1091/mbc.11.1.277; Jourquin J, 2006, J CELL PHYSIOL, V206, P337, DOI 10.1002/jcp.20470; Kedar D, 2002, CLIN CANCER RES, V8, P3592; Koster J, 2004, MOL BIOL CELL, V15, P1211, DOI 10.1091/mbc.E03-09-0697; Lee D, 1998, J BIOL CHEM, V273, P13022, DOI 10.1074/jbc.273.21.13022; Liu X, 2013, STRUCTURE, V21, P342, DOI 10.1016/j.str.2013.01.004; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; Mainiero F, 1996, J CELL BIOL, V134, P241, DOI 10.1083/jcb.134.1.241; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Merdek KD, 2007, J BIOL CHEM, V282, P30322, DOI 10.1074/jbc.M703156200; Niessen CM, 1997, MOL BIOL CELL, V8, P555, DOI 10.1091/mbc.8.4.555; Nievers MG, 1999, MATRIX BIOL, V18, P5, DOI 10.1016/S0945-053X(98)00003-1; Nikolopoulos SN, 2004, CANCER CELL, V6, P471, DOI 10.1016/j.ccr.2004.09.029; O'Connor KL, 2012, AM J PHYSIOL-CELL PH, V302, pC605, DOI 10.1152/ajpcell.00095.2011; O'Connor KL, 1998, J CELL BIOL, V143, P1749, DOI 10.1083/jcb.143.6.1749; Ogawa T, 2007, MOL BIOL CELL, V18, P1621, DOI 10.1091/mbc.E06-09-0806; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Okamoto O, 2003, J BIOL CHEM, V278, P44168, DOI 10.1074/jbc.M300726200; OrianRousseau V, 1996, DEV DYNAM, V206, P12, DOI 10.1002/(SICI)1097-0177(199605)206:1<12::AID-AJA2>3.0.CO;2-3; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; Rezniczek GA, 1998, J CELL BIOL, V141, P209, DOI 10.1083/jcb.141.1.209; ROUSSELLE P, 1994, J CELL BIOL, V125, P205, DOI 10.1083/jcb.125.1.205; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Saito Y, 2007, J BIOL CHEM, V282, P34929, DOI 10.1074/jbc.M705608200; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Shaw LM, 2001, MOL CELL BIOL, V21, P5082, DOI 10.1128/MCB.21.15.5082-5093.2001; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Shepherd TR, 2010, J MOL BIOL, V398, P730, DOI 10.1016/j.jmb.2010.03.047; Sulka B, 2009, J BIOL CHEM, V284, P10659, DOI 10.1074/jbc.M807643200; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Tsuruta D, 2008, CURR MED CHEM, V15, P1968, DOI 10.2174/092986708785132834; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Wang HY, 2010, J BIOL CHEM, V285, P13569, DOI 10.1074/jbc.M110.102137; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Wilhelmsen K, 2006, MOL CELL BIOL, V26, P2877, DOI 10.1128/MCB.26.8.2877-2886.2006; Wilhelmsen K, 2007, MOL BIOL CELL, V18, P3512, DOI 10.1091/mbc.E07-04-0306; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607; Woods A, 1998, TRENDS CELL BIOL, V8, P189, DOI 10.1016/S0962-8924(98)01244-6; Yamashita H, 2010, J ONCOL, V2010, DOI 10.1155/2010/107075; Yang XQ, 2010, MOL CELL BIOL, V30, P5306, DOI 10.1128/MCB.00326-10; Yoshioka T, 2013, J CLIN INVEST, V123, P682, DOI 10.1172/JCI60720; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	76	48	49	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30318	30332		10.1074/jbc.M114.586438	http://dx.doi.org/10.1074/jbc.M114.586438			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25202019	Green Published, hybrid			2022-12-28	WOS:000344549700015
J	Mallari, JP; Oksman, A; Vaupel, B; Goldberg, DE				Mallari, Jeremy P.; Oksman, Anna; Vaupel, Barbara; Goldberg, Daniel E.			Kinase-associated Endopeptidase 1 (Kae1) Participates in an Atypical Ribosome-associated Complex in the Apicoplast of Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Malaria; Nucleic Acid; Protein-Protein Interaction; Ribosome; Transfer RNA (tRNA)	KEOPS COMPLEX; T(6)A; BIOSYNTHESIS; PROTEINS; TRANSFORMATION; GLYCOPROTEASE; EXPRESSION; SEQUENCE; CLONING; DNA	Background: Kae1 proteins are universally conserved and are regulated by a variety of protein-protein interactions. Results:P. falciparum expresses two Kae1 proteins with distinct localizations and atypical binding partners. Conclusion: Kae1(api) is essential and a potential regulator of ribosome activity. Significance: The Kae1 protein family likely has an expanded role outside of its known tRNA-modifying activity. The universally conserved kinase-associated endopeptidase 1 (Kae1) protein family has established roles in N-6-threonylcarbamoyl adenosine tRNA modification, transcriptional regulation, and telomere homeostasis. These functions are performed in complex with a conserved core of protein binding partners. Herein we describe the localization, essentiality, and protein-protein interactions for Kae1 in the human malaria parasite Plasmodium falciparum. We found that the parasite expresses one Kae1 protein in the cytoplasm and a second protein in the apicoplast, a chloroplast remnant organelle involved in fatty acid, heme, and isoprenoid biosynthesis. To analyze the protein interaction networks for both Kae1 pathways, we developed a new proteomic cross-validation approach. This strategy compares immunoprecipitation-MS data sets across different cellular compartments to enrich for biologically relevant protein interactions. Our results show that cytoplasmic Kae1 forms a complex with Bud32 and Cgi121 as in other organisms, whereas apicoplast Kae1 makes novel interactions with multiple proteins in the apicoplast. Quantitative RT-PCR and immunoprecipitation studies indicate that apicoplast Kae1 and its partners interact specifically with the apicoplast ribosomes and with proteins involved in ribosome function. Together, these data indicate an expanded, apicoplast-specific role for Kae1 in the parasite.	Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Goldberg, DE (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, Campus Box 8230,660 S Euclid Ave, St Louis, MO 63110 USA.	dgoldberg@wustl.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007172] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ABDULLAH KM, 1992, INFECT IMMUN, V60, P56, DOI 10.1128/IAI.60.1.56-62.1992; ABDULLAH KM, 1991, J BACTERIOL, V173, P5597, DOI 10.1128/jb.173.18.5597-5603.1991; Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Bender A, 2003, MOL BIOCHEM PARASIT, V132, P59, DOI 10.1016/j.molbiopara.2003.07.001; Daugeron MC, 2011, NUCLEIC ACIDS RES, V39, P6148, DOI 10.1093/nar/gkr178; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Deutsch C, 2012, J BIOL CHEM, V287, P13666, DOI 10.1074/jbc.M112.344028; Downey M, 2006, CELL, V124, P1155, DOI 10.1016/j.cell.2005.12.044; El Yacoubi B, 2011, EMBO J, V30, P882, DOI 10.1038/emboj.2010.363; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Ganesan SM, 2011, MOL BIOCHEM PARASIT, V177, P29, DOI 10.1016/j.molbiopara.2011.01.004; Grieshaber NA, 2004, P NATL ACAD SCI USA, V101, P7451, DOI 10.1073/pnas.0400754101; Handford JI, 2009, J BACTERIOL, V191, P4732, DOI 10.1128/JB.00136-09; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kisseleva-Romanova E, 2006, EMBO J, V25, P3576, DOI 10.1038/sj.emboj.7601235; Lauhon CT, 2012, BIOCHEMISTRY-US, V51, P8950, DOI 10.1021/bi301233d; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Mao DYL, 2008, MOL CELL, V32, P259, DOI 10.1016/j.molcel.2008.10.002; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Perrochia L, 2013, NUCLEIC ACIDS RES, V41, P9484, DOI 10.1093/nar/gkt720; Perrochia L, 2013, NUCLEIC ACIDS RES, V41, P1953, DOI 10.1093/nar/gks1287; Rodgers JT, 2000, ANAL BIOCHEM, V277, P254, DOI 10.1006/abio.1999.4394; Srinivasan M, 2011, EMBO J, V30, P873, DOI 10.1038/emboj.2010.343; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Wan LCK, 2013, NUCLEIC ACIDS RES, V41, P6332, DOI 10.1093/nar/gkt322; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138; YOSHIKAWA A, 1987, MOL GEN GENET, V209, P481, DOI 10.1007/BF00331153; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	31	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					30025	30039		10.1074/jbc.M114.586735	http://dx.doi.org/10.1074/jbc.M114.586735			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25204654	Green Published, hybrid			2022-12-28	WOS:000344370800043
J	Stott, K; Watson, M; Bostock, MJ; Mortensen, SA; Travers, A; Grasser, KD; Thomas, JO				Stott, Katherine; Watson, Matthew; Bostock, Mark J.; Mortensen, Simon A.; Travers, Andrew; Grasser, Klaus D.; Thomas, Jean O.			Structural Insights into the Mechanism of Negative Regulation of Single-box High Mobility Group Proteins by the Acidic Tail Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin; Intrinsically Disordered Protein; Nuclear Magnetic Resonance (NMR); Phosphorylation; Protein Kinase C (PKC); HMGB Protein; Acidic Regulatory Domain; Casein Kinase 2 (CK2); Paramagnetic Relaxation Enhancement; Protein Kinase C	DNA-BINDING PROPERTIES; GROUP CHROMOSOMAL-PROTEINS; TRANSCRIPTION FACTOR DOF2; TANDEM HMG BOXES; HISTONE H1; NMR-SPECTROSCOPY; DROSOPHILA-MELANOGASTER; REGIONS FLANKING; KINASE CK2; CHROMATIN	Background: HMG-box proteins bind and bend DNA, regulated by their acidic C-terminal tails. Results: The acidic tails of HMG-D (Drosophila) and ZmHMGB1 (maize) occlude the DNA-binding regions; the strength of the interaction is phosphorylation-dependent. Conclusion: Phosphorylation provides an additional mode of negative regulation. Significance: Phosphorylation of the tails of insect and plant HMG-box proteins may modulate chromatin structure and accessibility. The Drosophila and plant (maize) functional counterparts of the abundant vertebrate chromosomal protein HMGB1 (HMG-D and ZmHMGB1, respectively) differ from HMGB1 in having a single HMG box, as well as basic and acidic flanking regions that vary greatly in length and charge. We show that despite these variations, HMG-D and ZmHMGB1 exist in dynamic assemblies in which the basic HMG boxes and linkers associate with their intrinsically disordered, predominantly acidic, tails in a manner analogous to that observed previously for HMGB1. The DNA-binding surfaces of the boxes and linkers are occluded in auto-inhibited forms of the protein, which are in equilibrium with transient, more open structures that are binding-competent. This strongly suggests that the mechanism of auto-inhibition may be a general one. HMG-D and ZmHMGB1 differ from HMGB1 in having phosphorylation sites in their tail and linker regions. In both cases, in vitro phosphorylation of serine residues within the acidic tail stabilizes the assembled form, suggesting another level of regulation for interaction with DNA, chromatin, and other proteins that is not possible for the uniformly acidic (hence unphosphorylatable) tail of HMGB1.	[Stott, Katherine; Watson, Matthew; Bostock, Mark J.; Travers, Andrew; Thomas, Jean O.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Mortensen, Simon A.; Grasser, Klaus D.] Univ Regensburg, Biochem Zentrum Regensburg, Dept Cell Biol & Plant Biochem, D-93053 Regensburg, Germany	University of Cambridge; University of Regensburg	Thomas, JO (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	jot1@cam.ac.uk		Bostock, Mark John/0000-0001-6717-5786; Mortensen, Simon Arnold/0000-0001-9013-1802; Stott, Katherine/0000-0002-4014-1188	Biotechnology and Biological Sciences Research Council [BB/D002257/1]; Deutsche Forschungsgemeinschaft (DFG)	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Biotechnology and Biological Sciences Research Council through the award of Grant BB/D002257/1 (to J.O.T.) and a grant from the Deutsche Forschungsgemeinschaft (DFG) (to K.D.G.).	Agresti A, 2003, CURR OPIN GENET DEV, V13, P170, DOI 10.1016/S0959-437X(03)00023-6; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BERLINER LJ, 1982, ANAL BIOCHEM, V119, P450, DOI 10.1016/0003-2697(82)90612-1; BRADBURY EM, 1974, NATURE, V249, P553, DOI 10.1038/249553a0; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Cato L, 2008, J MOL BIOL, V384, P1262, DOI 10.1016/j.jmb.2008.10.001; Cavanagh J., 1996, PROTEIN NMR SPECTROS, P447; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dow LK, 2000, BIOCHEMISTRY-US, V39, P9725, DOI 10.1021/bi000723v; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Grasser KD, 1998, TRENDS PLANT SCI, V3, P260, DOI 10.1016/S1360-1385(98)01259-X; Grasser KD, 1998, EUR J BIOCHEM, V253, P787, DOI 10.1046/j.1432-1327.1998.2530787.x; Grasser M, 2007, BIOCHEMISTRY-US, V46, P6375, DOI 10.1021/bi6024947; Hardman CH, 1995, BIOCHEMISTRY-US, V34, P16596, DOI 10.1021/bi00051a007; HILL CS, 1991, EMBO J, V10, P1939, DOI 10.1002/j.1460-2075.1991.tb07720.x; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; JONES DNM, 1994, STRUCTURE, V2, P609, DOI 10.1016/S0969-2126(00)00063-0; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Krohn NM, 2002, J BIOL CHEM, V277, P32438, DOI 10.1074/jbc.M203814200; Lee KB, 2000, J MOL BIOL, V304, P135, DOI 10.1006/jmbi.2000.4206; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Murphy FV, 1999, EMBO J, V18, P6610, DOI 10.1093/emboj/18.23.6610; NER SS, 1994, EMBO J, V13, P1817, DOI 10.1002/j.1460-2075.1994.tb06450.x; Ner SS, 2001, J BIOL CHEM, V276, P37569, DOI 10.1074/jbc.M105635200; Payet D, 1997, J MOL BIOL, V266, P66, DOI 10.1006/jmbi.1996.0782; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Pedersen DS, 2010, PLANT PHYSIOL, V154, P1831, DOI 10.1104/pp.110.163055; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; POCCIA D, 1989, Molecular Reproduction and Development, V1, P219, DOI 10.1002/mrd.1080010310; Ragab A, 2003, NUCLEIC ACIDS RES, V31, P7083, DOI 10.1093/nar/gkg923; Ritt C, 1998, BIOCHEMISTRY-US, V37, P2673, DOI 10.1021/bi972620r; Roque A, 2008, NUCLEIC ACIDS RES, V36, P4719, DOI 10.1093/nar/gkn440; Stemmer C, 2003, BIOCHEMISTRY-US, V42, P3503, DOI 10.1021/bi027350d; Stemmer C, 2002, J BIOL CHEM, V277, P1092, DOI 10.1074/jbc.M109503200; Stott K, 2006, J MOL BIOL, V360, P90, DOI 10.1016/j.jmb.2006.04.059; Stott K, 2010, J MOL BIOL, V403, P706, DOI 10.1016/j.jmb.2010.07.045; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; Stros M, 1998, J BIOL CHEM, V273, P10355; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; SUNG MT, 1977, BIOCHEMISTRY-US, V16, P286, DOI 10.1021/bi00621a020; SUNG MT, 1977, BIOCHEMISTRY-US, V16, P279, DOI 10.1021/bi00621a019; TEO SH, 1995, EUR J BIOCHEM, V230, P943, DOI 10.1111/j.1432-1033.1995.tb20640.x; Thomas JO, 2012, BIOCHEM SOC T, V40, P341, DOI 10.1042/BST20120014; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Thomsen MS, 2004, BIOCHEMISTRY-US, V43, P8029, DOI 10.1021/bi0499009; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Travers AA, 2003, EMBO REP, V4, P131, DOI 10.1038/sj.embor.embor741; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Watson M, 2007, J MOL BIOL, V374, P1286, DOI 10.1016/j.jmb.2007.09.075; Watson M, 2014, NUCLEIC ACIDS RES, V42, P848, DOI 10.1093/nar/gkt950; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; Winiewski J., 1999, J BIOL CHEM, V274, P20116; Winiewski J. R., 1994, EUR J BIOCHEM, V225, P687; Winiewski J. R., 1994, J BIOL CHEM, V269, P10713; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	58	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29817	29826		10.1074/jbc.M114.591115	http://dx.doi.org/10.1074/jbc.M114.591115			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25190813	Green Published, hybrid			2022-12-28	WOS:000344370800027
J	Tigno-Aranjuez, JT; Benderitter, P; Rombouts, F; Deroose, F; Bai, XD; Mattioli, B; Cominelli, F; Pizarro, TT; Hoflack, J; Abbott, DW				Tigno-Aranjuez, Justine T.; Benderitter, Pascal; Rombouts, Frederik; Deroose, Frederik; Bai, XiaoDong; Mattioli, Benedetta; Cominelli, Fabio; Pizarro, Theresa T.; Hoflack, Jan; Abbott, Derek W.			In Vivo Inhibition of RIPK2 Kinase Alleviates Inflammatory Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitor; Immunology; Innate Immunity; Nod-like Receptor (NLR); Signal Transduction; Dual Specificity Kinase	FACTOR-KAPPA-B; OLIGOMERIZATION DOMAIN 2; CROHNS-DISEASE; CELLULAR TARGETS; MURINE MODEL; NOD2; ACTIVATION; MUTATION; SUSCEPTIBILITY; RECOGNITION	Background: Overactive signaling through NLRs is associated with inflammatory disease. Results:In vivo inhibition of RIPK2 alleviates inflammation in two inflammatory disease models: an acute peritonitis model and a spontaneous CD-like ileitis model. Conclusion: Inhibition of RIPK2 may be beneficial in certain inflammatory states. Significance: This work supports further development of RIPK2-targeted therapies as well as proposes biomarkers to guide treatment. The RIPK2 kinase transduces signaling downstream of the intracellular peptidoglycan sensors NOD1 and NOD2 to promote a productive inflammatory response. However, excessive NOD2 signaling has been associated with numerous diseases, including inflammatory bowel disease (IBD), sarcoidosis and inflammatory arthritis, making pharmacologic inhibition of RIPK2 an appealing strategy. In this work, we report the generation, identification, and evaluation of novel RIPK2 specific inhibitors. These compounds potently inhibit the RIPK2 tyrosine kinase activity in in vitro biochemical assays and cellular assays, as well as effectively reduce RIPK2-mediated effects in an in vivo peritonitis model. In conjunction with the development of these inhibitors, we have also defined a panel of genes whose expression is regulated by RIPK2 kinase activity. Such RIPK2 activation markers may serve as a useful tool for predicting settings likely to benefit from RIPK2 inhibition. Using these markers and the FDA-approved RIPK2 inhibitor Gefitinib, we show that pharmacologic RIPK2 inhibition drastically improves disease in a spontaneous model of Crohn Disease-like ileitis. Furthermore, using novel RIPK2-specific inhibitors, we show that cellular recruitment is inhibited in an in vivo peritonitis model. Altogether, the data presented in this work provides a strong rationale for further development and optimization of RIPK2-targeted pharmaceuticals and diagnostics.	[Tigno-Aranjuez, Justine T.; Mattioli, Benedetta; Cominelli, Fabio; Pizarro, Theresa T.; Abbott, Derek W.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Benderitter, Pascal; Hoflack, Jan] Oncodesign SA, F-21076 Dijon, France; [Rombouts, Frederik] Janssen Res & Dev, B-2340 Beerse, Belgium; [Deroose, Frederik] Asclepia Outsourcing Solut, B-9070 Destelbergen, Belgium; [Bai, XiaoDong] Case Western Reserve Univ, RNA Ctr, Cleveland, OH 44106 USA; [Cominelli, Fabio] Univ Hosp Cleveland, Dept Med, Div Gastroenterol, Cleveland, OH 44106 USA	Case Western Reserve University; Johnson & Johnson; Janssen Pharmaceuticals; Case Western Reserve University; University Hospitals of Cleveland	Abbott, DW (corresponding author), Case Western Reserve Univ, Dept Pathol, Room 6533 Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	dwa4@case.edu		Abbott, Derek/0000-0003-4387-8094; Tigno-Aranjuez, Justine/0000-0002-6843-7490; MATTIOLI, Benedetta/0000-0003-4270-245X	Burroughs Wellcome Career Award; American Cancer Society [PF-11-058-01-MPC, K99 HL122365-01];  [R01 GM086550];  [P01 DK091222]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL122365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK091222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086550] Funding Source: NIH RePORTER	Burroughs Wellcome Career Award(Burroughs Wellcome Fund); American Cancer Society(American Cancer Society); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Burroughs Wellcome Career Award (to D. W. A.), an R01 GM086550 (DWA) and a P01 DK091222 (to F. C., T. T. P., and D. W. A.) and an American Cancer Society Postdoctoral Fellowship Award PF-11-058-01-MPC and K99 HL122365-01 award (to J. T. T-A). Financial Conflict of Interest: Drs. Benderitter, Hoflack, and Abbott have financial interests in the development of novel RIP2 inhibitors.	Amendola A, 2014, MUCOSAL IMMUNOL, V7, P391, DOI 10.1038/mi.2013.58; [Anonymous], 2005, GUID IND EST MAX SAF; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Brehmer D, 2005, CANCER RES, V65, P379; Desai B, 2012, J IMMUNOL, V188; Dorsch M, 2006, CELL SIGNAL, V18, P2223, DOI 10.1016/j.cellsig.2006.05.005; Duan W, 2010, J ALLERGY CLIN IMMUN, V126, P1284, DOI 10.1016/j.jaci.2010.09.021; Girardin M, 2012, DIGESTION, V86, P6, DOI 10.1159/000341951; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Gorfu G, 2010, J IMMUNOL, V185, P5561, DOI 10.4049/jimmunol.0903938; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Henckaerts L, 2007, INFLAMM BOWEL DIS, V13, P235, DOI 10.1002/ibd.20066; Hollenbach E, 2004, FASEB J, V18, P1550, DOI 10.1096/fj.04-1642fje; Hollenbach E, 2005, J BIOL CHEM, V280, P14981, DOI 10.1074/jbc.M500966200; Homer CR, 2012, J BIOL CHEM, V287, P25565, DOI 10.1074/jbc.M111.326835; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Negroni A, 2009, INFLAMM BOWEL DIS, V15, P1145, DOI 10.1002/ibd.20907; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Okafuji I, 2009, ARTHRITIS RHEUM-US, V60, P242, DOI 10.1002/art.24134; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Pizarro TT, 2011, INFLAMM BOWEL DIS, V17, P2566, DOI 10.1002/ibd.21638; Reuter BK, 2011, GASTROENTEROLOGY, V141, P1709, DOI 10.1053/j.gastro.2011.06.041; Rosenzweig HL, 2011, INFLAMM RES, V60, P705, DOI 10.1007/s00011-011-0324-7; Rosenzweig HL, 2010, ARTHRITIS RHEUM-US, V62, P1051, DOI 10.1002/art.27335; Schurmann M, 2003, EUR RESPIR J, V22, P748, DOI 10.1183/09031936.03.00040602; Shaw PJ, 2011, IMMUNITY, V34, P75, DOI 10.1016/j.immuni.2010.12.015; Stronati L, 2008, INFLAMM BOWEL DIS, V14, P295, DOI 10.1002/ibd.20332; Tanabe T, 2006, BBA-MOL BASIS DIS, V1762, P794, DOI 10.1016/j.bbadis.2006.07.006; Tao MF, 2009, CURR BIOL, V19, P1255, DOI 10.1016/j.cub.2009.06.038; Thongprasert S, 2011, J THORAC ONCOL, V6, P1872, DOI 10.1097/JTO.0b013e31822adaf7; Tigno-Aranjuez JT, 2013, MOL CELL BIOL, V33, P146, DOI 10.1128/MCB.01049-12; Tigno-Aranjuez JT, 2010, GENE DEV, V24, P2666, DOI 10.1101/gad.1964410; Zhao Y, 2012, J IMMUNOL, V188	44	67	69	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29651	29664		10.1074/jbc.M114.591388	http://dx.doi.org/10.1074/jbc.M114.591388			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25213858	Green Published, hybrid			2022-12-28	WOS:000344370800015
J	Yi, CR; Allen, JE; Russo, B; Lee, SY; Heindl, JE; Baxt, LA; Herrera, BB; Kahoud, E; MacBeath, G; Goldberg, MB				Yi, Chae-ryun; Allen, John E.; Russo, Brian; Lee, Soo Young; Heindl, Jason E.; Baxt, Leigh A.; Herrera, Bobby Brooke; Kahoud, Emily; MacBeath, Gavin; Goldberg, Marcia B.			Systematic Analysis of Bacterial Effector-Postsynaptic Density 95/Disc Large/Zonula Occludens-1 (PDZ) Domain Interactions Demonstrates Shigella OspE Protein Promotes Protein Kinase C Activation via PDLIM Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; PDZ Domain; Protein Kinase C (PKC); Protein-Protein Interaction; Secretion; Type III Secretion System (T3SS); OspE; PDLIM Proteins; Shigella	III SECRETION SYSTEM; ENTEROPATHOGENIC ESCHERICHIA-COLI; VIRULENCE FACTOR NLEA; LIM DOMAINS; HOST-CELLS; BINDING; EXPRESSION; TARGETS; PHOSPHORYLATION; JUNCTIONS	Background: PDZ domains provide specificity in protein-protein interactions in eukaryotic systems. Results:Shigella OspE, which is delivered into human cells during infection, binds PDLIM7 via a PDZ interaction and contributes to activation of PKC. Conclusion: During infection, OspE contributes to activation of PKC through PDZ-mediated binding to PDLIM7. Significance: PDZ interactions likely contribute to pathogenesis of several bacterial pathogens. Diseases caused by many Gram-negative bacterial pathogens depend on the activities of bacterial effector proteins that are delivered into eukaryotic cells via specialized secretion systems. Effector protein function largely depends on specific subcellular targeting and specific interactions with cellular ligands. PDZ domains are common domains that serve to provide specificity in protein-protein interactions in eukaryotic systems. We show that putative PDZ-binding motifs are significantly enriched among effector proteins delivered into mammalian cells by certain bacterial pathogens. We use PDZ domain microarrays to identify candidate interaction partners of the Shigella flexneri effector proteins OspE1 and OspE2, which contain putative PDZ-binding motifs. We demonstrate in vitro and in cells that OspE proteins interact with PDLIM7, a member of the PDLIM family of proteins, which contain a PDZ domain and one or more LIM domains, protein interaction domains that participate in a wide variety of functions, including activation of isoforms of protein kinase C (PKC). We demonstrate that activation of PKC during S. flexneri infection is attenuated in the absence of PDLIM7 or OspE proteins and that the OspE PDZ-binding motif is required for wild-type levels of PKC activation. These results are consistent with a model in which binding of OspE to PDLIM7 during infection regulates the activity of PKC isoforms that bind to the PDLIM7 LIM domain.	[Yi, Chae-ryun; Russo, Brian; Baxt, Leigh A.; Herrera, Bobby Brooke; Kahoud, Emily; Goldberg, Marcia B.] Massachusetts Gen Hosp, Div Infect Dis, Cambridge, MA 02139 USA; [Allen, John E.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Lee, Soo Young] Harvard Univ, Sch Med, Program Immunol, Boston, MA 02115 USA; [Russo, Brian; Heindl, Jason E.; Goldberg, Marcia B.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [MacBeath, Gavin] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Goldberg, MB (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Cambridge, MA 02139 USA.	marcia.goldberg@mgh.harvard.edu	Goldberg, Marcia/U-8604-2019	Herrera, Bobby Brooke/0000-0002-2438-6716; Baxt, Leigh/0000-0001-8286-3907; Allen, John/0000-0001-5005-5139; Lee, Soo Young/0000-0003-1524-836X; MacBeath, Gavin/0000-0003-2585-6772; Heindl, Jason/0000-0003-3919-8045	National Institutes of Health [F32 AI092967, R01 AI081724]; American Heart Association [09POST2260574]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081724, T32AI007061, F32AI092967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 AI092967 (to L. A. B.) and R01 AI081724 (to M. B. G.). G. M. and J. E. A. are employees and stockholders of Merrimack Pharmaceuticals, Inc.; Supported by American Heart Association Postdoctoral Fellowship 09POST2260574.	Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Ashida H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003409; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Defilippi P, 1997, J BIOL CHEM, V272, P21726, DOI 10.1074/jbc.272.35.21726; Dewoody R, 2011, MOL MICROBIOL, V79, P1445, DOI 10.1111/j.1365-2958.2011.07534.x; Elkins JM, 2010, PROTEIN SCI, V19, P731, DOI 10.1002/pro.349; Farhadi A, 2006, J PHARMACOL EXP THER, V316, P1, DOI 10.1124/jpet.105.085449; Fukumatsu M, 2012, CELL HOST MICROBE, V11, P325, DOI 10.1016/j.chom.2012.03.001; Gardiol D, 2012, FEBS J, V279, P3529, DOI 10.1111/j.1742-4658.2012.08685.x; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GRAFF JM, 1989, J BIOL CHEM, V264, P21818; Heindl JE, 2010, INFECT IMMUN, V78, P193, DOI 10.1128/IAI.00252-09; Javier RT, 2011, J VIROL, V85, P11544, DOI 10.1128/JVI.05410-11; Kaushansky A, 2010, NAT PROTOC, V5, P773, DOI 10.1038/nprot.2010.36; Kim J, 2007, CELL HOST MICROBE, V2, P160, DOI 10.1016/j.chom.2007.07.010; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Kotaka M, 1999, J CELL BIOCHEM, V72, P279, DOI 10.1002/(SICI)1097-4644(19990201)72:2<279::AID-JCB12>3.0.CO;2-7; Kuroda S, 1996, J BIOL CHEM, V271, P31029, DOI 10.1074/jbc.271.49.31029; LABIGNEROUSSEL AF, 1984, INFECT IMMUN, V46, P251, DOI 10.1128/IAI.46.1.251-259.1984; LABREC EH, 1964, J BACTERIOL, V88, P1503, DOI 10.1128/JB.88.5.1503-1518.1964; Lee SF, 2008, CELL MICROBIOL, V10, P499, DOI [10.1111/j.1462-5822.2007.01065x, 10.1111/j.1462-5822.2007.01065.x]; Liu YS, 2002, J BONE MINER RES, V17, P406, DOI 10.1359/jbmr.2002.17.3.406; Loughran G, 2005, MOL BIOL CELL, V16, P1811, DOI 10.1091/mbc.E04-12-1052; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Matsumoto H, 2009, CURR OPIN MICROBIOL, V12, P94, DOI 10.1016/j.mib.2008.12.005; Maturana AD, 2011, CELL SIGNAL, V23, P928, DOI 10.1016/j.cellsig.2011.01.021; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Miura M, 2006, INFECT IMMUN, V74, P2587, DOI 10.1128/IAI.74.5.2587-2595.2006; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Radhakrishnan P, 2007, BBA-GEN SUBJECTS, V1770, P884, DOI 10.1016/j.bbagen.2007.01.019; Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102; Schmitz AM, 2009, NAT METHODS, V6, P500, DOI 10.1038/nmeth.1337; Simpson N, 2006, MOL MICROBIOL, V60, P349, DOI 10.1111/j.1365-2958.2006.05109.x; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Thanabalasuriar A, 2010, CELL MICROBIOL, V12, P31, DOI 10.1111/j.1462-5822.2009.01376.x; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Watarai M, 1997, J EXP MED, V185, P281, DOI 10.1084/jem.185.2.281; Winnen B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002178; Zheng Q, 2007, BIOL CELL, V99, P489, DOI 10.1042/BC20060126	42	9	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					30101	30113		10.1074/jbc.M114.595868	http://dx.doi.org/10.1074/jbc.M114.595868			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25124035	Green Published, hybrid			2022-12-28	WOS:000344370800050
J	Huyghe, D; Nakamura, Y; Terunuma, M; Faideau, M; Haydon, P; Pangalos, MN; Moss, SJ				Huyghe, Deborah; Nakamura, Yasuko; Terunuma, Miho; Faideau, Mathilde; Haydon, Philip; Pangalos, Menelas N.; Moss, Stephen J.			Glutamine Synthetase Stability and Subcellular Distribution in Astrocytes Are Regulated by gamma-Aminobutyric Type B Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATIVE GABA(B) RECEPTORS; TEMPORAL-LOBE EPILEPSY; EXPRESSION; PROTEIN; TRAFFICKING; DEFICIENCY; SUBUNITS; CORTEX; BRAIN; REDISTRIBUTION	Emerging evidence suggests that functional gamma-aminobutyric acid B receptors (GABA(B)Rs) are expressed by astrocytes within the mammalian brain. GABA(B)Rs are heterodimeric G-protein-coupled receptors that are composed of R1/R2 subunits. To date, they have been characterized in neurons as the principal mediators of sustained inhibitory signaling; however their roles in astrocytic physiology have been ill defined. Here we reveal that the cytoplasmic tail of the GABA(B)R2 subunit binds directly to the astrocytic protein glutamine synthetase (GS) and that this interaction determines the subcellular localization of GS. We further demonstrate that the binding of GS to GABA(B)R2 increases the steady state expression levels of GS in heterologous cells and in mouse primary astrocyte culture. Mechanistically this increased stability of GS in the presence of GABA(B)R2 occurs via reduced proteasomal degradation. Collectively, our results suggest a novel role for GABA(B)Rs as regulators of GS stability. Given the critical role that GS plays in the glutamineglutamate cycle, astrocytic GABA(B)Rs may play a critical role in supporting both inhibitory and excitatory neurotransmission.	[Huyghe, Deborah; Nakamura, Yasuko; Haydon, Philip; Moss, Stephen J.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Terunuma, Miho] Univ Leicester, Dept Cell Physiol & Pharmacol, Coll Med Biol Sci & Psychol, Leicester LE1 9HN, Leics, England; [Faideau, Mathilde] Lund Univ, Dept Expt Dementia Res, SE-22100 Lund, Sweden; [Pangalos, Menelas N.] AstraZeneca, Innovat Med, Alderley Pk SK10 4TF, Cheshire, England; [Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6B, England	Tufts University; University of Leicester; Lund University; AstraZeneca; University of London; University College London	Moss, SJ (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA.	Stephen.Moss@Tufts.edu	Nakamura, Yasuko/O-5551-2016	Nakamura, Yasuko/0000-0002-0660-4126; Terunuma, Miho/0000-0003-1876-9726	National Institutes of Health-NINDS Grants [NS051195, NS056359, NS081735]; NIH-NIMH Grant [MH097446]; Simons Foundation [206026]; American Heart Association [09SDG2260557]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051195, R01NS081986, R01NS056359] Funding Source: NIH RePORTER	National Institutes of Health-NINDS Grants; NIH-NIMH Grant; Simons Foundation; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health-NINDS Grants NS051195, NS056359, NS081735 (to S. J. M.), NIH-NIMH Grant MH097446, (to P. D. and S. J. M.), and a grant from the Simons Foundation (No. 206026 to S. J. M.).; Recipient of a National Scientist Development Grant (09SDG2260557) from the American Heart Association.	Anlauf Enrico, 2013, Front Endocrinol (Lausanne), V4, P144, DOI 10.3389/fendo.2013.00144; Bettler B, 2006, PHARMACOL THERAPEUT, V110, P533, DOI 10.1016/j.pharmthera.2006.03.006; Burbaeva GS, 2005, NEUROCHEM RES, V30, P1443, DOI 10.1007/s11064-005-8654-x; Calver AR, 2001, J NEUROSCI, V21, P1203; Chalifoux JR, 2011, CURR OPIN NEUROBIOL, V21, P339, DOI 10.1016/j.conb.2011.02.004; Charles KJ, 2003, MOL CELL NEUROSCI, V24, P214, DOI 10.1016/S1044-7431(03)00162-3; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; DEROUICHE A, 1991, BRAIN RES, V552, P346, DOI 10.1016/0006-8993(91)90103-3; Eid T, 2012, NEUROCHEM RES, V37, P2339, DOI 10.1007/s11064-012-0766-5; Filippov AK, 2000, J NEUROSCI, V20, P2867; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; Haberle J, 2005, NEW ENGL J MED, V353, P1926, DOI 10.1056/NEJMoa050456; Haberle J, 2006, J INHERIT METAB DIS, V29, P352, DOI 10.1007/s10545-006-0256-5; Haberle J, 2011, MOL GENET METAB, V103, P89, DOI 10.1016/j.ymgme.2011.02.001; Hammer J, 2008, GLIA, V56, P856, DOI 10.1002/glia.20659; He YJ, 2010, GLIA, V58, P741, DOI 10.1002/glia.20960; HOSLI E, 1990, EXP BRAIN RES, V80, P621; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Liang SL, 2006, J NEUROSCI, V26, P8537, DOI 10.1523/JNEUROSCI.0329-06.2006; Lunn ML, 2007, NAT NEUROSCI, V10, P1249, DOI 10.1038/nn1953; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; NORENBERG MD, 1979, J HISTOCHEM CYTOCHEM, V27, P756, DOI 10.1177/27.3.39099; Oka M, 2006, BIOCHEM BIOPH RES CO, V341, P874, DOI 10.1016/j.bbrc.2006.01.039; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Papageorgiou IE, 2011, GLIA, V59, P1706, DOI 10.1002/glia.21217; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Saitoh F, 2010, J NEUROSCI, V30, P1204, DOI 10.1523/JNEUROSCI.3591-09.2010; Schousboe Arne, 2013, Front Endocrinol (Lausanne), V4, P102, DOI 10.3389/fendo.2013.00102; SCHWARTZ JP, 1992, GLIA, V5, P75, DOI 10.1002/glia.440050111; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Steffek AE, 2008, SCHIZOPHR RES, V103, P71, DOI 10.1016/j.schres.2008.04.032; Suarez I, 2002, NEUROCHEM INT, V41, P123, DOI 10.1016/S0197-0186(02)00033-5; Taylor PM, 1999, J NEUROSCI, V19, P6360; Thuault SJ, 2004, BIOCHEM PHARMACOL, V68, P1655, DOI 10.1016/j.bcp.2004.07.032; van der Hel WS, 2005, NEUROLOGY, V64, P326, DOI 10.1212/01.WNL.0000149636.44660.99; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x	39	10	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28808	28815		10.1074/jbc.M114.583534	http://dx.doi.org/10.1074/jbc.M114.583534			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25172509	Green Published, hybrid			2022-12-28	WOS:000344141000005
J	Wang, LJ; Huang, HY; Huang, MP; Liou, W; Chang, YT; Wu, CC; Ojcius, DM; Chang, YS				Wang, Li-Jie; Huang, Hsin-Yi; Huang, Meng-Pin; Liou, Willisa; Chang, Ya-Ting; Wu, Chih-Ching; Ojcius, David M.; Chang, Yu-Sun			The Microtubule-associated Protein EB1 Links AIM2 Inflammasomes with Autophagy-dependent Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END-BINDING PROTEIN-1; NLRP3 INFLAMMASOME; CELL-DEATH; ACTIVATION; PHOSPHORYLATION; INTERLEUKIN-1-BETA; IL-1-BETA; RECEPTOR; PROGRAM; PATHWAY	Inflammasomes are multi-protein complexes that regulate chronic inflammation-associated diseases by inducing interleukin-1 beta (IL-1 beta) secretion. Numerous components involved in inflammasome activation have been identified, but the mechanisms of inflammasome-mediated IL-1 beta secretion have not yet been fully explored. Here, we demonstrate that end-binding protein 1 (EB1), which is required for activation of AIM2 inflammasome complex, links the AIM2 inflammasome to autophagy-dependent secretion. Imaging studies revealed that AIM2 inflammasomes colocalize with microtubule organizing centers and autophagosomes. Biochemical analyses showed that poly(dA-dT)-activated AIM2 inflammasomes induce autophagy and IL-1 beta secretion in an LC3-dependent fashion. Furthermore, depletion of EB1 decreases autophagic shedding and intracellular trafficking. Finally, we found that the 5'-AMP activated protein kinase may regulate this EB1-mediated autophagy-based inflammasome-induced secretion of IL-1 beta. These findings reveal a novel EB1-mediated pathway for the secretion of IL-1 beta.	[Wang, Li-Jie; Huang, Meng-Pin; Chang, Ya-Ting; Wu, Chih-Ching; Chang, Yu-Sun] Chang Gung Univ, Mol Med Res Ctr, Coll Med, Taoyuan 333, Taiwan; [Huang, Hsin-Yi; Chang, Yu-Sun] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan 333, Taiwan; [Liou, Willisa] Chang Gung Univ, Dept Anat, Coll Med, Taoyuan 333, Taiwan; [Wu, Chih-Ching] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Taoyuan 333, Taiwan; [Ojcius, David M.] Univ Calif, Hlth Sci Res Inst, Merced, CA 95343 USA; [Ojcius, David M.] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; University of California System; University of California Merced; University of California System; University of California Merced	Chang, YS (corresponding author), Chang Gung Univ, Mol Med Res Ctr, 259 Wen Hwa 1st Rd, Taoyuan 333, Taiwan.	ysc@mail.cgu.edu.tw	Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495; Liou, Willisa/0000-0002-3280-9635; Wu, Chih-Ching/0000-0002-7264-9672; Chang, Yu-Sun/0000-0002-6457-3890	National Science Council of Taiwan [NSC101-2320-B-182-010-MY3, MOST 103-2325-B-182-006]; Ministry of Education of Taiwan [EMRPD1D0031, 1D0631]; Chang Gung Memorial Hospital (Tao-Yuan, Taiwan) [CMRPD1D0101]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education of Taiwan(Ministry of Education, Taiwan); Chang Gung Memorial Hospital (Tao-Yuan, Taiwan)(Chang Gung Memorial Hospital)	This work was supported by Grants NSC101-2320-B-182-010-MY3 and MOST 103-2325-B-182-006 (to Y.-S. C.) from the National Science Council of Taiwan; Grants EMRPD1D0031 and 1D0631 (to Y.-S. C.) from the Ministry of Education of Taiwan; and Grant CMRPD1D0101 (to Y.-S. C.) from the Chang Gung Memorial Hospital (Tao-Yuan, Taiwan).	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126; Chen LC, 2012, EMBO MOL MED, V4, P1276, DOI 10.1002/emmm.201201569; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Ferreira JG, 2013, J CELL BIOL, V201, P709, DOI 10.1083/jcb.201301131; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Jiang K, 2011, CURR OPIN CELL BIOL, V23, P94, DOI 10.1016/j.ceb.2010.08.008; Jiang S, 2013, J INNATE IMMUN, V5, P471, DOI 10.1159/000346707; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Korolchuk VI, 2011, AUTOPHAGY, V7, P927, DOI 10.4161/auto.7.8.15862; Lesniewska K, 2014, MOL BIOL CELL, V25, P1025, DOI 10.1091/mbc.E13-08-0504; Liao KC, 2013, INFECT IMMUN, V81, P570, DOI 10.1128/IAI.01003-12; Mackeh R, 2013, J CELL SCI, V126, P1071, DOI 10.1242/jcs.115626; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Martin-Cofreces NB, 2012, EMBO J, V31, P4140, DOI 10.1038/emboj.2012.242; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Messaed C, 2011, J BIOL CHEM, V286, P43313, DOI 10.1074/jbc.M111.306191; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; Ponomareva L, 2013, MOL CANCER RES, V11, P1193, DOI 10.1158/1541-7786.MCR-13-0145; Reinholz M, 2013, ARCH DERMATOL RES, V305, P723, DOI 10.1007/s00403-013-1375-0; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Sirois I, 2012, AUTOPHAGY, V8, P927, DOI 10.4161/auto.19768; Stow JL, 2013, NAT REV IMMUNOL, V13, P830, DOI 10.1038/nri3564; Wang LJ, 2012, MOL CELL PROTEOMICS, V11, P1230, DOI 10.1074/mcp.M112.020594; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	39	40	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					29322	29333		10.1074/jbc.M114.559153	http://dx.doi.org/10.1074/jbc.M114.559153			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25164813	Green Published, hybrid			2022-12-28	WOS:000344141000045
J	Henning, C; Liehr, K; Girndt, M; Ulrich, C; Glomb, MA				Henning, Christian; Liehr, Kristin; Girndt, Matthias; Ulrich, Christof; Glomb, Marcus A.			Extending the Spectrum of alpha-Dicarbonyl Compounds in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERITONEAL-DIALYSIS FLUIDS; GLYCATION END-PRODUCTS; GLUCOSE DEGRADATION-PRODUCTS; HUMAN SERUM-ALBUMIN; MAILLARD REACTION; DEHYDROASCORBIC ACID; OXIDATIVE STRESS; ASCORBIC-ACID; 1,2-DICARBONYL COMPOUNDS; EXTRACELLULAR-MATRIX	Maillard alpha-dicarbonyl compounds are known as central intermediates in advanced glycation end product (AGE) formation. Glucose is the primary source of energy for the human body, whereas L-threo-ascorbic acid (vitamin C) is an essential nutrient, involved in a variety of enzymatic reactions. Thus, the Maillard degradation of glucose and ascorbic acid is of major importance in vivo. To understand the complex mechanistic pathways of AGE formation, it is crucial to extend the knowledge on plasma concentrations of reactive key alpha-dicarbonyl compounds (e. g. 1-deoxyglucosone). With the present work, we introduce a highly sensitive LC-MS/MS multimethod for human blood plasma based on derivatization with o-phenylenediamine under acidic conditions. The impact of workup and reaction conditions, particularly of pH, was thoroughly evaluated. A comprehensive validation provided the limit of detection, limit of quantitation, coefficients of variation, and recovery rates. The method includes the alpha-dicarbonyls 1-deoxyglucosone, 3-deoxyglucosone, glucosone, Lederer's glucosone, dehydroascorbic acid, 2,3-diketogulonic acid, 1-deoxypentosone, 3-deoxypentosone, 3,4-dideoxypentosone, pentosone, 1-deoxythreosone, 3-deoxythreosone, threosone, methylglyoxal, glyoxal; the alpha-keto-carboxylic acids pyruvic acid and glyoxylic acid; and the dicarboxylic acid oxalic acid. The method was then applied to the analyses of 15 healthy subjects and 24 uremic patients undergoing hemodialysis. The comparison of the results revealed a clear shift in the product spectrum. Inmost cases, the plasma levels of target analytes were significantly higher. Thus, this is the first time that a complete spectrum of alpha-dicarbonyl compounds relevant in vivo has been established. The results provide further insights into the chemistry of AGE formation and will be helpful to find specific markers to differentiate between the various precursors of glycation.	[Henning, Christian; Liehr, Kristin; Glomb, Marcus A.] Univ Halle Wittenberg, Inst Chem Food Chem, D-06120 Halle, Germany; [Girndt, Matthias; Ulrich, Christof] Univ Halle Wittenberg, Dept Internal Med 2, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Glomb, MA (corresponding author), Univ Halle Wittenberg, Inst Chem Food Chem, Kurt Mothes Str 2, D-06120 Halle, Germany.	marcus.glomb@chemie.uni-halle.de	Girndt, Matthias/M-1436-2019	Girndt, Matthias/0000-0003-2823-0847	German Federal Ministry of Education and Research (BMBF) [13N11798]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by German Federal Ministry of Education and Research (BMBF) Project 13N11798.	Ahmed N, 2002, BIOCHEM J, V364, P15, DOI 10.1042/bj3640015; Ankrah NA, 1999, TOXICOL LETT, V109, P61, DOI 10.1016/S0378-4274(99)00114-9; Arribas-Lorenzo G, 2010, J AGR FOOD CHEM, V58, P2966, DOI 10.1021/jf902815p; Arun V, 2009, DYES PIGMENTS, V82, P268, DOI 10.1016/j.dyepig.2009.01.010; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Baynes JW, 2001, EXP GERONTOL, V36, P1527, DOI 10.1016/S0531-5565(01)00138-3; Biemel KM, 2002, J BIOL CHEM, V277, P24907, DOI 10.1074/jbc.M202681200; Chaplen FWR, 1996, ANAL BIOCHEM, V236, P262, DOI 10.1006/abio.1996.0165; Chaplen FWR, 1998, P NATL ACAD SCI USA, V95, P5533, DOI 10.1073/pnas.95.10.5533; Chaplen FWR, 1996, ANAL BIOCHEM, V238, P171, DOI 10.1006/abio.1996.0271; Degen J, 2012, J AGR FOOD CHEM, V60, P7071, DOI 10.1021/jf301306g; Degenhardt T. P., 1998, MAILLARD REACTION FO, P3; Dhar A, 2009, J CHROMATOGR B, V877, P1093, DOI 10.1016/j.jchromb.2009.02.055; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Fu MX, 1996, J BIOL CHEM, V271, P9982, DOI 10.1074/jbc.271.17.9982; Gensberger S, 2012, ANAL BIOANAL CHEM, V403, P2923, DOI 10.1007/s00216-012-5817-x; Glomb MA, 2010, ACS SYM SER, V1042, P35; Glomb MA, 2001, J AGR FOOD CHEM, V49, P5543, DOI 10.1021/jf010148h; Glomb MA, 2001, J AGR FOOD CHEM, V49, P1493, DOI 10.1021/jf001082d; Glomb MA, 2000, CARBOHYD RES, V329, P515, DOI 10.1016/S0008-6215(00)00219-6; GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017; Glomb MA, 2001, J BIOL CHEM, V276, P41638, DOI 10.1074/jbc.M103557200; Gobert J, 2009, J AGR FOOD CHEM, V57, P8591, DOI 10.1021/jf9019085; Hamada Y, 1996, BIOCHEM BIOPH RES CO, V228, P539, DOI 10.1006/bbrc.1996.1695; Hellwig M, 2010, J AGR FOOD CHEM, V58, P10752, DOI 10.1021/jf102388v; Henning C, 2011, J BIOL CHEM, V286, P44350, DOI 10.1074/jbc.M111.282442; HENSEKE G, 1959, CHEM BER-RECL, V92, P501, DOI 10.1002/cber.19590920236; Karmali A, 2011, APPL BIOCHEM BIOTECH, V163, P906, DOI 10.1007/s12010-010-9094-x; KNECHT KJ, 1992, ARCH BIOCHEM BIOPHYS, V294, P130, DOI 10.1016/0003-9861(92)90146-N; Lapolla A, 2005, ANN NY ACAD SCI, V1043, P217, DOI 10.1196/annals.1333.027; Lapolla A, 2005, MOL NUTR FOOD RES, V49, P685, DOI 10.1002/mnfr.200400093; Linden T, 2001, PERITON DIALYSIS INT, V21, P607; LO TWC, 1994, J BIOL CHEM, V269, P32299; LOPEZANAYA A, 1987, CLIN CHEM, V33, P1874; Lykkesfeldt J, 1997, AM J CLIN NUTR, V65, P959, DOI 10.1093/ajcn/65.4.959; MARGOLIS SA, 1991, AM J CLIN NUTR, V54, pS1315, DOI 10.1093/ajcn/54.6.1315s; Materials Testing Standards Committee NA 062 of the Deutsches Institut fuer Normung (German Institute for Standardization), 1994, 32645 DIN MAT TEST S; MCCANCE DR, 1993, J CLIN INVEST, V91, P2470, DOI 10.1172/JCI116482; MCLELLAN AC, 1992, ANAL BIOCHEM, V206, P17, DOI 10.1016/S0003-2697(05)80005-3; Mirza MA, 2007, ELECTROPHORESIS, V28, P3940, DOI 10.1002/elps.200700129; Mittelmaier S, 2011, ANAL BIOANAL CHEM, V401, P1183, DOI 10.1007/s00216-011-5195-9; Mittelmaier S, 2011, ANAL BIOANAL CHEM, V399, P1689, DOI 10.1007/s00216-010-4456-3; Mittelmaier S, 2010, J CHROMATOGR B, V878, P877, DOI 10.1016/j.jchromb.2010.02.004; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P533, DOI 10.1196/annals.1333.061; Nakayama K, 2008, AM J NEPHROL, V28, P871, DOI 10.1159/000139653; Nemet I, 2011, J BIOL CHEM, V286, P37128, DOI 10.1074/jbc.M111.245100; Niwa T, 1999, J CHROMATOGR B, V731, P23, DOI 10.1016/S0378-4347(99)00113-9; Odani H, 1999, BIOCHEM BIOPH RES CO, V256, P89, DOI 10.1006/bbrc.1999.0221; OTSUKA M, 1986, AGR BIOL CHEM TOKYO, V50, P531, DOI 10.1080/00021369.1986.10867421; Rabbani N, 2012, AMINO ACIDS, V42, P1133, DOI 10.1007/s00726-010-0783-0; Reihl O, 2004, CARBOHYD RES, V339, P483, DOI 10.1016/j.carres.2003.12.004; Rossner J., 2001, Czech Journal of Food Science, V19, P41; Schalkwijk CG, 1999, PERITON DIALYSIS INT, V19, P325; Sell DR, 2005, J BIOL CHEM, V280, P12310, DOI 10.1074/jbc.M500733200; SELL DR, 1992, DIABETES, V41, P1286, DOI 10.2337/diabetes.41.10.1286; SHIN DB, 1990, J CARBOHYD CHEM, V9, P461, DOI 10.1080/07328309008543846; Smuda M, 2013, J AGR FOOD CHEM, V61, P10198, DOI 10.1021/jf305117s; Smuda M, 2013, ANGEW CHEM INT EDIT, V52, P4887, DOI 10.1002/anie.201300399; Smuda M, 2011, J AGR FOOD CHEM, V59, P13254, DOI 10.1021/jf203346b; Smuda M, 2010, J AGR FOOD CHEM, V58, P6458, DOI 10.1021/jf100334r; Sugiyama S, 1998, J AM SOC NEPHROL, V9, P1681; TAKAGI M, 1987, BIOELECTROCH BIOENER, V18, P171, DOI 10.1016/0302-4598(87)85019-5; Tauer A, 2005, MOL NUTR FOOD RES, V49, P710, DOI 10.1002/mnfr.200400111; Tessier FJ, 2012, AMINO ACIDS, V42, P1119, DOI 10.1007/s00726-010-0776-z; Thornalley PJ, 1998, CHEM-BIOL INTERACT, V112, P137, DOI 10.1016/S0009-2797(97)00157-9; Tsukushi S, 1999, KIDNEY INT, V55, P1970, DOI 10.1046/j.1523-1755.1999.00418.x; Vistoli G, 2013, FREE RADICAL RES, V47, P3, DOI 10.3109/10715762.2013.815348; Voigt M, 2009, J AGR FOOD CHEM, V57, P4765, DOI 10.1021/jf900459x; WELLSKNECHT KJ, 1995, BIOCHEMISTRY-US, V34, P3702, DOI 10.1021/bi00011a027	69	71	71	5	82	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28676	28688		10.1074/jbc.M114.563593	http://dx.doi.org/10.1074/jbc.M114.563593			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25164824	Green Published, hybrid			2022-12-28	WOS:000343765400055
J	Westfall, CS; Xu, A; Jez, JM				Westfall, Corey S.; Xu, Ang; Jez, Joseph M.			Structural Evolution of Differential Amino Acid Effector Regulation in Plant Chorismate Mutases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHENYLALANINE BIOSYNTHESIS; ALLOSTERIC REGULATION; CRYSTAL-STRUCTURE; YEAST; STATE; MECHANISMS; SEPARATION; ISOENZYMES; SHIKIMATE; ISOZYMES	Chorismate mutase converts chorismate into prephenate for aromatic amino acid biosynthesis. To understand the molecular basis of allosteric regulation in the plant chorismate mutases, we analyzed the three Arabidopsis thaliana chorismate mutase isoforms (AtCM1-3) and determined the x-ray crystal structures of AtCM1 in complex with phenylalanine and tyrosine. Functional analyses show a wider range of effector control in the Arabidopsis chorismate mutases than previously reported. AtCM1 is activated by tryptophan with phenylalanine and tyrosine acting as negative effectors; however, tryptophan, cysteine, and histidine activate AtCM3. AtCM2 is a nonallosteric form. The crystal structure of AtCM1 in complex with tyrosine and phenylalanine identifies differences in the effector sites of the allosterically regulated yeast enzyme and the other two Arabidopsis isoforms. Site-directed mutagenesis of residues in the effector site reveals key features leading to differential effector regulation in these enzymes. In AtCM1, mutations of Gly-213 abolish allosteric regulation, as observed in AtCM2. A second effector site position, Gly-149 in AtCM1 and Asp-132 in AtCM3, controls amino acid effector specificity in AtCM1 and AtCM3. Comparisons of chorismate mutases from multiple plants suggest that subtle differences in the effector site are conserved in different lineages and may lead to specialized regulation of this branch point enzyme.	[Westfall, Corey S.; Xu, Ang; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Jez, JM (corresponding author), Washington Univ, Dept Biol, One Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu			United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	Portions of this research were carried out at the Argonne National Laboratory, Structural Biology Center of the Advanced Photon Source, a national user facility operated by the University of Chicago for the United States Department of Energy, Office of Biological and Environmental Research (supported by Grant DE-AC02-06CH11357).	Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; BENESOVA M, 1992, PHYTOCHEMISTRY, V31, P2983, DOI 10.1016/0031-9422(92)83431-W; BORNEMANN S, 1995, J BIOL CHEM, V270, P22811, DOI 10.1074/jbc.270.39.22811; CHOOK YM, 1993, P NATL ACAD SCI USA, V90, P8600, DOI 10.1073/pnas.90.18.8600; Colquhoun TA, 2010, PLANT J, V61, P145, DOI 10.1111/j.1365-313X.2009.04042.x; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DAMATO TA, 1984, PLANTA, V162, P104, DOI 10.1007/BF00410205; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Eberhard J, 1996, PLANT J, V10, P815, DOI 10.1046/j.1365-313X.1996.10050815.x; EBERHARD J, 1993, FEBS LETT, V334, P233, DOI 10.1016/0014-5793(93)81718-F; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GILCHRIST DG, 1972, PLANT PHYSIOL, V49, P52, DOI 10.1104/pp.49.1.52; GOERS SK, 1984, PLANTA, V162, P109, DOI 10.1007/BF00410206; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gosset G, 2009, CURR OPIN BIOTECH, V20, P651, DOI 10.1016/j.copbio.2009.09.012; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Helmstaedt K, 2002, P NATL ACAD SCI USA, V99, P6631, DOI 10.1073/pnas.092130899; Kong YF, 2006, J MOL BIOL, V356, P237, DOI 10.1016/j.jmb.2005.10.064; KUROKI GW, 1988, ARCH BIOCHEM BIOPHYS, V260, P616, DOI 10.1016/0003-9861(88)90489-4; KUROKI GW, 1989, PLANT PHYSIOL, V89, P472, DOI 10.1104/pp.89.2.472; LEE AY, 1995, J AM CHEM SOC, V117, P3627, DOI 10.1021/ja00117a038; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mobley EM, 1999, GENE, V240, P115, DOI 10.1016/S0378-1119(99)00423-0; Rippert P, 2009, PLANT PHYSIOL, V149, P1251, DOI 10.1104/pp.108.130070; SCHMIDHEINI T, 1990, BIOCHEMISTRY-US, V29, P3660, DOI 10.1021/bi00467a011; Schnappauf G, 1998, P NATL ACAD SCI USA, V95, P2868, DOI 10.1073/pnas.95.6.2868; Schnappauf G, 1998, J BIOL CHEM, V273, P17012, DOI 10.1074/jbc.273.27.17012; Stepansky A, 2006, AMINO ACIDS, V30, P121, DOI 10.1007/s00726-005-0246-1; Strater N, 1997, STRUCTURE, V5, P1437, DOI 10.1016/S0969-2126(97)00294-3; Strater N, 1996, P NATL ACAD SCI USA, V93, P3330, DOI 10.1073/pnas.93.8.3330; Tohge T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00062; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; XUE YF, 1994, P NATL ACAD SCI USA, V91, P10814, DOI 10.1073/pnas.91.23.10814; Yi H, 2010, MOL PLANT, V3, P269, DOI 10.1093/mp/ssp112; Yoo H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3833; Yu O, 2008, PLANT J, V54, P750, DOI 10.1111/j.1365-313X.2008.03436.x	38	29	29	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28619	28628		10.1074/jbc.M114.591123	http://dx.doi.org/10.1074/jbc.M114.591123			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25160622	Green Published, hybrid			2022-12-28	WOS:000343765400050
J	Kim, PY; Vu, TT; Leslie, BA; Stafford, AR; Fredenburgh, JC; Weitz, JI				Kim, Paul Y.; Vu, Trang T.; Leslie, Beverly A.; Stafford, Alan R.; Fredenburgh, James C.; Weitz, Jeffrey I.			Reduced Plasminogen Binding and Delayed Activation Render gamma '-Fibrin More Resistant to Lysis than gamma(A)-Fibrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Fibrinogen; Fibrinolysis; Plasminogen; Tissue Plasminogen Activator (tPA); -Fibrinogen	HIGH-AFFINITY INTERACTION; MYOCARDIAL-INFARCTION; PLASMA-FIBRINOGEN; FACTOR-XIII; CARDIOVASCULAR-DISEASE; SPLICE VARIANT; CLOT STRUCTURE; THROMBIN; TISSUE; INHIBITION	Background: When compared with degradation of the predominant (A)-fibrin, lysis of variant -fibrin is delayed. Results: Thrombin-mediated fibrinopeptide B release is slower from -fibrinogen than from (A)-fibrinogen, resulting in delayed binding and activation of plasminogen. Conclusion: Delayed plasmin generation renders -fibrin resistant to lysis. Significance: The association between slower clotting and delayed lysis highlights the links between coagulation and fibrinolysis. Fibrin (Fn) clots formed from -fibrinogen (-Fg), a variant with an elongated -chain, are resistant to lysis when compared with clots formed from the predominant (A)-Fg, a finding previously attributed to differences in clot structure due to delayed thrombin-mediated fibrinopeptide (FP) B release or impaired cross-linking by factor XIIIa. We investigated whether slower lysis of -Fn reflects delayed plasminogen (Pg) binding and/or activation by tissue plasminogen activator (tPA), reduced plasmin-mediated proteolysis of -Fn, and/or altered cross-linking. Clots formed from -Fg lysed more slowly than those formed from (A)-Fg when lysis was initiated with tPA/Pg when FPA and FPB were both released, but not when lysis was initiated with plasmin, or when only FPA was released. Pg bound to -Fn with an association rate constant 22% lower than that to (A)-Fn, and the lag time for initiation of Pg activation by tPA was longer with -Fn than with (A)-Fn. Once initiated, however, Pg activation kinetics were similar. Factor XIIIa had similar effects on clots formed from both Fg isoforms. Therefore, slower lysis of -Fn clots reflects delayed FPB release, which results in delayed binding and activation of Pg. When clots were formed from Fg mixtures containing more than 20% -Fg, the upper limit of the normal level, the delay in lysis was magnified. These data suggest that circulating levels of -Fg modulate the susceptibility of clots to lysis by slowing Pg activation by tPA and provide another example of the intimate connections between coagulation and fibrinolysis.	[Kim, Paul Y.; Leslie, Beverly A.; Stafford, Alan R.; Fredenburgh, James C.; Weitz, Jeffrey I.] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada; [Vu, Trang T.; Weitz, Jeffrey I.] McMaster Univ, Dept Biomed Sci, Hamilton, ON L8S 4L8, Canada; [Weitz, Jeffrey I.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4L8, Canada; [Kim, Paul Y.; Vu, Trang T.; Leslie, Beverly A.; Stafford, Alan R.; Fredenburgh, James C.; Weitz, Jeffrey I.] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8L 2X2, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Weitz, JI (corresponding author), Thrombosis & Atherosclerosis Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada.	weitzj@taari.ca	Kim, Paul/GYV-3258-2022; Weitz, Jeffrey/AAD-1929-2019	Kim, Paul/0000-0003-0943-4924; Weitz, Jeffrey/0000-0002-1092-7550	Canadian Institutes of Health Research [MOP3992, MOP102735, CTP 79846]; Heart and Stroke Foundation of Ontario; Ontario Research and Development Challenge Fund; Canadian Institutes of Health Research Fellowship; National Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Research and Development Challenge Fund(General Electric); Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported in part by Canadian Institutes of Health Research Grants MOP3992, MOP102735, and CTP 79846, the Heart and Stroke Foundation of Ontario, and the Ontario Research and Development Challenge Fund.; The recipient of a Canadian Institutes of Health Research Fellowship.; The recipient of a National Sciences and Engineering Research Council of Canada Award.	Allan P, 2012, J THROMB HAEMOST, V10, P1072, DOI 10.1111/j.1538-7836.2012.04717.x; Ariens RAS, 2002, BLOOD, V100, P743, DOI 10.1182/blood.V100.3.743; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; Chan HH, 2012, BIOCHEMISTRY-US, V51, P7964, DOI 10.1021/bi301046b; Cheung EYL, 2008, STROKE, V39, P1033, DOI 10.1161/STROKEAHA.107.495499; Collet JP, 2004, ARTERIOSCL THROM VAS, V24, P382, DOI 10.1161/01.ATV.0000109748.77727.3e; Cooper AV, 2003, BLOOD, V102, P535, DOI 10.1182/blood-2002-10-3150; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; de Willige SU, 2005, BLOOD, V106, P4176, DOI 10.1182/blood-2005-05-2180; Dejouvencel T, 2010, BLOOD, V115, P2048, DOI 10.1182/blood-2009-06-228817; Doolittle RF, 2006, BIOCHEMISTRY-US, V45, P2657, DOI 10.1021/bi0524767; Falls LA, 1997, J BIOL CHEM, V272, P14251, DOI 10.1074/jbc.272.22.14251; Fredenburgh JC, 2008, J BIOL CHEM, V283, P2470, DOI 10.1074/jbc.M707710200; Gersh KC, 2009, THROMB RES, V124, P356, DOI 10.1016/j.thromres.2008.11.016; Hethershaw EL, 2014, J THROMB HAEMOST, V12, P197, DOI 10.1111/jth.12455; Horrevoets AJG, 1997, J BIOL CHEM, V272, P2183; Horrevoets AJG, 1997, J BIOL CHEM, V272, P2176; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; Kim PY, 2007, J THROMB HAEMOST, V5, P1250, DOI 10.1111/j.1538-7836.2007.02426.x; Kim PY, 2012, J BIOL CHEM, V287, P4652, DOI 10.1074/jbc.M111.317719; Lovely RS, 2010, CLIN CHEM, V56, P781, DOI 10.1373/clinchem.2009.138347; Lovely RS, 2002, THROMB HAEMOSTASIS, V88, P26; Ma J, 1999, J AM COLL CARDIOL, V33, P1347, DOI 10.1016/S0735-1097(99)00007-8; Mannila MN, 2007, J THROMB HAEMOST, V5, P766, DOI 10.1111/j.1538-7836.2007.02406.x; Maresca G, 1999, ARTERIOSCL THROM VAS, V19, P1368, DOI 10.1161/01.ATV.19.6.1368; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Pieters M, 2013, BLOOD, V121, P3254, DOI 10.1182/blood-2012-12-471482; Pospisil CH, 2003, J BIOL CHEM, V278, P21584, DOI 10.1074/jbc.M300545200; Schneider M, 2004, J BIOL CHEM, V279, P13333, DOI 10.1074/jbc.M313164200; Senis YA, 2006, BBA-PROTEINS PROTEOM, V1764, P863, DOI 10.1016/j.bbapap.2006.03.004; Siebenlist KR, 1996, BIOCHEMISTRY-US, V35, P10448, DOI 10.1021/bi9606206; Stewart RJ, 1998, J BIOL CHEM, V273, P18292, DOI 10.1074/jbc.273.29.18292; SUENSON E, 1990, J BIOL CHEM, V265, P22228; Tribouilloy C, 1998, AM J CARDIOL, V81, P321, DOI 10.1016/S0002-9149(97)00900-4; Tsurupa G, 2001, BIOCHEMISTRY-US, V40, P801, DOI 10.1021/bi001789t; Vu TT, 2013, J BIOL CHEM, V288, P16862, DOI 10.1074/jbc.M113.464750; Vu TT, 2011, J BIOL CHEM, V286, P30314, DOI 10.1074/jbc.M111.253831; Walker JB, 1999, J BIOL CHEM, V274, P5201, DOI 10.1074/jbc.274.8.5201; Wolberg AS, 2012, CURR OPIN HEMATOL, V19, P349, DOI 10.1097/MOH.0b013e32835673c2; YE J, 1994, J BIOL CHEM, V269, P17965	41	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27494	27503		10.1074/jbc.M114.588640	http://dx.doi.org/10.1074/jbc.M114.588640			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25128532	hybrid, Green Published			2022-12-28	WOS:000342852800012
J	Rharass, T; Lemcke, H; Lantow, M; Kuznetsov, SA; Weiss, DG; Panakova, D				Rharass, Tareck; Lemcke, Heiko; Lantow, Margareta; Kuznetsov, Sergei A.; Weiss, Dieter G.; Panakova, Daniela			Ca2+-mediated Mitochondrial Reactive Oxygen Species Metabolism Augments Wnt/beta-Catenin Pathway Activation to Facilitate Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Signaling; Mitochondrial Metabolism; Reactive Oxygen Species (ROS); Redox Signaling; Wnt Pathway; Dishevelled; Human Neural Progenitor Cells; Nucleoredoxin	INTRACELLULAR CALCIUM; SIGNALING PATHWAY; GROWTH-FACTOR; CA2+ RELEASE; MECHANISMS; INCREASE; PATTERNS; FRET; POOL; ROS	Background: Dissociation of the Wnt/-catenin pathway effector Dishevelled from its complex with nucleoredoxin is a redox-sensitive process, yet the ROS sources remain elusive. Results: Mitochondrial Ca2+ influx stimulates endogenous ROS production and mediates Wnt/-catenin pathway activity. Conclusion: Ca2+-mediated ROS production modulates the signaling efficiency of the Wnt/-catenin pathway. Significance: Metabolic states influence fundamental and developmental signaling to drive cell differentiation. Emerging evidence suggests that reactive oxygen species (ROS) can stimulate the Wnt/-catenin pathway in a number of cellular processes. However, potential sources of endogenous ROS have not been thoroughly explored. Here, we show that growth factor depletion in human neural progenitor cells induces ROS production in mitochondria. Elevated ROS levels augment activation of Wnt/-catenin signaling that regulates neural differentiation. We find that growth factor depletion stimulates the release of Ca2+ from the endoplasmic reticulum stores. Ca2+ subsequently accumulates in the mitochondria and triggers ROS production. The inhibition of mitochondrial Ca2+ uptake with simultaneous growth factor depletion prevents the rise in ROS metabolism. Moreover, low ROS levels block the dissociation of the Wnt effector Dishevelled from nucleoredoxin. Attenuation of the response amplitudes of pathway effectors delays the onset of the Wnt/-catenin pathway activation and results in markedly impaired neuronal differentiation. Our findings reveal Ca2+-mediated ROS metabolic cues that fine-tune the efficiency of cell differentiation by modulating the extent of the Wnt/-catenin signaling output.	[Rharass, Tareck; Panakova, Daniela] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Rharass, Tareck; Lemcke, Heiko; Lantow, Margareta; Weiss, Dieter G.] Univ Rostock, Inst Biol Sci, D-18059 Rostock, Germany; [Rharass, Tareck; Lemcke, Heiko; Kuznetsov, Sergei A.; Weiss, Dieter G.] Univ Rostock, Live Cell Imaging Ctr, D-18059 Rostock, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Rostock; University of Rostock	Panakova, D (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	daniela.panakova@mdc-berlin.de	Lantow, Margareta/A-1797-2017; Lemcke, Heiko/ABI-1979-2020	Panakova, Daniela/0000-0002-8739-6225; Rharass, Tareck/0000-0001-9406-1776	Helmholtz Association Young Investigator Groups program; Marie Curie Career Integration Grant; German Research Foundation as part of the Research Training School 1387 dIEM oSiRiS (Rostock, Germany)	Helmholtz Association Young Investigator Groups program; Marie Curie Career Integration Grant; German Research Foundation as part of the Research Training School 1387 dIEM oSiRiS (Rostock, Germany)	This work was supported by the Helmholtz Association Young Investigator Groups program to D. P., by Marie Curie Career Integration Grant to D. P., and by the German Research Foundation as part of the Research Training School 1387 dIEM oSiRiS (Rostock, Germany) to D. G. W.	Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Buckman JF, 2001, J NEUROSCI METH, V104, P165, DOI 10.1016/S0165-0270(00)00340-X; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Funato Y, 2010, CURR BIOL, V20, P1945, DOI 10.1016/j.cub.2010.09.065; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gerencser AA, 2005, BIOPHYS J, V88, P698, DOI 10.1529/biophysj.104.050062; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hofer A. M., 1999, IMAGING LIVING CELLS, P53; Hoffrogge R, 2006, PROTEOMICS, V6, P1833, DOI 10.1002/pmic.200500556; HORWITZ LD, 1995, J MOL CELL CARDIOL, V27, P909, DOI 10.1016/0022-2828(95)90041-1; Hubner R, 2010, BIOCHEM BIOPH RES CO, V400, P358, DOI 10.1016/j.bbrc.2010.08.066; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kajla S, 2012, FASEB J, V26, P2049, DOI 10.1096/fj.11-196360; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kim HY, 2011, J NEUROSCI, V31, P12982, DOI 10.1523/JNEUROSCI.3093-11.2011; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lajas AI, 1998, BIOCHEM PHARMACOL, V55, P903, DOI 10.1016/S0006-2952(97)00546-7; Lee WT, 2002, NEUROSCIENCE, V112, P707, DOI 10.1016/S0306-4522(02)00097-0; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Love NR, 2013, NAT CELL BIOL, V15, P222, DOI 10.1038/ncb2659; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mazemondet O, 2011, CELL MOL BIOL LETT, V16, P515, DOI 10.2478/s11658-011-0021-0; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Mussmann C, 2014, STEM CELLS DEV, V23, P1328, DOI 10.1089/scd.2013.0557; Novo E, 2012, J PATHOL, V226, P588, DOI 10.1002/path.3005; Ohno A, 2009, J PHARMACOL SCI, V110, P78, DOI 10.1254/jphs.09037FP; Panakova D, 2010, NATURE, V466, P874, DOI 10.1038/nature09249; Park MK, 2000, EMBO J, V19, P5729, DOI 10.1093/emboj/19.21.5729; Petrosillo G, 2004, J BIOL CHEM, V279, P53103, DOI 10.1074/jbc.M407500200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pietraszewska-Bogiel A, 2011, J MICROSC-OXFORD, V241, P111, DOI 10.1111/j.1365-2818.2010.03437.x; Poenie Martin, 2006, P1; PROFROCK A, 1991, BIOCHEM BIOPH RES CO, V180, P900, DOI 10.1016/S0006-291X(05)81150-7; Sandieson L, 2014, STEM CELLS DEV, V23, P1037, DOI 10.1089/scd.2014.0010; Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591; Spagnuolo G, 2006, BIOMATERIALS, V27, P1803, DOI 10.1016/j.biomaterials.2005.10.022; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tsuang Yang-Hwei, 2006, J Orthop Surg Res, V1, P7, DOI 10.1186/1749-799X-1-7; UEDA N, 1992, AM J PHYSIOL, V263, pF214, DOI 10.1152/ajprenal.1992.263.2.F214; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Wen JWH, 2012, CELL SIGNAL, V24, P2337, DOI 10.1016/j.cellsig.2012.07.024	52	66	69	4	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27937	27951		10.1074/jbc.M114.573519	http://dx.doi.org/10.1074/jbc.M114.573519			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25124032	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000342852800048
J	Zhang, ZL; Wu, J; Lin, W; Wang, J; Yan, H; Zhao, W; Ma, J; Ding, JP; Zhang, P; Zhao, GP				Zhang, Zilong; Wu, Jian; Lin, Wei; Wang, Jin; Yan, Han; Zhao, Wei; Ma, Jun; Ding, Jianping; Zhang, Peng; Zhao, Guo-Ping			Subdomain II of alpha-Isopropylmalate Synthase Is Essential for Activity INFERRING A MECHANISM OF FEEDBACK INHIBITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Cooperativity; Enzyme Catalysis; Enzyme Structure; Protein Conformation; Catalytic Module; Feedback Inhibition	TERMINAL REGULATORY DOMAIN; MYCOBACTERIUM-TUBERCULOSIS; LEPTOSPIRA-INTERROGANS; SALMONELLA-TYPHIMURIUM; SUBSTRATE-SPECIFICITY; CITRAMALATE SYNTHASE; HOMOCITRATE SYNTHASE; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; LEUCINE OPERON	Background: Isopropylmalate synthases (IPMSs) with and without a regulatory domain were found. Results: IPMS subdomain II is essential for activities and likely involved in acetyl-CoA binding-mediated conformation transition. Conclusion: The N-terminal domain and the two subdomains comprise the complete and independently functional catalytic module of IPMS. Significance: The IPMS catalytic module was defined and characterized, which inferred a probable feedback inhibition mechanism. The committed step of leucine biosynthesis, converting acetyl-CoA and -ketoisovalerate into -isopropylmalate, is catalyzed by -isopropylmalate synthase (IPMS), an allosteric enzyme subjected to feedback inhibition by the end product l-leucine. We characterized the short form IPMS from Leptospira biflexa (LbIPMS2), which exhibits a catalytic activity comparable with that of the long form IPMS (LbIPMS1) and has a similar N-terminal domain followed by subdomain I and subdomain II but lacks the whole C-terminal regulatory domain. We found that partial deletion of the regulatory domain of LbIPMS1 resulted in a loss of about 50% of the catalytic activity; however, when the regulatory domain was deleted up to Arg-385, producing a protein that is almost equivalent to the intact LbIPMS2, about 90% of the activity was maintained. Moreover, in LbIPMS2 or LbIPMS1, further deletion of several residues from the C terminus of subdomain II significantly impaired or completely abolished the catalytic activity, respectively. These results define a complete and independently functional catalytic module of IPMS consisting of both the N-terminal domain and the two subdomains. Structural comparison of LbIPMS2 and the Mycobacterium tuberculosis IPMS revealed two different conformations of subdomain II that likely represent two substrate-binding states related to cooperative catalysis. The biochemical and structural analyses together with the previously published hydrogen-deuterium exchange data led us to propose a conformation transition mechanism for feedback inhibition mediated by subdomains I and II that might associated with alteration of the binding affinity toward acetyl-CoA.	[Ma, Jun; Zhang, Peng; Zhao, Guo-Ping] Chinese Acad Sci, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [Zhang, Peng] Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China; [Wu, Jian; Ding, Jianping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Zhao, Wei; Zhao, Guo-Ping] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Educ, Shanghai 200433, Peoples R China; [Zhao, Wei; Zhao, Guo-Ping] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Hlth, Shanghai 200433, Peoples R China; [Zhao, Wei; Zhao, Guo-Ping] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Shanghai 200433, Peoples R China; [Zhao, Guo-Ping] Chinese Natl Human Genome Ctr, Shanghai Minist Sci & Technol, Key Lab Hlth & Dis Genom, Shanghai 201203, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Zhang, Zilong] Shanghai Entry Exit Inspect & Quarantine Bur, Shanghai Int Travel Healthcare Ctr, Shanghai 200335, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Fudan University; Fudan University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Ding, JP (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China.	jpding@sibs.ac.cn; pengzhang01@sibs.ac.cn; gpzhao@sibs.ac.cn		Zhao, Wei/0000-0002-2422-8398; ding, jian ping/0000-0001-7029-7346	National Basic Research Program of China [2012CB721102]; National Nature Science Foundation of China [31322016, 31170690, 31121001, 30830002]; "Special Talent" Program of the Shanghai Institutes for Biological Sciences [2012OHTP]; National Key Laboratory of Plant Molecular Genetics, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Special Talent" Program of the Shanghai Institutes for Biological Sciences; National Key Laboratory of Plant Molecular Genetics, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences	This work was supported by National Basic Research Program of China Grant 2012CB721102; National Nature Science Foundation of China Grants 31322016, 31170690, 31121001, and 30830002; and "Special Talent" Program Grant 2012OHTP of the Shanghai Institutes for Biological Sciences and The National Key Laboratory of Plant Molecular Genetics, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bulfer SL, 2010, J BIOL CHEM, V285, P10446, DOI 10.1074/jbc.M109.094383; Bulfer SL, 2009, J BIOL CHEM, V284, P35769, DOI 10.1074/jbc.M109.046821; BURNS RO, 1966, J BACTERIOL, V91, P1570, DOI 10.1128/JB.91.4.1570-1576.1966; Casey AK, 2013, BIOCHEMISTRY-US, V52, P6737, DOI 10.1021/bi401186v; Cavalieri D, 1999, MOL GEN GENET, V261, P152, DOI 10.1007/s004380050952; Chanchaem W, 2002, TUBERCULOSIS, V82, P1, DOI 10.1054/tube.2001.0314; de Carvalho LPS, 2005, J AM CHEM SOC, V127, P10004, DOI 10.1021/ja052513h; de Carvalho LPS, 2006, BIOCHEMISTRY-US, V45, P8988, DOI 10.1021/bi0606602; de Carvalho LPS, 2006, ARCH BIOCHEM BIOPHYS, V451, P141, DOI 10.1016/j.abb.2006.03.030; de Carvalho LPS, 2009, BIOCHEMISTRY-US, V48, P1996, DOI 10.1021/bi801707t; de Kraker JW, 2007, PLANT PHYSIOL, V143, P970, DOI 10.1104/pp.106.085555; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frantom PA, 2009, BIOCHEMISTRY-US, V48, P7457, DOI 10.1021/bi900851q; GODON JJ, 1992, J BACTERIOL, V174, P6580, DOI 10.1128/JB.174.20.6580-6589.1992; Huisman FHA, 2013, BIOCHEM BIOPH RES CO, V433, P249, DOI 10.1016/j.bbrc.2013.02.092; Huisman FHA, 2012, BIOCHEMISTRY-US, V51, P2289, DOI 10.1021/bi201717j; Huisman FHA, 2010, BIOCHEM BIOPH RES CO, V393, P168, DOI 10.1016/j.bbrc.2010.01.114; KOHLHAW G, 1969, J BIOL CHEM, V244, P2218; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; LEARY TR, 1972, J BIOL CHEM, V247, P1089; Ma J, 2008, BIOCHEM J, V415, P45, DOI 10.1042/BJ20080242; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Singh K, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-39; SOMERS JM, 1973, J BACTERIOL, V113, P1268, DOI 10.1128/JB.113.3.1268-1272.1973; SOPER TS, 1976, ARCH BIOCHEM BIOPHYS, V173, P362, DOI 10.1016/0003-9861(76)90271-X; Stols Lucy, 2004, Journal of Structural and Functional Genomics, V5, P95, DOI 10.1023/B:JSFG.0000029196.87615.6e; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1872, DOI 10.1107/S090744499901029X; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; ULM EH, 1972, J BACTERIOL, V110, P1118, DOI 10.1128/JB.110.3.1118-1126.1972; WEBSTER RE, 1965, BIOCHEMISTRY-US, V4, P2319, DOI 10.1021/bi00887a009; WIEGEL J, 1977, ARCH MICROBIOL, V114, P203, DOI 10.1007/BF00446863; WIEGEL J, 1977, ARCH MICROBIOL, V112, P239, DOI 10.1007/BF00413087; WIEGEL J, 1977, ARCH MICROBIOL, V112, P247, DOI 10.1007/BF00413088; Zhang P, 2009, BIOCHEM J, V421, P133, DOI 10.1042/BJ20090336	41	12	17	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27966	27978		10.1074/jbc.M114.559716	http://dx.doi.org/10.1074/jbc.M114.559716			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25128527	hybrid, Green Published			2022-12-28	WOS:000342852800050
J	Okumura, M; Kadokura, H; Hashimoto, S; Yutani, K; Kanemura, S; Hikima, T; Hidaka, Y; Ito, L; Shiba, K; Masui, S; Imai, D; Imaoka, S; Yamaguchi, H; Inaba, K				Okumura, Masaki; Kadokura, Hiroshi; Hashimoto, Shoko; Yutani, Katsuhide; Kanemura, Shingo; Hikima, Takaaki; Hidaka, Yuji; Ito, Len; Shiba, Kohei; Masui, Shoji; Imai, Daiki; Imaoka, Susumu; Yamaguchi, Hiroshi; Inaba, Kenji			Inhibition of the Functional Interplay between Endoplasmic Reticulum (ER) Oxidoreduclin-1 alpha (Ero1 alpha) and Protein-disulfide Isomerase (PDI) by the Endocrine Disruptor Bisphenol A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXIREDOXIN IV; BINDING-SITE; FAMILY; DOMAIN; SCATTERING; EXPOSURE; IDENTIFICATION; THIOREDOXIN; MECHANISMS; EXPRESSION	Bisphenol A (BPA) is an endocrine disruptor that may have adverse effects on human health. We recently isolated protein-disulfide isomerase (PDI) as a BPA-binding protein from rat brain homogenates and found that BPA markedly inhibited PDI activity. To elucidate mechanisms of this inhibition, detailed structural, biophysical, and functional analyses of PDI were performed in the presence of BPA. BPA binding to PDI induced significant rearrangement of the N-terminal thioredoxin domain of PDI, resulting in more compact overall structure. This conformational change led to closure of the substrate-binding pocket in b' domain, preventing PDI from binding to unfolded proteins. The b' domain also plays an essential role in the interplay between PDI and ER oxidoreduclin 1 alpha (Ero1 alpha), a flavoenzyme responsible for reoxidation of PDI. We show that BPA inhibited Ero1 alpha-catalyzed PDI oxidation presumably by inhibiting the interaction between the b' domain of PDI and Ero1 alpha; the phenol groups of BPA probably compete with a highly conserved tryptophan residue, located in the protruding beta-hairpin of Ero1 alpha, for binding to PDI. Consistently, BPA slowed down the reoxidation of PDI and caused the reduction of PDI in HeLa cells, indicating that BPA has a great impact on the redox homeostasis of PDI within cells. However, BPA had no effect on the interaction between PDI and peroxiredoxin-4 (Prx4), another PDI family oxidase, suggesting that the interaction between Prx4 and PDI is different from that of Ero1 alpha and PDI. These results indicate that BPA, a widely distributed and potentially harmful chemical, inhibits Ero1-PDI-mediated disulfide bond formation.	[Okumura, Masaki; Hashimoto, Shoko; Kanemura, Shingo; Ito, Len; Imai, Daiki; Imaoka, Susumu; Yamaguchi, Hiroshi] Kwansei Gakuin Univ, Sch Sci & Technol, Sanda, Hyogo 6691337, Japan; [Okumura, Masaki; Masui, Shoji; Inaba, Kenji] Kyushu Univ, Med Inst Bioregulat, Div Prot Chem, Higashi Ku, Fukuoka 8128582, Japan; [Okumura, Masaki; Yutani, Katsuhide; Kanemura, Shingo; Hikima, Takaaki; Yamaguchi, Hiroshi] RIKEN, RIKEN SPring Ctr 8, Sayo, Hyogo 6795148, Japan; [Okumura, Masaki; Hidaka, Yuji] Kinki Univ, Sch Fac Sci & Engn, Higashiosaka, Osaka 5778502, Japan; [Shiba, Kohei] Sysmex Corp, ProCube Business Div, Nishi Ku, Kobe, Hyogo 6512241, Japan; [Okumura, Masaki; Kadokura, Hiroshi; Kanemura, Shingo; Masui, Shoji; Inaba, Kenji] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Kwansei Gakuin University; Kyushu University; RIKEN; Kindai University (Kinki University); Sysmex Corporation; Tohoku University	Okumura, M (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.	okmasaki@mail.tagen.tohoku.ac.jp; hiroshi@kwansei.ac.jp; kinaba@tagen.tohoku.ac.jp	okumura, masaki/AAO-3454-2020; Kadokura, Hiroshi/AAE-1645-2019	okumura, masaki/0000-0001-8130-2470; Kanemura, Shingo/0000-0002-7012-8179; Kadokura, Hiroshi/0000-0001-7308-7141; HIDAKA, YUJI/0000-0002-3131-2619; Inaba, Kenji/0000-0001-8229-0467	Next Generation World-leading Researchers program (MEXT)	Next Generation World-leading Researchers program (MEXT)	This work was supported by funding from the Next Generation World-leading Researchers program (MEXT) (to K. I.), by a grant-in-aid for scientific research (B) (to S. I.), by a grant-in-aid for scientific research (C) (to H. Y. and H. K.), by a grant-in-aid for scientific research on innovative areas (to K. I. and H. K.), and by a grant-in-aid for Japan Society for the Promotion of Science fellows (to M. O., S. H., and S. M.).	[Anonymous], 1956, J POLYM SCI, DOI DOI 10.1002/POL.1956.120199326; Araki K, 2013, J CELL BIOL, V202, P861, DOI 10.1083/jcb.201303027; Araki K, 2012, ANTIOXID REDOX SIGN, V16, P790, DOI 10.1089/ars.2011.4418; Asahi J, 2010, LIFE SCI, V87, P431, DOI 10.1016/j.lfs.2010.08.007; Bindhumol V, 2003, TOXICOLOGY, V188, P117, DOI 10.1016/S0300-483X(03)00056-8; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Byrne LJ, 2009, BIOCHEM J, V423, P209, DOI 10.1042/BJ20090565; Cao ZB, 2014, J BIOL CHEM, V289, P5490, DOI 10.1074/jbc.M113.529305; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; Fagin D, 2012, NATURE, V490, P462, DOI 10.1038/490462a; Fujisawa T, 2000, J APPL CRYSTALLOGR, V33, P797, DOI 10.1107/S002188980000131X; Hashimoto S, 2012, ACTA CRYSTALLOGR F, V68, P476, DOI 10.1107/S1744309112007439; Hashimoto S, 2012, CHEM RES TOXICOL, V25, P656, DOI 10.1021/tx200374s; Hashimoto S, 2012, J BIOCHEM, V151, P35, DOI 10.1093/jb/mvr122; Hiroi T, 2006, ENDOCRINOLOGY, V147, P2773, DOI 10.1210/en.2005-1235; Imaoka S, 2007, BIOL PHARM BULL, V30, P371, DOI 10.1248/bpb.30.371; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Jenkins S, 2011, ENVIRON HEALTH PERSP, V119, P1604, DOI 10.1289/ehp.1103850; Kadokura H, 2013, BIOCHEM BIOPH RES CO, V440, P245, DOI 10.1016/j.bbrc.2013.09.063; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kidani T, 2010, J ATHEROSCLER THROMB, V17, P834, DOI 10.5551/jat.4051; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Kojima R., 2013, ELS, DOI [10.1002/9780470015902.a0024169, DOI 10.1002/9780470015902.A0024169]; Kojima R, 2014, STRUCTURE, V22, P431, DOI 10.1016/j.str.2013.12.013; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Narayan M, 2012, FEBS J, V279, P2272, DOI 10.1111/j.1742-4658.2012.08636.x; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Obata T, 2000, NEUROSCI LETT, V296, P41, DOI 10.1016/S0304-3940(00)01619-0; Okumura M., 2014, CURR PROTOC PROTEIN, V76; Okumura M, 2012, FEBS LETT, V586, P3926, DOI 10.1016/j.febslet.2012.09.031; Okumura M, 2012, FEBS J, V279, P2283, DOI 10.1111/j.1742-4658.2012.08596.x; Okumura M, 2011, FEBS J, V278, P1137, DOI 10.1111/j.1742-4658.2011.08039.x; Papaconstantinou AD, 2001, TOXICOL SCI, V63, P173, DOI 10.1093/toxsci/63.2.173; Pirneskoski A, 2001, J BIOL CHEM, V276, P11287, DOI 10.1074/jbc.M010656200; Plotnikov V, 2002, ASSAY DRUG DEV TECHN, V1, P83, DOI 10.1089/154065802761001338; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; Ramming T, 2012, ANTIOXID REDOX SIGN, V16, P1109, DOI 10.1089/ars.2011.4475; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Sato Y, 2012, FEBS J, V279, P2262, DOI 10.1111/j.1742-4658.2012.08593.x; SCHELLMAN JA, 1976, BIOPOLYMERS, V15, P999, DOI 10.1002/bip.1976.360150513; SCHELLMAN JA, 1975, BIOPOLYMERS, V14, P999, DOI 10.1002/bip.1975.360140509; Shao F, 2000, J BIOL CHEM, V275, P13349, DOI 10.1074/jbc.275.18.13349; Shiba K, 2010, ANAL SCI, V26, P659, DOI 10.2116/analsci.26.659; SVERGUN DI, 1991, J APPL CRYSTALLOGR, V24, P485, DOI 10.1107/S0021889891001280; Tabuchi Y, 2006, BIOCHEM BIOPH RES CO, V345, P1044, DOI 10.1016/j.bbrc.2006.04.177; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tian G, 2008, J BIOL CHEM, V283, P33630, DOI 10.1074/jbc.M806026200; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; WALKER KW, 1995, BIOCHEMISTRY-US, V34, P13642, DOI 10.1021/bi00041a045; Wang C, 2013, ANTIOXID REDOX SIGN, V19, P44, DOI 10.1089/ars.2012.4630; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0; WEISSMAN JS, 1995, NAT STRUCT BIOL, V2, P1123, DOI 10.1038/nsb1295-1123; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; Wijesekara N, 2010, J BIOL CHEM, V285, P33623, DOI 10.1074/jbc.M109.085084	56	30	32	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27004	27018		10.1074/jbc.M114.564104	http://dx.doi.org/10.1074/jbc.M114.564104			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122773	Green Published, hybrid			2022-12-28	WOS:000342853900029
J	Evron, T; Peterson, SM; Urs, NM; Bai, YS; Rochelle, LK; Caron, MG; Barak, LS				Evron, Tama; Peterson, Sean M.; Urs, Nikhil M.; Bai, Yushi; Rochelle, Lauren K.; Caron, Marc G.; Barak, Larry S.			G Protein and beta-Arrestin Signaling Bias at the Ghrelin Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-HORMONE SECRETAGOGUE; COUPLED RECEPTORS; CONSTITUTIVE ACTIVITY; NUCLEUS-ACCUMBENS; FOOD-INTAKE; BINDING PROTEIN; MESSENGER-RNA; DENTATE GYRUS; IN-VIVO; ANTAGONISTS	The G protein-coupled ghrelin receptor GHSR1a is a potential pharmacological target for treating obesity and addiction because of the critical role ghrelin plays in energy homeostasis and dopamine-dependent reward. GHSR1a enhances growth hormone release, appetite, and dopamine signaling through G(q/11), G(i/o), and G(12/13) as well as beta-arrestin-based scaffolds. However, the contribution of individual G protein and beta-arrestin pathways to the diverse physiological responses mediated by ghrelin remains unknown. To characterize whether a signaling bias occurs for GHSR1a, we investigated ghrelin signaling in a number of cell-based assays, including Ca2+ mobilization, serum response factor response element, stress fiber formation, ERK1/2 phosphorylation, and beta-arrestin translocation, utilizing intracellular second loop and C-tail mutants of GHSR1a. We observed that GHSR1a and beta-arrestin rapidly form metastable plasma membrane complexes following exposure to an agonist, but replacement of the GHSR1a C-tail by the tail of the vasopressin 2 receptor greatly stabilizes them, producing complexes observable on the plasma membrane and also in endocytic vesicles. Mutations of the contiguous conserved amino acids Pro-148 and Leu-149 in the GHSR1a intracellular second loop generate receptors with a strong bias to G protein and beta-arrestin, respectively, supporting a role for conformation-dependent signaling bias in the wild-type receptor. Our results demonstrate more balance in GHSR1a-mediated ERK signaling from G proteins and beta-arrestin but uncover an important role for beta-arrestin in RhoA activation and stress fiber formation. These findings suggest an avenue for modulating drug abuse-associated changes in synaptic plasticity via GHSR1a and indicate the development of GHSR1a-biased ligands as a promising strategy for selectively targeting downstream signaling events.	[Evron, Tama; Peterson, Sean M.; Urs, Nikhil M.; Bai, Yushi; Rochelle, Lauren K.; Caron, Marc G.; Barak, Larry S.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3287, Durham, NC 27710 USA.	marc.caron@dm.duke.edu; lawrence.barak@dm.duke.edu		Peterson, Sean/0000-0003-4873-0283	National Institute on Drug Abuse [IP30-DA-029925-01, R37-MH-073853, U19-MH-08244]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH073853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA029925] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institute on Drug Abuse Grants IP30-DA-029925-01, R37-MH-073853, and U19-MH-08244.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Barak LS, 2012, BIOCHEMISTRY-US, V51, P1114, DOI 10.1021/bi201308s; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; Bennett KA, 2009, MOL PHARMACOL, V76, P802, DOI 10.1124/mol.109.056101; Camina JP, 2006, J NEUROENDOCRINOL, V18, P65, DOI 10.1111/j.1365-2826.2005.01379.x; Camina JP, 2004, ENDOCRINOLOGY, V145, P930, DOI 10.1210/en.2003-0974; Charoenthongtrakul S, 2009, J PHARMACOL EXP THER, V329, P1178, DOI 10.1124/jpet.108.150193; Chen LA, 2011, EUR J NEUROSCI, V33, P266, DOI 10.1111/j.1460-9568.2010.07491.x; Cheng Zhijie, 2010, Curr Chem Genomics, V4, P84, DOI 10.2174/1875397301004010084; Costantini VJA, 2011, NEUROENDOCRINOLOGY, V94, P158, DOI 10.1159/000328968; Davis JF, 2011, PHYSIOL BEHAV, V103, P39, DOI 10.1016/j.physbeh.2010.10.017; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Dickson SL, 2011, MOL CELL ENDOCRINOL, V340, P80, DOI 10.1016/j.mce.2011.02.017; Dietz DM, 2012, NAT NEUROSCI, V15, P891, DOI 10.1038/nn.3094; Esler WP, 2007, ENDOCRINOLOGY, V148, P5175, DOI 10.1210/en.2007-0239; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Hershberger PM, 2014, BIOORG MED CHEM LETT, V24, P262, DOI 10.1016/j.bmcl.2013.11.026; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Holliday ND, 2007, MOL ENDOCRINOL, V21, P3100, DOI 10.1210/me.2007-0254; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Holst B, 2005, MOL ENDOCRINOL, V19, P2400, DOI 10.1210/me.2005-0059; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; JACKS T, 1994, J ENDOCRINOL, V143, P399, DOI 10.1677/joe.0.1430399; Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x; Jerlhag E, 2010, PSYCHOPHARMACOLOGY, V211, P415, DOI 10.1007/s00213-010-1907-7; Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106; Kapur A, 2009, J BIOL CHEM, V284, P29817, DOI 10.1074/jbc.M109.050187; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Marion S, 2006, J BIOL CHEM, V281, P2932, DOI 10.1074/jbc.M508074200; Mary S, 2012, P NATL ACAD SCI USA, V109, P8304, DOI 10.1073/pnas.1119881109; McKee KK, 1997, MOL ENDOCRINOL, V11, P415, DOI 10.1210/me.11.4.415; Mihalic JT, 2012, BIOORG MED CHEM LETT, V22, P2046, DOI 10.1016/j.bmcl.2012.01.014; Mokrosinski J, 2012, J BIOL CHEM, V287, P33488, DOI 10.1074/jbc.M112.383240; MORO O, 1993, J BIOL CHEM, V268, P22273; Moulin A, 2008, J MED CHEM, V51, P689, DOI 10.1021/jm701292s; Moulin A, 2013, AMINO ACIDS, V44, P301, DOI 10.1007/s00726-012-1355-2; Mousseaux D, 2006, BRIT J PHARMACOL, V148, P350, DOI 10.1038/sj.bjp.0706727; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Naleid AM, 2005, PEPTIDES, V26, P2274, DOI 10.1016/j.peptides.2005.04.025; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Peddibhotla S, 2013, ACS MED CHEM LETT, V4, P846, DOI 10.1021/ml400176n; Perdona E, 2011, EUR J PHARMACOL, V650, P178, DOI 10.1016/j.ejphar.2010.10.042; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Sabbatini FM, 2010, CHEMMEDCHEM, V5, P1450, DOI 10.1002/cmdc.201000185; Sivertsen B, 2013, BRIT J PHARMACOL, V170, P1349, DOI 10.1111/bph.12361; Sivertsen B, 2011, J BIOL CHEM, V286, P20845, DOI 10.1074/jbc.M110.173237; Skibicka KP, 2011, NEUROSCIENCE, V180, P129, DOI 10.1016/j.neuroscience.2011.02.016; Skolnick P, 2012, BIOL PSYCHIAT, V72, P890, DOI 10.1016/j.biopsych.2012.08.004; Smith RG, 1997, ENDOCR REV, V18, P621, DOI 10.1210/er.18.5.621; Snyder JC, 2013, J BIOL CHEM, V288, P10286, DOI 10.1074/jbc.M112.447540; Stavenger RA, 2007, J MED CHEM, V50, P2, DOI 10.1021/jm060873p; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	66	54	54	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2014	289	48					33442	33455		10.1074/jbc.M114.581397	http://dx.doi.org/10.1074/jbc.M114.581397			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU5HC	25261469	Green Published, hybrid			2022-12-28	WOS:000345636600033
J	Jin, ES; Sherry, AD; Malloy, CR				Jin, Eunsook S.; Sherry, A. Dean; Malloy, Craig R.			Interaction between the Pentose Phosphate Pathway and Gluconeogenesis from Glycerol in the Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTOPOMER DISTRIBUTION ANALYSIS; KREBS CYCLE; GLUCOSE-PRODUCTION; MASS; METABOLISM; LIMITATIONS; (H2O)-H-2; DEUTERIUM; CARBON; FLUX	After exposure to [U-C-13(3)] glycerol, the liver produces primarily [1,2,3-C-13(3)]- and [4,5,6-C-13(3)] glucose in equal proportions through gluconeogenesis from the level of trioses. Other C-13-labeling patterns occur as a consequence of alternative pathways for glucose production. The pentose phosphate pathway (PPP), metabolism in the citric acid cycle, incomplete equilibration by triose phosphate isomerase, or the transaldolase reaction all interact to produce complex C-13-labeling patterns in exported glucose. Here, we investigated C-13 labeling in plasma glucose in rats given [U-C-13(3)]glycerol under various nutritional conditions. Blood was drawn at multiple time points to extract glucose for NMR analysis. Because the transaldolase reaction and incomplete equilibrium by triose phosphate isomerase cannot break a C-13-C-13 bond within the trioses contributing to glucose, the appearance of [1,2-C-13(2)]-, [2,3-C-13(2)]-, [5,6-C-13(2)]-, and [4,5-C-13(2)] glucose provides direct evidence for metabolism of glycerol in the citric acid cycle or the PPP but not an influence of either triose phosphate isomerase or the transaldolase reaction. In all animals, [1,2-C-13(2)] glucose/[2,3-C-13(2)] glucose was significantly greater than [5,6-C-13(2)] glucose/[4,5-C-13(2)] glucose, a relationship that can only arise from gluconeogenesis followed by passage of substrates through the PPP. In summary, the hepatic PPP in vivo can be detected by C-13 distribution in blood glucose after [U-C-13(3)] glycerol administration.	[Jin, Eunsook S.; Sherry, A. Dean; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Jin, Eunsook S.; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Sherry, A. Dean; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Sherry, A. Dean] Univ Texas Dallas, Dept Chem, Richardson, TX 75080 USA; [Malloy, Craig R.] Vet Affairs North Texas Hlth Care Syst, Dallas, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Jin, ES (corresponding author), Adv Imaging Res Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eunsook.jin@utsouthwestern.edu	Sherry, Dean/P-2348-2018	Sherry, Dean/0000-0001-7150-8301; Malloy, Craig/0000-0001-5077-0642	National Institutes of Health [DK078933, DK099289, RR 002584, EB 015908, HL-34557]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034557, R37HL034557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078933, P01DK058398, R01DK099289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK078933 and DK099289 (to E. S. J.), RR 002584 and EB 015908 (to C. R. M.), and HL-34557 (to A. D. S.).	Bock G, 2008, DIABETES, V57, P50, DOI 10.2337/db07-0694; Browning JD, 2012, AM J PHYSIOL-ENDOC M, V303, pE1304, DOI 10.1152/ajpendo.00306.2012; GUO ZK, 1992, ANAL BIOCHEM, V204, P273, DOI 10.1016/0003-2697(92)90238-3; HOSTETLER KY, 1969, J BIOL CHEM, V244, P2075; INBAR L, 1991, J BACTERIOL, V173, P7790, DOI 10.1128/jb.173.24.7790-7801.1991; Jin ES, 2004, ANAL BIOCHEM, V327, P149, DOI 10.1016/j.ab.2003.12.036; Jin ES, 2013, J BIOL CHEM, V288, P2914, DOI 10.1074/jbc.M112.409441; Jones JG, 2008, MAGN RESON MED, V59, P423, DOI 10.1002/mrm.21451; KATZ J, 1993, J BIOL CHEM, V268, P25509; Kurland IJ, 2000, J BIOL CHEM, V275, P36787, DOI 10.1074/jbc.M004739200; Landau BR, 1996, J CLIN INVEST, V98, P378, DOI 10.1172/JCI118803; LANDAU BR, 1964, J BIOL CHEM, V239, P686; LJUNGDAHL L, 1961, J BIOL CHEM, V236, P1622; MAGNUSSON I, 1988, P NATL ACAD SCI USA, V85, P4682, DOI 10.1073/pnas.85.13.4682; MAGNUSSON I, 1991, J BIOL CHEM, V266, P6975; NEESE RA, 1995, J BIOL CHEM, V270, P14452, DOI 10.1074/jbc.270.24.14452; Previs SF, 1998, J BIOL CHEM, V273, P16853, DOI 10.1074/jbc.273.27.16853; PREVIS SF, 1995, J BIOL CHEM, V270, P19806, DOI 10.1074/jbc.270.34.19806; SCHUMANN WC, 1991, J BIOL CHEM, V266, P6985; VEECH RL, 1969, BIOCHEM J, V115, P837, DOI 10.1042/bj1150837	20	24	25	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.577692	http://dx.doi.org/10.1074/jbc.M114.577692			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25288790	Green Published, hybrid			2022-12-28	WOS:000345335000018
J	Lee, Y; Stiers, KM; Kain, BN; Beamer, LJ				Lee, Yingying; Stiers, Kyle M.; Kain, Bailee N.; Beamer, Lesa J.			Compromised Catalysis and Potential Folding Defects in in Vitro Studies of Missense Mutants Associated with Hereditary Phosphoglucomutase 1 Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Mutation; Genetic Disease; Kinetics; Metabolic Disease; N-linked Glycosylation; Protein Misfolding	LYSOSOMAL STORAGE DISEASES; PHARMACOLOGICAL CHAPERONES; INTRAGENIC RECOMBINATION; EXPRESSION ANALYSIS; MECHANISM; PROTEIN; PGM1; IDENTIFICATION; POLYMORPHISM; STRATEGIES	Background: Phosphoglucomutase 1 deficiency is a newly described inherited disorder in humans. Results:In vitro studies of 13 missense variants associated with disease are presented. Conclusion: Compromised catalysis and differential effects on recombinant protein folding/stability are found. Significance: Biochemical defects are consistent with previous in vivo studies and may have clinical relevance. Recent studies have identified phosphoglucomutase 1 (PGM1) deficiency as an inherited metabolic disorder in humans. Affected patients show multiple disease phenotypes, including dilated cardiomyopathy, exercise intolerance, and hepatopathy, reflecting the central role of the enzyme in glucose metabolism. We present here the first in vitro biochemical characterization of 13 missense mutations involved in PGM1 deficiency. The biochemical phenotypes of the PGM1 mutants cluster into two groups: those with compromised catalysis and those with possible folding defects. Relative to the recombinant wild-type enzyme, certain missense mutants show greatly decreased expression of soluble protein and/or increased aggregation. In contrast, other missense variants are well behaved in solution, but show dramatic reductions in enzyme activity, with k(cat)/K-m often <1.5% of wild-type. Modest changes in protein conformation and flexibility are also apparent in some of the catalytically impaired variants. In the case of the G291R mutant, severely compromised activity is linked to the inability of a key active site serine to be phosphorylated, a prerequisite for catalysis. Our results complement previous in vivo studies, which suggest that both protein misfolding and catalytic impairment may play a role in PGM1 deficiency.	[Lee, Yingying; Stiers, Kyle M.; Kain, Bailee N.; Beamer, Lesa J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Beamer, LJ (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	beamerl@missouri.edu		Stiers, Kyle/0000-0001-5542-022X	National Science Foundation [MCB-1409898]	National Science Foundation(National Science Foundation (NSF))	This work was supported National Science Foundation Grant MCB-1409898 (to L. J. B.).	Beamer L, 2015, J INHERIT METAB DIS, V38, P243, DOI 10.1007/s10545-014-9757-9; Boyd RE, 2013, J MED CHEM, V56, P2705, DOI 10.1021/jm301557k; Gamez A, 2000, J BIOL CHEM, V275, P29737, DOI 10.1074/jbc.M003231200; Gloria-Bottini F, 2001, AM J HUM BIOL, V13, P417, DOI 10.1002/ajhb.1066; Gloria-Bottini F, 2007, AM J MED SCI, V334, P421, DOI 10.1097/MAJ.0b013e3180a5e934; Gregersen N, 2006, J INHERIT METAB DIS, V29, P456, DOI 10.1007/s10545-006-0301-4; Gururaj A, 2004, ONCOGENE, V23, P8118, DOI 10.1038/sj.onc.1207969; Vega AI, 2011, J INHERIT METAB DIS, V34, P929, DOI 10.1007/s10545-011-9328-2; JENSEN TG, 1995, HUM MUTAT, V6, P226, DOI 10.1002/humu.1380060305; Jolly L, 1999, EUR J BIOCHEM, V262, P202, DOI 10.1046/j.1432-1327.1999.00373.x; Jorge-Finnigan A, 2013, HUM MOL GENET, V22, P3680, DOI 10.1093/hmg/ddt217; Leandro J, 2011, BBA-MOL BASIS DIS, V1812, P106, DOI 10.1016/j.bbadis.2010.09.015; Lee Y, 2014, J BIOL CHEM, V289, P4674, DOI 10.1074/jbc.M113.532226; Liu YW, 1997, ACTA CRYSTALLOGR D, V53, P392, DOI 10.1107/S0907444997000875; Maier EM, 2009, HUM MOL GENET, V18, P1612, DOI 10.1093/hmg/ddp079; Majtan T, 2010, J BIOL CHEM, V285, P15866, DOI 10.1074/jbc.M110.107722; MARCH RE, 1993, P NATL ACAD SCI USA, V90, P10730, DOI 10.1073/pnas.90.22.10730; MCALPINE PJ, 1970, ANN HUM GENET, V34, P169, DOI 10.1111/j.1469-1809.1970.tb00230.x; Morava E, 2014, MOL GENET METAB, V112, P275, DOI 10.1016/j.ymgme.2014.06.002; Muntau AC, 2014, J INHERIT METAB DIS, V37, P505, DOI 10.1007/s10545-014-9701-z; Ondruskova N, 2014, NEUROENDOCRINOL LETT, V35, P137; Parenti G, 2013, INT J MOL MED, V31, P11, DOI 10.3892/ijmm.2012.1187; Perez B, 2013, J INHERIT METAB DIS, V36, P535, DOI 10.1007/s10545-012-9525-7; QUICK CB, 1974, EUR J BIOCHEM, V42, P511, DOI 10.1111/j.1432-1033.1974.tb03366.x; RAY WJ, 1990, BIOCHEMISTRY-US, V29, P2770, DOI 10.1021/bi00463a021; Shackelford GS, 2004, PROTEIN SCI, V13, P2130, DOI 10.1110/ps.04801104; Stojkovic T, 2009, NEW ENGL J MED, V361, P425, DOI 10.1056/NEJMc0901158; TAKAHASHI N, 1993, P NATL ACAD SCI USA, V90, P10725, DOI 10.1073/pnas.90.22.10725; Tegtmeyer LC, 2014, NEW ENGL J MED, V370, P533, DOI 10.1056/NEJMoa1206605; Timal S, 2012, HUM MOL GENET, V21, P4151, DOI 10.1093/hmg/dds123; Waters PJ, 2000, MOL GENET METAB, V69, P101, DOI 10.1006/mgme.2000.2965; Whitehouse DB, 1998, MOL BIOL EVOL, V15, P456, DOI 10.1093/oxfordjournals.molbev.a025942	32	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32010	32019		10.1074/jbc.M114.597914	http://dx.doi.org/10.1074/jbc.M114.597914			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25288802	Green Published, hybrid			2022-12-28	WOS:000345314700030
J	Adamczack, J; Hoffmann, M; Papke, U; Haufschildt, K; Nicke, T; Broring, M; Sezer, M; Weimar, R; Kuhlmann, U; Hildebrandt, P; Layer, G				Adamczack, Julia; Hoffmann, Martin; Papke, Ulrich; Haufschildt, Kristin; Nicke, Tristan; Broering, Martin; Sezer, Murat; Weimar, Rebecca; Kuhlmann, Uwe; Hildebrandt, Peter; Layer, Gunhild			NirN Protein from Pseudomonas aeruginosa is a Novel Electron-bifurcating Dehydrogenase Catalyzing the Last Step of Heme d(1) Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD(1) NITRITE REDUCTASE; RESONANCE RAMAN-SPECTRA; CYTOCHROME CD(1); GENE-CLUSTER; VINYL INFLUENCES; OXIDASE; PROTOPORPHYRIN; BIOGENESIS; LOCUS; BANDS	Heme d(1) plays an important role in denitrification as the essential cofactor of the cytochrome cd(1) nitrite reductase NirS. At present, the biosynthesis of heme d(1) is only partially understood. The last step of heme d(1) biosynthesis requires a so far unknown enzyme that catalyzes the introduction of a double bond into one of the propionate side chains of the tetrapyrrole yielding the corresponding acrylate side chain. In this study, we show that a Pseudomonas aeruginosa PAO1 strain lacking the NirN protein does not produce heme d(1). Instead, the NirS purified from this strain contains the heme d(1) precursor dihydro-heme d(1) lacking the acrylic double bond, as indicated by UV-visible absorption spectroscopy and resonance Raman spectroscopy. Furthermore, the dihydro-heme d(1) was extracted from purified NirS and characterized by UV-visible absorption spectroscopy and finally identified by high-resolution electrospray ionization mass spectrometry. Moreover, we show that purified NirN from P. aeruginosa binds the dihydro-heme d(1) and catalyzes the introduction of the acrylic double bond in vitro. Strikingly, NirN uses an electron bifurcation mechanism for the two-electron oxidation reaction, during which one electron ends up on its heme c cofactor and the second electron reduces the substrate/product from the ferric to the ferrous state. On the basis of our results, we propose novel roles for the proteins NirN and NirF during the biosynthesis of heme d(1).	[Adamczack, Julia; Haufschildt, Kristin; Nicke, Tristan; Layer, Gunhild] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Hoffmann, Martin; Broering, Martin] Tech Univ Carolo Wilhelmina Braunschweig, Inst Inorgan & Analyt Chem, D-38106 Braunschweig, Germany; [Papke, Ulrich] Tech Univ Carolo Wilhelmina Braunschweig, Inst Organ Chem, D-38106 Braunschweig, Germany; [Sezer, Murat; Weimar, Rebecca; Kuhlmann, Uwe; Hildebrandt, Peter] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany	Braunschweig University of Technology; Braunschweig University of Technology; Braunschweig University of Technology; Technical University of Berlin	Layer, G (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Spielmannstr 7, D-38106 Braunschweig, Germany.	g.layer@tu-braunschweig.de	Sezer, Murat/AAE-5807-2020; Hildebrandt, Peter/J-5658-2014	Hildebrandt, Peter/0000-0003-1030-5900; Hoffmann, Martin/0000-0001-9124-8762	Deutsche Forschungsgemeinschaft [BR 2010/12-1, LA 2412/3-2]; Cluster of Excellence "UniCat" - Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "UniCat" - Deutsche Forschungsgemeinschaft	This work was supported by Deutsche Forschungsgemeinschaft Grants BR 2010/12-1 (to M. B.) and LA 2412/3-2 (to G. L.).; Supported by the Cluster of Excellence "UniCat" funded by the Deutsche Forschungsgemeinschaft.	Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Bali S, 2011, P NATL ACAD SCI USA, V108, P18260, DOI 10.1073/pnas.1108228108; Bali S, 2010, FEBS J, V277, P4944, DOI 10.1111/j.1742-4658.2010.07899.x; CHANG CK, 1986, BIOCHEMISTRY-US, V25, P8447, DOI 10.1021/bi00374a019; CHANG CK, 1994, CIBA F SYMP, V180, P228; CHING Y, 1982, FEBS LETT, V138, P239, DOI 10.1016/0014-5793(82)80451-1; CHOI S, 1982, J AM CHEM SOC, V104, P4337, DOI 10.1021/ja00380a005; CHOI S, 1982, J AM CHEM SOC, V104, P4345, DOI 10.1021/ja00380a006; Cutruzzola F, 2003, IUBMB LIFE, V55, P617, DOI 10.1080/15216540310001628672; DEBOER APN, 1994, ANTON LEEUW INT J G, V66, P111, DOI 10.1007/BF00871635; DEVITO VL, 1989, J AM CHEM SOC, V111, P9143, DOI 10.1021/ja00208a001; FULOP V, 1995, CELL, V81, P369, DOI 10.1016/0092-8674(95)90390-9; Hasegawa N, 2001, BIOCHEM BIOPH RES CO, V288, P1223, DOI 10.1006/bbrc.2001.5919; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Kawasaki S, 1997, J BACTERIOL, V179, P235, DOI 10.1128/jb.179.1.235-242.1997; LEE H, 1986, J MOL STRUCT, V146, P329, DOI 10.1016/0022-2860(86)80302-7; Li YJ, 2013, J BACTERIOL, V195, P4297, DOI 10.1128/JB.00686-13; Nicke T, 2013, BIOSCIENCE REP, V33, P529, DOI 10.1042/BSR20130043; Oellerich S, 2002, J PHYS CHEM B, V106, P6566, DOI 10.1021/jp013841g; PALMEDO G, 1995, EUR J BIOCHEM, V232, P737, DOI 10.1111/j.1432-1033.1995.tb20868.x; PARR SR, 1976, BIOCHEM J, V157, P423, DOI 10.1042/bj1570423; PARTHASARATHI N, 1987, J AM CHEM SOC, V109, P3865, DOI 10.1021/ja00247a009; Remans K, 2010, MICROBIOL-SGM, V156, P2597, DOI 10.1099/mic.0.040659-0; SILVESTRINI MC, 1989, FEBS LETT, V254, P33, DOI 10.1016/0014-5793(89)81004-X; SPIRO TG, 1985, ADV PROTEIN CHEM, V37, P111, DOI 10.1016/S0065-3233(08)60064-9; STEUP MB, 1989, J INORG BIOCHEM, V37, P233, DOI 10.1016/0162-0134(89)80045-5; Storbeck S, 2009, FEBS J, V276, P5973, DOI 10.1111/j.1742-4658.2009.07306.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tartof K.D., 1987, BETHESDA RES LAB FOC, V9, P12; WALSH TA, 1981, J INORG BIOCHEM, V14, P1, DOI 10.1016/S0162-0134(00)80010-0; Zajicek RS, 2009, FEBS J, V276, P6399, DOI 10.1111/j.1742-4658.2009.07354.x; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	32	17	18	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30753	30762		10.1074/jbc.M114.603886	http://dx.doi.org/10.1074/jbc.M114.603886			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25204657	hybrid, Green Published			2022-12-28	WOS:000344549700050
J	Korkmaz, G; Holm, M; Wiens, T; Sanyal, S				Korkmaz, Gurkan; Holm, Mikael; Wiens, Tobias; Sanyal, Suparna			Comprehensive Analysis of Stop Codon Usage in Bacteria and Its Correlation with Release Factor Abundance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENT GROWTH-RATES; ESCHERICHIA-COLI; TRANSLATION TERMINATION; MYCOPLASMA-GENITALIUM; IN-VIVO; EVOLUTION; EFFICIENCY; CONTEXT; SIGNALS; PREDICT	We present a comprehensive analysis of stop codon usage in bacteria by analyzing over eight million coding sequences of 4684 bacterial sequences. Using a newly developed program called "stop codon counter," the frequencies of the three classical stop codons TAA, TAG, and TGA were analyzed, and a publicly available stop codon database was built. Our analysis shows that with increasing genomic GC content the frequency of the TAA codon decreases and that of the TGA codon increases in a reciprocal manner. Interestingly, the release factor 1-specific codon TAG maintains a more or less uniform frequency (similar to 20%) irrespective of the GC content. The low abundance of TAG is also valid with respect to expression level of the genes ending with different stop codons. In contrast, the highly expressed genes predominantly end with TAA, ensuring termination with either of the two release factors. Using three model bacteria with different stop codon usage (Escherichia coli, Mycobacterium smegmatis, and Bacillus subtilis), we show that the frequency of TAG and TGA codons correlates well with the relative steady state amount of mRNA and protein for release factors RF1 and RF2 during exponential growth. Furthermore, using available microarray data for gene expression, we show that in both fast growing and contrasting biofilm formation conditions, the relative level of RF1 is nicely correlated with the expression level of the genes ending with TAG.	[Korkmaz, Gurkan; Holm, Mikael; Wiens, Tobias; Sanyal, Suparna] Uppsala Univ, Dept Cell & Mol Biol, BMC, S-75124 Uppsala, Sweden	Uppsala University	Sanyal, S (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, BMC, Box 596, S-75124 Uppsala, Sweden.	suparna.sanyal@icm.uu.se		Korkmaz, Gurkan/0000-0003-1911-027X	Swedish Research Council [2010-2619, 2011-6088, 2008-6593]; Carl-Tryggers Foundation [CTS 09:341, 10:330]; Wenner-Gren Foundation; Knut and Alice Wallenberg Foundation [KAW 2011.0081]; Sven and Lilly Lawski Foundation for Scientific Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl-Tryggers Foundation; Wenner-Gren Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Sven and Lilly Lawski Foundation for Scientific Research	This work was supported by Swedish Research Council Research Grants 2010-2619 Medicin, 2011-6088 (Natural Science) and 2008-6593, a Linnaeus grant to the Uppsala RNA Research Center (all to S. S.); Carl-Tryggers Foundation Grants CTS 09:341 and 10:330; the Wenner-Gren Foundation; and Knut and Alice Wallenberg Foundation Grant KAW 2011.0081 (to RiboCORE).; Supported by a scholarship from the Sven and Lilly Lawski Foundation for Scientific Research.	ADAMSKI FM, 1994, J MOL BIOL, V238, P302, DOI 10.1006/jmbi.1994.1293; BONETTI B, 1995, J MOL BIOL, V251, P334, DOI 10.1006/jmbi.1995.0438; BROWN CM, 1993, NUCLEIC ACIDS RES, V21, P3119, DOI 10.1093/nar/21.13.3119; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Cridge AG, 2006, NUCLEIC ACIDS RES, V34, P1959, DOI 10.1093/nar/gkl074; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Duarte I, 2012, MOL BIOL EVOL, V29, P3497, DOI 10.1093/molbev/mss157; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Gao HX, 2007, CELL, V129, P929, DOI 10.1016/j.cell.2007.03.050; Gilchrist MA, 2007, MOL BIOL EVOL, V24, P2362, DOI 10.1093/molbev/msm169; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; INAMINE JM, 1990, J BACTERIOL, V172, P504, DOI 10.1128/JB.172.1.504-506.1990; Ivanova NN, 2014, SCIENCE, V344, P909, DOI 10.1126/science.1250691; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Lind C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3940; Major LL, 2002, FEBS LETT, V514, P84, DOI 10.1016/S0014-5793(02)02301-3; Margus T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-15; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mora L, 2007, J BIOL CHEM, V282, P35638, DOI 10.1074/jbc.M706076200; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; Pavlov MY, 1998, J MOL BIOL, V284, P579, DOI 10.1006/jmbi.1998.2220; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; Povolotskaya IS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-30; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos MAS, 2004, TRENDS GENET, V20, P95, DOI 10.1016/j.tig.2003.12.009; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; SHARP PM, 1988, GENE, V63, P141, DOI 10.1016/0378-1119(88)90553-7; Sun JC, 2005, J MOL EVOL, V61, P437, DOI 10.1007/s00239-004-0277-3; Tate WP, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1342; Yang XO, 2008, APPL ENVIRON MICROB, V74, P2690, DOI 10.1128/AEM.02809-07; Zhang G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005036	35	39	40	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30334	30342		10.1074/jbc.M114.606632	http://dx.doi.org/10.1074/jbc.M114.606632			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25217634	Green Published, hybrid			2022-12-28	WOS:000344549700016
J	Bharti, SK; Sommers, JA; Zhou, J; Kaplan, DL; Spelbrink, JN; Mergny, JL; Brosh, RM				Bharti, Sanjay Kumar; Sommers, Joshua A.; Zhou, Jun; Kaplan, Daniel L.; Spelbrink, Johannes N.; Mergny, Jean-Louis; Brosh, Robert M., Jr.			DNA Sequences Proximal to Human Mitochondrial DNA Deletion Breakpoints Prevalent in Human Disease Form G-quadruplexes, a Class of DNA Structures Inefficiently Unwound by the Mitochondrial Replicative Twinkle Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						DNA Helicase; DNA Replication; G-quadruplex; Genetic Disease; Genomic Instability; Mitochondria; Twinkle	KEARNS-SAYRE SYNDROME; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; SUBSTANTIA-NIGRA NEURONS; MARROW-PANCREAS SYNDROME; LARGE-SCALE DELETIONS; SACCHAROMYCES-CEREVISIAE; DIRECT REPEATS; HOMOLOGOUS RECOMBINATION; GENOMIC STABILITY; PARKINSON-DISEASE	Background: Mitochondrial DNA deletions are prominent in human genetic disorders and cancer. Results: Predicted mitochondrial G-quadruplex-forming sequences map in close proximity to known deletion breakpoints and form G-quadruplexes in vitro. Conclusion: The mitochondrial replicative helicase Twinkle inefficiently unwinds intra- and intermolecular G-quadruplexes. Significance: Mitochondrial G-quadruplexes are likely to cause genome instability by perturbing replication machinery. Mitochondrial DNA deletions are prominent in human genetic disorders, cancer, and aging. It is thought that stalling of the mitochondrial replication machinery during DNA synthesis is a prominent source of mitochondrial genome instability; however, the precise molecular determinants of defective mitochondrial replication are not well understood. In this work, we performed a computational analysis of the human mitochondrial genome using the Pattern Finder G-quadruplex (G4) predictor algorithm to assess whether G4-forming sequences reside in close proximity (within 20 base pairs) to known mitochondrial DNA deletion breakpoints. We then used this information to map G4P sequences with deletions characteristic of representative mitochondrial genetic disorders and also those identified in various cancers and aging. Circular dichroism and UV spectral analysis demonstrated that mitochondrial G-rich sequences near deletion breakpoints prevalent in human disease form G-quadruplex DNA structures. A biochemical analysis of purified recombinant human Twinkle protein (gene product of c10orf2) showed that the mitochondrial replicative helicase inefficiently unwinds well characterized intermolecular and intramolecular G-quadruplex DNA substrates, as well as a unimolecular G4 substrate derived from a mitochondrial sequence that nests a deletion breakpoint described in human renal cell carcinoma. Although G4 has been implicated in the initiation of mitochondrial DNA replication, our current findings suggest that mitochondrial G-quadruplexes are also likely to be a source of instability for the mitochondrial genome by perturbing the normal progression of the mitochondrial replication machinery, including DNA unwinding by Twinkle helicase.	[Bharti, Sanjay Kumar; Sommers, Joshua A.; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [Zhou, Jun; Mergny, Jean-Louis] Univ Bordeaux 2, ARNA Lab, F-33000 Bordeaux, France; [Zhou, Jun; Mergny, Jean-Louis] IECB, INSERM U869, F-33600 Pessac, France; [Kaplan, Daniel L.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32312 USA; [Spelbrink, Johannes N.] Univ Tampere, Pirkanmaa Hosp Dist, BioMediTech, FinMIT Ctr Excellence, FI-33014 Tampere, Finland; [Spelbrink, Johannes N.] Univ Tampere, Pirkanmaa Hosp Dist, Tampere Univ Hosp, FI-33014 Tampere, Finland; [Spelbrink, Johannes N.] Radboud Univ Nijmegen, Med Ctr, Nijmegan Ctr Mitochondrial Disorders, Dept Pediat, NL-6500 HB Nijmegen, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; State University System of Florida; Florida State University; Pirkanmaa Hospital District; Tampere University; Pirkanmaa Hospital District; Tampere University; Tampere University Hospital; Radboud University Nijmegen	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, 251 Bayview Blvd, Baltimore, MD 21224 USA.	broshr@mail.nih.gov	Spelbrink, Johannes N/L-4661-2015; Brosh, Robert/AAR-6124-2020; ZHOU, JUN/N-2892-2014; Mergny, Jean-Louis/E-2860-2013	Spelbrink, Johannes N/0000-0002-9756-2602; ZHOU, JUN/0000-0002-6793-3169; Mergny, Jean-Louis/0000-0003-3043-8401; Kaplan, Daniel/0000-0003-2760-7745	National Institutes of Health, NIA; European Union; Academy of Finland (Centre of Excellence funding); Netherlands Organization for Scientific Research (NWO), VICI Grant [865.10.004]; Fondation ARC; Aquitaine Regional Council; Agence Nationale de la Recherche (ANR); NATIONAL INSTITUTE ON AGING [ZIAAG000741] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); European Union(European Commission); Academy of Finland (Centre of Excellence funding)(Academy of Finland); Netherlands Organization for Scientific Research (NWO), VICI Grant(Netherlands Organization for Scientific Research (NWO)); Fondation ARC; Aquitaine Regional Council(Region Nouvelle-Aquitaine); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported, in whole or in part, by the National Institutes of Health, NIA, Intramural Research Program.; Recipient of a European Union Marie Curie International Incoming Fellowship (IIF).; Supported by the Academy of Finland (Centre of Excellence funding) and the Netherlands Organization for Scientific Research (NWO), VICI Grant 865.10.004.; Supported by Fondation ARC, the Aquitaine Regional Council, and the Agence Nationale de la Recherche (ANR Grants Quarpdiem and Oligoswitch).	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arimondo PB, 2000, NUCLEIC ACIDS RES, V28, P4832, DOI 10.1093/nar/28.24.4832; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; Barros P, 2009, FEBS J, V276, P2983, DOI 10.1111/j.1742-4658.2009.07013.x; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bharti SK, 2013, J BIOL CHEM, V288, P28217, DOI 10.1074/jbc.M113.496463; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97; Chen XJ, 2013, MICROBIOL MOL BIOL R, V77, P476, DOI 10.1128/MMBR.00007-13; Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763; Damas J, 2012, NUCLEIC ACIDS RES, V40, P7606, DOI 10.1093/nar/gks500; DEGOUL F, 1991, J NEUROL SCI, V101, P168, DOI 10.1016/0022-510X(91)90042-6; Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08; Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088; Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025; GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; GOLIK P, 1995, CURR GENET, V28, P217, DOI 10.1007/BF00309780; Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028; HARDING AE, 1992, J INHERIT METAB DIS, V15, P480, DOI 10.1007/BF01799606; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Horton TM, 1996, GENE CHROMOSOME CANC, V15, P95, DOI 10.1002/(SICI)1098-2264(199602)15:2<95::AID-GCC3>3.0.CO;2-Z; JOHNS DR, 1989, P NATL ACAD SCI USA, V86, P8059, DOI 10.1073/pnas.86.20.8059; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kasiviswanathan R, 2012, BBA-GENE REGUL MECH, V1819, P970, DOI 10.1016/j.bbagrm.2011.12.005; KATAYAMA M, 1991, BIOCHEM INT, V25, P47; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Largy E, 2013, TOP CURR CHEM, V330, P111, DOI 10.1007/128_2012_346; LARSSON NG, 1992, BIOCHIM BIOPHYS ACTA, V1139, P311, DOI 10.1016/0925-4439(92)90106-W; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Levy G, 2007, ARCH NEUROL-CHICAGO, V64, P1242, DOI 10.1001/archneur.64.9.1242; Lim KW, 2009, J AM CHEM SOC, V131, P4301, DOI 10.1021/ja807503g; Lin WQ, 2013, EMBO J, V32, P1425, DOI 10.1038/emboj.2013.88; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; LORENZ JG, 1994, HUM BIOL, V66, P777; MADSEN CS, 1993, P NATL ACAD SCI USA, V90, P7671, DOI 10.1073/pnas.90.16.7671; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; Markaryan A, 2008, MUTAT RES-FUND MOL M, V640, P38, DOI 10.1016/j.mrfmmm.2007.12.007; Masuda-Sasa T, 2008, J BIOL CHEM, V283, P24359, DOI 10.1074/jbc.M802244200; Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni134; Mergny JL, 1998, FEBS LETT, V435, P74, DOI 10.1016/S0014-5793(98)01043-6; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; Mkaouar-Rebai E, 2010, MITOCHONDRION, V10, P449, DOI 10.1016/j.mito.2010.04.003; NAKASE H, 1990, AM J HUM GENET, V46, P418; Oliveira PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059907; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Pandey M, 2014, CELL REP, V6, P1129, DOI 10.1016/j.celrep.2014.02.025; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Piazza A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003033; Piazza A, 2010, NUCLEIC ACIDS RES, V38, P4337, DOI 10.1093/nar/gkq136; Pinto M., 2013, BIOCHIM BIOPHYS ACTA, V1842, P1198; Rajala N, 2014, NUCLEIC ACIDS RES, V42, P952, DOI 10.1093/nar/gkt988; Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Rogounovitch T, 2004, ENDOCR J, V51, P265, DOI 10.1507/endocrj.51.265; Rogounovitch TI, 2002, CANCER RES, V62, P7031; Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014; Roos S, 2013, HUM MOL GENET, V22, P2411, DOI 10.1093/hmg/ddt094; ROTIG A, 1995, HUM MOL GENET, V4, P1327, DOI 10.1093/hmg/4.8.1327; ROTIG A, 1991, GENOMICS, V10, P502, DOI 10.1016/0888-7543(91)90342-C; Rubicz R, 2003, HUM BIOL, V75, P809, DOI 10.1353/hub.2004.0009; Rubicz RC, 2007, ANTHROPOLOGICAL GENETICS: THEORY, METHODS AND APPLICATIONS, P141; Sabouri N, 2012, GENE DEV, V26, P581, DOI 10.1101/gad.184697.111; Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003; Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612; SAVRETRAIN I, 1992, HUM MOL GENET, V1, P203, DOI 10.1093/hmg/1.3.203; Schaffitzel C, 2010, METHODS MOL BIOL, V608, P159, DOI 10.1007/978-1-59745-363-9_11; Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468; STEPIEN PP, 1992, P NATL ACAD SCI USA, V89, P6813, DOI 10.1073/pnas.89.15.6813; Suhasini AN, 2012, J BIOL CHEM, V287, P19188, DOI 10.1074/jbc.M112.352757; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tseng TY, 2013, NUCLEIC ACIDS RES, V41, P10605, DOI 10.1093/nar/gkt814; Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wanrooij PH, 2012, NUCLEIC ACIDS RES, V40, P10334, DOI 10.1093/nar/gks802; Wanrooij PH, 2010, P NATL ACAD SCI USA, V107, P16072, DOI 10.1073/pnas.1006026107; Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2012, J BIOL CHEM, V287, P21699, DOI 10.1074/jbc.M112.351338; Wu YL, 2010, FEBS J, V277, P3470, DOI 10.1111/j.1742-4658.2010.07760.x; XU BJ, 1995, MOL CELL BIOL, V15, P580, DOI 10.1128/MCB.15.1.580; Yadav VK, 2008, NUCLEIC ACIDS RES, V36, pD381, DOI 10.1093/nar/gkm781; YAMAMOTO H, 1992, BIOCHEM BIOPH RES CO, V182, P913, DOI 10.1016/0006-291X(92)91819-C; Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8; Zapico SC, 2013, AGING DIS, V4, P364, DOI 10.14336/AD.2013.0400364; ZEVIANI M, 1988, NEUROLOGY, V38, P1339; Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024; Zheng SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031322; ZUPANC ML, 1991, ANN NEUROL, V29, P680, DOI 10.1002/ana.410290619	102	79	81	3	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29975	29993		10.1074/jbc.M114.567073	http://dx.doi.org/10.1074/jbc.M114.567073			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25193669	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000344370800039
J	Dong, S; Wei, TD; Chen, XL; Li, CY; Wang, P; Xie, BB; Qin, QL; Zhang, XY; Pang, XH; Zhou, BC; Zhang, YZ				Dong, Sheng; Wei, Tian-Di; Chen, Xiu-Lan; Li, Chun-Yang; Wang, Peng; Xie, Bin-Bin; Qin, Qi-Long; Zhang, Xi-Ying; Pang, Xiu-Hua; Zhou, Bai-Cheng; Zhang, Yu-Zhong			Molecular Insight into the Role of the N-terminal Extension in the Maturation, Substrate Recognition, and Catalysis of a Bacterial Alginate Lyase from Polysaccharide Lyase Family 18	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alginate Lyase; Carbohydrate Metabolism; Crystal Structure; Docking; Mutagenesis; Alginate Depolymerization; Catalytic Mechanism; N-terminal Extension Function; Polysaccharide Lyase Family 18	CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; PSEUDOMONAS-AERUGINOSA; CLONING; A1-III; A1; EXPRESSION; GENES	Background: The maturation and catalysis mechanisms of the PL18 alginate lyases have not yet been reported. Results: The N-terminal extension in the precursor of PL18, aly-SJ02, helped the catalytic domain fold correctly. Key residues for substrate recognition and catalysis were determined. Conclusion: The catalytic mechanism of aly-SJ02 is proposed. Significance: This study provides the foremost insight into maturation and catalysis of PL18 alginate lyases. Bacterial alginate lyases, which are members of several polysaccharide lyase (PL) families, have important biological roles and biotechnological applications. The mechanisms for maturation, substrate recognition, and catalysis of PL18 alginate lyases are still largely unknown. A PL18 alginate lyase, aly-SJ02, from Pseudoalteromonas sp. 0524 displays a -jelly roll scaffold. Structural and biochemical analyses indicated that the N-terminal extension in the aly-SJ02 precursor may act as an intramolecular chaperone to mediate the correct folding of the catalytic domain. Molecular dynamics simulations and mutational assays suggested that the lid loops over the aly-SJ02 active center serve as a gate for substrate entry. Molecular docking and site-directed mutations revealed that certain conserved residues at the active center, especially those at subsites +1 and +2, are crucial for substrate recognition. Tyr(353) may function as both a catalytic base and acid. Based on our results, a model for the catalysis of aly-SJ02 in alginate depolymerization is proposed. Moreover, although bacterial alginate lyases from families PL5, 7, 15, and 18 adopt distinct scaffolds, they share the same conformation of catalytic residues, reflecting their convergent evolution. Our results provide the foremost insight into the mechanisms of maturation, substrate recognition, and catalysis of a PL18 alginate lyase.	[Dong, Sheng; Wei, Tian-Di; Chen, Xiu-Lan; Li, Chun-Yang; Wang, Peng; Xie, Bin-Bin; Qin, Qi-Long; Zhang, Xi-Ying; Pang, Xiu-Hua; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Dong, Sheng; Chen, Xiu-Lan; Li, Chun-Yang; Wang, Peng; Xie, Bin-Bin; Qin, Qi-Long; Zhang, Xi-Ying; Pang, Xiu-Hua; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University	Zhang, YZ (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn	WANG, Peng/GSN-5263-2022	Zhang, Yu-Zhong/0000-0002-2017-1005; Li, Chun-Yang/0000-0002-1151-4897	National Natural Science Foundation of China [41176130, 91228210, 31025001]; Hi-Tech Research and Development Program of China [2012AA092105, 2014AA093509]; China Ocean Mineral Resources R&D Association Special Foundation [DY125-15-T-05]; Program of Shandong for Taishan Scholars [2008BS02019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); China Ocean Mineral Resources R&D Association Special Foundation; Program of Shandong for Taishan Scholars	This work was supported by Grants 41176130, 91228210, and 31025001 from the National Natural Science Foundation of China, Grants 2012AA092105 and 2014AA093509 from the Hi-Tech Research and Development Program of China, Grant DY125-15-T-05 from the China Ocean Mineral Resources R&D Association Special Foundation, and Grant 2008BS02019 from the Program of Shandong for Taishan Scholars.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agulhon P, 2012, BIOMACROMOLECULES, V13, P215, DOI 10.1021/bm201477g; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GACESA P, 1988, CARBOHYD POLYM, V8, P161, DOI 10.1016/0144-8617(88)90001-X; Hashimoto W, 1998, J FERMENT BIOENG, V86, P236, DOI 10.1016/S0922-338X(98)80120-7; Kawamoto H, 2006, MAR BIOTECHNOL, V8, P481, DOI 10.1007/s10126-005-6157-z; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Li JW, 2011, MAR DRUGS, V9, P109, DOI 10.3390/md9010109; LINHARDT RJ, 1986, APPL BIOCHEM BIOTECH, V12, P135; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; MACIVER B, 1994, APPL ENVIRON MICROB, V60, P3981, DOI 10.1128/AEM.60.11.3981-3988.1994; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Matsushima R, 2010, APPL MICROBIOL BIOT, V86, P567, DOI 10.1007/s00253-009-2278-z; May Thomas B., 1994, Trends in Microbiology, V2, P151, DOI 10.1016/0966-842X(94)90664-5; Mikami B, 2012, ACTA CRYSTALLOGR D, V68, P1207, DOI 10.1107/S090744491202495X; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mrsny RJ, 1996, J DRUG TARGET, V4, P233, DOI 10.3109/10611869608995625; Ochiai A, 2010, J BIOL CHEM, V285, P24519, DOI 10.1074/jbc.M110.125450; Ogura K, 2008, J MOL BIOL, V380, P373, DOI 10.1016/j.jmb.2008.05.008; Ogura K, 2009, J BIOL CHEM, V284, P35572, DOI 10.1074/jbc.M109.068056; Osawa T, 2005, J MOL BIOL, V345, P1111, DOI 10.1016/j.jmb.2004.10.081; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; PREISS J, 1962, J BIOL CHEM, V237, P309; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sawabe T, 2001, CARBOHYD RES, V335, P11, DOI 10.1016/S0008-6215(01)00198-7; SHIRAIWA Y, 1975, BOT MAR, V18, P97, DOI 10.1515/botm.1975.18.2.97; Smidsrod O., 1996, CARBOHYDR EUR, V14, P6; Thomas F, 2013, J BIOL CHEM, V288, P23021, DOI 10.1074/jbc.M113.467217; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200; Yoon HJ, 1999, J MOL BIOL, V290, P505, DOI 10.1006/jmbi.1999.2883; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509	39	45	49	5	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29558	29569		10.1074/jbc.M114.584573	http://dx.doi.org/10.1074/jbc.M114.584573			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25210041	Green Published, hybrid			2022-12-28	WOS:000344370800008
J	Hartmann, T; Baronian, G; Nippe, N; Voss, M; Schulthess, B; Wolz, C; Eisenbeis, J; Schmidt-Hohagen, K; Gaupp, R; Sunderkotter, C; Beisswenger, C; Bals, R; Somerville, GA; Herrmann, M; Molle, V; Bischoff, M				Hartmann, Torsten; Baronian, Gregory; Nippe, Nadine; Voss, Meike; Schulthess, Bettina; Wolz, Christiane; Eisenbeis, Janina; Schmidt-Hohagen, Kerstin; Gaupp, Rosmarie; Sunderkoetter, Cord; Beisswenger, Christoph; Bals, Robert; Somerville, Greg A.; Herrmann, Mathias; Molle, Virginie; Bischoff, Markus			The Catabolite Control Protein E (CcpE) Affects Virulence Determinant Production and Pathogenesis of Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Staphylococcus aureus (S; aureus); Transcription Regulation; Tricarboxylic Acid Cycle (TCA Cycle) (Krebs Cycle); Virulence Factor	TRICARBOXYLIC-ACID CYCLE; GENE REGULATOR AGR; BACILLUS-SUBTILIS ACONITASE; STATIONARY-PHASE SURVIVAL; COLONY-STIMULATING FACTOR; ALPHA-HEMOLYSIN; G-CSF; CAPSULAR POLYSACCHARIDES; NEUTROPHIL RECRUITMENT; RABBIT MODEL	Background: Carbon metabolism and virulence are often linked in pathogenic bacteria. Results: Deletion of the catabolite control protein E (CcpE) affects the expression of virulence factors and pathogenicity of Staphylococcus aureus. Conclusion: Our data suggest that CcpE acts as an attenuator of virulence in S. aureus.Significance: CcpE may serve to link S. aureus nutritional status to virulence determinant biosynthesis. Carbon metabolism and virulence determinant production are often linked in pathogenic bacteria, and several regulatory elements have been reported to mediate this linkage in Staphylococcus aureus. Previously, we described a novel protein, catabolite control protein E (CcpE) that functions as a regulator of the tricarboxylic acid cycle. Here we demonstrate that CcpE also regulates virulence determinant biosynthesis and pathogenesis. Specifically, deletion of ccpE in S. aureus strain Newman revealed that CcpE affects transcription of virulence factors such as capA, the first gene in the capsule biosynthetic operon; hla, encoding -toxin; and psm, encoding the phenol-soluble modulin cluster . Electrophoretic mobility shift assays demonstrated that CcpE binds to the hla promoter. Mice challenged with S. aureus strain Newman or its isogenic ccpE derivative revealed increased disease severity in the ccpE mutant using two animal models; an acute lung infection model and a skin infection model. Complementation of the mutant with the ccpE wild-type allele restored all phenotypes, demonstrating that CcpE is negative regulator of virulence in S. aureus.	[Hartmann, Torsten; Eisenbeis, Janina; Gaupp, Rosmarie; Herrmann, Mathias; Bischoff, Markus] Univ Saarland, Inst Med Microbiol & Hyg, D-66421 Homburg, Germany; [Baronian, Gregory; Molle, Virginie] Univ Montpellier 2, CNRS, UMR 5235, Lab Dynam Interact Membranaires Normales & Pathol, F-34090 Montpellier, France; [Nippe, Nadine] Univ Munster, Inst Immunol, D-48149 Munster, Germany; [Voss, Meike; Beisswenger, Christoph; Bals, Robert] Univ Saarland, Med Ctr, Dept Internal Med Pulmonol Allergol & Crit Care M, D-66421 Homburg, Germany; [Schulthess, Bettina] Univ Zurich, Inst Med Microbiol, CH-8006 Zurich, Switzerland; [Wolz, Christiane] Univ Tubingen Hosp, Inst Med Microbiol & Hyg, D-72076 Tubingen, Germany; [Schmidt-Hohagen, Kerstin] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, D-38106 Braunschweig, Germany; [Sunderkoetter, Cord] Univ Munster, Dept Dermatol, D-48149 Munster, Germany; [Somerville, Greg A.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA	Saarland University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Munster; Saarland University; University of Zurich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Braunschweig University of Technology; University of Munster; University of Nebraska System; University of Nebraska Lincoln	Bischoff, M (corresponding author), Univ Saarland, Inst Med Microbiol & Hyg, D-66421 Homburg, Germany.	markus.bischoff@uks.eu	Schulthess, Bettina/ABA-8795-2021; MOLLE, Virginie/D-4050-2019; Bischoff, Markus/D-2130-2014; Beisswenger, Christoph/GRO-6580-2022; Somerville, Greg A/B-1326-2013; Herrmann, Mathias/B-6475-2013	Schulthess, Bettina/0000-0002-1562-4583; MOLLE, Virginie/0000-0002-6573-3411; Bischoff, Markus/0000-0001-6734-2732; Somerville, Greg A/0000-0002-0991-8737; Herrmann, Mathias/0000-0003-2638-2257; Sunderkotter, Cord/0000-0002-2929-145X; Wolz, Christiane/0000-0003-3909-5281	National Institutes of Health [AI087668]; Deutsche Forschungsgemeinschaft (DFG) [BI 1350/1-1, BI 1350/1-2]; region Languedoc-Roussillon-Chercheur d'Avenir grant; Swiss National Science Foundation [31-117707]; Deutsche Forschungsgemeinschaft [SFB766]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); region Languedoc-Roussillon-Chercheur d'Avenir grant(Region Occitanie); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI087668 (to G. A. S.) and Grants BI 1350/1-1 and BI 1350/1-2 from the Deutsche Forschungsgemeinschaft (DFG).; Supported by a region Languedoc-Roussillon-Chercheur d'Avenir grant.; Supported by Swiss National Science Foundation Grant 31-117707.; Supported by Deutsche Forschungsgemeinschaft Grant SFB766 project A7.	ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879, DOI 10.1128/IAI.61.9.3879-3885.1993; Alen C, 1999, P NATL ACAD SCI USA, V96, P10412, DOI 10.1073/pnas.96.18.10412; Anderson KL, 2010, FEMS IMMUNOL MED MIC, V60, P208, DOI 10.1111/j.1574-695X.2010.00736.x; Balamayooran G, 2012, J IMMUNOL, V189, P5849, DOI 10.4049/jimmunol.1200585; Bartlett AH, 2008, J INFECT DIS, V198, P1529, DOI 10.1086/592758; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Boyle-Vavra S, 2006, FEMS MICROBIOL LETT, V262, P163, DOI 10.1111/j.1574-6968.2006.00384.x; Chatterjee I, 2005, J BACTERIOL, V187, P4488, DOI 10.1128/JB.187.13.4488-4496.2005; Chatterjee I, 2007, J BACTERIOL, V189, P2936, DOI 10.1128/JB.01444-06; CHEUNG AL, 1994, J BACTERIOL, V176, P580, DOI 10.1128/jb.176.3.580-585.1994; CHEUNG AL, 1994, J CLIN INVEST, V94, P1815, DOI 10.1172/JCI117530; CHEUNG AL, 1994, ANAL BIOCHEM, V222, P511, DOI 10.1006/abio.1994.1528; Cheung GYC, 2011, INFECT IMMUN, V79, P1927, DOI 10.1128/IAI.00046-11; Chua KYL, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-31; DUTHIE ES, 1952, J GEN MICROBIOL, V7, P320, DOI 10.1099/00221287-7-3-4-320; Gaupp R, 2010, J BACTERIOL, V192, P2385, DOI 10.1128/JB.01472-09; Geiger T, 2010, INFECT IMMUN, V78, P1873, DOI 10.1128/IAI.01439-09; Geisinger E, 2012, J BACTERIOL, V194, P2854, DOI 10.1128/JB.06685-11; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gupta RK, 2013, J INFECT DIS, V208, P1841, DOI 10.1093/infdis/jit367; Hartmann T, 2013, J BIOL CHEM, V288, P36116, DOI 10.1074/jbc.M113.516302; HOEGER PH, 1992, J INFECT DIS, V165, P1064, DOI 10.1093/infdis/165.6.1064; Hua L, 2014, ANTIMICROB AGENTS CH, V58, P1108, DOI 10.1128/AAC.02190-13; Ingavale S, 2005, INFECT IMMUN, V73, P1423, DOI 10.1128/IAI.73.3.1423-1431.2005; Kebaier C, 2012, J INFECT DIS, V205, P807, DOI 10.1093/infdis/jir846; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Koyama S, 1998, AM J PHYSIOL-LUNG C, V275, pL687, DOI 10.1152/ajplung.1998.275.4.L687; Koyama S, 2000, AM J PHYSIOL-LUNG C, V278, pL658, DOI 10.1152/ajplung.2000.278.4.L658; Lan LF, 2010, J BACTERIOL, V192, P3068, DOI 10.1128/JB.00928-09; Leiba J, 2012, J BIOL CHEM, V287, P43607, DOI 10.1074/jbc.M112.418913; Li CL, 2010, J BACTERIOL, V192, P3883, DOI 10.1128/JB.00237-10; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Luong T, 2002, INFECT IMMUN, V70, P444, DOI 10.1128/IAI.70.2.444-450.2002; Majerczyk CD, 2008, J BACTERIOL, V190, P2257, DOI 10.1128/JB.01545-07; Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10; Massilamany C, 2011, MOL CELL BIOCHEM, V355, P75, DOI 10.1007/s11010-011-0840-3; Mayville P, 1999, P NATL ACAD SCI USA, V96, P1218, DOI 10.1073/pnas.96.4.1218; McCallum N, 2006, ANTIMICROB AGENTS CH, V50, P2352, DOI 10.1128/AAC.00073-06; Montgomery CP, 2012, INFECT IMMUN, V80, P2382, DOI 10.1128/IAI.06172-11; Montgomery CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015177; MORFELDT E, 1995, EMBO J, V14, P4569, DOI 10.1002/j.1460-2075.1995.tb00136.x; Morikawa K, 2001, BIOCHEM BIOPH RES CO, V288, P385, DOI 10.1006/bbrc.2001.5774; Nippe N, 2011, J INVEST DERMATOL, V131, P125, DOI 10.1038/jid.2010.282; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Nuxoll AS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003033; Oscarsson J, 2006, J BACTERIOL, V188, P8526, DOI 10.1128/JB.00866-06; Pane-Farre J, 2006, INT J MED MICROBIOL, V296, P237, DOI 10.1016/j.ijmm.2005.11.011; Pechter KB, 2013, J BACTERIOL, V195, P1525, DOI 10.1128/JB.01690-12; Pelz A, 2005, J BIOL CHEM, V280, P32493, DOI 10.1074/jbc.M505070200; Peschel A, 2013, NAT REV MICROBIOL, V11, P667, DOI 10.1038/nrmicro3110; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Poncet S, 2009, CONTRIB MICROBIOL, V16, P88, DOI 10.1159/000219374; Pragman AA, 2004, FEMS IMMUNOL MED MIC, V42, P147, DOI 10.1016/j.femsim.2004.05.005; Qazi SNA, 2001, INFECT IMMUN, V69, P7074, DOI 10.1128/IAI.69.11.7074-7082.2001; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; REGASSA LB, 1992, J BACTERIOL, V174, P5095, DOI 10.1128/JB.174.15.5095-5100.1992; Reyes D, 2011, J BACTERIOL, V193, P6020, DOI 10.1128/JB.05436-11; Saba S, 2002, AM J RESP CELL MOL, V27, P561, DOI 10.1165/rcmb.2002-0019OC; Sadykov MR, 2010, J BACTERIOL, V192, P1459, DOI 10.1128/JB.01377-09; Schmitt J, 2012, MICROBIOL-SGM, V158, P2619, DOI 10.1099/mic.0.060129-0; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Seidl K, 2008, INFECT IMMUN, V76, P5093, DOI 10.1128/IAI.00724-08; Seidl K, 2008, INFECT IMMUN, V76, P2044, DOI 10.1128/IAI.00035-08; Seidl K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-95; Seiler F, 2013, J IMMUNOL, V190, P1603, DOI 10.4049/jimmunol.1200596; Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018; Serio AW, 2006, J BACTERIOL, V188, P6396, DOI 10.1128/JB.00249-06; Sheldon JR, 2014, MOL MICROBIOL, V92, P824, DOI 10.1111/mmi.12593; Somerville GA, 2003, J BACTERIOL, V185, P6686, DOI 10.1128/JB.185.22.6686-6694.2003; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; Suzuki S, 2002, BLOOD, V99, P1863, DOI 10.1182/blood.V99.5.1863.h8001863_1863_1865; Valihrach L, 2012, J MICROBIOL METH, V90, P214, DOI 10.1016/j.mimet.2012.05.008; van Wamel W, 2002, MICROB PATHOGENESIS, V33, P73, DOI 10.1006/mpat.2002.0513; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Wright JS, 2005, P NATL ACAD SCI USA, V102, P1691, DOI 10.1073/pnas.0407661102; Zhang P, 2001, J IMMUNOL, V166, P458, DOI 10.4049/jimmunol.166.1.458; Zhu YF, 2011, J BACTERIOL, V193, P6187, DOI 10.1128/JB.05930-11; Zhu YF, 2009, INFECT IMMUN, V77, P4256, DOI 10.1128/IAI.00195-09; Zielinska AK, 2011, J BACTERIOL, V193, P2948, DOI 10.1128/JB.01517-10	83	24	24	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29701	29711		10.1074/jbc.M114.584979	http://dx.doi.org/10.1074/jbc.M114.584979			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25193664	Green Published, hybrid			2022-12-28	WOS:000344370800019
J	Gupta, S; Yeeles, JTP; Marians, KJ				Gupta, Sankalp; Yeeles, Joseph T. P.; Marians, Kenneth J.			Regression of Replication Forks Stalled by Leading-strand Template Damage II-REGRESSION BY RecA IS INHIBITED BY SSB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING-PROTEIN; PROMOTED BRANCH MIGRATION; ESCHERICHIA-COLI; IN-VITRO; GENETIC-RECOMBINATION; HOLLIDAY JUNCTIONS; RUVC PROTEIN; INITIATION; REPLISOME; REPAIR	Stalled replication forks are sites of chromosome breakage and the formation of toxic recombination intermediates that undermine genomic stability. Thus, replication fork repair and reactivation are essential processes. Among the many models of replication fork reactivation is one that invokes fork regression catalyzed by the strand exchange protein RecA as an intermediate in the processing of the stalled fork. We have investigated the replication fork regression activity of RecA using a reconstituted DNA replication system where the replisome is stalled by collision with leading-strand template damage. We find that RecA is unable to regress the stalled fork in the presence of the replisome and SSB. If the replication proteins are removed from the stalled fork, RecA will catalyze net regression as long as the Okazaki fragments are sealed. RecA-generated Holliday junctions can be detected by RuvC cleavage, although this is not a robust reaction. On the other hand, extensive branch migration by RecA, where a completely unwound product consisting of the paired nascent leading and lagging strands is produced, is observed under conditions where RuvC activity is suppressed. This branch migration reaction is inhibited by SSB, possibly accounting for the failure of RecA to generate products in the presence of the replication proteins. Interestingly, we find that the RecA-RuvC reaction is supported to differing extents, depending on the template damage; templates carrying a cyclopyrimidine dimer elicit more RecA-RuvC product than those carrying a synthetic abasic site. This difference could be ascribed to a higher affinity of RecA binding to DNAs carrying a thymidine dimer than to those with an abasic site.	[Gupta, Sankalp; Yeeles, Joseph T. P.; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu	Gupta, Sankalp/M-1907-2014	Yeeles, Joseph/0000-0002-2255-2119	National Institutes of Health [GM34557]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034557, R37GM034557] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34557 (to K. J. M.).	ASAI T, 1993, EMBO J, V12, P3287, DOI 10.1002/j.1460-2075.1993.tb05998.x; Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; BENSON FE, 1994, J BIOL CHEM, V269, P5195; BOBST EV, 1985, FEBS LETT, V181, P133, DOI 10.1016/0014-5793(85)81128-5; CASSUTO E, 1980, P NATL ACAD SCI-BIOL, V77, P3962, DOI 10.1073/pnas.77.7.3962; Chow KH, 2004, J BIOL CHEM, V279, P3492, DOI 10.1074/jbc.M311012200; CONNOLLY B, 1991, P NATL ACAD SCI USA, V88, P6063, DOI 10.1073/pnas.88.14.6063; Courcelle J, 2001, GENETICS, V158, P41; Courcelle J, 2003, SCIENCE, V299, P1064, DOI 10.1126/science.1081328; COX MM, 1983, J BIOL CHEM, V258, P2577; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P6018, DOI 10.1073/pnas.78.10.6018; Ferrari ME, 1997, BIOPHYS CHEM, V64, P235, DOI 10.1016/S0301-4622(96)02223-5; Gabbai CB, 2010, DNA REPAIR, V9, P202, DOI 10.1016/j.dnarep.2009.12.009; Gupta S, 2014, J BIOL CHEM, V289, P28376, DOI 10.1074/jbc.M114.587881; HAHN TR, 1988, J BIOL CHEM, V263, P7431; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Indiani C, 2013, P NATL ACAD SCI USA, V110, P5410, DOI 10.1073/pnas.1303301110; Kogoma T, 1996, CELL, V85, P625, DOI 10.1016/S0092-8674(00)81229-5; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kurth I, 2013, NATURE, V496, P119, DOI 10.1038/nature11988; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; MASAI H, 1994, EMBO J, V13, P5338, DOI 10.1002/j.1460-2075.1994.tb06868.x; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McInerney P, 2007, J BIOL CHEM, V282, P25903, DOI 10.1074/jbc.M703777200; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Robu ME, 2001, P NATL ACAD SCI USA, V98, P8211, DOI 10.1073/pnas.131022698; ROSENBERG M, 1990, J BIOL CHEM, V265, P20641; Rothstein R, 2000, GENE DEV, V14, P1; Seigneur M, 2000, MOL MICROBIOL, V38, P565, DOI 10.1046/j.1365-2958.2000.02152.x; SHAH R, 1994, CELL, V79, P853, DOI 10.1016/0092-8674(94)90074-4; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P5100, DOI 10.1073/pnas.76.10.5100; Sommer S, 1998, MOL MICROBIOL, V28, P281, DOI 10.1046/j.1365-2958.1998.00803.x; Stohl EA, 2003, J BIOL CHEM, V278, P2278, DOI 10.1074/jbc.M210496200; TSANEVA IR, 1992, CELL, V69, P1171, DOI 10.1016/0092-8674(92)90638-S; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; WEST SC, 1984, CELL, V37, P683, DOI 10.1016/0092-8674(84)90401-X; WEST SC, 1981, P NATL ACAD SCI-BIOL, V78, P6149, DOI 10.1073/pnas.78.10.6149; WEST SC, 1982, MOL GEN GENET, V186, P333, DOI 10.1007/BF00729451; WHITBY MC, 1994, EMBO J, V13, P5220, DOI 10.1002/j.1460-2075.1994.tb06853.x; WU CA, 1992, J BIOL CHEM, V267, P4030; Yeeles JTP, 2013, MOL CELL, V52, P855, DOI 10.1016/j.molcel.2013.10.020; Yeeles JTP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012815; Yeeles JTP, 2011, SCIENCE, V334, P235, DOI 10.1126/science.1209111	50	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28388	28398		10.1074/jbc.M114.587907	http://dx.doi.org/10.1074/jbc.M114.587907			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25138217	Green Published, hybrid			2022-12-28	WOS:000343765400032
J	Kidwell, MA; Chan, JM; Doudna, JA				Kidwell, Mary Anne; Chan, Jessica M.; Doudna, Jennifer A.			Evolutionarily Conserved Roles of the Dicer Helicase Domain in Regulating RNA Interference Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR RIG-I; STRUCTURAL BASIS; DROSOPHILA DICER-1; RECOGNITION; PROTEINS; ACCUMULATION; ACTIVATION; INSIGHTS; BINDING; GENES	The enzyme Dicer generates 21-25 nucleotide RNAs that target specific mRNAs for silencing during RNA interference and related pathways. Although their active sites and RNA binding regions are functionally conserved, the helicase domains have distinct activities in the context of different Dicer enzymes. To examine the evolutionary origins of Dicer helicase functions, we investigated two related Dicer enzymes from the thermophilic fungus Sporotrichum thermophile. RNA cleavage assays showed that S. thermophile Dicer-1 (StDicer-1) can process hairpin precursor microRNAs, whereas StDicer-2 can only cleave linear double-stranded RNAs. Furthermore, only StDicer-2 possesses robust ATP hydrolytic activity in the presence of double-stranded RNA. Deletion of the StDicer-2 helicase domain increases both StDicer-2 cleavage activity and affinity for hairpin RNA. Notably, both StDicer-1 and StDicer-2 could complement the distantly related yeast Schizosaccharomyces pombe lacking its endogenous Dicer gene but only in their full-length forms, underscoring the importance of the helicase domain. These results suggest an in vivo regulatory function for the helicase domain that may be conserved from fungi to humans.	[Kidwell, Mary Anne; Chan, Jessica M.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, 731 Stanley Hall,MS 3220, Berkeley, CA 94720 USA.	doudna@berkeley.edu			National Institutes of Health [5R01GM073794]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01GM073794.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Beeson WT, 2011, APPL ENVIRON MICROB, V77, P650, DOI 10.1128/AEM.01922-10; Catalanotto C, 2004, MOL CELL BIOL, V24, P2536, DOI 10.1128/MCB.24.6.2536-2545.2004; Cenik ES, 2011, MOL CELL, V42, P172, DOI 10.1016/j.molcel.2011.03.002; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Chakravarthy S, 2010, J MOL BIOL, V404, P392, DOI 10.1016/j.jmb.2010.09.030; Civril F, 2011, EMBO REP, V12, P1127, DOI 10.1038/embor.2011.190; de Jong D, 2009, MOL BIOL EVOL, V26, P1333, DOI 10.1093/molbev/msp042; De N, 2013, MOL CELL, V50, P344, DOI 10.1016/j.molcel.2013.04.001; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; FerreDAmare AR, 1996, NUCLEIC ACIDS RES, V24, P977, DOI 10.1093/nar/24.5.977; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Kadotani N, 2004, J BIOL CHEM, V279, P44467, DOI 10.1074/jbc.M408259200; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lau PW, 2012, NAT STRUCT MOL BIOL, V19, P436, DOI 10.1038/nsmb.2268; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Lee HY, 2012, RNA, V18, P2012, DOI 10.1261/rna.035501.112; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lindner K, 2002, MOL BIOL CELL, V13, P435, DOI 10.1091/mbc.01-11-0537; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Ma EB, 2012, J MOL BIOL, V422, P466, DOI 10.1016/j.jmb.2012.06.009; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Moran Y, 2013, MOL BIOL EVOL, V30, P2541, DOI 10.1093/molbev/mst159; Mukherjee K, 2013, MOL BIOL EVOL, V30, P627, DOI 10.1093/molbev/mss263; Provost P, 2002, P NATL ACAD SCI USA, V99, P16648, DOI 10.1073/pnas.212633199; Sasaki T, 2007, GENE, V396, P312, DOI 10.1016/j.gene.2007.04.001; Taylor DW, 2013, NAT STRUCT MOL BIOL, V20, P662, DOI 10.1038/nsmb.2564; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Welker NC, 2010, RNA, V16, P893, DOI 10.1261/rna.2122010; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	35	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28352	28362		10.1074/jbc.M114.589051	http://dx.doi.org/10.1074/jbc.M114.589051			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25135636	Green Published, hybrid			2022-12-28	WOS:000343765400029
J	Laflamme, G; Tremblay-Boudreault, T; Roy, MA; Andersen, P; Bonneil, E; Atchia, K; Thibault, P; D'Amours, D; Kwok, BH				Laflamme, Guillaume; Tremblay-Boudreault, Thierry; Roy, Marc-Andre; Andersen, Parker; Bonneil, Eric; Atchia, Kaleem; Thibault, Pierre; D'Amours, Damien; Kwok, Benjamin H.			Structural Maintenance of Chromosome (SMC) Proteins Link Microtubule Stability to Genome Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Division; Chromosomes; Microtubule; Mitosis; Mitotic Spindle; SMC Proteins	KINESIN; CONDENSIN; DNA; TUBULIN; YEAST; KINETOCHORE; MITOSIS; SPINDLE; COMPLEX; IDENTIFICATION	Background: SMC proteins organize chromosome architecture, whereas microtubules form the structural framework for chromosome movement in mitosis. Results: SMC proteins bind to and stabilize microtubules to promote proper mitotic spindle formation. Conclusion: SMC proteins can provide a functional link between microtubules and DNA to ensure faithful chromosome segregation. Significance: SMC-microtubule interactions are essential to establish a robust system for maintaining genome integrity. Structural maintenance of chromosome (SMC) proteins are key organizers of chromosome architecture and are essential for genome integrity. They act by binding to chromatin and connecting distinct parts of chromosomes together. Interestingly, their potential role in providing connections between chromatin and the mitotic spindle has not been explored. Here, we show that yeast SMC proteins bind directly to microtubules and can provide a functional link between microtubules and DNA. We mapped the microtubule-binding region of Smc5 and generated a mutant with impaired microtubule binding activity. This mutant is viable in yeast but exhibited a cold-specific conditional lethality associated with mitotic arrest, aberrant spindle structures, and chromosome segregation defects. In an in vitro reconstitution assay, this Smc5 mutant also showed a compromised ability to protect microtubules from cold-induced depolymerization. Collectively, these findings demonstrate that SMC proteins can bind to and stabilize microtubules and that SMC-microtubule interactions are essential to establish a robust system to maintain genome integrity.	[Laflamme, Guillaume; Tremblay-Boudreault, Thierry; Andersen, Parker; Atchia, Kaleem; Kwok, Benjamin H.] Univ Montreal, Stn Ctr Ville, Inst Res Immunol & Canc, Chem Biol Cell Div Lab, Montreal, PQ H3C 3J7, Canada; [Laflamme, Guillaume; Roy, Marc-Andre; D'Amours, Damien] Univ Montreal, Stn Ctr Ville, Inst Res Immunol & Canc, Lab Cell Cycle Regulat & Chromosome Struct, Montreal, PQ H3C 3J7, Canada; [Bonneil, Eric; Thibault, Pierre] Univ Montreal, Stn Ctr Ville, Inst Res Immunol & Canc, Lab Prote & Bioanalyt Mass Spectrometry, Montreal, PQ H3C 3J7, Canada; [Thibault, Pierre] Univ Montreal, Stn Ctr Ville, Dept Chem, Montreal, PQ H3C 3J7, Canada; [D'Amours, Damien] Univ Montreal, Stn Ctr Ville, Dept Pathol & Cellular Biol, Montreal, PQ H3C 3J7, Canada; [Kwok, Benjamin H.] Univ Montreal, Stn Ctr Ville, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	D'Amours, D (corresponding author), Univ Montreal, Stn Ctr Ville, Inst Res Immunol & Canc, Lab Cell Cycle Regulat & Chromosome Struct, Montreal, PQ H3C 3J7, Canada.	damien.damours@umontreal.ca; benjamin.kwok@umontreal.ca		Laflamme, Guillaume/0000-0002-9083-4572	Canadian Institutes of Health Research (CIHR) [MOP-82912, MOP-97928]; Canadian Cancer Society Research Institute [020304]; Fonds de Recherche du Quebec en Sante [22131]; Natural Sciences and Engineering Research Council; Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation; Fonds de Recherche Sante (FRQS); Fonds Perseverance (IRIC, Universite de Montreal); FRQS	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Fonds de Recherche du Quebec en Sante(Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Fonds de Recherche Sante (FRQS); Fonds Perseverance (IRIC, Universite de Montreal); FRQS	This work was supported by Canadian Institutes of Health Research (CIHR) Grants MOP-82912 (to D. D.) and MOP-97928 (to B. H. K.), Canadian Cancer Society Research Institute Grant 020304 (to D. D.), Fonds de Recherche du Quebec en Sante Grant 22131 (to B. H. K.), and the Natural Sciences and Engineering Research Council (to P. T.). The Institute for Research in Immunology and Cancer (IRIC) is supported in part by the Canadian Center of Excellence in Commercialization and Research (CECR), the Canada Foundation for Innovation, and Fonds de Recherche Sante (FRQS).; Supported by a graduate scholarship from the Fonds Perseverance (IRIC, Universite de Montreal).; Supported by a Ph.D. scholarship from FRQS.	Akhmedov AT, 1998, J BIOL CHEM, V273, P24088, DOI 10.1074/jbc.273.37.24088; Akiyoshi B, 2009, GENE DEV, V23, P2887, DOI 10.1101/gad.1865909; Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Arora K, 2014, J MOL BIOL, V426, P2997, DOI 10.1016/j.jmb.2014.05.030; Bazile F, 2010, CELL CYCLE, V9, P3243, DOI 10.4161/cc.9.16.12620; BROACH JR, 1986, CELL, V44, P3, DOI 10.1016/0092-8674(86)90477-0; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Chiu A, 2004, J BIOL CHEM, V279, P26233, DOI 10.1074/jbc.M402439200; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Crevel IMTC, 1996, J MOL BIOL, V257, P66, DOI 10.1006/jmbi.1996.0147; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; ELINSON RP, 1985, DEV BIOL, V109, P224, DOI 10.1016/0012-1606(85)90362-8; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Gache V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009248; GARD DL, 1987, J CELL BIOL, V105, P2191, DOI 10.1083/jcb.105.5.2191; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; HEIDEMANN SR, 1975, J CELL BIOL, V67, P105, DOI 10.1083/jcb.67.1.105; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; HUFFAKER TC, 1988, J CELL BIOL, V106, P1997, DOI 10.1083/jcb.106.6.1997; JARVIK J, 1975, P NATL ACAD SCI USA, V72, P2738, DOI 10.1073/pnas.72.7.2738; JOHNSON KA, 1977, J MOL BIOL, V117, P1, DOI 10.1016/0022-2836(77)90020-1; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Kegel A, 2010, COLD SH Q B, V75, P179, DOI 10.1101/sqb.2010.75.047; Kinoshita K, 2002, TRENDS CELL BIOL, V12, P267, DOI 10.1016/S0962-8924(02)02295-X; Kwok BH, 2004, CURR BIOL, V14, P1783, DOI 10.1016/j.cub.2004.09.052; Lee YM, 2001, BIOCHEM J, V360, P549, DOI 10.1042/0264-6021:3600549; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Nakazawa N, 2008, J CELL BIOL, V180, P1115, DOI 10.1083/jcb.200708170; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Pebernard S, 2008, EMBO J, V27, P3011, DOI 10.1038/emboj.2008.220; Ramey VH, 2011, MOL BIOL CELL, V22, P457, DOI 10.1091/mbc.E10-10-0841; Ratsima H, 2011, P NATL ACAD SCI USA, V108, pE914, DOI 10.1073/pnas.1106448108; REIJO RA, 1994, MOL BIOL CELL, V5, P29, DOI 10.1091/mbc.5.1.29; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; Rossio V, 2010, J CELL BIOL, V191, P981, DOI 10.1083/jcb.201007025; Roy MA, 2011, CELL CYCLE, V10, P690, DOI 10.4161/cc.10.4.14860; SALMON ED, 1980, J CELL BIOL, V85, P853, DOI 10.1083/jcb.85.3.853; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Solinet S, 2013, J CELL BIOL, V202, P251, DOI 10.1083/jcb.201304052; St-Pierre J, 2009, MOL CELL, V34, P416, DOI 10.1016/j.molcel.2009.04.013; Stephens AD, 2011, J CELL BIOL, V193, P1167, DOI 10.1083/jcb.201103138; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Weinger JS, 2011, CURR BIOL, V21, P154, DOI 10.1016/j.cub.2010.12.038; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yoshimura SH, 2002, CURR BIOL, V12, P508, DOI 10.1016/S0960-9822(02)00719-4	61	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27418	27431		10.1074/jbc.M114.569608	http://dx.doi.org/10.1074/jbc.M114.569608			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25135640	hybrid, Green Published			2022-12-28	WOS:000342852800006
J	Nair, V; Sreevalsan, S; Basha, R; Abdelrahim, M; Abudayyeh, A; Hoffman, AR; Safe, S				Nair, Vijayalekshmi; Sreevalsan, Sandeep; Basha, Riyaz; Abdelrahim, Maen; Abudayyeh, Ala; Hoffman, Aline Rodrigues; Safe, Stephen			Mechanism of Metformin-dependent Inhibition of Mammalian Target of Rapamycin (mTOR) and Ras Activity in Pancreatic Cancer ROLE OF SPECIFICITY PROTEIN (Sp) TRANSCRIPTION FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epidermal Growth Factor Receptor (EGFR); Gene Expression; Insulin-like Growth Factor (IGF); Pancreatic Cancer; Specificity Protein 1 (Sp1); IGFR Down-regulation; Ras Inhibition; Sp Transcription Factors; mTOR Down-regulation; Metformin	GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; TUMOR-GROWTH; DIABETIC-PATIENTS; EGF RECEPTOR; IN-VITRO; CELL; EXPRESSION; PROLIFERATION; ACTIVATION	Background: Metformin inhibits pancreatic cancer cell and tumor growth and down-regulated Sp transcription factors. Results: Inhibition of mTOR and Ras signaling by metformin is due to decreased expression of Sp-regulated insulin-like growth factor-1 receptor (IGF-1R) and epidermal growth factor receptor (EGFR), respectively. Conclusion: Metformin-induced down-regulation of Sp proteins affects multiple pro-oncogenic pathways. Significance: These results identify important metformin-induced anticancer activities. The antidiabetic drug metformin exhibits both chemopreventive and chemotherapeutic activity for multiple cancers including pancreatic cancer; however, the underlying mechanism of action of metformin is unclear. A recent study showed that metformin down-regulated specificity protein (Sp) transcription factors (TFs) Sp1, Sp3, and Sp4 in pancreatic cancer cells and tumors, and this was accompanied by down-regulation of several pro-oncogenic Sp-regulated genes. Treatment with metformin or down-regulation of Sp TFs by RNAi also inhibits two major pro-oncogenic pathways in pancreatic cancer cells, namely mammalian target of rapamycin (mTOR) signaling and epidermal growth factor (EGFR)-dependent activation of Ras. Metformin and Sp knockdown by RNAi decreased expression of the insulin-like growth factor-1 receptor (IGF-1R), resulting in inhibition of mTOR signaling. Ras activity was also decreased by metformin and Sp knockdown of EGFR, another Sp-regulated gene. Thus, the antineoplastic activities of metformin in pancreatic cancer are due, in part, to down-regulation of Sp TFs and Sp-regulated IGF-1R and EGFR, which in turn results in inhibition of mTOR and Ras signaling, respectively.	[Nair, Vijayalekshmi; Sreevalsan, Sandeep; Safe, Stephen] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Hoffman, Aline Rodrigues] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Basha, Riyaz; Abdelrahim, Maen] Univ Texas MD Anderson Canc Ctr, Canc Res Inst, Orlando, FL 32806 USA; [Basha, Riyaz; Abdelrahim, Maen] Baylor Coll Med, Houston, TX 77030 USA; [Abudayyeh, Ala] Univ Texas MD Anderson Canc Ctr, Dept Emergency Med, Houston, TX 77030 USA; [Safe, Stephen] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Safe, S (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA.	ssafe@cvm.tamu.edu	rodrigues hoffmann, aline/L-6859-2017	rodrigues hoffmann, aline/0000-0001-6148-2531; Basha, Riyaz/0000-0002-4071-0993	National Institutes of Health [R01CA136571, P30ES023512]; Texas AgriLife Research; NATIONAL CANCER INSTITUTE [R01CA136571, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas AgriLife Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA136571 and P30ES023512 (to S. S.). This work was also supported by Texas AgriLife Research.	Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Abdelrahim M, 2007, CANCER RES, V67, P3286, DOI 10.1158/0008-5472.CAN-06-3831; American Cancer Society, 2011, CANC FACTS FIG 2011; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; BEITNERJOHNSON D, 1995, MOL ENDOCRINOL, V9, P1147, DOI 10.1210/me.9.9.1147; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; BERGMANN U, 1995, CANCER RES, V55, P2007; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Cerezo M, 2013, MOL CANCER THER, V12, P1605, DOI 10.1158/1535-7163.MCT-12-1226-T; Chadalapaka G, 2010, MOL CANCER RES, V8, P739, DOI 10.1158/1541-7786.MCR-09-0493; Deniaud E, 2006, ONCOGENE, V25, P7096, DOI 10.1038/sj.onc.1209696; Dowling RJO, 2012, J MOL ENDOCRINOL, V48, pR31, DOI 10.1530/JME-12-0007; Engelman JA, 2010, CANCER PREV RES, V3, P1049, DOI 10.1158/1940-6207.CAPR-10-0178; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Furuta E, 2008, CANCER RES, V68, P1003, DOI 10.1158/0008-5472.CAN-07-2489; Garrett CR, 2012, BRIT J CANCER, V106, P1374, DOI 10.1038/bjc.2012.71; Gotlieb WH, 2008, GYNECOL ONCOL, V110, P246, DOI 10.1016/j.ygyno.2008.04.008; Gou SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063969; Jiang NY, 2008, CANCER EPIDEM BIOMAR, V17, P1648, DOI 10.1158/1055-9965.EPI-07-2791; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; JOHNSON AC, 1988, J BIOL CHEM, V263, P5693; Jutooru I, 2014, MOL CELL BIOL, V34, P2382, DOI 10.1128/MCB.01602-13; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Jutooru I, 2010, MOL PHARMACOL, V78, P226, DOI 10.1124/mol.110.064451; Karnevi E, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-235; Kim HG, 2011, BRIT J PHARMACOL, V162, P1096, DOI 10.1111/j.1476-5381.2010.01101.x; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Lu SY, 2010, INT J CANCER, V126, P416, DOI 10.1002/ijc.24761; Murtola TJ, 2008, AM J EPIDEMIOL, V168, P925, DOI 10.1093/aje/kwn190; Nair V, 2013, CARCINOGENESIS, V34, P2870, DOI 10.1093/carcin/bgt231; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Pollak M, 2010, CANCER PREV RES, V3, P1060, DOI 10.1158/1940-6207.CAPR-10-0175; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229; Sadeghi N, 2012, CLIN CANCER RES, V18, P2905, DOI 10.1158/1078-0432.CCR-11-2994; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Sinnett-Smith J, 2013, BIOCHEM BIOPH RES CO, V430, P352, DOI 10.1016/j.bbrc.2012.11.010; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Spillane S, 2013, CANCER EPIDEM BIOMAR, V22, P1364, DOI 10.1158/1055-9965.EPI-13-0347; Sreevalsan S, 2013, MOL CANCER THER, V12, P2483, DOI 10.1158/1535-7163.MCT-13-0486; Storozhuk Y, 2013, BRIT J CANCER, V108, P2021, DOI 10.1038/bjc.2013.187; Tan BK, 2011, J CLIN ENDOCR METAB, V96, P808, DOI 10.1210/jc.2010-1803; Wang LW, 2008, WORLD J GASTROENTERO, V14, P7192, DOI 10.3748/wjg.14.7192; Wright JL, 2009, CANCER CAUSE CONTROL, V20, P1617, DOI 10.1007/s10552-009-9407-y; Yasmeen A, 2011, GYNECOL ONCOL, V121, P492, DOI 10.1016/j.ygyno.2011.02.021; Zhuang YX, 2011, MOL CANCER RES, V9, P603, DOI 10.1158/1541-7786.MCR-10-0343; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	51	96	96	2	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27692	27701		10.1074/jbc.M114.592576	http://dx.doi.org/10.1074/jbc.M114.592576			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25143389	hybrid, Green Published			2022-12-28	WOS:000342852800028
J	Racca, JD; Chen, YS; Maloy, JD; Wickramasinghe, N; Phillips, NB; Weiss, MA				Racca, Joseph D.; Chen, Yen-Shan; Maloy, James D.; Wickramasinghe, Nalinda; Phillips, Nelson B.; Weiss, Michael A.			Structure-Function Relationships in Human Testis-determining Factor SRY AN AROMATIC BUTTRESS UNDERLIES THE SPECIFIC DNA-BENDING SURFACE OF A HIGH MOBILITY GROUP (HMG) BOX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SEX REVERSAL; NUCLEAR-LOCALIZATION SIGNALS; DETERMINING REGION; BINDING DOMAINS; SOX PROTEINS; INDUCED-FIT; TRANSCRIPTION FACTORS; ALPHA-LACTALBUMIN; DETERMINING GENES; CRYSTAL-STRUCTURE	Human testis determination is initiated by SRY, a Y-encoded architectural transcription factor. Mutations in SRY cause 46 XY gonadal dysgenesis with female somatic phenotype (Swyer syndrome) and confer a high risk of malignancy (gonadoblastoma). Such mutations cluster in the SRY high mobility group (HMG) box, a conserved motif of specific DNA binding and bending. To explore structure-function relationships, we constructed all possible substitutions at a site of clinical mutation (W70L). Our studies thus focused on a core aromatic residue (position 15 of the consensus HMG box) that is invariant among SRY-related HMG box transcription factors (the SOX family) and conserved as aromatic (Phe or Tyr) among other sequence-specific boxes. In a yeast one-hybrid system sensitive to specific SRY-DNA binding, the variant domains exhibited reduced (Phe and Tyr) or absent activity (the remaining 17 substitutions). Representative nonpolar variants with partial or absent activity (Tyr, Phe, Leu, and Ala in order of decreasing side-chain volume) were chosen for study in vitro and in mammalian cell culture. The clinical mutation (Leu) was found to markedly impair multiple biochemical and cellular activities as respectively probed through the following: (i) in vitro assays of specific DNA binding and protein stability, and (ii) cell culture-based assays of proteosomal degradation, nuclear import, enhancer DNA occupancy, and SRY-dependent transcriptional activation. Surprisingly, however, DNA bending is robust to this or the related Ala substitution that profoundly impairs box stability. Together, our findings demonstrate that the folding, trafficking, and gene-regulatory function of SRY requires an invariant aromatic "buttress" beneath its specific DNA-bending surface.	[Racca, Joseph D.; Chen, Yen-Shan; Maloy, James D.; Wickramasinghe, Nalinda; Phillips, Nelson B.; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, 10900 Euclid Ave, Cleveland, OH 44106 USA.	maw21@case.edu	Wickramasinghe, Nalinda P/F-9465-2010	Wickramasinghe, Nalinda P./0000-0002-8700-2775	National Institutes of Health [GM080505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080505 (to M. A. W.). This work represents a contribution from the Cleveland Center for Membrane and Structural Biology.	Alatzoglou KS, 2009, J ENDOCRINOL, V200, P245, DOI 10.1677/JOE-08-0447; Argentaro A, 2003, J BIOL CHEM, V278, P33839, DOI 10.1074/jbc.M302078200; Arvidson DN, 1998, NAT STRUCT BIOL, V5, P436, DOI 10.1038/nsb0698-436; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Cameron FJ, 1997, HUM MUTAT, V9, P388; CHAKRABARTTY A, 1995, ADV PROTEIN CHEM, V46, P141, DOI 10.1016/S0065-3233(08)60334-4; Chen YS, 2013, P NATL ACAD SCI USA, V110, pE3567, DOI 10.1073/pnas.1300828110; Clore GM, 2014, BIOPHYS CHEM, V186, P3, DOI 10.1016/j.bpc.2013.08.006; CONNER F, 1994, NUCLEIC ACIDS RES, V22, P3339, DOI 10.1093/nar/22.16.3339; Crane-Robinson C, 1998, J MOL BIOL, V281, P705, DOI 10.1006/jmbi.1998.1895; Creighton TE, 1996, FASEB J, V10, P110, DOI 10.1096/fasebj.10.1.8566531; de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156; de Santa Barbara P, 2000, DEV DYNAM, V217, P293, DOI 10.1002/(SICI)1097-0177(200003)217:3<293::AID-DVDY7>3.0.CO;2-P; DOBSON CM, 1994, CURR BIOL, V4, P636, DOI 10.1016/S0960-9822(00)00141-X; Dong C, 2004, CYTOGENET GENOME RES, V105, P442, DOI 10.1159/000078217; DOOIJES D, 1993, J BIOL CHEM, V268, P24813; ELLENBERGER T, 1994, CURR OPIN STRUC BIOL, V4, P12, DOI 10.1016/S0959-440X(94)90054-X; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Forwood JK, 2001, J BIOL CHEM, V276, P46575, DOI 10.1074/jbc.M101668200; Gasca S, 2002, P NATL ACAD SCI USA, V99, P11199, DOI 10.1073/pnas.172383099; GEHRING WJ, 1990, TRENDS GENET, V6, P323, DOI 10.1016/0168-9525(90)90253-3; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Gontan C, 2009, J CELL BIOL, V185, P27, DOI 10.1083/jcb.200810106; GRAY DM, 1992, METHOD ENZYMOL, V211, P389; Haqq CM, 1998, PHYSIOL REV, V78, P1; HAQQ CM, 1994, SCIENCE, V266, P1494, DOI 10.1126/science.7985018; Harley VR, 2003, P NATL ACAD SCI USA, V100, P7045, DOI 10.1073/pnas.1137864100; HARRISON SC, 1991, NATURE, V353, P715, DOI 10.1038/353715a0; Hersmus R, 2009, EUR J HUM GENET, V17, P1642, DOI 10.1038/ejhg.2009.96; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; Jauch R, 2008, J MOL BIOL, V376, P758, DOI 10.1016/j.jmb.2007.11.091; Jauch R, 2012, BIOCHEM J, V443, P39, DOI 10.1042/BJ20111768; Jiang T., 2012, MOL BIOL REP, V316, P359; JONES DNM, 1994, STRUCTURE, V2, P609, DOI 10.1016/S0969-2126(00)00063-0; Josso Nathalie, 2006, Pediatr Endocrinol Rev, V3, P347; Junger Sebastian, 1997, PERFECT STORM TRUE S; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; KAPP OH, 1995, PROTEIN SCI, V4, P2179, DOI 10.1002/pro.5560041024; KARPLUS M, 1994, PROTEIN SCI, V3, P650; KIM J, 1989, GENE, V85, P15, DOI 10.1016/0378-1119(89)90459-9; KING CY, 1993, P NATL ACAD SCI USA, V90, P11990, DOI 10.1073/pnas.90.24.11990; Kleinjan DA, 2008, ADV GENET, V61, P339, DOI 10.1016/S0065-2660(07)00013-2; Knower KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017751; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Koopman P, 2001, J EXP ZOOL, V290, P463, DOI 10.1002/jez.1089; Kuwajima K, 1996, FASEB J, V10, P102, DOI 10.1096/fasebj.10.1.8566530; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lassalle MW, 2001, PROTEINS, V45, P96, DOI 10.1002/prot.1128; LAUDET V, 1993, NUCLEIC ACIDS RES, V21, P2493, DOI 10.1093/nar/21.10.2493; Li B, 2006, J MOL BIOL, V360, P310, DOI 10.1016/j.jmb.2006.04.048; Li BR, 2001, J BIOL CHEM, V276, P46480, DOI 10.1074/jbc.C100388200; Lipowsky G, 2000, EMBO J, V19, P4362, DOI 10.1093/emboj/19.16.4362; Liu ZR, 2014, PROTEIN SCI, V23, P539, DOI 10.1002/pro.2443; Love JJ, 2004, BIOCHEMISTRY-US, V43, P8725, DOI 10.1021/bi049591m; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Lovell-Badge R, 2002, NOVART FDN SYMP, V244, P4; Malki S, 2010, INT J BIOCHEM CELL B, V42, P411, DOI 10.1016/j.biocel.2009.09.020; Matthews BW, 2009, PROTEIN SCI, V18, P494, DOI 10.1002/pro.61; Matthews BW, 1996, FASEB J, V10, P35, DOI 10.1096/fasebj.10.1.8566545; McClelland K, 2012, ASIAN J ANDROL, V14, P164, DOI 10.1038/aja.2011.169; Murphy EC, 2001, J MOL BIOL, V312, P481, DOI 10.1006/jmbi.2001.4977; Murphy FV, 1999, EMBO J, V18, P6610, DOI 10.1093/emboj/18.23.6610; Myers JK, 1997, P NATL ACAD SCI USA, V94, P2833, DOI 10.1073/pnas.94.7.2833; NER S S, 1992, Current Biology, V2, P208, DOI 10.1016/0960-9822(92)90541-H; Phillips NB, 2006, J MOL BIOL, V358, P172, DOI 10.1016/j.jmb.2006.01.060; Phillips NB, 2004, BIOCHEMISTRY-US, V43, P7066, DOI 10.1021/bi049920a; Phillips NB, 2011, J BIOL CHEM, V286, P36787, DOI 10.1074/jbc.M111.260091; Prieve MG, 1998, MOL CELL BIOL, V18, P4819, DOI 10.1128/MCB.18.8.4819; Privalov PL, 1999, J MOL BIOL, V294, P997, DOI 10.1006/jmbi.1999.3285; READ CM, 1993, NUCLEIC ACIDS RES, V21, P3427, DOI 10.1093/nar/21.15.3427; Redfield C, 1999, NAT STRUCT BIOL, V6, P948, DOI 10.1038/13318; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Sekido R, 2010, INT J BIOCHEM CELL B, V42, P417, DOI 10.1016/j.biocel.2009.12.005; Sim H, 2005, MOL ENDOCRINOL, V19, P1884, DOI 10.1210/me.2004-0334; Sim H, 2011, ENDOCRINOLOGY, V152, P2883, DOI 10.1210/en.2010-1475; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Stewart M, 2006, BIOCHEM SOC T, V34, P701, DOI 10.1042/BST0340701; Sudbeck P, 1997, J BIOL CHEM, V272, P27848, DOI 10.1074/jbc.272.44.27848; Trimmer EE, 1998, BIOCHEMISTRY-US, V37, P352, DOI 10.1021/bi971675q; Tsuchiya M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025694; Ukiyama E, 2001, MOL ENDOCRINOL, V15, P363, DOI 10.1210/me.15.3.363; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; Weirauch MT, 2011, SUBCELL BIOCHEM, V52, P25, DOI 10.1007/978-90-481-9069-0_3; Weiss MA, 1997, J BIOMOL STRUCT DYN, V15, P177, DOI 10.1080/07391102.1997.10508185; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; WEISS MA, 1984, P NATL ACAD SCI-BIOL, V81, P130, DOI 10.1073/pnas.81.1.130; Weiss MA, 2001, MOL ENDOCRINOL, V15, P353, DOI 10.1210/me.15.3.353; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; WHITFIELD LS, 1993, NATURE, V364, P713, DOI 10.1038/364713a0; Wilhelm D, 2006, NAT REV GENET, V7, P620, DOI 10.1038/nrg1903; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Xu B, 2002, PROTEIN SCI, V11, P104, DOI 10.1110/ps.ps.32102; Zenteno JC, 2005, CLIN GENET, V68, P564, DOI 10.1111/j.1399-0004.2005.00518.x; Zhao L, 2012, CHROMOSOME RES, V20, P153, DOI 10.1007/s10577-011-9256-x	99	10	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.597526	http://dx.doi.org/10.1074/jbc.M114.597526			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25258310	Green Published, hybrid			2022-12-28	WOS:000345335000003
J	Bhattacharya, S; Auldridge, ME; Lehtivuori, H; Ihalainen, JA; Forest, KT				Bhattacharya, Shyamosree; Auldridge, Michele E.; Lehtivuori, Heli; Ihalainen, Janne A.; Forest, Katrina T.			Origins of Fluorescence in Evolved Bacteriophytochromes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fluorescence; Photoreceptor; Protein Engineering; Spectroscopy; Structural Biology; Phytochrome	CHROMOPHORE-BINDING DOMAIN; DEINOCOCCUS-RADIODURANS; BACTERIAL PHYTOCHROME; QUANTUM YIELD; PROTEIN; LIGHT; SPECTROSCOPY; PARAMETERS; RESIDUES; OXYGEN	Use of fluorescent proteins to study in vivo processes in mammals requires near-infrared (NIR) biomarkers that exploit the ability of light in this range to penetrate tissue. Bacteriophytochromes (BphPs) are photoreceptors that couple absorbance of NIR light to photoisomerization, protein conformational changes, and signal transduction. BphPs have been engineered to form NIR fluorophores, including IFP1.4, Wi-Phy, and the iRFP series, initially by replacement of Asp-207 by His. This position was suggestive because its main chain carbonyl is within hydrogen-bonding distance to pyrrole ring nitrogens of the biliverdin chromophore, thus potentially functioning as a crucial transient proton sink during photoconversion. To explain the origin of fluorescence in these phytofluors, we solved the crystal structures of IFP1.4 and a comparison non-fluorescent monomeric phytochrome DrCBD(mon). Met-186 and Val-288 in IFP1.4 are responsible for the formation of a tightly packed hydrophobic hub around the biliverdin D ring. Met-186 is also largely responsible for the blue-shifted IFP1.4 excitation maximum relative to the parent BphP. The structure of IFP1.4 revealed decreased structural heterogeneity and a contraction of two surface regions as direct consequences of side chain substitutions. Unexpectedly, IFP1.4 with Asp-207 reinstalled (IFPrev) has a higher fluorescence quantum yield (approximate to 9%) than most NIR phytofluors published to date. In agreement, fluorescence lifetime measurements confirm the exceptionally long excited state lifetimes, up to 815 ps, in IFP1.4 and IFPrev. Our research helps delineate the origin of fluorescence in engineered BphPs and will facilitate the wide-spread adoption of phytofluors as biomarkers.	[Bhattacharya, Shyamosree; Auldridge, Michele E.; Forest, Katrina T.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Lehtivuori, Heli; Ihalainen, Janne A.] Univ Jyvaskyla, Nanosci Ctr, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland	University of Wisconsin System; University of Wisconsin Madison; University of Jyvaskyla	Ihalainen, JA (corresponding author), Univ Jyvaskyla, POB 35,Survontie 9C, FI-40014 Jyvaskyla, Finland.	janne.ihalainen@jyu.fi; forest@bact.wisc.edu		Ihalainen, Janne/0000-0002-8741-1587; Lehtivuori, Heli/0000-0002-7450-2578	United States DOE [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]	United States DOE(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor	We thank Professor Felix Castellano and Dr. Rony S. Khnayzer for generous assistance with absolute quantum yield measurements, Professor Robert Landick for equipment access, and Dr. Kenneth Satyshur for technical assistance. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Dept. of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States DOE under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor (Grant 085P1000817).	Anders K, 2013, J BIOL CHEM, V288, P35714, DOI 10.1074/jbc.M113.510461; Auldridge ME, 2012, J BIOL CHEM, V287, P7000, DOI 10.1074/jbc.M111.295121; Auldridge ME, 2011, CRIT REV BIOCHEM MOL, V46, P67, DOI 10.3109/10409238.2010.546389; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Borg OA, 2008, PHYS CHEM CHEM PHYS, V10, P2528, DOI 10.1039/b719190a; Borucki B, 2005, J BIOL CHEM, V280, P34358, DOI 10.1074/jbc.M505493200; Dasgupta J, 2009, P NATL ACAD SCI USA, V106, P1784, DOI 10.1073/pnas.0812056106; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escobar FV, 2014, BIOCHEMISTRY-US, V53, P20, DOI 10.1021/bi401287u; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Fischer AJ, 2004, P NATL ACAD SCI USA, V101, P17334, DOI 10.1073/pnas.0407645101; Foerstendorf H, 1996, BIOCHEMISTRY-US, V35, P10793, DOI 10.1021/bi960960r; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; JOBSIS FF, 1974, AM REV RESPIR DIS, V110, P58; JOBSIS FF, 1977, ACTA NEUROL SCAND, V56, P452; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kim PW, 2014, BIOCHEMISTRY-US, V53, P2818, DOI 10.1021/bi500108s; Lehtivuori H, 2013, J PHYS CHEM B, V117, P11049, DOI 10.1021/jp312061b; Magyar C, 2005, NUCLEIC ACIDS RES, V33, pW303, DOI 10.1093/nar/gki409; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller AE, 2006, P NATL ACAD SCI USA, V103, P11136, DOI 10.1073/pnas.0604724103; MUJUMDAR RB, 1993, BIOCONJUGATE CHEM, V4, P105, DOI 10.1021/bc00020a001; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Piatkevich KD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3153; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Shcherbakova DM, 2013, NAT METHODS, V10, P751, DOI 10.1038/nmeth.2521; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Stepanenko OV, 2008, CURR PROTEIN PEPT SC, V9, P338, DOI 10.2174/138920308785132668; Suzuki K, 2009, PHYS CHEM CHEM PHYS, V11, P9850, DOI 10.1039/b912178a; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Toh KC, 2011, PHYS CHEM CHEM PHYS, V13, P11985, DOI 10.1039/c1cp00050k; Toh KC, 2010, P NATL ACAD SCI USA, V107, P9170, DOI 10.1073/pnas.0911535107; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yang XJ, 2011, NATURE, V479, P428, DOI 10.1038/nature10506; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; Ying BW, 2007, RNA, V13, P2042, DOI 10.1261/rna.637907; Yu D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4626; Zhang JA, 2010, ANGEW CHEM INT EDIT, V49, P5456, DOI 10.1002/anie.201001094	47	55	59	3	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32144	32152		10.1074/jbc.M114.589739	http://dx.doi.org/10.1074/jbc.M114.589739			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25253687	Green Published, hybrid			2022-12-28	WOS:000345314700042
J	Brocato, J; Fang, L; Chervona, Y; Chen, DQ; Kiok, K; Sun, H; Tseng, HC; Xu, DZ; Shamy, M; Jin, CY; Costa, M				Brocato, Jason; Fang, Lei; Chervona, Yana; Chen, Danqi; Kiok, Kathrin; Sun, Hong; Tseng, Hsiang-Chi; Xu, Dazhong; Shamy, Magdy; Jin, Chunyuan; Costa, Max			Arsenic Induces Polyadenylation of Canonical Histone mRNA by Down-regulating Stem-Loop-binding Protein Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Epigenetics; Histone; Metal; Polyadenylation; Arsenic; SLBP; Canonical Histone mRNA	BRONCHIAL EPITHELIAL-CELLS; VARIANT H3.3; DNA METHYLATION; SODIUM ARSENITE; 3' END; TRANSCRIPTIONAL ACTIVATION; INDUCED APOPTOSIS; IN-VIVO; DEGRADATION; EXPOSURE	Background: Canonical histones are regulated by stem-loop-binding protein (SLBP) and are expressed during S phase. Results: Arsenic decreases SLBP levels via epigenetic mechanisms, and histone mRNAs acquire a poly(A) tail. Conclusion: Poly(A) tails allow for the presence of canonical histones outside of S phase. Significance: These mechanisms may be involved in arsenic-induced carcinogenesis. The replication-dependent histone genes are the only metazoan genes whose messenger RNA (mRNA) does not terminate with a poly(A) tail at the 3-end. Instead, the histone mRNAs display a stem-loop structure at their 3-end. Stem-loop-binding protein (SLBP) binds the stem-loop and regulates canonical histone mRNA metabolism. Here we report that exposure to arsenic, a carcinogenic metal, decreased cellular levels of SLBP by inducing its proteasomal degradation and inhibiting SLBP transcription via epigenetic mechanisms. Notably, arsenic exposure dramatically increased polyadenylation of canonical histone H3.1 mRNA possibly through down-regulation of SLBP expression. The polyadenylated H3.1 mRNA induced by arsenic was not susceptible to normal degradation that occurs at the end of S phase, resulting in continued presence into mitosis, increased total H3.1 mRNA, and increased H3 protein levels. Excess expression of canonical histones have been shown to increase sensitivity to DNA damage as well as increase the frequency of missing chromosomes and induce genomic instability. Thus, polyadenylation of canonical histone mRNA following arsenic exposure may contribute to arsenic-induced carcinogenesis.	[Brocato, Jason; Fang, Lei; Chervona, Yana; Chen, Danqi; Kiok, Kathrin; Sun, Hong; Tseng, Hsiang-Chi; Xu, Dazhong; Jin, Chunyuan; Costa, Max] NYU, Dept Environm Med, Sch Med, New York, NY 10016 USA; [Shamy, Magdy] King Abdulaziz Univ, Fac Meteorol Environm & Arid Land Agr, Dept Environm Sci, Jeddah 21432, Saudi Arabia	New York University; King Abdulaziz University	Jin, CY (corresponding author), NYU, Dept Environm Med, Sch Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	Chunyuan.Jin@nyumc.org; Max.Costa@nyumc.org	Chen, Danqi/AAP-1269-2020; Jin, Chunyuan/GRX-9623-2022	Xu, Dazhong/0000-0001-9264-3342; Fang, Lei/0000-0002-2582-4845	National Institutes of Health [ES010344, ES014454, ES000260, ES022935, ES023174, ES005512]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010344, P30ES000260, R01ES023174, R01ES005512, R01ES014454, R01ES022935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES010344, ES014454, ES000260, ES022935, ES023174, and ES005512.	Ahlborn GJ, 2008, TOXICOL APPL PHARM, V227, P400, DOI 10.1016/j.taap.2007.10.029; Albig W, 1997, HUM GENET, V101, P284, DOI 10.1007/s004390050630; Andrew AS, 2008, ENVIRON HEALTH PERSP, V116, P524, DOI 10.1289/ehp.10861; Arain MB, 2015, ENVIRON SCI POLLUT R, V22, P350, DOI 10.1007/s11356-014-3339-0; Argos M, 2006, CANCER EPIDEM BIOMAR, V15, P1367, DOI 10.1158/1055-9965.EPI-06-0106; Arita A, 2009, METALLOMICS, V1, P222, DOI 10.1039/b903049b; Barr FD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006766; Boellmann F, 2010, TOXICOL SCI, V117, P404, DOI 10.1093/toxsci/kfq225; Brocato J, 2013, CRIT REV TOXICOL, V43, P493, DOI 10.3109/10408444.2013.794769; Chen DQ, 2013, J BIOL CHEM, V288, P21678, DOI 10.1074/jbc.M113.476630; Chen Ya-Juan, 2013, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V21, P1454, DOI 10.7534/j.issn.1009-2137.2013.06.016; Chervona Y, 2012, CANCER EPIDEM BIOMAR, V21, P2252, DOI 10.1158/1055-9965.EPI-12-0833; Choe J, 2013, NUCLEIC ACIDS RES, V41, P1307, DOI 10.1093/nar/gks1196; Chow CM, 2005, EMBO REP, V6, P354, DOI 10.1038/sj.embor.7400366; Clancy HA, 2012, METALLOMICS, V4, P784, DOI 10.1039/c2mt20074k; Davey JC, 2007, TOXICOL SCI, V98, P75, DOI 10.1093/toxsci/kfm013; Delbarre E, 2010, MOL BIOL CELL, V21, P1872, DOI 10.1091/mbc.E09-09-0839; Djakbarova U, 2014, J CELL BIOCHEM, V115, P523, DOI 10.1002/jcb.24686; Dominski Z, 1999, GENE, V239, P1, DOI 10.1016/S0378-1119(99)00367-4; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; GRAVES RA, 1987, CELL, V48, P615, DOI 10.1016/0092-8674(87)90240-6; Hake S B, 2007, Br J Cancer, V96 Suppl, pR31; Hake SB, 2005, P NATL ACAD SCI USA, V102, P6344, DOI 10.1073/pnas.0502413102; HARRIS ME, 1991, MOL CELL BIOL, V11, P2416, DOI 10.1128/MCB.11.5.2416; He Yi, 2008, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V16, P794; Hoefig KP, 2013, NAT STRUCT MOL BIOL, V20, P73, DOI 10.1038/nsmb.2450; Hong GM, 2012, TOXICOL APPL PHARM, V260, P250, DOI 10.1016/j.taap.2012.03.002; Jensen TJ, 2009, TOXICOL APPL PHARM, V235, P39, DOI 10.1016/j.taap.2008.10.013; Jurado AR, 2014, BIOCHEMISTRY-US, V53, P1882, DOI 10.1021/bi401715v; Kaygun H, 2005, MOL CELL BIOL, V25, P6879, DOI 10.1128/MCB.25.16.6879-6888.2005; Kile ML, 2014, EPIGENETICS-US, V9, P774, DOI 10.4161/epi.28153; Kurat CF, 2014, CELL MOL LIFE SCI, V71, P599, DOI 10.1007/s00018-013-1443-9; Lanzotti DJ, 2002, MOL CELL BIOL, V22, P2267, DOI 10.1128/MCB.22.7.2267-2282.2002; Li HM, 2010, ONCOL RES, V19, P149, DOI 10.3727/096504011X12935427587885; Li J, 2003, J BIOL CHEM, V278, P13183, DOI 10.1074/jbc.M300269200; Li LZ, 2014, TOXICOL APPL PHARM, V276, P165, DOI 10.1016/j.taap.2014.02.005; Lombardo T, 2012, TOXICOL APPL PHARM, V258, P351, DOI 10.1016/j.taap.2011.11.018; Lu D, 2004, BRIT J HAEMATOL, V125, P512, DOI 10.1111/j.1365-2141.2004.04940.x; Lu Di, 2004, Di Yi Jun Yi Da Xue Xue Bao, V24, P375; Lu Di, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P997; Martin-Chouly C, 2011, MOL IMMUNOL, V48, P956, DOI 10.1016/j.molimm.2011.01.005; Marzluff WF, 2005, CURR OPIN CELL BIOL, V17, P274, DOI 10.1016/j.ceb.2005.04.010; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; McNeely SC, 2008, TOXICOL APPL PHARM, V231, P61, DOI 10.1016/j.taap.2008.03.020; Medeiros M, 2012, TOXICOLOGY, V291, P102, DOI 10.1016/j.tox.2011.11.002; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; Muscarella DE, 2002, TOXICOL SCI, V68, P82, DOI 10.1093/toxsci/68.1.82; Passantino L, 2013, METALLOMICS, V5, P1357, DOI 10.1039/c3mt00149k; Percherancier Y, 2009, J BIOL CHEM, V284, P16595, DOI 10.1074/jbc.M109.006387; Preiss T, 1998, NATURE, V392, P516, DOI 10.1038/33192; Rattray A. M., 2013, BIOSCIENCE REP, V33; Salzler HR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008168; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shen L, 2000, J BIOL REG HOMEOS AG, V14, P116; Smith AH, 2009, J EXPO SCI ENV EPID, V19, P343, DOI 10.1038/jes.2008.73; Stueckle TA, 2012, TOXICOL APPL PHARM, V261, P204, DOI 10.1016/j.taap.2012.04.003; Sullivan E, 2001, GENE DEV, V15, P173, DOI 10.1101/gad.862801; Sullivan KD, 2009, MOL CELL, V34, P322, DOI 10.1016/j.molcel.2009.04.024; Sun H, 2012, TOXICOL APPL PHARM, V265, P147, DOI 10.1016/j.taap.2012.10.008; Sun H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017982; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Tan DZ, 2013, SCIENCE, V339, P318, DOI 10.1126/science.1228705; Tang FQ, 2006, MOL CARCINOGEN, V45, P861, DOI 10.1002/MC.20245; Whitfield ML, 2004, NUCLEIC ACIDS RES, V32, P4833, DOI 10.1093/nar/gkh798; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; Zheng LX, 2003, MOL CELL BIOL, V23, P1590, DOI 10.1128/MCB.23.5.1590-1601.2003; Zhou X, 2008, CARCINOGENESIS, V29, P1831, DOI 10.1093/carcin/bgn063; Zhu Qi, 2000, Zhonghua Zhongliu Zazhi, V22, P359	70	26	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31751	31764		10.1074/jbc.M114.591883	http://dx.doi.org/10.1074/jbc.M114.591883			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25266719	Green Published, hybrid			2022-12-28	WOS:000345314700008
J	Turner, RM; Derryberry, SL; Kumar, BN; Brittain, T; Zwiebel, LJ; Newcomb, RD; Christie, DL				Turner, Rebecca M.; Derryberry, Stephen L.; Kumar, Brijesh N.; Brittain, Thomas; Zwiebel, Laurence J.; Newcomb, Richard D.; Christie, David L.			Mutational Analysis of Cysteine Residues of the Insect Odorant Co-receptor (Orco) from Drosophila melanogaster Reveals Differential Effects on Agonist-and Odorant-tuning Receptor-dependent Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-Helix Ligand-gated Channel; Insect; Ion Channel; Mutagenesis; Neurobiology; Receptor Structure-Function; Channel Activation; Cysteine Residues; Olfaction	MOSQUITO ANOPHELES-GAMBIAE; ION CHANNELS; AMILORIDE DERIVATIVES; TRANSMEMBRANE DOMAIN; MEMBRANE TOPOLOGY; MOLECULAR-BASIS; SYSTEM; SITE	Background: Orco is a highly conserved co-receptor required for insects to respond to odorants. Results: Mutation of two cysteine residues in the third intracellular loop of Orco increases direct agonist, but reduces odorant-tuning receptor-dependent channel activation. Conclusion: Intracellular loop 3 is important for activation of the Orco channel. Significance: The research identifies a region of Orco that may regulate odorant sensing by insects. Insect odorant receptors are heteromeric odorant-gated cation channels comprising a conventional odorant-sensitive tuning receptor (ORx) and a highly conserved co-receptor known as Orco. Orco is found only in insects, and very little is known about its structure and the mechanism leading to channel activation. In the absence of an ORx, Orco forms homomeric channels that can be activated by a synthetic agonist, VUAA1. Drosophila melanogaster Orco (DmelOrco) contains eight cysteine amino acid residues, six of which are highly conserved. In this study, we replaced individual cysteine residues with serine or alanine and expressed Orco mutants in Flp-In 293 T-Rex cells. Changes in intracellular Ca2+ levels were used to determine responses to VUAA1. Replacement of two cysteines (Cys-429 and Cys-449) in a predicted intracellular loop (ICL3), individually or together, gave variants that all showed similar increases in the rate of response and sensitivity to VUAA1 compared with wild-type DmelOrco. Kinetic modeling indicated that the response of the Orco mutants to VUAA1 was faster than wild-type Orco. The enhanced sensitivity and faster response of the Cys mutants was confirmed by whole-cell voltage clamp electrophysiology. In contrast to the results from direct agonist activation of Orco, the two cysteine replacement mutants when co-expressed with a tuning receptor (DmelOR22a) showed an approximate to 10-fold decrease in potency for activation by 2-methyl hexanoate. Our work has shown that intracellular loop 3 is important for Orco channel activation. Importantly, this study also suggests differences in the structural requirements for the activation of homomeric and heteromeric Orco channel complexes.	[Turner, Rebecca M.; Kumar, Brijesh N.; Brittain, Thomas; Newcomb, Richard D.; Christie, David L.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Derryberry, Stephen L.; Zwiebel, Laurence J.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Newcomb, Richard D.] Plant & Food Res, Auckland 1142, New Zealand	University of Auckland; Vanderbilt University; New Zealand Institute for Plant & Food Research Ltd	Christie, DL (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1142, New Zealand.	d.christie@auckland.ac.nz	Kumar, Brijesh/GPP-3392-2022; Newcomb, Richard/C-2067-2009; Christie, David L/C-8065-2009	Kumar, Brijesh/0000-0003-0271-3445; Newcomb, Richard/0000-0002-7307-9755; Turner, Rebecca/0000-0002-7885-3092; Zwiebel, Laurence/0000-0001-6686-7289	Marsden Fund [PAF-09-01]	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by Grant PAF-09-01 from the Marsden Fund administered by the Royal Society of New Zealand (to R. D. N.).	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chen SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084575; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Colquhoun D, 2006, BRIT J PHARMACOL, V147, pS17, DOI 10.1038/sj.bjp.0706502; Deng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018605; Dodd JR, 2001, J BIOL CHEM, V276, P46983, DOI 10.1074/jbc.M107137200; German PF, 2013, INSECT BIOCHEM MOLEC, V43, P138, DOI 10.1016/j.ibmb.2012.11.002; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Ishii TM, 1998, METHOD ENZYMOL, V293, P53; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar BN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070218; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Nichols AS, 2010, J BIOL CHEM, V285, P11854, DOI 10.1074/jbc.M109.058321; Pask GM, 2013, CHEM SENSES, V38, P221, DOI 10.1093/chemse/bjs100; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Rollecke K, 2013, CHEM SENSES, V38, P231, DOI 10.1093/chemse/bjs140; Sargsyan V, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00005; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Taylor RW, 2012, ACS CHEM BIOL, V7, P1647, DOI 10.1021/cb300331z; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wicher D, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00001	34	17	18	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31837	31845		10.1074/jbc.M114.603993	http://dx.doi.org/10.1074/jbc.M114.603993			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25271160	Green Published, hybrid			2022-12-28	WOS:000345314700015
J	Wratil, PR; Rigol, S; Solecka, B; Kohla, G; Kannicht, C; Reutter, W; Giannis, A; Nguyen, LD				Wratil, Paul R.; Rigol, Stephan; Solecka, Barbara; Kohla, Guido; Kannicht, Christoph; Reutter, Werner; Giannis, Athanassios; Nguyen, Long D.			A Novel Approach to Decrease Sialic Acid Expression in Cells by a C-3-modified N-Acetylmannosamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitor; Flow Cytometry; Glycosylation Inhibitor; High-performance Liquid Chromatography (HPLC); Sialic Acid; Surface Plasmon Resonance (SPR)	UDP-GLCNAC 2-EPIMERASE; ACETYLGLUCOSAMINE KINASE; FUCOSYL-TRANSFERASES; INHIBITORS; ANALOGS; BIOSYNTHESIS; SPECIFICITY; COMBINATION; INSIGHTS; ENZYME	Background: Inhibitors of cellular sialic acid expression offer substantial therapeutic promise for diseases associated with oversialylation. Results: 2-Acetylamino-2-deoxy-3-O-methyl-d-mannose reduces the sialic acid concentration in cells and inhibits the UDP-GlcNAc-2-epimerase/ManNAc kinase. Conclusion: Inhibition of the key enzyme of sialic acid biosynthesis by a ManNAc analog decreases cellular sialic acid expression. Significance: ManNAc analogs represent a new class of sialic acid inhibitors. Due to its position at the outermost of glycans, sialic acid is involved in a myriad of physiological and pathophysiological cell functions such as host-pathogen interactions, immune regulation, and tumor evasion. Inhibitors of cell surface sialylation could be a useful tool in cancer, immune, antibiotic, or antiviral therapy. In this work, four different C-3 modified N-acetylmannosamine analogs were tested as potential inhibitors of cell surface sialylation. Peracetylated 2-acetylamino-2-deoxy-3-O-methyl-d-mannose decreases cell surface sialylation in Jurkat cells in a dose-dependent manner up to 80%, quantified by flow cytometry and enzyme-linked lectin assays. High-performance liquid chromatography experiments revealed that not only the concentration of membrane bound but also of cytosolic sialic acid is reduced in treated cells. We have strong evidence that the observed reduction of sialic acid expression in cells is caused by the inhibition of the bifunctional enzyme UDP-GlcNAc-2-epimerase/ManNAc kinase. 2-Acetylamino-2-deoxy-3-O-methyl-d-mannose inhibits the human ManNAc kinase domain of the UDP-GlcNAc-2-epimerase/ManNAc kinase. Binding kinetics of the inhibitor and human N-acetylmannosamine kinase were evaluated using surface plasmon resonance. Specificity studies with human N-acetylglucosamine kinase and hexokinase IV indicated a high specificity of 2-acetylamino-2-deoxy-3-O-methyl-d-mannose for MNK. This substance represents a novel class of inhibitors of sialic acid expression in cells, targeting the key enzyme of sialic acid de novo biosynthesis.	[Wratil, Paul R.; Reutter, Werner; Nguyen, Long D.] Charite, Inst Lab Med Klin Chem & Pathobiochem, D-14195 Berlin, Germany; [Rigol, Stephan; Giannis, Athanassios] Univ Leipzig, Inst Organ Chem, Fak Chem & Mineral, D-04103 Leipzig, Germany; [Solecka, Barbara; Kohla, Guido; Kannicht, Christoph] Mol Biochem Berlin, Octapharma R&D, D-12489 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University; Octapharma	Giannis, A (corresponding author), Univ Leipzig, Inst Organ Chem, Fak Chem & Mineral, Johannisallee 29, D-04103 Leipzig, Germany.	giannis@uni-leipzig.de; long-duc.nguyen@charite.de		Solecka-Witulska, Barbara/0000-0001-6804-5983	Freie Universitat Berlin	Freie Universitat Berlin	We thank Prof. Hans-Joachim Gabius (Technische Universitat Munchen) for providing FITC-conjugated Polyporus squamosus lectin. We also thank the Freie Universitat Berlin for supporting our research.	Al-Rawi S, 2004, ANGEW CHEM INT EDIT, V43, P4366, DOI 10.1002/anie.200453863; Chen L, 2012, EUR J PHARM BIOPHARM, V81, P339, DOI 10.1016/j.ejpb.2012.03.012; Chen SH, 2006, METHOD ENZYMOL, V416, P371, DOI 10.1016/S0076-6879(06)16024-3; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; de Mol N. J., 2010, SURFACE PLASMON RESO, P91; Du J, 2009, GLYCOBIOLOGY, V19, P1382, DOI 10.1093/glycob/cwp115; Galuska SP, 2010, ANAL CHEM, V82, P4591, DOI 10.1021/ac100627e; Grewal PK, 2010, METHOD ENZYMOL, V479, P223, DOI 10.1016/S0076-6879(10)79013-3; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; Hartlieb S, 2008, CARBOHYD RES, V343, P2075, DOI 10.1016/j.carres.2008.02.003; Jones MB, 2004, BIOTECHNOL BIOENG, V85, P394, DOI 10.1002/bit.10901; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Lehmann F, 2006, CELL MOL LIFE SCI, V63, P1331, DOI 10.1007/s00018-005-5589-y; Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125; Martinez J, 2012, J BIOL CHEM, V287, P13656, DOI 10.1074/jbc.M111.318170; MENDLA K, 1988, BIOCHEM J, V250, P261, DOI 10.1042/bj2500261; Moller H, 2012, ANGEW CHEM INT EDIT, V51, P5986, DOI 10.1002/anie.201108809; Niederwieser A, 2013, ANGEW CHEM INT EDIT, V52, P4265, DOI 10.1002/anie.201208991; Oetke C, 2001, EUR J BIOCHEM, V268, P4553, DOI 10.1046/j.1432-1327.2001.02379.x; Paulsen H., 1987, LIEBIGS ANN, DOI [10.1002/jlac.198719870349, DOI 10.1002/JLAC.198719870349]; Preidl JJ, 2014, ANGEW CHEM INT EDIT, V53, P5700, DOI 10.1002/anie.201400394; Reinke SO, 2009, BIOL CHEM, V390, P591, DOI 10.1515/BC.2009.073; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Rillahan CD, 2011, ANGEW CHEM INT EDIT, V50, P12534, DOI 10.1002/anie.201105065; Russell CJ, 2005, CELL, V123, P368, DOI 10.1016/j.cell.2005.10.019; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; SCHWARTZ EL, 1983, BIOCHIM BIOPHYS ACTA, V762, P489, DOI 10.1016/0167-4889(83)90051-4; Stolz F, 2004, J ORG CHEM, V69, P665, DOI 10.1021/jo0353029; Tanner ME, 2005, BIOORG CHEM, V33, P216, DOI 10.1016/j.bioorg.2005.01.005; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Weihofen WA, 2006, J MOL BIOL, V364, P388, DOI 10.1016/j.jmb.2006.08.085; ZEITLER R, 1992, EUR J BIOCHEM, V204, P1165, DOI 10.1111/j.1432-1033.1992.tb16743.x; Zhu XM, 2004, J ORG CHEM, V69, P7367, DOI 10.1021/jo049077m	36	14	14	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32056	32063		10.1074/jbc.M114.608398	http://dx.doi.org/10.1074/jbc.M114.608398			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25278018	hybrid, Green Published			2022-12-28	WOS:000345314700034
J	Pinto, JT; Krasnikov, BF; Alcutt, S; Jones, ME; Dorai, T; Villar, MT; Artigues, A; Li, JY; Cooper, AJL				Pinto, John T.; Krasnikov, Boris F.; Alcutt, Steven; Jones, Melanie E.; Dorai, Thambi; Villar, Maria T.; Artigues, Antonio; Li, Jianyong; Cooper, Arthur J. L.			Kynurenine Aminotransferase III and Glutamine Transaminase L Are Identical Enzymes that have Cysteine S-Conjugate beta-Lyase Activity and Can Transaminate L-Selenomethionine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-KETO ACID; MITOCHONDRIAL ASPARTATE-AMINOTRANSFERASE; GLUTATHIONE-DEPENDENT BIOACTIVATION; PREVENTION TRIAL SELECT; RAT-KIDNEY; PROSTATE-CANCER; VITAMIN-E; ORGANOSELENIUM COMPOUNDS; SUBSTRATE-SPECIFICITY; SELENIUM METABOLISM	Three of the four kynurenine aminotransferases (KAT I, II, and IV) that synthesize kynurenic acid, a neuromodulator, are identical to glutamine transaminase K (GTK), alpha-aminoadipate aminotransferase, and mitochondrial aspartate aminotransferase, respectively. GTK/KAT I and aspartate aminotransferase/KAT IV possess cysteine S-conjugate beta-lyase activity. The gene for the former enzyme, GTK/KAT I, is listed in mammalian genome data banks as CCBL1 (cysteine conjugate beta-lyase 1). Also listed, despite the fact that no beta-lyase activity has been assigned to the encoded protein in the genome data bank, is a CCBL2 (synonym KAT III). We show that human KAT III/CCBL2 possesses cysteine S-conjugate beta-lyase activity, as does mouse KAT II. Thus, depending on the nature of the substrate, all four KATs possess cysteine S-conjugate beta-lyase activity. These present studies show that KAT III and glutamine transaminase L are identical enzymes. This report also shows that KAT I, II, and III differ in their ability to transaminate methyl-L-selenocysteine (MSC) and L-selenomethionine (SM) to beta-methylselenopyruvate (MSP) and alpha-ketomethylselenobutyrate, respectively. Previous studies have identified these seleno-alpha-keto acids as potent histone deacetylase inhibitors. Methylselenol (CH3SeH), also purported to have chemopreventive properties, is the gamma-elimination product of SM and the beta-elimination product of MSC catalyzed by cystathionine gamma-lyase (gamma-cystathionase). KAT I, II, and III, in part, can catalyze beta-elimination reactions with MSC generating CH3SeH. Thus, the anticancer efficacy of MSC and SM will depend, in part, on the endogenous expression of various KAT enzymes and cystathionine gamma-lyase present in target tissue coupled with the ability of cells to synthesize in situ either CH3SeH and/or seleno-keto acid metabolites.	[Pinto, John T.; Krasnikov, Boris F.; Alcutt, Steven; Jones, Melanie E.; Cooper, Arthur J. L.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA; [Dorai, Thambi] New York Med Coll, Dept Urol, Valhalla, NY 10595 USA; [Villar, Maria T.; Artigues, Antonio] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Li, Jianyong] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA	New York Medical College; New York Medical College; University of Kansas; University of Kansas Medical Center; Virginia Polytechnic Institute & State University	Pinto, JT (corresponding author), New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA.	john_pinto@nymc.edu; arthur_cooper@nymc.edu	Krasnikov, Boris/R-2244-2019; Cooper, Arthur J.L./H-5171-2016; Krasnikov, Boris F/GZG-7807-2022	Krasnikov, Boris F/0000-0001-9525-4385	National Institutes of Health [CA111842, ES8421]; NATIONAL CANCER INSTITUTE [R01CA111842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA111842 (to J. T. P.) and ES8421 (to A. J. L. C.).	Abraham DG, 1996, ARCH BIOCHEM BIOPHYS, V335, P311, DOI 10.1006/abbi.1996.0512; Anders MW, 2004, DRUG METAB REV, V36, P583, DOI 10.1081/DMR-200033451; Anders MW, 1998, ANNU REV PHARMACOL, V38, P501, DOI 10.1146/annurev.pharmtox.38.1.501; Birner G, 1997, ARCH TOXICOL, V72, P1, DOI 10.1007/s002040050461; BLARZINO C, 1994, BIOCHEM MOL BIOL INT, V32, P79; BRAUNSTEIN AE, 1984, ADV ENZYMOL RAMB, V56, P1; Bruning T, 2000, CRIT REV TOXICOL, V30, P253, DOI 10.1080/10408440091159202; Commandeur JNM, 2000, J PHARMACOL EXP THER, V294, P753; Cooper AJL, 2005, BIOCHEM PHARMACOL, V69, P209, DOI 10.1016/j.bcp.2004.08.034; Cooper AJL, 2004, NEUROCHEM INT, V44, P557, DOI 10.1016/j.neuint.2003.12.002; Cooper AJL, 2003, BIOCHEM PHARMACOL, V65, P181, DOI 10.1016/S0006-2952(02)01513-7; Cooper AJL, 2002, BIOCHEM J, V368, P253, DOI 10.1042/BJ20020531; COOPER AJL, 1981, COMP BIOCHEM PHYS B, V69, P137, DOI 10.1016/0305-0491(81)90223-6; COOPER AJL, 1972, BIOCHEMISTRY-US, V11, P661; Cooper AJL, 2001, BIOCHEM PHARMACOL, V62, P1345, DOI 10.1016/S0006-2952(01)00802-4; COOPER AJL, 1974, J BIOL CHEM, V249, P2554; COOPER AJL, 1985, METHOD ENZYMOL, V113, P338; COOPER AJL, 1973, J BIOL CHEM, V248, P8499; Cooper AJL., GLUTAMINE GLUTAMATE, VVol. 1, P33; Cooper AJL, 2008, ARCH BIOCHEM BIOPHYS, V474, P72, DOI 10.1016/j.abb.2008.02.038; Cooper AJL, 2011, AMINO ACIDS, V41, P7, DOI 10.1007/s00726-010-0552-0; Dantzler WH, 1998, J PHARMACOL EXP THER, V286, P52; Dekant W, 2003, TOXICOL LETT, V144, P49, DOI 10.1016/S0378-4274(02)00338-7; ELFARRA AA, 1990, DRUG METAB DISPOS, V18, P917; Gammelgaard B, 2008, ANAL BIOANAL CHEM, V390, P1691, DOI 10.1007/s00216-007-1788-8; Guidetti P, 1997, J NEUROSCI RES, V50, P457; Guidetti P, 2007, J NEUROCHEM, V102, P103, DOI 10.1111/j.1471-4159.2007.04556.x; Han Q, 2004, EUR J BIOCHEM, V271, P4804, DOI 10.1111/j.1432-1033.2004.04446.x; Han Q, 2011, BIOSCIENCE REP, V31, P323, DOI 10.1042/BSR20100117; Han Q, 2009, J MED CHEM, V52, P2786, DOI 10.1021/jm9000874; Han Q, 2009, MOL CELL BIOL, V29, P784, DOI 10.1128/MCB.01272-08; HAYDEN PJ, 1990, MOL PHARMACOL, V37, P468; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Lee JI, 2009, CANCER PREV RES, V2, P683, DOI 10.1158/1940-6207.CAPR-09-0047; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; MALHERBE P, 1995, FEBS LETT, V367, P141, DOI 10.1016/0014-5793(95)00546-L; Marshall JR, 2001, NUTR CANCER, V40, P74, DOI 10.1207/S15327914NC401_13; MATSUO Y, 1958, J BIOL CHEM, V230, P545; MEISTER A, 1953, J BIOL CHEM, V200, P571; MEISTER A, 1955, J BIOL CHEM, V215, P441; MEISTER A, 1952, J BIOL CHEM, V197, P319; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Newman D, 2007, DRUG METAB DISPOS, V35, P43, DOI 10.1124/dmd.106.012062; Nian H, 2009, CARCINOGENESIS, V30, P1416, DOI 10.1093/carcin/bgp147; Okuno T, 2006, BIOL TRACE ELEM RES, V109, P155, DOI 10.1385/BTER:109:2:155; OTANI TT, 1957, J BIOL CHEM, V224, P137; PERRY SJ, 1993, MOL PHARMACOL, V43, P660; Pinto JT, 2011, AMINO ACIDS, V41, P29, DOI 10.1007/s00726-010-0578-3; Pinto JT, 2009, J CHROMATOGR B, V877, P3434, DOI 10.1016/j.jchromb.2009.05.041; Pinto JT, 2006, J NUTR, V136, p835S, DOI 10.1093/jn/136.3.835S; Potter MC, 2010, NEUROPSYCHOPHARMACOL, V35, P1734, DOI 10.1038/npp.2010.39; Rossi F, 2008, J BIOL CHEM, V283, P3559, DOI 10.1074/jbc.M707925200; Saito K, 2000, AM J PHYSIOL-RENAL, V279, pF565, DOI 10.1152/ajprenal.2000.279.3.F565; SHRAWDER E, 1972, J BIOL CHEM, V247, P2486; STEVENS JL, 1986, J BIOL CHEM, V261, P5529; STEVENS JL, 1988, J BIOL CHEM, V263, P3395; Suzuki KT, 2008, TOXICOL APPL PHARM, V227, P76, DOI 10.1016/j.taap.2007.10.001; Suzuki KT, 2007, BBA-GEN SUBJECTS, V1770, P1053, DOI 10.1016/j.bbagen.2007.03.007; Taylor PR, 2003, J NATL CANCER I, V95, P1414, DOI 10.1093/jnci/djg044; Tsuji Y, 2009, J TOXICOL SCI, V34, P191, DOI 10.2131/jts.34.191; Wei WQ, 2004, AM J CLIN NUTR, V79, P80; Wessjohann LA, 2007, BIOL CHEM, V388, P997, DOI 10.1515/BC.2007.138; Yu P, 2006, GENE, V365, P111, DOI 10.1016/J.gene.2005.09.034	64	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					30950	30961		10.1074/jbc.M114.591461	http://dx.doi.org/10.1074/jbc.M114.591461			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25231977	Green Published, hybrid			2022-12-28	WOS:000344549900007
J	Carter, CW				Carter, Charles W., Jr.			Urzymology: Experimental Access to a Key Transition in the Appearance of Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TRANSFER-RNA-SYNTHETASE; RODIN-OHNO HYPOTHESIS; GENETIC-CODE; CLASS-I; MOLECULAR EVOLUTION; PROTEIN EVOLUTION; CATALYTIC DOMAIN; MODEL; ACID; AMINOACYLATION	Urzymes are catalysts derived from invariant cores of protein superfamilies. Urzymes from both aminoacyl-tRNA synthetase classes possess sophisticated catalytic mechanisms: pre-steady state bursts, significant transition-state stabilization of both amino acid activation, and tRNA acylation. However, they have insufficient specificity to ensure a fully developed genetic code, suggesting that they participated in synthesizing statistical proteins. They represent a robust experimental platform from which to articulate and test hypotheses both about their own ancestors and about how they, in turn, evolved into modern enzymes. They help reshape numerous paradigms from the RNA World hypothesis to protein structure databases and allostery.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Carter, CW (corresponding author), Univ N Carolina, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	carter@med.unc.edu			National Institutes of Health through the NIGMS [GM 78227, GM 90406]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090406, R01GM078227] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 78227 and GM 90406 through the NIGMS (to C. W. C.). This is the third article in the Thematic Minireview series "Enzyme Evolution."	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; ARTYMIUK PJ, 1994, NAT STRUCT BIOL, V1, P758, DOI 10.1038/nsb1194-758; Augustine J, 1997, BIOCHEMISTRY-US, V36, P3473, DOI 10.1021/bi962395y; Benner Steven A., 2007, V75, P1; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Bullock TL, 2008, P NATL ACAD SCI USA, V105, P7428, DOI 10.1073/pnas.0711812105; BURBAUM JJ, 1990, PROTEINS, V7, P99, DOI 10.1002/prot.340070202; Caetano-Anolles G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072225; Cammer S, 2010, BIOINFORMATICS, V26, P709, DOI 10.1093/bioinformatics/btq039; Carter C. W. J., 1975, NEW SCI, V65, P784; Carter CW, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-11; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Carter CW, 2002, MOL CELL, V10, P705, DOI 10.1016/S1097-2765(02)00688-3; CARTER CW, 1974, P NATL ACAD SCI USA, V71, P283, DOI 10.1073/pnas.71.2.283; Chandrasekaran SN, 2013, MOL BIOL EVOL, V30, P1588, DOI 10.1093/molbev/mst070; Corigliano EM, 2009, BIOCHEMISTRY-US, V48, P676, DOI 10.1021/bi801552y; Covert AW, 2013, P NATL ACAD SCI USA, V110, pE3171, DOI 10.1073/pnas.1313424110; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; Dokholyan NV, 2001, J MOL BIOL, V312, P289, DOI 10.1006/jmbi.2001.4949; Fersht A. R., 1999, STRUCTURE MECH PROTE, P217; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P8031, DOI 10.1021/bi00399a001; FRANCKLYN C, 1989, NATURE, V337, P478, DOI 10.1038/337478a0; FRANCKLYN C, 1990, P NATL ACAD SCI USA, V87, P8655, DOI 10.1073/pnas.87.21.8655; FRANCKLYN C, 1992, EUR J BIOCHEM, V206, P315, DOI 10.1111/j.1432-1033.1992.tb16929.x; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; Goldstein RA, 2008, CURR OPIN STRUC BIOL, V18, P170, DOI 10.1016/j.sbi.2008.01.006; Gong LI, 2013, ELIFE, V2, DOI 10.7554/eLife.00631; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Hanson-Smith V, 2010, MOL BIOL EVOL, V27, P1988, DOI 10.1093/molbev/msq081; Hu H, 2014, SCI CHINA CHEM, V57, P156, DOI 10.1007/s11426-013-5021-7; Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404; Isaacson W., 2011, STEVE JOBS, P364; Jimenez M, 2014, BIOPHYS J, V106, p675A, DOI 10.1016/j.bpj.2013.11.3740; Kapustina M, 2007, STRUCTURE, V15, P1272, DOI 10.1016/j.str.2007.08.010; Klipcan L, 2004, J THEOR BIOL, V228, P389, DOI 10.1016/j.jtbi.2004.01.014; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kumar RK, 2001, BIOCHEMISTRY-US, V40, P6998, DOI 10.1021/bi010710x; Li L, 2013, J BIOL CHEM, V288, P34736, DOI 10.1074/jbc.M113.510958; Li L, 2013, J BIOL CHEM, V288, P26856, DOI 10.1074/jbc.M113.496125; Li L, 2011, J BIOL CHEM, V286, P10387, DOI 10.1074/jbc.M110.198929; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Nasrallah CA, 2013, MOL BIOL EVOL, V30, P2197, DOI 10.1093/molbev/mst108; Pearl FMG, 2003, NUCLEIC ACIDS RES, V31, P452, DOI 10.1093/nar/gkg062; Perona JJ, 2014, TOP CURR CHEM, V344, P1, DOI 10.1007/128_2013_456; Pervushin K, 2007, NAT STRUCT MOL BIOL, V14, P1202, DOI 10.1038/nsmb1325; Pham Y, 2007, MOL CELL, V25, P851, DOI 10.1016/j.molcel.2007.02.010; Pham Y, 2010, J BIOL CHEM, V285, P38590, DOI 10.1074/jbc.M110.136911; Popper K. R., 1959, LOGIC SCI DISCOVERY, P124; Praetorius-Ibba M, 2000, BIOCHEMISTRY-US, V39, P13136; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; RODIN SN, 1995, ORIGINS LIFE EVOL B, V25, P565, DOI 10.1007/BF01582025; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; Schroeder GK, 2007, BIOCHEMISTRY-US, V46, P4037, DOI 10.1021/bi602600p; SCHWOB E, 1993, EMBO J, V12, P5201, DOI 10.1002/j.1460-2075.1993.tb06215.x; Shakhnovich BE, 2003, J MOL BIOL, V326, P1, DOI 10.1016/S0022-2836(02)01362-1; STACKHOUSE J, 1990, FEBS LETT, V262, P104, DOI 10.1016/0014-5793(90)80164-E; Stockbridge RB, 2010, P NATL ACAD SCI USA, V107, P22102, DOI 10.1073/pnas.1013647107; Stockbridge RB, 2009, J BIOL CHEM, V284, P22747, DOI 10.1074/jbc.M109.017806; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Weiner AM, 1999, CURR BIOL, V9, pR842, DOI 10.1016/S0960-9822(00)80041-X; Weinreb V, 2014, J BIOL CHEM, V289, P4367, DOI 10.1074/jbc.M113.538660; Weinreb V, 2009, STRUCTURE, V17, P952, DOI 10.1016/j.str.2009.05.007; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; WOESE CR, 1965, P NATL ACAD SCI USA, V54, P1546, DOI 10.1073/pnas.54.6.1546; Wolfenden R, 2001, ACCOUNTS CHEM RES, V34, P938, DOI 10.1021/ar000058i; Wolfenden R, 2011, ANNU REV BIOCHEM, V80, P645, DOI 10.1146/annurev-biochem-060409-093051; ZULL JE, 1990, TRENDS BIOCHEM SCI, V15, P257, DOI 10.1016/0968-0004(90)90048-G	72	26	27	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30213	30220		10.1074/jbc.R114.567495	http://dx.doi.org/10.1074/jbc.R114.567495			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25210034	Green Published, hybrid			2022-12-28	WOS:000344549700005
J	Good, ME; Ek-Vitorin, JF; Burt, JM				Good, Miranda E.; Ek-Vitorin, Jose F.; Burt, Janis M.			Structural Determinants and Proliferative Consequences of Connexin 37 Hemichannel Function in Insulinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION CHANNELS; CX37; GROWTH; PHOSPHORYLATION; OLIGOMERIZATION; PERMEABILITY; SUPPRESSION; EXPRESSION; INTERFACE; MUTANT	Connexin (Cx) 37 suppresses vascular and cancer cell proliferation. The C terminus and a channel able to function are necessary, and neither by itself is sufficient, for Cx37 to mediate growth suppression. Cx37 supports transmembrane and intercellular signaling by forming functional hemichannels (HCs) and gap junction channels (GJCs), respectively. Here we determined whether Cx37 with HC, but not GJC, functionality would suppress proliferation of rat insulinoma (Rin) cells comparably to wild-type Cx37 (Cx37-WT). We mutated extracellular loop residues hypothesized to compromise HC docking but not HC function (six cysteines mutated to alanine, C54A, C61A, C65A, C187A, C192A, C198A (designated as C(6)A); N55I; and Q58L). All three mutants trafficked to the plasma membrane and formed protein plaques comparably to Cx37-WT. None of the mutants formed functional GJCs, and Cx37-C6A did not form functional HCs. Cx37-N55I and-Q58L formed HCs with behavior and permeation properties similar to Cx37-WT (especially Q58L), but none of the mutants suppressed Rin cell proliferation. The data indicate that determinants of Cx37 HC function differ from other Cxs and that HC functions with associated HC-supported protein-protein interactions are not sufficient for Cx37 to suppress Rin cell proliferation. Together with previously published data, these results suggest that Cx37 suppresses Rin cell proliferation only when in a specific conformation achieved by interaction of the C terminus with a Cx37 poreforming domain able to open as a GJC.	[Good, Miranda E.; Ek-Vitorin, Jose F.; Burt, Janis M.] Univ Arizona, Dept Physiol, Tucson, AZ 85724 USA	University of Arizona	Burt, JM (corresponding author), Univ Arizona, Dept Physiol, POB 245051, Tucson, AZ 85724 USA.	jburt@u.arizona.edu	Ek-Vitorin, Jose F./AAF-8533-2020	Good, Miranda/0000-0001-7775-1863	National Institutes of Health [R01 HL058732, T32HL007249]; Finley and Florence Brown Endowed Research Award from the Sarver Heart Center, University of Arizona; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007249, R01HL058732, F32HL131399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Finley and Florence Brown Endowed Research Award from the Sarver Heart Center, University of Arizona; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL058732 (to J. M. B.) and T32HL007249 (to M. E. G. and J. M. B.). This work was also supported by The Finley and Florence Brown Endowed Research Award from the Sarver Heart Center, University of Arizona (to M. E. G.).	Bao XY, 2004, J BIOL CHEM, V279, P9689, DOI 10.1074/jbc.M311438200; Bednarczyk D, 2000, PFLUG ARCH EUR J PHY, V440, P184, DOI 10.1007/s004240051038; BUEHLER LK, 1995, BIOPHYS J, V68, P1767, DOI 10.1016/S0006-3495(95)80353-X; Burt JM, 2008, AM J PHYSIOL-CELL PH, V295, pC1103, DOI 10.1152/ajpcell.299.2008; DAHL G, 1991, EUR J BIOCHEM, V197, P141, DOI 10.1111/j.1432-1033.1991.tb15892.x; Das S, 2009, MOL BIOL CELL, V20, P2593, DOI 10.1091/mbc.E08-07-0790; Derouette JP, 2009, J MOL CELL CARDIOL, V46, P499, DOI 10.1016/j.yjmcc.2008.12.018; Ek-Vitorin JF, 2005, AM J PHYSIOL-CELL PH, V289, pC1535, DOI 10.1152/ajpcell.00182.2005; Ek-Vitorin JF, 2013, BBA-BIOMEMBRANES, V1828, P51, DOI 10.1016/j.bbamem.2012.02.003; Fang JS, 2011, AM J PHYSIOL-HEART C, V301, pH1872, DOI 10.1152/ajpheart.00683.2011; Foote CI, 1998, J CELL BIOL, V140, P1187, DOI 10.1083/jcb.140.5.1187; Gong XQ, 2013, J CELL SCI, V126, P3113, DOI 10.1242/jcs.123430; Good ME, 2012, J MEMBRANE BIOL, V245, P369, DOI 10.1007/s00232-012-9459-x; Good ME, 2011, J CELL SCI, V124, P2448, DOI 10.1242/jcs.081695; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Grosely R, 2013, J BIOL CHEM, V288, P24857, DOI 10.1074/jbc.M113.454389; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Herve JC, 2013, CELL TISSUE RES, V352, P21, DOI 10.1007/s00441-012-1485-6; Kardami E, 2007, PROG BIOPHYS MOL BIO, V94, P245, DOI 10.1016/j.pbiomolbio.2007.03.009; Koval M, 2014, FEBS LETT, V588, P1193, DOI 10.1016/j.febslet.2014.02.025; Larson D. M., 2000, Molecular Cell Biology Research Communications, V3, P115, DOI 10.1006/mcbr.2000.0200; Larson DM, 1997, AM J PHYSIOL-CELL PH, V272, pC405, DOI 10.1152/ajpcell.1997.272.2.C405; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Morel S, 2010, CARCINOGENESIS, V31, P1922, DOI 10.1093/carcin/bgq170; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; Nakagawa S, 2010, CURR OPIN STRUC BIOL, V20, P423, DOI 10.1016/j.sbi.2010.05.003; Nelson TK, 2013, AM J PHYSIOL-CELL PH, V305, pC1246, DOI 10.1152/ajpcell.00159.2013; Simon AM, 2006, CELL COMMUN ADHES, V13, P61, DOI 10.1080/15419060600631748; Smith TD, 2012, J MEMBRANE BIOL, V245, P221, DOI 10.1007/s00232-012-9443-5; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Tong D, 2007, J CELL SCI, V120, P4016, DOI 10.1242/jcs.011775; Vinken M, 2012, BBA-BIOMEMBRANES, V1818, P2002, DOI 10.1016/j.bbamem.2011.06.011; Vinken M, 2011, BBA-REV CANCER, V1815, P13, DOI 10.1016/j.bbcan.2010.08.004; Weber PA, 2004, BIOPHYS J, V87, P958, DOI 10.1529/biophysj.103.036350	34	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30379	30386		10.1074/jbc.M114.583054	http://dx.doi.org/10.1074/jbc.M114.583054			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25217644	Green Published, hybrid			2022-12-28	WOS:000344549700020
J	Humphrey, RK; Ray, A; Gonuguntla, S; Hao, EG; Jhala, US				Humphrey, Rohan K.; Ray, Anamika; Gonuguntla, Sumati; Hao, Ergeng; Jhala, Ulupi S.			Loss of TRB3 Alters Dynamics of MLK3-JNK Signaling and Inhibits Cytokine-activated Pancreatic Beta Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; Diabetes; Pancreatic Islet; Protein Degradation; Protein Phosphorylation; IL-1; JNK Module; Ubiquitination	MIXED LINEAGE KINASE-3; GLYCOGEN-SYNTHASE KINASE-3; JIP1 SCAFFOLD PROTEIN; DEPENDENT APOPTOSIS; TRIBBLES HOMOLOG; AKT ACTIVATION; CYTOCHROME-C; INSULIN; JNK; PHOSPHORYLATION	Background: MLK3 induces TRB3 to inhibit AKT and compromise beta cell survival. Results: AKT regulates novel phosphorylation, ubiquitination, and degradation of MLK3, explaining why TRB3(-/-) islets display attenuated MLK3/JNK activation and beta cell death. Conclusion: TRB3 functionally cooperates with the JNK module to fine-tune inflammatory signaling in beta cells. Significance: Even modest modulation of signaling dynamics can alter inflammatory outcomes. Disabling cellular defense mechanisms is essential for induction of apoptosis. We have previously shown that cytokine-mediated activation of the MAP3K MLK3 stabilizes TRB3 protein levels to inhibit AKT and compromise beta cell survival. Here, we show that genetic deletion of TRB3 results in basal activation of AKT, preserves mitochondrial integrity, and confers resistance against cytokine-induced pancreatic beta cell death. Mechanistically, we find that TRB3 stabilizes MLK3, most likely by suppressing AKT-directed phosphorylation, ubiquitination, and proteasomal degradation of MLK3. Accordingly, TRB3(-/-) islets show a decrease in both the amplitude and duration of cytokine-stimulated MLK3 induction and JNK activation. It is well known that JNK signaling is facilitated by a feed forward loop of sequential kinase phosphorylation and is reinforced by a mutual stabilization of the module components. The failure of TRB3(-/-) islets to mount an optimal JNK activation response, coupled with the ability of TRB3 to engage and maintain steady state levels of MLK3, recasts TRB3 as an integral functional component of the JNK module in pancreatic beta cells.	[Humphrey, Rohan K.; Ray, Anamika; Gonuguntla, Sumati; Hao, Ergeng; Jhala, Ulupi S.] Univ Calif San Diego, San Diego Sch Med, Pediat Diabet Res Ctr, La Jolla, CA 92037 USA	University of California System; University of California San Diego	Jhala, US (corresponding author), Pediat Diabet Res Ctr, 3525 John Hopkins Court, San Diego, CA 92121 USA.	ujhala@ucsd.edu			National Institutes of Health [R01DK080147]; Juvenile Diabetes Research Foundation [40-2009-706]; Hillblom Foundation Network Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Hillblom Foundation Network Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01DK080147, Juvenile Diabetes Research Foundation Research Grant 40-2009-706, and a Hillblom Foundation Network Grant.	Aikin R, 2006, DIABETOLOGIA, V49, P2900, DOI 10.1007/s00125-006-0476-0; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Barthwal MK, 2003, J BIOL CHEM, V278, P3897, DOI 10.1074/jbc.M211598200; Boucher MJ, 2006, J BIOL CHEM, V281, P6395, DOI 10.1074/jbc.M511597200; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Gadang V, 2013, AM J PHYSIOL-ENDOC M, V305, pE549, DOI 10.1152/ajpendo.00197.2013; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Guo SL, 2009, J BIOL CHEM, V284, P759, DOI 10.1074/jbc.M806314200; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; He L, 2006, J BIOL CHEM, V281, P11126, DOI 10.1074/jbc.M510724200; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Humphrey RK, 2013, J BIOL CHEM, V288, P2428, DOI 10.1074/jbc.M112.425884; Humphrey RK, 2010, J BIOL CHEM, V285, P22426, DOI 10.1074/jbc.M110.123786; Humphrey RK, 2010, J BIOL CHEM, V285, P3406, DOI 10.1074/jbc.M109.006734; Ibrahim SH, 2014, LIVER INT, V34, P427, DOI 10.1111/liv.12353; Jaeschke A, 2007, MOL CELL, V27, P498, DOI 10.1016/j.molcel.2007.07.008; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Jiang JX, 2014, LIVER INT, V34, P1131, DOI 10.1111/liv.12556; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kant S, 2013, CELL REP, V4, P681, DOI 10.1016/j.celrep.2013.07.019; Kato S, 2007, BIOCHEM BIOPH RES CO, V353, P933, DOI 10.1016/j.bbrc.2006.12.161; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Korchnak AC, 2009, CELL SIGNAL, V21, P1620, DOI 10.1016/j.cellsig.2009.06.008; Kristiansen M, 2010, J NEUROSCI, V30, P10820, DOI 10.1523/JNEUROSCI.2824-10.2010; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nihalani D, 2003, J BIOL CHEM, V278, P28694, DOI 10.1074/jbc.M304212200; Novotny GW, 2012, ARCH BIOCHEM BIOPHYS, V528, P171, DOI 10.1016/j.abb.2012.09.014; Okamoto H, 2007, DIABETES, V56, P1350, DOI 10.2337/db06-1448; Park S, 2006, J BIOL CHEM, V281, P1159, DOI 10.1074/jbc.M508307200; Perier C, 2007, P NATL ACAD SCI USA, V104, P8161, DOI 10.1073/pnas.0609874104; Pineda G, 2007, ADV EXP MED BIOL, V597, P80; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Sharma M, 2012, J HEPATOL, V56, P192, DOI 10.1016/j.jhep.2011.03.019; Sondarva G, 2010, CELL RES, V20, P89, DOI 10.1038/cr.2009.125; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Wang YQ, 2006, J BIOL CHEM, V281, P13628, DOI 10.1074/jbc.M513730200; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Xu ZH, 2005, MOL CELL BIOL, V25, P9949, DOI 10.1128/MCB.25.22.9949-9959.2005; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07	57	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29994	30004		10.1074/jbc.M114.575613	http://dx.doi.org/10.1074/jbc.M114.575613			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25204656	Green Published, hybrid			2022-12-28	WOS:000344370800040
J	Patil, H; Saha, A; Senda, E; Cho, KI; Haque, M; Yu, MZ; Qiu, S; Yoon, D; Hao, Y; Peachey, NS; Ferreira, PA				Patil, Hemangi; Saha, Arjun; Senda, Eugene; Cho, Kyoung-in; Haque, MdEmdadul; Yu, Minzhong; Qiu, Sunny; Yoon, Dosuk; Hao, Ying; Peachey, Neal S.; Ferreira, Paulo A.			Selective Impairment of a Subset of Ran-GTP-binding Domains of Ran-binding Protein 2 (Ranbp2) Suffices to Recapitulate the Degeneration of the Retinal Pigment Epithelium (RPE) Triggered by Ranbp2 Ablation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cell Death; Cellular Regulation; Electrophysiology; Epithelial Cell; Gene Knockout; Microscopic Imaging; Transgenic Mice; RNA Regulation; Proteostasis	LIGHT-EVOKED RESPONSES; NUCLEAR-PORE COMPLEX; MACULAR DEGENERATION; MALATTIA LEVENTINESE; SYSTEMS-ANALYSIS; GENE-EXPRESSION; DOWN-REGULATION; VISUAL CYCLE; TRANSPORT; PARKIN	Background: Ranbp2 and its Ran-GTP-binding domains' roles in RPE survival/function, a multidisease target, are elusive. Results: RPE undergoes degeneration, disruptions of proteostasis of Ranbp2 partners, and blood-retinal barrier upon Ranbp2 ablation. Impairment of selective Ran-GTP-binding domains of Ranbp2 suffices to promote RPE degeneration. Conclusion: Ran GTPase regulation by Ranbp2 is vital to RPE. Significance: Ranbp2-dependent targets/mechanisms with therapeutic potential in RPE degeneration are uncovered. Retinal pigment epithelium (RPE) degeneration underpins diseases triggered by disparate genetic lesions, noxious insults, or both. The pleiotropic Ranbp2 controls the expression of intrinsic and extrinsic pathological stressors impinging on cellular viability. However, the physiological targets and mechanisms controlled by Ranbp2 in tissue homeostasis, such as RPE, are ill defined. We show that mice, RPE-cre::Ranbp2(-/-), with selective Ranbp2 ablation in RPE develop pigmentary changes, syncytia, hypoplasia, age-dependent centrifugal and non-apoptotic degeneration of the RPE, and secondary leakage of choriocapillaris. These manifestations are accompanied by the development of F-actin clouds, metalloproteinase-11 activation, deregulation of expression or subcellular localization of critical RPE proteins, atrophic cell extrusions into the subretinal space, and compensatory proliferation of peripheral RPE. To gain mechanistic insights into what Ranbp2 activities are vital to the RPE, we performed genetic complementation analyses of transgenic lines of bacterial artificial chromosomes of Ranbp2 harboring loss of function of selective Ranbp2 domains expressed in a Ranbp2(-/-) background. Among the transgenic lines produced, only Tg(RBD2/3*-HA)::RPE-cre::Ranbp2(-/-)-expressing mutations, which selectively impair binding of RBD2/3 (Ran-binding domains 2 and 3) of Ranbp2 to Ran-GTP, recapitulate RPE degeneration, as observed with RPE-cre::Ranbp2(-/-). By contrast, Tg(RBD2/3*-HA) expression rescues the degeneration of cone photoreceptors lacking Ranbp2. The RPE of RPE-cre::Ranbp2(-/-) and Tg(RBD2/3*-HA)::RPE-cre::Ranbp2(-/-) share proteostatic deregulation of Ran GTPase, serotransferrin, and -tubulin and suppression of light-evoked electrophysiological responses. These studies unravel selective roles of Ranbp2 and its RBD2 and RBD3 in RPE survival and functions. We posit that the control of Ran GTPase by Ranbp2 emerges as a novel therapeutic target in diseases promoting RPE degeneration.	[Patil, Hemangi; Saha, Arjun; Senda, Eugene; Cho, Kyoung-in; Haque, MdEmdadul; Qiu, Sunny; Yoon, Dosuk; Hao, Ying; Ferreira, Paulo A.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Ferreira, Paulo A.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Yu, Minzhong; Peachey, Neal S.] Cleveland Clin Fdn, Cole Eye Inst, Dept Ophthalm Res, Cleveland, OH 44195 USA; [Peachey, Neal S.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA; [Peachey, Neal S.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Ophthalmol, Cleveland, OH 44195 USA	Duke University; Duke University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Ferreira, PA (corresponding author), Duke Univ, Med Ctr, DUEC 3802,2351 Erwin Rd, Durham, NC 27710 USA.	paulo.ferreira@duke.edu	Peachey, Neal/G-5533-2010; Ferreira, Paulo A/S-4209-2016	Peachey, Neal/0000-0002-4419-7226; Ferreira, Paulo A/0000-0003-4585-1717	National Institutes of Health [EY019492, GM083165, GM083165-04S1, 2P30-EY005722, 5P30NS061789]; Foundation Fighting Blindness; Department of Veterans Affairs; Research to Prevent Blindness; Duke University; Jules and Doris Stein Research to Prevent Blindness Professorship; NATIONAL EYE INSTITUTE [P30EY005722, R01EY019492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Department of Veterans Affairs(US Department of Veterans Affairs); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Duke University; Jules and Doris Stein Research to Prevent Blindness Professorship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY019492, GM083165, and GM083165-04S1 (to P. A. F.), 2P30-EY005722 (to the Duke University Eye Center), and 5P30NS061789 (to the Duke Neurotransgenic Laboratory). This work was also supported by the Foundation Fighting Blindness and the Department of Veterans Affairs and an unrestricted award from Research to Prevent Blindness to Cleveland Clinic.; Supported by a Duke University Dean's Summer Undergraduate Research Fellowship.; Supported in part by the Jules and Doris Stein Research to Prevent Blindness Professorship. To whom correspondence should be addressed: Duke University Medical Center, DUEC 3802, 2351 Erwin Rd., Durham, NC27710. Tel.: 919-684-8457; Fax:919-684-3826; E-mail: paulo.ferreira@duke.edu.	Aslanukov A, 2006, PLOS GENET, V2, P1653, DOI 10.1371/journal.pgen.0020177; Ballestrem C, 1998, J CELL SCI, V111, P1649; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; BOK D, 1993, J CELL SCI, P189; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Braslavsky CIV, 2000, BIOCHEMISTRY-US, V39, P11629, DOI 10.1021/bi001010f; Cai H, 2006, ARCH OPHTHALMOL-CHIC, V124, P1276, DOI 10.1001/archopht.124.9.1276; Cai YF, 2001, J BIOL CHEM, V276, P41594, DOI 10.1074/jbc.M104514200; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Cho KI, 2009, CELL DEATH DIFFER, V16, P287, DOI 10.1038/cdd.2008.153; Cho KI, 2007, TRAFFIC, V8, P1722, DOI 10.1111/j.1600-0854.2007.00647.x; Cho KI, 2014, J BIOL CHEM, V289, P4600, DOI 10.1074/jbc.M113.538215; Cho KI, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003555; Cho KI, 2012, CELL MOL LIFE SCI, V69, P3511, DOI 10.1007/s00018-012-1071-9; Cho KI, 2010, DIS MODEL MECH, V3, P595, DOI 10.1242/dmm.004648; Cho KI, 2009, EMBO REP, V10, P480, DOI 10.1038/embor.2009.29; Chucair-Elliott AJ, 2012, J BIOL CHEM, V287, P24092, DOI 10.1074/jbc.M112.378240; Ciccarelli FD, 2005, GENOME RES, V15, P343, DOI 10.1101/gr.3266405; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; COUTAVAS E, 1993, NATURE, V366, P585, DOI 10.1038/366585a0; CRUICKSHANKS KJ, 1993, ARCH OPHTHALMOL-CHIC, V111, P514, DOI 10.1001/archopht.1993.01090040106042; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; Dawson TM, 2014, NEURODEGENER DIS, V13, P69, DOI 10.1159/000354307; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; Delphin C, 1997, MOL BIOL CELL, V8, P2379, DOI 10.1091/mbc.8.12.2379; Duke-Elder W. S., 1966, SYSTEM OPHTHALMOLOGY, P675; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; FERREIRA PA, 1995, J BIOL CHEM, V270, P23179, DOI 10.1074/jbc.270.39.23179; Fu SH, 2014, MOL VIS, V20, P480; FUCHS U, 1991, INVEST OPHTH VIS SCI, V32, P3178; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Hamada M, 2011, J CELL BIOL, V194, P597, DOI 10.1083/jcb.201102018; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hashizume C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.370; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kaylor JJ, 2013, NAT CHEM BIOL, V9, P30, DOI [10.1038/nchembio.1114, 10.1038/NCHEMBIO.1114]; Kokkinopoulos I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018921; Kunzler M, 2001, GENETICS, V157, P1089; Le YZ, 2008, INVEST OPHTH VIS SCI, V49, P1248, DOI 10.1167/iovs.07-1105; Longbottom R, 2009, P NATL ACAD SCI USA, V106, P18728, DOI 10.1073/pnas.0902593106; Lonnqvist T, 2011, NEUROLOGY, V76, P101, DOI 10.1212/WNL.0b013e318203e908; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Marmor M. F., 1998, RETINAL PIGMENT EPIT, DOI [10.1098/rsif.2015.0563, DOI 10.1098/RSIF.2015.0563]; Marmorstein AD, 2009, PROG RETIN EYE RES, V28, P206, DOI 10.1016/j.preteyeres.2009.04.004; Marmorstein LHY, 2002, P NATL ACAD SCI USA, V99, P13067, DOI 10.1073/pnas.202491599; Marneros AG, 2013, CELL REP, V4, P945, DOI 10.1016/j.celrep.2013.08.002; Maw MA, 1997, NAT GENET, V17, P198, DOI 10.1038/ng1097-198; Nagai M, 2013, BBA-GEN SUBJECTS, V1830, P2813, DOI 10.1016/j.bbagen.2012.11.001; Nagai M, 2011, FEBS LETT, V585, P791, DOI 10.1016/j.febslet.2011.02.002; Neilson DE, 2009, AM J HUM GENET, V84, P44, DOI 10.1016/j.ajhg.2008.12.009; Patel Amit K, 2013, JAKSTAT, V2, pe25434, DOI 10.4161/jkst.25434; Patil H, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120183; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Poulogiannis G, 2010, P NATL ACAD SCI USA, V107, P15145, DOI 10.1073/pnas.1009941107; Rattner A, 2006, NAT REV NEUROSCI, V7, P860, DOI 10.1038/nrn2007; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; ROHRER B, 1993, VISUAL NEUROSCI, V10, P447, DOI 10.1017/S0952523800004673; Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080; Samuels IS, 2010, J NEUROPHYSIOL, V104, P391, DOI 10.1152/jn.00088.2010; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Singh BB, 1999, J BIOL CHEM, V274, P37370, DOI 10.1074/jbc.274.52.37370; Smith AE, 2002, SCIENCE, V295, P488, DOI 10.1126/science.1064732; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Suzuki M, 2012, J CELL SCI, V125, P2407, DOI 10.1242/jcs.097683; TAYLOR HR, 1992, ARCH OPHTHALMOL-CHIC, V110, P99, DOI 10.1001/archopht.1992.01080130101035; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Um JW, 2006, J NEUROSCI RES, V84, P1543, DOI 10.1002/jnr.21041; Um JW, 2006, J BIOL CHEM, V281, P3595, DOI 10.1074/jbc.M504994200; van Soest SS, 2007, MOL VIS, V13, P1608; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Walde S, 2012, TRAFFIC, V13, P218, DOI 10.1111/j.1600-0854.2011.01302.x; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Wolf K, 2013, J NEUROL, V260, P1545, DOI 10.1007/s00415-012-6825-7; Wu J, 2004, J NEUROPHYSIOL, V91, P1134, DOI 10.1152/jn.00958.2003; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P2242, DOI 10.1167/iovs.06-0560; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yi HQ, 2007, J BIOL CHEM, V282, P34770, DOI 10.1074/jbc.M706903200; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Yu MZ, 2012, EXP EYE RES, V96, P124, DOI 10.1016/j.exer.2011.12.011; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303	96	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29767	29789		10.1074/jbc.M114.586834	http://dx.doi.org/10.1074/jbc.M114.586834			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25187515	Green Published, hybrid			2022-12-28	WOS:000344370800024
J	French, RL; Gupta, N; Copeland, PR; Simonovic, M				French, Rachel L.; Gupta, Nirupama; Copeland, Paul R.; Simonovic, Miljan			Structural Asymmetry of the Terminal Catalytic Complex in Selenocysteine Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; SCATTERING DATA-ANALYSIS; OF-SITES REACTIVITY; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; THERMUS-THERMOPHILUS; ADENYLATE FORMATION; ACTIVE-SITE; MECHANISM; STOICHIOMETRY	Selenocysteine (Sec), the 21st amino acid, is synthesized from a serine precursor in a series of reactions that require selenocysteine tRNA (tRNA(Sec)). In archaea and eukaryotes, O-phosphoseryl-tRNA(Sec): selenocysteinyl-tRNA(Sec) synthase (SepSecS) catalyzes the terminal synthetic reaction during which the phosphoseryl intermediate is converted into the selenocysteinyl moiety while being attached to tRNA(Sec). We have previously shown that only the SepSecS tetramer is capable of binding to and recognizing the distinct fold of tRNA(Sec). Because only two of the four tRNA-binding sites were occupied in the crystal form, a question was raised regarding whether the observed arrangement and architecture faithfully recapitulated the physiologically relevant ribonucleoprotein complex important for selenoprotein formation. Herein, we determined the stoichiometry of the human terminal synthetic complex of selenocysteine by using small angle x-ray scattering, multi-angle light scattering, and analytical ultracentrifugation. In addition, we provided the first estimate of the ratio between SepSecS and tRNA(Sec) in vivo. We show that SepSecS preferentially binds one or two tRNA(Sec) molecules at a time and that the enzyme is present in large molar excess over the substrate tRNA in vivo. Moreover, we show that in a complex between SepSecS and two tRNAs, one enzyme homodimer plays a role of the noncatalytic unit that positions CCA ends of two tRNA(Sec) molecules into the active site grooves of the other, catalytic, homodimer. Finally, our results demonstrate that the previously determined crystal structure represents the physiologically and catalytically relevant complex and suggest that allosteric regulation of SepSecS might play an important role in regulation of selenocysteine and selenoprotein synthesis.	[French, Rachel L.; Simonovic, Miljan] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Gupta, Nirupama; Copeland, Paul R.] Rutgers Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center	Simonovic, M (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Coll Med, 900 S Ashland Ave,MBRB1354 M-C 669, Chicago, IL 60607 USA.	msimon5@uic.edu		Copeland, Paul/0000-0003-3343-0587; Simonovic, Miljan/0000-0002-1576-2222	National Institutes of Health [R01 GM097042, GM077073, P41 GM103622]; U.S. Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097042, R01GM077073, P41GM103622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM097042 (to M. S.), GM077073 (to P. R. C.), and P41 GM103622 (to BioCAT). This work was also supported by the U.S. Department of Energy under contract DE-AC02-06CH11357.	Agamy O, 2010, AM J HUM GENET, V87, P538, DOI 10.1016/j.ajhg.2010.09.007; Ambrogelly A, 2005, FEBS LETT, V579, P6017, DOI 10.1016/j.febslet.2005.09.025; Araiso Y, 2008, NUCLEIC ACIDS RES, V36, P1187, DOI 10.1093/nar/gkm1122; Bhattacharyya M, 2011, BIOCHEMISTRY-US, V50, P6225, DOI 10.1021/bi200306u; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; BOREL F, 1994, NUCLEIC ACIDS RES, V22, P2963, DOI 10.1093/nar/22.15.2963; Cornish-Bowden A, 2014, FEBS J, V281, P621, DOI 10.1111/febs.12469; Demeler B, 1997, BIOPHYS J, V72, P397, DOI 10.1016/S0006-3495(97)78680-6; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B., 2005, BIOINFORMATICS BASIC, P226; Demeler B., ULTRASCAN VERSION 3; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P5, DOI 10.1021/bi00672a002; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Fischetti R, 2004, J SYNCHROTRON RADIAT, V11, P399, DOI 10.1107/S0909049504016760; FORCHHAMMER K, 1991, J BIOL CHEM, V266, P6318; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Ganichkin OM, 2008, J BIOL CHEM, V283, P5849, DOI 10.1074/jbc.M709342200; Gonzalez-Flores JN, 2012, J BIOL CHEM, V287, P38936, DOI 10.1074/jbc.M112.415463; Guth E, 2009, J BIOL CHEM, V284, P20753, DOI 10.1074/jbc.M109.021311; Hauenstein SI, 2008, J BIOL CHEM, V283, P21997, DOI 10.1074/jbc.M801838200; Hughes Samantha J, 2003, BMC Struct Biol, V3, P5, DOI 10.1186/1472-6807-3-5; Hughes SJ, 2006, PROTEINS, V62, P649, DOI 10.1002/prot.20609; HYAFIL F, 1976, BIOCHEMISTRY-US, V15, P3678, DOI 10.1021/bi00662a006; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JAKES R, 1975, BIOCHEMISTRY-US, V14, P3344, DOI 10.1021/bi00686a009; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KRAUSS G, 1975, EUR J BIOCHEM, V55, P517, DOI 10.1111/j.1432-1033.1975.tb02189.x; Larson ET, 2012, ACTA CRYSTALLOGR D, V68, P1194, DOI 10.1107/S0907444912024699; LEE BJ, 1990, MOL CELL BIOL, V10, P1940, DOI 10.1128/MCB.10.5.1940; LEE BJ, 1989, J BIOL CHEM, V264, P9724; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MOSYAK L, 1993, BIOCHIMIE, V75, P1091, DOI 10.1016/0300-9084(93)90008-G; Nozawa K, 2009, NATURE, V457, P1163, DOI 10.1038/nature07611; Palioura S, 2009, SCIENCE, V325, P321, DOI 10.1126/science.1173755; Perona JJ, 2012, BIOCHEMISTRY-US, V51, P8705, DOI 10.1021/bi301180x; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Rebsch CM, 2006, CELL RES, V16, P940, DOI 10.1038/sj.cr.7310117; Rigger L, 2013, CHEM-EUR J, V19, P15872, DOI 10.1002/chem.201302188; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; Schmidt RL, 2012, CROAT MED J, V53, P535, DOI 10.3325/cmj.2012.53.535; Schmitt E, 1998, EMBO J, V17, P5227, DOI 10.1093/emboj/17.17.5227; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; WARD WHJ, 1988, BIOCHEMISTRY-US, V27, P1041, DOI 10.1021/bi00403a029; WARD WHJ, 1988, BIOCHEMISTRY-US, V27, P5525, DOI 10.1021/bi00415a021; Yadavalli SS, 2012, ADV PROTEIN CHEM STR, V86, P1, DOI 10.1016/B978-0-12-386497-0.00001-3; ZINONI F, 1987, P NATL ACAD SCI USA, V84, P3156, DOI 10.1073/pnas.84.10.3156	51	10	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28783	28794		10.1074/jbc.M114.597955	http://dx.doi.org/10.1074/jbc.M114.597955			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25190812	Green Published, hybrid			2022-12-28	WOS:000344141000003
J	Thompson, JW; Nagel, J; Hoving, S; Gerrits, B; Bauer, A; Thomas, JR; Kirschner, MW; Schirle, M; Luchansky, SJ				Thompson, Joel W.; Nagel, Jane; Hoving, Sjouke; Gerrits, Bertran; Bauer, Andreas; Thomas, Jason R.; Kirschner, Marc W.; Schirle, Markus; Luchansky, Sarah J.			Quantitative Lys-epsilon-Gly-Gly (diGly) Proteomics Coupled with Inducible RNAi Reveals Ubiquitin-mediated Proteolysis of DNA Damage-inducible Transcript 4 (DDIT4) by the E3 Ligase HUWE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HECT-DOMAIN; PROTEIN; IDENTIFICATION; HYPOXIA; ACTIVATION; REDD1; DEGRADATION; PROTEASOME; SUPPRESSOR; EXPRESSION	Targeted degradation of proteins through the ubiquitin-proteasome system (UPS) via the activities of E3 ubiquitin ligases regulates diverse cellular processes, and misregulation of these enzymes contributes to the pathogenesis of human diseases. One of the challenges facing the UPS field is to delineate the complete cohort of substrates for a particular E3 ligase. Advances in mass spectrometry and the development of antibodies recognizing the Lys-epsilon-Gly-Gly (diGly) remnant from ubiquitinated proteins following trypsinolysis have provided a tool to address this question. We implemented an inducible loss of function approach in combination with quantitative diGly proteomics to find novel substrates of HUWE1 (HECT, UBA, and WWE domain containing 1, E3 ubiquitin protein ligase), an E3 ligase implicated in cancer and intellectual disabilities. diGly proteomics results led to the identification of DNA damage-inducible transcript 4 (DDIT4) as a putative HUWE1 substrate. Cell-based assays demonstrated that HUWE1 interacts with and regulates ubiquitination and stability of DDIT4. Together these data suggest a model in which HUWE1 mediates DDIT4 proteasomal degradation. Our results demonstrate proof of concept that inducible knockdown of an E3 ligase in combination with diGly proteomics provides a potentially advantageous method for identifying novel E3 substrates that may help to identify candidates for therapeutic modulation in the UPS.	[Thompson, Joel W.; Nagel, Jane; Thomas, Jason R.; Schirle, Markus; Luchansky, Sarah J.] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Hoving, Sjouke; Gerrits, Bertran; Bauer, Andreas] Novartis Inst BioMed Res, CH-4056 Basel, Switzerland; [Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Novartis; Novartis; Harvard University; Harvard Medical School	Luchansky, SJ (corresponding author), Novartis Inst BioMed Res, Cambridge, MA 02139 USA.	sarah.luchansky@novartis.com		Thompson, Joel/0000-0002-5131-3248	Novartis Institutes for BioMedical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039023] Funding Source: NIH RePORTER	Novartis Institutes for BioMedical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by a Novartis Institutes for BioMedical Research presidential postdoctoral fellowship.	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Bloom J, 2005, METHOD ENZYMOL, V399, P249, DOI 10.1016/S0076-6879(05)99017-4; Brafman A, 2004, INVEST OPHTH VIS SCI, V45, P3796, DOI 10.1167/iovs.04-0052; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Cano F, 2012, EMBO J, V31, P3596, DOI 10.1038/emboj.2012.218; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Confalonieri S, 2009, ONCOGENE, V28, P2959, DOI 10.1038/onc.2009.156; D'Arca D, 2010, P NATL ACAD SCI USA, V107, P5875, DOI 10.1073/pnas.0912874107; Danielsen JMR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003590; Davis MA, 2013, GENE DEV, V27, P151, DOI 10.1101/gad.207720.112; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Froyen G, 2008, AM J HUM GENET, V82, P432, DOI 10.1016/j.ajhg.2007.11.002; Froyen G, 2012, AM J HUM GENET, V91, P252, DOI 10.1016/j.ajhg.2012.06.010; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P864, DOI 10.1073/pnas.74.3.864; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Horak P, 2010, P NATL ACAD SCI USA, V107, P4675, DOI 10.1073/pnas.0907705107; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Khoronenkova SV, 2013, NUCLEIC ACIDS RES, V41, P1750, DOI 10.1093/nar/gks1359; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041; Lee KA, 2011, J BIOL CHEM, V286, P41530, DOI 10.1074/jbc.M111.248856; Love KR, 2009, ACS CHEM BIOL, V4, P275, DOI 10.1021/cb9000348; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Mark KG, 2014, MOL CELL, V53, P148, DOI 10.1016/j.molcel.2013.12.003; Merbl Y, 2013, CELL, V152, P1160, DOI 10.1016/j.cell.2013.02.007; Merbl Y, 2009, P NATL ACAD SCI USA, V106, P2543, DOI 10.1073/pnas.0812892106; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Pandya RK, 2010, J BIOL CHEM, V285, P5664, DOI 10.1074/jbc.M109.051805; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Poulsen EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050548; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Schwarzer R, 2005, ONCOGENE, V24, P1138, DOI 10.1038/sj.onc.1208236; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tai HC, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00012; Tan CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063970; Tan MKM, 2013, MOL CELL, V52, P9, DOI 10.1016/j.molcel.2013.08.018; TURNER G, 1994, AM J MED GENET, V51, P575, DOI 10.1002/ajmg.1320510456; Udeshi ND, 2013, MOL CELL PROTEOMICS, V12, P825, DOI 10.1074/mcp.O112.027094; Udeshi ND, 2012, MOL CELL PROTEOMICS, V11, P148, DOI 10.1074/mcp.M111.016857; Vega-Rubin-de-Celis S, 2010, BIOCHEMISTRY-US, V49, P2491, DOI 10.1021/bi902135e; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang ZQ, 2003, J BIOL CHEM, V278, P27053, DOI 10.1074/jbc.M303723200; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Williamson A, 2013, MOL CELL, V49, P591, DOI 10.1016/j.molcel.2013.01.028; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Yoon SY, 2005, BIOCHEM BIOPH RES CO, V326, P7, DOI 10.1016/j.bbrc.2004.11.004; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Zhang J, 2011, GENE DEV, V25, P2610, DOI 10.1101/gad.170605.111; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	75	41	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28942	28955		10.1074/jbc.M114.573352	http://dx.doi.org/10.1074/jbc.M114.573352			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25147182	Green Published, hybrid			2022-12-28	WOS:000344141000016
J	Wakasugi, M; Sasaki, T; Matsumoto, M; Nagaoka, M; Inoue, K; Inobe, M; Horibata, K; Tanaka, K; Matsunaga, T				Wakasugi, Mitsuo; Sasaki, Takuma; Matsumoto, Megumi; Nagaoka, Miyuki; Inoue, Keiko; Inobe, Manabu; Horibata, Katsuyoshi; Tanaka, Kiyoji; Matsunaga, Tsukasa			Nucleotide Excision Repair-dependent DNA Double-strand Break Formation and ATM Signaling Activation in Mammalian Quiescent Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H2AX PHOSPHORYLATION; RAD3-RELATED PROTEIN ATR; ATAXIA-TELANGIECTASIA; DAMAGE RESPONSE; UV-IRRADIATION; CHECKPOINT ACTIVATION; IONIZING-RADIATION; S-PHASE; NUCLEASE; ESTABLISHMENT	Histone H2A variant H2AX is phosphorylated at Ser(139) in response to DNA double-strand break (DSB) and single-stranded DNA (ssDNA) formation. UV light dominantly induces pyrimidine photodimers, which are removed from the mammalian genome by nucleotide excision repair (NER). We previously reported that in quiescent G(0) phase cells, UV induces ATR-mediated H2AX phosphorylation plausibly caused by persistent ssDNA gap intermediates during NER. In this study, we have found that DSB is also generated following UV irradiation in an NER-dependent manner and contributes to an earlier fraction of UV-induced H2AX phosphorylation. The NER-dependent DSB formation activates ATM kinase and triggers the accumulation of its downstream factors, MRE11, NBS1, and MDC1, at UV-damaged sites. Importantly, ATM-deficient cells exhibited enhanced UV sensitivity under quiescent conditions compared with asynchronously growing conditions. Finally, we show that the NER-dependent H2AX phosphorylation is also observed in murine peripheral T lymphocytes, typical nonproliferating quiescent cells in vivo. These results suggest that in vivo quiescent cells may suffer from NER-mediated secondary DNA damage including ssDNA and DSB.	[Wakasugi, Mitsuo; Sasaki, Takuma; Matsumoto, Megumi; Nagaoka, Miyuki; Inoue, Keiko; Inobe, Manabu; Matsunaga, Tsukasa] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharm, Kanazawa, Ishikawa 9201192, Japan; [Horibata, Katsuyoshi; Tanaka, Kiyoji] Osaka Univ, Grad Sch Frontier Biosci, Human Cell Biol Grp, Suita, Osaka 5650871, Japan	Kanazawa University; Osaka University	Matsunaga, T (corresponding author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharm, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	matsukas@p.kanazawa-u.ac.jp	INOBE, Manabu/D-8393-2015; Wakasugi, Mitsuo/D-8417-2015	Wakasugi, Mitsuo/0000-0001-9593-0566	Ministry of Education, Culture, Sports, Science and Technology of Japan [21510055, 24510068]; Hokkoku Cancer Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [26870867, 22131009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hokkoku Cancer Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants 21510055 and 24510068 from the Ministry of Education, Culture, Sports, Science and Technology of Japan and also grants from Hokkoku Cancer Foundation (to T. M.) and Takeda Science Foundation (to M. W.).	Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bootsma D., 1998, GENETIC BASIS HUMAN, P245; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Giannattasio M, 2010, MOL CELL, V40, P50, DOI 10.1016/j.molcel.2010.09.004; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Lindsey-Boltz LA, 2014, J BIOL CHEM, V289, P5074, DOI 10.1074/jbc.M113.542787; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391; MATSUNAGA T, 1995, J BIOL CHEM, V270, P20862, DOI 10.1074/jbc.270.35.20862; MORI T, 1991, PHOTOCHEM PHOTOBIOL, V54, P225, DOI 10.1111/j.1751-1097.1991.tb02010.x; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; Nakamura H, 2002, J RADIAT RES, V43, P167, DOI 10.1269/jrr.43.167; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Oh KS, 2011, DNA REPAIR, V10, P5, DOI 10.1016/j.dnarep.2010.09.004; Olson E, 2007, J BIOL CHEM, V282, P22939, DOI 10.1074/jbc.M702162200; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Reardon JT, 1997, NUCLEIC ACIDS RES, V25, P1015, DOI 10.1093/nar/25.5.1015; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Sertic S, 2011, P NATL ACAD SCI USA, V108, P13647, DOI 10.1073/pnas.1108547108; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Stiff T, 2008, HUM MOL GENET, V17, P3247, DOI 10.1093/hmg/ddn220; Suzuki K, 1999, J BIOL CHEM, V274, P25571, DOI 10.1074/jbc.274.36.25571; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vrouwe MG, 2011, J CELL SCI, V124, P435, DOI 10.1242/jcs.075325; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031; Yajima H, 2009, J MOL BIOL, V385, P800, DOI 10.1016/j.jmb.2008.11.036	39	33	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28730	28737		10.1074/jbc.M114.589747	http://dx.doi.org/10.1074/jbc.M114.589747			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25164823	Green Published, hybrid			2022-12-28	WOS:000343765400060
J	Kuzynski, M; Goss, M; Bottini, M; Yadav, MC; Mobley, C; Winters, T; Poliard, A; Kellermann, O; Lee, B; Millan, JL; Napierala, D				Kuzynski, Maria; Goss, Morgan; Bottini, Massimo; Yadav, Manisha C.; Mobley, Callie; Winters, Tony; Poliard, Anne; Kellermann, Odile; Lee, Brendan; Millan, Jose Luis; Napierala, Dobrawa			Dual Role of the Trps1 Transcription Factor in Dentin Mineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biomineralization; Dentin; Differentiation; Extracellular Matrix; Gene Expression; Trps1; Odontoblast	MATRIX VESICLES; TRICHORHINOPHALANGEAL SYNDROME; DENTINOGENESIS IMPERFECTA; HYPOPHOSPHATEMIC RICKETS; ALKALINE-PHOSPHATASE; SKELETAL MINERALIZATION; BONE MINERALIZATION; TOOTH DEVELOPMENT; VITAMIN-D; EXPRESSION	Background: Regulation of dentin mineralization at the gene expression level is poorly understood. Results: Trps1 supports expression of osteogenic genes Alpl, Phospho1, Runx2, and Sp7 in preodontoblastic cells, and in mature cells Trps1 represses phosphate metabolism genes Phex and Vdr. Conclusion: The role of Trps1 in mineralization depends on odontoblastic differentiation stage. Significance: These findings provide insights into regulation of odontoblastic maturation and function. TRPS1 (tricho-rhino-phalangeal syndrome) is a unique GATA-type transcription factor that acts as a transcriptional repressor. TRPS1 deficiency and dysregulated TRPS1 expression result in skeletal and dental abnormalities implicating TRPS1 in endochondral bone formation and tooth development. Moreover, patients with tricho-rhino-phalangeal syndrome frequently present with low bone mass indicating TRPS1 involvement in bone homeostasis. In addition, our previous data demonstrated accelerated mineralization of the perichondrium in Trps1 mutant mice and impaired dentin mineralization in Col1a1-Trps1 transgenic mice, implicating Trps1 in the mineralization process. To understand the role of Trps1 in the differentiation and function of cells producing mineralized matrix, we used a preodontoblastic cell line as a model of dentin mineralization. We generated both Trps1-deficient and Trps1-overexpressing stable cell lines and analyzed the progression of mineralization by alkaline phosphatase and alizarin red staining. As predicted, based on our previous in vivo data, delayed and decreased mineralization of Trps1-overexpressing odontoblastic cells was observed when compared with control cells. This was associated with down-regulation of genes regulating phosphate homeostasis. Interestingly, Trps1-deficient cells lost the ability to mineralize and demonstrated decreased expression of several genes critical for initiating the mineralization process, including Alpl and Phospho1. Based on these data, we have concluded that Trps1 serves two critical and context-dependent functions in odontoblast-regulated mineralization as follows: 1) Trps1 is required for odontoblast maturation by supporting expression of genes crucial for initiating the mineralization process, and 2) Trps1 represses the function of mature cells and, consequently, restricts the extent of extracellular matrix mineralization.	[Kuzynski, Maria; Goss, Morgan; Mobley, Callie; Winters, Tony; Napierala, Dobrawa] Univ Alabama Birmingham, Sch Dent, Dept Oral & Maxillofacial Surg, Inst Oral Hlth Res, Birmingham, AL 35294 USA; [Bottini, Massimo; Yadav, Manisha C.; Millan, Jose Luis] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA; [Bottini, Massimo] Univ Roma Tor Vergata, Dept Expt Med & Surg, I-00133 Rome, Italy; [Poliard, Anne] Univ Paris 05, UFR Odontol EA2496, F-92120 Montrouge, France; [Kellermann, Odile] Univ Paris 05, Ctr Univ St Peres, INSERM UMR S 1124, F-75270 Paris 06, France; [Lee, Brendan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lee, Brendan] Howard Hughes Med Inst, Houston, TX 77030 USA	University of Alabama System; University of Alabama Birmingham; Sanford Burnham Prebys Medical Discovery Institute; University of Rome Tor Vergata; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Baylor College of Medicine; Howard Hughes Medical Institute	Napierala, D (corresponding author), Univ Alabama Birmingham, Sch Dent, Dept Oral & Maxillofacial Surg, 707 SDB,1919 7th Ave South, Birmingham, AL 35294 USA.	dobrawan@uab.edu		Napierala, Dobrawa/0000-0002-7383-1011; Bottini, Massimo/0000-0001-9237-8972	National Institutes of Health, NIDCR [R01DE023083]; NIAMS [T90DE022736, DE12889, R01AR53102]; University of Alabama at Birmingham Center for Metabolic Bone Disease; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012889, T90DE022736, R01DE023083] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Alabama at Birmingham Center for Metabolic Bone Disease; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE023083 from NIDCR (to D. N.), T90DE022736 (to M. K.), DE12889 and R01AR53102 from NIAMS (to J. L. M.). This work was also supported by a grant from University of Alabama at Birmingham Center for Metabolic Bone Disease (to D. N.).	Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Anderson HC, 2005, FRONT BIOSCI-LANDMRK, V10, P822, DOI 10.2741/1576; Balcerzak M, 2008, PROTEOMICS, V8, P192, DOI 10.1002/pmic.200700612; Barron MJ, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-31; Bergwitz C, 2012, ADV EXP MED BIOL, V728, P41, DOI 10.1007/978-1-4614-0887-1_3; Boukpessi T, 2006, CALCIFIED TISSUE INT, V79, P294, DOI 10.1007/s00223-006-0182-4; Chaussain-Miller C, 2007, ORAL DIS, V13, P482, DOI 10.1111/j.1601-0825.2006.01326.x; Ciancaglini P, 2010, J BONE MINER RES, V25, P716, DOI 10.1359/jbmr.091023; Fantauzzo KA, 2008, HUM MOL GENET, V17, P3539, DOI 10.1093/hmg/ddn247; Fantauzzo KA, 2012, DEVELOPMENT, V139, P203, DOI 10.1242/dev.069971; Foster BL, 2013, J BONE MINER RES, V28, P271, DOI 10.1002/jbmr.1767; Garces-Ortiz M, 2013, MED ORAL PATOL ORAL, V18, pE537, DOI 10.4317/medoral.18650; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Goldberg M, 2002, CONNECT TISSUE RES, V43, P482, DOI 10.1080/03008200290000817; Goldberg Michel, 2011, Front Biosci (Elite Ed), V3, P711, DOI 10.2741/e281; Golub EE, 2011, SEMIN IMMUNOPATHOL, V33, P409, DOI 10.1007/s00281-010-0230-z; Golub EE, 2009, BBA-GEN SUBJECTS, V1790, P1592, DOI 10.1016/j.bbagen.2009.09.006; Gorski JP, 2011, FRONT BIOSCI-LANDMRK, V16, P2598, DOI 10.2741/3875; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Huang BZ, 2008, EUR J ORAL SCI, V116, P104, DOI 10.1111/j.1600-0722.2008.00522.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; James MJ, 2006, J BONE MINER RES, V21, P1034, DOI 10.1359/JBMR.060413; Johnson K, 2003, J BONE MINER RES, V18, P994, DOI 10.1359/jbmr.2003.18.6.994; Kantaputra P, 2008, J DENT RES, V87, P1027, DOI 10.1177/154405910808701102; KATCHBURIAN E, 1973, J ANAT, V116, P285; Kim JW, 2007, J DENT RES, V86, P392, DOI 10.1177/154405910708600502; Kirsch T, 1997, J CELL BIOL, V137, P1149, DOI 10.1083/jcb.137.5.1149; Kunath M, 2002, MECH DEVELOP, V119, pS117, DOI 10.1016/S0925-4773(03)00103-5; Lacerda-Pinheiro S, 2012, EUR CELLS MATER, V23, P371, DOI 10.22203/eCM.v023a29; Liu H, 2010, J DENT RES, V89, P1373, DOI 10.1177/0022034510379017; MacDougall M, 2006, AM J MED GENET A, V140A, P2536, DOI 10.1002/ajmg.a.31359; Malik TH, 2001, EMBO J, V20, P1715, DOI 10.1093/emboj/20.7.1715; Massa LF, 2005, HISTOCHEM CELL BIOL, V124, P197, DOI 10.1007/s00418-005-0009-9; McKee MD, 2013, J DENT RES, V92, P721, DOI 10.1177/0022034513490958; McKee MD, 2013, PERIODONTOL 2000, V63, P102, DOI 10.1111/prd.12029; Millan JL, 2013, CALCIFIED TISSUE INT, V93, P299, DOI 10.1007/s00223-012-9672-8; Momeni P, 2000, NAT GENET, V24, P71, DOI 10.1038/71717; Napierala D, 2008, HUM MOL GENET, V17, P2244, DOI 10.1093/hmg/ddn125; Napierala D, 2012, J BONE MINER RES, V27, P1735, DOI 10.1002/jbmr.1636; Piscopo DM, 2009, J BIOL CHEM, V284, P31690, DOI 10.1074/jbc.M109.052316; Polewski MD, 2010, BONE, V46, P81, DOI 10.1016/j.bone.2009.08.055; Priam F, 2005, ARCH ORAL BIOL, V50, P271, DOI 10.1016/j.archoralbio.2004.10.007; Rafaelsen SH, 2013, J BONE MINER RES, V28, P1378, DOI 10.1002/jbmr.1850; Salmon B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056749; Souza MA, 2010, CLINICS, V65, P1023, DOI 10.1590/S1807-59322010001000017; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Stewart AJ, 2006, BONE, V39, P1000, DOI 10.1016/j.bone.2006.05.014; Stratmann U, 1996, CELL TISSUE RES, V284, P223, DOI 10.1007/s004410050582; Street SE, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-80; Suemoto H, 2007, DEV BIOL, V312, P572, DOI 10.1016/j.ydbio.2007.10.001; Suzuki H, 2008, ANAT REC, V291, P183, DOI 10.1002/ar.20630; Takano Y, 2000, BONE, V26, P333, DOI 10.1016/S8756-3282(00)00243-X; Thompson DL, 2002, J BONE MINER RES, V17, P311, DOI 10.1359/jbmr.2002.17.2.311; van den Bos T, 2005, J DENT RES, V84, P1021, DOI 10.1177/154405910508401110; Verdelis K, 2007, BONE, V40, P1399, DOI 10.1016/j.bone.2006.12.061; Vital SO, 2012, BONE, V50, P989, DOI 10.1016/j.bone.2012.01.010; Wuelling M, 2009, DEV BIOL, V328, P40, DOI 10.1016/j.ydbio.2009.01.012; Yadav MC, 2011, J BONE MINER RES, V26, P286, DOI 10.1002/jbmr.195; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200; Yoshiko Y, 2007, BONE, V40, P1565, DOI 10.1016/j.bone.2007.01.017; Zhang XM, 2007, ARCH ORAL BIOL, V52, P1172, DOI 10.1016/j.archoralbio.2007.06.010	62	14	14	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27481	27493		10.1074/jbc.M114.550129	http://dx.doi.org/10.1074/jbc.M114.550129			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25128529	Green Published, hybrid			2022-12-28	WOS:000342852800011
J	Roder, K; Werdich, AA; Li, WY; Liu, M; Kim, TY; Organ-Darling, LE; Moshal, KS; Hwang, JM; Lu, YC; Choi, BR; MacRae, CA; Koren, G				Roder, Karim; Werdich, Andreas A.; Li, Weiyan; Liu, Man; Kim, Tae Yun; Organ-Darling, Louise E.; Moshal, Karni S.; Hwang, Jung Min; Lu, Yichun; Choi, Bum-Rak; MacRae, Calum A.; Koren, Gideon			RING Finger Protein RNF207, a Novel Regulator of Cardiac Excitation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); HERG; Protein Complex; SNP; Zebrafish; HSP70; RNF207; Action Potential Duration; Conduction Velocity	QT INTERVAL DURATION; POTASSIUM CHANNEL KV1.5; COMMON VARIANTS; GENERAL-POPULATION; HERG; ZEBRAFISH; HEART; CHAPERONES; DEATH; DEGRADATION	Background: A genetic variant within RNF207 is associated with a prolonged QT interval. QT interval prolongation may lead to arrhythmia, a risk factor for sudden cardiac death. Results: RNF207 regulates action potential duration and the repolarizing channel HERG. Conclusion: RNF207 is an important regulator of cardiac excitation. Significance: Understanding the composition and dynamics of membrane complexes is important in unraveling the mechanism of arrhythmias. Two recent studies (Newton-Cheh, C. et al. (2009) Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat. Genet. 41, 399-406 and Pfeufer, A. et al. (2009) Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat. Genet. 41, 407-414) identified an association, with genome-wide significance, between a single nucleotide polymorphism within the gene encoding RING finger protein 207 (RNF207) and the QT interval. We sought to determine the role of RNF207 in cardiac electrophysiology. Morpholino knockdown of RNF207 in zebrafish embryos resulted in action potential duration prolongation, occasionally a 2:1 atrioventricular block, and slowing of conduction velocity. Conversely, neonatal rabbit cardiomyocytes infected with RNF207-expressing adenovirus exhibited shortened action potential duration. Using transfections of U-2 OS and HEK293 cells, Western blot analysis and immunocytochemistry data demonstrate that RNF207 and the human ether-a-go-go-related gene (HERG) potassium channel interact and colocalize. Furthermore, RNF207 overexpression significantly elevated total and membrane HERG protein and HERG-encoded current density by approximate to 30-50%, which was dependent on the intact N-terminal RING domain of RNF207. Finally, coexpression of RNF207 and HSP70 increased HERG expression compared with HSP70 alone. This effect was dependent on the C terminus of RNF207. Taken together, the evidence is strong that RNF207 is an important regulator of action potential duration, likely via effects on HERG trafficking and localization in a heat shock protein-dependent manner.	[Roder, Karim; Li, Weiyan; Liu, Man; Kim, Tae Yun; Moshal, Karni S.; Hwang, Jung Min; Lu, Yichun; Choi, Bum-Rak; Koren, Gideon] Brown Univ, Warren Alpert Med Sch, Rhode Isl Hosp, Cardiovasc Res Ctr,Div Cardiol,Dept Med, Providence, RI 02903 USA; [Werdich, Andreas A.; MacRae, Calum A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA; [Organ-Darling, Louise E.] Wellesley Coll, Dept Biol Sci, Wellesley, MA 02481 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Wellesley College	Koren, G (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Cardiovasc Res Ctr, 1 Hoppin St, Providence, RI 02903 USA.	Gideon_Koren@Brown.edu	Koren, Gideon/AAG-7726-2019; Liu, Man/GXH-3184-2022; Kim, Tae Yun/AFU-8071-2022	Koren, Gideon/0000-0002-9234-0875; Liu, Man/0000-0002-1390-7862; Kim, Tae Yun/0000-0003-0605-9575; Darling, Louise/0000-0002-7798-8024; Werdich, Andreas/0000-0002-1222-1180	NHLBI NIH HHS [K99 HL112724] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL112724] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aberg K, 2012, PHARMACOGENOMICS J, V12, P165, DOI 10.1038/tpj.2010.76; Akylbekova EL, 2009, CIRC-ARRHYTHMIA ELEC, V2, P427, DOI 10.1161/CIRCEP.109.858894; Amin AS, 2013, J PHYSIOL-LONDON, V591, P4125, DOI 10.1113/jphysiol.2013.254920; Arnaout R, 2007, P NATL ACAD SCI USA, V104, P11316, DOI 10.1073/pnas.0702724104; Badciong JC, 2002, J BIOL CHEM, V277, P49668, DOI 10.1074/jbc.M208593200; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Brunner M, 2008, J CLIN INVEST, V118, P2246, DOI 10.1172/JCI33578; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Ciechanover A, 2006, EXP BIOL MED, V231, P1197; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Folco EJ, 2004, AM J PHYSIOL-HEART C, V287, pH681, DOI 10.1152/ajpheart.00152.2004; Galindo Cristi L., 2009, BMC Physiology, V9, P23, DOI 10.1186/1472-6793-9-23; Gopalakrishnan Kathirvel, 2012, Frontiers in Genetics, V3, P138, DOI 10.3389/fgene.2012.00138; Gopalakrishnan K, 2011, HYPERTENSION, V57, P764, DOI 10.1161/HYPERTENSIONAHA.110.165803; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hong Y, 2001, CLIN GENET, V59, P171, DOI 10.1034/j.1399-0004.2001.590305.x; Huang YZ, 2007, INFLAMM BOWEL DIS, V13, P120, DOI 10.1002/ibd.20010; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Iwai C, 2013, CARDIOVASC RES, V100, P520, DOI 10.1093/cvr/cvt200; Jindal HK, 2008, AM J PHYSIOL-HEART C, V294, pH2012, DOI 10.1152/ajpheart.01374.2007; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Langheinrich U, 2003, TOXICOL APPL PHARM, V193, P370, DOI 10.1016/j.taap.2003.07.012; Leong IUS, 2010, BIOCHEM BIOPH RES CO, V396, P817, DOI 10.1016/j.bbrc.2010.04.157; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Li PL, 2011, CIRC RES, V108, P458, DOI 10.1161/CIRCRESAHA.110.227835; Lu JT, 2010, CURR OPIN CARDIOL, V25, P216, DOI 10.1097/HCO.0b013e32833846b3; Marin I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050030; Marjamaa A, 2009, J INTERN MED, V265, P448, DOI 10.1111/j.1365-2796.2008.02026.x; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Milan DJ, 2009, CIRCULATION, V120, P553, DOI 10.1161/CIRCULATIONAHA.108.821082; Milan DJ, 2006, DEVELOPMENT, V133, P1125, DOI 10.1242/dev.02279; Napolitano LM, 2012, IUBMB LIFE, V64, P64, DOI 10.1002/iub.580; Newton-Cheh C, 2005, HEART RHYTHM, V2, P277, DOI 10.1016/j.hrthm.2004.11.009; Newton-Cheh C, 2007, CURR OPIN GENET DEV, V17, P213, DOI 10.1016/j.gde.2007.04.010; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Noseworthy PA, 2011, CIRC-CARDIOVASC GENE, V4, P305, DOI 10.1161/CIRCGENETICS.110.959049; Organ-Darling LE, 2013, AM J PHYSIOL-HEART C, V304, pH589, DOI 10.1152/ajpheart.00385.2012; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Panakova D, 2010, NATURE, V466, P874, DOI 10.1038/nature09249; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Ren XQ, 2010, AM J PHYSIOL-HEART C, V299, pH1525, DOI 10.1152/ajpheart.00479.2009; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Roden DM, 1998, PACE, V21, P1029, DOI 10.1111/j.1540-8159.1998.tb00148.x; Roder K, 2006, BIOL CHEM, V387, P1237, DOI 10.1515/BC.2006.153; SADIS S, 1992, BIOCHEMISTRY-US, V31, P9406, DOI 10.1021/bi00154a012; Shirk AJ, 2005, J NEUROSCI RES, V82, P43, DOI 10.1002/jnr.20628; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; TOMASELLI GF, 1994, CIRCULATION, V90, P2534, DOI 10.1161/01.CIR.90.5.2534; van Rijen HVM, 2005, CARDIOVASC RES, V66, P9, DOI 10.1016/j.cardiores.2005.02.003; Volpi S, 2009, MOL PSYCHIATR, V14, P1024, DOI 10.1038/mp.2008.52; Walker VE, 2007, J BIOL CHEM, V282, P23509, DOI 10.1074/jbc.M701006200; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029885; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Werdich AA, 2012, PROG BIOPHYS MOL BIO, V110, P154, DOI 10.1016/j.pbiomolbio.2012.07.006; Wong J, 2010, CRIT CARE MED, V38, P25, DOI 10.1097/CCM.0b013e3181b427e8; Yang YZ, 2010, AM J HUM GENET, V86, P872, DOI 10.1016/j.ajhg.2010.04.017	65	26	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2014	289	49					33730	33740		10.1074/jbc.M114.592295	http://dx.doi.org/10.1074/jbc.M114.592295			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AW1UZ	25281747	Green Published, hybrid			2022-12-28	WOS:000346077600002
J	Rodriguez-Contreras, D; Hamilton, N				Rodriguez-Contreras, Dayana; Hamilton, Nicklas			Gluconeogenesis in Leishmania mexicana CONTRIBUTION OF GLYCEROL KINASE, PHOSPHOENOLPYRUVATE CARBOXYKINASE, AND PYRUVATE PHOSPHATE DIKINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-TRANSPORTER; TRYPANOSOMA-CRUZI; MICE REQUIRES; ENZYME; PROMASTIGOTES; METABOLISM; AMASTIGOTES; FERMENTATION; CYCLE; IDENTIFICATION	Gluconeogenesis is an active pathway in Leishmania amastigotes and is essential for their survival within the mammalian cells. However, our knowledge about this pathway in trypanosomatids is very limited. We investigated the role of glycerol kinase (GK), phosphoenolpyruvate carboxykinase (PEPCK), and pyruvate phosphate dikinase (PPDK) in gluconeogenesis by generating the respective Leishmania mexicana Delta gk, Delta pepck, and Delta ppdk null mutants. Our results demonstrated that indeed GK, PEPCK, and PPDK are key players in the gluconeogenesis pathway in Leishmania, although stage-specific differences in their contribution to this pathway were found. GK participates in the entry of glycerol in promastigotes and amastigotes; PEPCK participates in the entry of aspartate in promastigotes, and PPDK is involved in the entry of alanine in amastigotes. Furthermore, the majority of alanine enters into the pathway via decarboxylation of pyruvate in promastigotes, whereas pathway redundancy is suggested for the entry of aspartate in amastigotes. Interestingly, we also found that L-lactate, an abundant glucogenic precursor in mammals, was used by Leishmania amastigotes to synthesize mannogen, entering the pathway through PPDK. On the basis of these new results, we propose a revision in the current model of gluconeogenesis in Leishmania, emphasizing the differences between amastigotes and promastigotes. This work underlines the importance of studying the trypanosomatid intracellular life cycle stages to gain a better understanding of the pathologies caused in humans.	[Rodriguez-Contreras, Dayana; Hamilton, Nicklas] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA	Oregon Health & Science University	Rodriguez-Contreras, D (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	rodrigud@ohsu.edu			American Heart Association [10BGIA2610035]	American Heart Association(American Heart Association)	This work was supported by American Heart Association Grant 10BGIA2610035.	Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; BATES PA, 1994, PARASITOLOGY, V108, P1, DOI 10.1017/S0031182000078458; Besteiro S, 2002, J BIOL CHEM, V277, P38001, DOI 10.1074/jbc.M201759200; Blume M, 2011, FASEB J, V25, P1218, DOI 10.1096/fj.10-173278; Bringaud F, 1998, P NATL ACAD SCI USA, V95, P7963, DOI 10.1073/pnas.95.14.7963; Burchmore RJS, 1998, J BIOL CHEM, V273, P29118, DOI 10.1074/jbc.273.44.29118; Burchmore RJS, 1995, MOL BIOCHEM PARASIT, V74, P77, DOI 10.1016/0166-6851(95)02485-9; CAZZULO JJ, 1992, FASEB J, V6, P3153, DOI 10.1096/fasebj.6.13.1397837; CAZZULO JJ, 1985, MOL BIOCHEM PARASIT, V16, P329, DOI 10.1016/0166-6851(85)90074-X; Christie W. W., 2003, LIPID ANAL ISOLATION, P343; COOMBS GH, 1982, MOL BIOCHEM PARASIT, V5, P199, DOI 10.1016/0166-6851(82)90021-4; Costa TL, 2011, EXP PARASITOL, V128, P438, DOI 10.1016/j.exppara.2011.05.018; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; CYMERYNG C, 1995, MOL BIOCHEM PARASIT, V73, P91, DOI 10.1016/0166-6851(95)00099-M; Dean S, 2009, NATURE, V459, P213, DOI 10.1038/nature07997; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dougherty MJ, 2006, J BIOL CHEM, V281, P33892, DOI 10.1074/jbc.M604429200; Ewaschuk JB, 2005, J NUTR, V135, P1619, DOI 10.1093/jn/135.7.1619; Feng XH, 2013, MOL MICROBIOL, V87, P412, DOI 10.1111/mmi.12106; Igoillo-Esteve M, 2011, INT J PARASITOL, V41, P429, DOI 10.1016/j.ijpara.2010.11.002; Ilgoutz SC, 2001, INT J PARASITOL, V31, P899, DOI 10.1016/S0020-7519(01)00197-7; IOVANNISCI DM, 1983, J PARASITOL, V69, P633, DOI 10.2307/3281131; Kerkhoven EJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003371; Lee SH, 2007, NAT REV MICROBIOL, V5, P287, DOI 10.1038/nrmicro1617; Leroux AE, 2011, FEMS MICROBIOL LETT, V314, P25, DOI 10.1111/j.1574-6968.2010.02142.x; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; McConville MJ, 2011, ANNU REV MICROBIOL, V65, P543, DOI 10.1146/annurev-micro-090110-102913; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Michels PAM, 2000, PARASITOL TODAY, V16, P482, DOI 10.1016/S0169-4758(00)01810-X; MOTTRAM JC, 1985, EXP PARASITOL, V59, P265, DOI 10.1016/0014-4894(85)90081-5; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; Nelson D. L., 2005, PRINCIPLES BIOCH, P551; Newsholme P, 1996, CELL BIOCHEM FUNCT, V14, P1, DOI 10.1002/cbf.644; Osteras M, 1997, MICROBIOL-SGM, V143, P1639, DOI 10.1099/00221287-143-5-1639; Pieretti S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002012; POOLE RC, 1993, AM J PHYSIOL, V264, pC761, DOI 10.1152/ajpcell.1993.264.4.C761; RAINEY PM, 1991, MOL BIOCHEM PARASIT, V45, P307, DOI 10.1016/0166-6851(91)90099-R; Ralton JE, 2003, J BIOL CHEM, V278, P40757, DOI 10.1074/jbc.M307660200; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Rodriguez-Contreras D, 2007, MOL BIOCHEM PARASIT, V153, P9, DOI 10.1016/j.molbiopara.2007.01.010; Rodriguez-Contreras D, 2006, J BIOL CHEM, V281, P20068, DOI 10.1074/jbc.M603265200; Sanchez MA, 2013, J BIOL CHEM, V288, P14428, DOI 10.1074/jbc.M113.473157; Saunders EC, 2011, J BIOL CHEM, V286, P27706, DOI 10.1074/jbc.M110.213553; Seyfang A, 2000, J BIOL CHEM, V275, P5687, DOI 10.1074/jbc.275.8.5687; SIMON MW, 1978, J BACTERIOL, V135, P895, DOI 10.1128/JB.135.3.895-899.1978; Steinborn K, 2000, BIOL CHEM, V381, P1071, DOI 10.1515/BC.2000.132; Tran KD, 2013, J BIOL CHEM, V288, P22721, DOI 10.1074/jbc.M113.483461; Usui Y, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-87; Yang T, 2010, BIOCHEM J, V429, P533, DOI 10.1042/BJ20100238; Yao CQ, 2002, MOL BIOCHEM PARASIT, V121, P119, DOI 10.1016/S0166-6851(02)00030-0; Zelezniak A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003572	53	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2014	289	47								10.1074/jbc.M114.569434	http://dx.doi.org/10.1074/jbc.M114.569434			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0SO	25288791	Green Published, hybrid			2022-12-28	WOS:000345335000049
J	Ishimoto, T; Fujiwara, K; Niwa, T; Taguchi, H				Ishimoto, Takuya; Fujiwara, Kei; Niwa, Tatsuya; Taguchi, Hideki			Conversion of a Chaperonin GroEL-independent Protein into an Obligate Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chaperone; Protein Aggregation; Protein Evolution; Protein Folding; Protein Misfolding; Chaperonin; GroEL	DEPLETED ESCHERICHIA-COLI; MOLECULAR CHAPERONES; AGGREGATION; EVOLUTION; OVEREXPRESSION; MUTATIONS; MECHANISM; INTERACT; SYNTHASE; NETWORK	Background: Chaperonin GroEL and GroES (GroE) assist a subset of proteins in the cell. Results: Conversion of a GroE-independent MetK into an obligate MetK occurred; GroE dependence was correlated with the propensity to form protein aggregates. Conclusion: Subtle differences, even at single point mutations, determine the GroE dependence. Significance: Buffering the aggregation-prone mutations by GroE plays a role in maintaining diversity of proteins. Chaperones assist protein folding by preventing unproductive protein aggregation in the cell. In Escherichia coli, chaperonin GroEL/GroES (GroE) is the only indispensable chaperone and is absolutely required for the de novo folding of at least approximate to 60 proteins. We previously found that several orthologs of the obligate GroE substrates in Ureaplasma urealyticum, which lacks the groE gene in the genome, are E. coli GroE-independent folders, despite their significant sequence identities. Here, we investigated the key features that define the GroE dependence. Chimera or random mutagenesis analyses revealed that independent multiple point mutations, and even single mutations, were sufficient to confer GroE dependence on the Ureaplasma MetK. Strikingly, the GroE dependence was well correlated with the propensity to form protein aggregates during folding. The results reveal the delicate balance between GroE dependence and independence. The function of GroE to buffering the aggregation-prone mutations plays a role in maintaining higher genetic diversity of proteins.	[Ishimoto, Takuya; Niwa, Tatsuya; Taguchi, Hideki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Fujiwara, Kei] Keio Univ, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Tokyo Institute of Technology; Keio University	Taguchi, H (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, B-56,4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	taguchi@bio.titech.ac.jp	taguchi, hideki/AAM-2663-2021; FUJIWARA, KEI/U-8308-2019; Taguchi, Hideki/B-6946-2009; FUJIWARA, KEI/G-5467-2010	taguchi, hideki/0000-0002-6612-9339; FUJIWARA, KEI/0000-0001-7308-774X; Taguchi, Hideki/0000-0002-6612-9339; FUJIWARA, KEI/0000-0001-7308-774X; Niwa, Tatsuya/0000-0002-1330-8974	Japan Society for the Promotion of Science (JSPS) [19058002, 17049009]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Mochida Memorial Foundation; Takeda Science Foundation; Uehara Memorial Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by Grants-in-aid for Scientific Research 19058002 and 17049009 (to H. T.) from Japan Society for the Promotion of Science (JSPS) and Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. This work was also supported by grants from the Mochida Memorial Foundation, Takeda Science Foundation, and Uehara Memorial Foundation (to H. T.).	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Azia A, 2012, FEBS J, V279, P543, DOI 10.1111/j.1742-4658.2011.08458.x; Bogumil D, 2012, BIOCHEMISTRY-US, V51, P9941, DOI 10.1021/bi3013643; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Chapman E, 2006, P NATL ACAD SCI USA, V103, P15800, DOI 10.1073/pnas.0607534103; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; Ellis RJ, 2006, BIOL CHEM, V387, P485, DOI 10.1515/BC.2006.064; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Fujiwara K, 2007, J BACTERIOL, V189, P5860, DOI 10.1128/JB.00493-07; Fujiwara K, 2013, ANAL METHODS-UK, V5, P5918, DOI 10.1039/c3ay41092g; Fujiwara K, 2012, MICROBIOL-SGM, V158, P917, DOI 10.1099/mic.0.055079-0; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; Georgescauld F, 2014, CELL, V157, P922, DOI 10.1016/j.cell.2014.03.038; Gershenson A, 2011, CURR OPIN STRUC BIOL, V21, P32, DOI 10.1016/j.sbi.2010.11.001; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Masters M, 2009, RES MICROBIOL, V160, P267, DOI 10.1016/j.resmic.2009.04.002; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; Niwa T, 2012, P NATL ACAD SCI USA, V109, P8937, DOI 10.1073/pnas.1201380109; Niwa T, 2009, P NATL ACAD SCI USA, V106, P4201, DOI 10.1073/pnas.0811922106; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sparrer H, 1996, J MOL BIOL, V258, P74, DOI 10.1006/jmbi.1996.0235; Stan G, 2006, P NATL ACAD SCI USA, V103, P4433, DOI 10.1073/pnas.0600433103; TAGUCHI H, 1994, J BIOL CHEM, V269, P8529; Takemoto K, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-98; Takusagawa F, 1996, J BIOL CHEM, V271, P136, DOI 10.1074/jbc.271.1.136; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Tartaglia GG, 2010, J MOL BIOL, V400, P579, DOI 10.1016/j.jmb.2010.03.066; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Wyganowski KT, 2013, J MOL BIOL, V425, P3403, DOI 10.1016/j.jmb.2013.06.028	38	9	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					32073	32080		10.1074/jbc.M114.610444	http://dx.doi.org/10.1074/jbc.M114.610444			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25288795	Green Published, hybrid			2022-12-28	WOS:000345314700036
J	Ozek, C; Kanoski, SE; Zhang, ZY; Grill, HJ; Bence, KK				Ozek, Ceren; Kanoski, Scott E.; Zhang, Zhong-Yin; Grill, Harvey J.; Bence, Kendra K.			Protein-tyrosine Phosphatase 1B (PTP1B) Is a Novel Regulator of Central Brain-derived Neurotrophic Factor and Tropomyosin Receptor Kinase B (TrkB) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain-derived Neurotrophic Factor (BDNF); Hypothalamus; Metabolism; Phosphotyrosine Signaling; Receptor Tyrosine Kinase; Signal Transduction; Tyrosine-Protein Phosphatase (Tyrosine Phosphatase)	INSULIN SENSITIVITY; ENERGY-EXPENDITURE; BODY-WEIGHT; LEPTIN; BDNF; NUCLEUS; OBESITY; ADIPOSITY; DEPHOSPHORYLATION; DOWNSTREAM	Background: The tropomyosin receptor kinase B (TrkB) is a potential novel substrate of protein-tyrosine phosphatase 1B (PTP1B). Results: PTP1B associates with and plays a modulatory role in BDNF-induced TrkB signaling. Conclusion: PTP1B is a novel negative regulator of central BDNF/TrkB signaling. Significance: This is the first evidence that PTP1B deficiency enhances central TrkB signaling and alters BDNF-induced thermogenesis in vivo. Neuronal protein-tyrosine phosphatase 1B (PTP1B) deficiency in mice results in enhanced leptin signaling and protection from diet-induced obesity; however, whether additional signaling pathways in the brain contribute to the metabolic effects of PTP1B deficiency remains unclear. Here, we show that the tropomyosin receptor kinase B (TrkB) receptor is a direct PTP1B substrate and implicate PTP1B in the regulation of the central brain-derived neurotrophic factor (BDNF) signaling. PTP1B interacts with activated TrkB receptor in mouse brain and human SH-SY5Y neuroblastoma cells. PTP1B overexpression reduces TrkB phosphorylation and activation of downstream signaling pathways, whereas PTP1B inhibition augments TrkB signaling. Notably, brains of Ptpn1(-/-) mice exhibit enhanced TrkB phosphorylation, and Ptpn1(-/-) mice are hypersensitive to central BDNF-induced increase in core temperature. Taken together, our findings demonstrate that PTP1B is a novel physiological regulator of TrkB and that enhanced BDNF/TrkB signaling may contribute to the beneficial metabolic effects of PTP1B deficiency.	[Ozek, Ceren; Bence, Kendra K.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Grill, Harvey J.] Univ Penn, Sch Arts & Sci, Dept Psychol, Philadelphia, PA 19104 USA; [Kanoski, Scott E.] Univ So Calif, Human & Evolutionary Biol Sect, Dept Biol Sci, Los Angeles, CA 90089 USA; [Zhang, Zhong-Yin] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	University of Pennsylvania; University of Pennsylvania; University of Southern California; Indiana University System; Indiana University-Purdue University Indianapolis	Bence, KK (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, 3800 Spruce St, Philadelphia, PA 19104 USA.	kbence@vet.upenn.edu		Bence, Kendra/0000-0002-5879-4726	National Institutes of Health [R01DK082417, R01DK021397, K01DK097147, R01CA69202]; University of Pennsylvania Diabetes Endocrinology Research Center Grant [5P30DK019525]; NATIONAL CANCER INSTITUTE [R01CA069202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082417, R01DK021397, K01DK097147, P30DK019525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Diabetes Endocrinology Research Center Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK082417 (to K. K. B.), R01DK021397 (to H. J. G.), K01DK097147 (to S. E. K.), and R01CA69202 (to Z. Y. Z.) and University of Pennsylvania Diabetes Endocrinology Research Center Grant 5P30DK019525.	Ambjorn M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065371; Banno R, 2010, J CLIN INVEST, V120, P720, DOI 10.1172/JCI39620; Bariohay B, 2005, ENDOCRINOLOGY, V146, P5612, DOI 10.1210/en.2005-0419; Bariohay B, 2009, ENDOCRINOLOGY, V150, P2646, DOI 10.1210/en.2008-1184; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Boubekeur S, 2011, J BIOL CHEM, V286, P19373, DOI 10.1074/jbc.M111.222984; Bouret SG, 2008, CELL METAB, V7, P179, DOI 10.1016/j.cmet.2007.12.001; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Cordeira J, 2011, MOL NEUROBIOL, V44, P441, DOI 10.1007/s12035-011-8212-2; De Jonghe BC, 2012, AM J PHYSIOL-ENDOC M, V303, pE644, DOI 10.1152/ajpendo.00009.2012; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Espanel X, 2002, PROTEIN SCI, V11, P2326, DOI 10.1110/ps.0213402; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Fuentes F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041536; Gatto G, 2013, J NEUROSCI, V33, P5399, DOI 10.1523/JNEUROSCI.4707-12.2013; Godar R, 2011, NEUROSCIENCE, V194, P36, DOI 10.1016/j.neuroscience.2011.07.079; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Jeanneteau F, 2010, NAT NEUROSCI, V13, P1373, DOI 10.1038/nn.2655; Kaszubska W, 2002, MOL CELL ENDOCRINOL, V195, P109, DOI 10.1016/S0303-7207(02)00178-8; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; KLEIN R, 1990, DEVELOPMENT, V109, P845; Lazo OM, 2013, J NEUROSCI, V33, P6112, DOI 10.1523/JNEUROSCI.4630-12.2013; Ma YM, 2011, MOL CELL BIOCHEM, V357, P65, DOI 10.1007/s11010-011-0876-4; Morrison CD, 2007, ENDOCRINOLOGY, V148, P433, DOI 10.1210/en.2006-0672; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Ohira K, 2009, CURR NEUROPHARMACOL, V7, P276, DOI 10.2174/157015909790031210; Pathre P, 2001, J NEUROSCI RES, V63, P143, DOI 10.1002/1097-4547(20010115)63:2<143::AID-JNR1006>3.0.CO;2-1; PELLEYMOUNTER MA, 1995, EXP NEUROL, V131, P229, DOI 10.1016/0014-4886(95)90045-4; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rios M, 2013, TRENDS NEUROSCI, V36, P83, DOI 10.1016/j.tins.2012.12.009; Rusanescu G, 2005, EMBO J, V24, P305, DOI 10.1038/sj.emboj.7600522; Sharma S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00431; Spaeth AM, 2012, AM J PHYSIOL-ENDOC M, V302, pE1252, DOI 10.1152/ajpendo.00025.2012; Stuible M, 2010, TRENDS CELL BIOL, V20, P672, DOI 10.1016/j.tcb.2010.08.013; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tsou RC, 2014, MOL METAB, V3, P301, DOI 10.1016/j.molmet.2014.01.008; Tsou RC, 2012, J OBES, V2012, DOI 10.1155/2012/926857; Tsou RC, 2012, ENDOCRINOLOGY, V153, P4227, DOI 10.1210/en.2012-1548; Vanesvki F, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00037; Wang CF, 2007, AM J PHYSIOL-REG I, V293, pR1037, DOI 10.1152/ajpregu.00125.2007; Wang CF, 2007, AM J PHYSIOL-REG I, V293, pR992, DOI 10.1152/ajpregu.00516.2006; Wang CF, 2007, AM J PHYSIOL-REG I, V293, pR1003, DOI 10.1152/ajpregu.00011.2007; Wang CF, 2010, BRAIN RES, V1336, P66, DOI 10.1016/j.brainres.2010.04.013; Wang CF, 2010, AM J PHYSIOL-REG I, V298, pR1320, DOI 10.1152/ajpregu.00844.2009; Webster MJ, 2006, GENE EXPR PATTERNS, V6, P941, DOI 10.1016/j.modgep.2006.03.009; Woo J, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-144; Wu CL, 2011, BIOCHEM J, V439, P151, DOI 10.1042/BJ20110799; Xie LP, 2003, BIOCHEMISTRY-US, V42, P12792, DOI 10.1021/bi035238p; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yan Q, 1997, J COMP NEUROL, V378, P135; Yang T, 2006, J NEUROBIOL, V66, P1420, DOI 10.1002/neu.20291; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199	58	40	40	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31682	31692		10.1074/jbc.M114.603621	http://dx.doi.org/10.1074/jbc.M114.603621			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25288805	hybrid, Green Published			2022-12-28	WOS:000345314700003
J	Singh, P; Thomas, GE; Gireesh, KK; Manna, TK				Singh, Puja; Thomas, Geethu Emily; Gireesh, Koyikulangara K.; Manna, Tapas K.			TACC3 Protein Regulates Microtubule Nucleation by Affecting gamma-Tubulin Ring Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Centrosome; Microtubule; Mitosis; Mitotic Spindle; Tubulin; Microtubule Nucleation; TACC3; {gamma}-Tubulin	CENTROSOMAL PROTEINS; CRYSTAL-STRUCTURE; ORGANIZATION; NINEIN; AURORA; CELLS; PERICENTRIN; CDK5RAP2; INTERACT; DYNAMICS	Background: The nucleation of centrosomal microtubules requires proper regulation of the -tubulin complex proteins. Results: TACC3 depletion impairs microtubule nucleation and disrupts the assembly of the -tubulin ring complex components and their localization at the centrosome. Conclusion: TACC3 is involved in microtubule nucleation and in stabilization of the -tubulin ring complex. Significance: These results provide additional insights into the regulation of centrosomal microtubule nucleation. Centrosome-mediated microtubule nucleation is essential for spindle assembly during mitosis. Although -tubulin complexes have primarily been implicated in the nucleation process, details of the underlying mechanisms remain poorly understood. Here, we demonstrated that a member of the human transforming acidic coiled-coil (TACC) protein family, TACC3, plays a critical role in microtubule nucleation at the centrosome. In mitotic cells, TACC3 knockdown substantially affected the assembly of microtubules in the astral region and impaired microtubule nucleation at the centrosomes. The TACC3 depletion-induced mitotic phenotype was rescued by expression of the TACC3 C terminus predominantly consisting of the TACC domain, suggesting that the TACC domain plays an important role in microtubule assembly. Consistently, experiments with the recombinant TACC domain of TACC3 demonstrated that this domain possesses intrinsic microtubule nucleating activity. Co-immunoprecipitation and sedimentation experiments revealed that TACC3 mediates interactions with proteins of both the -tubulin ring complex (-TuRC) and the -tubulin small complex (-TuSC). Interestingly, TACC3 depletion resulted in reduced levels of -TuRC and increased levels of -TuSC, indicating that the assembly of -TuRC from -TuSC requires TACC3. Detailed analyses suggested that TACC3 facilitates the association of -TuSC-specific proteins with the proteins known to be involved in the assembly of -TuRC. Consistent with such a role for TACC3, the suppression of TACC3 disrupted localization of -TuRC proteins to the centrosome. Our findings reveal that TACC3 is involved in the regulation of microtubule nucleation at the centrosome and functions in the stabilization of the -tubulin ring complex assembly.	[Singh, Puja; Thomas, Geethu Emily; Gireesh, Koyikulangara K.; Manna, Tapas K.] Indian Inst Sci Educ & Res, Sch Biol, Thiruvananthapuram 695016, Kerala, India	Indian Institute of Science Education & Research (IISER) - Thiruvananthapuram	Manna, TK (corresponding author), Indian Inst Sci Educ & Res, Sch Biol, CET Campus, Thiruvananthapuram 695016, Kerala, India.	tmanna@iisertvm.ac.in	SINGH, PUJA/AGE-0583-2022	SINGH, PUJA/0000-0003-1011-7221; Manna, Tapas/0000-0002-2213-6246	Department of Science and Technology, Government of India; Department of Atomic Energy-Board of Research in Nuclear Science, Government of India; University Grant Commission, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Atomic Energy-Board of Research in Nuclear Science, Government of India; University Grant Commission, Government of India(University Grants Commission, India)	This work was supported in part by Department of Science and Technology, Government of India, and Department of Atomic Energy-Board of Research in Nuclear Science, Government of India.; Supported by a fellowship from University Grant Commission, Government of India.	Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Banerjee B, 2014, J CELL BIOL, V204, P947, DOI 10.1083/jcb.201307119; Bellanger JM, 2003, CURR BIOL, V13, P1488, DOI 10.1016/S0960-9822(03)00582-7; Bird AW, 2012, NAT METHODS, V9, P103, DOI [10.1038/NMETH.1803, 10.1038/nmeth.1803]; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; Bouissou A, 2014, EMBO J, V33, P114, DOI 10.1002/embj.201385967; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Calegari F, 2002, P NATL ACAD SCI USA, V99, P14236, DOI 10.1073/pnas.192559699; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; Ciani B, 2010, P NATL ACAD SCI USA, V107, P19850, DOI 10.1073/pnas.1008502107; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Dos Santos HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062633; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Gergely F, 2000, EMBO J, V19, P241, DOI 10.1093/emboj/19.2.241; Gergely F, 2000, P NATL ACAD SCI USA, V97, P14352, DOI 10.1073/pnas.97.26.14352; Guillet V, 2011, NAT STRUCT MOL BIOL, V18, P915, DOI 10.1038/nsmb.2083; Hood FE, 2013, J CELL BIOL, V202, P463, DOI 10.1083/jcb.201211127; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Jeffery JM, 2013, CELL CYCLE, V12, P899, DOI 10.4161/cc.23879; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Kollman JM, 2008, MOL BIOL CELL, V19, P207, DOI 10.1091/mbc.E07-09-0879; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Kollman JM, 2010, NATURE, V466, P879, DOI 10.1038/nature09207; Kotak S, 2013, CURR OPIN CELL BIOL, V25, P741, DOI 10.1016/j.ceb.2013.07.008; Lioutas A, 2013, EMBO REP, V14, P829, DOI 10.1038/embor.2013.109; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Manna T, 2006, J BIOL CHEM, V281, P2071, DOI 10.1074/jbc.M510661200; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; Mogensen MM, 2000, J CELL SCI, V113, P3013; Moritz M, 1998, J CELL BIOL, V142, P775, DOI 10.1083/jcb.142.3.775; Muller H, 2010, EMBO J, V29, P3344, DOI 10.1038/emboj.2010.210; Nakamura M, 2012, PLANT J, V71, P216, DOI 10.1111/j.1365-313X.2012.04988.x; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Ou YY, 2002, J CELL SCI, V115, P1825; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Raff JW, 2002, TRENDS CELL BIOL, V12, P222, DOI 10.1016/S0962-8924(02)02268-7; Ray A, 2007, CANCER RES, V67, P3767, DOI 10.1158/0008-5472.CAN-06-3065; Ringhoff DN, 2009, MOL BIOL CELL, V20, P3451, DOI 10.1091/mbc.E09-02-0140; Schneider L, 2007, J BIOL CHEM, V282, P29273, DOI 10.1074/jbc.M704151200; Stern AL, 2007, BIOCHEM J, V401, P279, DOI 10.1042/BJ20061049; Stillwell EE, 2004, CELL CYCLE, V3, P923; Thakur HC, 2014, J BIOL CHEM, V289, P74, DOI 10.1074/jbc.M113.532333; Uehara R, 2010, J CELL BIOL, V191, P259, DOI 10.1083/jcb.201004150; Yao R., 2013, ONCOGENE, V33, P1; Yao R, 2007, CANCER SCI, V98, P555, DOI 10.1111/j.1349-7006.2007.00433.x; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	59	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2014	289	46					31719	31735		10.1074/jbc.M114.575100	http://dx.doi.org/10.1074/jbc.M114.575100			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AU0LP	25246530	Green Published, hybrid			2022-12-28	WOS:000345314700006
J	Sainz-Polo, MA; Valenzuela, SV; Gonzalez, B; Pastor, FIJ; Sanz-Aparicio, J				Angela Sainz-Polo, M.; Valeria Valenzuela, Susana; Gonzalez, Beatriz; Javier Pastor, F. I.; Sanz-Aparicio, Julia			Structural Analysis of Glucuronoxylan-specific Xyn30D and Its Attached CBM35 Domain Gives Insights into the Role of Modularity in Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; GLYCOSIDE HYDROLASE FAMILY-5; PAENIBACILLUS-BARCINONENSIS; POLYSACCHARIDE RECOGNITION; ERWINIA-CHRYSANTHEMI; MOLECULAR-BASIS; XYLANASE; FAMILIES; OLIGOSACCHARIDES; XYLANOHYDROLASE	Glucuronoxylanase Xyn30D is a modular enzyme containing a family 30 glycoside hydrolase catalytic domain and an attached carbohydrate binding module of the CBM35 family. We present here the three-dimensional structure of the full-length Xyn30D at 2.4 angstrom resolution. The catalytic domain folds into an (alpha/beta)(8) barrel with an associated beta-structure, whereas the attached CBM35 displays a jellyroll beta-sandwich including two calcium ions. Although both domains fold in an independent manner, the linker region makes polar interactions with the catalytic domain, allowing a moderate flexibility. The ancillary Xyn30D-CBM35 domain has been expressed and crystallized, and its binding abilities have been investigated by soaking experiments. Only glucuronic acid-containing ligands produced complexes, and their structures have been solved. A calcium-dependent glucuronic acid binding site shows distinctive structural features as compared with other uronic acid-specific CBM35s, because the presence of two aromatic residues delineates a wider pocket. The nonconserved Glu(129) makes a bidentate link to calcium and defines region E, previously identified as specificity hot spot. The molecular surface of Xyn30D-CBM35 shows a unique stretch of negative charge distribution extending from its binding pocket that might indicate some oriented interaction with its target substrate. The binding ability of Xyn30D-CBM35 to different xylans was analyzed by affinity gel electrophoresis. Some binding was observed with rye glucuronoarabinoxylan in presence of calcium dictating EDTA, which would indicate that Xyn30D-CBM35 might establish interaction to other components of xylan, such as arabinose decorations of glucuronoarabinoxylan. A role in depolymerization of highly substituted chemically complex xylans is proposed.	[Angela Sainz-Polo, M.; Gonzalez, Beatriz; Sanz-Aparicio, Julia] CSIC, Inst Quim Fis Rocasolano, Dept Cristalog & Biol Estruct, Madrid 28006, Spain; [Valeria Valenzuela, Susana; Javier Pastor, F. I.] Univ Barcelona, Fac Biol, Dept Microbiol, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Barcelona	Sanz-Aparicio, J (corresponding author), CSIC, Inst Quim Fis Rocasolano, Dept Cristalog & Biol Estruct, Madrid 28006, Spain.	xjulia@iqfr.csic.es	Valenzuela, Susana V/G-4806-2016; Sainz-Polo, Maria-Angela/F-3947-2016; Gonzalez, Beatriz/M-1219-2014; Sanz-Aparicio, Julia/F-6201-2013; saso, luciano/F-6306-2012	Valenzuela, Susana V/0000-0002-1684-9514; Sainz-Polo, Maria-Angela/0000-0002-6269-4330; Gonzalez, Beatriz/0000-0002-0710-0202; Sanz-Aparicio, Julia/0000-0002-6849-8621; saso, luciano/0000-0003-4530-8706; Pastor, Francisco/0000-0003-0326-2527	Spanish Ministry of Science and Innovation [BIO2010-20508-004-03, CTQ2010-20238-C03-02]; Generalitat de Catalunya [2009-SGR-819-AGAUR]; Bio-Struct-X program through the European Commission.	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Bio-Struct-X program through the European Commission.	This work was supported by Grants BIO2010-20508-004-03 and CTQ2010-20238-C03-02 from the Spanish Ministry of Science and Innovation, Grant 2009-SGR-819-AGAUR from Generalitat de Catalunya, and by the Bio-Struct-X program through the European Commission.	Abbott DW, 2009, BIOCHEMISTRY-US, V48, P10395, DOI 10.1021/bi9013424; Sainz-Polo MA, 2014, ACTA CRYSTALLOGR F, V70, P963, DOI 10.1107/S2053230X14012035; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Correia MAS, 2011, J BIOL CHEM, V286, P22510, DOI 10.1074/jbc.M110.217315; Correia MAS, 2010, BIOCHEMISTRY-US, V49, P6193, DOI 10.1021/bi1006139; Couturier M, 2013, J BIOL CHEM, V288, P14624, DOI 10.1074/jbc.M113.459438; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gallardo O, 2010, APPL ENVIRON MICROB, V76, P6290, DOI 10.1128/AEM.00871-10; Gallardo O, 2010, J BIOL CHEM, V285, P2721, DOI 10.1074/jbc.M109.064394; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Grootaert C, 2009, FEMS MICROBIOL ECOL, V69, P231, DOI 10.1111/j.1574-6941.2009.00712.x; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jang YS, 2012, BIOTECHNOL BIOENG, V109, P2437, DOI 10.1002/bit.24599; John FJS, 2006, J BACTERIOL, V188, P8617, DOI 10.1128/JB.01283-06; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kolenova K, 2006, J BIOTECHNOL, V121, P338, DOI 10.1016/j.jbiotec.2005.08.001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larson SB, 2003, BIOCHEMISTRY-US, V42, P8411, DOI 10.1021/bi034144c; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leu SY, 2013, BIOENERG RES, V6, P405, DOI 10.1007/s12155-012-9276-1; Lo Leggio L, 2000, PROTEINS, V41, P362, DOI 10.1002/1097-0134(20001115)41:3<362::AID-PROT80>3.0.CO;2-N; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Meng XZ, 2014, CURR OPIN BIOTECH, V27, P150, DOI 10.1016/j.copbio.2014.01.014; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pollet A, 2010, CRIT REV BIOTECHNOL, V30, P176, DOI 10.3109/07388551003645599; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Sanchez MM, 2005, INT J SYST EVOL MICR, V55, P935, DOI 10.1099/ijs.0.63383-0; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; St John FJ, 2011, J MOL BIOL, V407, P92, DOI 10.1016/j.jmb.2011.01.010; St John FJ, 2010, FEBS LETT, V584, P4435, DOI 10.1016/j.febslet.2010.09.051; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Tuck CO, 2012, SCIENCE, V337, P695, DOI 10.1126/science.1218930; Urbanikova L, 2011, FEBS J, V278, P2105, DOI 10.1111/j.1742-4658.2011.08127.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valenzuela SV, 2014, APPL MICROBIOL BIOT, V98, P5949, DOI 10.1007/s00253-014-5565-2; Valenzuela SV, 2010, J AGR FOOD CHEM, V58, P4814, DOI 10.1021/jf9045792; Valenzuela SV, 2012, APPL ENVIRON MICROB, V78, P3923, DOI 10.1128/AEM.07932-11; Vrsanska M, 2007, FEBS J, V274, P1666, DOI 10.1111/j.1742-4658.2007.05710.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wyman CE, 2011, BIORESOURCE TECHNOL, V102, P11052, DOI 10.1016/j.biortech.2011.06.069	49	25	26	5	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					31088	31101		10.1074/jbc.M114.597732	http://dx.doi.org/10.1074/jbc.M114.597732			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25202007	hybrid, Green Published			2022-12-28	WOS:000344549900018
J	Cole, SPC				Cole, Susan P. C.			Multidrug Resistance Protein 1 (MRP1, ABCC1), a "Multitasking" ATP-binding Cassette (ABC) Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ORGANIC ANION TRANSPORTER; ANTHRACYCLINE-INDUCED CARDIOTOXICITY; CHARGED AMINO-ACIDS; P-GLYCOPROTEIN; LEUKOTRIENE C-4; SUBSTRATE RECOGNITION; GLUTATHIONE DISULFIDE; INCREASED SENSITIVITY; MUTATIONAL ANALYSIS; LIPID-PEROXIDATION	The multidrug resistance protein 1 (MRP1) encoded by ABCC1 was originally discovered as a cause of multidrug resistance in tumor cells. However, it is now clear that MRP1 serves a broader role than simply mediating the ATP-dependent efflux of drugs from cells. The antioxidant GSH and the pro-inflammatory cysteinyl leukotriene C4 have been identified as key physiological organic anions effluxed by MRP1, and an ever growing body of evidence indicates that additional lipid-derived mediators are also substrates of this transporter. As such, MRP1 is a multitasking transporter that likely influences the etiology and progression of a host of human diseases.	[Cole, Susan P. C.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada; [Cole, Susan P. C.] Queens Univ, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada	McMaster University; Queens University - Canada; Queens University - Canada	Cole, SPC (corresponding author), Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada.	spc.cole@queensu.ca	Cole, Susan P.C./I-6389-2017	Cole, Susan P.C./0000-0001-6571-6884	Canadian Institutes of Health Research [MOP-10519, MOP-133584]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grants MOP-10519 and MOP-133584 horn the Canadian Institutes of Health Research.	Bagnoli M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/143202; Bakos E, 2000, J CELL SCI, V113, P4451; Ballatori N, 2009, MOL ASPECTS MED, V30, P13, DOI 10.1016/j.mam.2008.08.004; Bast A, 2013, TRENDS PHARMACOL SCI, V34, P430, DOI 10.1016/j.tips.2013.05.010; Becher UM, 2011, J MOL CELL CARDIOL, V50, P570, DOI 10.1016/j.yjmcc.2010.11.013; Bellarosa C, 2009, CURR PHARM DESIGN, V15, P2884, DOI 10.2174/138161209789058246; Blokzijl H, 2008, J BIOL CHEM, V283, P35630, DOI 10.1074/jbc.M804374200; Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9; Brechbuhl HM, 2012, TOXICOL APPL PHARM, V258, P1, DOI 10.1016/j.taap.2011.08.004; Budulac SE, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-60; Cartwright TA, 2013, J CEREBR BLOOD F MET, V33, P381, DOI 10.1038/jcbfm.2012.174; Chang XB, 2010, METHODS MOL BIOL, V596, P223, DOI 10.1007/978-1-60761-416-6_11; Cheung L, 2014, BIOCHEM PHARMACOL, V91, P97, DOI 10.1016/j.bcp.2014.05.023; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Cole SPC, 2014, ANNU REV PHARMACOL, V54, P95, DOI 10.1146/annurev-pharmtox-011613-135959; Conseil GRL, 2006, J BIOL CHEM, V281, P43, DOI 10.1074/jbc.M510143200; Conseil G, 2009, MOL PHARMACOL, V75, P397, DOI 10.1124/mol.108.052860; Crowley E, 2010, FEBS J, V277, P3974, DOI 10.1111/j.1742-4658.2010.07789.x; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; de Waart DR, 2006, LIVER INT, V26, P362, DOI 10.1111/j.1478-3231.2005.01234.x; Deeley RG, 2006, FEBS LETT, V580, P1103, DOI 10.1016/j.febslet.2005.12.036; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; DeGorter MK, 2008, BIOCHEM BIOPH RES CO, V365, P29, DOI 10.1016/j.bbrc.2007.10.141; El-Sheikh AAK, 2008, MOL PHARMACOL, V74, P964, DOI 10.1124/mol.107.043661; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Evers R, 1997, FEBS LETT, V419, P112, DOI 10.1016/S0014-5793(97)01442-7; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Frohnert BI, 2014, ADIPOCYTE, V3, P224, DOI [10.2337/db13-0777, 10.4161/adip.28851]; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Haber M, 2006, J CLIN ONCOL, V24, P1546, DOI 10.1200/JCO.2005.01.6196; Haimeur A, 2002, J BIOL CHEM, V277, P41326, DOI 10.1074/jbc.M206228200; Hamdoun AM, 2004, DEV BIOL, V276, P452, DOI 10.1016/j.ydbio.2004.09.013; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hlavac V, 2013, PHARMACOGENOMICS, V14, P515, DOI [10.2217/PGS.13.26, 10.2217/pgs.13.26]; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Iram SH, 2012, J BIOL CHEM, V287, P7543, DOI 10.1074/jbc.M111.310409; Iram SH, 2011, J BIOL CHEM, V286, P7202, DOI 10.1074/jbc.M110.166959; ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Ito K, 2001, J BIOL CHEM, V276, P38108; Ito S, 2013, CORONARY ARTERY DIS, V24, P642, DOI 10.1097/MCA.0000000000000033; Jedlitschky G, 1996, CANCER RES, V56, P988; Jones DC, 2005, J PHARMACOL EXP THER, V313, P422, DOI 10.1124/jpet.104.077628; Jones PM, 2014, Q REV BIOPHYS, V47, P189, DOI 10.1017/S0033583514000031; Karwatsky J, 2003, BIOCHEMISTRY-US, V42, P3286, DOI 10.1021/bi0268807; Klein M, 2006, FEBS LETT, V580, P1112, DOI 10.1016/j.febslet.2005.11.056; Knauer MJ, 2010, CIRC RES, V106, P297, DOI 10.1161/CIRCRESAHA.109.203596; Koike K, 2004, J BIOL CHEM, V279, P12325, DOI 10.1074/jbc.M311435200; Krohn M, 2011, J CLIN INVEST, V121, P3924, DOI 10.1172/JCI57867; Lee SH, 2010, J CLIN PSYCHOPHARM, V30, P116, DOI 10.1097/JCP.0b013e3181d2ef42; Leier I, 1996, BIOCHEM J, V314, P433, DOI 10.1042/bj3140433; LEIER I, 1994, J BIOL CHEM, V269, P27807; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Leslie EM, 2003, J PHARMACOL EXP THER, V304, P643, DOI 10.1124/jpet.102.044073; Leslie EM, 2003, DRUG METAB DISPOS, V31, P11, DOI 10.1124/dmd.31.1.11; Leslie EM, 2001, J BIOL CHEM, V276, P27846, DOI 10.1074/jbc.M102453200; Letourneau IJ, 2007, DRUG METAB DISPOS, V35, P1372, DOI 10.1124/dmd.107.015479; Li JA, 2010, LUNG CANCER, V69, P116, DOI 10.1016/j.lungcan.2009.09.013; Lima JJ, 2009, CURR OPIN PULM MED, V15, P57, DOI 10.1097/MCP.0b013e32831da8be; Lin ZP, 2008, MOL PHARMACOL, V73, P243, DOI 10.1124/mol.107.039594; Liu B, 2015, PHARMACOL THERAPEUT, V145, P35, DOI 10.1016/j.pharmthera.2014.06.007; Loe DW, 1998, CANCER RES, V58, P5130; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Lok HC, 2012, J BIOL CHEM, V287, P607, DOI 10.1074/jbc.M111.310987; Lorico A, 1997, CANCER RES, V57, P5238; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Maeno K, 2009, DRUG METAB DISPOS, V37, P1411, DOI 10.1124/dmd.109.026633; Minich T, 2006, J NEUROCHEM, V97, P373, DOI 10.1111/j.1471-4159.2006.03737.x; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Montuschi P, 2010, CLIN EXP ALLERGY, V40, P1732, DOI 10.1111/j.1365-2222.2010.03630.x; Moreau C, 2005, MOL PHARMACOL, V67, P1026, DOI 10.1124/mol.104.008698; Newcomer ME, 2010, J BIOL CHEM, V285, P25109, DOI 10.1074/jbc.R110.125880; Park HA, 2011, STROKE, V42, P2308, DOI 10.1161/STROKEAHA.110.608547; Paumi CM, 2003, BIOCHEMISTRY-US, V42, P5429, DOI 10.1021/bi027347u; Pineiro R, 2011, ONCOGENE, V30, P142, DOI 10.1038/onc.2010.417; Pineiro R, 2012, BBA-MOL CELL BIOL L, V1821, P694, DOI 10.1016/j.bbalip.2012.01.009; Qian YM, 2001, J BIOL CHEM, V276, P6404, DOI 10.1074/jbc.M008251200; Rappa G, 1997, CANCER RES, V57, P5232; Renes J, 2000, BIOCHEM J, V350, P555, DOI 10.1042/0264-6021:3500555; Rosenberg MF, 2010, J STRUCT BIOL, V170, P540, DOI 10.1016/j.jsb.2010.01.011; Rothnie A, 2008, MOL PHARMACOL, V74, P1630, DOI 10.1124/mol.108.049080; Sakamoto H, 1999, CANCER LETT, V135, P113; Seelig A, 2000, INT J CLIN PHARM TH, V38, P111; Semsei AF, 2012, CELL BIOL INT, V36, P79, DOI 10.1042/CBI20110264; Slot AJ, 2008, DRUG METAB DISPOS, V36, P552, DOI 10.1124/dmd.107.019661; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; Sreekumar PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033420; Su W, 2013, SYNAPSE, V67, P609, DOI 10.1002/syn.21667; Sylantyev S, 2013, P NATL ACAD SCI USA, V110, P5193, DOI 10.1073/pnas.1211204110; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; Tanfin Z, 2011, CELL SIGNAL, V23, P1997, DOI 10.1016/j.cellsig.2011.07.010; Visscher H, 2012, J CLIN ONCOL, V30, P1422, DOI 10.1200/JCO.2010.34.3467; Westlake CJ, 2005, MOL BIOL CELL, V16, P2483, DOI 10.1091/mbc.E04-12-1113; Wijnholds J, 2000, J CLIN INVEST, V105, P279, DOI 10.1172/JCI8267; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; Wojnowski L, 2005, CIRCULATION, V112, P3754, DOI 10.1161/CIRCULATIONAHA.105.576850; Wu P, 2005, MOL PHARMACOL, V68, P1455, DOI 10.1124/mol.105.016576; Yamashita A, 2013, PROSTAG OTH LIPID M, V107, P103, DOI 10.1016/j.prostaglandins.2013.05.004; Yoshioka M, 2009, AM J PHYSIOL-LUNG C, V296, pL30, DOI 10.1152/ajplung.00026.2008; ZAMAN GJR, 1995, P NATL ACAD SCI USA, V92, P7690, DOI 10.1073/pnas.92.17.7690; Zelcer N, 2003, BIOCHEM J, V371, P361, DOI 10.1042/BJ20021886; Zhang DW, 2006, DRUG METAB DISPOS, V34, P539, DOI 10.1124/dmd.105.007740	103	195	200	0	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2014	289	45					30880	30888		10.1074/jbc.R114.609248	http://dx.doi.org/10.1074/jbc.R114.609248			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9GA	25281745	Green Published, hybrid			2022-12-28	WOS:000344549900001
J	Coelho, FR; Iqbal, A; Linares, E; Silva, DF; Lima, FS; Cuccovia, IM; Augusto, O				Coelho, Fernando R.; Iqbal, Asif; Linares, Edlaine; Silva, Daniel F.; Lima, Filipe S.; Cuccovia, Iolanda M.; Augusto, Ohara			Oxidation of the Tryptophan 32 Residue of Human Superoxide Dismutase 1 Caused by Its Bicarbonate-dependent Peroxidase Activity Triggers the Non-amyloid Aggregation of the Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN SECONDARY STRUCTURE; CU,ZN-SUPEROXIDE DISMUTASE; WILD-TYPE; COVALENT AGGREGATION; RADICAL-ANION; HUMAN COPPER; MUTANT; SOD1; MECHANISM	The role of oxidative post-translational modifications of human superoxide dismutase 1 (hSOD1) in the amyotrophic lateral sclerosis (ALS) pathology is an attractive hypothesis to explore based on several lines of evidence. Among them, the remarkable stability of hSOD1(WT) and several of its ALS-associated mutants suggests that hSOD1 oxidation may precede its conversion to the unfolded and aggregated forms found in ALS patients. The bicarbonate-dependent peroxidase activity of hSOD1 causes oxidation of its own solvent-exposed Trp(32) residue. The resulting products are apparently different from those produced in the absence of bicarbonate and are most likely specific for simian SOD1s, which contain the Trp(32) residue. The aims of this work were to examine whether the bicarbonate-dependent peroxidase activity of hSOD1 ( hSOD1WT and hSOD1(G93A) mutant) triggers aggregation of the enzyme and to comprehend the role of the Trp(32) residue in the process. The results showed that Trp(32) residues of both enzymes are oxidized to a similar extent to hSOD1-derived tryptophanyl radicals. These radicals decayed to hSOD1-N-formylkynurenine and hSOD1-kynurenine or to a hSOD1 covalent dimer cross-linked by a ditryptophan bond, causing hSOD1 unfolding, oligomerization, and non-amyloid aggregation. The latter process was inhibited by tempol, which recombines with the hSOD1-derived tryptophanyl radical, and did not occur in the absence of bicarbonate or with enzymes that lack the Trp(32) residue (bovine SOD1 and hSOD1(W32F) mutant). The results support a role for the oxidation products of the hSOD1-Trp(32) residue, particularly the covalent dimer, in triggering the non-amyloid aggregation of hSOD1.	[Coelho, Fernando R.; Iqbal, Asif; Linares, Edlaine; Silva, Daniel F.; Lima, Filipe S.; Cuccovia, Iolanda M.; Augusto, Ohara] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05513970 Sao Paulo, Brazil	Universidade de Sao Paulo	Augusto, O (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05513970 Sao Paulo, Brazil.	oaugusto@iq.usp.br	Lima, Filipe S/E-7740-2012; Augusto, Ohara/D-3839-2012; Silva, Daniel/N-7754-2015; Linares, Edlaine/AAR-8753-2020	Lima, Filipe S/0000-0002-3420-8155; Augusto, Ohara/0000-0002-7220-4286; Linares, Edlaine/0000-0001-8164-3013	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/57721-3, 2013/07937-8]; Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq) [573530/2008-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (PRPUSP) [2011.1.9352.1.8]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (PRPUSP)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 2008/57721-3 and 2013/07937-8, Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq) Grant 573530/2008-4, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (PRPUSP) Grant 2011.1.9352.1.8. The authors are members of INCT Redoxoma (FAPESP/CNPq/CAPES), NAP Redoxoma (PRPUSP), and the CEPID Redoxoma (FAPESP).	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Bonini MG, 2004, BIOCHEMISTRY-US, V43, P344, DOI 10.1021/bi035606p; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Ehrenshaft M, 2009, FREE RADICAL BIO MED, V46, P1260, DOI 10.1016/j.freeradbiomed.2009.01.020; Elam JS, 2003, J BIOL CHEM, V278, P21032, DOI 10.1074/jbc.M300484200; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Graffmo KS, 2013, HUM MOL GENET, V22, P51, DOI 10.1093/hmg/dds399; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; Guareschi S, 2012, P NATL ACAD SCI USA, V109, P5074, DOI 10.1073/pnas.1115402109; HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5294, DOI 10.1021/bi00695a010; Hwang YM, 2010, J BIOL CHEM, V285, P41701, DOI 10.1074/jbc.M110.113696; Jewett SL, 1999, FREE RADICAL BIO MED, V26, P905, DOI 10.1016/S0891-5849(98)00274-3; Karunakaran C, 2004, J BIOL CHEM, V279, P32534, DOI 10.1074/jbc.M314272200; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Liochev SI, 2004, P NATL ACAD SCI USA, V101, P743, DOI 10.1073/pnas.0307635100; Medinas DB, 2010, FREE RADICAL BIO MED, V49, P1046, DOI 10.1016/j.freeradbiomed.2010.06.018; Medinas DB, 2009, CHEM RES TOXICOL, V22, P639, DOI 10.1021/tx800287m; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Munch C, 2010, J MOL BIOL, V399, P512, DOI 10.1016/j.jmb.2010.04.019; Mulligan VK, 2012, J MOL BIOL, V421, P631, DOI 10.1016/j.jmb.2012.04.016; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Poon HF, 2005, FREE RADICAL BIO MED, V39, P453, DOI 10.1016/j.freeradbiomed.2005.03.030; Proctor EA, 2011, J MOL BIOL, V408, P555, DOI 10.1016/j.jmb.2011.03.004; Queiroz RF, 2013, BIOCHEM J, V455, P37, DOI 10.1042/BJ20130180; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Ranguelova K, 2012, FREE RADICAL BIO MED, V53, P589, DOI 10.1016/j.freeradbiomed.2012.04.029; Redler RL, 2011, BIOCHEMISTRY-US, V50, P7057, DOI 10.1021/bi200614y; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTILIO G, 1972, BIOCHEMISTRY-US, V11, P2187, DOI 10.1021/bi00761a028; Sankarapandi S, 1999, J BIOL CHEM, V274, P1226, DOI 10.1074/jbc.274.3.1226; Seetharaman SV, 2009, EXP BIOL MED, V234, P1140, DOI 10.3181/0903-MR-104; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Strange RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044811; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Toledo JC, 2011, FREE RADICAL BIO MED, V50, P1032, DOI 10.1016/j.freeradbiomed.2011.02.020; Trumbull KA, 2009, ANTIOXID REDOX SIGN, V11, P1627, DOI 10.1089/ARS.2009.2574; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wilcox KC, 2009, J BIOL CHEM, V284, P13940, DOI 10.1074/jbc.M809687200; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Zhang H, 2004, FREE RADICAL BIO MED, V36, P1355, DOI 10.1016/j.freeradbiomed.2004.02.038; Zhang H, 2003, J BIOL CHEM, V278, P24078, DOI 10.1074/jbc.M302051200; ZILBER LA, 1963, B WORLD HEALTH ORGAN, V29, P449	58	29	29	0	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30690	30701		10.1074/jbc.M114.586370	http://dx.doi.org/10.1074/jbc.M114.586370			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25237191	hybrid, Green Published			2022-12-28	WOS:000344549700045
J	Zhu, X; Zhang, J; Sun, HY; Jiang, CC; Dong, YS; Shan, Q; Su, SY; Xie, YY; Xu, NZ; Lou, XM; Liu, SQ				Zhu, Xu; Zhang, Ju; Sun, Huiying; Jiang, Cuicui; Dong, Yusheng; Shan, Qiang; Su, Siyuan; Xie, Yingying; Xu, Ningzhi; Lou, Xiaomin; Liu, Siqi			Ubiquitination of Inositol-requiring Enzyme 1 (IRE1) by the E3 Ligase CHIP Mediates the IRE1/TRAF2/JNK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC-RETICULUM STRESS; C-TERMINUS; PROTEASOMAL DEGRADATION; CELLULAR SENESCENCE; QUALITY-CONTROL; ER-STRESS; ACTIVATION; APOPTOSIS	Deciphering the inositol-requiring enzyme 1 (IRE1) signaling pathway is fundamentally important for understanding the unfolded protein response (UPR). The ubiquitination of proteins residing on the endoplasmic reticulum (ER) membrane has been reported to be involved in the UPR, although the mechanism has yet to be fully elucidated. Using immunoprecipitation and mass spectrometry, IRE1 was identified as a substrate of the E3 ligase CHIP (carboxyl terminus of HSC70-interacting protein) in HEK293 cells under geldanamycin-induced ER stress. Two residues of IRE1, Lys(545) and Lys(828), were targeted for Lys(63)-linked ubiquitination. Moreover, in CHIP knockdown cells, IRE1 phosphorylation and the IRE1-TRAF2 interaction were nearly abolished under ER stress, which may be due to lacking ubiquitination of IRE1 on Lys545 and Lys828, respectively. The cellular responses were evaluated, and the data indicated that CHIP-regulated IRE1/TRAF2/JNK signaling antagonized the senescence process. Therefore, our findings suggest that CHIP-mediated ubiquitination of IRE1 contributes to the dynamic regulation of the UPR.	[Zhu, Xu; Zhang, Ju; Sun, Huiying; Shan, Qiang; Su, Siyuan; Xie, Yingying; Lou, Xiaomin; Liu, Siqi] Chinese Acad Sci, Beijing Inst Genom, Beijing 100101, Peoples R China; [Zhu, Xu; Su, Siyuan; Xie, Yingying; Liu, Siqi] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Jiang, Cuicui; Dong, Yusheng] Beijing Prot Innovat, Beijing 101318, Peoples R China; [Xu, Ningzhi] Chinese Acad Med Sci, Lab Cell & Mol Biol, Inst Canc, Beijing 100021, Peoples R China; [Xu, Ningzhi] Chinese Acad Med Sci, Canc Hosp, Beijing 100021, Peoples R China; [Xu, Ningzhi] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Lou, XM (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Beijing 100101, Peoples R China.	louxm@big.ac.cn; siqiliu@big.ac.cn		Zhu, Xu/0000-0003-2531-2820; Shan, Qiang/0000-0002-7089-0278; Su, Siyuan/0000-0002-8816-9577	National High Technology Research and Development Program [2012AA020206]; National Basic Research Program of China [2011CB910704]	National High Technology Research and Development Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National High Technology Research and Development Program Grant 2012AA020206 and National Basic Research Program of China Grant 2011CB910704.	Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; Arshad M, 2013, J BIOL CHEM, V288, P8726, DOI 10.1074/jbc.M112.368829; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919; Demidenko ZN, 2009, CELL CYCLE, V8, P1888, DOI 10.4161/cc.8.12.8606; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; El Khouri E, 2013, J BIOL CHEM, V288, P31177, DOI 10.1074/jbc.M113.470500; Gao BX, 2008, EMBO REP, V9, P480, DOI 10.1038/embor.2008.37; Jwa M, 2012, NAT CELL BIOL, V14, P1223, DOI 10.1038/ncb2593; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee JJ, 2010, ONCOGENE, V29, P561, DOI 10.1038/onc.2009.355; Li XN, 2008, J CELL BIOL, V181, P959, DOI 10.1083/jcb.200711044; Lim KL, 2011, NEUROBIOL DIS, V43, P9, DOI 10.1016/j.nbd.2010.08.001; Lu G, 2013, MOL METAB, V2, P405, DOI 10.1016/j.molmet.2013.07.005; Merksamer PI, 2010, J CELL SCI, V123, P1003, DOI 10.1242/jcs.035832; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Pabarcus MK, 2009, ARCH BIOCHEM BIOPHYS, V483, P66, DOI 10.1016/j.abb.2008.12.001; Raciti M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.167; Schmidt BZ, 2009, J BIOL CHEM, V284, P4168, DOI 10.1074/jbc.M806485200; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Sisoula C, 2011, FREE RADICAL BIO MED, V50, P157, DOI 10.1016/j.freeradbiomed.2010.10.701; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Thorpe JA, 2010, CELL STRESS CHAPERON, V15, P497, DOI 10.1007/s12192-009-0163-4; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Woo CH, 2010, FASEB J, V24, P4917, DOI 10.1096/fj.10-162636; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yang MJ, 2011, J EXP MED, V208, P2099, DOI 10.1084/jem.20102667; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	37	48	51	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30567	30577		10.1074/jbc.M114.562868	http://dx.doi.org/10.1074/jbc.M114.562868			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25225294	Green Published, hybrid			2022-12-28	WOS:000344549700034
J	Olsen, JD; Adams, PG; Jackson, PJ; Dickman, MJ; Qian, P; Hunter, CN				Olsen, John D.; Adams, Peter G.; Jackson, Philip J.; Dickman, Mark J.; Qian, Pu; Hunter, C. Neil			Aberrant Assembly Complexes of the Reaction Center Light-harvesting 1 PufX (RC-LH1-PufX) Core Complex of Rhodobacter sphaeroides Imaged by Atomic Force Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atomic Force Microscopy (AFM); Bacteria; Membrane Biogenesis; Membrane Protein; Photosynthesis; Light Harvesting; Reaction Center	SP PCC 6803; RHODOSPIRILLUM-RUBRUM; PHOTOSYNTHETIC MEMBRANES; NATIVE MEMBRANES; PHOTOSYSTEM-II; RECONSTITUTION METHODOLOGY; STRUCTURAL REQUIREMENTS; PROJECTION STRUCTURE; PROTEIN; ORGANIZATION	Background: Photosynthesis relies upon connected pigment protein complexes to capture, transfer, and utilize light energy. Results: Aberrant forms of light-harvesting 1 (LH1) complex occur without the reaction center (RC); complete RC-LH1 complexes and isolated RCs were found when LH1 levels were reduced. Conclusion: The subunits of the RC-LH1 complex of Rhodobacter sphaeroides are assembled cooperatively. Significance: This represents a paradigm for assembly of other purple bacterial photosystems. In the purple phototrophic bacterium Rhodobacter sphaeroides, many protein complexes congregate within the membrane to form operational photosynthetic units consisting of arrays of light-harvesting LH2 complexes and monomeric and dimeric reaction center (RC)-light-harvesting 1 (LH1)-PufX core complexes. Each half of a dimer complex consists of a RC surrounded by 14 LH1 subunits, with two bacteriochlorophylls (Bchls) sandwiched between each pair of transmembrane helices. We used atomic force microscopy (AFM) to investigate the assembly of single molecules of the RC-LH1-PufX complex using membranes prepared from LH2-minus mutants. When the RC and PufX components were also absent, AFM revealed a series of LH1 variants where the repeating (11)(Bchl)(2) units had formed rings of variable size, ellipses, and spirals and also arcs that could be assembly products. The spiral complexes occur when the LH1 ring has failed to close, and short arcs are suggestive of prematurely terminated LH1 complex assembly. In the absence of RCs, we occasionally observed captive proteins enclosed by the LH1 ring. When production of LH1 units was restricted by lowering the relative levels of the cognate pufBA transcript, we imaged a mixture of complete RC-LH1 core complexes, empty LH1 rings, and isolated RCs, leading us to conclude that once a RC associates with the first (11)(Bchl)(2) subunit, cooperative associations between subsequent subunits and the RC tend to drive LH1 ring assembly to completion.	[Olsen, John D.; Adams, Peter G.; Jackson, Philip J.; Qian, Pu; Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Jackson, Philip J.; Dickman, Mark J.] Univ Sheffield, ChELSI Inst, Dept Chem & Biol Engn, Sheffield S1 3JD, S Yorkshire, England	University of Sheffield; University of Sheffield	Hunter, CN (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	c.n.hunter@sheffield.ac.uk	Qian, Pu/GZM-2400-2022; Adams, Peter G/B-6539-2013	Adams, Peter G/0000-0002-3940-8770; Dickman, Mark/0000-0002-9236-0788	Biotechnology and Biological Sciences Research Council; Photosynthetic Antenna Research Center, an Energy Frontier Research Center - U.S. Department of Energy [DE-SC 0001035]; Photosynthetic Antenna Research Center; European Research Council; BBSRC [BB/G021546/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G021546/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Photosynthetic Antenna Research Center, an Energy Frontier Research Center - U.S. Department of Energy(United States Department of Energy (DOE)); Photosynthetic Antenna Research Center; European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from the Biotechnology and Biological Sciences Research Council (to J. D. O., P. G. A., P. J. J., M. J. D., P. Q., and C. N. H.). This work was also supported as part of the Photosynthetic Antenna Research Center, an Energy Frontier Research Center funded by the U.S. Department of Energy under Award DE-SC 0001035. The role of the Photosynthetic Antenna Research Center was to partially fund the Multimode VIII AFM system and to provide partial support for C. N. H. C. N. H. was also partly funded by an Advanced Award from the European Research Council.	Adams PG, 2011, BBA-BIOENERGETICS, V1807, P1044, DOI 10.1016/j.bbabio.2011.05.019; Addlesee HA, 2000, J BACTERIOL, V182, P3175, DOI 10.1128/JB.182.11.3175-3182.2000; Bahatyrova S, 2004, J BIOL CHEM, V279, P21327, DOI 10.1074/jbc.M313039200; Bahatyrova S, 2004, NATURE, V430, P1058, DOI 10.1038/nature02823; BUSTAMANTE PL, 1994, BIOCHEMISTRY-US, V33, P13329, DOI 10.1021/bi00249a020; CHORY J, 1984, J BACTERIOL, V159, P540, DOI 10.1128/JB.159.2.540-554.1984; DAVIS CM, 1995, J BIOL CHEM, V270, P5793, DOI 10.1074/jbc.270.11.5793; Davis CM, 1996, BIOCHEMISTRY-US, V35, P3072, DOI 10.1021/bi951777l; de Rivoyre M, 2010, BBA-BIOENERGETICS, V1797, P1780, DOI 10.1016/j.bbabio.2010.07.011; Dobakova M, 2009, PLANT PHYSIOL, V149, P1076, DOI 10.1104/pp.108.130039; Fotiadis D, 2004, J BIOL CHEM, V279, P2063, DOI 10.1074/jbc.M310382200; Francia F, 2002, EUR J BIOCHEM, V269, P1877, DOI 10.1046/j.1432-1033.2002.02834.x; Frese RN, 2004, P NATL ACAD SCI USA, V101, P17994, DOI 10.1073/pnas.0407295102; Goncalves RP, 2005, J STRUCT BIOL, V152, P221, DOI 10.1016/j.jsb.2005.10.002; Jackson PJ, 2012, MOL MICROBIOL, V84, P1062, DOI 10.1111/j.1365-2958.2012.08074.x; Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410; JONES MR, 1992, MOL MICROBIOL, V6, P1173, DOI 10.1111/j.1365-2958.1992.tb01556.x; KARRASCH S, 1995, EMBO J, V14, P631, DOI 10.1002/j.1460-2075.1995.tb07041.x; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Komenda J, 2012, PLANT PHYSIOL, V158, P476, DOI 10.1104/pp.111.184184; Liu LN, 2011, P NATL ACAD SCI USA, V108, P9455, DOI 10.1073/pnas.1004205108; LOACH PA, 1994, PHOTOSYNTH RES, V40, P231, DOI 10.1007/BF00034773; MCGLYNN P, 1994, FEBS LETT, V349, P349, DOI 10.1016/0014-5793(94)00701-2; McGlynn P, 1996, J BIOL CHEM, V271, P3285, DOI 10.1074/jbc.271.6.3285; Meadows KA, 1998, BIOCHEMISTRY-US, V37, P3411, DOI 10.1021/bi972269+; Mothersole D. J., 2013, THESIS U SHEFFIELD S; Ng IW, 2011, BBA-BIOENERGETICS, V1807, P1056, DOI 10.1016/j.bbabio.2011.05.020; Olsen JD, 2008, J BIOL CHEM, V283, P30772, DOI 10.1074/jbc.M804824200; PANDEY A, 2000, SCI STKE; Pugh RJ, 1998, BBA-BIOENERGETICS, V1366, P301, DOI 10.1016/S0005-2728(98)00131-5; Qian P, 2005, J MOL BIOL, V349, P948, DOI 10.1016/j.jmb.2005.04.032; Qian P, 2013, BIOCHEMISTRY-US, V52, P7575, DOI 10.1021/bi4011946; Ratcliffe EC, 2011, BBA-BIOENERGETICS, V1807, P95, DOI 10.1016/j.bbabio.2010.10.003; Scheuring S, 2006, J MOL BIOL, V358, P83, DOI 10.1016/j.jmb.2006.01.085; Scheuring S, 2005, BBA-BIOMEMBRANES, V1712, P109, DOI 10.1016/j.bbamem.2005.04.005; Scheuring S, 2004, EMBO J, V23, P4127, DOI 10.1038/sj.emboj.7600429; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; Siebert CA, 2004, EMBO J, V23, P690, DOI 10.1038/sj.emboj.7600092; Sturgis JN, 2009, BIOCHEMISTRY-US, V48, P3679, DOI 10.1021/bi900045x; Tucker JD, 2010, MOL MICROBIOL, V76, P833, DOI 10.1111/j.1365-2958.2010.07153.x; Walz T, 1998, J MOL BIOL, V282, P833, DOI 10.1006/jmbi.1998.2050; Westerhuis WHJ, 2002, BIOCHEMISTRY-US, V41, P8698, DOI 10.1021/bi011663b; Young CS, 1998, J BACTERIOL, V180, P4742, DOI 10.1128/JB.180.17.4742-4745.1998	43	16	16	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29927	29936		10.1074/jbc.M114.596585	http://dx.doi.org/10.1074/jbc.M114.596585			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25193660	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000344370800035
J	El-Kasaby, A; Koban, F; Sitte, HH; Freissmuth, M; Sucic, S				El-Kasaby, Ali; Koban, Florian; Sitte, Harald H.; Freissmuth, Michael; Sucic, Sonja			A Cytosolic Relay of Heat Shock Proteins HSP70-1A and HSP90 beta Monitors the Folding Trajectory of the Serotonin Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT GABA TRANSPORTER-1; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONES; HARTNUP DISORDER; C-TERMINUS; DOPAMINE TRANSPORTER; OLIGOMER FORMATION; CARBOXYL-TERMINUS; MEMBRANE-PROTEINS; STARTLE DISEASE	Mutations in the C terminus of the serotonin transporter (SERT) disrupt folding and export from the endoplasmic reticulum. Here we examined the hypothesis that a cytosolic heat shock protein relay was recruited to the C terminus to assist folding of SERT. This conjecture was verified by the following observations. (i) The proximal portion of the SERT C terminus conforms to a canonical binding site for DnaK/heat shock protein of 70 kDa (HSP70). A peptide covering this segment stimulated ATPase activity of purified HSP70-1A. (ii) A GST fusion protein comprising the C terminus of SERT pulled down HSP70-1A. The interaction between HSP70-1A and SERT was visualized in live cells by Forster resonance energy transfer: it was restricted to endoplasmic reticulum-resident transporters and enhanced by an inhibitor that traps HSP70-1A in its closed state. (iv) Co-immunoprecipitation confirmed complex formation of SERT with HSP70-1A and HSP90 beta. Consistent with an HSP relay, co-chaperones (e.g. HSC70-HSP90-organizing protein) were co-immunoprecipitated with the stalled mutants SERT-R607A/I608A and SERT-P601A/G602A. (v) Depletion of HSP90 beta by siRNA or its inhibition increased the cell surface expression of wild type SERT and SERT-F604Q. In contrast, SERT-R607A/I608A and SERT-P601A/G602A were only rendered susceptible to inhibition of HSP70 and HSP90 by concomitant pharmacochaperoning with noribogaine. (vi) In JAR cells, inhibition of HSP90 also increased the levels of SERT, indicating that endogenously expressed transporter was also susceptible to control by HSP90 beta. These findings support the concept that the folding trajectory of SERT is sampled by a cytoplasmic chaperone relay.	[El-Kasaby, Ali; Koban, Florian; Sitte, Harald H.; Freissmuth, Michael; Sucic, Sonja] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [El-Kasaby, Ali] Mansoura Univ, Dept Pharmacol, Fac Vet Med, Mansoura 35516, Egypt	Medical University of Vienna; Egyptian Knowledge Bank (EKB); Mansoura University	Sucic, S (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringer Str 13A, A-1090 Vienna, Austria.	sonja.sucic@meduniwien.ac.at	Sitte, Harald/N-2681-2013; Sitte, Harald/O-7025-2019	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Koban, Florian/0000-0003-0912-3114; Sucic, Sonja/0000-0001-5136-8022; Freissmuth, Michael/0000-0001-9398-1765	Austrian Science Fund/Fonds zur Forderung der wissenschaftlichen Forschung Project Program Grant [SFB35]	Austrian Science Fund/Fonds zur Forderung der wissenschaftlichen Forschung Project Program Grant(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund/Fonds zur Forderung der wissenschaftlichen Forschung Project Program Grant SFB35 (to M. F.).	Azmanov DN, 2008, HUM MUTAT, V29, P1217, DOI 10.1002/humu.20777; Bergmayr C, 2013, J BIOL CHEM, V288, P28831, DOI 10.1074/jbc.M113.464776; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Carta E, 2012, J BIOL CHEM, V287, P28975, DOI 10.1074/jbc.M112.372094; Chanoux RA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00137; Chanrion B, 2007, P NATL ACAD SCI USA, V104, P8119, DOI 10.1073/pnas.0610964104; Chiba P, 2014, PHARMACOL RES, V83, P63, DOI 10.1016/j.phrs.2013.11.009; Coppinger JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037682; Donnelly BF, 2013, J BIOL CHEM, V288, P13124, DOI 10.1074/jbc.M113.455394; El-Kasaby A, 2010, J BIOL CHEM, V285, P39201, DOI 10.1074/jbc.M110.118000; Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Fujiwara M, 2013, J PHARMACOL SCI, V122, P71, DOI 10.1254/jphs.12194FP; Gimenez C, 2012, J BIOL CHEM, V287, P28986, DOI 10.1074/jbc.M111.319244; Hahn MK, 2003, J NEUROSCI, V23, P4470; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hohenegger M, 1996, MOL PHARMACOL, V49, P73; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; Keuerleber S, 2011, BBA-BIOMEMBRANES, V1808, P1350, DOI 10.1016/j.bbamem.2010.05.009; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Korkhov VM, 2008, J MOL BIOL, V378, P337, DOI 10.1016/j.jmb.2008.02.056; Kurian MA, 2011, LANCET NEUROL, V10, P54, DOI 10.1016/S1474-4422(10)70269-6; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Larsen MB, 2006, BIOCHEMISTRY-US, V45, P1331, DOI 10.1021/bi0508688; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Lee K, 2012, FEBS LETT, V586, P2535, DOI 10.1016/j.febslet.2012.06.023; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Ng DP, 2012, BBA-BIOMEMBRANES, V1818, P1115, DOI 10.1016/j.bbamem.2011.07.046; Ng J, 2014, BRAIN, V137, P1107, DOI 10.1093/brain/awu022; Onuoha SC, 2007, J MOL BIOL, V372, P287, DOI 10.1016/j.jmb.2007.06.065; Pae CU, 2007, PROG NEURO-PSYCHOPH, V31, P1006, DOI 10.1016/j.pnpbp.2007.02.011; Rahbek-Clemmensen T, 2014, J BIOL CHEM, V289, P23004, DOI 10.1074/jbc.M113.495754; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Sanders CR, 2004, ANNU REV BIOPH BIOM, V33, P25, DOI 10.1146/annurev.biophys.33.110502.140348; Schlecht R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078443; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Seimandi M, 2013, J NEUROSCI, V33, P16189, DOI 10.1523/JNEUROSCI.0076-13.2013; Seow HF, 2004, NAT GENET, V36, P1003, DOI 10.1038/ng1406; Sucic S, 2013, J BIOL CHEM, V288, P5330, DOI 10.1074/jbc.M112.408237; Sucic S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230037; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Van Durme J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000475; Zhong HL, 2012, BIOCHEM PHARMACOL, V83, P435, DOI 10.1016/j.bcp.2011.09.020; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	49	30	30	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2014	289	42					28987	29000		10.1074/jbc.M114.595090	http://dx.doi.org/10.1074/jbc.M114.595090			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS2XZ	25202009	Green Published, hybrid			2022-12-28	WOS:000344141000019
J	Tripsianes, K; Friberg, A; Barrandon, C; Brooks, M; van Tilbeurgh, H; Seraphin, B; Sattler, M				Tripsianes, Konstantinos; Friberg, Anders; Barrandon, Charlotte; Brooks, Mark; van Tilbeurgh, Herman; Seraphin, Bertrand; Sattler, Michael			A Novel Protein-Protein Interaction in the RES (REtention and Splicing) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA RETENTION; RECOGNITION MOTIF; NMR; YEAST; CRYSTALLOGRAPHY; SPLICEOSOME; SYSTEM; DOMAIN; CORE	The retention and splicing (RES) complex is a conserved spliceosome-associated module that was shown to enhance splicing of a subset of transcripts and promote the nuclear retention of unspliced pre-mRNAs in yeast. The heterotrimeric RES complex is organized around the Snu17p protein that binds to both the Bud13p and Pml1p subunits. Snu17p exhibits an RRM domain that resembles a U2AF homology motif (UHM) and Bud13p harbors a Trp residue reminiscent of an UHM-ligand motif (ULM). It has therefore been proposed that the interaction between Snu17p and Bud13p resembles canonical UHM-ULM complexes. Here, we have used biochemical and NMR structural analysis to characterize the structure of the yeast Snu17p-Bud13p complex. Unlike known UHMs that sequester the Trp residue of the ULM ligand in a hydrophobic pocket, Snu17p and Bud13p utilize a large interaction surface formed around the two helices of the Snu17p domain. In total 18 residues of the Bud13p ligand wrap around the Snu17p helical surface in an U-turn-like arrangement. The invariant Trp232 in Bud13p is located in the center of the turn, and contacts surface residues of Snu17p. The structural data are supported by mutational analysis and indicate that Snu17p provides an extended binding surface with Bud13p that is notably distinct from canonical UHM-ULM interactions. Our data highlight structural diversity in RRM-protein interactions, analogous to the one seen for nucleic acid interactions.	[Tripsianes, Konstantinos] Masaryk Univ, Cent European Inst Technol CEITEC, Brno 62500, Czech Republic; [Friberg, Anders; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany; [Friberg, Anders; Sattler, Michael] Tech Univ Munich, Ctr Integrated Prot Sci Munich, D-85747 Garching, Germany; [Friberg, Anders; Sattler, Michael] Tech Univ Munich, Chair Biomol NMR, D-85747 Garching, Germany; [Barrandon, Charlotte; Seraphin, Bertrand] CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; [Brooks, Mark; van Tilbeurgh, Herman] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, UMR8619, F-91405 Orsay, France; [Seraphin, Bertrand] Univ Strasbourg, CNRS, UMR 7104, Equipe Labellisee La Ligue,IGBMC,INSERM,U964, F-67404 Illkirch Graffenstaden, France	Masaryk University Brno; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Tripsianes, K (corresponding author), Masaryk Univ, Cent European Inst Technol, Kamenice 5, Brno 62500, Czech Republic.	kostas.tripsianes@ceitec.muni.cz; sattler@helmholtz-muenchen.de	Tripsianes, Konstantinos/I-8382-2014; Sattler, Michael/A-2407-2012	Tripsianes, Konstantinos/0000-0003-0948-813X; Sattler, Michael/0000-0002-1594-0527; Seraphin, Bertrand/0000-0002-5168-1921; Brooks, Mark/0000-0003-2614-6115; Friberg, Anders/0000-0002-3912-8162	European Social Fund; state budget of the Czech Republic [CZ.1.07/2.3.00/20.0042]; Centre National pour la Recherche Scientifique; European Union [LSHG-CT-2005-512028, LSHG-CT-2005-518238]; Ligue Contre le Cancer (Equipe Labellisee); CERBM-IGBMC; Deutsche Forschungsgemeinschaft [SFB1035]; Elitenetzwerk Bayern;  [ANR-10-LABX-0030-INRT];  [ANR-10-IDEX-0002-02]	European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; Centre National pour la Recherche Scientifique; European Union(European Commission); Ligue Contre le Cancer (Equipe Labellisee); CERBM-IGBMC; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Elitenetzwerk Bayern; ; 	This work was supported, in whole or in part, by the European Social Fund and state budget of the Czech Republic Grant CZ.1.07/2.3.00/20.0042 (to K. T.), the Centre National pour la Recherche Scientifique (to B. S.), Grant ANR-10-LABX-0030-INRT managed under the program Investissements d'Avenir ANR-10-IDEX-0002-02 (to B. S.), the European Union Sixth Framework program "3D-Repertoire" Grant LSHG-CT-2005-512028 (to B. S. and M. S.) and EURASNET Grant LSHG-CT-2005-518238 (to B. S.), Ligue Contre le Cancer (Equipe Labellisee 2014) (to B. S.), the CERBM-IGBMC (to B. S.), and Deutsche Forschungsgemeinschaft Grant SFB1035 (to M. S.).; Supported by Elitenetzwerk Bayern. Present address: Bayer HealthCare Pharmaceuticals, Lead Discovery, Mullerstr. 178, 13353 Berlin, Germany.	Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Brooks MA, 2009, NUCLEIC ACIDS RES, V37, P129, DOI 10.1093/nar/gkn894; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Collinet B, 2011, J STRUCT BIOL, V175, P147, DOI 10.1016/j.jsb.2011.03.018; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P620, DOI 10.1038/nsmb1260; Corsini L, 2009, J BIOL CHEM, V284, P630, DOI 10.1074/jbc.M805395200; Daubner GM, 2013, CURR OPIN STRUC BIOL, V23, P100, DOI 10.1016/j.sbi.2012.11.006; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dreumont N, 2013, FEBS J, V280, P2712, DOI 10.1111/febs.12277; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; ElAntak L, 2010, J MOL BIOL, V396, P1097, DOI 10.1016/j.jmb.2009.12.047; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Hausmann S, 2008, J BIOL CHEM, V283, P31706, DOI 10.1074/jbc.M806127200; Joshi A, 2011, STRUCTURE, V19, P1816, DOI 10.1016/j.str.2011.09.020; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Loerch S, 2014, J BIOL CHEM, V289, P17325, DOI 10.1074/jbc.M114.558825; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Rideau AP, 2006, NAT STRUCT MOL BIOL, V13, P839, DOI 10.1038/nsmb1137; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scherrer FW, 2006, RNA, V12, P1361, DOI 10.1261/rna.2276806; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Trowitzsch S, 2008, J BIOL CHEM, V283, P32317, DOI 10.1074/jbc.M804977200; Trowitzsch S, 2009, J MOL BIOL, V385, P531, DOI 10.1016/j.jmb.2008.10.087; Tunnicliffe RB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003907; Tunnicliffe RB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001244; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2	35	16	16	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28640	28650		10.1074/jbc.M114.592311	http://dx.doi.org/10.1074/jbc.M114.592311			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25160624	Green Published, hybrid			2022-12-28	WOS:000343765400052
J	Ishii, H; Saitoh, M; Sakamoto, K; Kondo, T; Katoh, R; Tanaka, S; Motizuki, M; Masuyama, K; Miyazawa, K				Ishii, Hiroki; Saitoh, Masao; Sakamoto, Kei; Kondo, Tetsuo; Katoh, Ryohei; Tanaka, Shota; Motizuki, Mitsuyoshi; Masuyama, Keisuke; Miyazawa, Keiji			Epithelial Splicing Regulatory Proteins 1 (ESRP1) and 2 (ESRP2) Suppress Cancer Cell Motility via Different Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Cell Invasion; Cell Motility; Epithelial-Mesenchymal Transition (EMT); RNA Splicing; ESRP; Rac1b; SIP1; EF1	MESENCHYMAL TRANSITION; MESSENGER-RNA; E-CADHERIN; RAC1B; EXPRESSION; ISOFORM; SIP1; BETA; EMT; PROGRESSION	Background: The roles of ESRP1 and ESRP2 during carcinogenesis remain unknown. Results: ESRPs are up-regulated during carcinogenesis but down-regulated in invasive fronts. ESRP1 suppresses expression of the Rac1b isoform, whereas ESRP2 represses epithelial-mesenchymal transition-inducing transcription factors. Conclusion: ESRP1 and ESRP2 suppress cell motility through distinct transcriptional and/or post-transcriptional mechanisms. Significance: Our findings reveal a novel molecular network that regulates cancer cell motility. ESRP1 (epithelial splicing regulatory protein 1) and ESRP2 regulate alternative splicing events associated with epithelial phenotypes of cells, and both are down-regulated during the epithelial-mesenchymal transition. However, little is known about their expression and functions during carcinogenesis. In this study, we found that expression of both ESRP1 and ESRP2 is plastic: during oral squamous cell carcinogenesis, these proteins are up-regulated relative to their levels in normal epithelium but down-regulated in invasive fronts. Importantly, ESRP1 and ESRP2 are re-expressed in the lymph nodes, where carcinoma cells metastasize and colonize. In head and neck carcinoma cell lines, ESRP1 and ESRP2 suppress cancer cell motility through distinct mechanisms: knockdown of ESRP1 affects the dynamics of the actin cytoskeleton through induction of Rac1b, whereas knockdown of ESRP2 attenuates cell-cell adhesion through increased expression of epithelial-mesenchymal transition-associated transcription factors. Down-regulation of ESRP1 and ESRP2 is thus closely associated with a motile phenotype of cancer cells.	[Ishii, Hiroki; Saitoh, Masao; Motizuki, Mitsuyoshi; Miyazawa, Keiji] Univ Yamanashi, Dept Biochem, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4093898, Japan; [Ishii, Hiroki; Tanaka, Shota; Masuyama, Keisuke] Univ Yamanashi, Dept Otolaryngol Head & Neck Surg, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4093898, Japan; [Kondo, Tetsuo; Katoh, Ryohei] Univ Yamanashi, Dept Human Pathol, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4093898, Japan; [Sakamoto, Kei] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Oral Pathol, Bunkyo Ku, Tokyo 1130034, Japan	University of Yamanashi; University of Yamanashi; University of Yamanashi; Tokyo Medical & Dental University (TMDU)	Miyazawa, K (corresponding author), Univ Yamanashi, Dept Biochem, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4093898, Japan.	kmiyazawa@yamanashi.ac.jp			Vehicle Racing Commemorative Foundation; Japan Society for the Promotion of Science (JSPS) KAKENHI [24791764, 24592592]; Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) of the Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS; Grants-in-Aid for Scientific Research [24592592, 25293087] Funding Source: KAKEN	Vehicle Racing Commemorative Foundation; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) of the Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Vehicle Racing Commemorative Foundation; Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 24791764 and 24592592; the research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) of the Ministry of Education, Culture, Sports, Science and Technology of Japan; and the JSPS Core-to-Core Program Cooperative International Framework in TGF-beta Family Signaling.	Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Chikamatsu K, 2008, ORAL ONCOL, V44, P870, DOI 10.1016/j.oraloncology.2007.11.001; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Di Modugno F, 2012, P NATL ACAD SCI USA, V109, P19280, DOI 10.1073/pnas.1214394109; Fagoonee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072300; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; Gemmill RM, 2011, CANCER LETT, V300, P66, DOI 10.1016/j.canlet.2010.09.007; Goncalves V, 2009, HUM MOL GENET, V18, P3696, DOI 10.1093/hmg/ddp317; Gout S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046539; Hahn S, 2013, EMBO J, V32, P3079, DOI 10.1038/emboj.2013.236; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Ikushima H, 2008, EMBO J, V27, P2955, DOI 10.1038/emboj.2008.218; Ishii H, 2010, ORAL ONCOL, V46, P373, DOI 10.1016/j.oraloncology.2010.02.014; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Leontieva OV, 2009, CELL CYCLE, V8, P490, DOI 10.4161/cc.8.3.7679; Lu HZ, 2013, DEV CELL, V27, P560, DOI 10.1016/j.devcel.2013.10.020; Maeda G, 2005, INT J ONCOL, V27, P1535; Melamed Z, 2013, MOL CELL, V50, P869, DOI 10.1016/j.molcel.2013.05.007; Motizuki M, 2013, J BIOL CHEM, V288, P18911, DOI 10.1074/jbc.M113.480996; Okugawa Y, 2013, CLIN EXP METASTAS, V30, P417, DOI 10.1007/s10585-012-9547-4; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Reinke LM, 2012, J BIOL CHEM, V287, P36435, DOI 10.1074/jbc.M112.397125; Revil T, 2013, DEV DYNAM, V242, P281, DOI 10.1002/dvdy.23918; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Shirakihara T, 2013, CANCER SCI, V104, P1189, DOI 10.1111/cas.12220; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Ueda J, 2014, ONCOGENE, V33, P4485, DOI 10.1038/onc.2013.392; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Warzecha CC, 2012, SEMIN CANCER BIOL, V22, P417, DOI 10.1016/j.semcancer.2012.04.003; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, RNA BIOL, V6, P546, DOI 10.4161/rna.6.5.9606; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Wu H, 2010, MOL CELL, V38, P67, DOI 10.1016/j.molcel.2010.02.021; Xiang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050781; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	44	106	110	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27386	27399		10.1074/jbc.M114.589432	http://dx.doi.org/10.1074/jbc.M114.589432			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25143390	Green Published, hybrid			2022-12-28	WOS:000342852800003
J	Sergeeva, OA; Tran, MT; Haase-Pettingell, C; King, JA				Sergeeva, Oksana A.; Tran, Meme T.; Haase-Pettingell, Cameron; King, Jonathan A.			Biochemical Characterization of Mutants in Chaperonin Proteins CCT4 and CCT5 Associated with Hereditary Sensory Neuropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Crystallin; Molecular Chaperone; Protein Folding; Protein Stability; CCT; TRiC; Chaperonin; Complex Assembly; Neuropathy	GAMMA-D-CRYSTALLIN; SPASTIC PARAPLEGIA SPG13; HUNTINGTONS-DISEASE; IN-VITRO; MOLECULAR CHAPERONES; SUBUNIT; MUTATION; AGGREGATION; GENE; FLUORESCENCE	Background: Point mutations in two genes encoding chaperonin subunits have been implicated in neuropathies. Results: CCT4 and CCT5 proteins carrying these mutations were expressed in bacteria and investigated for their biochemical defects. Conclusion: H147R CCT5 is faulty in chaperoning function, whereas C450Y CCT4 may be defective in protein stability. Significance: These biochemical defects may be the source of these neuropathies in patients. Hereditary sensory neuropathies are a class of disorders marked by degeneration of the nerve fibers in the sensory periphery neurons. Recently, two mutations were identified in the subunits of the eukaryotic cytosolic chaperonin TRiC, a protein machine responsible for folding actin and tubulin in the cell. C450Y CCT4 was identified in a stock of Sprague-Dawley rats, whereas H147R CCT5 was found in a human Moroccan family. As with many genetically identified mutations associated with neuropathies, the underlying molecular basis of the mutants was not defined. We investigated the biochemical properties of these mutants using an expression system in Escherichia coli that produces homo-oligomeric rings of CCT4 and CCT5. Full-length versions of both mutant protein chains were expressed in E. coli at levels approaching that of the WT chains. Sucrose gradient centrifugation revealed chaperonin-sized complexes of both WT and mutant chaperonins, but with reduced recovery of C450Y CCT4 soluble subunits. Electron microscopy of negatively stained samples of C450Y CCT4 revealed few ring-shaped species, whereas WT CCT4, H147R CCT5, and WT CCT5 revealed similar ring structures. CCT5 complexes were assayed for their ability to suppress aggregation of and refold the model substrate d-crystallin, suppress aggregation of mutant huntingtin, and refold the physiological substrate -actin in vitro. H147R CCT5 was not as efficient in chaperoning these substrates as WT CCT5. The subtle effects of these mutations are consistent with the homozygous disease phenotype, in which most functions are carried out during development and adulthood, but some selective function is lost or reduced.	[Sergeeva, Oksana A.; Tran, Meme T.; Haase-Pettingell, Cameron; King, Jonathan A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	King, JA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave,68-330, Cambridge, MA 02139 USA.	jaking@mit.edu		Sergeeva, Oksana/0000-0002-4830-0518	National Science Foundation [NSF-007031]; NATIONAL EYE INSTITUTE [R01EY015834, PN2EY016525] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Dr. Chengbiao Wu for helpful discussions, Koning Shen and Dr. Judith Frydman for the mHtt plasmid, and Drs. Emily Sontag and Leslie Thompson for mHtt protocol suggestions. We thank the Biophysical Instrumentation Facility for the Study of Complex Macromolecular Systems (supported by National Science Foundation Grant NSF-007031).	Abe Y, 2009, J BIOL CHEM, V284, P14939, DOI 10.1074/jbc.M900097200; Acosta-Sampson L, 2010, J MOL BIOL, V401, P134, DOI 10.1016/j.jmb.2010.05.067; Arrasate M, 2012, EXP NEUROL, V238, P1, DOI 10.1016/j.expneurol.2011.12.013; Auer-Grumbach M, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-7; Bates GP, 2005, NAT REV GENET, V6, P766, DOI 10.1038/nrg1686; Bouhouche A, 2006, J MED GENET, V43, P441, DOI 10.1136/jmg.2005.039230; Bross P, 2008, J BIOL CHEM, V283, P15694, DOI 10.1074/jbc.M800548200; CAVANAGH NPC, 1979, BRAIN, V102, P79, DOI 10.1093/brain/102.1.79; Chen JJ, 2006, BIOCHEMISTRY-US, V45, P11552, DOI 10.1021/bi060988v; Clabough Erin B. D., 2013, Yale Journal of Biology and Medicine, V86, P217; Flaugh SL, 2006, J BIOL CHEM, V281, P30782, DOI 10.1074/jbc.M603882200; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Hagiwara Hiroki, 2004, Breast Cancer, V11, P82, DOI 10.1007/BF02968008; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Knee KM, 2013, CELL STRESS CHAPERON, V18, P137, DOI 10.1007/s12192-012-0357-z; Knee KM, 2011, PROTEIN SCI, V20, P30, DOI 10.1002/pro.531; Kong FR, 2011, PROTEIN SCI, V20, P513, DOI 10.1002/pro.583; Kosinski-Collins MS, 2004, PROTEIN SCI, V13, P2223, DOI 10.1110/ps.04627004; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Lee MJ, 2003, HUM MOL GENET, V12, P1917, DOI 10.1093/hmg/ddg198; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; Lundin VF, 2010, TRENDS BIOCHEM SCI, V35, P288, DOI 10.1016/j.tibs.2009.12.007; Machida K, 2012, PROTEIN EXPRES PURIF, V82, P61, DOI 10.1016/j.pep.2011.11.010; Moreau KL, 2009, J BIOL CHEM, V284, P33285, DOI 10.1074/jbc.M109.031344; Pappenberger G, 2006, J MOL BIOL, V360, P484, DOI 10.1016/j.jmb.2006.05.003; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Rotthier A, 2009, BRAIN, V132, P2699, DOI 10.1093/brain/awp198; Sergeeva OA, 2014, PROTEIN SCI, V23, P693, DOI 10.1002/pro.2452; Sergeeva OA, 2013, J BIOL CHEM, V288, P17734, DOI 10.1074/jbc.M112.443929; Shahmoradian SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00710; Sontag EM, 2013, P NATL ACAD SCI USA, V110, P3077, DOI 10.1073/pnas.1222663110; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; THOMAS PK, 1994, BRAIN, V117, P651, DOI 10.1093/brain/117.4.651; Timmerman V, 2013, EXP NEUROL, V246, P14, DOI 10.1016/j.expneurol.2012.01.010; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030	40	18	18	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27470	27480		10.1074/jbc.M114.576033	http://dx.doi.org/10.1074/jbc.M114.576033			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25124038	Green Published, hybrid			2022-12-28	WOS:000342852800010
